1188130;Humans;Radiography/methods*;Stomach/diagnostic imaging*;Stomach Diseases/diagnostic imaging
1192292;Animals;Epithelial Cells;Epithelium/ultrastructure;Fishes/anatomy & histology*;Gills/ultrastructure
1230106;Alkaline Phosphatase/blood;Alkaline Phosphatase/metabolism*;Animals;Bile/enzymology;Bone and Bones/enzymology;Cattle;Enzyme Inhibitors;Hot Temperature;Intestine, Small/enzymology;Kidney/enzymology;Liver/enzymology;Magnesium/pharmacology;Phenylalanine/pharmacology
1267952;Biliary Fistula/etiology*;Biliary Fistula/surgery;Cholelithiasis/complications*;Cholelithiasis/surgery;Colonic Diseases/etiology*;Colonic Diseases/surgery;Common Bile Duct*/surgery;Duodenal Diseases/etiology*;Duodenal Diseases/surgery;Female;Humans;Intestinal Fistula/etiology*;Intestinal Fistula/surgery;Male;Middle Aged
1303387;Adaptation, Physiological*;Adult;Body Temperature Regulation/physiology;Cardiovascular Physiological Phenomena;Desert Climate;Hot Temperature*;Humans;Kazakhstan;Male;Metallurgy*;Respiratory Physiological Phenomena;Task Performance and Analysis;Temperature;Time Factors
1307635;Adult;Benzoates*/pharmacokinetics;Benzoic Acid;Female;Humans;Liver Cirrhosis/metabolism*;Male;Metabolic Clearance Rate
1307788;Animals;Environmental Monitoring*;Environmental Pollution/prevention & control*;Germany;Humans
1320622;Animals;Anti-Bacterial Agents/administration & dosage*;Biological Assay;Cefoperazone/administration & dosage;Cephalosporins/administration & dosage;Ceramics;Drug Carriers;Durapatite;Gentamicins/administration & dosage;Hydroxyapatites*;In Vitro Techniques;Microbiological Techniques;Osteomyelitis/drug therapy;Rats;Rats, Inbred Strains
1322203;Acquired Immunodeficiency Syndrome/complications;Antigens, Surface/analysis;B-Lymphocytes/immunology;Blotting, Southern;Burkitt Lymphoma/etiology;Burkitt Lymphoma/genetics;Burkitt Lymphoma/immunology;Carcinogens/pharmacology;Cell Line;DNA, Neoplasm/genetics*;DNA, Neoplasm/isolation & purification;Enzyme Activation;Flow Cytometry;Gene Expression/drug effects;Gene Expression Regulation, Neoplastic/drug effects;Gene Rearrangement;Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;Genes, Immunoglobulin;Humans;Immunoglobulin Heavy Chains/genetics;Indoles/pharmacology;Interferon-gamma/genetics*;Interleukin-1/pharmacology;Interleukin-2/pharmacology*;Interleukin-4/pharmacology;Interleukin-6/pharmacology;Lactams/pharmacology;Methylation;Protein Kinase C/metabolism*;Recombinant Proteins/pharmacology;Tetradecanoylphorbol Acetate/pharmacology
1364399;Azo Compounds/isolation & purification;Azo Compounds/standards*;Chromatography, High Pressure Liquid;Food Coloring Agents/isolation & purification;Food Coloring Agents/standards*;Government Agencies*;Hygiene;Japan;Spectrophotometry, Infrared
1371240;Amino Acid Sequence;Animals;Antibodies, Monoclonal/immunology;Binding Sites, Antibody/analysis*;Cell Division;Epitopes/analysis*;Eye Proteins*;Histocompatibility Antigens Class II/immunology;Immunization;Lymphocyte Activation/immunology;Male;Molecular Sequence Data;Peptides/administration & dosage*;Peptides/pharmacology;Rats;Retinol-Binding Proteins/administration & dosage;Retinol-Binding Proteins/analysis*;Retinol-Binding Proteins/immunology;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;Tryptophan
1393201;Computer Graphics;Computer Systems*;Data Display*;Monitoring, Physiologic/instrumentation;Monitoring, Physiologic/methods;Respiration/physiology*;Respiration, Artificial*
1410821;Animals;Hot Temperature;Listeria monocytogenes/classification*;Listeria monocytogenes/isolation & purification;Listeriosis/microbiology;Listeriosis/veterinary*;Mass Spectrometry/methods*;Sheep;Sheep Diseases/microbiology*
1421050;Adolescent;Adult;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/pharmacokinetics*;Carbamazepine/therapeutic use;Child;Delayed-Action Preparations;Drug Administration Schedule;Epilepsy/drug therapy*;Epilepsy/metabolism;Female;Humans;Male;Middle Aged
1437042;Adult;Aged;Basement Membrane/pathology;Blister/pathology;Candy;Chewing Gum;Cinnamomum zeylanicum/adverse effects*;Female;Humans;Hypersensitivity/etiology*;Hypersensitivity/pathology;Keratosis;Lymphocytes/pathology;Male;Middle Aged;Mouth Mucosa/pathology;Plasma Cells/pathology;Stomatitis/etiology*;Stomatitis/pathology;Ulcer/pathology
1445325;Amino Acid Sequence;Base Sequence;Cloning, Molecular;DNA Probes;Escherichia coli/genetics*;Gene Expression;Genes, Bacterial*;Lyases/genetics*;Lyases/isolation & purification;Lyases/metabolism;Molecular Sequence Data;Oligonucleotide Probes;Plasmids;Pseudomonas/enzymology*;Pseudomonas/genetics*;Recombinant Proteins/isolation & purification;Recombinant Proteins/metabolism;Restriction Mapping
1476918;Adult;Female;Humans;Immunoenzyme Techniques;Interleukin-1/analysis*;Male;Middle Aged;Sebaceous Glands/chemistry*;Tissue Fixation/methods
1484835;Aging/psychology*;Animals;Cognition/physiology*;Environment;Exploratory Behavior/physiology*;Habituation, Psychophysiologic;Male;Motor Activity/physiology;Rats;Rats, Wistar
1539753;Aedes/parasitology;Animals;Brugia/drug effects*;Gerbillinae/parasitology;Ivermectin/pharmacology*;Male;Microfilariae/drug effects*;Microfilariae/physiology
1542194;Aged;Anastomosis, Surgical;Esophageal Stenosis/etiology;Esophageal Stenosis/surgery*;Esophageal and Gastric Varices/surgery*;Esophagitis/etiology;Esophagus/surgery*;Female;Gastrectomy/adverse effects*;Gastrectomy/methods;Gastroesophageal Reflux/etiology;Humans;Reoperation
1547638;Colectomy;Colitis, Ulcerative/pathology*;Colitis, Ulcerative/surgery;Crohn Disease/pathology*;Crohn Disease/surgery;Diagnosis, Differential;Humans;Intestinal Mucosa/pathology
1547697;Diabetes Mellitus*;Humans
1548521;Adult;Aged;Bone Neoplasms/radiotherapy*;Female;Humans;Male;Middle Aged;Multiple Myeloma/radiotherapy;Plasmacytoma/radiotherapy*;Survival Analysis
1565369;Adult;Electrocardiography;Female;Heart Block/diagnosis;Heart Block/etiology;Heart Block/therapy*;Humans;Infant, Newborn;Pacemaker, Artificial;Pregnancy;Pregnancy Complications, Cardiovascular/diagnosis;Pregnancy Complications, Cardiovascular/therapy*
1579697;Adolescent;Adult;Axillary Vein*/diagnostic imaging;Humans;Male;Physical Exertion*;Radiography;Subclavian Vein*/diagnostic imaging;Thrombolytic Therapy;Thrombosis/diagnosis*;Thrombosis/drug therapy;Time Factors;Ultrasonography
1623435;Canada;Delivery of Health Care;Health Services/legislation & jurisprudence*;Humans;Operating Room Nursing*;Societies, Nursing
1639623;Hospitals, Community;Humans;Maintenance and Engineering, Hospital/economics;Maintenance and Engineering, Hospital/organization & administration*;Program Development*;Radiography/economics;Radiography/instrumentation*
1671744;Animals;Brain/metabolism;Brain/physiopathology;Humans;Magnetic Resonance Imaging;Nervous System/growth & development;Nervous System/physiopathology;Schizophrenia/diagnosis*;Schizophrenia/etiology;Schizophrenia/physiopathology;Tomography, Emission-Computed;Tomography, Emission-Computed, Single-Photon
1684221;Animals;Bacterial Proteins/genetics;Chaperonins;Cytoplasm/metabolism;Heat-Shock Proteins/genetics*;Intracellular Signaling Peptides and Proteins*;Macromolecular Substances;Mice;Microtubule-Associated Proteins*;Nuclear Proteins/genetics;Protein Conformation;Proteins/genetics*;Sequence Homology, Nucleic Acid*;Sulfolobus/genetics*;Temperature;t-Complex Genome Region
1686004;Adrenergic alpha-Antagonists/therapeutic use;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Calcium Channel Blockers/therapeutic use*;Hemodynamics;Humans;Hypertension, Portal/drug therapy*;Hypertension, Portal/etiology;Hypertension, Portal/physiopathology;Liver Cirrhosis/complications*;Nitro Compounds/therapeutic use*;Serotonin Antagonists/therapeutic use*;Verapamil/therapeutic use
1703625;Autoantibodies/analysis;Cell Adhesion Molecules, Neuronal/analysis*;Cell Adhesion Molecules, Neuronal/immunology;Humans;Immunohistochemistry;Neoplasm Invasiveness;Neoplasm Recurrence, Local/pathology*;Rectal Neoplasms/pathology*;Staining and Labeling
1704453;Adult;Aged;Aged, 80 and over;Anemia, Aplastic/physiopathology;Humans;Leukemia/physiopathology*;Middle Aged;Thyroid Gland/physiopathology*
1796730;Brain/metabolism*;Catheterization, Peripheral;Humans;Intraoperative Period;Jugular Veins;Neurosurgery;Oxygen/blood*;Oxygen Consumption*;Spectrophotometry/methods
1820624;Animals;Biomphalaria/physiology*;Brazil/epidemiology;Disease Vectors;Ecology;Host-Parasite Interactions;Humans;Schistosomiasis mansoni/epidemiology*;Socioeconomic Factors
1838664;Adolescent;Adult;Diagnosis, Differential;False Negative Reactions;Female;Humans;Infertility, Female/diagnosis;Infertility, Female/diagnostic imaging;Infertility, Female/etiology;Infertility, Female/pathology;Laparoscopy*;Middle Aged;Oophoritis/diagnosis;Oophoritis/diagnostic imaging;Oophoritis/pathology;Ovarian Cysts/complications;Ovarian Cysts/diagnosis*;Ovarian Cysts/diagnostic imaging;Ovarian Cysts/pathology;Ultrasonography
1845250;Basement Membrane/metabolism;Humans;Hypertension, Portal/blood;Hypertension, Portal/etiology;Hypertension, Portal/physiopathology*;Laminin/blood*;Liver Circulation;Liver Cirrhosis, Alcoholic/complications;Liver Cirrhosis, Alcoholic/metabolism;Liver Cirrhosis, Alcoholic/pathology;Liver Diseases, Parasitic/complications;Liver Diseases, Parasitic/metabolism;Liver Diseases, Parasitic/pathology;Radioimmunoassay;Schistosomiasis mansoni/complications;Schistosomiasis mansoni/metabolism;Schistosomiasis mansoni/pathology
1850505;Alanine/analogs & derivatives*;Animals;Brain;Chickens;Female;Ibotenic Acid/analogs & derivatives;Ibotenic Acid/pharmacology;Injections;Kainic Acid/analogs & derivatives;Membrane Potentials/drug effects;Neuromuscular Depolarizing Agents;Oocytes/metabolism*;Quisqualic Acid;RNA, Messenger/administration & dosage;RNA, Messenger/metabolism*;Receptors, Dopamine/drug effects*;Receptors, Kainic Acid;Receptors, N-Methyl-D-Aspartate/physiology;Receptors, Neurotransmitter/metabolism;Xenopus laevis/metabolism*;alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
1858390;Community Health Services/trends*;Global Health;Health Occupations/education;Health Promotion*;Health Services Accessibility;Humans;Patient Participation;Program Evaluation;World Health Organization*
1890662;Abscess/blood;Adult;Aged;Aged, 80 and over;Antibodies, Monoclonal;Candidiasis, Oral/blood;Carcinoma, Squamous Cell/blood;Child;Child, Preschool;Enzyme-Linked Immunosorbent Assay;Female;Granulocyte-Macrophage Colony-Stimulating Factor/blood*;Humans;Interleukin-3/analysis*;Interleukin-4/analysis*;Interleukin-6/analysis*;Lichen Planus/blood;Male;Middle Aged;Mouth Diseases/blood*;Mouth Neoplasms/blood*;Stomatitis, Aphthous/blood;Stomatitis, Herpetic/blood;Tumor Necrosis Factor-alpha/analysis*
1893216;Animals;Cat Diseases/therapy*;Cats;Dog Diseases/therapy*;Dogs;Mouth Diseases/veterinary*;Tooth Diseases/veterinary*
1899697;Computer User Training/economics;Computer User Training/methods*;Computer User Training/standards;Cost-Benefit Analysis;Humans;Nursing Staff, Hospital/education*;Nursing Staff, Hospital/utilization;Patient Care Planning*;Professional Staff Committees/organization & administration
1964678;Antineoplastic Agents/adverse effects*;Double-Blind Method;Drugs, Investigational/administration & dosage*;Female;Granisetron;Humans;Indazoles/administration & dosage*;Male;Middle Aged;Nausea/chemically induced;Nausea/prevention & control*;Random Allocation;Serotonin Antagonists/administration & dosage*;Vomiting/chemically induced;Vomiting/prevention & control*
1972098;Adolescent;Adult;Douglas' Pouch/pathology;Fallopian Tubes/pathology;Female;Genital Diseases, Female/diagnosis*;Genital Diseases, Female/etiology;Genital Diseases, Female/pathology;Humans;Laparoscopy;Middle Aged;Ovary/pathology;Tuberculosis, Pulmonary/complications*;Uterus/pathology
1985349;Biomarkers, Tumor/analysis;Biomarkers, Tumor/genetics;Gene Amplification/genetics;Genes, myc*;Humans;Neoplasm Staging;Neuroblastoma/etiology;Neuroblastoma/genetics*;Neuroblastoma/pathology;Prognosis
1989090;Animals;Breath Tests;Child;Child, Institutionalized;Child, Preschool;Diet;Female;Humans;Hydrogen/analysis;Lactose/administration & dosage;Lactose Intolerance*/diagnosis;Male;Milk
2011143;Aryl Hydrocarbon Hydroxylases/metabolism;Arylamine N-Acetyltransferase/metabolism;Cytochrome P-450 Enzyme System/genetics;Disease Susceptibility;Environment*;Environmental Pollution/adverse effects;Glutathione Transferase/metabolism;Humans;Isoenzymes/genetics;Neoplasms/genetics*;Phenotype;Polymorphism, Genetic/genetics*;Smoking/adverse effects
2018685;Dentists*;England;Eye Infections/prevention & control;Eye Injuries/prevention & control;Eye Protective Devices*;Humans;Surveys and Questionnaires
2019471;Animals;Carbohydrate Sequence;Cell Line, Transformed;Genes, myc/physiology*;Glycosylation;Membrane Glycoproteins/biosynthesis;Membrane Glycoproteins/chemistry;Membrane Glycoproteins/genetics*;Molecular Sequence Data;Oligosaccharides/analysis;Rats;Transfection
2030012;Consultants/psychology;Drug Prescriptions/standards*;Humans;Mental Disorders/drug therapy*;Patient Care Team/standards*;Psychiatry/standards*;Psychotherapy*;Psychotropic Drugs/therapeutic use
2066449;Chewing Gum*;Dental Plaque/prevention & control*;Dental Plaque Index;Double-Blind Method;Evaluation Studies as Topic;Humans;Hydrogen Peroxide/therapeutic use*;Random Allocation;Sorbitol
2078652;Algorithms*;Blood Gas Analysis/instrumentation*;Body Temperature/physiology;Humans;Hydrogen-Ion Concentration;Mathematical Computing*
2089730;Cytokines/biosynthesis*;Cytokines/immunology;Cytokines/ultrastructure;Humans;Infection/immunology*;Interleukin-1/immunology;Interleukin-2/biosynthesis;T-Lymphocytes/metabolism;Tumor Necrosis Factor-alpha/metabolism
2137630;Animals;Brain/metabolism;Endorphins/metabolism*;Enkephalin, Leucine/metabolism;Enkephalin, Methionine/metabolism;Female;Morphine Dependence/metabolism*;Naloxone/pharmacology;Neurons/drug effects;Neurons/metabolism;Pregnancy;Rats;Stress, Physiological/metabolism*;Tissue Distribution;beta-Endorphin/metabolism
2141299;Adult;Amitriptyline/administration & dosage;Amitriptyline/adverse effects;Amitriptyline/analogs & derivatives*;Amitriptyline/therapeutic use;Back Pain/drug therapy*;Back Pain/physiopathology;Drug Therapy, Combination;Female;Humans;Male;Middle Aged;Naproxen/administration & dosage;Naproxen/adverse effects;Naproxen/therapeutic use*;Spasm/drug therapy*;Spasm/physiopathology
2150301;Acne Vulgaris/drug therapy;Acne Vulgaris/metabolism;Drug Synergism;Fatty Acids, Monounsaturated*;Free Radicals;Humans;Inflammation/drug therapy;Inflammation/metabolism;Metronidazole/pharmacology*;Metronidazole/therapeutic use;Neutrophils/drug effects*;Neutrophils/metabolism;Neutrophils/physiology;Oxygen/metabolism;Palmitic Acids/pharmacology*;Palmitic Acids/therapeutic use;Propionibacterium acnes/drug effects;Propionibacterium acnes/physiology;Rosacea/drug therapy;Rosacea/metabolism
2167629;DNA Restriction Enzymes/metabolism*;Humans;Japan;Salmonella/classification;Salmonella/enzymology*;Salmonella/isolation & purification;Salmonella Infections/microbiology;Serotyping;Time Factors
2177383;Acupuncture Analgesia*;Animals;Brain/metabolism*;Cyclic AMP/metabolism*;Electroacupuncture*;Injections, Intraventricular;Pain/physiopathology;Pituitary Gland/metabolism;Rats;Rats, Inbred Strains;Sensory Thresholds;Septal Nuclei/metabolism;Thyrotropin-Releasing Hormone/pharmacology*
2188552;Age Factors;Child;Child, Preschool;Diagnosis, Differential;Female;Humans;Male;Melanoma/classification;Melanoma/diagnosis*;Melanoma/therapy;Nevus/classification;Nevus/diagnosis*;Nevus/therapy;Skin Neoplasms/classification;Skin Neoplasms/diagnosis*;Skin Neoplasms/therapy;Skin Transplantation;Tissue Expansion
2193525;Acidosis/physiopathology;Animals;Hydrogen-Ion Concentration*;Mitochondria, Heart/metabolism;Myocardial Contraction*;Myocardium/metabolism;Sarcolemma/physiology;Sarcoplasmic Reticulum/physiology
2198246;Chromosomes, Bacterial;Gene Amplification;Gene Rearrangement*;Genes, Bacterial*;Streptomyces/genetics*
2213365;Carcinoma, Squamous Cell/pathology*;Female;Glottis*;Humans;Laryngeal Neoplasms/pathology*;Male;Multivariate Analysis;Prognosis
2243727;Adolescent;Adult;Antibodies, Monoclonal*;Female;Fluorescent Antibody Technique;Granuloma/etiology;Granuloma/immunology*;Granuloma/pathology;Humans;Leukocyte Count;Male;Middle Aged;T-Lymphocyte Subsets/immunology*;Tuberculosis, Lymph Node/complications;Tuberculosis, Lymph Node/immunology*
2247350;Adult;Aged;Angiocardiography*;Contrast Media*;Evaluation Studies as Topic;Female;Humans;Iopamidol*;Male;Middle Aged;Triiodobenzoic Acids*
2260590;Abnormalities, Multiple/genetics*;Chromosome Deletion*;Chromosomes, Human, Pair 14*;Humans;Infant, Newborn;Intellectual Disability/genetics;Karyotyping;Male;Phenotype;Syndrome
2267996;Aged;Bronchi/pathology;Granuloma/complications;Granuloma/pathology*;Humans;Immunoglobulin A/analysis*;Larynx/pathology;Male;Mucous Membrane/pathology;Paraproteinemias/complications*;Skin/pathology;Skin Diseases/complications;Skin Diseases/pathology;Trachea/pathology;Vocal Cords/pathology;Xanthomatosis/complications;Xanthomatosis/pathology*
2282213;Animals;Basement Membrane/metabolism;Basement Membrane/ultrastructure;Chinchilla;Connective Tissue/metabolism;Connective Tissue/ultrastructure;Ear, Middle/metabolism*;Histocytochemistry;Horseradish Peroxidase/pharmacokinetics*;Hydroxydopamines/pharmacokinetics;Intercellular Junctions/metabolism;Intercellular Junctions/ultrastructure;Microscopy, Electron;Mucous Membrane/metabolism;Mucous Membrane/ultrastructure;Otitis Media/metabolism*;Otitis Media/pathology;Otitis Media with Effusion/metabolism;Otitis Media with Effusion/pathology;Otitis Media, Suppurative/metabolism;Otitis Media, Suppurative/pathology;Permeability
2349132;Blotting, Southern/methods*;Humans;Hydrogen-Ion Concentration
2426867;Animals;Antibodies, Viral/immunology;Antigens, Viral*;Cloning, Molecular;DNA, Viral/analysis;Epitopes;Escherichia coli/genetics;Genes, Viral*;Glycoproteins/analysis;Glycoproteins/biosynthesis;Glycoproteins/genetics*;Glycoproteins/immunology;Herpesvirus 1, Suid/genetics*;Herpesvirus 1, Suid/metabolism;Protein Biosynthesis;Protein Precursors/analysis;Protein Precursors/genetics;Viral Proteins/analysis;Viral Proteins/biosynthesis;Viral Proteins/genetics*;Viral Proteins/immunology
2488173;Capsules;Erythromycin/analysis*;Luminescent Measurements;Tablets
2491347;Animals;Microscopy, Electron;Receptors, Nicotinic/ultrastructure*
2501551;Aged;Aged, 80 and over;Diverticulum/surgery*;Female;Follow-Up Studies;Humans;Male;Methods;Middle Aged;Urinary Bladder Diseases/surgery*
2519657;Animals;Lectins/physiology*;Male;Trypanosoma congolense/growth & development*;Tsetse Flies/parasitology*
2553305;Acid Anhydride Hydrolases*;Adenosine Triphosphatases/blood;Adult;Erythrocyte Membrane/enzymology;Erythrocytes/drug effects;Erythrocytes/enzymology*;Female;Glucosephosphate Dehydrogenase/metabolism;Hexokinase/metabolism;Humans;Hyperthyroidism/drug therapy;Hyperthyroidism/enzymology*;Male;Methimazole/pharmacology;Methimazole/therapeutic use;Middle Aged;Phosphoric Monoester Hydrolases/blood*;Thyrotropin/blood;Thyroxine/blood;Triiodothyronine/blood
2572541;Antigen-Presenting Cells/immunology*;B-Lymphocytes/immunology*;Biological Factors/physiology;CD4 Antigens/analysis;Cell Adhesion;Cell Adhesion Molecules/immunology;Clone Cells;Cytokines;HLA-D Antigens/immunology*;Humans;Intercellular Adhesion Molecule-1;Lymphocyte Activation*;Membrane Glycoproteins/immunology;Sialic Acids/physiology;T-Lymphocytes/immunology*
2585394;Adenocarcinoma/drug therapy;Adenocarcinoma/pathology*;Adenocarcinoma/surgery;Adult;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Cisplatin/administration & dosage;Doxorubicin/administration & dosage;Female;Fluorouracil/administration & dosage;Humans;Intestinal Neoplasms/drug therapy;Intestinal Neoplasms/pathology*;Intestinal Neoplasms/surgery;Ovarian Neoplasms/drug therapy;Ovarian Neoplasms/pathology;Ovarian Neoplasms/secondary*
2603986;Animals;Blood Pressure*;Capillary Permeability*;Cats;Hindlimb/blood supply;Models, Cardiovascular;Muscles/blood supply*;Perfusion;Regional Blood Flow;Vascular Resistance;Veins/physiology
2604945;Chemical Phenomena;Chemistry, Physical;Crystallization;Crystallography;Ferric Compounds*;Metalloporphyrins*;Molecular Structure
2613492;Euthanasia, Active;Female;Humans;Informed Consent/legislation & jurisprudence*;Intention;Liability, Legal;Life Support Care*;Male;Patient Advocacy/legislation & jurisprudence;Patient Compliance*;Personal Autonomy*;Quality of Life;Risk Assessment;United States;Withholding Treatment*
2645893;Acquired Immunodeficiency Syndrome/diagnosis;Acquired Immunodeficiency Syndrome/epidemiology*;Acquired Immunodeficiency Syndrome/therapy;Adolescent;Child;Child, Preschool;Humans;Infant
2675006;Administration, Intravesical;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/therapeutic use*;Clinical Trials as Topic;Humans;Instillation, Drug;Random Allocation;Urinary Bladder Neoplasms/drug therapy*
2681447;Humans;Lung Neoplasms/pathology;Lung Neoplasms/surgery*;Male;Middle Aged;Neurilemmoma/pathology;Neurilemmoma/surgery*;Pneumonectomy
2727832;Aged;Aged, 80 and over;Diagnosis, Differential;Female;Humans;Lung Neoplasms/diagnostic imaging*;Neoplasm Metastasis/diagnostic imaging;Pleural Effusion/diagnostic imaging*;Radiography
2742467;Adult;Aged;Aged, 80 and over;Cerebral Infarction/physiopathology;Cerebral Infarction/rehabilitation*;Evoked Potentials, Somatosensory*;Female;Humans;Male;Middle Aged;Prognosis
2762922;Adult;Aged;Angina Pectoris/therapy*;Autonomic Nerve Block*;Humans;Male;Middle Aged;Myocardial Infarction/therapy*;Pleura/innervation*;Procaine
2774735;Aged;Aged, 80 and over;Calcinosis/complications;Calcinosis/surgery*;Heart Valve Prosthesis*;Humans;Male;Methods;Middle Aged;Mitral Valve/surgery*;Mitral Valve Insufficiency/etiology;Mitral Valve Insufficiency/surgery
2835990;Adenosine Diphosphate/antagonists & inhibitors;Blood Platelets/enzymology*;Cyclic AMP/pharmacology*;Diglycerides/pharmacology;Epoprostenol/pharmacology;Humans;In Vitro Techniques;Phosphoproteins/blood;Platelet Aggregation/drug effects*;Prostaglandin-Endoperoxide Synthases/blood;Protein Kinase C/blood*;Tetradecanoylphorbol Acetate/pharmacology
2847621;Acrodermatitis/complications*;Biopsy;Chronic Disease;Electrophysiology;Humans;Immunoglobulin A/analysis;Immunoglobulin M/analysis;Lyme Disease/complications;Microscopy, Electron;Nerve Fibers, Myelinated/pathology;Nerve Fibers, Myelinated/ultrastructure;Pain;Paresthesia/complications;Peripheral Nervous System Diseases/complications*;Peripheral Nervous System Diseases/pathology;Peripheral Nervous System Diseases/physiopathology;Sural Nerve/analysis;Sural Nerve/pathology;Sural Nerve/ultrastructure
2848235;Adipose Tissue/analysis;Adipose Tissue/metabolism;Adolescent;Adrenal Cortex Neoplasms/metabolism;Adrenal Gland Neoplasms/metabolism;Adult;Biliary Tract Diseases/metabolism;Cushing Syndrome/metabolism*;Humans;Lipid Peroxidation*;Lipids/analysis;Liver/analysis;Liver/metabolism;Muscles/analysis;Muscles/metabolism;Neoplasms, Germ Cell and Embryonal/metabolism;Pheochromocytoma/metabolism;Recurrence;Remission Induction
2886178;Arthritis, Rheumatoid/drug therapy*;Arthritis, Rheumatoid/immunology;Humans;Intestines/immunology;Lymphocyte Activation;Lymphocytes/drug effects;Lymphocytes/immunology*;Salicylates/pharmacology;Salicylates/therapeutic use;Salicylic Acid;Sulfapyridine/pharmacology;Sulfapyridine/therapeutic use;Sulfasalazine/pharmacology;Sulfasalazine/therapeutic use*
2906011;Administration, Oral;Animals;Female;Gastric Acid/secretion;Gastrointestinal Motility/drug effects;Histamine H2 Antagonists/therapeutic use*;Omeprazole/therapeutic use*;Parasympatholytics/therapeutic use*;Rats;Rats, Inbred Strains;Stomach Ulcer/chemically induced;Stomach Ulcer/drug therapy*;Time Factors
2906645;Adult;Aminosalicylic Acids/adverse effects*;Colitis, Ulcerative/drug therapy*;Desensitization, Immunologic;Drug Hypersensitivity;Drug Tolerance;Humans;Male;Mesalamine;Middle Aged;Sulfapyridine/adverse effects;Sulfasalazine/adverse effects;Sulfasalazine/immunology
2909115;Contrast Media/adverse effects*;Humans;Osmolar Concentration
2909389;Animals;Cell Line;DNA, Neoplasm/analysis;Friend murine leukemia virus;Histones/analysis*;Leukemia, Erythroblastic, Acute/metabolism*;Leukemia, Erythroblastic, Acute/pathology;Mice;Mice, Inbred DBA;Neoplasm Transplantation;Nucleosomes/analysis*
2911616;Aging/physiology*;Animals;Body Weight;Female;Isometric Contraction;Muscles/anatomy & histology;Muscles/physiology*;Organ Size;Physical Conditioning, Animal*;Rats;Rats, Inbred Strains;Reference Values
2944951;Antibody Formation;Antigens, Differentiation, T-Lymphocyte;Antigens, Surface/analysis;B-Lymphocytes/immunology;Bone Marrow Transplantation*;Humans;Killer Cells, Natural/immunology;Leukocyte Count;Monocytes/immunology;Pokeweed Mitogens;T-Lymphocytes, Regulatory/classification;T-Lymphocytes, Regulatory/immunology*;T-Lymphocytes, Regulatory/ultrastructure;Time Factors
2952505;Abscess/diagnostic imaging*;Animals;Blood Coagulation/drug effects;Fibrinogen;Fibrinolysin*;Gallium Radioisotopes;Humans;Iodine Radioisotopes;Organometallic Compounds*;Organotechnetium Compounds*;Radionuclide Imaging;Rats;Serum Albumin, Radio-Iodinated;Technetium Tc 99m Aggregated Albumin
2983621;Carcinoma, Transitional Cell/pathology;Humans;Male;Middle Aged;Neoplasms, Multiple Primary/pathology*;Paget Disease, Extramammary/metabolism;Paget Disease, Extramammary/pathology*;Penile Neoplasms/metabolism;Penile Neoplasms/pathology*;Skin Neoplasms/pathology*;Urethral Neoplasms/pathology;Urinary Bladder Neoplasms/pathology
2985487;17-Hydroxysteroid Dehydrogenases/metabolism;17-alpha-Hydroxyprogesterone;Adolescent;Adult;Aldehyde-Lyases/metabolism;Androstenedione/blood;Gonadal Steroid Hormones/blood*;Humans;Hydroxyprogesterones/blood;Leydig Cells/metabolism;Male;Progesterone/blood;Steroid 17-alpha-Hydroxylase;Testis/blood supply;Testosterone/blood;Varicocele/blood*
2995212;Adult;Corpus Luteum/physiology*;Female;Humans;Kinetics;Luteinizing Hormone/metabolism*;Middle Aged;Ovary/physiology;Receptors, Cell Surface/drug effects;Receptors, Cell Surface/metabolism*;Receptors, LH;Tissue Extracts/pharmacology*
2995797;Adjuvants, Immunologic/therapeutic use;Adrenocorticotropic Hormone/therapeutic use;Anti-Inflammatory Agents/therapeutic use*;Antimalarials/therapeutic use;Arthritis, Juvenile/drug therapy*;Aspirin/therapeutic use;Child;Combined Modality Therapy;Dose-Response Relationship, Drug;Drug Therapy, Combination;Glucocorticoids/therapeutic use;Gold/therapeutic use;Humans;Immunosuppressive Agents/therapeutic use;Penicillamine/therapeutic use
2999779;Adenylyl Cyclases/genetics;Adenylyl Cyclases/metabolism*;Cell Cycle;Cyclic AMP/biosynthesis;Escherichia coli/enzymology;Escherichia coli/genetics;GTP-Binding Proteins/genetics*;GTP-Binding Proteins/metabolism;Gene Expression Regulation;Genes, Bacterial;Genes, Fungal;Genetic Complementation Test;Genetic Engineering;Mutation;Proto-Oncogene Proteins/genetics*;Proto-Oncogenes;Saccharomyces cerevisiae/enzymology;Saccharomyces cerevisiae/genetics;beta-Galactosidase/genetics
3023423;Adolescent;Adrenocorticotropic Hormone/blood;Adrenocorticotropic Hormone/secretion*;Adult;Corticotropin-Releasing Hormone/antagonists & inhibitors*;Cushing Syndrome/blood*;D-Ala(2),MePhe(4),Met(0)-ol-enkephalin/pharmacology*;Endorphins/blood;Female;Humans;Hydrocortisone/blood;Male;Middle Aged;Time Factors;beta-Endorphin
3041956;Altitude;Animals;Ascites/etiology;Ascites/pathology;Ascites/veterinary*;Cardiomyopathy, Dilated/etiology;Cardiomyopathy, Dilated/pathology;Cardiomyopathy, Dilated/veterinary;Chickens*;Furazolidone/toxicity;Liver/pathology;Lung/pathology;Lymphoid Tissue/pathology;Myocardium/pathology;Ontario;Poultry Diseases/pathology*;Pulmonary Edema/pathology;Pulmonary Edema/veterinary;Sodium Chloride/poisoning;Sodium Chloride/toxicity;Syndrome/veterinary;Vitamin E Deficiency/pathology;Vitamin E Deficiency/veterinary
3078987;Alveolar Process/physiopathology*;Bone Regeneration;Bone Resorption/physiopathology*;Humans;Periodontal Diseases/physiopathology
3106880;Carbon Dioxide;Humans;Laser Therapy*;Osteotomy/methods*
3130165;Adult;Child, Preschool;Collagen/analysis*;Femur/ultrastructure*;Humans;Microscopy, Electron;Models, Biological
3135610;Chlamydia trachomatis/isolation & purification;France;Humans;Male;Mycoplasma/isolation & purification;Neisseria gonorrhoeae/isolation & purification;Retrospective Studies;Risk Factors;Sexual Behavior*;Sexually Transmitted Diseases/etiology;Sexually Transmitted Diseases/microbiology;Smoking*;Ureaplasma/isolation & purification;Urethritis/epidemiology;Urethritis/etiology*;Urethritis/microbiology
3168624;Achievement*;Child;Child Behavior;Child Development;Environment*;Female;Follow-Up Studies;Humans;Infant;Male;Models, Psychological*;Parent-Child Relations
3176576;Femoral Neck Fractures/surgery*;Femur Head Necrosis/surgery*;Follow-Up Studies;Hip Fractures/surgery*;Hip Prosthesis*;Humans;Osteoarthritis/surgery*;Postoperative Complications/surgery;Prosthesis Failure;Reoperation
3189071;Adolescent;Adult;Electromyography;Exotropia/physiopathology*;Female;Humans;Male;Oculomotor Muscles/physiopathology*;Refraction, Ocular*;Strabismus/physiopathology*
3193354;Depression/psychology;Emotions*;Female;Humans;Life Change Events*;Male;Social Environment*;Social Support*;Surveys and Questionnaires
3193896;Aversive Therapy/methods*;Behavior Control*;Behavioral Research;Dissent and Disputes*;Education of Intellectually Disabled*;Ethics, Medical*;Group Processes*;Humans;Intellectual Disability/rehabilitation*;United States
3203157;Actomyosin/analysis*;Animals;Brain Chemistry*;Calmodulin-Binding Proteins/analysis*;Chromatography, Gel;Electrophoresis, Polyacrylamide Gel;Peptide Fragments/analysis;Rabbits
3206155;Adult;Aged;Female;Foot Diseases*/diagnosis;Foot Diseases*/etiology;Foot Diseases*/therapy;Humans;Male;Middle Aged;Musculocutaneous Nerve*;Nerve Compression Syndromes*/diagnosis;Nerve Compression Syndromes*/etiology;Nerve Compression Syndromes*/therapy
3210384;Arthritis, Rheumatoid/nursing*;Arthritis, Rheumatoid/rehabilitation;Humans;Patient Education as Topic;Self Care*
3214432;Animals;Circadian Rhythm;Cytosol/drug effects;Cytosol/metabolism;Diabetes Mellitus, Experimental/metabolism*;Fatty Acids/biosynthesis;Lipoproteins, VLDL/metabolism*;Lipoproteins, VLDL/secretion;Liver/drug effects;Liver/metabolism*;Male;Polyethylene Glycols/pharmacology;Rats;Rats, Inbred Strains;Starvation/metabolism*;Subcellular Fractions/drug effects;Subcellular Fractions/metabolism;Triglycerides/metabolism*;Triglycerides/secretion;Tritium/metabolism;Water/metabolism
3222870;Adolescent;Adrenal Cortex Hormones/secretion;Adrenal Gland Neoplasms/diagnosis*;Adrenal Gland Neoplasms/secretion;Adrenocortical Hyperfunction/diagnosis;Adrenocortical Hyperfunction/etiology;Child;Diagnosis, Differential;Female;Feminization/diagnosis;Feminization/etiology;Humans;Male;Paraneoplastic Endocrine Syndromes/diagnosis*;Virilism/diagnosis;Virilism/etiology
3226511;Adolescent;Age Factors;Arachnoid/surgery*;Brain Diseases/complications;Brain Diseases/surgery*;Child;Child, Preschool;Female;Humans;Hydrocephalus/complications;Infant;Infant, Newborn;Male;Neurosurgery/methods*;Peritoneovenous Shunt*;Postoperative Complications
3234996;Acquired Immunodeficiency Syndrome/drug therapy*;Antiviral Agents/therapeutic use*;Drug Industry;Germany, West;Humans;Research
3235440;Cardiovascular Diseases/etiology*;Humans;Lupus Erythematosus, Systemic/complications*
3244122;Adolescent;Adult;Aged;Enzyme-Linked Immunosorbent Assay/methods*;Female;Humans;Immunoglobulin G/analysis;Male;Middle Aged;Tuberculosis, Urogenital/diagnosis*;Tuberculosis, Urogenital/immunology
3249302;Dentist-Patient Relations*;Financial Management*;Humans;Risk Management*
3264632;Animals;B-Lymphocytes/immunology;Humans;Major Histocompatibility Complex*;Membrane Proteins/immunology*;Receptors, Immunologic*/immunology;Receptors, Interleukin-2/immunology;T-Lymphocytes/immunology
3268766;Administration, Oral;Animals;Antibodies, Viral/analysis;Dogs/immunology;Foxes*/immunology;Foxes*/physiology;Italy/epidemiology;Rabies/epidemiology;Rabies/prevention & control;Rabies/veterinary*;Rabies Vaccines*/administration & dosage;Rabies Vaccines*/immunology;Rabies virus/immunology;Species Specificity;Vaccination/methods;Vaccination/veterinary*;Vaccines, Attenuated/administration & dosage;Vaccines, Attenuated/immunology;Vaccines, Inactivated/administration & dosage;Vaccines, Inactivated/immunology
3268789;Crowns*;Dental Restoration, Permanent/methods*;Gold;Humans;Male;Middle Aged;Root Canal Therapy
3273613;Central Nervous System Diseases/epidemiology;Central Nervous System Diseases/etiology*;Denmark/epidemiology;Epilepsy/epidemiology;Epilepsy/etiology*;Humans;Immunization Schedule;Infant;Infection/epidemiology;Infection/etiology;Pertussis Vaccine/administration & dosage;Pertussis Vaccine/adverse effects*;Retrospective Studies;Seizures, Febrile/epidemiology;Seizures, Febrile/etiology*
3284308;Emergencies;Family Practice;Humans;Hypothermia/etiology;Immersion/adverse effects;Immersion/physiopathology;Near Drowning/physiopathology;Near Drowning/prevention & control;Near Drowning/therapy*;Resuscitation
3300719;Antibodies, Bacterial/analysis*;Brucella/immunology*;Brucellosis/diagnosis;Brucellosis/epidemiology*;Enzyme-Linked Immunosorbent Assay;Humans;Immunoenzyme Techniques*
3303887;Clinical Trials as Topic;Coronary Artery Bypass*;Coronary Disease/diagnosis*;Coronary Disease/mortality;Coronary Disease/surgery;Exercise Test*;Female;Humans;Male;Prognosis;Registries;Risk
3319049;Animals;Brain/metabolism;Brain/physiology*;Brain Chemistry;Epinephrine/analysis;Epinephrine/metabolism;Epinephrine/physiology*;Hypothalamus/analysis;Hypothalamus/metabolism;Hypothalamus/physiology;Models, Neurological;Neurons/analysis;Neurons/physiology;Phenylethanolamine N-Methyltransferase/analysis;Rats
3323262;Adult;Aged;Amitriptyline/adverse effects;Amitriptyline/therapeutic use*;Blood Pressure/drug effects;Clinical Trials as Topic;Depressive Disorder/drug therapy*;Dexamethasone;Dibenzazepines/therapeutic use*;Double-Blind Method;Electrocardiography;Female;Humans;Male;Middle Aged;Psychiatric Status Rating Scales;Random Allocation;Serotonin Antagonists/adverse effects;Serotonin Antagonists/therapeutic use*;Trimipramine/adverse effects;Trimipramine/therapeutic use*;Tryptophan/blood
3329243;Amino Acid Sequence;Base Sequence;Cloning, Molecular*;Escherichia coli/genetics*;Genes, Bacterial*;Hemolysin Proteins/genetics*;Hot Temperature;Molecular Sequence Data;Vibrio parahaemolyticus/genetics*
3334313;Female;Humans;Infant, Newborn;Male;Meningitis/etiology*;Pregnancy;Pregnancy Complications, Infectious*;Streptococcal Infections/complications;Streptococcal Infections/transmission*;Streptococcus agalactiae
3344762;Abnormalities, Multiple/genetics*;Agenesis of Corpus Callosum*;Cataract/genetics*;Child, Preschool;Cleft Lip/genetics;Cleft Palate/genetics;Humans;Immunologic Deficiency Syndromes/genetics*;Male;Pigmentation Disorders/genetics*;Syndrome
3353798;Adult;Humans;Intermittent Claudication/etiology;Intermittent Claudication/pathology;Male;Popliteal Artery*/pathology;Vascular Diseases/pathology;Vascular Diseases/surgery
3359321;Aging/metabolism*;Animals;Antibodies, Monoclonal;Coturnix;Embryonic and Fetal Development*;Microtubule-Associated Proteins/metabolism*;Microtubule-Associated Proteins/physiology;Molecular Weight;Retina/embryology;Retina/growth & development;Retina/metabolism*
3362099;Developing Countries*;Health Services Needs and Demand/trends*;Health Services Research/trends*;Humans;Socioeconomic Factors
3379255;Aged;Community Health Nursing/education*;Humans;Nursing Homes/manpower*;Psychiatric Nursing/education*;Students, Nursing
3381004;Adolescent;Adult;Arthroscopy/methods*;Elbow Joint*;Foreign Bodies/surgery*;Humans;Middle Aged
3390559;Epidemiologic Methods;Forecasting;Humans;Indonesia;Thalassemia/epidemiology*
3391119;Animals;Drug Evaluation, Preclinical;Drug Interactions;Enkephalins/isolation & purification;Enkephalins/therapeutic use*;Ethylnitrosourea/toxicity*;Female;Male;Neoplasms, Experimental/chemically induced*;Neoplasms, Experimental/epidemiology;Neoplasms, Experimental/prevention & control;Peptides/isolation & purification;Peptides/therapeutic use*;Placenta;Pregnancy;Prenatal Exposure Delayed Effects*;Rats
3391966;Animals;Butter/analysis*;Cattle;Quality Control;Water/analysis
3409690;Adult;Ambulatory Care;Humans;Mental Disorders/psychology;Mental Disorders/therapy*;Prognosis;Psychological Tests*;Psychometrics;Psychotherapy/methods*
3438573;Animals;Anti-Inflammatory Agents, Non-Steroidal*;Edema/chemically induced;Edema/prevention & control;Female;Granuloma/prevention & control;Leucine/analogs & derivatives*;Leucine/pharmacology;Male;Organ Size/drug effects;Phenylbutazone/pharmacology;Rats;Rats, Inbred Strains
3452024;Adolescent;Adult;Age Factors;Aged;Commitment of Mentally Ill*/legislation & jurisprudence;Ethnic Groups;Female;Humans;Male;Mental Disorders/diagnosis;Middle Aged;New Zealand;Sex Factors
3455392;Adolescent;Adult;Child;Child, Preschool;Female;Heart Septum/anatomy & histology*;Heart Septum/diagnostic imaging;Humans;Male;Radiography;Transposition of Great Vessels/diagnostic imaging;Transposition of Great Vessels/physiopathology*
3477604;Griseofulvin/therapeutic use*;Humans;Lichen Planus/drug therapy*;Male;Middle Aged;Mouth Diseases/drug therapy*
3497735;Animals;Humans;Nitroimidazoles/pharmacology*;Tinidazole/administration & dosage;Tinidazole/pharmacology*;Trichomonas/drug effects*;Trichomonas vaginalis/drug effects*
3519240;Adult;Aged;Asthma/drug therapy*;Asthma/physiopathology;Blood Pressure/drug effects;Clinical Trials as Topic;Dose-Response Relationship, Drug;Double-Blind Method;Electrocardiography;Female;Forced Expiratory Volume;Heart Rate/drug effects;Humans;Male;Middle Aged;Terbutaline/adverse effects;Terbutaline/analogs & derivatives*;Terbutaline/blood;Terbutaline/therapeutic use*;Time Factors;Vital Capacity
3537241;Animals;Biotin;Cartilage, Articular/cytology;Cartilage, Articular/metabolism*;Cartilage, Articular/pathology;Culture Media;Dogs;Fibronectins/blood;Fibronectins/isolation & purification;Fibronectins/metabolism*;Immunoenzyme Techniques;Iodine Radioisotopes;Osteoarthritis/metabolism*;Osteoarthritis/pathology;Serum Albumin, Radio-Iodinated/metabolism
3540351;Adult;Bacterial Infections/drug therapy*;Bacterial Infections/prevention & control;Ceftazidime/metabolism;Ceftazidime/therapeutic use*;Drug Evaluation;Female;Humans;Infant, Newborn;Infusions, Intravenous;Maternal-Fetal Exchange;Pregnancy;Pregnancy Complications, Infectious/drug therapy*;Pregnancy Complications, Infectious/prevention & control;Pregnancy Trimester, Third;Premedication;Puerperal Infection/drug therapy*;Puerperal Infection/prevention & control
3542337;Humans;Monitoring, Physiologic;Pharmaceutical Preparations/blood*;Protein Binding
3542713;Amino Acid Sequence;Base Sequence;Cytochrome P-450 Enzyme System/genetics*;DNA, Recombinant/metabolism;Drug Resistance;Genes*;Genes, Fungal*;Genetic Vectors;Genotype;Ketoconazole/pharmacology;Plasmids;Protein Biosynthesis;Saccharomyces cerevisiae/drug effects;Saccharomyces cerevisiae/genetics*;Sequence Homology, Nucleic Acid
3546819;Anti-Bacterial Agents/metabolism;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/urine*;Bacteria/drug effects*;Drug Resistance, Microbial;Humans;Kidney/metabolism*;Ureter/metabolism;Urine/microbiology*
3549254;Animals;Culture Techniques;Cycloheximide/pharmacology;Drug Tolerance;Glucose/pharmacology*;Insulin/metabolism;Islets of Langerhans/drug effects;Islets of Langerhans/metabolism*;Kinetics;Male;Proinsulin/biosynthesis*;Rats
3559394;Bile/analysis*;Cholestanols/analysis*;Cholestanols/chemical synthesis;Cholestanols/isolation & purification*;Female;Gallbladder/secretion*;Gas Chromatography-Mass Spectrometry;Humans;Middle Aged
3561005;Adaptation, Physiological;Adolescent;Adult;Age Factors;Child;Child, Preschool;Female;Follow-Up Studies;Forced Expiratory Volume;Functional Residual Capacity;Humans;Hyperplasia;Hypertrophy;Lung/growth & development;Lung/pathology;Lung/physiopathology*;Male;Pneumonectomy*;Tidal Volume;Total Lung Capacity;Vital Capacity
3563318;Animals;Antibody Formation;Antibody Specificity;Antigens, Helminth/immunology*;Antigens, Surface/immunology;Autoradiography;Electrophoresis, Polyacrylamide Gel;England;Humans;Mexico;Trichinella/immunology*;Trichinellosis/immunology*
3566971;Acetylcholinesterase/blood*;Acetylcholinesterase/isolation & purification;Animals;Cattle;Detergents;Enzyme Stability;Erythrocytes/enzymology*;Kinetics;Thermodynamics
3571849;Free Radicals;Hydrogen-Ion Concentration;Sulfhydryl Compounds*
3573966;Adolescent;Adult;Drug Therapy, Combination;Female;Humans;Leprostatic Agents/administration & dosage*;Leprosy/diagnosis;Leprosy/drug therapy*;Leprosy/pathology;Male;Middle Aged;Recurrence
3585817;Actin Cytoskeleton/physiology;Actin Cytoskeleton/ultrastructure*;Animals;Cytoskeleton/ultrastructure*;Microscopy, Electron;Microtubules/physiology;Microtubules/ultrastructure*;Movement;Toxoplasma/physiology;Toxoplasma/ultrastructure*
3588509;Acclimatization*;Animals;Body Temperature*;Chickens/physiology*;Hot Temperature*;Male
3592760;Animals;DDT/toxicity*;Intestines/drug effects;Intestines/enzymology*;Liver/drug effects;Liver/enzymology*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Mixed Function Oxygenases/metabolism*;Rats;Rats, Inbred Strains;Vitamin A Deficiency/metabolism*
3611593;Catalase;Chemical Phenomena;Chemistry;Free Radicals;Glutathione/analysis;Indoles/toxicity*;Kinetics;Oxidation-Reduction;Oxygen Consumption;Sporidesmins/toxicity*;Sulfhydryl Compounds/metabolism;Zinc
3638812;Employment*;France;Humans;Legislation as Topic*;Time Factors
3640906;Humans;Inservice Training;Japan;Nursing Service, Hospital/organization & administration*;Nursing Staff, Hospital/education*;Nursing Staff, Hospital/standards;Nursing, Supervisory;Quality Assurance, Health Care;Surveys and Questionnaires
3642177;Humans;Multiple Myeloma/complications*;Multiple Myeloma/diagnosis;Neurotic Disorders/diagnosis;Neurotic Disorders/etiology*;Prognosis;Syndrome
3654056;Animals;Buffaloes/parasitology*;Histocytochemistry;Intestines/ultrastructure;Platyhelminths/ultrastructure*
3655865;Adult;African Continental Ancestry Group*;Antineoplastic Combined Chemotherapy Protocols/adverse effects*;Hair Color/drug effects*;Humans;Male;Pigmentation Disorders/chemically induced*
3656305;Adult;Aged;Arthritis, Rheumatoid/physiopathology;Arthritis, Rheumatoid/therapy*;Depression/therapy;Disability Evaluation;Female;Humans;Male;Middle Aged;Pain Measurement;Psychotherapy*
3660248;Child;Child Development*;Denmark;Humans;Literature, Modern*;Reading*
3667512;Adolescent;Child;Depression/psychology*;Female;Humans;Longitudinal Studies;Male;Neoplasms/psychology*;Sick Role*
3694354;Animals;Bile/analysis;Bile/metabolism*;Bilirubin/biosynthesis;Carbon Monoxide/metabolism*;Heme/administration & dosage;Heme/metabolism*;Heme/pharmacokinetics;Metalloporphyrins*;Porphyrins/pharmacology*;Protoporphyrins/pharmacology*;Rats;Rats, Inbred Strains
3697365;Adrenal Cortex/enzymology;Animals;Binding Sites;Cattle;Cysteine/analysis*;Cytochrome P-450 Enzyme System/analysis*;Cytochrome P-450 Enzyme System/metabolism;Dithionitrobenzoic Acid/pharmacology;Electrophoresis, Polyacrylamide Gel;Heme/metabolism*;Isoenzymes/analysis*;Isoenzymes/metabolism;Kinetics;Mathematics;Molecular Weight;Structure-Activity Relationship
3707428;Adult;Aged;Apolipoproteins B/blood*;Cholesterol, HDL/blood;Dietary Fats*;Female;Humans;Hyperlipoproteinemia Type II/blood*;Kinetics;Lipoproteins, HDL/blood*;Lipoproteins, LDL/blood*;Lipoproteins, VLDL/blood*;Male;Middle Aged;Reference Values;Triglycerides/blood
3710558;Animals;Calcium/metabolism*;Desoxycorticosterone*;Dose-Response Relationship, Drug;Extracellular Space/metabolism;Femoral Artery;Hypertension/chemically induced*;Hypertension/metabolism;Hypertension/physiopathology;Isoproterenol/pharmacology;Male;Muscle Contraction/drug effects;Muscle, Smooth, Vascular/drug effects*;Muscle, Smooth, Vascular/physiopathology;Norepinephrine/pharmacology;Potassium Chloride/pharmacology;Rats;Rats, Inbred Strains;Sodium Chloride*;Sodium Nitrite/pharmacology
3716534;Aged;Female;Humans;Lupus Erythematosus, Discoid*;Paraneoplastic Syndromes*;Stomach Neoplasms/surgery
3728244;Aged;Female;Humans;Male;Postoperative Complications;Preoperative Care;Prostatectomy;Urinary Tract/surgery*;Urologic Diseases/surgery
3766164;Animals;Biological Transport;Calcium/metabolism*;Chemical Phenomena;Chemistry;Fatty Acids/analysis;Lipids/analysis*;Male;Mitochondria, Liver/analysis;Mitochondria, Liver/metabolism*;Phospholipids/analysis;Rats;Rats, Inbred Strains;Starvation/metabolism*
3772543;Disease Susceptibility;Environmental Exposure;Environmental Pollutants/adverse effects*;Genetic Variation;Genetics, Medical*;Humans;Occupational Diseases/chemically induced;Occupational Diseases/genetics*;Risk
3773063;Bacteriuria/diagnosis*;Colorimetry;Humans;Urology/instrumentation*
3775583;Coronary Disease/etiology*;Humans
3779207;Breast/surgery*;Female;Humans;Mastectomy;Middle Aged;Poland Syndrome/surgery;Polyurethanes*;Postoperative Complications/etiology*;Prostheses and Implants/adverse effects*;Surgery, Plastic/adverse effects*
3787560;Administration, Topical;Animals;Dose-Response Relationship, Drug;Male;Mesenteric Arteries;Mesenteric Vascular Occlusion/etiology*;Norepinephrine/administration & dosage;Norepinephrine/pharmacology;Rats;Thrombosis/etiology*;Vasoconstriction*/drug effects
3789898;Ampicillin/pharmacology*;Ampicillin/therapeutic use;Animals;Cloxacillin/pharmacology*;Cloxacillin/therapeutic use;Female;Fetus/drug effects*;Gestational Age;Lymphatic System/drug effects;Lymphatic System/growth & development*;Male;Mice;Mice, Inbred Strains;Organ Size;Pregnancy;Pregnancy, Animal/drug effects*;Spleen/cytology;Thymus Gland/cytology
3800875;Animals;Autoradiography;Centrifugation, Density Gradient;Digitonin/pharmacology;Iodine Radioisotopes;Iron/metabolism;Iron Radioisotopes;Liver/drug effects;Liver/metabolism*;Perfusion;Rats;Subcellular Fractions/metabolism;Transferrin/metabolism*
3802480;Humans;Osmolar Concentration;Reagent Strips;Refractometry;Specific Gravity;Urine/analysis*
3808357;Disasters*;Emergencies*;Health Planning;Hospitals, Community*;Italy;Surgical Procedures, Operative
3812055;Adolescent;Adult;Aged;Chewing Gum*;Family Practice;Female;Follow-Up Studies;Humans;Male;Middle Aged;Nicotine/therapeutic use*;Patient Acceptance of Health Care;Persuasive Communication;Physician-Patient Relations;Smoking Prevention*
3818463;Animals;Body Composition*;Body Weight*;Cattle/growth & development*;Male;Meat*
3818874;Adolescent;Adult;Age Factors;Aged;Aged, 80 and over;Child;Child, Preschool;Duodenal Ulcer/epidemiology;Duodenal Ulcer/etiology;Duodenal Ulcer/mortality;Europe;Humans;Infant;Infant, Newborn;Japan;Middle Aged;Peptic Ulcer/epidemiology;Peptic Ulcer/etiology*;Peptic Ulcer/mortality;Stomach Ulcer/epidemiology;Stomach Ulcer/etiology;Stomach Ulcer/mortality;United States
3826628;Ions/analysis*;Magnetics;Mass Spectrometry/instrumentation*
3828028;Animals;Anura/parasitology*;Chile;Intestine, Small/parasitology*;Trematoda/anatomy & histology;Trematoda/isolation & purification*
3841124;Adenosine/analogs & derivatives;Adenosine/pharmacology;Animals;Anti-Bacterial Agents/pharmacology*;Antiviral Agents/pharmacology*;Guanine/analogs & derivatives*;Guanine/pharmacology;Herpesviridae/drug effects*;Nucleic Acids/biosynthesis;RNA, Viral/biosynthesis;Rhabdoviridae/drug effects*;Salmon/microbiology
3843943;Clinical Competence*;Humans;Nursing Staff, Hospital/legislation & jurisprudence*
3845203;Adult;Esophageal and Gastric Varices/therapy*;Esophagoscopy;Female;Humans;Male;Methods;Middle Aged;Sclerosing Solutions/therapeutic use*
3859591;Adult;Aged;Cartilage, Articular/cytology;Cartilage, Articular/pathology*;Cartilage, Articular/ultrastructure;Collagen;Connective Tissue/ultrastructure;Humans;Lipids;Mandibular Condyle/pathology*;Mandibular Condyle/ultrastructure;Microscopy;Microscopy, Electron, Scanning;Osteoarthritis/pathology*;Temporomandibular Joint Disorders/pathology*
3860638;Adult;Carcinoma/pathology;Carcinoma/secondary*;Diagnosis, Differential;Female;Gingival Neoplasms/pathology;Gingival Neoplasms/secondary*;Humans;Mandible;Nasopharyngeal Neoplasms*;Periodontium/pathology
3876022;Antibodies, Monoclonal/immunology;B-Lymphocytes/immunology*;Humans;Lymphatic Diseases/pathology*
3878797;Cross-Sectional Studies;Follow-Up Studies;Forced Expiratory Volume;Humans;Lung Diseases, Obstructive/mortality*;Lung Diseases, Obstructive/physiopathology;Lung Volume Measurements;Netherlands;Smoking
3883794;Adult;Bone Transplantation*;Child;Cleft Palate/surgery*;Humans;Maxilla/abnormalities*;Maxilla/surgery;Time Factors
3884750;3-Iodobenzylguanidine;Adrenal Gland Neoplasms/radiotherapy;Adult;Antibodies, Neoplasm/therapeutic use;Brachytherapy/trends*;Child;Child, Preschool;Humans;Iodine Radioisotopes/therapeutic use;Iodobenzenes/therapeutic use;Middle Aged;Neoplasms/radiotherapy;Neuroblastoma/radiotherapy;Pheochromocytoma/radiotherapy;Phosphorus Radioisotopes/therapeutic use;Radioisotopes/adverse effects;Radioisotopes/therapeutic use*;Radiotherapy Dosage;Risk
3894944;Azo Compounds*;Coloring Agents;Connective Tissue/anatomy & histology*;Eosine Yellowish-(YS)*;Histological Techniques*;Humans;Methyl Green*;Muscles/anatomy & histology
3908935;Amino Acid Sequence;Animals;Antigens, Protozoan/immunology;Antigens, Protozoan/isolation & purification*;Chromatography, High Pressure Liquid;Chromatography, Ion Exchange;Cross Reactions;Female;Glycoproteins/immunology;Glycoproteins/isolation & purification*;Membrane Proteins/immunology;Membrane Proteins/isolation & purification;Molecular Weight;Plasmodium falciparum/immunology*
3926927;Animal Population Groups/immunology*;Animals;Animals, Suckling/immunology*;Animals, Suckling/metabolism;Electric Stimulation;Female;Hypothalamus/physiology*;Immunization, Passive;Male;Pregnancy;Prolactin/secretion*;Radioimmunoassay;Rats;Rats, Inbred Strains;Thyrotropin/secretion*;Thyrotropin-Releasing Hormone/physiology*
3927096;17-Hydroxycorticosteroids/urine;Adult;Body Water*;Chlorides/urine;Circadian Rhythm*;Crohn Disease/therapy;Electrolytes/urine*;Female;Humans;Male;Natriuresis;Parenteral Nutrition*;Parenteral Nutrition, Total*;Potassium/urine;Urine/analysis*
3931850;Antidepressive Agents/therapeutic use*;Benzodiazepines*;Humans;Substance-Related Disorders/drug therapy*
3947992;Animals;Biological Evolution;Brain Mapping;Digestive System/innervation;Efferent Pathways/physiology;Electric Stimulation;Frontal Lobe/physiology*;Gastrointestinal Motility*;Male;Medulla Oblongata/physiology;Rats;Temporal Lobe/physiology*;Vagus Nerve/physiology
3954055;Molybdenum;Spectrophotometry, Atomic;Tetracycline/analysis*
3957788;Anti-Bacterial Agents/chemical synthesis*;Anti-Bacterial Agents/pharmacology;Gram-Negative Bacteria/drug effects;Gram-Positive Bacteria/drug effects;Structure-Activity Relationship;beta-Lactams
3961900;Contrast Media;Humans;Kidney Failure, Chronic/physiopathology*;Male;Middle Aged;Renal Dialysis;Urinary Bladder/physiopathology*
3963112;Adult;Female;Humans;Pigment Epithelium of Eye;Retinal Diseases/diagnosis*
3964790;Adipose Tissue/enzymology*;Aging*;Androstenedione/metabolism;Aromatase/metabolism*;Castration;Female;Humans;Kinetics;Menopause;Obesity/enzymology*;Oxidoreductases/metabolism*
3968364;Age Factors;Aged;Anesthesia, Spinal;Creatinine/blood;Electrocardiography;Female;Femoral Neck Fractures/surgery*;Fracture Fixation, Internal/adverse effects;Health*;Health Status*;Hip Prosthesis/adverse effects;Humans;Locomotion;Male;Middle Aged;Nursing Homes;Retrospective Studies
3989875;Adolescent;Adult;Aged;Anxiety/complications;Attitude;Homosexuality*;Humans;Libido;Male;Middle Aged;Orgasm;Prostheses and Implants;Psychotherapy/methods;Religion and Sex;Sexual Dysfunctions, Psychological/etiology;Sexual Dysfunctions, Psychological/psychology;Sexual Dysfunctions, Psychological/therapy*
3990075;Coronary Angiography;Coronary Circulation*;Coronary Disease/diagnostic imaging;Coronary Disease/physiopathology*;Coronary Vessels/diagnostic imaging;Diastole;Exercise Test;Heart/diagnostic imaging;Heart/physiopathology*;Heart Ventricles/diagnostic imaging;Hemodynamics;Humans;Radionuclide Imaging;Systole;Xenon Radioisotopes
3992626;Adolescent;Adult;Age Factors;Child;Child, Preschool;Epilepsy/blood;Epilepsy/drug therapy*;Female;Humans;Infant;Male;Monitoring, Physiologic;Patient Compliance*;Phenobarbital/blood*;Phenobarbital/therapeutic use;Sex Factors
3993236;Adult;Elastic Tissue/pathology*;Epidermis/pathology;Forensic Medicine*;Humans;Male;Skin/pathology*
4008322;Aged;Aniseikonia/etiology;Diplopia/etiology;Female;Humans;Lenses, Intraocular/adverse effects*;Myopia/etiology*;Optics and Photonics
4014564;Aorta, Abdominal/injuries*;Aorta, Thoracic/injuries*;Aortography;Hemorrhage/surgery;Humans;Postoperative Complications/surgery;Prognosis;Wounds, Gunshot/surgery;Wounds, Nonpenetrating/surgery*;Wounds, Penetrating/surgery*;Wounds, Stab/surgery
4024620;Anti-Bacterial Agents/pharmacology;Bacteria/drug effects;Bacteria/isolation & purification*;Bacteriuria/microbiology;Chronic Disease;Humans;Microbial Sensitivity Tests;Pyelonephritis/microbiology*
4026340;Adolescent;Adult;Androgens/physiology;Child;Female;Hair/pathology;Hair/physiopathology;Hair Color;Hair Diseases/pathology*;Humans;Male;Puberty
4034207;Adult;Agammaglobulinemia/complications*;Arthritis, Rheumatoid/diagnosis;Arthritis, Rheumatoid/etiology*;Diagnosis, Differential;Humans;Immunoglobulin A;Immunoglobulin G;Immunoglobulin M;Male
4037061;Form Perception/physiology*;Humans;Retina/physiology;Visual Fields*
4037940;Adult;Aged;Cerebral Hemorrhage/diagnostic imaging*;Cerebral Hemorrhage/etiology;Cerebral Infarction/diagnostic imaging;Cerebral Infarction/etiology;Cerebrovascular Disorders/complications*;Cerebrovascular Disorders/diagnostic imaging;Diagnosis, Differential;Female;Humans;Male;Middle Aged;Prognosis;Time Factors;Tomography, X-Ray Computed
4047140;Breast Neoplasms/epidemiology;Canada;Computers*;Fluoroscopy/adverse effects;Follow-Up Studies;Humans;Isoniazid/adverse effects;Lung Neoplasms/epidemiology;Medical Record Linkage*;Medical Records*;Neoplasms/epidemiology*;Occupational Diseases/epidemiology;Probability;Prospective Studies
4052974;Adult;Brain Neoplasms/secondary;Breast Neoplasms/pathology;Female;Humans;Lung Neoplasms/pathology;Male;Middle Aged;Movement Disorders/etiology;Myelography;Pain/etiology;Paralysis/etiology;Paresthesia/etiology;Spinal Cord Neoplasms/complications;Spinal Cord Neoplasms/diagnosis;Spinal Cord Neoplasms/secondary*;Spinal Cord Neoplasms/therapy;Tomography, X-Ray Computed
4055596;Airway Resistance;Animals;Aorta, Thoracic/physiology;Blood Pressure;Collateral Circulation*;Diaphragm/blood supply*;Diaphragm/physiology;Dogs;Female;Intercostal Muscles/blood supply;Male;Mammary Arteries/physiology;Microspheres;Radioisotopes;Regional Blood Flow;Respiration;Thoracic Arteries/physiology
4057230;Curriculum*;Economics;Education, Medical, Undergraduate*;Ethics, Medical;Evaluation Studies as Topic;Humans;Jurisprudence;Professional Practice*;Sociology/education;Students, Medical/psychology
4064885;Electrodes;Electrophysiology/methods*;Electroretinography;History, Ancient;Humans;Nasopharynx/physiology*;Photic Stimulation;Visual Pathways/physiology*
4067805;Alcoholism/psychology*;Humans;Male;Mood Disorders/diagnosis;Mood Disorders/psychology*;Personality Disorders/diagnosis;Personality Disorders/psychology*;Personality Inventory*;Psychometrics
4071491;Adult;Aged;Female;Humans;Male;Medical Oncology/manpower*;Middle Aged;Neoplasms/diagnosis;Neoplasms/therapy;Norway;Physicians*
4073736;Adolescent;Adult;Aged;Child;Female;Fiber Optic Technology/instrumentation;Humans;Laryngeal Diseases/diagnosis;Laryngoscopes*;Laryngoscopy/methods;Male;Middle Aged;Vibration;Video Recording/instrumentation*;Vocal Cords/physiology*
4079852;Blood Pressure*;Disposable Equipment*;Evaluation Studies as Topic;Humans;Monitoring, Physiologic*
4084536;Acrolein/isolation & purification;Amines/pharmacology*;Animals;Benzylamines/metabolism;Benzylamines/pharmacology*;Binding Sites;Cattle;Kinetics;Mitochondria, Liver/enzymology*;Monoamine Oxidase/isolation & purification;Monoamine Oxidase Inhibitors/pharmacology*;Protein Binding
4092198;Child;Dianhydrogalactitol/adverse effects;Dianhydrogalactitol/therapeutic use*;Drug Evaluation;Hemorrhage/chemically induced;Humans;Leukemia/drug therapy;Leukopenia/chemically induced;Neoplasms/drug therapy;Sugar Alcohols/therapeutic use*;Thrombocytopenia/chemically induced
4092494;Animals;Calcium/pharmacology*;Calcium-Binding Proteins/metabolism*;Calmodulin/metabolism*;Calsequestrin/metabolism;Cations, Monovalent;Kinetics;Lactalbumin/metabolism;Protein Binding;Protein Kinase C/metabolism*;Troponin/metabolism;Troponin C
4094846;Adipose Tissue;Aged;Aging;Body Weight;Cognition/physiology*;Depression/physiopathology;Fear;Female;Humans;Leisure Activities;Male;Middle Aged;Physical Exertion*;Self Concept
4106854;Animals;Aorta/cytology*;Elastic Tissue/cytology*;Female;Microscopy, Electron;Osmium*;Rats;Staining and Labeling*
4113133;Cyclophosphamide/administration & dosage;Cyclophosphamide/therapeutic use*;Czechoslovakia;Dactinomycin/therapeutic use*;Female;Follow-Up Studies;Humans;Ovarian Neoplasms/drug therapy*;Retrospective Studies
4115178;Animals;Animals, Newborn;Embryonic and Fetal Development;Female;Gestational Age;Glycosaminoglycans/analysis;Histological Techniques*;Male;Mast Cells/analysis;Mast Cells/cytology;Mast Cells/growth & development*;Mast Cells/physiology;Mice;Mice, Inbred Strains/embryology;Staining and Labeling;Statistics as Topic;Surface Properties
4135017;Acoustic Stimulation*;Arousal;Cerebral Cortex/physiology*;Child, Preschool;Electroencephalography;Evoked Potentials*;Female;Humans;Male;Occipital Lobe/physiology;Refractory Period, Electrophysiological;Sleep*;Sleep Stages;Sleep, REM;Wakefulness
4135652;Adult;Bone Marrow Cells;Chromosome Aberrations*;Chromosome Mapping;Chromosomes, Human, 21-22 and Y*;Chromosomes, Human, 6-12 and X*;Female;Humans;Karyotyping;Leukemia, Myeloid, Acute/etiology;Leukemia, Myeloid, Acute/genetics*;Middle Aged;Mitosis;Sex Chromosomes
4135826;Bone Marrow Cells*;Chromosome Aberrations*;Chromosome Disorders*;Chromosomes, Human, 21-22 and Y*;Chromosomes, Human, 6-12 and X;Female;Fluorescent Dyes;Humans;Karyotyping;Leukemia, Myeloid/genetics*;Middle Aged;Quinacrine;Staining and Labeling
4136245;Adolescent;Adult;Carcinoma in Situ/chemically induced;Carcinoma in Situ/diagnosis;Carcinoma in Situ/epidemiology;Carcinoma in Situ/etiology*;Carcinoma in Situ/pathology;Cervix Uteri/surgery;Chile;Chlormadinone Acetate/administration & dosage;Chlormadinone Acetate/adverse effects*;Colposcopy;Contraceptive Agents/adverse effects*;Delayed-Action Preparations;Female;Humans;Injections;Intrauterine Devices/adverse effects*;Medroxyprogesterone/administration & dosage;Medroxyprogesterone/adverse effects*;Middle Aged;Pregnancy;Uterine Cervical Neoplasms/chemically induced;Uterine Cervical Neoplasms/diagnosis;Uterine Cervical Neoplasms/epidemiology;Uterine Cervical Neoplasms/etiology*;Uterine Cervical Neoplasms/pathology;Vaginal Smears
4137352;Adult;Clinical Laboratory Techniques*;Clinical Trials as Topic;Costs and Cost Analysis;Diagnostic Services;Economics, Hospital;Evaluation Studies as Topic;Humans;Laboratories/standards;Male;Mass Screening;Medical Laboratory Science;Middle Aged;Pathology;Specimen Handling;State Medicine;United Kingdom
4142305;Female;Fibrin;Humans;Microscopy, Fluorescence;Necrosis;Placenta/pathology*;Placenta Diseases/etiology*;Pregnancy
4144399;Consumer Behavior;Obstetric Nursing;Patient Care Team;Physician Assistants
4153444;Animals;Benzyl Compounds/pharmacology;Ethylenediamines/pharmacology;Gastric Juice/secretion;Gastric Mucosa/blood supply*;Gastric Mucosa/drug effects;Gastric Mucosa/secretion;Histamine;Histamine H1 Antagonists/pharmacology*;Hyperemia/chemically induced*;Imidazoles/pharmacology;Prostaglandins/pharmacology*;Pyridines/pharmacology;Rats;Thiourea/pharmacology*
4172312;Animals;Dogs;Hemodynamics;Histamine Release*;Injections, Intravenous;Radiation Effects*;Shock, Septic/prevention & control*
4173577;Animals;Blood;Blood Coagulation;Culture Media;Edetic Acid;Fluoresceins*;Fluorescence*;Humans;Lymphocytes/drug effects*;Papain;Peptide Hydrolases;Plasma;Snakes;Staining and Labeling*;Thrombin;Trypsin;Venoms/pharmacology*
4175143;Aged;Female;Humans;Immunochemistry;Immunoelectrophoresis;Knee;Macroglobulins/analysis;Skin Manifestations;Skin Neoplasms/immunology*;Waldenstrom Macroglobulinemia/diagnosis;Waldenstrom Macroglobulinemia/immunology*;gamma-Globulins/analysis
4175338;Nursing;Perioperative Nursing;Professional Practice;Professional Staff Committees;Tennessee
4186960;Humans;Lectins*;Lymphocyte Activation;Lymphocytes/immunology*;Phenothiazines/therapeutic use;Schizophrenia/drug therapy*
4189661;Animals;Antigen-Antibody Reactions*;Antigens;Cattle;Chlorides;Electrochemistry;Fluoresceins*;Fluorescence;Fluorides;Haptens;Immune Sera/analysis;Immunochemistry;Kinetics;Ovalbumin*;Perchlorates;Phosphates;Precipitin Tests;Rabbits;Serum Albumin, Bovine*;Sulfates;Sulfonic Acids*;Thiocyanates;gamma-Globulins*/isolation & purification
4190574;Economics, Nursing*;Education, Nursing*;England
4190708;Chymotrypsin/analysis;Diet;Feces/analysis*;Feces/microbiology;Gastrointestinal Diseases/diagnosis;Humans;Lipids/analysis;Methods;Nitrogen/analysis;Occult Blood;Trypsin/analysis
4191931;Azathioprine/adverse effects;Azathioprine/pharmacology;Azathioprine/therapeutic use*;Biopsy;Child;Clinical Trials as Topic;Humans;Kidney Glomerulus/drug effects;Kidney Glomerulus/pathology;Nephrotic Syndrome/drug therapy*;Nephrotic Syndrome/pathology;Placebos;Prospective Studies
4200214;Adolescent;Adult;Aged;Anemia, Hemolytic/etiology;Angina Pectoris/etiology;Aortic Valve Insufficiency/surgery*;Aortic Valve Stenosis/surgery*;Child;Child, Preschool;Endocarditis, Bacterial/etiology;Female;Heart Valve Prosthesis*/adverse effects;Humans;Male;Middle Aged;Myocardial Infarction/etiology;Prognosis;Thromboembolism/etiology
4219716;Animals;Apoproteins/metabolism;Cholesterol/metabolism;Chylomicrons/metabolism;Cytosol/ultrastructure;Endoplasmic Reticulum/drug effects;Endoplasmic Reticulum/ultrastructure*;Ethanol/pharmacology*;Fatty Acids, Nonesterified/metabolism;Fatty Liver/chemically induced;Haplorhini;Humans;Intestine, Small/metabolism;Lipid Metabolism*;Lipoproteins/metabolism;Liver/metabolism*;Mitochondria, Liver/drug effects;Mitochondria, Liver/ultrastructure;Pharmaceutical Preparations/metabolism*;Rabbits;Rats;Triglycerides/metabolism
4219970;Brain/blood supply*;Dextrans/therapeutic use;Dihydroergotoxine/therapeutic use*;Ergoloid Mesylates/therapeutic use*;Humans;Intracranial Arteriosclerosis/drug therapy;Intracranial Embolism and Thrombosis/drug therapy;Ischemia/drug therapy*;Lidocaine/therapeutic use;Papaverine/therapeutic use;Prednisone/therapeutic use
4224631;Public Health Administration*
4225917;Adenosine Triphosphatases/metabolism*;Amines/pharmacology*;Aniline Compounds/pharmacology*;Animals;Biphenyl Compounds/pharmacology*;Dinitrophenols;Glutarates;Hydroxybutyrates;In Vitro Techniques;Liver/metabolism;Mitochondria/drug effects*;Mitochondria/metabolism*;Naphthalenes/pharmacology*;Naphthoquinones/pharmacology*;Oxidative Phosphorylation/drug effects*;Phenols/pharmacology;Phosphates/metabolism*;Rats;Rotenone;Succinates;ortho-Aminobenzoates/pharmacology*
4232754;Afibrinogenemia/drug therapy;Afibrinogenemia/etiology;Aminocaproates/therapeutic use*;Antifibrinolytic Agents/therapeutic use*;Aprotinin/therapeutic use*;Blood Coagulation Disorders/drug therapy*;Female;Fibrinogen/administration & dosage;Fibrinogen/therapeutic use*;Humans;Peptides/therapeutic use*;Pregnancy;Pregnancy Complications, Hematologic/drug therapy*;Prognosis;Statistics as Topic
4235796;Aged;Cysts/etiology*;Cysts/pathology;Edema*;Eye Diseases;Glaucoma/complications;Glycosaminoglycans/analysis;Humans;Macula Lutea*/pathology;Male;Retina*;Tissue Adhesions/complications*;Vitreous Body*
4239818;Glycosaminoglycans/blood*;Hexosamines/blood;Medical Laboratory Science;Methods
4258488;Acetylcholine/pharmacology;Animals;Carbachol/pharmacology;Drug Antagonism;Female;Guinea Pigs;Intestine, Small/drug effects*;Jejunum;Methacholine Compounds/pharmacology;Neuromuscular Nondepolarizing Agents/pharmacology*;Nicotine/antagonists & inhibitors;Quaternary Ammonium Compounds/pharmacology*;Rats;Receptors, Drug*
4301925;Cell Nucleus;Cochlea/pathology;Cytomegalovirus Infections/pathology*;Cytoplasm;Dermatitis, Exfoliative/complications;Female;Humans;Infant, Newborn;Labyrinth Diseases/pathology*;Microscopy, Electron;Splenomegaly/complications;Temporal Bone/pathology;Vestibule, Labyrinth/pathology
4308411;Cold Temperature*;History, 20th Century;Humans;Muscles/history;Muscles/pharmacology*;Neuromuscular Junction/drug effects*;Synaptic Transmission/drug effects
4313670;Adrenal Glands/anatomy & histology;Adrenal Glands/cytology*;Adrenal Glands/drug effects;Adrenal Glands/embryology;Adrenal Glands/metabolism;Adrenal Glands/physiology;Adrenocorticotropic Hormone/biosynthesis;Adrenocorticotropic Hormone/pharmacology;Animals;Anura;Birds/anatomy & histology;Cattle;Cell Nucleolus;Cell Nucleus;Cricetinae;Cytoplasm;Dogs;Endoplasmic Reticulum/metabolism;Fishes/anatomy & histology;Guinea Pigs;Haplorhini;Histiocytes;Histological Techniques;Histology, Comparative;Humans;Hypophysectomy;Insectivora/anatomy & histology;Lipids/analysis;Mammals/anatomy & histology*;Methods;Metyrapone/antagonists & inhibitors;Mice;Microscopy, Electron;Mitochondria/drug effects;Mitochondria/metabolism;Organoids/metabolism;Pinocytosis;Polymorphism, Genetic;Rabbits;Rats
4316624;Angiotensin II/adverse effects*;Animals;Arrhythmias, Cardiac/chemically induced*;Arrhythmias, Cardiac/diagnosis;Electrocardiography;Female;Hypertension, Renal/complications*;Male;Rabbits
4319791;17-Hydroxycorticosteroids/urine;17-Ketosteroids/urine;Adolescent;Adrenal Glands/metabolism;Adrenal Glands/secretion;Adrenocorticotropic Hormone;Age Factors;Body Weight;Child;Female;Humans;Male;Pituitary-Adrenal Function Tests*;Potassium/urine;Sex Factors;Sodium/urine
4321923;Animals;Autoanalysis;Cattle;Cobalt Isotopes;Dietary Proteins/radiation effects;Electron Spin Resonance Spectroscopy;Enzyme Precursors/radiation effects;Freeze Drying;Gelatin/radiation effects;Methylation;Muramidase/radiation effects;Ovalbumin/radiation effects;Proteins/radiation effects*;Radiation Effects*;Ribonucleases/radiation effects;Spectrum Analysis;Tritium
4323779;Animals;Aorta, Abdominal/cytology*;Blood Platelets*;Collagen/metabolism*;Elastin/metabolism;Epithelial Cells;Methods;Microbial Collagenase/metabolism;Microscopy, Electron;Muscle, Smooth/cytology*;Perfusion;Platelet Adhesiveness;Rabbits;Surface Properties;Trypsin/metabolism
4351043;Alkylation;Amines;Antiviral Agents/chemical synthesis*;Antiviral Agents/pharmacology;Chemical Phenomena;Chemistry;HeLa Cells;Herpesviridae/drug effects;Microbial Sensitivity Tests;Morpholines;Nitrogen;Orthomyxoviridae/drug effects;Respirovirus/drug effects;Rhinovirus/drug effects;Structure-Activity Relationship;Vaccinia virus/drug effects
4358414;Humans;Injections, Intramuscular;Mesylates/administration & dosage;Mesylates/adverse effects;Mesylates/blood;Mesylates/pharmacology;Pralidoxime Compounds/administration & dosage*;Pralidoxime Compounds/adverse effects;Pralidoxime Compounds/blood;Pralidoxime Compounds/pharmacology;Thigh;Vision Disorders/chemically induced
4367960;Binding Sites;Cytochrome c Group;Electron Transport Complex IV/antagonists & inhibitors*;Fluorides/pharmacology*;Kinetics;Mathematics;Oxidation-Reduction;Protein Binding;Protein Conformation;Spectrophotometry;Spectrophotometry, Ultraviolet;Surface-Active Agents;Time Factors
4375890;Animals;Cerebral Cortex/drug effects;Cerebral Cortex/physiology*;Cortical Spreading Depression;Electric Stimulation;Electroencephalography;Evoked Potentials;Humans;Microelectrodes;Neural Inhibition;Neurons/physiology;Neurophysiology/methods;Stimulation, Chemical;Synaptic Transmission
4375948;Animals;Cell Nucleus/ultrastructure;Cytoplasm/ultrastructure;Dogs;Gastrectomy;Histocytochemistry*;Inclusion Bodies/ultrastructure;Microscopy, Electron;Pancreas/cytology;Pancreas/secretion*;RNA/analysis;Regeneration;Stomach/physiology*;Time Factors
4376022;Acylation;Amino Acyl-tRNA Synthetases/metabolism;Borohydrides;Carbon Radioisotopes;Electrophoresis, Polyacrylamide Gel;Escherichia coli*/enzymology;Hydrogen-Ion Concentration;Kinetics;Oxidation-Reduction;Periodic Acid;Polynucleotide Ligases/metabolism;RNA, Bacterial*/metabolism;RNA, Transfer*/metabolism;Spectrophotometry, Ultraviolet;Time Factors;Transfer RNA Aminoacylation;Valine*
4393928;Angiography*/instrumentation;Aortography;Catheterization;Humans;Methods;Renal Artery
4410949;Diagnosis, Computer-Assisted;History of Medicine
4412184;Amino Acid Sequence;Bridged-Ring Compounds*;Buffers;Cysteine*;Dinitrophenols*;Hydrogen-Ion Concentration;Methods;Oxytocin/analogs & derivatives;Oxytocin/chemical synthesis*
4422413;Adult;Female;Hospitalization*;Humans;Lumbosacral Plexus*;Male;Middle Aged;Procaine/therapeutic use;Romania;Sciatica*/diagnosis;Sciatica*/drug therapy
4426298;Animals;Antibody Specificity;Cattle;Chromatography;Dihydrotestosterone/immunology;Male;Mice;Rabbits;Radioimmunoassay*;Rats;Rodentia;Sheep;Swine;Testosterone/blood*;Testosterone/immunology
4437727;Animals;Aorta/metabolism;Atropine/pharmacology;Blood Pressure/drug effects;Cocaine/pharmacology;Denervation;Dose-Response Relationship, Drug;Hydroxydopamines/pharmacology;Hypertension/physiopathology*;Male;Mesentery/metabolism;Myocardium/metabolism;Neurons/drug effects;Norepinephrine/analysis;Norepinephrine/pharmacology;Propranolol/pharmacology;Prostaglandins/pharmacology;Rats;Sympathectomy*;Tyramine/pharmacology
4438236;Diagnosis, Differential;Facial Neuralgia*/diagnosis;Headache*/diagnosis;Horner Syndrome/diagnosis;Humans;Migraine Disorders/diagnosis;Temporomandibular Joint Dysfunction Syndrome/diagnosis;Vascular Headaches/diagnosis
4441959;Enzyme Induction;Humans;Hypocalcemia/drug therapy;Hypocalcemia/etiology;Liver/enzymology;Liver Cirrhosis/complications;Liver Diseases/drug therapy*;Vitamin D/therapeutic use
4449417;Accidents;Autopsy;Blast Injuries/mortality*;Child;Explosions*;Humans;Male;Middle Aged
4456251;Child;Dehydration/therapy*;Glucose/administration & dosage;Glucose/therapeutic use*;Humans;Potassium/therapeutic use;Sodium Chloride/therapeutic use;Solutions
4473938;Acoustic Stimulation;Animals;Anticonvulsants/therapeutic use*;Brain/physiopathology;Chromatography, Gas;Cortical Synchronization;Diazepam/therapeutic use*;Dogs;Electroencephalography;Ethosuximide/therapeutic use*;Methyl Ethers;Phenytoin/therapeutic use*;Seizures/drug therapy*;Seizures/prevention & control;Trimethadione/therapeutic use*
4474819;Adenocarcinoma/complications*;Adnexal Diseases/complications*;Adult;Age Factors;Endometriosis/complications*;Female;Humans;Leiomyoma/complications*;Male;Middle Aged;Sarcoma/complications*;Uterine Cervical Neoplasms/complications;Uterine Neoplasms/complications*
4478416;Gastrointestinal Motility*;In Vitro Techniques;Intestine, Small/physiology*;Myenteric Plexus/physiology*
4480856;Animals;Cysts/veterinary*;Dog Diseases*;Dogs;Eye Diseases/veterinary;Iris*
4490214;Diet Therapy
4497722;Quality Control;Sterilization/methods*
4504528;Adult;Curettage;Diagnosis, Differential;Eosinophilic Granuloma/complications*;Eosinophilic Granuloma/diagnosis;Humans;Male;Mandibular Diseases/diagnosis;Mandibular Diseases/radiotherapy;Oral Manifestations*;Periodontitis/etiology*;Periodontitis/pathology;Periodontitis/therapy;Tooth Extraction
4508910;Adhesiveness;Dental Cements/standards*;Dental Stress Analysis;Surface Properties
4508932;Adsorption;Aluminum Hydroxide;Animals;Blood Chemical Analysis;Blood Coagulation/drug effects;Calcium;Cattle;Cysteine/pharmacology;Erythrocytes;Factor XIII/antagonists & inhibitors*;Fibrinogen;Hot Temperature;Humans;Plasma
4510131;17-Ketosteroids/urine;Adrenal Hyperplasia, Congenital/complications*;Adrenal Hyperplasia, Congenital/congenital;Adrenal Hyperplasia, Congenital/genetics;Adrenal Hyperplasia, Congenital/urine;Autistic Disorder/complications*;Cells, Cultured;Child;Child, Preschool;Humans;Karyotyping;Lymphocytes;Male;Osteosarcoma/complications*;Pregnanetriol/urine;Sex Chromosome Aberrations*
4513649;Exudates and Transudates/analysis;Fibrinogen/analysis;Fibrinogen/blood;Fibrinolysis*;Humans;Immunoassay;Immunoelectrophoresis;Keratins;Molecular Weight;Odontogenic Cysts/metabolism*;Odontogenic Cysts/pathology
4518316;Medical Laboratory Science;Nursing Care;Philosophy, Nursing;Social Change
4519118;Accidents, Traffic;Adult;Gastric Dilatation/etiology;Humans;Male;Pancreas/injuries*;Stomach Diseases/etiology
4526583;Education, Nursing/standards;New Zealand;Nursing Service, Hospital;Societies, Nursing
4529035;Adolescent;Adult;Child;Female;Humans;Infant;New Zealand;Orthoptics*/education;Vision Disorders/therapy*
4537421;Bacteriolysis;Centrifugation, Density Gradient;Cesium;Chlorides;DNA, Bacterial/analysis*;DNA, Bacterial/biosynthesis;DNA, Bacterial/isolation & purification;Genetics, Microbial;Haemophilus influenzae/analysis*;Haemophilus influenzae/cytology;Haemophilus influenzae/drug effects;Haemophilus influenzae/metabolism;Microscopy, Electron;Molecular Weight;Mutation*;Nitrogen Isotopes;Phosphorus Isotopes;Recombination, Genetic;Saponins/pharmacology;Sucrose;Transformation, Genetic*;Tritium
4538602;Child;Color Perception Tests;Color Vision Defects/epidemiology*;Female;Humans;Male;Sex Factors;United Kingdom
4542593;Animals;Antibody Formation;Antigen-Antibody Reactions*;Antilymphocyte Serum/pharmacology;Bone Marrow/immunology;Bone Marrow Cells;Cells, Cultured;Cortisone/pharmacology;Erythrocytes/immunology;Female;Hemocyanins;Histocompatibility;Male;Mice/immunology;Mice, Inbred CBA;Mollusca;Radiation Effects;Spleen/cytology;Spleen/radiation effects;T-Lymphocytes/immunology;Thymectomy;Thymus Gland/cytology;Thymus Gland/drug effects
4547177;5-Hydroxytryptophan/metabolism;Contraceptives, Oral/adverse effects*;Depression/chemically induced*;Depression/diagnosis;Depression/drug therapy;Depression/metabolism;Depression/prevention & control;Female;Humans;Pyridoxine/therapeutic use*;Serotonin/metabolism;Tryptophan/metabolism;Vitamin B 6 Deficiency/chemically induced;Vitamin B 6 Deficiency/drug therapy
4558184;Cerebral Hemorrhage/diagnosis*;Craniocerebral Trauma/history*;Craniocerebral Trauma/surgery;Dilatation;Europe;History, 16th Century;History, 17th Century;History, 18th Century;History, 19th Century;Pupil/pathology*
4559275;Adult;Fissure in Ano/surgery*;Humans;Male;Middle Aged;Skin Transplantation;Transplantation, Autologous
4565295;Diagnosis, Computer-Assisted*;Humans;Mass Screening*
4572118;Antibody Formation;Antilymphocyte Serum/therapeutic use;Azathioprine/therapeutic use;Cyclophosphamide/therapeutic use;Dialysis;Graft Rejection;Histocompatibility Testing;Humans;Immunosuppression;Kidney Transplantation*;Methylprednisolone/therapeutic use;Prednisone/therapeutic use;Transplantation Immunology*
4578564;Animals;Antibodies, Neoplasm;Antibodies, Viral;Carmustine/administration & dosage;Carmustine/therapeutic use*;Fluorescent Antibody Technique;Immunization, Passive*;Immunization, Secondary;Isoantibodies;Leukemia, Experimental/drug therapy;Leukemia, Experimental/microbiology;Leukemia, Experimental/therapy*;Male;Mice;Moloney murine leukemia virus*/immunology;Neutralization Tests;Sarcoma, Experimental/immunology
4593963;Acyltransferases/isolation & purification*;Acyltransferases/metabolism;Alanine;Ampicillin;Carbon Radioisotopes;Carboxypeptidases/isolation & purification*;Carboxypeptidases/metabolism;Cell Membrane/enzymology;Centrifugation, Density Gradient;Chromatography, Affinity;Chromatography, DEAE-Cellulose;Electrophoresis, Paper;Escherichia coli/cytology;Escherichia coli/enzymology*;Glycine;Hydrogen-Ion Concentration;Kinetics;Microscopy, Electron;Mutation;Osmolar Concentration;Peptidoglycan/biosynthesis;Solubility;Spectrophotometry;Spectrophotometry, Ultraviolet;Surface-Active Agents
4596518;Animals;Antigens, Bacterial;Complement Fixation Tests;Disease Vectors;Fluorescent Antibody Technique;Hemagglutination Tests;Humans;Immunization*;Military Medicine;Plague/prevention & control*;Plague Vaccine/pharmacology*;Rats;Rickettsia/immunology;Siphonaptera;Typhus, Epidemic Louse-Borne/immunology;United States;Vietnam;Yersinia pestis/immunology
4598245;Bone Neoplasms/drug therapy*;Bone Neoplasms/radiotherapy;Clinical Trials as Topic;Drug Therapy, Combination;Humans;Leucovorin/administration & dosage;Leucovorin/therapeutic use*;Methotrexate/administration & dosage;Methotrexate/adverse effects;Methotrexate/therapeutic use*;Neoplasm Metastasis;Osteosarcoma/drug therapy;Remission, Spontaneous;Sarcoma/drug therapy;Vincristine/therapeutic use
4603904;Aged;Anti-Inflammatory Agents/therapeutic use*;Benzophenones/therapeutic use*;Clinical Trials as Topic;Drug Evaluation;Female;Hip Joint*;Humans;Indomethacin/therapeutic use;Male;Middle Aged;Osteoarthritis/drug therapy*;Propionates/therapeutic use*
4604474;Beer;Carbohydrates;Drug Industry*;Fermentation*;Food-Processing Industry;Industrial Waste;Molasses;Sewage;Wine;Zea mays*
4618170;History, 20th Century;Neurosurgery/history;United States
4626564;Child Nutritional Physiological Phenomena;Child, Preschool;Diet;Female;Forecasting;Health Planning*;Humans;Infant;Infant Nutritional Physiological Phenomena;Male;Nutrition Disorders/prevention & control*;Nutrition Surveys;Nutritional Physiological Phenomena*;Pregnancy;Protein-Energy Malnutrition/prevention & control;Rural Health;Socioeconomic Factors;Time Factors;Urban Population
4633207;ABO Blood-Group System;Abortion, Spontaneous/immunology;Abruptio Placentae/immunology;Antibody Formation;Erythroblastosis, Fetal/immunology;Female;Fetus/immunology;Histocompatibility Antigens;Humans;Immunization;Isoantigens;Placenta/immunology;Pre-Eclampsia/immunology;Pregnancy;Pregnancy Complications/immunology*;Rh-Hr Blood-Group System
4641332;Alpha Particles*;Environmental Exposure;Humans;Lung;Maximum Allowable Concentration;Mining;Polonium*;Radiation Dosage*;Uranium
4650036;Art;Female;Humans;Personality*;Personality Inventory;Psychology;Science;Students*;Women*
4653342;Animals;Avoidance Learning;Behavior, Animal;Dark Adaptation*;Female;Photoreceptor Cells/physiology;Turtles/physiology*
4654103;Animals;Blood Circulation;Blood Vessels/physiology*;Blood Vessels/physiopathology;Dilatation;Dogs;Humans;Hyperemia/physiopathology;Hypoxia/physiopathology;Ischemia/physiopathology*;Vasomotor System/physiology
4657773;Adult;Amputation Stumps*;Arm*;Artificial Limbs*;Child;Forearm Injuries/rehabilitation;Hand*;Hand Injuries/rehabilitation;Humans
4667418;Cells/metabolism*;Glyoxylates/metabolism*
4674763;Adult;Humans;Hypertrophy;Male;Muscular Atrophy/complications;Muscular Atrophy/pathology;Nerve Tissue/pathology;Neuritis/complications;Neuritis/genetics*;Neuritis/pathology;Schizophrenia/complications*
4675537;Adrenal Cortex Hormones/urine;Adrenal Glands/physiopathology*;Female;Humans;Infant, Newborn*;Male;Pre-Eclampsia/complications*;Pregnancy;Time Factors
4678866;Biopsy, Needle*;Evaluation Studies as Topic;Humans;Methods;Thyroiditis, Autoimmune/diagnosis*
4679241;Acromegaly/metabolism*;Acromegaly/physiopathology;Adult;Arginine/pharmacology;Female;Growth Hormone/blood;Growth Hormone/secretion*;Humans;Hyperglycemia/chemically induced;Hypoglycemia/chemically induced;Hypothalamus/physiopathology;Insulin/pharmacology;Male;Middle Aged
4682589;Female;Humans;Intrauterine Devices*/adverse effects;Postpartum Period*;Pregnancy
4684066;Antibodies, Viral*/analysis;Hemagglutination Inhibition Tests;Hemagglutination, Viral*;Humans;Influenza Vaccines;Influenza, Human/epidemiology;Influenza, Human/immunology*;Influenza, Human/prevention & control;Orthomyxoviridae/immunology*;Recurrence;Vaccination
4684860;Adrenal Glands/physiology*;Blood Donors*;Humans;Hydrocortisone/blood*;Pituitary-Adrenal Function Tests;Stress, Psychological/blood
4693850;Adult;Aged;Female;Humans;Mexico;Middle Aged;Ovarian Neoplasms/epidemiology*
4699171;Abscess/epidemiology;Adolescent;Adult;Aged;Anal Canal/blood supply;Anus Diseases/epidemiology*;Condylomata Acuminata/epidemiology*;Eczema/epidemiology;Female;Fissure in Ano/epidemiology;Germany, West;Hemorrhoids/epidemiology;Humans;Intestinal Polyps/epidemiology*;Male;Middle Aged;Rectal Diseases/epidemiology*;Rectal Fistula/epidemiology;Rectal Neoplasms/epidemiology*;Rectal Prolapse/epidemiology;Thrombosis/epidemiology
4711343;Adult;Aged;Breast Neoplasms/urine*;Chromatography, Thin Layer;Estradiol/urine;Estriol/urine;Estrogens/urine*;Estrone/urine;Humans;Male;Middle Aged
4715124;Adolescent;Adult;Age Factors;Child;Female;Fingers;Humans;Iron/analysis*;Liver/analysis*;Male;Middle Aged;Nails/analysis*;Sex Factors;Spectrophotometry
4716083;Acoustic Stimulation;Auditory Perception*;Auditory Threshold;Discrimination (Psychology)*;Habituation, Psychophysiologic;Heart Rate;Humans;Infant, Newborn*;Pitch Discrimination;Probability;Reaction Time;Time Perception
4720878;Animals;Cell Line;Female;Foreign Bodies*;Humans;Karyotyping;Lymphoma*;Male;Mice;Mice, Inbred AKR;Mice, Inbred BALB C;Neoplasm Transplantation*;Oncogenic Viruses/isolation & purification;Plastics;Sarcoma/etiology*;Sarcoma/genetics;Sarcoma/microbiology;Sarcoma/pathology;Transplantation, Heterologous*
4722465;Acetates/metabolism;Adipose Tissue, Brown/metabolism*;Animal Nutritional Physiological Phenomena;Animals;Betaine/metabolism;Butyrates/metabolism;Carnitine/biosynthesis;Carnitine/metabolism*;Dietary Carbohydrates;Dietary Fats*;Fatty Acids/metabolism;Liver/metabolism*;Male;Myocardium/metabolism*;Oils/pharmacology;Organ Specificity;Propionates/metabolism;Rats;Seeds;Solubility;Triglycerides/metabolism;Tritium;Water;Zea mays
4722571;Administration, Oral;Aged;Amantadine/administration & dosage;Amantadine/therapeutic use;Aromatic Amino Acid Decarboxylase Inhibitors*;Biopharmaceutics;Brain/metabolism;Dihydroxyphenylalanine/administration & dosage;Dihydroxyphenylalanine/blood*;Dihydroxyphenylalanine/metabolism;Dihydroxyphenylalanine/therapeutic use;Drug Synergism;Evaluation Studies as Topic;Female;Humans;Hydrazines/administration & dosage;Hydrazines/therapeutic use*;Injections, Intravenous;Male;Motor Activity/drug effects;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism
4739197;Adolescent;Age Factors;Alaska;Child;Health Surveys;Humans;Substance-Related Disorders*/epidemiology
4744570;Animals;Captan/pharmacology;Chromosome Aberrations;Fungicides, Industrial/pharmacology;Genes, Lethal/drug effects;Genes, Recessive/drug effects;Hydrocarbons, Chlorinated/pharmacology;Indoles/pharmacology;Larva/drug effects;Male;Mosaicism/drug effects;Mutagens*;Mutation/drug effects;Sex Chromosomes/drug effects;Sulfides/pharmacology
4749313;Adult;Diabetes Mellitus*;Female;Humans;Male;Middle Aged
4752343;Clostridium/cytology*;Clostridium/metabolism;Culture Media;Cytoplasmic Granules*;Freeze Etching;Glucose/metabolism*;Microscopy, Electron;Polymers
4760491;Adaptation, Physiological;Animals;Carbon Radioisotopes;Cattle;Deoxycholic Acid/pharmacology;Epithelial Cells;Epithelium/enzymology;Hot Temperature;Hydrogen-Ion Concentration;Light;Lysosomes/enzymology;Microsomes/enzymology;Mitochondria/enzymology;Phosphatidylcholines/metabolism;Phosphatidylethanolamines/metabolism;Phospholipases/metabolism*;Photoreceptor Cells/enzymology*;Retina/cytology;Retina/enzymology*;Structure-Activity Relationship;Ultrasonics;Vitamin A/pharmacology
4761151;Adult;Aged;Arrhythmias, Cardiac/complications;Bronchitis/complications;Chronic Disease;Death, Sudden;Female;Heart Failure/complications;Humans;Intensive Care Units*;Male;Middle Aged;Myocardial Infarction/complications;Pulmonary Embolism/complications;Pulmonary Emphysema/complications;Respiratory Insufficiency/etiology;Respiratory Insufficiency/mortality*;Respiratory Insufficiency/therapy;Shock/etiology
4764106;Animals;Erythropoiesis/radiation effects*;Male;Rabbits;Radiation Effects*;Ultraviolet Rays*
4774989;Adolescent;Adult;Cell Division*;Ciliary Body/pathology;Corneal Ulcer/pathology;Eosinophils;Epithelial Cells;Eye Diseases/pathology*;Eye Foreign Bodies/pathology;Eye Neoplasms/pathology*;Female;Granulation Tissue/pathology;Humans;Hyperplasia;Male;Middle Aged;Neuroectodermal Tumors, Primitive, Peripheral/pathology*;Retina/pathology*;Retinal Detachment/pathology;Retinal Pigments*
4782565;Animals;Anthelmintics/therapeutic use;Cat Diseases*/diagnosis;Cat Diseases*/drug therapy;Cat Diseases*/pathology;Cat Diseases*/prevention & control;Cats;Female;Male;Metastrongyloidea;Nematode Infections/diagnosis;Nematode Infections/drug therapy;Nematode Infections/pathology;Nematode Infections/prevention & control;Nematode Infections/veterinary;Thiazoles/therapeutic use
4794586;Female;Growth Hormone/analysis;Growth Hormone/physiology*;Humans;Male;Pituitary Function Tests
4796387;Amino Acid Sequence;Amino Acids/analysis;Animals;Centrifugation, Density Gradient;Chemical Phenomena;Chemistry;Chickens;Chromatography, Gel;Chromatography, Ion Exchange;DNA/analysis;Electrophoresis, Polyacrylamide Gel;Hydrolysis;Male;Molecular Weight;Protamines/analysis*;Protamines/isolation & purification;RNA/analysis;Spectrophotometry, Ultraviolet;Spermatozoa/analysis*
4801453;Abortion, Induced;Abortion, Spontaneous;Contraception;Female;Humans;Pregnancy*;Pregnancy, Unwanted
4803819;Adult;Burns, Chemical/complications*;Caustics/adverse effects*;Child;Female;Gastrectomy;Gastritis/chemically induced*;Gastritis/diagnosis;Gastroscopy;Humans;Male;Middle Aged;Pyloric Stenosis/chemically induced;Suicide
4804837;Anhydrides/pharmacology*;Carbohydrates/blood;Cell Membrane/analysis;Cell Membrane/drug effects*;Chloromercuribenzoates/pharmacology*;Electrophoresis, Polyacrylamide Gel;Erythrocytes/analysis;Erythrocytes/cytology;Erythrocytes/drug effects*;Glycoproteins/blood;Guanidines/pharmacology;Humans;Lithium/pharmacology;Maleates/pharmacology;Mercury/pharmacology;Neuraminic Acids/blood;Organometallic Compounds/pharmacology;Peptides/isolation & purification*;Phospholipids/blood;Salicylates/pharmacology*;Sodium Dodecyl Sulfate;Sodium Hydroxide/pharmacology*;Succinates/pharmacology;Sulfonic Acids/pharmacology
4806346;Age Factors;Aged;Blood Glucose/analysis;Bornanes/administration & dosage;Bornanes/adverse effects;Bornanes/therapeutic use;Diabetes Mellitus/drug therapy*;Drug Hypersensitivity/etiology;Female;Humans;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Sulfonylurea Compounds/therapeutic use*;Time Factors
4806632;Arm/blood supply;Arteriovenous Shunt, Surgical/methods*;Brachial Artery;Humans;Renal Dialysis/methods*;Veins
4808188;Alcoholism/therapy;Costs and Cost Analysis;Fees, Medical;Foreign Professional Personnel;Heroin Dependence/drug therapy;Heroin Dependence/therapy*;Hospitalization;Humans;Kentucky;Methadone/therapeutic use;Rehabilitation Centers/manpower*
4814185;Aged;Arthroplasty*;Hip/diagnostic imaging;Hip/surgery*;Hip Joint*;Humans;Joint Prosthesis/instrumentation*;Methods;Orthopedic Fixation Devices;Postoperative Complications;Prosthesis Design*;Radiography
4820404;Arrhythmias, Cardiac/diagnosis*;Cardiac Catheterization;Electrocardiography;Electrodes;Heart Atria/physiopathology;Heart Conduction System/physiopathology*;Humans
4825891;Animals;Mandible/anatomy & histology*;Microscopy, Electron, Scanning;Molar/anatomy & histology;Montana;Paleodontology*;Primates/anatomy & histology*;Tooth/anatomy & histology
4831290;Animals;Brain/pathology;Encephalitis/pathology;Encephalitis/veterinary*;Female;Goats*;Toxoplasmosis, Animal/pathology*
4833257;Adaptation, Physiological;Color Perception;Fixation, Ocular*;Form Perception;Humans;Orientation*;Retina/physiology;Visual Perception*
4837499;Alkaline Phosphatase/secretion;Amylases/secretion;Animals;Dogs;Endopeptidases/secretion;Intestinal Secretions/enzymology*;Intestine, Small/enzymology*;Intestine, Small/secretion;Lipase/secretion;Physical Stimulation;Stimulation, Chemical;Sucrase/secretion
4843482;Adult;Aged;Cryosurgery*;Epistaxis/surgery*;Female;Humans;Male;Methods;Middle Aged;Recurrence
4843521;Adult;Creatinine;Cysts/diagnosis;Female;Humans;Kidney Diseases/diagnosis*;Kidney Function Tests;Liver Diseases/diagnosis;Male;Middle Aged;Pancreatic Cyst/diagnosis;Pancreatic Diseases/diagnosis;Polycystic Kidney Diseases/diagnosis*;Polycystic Kidney Diseases/diagnostic imaging;Radionuclide Imaging;Ultrasonography*;Urography
4845072;Computers;Czechoslovakia;Female;Hospital Administration*;Hospitals/utilization*;Humans;Information Services;Information Systems*;Male;Medical Records;Methods
4849227;Adolescent;Adult;Age Factors;Buttocks;Female;Humans;Lipomatosis/diagnosis*;Lipomatosis/pathology;Male;Nevus/diagnosis*;Nevus/pathology;Sex Factors;Skin Neoplasms/diagnosis*;Skin Neoplasms/pathology
4852732;Breast Neoplasms/mortality;Breast Neoplasms/pathology;Breast Neoplasms/surgery*;Female;Humans;Mastectomy
4855351;Antineoplastic Agents/toxicity*;Cell Count;Cell Survival/drug effects;Cells, Cultured/drug effects;Chlorpromazine/toxicity;Dactinomycin/toxicity;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Evaluation Studies as Topic;Fibroblasts/drug effects*;Humans;Lasers*;Rotenone/toxicity;Trypan Blue
4864564;Adult;Age Factors;Aged;Bone Diseases/etiology*;Bone Regeneration;Femoral Neck Fractures/complications;Femoral Neck Fractures/surgery*;Femur Head;Fracture Fixation*;Humans;Middle Aged;Necrosis/etiology;Postoperative Complications/diagnostic imaging;Prognosis;Pseudarthrosis/etiology;Radiography;Wound Healing
4871978;History, 16th Century*;Italy;Philosophy, Medical/history*
4872103;Adrenal Medulla/enzymology*;Animals;Catecholamines;Chromaffin System/metabolism;Cytoplasm;Dihydroxyphenylalanine/biosynthesis;Dopamine/biosynthesis;Epinephrine/biosynthesis*;Methylation;Mixed Function Oxygenases/metabolism;Norepinephrine/metabolism;Tyrosine/metabolism
4875595;Engraving and Engravings*;Germany;History, 17th Century;Medicine in the Arts;Religion*
4878278;Czechoslovakia;History, 20th Century;Internal Medicine/history;Universities/history
4882252;Disease Outbreaks*;History, 20th Century;Humans;Influenza, Human/epidemiology*;Influenza, Human/history;Orthomyxoviridae;Retrospective Studies
4884999;Awards and Prizes/history*;Citric Acid Cycle*;Coenzyme A/history*;Germany;History, 20th Century;United States
4893875;Abscess/etiology;Adolescent;Adult;Age Factors;Anti-Bacterial Agents/therapeutic use;Appendectomy*;Appendicitis/pathology;Child;Humans;Methods;Middle Aged;Pelvis;Postoperative Complications;Retrospective Studies;Subphrenic Abscess/etiology;Surgical Wound Infection/drug therapy;Surgical Wound Infection/epidemiology;Suture Techniques
4896459;Anti-Bacterial Agents/pharmacology*;Carbon Isotopes;Centrifugation, Density Gradient;Chloramphenicol/pharmacology;Erythromycin/pharmacology;Escherichia coli/metabolism*;Guanine Nucleotides/metabolism;Magnesium/pharmacology;Nucleosides/metabolism;Organophosphonates;Peptides;Phenylalanine;Puromycin/antagonists & inhibitors;Quaternary Ammonium Compounds/pharmacology;RNA, Bacterial/metabolism*;RNA, Transfer/metabolism*;Ribosomes/metabolism*;Stimulation, Chemical
4898044;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Bacteriological Techniques;Humans
4903614;General Surgery/history*;History, 20th Century;USSR
4904799;Auditory Cortex/physiopathology;Child;Deafness/genetics;Deafness/physiopathology;Ear Diseases/physiopathology*;Humans;Infant;Labyrinth Diseases/physiopathology;Male;Middle Aged;Neurilemmoma/physiopathology;Otitis/physiopathology;Peripheral Nervous System Neoplasms/physiopathology;Stapes Surgery;Vestibule, Labyrinth/physiopathology;Vestibulocochlear Nerve/physiopathology
4905988;Bacteriological Techniques;Drug Antagonism*;Fusidic Acid/pharmacology*;Hydrocortisone/pharmacology*;Oxygen Consumption;Staphylococcus/drug effects;Staphylococcus/metabolism
4909996;Humans;Kidney Transplantation*;Methods;Transplantation Immunology*;Transplantation, Homologous;Ultrasonography*
4913230;Adult;Brain/physiology*;Electric Stimulation*;Electroencephalography;Evoked Potentials*;Female;History, 19th Century;History, 20th Century;Humans;Male;Neurophysiology/history;Taste Buds/physiology*
4934860;Animals;Antacids/administration & dosage*;Antacids/adverse effects;Clinical Trials as Topic;Diet Therapy*;Duodenal Ulcer/therapy*;Humans;Milk*
4953855;Adult;Aged;Antihypertensive Agents/adverse effects;Antihypertensive Agents/therapeutic use*;Humans;Hypertension, Malignant/drug therapy*;Hypertension, Renal/drug therapy*;Male;Middle Aged;Pyelonephritis/complications
4954300;Drug Resistance, Microbial;Humans;In Vitro Techniques;Isoniazid/pharmacology*;Mycobacterium tuberculosis/drug effects*;Sputum
4955725;Animals;Clinical Trials as Topic;Dogs;Haplorhini;Humans;Motion Sickness/drug therapy*;Thiethylperazine/therapeutic use*
4959889;Animals;Biological Transport/drug effects*;Calcium/pharmacology*;Cell Membrane Permeability/drug effects*;Crustacea;Edetic Acid/pharmacology*;Electrophysiology;Lithium/pharmacology*;Muscles/physiology*;Sodium/pharmacology*;Tetrodotoxin/pharmacology;Toxins, Biological/pharmacology*;Tromethamine/pharmacology*
4960061;Absorption;Agglutination Tests;Animals;Antigens/analysis*;Erythrocytes/analysis*;Immune Sera;Immune Tolerance;Immunodiffusion;Mice;Rabbits;Salmonella typhimurium/analysis*;Swine
4960945;Animals;Calcium/pharmacology;Chondroitin/pharmacology*;Demeclocycline/pharmacology*;Dental Pulp/drug effects*;Dental Pulp Capping;Dogs;Gluconates/pharmacology*;Potassium Permanganate/pharmacology*;Sulfates/pharmacology;Triamcinolone/pharmacology*
4968704;Amino Acids/metabolism*;Animals;Animals, Newborn;Autoradiography;Endoplasmic Reticulum;Leucine/metabolism;Microscopy, Electron;Mitosis*;Pancreas/cytology;Pancreas/metabolism*;Phenylalanine/metabolism;Thymidine/metabolism;Tritium;Tryptophan/metabolism
4969562;Aged;Anemia/etiology;Blood Coagulation Disorders/etiology;Emulsions;Fats, Unsaturated/adverse effects*;Female;Fever/etiology;Gastrointestinal Hemorrhage/etiology;Hepatomegaly/etiology;Humans;Hyperlipidemias/etiology;Jaundice/etiology;Parenteral Nutrition/adverse effects*;Thrombocytopenia/etiology;Vomiting/etiology
4977836;Bacillus subtilis*;Bacteriophages;Dactinomycin/pharmacology*;Infection Control*;Phosphorus Isotopes
4998862;Adult;Aged;Humans;Middle Aged;Mycobacterium tuberculosis/isolation & purification;Tuberculosis, Pulmonary/microbiology;Tuberculosis, Pulmonary/mortality;Tuberculosis, Pulmonary/surgery*
4999590;Adult;Aged;Blood Group Antigens;Body Height;Color Vision Defects/genetics;Female;Genes, Recessive;Genetic Linkage;Genotype;Humans;Male;Middle Aged;Mucopolysaccharidosis IV/diagnostic imaging;Mucopolysaccharidosis IV/genetics*;Mucopolysaccharidosis IV/pathology;Pedigree;Radiography;Recombination, Genetic;Sex Chromosomes*
5004705;Alcoholism;Animals;Behavior, Animal/drug effects;Discrimination Learning/drug effects*;Ethanol/administration & dosage;Ethanol/blood;Ethanol/pharmacology*;Generalization (Psychology);Haplorhini;Humans;Macaca;Male;Memory, Short-Term/drug effects*;Size Perception;Time Factors;Visual Perception
5009430;Achievement;Adolescent;Adult;Aggression;Antisocial Personality Disorder;Criminal Psychology*;Educational Status;Employment;Family Characteristics;Forensic Psychiatry*;Humans;Male;Marriage;Mental Disorders/diagnosis*;Paraphilic Disorders;Prisons;Social Behavior;Social Conformity;Substance-Related Disorders;United States
5014591;Animals;Liver/enzymology*;Magnetics*;Male;Oxidoreductases/metabolism*;Rats
5015133;Arthritis, Rheumatoid/rehabilitation;Arthritis, Rheumatoid/therapy*;Exercise Therapy;Humans;Immobilization;Splints
5016390;Fractures, Bone/nursing*;Humans;Pelvic Bones/injuries*
5017679;Ammonia/biosynthesis;Bacteria/drug effects*;Bacteria/growth & development;Bacteria/metabolism;Benzofurans/pharmacology;Carbamates/pharmacology;Chlorine/pharmacology;Fumigation;Fungi/drug effects*;Fungi/growth & development;Fungi/metabolism;Hydrocarbons, Halogenated/pharmacology;Nematoda;Organothiophosphorus Compounds/pharmacology;Oxygen Consumption;Pesticides/pharmacology*;Soil Microbiology*;Sulfones/pharmacology;Sulfur/metabolism;Thiocyanates/pharmacology
5022938;Carbohydrate Metabolism, Inborn Errors/complications*;Feces/microbiology;Female;Fructose/metabolism*;Giardia/isolation & purification;Giardiasis/complications*;Humans;Infant;Microscopy, Electron;Mitochondria, Liver;Mitochondrial Swelling
5039654;Anti-Bacterial Agents/therapeutic use*;Antiviral Agents/therapeutic use*;Dihydroxyphenylalanine/therapeutic use*;Humans;Parkinson Disease/drug therapy*;Sulfonamides/therapeutic use*
5045134;Allied Health Personnel;Anesthesiology*;Hospital Administration*;Hospital Departments;Intensive Care Units*/manpower;Medical Staff, Hospital;Monitoring, Physiologic;Nursing Staff, Hospital;Patient Care Team;Personnel, Hospital/education;Renal Dialysis
5049147;Birth Injuries/etiology*;Brazil;Female;Humans;Infant, Newborn;Infant, Newborn, Diseases/etiology*;Obstetrical Forceps/adverse effects*;Ophthalmoscopy;Pregnancy;Retinal Hemorrhage/etiology*
5053738;Adult;Heart Failure/diagnosis;Humans;Male;Munchausen Syndrome*;Pennsylvania
5065366;Aggression*;Animals;Behavior, Animal;Cats;Electric Stimulation;Emotions;Humans;Hypothalamus/physiology*;Neural Inhibition;Optic Lobe, Nonmammalian/physiology*
5069148;Anesthesia, General*/adverse effects;Anesthetics/adverse effects*;Cerebral Angiography*/adverse effects;Cerebrospinal Fluid;Cerebrovascular Circulation/drug effects*;Cerebrovascular Disorders/chemically induced*;Contrast Media/adverse effects;Halothane/adverse effects;Humans;Hypercapnia/complications;Hypotension/complications;Ischemic Attack, Transient/chemically induced;Methods;Venous Pressure
5069205;Cholecystectomy;Disposable Equipment;Drainage;Gases;Gastrectomy;Humans;Intubation, Gastrointestinal*/instrumentation;Postoperative Care;Pylorus/surgery;Vagotomy
5076717;Amino Acid Sequence;Chromatography, Ion Exchange;Electrophoresis;Methods;Secretin/chemical synthesis*;Secretin/isolation & purification
5081392;Adult;Chromosome Aberrations*;Chromosomes/drug effects*;Cyclamates/administration & dosage;Cyclamates/toxicity*;Female;Humans;In Vitro Techniques;Lymphocytes/drug effects*;Lymphocytes/growth & development;Male;Middle Aged;Mitosis/drug effects;Sodium
5088408;Acetylcholine/metabolism;Animals;Benzopyrenes/metabolism;Chemical Phenomena;Chemistry;Cholinesterase Inhibitors/metabolism*;Electron Transport;Female;Guinea Pigs;Insecticides/metabolism*;Kidney/enzymology;Kidney/metabolism;Liver/enzymology;Liver/metabolism;Lung/enzymology;Lung/metabolism;Male;Mice;Organothiophosphorus Compounds/metabolism;Organothiophosphorus Compounds/poisoning;Oxidation-Reduction;Parathion/metabolism;Phenobarbital/metabolism;Phosphoric Acids/metabolism*;Rats
5091051;Drug-Related Side Effects and Adverse Reactions*;Female;Humans;Iatrogenic Disease*;Infant, Newborn;Medication Errors;Pregnancy;Pregnancy Complications*;Radiotherapy/adverse effects*
5091851;Absorption;Animals;Aorta/surgery;Body Weight;Bone Marrow/analysis;Dogs;Erythropoiesis;Gastrectomy;Hematopoiesis;Hemosiderin/analysis*;Hemosiderosis/etiology*;Hemosiderosis/physiopathology;Iron/blood*;Liver/analysis;Spleen/analysis;Tendons/surgery
5094161;Bipolar Disorder/blood;Blood Sedimentation*;Epilepsy/blood;Erythrocytes*;Hematocrit;Humans;Mental Disorders/blood*;Neurocognitive Disorders/blood;Neurotic Disorders/blood;Phenothiazines/therapeutic use;Schizophrenia/blood;Schizophrenia/drug therapy;Substance-Related Disorders
5108252;Drug and Narcotic Control;Humans;Legislation as Topic;Substance-Related Disorders/epidemiology*;United States
5109152;Asphyxia Neonatorum/therapy*;Brain Damage, Chronic/chemically induced;Humans;Infant, Newborn;Lung Diseases/chemically induced;Oxygen/blood;Oxygen Inhalation Therapy/adverse effects*;Pulmonary Surfactants/metabolism;Respiratory Distress Syndrome, Newborn/metabolism;Respiratory Distress Syndrome, Newborn/therapy*;Retinopathy of Prematurity/chemically induced*
5111380;Fractures, Bone/therapy*;Humans;Pseudarthrosis/etiology;Spinal Injuries/therapy*
5121428;Humans;Lung Compliance;Pulmonary Alveoli/physiopathology;Respiration*;Shock/physiopathology*
5130028;Cell Division*;Cycloheximide/administration & dosage;Cycloheximide/pharmacology;Depression, Chemical;Leucine/metabolism;Morphogenesis*;Paramecium/drug effects;Paramecium/growth & development*;Protein Biosynthesis*;Time Factors;Tritium
5130145;Adrenal Glands/anatomy & histology;Adrenalectomy;Animals;Anti-Inflammatory Agents/administration & dosage;Anti-Inflammatory Agents/therapeutic use*;Arthritis/prevention & control;Aspirin/therapeutic use;Benzoates/therapeutic use;Carrageenan;Cyproheptadine/therapeutic use;Drug Combinations;Edema/prevention & control;Erythema/prevention & control;Flufenamic Acid;Fluorine/therapeutic use;Granuloma/prevention & control;Guinea Pigs;Hindlimb;Hydrocortisone/therapeutic use;Indomethacin/therapeutic use;Male;Morphine/therapeutic use;Organ Size;Phenolphthaleins/blood;Phenylbutazone/therapeutic use;Pressure;Rats;Sulfonamides/therapeutic use*;Thymus Gland/anatomy & histology
5132606;Animals;Bone Marrow Cells;Chromosomes*;Diploidy;England;France;Italy;Karyotyping;Polymorphism, Genetic*;Rats/classification*;Switzerland
5150420;Female;Humans;Lymphography/adverse effects*
5155538;Automobiles*;Dust*;Environmental Exposure;Humans;Occupational Medicine*;Pneumoconiosis/epidemiology*;Resins, Plant/poisoning*
5167671;Animals;Australia;Dog Diseases/epidemiology*;Dogs;Quarantine;Rabies/epidemiology;Rabies/veterinary*
5169545;Animals;Estradiol/pharmacology;Estrus/drug effects*;Ethynodiol Diacetate/pharmacology*;Female;Fertilization/drug effects*;Pregnancy;Progesterone/pharmacology;Rats;Sexual Behavior, Animal/drug effects;Testosterone/pharmacology;Vaginal Smears
5171270;Curriculum;Education, Veterinary*;Finland;Food-Processing Industry*;Meat
5172981;Adoption;Humans;Schizophrenia/etiology*;Schizophrenia/genetics;Social Environment
5178101;Air Pollution, Radioactive*;Humans;Radiation Protection;Radioactive Fallout*;Radiochemistry;Radioisotopes*
5186201;Finland;Health Manpower/utilization;Humans;Nursing;Suicide/prevention & control
5187477;Asthma;Nursing
5198304;Acute Disease;Chemistry, Clinical*;Humans;Methods;Poisoning/diagnosis*;Toxicology
5199879;Diagnostic Services;Germany, West
5203003;Burns/nursing;Hospitals, Special;Nursing
5203099;Adenocarcinoma/diagnostic imaging*;Angiography*;Humans;Kidney Neoplasms/diagnostic imaging*;Renal Artery/diagnostic imaging;Renal Veins/diagnostic imaging
5203653;Achievement;Education, Nursing*;Educational Measurement/standards*;Societies, Nursing;United States
5209118;Absenteeism;Accidents, Occupational*;Adult;Age Factors;Chemical Industry*;Humans;Middle Aged;Yugoslavia
5217185;Humans;Leg;Vascular Diseases*
5224465;Cytodiagnosis;Dentistry;Mouth Neoplasms/diagnosis;Mouth Neoplasms/etiology;Neoplasm Metastasis
5245062;Dentistry;Denture, Complete
5246783;Adolescent;Adult;Female;Humans;Male;Odontogenic Tumors/pathology*
5260232;Electrochemistry/instrumentation;Gingiva/analysis*;Humans;Oxygen/analysis*;Partial Pressure*
5262753;Animals;Dental Pulp/transplantation*;Dentinogenesis*;Rabbits;Transplantation, Autologous
5263028;Alcoholism*/prevention & control;Alcoholism*/rehabilitation;Humans;Occupational Medicine*
5271030;Dental Offices;Dentistry;Efficiency;Ergonomics;Practice Management, Dental
5278307;Dental Caries/etiology*;Dental Caries Susceptibility*;Nephritis/complications*;Oral Manifestations
5299784;Adult;Female;Humans;Infection/drug therapy*;Injections, Intramuscular;Male;Middle Aged;Penicillins/adverse effects;Penicillins/metabolism;Penicillins/therapeutic use*
5305720;Adult;Arteries/pathology;Diagnosis, Differential;Female;Humans;Kidney Glomerulus/pathology;Lung/pathology;Metabolic Diseases/pathology*;Metabolism, Inborn Errors/pathology;Muscle, Smooth/pathology;Oxalates/metabolism*;Raynaud Disease/pathology;Skin/pathology;Urogenital System/pathology
5306740;Basement Membrane/pathology;Biopsy;Capillaries/pathology;Female;Humans;Kidney Glomerulus/pathology*;Nephrosis, Lipoid/pathology*
5307138;Acids;Chemistry, Pharmaceutical;Chromatography;Drug Stability*;Ergocalciferols*;Humidity;Hydrogen-Ion Concentration;Pharmaceutic Aids;Powders;Ultraviolet Rays
5310146;Aircraft*;International Cooperation;Mosquito Control*
5312482;Adult;Afibrinogenemia/etiology;Blood Coagulation Disorders/complications*;Female;Hemorrhagic Disorders/etiology*;Humans;Obstetric Labor Complications*;Postpartum Hemorrhage/etiology;Pregnancy
5321246;Ear/surgery*;Humans;Larynx/surgery*;Skin Transplantation*
5324099;Counseling;Humans;Muscles/enzymology*;Muscular Diseases/genetics*;Mutation
5331901;Amidohydrolases/pharmacology*;Animals;Antineoplastic Agents*;Escherichia coli/enzymology*;Mice;Neoplasms, Experimental*
5333789;Blood Pressure*;Female;Humans;Pre-Eclampsia/physiopathology*;Pregnancy
5336188;Follicle Stimulating Hormone;Gonadotropins, Pituitary*;Humans;Hypothalamo-Hypophyseal System/physiology*;Luteinizing Hormone;Prolactin
5345403;Aneuploidy*;Animals;Cell Differentiation;Chromosomes*;Crosses, Genetic;Drosophila;Female;Male;RNA, Messenger/biosynthesis;Spermatozoa/cytology;Spermatozoa/growth & development*
5351163;Abortion, Spontaneous/etiology*;Adult;Chromosome Aberrations/complications*;Chromosome Disorders;Female;Fetal Death/etiology;Gestational Age;Humans;Infant;Infant Mortality;Infant, Newborn;Pregnancy;Sex Chromosome Aberrations/complications;Trisomy
5354898;Adolescent;Adult;Africa, Eastern;African Continental Ancestry Group;Child;Child, Preschool;European Continental Ancestry Group;Female;Humans;Infant;Infectious Mononucleosis/epidemiology*;Infectious Mononucleosis/immunology;Male
5356319;Aged;Diagnosis, Differential;Electromyography;Female;Herpes Zoster/complications*;Humans;Male;Middle Aged;Paralysis/diagnosis;Paralysis/etiology*;Polyradiculopathy/etiology*;Prognosis;Reflex
5359365;Animals;Cadaver;Dogs;Kidney*;Kidney Function Tests;Perfusion/instrumentation*;Tissue Preservation/instrumentation*
5369761;Bronchial Fistula/surgery*;Fistula/surgery*;Foreign Bodies/complications*;Humans;Male;Middle Aged;Neck Injuries*;Thoracic Diseases/surgery*
5372537;Agriculture*;Germany, East;Humans;Occupational Health Services*
5393288;Animals;Brucella Vaccine;Brucellosis, Bovine/prevention & control*;Cattle;Costs and Cost Analysis;USSR;Vaccination/veterinary*
5398559;Achievement;Adolescent;Child;Child Behavior Disorders/therapy;Counseling*;Education of Intellectually Disabled*;Humans;Male;Psychotherapy, Group;Regression (Psychology);Social Adjustment;Social Class;Socioeconomic Factors;Verbal Behavior
5407098;Abortion, Septic/therapy;Abortion, Therapeutic*;Adolescent;Adult;Extraction, Obstetrical*;Female;Humans;Inhalation;Pregnancy
5409081;Animals;Cerebellum/analysis;Cerebral Cortex/analysis;Estradiol/blood;Estradiol/metabolism*;Estrus*;Female;Hypothalamo-Hypophyseal System/physiology;Hypothalamus/metabolism*;Muscles/analysis;Pituitary Gland/analysis;Pregnancy;Rats;Receptors, Drug;Tritium
5418366;Air Pollution, Radioactive;Chromium Isotopes;Lead;Poaceae/radiation effects*;Radiation Effects*;Radioisotopes;Seasons;Strontium Isotopes;Time Factors
5421429;Animals;Antibody Formation;Biological Assay*;Chinchilla*;Cholera Vaccines/analysis*
5426279;Antifungal Agents/therapeutic use;Autopsy;Biopsy;Burns/complications*;Candidiasis/complications*;Candidiasis/drug therapy;Child, Preschool;Female;Humans;Male;Skin
5427796;Adult;Athletic Injuries*;Eye Injuries*;Female;Humans
5429590;Acid Phosphatase/analysis;Alkaline Phosphatase/analysis;Animals;Brain Neoplasms/chemically induced;Brain Neoplasms/enzymology*;Disease Models, Animal;Enzymes/analysis*;Esterases/analysis;Glioma/chemically induced;Glioma/enzymology*;Glucuronidase/analysis;Histocytochemistry;Neoplasms, Experimental/chemically induced;Neurilemmoma/chemically induced;Neurilemmoma/enzymology*;Nitroso Compounds/pharmacology;Oligodendroglioma/chemically induced;Oligodendroglioma/enzymology;Rats
5439238;Butanones*;Chemical Phenomena;Chemistry;Cholestanes;Cycloparaffins*;Hydrocarbons, Halogenated;Infrared Rays;Magnetic Resonance Spectroscopy;Spectrum Analysis
5446415;Acrylic Resins;Chloramphenicol;Chlorothiazide;Delayed-Action Preparations*;Drug Compounding*;Glutarates;Hydrocortisone;Imides;Methods;Papaverine;Pentobarbital;Polymers;Solubility;Water
5465432;Abortion, Criminal*;Abortion, Legal*;Abortion, Septic/complications*;Adult;Affective Symptoms/etiology;Catatonia/etiology;Delirium/etiology;Female;Humans;Pregnancy;Psychotic Disorders/etiology*;Schizophrenia/etiology
5467385;Anesthesia, Spinal;Catheterization*;Diatrizoate/adverse effects*;Female;Humans;Middle Aged;Radiography;Spasm/chemically induced*;Subarachnoid Space/diagnostic imaging*
5471354;Arrhythmias, Cardiac/classification*;Arrhythmias, Cardiac/physiopathology;Computers*;Heart/physiopathology*;Humans;Mathematics;Models, Theoretical;Tachycardia/classification
5483303;Arthritis, Rheumatoid/physiopathology*;Body Temperature*;Humans;Knee/blood supply;Radionuclide Imaging*;Synovial Membrane/blood supply*;Technetium*;Thermography
5483317;Cosmic Radiation*;Humans;Radiation Effects*;Retina/radiation effects*;Space Flight*
5489122;Adolescent;Asthma/complications;Cystic Fibrosis/complications*;Female;Humans;Infant;Male;Marfan Syndrome/complications*;Pneumothorax/diagnostic imaging;Pneumothorax/etiology*;Pneumothorax/genetics*;Pulmonary Emphysema/complications;Pulmonary Fibrosis/complications;Radiography;Tuberous Sclerosis/complications
5490689;Animals;Cats;Digestive System/innervation*;Electromyography;Esophagus/innervation;Female;Gastrointestinal Motility;Male;Manometry;Mechanoreceptors/physiology*;Myelin Sheath;Nerve Fibers, Myelinated/physiology;Neural Conduction;Vagus Nerve/physiology*
5497270;Culture Media;Flavin Mononucleotide/metabolism;Flavin-Adenine Dinucleotide/metabolism;Flavins/biosynthesis*;Mycobacterium/metabolism*;Phosphorus/metabolism*
5508361;Animals;Bacillus/growth & development*;Biological Assay;Crowding*;Culex/growth & development*;Larva/growth & development;Metamorphosis, Biological;Pupa/growth & development;Time Factors
5509521;Costs and Cost Analysis;Humans;Insurance, Health*;Societies, Medical*;Switzerland
5513489;Cesium Isotopes;Cobalt Isotopes;Film Dosimetry;Glass*;Humans;Iridium;Methods;Radiation Monitoring*/instrumentation;Radioisotopes
5519468;Endoscopes*;Peritoneal Cavity*
5520577;Adenosine Triphosphate/metabolism*;Amino Acids/biosynthesis;Citrates/metabolism;Glycolysis;Metabolism;Thermodynamics
5521130;Amnion*;Endoscopy*;Female;Fetoscopy;Humans;Methods;Pregnancy;Pregnancy Complications/diagnosis*;Transillumination*
5524555;Carbon Dioxide/analysis;Computers*;Computers, Hybrid;Humans;Lung/physiology;Mass Spectrometry;Online Systems;Oscillometry;Oxygen/analysis;Physical Exertion;Pulmonary Ventilation;Respiratory Function Tests*;Ventilation-Perfusion Ratio
5529840;Acetates*;Amino Acids*;Chemical Phenomena;Chemistry;Stereoisomerism
5539178;Cross Infection/prevention & control;Hospital Design and Construction*;Humans;Staphylococcal Infections/epidemiology;Surgical Wound Infection/epidemiology*;Ventilation
5541909;Atrial Fibrillation/physiopathology*;Blood Flow Velocity
5542911;Chemical Phenomena;Chemistry
5547441;Coronary Care Units;Hospital Departments*;Humans;Intensive Care Units*;Monitoring, Physiologic*
5557543;Curriculum;Education, Medical, Graduate*;England;Family Practice/education*;Hospitals, General;Hospitals, Teaching;Schools, Medical*;Teaching
5566336;Chlorpromazine/administration & dosage*;Chronic Disease;Female;Hospitals, Psychiatric;Humans;Length of Stay;Middle Aged;Phenothiazines/metabolism;Psychiatric Status Rating Scales;Recurrence;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Substance Withdrawal Syndrome;Time Factors;Trifluoperazine/administration & dosage*
5567002;Accidents;Burns/diagnosis;Contusions/diagnosis;Fractures, Bone/diagnosis;Hemorrhage/diagnosis;Humans;Joint Dislocations/diagnosis;Wounds and Injuries/diagnosis*
5584804;Arrhythmias, Cardiac/drug therapy;Arrhythmias, Cardiac/therapy*;Digitalis Glycosides/therapeutic use*;Digitoxin/therapeutic use;Electric Countershock;Humans;Tachycardia, Paroxysmal/drug therapy*
5606722;Anuria/drug therapy*;Anuria/etiology;Female;Humans;Lidocaine/therapeutic use*;Middle Aged;Peritonitis/complications;Reflex;Shock/complications
5611749;Animals;Immunity;Influenza Vaccines*;Interferons/metabolism*;Mice;Orthomyxoviridae Infections/metabolism*;Viral Interference*
5613284;Adolescent;Adult;Calcium Metabolism Disorders/complications*;Decalcification, Pathologic;Dental Caries/etiology*;Female;Humans;Male;Middle Aged;Tuberculosis, Pulmonary/complications*
5621562;Animals;Blood Gas Analysis;Coronary Disease/metabolism*;Dogs;Glycogen/metabolism;Glycolysis*;Heart/drug effects;Iodoacetates/pharmacology*;Ischemia;Myocardium/metabolism*;Oxidation-Reduction*;Oxygen;Pressure
5627967;Animals;Chile;Embryonic and Fetal Development*;Female;Lizards/embryology*;Ovulation
5629823;Animal Diseases/prevention & control*;Animals;Zimbabwe
5647807;California;Minnesota;New York;Radiation Monitoring*;Washington;Water Pollution, Radioactive*
5648044;Adenocarcinoma/etiology*;Analysis of Variance;Epidemiologic Methods;Humans;Kidney Neoplasms/etiology*;Retrospective Studies;Smoking*
5655253;Animals;Intestinal Mucosa*;Intestine, Small*;Mathematics;Methods;Organ Size*;Rats
5665320;Formularies as Topic*;Pharmaceutical Preparations/standards*;Pharmacopoeias as Topic*;Pharmacy*;United States;United States Food and Drug Administration*
5667190;Animals;Chemical and Drug Induced Liver Injury;Dogs;Environmental Exposure;Fluorides/toxicity*;Fluorine/toxicity;Fluorocarbon Polymers/toxicity*;Guinea Pigs;Hot Temperature;Liver/pathology;Lung/pathology;Lung Diseases/chemically induced;Mice;Rabbits;Rats;Silicon/toxicity*;Time Factors
5667732;Aged;Elbow/injuries*;Female;Fracture Fixation/instrumentation;Humans;Male;Methods;Middle Aged;Ulna/injuries*
5668425;Anthracenes/radiation effects*;Cyclohexanes;Electricity*;Fluorescence*;Phenanthrenes/radiation effects*;Radiation Effects;Radiochemistry;Solutions
5673790;Adult;Female;Granuloma*;Humans;Lung Diseases*;Lung Neoplasms/diagnosis*
5690986;Animals;Carcinoma, Ehrlich Tumor/metabolism;Chromatography, Paper;Chromatography, Thin Layer;DNA, Neoplasm/metabolism*;Nitrogen;Nucleosides/pharmacology*;Oxides/pharmacology*;Phosphorus Isotopes;Thymidine/metabolism;Tritium
5700905;Cystadenoma/diagnostic imaging;Disorders of Sex Development/diagnostic imaging;Female;Humans;Hysterosalpingography;Ovarian Cysts/diagnostic imaging;Ovarian Diseases/diagnostic imaging*;Ovarian Neoplasms/diagnostic imaging;Ovary/abnormalities;Ovary/diagnostic imaging;Pneumoperitoneum, Artificial;Polycystic Ovary Syndrome/diagnostic imaging;Uterus/abnormalities
5703761;Adolescent;Adult;Brain Neoplasms/diagnosis*;Brain Neoplasms/diagnostic imaging;Brain Neoplasms/pathology;Child;Electroencephalography;Humans;Male;Methods;Middle Aged;Radiography;Thalamus*/diagnostic imaging;Thalamus*/pathology
5704541;Anticholesteremic Agents/pharmacology*;Arteriosclerosis/drug therapy*;Bibenzyls/pharmacology*;Cholesterol/blood*;Ethylamines/pharmacology*;Female;Humans;Hypolipidemic Agents/pharmacology;Lipid Metabolism*;Male;Vasodilator Agents/pharmacology*
5708210;Absorption;Acid-Base Equilibrium;Acute Disease;Dehydration/complications;Diarrhea, Infantile/complications;Gastrointestinal Diseases/metabolism*;Humans;Infant;Infant Nutrition Disorders/metabolism*;Infant, Newborn;Potassium;Sodium;Water-Electrolyte Balance
5709443;Adenoids;Adolescent;Bronchial Diseases/complications*;Child;Child, Preschool;Chronic Disease;Humans;Nasopharyngeal Diseases/complications*;Pneumonia/etiology*;Sinusitis/complications*;Tonsillitis/complications*
5721117;Hospitals;Humans;Kenya;Neoplasms/epidemiology*
5722304;Body Fluids/analysis;Calcium/analysis;Calcium/blood;Calcium/metabolism*;Calcium Isotopes;Humans
5723307;Animals;Arginase/analysis*;Arginine;Carbon Dioxide;Carbon Isotopes;Chemical Phenomena;Chemistry;Guanidines;Liver/enzymology;Methods;Rats;Urea;Urease
5743988;Adolescent;Adult;Allergens*;Antigens*;Female;Humans;Skin Tests;Streptococcus*;Uveitis/immunology;Uveitis/therapy
5747652;Acute Kidney Injury/therapy*;Humans;Kidney Failure, Chronic/therapy*;Kidneys, Artificial/utilization;Peritoneal Dialysis/utilization*;Time Factors
5748345;Adolescent;Age Factors;Child;Endocrine System Diseases/epidemiology*;Female;Humans;Italy;Male
5748769;Animals;Antiprotozoal Agents*;Cattle;Cattle Diseases/prevention & control*;Insecticide Resistance*;Insecticides*;Nigeria;Trypanosomiasis/prevention & control;Trypanosomiasis/veterinary*
5754127;Adult;Cesarean Section;Female;Fistula*;Humans;Postoperative Complications;Pregnancy;Puerperal Disorders;Uterine Diseases*
5767216;Curriculum*;Dermatology/education*;Education, Medical, Graduate*;Research;United States
5771002;Automation;Culture Techniques/instrumentation;Humans;Syringes*
5786846;Blood Flow Velocity;Computers;Gravitation;Models, Biological*;Models, Theoretical;Pressure;Pulmonary Alveoli/physiology*;Pulmonary Circulation*;Vascular Resistance
5791423;Animals;Assisted Circulation;Biomedical Engineering;Dogs;Heart Ventricles/surgery;Heart, Artificial*;Hemodynamics;Mitral Valve Insufficiency/epidemiology;Myocardium/pathology;Polymers;Polyurethanes;Postoperative Complications/epidemiology;Prostheses and Implants*
5795890;Adult;Carbon Dioxide/blood;Female;Humans;Lung Diseases/drug therapy*;Lung Diseases/physiopathology;Male;Middle Aged;Oxygen/blood;Prednisone/therapeutic use*;Radiography, Thoracic;Sarcoidosis/drug therapy*;Sarcoidosis/physiopathology;Spirometry
5799919;Animals;Cytoplasmic Granules;Histocytochemistry;Lizards/metabolism*;Microscopy, Electron;Microscopy, Fluorescence;Nialamide/pharmacology;Pineal Gland/cytology;Pineal Gland/drug effects;Pineal Gland/metabolism*;Reserpine/pharmacology;Serotonin/analysis;Serotonin/metabolism*
5808151;Beds;Body Temperature*;Body Temperature Regulation*;Child;Child, Preschool;Cold Temperature;Drug Hypersensitivity/complications;Environment;Fever/diagnosis;Hot Temperature;Humans;Hypothermia/diagnosis;Infant;Infant, Newborn;Infant, Premature;Medical Records;Methods;Monitoring, Physiologic*;Surgical Procedures, Operative;Temperature;Thermometers;Water
5819496;Animals;Feces/analysis;Female;Flavin Mononucleotide/metabolism*;Rats;Riboflavin/analysis;Riboflavin/metabolism*;Riboflavin/urine*
5821666;Adult;Aged;Arteriosclerosis/complications;Arteriosclerosis/metabolism*;Blood Proteins/analysis;Female;Glycoproteins/blood;Humans;Lipoproteins/blood;Male;Middle Aged;Tuberculosis, Pulmonary/complications;Tuberculosis, Pulmonary/metabolism*
5823715;Alkenes/metabolism*;Chemical Phenomena;Chemistry;Chemistry, Physical;Chromatography, Gas;Culture Media;Esters/metabolism;Fatty Acids/biosynthesis;Fatty Acids/metabolism*;Fatty Acids, Essential/metabolism;Fermentation;Hydro-Lyases/metabolism*;Infrared Rays;Keto Acids/biosynthesis;Linoleic Acids/metabolism;Methods;Oleic Acids;Optical Rotatory Dispersion;Pseudomonas/enzymology*;Pseudomonas/growth & development;Soil Microbiology;Spectrophotometry;Spectrum Analysis;Temperature;Time Factors;Triolein
5831784;Animals;Cineradiography;Dogs;Duodenum/physiology*;Electrophysiology;Gastric Mucosa;Manometry;Muscle, Smooth/physiology*;Stomach/physiology*
5836007;Animals;Blood;L-Lactate Dehydrogenase;Mice;Mycoplasma/pathogenicity*;Organ Size*;Spleen*;Splenectomy;Splenomegaly/etiology
5851791;Adult;Aneurysm/complications*;Aortic Aneurysm/complications*;Humans;Male;Subclavian Artery/physiopathology*
5856599;Adolescent;Adult;Child;Discrimination (Psychology)*;Humans;Intellectual Disability*;Middle Aged
5874106;Adolescent;Adult;Arthritis*;Brucellosis*;Female;Humans;Male;Middle Aged;Shoulder Joint*
5889070;Animals;Cartilage, Articular/pathology*;Immobilization*;Knee Joint/pathology*;Models, Biological;Osteoarthritis;Rats
5897229;Blood Banks*;California;Computers*;Humans;Information Systems*
5897267;Breast Neoplasms/radiotherapy*;Breast Neoplasms/surgery*;Female;Humans;Mastectomy*
5901045;Chemical Phenomena;Chemistry, Physical;Hyaluronic Acid*;Light*;Photometry;Serum Albumin, Bovine*
5906802;Acetazolamide/pharmacology*;Ammonia/metabolism*;Animals;Bicarbonates/pharmacology*;Carbonates/metabolism;Colorimetry;Diuresis;Hydrogen-Ion Concentration;In Vitro Techniques;Inulin/metabolism;Kidney Tubules/metabolism*;Kidney Tubules/physiology*;Mannitol/pharmacology;Rats;Sodium;Urine
5910919;Amines*;Chemical Phenomena;Chemistry;Polynucleotides*
5918848;Amino Acids/metabolism*;Animals;Diet Therapy;Drosophila/growth & development*;Drosophila/metabolism;Histidine/metabolism;Methionine/metabolism;Phenylalanine/metabolism
5926169;Adrenalectomy;Animals;Diabetes Mellitus, Experimental/metabolism*;Glucagon/pharmacology*;Glutamate Dehydrogenase/metabolism*;Hydrocortisone/pharmacology;In Vitro Techniques;Insulin, Long-Acting/pharmacology;Liver/enzymology*;Rats
5932252;Animals;Cattle;Cattle Diseases*;Glomerulonephritis/veterinary*
5940105;Humans;Reading*;Writing*
5943074;Humans;Posture*;Radiography;Scoliosis/surgery*
5943790;Animals;Cats;Cerebellum/physiology*;Electric Stimulation;Nerve Endings/physiology*;Spinal Cord/physiology*
5943943;Animals;Brain;Chick Embryo;Culture Techniques*;Encephalitis Viruses/metabolism*;Encephalitis Viruses/pathogenicity*;Fibroblasts;L Cells (Cell Line);Lipid Metabolism;Mice;Virus Cultivation*
5954156;Humans;Liver Diseases/drug therapy*;Liver Function Tests;Vitamins/therapeutic use*
5957598;Adult;Aged;Coronary Disease/rehabilitation*;Female;Humans;Male;Middle Aged;Prognosis;Psychological Tests;Psychology, Social
5975240;Animals;Anthelmintics/urine*;Chromatography, Thin Layer;Sheep/metabolism*;Spectrophotometry
5975848;Adolescent;Humans;Iris*;Leiomyoma/surgery*;Male
5984282;Adult;Aged;Anabolic Agents/therapeutic use*;Estradiol/therapeutic use*;Female;Humans;Male;Middle Aged;Osteoporosis/drug therapy*;Testosterone/therapeutic use*
5996441;Adult;Blood Vessels/pathology*;Granulomatosis with Polyangiitis/pathology*;Humans;Male;Necrosis/pathology*;Respiratory System/pathology*;Respiratory Tract Neoplasms/pathology*
5998648;Adolescent;Adult;Aged;Blood Preservation*;Blood Transfusion*;Bromides;Child;Child, Preschool;Citrates;Dehydration/therapy;Ethanol;Glucose;Hemorrhage/therapy;Humans;Hypoproteinemia/therapy;Middle Aged;Nitrofurazone;Plasma Substitutes*;Postoperative Care;Protein Hydrolysates;Shock, Surgical/prevention & control;Shock, Traumatic/therapy;Sodium Chloride;Solutions;Sucrose;Sulfacetamide;Surgical Procedures, Operative*
5999842;Autoanalysis;Buffers;Cholinesterase Inhibitors;Cholinesterases/analysis*;Electrochemistry;Hydrogen-Ion Concentration*;Kinetics;Methods;Tromethamine
6008953;Animals;Female;Fetal Death;Gases/toxicity*;Infertility, Female/etiology*;Liver/pathology;Lung/pathology;Pregnancy;Pregnancy, Animal*;Rats;Uterus/pathology;Welding*
6009988;Adolescent;Adult;Electrocardiography;Female;Humans;Male;Middle Aged;Radiography;Tricuspid Valve Insufficiency/diagnosis*;Tricuspid Valve Insufficiency/diagnostic imaging
6012901;ABO Blood-Group System;Acid Phosphatase*;African Americans;Australia;Blood Group Antigens*;Electrophoresis;European Continental Ancestry Group;Female;Genetics, Medical;Humans;Immune Sera;Male;New Guinea
6028444;Alcoholism/metabolism;Bone Neoplasms/metabolism;Feces/analysis;Humans;Hypothyroidism/metabolism;Magnesium/blood*;Magnesium/metabolism*;Magnesium/urine*;Radioisotopes;Tetany/metabolism*
6041124;Chemical Phenomena;Chemistry, Organic;Chemistry, Physical;Cysteine;Organic Chemistry Phenomena;Peptides*;Solutions;Spectrophotometry;Viscosity
6048572;Adaptation, Biological*;Animals;Nematoda*;Rats;Rodent Diseases
6049463;Amino Acids/analysis;Chromatography;Electrophoresis;Fluoresceins*;Insulin/analysis*;Spectrophotometry;Thiocarbamates*;Trypsin/pharmacology
6050082;Biological Transport, Active;Choline/metabolism*;Erythrocytes/metabolism*;Humans;In Vitro Techniques;Membrane Potentials;Sodium/metabolism
6060773;Duodenal Ulcer/surgery*;Female;Gastrectomy*;Humans;Jejunum*;Male;Middle Aged;Peptic Ulcer/surgery;Peptic Ulcer Perforation/diagnostic imaging;Peptic Ulcer Perforation/etiology*;Peptic Ulcer Perforation/surgery;Postoperative Complications*;Radiography
6075987;Animals;Folic Acid/metabolism*;Formates/metabolism*;Insecta/enzymology;Tetrahydrofolate Dehydrogenase/metabolism*
6076010;Asthma*;Bronchitis*;Chronic Disease;Humans;Pulmonary Emphysema*
6088260;Adrenocorticotropic Hormone/pharmacology*;Animals;Chorionic Gonadotropin/pharmacology;Male;Rabbits;Receptors, Cell Surface/drug effects;Receptors, LH;Stimulation, Chemical;Testis/drug effects*;Testis/secretion;Testosterone/secretion*
6100808;Animals;Catecholamines/physiology;Chemical Phenomena;Chemistry;Estrogens, Catechol/biosynthesis;Estrogens, Catechol/physiology*;Female;Follicle Stimulating Hormone/secretion;Humans;Luteinizing Hormone/secretion;Pituitary Gland, Anterior/secretion;Prolactin/secretion;Rats;Receptors, Estrogen/physiology
6104164;Adolescent;Adult;Aged;Australia;Female;Humans;Male;Middle Aged;Mitral Valve Prolapse/epidemiology*
6122431;Adrenergic beta-Antagonists/therapeutic use;Cardiomyopathies/physiopathology;Cardiomyopathies/therapy*;Cardiotonic Agents/therapeutic use;Heart Failure/physiopathology;Heart Failure/therapy*;Heart Ventricles/physiopathology;Humans;Prognosis
6125287;Adrenergic beta-Antagonists/therapeutic use*;Angina Pectoris/diagnostic imaging;Angina Pectoris/drug therapy*;Blood Pressure/drug effects;Cardiac Volume/drug effects;Chronic Disease;Echocardiography;Female;Humans;Male;Metoprolol/therapeutic use;Middle Aged;Myocardial Contraction/drug effects;Propranolol/therapeutic use;Radionuclide Imaging;Sotalol/therapeutic use;Stroke Volume/drug effects
6128984;Adult;Aged;DNA/blood*;Female;Humans;Male;Middle Aged;Polyarteritis Nodosa/blood*;Skin/blood supply;Vasculitis/blood
6138075;Adult;Anti-Anxiety Agents/therapeutic use*;Benzodiazepines/therapeutic use*;Clinical Trials as Topic;Double-Blind Method;Female;Humans;Hypnotics and Sedatives;Male;Midazolam;Sleep Initiation and Maintenance Disorders/drug therapy*;Triazolam/therapeutic use*
6138338;Adult;Arthritis, Reactive/diagnosis*;Arthritis, Reactive/drug therapy;Humans;Male
6151686;Amino Acid Sequence;Animals;Antigens, Protozoan/genetics;Cell Membrane/metabolism;Glycoproteins/genetics*;Glycoproteins/immunology;Glycoproteins/metabolism;Trypanosoma brucei brucei/genetics*;Trypanosoma brucei brucei/immunology;Trypanosoma brucei brucei/metabolism;Variant Surface Glycoproteins, Trypanosoma
6152906;Aged;Glutamates/metabolism*;Glutamic Acid;Humans;Leukocytes/metabolism;Olivopontocerebellar Atrophies/metabolism*
6160767;Adult;Female;Fluorescein Angiography;Humans;Injections, Intravenous;Male;Methylphenidate*;Middle Aged;Neovascularization, Pathologic;Retinal Detachment/complications;Retinal Diseases/diagnosis;Retinal Diseases/etiology*;Retinal Diseases/pathology;Retinal Vessels/pathology;Substance-Related Disorders/complications*;Talc/adverse effects*;Visual Acuity;Vitreous Body/surgery
6161028;Acetylcholinesterase/metabolism*;Animals;Histocytochemistry;Mice;Motor Endplate/enzymology*;Myelin Sheath/enzymology;Neuromuscular Junction/enzymology*;Neurons/enzymology;Silver Nitrate/pharmacology*;Staining and Labeling
6161658;Engineering;Technology;Vehicle Emissions*/adverse effects
6163587;Female;Gastrointestinal Diseases/etiology;Heart Diseases/etiology;Humans;Kidney Diseases/etiology;Lung Diseases/etiology;Male;Muscular Diseases/etiology;Palliative Care;Raynaud Disease/diagnosis*;Raynaud Disease/drug therapy;Raynaud Disease/physiopathology;Scleroderma, Systemic/complications;Scleroderma, Systemic/diagnosis*;Scleroderma, Systemic/drug therapy;Sex Factors;Skin Diseases/etiology
6175980;Adenocarcinoma/genetics;Androgen-Binding Protein/genetics*;Androgen-Binding Protein/isolation & purification;Animals;Carrier Proteins/genetics*;DNA, Circular/isolation & purification;Electrophoresis, Polyacrylamide Gel;Immunoelectrophoresis;Male;Models, Genetic*;Molecular Weight;Neoplasm Proteins/analysis;Nucleic Acid Hybridization;Prostate/analysis*;Prostatein;Prostatic Neoplasms/genetics;Protein Biosynthesis;RNA/isolation & purification;Rats;Secretoglobins;Transferrin/analysis;Uteroglobin
6178530;Acute Kidney Injury/physiopathology*;Animals;Dogs;Female;Indomethacin/pharmacology;Kidney/drug effects*;Male;Oligopeptides/toxicity*;Teprotide/pharmacology;Teprotide/toxicity*
6179514;Cell Cycle/drug effects;Cell Division/drug effects;Cell Line;DNA-Directed DNA Polymerase/metabolism*;Flow Cytometry;Glioma;Humans;Interferons/pharmacology*;Kinetics;Thymidine Kinase/metabolism*
6180895;Antibodies, Bacterial/analysis;Chromatography, Gel;Epitopes/isolation & purification*;Immunochemistry;Polysaccharides, Bacterial/immunology;Salmonella/immunology*
6183033;Amino Acid Sequence;Animals;Cloning, Molecular;DNA, Recombinant;Diabetes Mellitus/drug therapy*;Humans;Insulin/genetics*;Insulin/therapeutic use;Islets of Langerhans/analysis;Plasmids;RNA, Messenger/genetics;RNA-Directed DNA Polymerase/metabolism;Species Specificity;Swine
6183745;Adenosine Triphosphate/physiology;Animals;Axonal Transport*;Axons/physiology*;Biological Transport, Active;Cell-Free System;Cytoplasmic Granules/physiology;Cytoskeleton/physiology;Decapodiformes;Intracellular Membranes/physiology;Microscopy/methods;Microtubules/physiology;Motion Pictures
6185292;Amygdala/physiopathology*;Electrodes;Electroencephalography*;Epilepsy, Temporal Lobe/physiopathology*;Hippocampus/physiopathology*;Humans;Neural Pathways
6187210;Boston;Child;Developmental Disabilities/psychology*;Educational Measurement*;Female;Humans;Learning Disorders/psychology*;Male;Memory;Motor Skills;Self-Evaluation Programs*;Surveys and Questionnaires
6187583;Animals;B-Lymphocytes/immunology*;Cell Cycle;Cells, Cultured;Clone Cells;Female;Fluoresceins;Haptens;Humans;Kinetics;Lymphocyte Activation;Mice;Mice, Inbred CBA;Pregnancy;Spleen/immunology;gamma-Globulins/immunology*
6190814;Amino Acid Sequence;Animals;Bacteriophage lambda/genetics;Base Sequence;Brain/metabolism;Chick Embryo;Cloning, Molecular*;DNA/genetics*;DNA Restriction Enzymes;DNA, Recombinant/metabolism*;Genes*;Histones/genetics*;Liver/metabolism;Nucleic Acid Hybridization;Protein Biosynthesis;RNA/isolation & purification;Repetitive Sequences, Nucleic Acid
6191880;Adult;Africa;Asia;Australia;Europe;Female;Fetal Hemoglobin/analysis;Hemoglobin A/analysis;Hemoglobin A2/analysis;Hemoglobins, Abnormal/analysis*;Humans;Male;Middle East;North America;Pacific Islands;South America;Thalassemia/epidemiology*
6203366;1-Methyl-3-isobutylxanthine/pharmacology;Adrenergic beta-Agonists/pharmacology*;Adult;Alprostadil;Autacoids/pharmacology*;Calcimycin/pharmacology;Glucuronidase/secretion;Histamine/pharmacology;Humans;In Vitro Techniques;Lysosomes/enzymology*;Muramidase/secretion;N-Formylmethionine Leucyl-Phenylalanine/pharmacology*;Neutrophils/enzymology*;Prostaglandins E/pharmacology
6206675;Female;Humans;Male;Scalp/injuries;Scalp/surgery*;Skin Neoplasms/surgery;Surgery, Plastic/methods*;Surgical Flaps*;Wounds, Gunshot/surgery
6206821;Animals;Coronary Disease/metabolism*;Dogs;Fluorescent Antibody Technique;Gold;Myocardium/immunology;Myocardium/ultrastructure;Myoglobin/analysis*;Myoglobin/immunology;Staining and Labeling
6216664;Anti-Glomerular Basement Membrane Disease/therapy;Blood Group Incompatibility/therapy;Blood Viscosity;Humans;Immune Complex Diseases/therapy;Paraproteinemias/therapy;Plasma;Plasma Exchange*/methods;Plasmapheresis;Purpura, Thrombocytopenic/therapy;Serum Albumin/therapeutic use
6219030;Aged;Antihypertensive Agents/therapeutic use*;Cardiomegaly/drug therapy*;Chlorthalidone/therapeutic use*;Female;Humans;Male;Metoprolol/therapeutic use*;Middle Aged;Propanolamines/therapeutic use*
6221187;Accidents, Occupational;Acne Vulgaris/chemically induced;Dioxins/adverse effects*;Environmental Exposure;Germany, West;Humans;Italy;Military Medicine;Occupational Diseases/chemically induced;Polychlorinated Dibenzodioxins/adverse effects*;United States;Vietnam
6223873;Animals;Cardiac Output;Cardiomegaly/complications*;Cardiomegaly/pathology;Cardiomegaly/physiopathology;Coronary Circulation;Heart/physiopathology;Heart Failure/etiology*;Heart Failure/pathology;Humans;Hypertension/complications;Myocardial Contraction;Myocardium/pathology;Organ Size;Rats;Stroke Volume
6230037;Animals;Cytotoxicity Tests, Immunologic;Friend murine leukemia virus/immunology;Leukemia, Erythroblastic, Acute/immunology;Leukemia, Experimental/immunology*;Mice;Mice, Inbred DBA;Spleen/immunology;T-Lymphocytes/immunology*;T-Lymphocytes, Cytotoxic/immunology;T-Lymphocytes, Regulatory/immunology
6231222;Computers;Information Systems/organization & administration*;Management Information Systems/organization & administration*;Public Health Administration/methods*;Russia
6234823;Animals;Dominance, Cerebral/physiology;Facial Nerve/anatomy & histology*;Horseradish Peroxidase;Insectivora/anatomy & histology*;Mechanoreceptors/anatomy & histology;Moles/anatomy & histology*;Motor Neurons/ultrastructure*;Mouth/innervation*;Muscle Spindles/anatomy & histology;Muscles/innervation*;Nerve Fibers/ultrastructure;Raphe Nuclei/anatomy & histology;Shrews/anatomy & histology*
6234984;Abnormalities, Drug-Induced;Adult;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carmustine/administration & dosage;Female;Fetus/drug effects;Humans;Infant, Newborn;Lymphoma, Large B-Cell, Diffuse/drug therapy*;Male;Pregnancy;Pregnancy Complications, Neoplastic/drug therapy*;Pregnancy Trimester, First;Procarbazine/administration & dosage;Streptozocin/administration & dosage;Time Factors
6245117;Child;Child, Preschool;Collagen/metabolism;Dental Cementum/analysis;Dentin/analysis;Female;Glucuronidase/metabolism*;Glycosaminoglycans/analysis*;Humans;Lyases/metabolism*;Male;Microbial Collagenase/metabolism;Periodontal Ligament/enzymology*;Tooth Resorption/metabolism*;Tooth, Deciduous/analysis*;Tooth, Deciduous/injuries
6246745;Affinity Labels;Animals;Autoradiography;Benzodiazepines/metabolism*;Cerebral Cortex/metabolism*;Cerebral Cortex/ultrastructure;Diazepam/metabolism;Flunitrazepam/metabolism;Ligands;Niacinamide/metabolism;Photochemistry;Rats;Receptors, Drug/metabolism*;Receptors, GABA-A;Receptors, Neurotransmitter/metabolism*;Synaptosomes/metabolism
6253008;Carcinoma, Small Cell/pathology;Humans;Lung Neoplasms/pathology*;Neoplasm Metastasis;Neoplasm Staging/methods*;Prognosis
6277616;Animals;Benzopyrenes/toxicity;Bone Marrow/drug effects*;Diethylstilbestrol/toxicity;Environmental Pollutants/toxicity*;Erythropoiesis/drug effects;Female;Granulocytes/drug effects;Hematopoietic Stem Cells/drug effects;Macrophages/drug effects;Mice;Polybrominated Biphenyls/toxicity;Polychlorinated Dibenzodioxins/toxicity
6289488;Amidohydrolases/metabolism;Animals;Chromogenic Compounds/pharmacology;Dose-Response Relationship, Drug;Endotoxins/blood*;Humans;Limulus Test*;Oligopeptides/pharmacology;Perchlorates/pharmacology*
6300390;Animals;Dinoprost;Estrogens, Conjugated (USP)/blood*;Estrone/analogs & derivatives*;Estrone/blood;Female;Gonadotropins, Equine/blood*;Horses/physiology*;Pregnancy;Pregnancy, Animal*;Progesterone/blood*;Prostaglandins F/blood*;Radioimmunoassay;Time Factors
6301418;Aged;Diagnosis, Differential;Female;Humans;Neoplasms, Germ Cell and Embryonal/pathology*;Polyps/pathology*;Uterine Neoplasms/pathology*
6327484;Acute Disease;Adolescent;Adult;Aged;Antibodies, Viral/analysis;Epidemiologic Methods;Female;Greece;Hepatic Encephalopathy/epidemiology;Hepatitis A/diagnosis;Hepatitis B/diagnosis;Hepatitis B Antibodies/analysis;Hepatitis B Antigens/analysis;Hepatitis B Surface Antigens/analysis;Hepatitis C/diagnosis;Hepatitis, Viral, Human/diagnosis*;Hepatitis, Viral, Human/epidemiology;Hepatitis, Viral, Human/mortality;Hepatovirus/immunology;Humans;Immunoglobulin M/analysis;Male;Middle Aged
6329336;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors;Animals;Body Fluids/physiology;Cattle;Cyclic AMP/metabolism;Epididymis/physiology*;Hydrogen-Ion Concentration;Kinetics;Male;Semen/physiology;Sperm Count;Sperm Motility*;Spermatozoa/physiology;Viscosity
6329422;Animals;Atropine;Cats;Microinjections;Pain/physiopathology*;Pons/physiopathology*;Reaction Time;Receptors, Muscarinic/physiology*;Synaptic Transmission
6335095;Antigen-Presenting Cells/immunology;Clone Cells/immunology;Hemagglutinins, Viral/immunology;Histocompatibility Antigens Class II/immunology*;Humans;Influenza A virus/immunology;Major Histocompatibility Complex*;Receptors, Antigen, T-Cell/immunology*;Solubility;T-Lymphocytes/immunology*
6372227;Animals;Cat Diseases/surgery*;Cats;Dog Diseases/surgery*;Dogs;Emergencies;Female;Kidney Calculi/surgery;Kidney Calculi/veterinary;Male;Methods;Postoperative Care;Ureteral Calculi/surgery;Ureteral Calculi/veterinary;Urethral Obstruction/surgery;Urethral Obstruction/veterinary;Urinary Calculi/surgery;Urinary Calculi/veterinary*
6375897;Antibodies/isolation & purification;Antibody Specificity;Electrodes;Estradiol/analysis*;Humans;Immunoenzyme Techniques;Kinetics;Potentiometry/methods
6377262;Adolescent;Adult;Animals;Bone Diseases, Developmental/pathology*;Bone Neoplasms/diagnostic imaging;Bone Neoplasms/etiology*;Cell Differentiation;Cell Division;Cell Transformation, Neoplastic/pathology*;Child;Dogs;Female;Humans;Male;Neoplasm Staging;Radiography
6380830;Azides/pharmacology;Catalase/pharmacology;Humans;In Vitro Techniques;Neutrophils/drug effects;Neutrophils/immunology*;Phagocytosis/drug effects;Plasmodium falciparum/growth & development;Plasmodium falciparum/immunology*;Sodium Azide;Superoxide Dismutase/pharmacology;Tetradecanoylphorbol Acetate/pharmacology
6387389;Genes, Fungal*;Genes, Recessive*;Genotype;Mutation*;Phenotype;RNA, Ribosomal/genetics;RNA, Ribosomal/isolation & purification;Saccharomyces cerevisiae/genetics*;Transcription, Genetic
6390819;Autoantibodies/immunology;Blood Transfusion*;Female;Graft Rejection*;Humans;Isoantibodies/immunology;Kidney Transplantation*;Leukocytes/immunology*;Male
6394109;Female;Fetal Blood/analysis*;Folic Acid/blood;Folic Acid Deficiency/complications;Humans;Infant, Low Birth Weight*;Infant, Newborn;Postpartum Period;Pregnancy;Vitamins/blood*
6415176;Anti-Bacterial Agents/pharmacology;Blood Bactericidal Activity*;Drug Resistance, Microbial;Gentamicins/pharmacology*;Humans;In Vitro Techniques;Microbial Sensitivity Tests;Neutrophils/immunology;Neutrophils/physiology*;Phagocytosis*;Pseudomonas aeruginosa/drug effects;Pseudomonas aeruginosa/immunology*
6419773;Animals;Cattle;DNA/genetics;Euglena gracilis/drug effects;Euglena gracilis/genetics*;Euglena gracilis/growth & development;Genes/drug effects*;Histones/genetics*;Histones/isolation & purification;Molecular Weight;Thymus Gland/analysis;Zinc/pharmacology*
6423614;Adult;Aged;Bacterial Infections/drug therapy;Ceftazidime;Cephalosporins/toxicity*;Chromium Radioisotopes;Edetic Acid;Female;Glomerular Filtration Rate/drug effects;Half-Life;Humans;Kidney/drug effects*;Male;Middle Aged
6431480;Adolescent;Adult;Child;Decision Making*;Disease Outbreaks/epidemiology*;Epidemiologic Methods;Female;Humans;Male;Middle Aged;Product Labeling;Shock, Septic/epidemiology*;Shock, Septic/etiology;Tampons, Surgical/adverse effects*;United States;United States Food and Drug Administration
6433129;Animals;Animals, Newborn;B-Lymphocytes/drug effects;B-Lymphocytes/immunology*;Castration;Follicle Stimulating Hormone/blood;Glutamates/pharmacology*;Luteinizing Hormone/blood;Lymphocyte Activation;Male;Mitogens;Organ Size/drug effects;Rats;Rats, Inbred Strains;Sodium Glutamate/pharmacology*;Spleen/anatomy & histology;T-Lymphocytes/drug effects;T-Lymphocytes/immunology*;Thymus Gland/anatomy & histology
6433758;Adult;Aged;Alveolitis, Extrinsic Allergic/etiology;Alveolitis, Extrinsic Allergic/immunology*;Animals;Antibodies, Fungal/analysis;Antigens, Fungal/immunology;Birds/microbiology;Bronchial Provocation Tests;Child;Cross Reactions;Cryptococcus neoformans/immunology;Dust;Female;Fluorescent Antibody Technique;Humans;Immunodiffusion;Immunoglobulins/analysis;Male;Middle Aged;Mitosporic Fungi/immunology*;Skin Tests
6440516;Aged*;Attitude of Health Personnel;Communication*;Dentist-Patient Relations*;Humans
6448723;Anemia, Sickle Cell/immunology*;Animals;B-Lymphocytes;Humans;Leukocyte Count;Rabbits;Receptors, Fc;Rosette Formation;Splenectomy;T-Lymphocytes/classification*;T-Lymphocytes, Regulatory
6449966;Animals;Cattle;Chromatography, Gel;Chromatography, Ion Exchange;Chromatography, Thin Layer;Growth Inhibitors/isolation & purification*;Growth Inhibitors/physiology;Molecular Weight;Spectrophotometry, Ultraviolet;Spleen/analysis
6450144;Coronary Disease/etiology*;Fistula/etiology*;Humans;Male;Middle Aged;Myocardial Infarction/complications*
6454764;Acute Kidney Injury/diagnostic imaging;Aged;Blood Circulation;Bone Development;Bone and Bones/blood supply;Bone and Bones/diagnostic imaging*;Cardiac Output;Computers;Diphosphonates*;Edema/diagnostic imaging;Humans;Kidney Failure, Chronic/diagnostic imaging;Middle Aged;Radiographic Image Enhancement/methods;Radionuclide Imaging;Technetium*;Technetium Tc 99m Medronate;Technology, Radiologic
6457542;Societies, Scientific*;Terminology as Topic*
6460200;Adolescent;Adult;Age Factors;Aged;Child;Dyskinesia, Drug-Induced/epidemiology*;Dystonia Musculorum Deformans/drug therapy;Humans;Huntington Disease/drug therapy;Levodopa/adverse effects*;Male;Middle Aged;Pantothenate Kinase-Associated Neurodegeneration/drug therapy;Sex Factors
6469861;Adult;Defense Mechanisms;Fear*;Female;Humans;Middle Aged;Narcissism;Professional-Patient Relations;Schizoid Personality Disorder/psychology*
6470942;Administration, Oral;Biological Availability;Caffeine/administration & dosage;Caffeine/blood*;Chromatography, High Pressure Liquid/methods;Female;Humans;Kinetics;Male;Sex Characteristics;Tablets
6471656;Ampicillin/urine*;Cefoperazone/urine*;Gentamicins/urine*;Humans;Kinetics;Models, Biological;Time Factors
6480768;Chromatography, High Pressure Liquid/methods;Humans;Kinetics;Metoprolol/analogs & derivatives;Metoprolol/urine*
6482188;Child;Humans;Schistosoma haematobium/ultrastructure;Schistosomiasis/diagnosis*;Schistosomiasis/transmission;Snails/parasitology;Urinary Bladder Diseases/diagnosis*
6482798;Australia;Female;Hospitals, General;Humans;Male;Nursing Staff*;Respiration, Artificial*;Resuscitation*
6488872;Animals;Ascitic Fluid/physiopathology*;Hemorrhage/physiopathology;Infusions, Parenteral;Pancreatitis/complications;Pancreatitis/physiopathology*;Pulmonary Circulation*;Respiratory Insufficiency/etiology;Respiratory Insufficiency/physiopathology*;Swine
6494282;Animals;Blood Pressure;Cardiovascular System/physiopathology;Disease Models, Animal;Female;Heart Rate;Hypertension/etiology*;Hypertension/genetics;Hypertension/physiopathology;Macaca fascicularis;Male;Noise/adverse effects*
6494671;Accidents;Autopsy*;Body Temperature;Confidentiality;Forensic Medicine*;Humans;Legislation, Medical;Physicians, Family*;Poisoning/diagnosis;Registries;Rigor Mortis/pathology;Switzerland;Time Factors
6501598;Articulation Disorders/diagnosis*;Child;Humans;Phonetics*
6502402;Child, Preschool;Failure to Thrive/psychology*;Humans;Infant;Intelligence*;Longitudinal Studies;Memory;Pattern Recognition, Visual;Psychomotor Performance
6514432;Adolescent;Anorexia Nervosa/diagnosis;Anorexia Nervosa/therapy*;Behavior Therapy/methods;Body Image;Combined Modality Therapy;Energy Intake;Female;Follow-Up Studies;Hospitalization;Humans;Male
6516208;Age Factors;Animals;Cattle;Cattle Diseases/chemically induced*;Cattle Diseases/metabolism;Female;Lead/metabolism;Lead Poisoning/diagnosis;Lead Poisoning/metabolism;Lead Poisoning/veterinary*;Male;Seasons;Sex Factors;Species Specificity;Tissue Distribution
6520978;Aminopeptidases/blood*;Diagnosis, Differential;Factor Analysis, Statistical;Humans;Liver Diseases/diagnosis*;Liver Diseases/enzymology
6530042;Animals;Cattle;Disulfides/metabolism*;In Vitro Techniques;Isomerases/metabolism*;Mice;Protein Biosynthesis;Protein Disulfide-Isomerases;Protein Processing, Post-Translational*;Rats
6535305;Alanine Transaminase/blood;Alkaline Phosphatase/blood;Bile Acids and Salts/blood*;Chemical and Drug Induced Liver Injury*;Cholestasis/blood;Hepatitis, Viral, Human/blood;Humans;Liver Diseases/blood
6535996;Adult;Assertiveness;Behavior Therapy/trends*;Child, Preschool;Delivery of Health Care/trends;Female;Forecasting;Humans;Male;Mental Disorders/therapy;Private Practice/trends*;Professional-Patient Relations;Referral and Consultation/trends;United States
6542753;Child, Preschool;Drug Hypersensitivity/complications;Drug Hypersensitivity/diagnosis;Female;Food Hypersensitivity/complications;Food Hypersensitivity/diagnosis;Humans;Hypersensitivity/complications*;Otitis Media/etiology*;Otitis Media with Effusion/etiology*;Otitis Media with Effusion/therapy
6547983;Education, Medical, Graduate*;Foreign Medical Graduates/supply & distribution;Humans;Internship and Residency/supply & distribution;Osteopathic Medicine/education;Physicians, Women/supply & distribution;Statistics as Topic;United States
6548051;Animals;Chromium/administration & dosage;Chromium/metabolism*;Erythrocytes/metabolism;Injections, Spinal;Kidney/metabolism;Liver/metabolism;Male;Rabbits;Time Factors;Tissue Distribution
6550021;Acetaminophen/standards*;Drug Packaging/standards*;Nursing*;United States
6550813;Humans;Respiratory Distress Syndrome, Adult/etiology;Respiratory Distress Syndrome, Adult/physiopathology;Respiratory Distress Syndrome, Adult/therapy*
6551540;Adult;Breathing Exercises;Female;Humans;Internal-External Control;Labor Stage, First*;Labor, Obstetric*;Muscle Contraction*;Muscle Relaxation*;Natural Childbirth*;Obstetric Nursing;Practice (Psychology);Pregnancy;Teaching/methods;Uterine Contraction
6553800;Humans;Nurses/psychology*;Quality of Life*;Self Concept*
6556527;Antisepsis/methods*;Female;Humans;Male;Operating Room Nursing*;Skin/microbiology*
6558536;Bandages*;Humans;Pressure;Varicose Ulcer/therapy*
6564403;Nursing Care/standards*;Quality Assurance, Health Care*
6569692;France;Legislation, Nursing*
6582868;Adult;Counseling;Dental Occlusion;Female;Humans;Mastication;Medical History Taking;Patient Care Planning;Physical Examination;Physical Therapy Modalities;Splints;Temporomandibular Joint Disorders/diagnosis*;Temporomandibular Joint Disorders/physiopathology;Temporomandibular Joint Disorders/therapy
6587656;Adult;Aged;Cross Reactions;HLA Antigens/analysis*;HLA-A Antigens;HLA-B Antigens;Humans;Male;Middle Aged;Penile Induration/etiology;Penile Induration/immunology*
6591834;Anesthesia, General/instrumentation*;Humans;Monitoring, Physiologic;Ventilators, Mechanical*
6592091;Adolescent;Adult;Bicuspid/physiology*;Circadian Rhythm;Functional Laterality/physiology*;Humans;Male;Sensation/physiology*;Thermosensing/physiology;Time Factors;Touch/physiology
6601425;Acquired Immunodeficiency Syndrome/complications*;Acquired Immunodeficiency Syndrome/diagnostic imaging;Acquired Immunodeficiency Syndrome/pathology;Adult;Encephalitis/complications*;Encephalitis/diagnostic imaging;Encephalitis/pathology;Female;Haiti/ethnology;Humans;Male;Middle Aged;Retrospective Studies;Tomography, X-Ray Computed*;Toxoplasmosis/complications*;Toxoplasmosis/diagnostic imaging;Toxoplasmosis/pathology
6603573;Amino Acid Sequence;Anaphylatoxins*/pharmacology*;Animals;Binding Sites;Complement C3/pharmacology;Complement C3a;Complement C4*/pharmacology;Complement C4a;Guinea Pigs;Humans;Muscle Contraction/drug effects;Muscle, Smooth/drug effects;Oligopeptides/chemical synthesis;Oligopeptides/pharmacology;Peptide Fragments/pharmacology;Peptides*/pharmacology;Skin Tests
6604858;Adolescent;Adult;Child;Fructose Intolerance/diagnosis;Galactosemias/diagnosis;Hepatolenticular Degeneration/diagnosis;Humans;Infant, Newborn;Liver Diseases/etiology*;Metabolism, Inborn Errors/diagnosis*;Phenotype;Tyrosine/blood;alpha 1-Antitrypsin Deficiency
6604980;Animals;Cat Diseases/diagnostic imaging*;Cats;Dog Diseases/diagnostic imaging*;Dogs;Heart/diagnostic imaging*;Heart Diseases/diagnostic imaging;Heart Diseases/veterinary;Lung/diagnostic imaging*;Lung Diseases/diagnostic imaging;Lung Diseases/veterinary;Mediastinal Diseases/diagnostic imaging;Mediastinal Diseases/veterinary;Pleural Diseases/diagnostic imaging;Pleural Diseases/veterinary;Radiography, Thoracic/methods;Radiography, Thoracic/veterinary
6608389;Action Potentials/drug effects;Afferent Pathways/drug effects;Amino Acids/antagonists & inhibitors*;Animals;GABA Antagonists;Hydroxylation;In Vitro Techniques;Neural Inhibition/drug effects*;Picrotoxin/analogs & derivatives*;Picrotoxin/pharmacology;Rana catesbeiana;Reflex/drug effects;Spinal Cord/drug effects*;Structure-Activity Relationship
6620805;Biopsy/methods;Cardiac Care Facilities;Cardiac Surgical Procedures;Cardiomyopathies/pathology;Child;Child, Preschool;Heart Arrest, Induced;Humans;Infant;Microscopy, Electron;Myocardium/metabolism;Myocardium/pathology*;Myocardium/ultrastructure
6624292;Diagnosis, Differential;Female;Humans;Pregnancy;Pregnancy, Abdominal/diagnosis*;Pregnancy, Tubal/diagnosis*;Ultrasonography*
6643013;Adult;Cystadenocarcinoma/diagnostic imaging*;Cystadenoma/diagnostic imaging*;Female;Humans;Male;Middle Aged;Pancreatic Neoplasms/diagnostic imaging*;Tomography, X-Ray Computed
6643436;Animals;Cytochrome P-450 Enzyme System/isolation & purification;Cytochrome P-450 Enzyme System/metabolism*;Cytochrome b Group/isolation & purification;Cytochrome b Group/metabolism*;Cytochromes b5;Kinetics;Ligands;Male;Mathematics;Microsomes, Liver/metabolism*;Models, Biological;Protein Binding;Rats;Rats, Inbred Strains;Spectrophotometry;Thermodynamics
6646352;Animals;Dopamine/pharmacology;Dopamine/physiology*;Dose-Response Relationship, Drug;Injections, Intraventricular;Male;Mesencephalon/physiology*;Mice;Motor Activity/drug effects*;Tetrahydronaphthalenes/pharmacology;Time Factors
6647916;Child;Female;Humans;Measles/complications*;Mediastinal Emphysema/complications*;Mediastinal Emphysema/diagnostic imaging;Pneumothorax/complications*;Pneumothorax/diagnostic imaging;Radiography
6649295;Adolescent;Adult;Child;Child, Preschool;Diagnostic Errors;Diaphragm/injuries*;Female;Hernia, Diaphragmatic, Traumatic/diagnosis*;Humans;Male;Middle Aged
6650925;Anesthesia, Local/instrumentation*;Anesthetics, Local/administration & dosage*;Humans;Nasal Mucosa*
6653814;Action Potentials;Amygdala/physiology*;Animals;Cats;Electric Stimulation;Female;Male;Neurons/physiology;Ophthalmic Nerve/physiology;Skin/innervation
6654579;Animals;Gerbillinae*;Liver/pathology;Mice*;Rodent Diseases/parasitology;Rodent Diseases/pathology*;Schistosoma japonicum/growth & development*;Schistosomiasis/parasitology;Schistosomiasis/pathology;Schistosomiasis/veterinary*;Species Specificity
6658170;Humans;Myocardial Infarction*/enzymology;Myocardial Infarction*/etiology;Myocardial Infarction*/mortality;Myocardial Infarction*/pathology;Prognosis;Risk
6658180;Abdominal Neoplasms/pathology;Adolescent;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Child;Combined Modality Therapy;Humans;Leukemia/pathology;Lymphoma/pathology*;Lymphoma/therapy;Male;Mediastinal Neoplasms/pathology;Neoplasm Staging;Prognosis
6671502;Acetates/metabolism;Air Pollutants, Occupational/blood*;Chemical Phenomena;Chemistry;Humans;Solubility;Solvents/metabolism*
6679050;Adult;Appetite Depressants/adverse effects*;Female;Humans;Hypertension/chemically induced*;Middle Aged;Nonprescription Drugs/adverse effects*;Phenylpropanolamine/administration & dosage;Phenylpropanolamine/adverse effects*;Self Medication/adverse effects
6683566;Adult;Argon;Diabetic Retinopathy/surgery*;Electroretinography;Female;Humans;Laser Therapy*;Lasers*;Male;Middle Aged;Retina/surgery;Xenon
6684349;Humans;Tomography, X-Ray Computed;Ultrasonography;Urinary Bladder Neoplasms/diagnosis*;Urinary Bladder Neoplasms/immunology;Urinary Bladder Neoplasms/pathology
6687886;Animals;Blood*;Disinfectants/antagonists & inhibitors*;Fish Products*;Milk*;Solubility
6694342;Adhesives;Adolescent;Cystic Fibrosis/complications*;Drainage;Female;Fibrin/therapeutic use;Humans;Pneumothorax/etiology;Pneumothorax/therapy*
6694817;C-Reactive Protein/analysis*;Female;Humans;Obstetric Labor, Premature/diagnosis*;Pregnancy;Pregnancy Complications, Infectious/diagnosis*;Prospective Studies;Urinary Tract Infections/diagnosis*
6696777;Bursitis/diagnostic imaging*;Diagnosis, Differential;Female;Hip Joint/diagnostic imaging*;Humans;Middle Aged;Radiography
6699527;Electrocardiography/methods*;Heart/diagnostic imaging;Humans;Myocardial Infarction/diagnosis*;Radioisotopes;Radionuclide Imaging;Retrospective Studies;Thallium
6702475;Borderline Personality Disorder/diagnosis*;Depressive Disorder/diagnosis;Diagnosis, Differential;Electroencephalography*;Evoked Potentials;Humans;Male;Personality Disorders/diagnosis*
6712753;Aged;Calcinosis/etiology;Calcinosis/metabolism;Female;Humans;Intervertebral Disc/ultrastructure;Male;Middle Aged;Radiography;Renal Dialysis/adverse effects*;Spinal Diseases/diagnostic imaging;Spinal Diseases/etiology*;Spondylitis, Ankylosing/diagnostic imaging;Spondylitis, Ankylosing/etiology*
6713750;Electrocardiography;Heart Injuries/complications*;Heart Injuries/surgery;Hemodynamics*;Humans;Tricuspid Valve Insufficiency/etiology*;Tricuspid Valve Insufficiency/surgery
6724299;Animals;Female;Gene Frequency;Genes, Lethal*;Genetic Complementation Test;H-2 Antigens/genetics;Male;Mice/genetics*
6739151;Bacteroides fragilis/drug effects*;Cephalosporins/pharmacology*;Clavulanic Acid;Clavulanic Acids/pharmacology*;Drug Therapy, Combination;Metronidazole/pharmacology*;Penicillins/pharmacology*;Ticarcillin/pharmacology*
6741357;Carrier State/microbiology;Cholera/microbiology;Feces/analysis;Feces/microbiology;Household Articles*;Humans;Proteins/analysis;Solutions;Surface Properties;Time Factors;Vibrio cholerae/physiology*
6743812;Animals;Colloids;Gold;Leukemia, Experimental/pathology*;Male;Mice;Monocytes/physiology*;Phagocytosis*;Rauscher Virus;Spleen/pathology*
6744163;Canada;Education, Medical, Continuing;Electroconvulsive Therapy/trends*;Humans;Legislation, Medical
6753192;Candida albicans/drug effects;Candida albicans/growth & development;Candida albicans/ultrastructure*;Cell Division;Cell Nucleus*;Cold Temperature*;Heterozygote;Protoplasts
6755263;Bacterial Proteins/genetics*;Cloning, Molecular;Electrophoresis, Polyacrylamide Gel;Escherichia coli/genetics;Escherichia coli/radiation effects*;Molecular Weight;Mutation*;Plasmids*;Ultraviolet Rays
6782120;Adenosylhomocysteinase;Erythrocytes/enzymology;Humans;Hydrolases/antagonists & inhibitors;Hydrolases/deficiency*;Hypoxanthine Phosphoribosyltransferase/deficiency*;Immunologic Deficiency Syndromes/enzymology;Lymphocytes/enzymology;Pentosyltransferases/deficiency*;Phosphates/metabolism;Placenta/enzymology;Purine Nucleosides/metabolism;Purine-Nucleoside Phosphorylase/deficiency*;Purine-Pyrimidine Metabolism, Inborn Errors/enzymology*
6797628;Adolescent;Adult;Aged;Child;Child, Preschool;Drug Prescriptions*;England;Female;Humans;Infant;Male;Middle Aged;Patient Compliance*;Social Class
6798578;Animals;Chemical Phenomena;Chemistry, Physical;Cytosol/metabolism;Egtazic Acid/pharmacology;Hot Temperature;Kidney/metabolism;Leupeptins/pharmacology*;Male;Molybdenum/pharmacology*;Oligopeptides/pharmacology*;Rats;Rats, Inbred Strains;Receptors, Glucocorticoid/drug effects*;Receptors, Glucocorticoid/metabolism;Receptors, Steroid/drug effects*
6799757;Electrophoresis, Polyacrylamide Gel/methods;Fungal Proteins/analysis;Fungal Proteins/classification*;Methylococcaceae/analysis;Methylococcaceae/classification*;Phylogeny
6799801;Animals;Benzyl Compounds/pharmacology*;Biphenyl Compounds/pharmacology*;Drosophila melanogaster/drug effects;Drosophila melanogaster/genetics;Embryo, Nonmammalian/drug effects;Female;Larva/drug effects;Male;Mutagenicity Tests;Mutagens/pharmacology*;Mutation*;X Chromosome/drug effects
6800563;Anesthesia, General;Animals;Body Temperature;Brain Stem/physiology*;Carbon Dioxide/blood;Cats;Cerebral Cortex/physiology;Evoked Potentials/drug effects;Laryngeal Nerves/physiology*;Medulla Oblongata/physiology;Nerve Fibers/physiology;Neurons/physiology;Phrenic Nerve/physiology*;Pulmonary Stretch Receptors/physiology;Recurrent Laryngeal Nerve/physiology*;Respiration*/drug effects;Respiratory Center/physiology*
6803890;Adult;Angina Pectoris/drug therapy;Blood Pressure/drug effects;Drug Storage;Female;Heart Rate/drug effects;Humans;Nitroglycerin/therapeutic use*;Time Factors
6807755;Aging*;Animals;Body Weight;Calcium/metabolism*;Calcium/urine;Eating;Hybridization, Genetic;Intestinal Absorption;Lysine/deficiency*;Male;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL
6808355;Amino Acid Sequence;Amyloid/analysis*;Amyloid/immunology;Amyloidosis/metabolism*;Antigen-Antibody Reactions;Antigens/immunology;Humans;Immunodiffusion;Immunoglobulin kappa-Chains/immunology;Laryngeal Diseases/metabolism*;Male;Middle Aged
6826443;Abdomen;Animals;Atropine/administration & dosage;Atropine/adverse effects*;Colic/chemically induced;Colic/veterinary*;Female;Gastrointestinal Motility/drug effects;Horse Diseases/chemically induced*;Horse Diseases/drug therapy;Horses;Intestinal Obstruction/chemically induced;Intestinal Obstruction/veterinary*;Male;Pain/drug therapy;Pain/veterinary
6829758;Animals;Body Water/metabolism*;Epithelium/physiology;Furosemide/pharmacology;In Vitro Techniques;Kidney Tubules/physiology*;Kidney Tubules, Distal/drug effects;Kidney Tubules, Distal/physiology*;Kinetics;Nephrons/physiology;Perfusion;Sodium Chloride/metabolism*;Trout
6834216;Chlorofluorocarbons, Methane*;Ethylene Oxide/analysis*;Spectrophotometry, Infrared*;Sterilization*
6837238;Adolescent;Adult;Aged;Anesthesia, Inhalation;Brain/blood supply;Cerebrovascular Circulation/drug effects*;Female;Ferricyanides/pharmacology*;Hemodynamics/drug effects;Humans;Hypotension, Controlled*;Intracranial Aneurysm/surgery*;Male;Middle Aged;Nitroprusside/pharmacology*;Oxygen/blood;Regional Blood Flow/drug effects;Xenon Radioisotopes
6839668;Evoked Potentials, Visual/drug effects;Hot Temperature/therapeutic use*;Humans;Hypothyroidism/drug therapy;Hypothyroidism/physiopathology*;Median Nerve/physiopathology;Motor Neurons/physiology;Neural Conduction*/drug effects;Neurons, Afferent/physiology;Thyroxine/therapeutic use*;Ulnar Nerve/physiopathology
6843415;Automation/economics;Costs and Cost Analysis;Laboratories/economics*
6849371;Animals;Blood Pressure/drug effects*;Body Weight/drug effects;Calcium/blood;Coronary Vessels/drug effects;Desoxycorticosterone;Drinking;Female;Heart/drug effects*;Hypertension/chemically induced*;Hypertension/drug therapy;Kidney/drug effects*;Kidney/pathology;Myocardium/pathology;Organ Size/drug effects;Rats;Rats, Inbred Strains;Time Factors;Verapamil/blood;Verapamil/pharmacology*
6870946;Animals;Carbachol/pharmacology;Dose-Response Relationship, Drug;Epinephrine/pharmacology;Glycerol/metabolism;In Vitro Techniques;Parotid Gland/metabolism*;Pentobarbital/pharmacology*;Phosphatidic Acids/metabolism*;Phosphatidylinositols/metabolism*;Rats;Synaptosomes/metabolism;Veratridine/pharmacology*;Veratrine/analogs & derivatives*
6876569;Adult;Aged;Biocompatible Materials;Humans;Hypoxia/etiology*;Hypoxia/metabolism;Kidneys, Artificial*;Middle Aged;Oxygen/blood;Pulmonary Alveoli/metabolism;Renal Dialysis/adverse effects*;Renal Dialysis/methods;Solutions
6892672;Adolescent;Adult;Child;Female;Follow-Up Studies;Graves Disease/blood;Graves Disease/drug therapy*;Humans;Male;Methimazole/therapeutic use*;Propylthiouracil/therapeutic use*;Recurrence;Thyroid Function Tests;Thyrotropin/blood;Thyroxine/blood;Time Factors;Triiodothyronine/blood
6895257;Child;Female;Genetic Variation;Hemoglobins, Abnormal/genetics*;Humans;Kinetics;Male;Pedigree;Phenotype;Thalassemia/genetics*
6897420;Animals;Bone and Bones/drug effects;Bone and Bones/embryology*;Bone and Bones/metabolism;Calcifediol/pharmacology*;Calcitriol/pharmacology*;Calcium/metabolism;Chick Embryo;Kinetics;Organ Culture Techniques
6914006;Employment*;Female;Humans;Louisiana;Personnel Administration, Hospital/legislation & jurisprudence*;Physical Examination*;Radiography;Truth Disclosure;Tuberculosis, Pulmonary/diagnostic imaging*
6920397;Animals;Cadmium/administration & dosage*;Chickens/metabolism*;Copper/administration & dosage*;Copper/metabolism;Elastin/metabolism*;Iron/metabolism;Lung/anatomy & histology;Lung/cytology;Lung/metabolism*;Male;Pancreatic Elastase/metabolism;Trypsin/metabolism;Zinc/administration & dosage*;Zinc/metabolism
6924123;Adolescent;Child;Female;Health Education;Health Promotion*;Humans;Male;Smoking Prevention*;Substance-Related Disorders/prevention & control*
6926789;Female;Fetal Growth Retardation/etiology*;Humans;Infant, Newborn;Pregnancy;Pregnancy in Diabetics*
6936367;Biomechanical Phenomena;Cineradiography/methods*;Humans;Image Enhancement;Joint Dislocations/diagnostic imaging;Joint Dislocations/physiopathology;Mandibular Condyle/diagnostic imaging;Mandibular Condyle/injuries;Mandibular Condyle/physiopathology;Mandibular Fractures/diagnostic imaging*;Mandibular Fractures/physiopathology;Temporomandibular Joint/diagnostic imaging;Temporomandibular Joint/injuries;Temporomandibular Joint/physiopathology
6937815;Constitution and Bylaws;New York;Societies, Dental*
6938993;Aerosols;Animals;Capsules;Cricetinae;Delayed-Action Preparations*;Dental Caries/prevention & control*;Dogs;Humans;Membranes, Artificial;Methacrylates;Methylmethacrylates;Rats;Sodium Fluoride/administration & dosage;Tablets
6945365;Elasticity;Inlay Casting Wax*;Viscosity
6948077;Autonomic Nervous System Diseases/therapy*;Humans;Male;Middle Aged;Shy-Drager Syndrome/diagnosis;Shy-Drager Syndrome/pathology;Shy-Drager Syndrome/therapy*
6951648;Colombia;Culture Media;Dental Plaque/etiology;Dental Plaque/microbiology*;Dextranase/pharmacology*;Dietary Carbohydrates/metabolism*;Food;Humans;Streptococcus mutans/metabolism*
6960026;Group Practice, Dental/trends*;Practice Management, Dental;Private Practice/trends*
6961090;Aged;Denture Precision Attachment*;Denture, Overlay;Denture, Partial, Removable;Female;Humans;Jaw, Edentulous, Partially/rehabilitation*;Splints*
6961962;Adolescent;Adult;Aged;Analgesia/methods;Child;Electronarcosis/instrumentation;Electronarcosis/methods*;Face/surgery;Female;Humans;Jaw/surgery;Male;Middle Aged;Mouth/surgery;Temporomandibular Joint Disorders/therapy;Trigeminal Neuralgia/therapy
6968969;Allied Health Personnel/education*;Education, Continuing*;Idaho;Nurses*
6976555;Adolescent;Chromosome Fragile Sites;Chromosome Fragility*;Female;Genetic Markers;Heterozygote;Humans;Hyperkinesis/drug therapy;Intellectual Disability/genetics;Leucovorin/therapeutic use;Male;Prenatal Diagnosis;Sex Chromosome Aberrations/diagnosis;Testis/abnormalities;X Chromosome
6978672;Humans;Multiple Sclerosis/blood*;T-Lymphocytes/analysis*;T-Lymphocytes/classification;Time Factors
6984807;Acupuncture Therapy;Biofeedback, Psychology;Electric Stimulation Therapy;Humans;Manipulation, Orthopedic;Nerve Block;Pain, Intractable/therapy*;Physical Therapy Modalities;Psychotherapy;Sympathectomy
6993107;Animals;Cell Cycle;Cell Line;Centromere/ultrastructure;Chromosomes/ultrastructure*;Cricetinae;Cricetulus;Culture Media;Cytogenetics;Female;Fibroblasts;Fluorescent Antibody Technique;Hypotonic Solutions/pharmacology*;Male;Microtubules/ultrastructure;Mitosis*;Tubulin/immunology
7012513;Animals;Brain/metabolism*;Kinetics;Liver/metabolism*;Male;Methionine/metabolism;RNA, Ribosomal/biosynthesis*;Radioisotope Dilution Technique;Rats;Ribosomal Proteins/biosynthesis*;Ribosomes/metabolism*;Tritium;Uridine/metabolism
7017850;Diabetes Mellitus/physiopathology;Diabetes Mellitus/therapy*;Diet, Diabetic;Humans;Insulin/therapeutic use*;Insulin Resistance;Sulfonylurea Compounds/therapeutic use*
7029839;Administration, Oral;Adult;Biological Availability;Clinical Trials as Topic;Female;Humans;Male;Middle Aged;Potassium/administration & dosage;Potassium/metabolism*;Potassium/urine
7047298;Directories as Topic*;Genetics*;Societies, Scientific*;United States
7054520;Colic/diagnostic imaging*;Colic/etiology;Humans;Kidney Calculi/complications;Kidney Diseases/diagnostic imaging*;Kidney Diseases/etiology;Male;Middle Aged;Radiography
7063181;Evoked Potentials, Visual*;Form Perception/physiology*;Humans;Occipital Lobe/physiology*;Pattern Recognition, Visual/physiology*;Reaction Time/physiology
7084715;Industrial Waste/analysis*;Prognosis;Regression Analysis;Sanitation/methods*;USSR;Water Pollution/analysis*;Water Supply/analysis
7085663;Animals;Cells, Cultured;Chromatography, High Pressure Liquid;Concanavalin A;Kinetics;Lymph Nodes/metabolism;Lymphocyte Activation*;Lymphocytes/immunology*;Lymphocytes/metabolism;Methionine/metabolism;Methylation;Mice;Phospholipids/metabolism*;Spleen/metabolism;Swine;Thymus Gland/metabolism
7086599;Blood Flow Velocity;Blood Gas Analysis;Blood Pressure;Cerebral Hemorrhage/diagnosis;Cerebral Hemorrhage/physiopathology*;Cerebral Ventricles*;Cerebrovascular Circulation*;Humans;Infant, Newborn;Infant, Premature, Diseases/physiopathology*;Ultrasonography
7087713;Adolescent;Adult;Hot Temperature*;Humans;Hydrotherapy*;Kidney Function Tests*;Male;Temperature
7111428;Aged;Anticoagulants/therapeutic use;Hemodilution;Humans;Middle Aged;Postoperative Complications/therapy;Prognosis;Pulmonary Embolism/diagnosis;Rheology;Thrombophlebitis/diagnosis*;Thrombophlebitis/therapy;Ultrasonography
7115809;Ammonium Sulfate;Fibrin/isolation & purification*;Fibrin/metabolism;Fibrin Fibrinogen Degradation Products/isolation & purification*;Fibrin Fibrinogen Degradation Products/metabolism;Kinetics;Macromolecular Substances;Osmolar Concentration;Protein Binding
7129093;Animals;Chromosome Banding;Chromosomes/ultrastructure*;DNA Replication*;Drosophila/genetics*
7129338;Adolescent;Adult;Colonoscopy;Cross Reactions;Duodenoscopy;Endoscopy*;Female;Gastrointestinal Hormones/blood*;Gastroscopy;Humans;Male;Physical Stimulation;Radioimmunoassay;Vasoactive Intestinal Peptide/blood*;Vasoactive Intestinal Peptide/secretion
7138092;Child;Child, Preschool;Diagnosis, Differential;Humans;Infant;Infant, Newborn;Male;Spermatic Cord Torsion/diagnosis*;Spermatic Cord Torsion/pathology;Spermatic Cord Torsion/surgery;Testicular Diseases/diagnosis
7139035;Diffusion;Lasers;Lipid Bilayers*;Mathematics;Membrane Fluidity*;Models, Biological;Photolysis;Spectrometry, Fluorescence/methods
7147253;Adrenal Cortex/drug effects*;Adrenal Cortex/metabolism;Animals;Carbon Tetrachloride Poisoning/metabolism*;Corticosterone/blood;Female;Half-Life;Liver/metabolism;Rats;Rats, Inbred Strains
7149806;Arthritis, Rheumatoid/complications*;Bacteroides Infections*;Bacteroides fragilis;Humans;Male;Osteomyelitis/etiology*
7154038;Adolescent;Anemia, Aplastic/diagnosis*;Child;Child, Preschool;Congenital Abnormalities/diagnosis;Fanconi Anemia/diagnosis*;Fanconi Anemia/genetics;Female;Humans;Male
7156731;Aged;Aneurysm, Dissecting/surgery*;Aorta, Abdominal;Aorta, Thoracic;Aortic Aneurysm/surgery*;Female;Humans;Methods
7165189;Adult;Aged;Constriction*;Female;Humans;Male;Middle Aged;Pulmonary Embolism/etiology;Pulmonary Embolism/prevention & control*;Surgical Procedures, Operative/adverse effects*;Thromboembolism/prevention & control*;Vena Cava, Inferior*
7172197;Animals;Epithelial Cells;Intestine, Small/cytology*;Kinetics;Male;Mice;Mice, Inbred BALB C;Time Factors
7180203;Abscess/surgery;Child;Chronic Disease;Drainage;Gentamicins/therapeutic use;Humans;Methylmethacrylates/therapeutic use;Osteomyelitis/diagnostic imaging;Osteomyelitis/surgery*;Postoperative Complications/diagnostic imaging;Radiography
7192303;Adult;Breast Neoplasms/surgery*;Female;Hemangiosarcoma/surgery*;Humans;Mastectomy
7195586;Aggression/drug effects*;Amitriptyline/pharmacology;Animals;Antidepressive Agents, Tricyclic/pharmacology*;Clomipramine/pharmacology;Humans;Imipramine/pharmacology;Maprotiline/pharmacology;Mice;Social Isolation
7202846;Adenosine Triphosphate/metabolism;Animals;Cells, Cultured;Forelimb/innervation;Histones/metabolism*;Molecular Weight;Phosphorus Radioisotopes;Phosphorylation;Regeneration*;Salamandridae
7207176;Dementia/complications*;Dementia/etiology;Diagnosis, Differential;Fever of Unknown Origin/pathology*;Granuloma, Giant Cell/pathology;Humans;Lung Diseases/pathology;Male;Middle Aged;Pneumonia, Aspiration/diagnosis
7207714;Adolescent;Attitude of Health Personnel*;Day Care, Medical/psychology*;Humans;Mental Disorders/therapy*;Patient Care Team*;Psychotherapy*
7207915;Age Factors;Disease Susceptibility;Hearing Loss, Noise-Induced/diagnosis;Hearing Loss, Noise-Induced/etiology;Hearing Loss, Noise-Induced/prevention & control*;Hearing Tests;Humans;Noise, Occupational;Occupational Diseases/diagnosis;Occupational Diseases/etiology;Occupational Diseases/prevention & control*;Time Factors;Tinnitus/prevention & control
7210309;Education, Medical/standards*;Teaching/methods
7225439;Aldehydes;Catalysis;Flavin Mononucleotide*;Luciferases*;Luminescence;Oxidation-Reduction;Oxygen;Photobacterium/enzymology*
7232167;Autoantibodies/analysis*;Gastritis/immunology*;Gastritis/pathology;Humans;Stomach/immunology*;Stomach/pathology
7235568;Endocarditis, Bacterial/surgery*;Heart Valve Prosthesis*;Humans
7237059;Hemostasis, Surgical/methods*;Humans;Kidney/surgery*;Kidney Calices/surgery
7243149;Adolescent;Adult;Biopsy;Carcinoma/classification;Carcinoma/diagnosis;Carcinoma/surgery*;Cervix Uteri/surgery;Colposcopy;Cryosurgery*;Electrocoagulation;Female;Follow-Up Studies;Humans;Hysterectomy;Middle Aged;Uterine Cervical Dysplasia/classification;Uterine Cervical Dysplasia/diagnosis;Uterine Cervical Dysplasia/surgery*;Uterine Cervical Neoplasms/surgery*
7243350;Animals;Carbohydrates/analysis;Cytoplasm/ultrastructure;Hymenolepis/embryology;Hymenolepis/ultrastructure*;Membranes/analysis;Membranes/ultrastructure;Microscopy, Electron;Organoids/ultrastructure
7250854;Humans;Osteitis Deformans/therapy*
7253856;Radiographic Image Enhancement/instrumentation*;Technology, Radiologic
7263598;Drug Therapy, Combination;Humans;Hydralazine/administration & dosage*;Hypertension/drug therapy*;Propranolol/administration & dosage*
7268883;Antibody Formation/radiation effects*;Dose-Response Relationship, Radiation;Gamma Rays;Hodgkin Disease/radiotherapy;Humans;Lymphocytes/immunology;Lymphoid Tissue/radiation effects*;X-Rays
7269343;Adolescent;Adult;Aged;Biopsy, Needle*/adverse effects;Female;Humans;Kidney/pathology*;Kidney Diseases/diagnosis;Male;Middle Aged
7272446;Animals;Cell Membrane/metabolism;Cell Membrane Permeability*;Chlorides/metabolism*;Electric Organ/metabolism*;Kinetics;Light;Scattering, Radiation;Torpedo
7272814;Adult;Humans;Hymenolepiasis/drug therapy*;Intestinal Diseases, Parasitic/drug therapy*;Male;Niclosamide/therapeutic use*
7275421;Adolescent;Adult;Anterior Compartment Syndrome/diagnosis;Anterior Compartment Syndrome/etiology;Anterior Compartment Syndrome/surgery*;Compartment Syndromes/surgery*;Fasciotomy;Humans;Leg/surgery;Leg Injuries/complications*;Male;Methods;Middle Aged;Postoperative Complications
7278198;Animals;Arteries/injuries;Arteries/metabolism*;Biological Transport;Endothelium/cytology;Endothelium/metabolism;Models, Biological*;Particle Size;Permeability;Swine
7284239;Adult;Anemia/etiology*;Carboxyhemoglobin/metabolism;Carcinoma/blood*;Carcinoma/complications;Erythrocyte Count;Erythrocytes/physiology*;Female;Hemoglobinometry;Hodgkin Disease/blood;Humans;Lymphoma/blood*;Lymphoma/complications;Male;Middle Aged;Reticulocytes
7287202;Age Factors;Body Fluids/physiology;Body Temperature Regulation*;Desert Climate*;Female;Humans;Male;Sex Factors;Sweat/analysis;Sweat Glands/physiology;Sweating*
7299432;Animals;Biomechanical Phenomena;Cats;Electric Stimulation;Evoked Potentials;Iontophoresis;Nerve Fibers/drug effects;Nerve Fibers/physiology*;Neurons, Afferent/physiology;Neurons, Efferent/physiology;Potassium/administration & dosage;Potassium/pharmacology;Red Nucleus/physiology*;Spinal Cord/physiology*;Synapses/physiology*;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/pharmacology
7307172;Aged*;Czechoslovakia;Female;Humans;Interpersonal Relations*;Loneliness;Male;Residence Characteristics*;Social Isolation*
7313101;Educational Measurement*;Radiography/education*;Radiography/standards;United Kingdom
7321922;National Center for Health Care Technology (U.S.)*;Technology Assessment, Biomedical*;United States;United States Public Health Service*
7323922;ABO Blood-Group System/genetics*;Erythrocyte Membrane/immunology;Erythrocytes/classification*;Female;Humans;Male;Phenotype;Saliva/immunology
7337917;Abscess/complications;Abscess/veterinary*;Animals;Female;Fistula/etiology;Fistula/veterinary*;Hemiplegia/etiology;Hemiplegia/veterinary;Horse Diseases*/etiology;Horses;Laryngeal Diseases/complications;Laryngeal Diseases/veterinary*;Staphylococcal Infections/complications;Staphylococcal Infections/veterinary;Vocal Cord Paralysis/veterinary*
7340246;Electronics*;Equipment and Supplies;Humans;Lighting;Microcomputers;Occupational Medicine;Task Performance and Analysis*;Vision, Ocular*;Work
7354514;Adolescent;Adult;Aged;Cystoscopy*;Evaluation Studies as Topic;Female;Humans;Middle Aged;Recurrence;Urinary Tract Infections/diagnosis*;Urography*
7362960;Coronary Angiography*;Coronary Vessels/anatomy & histology;Heart/anatomy & histology;Humans;Models, Anatomic
7369484;Adolescent;Adult;Drug Therapy, Combination;Fasting;Female;Humans;Middle Aged;Obesity/diagnosis*;Obesity/etiology;Obesity/therapy;Pregnancy;Puerperal Disorders/diagnosis*;Puerperal Disorders/etiology;Puerperal Disorders/therapy
7390594;Abortion, Threatened/blood;Birth Weight;Copper/blood*;Female;Humans;Pre-Eclampsia/blood;Pregnancy;Pregnancy Complications/blood*;Zinc/blood*
7400418;Breast Diseases/pathology*;Collagen;Cytoplasm/ultrastructure;Female;Fibroblasts/ultrastructure;Humans;Keloid/pathology*;Microscopy, Electron;Middle Aged
7403755;Humans;Mouth Diseases/diagnostic imaging*;Radionuclide Imaging;Tomography, X-Ray Computed/methods*
7405788;Adolescent;Adult;Aged;Aorta/physiopathology*;Aortic Valve;Carotid Arteries/physiopathology;Child;Echocardiography*;Electrocardiography;Female;Heart Atria/physiopathology;Heart Block/diagnosis;Heart Valve Prosthesis;Humans;Kinetocardiography;Male;Middle Aged;Movement*;Phonocardiography;Pulse;Time Factors
7410554;Anesthesia;Animals;Catheterization;Electrodes, Implanted;Femoral Artery/metabolism*;Mathematics;Oxygen Consumption*;Rabbits;Regional Blood Flow;Time Factors
7411812;Bible*;Ethics, Medical*;Philosophy;Religion and Medicine*
7421354;Adrenal Gland Diseases/diagnosis*;Adrenal Gland Neoplasms/diagnosis;Female;Genital Diseases, Male/diagnosis*;Genital Neoplasms, Male/diagnosis;Humans;Male;Ultrasonography*;Urinary Bladder Diseases/diagnosis*;Urinary Bladder Neoplasms/diagnosis
7422931;Adolescent;Adult;Coronary Circulation*;Female;Hemodynamics;Humans;Male;Middle Aged;Mitral Valve Stenosis/physiopathology*;Myocardial Contraction
7424468;Fracture Fixation, Internal/instrumentation*;Fracture Fixation, Internal/methods;Humans
7424788;Community Pharmacy Services/trends*;Curriculum;Education, Pharmacy;Students, Pharmacy*
7431779;Bronchial Neoplasms/diagnosis*;Bronchoscopy/methods*;Color;Humans;Lung Neoplasms/diagnosis;Male;Methylene Blue;Middle Aged;Neoplasm Recurrence, Local/diagnosis*;Pneumonectomy
7431920;Animals;BCG Vaccine/adverse effects*;Colonic Neoplasms/therapy;Female;Immunotherapy/adverse effects;Lung Neoplasms/secondary*;Mice;Mice, Inbred BALB C;Neoplasms, Experimental/therapy
7432376;Clinical Competence/standards;Education, Medical/standards*;Educational Measurement/methods;Governing Board;Licensure, Medical*;United States
7438238;Adult;Aged;Breast/pathology*;Breast Diseases/pathology*;Female;Fibrocystic Breast Disease/pathology*;Foam Cells/pathology*;Humans;Macrophages/pathology*;Middle Aged
7438713;Adult;Airway Resistance*;Humans;Middle Aged;Psychophysics;Respiration;Respiration, Artificial*;Sensation/physiology*
7442909;Facial Injuries/complications*;Facial Injuries/surgery;Humans;Male;Middle Aged;Optic Chiasm/surgery*;Vision Disorders/etiology;Vision Disorders/surgery*
7443382;Female;Humans;Interpersonal Relations*;Male;Stress, Psychological/psychology*
7445713;Anesthesia*;Animals;Central Nervous System/physiopathology*;Models, Neurological;Nociceptors/physiopathology;Pain/etiology;Pain/physiopathology*;Syndrome
7460568;Animals;Horse Diseases/microbiology*;Horse Diseases/pathology;Horses;Lung/microbiology;Lung/pathology;Male;Nocardia/isolation & purification;Nocardia Infections/microbiology;Nocardia Infections/veterinary*;Pleurisy/microbiology;Pleurisy/pathology;Pleurisy/veterinary*;Pneumonia/microbiology;Pneumonia/pathology;Pneumonia/veterinary*
7460886;Aneuploidy*;Chromosomes/metabolism;Meiosis;Mutagenicity Tests*;Nucleolus Organizer Region;Pollen*;Zea mays/genetics*
7467156;Adult;Coronary Disease/blood;Coronary Disease/complications*;Female;Humans;Hyperlipoproteinemias/complications*;Lipids/blood;Lipoproteins/blood;Male;Middle Aged;Myocardial Infarction/blood;Myocardial Infarction/complications*
7467586;Benzothiadiazines;Diuretics/therapeutic use*;Furosemide/therapeutic use;Glomerular Filtration Rate/drug effects;Humans;Kidney/drug effects;Kidney Failure, Chronic/drug therapy;Sodium Chloride Symporter Inhibitors/therapeutic use;Water-Electrolyte Balance/drug effects*
7474847;Adult;Duodenal Ulcer/complications*;Follow-Up Studies;Humans;Middle Aged;Occupations;Peptic Ulcer Perforation/etiology;Peptic Ulcer Perforation/surgery*;Stomach Ulcer/complications*;Sutures;Time Factors
7493552;Animals;Cell Survival/drug effects;Glutathione/physiology*;Glutathione/toxicity;In Vitro Techniques;Kidney Cortex/cytology;Kidney Cortex/metabolism*;Liver/cytology;Liver/metabolism*;Male;Mitochondria/drug effects*;Mitochondria, Liver/drug effects;Oxidation-Reduction;Oxygen Consumption/drug effects;Rats;Rats, Inbred F344;Solvents/metabolism*;Solvents/toxicity;Subcellular Fractions/drug effects;Subcellular Fractions/metabolism;Trichloroethylene/metabolism*;Trichloroethylene/toxicity
7504098;Adult;Behavior/drug effects;Humans;Hydromorphone/pharmacology;Male;Methadone/therapeutic use*;Naloxone/pharmacology;Pentazocine/adverse effects*;Psychomotor Performance/drug effects;Substance Withdrawal Syndrome/drug therapy*;Time Factors
7504889;Antibodies, Monoclonal;Cell Adhesion Molecules/analysis;Cell Adhesion Molecules/physiology;Cells, Cultured;Dose-Response Relationship, Drug;E-Selectin;Endothelium, Vascular/chemistry*;Endothelium, Vascular/cytology*;Endothelium, Vascular/metabolism;Flow Cytometry;Fluorescent Antibody Technique;Humans;Iodine Radioisotopes;Molecular Weight;Precipitin Tests;Receptors, Tumor Necrosis Factor/analysis*;Receptors, Tumor Necrosis Factor/chemistry;Receptors, Tumor Necrosis Factor/physiology*;Tumor Necrosis Factor-alpha/analysis;Tumor Necrosis Factor-alpha/metabolism;Tumor Necrosis Factor-alpha/pharmacology*
7506955;Adolescent;Adult;Child;Child, Preschool;Erythropoiesis*;Erythropoietin/blood*;Female;Fetal Hemoglobin/analysis*;Humans;Infant;Male;Receptors, Transferrin/analysis;beta-Thalassemia/blood*
7512838;Adolescent;Adult;Aged;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Bacterial Infections/prevention & control;Double-Blind Method;Female;Granulocyte Colony-Stimulating Factor/adverse effects;Granulocyte Colony-Stimulating Factor/therapeutic use*;Humans;Leukemia, Myeloid, Acute/blood;Leukemia, Myeloid, Acute/drug therapy*;Leukemia, Myeloid, Acute/mortality;Male;Middle Aged;Neutrophils/drug effects;Prospective Studies;Survival Rate
7514166;Alkaloids/pharmacology;Amino Acid Sequence;Antibodies;Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors*;Calcium-Calmodulin-Dependent Protein Kinases/isolation & purification;Cell Line;Electrophoresis, Polyacrylamide Gel;Ethers, Cyclic/pharmacology*;Glycogen Synthase Kinase 3;Humans;Immunoblotting;Kinetics;Molecular Sequence Data;Molecular Weight;Okadaic Acid;Oligopeptides/chemistry;Oligopeptides/immunology;Phosphoprotein Phosphatases/antagonists & inhibitors*;Phosphotyrosine;Protein Kinase C/antagonists & inhibitors;Staurosporine;Tumor Cells, Cultured;Tyrosine/analogs & derivatives*;Tyrosine/metabolism
7518544;Animals;Biological Factors/blood*;Blood Platelets/metabolism;Blood Pressure/physiology;Calcium/blood;Diet, Reducing;Female;Humans;Male;Obesity/blood;Obesity/diet therapy;Rats;Rats, Sprague-Dawley;Vascular Resistance/physiology;Weight Loss/physiology*
7522785;Alcohols/pharmacology;Alcohols/therapeutic use;Animals;Aspirin/analogs & derivatives;Aspirin/pharmacology;Cattle;Dose-Response Relationship, Drug;Drug Evaluation;Drug Evaluation, Preclinical;Electrophysiology;Humans;In Vitro Techniques;Ischemia/physiopathology;Leg/blood supply;Liver Diseases/drug therapy;Liver Diseases/physiopathology;Lymph/drug effects;Lymph/physiology;Lymphatic System/drug effects;Lymphatic System/physiopathology*;Male;Muscle Contraction/drug effects;Muscle Contraction/physiology;Muscle, Smooth/drug effects;Muscle, Smooth/physiopathology;Salts/pharmacology;Salts/therapeutic use;Stress, Physiological/physiopathology*;Temperature
7525715;Animals;Base Sequence;Cytokines/immunology*;Enzyme-Linked Immunosorbent Assay;Epitopes/immunology;Female;Flow Cytometry;Granulocyte-Macrophage Colony-Stimulating Factor/immunology;Immunoglobulin Idiotypes/immunology*;Interleukin-2/immunology;Interleukin-4/immunology;Mice;Mice, Inbred C3H;Molecular Sequence Data;Neoplasms, Experimental/immunology*;Recombinant Fusion Proteins/biosynthesis;Recombinant Fusion Proteins/immunology*;Vaccines, Synthetic/biosynthesis;Vaccines, Synthetic/immunology*
7532080;6-Ketoprostaglandin F1 alpha/biosynthesis;Amino Acid Oxidoreductases/analysis*;Animals;Blotting, Western;Carrageenan;Dinoprostone/biosynthesis;Immunohistochemistry;Isoenzymes/analysis*;Male;Nitric Oxide Synthase;Pleurisy/chemically induced;Pleurisy/enzymology*;Prostaglandin-Endoperoxide Synthases/analysis*;Rats;Rats, Wistar
7535048;Adrenergic Agonists/pharmacology;Animals;Cholinergic Agonists/pharmacology;Male;Rats;Rats, Sprague-Dawley;Saliva/enzymology;Saliva/secretion;Salivary Proteins and Peptides/agonists*;Salivation/drug effects*;Salivation/physiology;Serine Endopeptidases/agonists;Stimulation, Chemical;Submandibular Gland/drug effects*;Submandibular Gland/secretion;Substance P/pharmacology;Weaning
7542274;Acinetobacter/classification*;Acinetobacter/genetics*;Acinetobacter/isolation & purification;Acinetobacter Infections/epidemiology;Acinetobacter Infections/microbiology;Bacterial Typing Techniques*;Cross Infection/epidemiology;Cross Infection/microbiology;DNA, Bacterial/genetics;Disease Outbreaks;Electrophoresis, Gel, Pulsed-Field/methods*;Evaluation Studies as Topic;Humans;Polymorphism, Restriction Fragment Length*;RNA, Bacterial/genetics;RNA, Ribosomal/genetics
7545096;ADP-ribosyl Cyclase;ADP-ribosyl Cyclase 1;Age Factors;Aged;Antigens, CD/analysis*;Antigens, Differentiation/analysis*;Antigens, Differentiation, T-Lymphocyte/analysis*;CD56 Antigen;CD8 Antigens/analysis*;Cell Division;Depression/immunology*;Humans;Immunophenotyping;Membrane Glycoproteins;N-Glycosyl Hydrolases/analysis*;Professional-Patient Relations;Stress, Psychological/immunology;T-Lymphocytes/immunology*
7546595;Alzheimer Disease/classification;Alzheimer Disease/diagnosis*;Humans;Linear Models;Prognosis;Time Factors;Treatment Outcome
7547347;Asthma/complications*;Asthma/physiopathology;Bronchial Hyperreactivity/complications;Bronchial Hyperreactivity/physiopathology;Child;Child, Preschool;Gastroesophageal Reflux/complications*;Gastroesophageal Reflux/physiopathology;Humans
7552287;Adult;Aged;Aged, 80 and over;Catecholamines/biosynthesis;Dopamine beta-Hydroxylase/metabolism;Ganglia, Invertebrate;Ganglia, Parasympathetic/cytology;Ganglia, Parasympathetic/enzymology;Ganglia, Parasympathetic/metabolism*;Humans;Immunohistochemistry;Middle Aged;Neurons/enzymology;Neurons/metabolism;Neuropeptides/metabolism*;Tyrosine 3-Monooxygenase/metabolism
7556990;Animals;Antibodies, Monoclonal/pharmacology*;Antigens, Surface/analysis;Antigens, Surface/immunology;Antigens, Surface/physiology*;Calcium/pharmacology;Cytoplasmic Granules/physiology;Exocytosis;Immunohistochemistry;Insulin/secretion*;Islets of Langerhans/physiology*;Islets of Langerhans/secretion;Islets of Langerhans/ultrastructure;Male;Mice;Microsomes/physiology;Nerve Tissue Proteins/analysis;Nerve Tissue Proteins/immunology;Nerve Tissue Proteins/physiology*;Syntaxin 1
7575472;Adipose Tissue, Brown/drug effects;Adipose Tissue, Brown/ultrastructure*;Animals;Body Temperature Regulation;Carrier Proteins/metabolism*;Cell Fractionation;Cells, Cultured;Centrifugation, Density Gradient;Ion Channels;Male;Membrane Proteins/metabolism*;Mice;Mitochondria/drug effects;Mitochondria/metabolism*;Mitochondria/ultrastructure;Mitochondrial Proteins;Norepinephrine/administration & dosage;Norepinephrine/pharmacology*;Starvation;Uncoupling Agents/metabolism;Uncoupling Protein 1
7579743;Acute Disease;Administration, Oral;Adolescent;Adult;Aged;Antilymphocyte Serum;Azathioprine/administration & dosage;Azathioprine/therapeutic use;Creatinine/blood;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/therapeutic use*;Female;Follow-Up Studies;Glucocorticoids/administration & dosage;Glucocorticoids/therapeutic use;Graft Rejection/prevention & control*;Heart Transplantation*/adverse effects;Heart Transplantation*/methods;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/therapeutic use*;Incidence;Injections, Intravenous;Kidney/drug effects*;Male;Methylprednisolone/administration & dosage;Methylprednisolone/therapeutic use;Middle Aged;Muromonab-CD3;Prednisone/administration & dosage;Prednisone/therapeutic use;Premedication*;Renal Dialysis;Survival Rate
7580523;Decision Making;Emergency Medical Technicians*;Humans;Resuscitation*
7581833;Animals;Antioxidants/therapeutic use*;Blood Substitutes/adverse effects;Catalase/metabolism;Cattle;Evaluation Studies as Topic;Glutathione Peroxidase/metabolism;Hemoglobins/adverse effects*;Lipid Peroxidation/drug effects*;Male;Organ Specificity;Oxidative Stress/drug effects*;Rats;Rats, Sprague-Dawley;Selenium/therapeutic use*;Superoxide Dismutase/metabolism
7584901;Algorithms*;Cybernetics*;Models, Theoretical*;Neural Networks (Computer)*
7585263;Humans;Insurance, Disability*;Practice Management, Dental/economics*
7585460;Adenocarcinoma/chemically induced;Adenocarcinoma/pathology*;Animals;Carcinogens;Catechols/toxicity*;Cholic Acid;Cholic Acids/toxicity*;Gastric Mucosa/drug effects*;Gastric Mucosa/enzymology;Gastric Mucosa/pathology;Hyperplasia;Male;Methylnitronitrosoguanidine;Pepsinogens/metabolism*;Pyloric Antrum;Rats;Rats, Mutant Strains;Rats, Sprague-Dawley;Serum Albumin/deficiency*;Serum Albumin/genetics;Species Specificity;Stomach Neoplasms/chemically induced;Stomach Neoplasms/pathology*
7595138;Animals;Calcitonin/pharmacology;Calcitonin Gene-Related Peptide/pharmacology*;Climacteric/blood;Dose-Response Relationship, Drug;Estradiol/blood;Estradiol/pharmacology;Female;Humans;Ovariectomy;Rats;Rats, Sprague-Dawley;Skin Temperature/drug effects*;Tail;Vasodilation/drug effects*
7595913;Adult;Aged;Blood Pressure Monitoring, Ambulatory*;Female;Humans;Hypertension/physiopathology*;Magnetics*;Male;Middle Aged
7602307;Breast Implants/adverse effects*;Fatigue/physiopathology;Female;Humans;Lymphatic Diseases/physiopathology;Neuritis/physiopathology;Pain/physiopathology;Rheumatic Diseases/etiology*;Silicones/adverse effects*;Syndrome;Urinary Bladder Diseases/physiopathology
7603428;Adolescent;Adult;Child;Child, Preschool;Humans;Infant;Pertussis Vaccine;Population Surveillance;United States/epidemiology;Vaccination/utilization;Whooping Cough/epidemiology*;Whooping Cough/prevention & control
7616802;Adult;Autoimmune Diseases/drug therapy*;Blood Platelets/drug effects*;Chronic Disease;Female;Hematopoiesis/drug effects*;Heparin/administration & dosage;Heparin/pharmacology;Heparin/therapeutic use*;Humans;Injections, Subcutaneous;Male;Megakaryocytes/drug effects;Platelet Count/drug effects;Prednisone/administration & dosage;Prospective Studies;Purpura, Thrombocytopenic/drug therapy*
7620654;Codeine/therapeutic use*;Cross-Over Studies;Diarrhea/drug therapy*;Diarrhea/etiology;Female;Genital Neoplasms, Female/radiotherapy*;Humans;Psyllium/therapeutic use*;Radiotherapy/adverse effects*
7622381;Health Physics*;Humans;Radiation Protection;Risk Assessment*;Safety
7623457;Fucosidosis/complications;Fucosidosis/genetics*;Fucosidosis/pathology;Humans;Infant;Male;Pneumonia/complications
7624498;Amphetamine/pharmacology*;Animals;Apomorphine/pharmacology*;Behavior, Animal/drug effects*;Cats;Drug Interactions;Electroencephalography;Fear/drug effects;Female;Motor Activity/drug effects;Naloxone/pharmacology*;Smell/drug effects
7625673;Diphtheria-Tetanus-Pertussis Vaccine*;Haemophilus Vaccines*;Humans;Infant;Licensure;Meningitis, Bacterial/prevention & control;Pertussis Vaccine/standards;Vaccines, Combined*
7634660;Bone Nails*;Diaphyses/injuries;Equipment Failure;Female;Fracture Healing;Fractures, Ununited/diagnostic imaging;Fractures, Ununited/etiology;Humans;Infection/etiology;Male;Radiography;Tibial Fractures/complications;Tibial Fractures/diagnostic imaging;Tibial Fractures/surgery*
7639556;Adolescent;Adult;Biomarkers/analysis;Child;Cystic Fibrosis/drug therapy;Cystic Fibrosis/immunology*;Cystic Fibrosis/microbiology;Cystic Fibrosis/physiopathology;Feces/chemistry*;Humans;Interleukin-8/analysis*;Lipase/administration & dosage;Lung/physiopathology;Pancreatic Extracts/administration & dosage;Pancrelipase;Pseudomonas Infections/complications;Spirometry;Tumor Necrosis Factor-alpha/analysis*
7644628;Adult;Aged;Angiography, Digital Subtraction;Aortography;Captopril*;Confidence Intervals;Female;Humans;Hypertension, Renovascular/diagnostic imaging;Male;Middle Aged;Pattern Recognition, Automated;Prospective Studies;Pulse;Renal Artery/diagnostic imaging;Renal Artery/drug effects;Renal Artery Obstruction/diagnostic imaging*;Renal Artery Obstruction/physiopathology;Sensitivity and Specificity;Ultrasonography, Doppler*;Vascular Resistance/drug effects
7654088;Humans;Job Description;Nephrology*;Professional Competence;Societies, Nursing*;Specialties, Nursing*;United States
7670348;Diagnosis, Differential;Humans;Immunologic Tests*;Mycobacterium/immunology;Reagent Kits, Diagnostic;Serologic Tests;Tuberculosis/diagnosis*;Tuberculosis/immunology
7691273;Animals;Bacterial Infections/diagnosis;Bacterial Infections/veterinary;Communicable Diseases/diagnosis;Communicable Diseases/veterinary*;DNA/analysis*;DNA/isolation & purification;Nucleic Acid Hybridization/veterinary*;Polymerase Chain Reaction/veterinary*;RNA/analysis*;RNA/isolation & purification;Virus Diseases/diagnosis;Virus Diseases/veterinary
7692221;Animals;Capillaries/cytology*;Capillaries/ultrastructure;Cell Communication/physiology;Cell Count;Endothelium, Vascular/cytology*;Male;Neovascularization, Pathologic/pathology*;Rats;Rats, Wistar
7704598;3,4-Dihydroxyphenylacetic Acid/metabolism*;Adrenergic alpha-1 Receptor Agonists;Adrenergic alpha-2 Receptor Agonists;Adrenergic beta-Agonists/pharmacology;Adrenocorticotropic Hormone/metabolism;Animals;Corticosterone/blood;Corticotropin-Releasing Hormone/metabolism;Dopamine/metabolism*;Hypothalamo-Hypophyseal System/drug effects*;Hypothalamo-Hypophyseal System/metabolism;Male;Morphine/pharmacology*;Norepinephrine/metabolism*;Pituitary-Adrenal System/drug effects*;Pituitary-Adrenal System/metabolism;Prazosin/pharmacology;Rats;Rats, Sprague-Dawley;Receptors, Adrenergic, alpha-1/physiology*;Receptors, Adrenergic, alpha-2/physiology*;Reserpine;gamma-Aminobutyric Acid/metabolism
7713114;Connexin 43/analysis;Coronary Artery Bypass;Endomyocardial Fibrosis/pathology;Fluorescent Antibody Technique;Freeze Fracturing;Gap Junctions/pathology*;Heart Failure/pathology*;Heart Transplantation/pathology;Humans;Microscopy, Confocal;Microscopy, Electron;Myocardial Infarction/pathology;Myocardial Ischemia/pathology;Myocardium/pathology;Reference Values;Wolff-Parkinson-White Syndrome/pathology
7723082;Accidents, Traffic/mortality;Accidents, Traffic/statistics & numerical data*;Adolescent;Adult;Aged;Aged, 80 and over;Air Bags/adverse effects;Air Bags/statistics & numerical data*;Canada/epidemiology;Female;Humans;Male;Middle Aged;Wounds and Injuries/etiology
7740181;Animals;Apoptosis/drug effects;Cell Division/drug effects;DNA/biosynthesis;Epithelial Cells;Epithelium/drug effects;Estradiol/pharmacology;Female;Rats;Tetradecanoylphorbol Acetate/pharmacology*;Uterus/cytology;Uterus/drug effects*;Uterus/metabolism
7740352;Asia;Delivery of Health Care/standards*;Developing Countries;Health Resources;Insurance, Health/economics;Insurance, Health/trends*;Latin America;National Health Programs/economics;National Health Programs/organization & administration;South Africa
7743307;Adult;Aged;Aged, 80 and over;Cholangiography*;Cholangitis, Sclerosing/complications;Cholangitis, Sclerosing/diagnostic imaging*;Cholangitis, Sclerosing/mortality;Cholangitis, Sclerosing/surgery;Female;Humans;Liver Transplantation;Male;Middle Aged;Prognosis;Retrospective Studies;Survival Rate
7750606;Animals;Corpus Luteum/metabolism*;Female;Gene Expression*;Luteal Phase/metabolism*;Papio/metabolism*;RNA, Messenger/metabolism*;Receptor, Epidermal Growth Factor/genetics*
7759995;Animals;Antibodies, Monoclonal/pharmacology*;B-Lymphocytes/cytology;B-Lymphocytes/immunology;Cell Death/immunology*;Cell Line;Clone Cells;Complement System Proteins/physiology*;Cricetinae;Cytotoxicity, Immunologic*;Hybridomas/immunology;Immunoglobulin Fab Fragments/pharmacology;Lymphocytes/cytology*;Lymphocytes/immunology*;Lymphocytes/ultrastructure;Mice;Mice, Inbred C3H;Microscopy, Electron;Microscopy, Electron, Scanning;Rats;Rats, Sprague-Dawley;Spleen/immunology;T-Lymphocytes/cytology;T-Lymphocytes/immunology
7776052;Actuarial Analysis;Aged;Brachytherapy;Carcinoma/radiotherapy*;Carcinoma/secondary;Carcinoma/surgery;Carcinoma, Squamous Cell/radiotherapy;Carcinoma, Squamous Cell/secondary;Carcinoma, Squamous Cell/surgery;Combined Modality Therapy;Humans;Lymphatic Metastasis;Middle Aged;Mouth Floor/radiation effects;Mouth Floor/surgery;Mouth Neoplasms/radiotherapy*;Mouth Neoplasms/surgery;Radiotherapy, High-Energy/instrumentation;Survival Analysis;Tongue Neoplasms/radiotherapy;Tongue Neoplasms/surgery
7787100;Actins/chemistry*;Actins/genetics;Actins/physiology;Actomyosin/chemistry*;Actomyosin/physiology;Adenosine Triphosphate/chemistry;Animals;Binding Sites;Biophysical Phenomena;Biophysics;In Vitro Techniques;Kinetics;Molecular Structure;Muscle Contraction/physiology;Mutagenesis, Site-Directed;Myosin Subfragments/chemistry;Point Mutation;Protein Conformation;Rabbits;Recombinant Proteins/chemistry;Recombinant Proteins/genetics
7787184;Base Sequence;Cells, Cultured;Conserved Sequence;Genes, ras*;Humans;Molecular Sequence Data;Plant Shoots/growth & development;Plants, Genetically Modified;Plants, Toxic*;Saccharomyces cerevisiae/genetics;Sequence Homology, Amino Acid;Tobacco/genetics;Tobacco/growth & development*;Transcription, Genetic
7792593;Animals;Authorship*;Cryptococcus neoformans/immunology*;Fungal Vaccines*;Humans;Interprofessional Relations;Mice;National Institutes of Health (U.S.);Patents as Topic;Publishing*;United States;Vaccines, Conjugate
7806283;Amino Acid Sequence;Animals;Base Sequence;Blotting, Southern;Cloning, Molecular;Mice/genetics;Molecular Sequence Data;Multigene Family/genetics*;Polymerase Chain Reaction;Rats/genetics*;Receptors, Antigen, T-Cell, alpha-beta/genetics*;Sequence Analysis, DNA;Sequence Homology, Amino Acid;Sequence Homology, Nucleic Acid;Species Specificity;T-Lymphocytes/immunology*
7827696;Antioxidants/chemistry*;Diterpenes/chemistry*;Diterpenes, Abietane;Electron Spin Resonance Spectroscopy;Free Radicals;Lipids/chemistry;Oleic Acids/chemistry*;Phenanthrenes/chemistry;Plant Extracts/chemistry*;Spices
7848358;Animals;Behavior, Animal/drug effects;Benzaldehydes/toxicity*;Blood Cell Count;Blood Chemical Analysis;Blood Protein Electrophoresis;Dogs;Eating/drug effects;Eye Diseases/chemically induced;Eye Diseases/pathology;Female;Hearing Disorders/chemically induced;Hydrazones/toxicity*;Male;Organ Size/drug effects;Weight Gain/drug effects
7853132;Adult;Aggregatibacter actinomycetemcomitans/isolation & purification;Aggressive Periodontitis/microbiology;Aggressive Periodontitis/pathology;Analysis of Variance;Bacteroides/isolation & purification;Campylobacter/isolation & purification;Capnocytophaga/isolation & purification;Colony Count, Microbial;Dental Plaque/microbiology;Female;Fusobacterium nucleatum/isolation & purification;Gingival Hemorrhage;Humans;Likelihood Functions;Linear Models;Male;Peptostreptococcus/isolation & purification;Periodontal Index;Periodontal Pocket/microbiology;Periodontal Pocket/pathology;Periodontitis/microbiology*;Periodontitis/pathology*;Porphyromonas gingivalis/isolation & purification;Prevotella intermedia/isolation & purification;Statistics, Nonparametric;Streptococcus/isolation & purification;Streptococcus sanguis/isolation & purification;Suppuration
7857953;Adolescent;Adolescent Health Services/organization & administration;Adolescent Health Services/trends*;Ambulatory Care Facilities/organization & administration;Ambulatory Care Facilities/trends*;Female;Health Education;Humans;Male;Mental Health Services/trends;Models, Organizational;Pregnancy;Pregnancy in Adolescence;Primary Health Care/trends;School Health Services/organization & administration;School Health Services/trends*;Social Work;Urban Health/trends
7858017;Diagnosis, Computer-Assisted;Discriminant Analysis;False Positive Reactions;Humans;Neural Networks (Computer)*;ROC Curve;Radiographic Image Enhancement*;Radiographic Image Interpretation, Computer-Assisted*;Radiography, Thoracic/methods*;Solitary Pulmonary Nodule/diagnostic imaging*;Solitary Pulmonary Nodule/epidemiology
7858716;Busulfan/blood*;Chromatography, High Pressure Liquid;Ditiocarb;Humans;Spectrophotometry, Ultraviolet
7859930;Chromosome Mapping;Diabetes Mellitus, Type 1/genetics*;Disease Susceptibility;Genetic Linkage;Humans;Polymorphism, Genetic;Repetitive Sequences, Nucleic Acid
7860850;Adult;Chi-Square Distribution;Community Health Nursing*/statistics & numerical data;Female;Humans;Intellectual Disability/nursing*;Job Satisfaction*;Male;Methods;Middle Aged;Northern Ireland;Surveys and Questionnaires
7873948;Adolescent;Adult;Aged;Aged, 80 and over;Child;Denmark/epidemiology;Diseases in Twins*/etiology;Female;Fetal Growth Retardation/complications*;Follow-Up Studies;Humans;Infant, Newborn;Male;Middle Aged;Mortality*;Pregnancy;Prenatal Exposure Delayed Effects*;Sex Factors;Twins, Dizygotic;Twins, Monozygotic
7876479;Adult;Fractures, Ununited/complications;Fractures, Ununited/diagnosis*;Fractures, Ununited/therapy;Humans;Male;Ossification, Heterotopic/diagnosis*;Ossification, Heterotopic/etiology;Ossification, Heterotopic/therapy;Pain/etiology;Ulna Fractures/complications;Ulna Fractures/diagnosis*;Ulna Fractures/therapy;Wrist Injuries/complications;Wrist Injuries/diagnosis*;Wrist Injuries/therapy;Wrist Joint*
7890256;Cerebral Hemorrhage/chemically induced*;Cerebral Ventricles;Female;Humans;Infant, Newborn;Infant, Premature, Diseases/chemically induced*;Magnesium Sulfate/adverse effects;Nifedipine/adverse effects;Obstetric Labor, Premature/prevention & control;Pregnancy;Retrospective Studies;Ritodrine/adverse effects*;Tocolysis/adverse effects*
7891416;Adolescent;Adult;Anorexia Nervosa/epidemiology;Anorexia Nervosa/psychology;Body Height;Body Image*;Body Weight;Bulimia/epidemiology;Face;Feeding and Eating Disorders/epidemiology;Feeding and Eating Disorders/psychology*;Female;Humans;Obesity/epidemiology;Obesity/psychology;Psychology, Adolescent*;Self-Assessment*;Somatotypes*;Viscera
7894871;Aged;Alzheimer Disease/physiopathology*;Alzheimer Disease/psychology;Atrophy;Brain/pathology*;Brain/physiopathology;Brain Damage, Chronic/physiopathology;Brain Damage, Chronic/psychology;Humans;Memory/physiology*;Mental Recall/physiology;Nerve Degeneration/physiology;Neural Networks (Computer)*;Neurons/physiology;Retention (Psychology)/physiology;Synapses/physiology
7896257;Animals;Female;Male;Paraquat/toxicity*;Pulmonary Alveoli/pathology*;Pulmonary Alveoli/ultrastructure;Pulmonary Fibrosis/chemically induced*;Pulmonary Fibrosis/pathology;Rats;Rats, Wistar
7915857;Animals;Autoantigens/metabolism*;Fibronectins/blood*;Hepatectomy*;Liver/metabolism;Liver/physiology*;Liver Cirrhosis, Experimental/chemically induced;Liver Cirrhosis, Experimental/metabolism;Liver Cirrhosis, Experimental/physiopathology;Liver Regeneration/physiology*;Male;Nuclear Proteins/metabolism*;Organ Size;Proliferating Cell Nuclear Antigen;Rats;Rats, Inbred F344;Thioacetamide
7916649;Adenocarcinoma/pathology;Amino Acid Sequence;Antibodies, Monoclonal/biosynthesis;Antibodies, Monoclonal/chemistry;Antibodies, Monoclonal/metabolism*;Antibody Specificity;Antigens, Neoplasm/analysis*;Antigens, Neoplasm/immunology;B-Lymphocytes;Base Sequence;Breast Neoplasms;Carbohydrate Sequence;Cell Line, Transformed;Cloning, Molecular/methods;Colonic Neoplasms/pathology;DNA Primers;Female;G(M3) Ganglioside/analysis*;G(M3) Ganglioside/immunology;Gangliosides/chemistry;Gangliosides/immunology;Herpesvirus 4, Human/genetics;Humans;Immunoglobulin Heavy Chains/biosynthesis;Immunoglobulin Heavy Chains/chemistry;Immunoglobulin Light Chains/biosynthesis;Immunoglobulin Light Chains/chemistry;Immunoglobulin Variable Region/biosynthesis;Immunoglobulin Variable Region/chemistry;Lung Neoplasms/pathology;Melanoma/pathology;Molecular Sequence Data;Neoplasms/pathology*;Polymerase Chain Reaction;Recombinant Proteins/biosynthesis;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Skin Neoplasms/pathology
7917572;Adenocarcinoma/pathology*;Calcinosis/pathology*;Humans;Male;Middle Aged;Peritoneal Neoplasms/pathology*;Stomach Neoplasms/pathology*
7919274;Animals;Binding Sites;Cerebral Cortex/drug effects*;Cerebral Cortex/metabolism;Male;N-Methylscopolamine;Paraoxon/pharmacology*;Quinuclidinyl Benzilate/metabolism*;Rats;Receptors, Cholinergic/metabolism;Scopolamine Derivatives/metabolism*;Sulfhydryl Reagents/pharmacology*;Synaptic Membranes/drug effects*;Synaptic Membranes/metabolism;Tritium
7920879;Body Composition*;Exercise*;Female;Humans;Male;Meta-Analysis as Topic*;Weight Loss*
7924073;Adolescent;Atrophy;Bone Marrow/pathology;Brain/pathology;Brain Diseases, Metabolic/classification;Brain Diseases, Metabolic/diagnosis*;Brain Diseases, Metabolic/genetics;Brain Diseases, Metabolic/pathology;Female;Fibroblasts/pathology;Humans;Magnetic Resonance Imaging;Neurologic Examination;Neuropsychological Tests;Niemann-Pick Diseases/classification;Niemann-Pick Diseases/diagnosis*;Niemann-Pick Diseases/genetics;Niemann-Pick Diseases/pathology;Tomography, X-Ray Computed
7935051;Base Sequence;Cloning, Molecular*;Escherichia coli/enzymology;Genes, Bacterial*;Molecular Sequence Data;Mutation;Phenotype;Polymerase Chain Reaction;Sequence Homology, Nucleic Acid;Shigella flexneri/enzymology*;Shigella flexneri/genetics;Thymidylate Synthase/genetics*
7939288;Acute Disease;Adolescent;Adult;Child;Child, Preschool;Edema/diagnosis;Edema/etiology;Female;Humans;Male;Middle Aged;Parotid Diseases/diagnosis*;Parotid Diseases/etiology;Parotid Neoplasms/diagnosis;Parotid Neoplasms/pathology;Parotitis/diagnosis;Recurrence
7940003;Health Care Reform*;Health Policy;Mexico;National Health Programs
7942624;Adolescent;Adult;Aged;Aged, 80 and over;Cholestasis, Intrahepatic/blood;Female;Humans;Intercellular Adhesion Molecule-1/blood*;Liver Diseases/blood*;Liver Neoplasms/blood;Male;Middle Aged;Regression Analysis
7945019;Animals;Cats/anatomy & histology;Cats/physiology*;Deglutition/physiology;Eating/physiology*;Electromyography;Jaw/physiology;Mastication/physiology*;Movement;Neck Muscles/physiology*;Temporal Muscle/physiology*;Tongue/physiology
7946783;Catheterization;Coronary Artery Bypass*;Female;Follow-Up Studies;Graft Occlusion, Vascular/surgery*;Graft Occlusion, Vascular/therapy;Humans;Male;Middle Aged;Prospective Studies;Recurrence;Saphenous Vein/transplantation*;Stents*
7948603;Animals;Autoantibodies/immunology*;Diabetes Mellitus, Type 1/immunology*;Female;Glutamate Decarboxylase/immunology*;Glutamate Decarboxylase/metabolism;Lymphocyte Activation/immunology;Mice;Mice, Inbred NOD;Precipitin Tests;T-Lymphocytes/immunology*
7958077;ACTH Syndrome, Ectopic/diagnosis;ACTH Syndrome, Ectopic/etiology;Adolescent;Adrenal Cortex Neoplasms/complications;Adrenal Cortex Neoplasms/diagnosis;Adrenal Cortex Neoplasms/secretion;Adrenocorticotropic Hormone/secretion;Bronchial Neoplasms/complications;Bronchial Neoplasms/diagnosis;Bronchial Neoplasms/secretion;Carcinoid Tumor/complications;Carcinoid Tumor/diagnosis;Carcinoid Tumor/secretion;Corticotropin-Releasing Hormone;Cushing Syndrome/diagnosis*;Cushing Syndrome/etiology;Diagnosis, Differential;Female;Humans;Male;Middle Aged;Pituitary Neoplasms/complications;Pituitary Neoplasms/diagnosis;Pituitary Neoplasms/secretion
7961173;Aminoglycosides/toxicity;Animals;Auditory Threshold;Cochlear Implants;Deafness/chemically induced;Disease Models, Animal;Electric Stimulation;Electrophysiology;Evoked Potentials, Auditory, Brain Stem/physiology*;Female;Guinea Pigs;Male;Nerve Degeneration/physiology*;Vestibulocochlear Nerve/pathology*;Vestibulocochlear Nerve/physiology
7972414;Androstatrienes/pharmacology;Animals;Choice Behavior*/drug effects;Female;Male;Microcomputers;Motor Activity*/drug effects;Psychophysiology/instrumentation*;Rats;Rats, Wistar;Sexual Behavior, Animal*/drug effects;Signal Processing, Computer-Assisted/instrumentation*;Software
7980219;Addison Disease/complications*;Addison Disease/diagnosis;Fatal Outcome;Female;Humans;Hypercalcemia/etiology*;Middle Aged
7987373;Animals;Brain/drug effects*;Brain/physiology;Drug Implants;Female;Hypothalamus, Middle/drug effects;Hypothalamus, Middle/physiology;Male;Ovariectomy;Preoptic Area/drug effects;Preoptic Area/physiology;Sexual Behavior, Animal/drug effects*;Shrews/physiology*;Testosterone/administration & dosage;Testosterone/pharmacology*
7987920;Aged;Angioplasty, Balloon, Coronary/instrumentation*;Angioplasty, Balloon, Coronary/methods;Catheterization/instrumentation;Coronary Angiography;Coronary Disease/therapy*;Humans;Middle Aged;Stents;Treatment Failure
7991344;Attention/physiology*;Distance Perception;Form Perception;Humans;Models, Psychological*;Optical Illusions;Perceptual Closure;Visual Perception/physiology*
7997262;Amino Acid Sequence;Binding Sites;Computer Graphics;Conserved Sequence;Crystallography, X-Ray;Diabetes Mellitus, Type 2/enzymology;Diabetes Mellitus, Type 2/genetics;Enzyme Activation;Humans;Molecular Sequence Data;Mutation;Phosphorylation;Protein Conformation;Receptor, Insulin/antagonists & inhibitors;Receptor, Insulin/chemistry*;Receptor, Insulin/metabolism;Recombinant Proteins;Substrate Specificity;Tyrosine/metabolism
7998976;Carrier Proteins/metabolism*;Cholesterol/pharmacology*;Cholesterol Ester Transfer Proteins;Cholesterol Esters/metabolism;Emulsions;Glycoproteins*;Humans;Kinetics;Male;Phosphatidylcholines/metabolism;Spectrometry, Fluorescence;Tritium
8005623;HN Protein/metabolism*;HeLa Cells;Hemolysis;Humans;Membrane Fusion*;Parainfluenza Virus 1, Human/physiology*;Viral Envelope Proteins/metabolism*;Wheat Germ Agglutinins
8011551;Age Factors;Aged;Aged, 80 and over;Chromosome Aberrations;Clinical Trials as Topic;Female;Humans;Leukemia, Myeloid, Acute/drug therapy*;Leukemia, Myeloid, Acute/genetics;Leukemia, Myeloid, Acute/mortality;Male;Middle Aged;Prognosis;Remission Induction;Retrospective Studies;Selection Bias
8017511;Decision Making, Organizational*;Decision Trees*;Guidelines as Topic*;Humans;Occupational Therapy/organization & administration*;School Health Services/organization & administration*
8028885;Ankle Joint/pathology;Ankle Joint/physiology*;Biomechanical Phenomena;Bone Malalignment/complications;Bone Malalignment/pathology;Bone Malalignment/physiopathology*;Fractures, Malunited/complications;Fractures, Malunited/physiopathology*;Humans;Knee Joint/pathology;Knee Joint/physiology*;Osteoarthritis/etiology;Tibia/pathology*
8031571;Asian Continental Ancestry Group/genetics*;Complement C7/genetics*;Enzyme-Linked Immunosorbent Assay;Humans;Immunoblotting;Isoelectric Focusing;Phenotype;Polymorphism, Genetic/genetics*
8033891;Amino Acid Sequence;Animals;Collagenases/metabolism;Dogs;Endopeptidases/metabolism*;Enzyme Activation;Enzyme Precursors/metabolism*;Extracellular Matrix/metabolism;Gelatinases/metabolism;Humans;Mast Cells/enzymology*;Matrix Metalloproteinase 2;Matrix Metalloproteinase 3;Matrix Metalloproteinase 9;Metalloendopeptidases/metabolism;Molecular Sequence Data
8037780;Audiology/education;Audiology/manpower;Child;Child, Preschool;Ethics, Professional;Genetic Counseling;Hearing Disorders/prevention & control*;Humans
8049978;Adult;Aorta/pathology;Aortic Aneurysm, Thoracic/complications*;Aortic Aneurysm, Thoracic/pathology;Aortic Valve Insufficiency/complications*;Aortic Valve Insufficiency/pathology;Behcet Syndrome/complications*;Behcet Syndrome/pathology;Humans;Male
8055811;Adenoma/diagnostic imaging*;Aged;Carcinoma/diagnostic imaging*;Contrast Media*;Female;Humans;Male;Middle Aged;Radionuclide Imaging;Technetium Tc 99m Sestamibi*;Thyroid Neoplasms/diagnostic imaging*;Thyroid Neoplasms/secondary
8056998;Adult;Analysis of Variance;Double-Blind Method;Female;Humans;Lorazepam/administration & dosage*;Male;Mental Recall/drug effects;Psychomotor Performance/drug effects*;Reaction Time/drug effects;Reference Values
8063240;Female;Humans;Prostheses and Implants*;Ultrasonography/methods*;Uterine Cervical Neoplasms/diagnostic imaging*;Uterine Cervical Neoplasms/radiotherapy*
8078123;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/physiopathology;Humans;Research
8078910;Amino Acid Sequence;Base Sequence;Cloning, Molecular;Consensus Sequence;DNA, Complementary/genetics;Genes, Plant*;Molecular Sequence Data;Phosphorus-Oxygen Lyases*;Plant Proteins/genetics*;Sequence Alignment;Sequence Homology, Amino Acid;Structure-Activity Relationship;Terpenes/metabolism*;Transferases/genetics*
8081603;Czech Republic;Gynecology/history;History, 19th Century;Humans
8084523;Aged;Aged, 80 and over;Dopamine/physiology;Humans;Immunohistochemistry;Middle Aged;Neuroglia/immunology;Neuroglia/metabolism;Parkinson Disease/metabolism*;Parkinson Disease/pathology;Receptors, Tumor Necrosis Factor/biosynthesis*;Receptors, Tumor Necrosis Factor/immunology;Substantia Nigra/metabolism*;Substantia Nigra/pathology;Tumor Necrosis Factor-alpha/biosynthesis*;Tumor Necrosis Factor-alpha/immunology
8091434;Adolescent;Adult;Aged;Aged, 80 and over;Brain Ischemia/diagnosis;Brain Ischemia/therapy;Cerebrovascular Disorders/diagnosis;Cerebrovascular Disorders/therapy*;Child;Emergency Medical Services;Emergency Service, Hospital*/organization & administration;Female;Hospital Communication Systems*/organization & administration;Humans;Male;Medical Staff, Hospital;Middle Aged;Nursing Staff, Hospital;Patient Care Team;Referral and Consultation;Retrospective Studies;Time Factors
8091666;Amino Acid Sequence;Base Sequence;CD4 Antigens/chemistry;CD4 Antigens/genetics;CD4 Antigens/metabolism*;Cell Fusion;Endoplasmic Reticulum/metabolism*;Gene Expression;Gene Products, env/genetics;HIV Envelope Protein gp160;HIV-1/metabolism*;HeLa Cells;Human Immunodeficiency Virus Proteins;Humans;Molecular Sequence Data;Molecular Weight;Protein Precursors/genetics;Protein Precursors/metabolism;Protein Structure, Tertiary;Recombinant Fusion Proteins/chemistry;Recombinant Fusion Proteins/metabolism*;Viral Regulatory and Accessory Proteins/genetics;Viral Regulatory and Accessory Proteins/metabolism*
8111063;Animals;Cells, Cultured;Colony-Forming Units Assay;Dose-Response Relationship, Drug;Erythropoiesis/drug effects;Erythropoiesis/physiology;Erythropoietin/pharmacology*;Female;Hematopoietic Stem Cells/cytology*;Hematopoietic Stem Cells/drug effects;Humans;Immunoglobulin Fc Fragments/biosynthesis;Immunoglobulin Fc Fragments/metabolism;Immunoglobulin G/biosynthesis;Immunoglobulin G/metabolism;Immunoglobulin Heavy Chains/biosynthesis;Immunoglobulin Heavy Chains/metabolism;Interferon-gamma/pharmacology*;Kinetics;Mice;Mice, Inbred Strains;Receptors, Interferon/biosynthesis;Receptors, Interferon/physiology*;Recombinant Fusion Proteins/metabolism;Recombinant Proteins
8114228;Combined Modality Therapy/adverse effects;Humans;Lymphoma/complications*;Lymphoma/drug therapy;Male;Proctitis/etiology*;Proctitis/therapy*;Prostatic Neoplasms/complications;Prostatic Neoplasms/radiotherapy*;Radiation Injuries/etiology*;Radiation Injuries/therapy;Radiotherapy/adverse effects
8116089;Alzheimer Disease/etiology;Alzheimer Disease/metabolism*;Alzheimer Disease/pathology;Amyloid beta-Protein Precursor/metabolism*;Humans;Neurofibrillary Tangles/metabolism;tau Proteins/metabolism*
8118453;Animals;Barium/metabolism;Cell Membrane/metabolism*;Cells, Cultured;Culture Media;Hydrogen-Ion Concentration;Ion Channel Gating/drug effects;Magnesium/metabolism;Membrane Potentials;Oocytes;Ouabain/pharmacology;Potassium/metabolism*;Sodium/metabolism*;Sodium-Potassium-Exchanging ATPase/metabolism*;Torpedo;Xenopus laevis
8121421;Education, Medical, Undergraduate/economics*;Faculty, Medical/statistics & numerical data;Fellowships and Scholarships*;Geriatrics/education*;Humans;New York City;Schools, Medical
8122655;Acquired Immunodeficiency Syndrome/complications*;Adult;Biopsy;Esophageal Diseases/complications*;Esophageal Diseases/microbiology;Esophageal Diseases/pathology;Esophagus/microbiology;Esophagus/ultrastructure*;Female;Humans;Male;Microscopy, Electron;Middle Aged;Ulcer/complications;Ulcer/microbiology;Ulcer/pathology;Virion/isolation & purification
8128260;Adolescent;Adult;Ankle Injuries/diagnostic imaging*;Ankle Injuries/therapy;Child;Female;Humans;Joint Dislocations/diagnostic imaging*;Joint Dislocations/therapy;Joint Instability/diagnostic imaging;Joint Instability/therapy;Ligaments, Articular/diagnostic imaging;Ligaments, Articular/injuries*;Male;Ultrasonography;Video Recording
8130636;Chromatography/methods*;Stereoisomerism*
8133012;Adolescent;Adult;Age Factors;Aged;Aged, 80 and over;Antibodies, Viral/blood*;Chi-Square Distribution;Cross Infection/blood*;Cross Infection/epidemiology*;Cross Infection/immunology;Cross Infection/prevention & control;Cross Infection/transmission;Humans;Immunoglobulin G/immunology*;Infection Control;Mass Screening;Measles/blood*;Measles/epidemiology*;Measles/immunology;Measles/prevention & control;Measles/transmission;Measles Vaccine/administration & dosage;Measles Vaccine/economics;Measles virus/immunology*;Middle Aged;Multi-Institutional Systems*;Personnel, Hospital/statistics & numerical data*;Prevalence;Risk Factors;Seroepidemiologic Studies;Utah/epidemiology
8137310;Aflatoxins/toxicity*;Animals;Biomarkers/analysis*;Carcinogens/metabolism;DNA/metabolism;Gene Expression;Humans;Liver Neoplasms/epidemiology;Liver Neoplasms/prevention & control;Neoplasms/epidemiology*;Neoplasms/prevention & control*;Proteins/metabolism;Risk Factors
8137644;Female;Gonadal Dysgenesis/complications*;Gonadal Dysgenesis, 46,XY/complications;Gonadoblastoma/etiology;Humans;Male;Ovarian Neoplasms/etiology*;Sex Chromosome Aberrations;Testicular Neoplasms/etiology*;Turner Syndrome/complications;Y Chromosome*
8145597;Aged;Bayes Theorem;Catchment Area (Health)/statistics & numerical data;Diagnosis-Related Groups/statistics & numerical data;Hospitals/utilization*;Humans;Massachusetts;Patient Admission/standards;Practice Patterns, Physicians'/statistics & numerical data*;Small-Area Analysis
8146216;Angiotensin II/pharmacology;Animals;Appetite Depressants/administration & dosage;Appetite Depressants/chemistry;Appetite Depressants/pharmacology*;Body Weight/drug effects*;Chromatography, High Pressure Liquid;Drinking/drug effects;Eating/drug effects*;Glycopeptides/administration & dosage;Glycopeptides/chemistry;Glycopeptides/pharmacology*;Humans;Injections, Intraventricular;Male;Rats;Rats, Sprague-Dawley;Taste/drug effects*
8153437;Esthetics;Facial Neoplasms/psychology;Facial Neoplasms/rehabilitation*;Facial Neoplasms/surgery;Humans;Maxillofacial Prosthesis*/psychology;Quality of Life*
8154857;Acetylglucosaminidase/urine*;Adolescent;Child;Child, Preschool;Colorimetry;Female;Humans;Infant;Male;Reference Values
8154896;Administration, Oral;Aged;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carcinoma, Transitional Cell/drug therapy*;Carcinoma, Transitional Cell/pathology;Carcinoma, Transitional Cell/prevention & control;Humans;Male;Recurrence;Tegafur/administration & dosage;Uracil/administration & dosage;Urinary Bladder Neoplasms/drug therapy*;Urinary Bladder Neoplasms/pathology;Urinary Bladder Neoplasms/prevention & control
8175977;Choriocarcinoma/metabolism*;Chorionic Gonadotropin/biosynthesis*;Female;Humans;Pregnancy;RNA, Messenger/analysis;Receptors, LH/genetics;Tumor Cells, Cultured;Uterine Neoplasms/metabolism*
8184637;Adult;Aneuploidy;Cell Division/drug effects;Centromere/drug effects*;Centromere/ultrastructure;Humans;In Vitro Techniques;Lymphocytes/drug effects;Lymphocytes/ultrastructure;Male;Mitotic Index/drug effects;Vanadates/toxicity*
8195200;Amino Acid Sequence;Arginine;Base Sequence;Binding Sites;Circular Dichroism;Diphosphates/metabolism;Diphosphates/pharmacology;Electrophoresis, Polyacrylamide Gel;Kinetics;Molecular Sequence Data;Mutagenesis, Site-Directed;Oligodeoxyribonucleotides;Phosphotransferases/chemistry*;Phosphotransferases/isolation & purification;Phosphotransferases/metabolism*;Propionibacterium/enzymology*;Protein Conformation;Recombinant Proteins/chemistry;Recombinant Proteins/isolation & purification;Recombinant Proteins/metabolism
8197116;Allolevivirus/genetics*;Amino Acid Sequence;Bacterial Proteins/genetics*;Base Sequence;DNA, Viral;Escherichia coli/genetics;Escherichia coli Proteins*;Ethyl Methanesulfonate/pharmacology;Gene Expression Regulation, Bacterial;Genes, Bacterial*;Genetic Complementation Test;Host Factor 1 Protein*;Molecular Sequence Data;Mutation;Nitrogen Fixation/genetics*;RNA, Viral/biosynthesis*;RNA-Binding Proteins/genetics*;Rhizobiaceae/drug effects;Rhizobiaceae/genetics*;Transcription Factors/genetics*
8218036;Clinical Competence;History, 20th Century;Motor Skills*;Ophthalmology/education;Ophthalmology/history*
8218380;Buffers;Calorimetry, Differential Scanning;Chymopapain/chemistry*;Cysteine Endopeptidases/chemistry;Hot Temperature;Hydrogen-Ion Concentration;Papain/chemistry*;Plants/enzymology;Protein Conformation;Protein Denaturation
8230387;Biomechanical Phenomena;Humans;Research;Sports/physiology*;Sports Medicine/trends*
8231365;Aged;Cross Infection*;Female;Gram-Negative Bacterial Infections*;Humans;Xanthomonas*
8245833;Amino Acid Sequence;Antigenic Variation/genetics;Antigens, Bacterial/genetics;Bacterial Outer Membrane Proteins*;Bacterial Proteins/genetics*;Bacterial Proteins/immunology;Base Sequence;Carrier Proteins/genetics*;Carrier Proteins/immunology;Conserved Sequence;DNA, Bacterial/genetics;Gene Expression;Genes, Bacterial;Immunoglobulin A/metabolism;Molecular Sequence Data;Receptors, Fc/genetics*;Receptors, Fc/immunology;Sequence Homology, Amino Acid;Streptococcus pyogenes/genetics*;Streptococcus pyogenes/immunology
8254585;Biofeedback, Psychology*/methods;Electric Stimulation Therapy*/methods;Electromyography;Exercise Therapy*/methods;Fecal Incontinence/complications;Fecal Incontinence/physiopathology;Fecal Incontinence/rehabilitation*;Female;Follow-Up Studies;Humans;Middle Aged;Muscle Contraction;Pelvic Floor;Program Evaluation;Retrospective Studies;Treatment Outcome;Urinary Incontinence/classification;Urinary Incontinence/complications;Urinary Incontinence/physiopathology;Urinary Incontinence/rehabilitation*;Urodynamics
8255137;Adult;Colon/diagnostic imaging;Colon/pathology;Colonic Pseudo-Obstruction/diagnosis;Colonic Pseudo-Obstruction/history*;Colonic Pseudo-Obstruction/therapy;Female;General Surgery/history*;History, 19th Century;History, 20th Century;Humans;London;Radiography;Syndrome
8262471;Body Height/drug effects;Bone Development/drug effects;Buserelin/pharmacology;Buserelin/therapeutic use*;Child;Estradiol/blood;Female;Gonadotropin-Releasing Hormone;Growth/drug effects*;Humans;Luteinizing Hormone/blood;Ovary/drug effects;Ovary/physiopathology*;Pituitary Gland/drug effects;Pituitary Gland/physiopathology*;Puberty, Precocious/drug therapy*;Puberty, Precocious/physiopathology;Triptorelin Pamoate/pharmacology;Triptorelin Pamoate/therapeutic use*
8273599;Cells, Cultured;Guanine/analogs & derivatives*;Guanine/pharmacology;Humans;Immunosuppressive Agents/pharmacology*;Lymphocyte Culture Test, Mixed;Purine-Nucleoside Phosphorylase/antagonists & inhibitors*;Pyrimidines/pharmacology*;T-Lymphocytes/drug effects;T-Lymphocytes/immunology*;Thiophenes/pharmacology*
8275574;Abnormalities, Multiple/genetics*;Blepharophimosis/genetics*;Blepharoptosis/genetics;Child;Chromosome Deletion*;Chromosomes, Human, Pair 3*;Eye Abnormalities/genetics*;Humans;Intellectual Disability/genetics;Male;Syndrome;Toes/abnormalities
8276514;Adult;Composite Resins*/chemistry;Dental Amalgam*/chemistry;Dental Caries/therapy;Dental Cavity Preparation/classification;Dental Restoration, Permanent/statistics & numerical data*;Equipment Failure;Humans;Korea/epidemiology;Recurrence;Surface Properties;Time Factors
8286544;Animals;Cells, Cultured;Female;Hypersensitivity, Delayed/prevention & control*;Liver/radiation effects*;Liver Transplantation/immunology*;Mice;Mice, Inbred BALB C;Rats;Rats, Inbred F344;Transplantation, Heterologous/immunology*;Ultraviolet Rays*
8297097;Humans;Microsurgery*;Surgical Flaps*;Ultrasonography, Interventional*
8302069;Animals;Cardioplegic Solutions/analysis*;Coronary Vessels;Heart Arrest, Induced/methods*;Microspheres;Myocardium/chemistry*;Perfusion/methods*;Rheology*;Swine
8303267;Animals;Embryo, Nonmammalian/cytology*;Embryology/methods*;Magnetic Resonance Imaging/methods*;Xenopus laevis/embryology
8308316;Antibodies, Viral/blood*;Drug Combinations;HIV Infections/immunology*;HIV Seropositivity;Humans;Infant;Infant, Newborn;Measles/prevention & control;Measles Vaccine/immunology*;Measles virus/immunology;Measles-Mumps-Rubella Vaccine;Mumps/prevention & control;Mumps Vaccine/immunology*;Mumps virus/immunology;Prospective Studies;Risk Factors;Rubella/prevention & control;Rubella Vaccine/immunology*;Rubella virus/immunology;Vaccination*
8311145;Anal Canal/surgery*;Anastomosis, Surgical/methods;Colon/surgery*;Fecal Incontinence/epidemiology;Female;Follow-Up Studies;Humans;Male;Middle Aged;Patient Satisfaction;Rectal Neoplasms/epidemiology;Rectal Neoplasms/surgery*;Time Factors
8314017;Animals;Blood Glucose/metabolism;Cell Nucleus/pathology;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/chemically induced*;Diabetes Mellitus, Experimental/pathology;Diabetes Mellitus, Type 1/blood;Islets of Langerhans/pathology;Male;Mice;Mice, Inbred NOD;Mice, SCID;Spleen/cytology;Streptozocin/administration & dosage*;T-Lymphocytes/physiology*;T-Lymphocytes/transplantation
8314575;Animals;Chromosome Mapping/methods*;Chromosomes, Fungal;Chromosomes, Human, Pair 13*;DNA Probes*;Digoxigenin;Gene Library*;Genetic Markers*;Genome, Human;Humans;Hybrid Cells;In Situ Hybridization;Mice;Silver Staining
8321513;Collagen;Humans;Lacrimal Apparatus Diseases/etiology*;Lacrimal Duct Obstruction/complications*;Prostheses and Implants;Tears/secretion
8323145;Adult;Cognition/physiology;Dyslexia*/therapy;Female;Humans;Language;Male;Remedial Teaching/trends*;Space Perception/physiology*;Visual Perception/physiology*
8324184;Biophysical Phenomena;Biophysics;Lipid Bilayers/chemistry*;Magnetic Resonance Spectroscopy;Models, Chemical;Molecular Structure;Surface Properties
8329376;Aging;Animals;Body Weight/drug effects;Brain Ischemia/prevention & control*;Cerebral Cortex/drug effects;Cerebral Cortex/growth & development;Oxygen/metabolism;Rats;Rats, Wistar;Vitamin E/administration & dosage;Vitamin E/pharmacology*
8335990;Child;Disease Susceptibility;Erythrocytes/metabolism*;Glycosphingolipids/metabolism*;Hemolytic-Uremic Syndrome/blood*;Hemolytic-Uremic Syndrome/immunology;Humans
8339389;Aged;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Chromatography, High Pressure Liquid;Cyclophosphamide/administration & dosage;Dexamethasone;Doxorubicin/administration & dosage;Doxorubicin/pharmacokinetics*;Drug Administration Schedule;Humans;Infusions, Intravenous;Injections, Intravenous;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism;Middle Aged;Prednisone/administration & dosage;Vincristine/administration & dosage
8343154;Amino Acid Sequence;Animals;Antibodies;Base Sequence;Cerebral Cortex/metabolism*;Chick Embryo;Chickens;Cloning, Molecular;Dendrites/metabolism*;Electrophoresis, Polyacrylamide Gel;Glutathione Transferase/analysis;Glutathione Transferase/biosynthesis;Immunoblotting;Immunohistochemistry;Membrane Glycoproteins/analysis;Membrane Glycoproteins/biosynthesis*;Membrane Glycoproteins/genetics;Membrane Proteins/analysis;Membrane Proteins/biosynthesis*;Membrane Proteins/genetics;Molecular Sequence Data;Multigene Family;Neurons/metabolism*;Oligodeoxyribonucleotides;Polymerase Chain Reaction;Protein-Tyrosine Kinases/analysis;Protein-Tyrosine Kinases/biosynthesis*;Protein-Tyrosine Kinases/genetics;Rats;Receptor, Ciliary Neurotrophic Factor;Receptor, trkC;Recombinant Fusion Proteins/analysis;Retina/metabolism;Sequence Homology, Amino Acid
8346453;Adolescent;Blood Coagulation*;Brain Injuries/blood*;Brain Injuries/complications;Child;Child, Preschool;Disseminated Intravascular Coagulation/etiology;Female;Humans;Infant;Male;Skull Fractures/blood*;Skull Fractures/complications
8347068;Accidental Falls/prevention & control;Aged;Body Mass Index;Exercise*;Female;Humans;Middle Aged;Muscle Contraction;Pilot Projects;Postural Balance;Proprioception;Psychomotor Performance*;Reaction Time
8358339;Cell Line;Cellular Senescence*;Female;Fibroblasts/drug effects;Fibroblasts/metabolism*;Fructosediphosphates/metabolism*;Glycolysis;Humans;Insulin/pharmacology*;Lactates/metabolism;Lactic Acid;Phosphofructokinase-1/metabolism;Protein Biosynthesis
8367388;Abnormalities, Multiple/genetics;Abnormalities, Multiple/pathology;Brain/abnormalities*;Brain/pathology;Contracture/genetics*;Contracture/pathology;Eye Abnormalities/genetics*;Eye Abnormalities/pathology;Facial Bones/abnormalities*;Facial Bones/pathology;Fetal Growth Retardation/genetics*;Fetal Growth Retardation/pathology;Humans;Infant, Newborn;Microcephaly/genetics*;Microcephaly/pathology;Syndrome
8378018;Adult;Alcohol Oxidoreductases/deficiency*;Female;Humans;Obstetric Labor Complications*;Placenta/blood supply;Pregnancy;Umbilicus/blood supply*
8380845;Adult;Antibodies, Viral/analysis;Cerebellar Diseases/diagnosis*;Encephalitis/diagnosis*;Female;Follow-Up Studies;Herpesvirus 3, Human/immunology;Herpesvirus 4, Human/immunology;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Prognosis;Serologic Tests
8381386;Amino Acid Sequence;Animals;Base Sequence;Blotting, Northern;Chromosome Mapping;Chromosomes, Human, Pair 6*;Cloning, Molecular;Conserved Sequence*;Cricetinae;DNA Probes;Humans;Hybrid Cells;Mammals/genetics;Mice;Molecular Sequence Data;Nuclear Proteins/genetics*;Receptors, Cell Surface/genetics*;Receptors, Retinoic Acid*;Retinoid X Receptors;Sequence Alignment;Sequence Analysis, DNA;Sequence Homology, Amino Acid;Sequence Homology, Nucleic Acid;Transcription Factors*
8385052;Amino Acid Sequence;Animals;Base Sequence;Blotting, Northern;Cattle;Cells, Cultured;Cloning, Molecular;DNA;Endothelium, Vascular/cytology;Gene Expression Regulation, Enzymologic;Humans;Molecular Sequence Data;Polymerase Chain Reaction;Receptors, Cell Surface/genetics*;Receptors, Cell Surface/metabolism;Receptors, Urokinase Plasminogen Activator;Sequence Homology, Amino Acid;Tretinoin/pharmacology*;Urokinase-Type Plasminogen Activator/genetics*;Urokinase-Type Plasminogen Activator/metabolism
8400690;Alleles;Argentina;Base Sequence;DNA Fingerprinting;DNA, Mitochondrial/genetics*;Female;Gene Frequency;Genetic Markers;Genetic Variation*;HLA-DQ Antigens/genetics;HLA-DQ alpha-Chains;HLA-DR Antigens/genetics;HLA-DRB1 Chains;Histocompatibility Antigens Class II/genetics;Humans;Indians, South American/genetics*;Male;Repetitive Sequences, Nucleic Acid
8403890;American Medical Association*;Ethics, Medical*;Humans;Physician-Patient Relations;United States
8404589;Amnion/cytology;Amnion/metabolism*;Animals;Cells, Cultured;Colforsin/pharmacology;Cyclic AMP/metabolism;Cyclic AMP/physiology*;Dinoprostone/metabolism;Drug Synergism;Glucocorticoids/pharmacology*;Hydrocortisone/pharmacology;Intracellular Membranes/metabolism;Oxytocin/antagonists & inhibitors;Oxytocin/pharmacology;Rabbits;Receptors, Oxytocin/metabolism*;Transforming Growth Factor alpha/pharmacology;Up-Regulation*
8406286;Clofibric Acid/analogs & derivatives*;Clofibric Acid/therapeutic use;Follow-Up Studies;Humans;Hyperlipidemia, Familial Combined/blood;Hyperlipidemia, Familial Combined/drug therapy*;Hypolipidemic Agents/therapeutic use*;Lipids/blood;Long-Term Care
8408841;Adult;Arthritis/complications;Chromosome Aberrations/chemically induced;Chromosome Disorders;Genetic Counseling*;Humans;Male;Methotrexate/adverse effects*;Mutation;Psoriasis/complications;Psoriasis/drug therapy;Psoriasis/genetics;Spermatogenesis/drug effects*
8421072;Adult;Calcium/blood*;Calcium/deficiency;Calcium/urine;Calcium, Dietary/pharmacology*;Fasting;Female;Humans;Hydroxyproline/urine*;Menopause;Parathyroid Hormone/blood*;Reference Values;Time Factors
8426784;Amoxicillin/therapeutic use;Ceftriaxone/therapeutic use;Child;Diarrhea/etiology;Drug Therapy, Combination/therapeutic use;Humans;Male;Paratyphoid Fever/diagnosis*;Paratyphoid Fever/drug therapy;Salmonella paratyphi A*
8435209;Anesthetics/pharmacology*;Animals;Blood Urea Nitrogen;Cisplatin/adverse effects;Cisplatin/therapeutic use*;Dose-Response Relationship, Drug;Drug Synergism;Female;Fibrosarcoma/chemistry;Fibrosarcoma/therapy;Hypothermia, Induced*;Platinum/pharmacokinetics*;Rats;Rats, Inbred F344;Tissue Distribution
8441315;Cochlea/pathology;Cochlear Duct/pathology;Edema/pathology*;Endolymph;Humans;Labyrinth Diseases/pathology*;Meniere Disease/pathology*;Saccule and Utricle/pathology;Scala Tympani/pathology;Semicircular Canals/pathology;Spiral Lamina/pathology
8448140;Carboxyhemoglobin/chemistry;Carboxyhemoglobin/metabolism*;Carboxyhemoglobin/radiation effects;Heme/metabolism*;Hemoglobins/chemistry;Hemoglobins/metabolism*;Hemoglobins/radiation effects;Humans;Kinetics;Ligands;Photolysis;Spectrophotometry, Infrared;Spectrum Analysis, Raman/methods
8464717;Base Sequence;DNA, Fungal;Genes, Fungal;Molecular Sequence Data;Polyporaceae/genetics*;RNA, Fungal/genetics;RNA, Ribosomal, 5.8S/genetics*
8472909;Animals;Aspergillus niger/genetics*;Aspergillus niger/metabolism;Base Sequence;Chickens;Cloning, Molecular;DNA, Recombinant/genetics;Female;Genes, Fungal;Glucan 1,4-alpha-Glucosidase/genetics*;Molecular Sequence Data;Muramidase/biosynthesis;Muramidase/genetics;Recombinant Fusion Proteins/biosynthesis;Recombinant Fusion Proteins/genetics*
8478909;Amino Acid Sequence;Bacteriorhodopsins/metabolism*;Binding Sites;Models, Molecular;Molecular Sequence Data;Parasympathomimetics/metabolism*;Receptors, Muscarinic/metabolism*;Stereoisomerism
8486023;Acquired Immunodeficiency Syndrome/complications;Acquired Immunodeficiency Syndrome/diagnostic imaging*;Adult;Female;HIV Seropositivity/complications;HIV Seropositivity/diagnostic imaging*;Humans;Lung/diagnostic imaging;Lymphadenitis/diagnostic imaging;Lymphadenitis/etiology;Lymphatic Diseases/diagnostic imaging*;Lymphatic Diseases/etiology;Male;Retrospective Studies;Tomography, X-Ray Computed*;Tuberculosis, Pulmonary/complications;Tuberculosis, Pulmonary/diagnostic imaging*
8492179;Clinical Protocols/standards*;Decision Trees*;Humans;Nurse Clinicians*;Nurse Practitioners*
8496811;Angiotensin II/metabolism;Angiotensin II/pharmacology*;Angiotensin Receptor Antagonists;Animals;Biphenyl Compounds/pharmacology;Drug Interactions;Electric Stimulation;Imidazoles/pharmacology;Losartan;Male;Muscle Contraction;Pyridines/pharmacology;Rabbits;Receptors, Angiotensin/metabolism*;Tetrazoles/pharmacology;Vas Deferens/drug effects*;Vas Deferens/metabolism
8496985;African Americans;Cost Control;Health Policy*;Health Services Accessibility*;Humans;Medically Uninsured/ethnology;National Health Insurance, United States;Physicians;United States
8500967;Adult;Antisocial Personality Disorder/psychology;Antisocial Personality Disorder/rehabilitation*;Dangerous Behavior*;England;Female;Hospitals, Special/legislation & jurisprudence*;Humans;Insanity Defense*;Male;Mental Disorders/psychology;Mental Disorders/rehabilitation*;Middle Aged;Outcome and Process Assessment (Health Care);Security Measures/legislation & jurisprudence*;Violence*
8501165;Flow Cytometry;Fluorescent Antibody Technique;Goiter, Nodular/metabolism*;Goiter, Nodular/pathology;Humans;Integrins/metabolism*;Receptors, Very Late Antigen/metabolism;Reference Values;Thyroid Gland/metabolism*;Thyroid Gland/pathology;Tissue Distribution
8506976;Humans;Lymphatic Metastasis;Neoplasm Invasiveness;Neoplasm Staging;Predictive Value of Tests;Rectal Neoplasms/pathology;Rectal Neoplasms/surgery*
8508806;Amino Acid Sequence;Chondroitin Sulfates/chemistry;Chondroitin Sulfates/metabolism;Dermatan Sulfate/chemistry;Dermatan Sulfate/metabolism;Electrophoresis, Polyacrylamide Gel;Fibroblast Growth Factor 2/chemistry*;Fibroblast Growth Factor 2/genetics;Fibroblast Growth Factor 2/metabolism;Glycosaminoglycans/chemistry*;Glycosaminoglycans/metabolism;Heparin/chemistry*;Heparin/metabolism;Heparitin Sulfate/chemistry;Heparitin Sulfate/metabolism;Humans;Hyaluronic Acid/chemistry;Hyaluronic Acid/metabolism;Molecular Sequence Data;Molecular Weight;Mutagenesis, Site-Directed;Trypsin/metabolism
8516538;Adult;Aged;Chronic Disease;Double-Blind Method;Echocardiography/drug effects;Exercise Test;Female;Heart Failure/diagnostic imaging;Heart Failure/drug therapy*;Heart Failure/physiopathology;Hemodynamics/drug effects*;Humans;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/pharmacology;Isosorbide Dinitrate/therapeutic use;Male;Middle Aged;Vasodilator Agents/pharmacology;Vasodilator Agents/therapeutic use*
8519088;Complement System Proteins/biosynthesis*;Epithelium/metabolism;Humans;Interferon-gamma/pharmacology;Interleukin-1/pharmacology;Tumor Cells, Cultured;Tumor Necrosis Factor-alpha/pharmacology
8523300;Catheterization*;Humans;Urinary Catheterization*
8525365;Ethylenes/metabolism*;Plant Proteins/metabolism;Plants/metabolism*;Protein Kinases/metabolism;Receptors, Cell Surface/metabolism*;Signal Transduction
8527282;Cell Count;Child;Child, Preschool;Drug Therapy;Erythrocyte Aging*;Erythrocytes/metabolism*;Female;Humans;Leukemia/drug therapy*;Leukemia/metabolism*;Male;Mercaptopurine/metabolism*;Time Factors
8534434;Epithelium/metabolism;Epithelium/microbiology;Helicobacter Infections/metabolism*;Helicobacter pylori/physiology*;Humans;Hyaluronan Receptors/biosynthesis*;Intercellular Adhesion Molecule-1/biosynthesis*;Stomach/metabolism;Stomach/microbiology*;Tumor Cells, Cultured;Up-Regulation
8543850;Base Sequence;Female;Genital Neoplasms, Female/metabolism*;Humans;Immunohistochemistry;Insulin-Like Growth Factor Binding Protein 1/genetics;Molecular Sequence Data;Polymerase Chain Reaction;Pregnancy Proteins/genetics*;RNA, Messenger/metabolism*;RNA, Neoplasm/metabolism*
8546912;Antineoplastic Agents, Alkylating/therapeutic use;Bone Marrow Transplantation;Combined Modality Therapy;Flow Cytometry;Hematopoietic Stem Cell Transplantation;Humans;Interferon-alpha/pharmacology;Interferon-alpha/therapeutic use*;Interleukin-2/blood;Killer Cells, Natural/drug effects;Lymphocyte Count/drug effects;Lymphocyte Subsets/drug effects*;Lymphocyte Subsets/physiology;Melphalan/therapeutic use;Multiple Myeloma/immunology;Multiple Myeloma/physiopathology;Multiple Myeloma/therapy*;Prognosis;Receptors, Interleukin-2/analysis;Recombinant Proteins;Recurrence;Remission Induction;Statistics, Nonparametric
8547469;Adenoma/genetics;Adenoma/pathology;Adenoma/prevention & control;Animals;Delayed-Action Preparations;Female;Follicle Stimulating Hormone/blood;Genotype*;Goserelin/pharmacology*;Luteinizing Hormone/blood;Male;Mice;Mice, Inbred C3H;Mice, Inbred C57BL;Ovarian Neoplasms/genetics*;Ovarian Neoplasms/pathology;Ovarian Neoplasms/prevention & control*;Ovary/pathology;Uterus/pathology
8558929;Core Binding Factor Alpha 2 Subunit;DNA-Binding Proteins/genetics*;Humans;Leukemia, Myeloid, Acute/metabolism*;Neoplasm Proteins/genetics*;Oncogene Proteins, Fusion/genetics*;Polymerase Chain Reaction;Proto-Oncogene Proteins*;RNA, Messenger/analysis*;RUNX1 Translocation Partner 1 Protein;Remission Induction;Transcription Factors/genetics*
8570742;Animals;Cocarcinogenesis*;Dietary Fats/toxicity*;Female;Immune Tolerance/radiation effects*;Mice;Mice, Hairless;Neoplasms, Experimental/etiology;Neoplasms, Experimental/immunology;Neoplasms, Radiation-Induced/etiology;Neoplasms, Radiation-Induced/immunology;Ultraviolet Rays/adverse effects*
8572763;Adolescent;Adult;Aged;Aged, 80 and over;Child;Child, Preschool;Endoscopy/adverse effects*;Endoscopy/mortality;Female;Humans;Infant;Infant, Newborn;Male;Mediastinal Diseases/surgery;Middle Aged;Pain, Postoperative/prevention & control;Postoperative Complications/etiology*;Postoperative Complications/mortality;Prospective Studies;Survival Rate;Thoracic Diseases/surgery;Thoracoscopy/adverse effects*;Thoracotomy/methods*;Thoracotomy/mortality;Videotape Recording*
8584929;Animals;Carrier Proteins/biosynthesis;Carrier Proteins/chemistry;Carrier Proteins/genetics*;Chromosome Mapping;Cloning, Molecular;Diabetes Mellitus/genetics*;Humans;Leptin;Mice;Mutation;Obesity/genetics*;Proteins/genetics;RNA, Messenger/genetics;Rats;Receptors, Cell Surface*;Receptors, Cytokine/biosynthesis;Receptors, Cytokine/chemistry;Receptors, Cytokine/genetics*;Receptors, Leptin
8588146;Adult;Disseminated Intravascular Coagulation/etiology;Fatal Outcome;Female;Finland;Hantavirus Infections/diagnosis;Hantavirus Infections/etiology*;Hantavirus Infections/pathology;Hemorrhage/pathology;Hemorrhagic Fever with Renal Syndrome/diagnosis;Hemorrhagic Fever with Renal Syndrome/etiology;Hemorrhagic Fever with Renal Syndrome/pathology;Humans;Male;Middle Aged
8601622;Amino Acid Sequence;Animals;Chymases;Dogs;Enzyme Activation/drug effects;Enzyme Inhibitors/pharmacology;Gelatinases/genetics;Gelatinases/metabolism;Gelatinases/secretion*;Humans;Mast Cells/enzymology;Mast-Cell Sarcoma/enzymology*;Mast-Cell Sarcoma/genetics;Mice;Molecular Sequence Data;Molecular Weight;Rabbits;Sequence Homology, Amino Acid;Serine Endopeptidases/pharmacology;Tumor Cells, Cultured
8625627;Acute Disease;Aged;Combined Modality Therapy;Female;Growth Hormone/therapeutic use*;Humans;Male;Middle Aged;Nutritional Support;Prospective Studies;Recombinant Proteins/therapeutic use;Respiration, Artificial*;Respiratory Insufficiency/physiopathology;Respiratory Insufficiency/therapy;Respiratory Muscles/drug effects*;Respiratory Muscles/physiopathology
8631801;Adenosine Diphosphate;Animals;Aorta;CHO Cells;Carbohydrate Conformation;Carbohydrate Sequence;Chromatography, Affinity;Chromatography, Gel;Chromatography, High Pressure Liquid;Cricetinae;Disaccharides/chemistry;Disaccharides/isolation & purification;Disaccharides/metabolism;Heparitin Sulfate/metabolism;Hydrogen-Ion Concentration;Kinetics;Mice;Molecular Sequence Data;Molecular Weight;Sepharose/analogs & derivatives;Substrate Specificity;Sulfotransferases/chemistry;Sulfotransferases/isolation & purification*;Sulfotransferases/metabolism*;Swine;Tumor Cells, Cultured
8637591;Acinonyx*/genetics;Acinonyx*/immunology;Animals;DNA Fingerprinting;Genetic Variation;Homozygote;Rodentia/genetics;Rodentia/immunology;Skin Transplantation*/immunology;Transplantation, Homologous
8642132;Dental Care/standards;Humans;Insurance, Dental*;Managed Care Programs*;Practice Management, Dental/organization & administration*
8644270;Humans;Informed Consent/legislation & jurisprudence*;Kidney*;Kidney Transplantation*/statistics & numerical data;Latvia;Tissue Donors/legislation & jurisprudence*;Tissue and Organ Procurement/legislation & jurisprudence*
8650346;Animals;Base Sequence;Gamma Rays;Humans;Molecular Sequence Data;Phosphorus Radioisotopes;Polymerase Chain Reaction/methods*;RNA, Messenger/analysis*;Sulfur Radioisotopes
8651706;Animals;Autoradiography;Baculoviridae;Cell Line;Gene Expression;Genes, p53*;Humans;Immunoblotting;Kinetics;Methionine/metabolism;Phosphates/metabolism;Phosphorus Radioisotopes;Phosphorylation;Recombinant Proteins/biosynthesis;Recombinant Proteins/isolation & purification;Spodoptera;Subcellular Fractions/metabolism;Sulfur Radioisotopes;Time Factors;Transfection;Tumor Suppressor Protein p53/biosynthesis*;Tumor Suppressor Protein p53/isolation & purification
8656867;Aged;Evaluation Studies as Topic;Female;Humans;Mammography*;Mass Screening*;Middle Aged;Randomized Controlled Trials as Topic;Sweden;United States
8659606;Brain/physiology*;Female;Form Perception;Frontal Lobe/physiology;Functional Laterality/physiology*;Humans;Language*;Magnetic Resonance Imaging*;Male;Reading;Sex Factors
8663394;Amino Acid Sequence;Biological Transport;Cross-Linking Reagents;Fungal Proteins/genetics*;Genes, Fungal;Membrane Proteins/genetics;Mitochondria/genetics*;Mitochondrial ADP, ATP Translocases/metabolism;Mitochondrial Membrane Transport Proteins;Molecular Sequence Data;Protein Binding;Protein Precursors/metabolism;Receptors, Cytoplasmic and Nuclear/genetics*;Saccharomyces cerevisiae/genetics*;Saccharomyces cerevisiae Proteins*;Sequence Homology, Amino Acid
8669559;Calcium Channels/genetics*;Chromosome Mapping;Chromosomes, Human, Pair 19/genetics*;Creatine Kinase/blood;Female;Genes/genetics*;Genetic Linkage*;Genetic Predisposition to Disease;Humans;Male;Malignant Hyperthermia/diagnosis;Malignant Hyperthermia/genetics*;Muscle Proteins/genetics*;Pedigree;Polymorphism, Genetic;Repetitive Sequences, Nucleic Acid;Ryanodine Receptor Calcium Release Channel
8674272;Animals;Antineoplastic Agents/metabolism*;Biological Factors/biosynthesis*;Cell Cycle;Cell Division;Cells, Cultured;Culture Media, Conditioned;Humans;Melanoma, Experimental/pathology;Mice;Mice, Inbred C57BL;Molecular Weight;Muscle, Skeletal/cytology;Muscle, Skeletal/drug effects;Muscle, Skeletal/metabolism*;Rats;Sarcoma, Experimental/pathology;Tumor Cells, Cultured
8675264;Acute Disease;Animals;Aorta/metabolism*;Base Sequence;Blotting, Northern;Blotting, Western;DNA-Binding Proteins/biosynthesis;DNA-Binding Proteins/genetics*;Gene Expression Regulation;Heat Shock Transcription Factors;Heat-Shock Proteins/biosynthesis;Heat-Shock Proteins/genetics*;Hypertension/genetics*;Hypertension/metabolism;In Vitro Techniques;Male;Molecular Sequence Data;Phosphorylation;Rats;Rats, Wistar;Restraint, Physical;Stress, Physiological/metabolism;Transcription Factors/biosynthesis;Transcription Factors/genetics*;Transcription, Genetic
8683560;Animals;Animals, Newborn;Astrocytes/cytology*;Cell Membrane;Cells, Cultured;Fluorescent Dyes;Hippocampus/cytology;Microscopy, Atomic Force*/instrumentation;Microscopy, Atomic Force*/methods;Rats;Rats, Sprague-Dawley;Visual Cortex/cytology
8689490;Anti-Inflammatory Agents/therapeutic use;Chorioretinitis/diagnosis;Chorioretinitis/drug therapy;Chorioretinitis/immunology;Female;Fluorescein Angiography;Follow-Up Studies;Fundus Oculi;HLA-A Antigens/immunology*;Humans;Male;Middle Aged;Prednisolone/therapeutic use;Uveitis, Posterior/diagnosis;Uveitis, Posterior/drug therapy;Uveitis, Posterior/immunology*;Vasculitis/diagnosis;Vasculitis/drug therapy;Vasculitis/immunology;Visual Acuity
8690911;Animals;Base Sequence;Hybridomas/metabolism;Hybridomas/microbiology;Listeria monocytogenes/growth & development;Listeriosis/immunology*;Listeriosis/microbiology;Liver Diseases/immunology;Liver Diseases/microbiology;Lymphocyte Activation;Mice;Mice, Inbred C57BL;Molecular Sequence Data;Receptors, Antigen, T-Cell, gamma-delta/immunology*;T-Lymphocyte Subsets/classification;T-Lymphocyte Subsets/immunology*;T-Lymphocyte Subsets/microbiology
8693189;Activities of Daily Living/psychology;Aged;Cerebrovascular Disorders/complications;Cerebrovascular Disorders/psychology;Cerebrovascular Disorders/rehabilitation*;Combined Modality Therapy;Female;Geriatric Assessment*;Humans;Occupational Therapy;Patient Care Team*;Physical Therapy Modalities;Psychotherapy;Rehabilitation Centers;Social Support
8699685;Humans;Interprofessional Relations;Medical Staff, Hospital*;Nursing Staff, Hospital*;Professional Autonomy*
8701505;Amino Acids/blood;Biomarkers/analysis*;Blood Chemical Analysis/methods;Blood Chemical Analysis/standards;Evaluation Studies as Topic;Folic Acid Deficiency/blood;Homocysteine/blood*;Homocysteine/chemistry;Humans;Methylmalonic Acid/blood*;Methylmalonic Acid/chemistry;Vitamin B 12 Deficiency/blood;Vitamin B 6 Deficiency/blood;Vitamin B Deficiency/blood*
8702228;Animals;Benzimidazoles;Blood Pressure/drug effects;Carbocyanines;Cryoultramicrotomy;Female;Fluorescent Dyes;Heart Rate/drug effects;Mammary Neoplasms, Experimental/blood supply*;Microscopy, Fluorescence;Neovascularization, Pathologic*;Norepinephrine/pharmacology*;Perfusion;Rats;Rats, Sprague-Dawley;Staining and Labeling/methods;Vasoconstrictor Agents/pharmacology*
8707410;Animals;Brain/immunology*;Brain Neoplasms/immunology*;Brain Neoplasms/pathology;Cell Division/physiology;Gene Expression Regulation, Neoplastic;H-2 Antigens/biosynthesis;H-2 Antigens/genetics;H-2 Antigens/immunology*;Immunity, Innate/immunology;Killer Cells, Natural/immunology;Lymphoma, T-Cell/immunology*;Lymphoma, T-Cell/pathology;Mice;Mice, Inbred CBA;Neoplasm Transplantation;T-Lymphocytes, Cytotoxic/immunology;beta 2-Microglobulin/analysis
8722107;Animals;Carcinogenicity Tests;Carcinogens, Environmental/administration & dosage;Carcinogens, Environmental/metabolism;Carcinogens, Environmental/toxicity*;Cocarcinogenesis;Cytochrome P-450 Enzyme System/metabolism;Disease Models, Animal;Liver Neoplasms/chemically induced*;Oncorhynchus mykiss*;Stomach Neoplasms/chemically induced*
8722573;Base Sequence;DNA, Plant/chemistry*;DNA, Ribosomal/chemistry*;Molecular Sequence Data;RNA, Ribosomal/genetics;Sequence Analysis;Sequence Homology, Nucleic Acid;Trees/genetics*
8724712;Adult;Cyclosporine/adverse effects*;Female;Gingival Hyperplasia/chemically induced*;Gingival Hyperplasia/virology*;Humans;Immunosuppressive Agents/adverse effects*;Kidney Transplantation/adverse effects;Papillomaviridae;Papillomavirus Infections/complications*;Papillomavirus Infections/virology;Tumor Virus Infections/complications*;Tumor Virus Infections/virology
8727701;Adenocarcinoma/metabolism;Adenocarcinoma/pathology*;Aneuploidy;Cell Division/physiology;DNA/analysis*;Diploidy;Endometrial Hyperplasia/metabolism;Endometrial Hyperplasia/pathology*;Endometrial Neoplasms/metabolism;Endometrial Neoplasms/pathology*;Endometrium/cytology*;Endometrium/metabolism;Female;Flow Cytometry;Humans;Proliferating Cell Nuclear Antigen/metabolism
8729644;Antipsychotic Agents/chemistry;Antipsychotic Agents/isolation & purification*;Chlorprothixene/chemistry;Chlorprothixene/isolation & purification*;Chromatography, Liquid/methods*;Molecular Conformation;Reproducibility of Results
8736770;Adipose Tissue/cytology;Adipose Tissue/immunology;Adipose Tissue/physiology*;Animals;B-Lymphocytes/cytology;B-Lymphocytes/immunology;B-Lymphocytes/physiology;Cell Division;Coculture Techniques;Dietary Fats*;Fatty Acids;Immune System/physiology*;Lymphoid Tissue/cytology;Mammals;Organ Culture Techniques;T-Lymphocytes/cytology;T-Lymphocytes/immunology;T-Lymphocytes/physiology
8748517;Anterior Cruciate Ligament/physiopathology;Anterior Cruciate Ligament Injuries*;Athletic Injuries/physiopathology*;Biomechanical Phenomena;Humans;Isometric Contraction/physiology;Knee Injuries/physiopathology*;Medial Collateral Ligament, Knee/injuries*;Medial Collateral Ligament, Knee/physiopathology;Range of Motion, Articular/physiology;Reference Values;Signal Processing, Computer-Assisted;Skiing/injuries*;Weight-Bearing/physiology*
8749123;Adult;Alcohol Drinking/adverse effects;Alcohol Drinking/physiopathology*;Alcoholic Intoxication/physiopathology;Dose-Response Relationship, Drug;Double-Blind Method;Ethanol/administration & dosage*;Ethanol/pharmacokinetics;Humans;Male;Postural Balance/drug effects*;Postural Balance/physiology;Posture/physiology*;Vestibular Function Tests
8758609;Adult;Female;Humans;Hypnotics and Sedatives/adverse effects*;Male;Middle Aged;Ossification, Heterotopic/chemically induced*;Ossification, Heterotopic/diagnostic imaging;Time Factors;Tomography, X-Ray Computed
8767204;Acanthocytes*;Adult;Athetosis/diagnosis;Athetosis/enzymology;Athetosis/genetics*;Atrophy;Caudate Nucleus/pathology;Chorea/diagnosis;Chorea/enzymology;Chorea/genetics*;Creatine Kinase/blood;Diagnosis, Differential;Globus Pallidus/pathology;Humans;Magnetic Resonance Imaging;Male;Neurologic Examination;Putamen/pathology
8773309;Animals;Blood Glucose/analysis*;Dogs;Equipment Design;Lactates/analysis*;Membranes;Microdialysis/instrumentation*;Miniaturization/instrumentation;Monitoring, Physiologic/instrumentation*;Regression Analysis;Renal Dialysis/instrumentation*
8781744;Aged;Aged, 80 and over;Breast/metabolism;Breast Neoplasms/blood*;Breast Neoplasms/therapy;Case-Control Studies;Combined Modality Therapy;Dichlorodiphenyl Dichloroethylene/pharmacokinetics;Female;Follow-Up Studies;Humans;Hydrocarbons, Chlorinated/pharmacokinetics*;Middle Aged;Polychlorinated Biphenyls/pharmacokinetics
8787267;Aged;Aged, 80 and over;Anesthesia, Inhalation/adverse effects*;Epiglottitis/etiology*;Humans;Laryngeal Masks/adverse effects*;Male
8799523;Administration, Oral;Administration, Sublingual;Adult;Affect/drug effects;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology;Benzodiazepinones/administration & dosage;Benzodiazepinones/blood;Benzodiazepinones/pharmacokinetics*;Benzodiazepinones/pharmacology;Diazepam/administration & dosage;Diazepam/blood;Diazepam/pharmacokinetics*;Diazepam/pharmacology;Double-Blind Method;Ethanol/administration & dosage;Ethanol/pharmacology*;Humans;Infusions, Intravenous;Male;Postural Balance/drug effects;Pursuit, Smooth/drug effects;Saccades/drug effects
8809957;Antibodies, Monoclonal;Antibody Specificity;Antigens, Human Platelet/immunology;Blood Platelets/immunology*;HLA Antigens/immunology*;Hematologic Neoplasms/immunology*;Humans;Immunization*;Immunoassay/methods;Isoantibodies/blood*;Transfusion Reaction*
8813871;Diagnosis, Differential;Diet, Protein-Restricted;Esophagus/physiopathology*;Female;Gastroesophageal Reflux/diet therapy;Gastroesophageal Reflux/etiology*;Gastroesophageal Reflux/physiopathology;Humans;Hydrogen-Ion Concentration;Infant;Male;Milk Hypersensitivity/complications*;Milk Hypersensitivity/diet therapy;Milk Hypersensitivity/physiopathology;Milk Proteins/adverse effects*
8819919;Animals;Chorionic Gonadotropin/pharmacology;Chorionic Gonadotropin/therapeutic use*;Chronic Disease;Humans;Liver/drug effects;Liver/immunology;Liver/metabolism;Liver Diseases/drug therapy*;Liver Diseases/immunology;Liver Diseases/metabolism
8830124;Adrenal Cortex Hormones/therapeutic use*;Adult;Alanine Transaminase/blood;Base Sequence;Chronic Disease;DNA Primers;DNA, Viral/blood;DNA, Viral/drug effects;Female;Hepatitis B/blood;Hepatitis B/drug therapy;Hepatitis B/virology*;Hepatitis B e Antigens/genetics*;Hepatitis B virus/genetics;Hepatitis B virus/isolation & purification*;Humans;Male;Molecular Sequence Data;Point Mutation;Polymerase Chain Reaction;Prevalence
8841445;Bacterial Outer Membrane Proteins/chemistry*;Bacterial Outer Membrane Proteins/immunology;Bacterial Outer Membrane Proteins/ultrastructure;Carbohydrates/chemistry;Carbohydrates/immunology;Cell Wall/chemistry;Cell Wall/immunology;Cell Wall/ultrastructure;Crystallization;Glycoproteins/chemistry*;Glycoproteins/immunology;Glycoproteins/ultrastructure;Gram-Positive Asporogenous Rods, Irregular/chemistry;Gram-Positive Asporogenous Rods, Irregular/immunology;Gram-Positive Asporogenous Rods, Irregular/ultrastructure;Humans;Immunoassay/methods*;Immunoglobulin G/chemistry;Immunoglobulin G/ultrastructure;Microscopy, Immunoelectron;Particle Size
8846860;Adult;Aged;Breast Neoplasms/drug therapy;Breast Neoplasms/pathology*;Breast Neoplasms/radiotherapy;Breast Neoplasms/surgery*;Chemotherapy, Adjuvant;Female;Humans;Lymphatic Metastasis;Mastectomy, Segmental/methods*;Middle Aged;Neoplasm Recurrence, Local;Radiotherapy, Adjuvant;Treatment Outcome
8859142;Adult;Child Abuse/statistics & numerical data*;Child, Preschool;Colorado/epidemiology;Female;Humans;Incidence;Infant;Infant Mortality*;Infant, Newborn;Marital Status;Maternal Age*;Mothers;Multivariate Analysis;Retrospective Studies;United States/epidemiology;Wounds and Injuries/epidemiology*
8859150;Cystic Fibrosis/diagnosis;Diagnosis*;Diagnostic Errors;Humans;Pediatrics*;Physician-Patient Relations;Telephone*
8873521;Adolescent;Adult;Age Distribution;Cardiovascular Diseases/epidemiology;Cause of Death;Child;Digestive System Diseases/epidemiology;Female;Follow-Up Studies;Humans;Incidence;Infection/epidemiology;Male;Middle Aged;Neoplasms/epidemiology;Nervous System Diseases/epidemiology;Respiratory Tract Diseases/epidemiology;Risk Assessment;Spleen/injuries;Splenectomy/mortality*;Sweden/epidemiology;Treatment Outcome
8875470;Animals;Cell Death/physiology;Cell Nucleolus/physiology;Cell Nucleolus/ultrastructure;Functional Laterality;Gerbillinae;Heat-Shock Proteins/metabolism;Hippocampus/pathology*;Hippocampus/ultrastructure;Hyperbaric Oxygenation*;Immunohistochemistry;Ischemic Attack, Transient/pathology*;Male;Microscopy, Electron;Neurons/physiology*;Neurons/ultrastructure
8889906;1-Naphthylamine/analogs & derivatives;1-Naphthylamine/metabolism;Animals;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology;Fluoxetine/metabolism;Fluvoxamine/metabolism;Humans;Mixed Function Oxygenases/antagonists & inhibitors;Paroxetine/metabolism;Serotonin Uptake Inhibitors/metabolism*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology;Sertraline
8894061;Adult;Affect/physiology;Attention*/physiology;Cerebral Cortex/physiopathology;Depressive Disorder/diagnosis*;Depressive Disorder/physiopathology;Depressive Disorder/psychology;Dominance, Cerebral/physiology;Facial Expression*;Female;Humans;Male;Pattern Recognition, Visual/physiology;Recurrence;Schizotypal Personality Disorder/diagnosis*;Schizotypal Personality Disorder/physiopathology;Schizotypal Personality Disorder/psychology;Social Perception*
8894127;Algorithms*;Animals;Genetics, Population*;Humans
8895821;Administration, Inhalation;Ascorbic Acid/administration & dosage;Ascorbic Acid/therapeutic use;Cystic Fibrosis/drug therapy;Cystic Fibrosis/metabolism*;Cystic Fibrosis/pathology;Humans;Lung Diseases/metabolism;Lung Diseases/pathology;Nitric Oxide/metabolism;Oxidative Stress*;Reactive Oxygen Species;Sulfhydryl Compounds/administration & dosage;Sulfhydryl Compounds/therapeutic use;Trachea/metabolism;Trachea/pathology;beta Carotene/deficiency
8897975;Adenosine Triphosphatases/antagonists & inhibitors;Animals;Cardiovascular Agents/pharmacology;Cytochrome P-450 Enzyme System/physiology*;Gas Chromatography-Mass Spectrometry;Hydroxyeicosatetraenoic Acids/chemistry;Hydroxyeicosatetraenoic Acids/metabolism*;Hydroxyeicosatetraenoic Acids/pharmacology;Kidney Medulla;Loop of Henle/drug effects;Loop of Henle/metabolism*;Male;Rabbits;Renal Circulation/drug effects;Stereoisomerism;Vasodilation
8907712;Amino Acid Sequence;Animals;Base Sequence;Cloning, Molecular;Glycoproteins*;Glycosylation;Humans;Macaca fascicularis;Male;Membrane Glycoproteins/genetics*;Membrane Proteins*;Molecular Sequence Data;Protein Structure, Tertiary*;Repetitive Sequences, Nucleic Acid;Sequence Homology, Amino Acid
8908459;Acute Disease;Adult;Endometriosis/complications*;Endometriosis/surgery;Female;Humans;Ileal Diseases/etiology*;Ileal Diseases/surgery;Intestinal Obstruction/etiology*;Intestinal Obstruction/surgery;Ovarian Diseases/complications*;Ovarian Diseases/surgery
8916802;Animals;Antibodies, Helminth/blood;Antigens, Helminth*;Cross Reactions;Cysteine Endopeptidases/immunology*;Enzyme-Linked Immunosorbent Assay*;Humans;Immune Sera/immunology;Paragonimiasis/diagnosis*;Paragonimus/enzymology;Paragonimus/immunology*;Sensitivity and Specificity
8917370;Aneuploidy*;Animals;Cell Line, Transformed;DNA/analysis;Epithelium/virology;Female;Flow Cytometry;Humans;Karyotyping;Mice;Mice, Nude;Mouth Mucosa*/virology;Simian virus 40*
8919913;Amylases/genetics;Animals;Base Sequence;Binding Sites/genetics;Consensus Sequence;DNA Primers/genetics;DNA, Plant/genetics;Genes, Plant*;Hybridization, Genetic;Introns;Molecular Sequence Data;Mutagenesis, Insertional;Mutation;Plants, Toxic;RNA Precursors/genetics;RNA Precursors/metabolism;RNA Splicing*;RNA, Plant/genetics;RNA, Plant/metabolism;Tobacco/genetics;Tobacco/metabolism
8919976;Clinical Competence;Decision Making;Health Personnel/education;Malpractice/legislation & jurisprudence*;Quality of Health Care/legislation & jurisprudence*;Suicide/legislation & jurisprudence*;Suicide/prevention & control;United States
8930531;Animals;CHO Cells;COS Cells;Cell Line;Cricetinae;DNA, Complementary/genetics*;Glycoside Hydrolases/pharmacology;Humans;Immunosorbent Techniques;Kinetics;Molecular Weight;Pituitary Gland;Prolactin/analogs & derivatives*;Prolactin/biosynthesis;Prolactin/chemistry;Prolactin/genetics*;Prolactin/secretion;Rats;Transfection
8937533;Acidosis, Lactic/cerebrospinal fluid;Acidosis, Lactic/diagnosis*;Adult;Blotting, Southern;Brain/physiopathology;DNA, Mitochondrial/genetics;Diagnosis, Differential;Diseases in Twins*;Electroencephalography;Fatal Outcome;Humans;MELAS Syndrome/diagnosis*;Male;Mitochondrial Myopathies/diagnosis;Mitochondrial Myopathies/genetics;Muscle, Skeletal/ultrastructure;Point Mutation;Status Epilepticus/physiopathology;Twins, Monozygotic*
8958864;Adult;Cystitis*/pathology;Gangrene;Humans;Male;Urinary Bladder/pathology*
8968138;Adolescent;Adult;Aged;Aged, 80 and over;Anesthesia, Inhalation/statistics & numerical data;Anesthesia, Intravenous/statistics & numerical data;Anesthetics, Intravenous*/administration & dosage;Anesthetics, Intravenous*/pharmacology;Child;Child, Preschool;Emergencies;Humans;Infant;Middle Aged;Propofol*/administration & dosage;Propofol*/pharmacology;Retrospective Studies;Risk Factors;Surgical Procedures, Operative*/statistics & numerical data
8976122;Adenosine Triphosphate/metabolism;Alcohol Drinking/adverse effects*;Aldehyde Dehydrogenase/genetics;Aldehyde Dehydrogenase/metabolism;Beer/adverse effects;Ethanol/metabolism;Female;Genotype;Gout/etiology*;Humans;Hypoxanthine/metabolism;Pregnancy;Purine Nucleotides/metabolism;Uric Acid/blood*
8976315;Adult;Brain Injuries/classification;Brain Injuries/physiopathology*;Brain Injuries/psychology;Case-Control Studies;Chi-Square Distribution;Demography;Female;Humans;Injury Severity Score;Male;Middle Aged;Nervous System Diseases/physiopathology;Pain/physiopathology*;Sleep Initiation and Maintenance Disorders/physiopathology*
8978492;Absorption;Animals;Cholesterol/analogs & derivatives;Cholesterol/pharmacokinetics*;Humans;Intestine, Small/cytology;Intestine, Small/metabolism*;Micelles;Microscopy, Electron;Microvilli/metabolism;Microvilli/ultrastructure;Models, Biological;Rabbits;Swine;Taurocholic Acid/pharmacology
8987794;Action Potentials/physiology;Adult;Animals;Attention;Dogs;Electroencephalography;Evoked Potentials, Visual/physiology*;Female;Humans;Male;Pattern Recognition, Visual/physiology*;Time Factors;Visual Perception/physiology
8987949;Adult;Blood Physiological Phenomena;Cells, Cultured;Culture Media;Cytokines/pharmacology;Epithelium/metabolism;Fallopian Tubes/cytology;Fallopian Tubes/metabolism;Fallopian Tubes/physiology*;Female;Gene Expression Regulation*;Growth Inhibitors/genetics*;Growth Inhibitors/metabolism*;Growth Substances/pharmacology;Hormones/pharmacology;Humans;Interleukin-6*;Leukemia Inhibitory Factor;Lymphokines/genetics*;Lymphokines/metabolism*;Middle Aged;Pregnancy;Pregnancy, Ectopic/metabolism;RNA, Messenger/metabolism;Stromal Cells/metabolism
8988775;Amputation, Traumatic/diagnostic imaging;Amputation, Traumatic/surgery*;Bone Lengthening/instrumentation*;Bone Regeneration/physiology;Bone Transplantation/instrumentation;Child, Preschool;Humans;Infant;Male;Osteotomy/instrumentation;Postoperative Complications/diagnostic imaging;Postoperative Complications/surgery*;Radiography;Reoperation;Replantation/instrumentation*;Thumb/injuries*;Treatment Outcome
8989931;Actins/analysis;Actins/genetics;Adenoma, Sweat Gland/genetics;Adenoma, Sweat Gland/pathology*;Biomarkers, Tumor/analysis;Biomarkers, Tumor/genetics;Coloring Agents;Eccrine Glands/metabolism;Eccrine Glands/pathology;Gene Expression Regulation, Neoplastic*;Humans;Immunohistochemistry;Keratins/analysis;Keratins/genetics*;Metaplasia;Mucin-1/analysis;Mucin-1/genetics;Phenotype;S100 Proteins/analysis;S100 Proteins/genetics;Sweat Gland Neoplasms/genetics;Sweat Gland Neoplasms/pathology*;Sweat Glands/metabolism;Sweat Glands/pathology
8990347;Animals;Antibodies;Antibodies, Monoclonal/metabolism;Fluorescein-5-isothiocyanate;Fluorescent Dyes;Graft Survival/immunology;Haptens/immunology*;Heart Transplantation/immunology*;Interleukin-2/immunology*;Interleukin-2/metabolism*;Lymphocyte Activation/immunology*;Male;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Protein Binding;Receptors, Interleukin-2/metabolism;T-Lymphocytes/immunology*
8999119;Aerosols;Carbon Dioxide;Drug Compounding/methods*;Microscopy, Electron, Scanning;Microspheres;Particle Size;Polyesters;Solvents;Ultrasonics
9000096;Amino Acid Sequence;Animals;Base Sequence;DNA, Viral/analysis;Molecular Sequence Data;Pneumovirus/classification;Pneumovirus/enzymology*;Pneumovirus/genetics;Polymerase Chain Reaction;RNA, Messenger;RNA, Viral/analysis;Sequence Analysis, DNA*;Sequence Homology, Amino Acid;Turkeys/virology;Viral Proteins/genetics*
9007744;Adult;Apocrine Glands/pathology*;Biopsy;Brain Diseases/complications;Brain Diseases/diagnosis*;Cytoplasm/ultrastructure;Dementia/etiology;Electroencephalography;Epilepsies, Myoclonic/etiology*;Fatal Outcome;Female;Humans;Male;Microscopy, Electron
9010987;Adult;Aged;Aged, 80 and over;Antiemetics/administration & dosage;Antiemetics/adverse effects;Antiemetics/therapeutic use*;Antineoplastic Agents/adverse effects*;Appetite/drug effects;Cisplatin/adverse effects*;Female;Follow-Up Studies;Granisetron/administration & dosage;Granisetron/adverse effects;Granisetron/therapeutic use*;Headache/chemically induced;Humans;Injections, Intravenous;Male;Middle Aged;Nausea/prevention & control;Neoplasms/drug therapy;Remission Induction;Safety;Time Factors;Vomiting/chemically induced;Vomiting/prevention & control*
9015757;Amino Acid Sequence;Animals;Base Sequence;Calcitriol/pharmacology*;Cells, Cultured;Chick Embryo/cytology;Chick Embryo/drug effects;Chickens/genetics*;Cloning, Molecular;Dexamethasone/pharmacology*;Integrin-Binding Sialoprotein;Molecular Sequence Data;Osteoblasts/drug effects;Osteoblasts/physiology;Parathyroid Hormone/pharmacology*;Promoter Regions, Genetic;Recombinant Proteins/genetics;Recombinant Proteins/metabolism;Regulatory Sequences, Nucleic Acid;Sequence Analysis, DNA;Sequence Homology, Amino Acid;Sequence Homology, Nucleic Acid;Sialoglycoproteins/drug effects;Sialoglycoproteins/genetics*;Tissue Distribution;Transcription, Genetic
9022221;Adult;Aged;Aged, 80 and over;Aging/blood*;Fatty Acids/blood*;Fatty Acids/chemistry*;Fatty Acids, Nonesterified/blood;Fatty Acids, Nonesterified/chemistry;Female;Humans;Lipid Peroxidation;Lipoproteins, LDL/blood*;Lipoproteins, LDL/chemistry*;Male;Middle Aged
9029551;Animals;Brain/metabolism*;Kinetics;Marine Toxins/metabolism*;Oxocins*;Protein Binding;Rats;Rats, Sprague-Dawley;Sodium Channels/metabolism*
9035745;Biocompatible Materials*;Bone Cements*;Drug Stability;Fumarates*;Humans;Microscopy, Electron, Scanning;Polypropylenes*
9040494;6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology;Animals;Benzoates/pharmacology;Biomarkers;Calcium Channels/drug effects;Citrulline/biosynthesis;Cycloleucine/analogs & derivatives;Cycloleucine/pharmacology;Dantrolene/pharmacology;Dizocilpine Maleate/pharmacology;Excitatory Amino Acid Agonists/pharmacology;Excitatory Amino Acid Antagonists/pharmacology;Glycine/analogs & derivatives;Glycine/pharmacology;Hippocampus/drug effects;Hippocampus/metabolism*;Male;Microdialysis;Muscle Proteins/drug effects;N-Methylaspartate/pharmacology;Nerve Tissue Proteins/antagonists & inhibitors;Nerve Tissue Proteins/metabolism;Nitric Oxide/biosynthesis*;Nitric Oxide Synthase/antagonists & inhibitors;Nitric Oxide Synthase/metabolism;Nitroarginine/pharmacology;Rats;Rats, Sprague-Dawley;Receptors, Metabotropic Glutamate/drug effects;Receptors, Metabotropic Glutamate/physiology*;Ryanodine Receptor Calcium Release Channel;Tetrodotoxin/pharmacology
9040821;Adolescent;Adult;Astrocytoma/diagnosis*;Astrocytoma/pathology;Astrocytoma/surgery*;Brain Neoplasms/diagnosis*;Brain Neoplasms/pathology;Brain Neoplasms/surgery*;Child;Child, Preschool;Female;Humans;Magnetic Resonance Imaging;Male;Neoplasm Recurrence, Local/prevention & control;Tomography, X-Ray Computed
9048249;Action Potentials/drug effects;Animals;Anti-Arrhythmia Agents/pharmacology*;Calcium Channel Blockers/pharmacology*;Dogs;Electric Stimulation;Electrophysiology;Heart/drug effects;Heart/physiology*;Hydantoins;Imidazoles/pharmacology*;Imidazolidines*;In Vitro Techniques;Myocardium/cytology;Patch-Clamp Techniques;Piperazines/pharmacology*;Potassium Channels/drug effects;Potassium Channels/physiology*;Sodium Channels/drug effects;Sodium Channels/physiology*;Time Factors
9049371;Amino Acid Sequence;Arthritis-Encephalitis Virus, Caprine/enzymology*;Arthritis-Encephalitis Virus, Caprine/genetics;Cloning, Molecular;Endonucleases/genetics;Escherichia coli/enzymology;Escherichia coli/genetics*;Genetic Vectors/biosynthesis*;HIV-1/enzymology*;HIV-1/genetics;Integrases/biosynthesis;Integrases/genetics*;Integrases/isolation & purification;Molecular Sequence Data;Restriction Mapping;Substrate Specificity;Virus Integration;Visna-maedi virus/enzymology*;Visna-maedi virus/genetics
9057880;Animals;Bacterial Proteins/genetics*;Epididymis/cytology;Escherichia coli Proteins*;Ethylnitrosourea/toxicity*;Lac Repressors;Male;Mesylates/toxicity*;Methyl Methanesulfonate/toxicity*;Mice;Mice, Inbred C57BL;Mice, Transgenic;Micronucleus Tests;Mutagenicity Tests*;Mutagens/toxicity*;Repressor Proteins/genetics*;Seminiferous Tubules/cytology;Spermatozoa/drug effects*
9064616;Animals;Environmental Exposure*;Humans;Mercury/adverse effects;Mercury/toxicity*;Mercury Poisoning*/physiopathology;Nervous System Diseases/etiology*;Risk Assessment
9067785;Female;Hepatitis A/diagnosis;Hepatitis A/drug therapy;Hepatitis A/transmission;Hepatitis B/diagnosis;Hepatitis B/drug therapy;Hepatitis B/transmission;Hepatitis C/diagnosis;Hepatitis C/drug therapy;Hepatitis C/transmission;Hepatitis, Viral, Human/transmission*;Humans;Infant, Newborn;Infectious Disease Transmission, Vertical*;Pregnancy;Pregnancy Complications, Infectious/diagnosis;Pregnancy Complications, Infectious/drug therapy*
9071411;Aggression*;Animals;Female;Ibotenic Acid/administration & dosage;Ibotenic Acid/pharmacology;Lactation;Male;Maternal Behavior*;Microinjections;Oligodeoxyribonucleotides/administration & dosage;Oligodeoxyribonucleotides/pharmacology;Oligonucleotides, Antisense/administration & dosage;Oligonucleotides, Antisense/pharmacology*;Oxytocin/biosynthesis;Oxytocin/physiology*;Paraventricular Hypothalamic Nucleus/drug effects;Paraventricular Hypothalamic Nucleus/physiology*;Pregnancy;Rats
9075251;Cephalometry;Child;Child, Preschool;Craniotomy*;Esthetics;Female;Follow-Up Studies;Humans;Infant;Intracranial Pressure/physiology;Male;Postoperative Complications/diagnostic imaging;Postoperative Complications/etiology*;Radiography;Synostosis/diagnostic imaging;Synostosis/surgery*;Treatment Outcome
9079296;Contract Services/organization & administration*;Economics, Nursing*;Education, Nursing/organization & administration*;Humans;Nursing Research/organization & administration*;Professional Autonomy*;Salaries and Fringe Benefits*;United Kingdom
9083395;Adolescent;Adult;Cicatrix/prevention & control;Dissection;Facial Muscles/anatomy & histology;Facial Muscles/surgery;Facial Paralysis/etiology;Fascia/anatomy & histology;Fasciotomy;Female;Fracture Fixation, Internal*;Hematoma/etiology;Humans;Male;Mandible/surgery*;Mandibular Fractures/surgery*;Middle Aged;Postoperative Complications/prevention & control;Rhytidoplasty*;Safety;Surgical Flaps/methods
9084925;Aged;Endometrium/drug effects;Endometrium/metabolism;Female;Humans;Interleukin-8/metabolism*;Leukocyte Count/drug effects;Middle Aged;Neutrophils/drug effects*;Roxithromycin/administration & dosage;Roxithromycin/therapeutic use*;Therapeutic Irrigation;Treatment Outcome;Uterine Diseases/drug therapy*;Uterine Diseases/microbiology*
9099675;Acrosome/physiology*;Animals;Carbohydrate Conformation;Carbohydrate Sequence;Carbohydrates/analysis;Female;Glycoproteins/chemistry*;Glycoproteins/isolation & purification;Glycoproteins/physiology;Magnetic Resonance Spectroscopy;Male;Methylation;Molecular Sequence Data;Molecular Structure;Oligosaccharides/chemistry;Oocytes/physiology*;Sperm-Ovum Interactions*;Starfish
9106211;Bacillus subtilis/genetics;Bacillus subtilis/metabolism*;Bacterial Proteins*;Base Sequence;Cyclic AMP Receptor Protein/genetics;Cyclic AMP Receptor Protein/pharmacology*;DNA Mutational Analysis;DNA, Recombinant/genetics;DNA, Recombinant/physiology;DNA-Binding Proteins/genetics;DNA-Binding Proteins/metabolism;Enhancer Elements, Genetic*;Gene Expression Regulation, Bacterial/genetics;Gene Expression Regulation, Bacterial/physiology*;Genes, Bacterial/genetics;Genes, Bacterial/physiology*;Glucose-6-Phosphate/genetics;Glucose-6-Phosphate/metabolism;Molecular Sequence Data;Operon/genetics*;Promoter Regions, Genetic/genetics;Promoter Regions, Genetic/physiology;Repressor Proteins/genetics;Repressor Proteins/metabolism
9116527;Germany;Health Care Reform/standards*;Humans;National Health Programs/standards*;Outcome and Process Assessment (Health Care);Quality Assurance, Health Care/organization & administration*
9127706;Dietary Carbohydrates/administration & dosage*;Dietary Fats/administration & dosage*;Energy Intake;Female;Glucose Tolerance Test;Humans;Hyperlipidemias/blood;Insulin Resistance*;Male;Obesity/diet therapy*;Obesity/metabolism
9134053;Albuminuria*;Clinical Laboratory Techniques;Diabetes Mellitus/urine*;Diabetic Nephropathies/diagnosis*;Diabetic Nephropathies/urine;Freezing;Humans;Monitoring, Physiologic;Nephelometry and Turbidimetry/methods;Regression Analysis;Reproducibility of Results;Sensitivity and Specificity;Specimen Handling;Spectrophotometry, Ultraviolet/methods
9145692;Antigen Presentation/physiology;Antigen-Presenting Cells/physiology*;Cells, Cultured;Enterotoxins/metabolism;Flow Cytometry;HLA-DR Antigens/metabolism*;Humans;Interferon-gamma/pharmacology;Jurkat Cells;Lymphocyte Activation/immunology;Major Histocompatibility Complex/physiology*;Pigment Epithelium of Eye/drug effects;Pigment Epithelium of Eye/physiology*;Recombinant Proteins;Staphylococcus aureus/metabolism*;Superantigens/metabolism*;T-Lymphocytes/immunology;T-Lymphocytes, Cytotoxic/immunology;Tumor Cells, Cultured
9149404;Adult;Aged;Bone and Bones/chemistry*;Burial/methods*;Female;Forensic Medicine;Humans;Male;Middle Aged;Mortuary Practice*;Nitrogen/analysis*;Retrospective Studies;Time Factors
9153996;Arabidopsis/genetics*;Arabidopsis Proteins*;Drosophila Proteins*;Gene Expression Regulation, Plant/physiology*;Homeodomain Proteins/genetics*;Insect Proteins*;Polycomb Repressive Complex 1
9160681;Biomarkers, Tumor/genetics;Burkitt Lymphoma/etiology;Burkitt Lymphoma/genetics;Cell Transformation, Neoplastic/genetics;DNA Mutational Analysis;DNA, Neoplasm/genetics*;DNA-Binding Proteins/genetics*;Humans;Lymphoma, AIDS-Related/classification;Lymphoma, AIDS-Related/genetics*;Lymphoma, AIDS-Related/pathology;Lymphoma, B-Cell/classification;Lymphoma, B-Cell/etiology;Lymphoma, B-Cell/genetics*;Lymphoma, B-Cell/pathology;Lymphoma, Large B-Cell, Diffuse/etiology;Lymphoma, Large B-Cell, Diffuse/genetics;Lymphoma, Large-Cell, Anaplastic/etiology;Lymphoma, Large-Cell, Anaplastic/genetics;Polymerase Chain Reaction;Polymorphism, Single-Stranded Conformational;Proto-Oncogene Proteins/genetics*;Proto-Oncogene Proteins c-bcl-6;Proto-Oncogenes*;Transcription Factors/genetics*;Tumor Cells, Cultured
9162471;Algorithms;Animals;Evolution, Molecular;Humans;Phylogeny*
9164297;Diet*;History, 20th Century;Humans;Pellagra/epidemiology;Pellagra/etiology*;Pellagra/history*
9165260;Female;Humans;Infant;Lymphangiomyoma/diagnosis;Lymphangiomyoma/pathology*;Lymphangiomyoma/surgery;Peritoneal Neoplasms/diagnosis;Peritoneal Neoplasms/pathology*;Peritoneal Neoplasms/surgery;Peritoneum/pathology*;Peritoneum/surgery;Tomography, X-Ray Computed;Ultrasonography
9168573;Adult;Age Factors;Chromosome Aberrations/diagnosis*;Chromosome Disorders;Down Syndrome/diagnosis*;Down Syndrome/diagnostic imaging;Down Syndrome/genetics;Female;Gestational Age;Humans;Karyotyping;Middle Aged;Pregnancy;Pregnancy Trimester, First;Prenatal Diagnosis;Risk Factors;Ultrasonography, Prenatal/methods*
9175605;Cholinergic Agents/pharmacology*;Computers;Models, Molecular;Receptors, Nicotinic/drug effects*;Structure-Activity Relationship*
9176310;Animals;Echocardiography/methods;Female;Heart Ventricles/pathology;Hypertrophy, Left Ventricular/diagnosis*;Magnetic Resonance Imaging/methods;Male;Mice/anatomy & histology*;Myocardium/pathology
9192990;Adenocarcinoma/genetics*;Aged;Aged, 80 and over;Carcinoma, Endometrioid/genetics*;Carcinoma, Squamous Cell/genetics*;Chromosome Aberrations*;Chromosome Deletion;Chromosomes, Human, Pair 6*;Cystadenocarcinoma, Papillary/genetics*;Diploidy;Endometrial Neoplasms/genetics*;Female;Humans;In Situ Hybridization, Fluorescence;Karyotyping;Middle Aged;Ovarian Neoplasms/genetics*
9195338;Aminacrine/pharmacology*;DNA/chemistry;DNA/drug effects*;Intercalating Agents/pharmacology*;Models, Molecular;Netropsin/pharmacology*;Nucleic Acid Conformation/drug effects*;Polydeoxyribonucleotides/chemistry
9203630;Base Sequence;Genes/genetics*;Humans;Molecular Sequence Data;Promoter Regions, Genetic/genetics*;Receptors, Nicotinic/genetics*
9214780;Animals;Electric Countershock/statistics & numerical data;Electric Impedance;Heart Conduction System/physiology*;Humans;Mathematics;Membrane Potentials;Nerve Fibers/physiology*
9218755;Animals;CD4 Antigens/analysis*;CD8 Antigens/analysis*;Cell Differentiation/immunology;Diabetes Mellitus, Type 1/immunology;Female;Flow Cytometry;Immunologic Deficiency Syndromes/genetics;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, Inbred CBA;Mice, Inbred NOD;Receptors, Antigen, T-Cell, alpha-beta/analysis*;Receptors, Antigen, T-Cell, gamma-delta/analysis;T-Lymphocyte Subsets/immunology*;Thymus Gland/cytology;Thymus Gland/immunology*
9224290;Animals;Anterior Chamber/surgery;Cell Transplantation*;Cells, Cultured;Conjunctiva/surgery;Graft Rejection;Hypersensitivity, Delayed/immunology;Hypersensitivity, Delayed/physiopathology;Immune System/physiology*;Immunity*;Male;Mice;Mice, Inbred C57BL;Pigment Epithelium of Eye/cytology*;Pigment Epithelium of Eye/immunology;Postoperative Complications;Retina/surgery;Spleen/cytology;Spleen/physiology;T-Lymphocytes, Regulatory/physiology;Time Factors
9231901;Amino Acid Sequence;Bacillus Phages/enzymology;Binding Sites;Conserved Sequence;DNA, Single-Stranded/metabolism;DNA-Directed DNA Polymerase/chemistry;DNA-Directed DNA Polymerase/genetics*;DNA-Directed DNA Polymerase/metabolism*;Eukaryotic Cells/enzymology*;Exonucleases/metabolism;Lysine;Mutation;Sequence Alignment
9238004;Chorismate Mutase/chemistry;Chorismate Mutase/genetics*;Chorismate Mutase/metabolism;Enzyme Activation/genetics;Glutamic Acid/chemistry;Glutamic Acid/genetics;Hydrogen-Ion Concentration;Plasmids;Saccharomyces cerevisiae/enzymology*
9252873;Animals;Child;Child, Preschool;Dermatitis, Atopic/etiology;Dermatitis, Atopic/immunology;Eggs/adverse effects;Fabaceae/adverse effects;Fish Products/adverse effects;Food Hypersensitivity/complications*;Food Hypersensitivity/diagnosis;Food Hypersensitivity/immunology*;Histamine Release;Humans;Immunoglobulin E/blood;Immunoglobulin G/blood;Milk Hypersensitivity/immunology;Nuts/adverse effects;Plants, Medicinal;Skin Diseases/diagnosis;Skin Diseases/etiology*;Skin Diseases/immunology*;Skin Tests;Urticaria/etiology;Urticaria/immunology
9253480;Acoustic Stimulation;Animals;Cochlea/physiology*;Electric Stimulation;Electrodes, Implanted;Evoked Potentials, Auditory, Brain Stem;Functional Laterality;Inferior Colliculi/physiology*;Neurons/physiology;Rats
9258056;Attitude of Health Personnel*;Catheters, Indwelling/standards*;Cross-Sectional Studies;Health Knowledge, Attitudes, Practice;Humans;Nursing Staff/education*;Nursing Staff/psychology*;Patient Selection;Surveys and Questionnaires;Urinary Catheterization/instrumentation*;Urinary Catheterization/nursing*
9260559;Animals;Carcinoma, Squamous Cell/drug therapy;Carcinoma, Squamous Cell/surgery*;Combined Modality Therapy;Head and Neck Neoplasms/drug therapy;Head and Neck Neoplasms/surgery*;Humans;Intraoperative Period;Microcirculation*;Neoplasm Recurrence, Local;Photochemotherapy*;Surgical Flaps*
9260657;Chromatography, Thin Layer;Colorimetry;Densitometry;Urea/analysis*
9263235;Animals;Blood Chemical Analysis;Blood Glucose/analysis;Blood Glucose/drug effects;Blood Glucose/metabolism;Body Weight/physiology;Burns/immunology*;Burns/metabolism*;Dietary Proteins/drug effects*;Dietary Proteins/metabolism*;Growth Hormone/pharmacology*;Humans;Hypersensitivity, Delayed/physiopathology;Immunity, Cellular/drug effects*;Insulin-Like Growth Factor I/pharmacology*;Intestine, Small/anatomy & histology*;Intestine, Small/drug effects*;Kidney/anatomy & histology;Male;Nitrogen/analysis;Nitrogen/metabolism;Organ Size;Pancreas/anatomy & histology;Rats;Rats, Sprague-Dawley;Recombinant Proteins/pharmacology;Stomach/anatomy & histology;Thymus Gland/anatomy & histology
9274269;Disabled Persons*;Humans;Nursing Assessment;Patient Care Team/organization & administration*;Pressure Ulcer/classification;Pressure Ulcer/prevention & control*;Severity of Illness Index;Wheelchairs
9275148;Allergens/chemistry*;Allergens/genetics;Allergens/immunology;Animals;Antibodies, Monoclonal;Antibody Specificity;Antigens, Plant;Asthma/blood;Asthma/etiology;Cattle;Cloning, Molecular;DNA, Complementary/genetics;Humans;Immunoglobulin E/blood;Proteins*;Recombinant Proteins/chemistry;Recombinant Proteins/genetics;Recombinant Proteins/immunology
9275408;Carcinoma, Endometrioid/pathology;Carcinoma, Endometrioid/surgery;Cystadenocarcinoma/pathology*;Cystadenocarcinoma/surgery;Female;Humans;Laparotomy;Middle Aged;Neoplasm Staging;Ovarian Neoplasms/pathology*;Ovarian Neoplasms/surgery;Retrospective Studies
9275440;Adult;Estradiol/blood*;Female;Humans;Hyaluronic Acid/blood*;Labor Onset*;Pregnancy/blood*;Progesterone/blood*
9280975;Breast Neoplasms/complications;Carcinoma, Ductal, Breast/complications;Cardiomyopathy, Dilated/complications*;Cardiomyopathy, Dilated/diagnostic imaging;Dyspnea/etiology*;Female;Humans;Middle Aged;Pericarditis, Constrictive/complications*;Pericarditis, Constrictive/diagnostic imaging;Radiography;Scimitar Syndrome/complications*;Scimitar Syndrome/diagnostic imaging
9283420;Canada;Disabled Persons*;Employee Discipline*;Employee Grievances*;Humans;Nursing Staff*;Sexual Behavior*
9284693;Adipocytes/metabolism;Animals;Endocrinology/trends*;Humans;Leptin;Obesity/physiopathology*;Proteins/genetics;Proteins/physiology*
9289042;Adult;Cartilage, Articular/injuries;Cartilage, Articular/pathology*;Contrast Media;Female;Gadolinium;Gadolinium DTPA;Humans;Injections, Intravenous;Ligaments, Articular/injuries;Ligaments, Articular/pathology*;Magnetic Resonance Imaging/instrumentation;Magnetic Resonance Imaging/methods*;Male;Middle Aged;Organometallic Compounds;Pentetic Acid/analogs & derivatives;Prospective Studies;Rotator Cuff/pathology;Rotator Cuff Injuries;Scapula/pathology*;Sensitivity and Specificity
9296884;CD-ROM;Computer-Assisted Instruction*;Education, Medical*
9308930;Adult;Aged;Brachytherapy;Carcinoma, Squamous Cell/pathology;Carcinoma, Squamous Cell/radiotherapy*;Female;Humans;Lymphatic Metastasis*;Male;Middle Aged;Neck;Neoplasms, Unknown Primary/pathology;Neoplasms, Unknown Primary/radiotherapy*;Radiotherapy Dosage;Tonsillar Neoplasms/pathology;Tonsillar Neoplasms/radiotherapy*;Tonsillectomy*
9310364;Amino Acid Sequence;Animals;Binding Sites;Binding, Competitive;Carbohydrate Conformation;Egg Proteins/chemistry;Egg Proteins/genetics;Egg Proteins/metabolism*;Female;Glycosylation;In Vitro Techniques;Male;Membrane Glycoproteins/chemistry;Membrane Glycoproteins/genetics;Membrane Glycoproteins/metabolism*;Molecular Sequence Data;Molecular Structure;Molecular Weight;Peptide Fragments/chemistry;Peptide Fragments/genetics;Peptide Fragments/metabolism;Receptors, Cell Surface*;Serine Endopeptidases;Sperm-Ovum Interactions/physiology*;Swine;Zona Pellucida Glycoproteins
9311773;Biology/history*;Europe;History, 20th Century
9312983;Alcohol Drinking/adverse effects;Alcoholism/complications*;Alcoholism/prevention & control;Humans;Neoplasms/etiology*;Portugal;Risk Factors
9314515;Biomechanical Phenomena;Humans;Lumbar Vertebrae/injuries;Lumbar Vertebrae/physiopathology*;Spinal Injuries/physiopathology;Thoracic Vertebrae/injuries;Thoracic Vertebrae/physiopathology*;Weight-Bearing/physiology
9322996;Adult;Aged;Brazil/epidemiology;Cross-Sectional Studies;Female;Humans;Hypertension/epidemiology*;Hypertension/etiology;Insulin/blood*;Japan/ethnology;Male;Middle Aged;Prevalence;Proinsulin/blood*;Risk Factors
9326282;Animals;Electron Transport Complex I;Endotoxins/metabolism;Enzyme Inhibitors/pharmacology;Male;Mitochondria/metabolism*;Mitochondria/physiology;NAD(P)H Dehydrogenase (Quinone)/antagonists & inhibitors*;NADH, NADPH Oxidoreductases/antagonists & inhibitors;NADH, NADPH Oxidoreductases/metabolism;Oxygen Consumption/drug effects;Parkinson Disease/metabolism;Rats;Rats, Sprague-Dawley;Substantia Nigra/metabolism;Thiazines/pharmacology*
9347405;Adult;Body Composition/physiology*;Female;Humans;Longitudinal Studies;Models, Biological*;Postpartum Period/physiology*;Reference Values;Time Factors
9352776;Analgesics, Opioid/administration & dosage;Anesthetics, Intravenous/administration & dosage*;Dose-Response Relationship, Drug;Drug Synergism;Fentanyl/administration & dosage;Hematoma/surgery;Humans;Hypnotics and Sedatives/administration & dosage*;Infusion Pumps;Infusions, Intravenous;Intubation, Intratracheal*;Morphine/administration & dosage;Neck/surgery;Propofol/administration & dosage*;Respiration/drug effects
9361658;Activities of Daily Living;Aged;Aged, 80 and over;Alzheimer Disease/complications*;Alzheimer Disease/physiopathology;Cognition Disorders/complications*;Cognition Disorders/physiopathology;Cross-Sectional Studies;Depression/epidemiology*;Depression/etiology;Factor Analysis, Statistical;Female;Follow-Up Studies;Humans;Longitudinal Studies;Male;Mental Disorders/classification;Mental Disorders/epidemiology*;Mental Disorders/etiology;New York/epidemiology;Psychotic Disorders/epidemiology*;Psychotic Disorders/etiology
9364944;Animals;Birds/genetics*;Chromosome Fragility*;Heterochromatin/genetics;Karyotyping;Mitosis/genetics;Recombination, Genetic/genetics*;Recombination, Genetic/physiology;Sex Chromosomes/genetics*;Sex Chromosomes/ultrastructure;Synaptonemal Complex/genetics
9364947;Adolescent;Adult;Female;Femur Head Necrosis/diagnosis*;Femur Head Necrosis/etiology*;Follow-Up Studies;Humans;Ischemia/complications;Kidney Transplantation/adverse effects*;Magnetic Resonance Imaging*;Male;Middle Aged;Postoperative Complications;Prognosis;Prospective Studies
9367763;Bacterial Proteins/chemistry;Bacterial Proteins/genetics;Bacterial Proteins/metabolism;Binding Sites;Cloning, Molecular;DNA, Bacterial/metabolism;DNA-Binding Proteins/chemistry*;DNA-Binding Proteins/genetics;DNA-Binding Proteins/metabolism*;DNA-Directed RNA Polymerases/metabolism;Escherichia coli/genetics;Escherichia coli Proteins;Gene Expression/genetics;Magnesium/metabolism;Magnetic Resonance Spectroscopy;Membrane Proteins/chemistry;Methyl-Accepting Chemotaxis Proteins;Models, Molecular;Mutagenesis/genetics;PII Nitrogen Regulatory Proteins;Phosphorylation;Protein Conformation;Protein Structure, Secondary;Recombinant Fusion Proteins/chemistry;Recombinant Fusion Proteins/metabolism;Signal Transduction;Trans-Activators*;Transcription Factors/chemistry*;Transcription Factors/genetics;Transcription Factors/metabolism*;Transcriptional Activation
9369597;Emergency Nursing*;Health Promotion*;Humans;Primary Prevention*;Societies, Nursing*;United States
9371718;Amino Acid Sequence;Bacteria, Anaerobic/enzymology*;Enzyme Stability;Glucans/metabolism;Glucose/metabolism;Gram-Positive Asporogenous Rods, Irregular/enzymology*;Hot Temperature;Hydrogen-Ion Concentration;Hydrolysis;Models, Biological;Molecular Sequence Data;Polysaccharides/metabolism;Sequence Analysis;Species Specificity;Starch/metabolism;Substrate Specificity;alpha-Glucosidases/chemistry;alpha-Glucosidases/isolation & purification;alpha-Glucosidases/metabolism*
9373771;Adjuvants, Immunologic/pharmacology*;Administration, Oral;Animals;B-Lymphocytes/cytology;B-Lymphocytes/drug effects;B-Lymphocytes/immunology;Cell Cycle/drug effects;Guinea Pigs;Lymphocyte Activation/drug effects*;Lymphoid Tissue/drug effects;Lymphoid Tissue/immunology;Male;Microscopy, Electron;Periodontal Diseases/prevention & control;Spleen/cytology;Stomatitis/prevention & control;T-Lymphocytes/cytology;T-Lymphocytes/drug effects;T-Lymphocytes/immunology
9374576;Asphyxia Neonatorum/complications;Asphyxia Neonatorum/therapy*;Brain Damage, Chronic/etiology;Brain Damage, Chronic/prevention & control*;Brain Ischemia/complications;Brain Ischemia/therapy*;Humans;Infant, Newborn
9375703;Aged;Carcinoma, Small Cell/blood;Carcinoma, Small Cell/complications*;Carcinoma, Small Cell/secondary;Colonic Neoplasms/complications;Female;Humans;Lung Neoplasms/complications;Risk Factors;Skin Neoplasms/complications;Tumor Lysis Syndrome/blood;Tumor Lysis Syndrome/etiology*
9378609;Adaptation, Physiological*;Animals;Attention/physiology*;Auditory Perception/physiology;Cerebellum/physiology*;Eye Movements/physiology;Humans;Magnetic Resonance Imaging;Orientation/physiology;Visual Perception/physiology
9389420;Acute-Phase Proteins/analysis*;Adult;Albuminuria/urine;C-Reactive Protein/analysis;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/immunology*;Female;Humans;Hydrocortisone/blood;Insulin Resistance/immunology*;Interleukin-6/blood*;Male;Middle Aged;N-Acetylneuraminic Acid/blood;Orosomucoid/analysis;Serum Amyloid A Protein/analysis
9396015;Adult;Aged;Autoantibodies/analysis;Autoimmune Diseases/complications;Autoimmune Diseases/immunology;Azathioprine/adverse effects*;Azathioprine/therapeutic use*;Chronic Disease;Female;Follow-Up Studies;Humans;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/therapeutic use*;Male;Middle Aged;Platelet Count;Schizophrenia/complications*;Schizophrenia/drug therapy*;Schizophrenia/immunology;Schizophrenic Psychology
9406336;Attitude of Health Personnel*;Hospital Bed Capacity;Hospitals, Rural*;Humans;Physicians*;Social Work*;Social Work Department, Hospital/organization & administration
9407552;Animals;Antigens, CD/biosynthesis*;Brain Chemistry*;Brain Ischemia/immunology;Brain Ischemia/metabolism*;Brain Ischemia/pathology;Cerebral Cortex/immunology;Cerebral Cortex/metabolism;Cerebral Cortex/pathology;Fluorescent Antibody Technique, Indirect;Male;Neuroglia/metabolism;Neurons/metabolism;Neutrophils;Rats;Rats, Inbred Lew;Receptors, Tumor Necrosis Factor/biosynthesis*;Receptors, Tumor Necrosis Factor, Type I;Receptors, Tumor Necrosis Factor, Type II;Up-Regulation
9412345;Age Factors;Artifacts;Catheterization/instrumentation;Child;Child, Preschool;Dilatation, Pathologic/physiopathology;Equipment Design;Female;Humans;Infant;Infant, Newborn;Male;Manometry/instrumentation;Monitoring, Physiologic;Neural Tube Defects/physiopathology*;Pressure;Prognosis;Pyelonephritis/physiopathology;Reproducibility of Results;Ureteral Diseases/physiopathology;Urinary Bladder/physiopathology*;Urinary Catheterization/instrumentation;Urination/physiology;Urodynamics*;Vesico-Ureteral Reflux/physiopathology
9414480;Acrosome/secretion*;Animals;Binding Sites;Cell Membrane/physiology;Exocytosis/physiology*;Female;Humans;Male;Membrane Potentials;Signal Transduction/physiology*;Spermine/metabolism;Zona Pellucida/physiology*
9421268;Aneuploidy;Animals;Azure Stains;Bromodeoxyuridine;Chromosome Banding;Chromosomes/genetics;DNA Replication;Female;Fishes/genetics*;Karyotyping;Male;Sex Chromosomes/genetics*
9429407;Bandages;Catheterization, Peripheral/adverse effects;Catheterization, Peripheral/instrumentation;Catheterization, Peripheral/methods;Catheterization, Peripheral/nursing*;Clinical Protocols;Humans;Nursing Staff, Hospital/education;Patient Education as Topic
9430482;Adolescent;Body Weight;Child;Child, Preschool;Humans;Infant;Infant, Newborn;Iodine Radioisotopes*;Organotechnetium Compounds*;Phantoms, Imaging;Radiation Dosage;Radiation Protection*;Radiopharmaceuticals*;Technetium Tc 99m Dimercaptosuccinic Acid
9433620;Analysis of Variance;Chromosome Mapping/methods;Female;Genetic Predisposition to Disease;Humans;Linear Models;Male;Matched-Pair Analysis;Models, Statistical*;Nuclear Family*;Phenotype;Quantitative Trait, Heritable*
9435981;Aged;Aged, 80 and over;Carcinoma in Situ/pathology*;Carcinoma in Situ/surgery;Corneal Diseases/pathology*;Corneal Diseases/surgery;Eye/pathology;Eye Neoplasms/pathology*;Eye Neoplasms/surgery;Female;Humans;Male;Middle Aged
9437776;Adult;Anti-Bacterial Agents/therapeutic use*;Chlamydia Infections/drug therapy*;Chlamydia trachomatis*;Doxycycline/therapeutic use*;Female;Humans;Male;Patient Compliance*
9439491;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/therapeutic use*;Double-Blind Method;Drug Therapy, Combination;Female;Follow-Up Studies;Hepacivirus/isolation & purification;Hepatitis C, Chronic/therapy*;Humans;Interferon-alpha/administration & dosage;Interferon-alpha/therapeutic use*;Male;Polymerase Chain Reaction;RNA, Viral/blood;Recombinant Proteins;Ribavirin/administration & dosage;Ribavirin/therapeutic use*;Time Factors;Treatment Outcome
9441387;Amino Acids/administration & dosage;Amino Acids, Essential/administration & dosage;Bile/diagnostic imaging;Cholestasis, Extrahepatic/diagnostic imaging*;Cholestasis, Extrahepatic/etiology;Electrolytes;Female;Food, Formulated;Gallbladder/diagnostic imaging*;Glucose;Humans;Infant Food;Infant, Newborn;Infant, Premature, Diseases/diagnostic imaging*;Infant, Premature, Diseases/etiology;Intensive Care, Neonatal;Jaundice, Neonatal/diagnostic imaging*;Jaundice, Neonatal/etiology;Male;Parenteral Nutrition Solutions;Parenteral Nutrition, Total*;Pregnancy;Solutions;Ultrasonography
9441515;Animals;Cell Transformation, Neoplastic/drug effects*;Dose-Response Relationship, Drug;Humans;Melatonin/adverse effects;Melatonin/physiology;Melatonin/therapeutic use*;Neoplasm Transplantation;Neoplasms/drug therapy*;Neoplasms/physiopathology;Neoplasms/prevention & control;Pineal Gland/physiopathology;Tumor Cells, Cultured/drug effects*;Tumor Cells, Cultured/physiology
9448681;Activities of Daily Living;Aged;Hip Fractures/complications;Hip Fractures/physiopathology;Hip Fractures/rehabilitation*;Hip Fractures/surgery;Humans;Movement;Patient Care Team*;Patient Discharge;Postoperative Complications
9450213;Consumer Behavior;Delivery of Health Care;Genetic Testing*;Genetics, Medical/education;Genetics, Medical/organization & administration;Genetics, Medical/trends;Health Services;Health Services Accessibility;Humans;Infant Mortality;Infant, Newborn;Life Expectancy;Outcome Assessment (Health Care);Pedigree;Primary Health Care;Romania
9451932;Bacterial Infections/economics;Bacterial Infections/prevention & control*;Bacterial Translocation/physiology;Controlled Clinical Trials as Topic;Cross Infection/economics;Cross Infection/prevention & control*;Decontamination/methods*;Digestive System/microbiology*;Digestive System Surgical Procedures/standards*;Drug Resistance, Microbial;Health Care Costs;Humans;Intensive Care Units/economics;Intensive Care Units/standards*;Netherlands;United Kingdom
9456881;Anti-Obesity Agents/therapeutic use*;Appetite Depressants/therapeutic use;Humans;Obesity/drug therapy*;Obesity/genetics
9460681;Abdomen;Fetus/embryology*;Gestational Age;Humans;Lymph/physiology*;Lymph Nodes/embryology*;Morphogenesis
9470239;Aged;Estrogen Replacement Therapy/utilization*;Female;Humans;Italy;Middle Aged
9482700;Antibodies, Monoclonal/pharmacology;Antigens, CD/immunology;Blood Proteins/metabolism;Cell Degranulation/drug effects*;Dextrans;Enzyme Inhibitors/pharmacology;Enzyme-Linked Immunosorbent Assay;Eosinophil Granule Proteins;Eosinophils/physiology*;Humans;Membrane Proteins*;Microspheres;Opsonin Proteins/metabolism*;Phagosomes/metabolism;Phospholipases A/antagonists & inhibitors;Phospholipases A2;Quinacrine/pharmacology;Receptors, Complement/physiology;Receptors, Fc/physiology;Ribonucleases*;Tumor Necrosis Factor-alpha/antagonists & inhibitors;Tumor Necrosis Factor-alpha/pharmacology*;Zymosan/metabolism
9488300;Adolescent;Adult;Aged;Analysis of Variance;Brain Edema/physiopathology;Cerebrospinal Fluid Rhinorrhea/etiology;Cerebrospinal Fluid Rhinorrhea/surgery;Child;Child, Preschool;Decision Making;Disease Susceptibility;Dura Mater/diagnostic imaging;Dura Mater/injuries;Dura Mater/surgery*;Ethmoid Bone/diagnostic imaging;Ethmoid Bone/injuries;Ethmoid Sinus/diagnostic imaging;Ethmoid Sinus/injuries;Female;Follow-Up Studies;Fractures, Open/classification*;Fractures, Open/diagnostic imaging;Fractures, Open/surgery;Fractures, Open/therapy;Frontal Bone/diagnostic imaging;Frontal Bone/injuries;Frontal Sinus/diagnostic imaging;Frontal Sinus/injuries;Humans;Joint Dislocations/classification;Joint Dislocations/diagnostic imaging;Joint Dislocations/surgery;Logistic Models;Male;Meningitis/etiology;Meningitis/prevention & control;Microsurgery;Middle Aged;Patient Selection*;Risk Factors;Skull Base/diagnostic imaging;Skull Base/injuries*;Skull Base/surgery;Skull Fractures/classification*;Skull Fractures/diagnostic imaging;Skull Fractures/surgery;Skull Fractures/therapy;Time Factors;Tomography, X-Ray Computed*/methods
9494359;Humans;Time*;Time Perception*
9496730;Adult;Aged;Blood Platelets/chemistry;Blood Platelets/metabolism*;Blood Platelets/physiology;Cellulose;Female;Humans;Male;Membranes, Artificial;Middle Aged;P-Selectin/blood*;Platelet Activation;Platelet Count;Platelet Factor 4/metabolism;Polymers;Renal Dialysis*;Solubility;Sulfones;beta-Thromboglobulin/metabolism
9500062;Animals;Capillaries/physiology*;Capillaries/physiopathology;Cricetinae;Ischemia/physiopathology*;Leukocytes/physiology*;Mesocricetus;Microcirculation/physiology;Muscle, Skeletal/blood supply*;Probability;Reperfusion*;Skin/blood supply;Time Factors
9500272;Animals;Brain/pathology*;Diathermy/instrumentation;Hyperthermia, Induced/methods*;Magnetic Resonance Imaging/methods*;Male;Microwaves/therapeutic use*;Rabbits
9506459;Antineoplastic Agents/therapeutic use*;Camptothecin/antagonists & inhibitors*;Cisplatin/therapeutic use;Cytotoxicity Tests, Immunologic;Distamycins/therapeutic use;Doxorubicin/therapeutic use;Etoposide/antagonists & inhibitors*;Immunosuppressive Agents/antagonists & inhibitors*;Interferon-beta/therapeutic use*;Killer Cells, Natural/drug effects*;Melphalan/therapeutic use;Nitrogen Mustard Compounds/therapeutic use;Recombinant Proteins/therapeutic use
9529764;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/therapeutic use*;Cross-Sectional Studies;Female;Headache/drug therapy*;Headache/epidemiology;Headache/psychology;Health Services/utilization;Humans;Life Style;Male;Middle Aged;Socioeconomic Factors;Sweden/epidemiology
9541939;Adenocarcinoma/pathology*;Cell Nucleolus/ultrastructure;Cell Nucleus/ultrastructure;Cell Transformation, Neoplastic/pathology;Diagnosis, Differential;Humans;Inclusion Bodies/ultrastructure;Male;Neoplasms, Hormone-Dependent/pathology;Prostate/pathology;Prostatic Neoplasms/pathology*
9544115;Adult;Attitude;Career Choice*;Denmark;Education, Nursing*;Female;Humans;Male;Middle Aged;Nursing*;Students/psychology*
9548063;Adult;Aged;Chicago;Female;Health Surveys;Humans;Male;Middle Aged;Myocardial Infarction/diagnosis*;Myocardial Infarction/nursing*;Surveys and Questionnaires
9575566;Animals;Enzyme-Linked Immunosorbent Assay;Escherichia coli Infections/immunology;Lipopolysaccharide Receptors/immunology*;Lipopolysaccharides/immunology;Mice;Mice, Inbred C3H;Mice, Knockout;Salmonella Infections, Animal/immunology*
9577996;Adaptation, Psychological;Adolescent;Adult;Attitude to Health*;Epilepsy, Temporal Lobe/diagnosis;Epilepsy, Temporal Lobe/psychology*;Epilepsy, Temporal Lobe/surgery*;Female;Health Status;Humans;Male;Middle Aged;Outcome Assessment (Health Care);Patient Acceptance of Health Care;Patient Satisfaction;Postoperative Complications/diagnosis;Postoperative Complications/psychology;Psychiatric Status Rating Scales;Quality of Life;Seizures/diagnosis;Seizures/psychology;Social Adjustment;Surveys and Questionnaires;Temporal Lobe/surgery*
9586564;Animals;Calcium-Binding Proteins/pharmacology*;Cytosol/drug effects;Cytosol/enzymology;Diglycerides/pharmacology;Enzyme Inhibitors/pharmacology*;Intracellular Signaling Peptides and Proteins;Kidney Cortex/drug effects;Kidney Cortex/enzymology*;Male;Phosphatidylserines/pharmacology;Protein Kinase C/antagonists & inhibitors*;Rats;Rats, Wistar;Sulfotransferases;Tetradecanoylphorbol Acetate/pharmacology
9591347;Alleles;Animals;Blood Protein Electrophoresis/veterinary;Blood Proteins/analysis;Blood Proteins/genetics;Cattle/blood;Cattle/genetics*;Electrophoresis, Polyacrylamide Gel/veterinary;Enzootic Bovine Leukosis/blood;Enzootic Bovine Leukosis/genetics;Genetic Linkage/genetics*;Genetic Linkage/radiation effects;Genetic Variation/genetics*;Genetic Variation/radiation effects;Power Plants;Radioactive Hazard Release;Radioactive Pollutants/adverse effects;Ukraine
9601231;Child, Preschool;Combined Modality Therapy;Down Syndrome/complications*;Down Syndrome/physiopathology;Facial Muscles/physiopathology*;Female;Humans;Infant;Male;Mouth Breathing/etiology;Mouth Breathing/therapy;Orthodontic Appliances;Palate;Physical Therapy Modalities/methods*;Retrospective Studies;Tongue Habits/therapy
9607700;Animals;Binding Sites/physiology;Brain/metabolism*;Brain/pathology;Brain Ischemia/metabolism*;Brain Ischemia/pathology;Cerebral Cortex/metabolism;Cerebral Cortex/pathology;Male;Mice;Mice, Inbred Strains;Receptors, GABA/physiology*;Receptors, Glutamate/metabolism*;Thalamic Nuclei/metabolism;Thalamus/metabolism;Thalamus/pathology;Time Factors
9612980;Analysis of Variance;Animals;Bone Diseases/pathology;Bone Diseases/physiopathology;Bone Diseases/surgery;Bone Regeneration*;Connective Tissue/pathology;Dental Implantation, Endosseous*;Dental Implants*;Dental Prosthesis Design;Follow-Up Studies;Hematoma/pathology;Membranes, Artificial;Osseointegration;Osteogenesis;Polytetrafluoroethylene;Rabbits;Surface Properties;Tibia/pathology;Tibia/physiopathology;Tibia/surgery;Titanium*
9617415;Achilles Tendon/injuries*;Achilles Tendon/surgery;Adult;Athletic Injuries/etiology*;Athletic Injuries/surgery;Female;Humans;Male;Muscle Fatigue;Physical Therapy Modalities;Reconstructive Surgical Procedures;Retrospective Studies;Risk Factors;Rupture;Tendon Injuries/etiology*;Tendon Injuries/surgery
9621025;Aorta/virology*;Brain/virology;Cell Cycle;Cells, Cultured;Cytomegalovirus/physiology*;Endothelium, Vascular/virology*;Humans;Virus Replication
9621963;Adult;Aged;Arteries/pathology;Blood Flow Velocity/physiology;Cervix Uteri/blood supply*;Contrast Media*;Female;Gadolinium DTPA*;Hemodynamics/physiology;Humans;Image Enhancement/instrumentation*;Magnetic Resonance Imaging/instrumentation*;Middle Aged;Neoplasm Staging;Neovascularization, Pathologic/diagnosis*;Perfusion;Sensitivity and Specificity;Uterine Cervical Neoplasms/blood supply*;Uterine Cervical Neoplasms/diagnosis;Uterine Cervical Neoplasms/pathology;Uterus/blood supply*;Water*
9624865;Adolescent;Adult;Child;Child, Preschool;Deficiency Diseases/epidemiology*;Female;Humans;India/epidemiology;Infant;Infant Mortality*;Male;Middle Aged
9634240;Bereavement*;Humans
9645003;Apolipoprotein B-48;Apolipoproteins B/blood;Apolipoproteins B/deficiency*;Diet, Fat-Restricted;Humans;Hypobetalipoproteinemias*/diagnosis;Hypobetalipoproteinemias*/etiology;Infant;Infant, Newborn;Vitamin A/administration & dosage;Vitamin E/administration & dosage
9645850;Animals;Antibodies, Monoclonal/immunology;Antigens, Helminth/analysis;Antigens, Helminth/chemistry;Antigens, Helminth/immunology;Blotting, Western/veterinary;Carbohydrates/analysis;Carbohydrates/immunology;Cattle;Cattle Diseases/immunology;Cattle Diseases/parasitology*;Electrophoresis, Polyacrylamide Gel/veterinary;Epitopes/analysis*;Epitopes/chemistry;Female;Helminth Proteins/analysis;Helminth Proteins/chemistry;Helminth Proteins/immunology;Immunohistochemistry;Intestinal Diseases, Parasitic/immunology;Intestinal Diseases, Parasitic/parasitology;Intestinal Diseases, Parasitic/veterinary*;Intestines/immunology;Male;Mice;Strongylida/immunology*;Strongylida Infections/immunology;Strongylida Infections/parasitology;Strongylida Infections/veterinary*
9650923;Adult;Aged;Aged, 80 and over;Bacterial Typing Techniques;Belgium/epidemiology;Child;Cross Infection/microbiology*;DNA Restriction Enzymes;DNA, Bacterial/analysis;Electrophoresis, Gel, Pulsed-Field;Humans;Klebsiella Infections/epidemiology*;Klebsiella Infections/microbiology*;Klebsiella pneumoniae/classification*;Klebsiella pneumoniae/genetics*;Klebsiella pneumoniae/isolation & purification;Microbial Sensitivity Tests;Middle Aged;Molecular Epidemiology;Plasmids
9652290;Centers for Medicare and Medicaid Services (U.S.)/economics*;Cost Control;Disease Management*;Humans;Kidney Failure, Chronic/economics;Kidney Failure, Chronic/therapy*;Reimbursement Mechanisms/organization & administration;United States
9653117;3T3 Cells;Animals;Mice;Oncogene Protein v-cbl;Protein-Tyrosine Kinases/metabolism*;Receptors, Platelet-Derived Growth Factor/metabolism*;Retroviridae Proteins, Oncogenic/metabolism*;Signal Transduction*;Ubiquitins/metabolism
9658698;Education, Medical, Graduate;Family Practice*/education;Family Practice*/trends;Mexico;National Health Programs
9679324;Acriflavine/pharmacology;Aminoglycosides*;Anti-Bacterial Agents/biosynthesis*;Anti-Bacterial Agents/chemistry;Anti-Bacterial Agents/pharmacology;Bacteria/drug effects;Carbazoles/chemistry;Carbazoles/isolation & purification;Carbazoles/metabolism;Carbazoles/pharmacology;Microbial Sensitivity Tests;Morphogenesis;Mutagenesis;Naphthoquinones/metabolism;Naphthoquinones/pharmacology;Neuroprotective Agents;Streptomyces/drug effects;Streptomyces/genetics*;Streptomyces/metabolism*
9685177;Antineoplastic Agents;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*;Vidarabine/administration & dosage;Vidarabine/analogs & derivatives;Vidarabine/therapeutic use
9690750;Diagnosis, Differential;Diagnostic Errors;Disease Notification/standards;Disease Notification/statistics & numerical data;Evaluation Studies as Topic;France/epidemiology;HIV Seronegativity;HIV Seropositivity/complications;HIV Seropositivity/epidemiology;Hospitals, University;Humans;Incidence;Mycobacterium Infections, Nontuberculous/diagnosis;Mycobacterium Infections, Nontuberculous/microbiology;Reproducibility of Results;Risk Factors;Tuberculosis/complications;Tuberculosis/diagnosis*;Tuberculosis/epidemiology*;Tuberculosis/microbiology
9705342;Adenosine Triphosphate/metabolism*;Animals;Anti-Bacterial Agents/pharmacology;Dithiothreitol/pharmacology;Endocytosis;Endosomes/metabolism*;Enzyme Inhibitors/pharmacology;Female;Humans;Insulin/metabolism*;Macrolides*;Protein Conformation;Protein-Tyrosine Kinases/metabolism*;Proton-Translocating ATPases/antagonists & inhibitors;Rats;Rats, Sprague-Dawley;Receptor, Insulin/metabolism*;Signal Transduction;Sulfhydryl Reagents/pharmacology;Swine
9748714;Animals;Animals, Newborn;Bone Development/drug effects;Bone Resorption/drug therapy*;Female;In Vitro Techniques;Lipoxygenase/metabolism;Lipoxygenase Inhibitors/chemical synthesis*;Lipoxygenase Inhibitors/chemistry;Lipoxygenase Inhibitors/pharmacology;Magnetic Resonance Spectroscopy;Male;Mice;Neutrophils/drug effects;Neutrophils/enzymology;Peritoneal Cavity/cytology;Rats;Rats, Inbred Lew;Skull/drug effects;Skull/growth & development;Spectrophotometry, Infrared;Structure-Activity Relationship;Thiophenes/chemical synthesis*;Thiophenes/chemistry
9750123;Biodegradation, Environmental;Culture Media;Fumigation*;Gram-Negative Bacteria/classification;Gram-Negative Bacteria/growth & development;Gram-Negative Bacteria/isolation & purification*;Gram-Negative Bacteria/metabolism*;Hydrocarbons, Brominated/metabolism*;Oxidation-Reduction;Pesticides/metabolism*;Phylogeny;Soil Microbiology*
9751617;Antigens, Neoplasm/metabolism*;Carcinoma, Renal Cell/metabolism*;Female;Humans;Kidney Neoplasms/metabolism*;Male;Melanoma-Specific Antigens;Neoplasm Proteins/metabolism;RNA, Messenger/metabolism;Tumor Cells, Cultured
9761615;Anticarcinogenic Agents/standards*;Brazil;Chamomile;Drug Contamination/prevention & control;Enzyme Inhibitors/standards*;Flavonoids/standards*;Hyaluronoglucosaminidase/antagonists & inhibitors*;Oils, Volatile/standards*;Phytotherapy*;Plants, Medicinal;Product Surveillance, Postmarketing
9772930;Aged;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Antihypertensive Agents/pharmacology;Antihypertensive Agents/therapeutic use*;Benzazepines/pharmacology;Benzazepines/therapeutic use*;Female;Humans;Hypertension/drug therapy*;Male;Middle Aged;Predictive Value of Tests;Severity of Illness Index
9782014;Cholangiography/methods*;Cholangiopancreatography, Endoscopic Retrograde/methods;Cholecystectomy, Laparoscopic/methods*;Gallstones/diagnosis*;Gallstones/surgery;Humans;Magnetic Resonance Imaging/methods;Preoperative Care/methods;Prospective Studies;Risk Factors;Sensitivity and Specificity
9786981;6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology;Animals;Cadmium/pharmacology;Calcium Channel Blockers/pharmacology;Calcium Channels/metabolism*;Cricetinae;Excitatory Amino Acid Antagonists/pharmacology;Excitatory Postsynaptic Potentials*/drug effects;Ganglia, Spinal/metabolism;In Vitro Techniques;Nickel/pharmacology;Patch-Clamp Techniques;Potassium/pharmacology;Potassium/physiology;Rats;Rats, Sprague-Dawley;Tetrodotoxin/pharmacology
9796925;Animals;Brugia/immunology*;CD4-Positive T-Lymphocytes/metabolism*;CD8-Positive T-Lymphocytes/metabolism*;Cytokines/genetics;Elephantiasis, Filarial/metabolism;Interleukin-10/genetics;Interleukin-2/genetics;Interleukin-4/biosynthesis*;Interleukin-4/genetics;Larva/immunology;Lymphocyte Activation;Male;Mice;Mice, Inbred BALB C;Microfilariae/immunology;RNA, Messenger/biosynthesis;Receptors, Antigen, T-Cell, alpha-beta/biosynthesis;Receptors, Antigen, T-Cell, gamma-delta/biosynthesis;T-Lymphocytes/immunology*;T-Lymphocytes/metabolism;T-Lymphocytes/physiology*;Th2 Cells/immunology*;Time Factors
9800136;Colposcopy;Female;Humans;Practice Guidelines as Topic;Risk Factors;Uterine Cervical Dysplasia/diagnosis*;Uterine Cervical Neoplasms/diagnosis*;Vaginal Smears*
9800288;Adult;Blood Transfusion, Autologous/adverse effects;California/epidemiology;Cohort Studies;Female;Follow-Up Studies;HIV/immunology;HIV Antibodies/blood;HIV Seropositivity/blood;HIV Seroprevalence;Hepacivirus/immunology;Hepatitis B virus/immunology;Hepatitis B virus/isolation & purification;Human T-lymphotropic virus 1/immunology;Human T-lymphotropic virus 2/immunology;Humans;Male;Mandatory Testing;Middle Aged;Prospective Studies;Risk Factors;Transfusion Reaction*;Virus Diseases/blood;Virus Diseases/epidemiology*;Virus Diseases/etiology*
9801538;Clinical Nursing Research/history*;England;History, 19th Century;Humans;Military Nursing/history*;Nurse Administrators/history*;Statistics as Topic/history*
9804606;Animals;Behavior, Animal/physiology*;Birds/physiology*;Monitoring, Physiologic/instrumentation*;Seals, Earless/physiology*;Telemetry/instrumentation*
9805118;Adult;Blood Specimen Collection/methods*;Catheterization, Peripheral*;Female;Hemoglobins/analysis*;Humans;Male;Middle Aged;Phlebotomy*;Potassium/blood*;Reproducibility of Results
9834671;Humans;Nevus, Pigmented/etiology;Nevus, Pigmented/pathology;Nevus, Pigmented/surgery*;Prognosis;Skin Neoplasms/etiology;Skin Neoplasms/pathology;Skin Neoplasms/surgery*
9840080;Animals;Bile/drug effects;Bile/secretion*;Bile Acids and Salts/analysis;Bile Acids and Salts/secretion;Cholagogues and Choleretics/pharmacology*;Leucovorin/pharmacology*;Male;Rats;Rats, Wistar;Stereoisomerism
9840365;Cerebral Hemorrhage/complications;Cerebrospinal Fluid Shunts*;Endoscopy*;Humans;Hydrocephalus/etiology;Hydrocephalus/surgery*;Infant;Infant, Newborn;Infant, Premature*;Meningitis/complications;Postoperative Complications;Reoperation;Treatment Outcome
9840654;Animals;Coronary Circulation/drug effects;Dexamethasone/pharmacology;Escherichia coli Infections/drug therapy;Escherichia coli Infections/metabolism;In Vitro Techniques;Isothiuronium/analogs & derivatives*;Isothiuronium/pharmacology;Male;Nitrates/blood;Nitric Oxide/physiology*;Nitric Oxide Synthase/antagonists & inhibitors;Nitric Oxide Synthase/biosynthesis;Nitric Oxide Synthase Type II;Nitrites/blood;Perfusion;Rats;Rats, Sprague-Dawley;Sepsis/drug therapy*;Sepsis/metabolism;Sepsis/physiopathology;Ventricular Function, Left/drug effects*
9842041;Child;Child, Preschool;Female;Granulocyte Colony-Stimulating Factor/blood;HIV Infections/complications;Humans;Immunoglobulins, Intravenous/therapeutic use;Liver Function Tests;Male;Thrombocytopenia/blood*;Thrombocytopenia/complications;Thrombopoietin/blood*
9852128;Amino Acid Substitution;Animals;Cysteine;Dithionitrobenzoic Acid/pharmacology;Dithiothreitol/pharmacology;Female;Hydrogen-Ion Concentration;In Vitro Techniques;Ion Channel Gating/drug effects;Ion Channel Gating/physiology*;Kidney/physiology;Membrane Potentials/drug effects;Membrane Potentials/physiology;Mutagenesis, Site-Directed;Oocytes/physiology;Oxidation-Reduction;Patch-Clamp Techniques;Potassium Channels/chemistry;Potassium Channels/physiology*;Potassium Channels, Inwardly Rectifying*;Protein Conformation*;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Xenopus laevis
9853204;Activins;Female;Follistatin;Glycoproteins/metabolism*;Growth Substances/metabolism*;Humans;Inhibins/metabolism*;Male;Pregnancy;Reproduction/physiology*
9855216;Animals;Callithrix;Cartilage, Articular/cytology*;Cell Culture Techniques/methods*;Cells, Cultured;Collagen/analysis;Fibroblasts/cytology;Organ Culture Techniques;Stem Cells/cytology*;Temporomandibular Joint Disc/cytology*
9866115;Actin Cytoskeleton/physiology;Actins/physiology;Animals;Biopolymers;Cell Cycle Proteins/physiology;Cell Division;Cell Movement/physiology*;Cytoskeleton/physiology;Cytoskeleton/ultrastructure;Extracellular Matrix/physiology;Fibroblast Growth Factor 2/physiology;GTP-Binding Proteins/physiology;Models, Molecular;Muscle Proteins/physiology;Muscle, Smooth, Vascular/cytology*;Phosphatidylinositol 3-Kinases/physiology;Phosphatidylinositol Phosphates/physiology;Platelet-Derived Growth Factor/physiology;Signal Transduction/physiology;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;rac GTP-Binding Proteins;rho GTP-Binding Proteins
9868386;Combined Modality Therapy;Humans;Laryngeal Neoplasms/therapy*;Laryngectomy/adverse effects*;Laryngectomy/methods*;Laryngectomy/psychology;Patient Selection*;Quality of Life;Research Design;Treatment Outcome
9875704;Analysis of Variance;Animals;Dentate Gyrus/physiology*;Electric Stimulation;Excitatory Postsynaptic Potentials;Linear Models;Long-Term Potentiation*;Male;Rats;Tetany;Time Factors
9890656;Calcium Signaling/drug effects*;Cell Nucleus/metabolism;Cytoplasm/metabolism;Enzyme Inhibitors/pharmacology;Free Radicals/metabolism;Humans;Jurkat Cells;Mercuric Chloride/administration & dosage;Mercuric Chloride/toxicity*;Microscopy, Confocal;Phosphorylation;Protein Kinase C/antagonists & inhibitors;Proteins/metabolism*;Staurosporine/pharmacology
9916276;Aged;Aged, 80 and over;Ambulatory Care/statistics & numerical data*;Cross-Sectional Studies;Dementia/epidemiology*;Dementia/rehabilitation;Female;Germany/epidemiology;Health Services for the Aged/statistics & numerical data*;Home Care Services/statistics & numerical data*;Home Nursing/statistics & numerical data;Humans;Incidence;Male;Mental Disorders/epidemiology*;Mental Disorders/rehabilitation;Middle Aged;Patient Care Team/statistics & numerical data
9919235;Attitude of Health Personnel;Clinical Competence/standards*;Education, Nursing, Baccalaureate/methods*;Humans;Mathematics*;Students, Nursing*/psychology;Surveys and Questionnaires
9924234;Anesthetics, Inhalation/pharmacology*;Animals;Chlorine/metabolism;Dose-Response Relationship, Drug;Electrophysiology;Female;Halothane/pharmacology;Isoflurane/analogs & derivatives;Isoflurane/pharmacology;Methyl Ethers/pharmacology;Oocytes/metabolism;Receptor, Muscarinic M1;Receptor, Muscarinic M3;Receptors, Angiotensin/drug effects;Receptors, Angiotensin/metabolism;Receptors, Muscarinic/drug effects*;Receptors, Muscarinic/metabolism;Recombinant Proteins;Signal Transduction/drug effects;Xenopus laevis
9928917;Antipsychotic Agents/therapeutic use;Double-Blind Method;Evaluation Studies as Topic;Haloperidol/therapeutic use;Humans;Placebos;Randomized Controlled Trials as Topic/utilization*;Schizophrenia/drug therapy*
9935105;Dermatologic Surgical Procedures*;Humans;Laser Therapy*/methods;Rhytidoplasty*/methods;Skin/blood supply;Skin/innervation
10049280;Algorithms;Aminoglycosides;Ampicillin/administration & dosage;Ampicillin/pharmacokinetics;Ampicillin/therapeutic use*;Animals;Anti-Bacterial Agents/pharmacology*;Ceftriaxone/administration & dosage;Ceftriaxone/pharmacokinetics;Ceftriaxone/therapeutic use*;Cephalosporins/administration & dosage;Cephalosporins/pharmacokinetics;Cephalosporins/therapeutic use*;Colony Count, Microbial;Drug Resistance, Microbial;Drug Synergism;Drug Therapy, Combination/administration & dosage;Drug Therapy, Combination/pharmacokinetics;Drug Therapy, Combination/therapeutic use*;Endocarditis, Bacterial/drug therapy*;Endocarditis, Bacterial/microbiology;Enterococcus faecalis*/drug effects;Infusion Pumps;Injections, Intravenous;Models, Biological;Penicillins/administration & dosage;Penicillins/pharmacokinetics;Penicillins/therapeutic use*;Rabbits
10050435;Acute Disease;Adult;Appendectomy;Appendicitis/complications*;Appendicitis/surgery;Appendix/pathology*;Cecal Diseases/etiology*;Cecal Diseases/surgery;Electrocoagulation;Gangrene;Gastrointestinal Hemorrhage/etiology*;Gastrointestinal Hemorrhage/surgery;Humans;Intestinal Perforation/etiology*;Intestinal Perforation/surgery;Male;Mallory-Weiss Syndrome/complications*;Mallory-Weiss Syndrome/surgery
10068849;Adrenomedullin;Atrial Natriuretic Factor/blood;Cardiac Catheterization;Cardiomyopathies/complications;Epinephrine/blood;Female;Follow-Up Studies;Heart Failure/blood*;Heart Failure/drug therapy*;Heart Failure/etiology;Humans;Male;Middle Aged;Natriuretic Peptide, Brain/blood;Peptide Fragments/metabolism*;Peptides/blood*;Prognosis;Proteins/metabolism*;Radioimmunoassay;Vasodilator Agents/blood*
10072599;Amino Acid Oxidoreductases/genetics*;Animals;Chromosome Mapping;Chromosomes/genetics*;Chromosomes, Human, Pair 9/genetics;Dinucleotide Repeats;Genes/genetics;Glycine Dehydrogenase (Decarboxylating);Humans;In Situ Hybridization, Fluorescence;Mice;Mice, Inbred BALB C;Mice, Inbred C3H;Mice, Inbred C57BL;Mice, Inbred DBA;Mice, Inbred Strains;Polymorphism, Genetic
10076726;Adolescent;Adult;Aged;Aged, 80 and over;Antibodies, Monoclonal*;Biopsy, Needle;Bone Marrow/diagnostic imaging;Bone Marrow Neoplasms/diagnostic imaging*;Bone Marrow Neoplasms/secondary;Female;Granulocytes/immunology*;Hodgkin Disease/diagnostic imaging*;Hodgkin Disease/pathology;Humans;Lymphoma, Non-Hodgkin/diagnostic imaging*;Lymphoma, Non-Hodgkin/pathology;Male;Middle Aged;Radioimmunodetection/methods*;Sensitivity and Specificity;Technetium*
10093647;Fluid Therapy;Humans;Oxygen/metabolism*;Oxygen Consumption;Oxygen Inhalation Therapy;Sepsis/metabolism*;Sepsis/physiopathology;Sepsis/therapy
10094898;Adenocarcinoma/complications;Adenocarcinoma/pathology*;Breast*;Choristoma/complications;Choristoma/pathology*;Female;Humans;Middle Aged;Vulvar Diseases/complications;Vulvar Diseases/pathology*;Vulvar Neoplasms/complications;Vulvar Neoplasms/pathology*
10104627;Hospital Administration*;Risk Management*;State Medicine;United Kingdom
10133565;Health Care Reform;Hospital Administration/trends*;Leadership*;Organizational Innovation*;Surveys and Questionnaires;United States
10137642;Humans;Medicaid/legislation & jurisprudence*;Medicare/legislation & jurisprudence*;Tissue and Organ Procurement/legislation & jurisprudence*;United States
10147293;Forecasting;Humans;Managed Care Programs;Neuroradiography/standards;Neuroradiography/utilization;Practice Guidelines as Topic*;Practice Patterns, Physicians';Radiology*/manpower;United States
10147961;Arteriosclerosis/diagnosis*;Arteriosclerosis/diagnostic imaging;Arteriosclerosis/physiopathology;Humans;Lipoproteins, VLDL*;Magnetic Resonance Spectroscopy/methods*;Radionuclide Imaging
10155030;Community Participation;Delivery of Health Care, Integrated/organization & administration*;Governing Board/organization & administration*;Health Facility Merger/organization & administration*;Hospitals;Insurance Carriers;Leadership;Managed Care Programs;Minnesota;Physicians
10160525;Adult;African Americans;Birth Weight*;Female;Health Services Needs and Demand*;Humans;Infant, Low Birth Weight*;Infant, Newborn;Models, Theoretical;Mothers*;Prenatal Care*;Socioeconomic Factors;United States
10170158;Community Networks/organization & administration;Delivery of Health Care/organization & administration*;Delivery of Health Care, Integrated/organization & administration;Managed Care Programs/organization & administration;Radiology
10176869;Cost Sharing*;Financing, Personal*;Humans;Managed Care Programs/economics*;Organizational Innovation;Pilot Projects;United States
10180161;Equipment and Supplies, Hospital;Health Care Surveys;Hospitals, Community/standards*;Humans;Management Quality Circles;Outcome and Process Assessment (Health Care);Patient Discharge;Patient Satisfaction*;Phlebotomy/standards;Total Quality Management;Wisconsin
10186009;Data Collection;Disease Management*;Health Services Research/methods;Health Status Indicators;Humans;Outcome and Process Assessment (Health Care);Quality of Life*;United States/epidemiology
10196461;Adult;Analysis of Variance;Brain Mapping/methods*;Female;Humans;Magnetic Resonance Imaging/methods*;Physical Stimulation;Reference Values;Somatosensory Cortex/pathology;Somatosensory Cortex/physiology*;Vibration
10198433;Amino Acid Sequence;Animals;Base Sequence;Calcium/metabolism*;DNA/chemistry;DNA/metabolism*;DNA Fragmentation;Endodeoxyribonucleases/chemistry;Endodeoxyribonucleases/metabolism*;HeLa Cells;Humans;Hydrolysis;Magnesium/metabolism*;Molecular Sequence Data;Molecular Weight;Nucleosomes/metabolism*;Sequence Homology, Amino Acid
10203053;Animals;COS Cells;Macaca fascicularis;SAIDS Vaccines/immunology*;Simian Acquired Immunodeficiency Syndrome/prevention & control*;Simian Immunodeficiency Virus/immunology*;Vaccines, DNA/immunology*;Viral Load
10207128;Antioxidants/metabolism*;Catechin/analogs & derivatives*;Catechin/metabolism;Chromatography, High Pressure Liquid;Magnetic Resonance Spectroscopy;Peroxides/metabolism*;Tea
10207180;Animals;Cattle;Cell Nucleus/enzymology;Chromatography, Affinity;DNA/metabolism;Electrophoresis, Polyacrylamide Gel;Glycosylation;Isoelectric Point;Molecular Weight;N-Acylneuraminate Cytidylyltransferase/chemistry;N-Acylneuraminate Cytidylyltransferase/isolation & purification*;N-Acylneuraminate Cytidylyltransferase/metabolism;Pituitary Gland, Anterior/enzymology*
10210735;Calorimetry, Differential Scanning;Chemical Phenomena;Chemistry, Physical;Crystallization;Diflunisal/chemistry*;Excipients;Polyethylene Glycols/chemistry*;Polymers;Solubility;Solvents;X-Ray Diffraction
10226974;Adult;Humans;Joint Diseases/pathology;Joint Diseases/surgery*;Male;Orthopedic Procedures/methods;Ossification, Heterotopic/pathology;Ossification, Heterotopic/surgery*;Physical Therapy Modalities;Range of Motion, Articular;Shoulder Joint/pathology*;Shoulder Joint/surgery;Treatment Outcome
10231546;Actins/chemistry;Actins/metabolism;Adenosine Triphosphate/chemistry;Adenosine Triphosphate/metabolism;Animals;Binding Sites;Ethenoadenosine Triphosphate/analogs & derivatives;Ethenoadenosine Triphosphate/chemistry;Ethenoadenosine Triphosphate/metabolism;Hydrolysis;Kinetics;Maleimides/chemistry*;Myosin Subfragments/chemistry*;Myosin Subfragments/metabolism*;Rabbits;Spectrometry, Fluorescence;Spectrophotometry
10250468;Efficiency;Humans;Job Satisfaction;Personnel Management/standards*
10263969;Capital Expenditures;Costs and Cost Analysis*;Decision Making;Information Systems/economics*;Management Information Systems/economics*;Microfilming/economics
10264350;Arizona;Hospital Administration*;Hospital Auxiliaries*;Hospital Bed Capacity, under 100;Hospital Shops*;Hospital Volunteers*
10269335;Culture;Health Maintenance Organizations/manpower*;Humans;Job Satisfaction*;Medical Staff/psychology*;United States
10270908;Hospital Bed Capacity, 100 to 299;Hospital Departments*;Hospital Design and Construction/standards*;Models, Theoretical;Pennsylvania;Radiology Department, Hospital*
10285371;Hospital Administration/manpower*;Hospital Shops/manpower*;Hospital Volunteers/standards*;Ohio;Personnel Management*;Personnel Selection*
10290717;Forecasting;Inventories, Hospital/trends;Materials Management, Hospital/trends*;Purchasing, Hospital/trends;Statistics as Topic;Surveys and Questionnaires;United States
10293492;Health Services Research/economics*;Practice Patterns, Physicians';Research Support as Topic/legislation & jurisprudence*;United States
10298159;Confidentiality/legislation & jurisprudence*;Data Collection;Evaluation Studies as Topic;Humans;Information Systems/legislation & jurisprudence*;Medicare/legislation & jurisprudence*;Pilot Projects;United States
10299485;Health Maintenance Organizations/economics*;Medicare/legislation & jurisprudence*;United States
10301995;Aged;Arizona;Demography;Group Practice/organization & administration*;Humans;Medicare;Ophthalmology/economics*;Pilot Projects;Referral and Consultation;Rural Health*;Surgicenters/organization & administration*;Surveys and Questionnaires
10302466;Catastrophic Illness/economics*;Insurance, Major Medical/legislation & jurisprudence*;Medicare/legislation & jurisprudence*;United States
10302546;Forecasting;History, 20th Century;State Medicine/history*;United Kingdom
10306108;Decision Making;Governing Board*;Hospital Administration*;Humans
10317083;Ambulatory Surgical Procedures/utilization*;Health*;Outpatient Clinics, Hospital/organization & administration*;United States;Urban Health*
10330321;Animals;Arthropods/drug effects*;Arthropods/growth & development;Female;Lethal Dose 50;Male;Nickel/toxicity*;Reproduction/drug effects;Soil Pollutants/toxicity*
10340603;Antineoplastic Agents/pharmacology*;Colonic Neoplasms/drug therapy;HeLa Cells;Humans;Ketones/chemical synthesis*;Ketones/pharmacology*;Kinetics;Models, Chemical;Tumor Cells, Cultured
10363680;ABO Blood-Group System*;Adult;Aged;Antibodies, Bacterial/blood*;Antigens, Bacterial*;Bacterial Proteins/immunology*;Blood Donors;Electrophoresis, Polyacrylamide Gel;Enzyme-Linked Immunosorbent Assay;Female;Helicobacter Infections/immunology*;Helicobacter pylori/immunology*;Humans;Immunoblotting;Male;Middle Aged;Neoplasm Staging;Recombinant Proteins/immunology;Stomach Neoplasms/blood;Stomach Neoplasms/immunology*;Stomach Neoplasms/pathology
10363963;Androgen Antagonists/therapeutic use*;Anilides/therapeutic use;Antineoplastic Agents, Hormonal/therapeutic use*;Biopsy;Bone Marrow/pathology;Bone Marrow Neoplasms/genetics*;Bone Marrow Neoplasms/secondary;Codon/genetics;DNA Mutational Analysis;Flutamide/therapeutic use;Humans;Male;Mutation/genetics*;Neoplasms, Hormone-Dependent/chemistry;Neoplasms, Hormone-Dependent/drug therapy;Neoplasms, Hormone-Dependent/genetics*;Neoplasms, Hormone-Dependent/pathology;Nitriles;Prostatic Neoplasms/chemistry;Prostatic Neoplasms/drug therapy;Prostatic Neoplasms/genetics*;Prostatic Neoplasms/pathology;Receptors, Androgen/genetics*;Reverse Transcriptase Polymerase Chain Reaction;Tosyl Compounds
10371901;Anatomy, Cross-Sectional;Computer Simulation*;Dental Models;Dental Pulp Cavity/anatomy & histology;Humans;Image Processing, Computer-Assisted*;Tooth Abnormalities/pathology*;Tooth Root/anatomy & histology*
10378858;Chronic Disease;Endarterectomy/history*;History, 20th Century;Humans;Hypertension, Pulmonary/history*;Hypertension, Pulmonary/surgery;Pulmonary Artery/surgery*;Pulmonary Embolism/history*;Pulmonary Embolism/surgery
10382082;Contraceptives, Oral, Hormonal*;Ethinyl Estradiol*/administration & dosage;Female;Hemorrhage;Humans;Levonorgestrel/administration & dosage;Menstrual Cycle/drug effects*
10385106;Biological Warfare*;United States
10386951;Animals;Calcium-Binding Proteins*;Carboxypeptidase H;Carboxypeptidases/biosynthesis;Carboxypeptidases/secretion;Clathrin/genetics;Dopamine beta-Hydroxylase/genetics;Dopamine beta-Hydroxylase/secretion;Gene Expression/drug effects*;Gene Targeting;Hybrid Cells;Membrane Glycoproteins/genetics;Membrane Glycoproteins/secretion;Microscopy, Electron;Mutation;Nerve Tissue Proteins/genetics*;Nerve Tissue Proteins/secretion*;Organelles/ultrastructure*;PC12 Cells/ultrastructure*;Rats;Synaptotagmin I;Synaptotagmins;Transfection
10388638;Aged;Arterial Occlusive Diseases/surgery;Chronic Disease;Endarterectomy/methods*;Female;Femoral Artery/surgery*;Follow-Up Studies;Humans;Intermittent Claudication/surgery;Ischemia/surgery;Leg/blood supply;Male;Popliteal Artery/surgery;Postoperative Complications;Prospective Studies;Treatment Outcome;Vascular Patency
10399003;Adolescent;Antithrombin III Deficiency/complications*;Factor VII Deficiency/complications*;Female;Homocystinuria/complications*;Humans;Sinus Thrombosis, Intracranial/complications*
10400181;Acute Disease;Age Factors;Aged;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Clinical Trials as Topic;Female;Forecasting;Humans;Leukemia, Myeloid*/drug therapy;Leukemia, Myeloid*/epidemiology;Leukemia, Myeloid*/pathology;Male;Middle Aged;Palliative Care;Patient Selection;Prognosis
10414061;Adult;Child;Decision Making;Female;Health Behavior;Health Knowledge, Attitudes, Practice*;Humans;Military Personnel/education;Military Personnel/psychology*;Models, Psychological*;Mothers/education;Mothers/psychology*;Research;Risk Factors;Self Efficacy;Smoking/adverse effects;Smoking/psychology*;Smoking Prevention*;Social Support;Tobacco Smoke Pollution/adverse effects;Tobacco Smoke Pollution/prevention & control*;United States
10415692;Acoustic Stimulation;Animals;Avoidance Learning/physiology*;Electroshock;Functional Laterality;Male;Nucleus Accumbens/anatomy & histology;Nucleus Accumbens/physiology*;Rats;Rats, Wistar
10424560;Autoantibodies/analysis*;Bronchoalveolar Lavage Fluid/immunology;Humans;Interleukin-8/immunology*;Respiratory Distress Syndrome, Adult/etiology;Respiratory Distress Syndrome, Adult/immunology*
10434029;Animals;Butyrates/pharmacology*;CHO Cells/cytology;CHO Cells/drug effects;CHO Cells/radiation effects;Centromere/drug effects;Centromere/radiation effects;Chromosome Aberrations/genetics*;Cricetinae;Dose-Response Relationship, Radiation;G1 Phase/drug effects;G1 Phase/genetics;G1 Phase/radiation effects;Ring Chromosomes;Sister Chromatid Exchange/drug effects*;Sister Chromatid Exchange/radiation effects*;X-Rays
10436614;Acute Disease;Adolescent;Adult;Argentina/epidemiology;Confidence Intervals;Diarrhea/diagnosis;Diarrhea/epidemiology*;Female;Hospitals;Humans;Male
10438544;Animals;Base Sequence;DNA;DNA-Binding Proteins*;Gene Expression Regulation*;Mice;Promoter Regions, Genetic;Protein Binding;Receptors, Opioid, delta/genetics*;Receptors, Opioid, delta/metabolism;Sp1 Transcription Factor/metabolism;Transcription Factors/metabolism;Transcription, Genetic*;Tumor Cells, Cultured;Upstream Stimulatory Factors
10438933;Aging/genetics*;Aging/immunology*;Animals;Antibodies, Heterophile/biosynthesis;CD4 Lymphocyte Count;CD4-Positive T-Lymphocytes/immunology;CD4-Positive T-Lymphocytes/metabolism;Cytokines/biosynthesis;Erythrocytes/immunology;Immune System/growth & development*;Immune System/immunology;Immunologic Memory/genetics;Lymphocyte Activation/genetics;Lymphoma/genetics;Lymphoma/immunology;Lymphoma/pathology;Male;Mice;Mice, Inbred CBA;Mice, Knockout;Receptors, Antigen, T-Cell/metabolism;Sheep;Spleen/cytology;Spleen/immunology;Spleen/pathology;Th2 Cells/immunology;Th2 Cells/metabolism;Tumor Suppressor Protein p53/biosynthesis;Tumor Suppressor Protein p53/deficiency*;Tumor Suppressor Protein p53/genetics*
10444069;3T3 Cells;Adaptor Protein Complex gamma Subunits;Adipocytes/cytology*;Adipocytes/drug effects;Adipocytes/metabolism;Adiponectin;Animals;Blood Proteins/analysis*;Blood Proteins/secretion;Coatomer Protein;Collagen/secretion;Endoplasmic Reticulum/chemistry;Endoplasmic Reticulum/secretion;Exocytosis/drug effects*;Fluorescent Antibody Technique;Glucose Transporter Type 4;Golgi Apparatus/chemistry;Insulin/pharmacology*;Intercellular Signaling Peptides and Proteins*;Membrane Glycoproteins/analysis;Membrane Proteins/analysis;Mice;Microtubule-Associated Proteins/analysis;Monosaccharide Transport Proteins/analysis*;Monosaccharide Transport Proteins/secretion;Muscle Proteins*;Phosphatidylinositol 3-Kinases/antagonists & inhibitors;Phosphatidylinositol 3-Kinases/metabolism;Proteins*;Receptors, Transferrin/analysis
10458179;Adolescent;Child;Depth Perception;Eye Movements;Female;Follow-Up Studies;Humans;Male;Oculomotor Muscles/surgery;Oculomotor Nerve Diseases*/etiology;Oculomotor Nerve Diseases*/physiopathology;Oculomotor Nerve Diseases*/surgery;Ophthalmologic Surgical Procedures;Remission, Spontaneous;Retrospective Studies;Treatment Outcome;Vision, Binocular;Visual Acuity
10470398;Adult;Anti-Arrhythmia Agents/poisoning*;Cardiopulmonary Bypass*;Drug Overdose;Electrocardiography;Extracorporeal Circulation;Female;Flecainide/poisoning*;Hemodiafiltration;Humans;Poisoning/diagnosis;Poisoning/therapy
10475748;Aftercare;Germany;Humans;Neoplasms/diagnosis*;Neoplasms/genetics;Neoplasms/therapy;Prognosis;Quality Assurance, Health Care
10477736;Cells, Cultured;Chemokine CCL11;Chemokines, CC*;Chemotactic Factors, Eosinophil/genetics;Chemotaxis, Leukocyte*;Cytokines/genetics*;Cytokines/secretion;Enzyme-Linked Immunosorbent Assay;Fibroblasts/cytology;Fibroblasts/pathology;Fibroblasts/physiology;Gene Expression Regulation;HeLa Cells;Hodgkin Disease/pathology*;Humans;In Situ Hybridization;Lymph Nodes/pathology;RNA, Messenger/genetics;Reed-Sternberg Cells/pathology*;Reed-Sternberg Cells/physiology;Skin/cytology*;Th2 Cells/physiology;Transcription, Genetic*;Tumor Cells, Cultured
10479135;Anti-HIV Agents/therapeutic use;Circadian Rhythm;Enzyme-Linked Immunosorbent Assay/methods;HIV Core Protein p24/blood*;HIV Infections/blood;HIV Infections/diagnosis*;HIV Infections/drug therapy;HIV-1/isolation & purification*;Humans;Infant;Infant, Newborn;Monitoring, Physiologic;Neutralization Tests;Polymerase Chain Reaction/methods;Prospective Studies;Protein Denaturation;RNA, Viral/blood;Reproducibility of Results;Sensitivity and Specificity;Viral Load/methods*
10484759;Anti-Bacterial Agents/pharmacology*;Drug Resistance, Multiple/genetics*;Enterococcus faecium/drug effects*;Humans;Plasmids/genetics;Vancomycin/pharmacology*;Virginiamycin/pharmacology*
10489616;5' Untranslated Regions;Actins/genetics;Animals;Endothelial Growth Factors/genetics;Gene Expression*;Genetic Therapy;Genetic Vectors;Granulocyte Colony-Stimulating Factor/genetics;Introns*;Kinetics;Lymphokines/genetics;Male;Mice;Mice, Inbred ICR;Nitric Oxide Synthase/genetics;Nitric Oxide Synthase Type II;Nitric Oxide Synthase Type III;RNA Splicing;RNA, Messenger/analysis;Reproducibility of Results;Reverse Transcriptase Polymerase Chain Reaction*;Sensitivity and Specificity;Transgenes*;Vascular Endothelial Growth Factor A;Vascular Endothelial Growth Factors
10491819;Animals;Brain Ischemia/physiopathology*;Cerebral Infarction/physiopathology*;Disease Models, Animal*;Gerbillinae;Laser-Doppler Flowmetry;Middle Cerebral Artery/surgery;Reperfusion Injury*
10496185;Amino Acid Sequence;Antibodies, Monoclonal/chemistry*;Antibodies, Monoclonal/genetics;Antibodies, Monoclonal/immunology;Antigen-Antibody Reactions;Autoantibodies/chemistry*;Autoantibodies/genetics;Autoantibodies/immunology;Autoimmune Diseases/genetics;Autoimmune Diseases/immunology*;Autoimmune Diseases/therapy;Base Sequence;Binding Sites, Antibody*;DNA, Complementary/genetics;Fluorescent Antibody Technique, Indirect;Gene Rearrangement, B-Lymphocyte;Genes, Immunoglobulin;HeLa Cells;Humans;Immunoglobulin M/chemistry*;Immunoglobulin M/genetics;Immunoglobulin M/immunology;Immunoglobulin Variable Region/genetics;Immunotherapy;Molecular Sequence Data;Multiple Sclerosis/genetics;Multiple Sclerosis/immunology*;Multiple Sclerosis/therapy;Myelin Sheath/immunology;Oligodendroglia/immunology*;Reverse Transcriptase Polymerase Chain Reaction;Sequence Alignment;Sequence Homology
10507207;Acrylic Resins;Dental Enamel/drug effects*;Dental Enamel/ultrastructure;Drug Carriers;Drug Combinations;Humans;Hydrogen Peroxide/administration & dosage;Hydrogen Peroxide/chemistry;Hydrogen Peroxide/therapeutic use*;Incisor;Microscopy, Atomic Force;Molecular Weight;Oxidants/administration & dosage;Oxidants/chemistry;Oxidants/therapeutic use*;Oxidation-Reduction;Peroxides/administration & dosage;Peroxides/chemistry;Peroxides/therapeutic use*;Polyvinyls;Time Factors;Tooth Bleaching*;Urea/administration & dosage;Urea/analogs & derivatives*;Urea/chemistry;Urea/therapeutic use
10509237;Animals;Cartilage, Articular/enzymology*;Cartilage, Articular/pathology;Collagenases/metabolism*;Contrast Media/administration & dosage;Gadolinium DTPA/administration & dosage;Liposomes;Magnetic Resonance Spectroscopy/methods*;Osteoarthritis/enzymology*;Osteoarthritis/pathology;Swine
10528819;Adult;Age Factors;Alcohol Drinking/blood*;Alcoholism/blood*;Alcoholism/diagnosis;Biomarkers/blood;Erythrocyte Indices;Humans;Male;Middle Aged;Temperance*;Transferrin/analogs & derivatives*;Transferrin/analysis;gamma-Glutamyltransferase/blood*
10532201;Adult;Aged;Cross-Sectional Studies;Female;Follow-Up Studies;Hawaii/epidemiology;Heart Aneurysm/diagnosis;Heart Aneurysm/mortality*;Heart Aneurysm/surgery;Humans;Incidence;Male;Middle Aged;Myocardial Infarction/diagnosis;Myocardial Infarction/mortality*;Myocardial Infarction/surgery;Postoperative Complications/mortality;Reoperation;Risk Factors;Survival Rate
10533853;Food Technology*;Genetic Engineering*;Humans;Plants/genetics*;Public Opinion*;Solanum tuberosum/genetics;United Kingdom
10537445;Analysis of Variance*;Data Interpretation, Statistical;Diffusion of Innovation;Health Care Sector/standards;Humans;Total Quality Management/statistics & numerical data*;United States
10541489;Amoxicillin/economics*;Drug Costs;Drugs, Generic/economics;Penicillins/economics*
10544959;Adenosine Monophosphate/metabolism;Animals;Energy Metabolism;Inosine Monophosphate/metabolism*;Isoenzymes;Kinetics;Magnesium/metabolism;Muscle Fibers, Fast-Twitch/metabolism;Muscle Fibers, Slow-Twitch/metabolism;Muscle, Skeletal/metabolism*;Nucleotidases/metabolism*;Precipitin Tests;Rats;Rats, Sprague-Dawley;Solubility;Substrate Specificity
10546105;Abnormalities, Multiple/genetics*;Child;Face/abnormalities;Female;Genes, Dominant/genetics*;Genes, Recessive/genetics*;Humans;Joint Diseases/genetics;Nuclear Family;Syndrome
10546197;Adolescent;Adult;Child;Child, Preschool;Democratic Republic of the Congo/epidemiology;Disease Outbreaks/statistics & numerical data*;Disease Reservoirs;Female;Humans;Infant;Male;Marburg Virus Disease/epidemiology*;Marburg Virus Disease/etiology;Marburg Virus Disease/transmission;Middle Aged;Population Surveillance;Retrospective Studies;Risk Factors;Seroepidemiologic Studies;Survival Analysis;Warfare*
10549923;Arkansas;History, 20th Century;Humans;Microsurgery/history*;Neurosurgery/history*;Schools, Medical/history*;Turkey
10551593;Acute-Phase Proteins/isolation & purification;Acute-Phase Proteins/pharmacology;Acute-Phase Proteins/therapeutic use*;Animals;Antigens, Neoplasm*;Biomarkers, Tumor*;Blood Pressure/drug effects;Chromatography, Affinity;In Vitro Techniques;Lectins, C-Type*;Leukocytes/pathology*;Lung/metabolism;Male;N-Formylmethionine Leucyl-Phenylalanine/pharmacology;Neutrophil Activation;Organ Size/drug effects;Pancreatitis-Associated Proteins;Pulmonary Artery/drug effects;Pulmonary Artery/physiopathology;Pulmonary Circulation/drug effects;Pulmonary Edema/pathology;Pulmonary Edema/physiopathology;Pulmonary Edema/prevention & control*;Rabbits;Rats;Rats, Sprague-Dawley;Thromboxane A2/biosynthesis;Thromboxane B2/biosynthesis;Vasoconstriction/drug effects*
10553283;Animals;Body Water/metabolism*;Cytoplasm/metabolism*;In Vitro Techniques;Mitochondria, Liver/metabolism;Models, Biological;Osmosis;Proteins/metabolism;Rats
10554995;Adult;Cerebral Cortex/ultrastructure*;Humans;Microscopy, Electron/methods*;Neurosciences/methods*;Synapses/ultrastructure*
10569294;Academic Medical Centers/organization & administration;Certification;Continuity of Patient Care;Cost-Benefit Analysis;Hospitalists*/education;Hospitalists*/standards;Hospitalists*/statistics & numerical data;Humans;Institutional Practice/economics;Institutional Practice/standards;Institutional Practice/trends*;Insurance, Health;Internal Medicine;United States
10574653;Adult;Biological Transport;Cholesterol/blood*;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/pharmacology;Fatty Acids, Unsaturated/administration & dosage;Female;Humans;Lauric Acids/administration & dosage*;Lipoproteins/blood*;Lipoproteins, LDL/blood;Lipoproteins, LDL/chemistry;Male;Particle Size;Receptors, LDL/metabolism;Triglycerides/administration & dosage*
10580234;Arytenoid Cartilage/surgery;Cricoid Cartilage/surgery;Electromyography;Humans;Reconstructive Surgical Procedures;Tracheotomy;Vocal Cord Paralysis/diagnosis*;Vocal Cord Paralysis/etiology;Vocal Cord Paralysis/therapy*
10581769;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Diagnosis, Differential;Free Radicals;Gastric Mucosa/pathology*;Gastroscopy;Histamine H2 Antagonists/therapeutic use;Humans;Nitric Oxide/physiology;Prostaglandins/physiology;Prostaglandins/therapeutic use;Proton Pump Inhibitors;Stomach Diseases*/etiology;Stomach Diseases*/pathology;Stress, Physiological/complications
10585968;Amino Acid Sequence;Amyloid/metabolism;Amyloid/ultrastructure;Animals;Ciliophora/genetics;Fungal Proteins;Glutathione Peroxidase;Models, Genetic;Molecular Sequence Data;Peptide Termination Factors;Prions/genetics*;Reproduction;Saccharomyces/genetics*;Saccharomyces cerevisiae Proteins*;Sordariales/genetics*
10592971;Developing Countries;Finland;Humans;Immunization Programs/organization & administration*;International Cooperation*;Philippines;Pneumococcal Vaccines/administration & dosage*;Pneumococcal Vaccines/pharmacology;Pneumonia, Pneumococcal/prevention & control*;Program Development
10594958;Genetics, Medical/trends;Human Genome Project*;Humans
10603357;Animals;Animals, Newborn;Cell Movement;DNA-Binding Proteins/genetics;DNA-Binding Proteins/metabolism;Diaphragm/embryology;Diaphragm/growth & development;Extremities/embryology*;Fluorescent Antibody Technique;Gene Expression Regulation, Developmental;Gene Targeting;Mice;Mice, Knockout;Muscle Development;Muscle Proteins/genetics*;Muscle Proteins/metabolism;Muscles/embryology*;Mutation;PAX3 Transcription Factor;Paired Box Transcription Factors;Proto-Oncogene Proteins c-met/genetics;Signal Transduction;Stem Cells/metabolism*;Tongue/embryology;Tongue/growth & development;Transcription Factors*
10603945;Amino Acid Sequence;Animals;Calcium-Binding Proteins/chemistry*;Intracellular Membranes/ultrastructure;Models, Molecular;Molecular Sequence Data;Mutagenesis, Site-Directed;Protein Conformation;Protein Structure, Quaternary;Recombinant Fusion Proteins/chemistry;Sarcoplasmic Reticulum/ultrastructure
10604147;Child, Preschool;Congenital Disorders of Glycosylation/diagnosis*;Congenital Disorders of Glycosylation/pathology;Humans;Liver/pathology;Male;Transferrin/genetics;Transferrin/metabolism
10620436;Adult;Aged;Aged, 80 and over;Carcinoma, Squamous Cell/pathology*;Carcinoma, Squamous Cell/secondary;Carcinoma, Squamous Cell/surgery;Female;Follow-Up Studies;Humans;Lymph Node Excision;Lymphatic Metastasis;Middle Aged;Neoplasm Invasiveness;Neoplasm Metastasis;Neoplasm Recurrence, Local;Postoperative Complications;Prognosis;Retrospective Studies;Risk Factors;Vulvar Neoplasms/pathology*;Vulvar Neoplasms/surgery
10622939;Centers for Medicare and Medicaid Services (U.S.);Documentation/standards;Drug Utilization Review;Emergency Service, Hospital/economics;Emergency Service, Hospital/standards*;Forms and Records Control/standards*;Guidelines as Topic*;Insurance Claim Reporting/standards*;Medical History Taking;Physical Examination;Practice Patterns, Physicians';United States
10627236;Academic Dissertations as Topic*;Academies and Institutes;Dentistry*;Dentistry, Operative;Libraries, Medical;Orthodontics;Preventive Dentistry;Russia;Surgery, Oral
10632251;Antibodies, Monoclonal/economics;Antibodies, Monoclonal/therapeutic use;Antibodies, Monoclonal, Humanized;Cohort Studies;Cost-Benefit Analysis;Costs and Cost Analysis;Hospitalization/economics*;Hospitalization/statistics & numerical data;Humans;Immunoglobulins, Intravenous/economics;Immunoglobulins, Intravenous/therapeutic use;Infant;Infant, Newborn;Infant, Premature;Infant, Premature, Diseases/economics*;Infant, Premature, Diseases/epidemiology;Infant, Premature, Diseases/prevention & control*;Palivizumab;Respiratory Syncytial Virus Infections/economics*;Respiratory Syncytial Virus Infections/epidemiology;Respiratory Syncytial Virus Infections/prevention & control*;Respiratory Syncytial Viruses
10633919;Animals;Bird Diseases/parasitology*;Bird Diseases/pathology;Brain/parasitology;Brain/pathology;Central Nervous System Helminthiasis/parasitology*;Central Nervous System Helminthiasis/pathology;Central Nervous System Helminthiasis/veterinary;Ducks/parasitology*;Mice;Mice, Inbred BALB C;Nasal Mucosa/parasitology;Paralysis/parasitology;Paralysis/veterinary;Schistosomatidae/isolation & purification;Schistosomatidae/pathogenicity*;Spinal Cord/parasitology;Spinal Cord/pathology;Trematode Infections/parasitology*;Trematode Infections/veterinary
10635179;Adult;Alveolar Ridge Augmentation/methods*;Anodontia/surgery*;Dental Implantation, Endosseous*;Gingivoplasty/methods*;Humans;Incisor;Male;Maxilla;Surgical Flaps
10636295;Animals;Avoidance Learning/drug effects;Avoidance Learning/physiology*;Confounding Factors (Epidemiology);Fear/drug effects;Fear/physiology*;GABA Agonists/administration & dosage*;Male;Mesencephalon/physiology;Microinjections;Muscimol/administration & dosage*;Rats;Rats, Sprague-Dawley;Reflex, Startle/drug effects;Reflex, Startle/physiology*;Reticular Formation/drug effects;Reticular Formation/physiology*;Superior Colliculi/drug effects;Superior Colliculi/physiology*
10639804;Computer-Assisted Instruction;Education, Medical;Humans;Internet*;Licensure/legislation & jurisprudence;Michigan;Quality of Health Care/organization & administration;Reimbursement Mechanisms;Telemedicine/methods;Telemedicine/standards*
10640762;Animals;Cytokines/biosynthesis;Genetic Predisposition to Disease*;Immune Tolerance/genetics;Immunity, Innate/genetics;Interleukin-13/biosynthesis;Interleukin-13/deficiency;Interleukin-13/genetics*;Interleukin-4/deficiency;Interleukin-4/genetics;Interleukin-4/physiology;Leishmania major/immunology*;Leishmaniasis, Cutaneous/genetics*;Leishmaniasis, Cutaneous/immunology*;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, Knockout;Mice, Transgenic;Th1 Cells/immunology;Th1 Cells/metabolism
10642681;Adolescent;Adult;Aged;Dermatitis, Atopic/pathology;Dermatitis, Atopic/radiotherapy*;Female;Humans;Male;Middle Aged;Radiotherapy Dosage;Recurrence;Treatment Outcome;Ultraviolet Rays;Ultraviolet Therapy/methods*
10642849;Animals;Apomorphine/pharmacology;Carotid Arteries/surgery;Dopamine/metabolism*;Dopamine Agonists/pharmacology;Ischemic Attack, Transient/metabolism*;Male;Motor Activity/drug effects;Motor Activity/physiology*;Nerve Degeneration/metabolism;RNA, Messenger/metabolism*;Rats;Receptors, Dopamine D1/metabolism*
10643205;Adolescent;Adolescent Behavior/psychology*;Humans;Louisiana/epidemiology;Primary Prevention/methods;Risk-Taking*;School Health Services;Social Behavior Disorders/epidemiology*;Social Behavior Disorders/mortality;Social Behavior Disorders/prevention & control;Social Behavior Disorders/psychology*
10643902;Adenosine Triphosphatases/drug effects*;Adenosine Triphosphatases/metabolism;Adult;Analysis of Variance;Animals;Antiprotozoal Agents/pharmacology*;Dose-Response Relationship, Drug;Female;Humans;Ivermectin/pharmacology*;Male;Nigeria;Onchocerca volvulus/drug effects*;Onchocerca volvulus/enzymology
10663723;Adenoma/pathology*;Adrenal Gland Neoplasms/pathology*;Biopsy;Diagnosis, Differential;Humans;Magnetic Resonance Imaging*;ROC Curve;Retrospective Studies;Sensitivity and Specificity
10664313;Adult;Cervical Vertebrae/surgery*;Humans;Internal Fixators;Male;Osteotomy/methods*;Spondylitis, Ankylosing/surgery*
10675481;Humans;JNK Mitogen-Activated Protein Kinases;Mitogen-Activated Protein Kinases/physiology*;Phosphorylation;Proto-Oncogene Proteins c-bcl-2/metabolism*;Tumor Cells, Cultured
10676020;Adolescent;Adult;Arthroplasty, Replacement, Knee/methods*;Bone Neoplasms/surgery*;Dermatofibrosarcoma/surgery;Female;Histiocytoma, Benign Fibrous/surgery;Humans;Middle Aged;Skin Neoplasms/surgery*;Surgical Flaps/blood supply*;Tibia/surgery*
10688130;Evolution, Molecular*;Phylogeny*;Plants/classification;Plants/genetics*
10700139;Biotechnology/economics*;Biotechnology/trends*;Financing, Government;International Cooperation;Portugal;Research Support as Topic*
10710088;Capsaicin*;Capsicum*;Garlic*;Helicobacter Infections/therapy*;Helicobacter pylori*;Humans;Plants, Medicinal*;Treatment Outcome
10712323;Aged;Aged, 80 and over;Aging/blood*;Carotenoids/blood*;Female;Forced Expiratory Volume/physiology;Humans;Lung Volume Measurements*;Male;Netherlands;Reference Values;Smoking/blood;Vital Capacity/physiology;Vitamin E/blood*
10719692;Adolescent;Adult;Age Distribution;Catchment Area (Health);Female;Headache/diagnosis;Headache/epidemiology*;Humans;Male;Poland/epidemiology;Prevalence;Schools;Severity of Illness Index;Sex Distribution;Students*;Surveys and Questionnaires
10719774;Asthma/drug therapy*;Humans;Leukotriene Antagonists*/therapeutic use*;Membrane Proteins*;Receptors, Leukotriene*;Rhinitis, Allergic, Perennial/drug therapy*;Rhinitis, Allergic, Seasonal/drug therapy*;Tosyl Compounds/therapeutic use
10722131;Animals;Bacterial Toxins/genetics*;Bacterial Typing Techniques*;Clostridium Infections/microbiology;Clostridium Infections/veterinary*;Clostridium perfringens/genetics*;Enterotoxins/genetics;Genotype;Horses;Polymerase Chain Reaction/methods*;Sheep;Swine
10727669;Calcium/physiology;Dietary Supplements;Disease;Female;Humans;Magnesium/blood;Magnesium/physiology*;Magnesium/therapeutic use;Magnesium Deficiency/physiopathology*;Male;Nutritional Physiological Phenomena;Pregnancy
10727972;Adolescent;Body Height*;Body Weight*;Child;Child Development*;Child, Preschool;Female;Growth*;Humans;Male;Menarche;Sex Factors;Social Class
10737362;Amino Acid Sequence;Animals;Base Sequence;Blotting, Northern;Calcium/metabolism;Cells, Cultured;Cricetinae;Gene Expression;Islets of Langerhans/chemistry;Islets of Langerhans/cytology;Islets of Langerhans/drug effects;Islets of Langerhans/metabolism*;Mice;Mice, Inbred ICR;Molecular Sequence Data;Pituitary Gland/chemistry;RNA/isolation & purification;RNA, Messenger/biosynthesis*;Receptors, Thyrotropin-Releasing Hormone/biosynthesis;Receptors, Thyrotropin-Releasing Hormone/chemistry;Receptors, Thyrotropin-Releasing Hormone/genetics*;Reverse Transcriptase Polymerase Chain Reaction;Thyrotropin-Releasing Hormone/pharmacology
10738437;Animals;Biomechanical Phenomena;Bone and Bones/pathology;Bone and Bones/physiology*;Cell Survival;Female;Hot Temperature;Hyperthermia, Induced*;In Vitro Techniques;Microwaves*;Rats
10742147;Animals;Cell Movement/drug effects;Cell Movement/physiology;Cell Survival/drug effects;Cells, Cultured;Disease Models, Animal;Endothelial Growth Factors/genetics*;Endothelial Growth Factors/pharmacology;Gene Transfer Techniques*;Genetic Therapy*;Hindlimb/innervation;Hindlimb/metabolism;Hindlimb/physiopathology;Ischemia/therapy*;Lymphokines/genetics*;Lymphokines/pharmacology;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism;Neuropilin-1;Peripheral Nervous System/blood supply*;Peripheral Nervous System Diseases/metabolism;Peripheral Nervous System Diseases/therapy*;Proto-Oncogene Proteins/genetics;Proto-Oncogene Proteins/metabolism;Rabbits;Rats;Rats, Sprague-Dawley;Receptor Protein-Tyrosine Kinases/genetics;Receptor Protein-Tyrosine Kinases/metabolism;Receptors, Growth Factor/genetics;Receptors, Growth Factor/metabolism;Receptors, Vascular Endothelial Growth Factor;Schwann Cells/drug effects;Schwann Cells/physiology;Vascular Endothelial Growth Factor A;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factors
10744421;Bilirubin/blood*;Biomarkers/blood;Female;Humans;Male;Peripheral Vascular Diseases/blood*
10744622;Animals;Antineoplastic Agents/pharmacology;Base Sequence;Breast Neoplasms/blood supply*;Breast Neoplasms/drug therapy;Breast Neoplasms/genetics*;Cell Hypoxia/genetics;DNA Primers/genetics;Doxorubicin/pharmacology;Drug Resistance;Endothelial Growth Factors/genetics*;Female;Gene Expression;Genes, bcl-2*;Genes, p53;Humans;Lymphokines/genetics*;Mice;Mice, Inbred C57BL;Mice, Nude;Neoplasm Transplantation;Neovascularization, Pathologic/genetics*;Transplantation, Heterologous;Tumor Cells, Cultured;Vascular Endothelial Growth Factor A;Vascular Endothelial Growth Factors
10745498;Aged;Angioplasty, Balloon, Coronary*;Electrocardiography;Female;Hospitalization;Humans;Male;Middle Aged;Myocardial Infarction/diagnosis;Myocardial Infarction/mortality;Myocardial Infarction/therapy*;Prospective Studies;Risk Factors;Sex Factors;Surveys and Questionnaires;Survival Analysis;Treatment Outcome*
10756443;Anti-Bacterial Agents/pharmacology*;Bronchi/cytology;Bronchi/drug effects*;Bronchi/metabolism;Calcium/metabolism*;Cells, Cultured;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Erythromycin/pharmacology*;Humans
10759340;Adolescent;Adult;Aged;Biomarkers/analysis;Blood Platelets/physiology;Calcium/analysis*;Depressive Disorder/physiopathology;Depressive Disorder/therapy*;Electroconvulsive Therapy*;Female;Humans;Intracellular Fluid/chemistry;Male;Middle Aged;Receptors, Serotonin/analysis*
10761697;Animals;Antibodies, Monoclonal;Antigens, Differentiation/analysis*;Antigens, Differentiation/genetics*;Antigens, Differentiation/immunology;COS Cells;Cell Nucleus/chemistry*;Cricetinae;DNA Primers;DNA, Complementary;Fluorescent Antibody Technique, Indirect;Galectin 3;Kidney/cytology;Membrane Glycoproteins/analysis;Membrane Glycoproteins/genetics;Muscle, Smooth/cytology;Mutagenesis/physiology;Rabbits;Transfection;Tubulin/analysis;Tubulin/immunology
10763142;Adult;Aged;Biomarkers, Tumor/blood*;Endothelin-1/blood*;Endothelin-1/secretion;Female;Gastrectomy;Humans;Lymphatic Metastasis;Male;Middle Aged;Neoplasm Staging;Stomach Neoplasms/blood*;Stomach Neoplasms/surgery*
10768587;Acute Disease;Aged;Clostridium difficile*;Diarrhea/complications*;Diarrhea/etiology;Enteral Nutrition/adverse effects*;Enterocolitis, Pseudomembranous/complications*;Fecal Incontinence/classification;Fecal Incontinence/epidemiology;Fecal Incontinence/etiology*;Female;Hospitalization*;Humans;Incidence;Logistic Models;Male;Minnesota/epidemiology;Risk Factors;Severity of Illness Index
10779842;Auditory Perception/physiology*;History, 20th Century;Memory/physiology*;Neuropsychological Tests/history*;Verbal Learning/physiology*
10783346;Adult;Biomarkers/blood;Blood Pressure/drug effects;Bone Density/drug effects;Estradiol/blood;Estriol/adverse effects;Estriol/therapeutic use*;Female;Gonadotropins/blood;Humans;Hysterectomy/adverse effects;Lipids/blood;Menopause/drug effects*;Menopause, Premature/drug effects;Middle Aged
10787036;AIDS Dementia Complex/pathology*;Adult;Cell Count;Cell Size;Female;HIV-1*;Humans;Male;Middle Aged;Neurons/pathology*;Substantia Nigra/pathology*
10801179;Adult;Alcoholic Beverages*;Beer*;Cross-Over Studies;Diet;Homocysteine/blood*;Humans;Male;Middle Aged;Pyridoxine/blood*;Wine*
10806938;Anodontia/complications;Cephalometry;Child;Cuspid/abnormalities*;Cuspid/transplantation*;Humans;Male;Malocclusion, Angle Class III/complications;Malocclusion, Angle Class III/therapy*;Maxilla;Tooth Ankylosis/complications;Tooth Ankylosis/therapy;Tooth Eruption, Ectopic/complications;Tooth Eruption, Ectopic/therapy*
10817404;4-Aminopyridine/analogs & derivatives;4-Aminopyridine/chemistry;Amino Acids/chemical synthesis*;Amino Acids/chemistry*;Oxazolone/chemistry;Phenylalanine/analogs & derivatives*;Protein Conformation;Serine/analogs & derivatives*
10819696;Animals;Birds;Herpesvirus 2, Gallid*/genetics;Herpesvirus 2, Gallid*/pathogenicity;Marek Disease*
10821831;Amino Acid Sequence;Animals;Carrier Proteins/chemistry*;Carrier Proteins/genetics;Carrier Proteins/physiology*;Cation Transport Proteins*;Cell Membrane/physiology;Cell Membrane Permeability/physiology*;Cloning, Molecular;Escherichia coli/physiology;Female;In Vitro Techniques;Kinetics;Membrane Proteins/chemistry*;Membrane Proteins/genetics;Membrane Proteins/physiology*;Models, Molecular;Molecular Sequence Data;Mutagenesis, Site-Directed;Oocytes/physiology;Plant Proteins/chemistry;Plant Proteins/physiology*;Potassium/metabolism*;Protein Structure, Secondary;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Saccharomyces cerevisiae/cytology;Saccharomyces cerevisiae/physiology*;Sequence Deletion;Sodium/metabolism;Symporters*;Xenopus laevis
10831755;Animals;Biocompatible Materials;Bone Density/physiology*;Computer Simulation;Dogs;Femur/physiology;Finite Element Analysis*;Hip/physiology;Models, Biological;Prostheses and Implants/standards;Prosthesis Design/standards*;Prosthesis Implantation;Stress, Mechanical;Titanium;Weight-Bearing
10833697;Adaptation, Psychological;Adult;Bone Marrow Transplantation*;Decision Making;Family/psychology;Female;Humans;Male;Middle Aged;New England;Tissue Donors/psychology*
10847065;Catheters, Indwelling*;Cystostomy/instrumentation;Cystostomy/methods*;Cystostomy/nursing*;Humans;Urinary Catheterization/instrumentation;Urinary Catheterization/methods*;Urinary Catheterization/nursing*
10851364;Aged;Aged, 80 and over;Alzheimer Disease/prevention & control*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Aspirin/therapeutic use*;Case-Control Studies;Data Collection;Histamine H2 Antagonists/therapeutic use*;Humans;Logistic Models
10852413;Education, Medical/history;History, 20th Century;Humans;Physician's Role;Physicians/history;Physicians/trends*;United States
10853775;Adolescent;Adult;Aged;Aged, 80 and over;Bone Transplantation/instrumentation;Bone Transplantation/methods*;Child;Child, Preschool;Female;Humans;Infant;Male;Middle Aged;Spinal Fusion/instrumentation;Spinal Fusion/methods*;Transplantation, Autologous;Transplantation, Homologous
10855962;Adolescent;Adult;Cultural Characteristics;Depressive Disorder;Forensic Psychiatry*;Homicide/ethnology*;Homicide/psychology;Humans;Laos/ethnology;Male;Middle Aged;Paranoid Disorders;Self Concept;Social Behavior
10857816;Glaucoma, Open-Angle/complications*;Glaucoma, Open-Angle/epidemiology;Humans;Myopia/complications*;Myopia/epidemiology;New South Wales/epidemiology;Ocular Hypertension/complications;Ocular Hypertension/epidemiology
10859626;Abdomen*;Compartment Syndromes/diagnosis;Compartment Syndromes/etiology;Compartment Syndromes/nursing*;Compartment Syndromes/physiopathology;Critical Care/methods*;Critical Illness;Cutaneous Fistula/etiology;Humans;Lower Body Negative Pressure/adverse effects;Lower Body Negative Pressure/instrumentation;Lower Body Negative Pressure/methods*;Lower Body Negative Pressure/mortality;Lower Body Negative Pressure/nursing*;Lower Body Negative Pressure/trends;Manometry/instrumentation;Manometry/methods;Manometry/nursing;Monitoring, Physiologic/instrumentation;Monitoring, Physiologic/methods;Monitoring, Physiologic/nursing;Nursing Assessment/methods;Retrospective Studies;Surgical Mesh/adverse effects;Surgical Wound Dehiscence/etiology;Suture Techniques;Treatment Outcome;Urinary Bladder/physiopathology
10872274;Animals;Apoptosis/physiology*;Caspases/physiology;Cytochrome c Group/physiology;Humans;Proto-Oncogene Proteins c-bcl-2/physiology;Tumor Necrosis Factor-alpha/physiology
10874993;Analysis of Variance;Female;Humans;Infant, Newborn;Male;Monitoring, Physiologic;Odds Ratio;Pulmonary Gas Exchange;Reference Values;Reproducibility of Results;Respiration*;Respiratory Distress Syndrome, Newborn/diagnosis*;Respiratory Distress Syndrome, Newborn/physiopathology;Respiratory Mechanics/physiology*;Tidal Volume
10875496;Anti-Asthmatic Agents/therapeutic use*;Asthma/drug therapy*;Child;Cromolyn Sodium/therapeutic use*;Humans;Tosyl Compounds/therapeutic use*
10883166;Animals;Aquaporins/genetics;Aquaporins/physiology*;Disease;Humans;Kidney/physiology*;Kidney/physiopathology
10891225;Aldehydes;Hydrolysis;Indicators and Reagents;Molecular Conformation;Oxidation-Reduction;Peptides/chemistry*;Pyrrolidinones/chemical synthesis*
10907381;Adaptation, Physiological;Adolescent;Adult;Aged;Anastomosis, Roux-en-Y*/adverse effects;Body Mass Index;Body Weight;Evaluation Studies as Topic;Feeding Behavior;Female;Follow-Up Studies;Gastric Bypass/adverse effects;Gastric Bypass/methods*;Humans;Male;Middle Aged;Obesity, Morbid/surgery*;Patient Satisfaction;Postoperative Complications;Postoperative Nausea and Vomiting/etiology;Prospective Studies;Safety;Survival Rate;Treatment Outcome;Weight Loss
10909239;Adolescent;Adult;Attention*;Color Perception*;Discrimination Learning*;Female;Humans;Inhibition (Psychology);Male;Pattern Recognition, Visual*;Psychophysics;Reaction Time
10912183;Animals;Cartilage, Articular/metabolism*;Cell Adhesion;Cell Culture Techniques;Chondrocytes/metabolism*;Cytokines/metabolism;Extracellular Matrix Proteins/metabolism;Growth Substances/metabolism;Humans;Integrins/biosynthesis*;Integrins/metabolism;Osteoarthritis/metabolism;Signal Transduction/physiology*;Stress, Mechanical
10913953;Adult;Age Factors;Aneuploidy;Blastocyst/cytology*;Chromosome Aberrations/genetics*;DNA Probes;Embryonic Development*;Female;Fertilization in Vitro;Humans;In Situ Hybridization, Fluorescence*;Karyotyping;Maternal Age;Mosaicism/genetics;Organ Culture Techniques;Ploidies;Polyploidy;Pregnancy;Pregnancy, High-Risk;Preimplantation Diagnosis*
10924954;Action Potentials/drug effects;Action Potentials/physiology*;Anesthetics, Intravenous/pharmacology;Animals;Brain Mapping*;Brain Stem/drug effects;Brain Stem/physiology*;Electric Stimulation;Male;Motor Activity/drug effects;Motor Activity/physiology*;Neurons/drug effects;Neurons/physiology*;Rats;Rats, Sprague-Dawley;Urethane/pharmacology
10932517;Female;Follow-Up Studies;Gastroschisis/diagnosis*;Gastroschisis/surgery*;Hospitals, Urban;Humans;Infant, Newborn;Surgical Procedures, Operative/methods;Thailand;Treatment Outcome
10937114;Adult;Aged;Carbon Dioxide;Elastic Tissue/physiology*;Elasticity;Female;Humans;Laser Therapy/methods*;Middle Aged;Prospective Studies;Rhytidoplasty/methods*;Skin Physiological Phenomena*;Treatment Outcome
10937660;Age Factors;Child Development/physiology*;Child, Preschool;Electrocardiography*;Female;Heart Rate/physiology*;Humans;Infant;Male;Prospective Studies;Reference Values;Respiratory Physiological Phenomena
10942449;Adult;Blood Pressure;Body Mass Index;Cardiovascular Diseases/epidemiology;Cardiovascular Diseases/etiology*;China/epidemiology;Educational Status;Exercise;Female;Humans;Male;Middle Aged;Risk Factors;Smoking/epidemiology;Smoking/trends;Socioeconomic Factors;Urban Health
10951444;Animals;Autoantibodies/blood;Autoantibodies/immunology;Autoantigens/immunology;Autoimmunity/drug effects*;Creatine Kinase/blood;Cysteine Endopeptidases/pharmacology*;Electromyography;Female;Immunization;Mice;Mice, Inbred BALB C;Monocytes/pathology;Muscle, Skeletal/drug effects;Muscle, Skeletal/immunology*;Muscle, Skeletal/pathology*;Muscle, Skeletal/physiopathology;Myosins/immunology;Myosins/metabolism;Spleen/immunology;Spleen/pathology
10951815;Adult;Constriction, Pathologic;Female;Humans;Male;Middle Aged;Peripheral Vascular Diseases*/diagnosis;Peripheral Vascular Diseases*/surgery;Popliteal Artery*
10952594;Agar/chemistry;Animals;Ascorbic Acid/pharmacology;Ascorbic Acid/therapeutic use*;Carotenoids/pharmacology;Disease Models, Animal;Helicobacter Infections/diet therapy;Helicobacter Infections/drug therapy*;Helicobacter Infections/pathology;Helicobacter pylori*/drug effects;Lipid Peroxidation/drug effects;Mice;Mice, Inbred BALB C;Xanthophylls;beta Carotene/analogs & derivatives*;beta Carotene/pharmacology;beta Carotene/therapeutic use*
10954102;Adolescent;Adult;Aged;Aged, 80 and over;Ameloblastoma/epidemiology;Ameloblastoma/secondary;Ameloblastoma/surgery*;Bone Neoplasms/epidemiology;Bone Neoplasms/pathology;Bone Neoplasms/surgery*;Child;Female;Follow-Up Studies;Humans;Male;Middle Aged;Neoplasm Recurrence, Local/epidemiology;Postoperative Complications/epidemiology;Retrospective Studies
10954755;Anticarcinogenic Agents/pharmacology*;Cell Nucleus/metabolism;Chromatin/metabolism;Cyclin-Dependent Kinase Inhibitor p21;Cyclins/genetics*;Cyclins/metabolism;DNA Primers;Enzyme Inhibitors/metabolism;Gene Expression Regulation, Enzymologic;Gene Expression Regulation, Neoplastic*;Histone Deacetylase Inhibitors;Histone Deacetylases/genetics*;Histone Deacetylases/metabolism*;Histones/metabolism;Humans;Hydroxamic Acids/pharmacology*;Polymerase Chain Reaction;Transcription, Genetic*;Tumor Cells, Cultured;Urinary Bladder Neoplasms
10959297;Antibodies, Viral/blood;Child;Female;Humans;Immunoglobulin M/blood;Neutropenia/etiology*;Parvoviridae Infections/blood;Parvoviridae Infections/diagnosis*;Parvoviridae Infections/physiopathology;Parvovirus B19, Human*
10962000;Animals;CDC2-CDC28 Kinases*;Cell Cycle*;Cell Cycle Proteins*;Cell Division;Cells, Cultured;Cellular Senescence;Cyclin G;Cyclin G1;Cyclin-Dependent Kinase 2;Cyclin-Dependent Kinase Inhibitor p27;Cyclin-Dependent Kinases/antagonists & inhibitors;Cyclin-Dependent Kinases/metabolism;Cyclins/metabolism;Enzyme Activation;G1 Phase;Hypertrophy/pathology;Insulin-Like Growth Factor I/genetics;Insulin-Like Growth Factor I/metabolism*;Mice;Mice, Transgenic;Microtubule-Associated Proteins/genetics;Microtubule-Associated Proteins/metabolism;Mitogen-Activated Protein Kinases/metabolism;Muscle, Skeletal/cytology*;Muscle, Skeletal/enzymology;Muscle, Skeletal/metabolism;Phosphatidylinositol 3-Kinases/antagonists & inhibitors;Phosphatidylinositol 3-Kinases/metabolism*;Protamine Kinase/metabolism;Protein-Serine-Threonine Kinases/antagonists & inhibitors;Protein-Serine-Threonine Kinases/metabolism;S Phase;Signal Transduction*;Stem Cells/cytology*;Stem Cells/enzymology;Stem Cells/metabolism;Tumor Suppressor Proteins*;Up-Regulation
10967900;Circadian Rhythm;Exercise;Hemodynamics;Humans;Hypertension, Pulmonary/diagnosis;Hypertension, Pulmonary/etiology;Lung Diseases, Obstructive/complications;Lung Diseases, Obstructive/diagnosis;Lung Diseases, Obstructive/metabolism*;Male;Middle Aged;Oximetry;Oxygen/blood*;Sleep;Sleep Apnea, Obstructive/complications;Sleep Apnea, Obstructive/diagnosis;Sleep Apnea, Obstructive/metabolism*;Syndrome
10971406;Amino Acid Substitution;Antigens, CD34;Cell Division;Cells, Cultured;Child, Preschool;Disease Progression;Female;Hematopoietic Stem Cells/cytology;Hematopoietic Stem Cells/immunology;Humans;Infant;Infant, Newborn;Male;Megakaryocytes/cytology;Point Mutation/genetics*;Thrombocytopenia/genetics*;Thrombopoietin/blood;Thrombopoietin/genetics*
10974928;Adult;Aged;Aged, 80 and over;Cell Cycle Proteins/genetics*;Cell Cycle Proteins/metabolism;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/metabolism;Colorectal Neoplasms/pathology;Cyclin D1/genetics*;Cyclin D1/metabolism;Cyclin-Dependent Kinase Inhibitor p21;Cyclin-Dependent Kinases/genetics;Cyclin-Dependent Kinases/metabolism;Cyclins/genetics*;Female;Gene Expression/genetics;Humans;Immunohistochemistry;Male;Middle Aged;Point Mutation/genetics;Tumor Suppressor Protein p53/genetics*
10986533;Aged;Community-Acquired Infections/complications;Empyema, Pleural/complications*;Empyema, Pleural/diagnostic imaging;Empyema, Pleural/therapy*;Humans;Male;Pneumonia, Pneumococcal/complications*;Pneumonia, Pneumococcal/diagnostic imaging;Tomography, X-Ray Computed
10987645;Adolescent;Adult;Age of Onset;Alleles;Child;Child, Preschool;DNA/chemistry;DNA/genetics;Diabetes Mellitus, Type 1/genetics*;Female;Gene Frequency;HLA-DR Antigens/genetics;HLA-DRB1 Chains;Humans;Linkage Disequilibrium;Male;Microsatellite Repeats/genetics*;Middle Aged;Proteins/genetics*;Sequence Analysis, DNA;Tumor Necrosis Factor-alpha/genetics
10992991;Anastomosis, Surgical/veterinary;Animals;Dog Diseases/diagnosis;Dog Diseases/pathology*;Dog Diseases/surgery;Dogs;Female;Intestinal Diseases/diagnosis;Intestinal Diseases/surgery;Intestinal Diseases/veterinary*;Mesentery/pathology;Torsion Abnormality/diagnosis;Torsion Abnormality/surgery;Torsion Abnormality/veterinary
10997374;Administration, Cutaneous;Body Height/drug effects*;Child;Child, Preschool;Cohort Studies;Female;Growth Disorders/drug therapy*;Growth Disorders/etiology;Human Growth Hormone/therapeutic use*;Humans;Insulin-Like Growth Factor I/analysis;Liver Failure/complications*;Liver Failure/physiopathology;Liver Failure/surgery;Liver Transplantation*;Male;Recombinant Proteins/therapeutic use;Safety;Time Factors;Treatment Outcome
10998386;Adult;Antimalarials/therapeutic use;Disease Outbreaks*;Dominican Republic/epidemiology;Europe;Female;Humans;Malaria, Falciparum/drug therapy;Malaria, Falciparum/epidemiology*;Male;Middle Aged;Sentinel Surveillance;Travel*
11010046;Adenoviridae/isolation & purification;Diet;Humans;Life Style;Obesity/epidemiology;Obesity/genetics;Obesity/virology*;United States/epidemiology
11037582;Ammonia/blood;Animals;Bromodeoxyuridine/analysis;Carbon/adverse effects*;DNA Damage;DNA Replication/radiation effects;Dose-Response Relationship, Radiation;Heavy Ions/adverse effects*;Hepatectomy*;Hepatocytes/radiation effects;Lethal Dose 50;Liver/pathology;Liver/radiation effects*;Liver Failure/blood;Liver Failure/etiology*;Liver Failure/pathology;Liver Regeneration/radiation effects*;Male;Mice;Mice, Inbred BALB C;Organ Size/radiation effects;Radiation Injuries, Experimental/blood;Radiation Injuries, Experimental/etiology*;Radiation Injuries, Experimental/pathology;Relative Biological Effectiveness;Serum Albumin/deficiency;Vincristine/pharmacology;X-Rays
11043128;Adult;Aged;Aged, 80 and over;Bone Nails*;Female;Follow-Up Studies;Fracture Fixation, Intramedullary/instrumentation*;Fracture Healing/physiology;Hip Fractures/diagnostic imaging;Hip Fractures/mortality;Hip Fractures/surgery*;Humans;Male;Middle Aged;Multiple Trauma/diagnostic imaging;Multiple Trauma/mortality;Multiple Trauma/surgery;Postoperative Complications/diagnostic imaging;Postoperative Complications/mortality;Postoperative Complications/surgery;Radiography;Reoperation;Survival Rate;Treatment Outcome;Weight-Bearing/physiology
11050289;Animals;Azepines/pharmacology;CHO Cells;Cricetinae;Dopamine Agonists/pharmacology*;Humans;Piperazines/pharmacology*;Quinpirole/pharmacology;Receptors, Dopamine D2/drug effects*;Receptors, Dopamine D2/physiology;Receptors, Dopamine D3
11059384;Aging/physiology;Animals;Estradiol/blood;Estradiol/physiology*;Female;Gonadotropins, Pituitary/analysis;Progesterone/blood;Progesterone/physiology*;Rats;Rats, Wistar;Sexual Maturation/physiology*;Testosterone/blood;Testosterone/physiology*
11061117;Database Management Systems/organization & administration*;Diagnosis-Related Groups;Humans;Information Services/organization & administration*;Total Quality Management/organization & administration*
11062210;Amoxicillin/therapeutic use;Amoxicillin/urine*;Bacteriological Techniques/methods;Drug Monitoring;Female;Humans;Male;Patient Compliance;Penicillins/therapeutic use;Penicillins/urine*;Pilot Projects;Reagent Kits, Diagnostic*;Residence Characteristics;Respiratory Tract Infections/drug therapy
11062811;Australia;Cephalosporins/therapeutic use;Global Health;Humans;Meningitis, Bacterial/drug therapy;Microbial Sensitivity Tests;Penicillin Resistance*;Pneumococcal Infections/drug therapy*;Prevalence;Streptococcus pneumoniae/drug effects*;Streptococcus pneumoniae/isolation & purification
11080550;Animals;Avoidance Learning/drug effects;Avoidance Learning/physiology*;Brain/drug effects;Brain/physiology;Choice Behavior/drug effects;Choice Behavior/physiology*;Conditioning, Classical/drug effects;Conditioning, Classical/physiology*;Dose-Response Relationship, Drug;Male;Mice;Mice, Inbred Strains;Motivation*;NG-Nitroarginine Methyl Ester/pharmacology;Nitric Oxide/physiology*;Nitric Oxide Synthase/antagonists & inhibitors;Phencyclidine/toxicity*
11093863;Antifibrinolytic Agents*/analysis;Enzyme-Linked Immunosorbent Assay;Fibrin Fibrinogen Degradation Products*/analysis;Humans;Venous Thrombosis/diagnosis*
11095417;Animals;Child;Child Development*;Child, Preschool;Developmental Disabilities/etiology*;Female;Humans;Hypothyroidism/physiopathology*;Intellectual Disability/etiology;Pregnancy;Pregnancy Complications/physiopathology*;Prenatal Exposure Delayed Effects*;Thyrotropin/blood;Thyroxine/blood*;Thyroxine/deficiency
11100489;Arteriovenous Malformations/complications*;Arteriovenous Malformations/diagnosis*;Cerebral Arteries/abnormalities*;Cerebral Veins/abnormalities*;Encephalocele/complications*;Encephalocele/diagnosis*;Female;Humans;Infant;Infant, Newborn;Magnetic Resonance Imaging;Male;Meningocele/complications*;Meningocele/diagnosis*;Retrospective Studies;Ultrasonography, Prenatal
11101010;Acute Disease;Animals;Cell Division;Cell Hypoxia;Disease Models, Animal;Disease Progression;Leukemia, Myeloid/metabolism;Leukemia, Myeloid/physiopathology*;Oxygen/metabolism*;Rats;Rats, Inbred BN;Tumor Cells, Cultured
11103755;Cardiotonic Agents/administration & dosage;Cardiotonic Agents/therapeutic use*;Catheterization, Swan-Ganz;Coronary Vessels/drug effects;Cross-Over Studies;Double-Blind Method;Female;Heart Failure/diagnostic imaging;Heart Failure/drug therapy*;Hemodynamics/drug effects*;Humans;Hydrazones/administration & dosage;Hydrazones/therapeutic use*;Infusions, Intravenous;Male;Middle Aged;Oxygen Consumption/drug effects;Pyridazines/administration & dosage;Pyridazines/therapeutic use*;Tomography, Emission-Computed;Ultrasonography
11111002;Animals;Animals, Suckling;Apoptosis;Body Weight;Cell Count;Cell Survival;Enteral Nutrition*;Food Deprivation/physiology;Gastrostomy;Intubation, Gastrointestinal;Lactation*;Maternal Deprivation*;Necrosis;Organ Size;Rats;Rats, Long-Evans;Stress, Physiological*/immunology;Thymus Gland/cytology*;Thymus Gland/growth & development;Thymus Gland/immunology
11111733;Faculty, Nursing*;Helping Behavior;Humans;Interpersonal Relations*;Social Support;Students, Nursing/psychology*
11116864;Biotechnology/legislation & jurisprudence*;Genes*;Genetic Techniques;Genetics, Medical/legislation & jurisprudence*;Patents as Topic/legislation & jurisprudence*;Sweden
11123692;Antigens, Bacterial/genetics;Antigens, Bacterial/metabolism*;Bacterial Proteins/secretion;Cells, Cultured;Epithelial Cells/microbiology;Genes, Bacterial;Hemolysis/genetics;Mutation;Phospholipids/metabolism;Plasmids/genetics*;Protein Binding;Sequence Deletion;Shigella flexneri/genetics;Shigella flexneri/pathogenicity*
11127079;Child;DNA, Mitochondrial/genetics*;Female;Humans;MELAS Syndrome/diagnostic imaging;MELAS Syndrome/genetics*;Magnetic Resonance Imaging;Male;Mutation/genetics*;Pedigree;RNA, Transfer, Leu/genetics*;Tomography, X-Ray Computed
11137110;Animals;Female;Humans;Immunoglobulin G/biosynthesis*;Interleukin-6/immunology*;Mice;Mice, Inbred BALB C;Placenta/immunology*;Pregnancy;Tumor Cells, Cultured;gamma-Globulins/immunology
11138893;Attitude of Health Personnel*;Child;Emergency Medicine*;Emergency Service, Hospital*;History, 21st Century;Humans;Neuromuscular Depolarizing Agents*/adverse effects;Neuromuscular Depolarizing Agents*/pharmacology
11142378;5' Untranslated Regions/physiology*;Cell-Free System*;Encephalomyocarditis virus/genetics;Gene Expression Regulation, Viral*;HeLa Cells;Hepatovirus/genetics;Humans;Peptide Chain Initiation, Translational*;Picornaviridae/genetics*;Poliovirus/genetics;Poly A/chemistry;Poly A/metabolism*;RNA Caps;RNA, Messenger/chemistry;RNA, Messenger/genetics*;RNA, Viral/chemistry;RNA, Viral/genetics*;Ribosomes/physiology
11145172;Animals;Blood Glucose/drug effects;Carbonates/pharmacology*;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/urine;Glucosides/pharmacology*;Glycosuria/urine;Hyperglycemia/blood;Hyperglycemia/drug therapy;Hyperglycemia/urine;Hypoglycemic Agents/pharmacology*;Kidney/drug effects*;Kidney/metabolism;Kidney/ultrastructure;Male;Microvilli/drug effects;Microvilli/metabolism;Monosaccharide Transport Proteins/antagonists & inhibitors*;Rats;Rats, Sprague-Dawley;Rats, Wistar
11155687;Animals;Cell Differentiation;Cell Division;Chondrocytes/cytology*;Gene Deletion;Mice;Mice, Knockout;Osteoblasts/cytology*;Osteochondrodysplasias/etiology;Parathyroid Hormone-Related Protein;Protein-Tyrosine Kinases*;Proteins/genetics;Proteins/physiology*;Receptor, Fibroblast Growth Factor, Type 3;Receptors, Fibroblast Growth Factor/genetics;Receptors, Fibroblast Growth Factor/physiology*
11157560;Aged;Apomorphine/administration & dosage*;Apomorphine/adverse effects;Apomorphine/blood;Apomorphine/pharmacokinetics;Catheters, Indwelling/adverse effects;Drug Administration Schedule;Female;Follow-Up Studies;Humans;Infection/etiology;Infusion Pumps;Infusions, Intravenous/adverse effects;Male;Middle Aged;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Thrombosis/chemically induced;Thrombosis/surgery;Treatment Outcome
11160763;Animal Feed*;Animals;Appetitive Behavior/physiology*;Columbidae/physiology*;Cues*;Discrimination (Psychology)/physiology;Functional Laterality/physiology;Maze Learning/physiology;Memory/physiology*;Space Perception/physiology*;Vision, Binocular/physiology;Vision, Monocular/physiology
11175732;Amino Acid Sequence;Homozygote;Molecular Sequence Data;Oryza/genetics*;Peptide Fragments/chemistry;Plant Proteins/analysis;Plant Proteins/chemistry;Plant Proteins/genetics*;Plants, Genetically Modified/genetics*;Polymerase Chain Reaction;Recombinant Proteins/biosynthesis;Recombinant Proteins/chemistry;Seeds;Starch/analysis;Triticum/genetics*
11187238;Case Management/standards*;Evidence-Based Medicine;Guidelines as Topic*;Inservice Training/organization & administration;United States
11196077;Adult;Cross-Sectional Studies;Female;Humans;Male;Middle Aged;Musculoskeletal Diseases/epidemiology;Musculoskeletal Diseases/physiopathology*;Netherlands/epidemiology;Occupational Diseases/epidemiology;Occupational Diseases/physiopathology*;Population Surveillance;Prevalence;Sex Factors*;Surveys and Questionnaires
11196081;Air Pollutants/analysis*;France/epidemiology;Humans;Industry*;Occupational Exposure/analysis*;Paint
11196716;3' Untranslated Regions;Alleles;Antigens, CD/genetics*;Case-Control Studies;Gene Frequency;Humans;Lupus Erythematosus, Systemic/genetics*;Lupus Erythematosus, Systemic/immunology*;Phenotype;Polymorphism, Genetic*;Receptors, Tumor Necrosis Factor/genetics*;Receptors, Tumor Necrosis Factor, Type II
11202729;Environmental Pollutants/pharmacokinetics*;Incineration*;Metals, Heavy/pharmacokinetics*;Refuse Disposal;Temperature
11203866;Acid Etching, Dental;Aluminum Oxide/chemistry;Analysis of Variance;Bicuspid;Bisphenol A-Glycidyl Methacrylate/chemistry;Coloring Agents;Composite Resins/chemistry;Dental Cavity Preparation/classification;Dental Cavity Preparation/instrumentation;Dental Cavity Preparation/methods*;Dental High-Speed Equipment;Dental Leakage/classification*;Dental Restoration, Permanent/classification;Dental Restoration, Permanent/methods;Dentin-Bonding Agents/chemistry;Electric Conductivity;Electrochemistry;Enamel Microabrasion;Humans;Polymethacrylic Acids/chemistry;Silver Nitrate;Statistics, Nonparametric;Thermodynamics;Tungsten Compounds
11229083;Diagnosis, Differential;Female;Humans;Pain/diagnosis*;Psychophysiologic Disorders/diagnosis*;Syndrome;Vulvar Diseases/diagnosis*;Vulvitis/diagnosis*;Vulvitis/pathology
11229182;Adolescent;Adult;Aged;Antitubercular Agents/adverse effects*;Ethambutol/adverse effects*;Evoked Potentials, Visual*;Female;Humans;Male;Middle Aged;Optic Neuritis/chemically induced;Optic Neuritis/diagnosis*;Reaction Time;Visual Acuity/drug effects
11234888;Activating Transcription Factor 2;Antineoplastic Agents/pharmacology*;Apoptosis/drug effects;Apoptosis/radiation effects;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Breast Neoplasms/therapy*;Cell Cycle/drug effects;Cell Cycle/radiation effects;Cyclic AMP Response Element-Binding Protein/pharmacology*;Drug Resistance, Neoplasm;Enzyme Inhibitors/pharmacology;Gene Expression;Humans;Janus Kinase 1;Melanoma/metabolism;Melanoma/pathology;Melanoma/therapy*;Mitogen-Activated Protein Kinases/antagonists & inhibitors;NF-kappa B/antagonists & inhibitors;Peptide Fragments/pharmacology;Protein-Tyrosine Kinases/antagonists & inhibitors;Radiation Tolerance/drug effects*;Transcription Factors/pharmacology*;Tumor Cells, Cultured/drug effects;Tumor Cells, Cultured/radiation effects;Ultraviolet Rays;fas Receptor/metabolism;p38 Mitogen-Activated Protein Kinases
11244294;Adenoviridae/genetics;Animals;Arginine Vasopressin/genetics;Diabetes Insipidus/genetics;Diabetes Insipidus/therapy;Disease Models, Animal*;Gene Transfer, Horizontal;Genes, Retinoblastoma/genetics;Genetic Therapy*;Genetic Vectors*;Herpesvirus 1, Human/genetics;Humans;Hypothalamic Diseases/genetics;Hypothalamic Diseases/therapy;Neurosecretory Systems*;Pituitary Neoplasms/genetics;Pituitary Neoplasms/therapy;Thymidine Kinase/genetics
11251201;Animals;Blindness, Cortical/metabolism;Blindness, Cortical/pathology;Cell Count;Cercopithecus aethiops;Cerebral Decortication*;Electron Transport Complex IV/analysis;Functional Laterality/physiology;Nerve Degeneration/pathology;Neurons/enzymology;Superior Colliculi/cytology*;Superior Colliculi/metabolism*;Visual Cortex/cytology;Visual Cortex/physiology*;Visual Pathways/cytology;Visual Pathways/enzymology;Visual Perception
11257878;Benzo(a)pyrene;Chrysenes;Fluorenes;Hydrogen-Ion Concentration;Kinetics;Models, Chemical;Oxygen;Photochemistry/instrumentation;Photochemistry/methods;Photolysis;Polycyclic Aromatic Hydrocarbons/chemistry*;Polycyclic Aromatic Hydrocarbons/isolation & purification;Thermodynamics;Water Pollutants, Chemical/isolation & purification*;Water Purification/methods;tert-Butyl Alcohol
11261571;Conservation of Natural Resources*;Crime*;Plants
11271868;Adolescent;Adult;Aged;Chronic Disease;Cognitive Therapy/methods*;Counseling/methods*;England;Family Practice;Fatigue/therapy*;Fatigue Syndrome, Chronic/therapy;Female;Follow-Up Studies;Humans;Male;Middle Aged;Patient Satisfaction;Treatment Outcome
11272132;Animals;Deoxyglucose/pharmacokinetics;Enzyme Inhibitors/pharmacology;Glucose/metabolism*;In Vitro Techniques;Insulin/physiology*;Male;Motor Activity/physiology;Muscle Contraction/physiology*;Muscle, Skeletal/drug effects;Muscle, Skeletal/physiology*;NG-Nitroarginine Methyl Ester/pharmacology;Nitric Oxide/physiology*;Nitroprusside/pharmacology;Rats;Rats, Sprague-Dawley;omega-N-Methylarginine/pharmacology
11275515;Adolescent;Adult;Community-Institutional Relations*;Depression;Female;Health Behavior;Humans;Middle Aged;North Carolina/epidemiology;Patient Acceptance of Health Care/statistics & numerical data*;Spouse Abuse/prevention & control*;Spouse Abuse/statistics & numerical data*;Surveys and Questionnaires;Women's Health
11278784;Bacterial Proteins*;Base Sequence;DNA Primers;DNA-Directed RNA Polymerases/metabolism*;Gene Expression Regulation, Bacterial/physiology*;Operon*;Promoter Regions, Genetic*;Repressor Proteins/metabolism;Repressor Proteins/physiology*;Streptococcus pneumoniae/genetics*;Transcription, Genetic/physiology*
11281577;Cross-Linking Reagents/pharmacology*;Equipment Failure Analysis;Gamma Rays*;Gels;Hip Prosthesis/adverse effects;Hip Prosthesis/standards*;Humans;Materials Testing;Oxidation-Reduction*;Polyethylenes/adverse effects;Polyethylenes/chemistry*;Polyethylenes/standards*;Prosthesis Failure;Silanes/pharmacology*;Surface Properties
11282548;Adult;Aging/blood;Alleles;Base Sequence;DNA Primers;Gene Expression Regulation/drug effects;Gene Frequency;Humans;Infant, Newborn;Interleukin-6/biosynthesis*;Interleukin-6/blood;Interleukin-6/genetics*;Lipopolysaccharides/pharmacology;Polymorphism, Genetic*;Promoter Regions, Genetic*
11285459;Adult;Biomarkers/blood;Clinical Protocols;Dexamethasone/pharmacology*;Energy Intake;Female;Glucocorticoids/pharmacology*;Humans;Leptin/blood*;Leptin/secretion;Male;Obesity/metabolism*;Weight Loss/physiology*
11290641;Age Factors;Ambulatory Care;Herpes Zoster/epidemiology*;Herpes Zoster/therapy;Humans;Iceland/epidemiology;Neuralgia/epidemiology*;Neuralgia/therapy;Neuralgia/virology;Pain Clinics
11308025;Animals;Glycolipids/analysis;Glycolipids/chemistry*;Glycolipids/isolation & purification;Phosphatidic Acids/chemistry;Phosphatidylglycerols/chemistry*;Spectrometry, Mass, Secondary Ion/methods;Trichomonas vaginalis/chemistry*;Tritrichomonas foetus/chemistry*
11336454;Anxiety/psychology*;Bias;Breast Neoplasms/blood;Breast Neoplasms/genetics*;Breast Neoplasms/prevention & control;Demography;Disclosure;Genes, BRCA1/genetics*;Genetic Predisposition to Disease/prevention & control;Genetic Predisposition to Disease/psychology;Genetic Testing/psychology*;Humans;Jews;Test Anxiety Scale/statistics & numerical data;Women/psychology*
11336703;3T3 Cells;Amino Acid Sequence;Animals;Axin Protein;COS Cells;Calcium-Calmodulin-Dependent Protein Kinases/genetics;Calcium-Calmodulin-Dependent Protein Kinases/metabolism;Gene Expression/physiology;Glycogen Synthase Kinase 3;LDL-Receptor Related Proteins;Low Density Lipoprotein Receptor-Related Protein-5;Mammals;Mice;Molecular Sequence Data;Mutagenesis/physiology;Protein Binding/physiology;Protein Structure, Tertiary;Proteins/genetics;Proteins/metabolism*;Proto-Oncogene Proteins/genetics;Proto-Oncogene Proteins/metabolism*;Receptors, LDL/chemistry;Receptors, LDL/genetics;Receptors, LDL/metabolism*;Repressor Proteins*;Signal Transduction/physiology*;Wnt Proteins;Zebrafish Proteins*
11337232;Aged;Aged, 80 and over;Amphotericin B/therapeutic use;Antifungal Agents/therapeutic use*;Candidiasis/drug therapy;Candidiasis/epidemiology*;Candidiasis/microbiology;Cross Infection/drug therapy;Cross Infection/epidemiology*;Cross Infection/microbiology;Female;Fluconazole/therapeutic use;Flucytosine/therapeutic use;Fungemia/drug therapy;Fungemia/epidemiology*;Fungemia/microbiology;Humans;Male;Postoperative Complications/drug therapy;Postoperative Complications/epidemiology;Postoperative Complications/microbiology;Risk Factors;Slovakia/epidemiology;Survival Rate
11337509;Amino Acid Sequence;Fungal Proteins*/biosynthesis;Fungal Proteins*/genetics;Gene Expression Regulation, Fungal*;Molecular Sequence Data;Pheromones/metabolism;Protein Kinases/biosynthesis;Protein Kinases/genetics*;Saccharomyces cerevisiae;Sequence Alignment
11338820;Ambulatory Care/organization & administration*;Home Care Services, Hospital-Based/organization & administration;Hospitals, Military/organization & administration;Humans;Length of Stay;Military Medicine/organization & administration*;Russia
11344299;Amyloid/antagonists & inhibitors*;Anti-Inflammatory Agents, Non-Steroidal/blood*;Chromatography, High Pressure Liquid;Humans;Prealbumin/metabolism*;Precipitin Tests
11344605;Blood Sedimentation;C-Reactive Protein/metabolism*;Cytokines/metabolism;Erythrocytes/physiology*;Humans;Inflammation/blood*;Tuberculosis, Pulmonary/blood*
11349693;Child;Cholesterol, Dietary/therapeutic use*;Humans;Smith-Lemli-Opitz Syndrome/diet therapy*;Smith-Lemli-Opitz Syndrome/psychology*;Treatment Outcome
11357170;Drug Carriers;Drug Delivery Systems/methods;Drug Delivery Systems/trends*;Gene Transfer Techniques;Genetic Therapy/methods;Humans;Liposomes/chemistry*;Liposomes/pharmacokinetics;Research/trends;Vaccines/administration & dosage*
11361368;AIDS-Related Opportunistic Infections/drug therapy;AIDS-Related Opportunistic Infections/economics;Acquired Immunodeficiency Syndrome/mortality;Acquired Immunodeficiency Syndrome/therapy*;Adult;Ambulatory Care/economics;Cost of Illness;Female;Hospitalization/economics;Humans;Male;Outcome Assessment (Health Care);Survival Analysis;Terminal Care/economics*
11365063;Employment/legislation & jurisprudence*;HIV Seropositivity*;Humans;Maryland;Prejudice*;United States Department of Veterans Affairs
11366471;Adult;Benzoxazines;Child;Drug Approval*;Drug Costs;Drug Therapy, Combination;Female;HIV Infections/drug therapy*;Humans;Male;Oxazines/economics;Oxazines/therapeutic use*;Reverse Transcriptase Inhibitors/economics;Reverse Transcriptase Inhibitors/therapeutic use*;United States Food and Drug Administration
11386828;Aged;Ataxia/etiology;Brain Edema/etiology;Brain Edema/surgery;Choroid Plexus Neoplasms/complications;Choroid Plexus Neoplasms/psychology*;Choroid Plexus Neoplasms/surgery;Cognition Disorders/etiology;Craniotomy;Headache/etiology;Humans;Magnetic Resonance Imaging;Male;Meningeal Neoplasms/complications;Meningeal Neoplasms/psychology*;Meningeal Neoplasms/surgery;Meningioma/complications;Meningioma/psychology*;Meningioma/surgery;Mental Disorders/etiology*;Posture;Psychomotor Agitation/etiology;Ventriculoperitoneal Shunt
11389318;Attitude to Health*;Humans;Information Services/supply & distribution*;Mass Media;Outcome and Process Assessment (Health Care);Public Opinion*;Quality of Health Care*;Total Quality Management;Truth Disclosure;United States
11390955;Animals;Endothelium, Vascular/immunology*;Humans;Inflammation/immunology*;Leukocytes/immunology*
11409449;Adolescent;Adult;Ankle Joint/physiology;Child;Female;Follow-Up Studies;Foot Deformities, Acquired/etiology;Foot Deformities, Acquired/surgery*;Humans;Male;Middle Aged;Range of Motion, Articular/physiology;Recovery of Function;Retrospective Studies;Tendon Transfer/methods*;Tendons/transplantation*;Tibia;Treatment Outcome
11423712;Adult;Aged;Aged, 80 and over;Angioplasty, Balloon, Coronary/methods*;Biomarkers/blood;Blood Coagulation*;Coronary Circulation;Coronary Disease/blood*;Coronary Disease/therapy;Female;Graft Occlusion, Vascular/blood;Graft Occlusion, Vascular/diagnosis*;Humans;Male;Middle Aged;Prognosis;Recurrence;Thromboplastin/metabolism*
11429523;Adolescent;Cholelithiasis/complications*;Humans;Male;Microscopy, Polarization;Pancreatitis/diagnosis;Pancreatitis/etiology*;Tomography, X-Ray Computed
11430896;4-Aminopyridine/pharmacology;6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology;Action Potentials/drug effects;Animals;Bicuculline/analogs & derivatives*;Bicuculline/pharmacology;Carbenoxolone/pharmacology;Convulsants/pharmacology;Evoked Potentials/drug effects;Evoked Potentials/physiology*;Excitatory Amino Acid Antagonists/pharmacology;GABA-A Receptor Antagonists;Gap Junctions/drug effects;Gap Junctions/physiology*;Guinea Pigs;Hippocampus/drug effects;Hippocampus/physiology*;Interneurons/drug effects;Interneurons/physiology*;Piperazines/pharmacology;Pyramidal Cells/drug effects;Pyramidal Cells/physiology;Receptors, AMPA/antagonists & inhibitors;Receptors, GABA-B/drug effects;Receptors, GABA-B/physiology*;Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors;Synaptic Transmission/drug effects
11433705;Biopsy;Cerebellar Diseases/diagnosis*;Cerebellar Diseases/pathology;Cerebellum/pathology;Diagnosis, Differential;Exophthalmos/diagnosis*;Exophthalmos/pathology;Histiocytosis, Non-Langerhans-Cell/diagnosis*;Histiocytosis, Non-Langerhans-Cell/pathology;Humans;Hypogonadism/diagnosis*;Hypogonadism/pathology;Magnetic Resonance Imaging;Male;Middle Aged;Skin/pathology;Tomography, X-Ray Computed;Xanthomatosis/diagnosis;Xanthomatosis/pathology
11435228;Animals;Fluorocarbons/pharmacology*;Humans;Liquid Ventilation/methods*;Pulmonary Gas Exchange/drug effects*;Swine
11437075;Animals;Antigens, CD1/genetics*;Antigens, CD1d;Brain Tissue Transplantation*;CD4-Positive T-Lymphocytes/cytology;CD4-Positive T-Lymphocytes/immunology;CD8-Positive T-Lymphocytes/cytology;CD8-Positive T-Lymphocytes/immunology;Fetal Tissue Transplantation*;Flow Cytometry;Graft Survival/immunology*;Killer Cells, Natural/cytology*;Killer Cells, Natural/immunology;Macrophages/cytology;Macrophages/immunology;Mice;Mice, Inbred C57BL;Mice, Mutant Strains;Microglia/cytology;Microglia/immunology;Swine;Transplantation, Heterologous
11441695;Africa/epidemiology;Animals;Antimalarials/therapeutic use*;Asia/epidemiology;Contraindications;Diagnosis, Differential;Drug Resistance;Fever/parasitology*;Humans;Malaria/diagnosis*;Malaria/drug therapy;Malaria/epidemiology;Malaria/parasitology;Plasmodium falciparum/drug effects;Plasmodium falciparum/isolation & purification*;Practice Guidelines as Topic;Reagent Kits, Diagnostic*;Self Medication/methods*;Self-Examination/methods*;South America/epidemiology;Travel*;World Health Organization
11447077;Adult;C-Reactive Protein/metabolism*;Comorbidity;Coronary Disease/blood;Coronary Disease/epidemiology*;Diabetes Mellitus/blood;Diabetes Mellitus/epidemiology;Europe;European Continental Ancestry Group*;Humans;India/ethnology;Inflammation/metabolism;Insulin Resistance*;Male;Middle Aged;Obesity/blood;Obesity/epidemiology*;Risk Assessment;Risk Factors;United Kingdom/epidemiology
11449049;Arabidopsis/genetics*;Arabidopsis/physiology;Arabidopsis Proteins*;Base Sequence;DNA-Binding Proteins/genetics;DNA-Binding Proteins/physiology*;Gene Expression Regulation, Plant*;Genes, Reporter;Genetic Complementation Test;Molecular Sequence Data;Plant Diseases;Plant Proteins/genetics*;Plant Proteins/physiology*;Plants, Genetically Modified;Promoter Regions, Genetic;RNA, Plant;Salicylic Acid/metabolism;Transcription Factors/genetics;Transcription Factors/physiology*
11454321;Aged;Aged, 80 and over;Alzheimer Disease/drug therapy;Alzheimer Disease/metabolism*;Alzheimer Disease/physiopathology;Astrocytes/drug effects;Astrocytes/metabolism;Astrocytes/pathology;Estrogen Receptor alpha;Estrogen Receptor beta;Estrogen Replacement Therapy*;Estrogens/therapeutic use*;Female;Hippocampus/metabolism*;Hippocampus/pathology;Hippocampus/physiopathology;Humans;Immunohistochemistry;Male;Menopause/physiology*;Nerve Degeneration/drug therapy;Nerve Degeneration/metabolism;Nerve Degeneration/physiopathology;Neurons/drug effects;Neurons/metabolism;Neurons/pathology;Neuroprotective Agents/therapeutic use*;Receptors, Estrogen/metabolism*;Sex Characteristics
11459590;Adult;Afterimage/physiology*;Differential Threshold/physiology;Humans;Optical Illusions*;Space Perception/physiology*
11461832;5' Untranslated Regions/genetics;8-Bromo Cyclic Adenosine Monophosphate/pharmacology;Animals;Base Sequence;Binding Sites;Carcinoma, Hepatocellular;Chloramphenicol O-Acetyltransferase/genetics;Cyclic AMP/metabolism;DNA/genetics*;DNA Footprinting;DNA-Binding Proteins/metabolism;Deoxyribonuclease I;Dihydrolipoamide Dehydrogenase/genetics*;Gene Expression Regulation, Enzymologic/drug effects;Humans;Liver Neoplasms;Mice;Molecular Sequence Data;Mutagenesis, Site-Directed;Promoter Regions, Genetic*;Repetitive Sequences, Nucleic Acid*;Sequence Alignment;Transcription, Genetic*;Transfection;Tumor Cells, Cultured
11483834;Administration, Intranasal;Child, Preschool;Cost of Illness;Cost-Benefit Analysis;Double-Blind Method;Drug Costs;Efficiency;Health Care Costs;Health Expenditures/statistics & numerical data;Health Services/economics;Health Services/utilization;Humans;Infant;Influenza Vaccines/administration & dosage;Influenza Vaccines/economics*;Influenza Vaccines/therapeutic use*;Influenza, Human/economics*;Influenza, Human/prevention & control*;Placebos;Prospective Studies;Vaccination/economics
11485504;Adult;Cause of Death;Coronary Disease/complications*;Coronary Disease/mortality*;Diabetes Mellitus, Type 2/complications*;Diabetes Mellitus, Type 2/mortality*;Female;Follow-Up Studies;Humans;Middle Aged;Multivariate Analysis;Risk;Risk Factors;United States/epidemiology
11487852;Adolescent;Child;Female;Fluoroscopy/adverse effects;Humans;Radiation Dosage;Radiation Injuries/etiology;Radiodermatitis/etiology;Radiodermatitis/pathology;Radiography, Interventional/adverse effects*;Skin/radiation effects
11489986;Animals;Antibodies, Monoclonal/pharmacology;B7-1 Antigen/immunology;B7-1 Antigen/metabolism;CD8-Positive T-Lymphocytes/enzymology*;CD8-Positive T-Lymphocytes/immunology*;CD8-Positive T-Lymphocytes/metabolism;Clonal Anergy*/genetics;Enzyme Activation/immunology;Intercellular Adhesion Molecule-1/immunology;Intercellular Adhesion Molecule-1/metabolism;Interleukin-2/antagonists & inhibitors;Interleukin-2/biosynthesis;Ionomycin/pharmacology;JNK Mitogen-Activated Protein Kinases;Lymphocyte Activation*/drug effects;Lymphocyte Activation*/genetics;MAP Kinase Signaling System/genetics;MAP Kinase Signaling System/immunology*;Mice;Mice, Inbred C57BL;Mice, Transgenic;Microspheres;Mitogen-Activated Protein Kinases/antagonists & inhibitors;Mitogen-Activated Protein Kinases/metabolism;Mitogen-Activated Protein Kinases/physiology;RNA, Messenger/antagonists & inhibitors;RNA, Messenger/biosynthesis;Tetradecanoylphorbol Acetate/pharmacology;Up-Regulation/genetics;Up-Regulation/immunology;p38 Mitogen-Activated Protein Kinases
11495723;3T3 Cells;Animals;Butadienes/pharmacology;CDC2 Protein Kinase/metabolism;Cell Division/drug effects;DNA/biosynthesis;Enzyme Inhibitors/pharmacology;Immunohistochemistry;Kinetochores/chemistry;MAP Kinase Kinase 1;MAP Kinase Kinase 2;MAP Kinase Signaling System;Mice;Mitogen-Activated Protein Kinase 1/analysis*;Mitogen-Activated Protein Kinase 1/immunology;Mitogen-Activated Protein Kinase 3;Mitogen-Activated Protein Kinase Kinases/analysis*;Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors;Mitogen-Activated Protein Kinase Kinases/immunology;Mitogen-Activated Protein Kinases/analysis*;Mitogen-Activated Protein Kinases/immunology;Mitosis;Nitriles/pharmacology;Protein-Serine-Threonine Kinases/analysis*;Protein-Serine-Threonine Kinases/antagonists & inhibitors;Protein-Serine-Threonine Kinases/immunology;Protein-Tyrosine Kinases/analysis*;Protein-Tyrosine Kinases/antagonists & inhibitors;Protein-Tyrosine Kinases/immunology;Ribosomal Protein S6 Kinases/analysis*;Ribosomal Protein S6 Kinases/immunology;Ribosomal Protein S6 Kinases, 90-kDa*;Tubulin/chemistry*
11500724;Adolescent;Adult;Hospitals, University;Humans;Infertility, Male/pathology*;Male;Middle Aged;Retrospective Studies;Saudi Arabia;Testis/pathology*
11502021;Administrative Personnel;Attitude to Health;Cost-Benefit Analysis;Drug Industry/organization & administration*;Health Promotion/economics;Health Promotion/trends*;Humans;Michigan;Occupational Health Services/economics;Occupational Health Services/trends*;Organizational Case Studies;Workplace
11508294;Algorithms;Counseling;Day Care, Medical/organization & administration*;Exercise Therapy;Heart Failure/psychology;Heart Failure/rehabilitation*;Heart Failure/therapy;Hospital Units/organization & administration*;Humans;Italy;Nursing Services;Risk Assessment;Risk Factors
11514290;Animals;Cell Separation;Hypothyroidism/physiopathology*;Isotonic Contraction*/physiology;Myocardial Contraction*/physiology;Myocardium/cytology;Myocardium/metabolism*;Myosin Heavy Chains/biosynthesis*;Protein Isoforms/biosynthesis;Rats;Rats, Sprague-Dawley;Stress, Mechanical;Thyroidectomy
11518833;Adult;Albuminuria/etiology;Albuminuria/urine;Blood Pressure*;Blood Pressure Monitoring, Ambulatory;Creatinine/blood;Creatinine/urine;Diastole;Echocardiography;Electrolytes/blood;Electrolytes/urine;Female;Fundus Oculi;Humans;Hypertension/complications;Hypertension/metabolism;Hypertension/pathology;Hypertension/physiopathology*;Kidney/pathology*;Male;Middle Aged;Myocardium/pathology*;Obesity/complications;Prospective Studies;Retina/pathology*;Single-Blind Method;Systole;Vascular Resistance
11520453;Cardiac Surgical Procedures/instrumentation*;Cardiac Surgical Procedures/trends*;Heart Diseases/surgery*;Humans;Patient Care/instrumentation;Robotics/instrumentation*
11521091;Acinetobacter/chemistry*;Acinetobacter/classification;Animals;Antibodies, Bacterial/immunology;Antibodies, Monoclonal/immunology;Blotting, Western;Carbohydrate Conformation;Carbohydrate Sequence;Cross Reactions;Epitopes;Humans;Magnetic Resonance Spectroscopy;Mice;Mice, Inbred BALB C;Molecular Sequence Data;O Antigens/chemistry*;Serotyping
11523518;Female;Gynecologic Surgical Procedures*;Humans;Laparoscopy*
11529862;Aged;Antibodies/metabolism;Anticoagulants/adverse effects*;Chondroitin Sulfates/adverse effects;Cross Reactions;Dermatan Sulfate/adverse effects;Drug Combinations;Factor Xa/immunology;Heparin/adverse effects*;Heparitin Sulfate/adverse effects;Hirudin Therapy;Humans;International Normalized Ratio;Male;Platelet Count;Syndrome;Thrombocytopenia/blood;Thrombocytopenia/chemically induced*;Thrombocytopenia/immunology;Thrombosis/blood;Thrombosis/chemically induced*;Thrombosis/immunology
11543875;Base Sequence;Humans;Molecular Biology*;Molecular Sequence Data;Pharmacogenetics;Polymorphism, Genetic;Receptors, Adrenergic, alpha-2/genetics*
11552162;Analysis of Variance;Calcium Sulfate/chemistry;Chemistry, Pharmaceutical;Colloids/chemistry*;Dental Abutments;Dental Casting Investment/chemistry;Dental Impression Materials/chemistry*;Dental Impression Technique/instrumentation;Dental Models;Humans;Humidity;Materials Testing;Microscopy;Reproducibility of Results;Stainless Steel/chemistry;Statistics as Topic;Surface Properties;Time Factors
11555910;Diagnosis, Differential;HTLV-I Infections*;Humans;Myositis/diagnosis;Myositis/physiopathology;Myositis/virology*;Paraparesis, Tropical Spastic/complications;Prognosis
11558274;DNA Damage;DNA-Binding Proteins*;Enzyme Inhibitors/pharmacology;Escherichia coli/physiology*;Escherichia coli Proteins;Gene Expression Regulation, Bacterial/drug effects;Gene Expression Regulation, Bacterial/physiology;Ornithine Decarboxylase/physiology;Ornithine Decarboxylase Inhibitors;Oxidative Stress/physiology*;Putrescine/analogs & derivatives*;Putrescine/pharmacology;Putrescine/physiology*;Reactive Oxygen Species;Repressor Proteins/physiology*;Transcription Factors/physiology*
11566879;Adherens Junctions/ultrastructure*;Animals;Collagen/genetics*;Collagen/metabolism;Collagen/physiology*;Embryonic and Fetal Development;Fetus/abnormalities;Fetus/blood supply;Heart/embryology;Heart Defects, Congenital/pathology*;Mice;Mice, Transgenic;Mutation;Myocardium/ultrastructure;Neovascularization, Physiologic*;Phenotype;Placenta/abnormalities;Placenta/blood supply;RNA, Messenger/biosynthesis;Survival Analysis
11572856;Adenoviridae/genetics*;Apoptosis;Blotting, Western;Cell Division;Cell Movement;Cell Separation;Cyclin-Dependent Kinase Inhibitor p16/genetics*;DNA, Complementary/metabolism;Down-Regulation*;Enzyme Inhibitors/pharmacology;Flow Cytometry;Gene Transfer Techniques;Glioma/metabolism*;Humans;Immunoblotting;Immunohistochemistry;Integrins/metabolism*;Models, Biological;Mutagenesis, Insertional;Oligonucleotides, Antisense/pharmacology*;Phenotype;Phosphatidylinositol 3-Kinases/metabolism;Protein Binding;Receptors, Cell Surface/genetics*;Receptors, Urokinase Plasminogen Activator;Receptors, Vitronectin/biosynthesis*;Signal Transduction*;Spheroids, Cellular/metabolism;Time Factors;Tumor Cells, Cultured;Vitronectin/metabolism
11576915;Apolipoproteins B/metabolism;Apoptosis;Arteriosclerosis/complications;Arteriosclerosis/metabolism;Cardiovascular Diseases/etiology*;Cardiovascular Diseases/prevention & control;Carrier Proteins/metabolism;Cholesterol Ester Transfer Proteins;Endothelium, Vascular/metabolism;Glycoproteins*;Humans;Hyperlipidemias/etiology*;Hyperlipidemias/metabolism;Hyperlipidemias/therapy;Kidney Failure, Chronic/etiology;Kidney Failure, Chronic/prevention & control;Lipoproteins/metabolism*;Lipoproteins, HDL/metabolism;Lipoproteins, VLDL/metabolism;Oxidative Stress;Phosphatidylcholine-Sterol O-Acyltransferase/metabolism;Uremia/complications*;Uremia/metabolism*
11579812;Hernia, Hiatal/diagnosis;Hernia, Hiatal/surgery*;Humans;Laparoscopy/adverse effects;Laparoscopy/methods*;Practice Guidelines as Topic;Risk Factors;Severity of Illness Index;Treatment Outcome
11589611;Animals;Cell Differentiation/drug effects;Cell Fusion;Cell Line;Cell Membrane/metabolism;Cholesterol/metabolism;Fatty Acids/metabolism;Fatty Acids/pharmacology;Membrane Fluidity;Membrane Lipids/metabolism*;Mice;Muscle, Skeletal/cytology*;Muscle, Skeletal/growth & development;Muscle, Skeletal/metabolism*;Respirovirus/physiology
11590518;Adult;Antiretroviral Therapy, Highly Active*;CD4 Lymphocyte Count;CD8-Positive T-Lymphocytes;Female;HIV Infections/drug therapy*;HIV Infections/immunology;HIV Infections/virology;HIV-1/physiology;Humans;Interleukin-7/blood*;Lymphocyte Count;Male;Middle Aged;RNA, Viral/blood
11593592;Abnormalities, Multiple*;Child;Female;Heart Defects, Congenital/surgery*;Humans;Ilium/transplantation;Ribs/transplantation;Sternum/abnormalities*;Sternum/surgery
11594162;Adolescent;Alcoholism/diagnosis*;Humans;Pediatrics
11594971;Aspirin/adverse effects;Biomarkers;Cataract/chemically induced;Cataract/mortality*;Humans;Risk Factors
11597867;Curriculum/trends*;Education, Medical, Undergraduate/methods*;Education, Medical, Undergraduate/trends*;Time Factors;United States
11603825;Adolescent;Adult;Calcium/analysis*;Child;Child, Preschool;Female;Humans;Infant;Magnesium/analysis*;Male;Middle Aged;Nails/chemistry*;Nails/metabolism;Osteogenesis Imperfecta/metabolism*;Zinc/analysis*
11606885;Acute Disease;Adult;Aged;Aged, 80 and over;Arthroplasty, Replacement;Bone Diseases, Infectious/diagnostic imaging*;Chronic Disease;Female;Humans;Inflammation;Leukocytes;Male;Middle Aged;Osteomyelitis/diagnostic imaging;Radionuclide Imaging;Radiopharmaceuticals/therapeutic use;Retrospective Studies;Technetium Tc 99m Exametazime*;Wounds and Injuries/diagnostic imaging
11616598;Greece, Ancient;History, Ancient;Philosophy/history*
11624622;History, 16th Century;History, 17th Century;Japan;Medicine*
11626151;Germany;History, Modern 1601-;Ophthalmology/history*
11632410;Germany;History, Ancient;History, Early Modern 1451-1600;History, Medieval;History, Modern 1601-;Hospitals/history*;Medicine*
11639582;Education/history;Historiography;History, 19th Century;History, 20th Century;Humans;Research/history*;Schools/history*;Science/history*;Terminology as Topic
11648637;Adolescent*;Civil Rights;Female;Humans;Jurisprudence*;Legal Guardians;Mentally Disabled Persons*;Minors*;Parental Consent;Risk;Risk Assessment;Sterilization, Reproductive*;Third-Party Consent;United Kingdom;Women
11663931;Abortion, Induced*;Attitude;Coercion;Counseling;Federal Government;Female;Financial Support;Government;Humans;Legislation as Topic*;Pregnancy;Pregnant Women;Risk;Risk Assessment;Stress, Psychological;Women
11665783;Action Potentials/physiology*;Animals;Central Nervous System/physiology*;Humans;Nerve Net/physiology*;Neural Networks (Computer)*;Neurons/physiology*;Nonlinear Dynamics*;Synaptic Transmission/physiology*
11684170;Adult;Female;Gravity Sensing*;Humans;Labyrinth Diseases/physiopathology*;Labyrinth Diseases/psychology*;Male;Middle Aged;Orientation*;Otolithic Membrane*;Posture;Proprioception*;Tilt-Table Test;Vestibular Function Tests
11684824;Adenoma/genetics*;Adenoma/pathology*;Aged;Antifungal Agents/analysis*;Colon/pathology;Colon/surgery;Colonic Polyps/genetics;Colonic Polyps/pathology*;Colonoscopy;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/pathology*;Enzyme-Linked Immunosorbent Assay;Feces/chemistry*;Female;Humans;Leukocyte L1 Antigen Complex;Male;Membrane Glycoproteins/analysis*;Middle Aged;Neoplasm Staging;Neural Cell Adhesion Molecules/analysis*;Occult Blood*;Prospective Studies;Rectum/pathology;Rectum/surgery;Reference Values;Sensitivity and Specificity
11685744;Antineoplastic Agents/therapeutic use*;Antineoplastic Agents, Hormonal/therapeutic use;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carcinoma, Hepatocellular/drug therapy*;Cisplatin/administration & dosage;Doxorubicin/administration & dosage;Fluorouracil/administration & dosage;Humans;Interferon-alpha/administration & dosage;Interferon-alpha/therapeutic use;Liver Neoplasms/drug therapy*;Recombinant Proteins
11686606;Cobalt/chemistry*;Crystallography, X-Ray;Dimerization;Electrochemistry;Hydrocarbons, Fluorinated/chemistry;Magnetic Resonance Spectroscopy;Molecular Structure;Organometallic Compounds/chemistry;Organophosphorus Compounds/chemistry;Porphyrins/chemical synthesis;Porphyrins/chemistry*
11687792;Biological Warfare/prevention & control*;Biological Warfare/trends;Bioterrorism/legislation & jurisprudence;Bioterrorism/prevention & control*;Bioterrorism/trends*;Genome, Bacterial;Genome, Viral;Genomics/methods;Genomics/trends*;International Cooperation;Vaccines/genetics
11693831;Catheterization, Central Venous/adverse effects;Catheterization, Central Venous/economics;Catheterization, Central Venous/methods*;Cost-Benefit Analysis*;Humans;Neoplasms/surgery*;Veins*
11702269;Adult;Facial Neoplasms/surgery;Head and Neck Neoplasms/surgery;Humans;Hypopharyngeal Neoplasms/surgery;Mouth Neoplasms/surgery;Oropharyngeal Neoplasms/surgery;Reconstructive Surgical Procedures*;Surgical Flaps*
11703582;Amino Acid Sequence;Amyloidosis/genetics*;Apolipoprotein A-II/genetics*;Base Sequence;Codon, Terminator*;Humans;Kidney Diseases/genetics*;Male;Middle Aged;Molecular Sequence Data;Mutation*;Polymerase Chain Reaction
11717439;Amino Acid Substitution;Binding Sites;Electron Transport Complex III/genetics*;Electron Transport Complex III/metabolism;Electron Transport Complex IV/genetics*;Electron Transport Complex IV/metabolism;Intracellular Membranes/metabolism;Membrane Proteins/metabolism*;Mitochondria/enzymology*;Mitochondrial Proteins;Nuclear Proteins/genetics*;Nuclear Proteins/metabolism;Nucleotidyltransferases/genetics*;Nucleotidyltransferases/metabolism
11721667;Aged;Alzheimer Disease/diagnosis;Alzheimer Disease/drug therapy*;Germany;Humans;Nootropic Agents/therapeutic use*;Practice Guidelines as Topic*;Treatment Outcome
11725266;Capillaries/diagnostic imaging;Capillaries/physiopathology*;Cardiac Volume/physiology*;Coronary Circulation/physiology*;Humans;Hyperemia/diagnostic imaging;Hyperemia/etiology*;Hyperemia/physiopathology*;Radionuclide Imaging;Stress, Physiological/complications*;Stress, Physiological/diagnostic imaging;Stress, Physiological/physiopathology*
11732795;Actins/metabolism;Animals;CD3 Complex/metabolism;Dog Diseases/immunology;Dog Diseases/pathology*;Dogs;Female;Fibroblasts/immunology;Fibroblasts/pathology;Fibrosis/immunology;Fibrosis/pathology;Fibrosis/veterinary;Hepatitis, Animal/immunology;Hepatitis, Animal/pathology*;Hepatitis, Chronic/immunology;Hepatitis, Chronic/pathology;Hepatitis, Chronic/veterinary*;Immunoglobulin Light Chains/metabolism;Immunohistochemistry;Kupffer Cells/immunology;Kupffer Cells/pathology;Liver/immunology;Liver/pathology;Male;Muramidase/metabolism;Neutrophils/immunology;Neutrophils/pathology;Retrospective Studies;Statistics, Nonparametric
11740753;Aged;Arthroplasty, Replacement, Knee*;Female;Foreign-Body Migration/diagnostic imaging*;Humans;Knee Joint/diagnostic imaging*;Knee Joint/physiopathology*;Knee Prosthesis*;Male;Middle Aged;Osteoarthritis, Knee/diagnostic imaging;Osteoarthritis, Knee/surgery;Photogrammetry;Prosthesis Design;Radiography;Range of Motion, Articular;Rotation
11742977;Amino Acid Sequence;Capsid/physiology*;Cell Movement*;Closterovirus/physiology*;Genome, Viral;HSP70 Heat-Shock Proteins/physiology*;Membrane Fusion*;Molecular Sequence Data;Plants/virology*;Sequence Homology, Amino Acid;Virus Assembly*
11746497;3T3 Cells/cytology*;3T3 Cells/drug effects;3T3 Cells/enzymology*;3T3 Cells/metabolism;Actins/antagonists & inhibitors;Actins/biosynthesis;Actins/metabolism*;Actins/physiology;Animals;Binding Sites/genetics;Cell Line, Transformed/cytology;Cell Line, Transformed/drug effects;Cell Line, Transformed/enzymology;Cell Line, Transformed/metabolism;Cell Size/genetics;Gene Deletion;Isoenzymes/biosynthesis;Isoenzymes/genetics;Isoenzymes/metabolism*;Isoenzymes/physiology;Mice;Microfilament Proteins/antagonists & inhibitors;Microfilament Proteins/metabolism;Microtubules/physiology;Phalloidine;Polymers/metabolism;Protein Kinase C/biosynthesis;Protein Kinase C/genetics;Protein Kinase C/metabolism*;Protein Kinase C/physiology;Protein Kinase C-epsilon;Protein Structure, Tertiary/genetics;Rabbits;Staining and Labeling;Thymosin/pharmacology
11746603;DNA, Complementary/chemistry;DNA, Fungal/chemistry;Down-Regulation;Electrophoresis, Polyacrylamide Gel;Food Preservatives/pharmacology*;Gas Chromatography-Mass Spectrometry;Gene Expression Regulation, Fungal/genetics;Gene Expression Regulation, Fungal/physiology;Image Processing, Computer-Assisted;Isoelectric Focusing;Oligonucleotide Array Sequence Analysis;Open Reading Frames/genetics;Open Reading Frames/physiology;Proteome/drug effects*;Proteome/physiology;RNA, Fungal/chemistry;RNA, Fungal/genetics;RNA, Fungal/isolation & purification;Reverse Transcriptase Polymerase Chain Reaction;Saccharomyces cerevisiae/drug effects;Saccharomyces cerevisiae/genetics*;Saccharomyces cerevisiae/metabolism;Saccharomyces cerevisiae Proteins/biosynthesis*;Saccharomyces cerevisiae Proteins/genetics;Sorbic Acid/pharmacology*;Up-Regulation
11761214;Clinical Competence;Family Practice/organization & administration*;Humans;Private Practice/standards*;Rural Health Services*;United Kingdom
11761275;Abortion, Habitual/therapy;Acute Kidney Injury/etiology;Adrenal Cortex Hormones/therapeutic use;Adult;Aged;Anti-Inflammatory Agents/therapeutic use;Antibody Affinity;Antibody Formation;Antibody Specificity;Autoimmune Diseases/immunology;Autoimmune Diseases/therapy;Blood Banks/standards;Blood Group Incompatibility/immunology;Combined Modality Therapy;Demyelinating Diseases/therapy;Dyspnea/drug therapy;Dyspnea/therapy;Erythroblastosis, Fetal/prevention & control;Female;Fibrosis/therapy;Hemorrhage/therapy;Homeostasis/immunology;Humans;Immunoglobulin Fragments/immunology;Immunoglobulins, Intravenous/administration & dosage;Immunoglobulins, Intravenous/adverse effects;Immunoglobulins, Intravenous/immunology;Immunoglobulins, Intravenous/therapeutic use*;Inflammation/drug therapy;Inflammation/immunology;Inflammation/therapy;Male;Middle Aged;Myopia/therapy;Plasma Exchange;Pregnancy;Sepsis/therapy;Steroids;Thalassemia/therapy
11763374;Adolescent;Adult;Child;Diagnosis, Differential;Female;Humans;Hypopigmentation/diagnosis*;Hypopigmentation/epidemiology;Incidence;Male;Mycosis Fungoides/diagnosis*;Mycosis Fungoides/epidemiology;Prognosis;Risk Assessment;Skin Neoplasms/diagnosis*;Skin Neoplasms/epidemiology;Tuberous Sclerosis/diagnosis*;Tuberous Sclerosis/epidemiology
11765306;Drug and Narcotic Control*;Humans;N-Methyl-3,4-methylenedioxyamphetamine/adverse effects*;N-Methyl-3,4-methylenedioxyamphetamine/therapeutic use
11771710;Bone Cements;Calcium Phosphates/chemistry*;Calcium Pyrophosphate/chemistry*;Ceramics/chemistry*;Hot Temperature;Microscopy, Electron, Scanning;Thermodynamics;X-Ray Diffraction
11776187;Adult;Chlamydia Infections/metabolism*;Chlamydia trachomatis*;DNA, Bacterial/analysis;Fallopian Tubes/chemistry*;Fallopian Tubes/microbiology;Female;Humans;Infertility, Female/metabolism*;Interleukin-6/analysis*;Tumor Necrosis Factor-alpha/analysis*
11790337;Animals;Crustacea/physiology*;Ecdysteroids/pharmacology*;Embryonic Development;Embryonic and Fetal Development/physiology*;Endocrine Glands/physiology;Female;Male;Molting/physiology;Oocytes/growth & development;Reproduction/physiology*
11795036;Breast Feeding/adverse effects*;Female;Humans;Infant;Infant, Newborn;Infectious Disease Transmission, Vertical*;Milk, Human/virology*;Virus Diseases/transmission*
11795060;Adult;Aged;Ambulatory Surgical Procedures/nursing*;Ambulatory Surgical Procedures/psychology*;Anesthesia/psychology;Female;Humans;Male;Middle Aged;New England;Nurse-Patient Relations*;Nursing Care/psychology*;Outpatients/psychology*;Perioperative Nursing*/standards
11803088;Animals;Antibodies, Viral/biosynthesis*;Cattle;Colostrum/immunology;Enzyme-Linked Immunosorbent Assay;Female;Immunoglobulin A/biosynthesis;Immunoglobulin G/biosynthesis;Immunoglobulin G/classification;Immunoglobulin M/biosynthesis;Milk/immunology*;Rotavirus/classification*;Rotavirus Vaccines/immunology*;Serotyping;Vaccination/veterinary*;Vaccines, Inactivated/immunology;Vaccines, Synthetic/immunology*;Virion/immunology*
11805062;Adenosine Triphosphatases/genetics;Adenosine Triphosphatases/physiology;Animals;Base Pair Mismatch*;Crosses, Genetic;DNA Repair*;DNA Repair Enzymes*;DNA-Binding Proteins/genetics;DNA-Binding Proteins/physiology;Female;Male;Mice;Mice, Inbred C57BL;Microsatellite Repeats;Mismatch Repair Endonuclease PMS2;Mosaicism/genetics;Mutation
11817828;Foundations/organization & administration*;Humans;Insurance, Health*;Japan;Naval Medicine/economics;Naval Medicine/organization & administration*;Occupational Health Services/economics;Occupational Health Services/organization & administration*;Ships*
11828217;Animal Husbandry;Child;Echinococcosis, Pulmonary/complications*;Echinococcosis, Pulmonary/therapy;Humans;Hydropneumothorax/diagnostic imaging;Hydropneumothorax/etiology*;Male;Radiography;Rupture, Spontaneous/complications;Thoracostomy
11834856;Acrodermatitis/diagnosis;Acrodermatitis/etiology*;Follow-Up Studies;Hepatitis B/prevention & control;Hepatitis B Vaccines/adverse effects*;Humans;Infant;Male;Measles/prevention & control;Measles Vaccine/adverse effects*;Risk Assessment;Syndrome;Vaccination/adverse effects*;Vaccination/methods;Vaccines, Combined/adverse effects
11836744;Afferent Pathways/physiology*;Animals;Axonal Transport;Eyelids/anatomy & histology;Eyelids/innervation*;Eyelids/physiology;Macaca mulatta;Microinjections;Motor Neurons/physiology;Photomicrography;Rats;Superior Colliculi/anatomy & histology;Superior Colliculi/physiology*;Trigeminal Ganglion/physiology
11837921;Anticoagulants/administration & dosage*;Anticoagulants/economics;Arthroplasty, Replacement, Hip*/economics;Drug Therapy, Computer-Assisted*/economics;Humans;Postoperative Period;Thromboembolism/prevention & control*;Warfarin/administration & dosage*;Warfarin/economics
11839094;Adult;Ataxia Telangiectasia/genetics*;Child;Chromosome Painting*;Female;Heterozygote*;Homozygote*;Humans;Male;Middle Aged;Radiation Tolerance/genetics*
11841046;Adult;Child;Enteral Nutrition/standards*;Humans;Parenteral Nutrition/standards*
11843743;Adolescent;Adult;Aged;Aged, 80 and over;Ambulatory Surgical Procedures*;Anesthetics, Inhalation/adverse effects*;Antiemetics/therapeutic use;Arthroscopy;Cardiovascular Diseases/chemically induced;Female;Humans;Isoflurane/adverse effects*;Knee Joint/surgery;Male;Methyl Ethers/adverse effects*;Middle Aged;Pain, Postoperative/prevention & control;Postoperative Nausea and Vomiting/chemically induced*;Postoperative Nausea and Vomiting/drug therapy;Respiration Disorders/chemically induced
11846855;Adult;Aged;Aged, 80 and over;Anticholesteremic Agents/pharmacology;Anticholesteremic Agents/therapeutic use*;Antioxidants/administration & dosage;Antioxidants/pharmacology;Cardiovascular Diseases/mortality;Cardiovascular Diseases/prevention & control*;Female;Humans;Male;Middle Aged;Placebos;Randomized Controlled Trials as Topic;Simvastatin/pharmacology;Simvastatin/therapeutic use*;Vitamins/administration & dosage;Vitamins/pharmacology
11848731;Chemotherapy, Adjuvant;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/pathology;Colonic Neoplasms/surgery;Colonoscopy/standards;Humans;Incidence;Neoplasms, Multiple Primary/diagnosis;Neoplasms, Second Primary/epidemiology*;Patient Compliance
11852035;Animals;Appetite Regulation/drug effects;Appetite Regulation/physiology*;Dose-Response Relationship, Drug;Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology;Feeding Behavior/drug effects;Feeding Behavior/physiology*;Male;Naltrexone/analogs & derivatives*;Naltrexone/pharmacology;Narcotic Antagonists/pharmacology*;Narcotics/pharmacology*;Neural Pathways/drug effects;Neural Pathways/metabolism;Neurons/drug effects;Neurons/metabolism*;Nucleus Accumbens/drug effects;Nucleus Accumbens/metabolism;Rats;Rats, Sprague-Dawley;Receptors, Opioid, delta/agonists;Receptors, Opioid, delta/antagonists & inhibitors;Receptors, Opioid, delta/metabolism;Receptors, Opioid, kappa/agonists;Receptors, Opioid, kappa/antagonists & inhibitors;Receptors, Opioid, kappa/metabolism;Receptors, Opioid, mu/agonists;Receptors, Opioid, mu/antagonists & inhibitors;Receptors, Opioid, mu/metabolism*;Synaptic Transmission/drug effects;Synaptic Transmission/physiology;Ventral Tegmental Area/drug effects;Ventral Tegmental Area/metabolism*
11863478;Aged;Aged, 80 and over;Anemia, Iron-Deficiency/diagnosis*;Blood Cell Count;Bone Marrow Examination;Chronic Disease;Enzyme-Linked Immunosorbent Assay;Female;Ferritins/blood*;Humans;Iron/blood;Male;Prospective Studies;Receptors, Transferrin/blood*;Sensitivity and Specificity
11879351;Adult;Age of Onset;Chronic Disease;Comorbidity;Disease Progression;Epilepsy/diagnosis*;Epilepsy/epidemiology;Epilepsy/surgery;Female;Humans;Male;Middle Aged;New York City/epidemiology;Prevalence;Psychotic Disorders/diagnosis*;Psychotic Disorders/epidemiology;Recurrence;Retrospective Studies;Risk Factors;Time Factors
11880600;Antibodies/chemistry*;Carbon/chemistry*;Carbon/immunology;Computer Simulation*;Models, Molecular;Nanotechnology;Protein Structure, Tertiary
11880735;Child;Humans;Magnetic Resonance Imaging;Menisci, Tibial/abnormalities*;Menisci, Tibial/surgery;Musculoskeletal Abnormalities/diagnosis;Musculoskeletal Abnormalities/surgery
11882490;Commerce*;Conservation of Natural Resources/economics*;Humans;Industry;Organizational Innovation;Organizational Policy;Public Policy*;Social Conditions*
11884874;Adult;Choroid Diseases/complications*;Choroid Diseases/diagnosis;Choroid Diseases/physiopathology;Female;Fluorescein Angiography;Follow-Up Studies;Humans;Interferometry;Laser Coagulation;Light;Male;Middle Aged;Recurrence;Retinal Diseases/complications*;Retinal Diseases/diagnosis;Retinal Diseases/physiopathology;Tomography;Visual Acuity
11888303;Aspartate Aminotransferases/chemistry;Aspartate Aminotransferases/genetics;Aspartate Aminotransferases/metabolism*;Base Sequence;Binding Sites;Catalysis;DNA Primers;Hydrogen-Ion Concentration;Imines/metabolism*;Kinetics;Lyases/chemistry;Lyases/genetics;Lyases/metabolism*;Mutagenesis, Site-Directed
11888341;Antipsychotic Agents*/adverse effects;Antipsychotic Agents*/pharmacokinetics;Antipsychotic Agents*/pharmacology;Antipsychotic Agents*/therapeutic use;Humans;Schizophrenia/drug therapy*;Sulpiride*/adverse effects;Sulpiride*/analogs & derivatives*;Sulpiride*/pharmacokinetics;Sulpiride*/pharmacology;Sulpiride*/therapeutic use
11888608;Anemia/blood;Anemia/genetics*;Animals;Disease Models, Animal;HLA Antigens/genetics*;Hemochromatosis/blood;Hemochromatosis/genetics*;Hemochromatosis Protein;Histocompatibility Antigens Class I/genetics*;Humans;Intestinal Absorption/genetics*;Iron/blood*;Iron Overload/blood;Iron Overload/genetics*;Membrane Proteins*;Models, Molecular;Mutation/genetics*;Receptors, Transferrin/blood;Transferrin/metabolism
11893011;Adult;Clomiphene/pharmacology*;Embryo Transfer;Endothelial Growth Factors/metabolism*;Female;Fertilization in Vitro;Follicular Fluid/metabolism*;Humans;Lymphokines/metabolism*;Male;Menotropins/pharmacology*;Ovulation Induction*;Vascular Endothelial Growth Factor A;Vascular Endothelial Growth Factors
11898927;Adolescent;Adult;Aged;Aged, 80 and over;Child;Child, Preschool;Death, Sudden, Cardiac/epidemiology*;Female;Humans;Infant;Male;Middle Aged;United States/epidemiology
11905478;Cloning, Organism*/legislation & jurisprudence;Europe;Government Regulation;Humans;Internationality
11916716;Bacteria/classification*;Bacteria/genetics;Bacteria/growth & development;Bacteria/metabolism*;Biofilms/growth & development*;Bioreactors*;Chlorides;DNA, Ribosomal Spacer/analysis;Mercury/metabolism*;Microscopy, Electron, Scanning;Oxidation-Reduction;Oxygen Consumption;RNA, Ribosomal, 16S/genetics;RNA, Ribosomal, 23S/genetics;Waste Disposal, Fluid/instrumentation;Waste Disposal, Fluid/methods;Water Microbiology;Water Pollution, Chemical
11924074;Hemofiltration*;Humans;Leukocyte Count*;Leukocyte Transfusion/adverse effects;Leukocyte Transfusion/economics*;Leukocyte Transfusion/standards*
11934239;Forecasting/methods*;Models, Chemical*;Polyethylene Glycols/chemistry*
11941293;Biocompatible Materials*;Humans;Neoplasms/surgery;Surgical Staplers/trends;Suture Techniques*/trends;Sutures*/trends
11948310;Animals;Animals, Domestic*;Animals, Wild*;Canada/epidemiology;Deer*;Prion Diseases/epidemiology;Prion Diseases/transmission*;Prion Diseases/veterinary;United States/epidemiology
11961313;Adolescent;Adult;Aged;Antibiotics, Antineoplastic/administration & dosage;Antibiotics, Antineoplastic/adverse effects;Antibiotics, Antineoplastic/therapeutic use*;Bleomycin/administration & dosage;Bleomycin/adverse effects;Bleomycin/therapeutic use*;Brain/radiation effects;Child;Child, Preschool;Craniopharyngioma/diagnostic imaging;Craniopharyngioma/drug therapy*;Craniopharyngioma/surgery;Female;Follow-Up Studies;Humans;Injections;L-Lactate Dehydrogenase/metabolism;Male;Middle Aged;Pituitary Neoplasms/diagnostic imaging;Pituitary Neoplasms/drug therapy*;Pituitary Neoplasms/surgery;Postoperative Care*;Retrospective Studies;Tomography, X-Ray Computed/methods
11966707;Adult;Aged;Agricultural Workers' Diseases/diagnosis*;Agricultural Workers' Diseases/immunology;Agricultural Workers' Diseases/pathology;Female;Humans;Immunocompromised Host;Male;Opportunistic Infections/diagnosis*;Opportunistic Infections/immunology;Opportunistic Infections/pathology;Prototheca*;Skin Diseases, Infectious/diagnosis*;Skin Diseases, Infectious/immunology;Skin Diseases, Infectious/pathology
11971643;Adenocarcinoma/chemically induced;Adenocarcinoma/chemistry;Adenocarcinoma/pathology;Adenocarcinoma/prevention & control*;Aminobiphenyl Compounds/toxicity*;Animals;Carcinogens/toxicity*;Diet;Disease Models, Animal;Dose-Response Relationship, Drug;Estrogens, Non-Steroidal/therapeutic use*;Hyperplasia/chemically induced;Hyperplasia/drug therapy;Hyperplasia/pathology;Immunoenzyme Techniques;Male;Phenols/therapeutic use*;Proliferating Cell Nuclear Antigen/analysis;Prostate/chemistry;Prostate/drug effects;Prostate/pathology;Prostatic Neoplasms/chemically induced;Prostatic Neoplasms/chemistry;Prostatic Neoplasms/pathology;Prostatic Neoplasms/prevention & control*;Rats;Rats, Inbred F344
11975118;Adult;Double-Blind Method;Enzyme Inhibitors/therapeutic use*;Female;Humans;Male;NG-Nitroarginine Methyl Ester/therapeutic use*;Nasal Lavage Fluid/chemistry;Nitric Oxide/analysis;Rhinitis, Allergic, Seasonal/drug therapy*;Rhinitis, Allergic, Seasonal/enzymology
11979216;Benchmarking;Curriculum;Enteral Nutrition/nursing*;Humans;Nurse Clinicians*/education;Nurse's Role*;United Kingdom
11979412;Algorithms;Emergencies;Female;Genital Diseases, Female/surgery*;Humans;Laparoscopy/methods*;Ovarian Cysts/surgery;Ovarian Neoplasms/surgery;Pelvic Inflammatory Disease/surgery;Pregnancy;Pregnancy, Ectopic/surgery;Teratoma/surgery;Torsion Abnormality/surgery
11984615;Aircraft*;Animals;Disinfection/methods*;Environmental Exposure;Humans;Insect Control/methods*;Insect Vectors;Insecticides*/adverse effects;Public Health;Pyrethrins*/adverse effects;World Health Organization
11986108;Adult;Aged;Aged, 80 and over;Anterior Chamber/microbiology;Bacteria/isolation & purification;Endophthalmitis/diagnosis;Endophthalmitis/etiology*;Endophthalmitis/therapy;Eye Infections, Bacterial/diagnosis;Eye Infections, Bacterial/drug therapy;Eye Infections, Bacterial/etiology*;Female;Filtering Surgery/adverse effects*;Fluorouracil/therapeutic use;Glaucoma/drug therapy;Glaucoma/surgery;Humans;Intraocular Pressure;Male;Middle Aged;Mitomycin/therapeutic use;Retrospective Studies;Risk Factors;Surgical Wound Infection/diagnosis;Surgical Wound Infection/etiology*;Surgical Wound Infection/therapy;Visual Acuity*;Vitreous Body/microbiology
12000745;Base Sequence;Cell Line;Consensus Sequence;Cyclic AMP/metabolism;Humans;Interleukin-6/genetics*;Kinetics;NF-kappa B/metabolism*;Oligodeoxyribonucleotides;Osteoblasts/drug effects;Osteoblasts/metabolism*;Parathyroid Hormone-Related Protein;Peptide Fragments/pharmacology*;Proteins/pharmacology*;RNA, Messenger/genetics;Transcription, Genetic/drug effects
12004042;Clinical Medicine/education*;Clinical Medicine/trends*;Humans;Orthopedics/education*;Orthopedics/trends*;Research/education*;Research/trends*
12010446;Cost-Benefit Analysis;Evidence-Based Medicine/economics;Evidence-Based Medicine/ethics;Health Care Rationing/economics;Health Care Rationing/ethics*;Hemophilia A/economics;Hemophilia A/therapy*;Humans
12012458;Adsorption;Chymotrypsin/chemistry;Enzymes/chemistry*;Kinetics;Lipase/chemistry;Protein Conformation;Protein Structure, Secondary;Protein Structure, Tertiary;Spectroscopy, Fourier Transform Infrared;Time Factors
12013105;Adult;Aged;Antineoplastic Agents, Phytogenic/therapeutic use*;Carcinoma, Squamous Cell/drug therapy*;Carcinoma, Squamous Cell/radiotherapy*;Combined Modality Therapy;Dose-Response Relationship, Drug;Dose-Response Relationship, Radiation;Female;Humans;Middle Aged;Neoplasm Recurrence, Local/drug therapy;Neoplasm Recurrence, Local/radiotherapy;Paclitaxel/therapeutic use*;Pilot Projects;Radiation-Sensitizing Agents/therapeutic use*;Uterine Cervical Neoplasms/drug therapy*;Uterine Cervical Neoplasms/radiotherapy*
12023345;Animals;B-Lymphocytes/physiology*;Basic Helix-Loop-Helix Transcription Factors;Cell Differentiation;DNA/metabolism;DNA-Binding Proteins/physiology*;Inhibitor of Differentiation Protein 2;Mice;Mice, Inbred C57BL;Repressor Proteins*;Spleen/immunology*;Transcription Factors/metabolism;Transcription Factors/physiology*;Transcription, Genetic
12034873;Animals;Ants/genetics*;Ants/physiology;DNA Primers;Female;Polymerase Chain Reaction;Reproduction;Seasons;Social Behavior*;Southwestern United States
12048495;Community Health Nursing*;Humans;Job Satisfaction*;United Kingdom
12059132;Angiography;Antibodies, Antiphospholipid/blood;Antiphospholipid Syndrome/complications*;Antiphospholipid Syndrome/immunology;Antiphospholipid Syndrome/pathology;Fatal Outcome;Female;Humans;Immunoglobulins/blood;Leiomyosarcoma/complications*;Leiomyosarcoma/immunology;Leiomyosarcoma/pathology;Magnetic Resonance Imaging;Middle Aged;Phlebography;Thromboembolism/etiology*;Thromboembolism/immunology;Thromboembolism/pathology;Vascular Neoplasms/complications*;Vascular Neoplasms/immunology;Vascular Neoplasms/pathology;Vena Cava, Inferior/pathology*;Venous Thrombosis/etiology*;Venous Thrombosis/immunology;Venous Thrombosis/pathology
12065277;Asia, Southeastern/ethnology;Coronary Artery Bypass/statistics & numerical data*;England;Ethnic Groups*;Health Services Accessibility/statistics & numerical data*;Humans;Medical Audit
12068796;Anemia, Sickle Cell/complications;Anemia, Sickle Cell/epidemiology;Anemia, Sickle Cell/therapy*;Comprehensive Health Care*;Europe/epidemiology;Female;Humans;Pregnancy
12071551;Aged;Developing Countries;Health Services Needs and Demand;Humans;Population Dynamics*;Rural Health/trends*
12079610;Adolescent;Adult;Antioxidants/chemistry;Dose-Response Relationship, Drug;Female;Humans;Hydroxyl Radical/analysis*;Lipid Peroxidation*;Male;Nickel/adverse effects*;Plasma/chemistry;alpha-Tocopherol/blood*
12079809;Aggression;Anger/physiology*;Cognitive Therapy*;Humans;Mental Disorders/psychology;Mental Disorders/therapy;Violence
12084977;Abnormalities, Multiple/genetics*;Adolescent;Chromosomes, Human, Pair 8*;Humans;Male;Mosaicism*;Trisomy*
12085651;Accidents, Traffic*;Automobiles;Biomechanical Phenomena;Humans;Manikins*;Posture;Seat Belts*
12085983;Age Distribution;Aged;Clinical Trials as Topic/methods*;Clinical Trials as Topic/trends;Female;Heart Failure/drug therapy*;Humans;Male;Middle Aged;Practice Guidelines as Topic;Selection Bias*;Sex Distribution
12105184;Animals;Blotting, Western;Calcium/metabolism*;Calcium-Binding Proteins/metabolism*;Calreticulin;Cell Differentiation;Cell Nucleus/metabolism;Cells, Cultured;Chelating Agents/pharmacology;Cytosol/metabolism;Electrophoresis, Gel, Two-Dimensional;Fluorescent Dyes/pharmacology;Heart/embryology;Heart/physiology*;Immunohistochemistry;Ionomycin/pharmacology*;Ionophores/metabolism;Ionophores/pharmacology;Mice;Muscle Development/physiology*;Myocardium/metabolism*;Organic Chemicals*;Phenotype;Phosphorylation;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Ribonucleoproteins/metabolism*;Time Factors
12107449;Animals;Erythrocytes/parasitology*;Fish Diseases/parasitology;Fishes/parasitology*;Microscopy, Electron;Parasites/isolation & purification;Parasites/ultrastructure*
12109927;Animals;Antithrombin III/adverse effects;Antithrombin III/agonists;Antithrombin III/pharmacokinetics;Antithrombin III/pharmacology;Antithrombin III/therapeutic use*;Biological Availability;Clinical Trials, Phase II as Topic;Clinical Trials, Phase III as Topic;Female;Humans;Male;Polysaccharides/adverse effects;Polysaccharides/pharmacokinetics;Polysaccharides/pharmacology;Polysaccharides/therapeutic use*;Thromboembolism/prevention & control*;Treatment Outcome
12110072;Aged;Aged, 80 and over;Body Composition;Diet;Exercise/physiology*;Female;Humans;Male;Middle Aged;Muscle, Skeletal/physiology;Physical Endurance/physiology;Psychomotor Performance/physiology*;Time Factors;Weight Lifting/physiology
12111619;Adolescent;Adult;Arousal/physiology;Behavioral Symptoms/epidemiology;Behavioral Symptoms/etiology*;Behavioral Symptoms/physiopathology;Chronobiology Disorders/complications;Chronobiology Disorders/epidemiology;Chronobiology Disorders/physiopathology;Cross-Sectional Studies;Female;Humans;Male;Mood Disorders/epidemiology;Mood Disorders/etiology*;Mood Disorders/physiopathology;Prevalence;Risk Factors;Sex Factors;Sleep Arousal Disorders/complications;Sleep Arousal Disorders/epidemiology;Sleep Arousal Disorders/physiopathology;Sleep Deprivation/complications*;Sleep Deprivation/epidemiology;Sleep Deprivation/psychology*;Sleep Initiation and Maintenance Disorders/complications;Sleep Initiation and Maintenance Disorders/epidemiology;Sleep Initiation and Maintenance Disorders/physiopathology;Sleep Stages/physiology;Surveys and Questionnaires
12113516;Book Selection;Education, Medical, Graduate;Evaluation Studies as Topic;Humans;Librarians;Libraries, Medical/standards*;Libraries, Medical/utilization;Library Collection Development/standards*;Library Collection Development/utilization;Library Materials/standards*;Library Materials/utilization;Saskatchewan;Toxicology*
12116480;Animals;Classification/methods;Developmental Biology/methods*;Models, Biological;Morphogenesis
12120444;Herpesvirus 8, Human*;Humans;Sarcoma, Kaposi/diagnosis*;Sarcoma, Kaposi/therapy*;Skin Neoplasms/diagnosis*;Skin Neoplasms/therapy*
12150038;Adaptation, Psychological;Animals;Cognition*;Female;Learning*;Male;Perception;Songbirds*
12194653;Chronic Disease;Diabetes Complications*;Diabetes Mellitus/epidemiology;Diabetes Mellitus/nursing*;Diabetes Mellitus, Type 1/complications;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 2/complications;Diabetes Mellitus, Type 2/drug therapy;Diabetic Neuropathies/etiology;Humans;Hypoglycemic Agents/therapeutic use;Male;Middle Aged;Perioperative Nursing*;United States/epidemiology
12208302;Aerobiosis;Anaerobiosis;Animals;Body Constitution;Decapodiformes/anatomy & histology;Decapodiformes/physiology;Energy Metabolism;Environment;Hydrogen-Ion Concentration;Invertebrates/anatomy & histology*;Invertebrates/physiology*;Marine Biology;Models, Biological;Muscles/physiology;Nematoda/anatomy & histology;Nematoda/physiology;Oxygen Consumption;Physical Exertion/physiology;Species Specificity;Temperature
12210256;Cell Separation/methods;Electrophoresis, Capillary/instrumentation;Electrophoresis, Capillary/methods*;Erythrocytes/cytology*;Humans;Miniaturization/methods;Weightlessness*
12210543;Animals;Antioxidants/administration & dosage;Antioxidants/therapeutic use*;Complement System Proteins/deficiency;Complement System Proteins/drug effects;Disease Models, Animal;Dose-Response Relationship, Drug;Elapid Venoms/pharmacology;Injections, Intraperitoneal;Intubation, Intratracheal;Lung/drug effects;Lung/pathology;Male;Mustard Gas/administration & dosage;Mustard Gas/analogs & derivatives*;Mustard Gas/toxicity*;Neutropenia/immunology;Neutrophils/immunology;Rats;Rats, Long-Evans;Respiratory Distress Syndrome, Adult/chemically induced;Respiratory Distress Syndrome, Adult/pathology;Respiratory Distress Syndrome, Adult/prevention & control*;Specific Pathogen-Free Organisms
12215098;Antibiotics, Antitubercular/adverse effects*;Antibiotics, Antitubercular/therapeutic use;Female;Humans;Lenses, Intraocular*;Middle Aged;Mycobacterium avium Complex/isolation & purification;Mycobacterium avium-intracellulare Infection/drug therapy;Pigmentation Disorders/chemically induced*;Rifabutin/adverse effects*;Rifabutin/therapeutic use;Silicone Elastomers*
12230323;Animals;Antibodies/pharmacology;Blotting, Northern;Blotting, Western;Brain/cytology;Brain/metabolism;Brain/secretion*;Brain Chemistry;CHO Cells;Cell Differentiation/drug effects;Cell Line;Cell Membrane/metabolism;Cricetinae;Enzyme Inhibitors/pharmacology;Female;Glycoproteins/antagonists & inhibitors;Glycoproteins/genetics;Glycoproteins/metabolism*;Glycoproteins/pharmacology;Humans;Male;Microscopy, Fluorescence;Nerve Growth Factor/pharmacology;Neurites/drug effects;Neurites/physiology;Neurites/ultrastructure;Neurons/cytology;Neurons/drug effects;Neurons/metabolism*;Organ Specificity;RNA, Messenger/analysis;RNA, Messenger/metabolism;RNA, Messenger/secretion*
12283786;Abortifacient Agents*;Abortion, Induced;Asia;Asia, Southeastern;Attitude;Behavior;Catholicism*;Christianity;Communication*;Contraception;Contraceptive Agents;Contraceptive Agents, Female;Contraceptives, Oral*;Demography;Developing Countries;Evaluation Studies as Topic;Family Planning Services;Health Knowledge, Attitudes, Practice*;Injections*;Intrauterine Devices*;Maternal Mortality*;Medroxyprogesterone Acetate*;Mortality;Philippines;Population;Population Dynamics;Psychology;Public Opinion*;Religion;Risk Assessment*
12297339;Animals;Catalysis;Cells, Cultured;Cellular Senescence*/physiology;Down-Regulation*;Electron Transport Complex IV/genetics;Electron Transport Complex IV/metabolism*;Endothelium, Vascular/cytology;Mitochondria/enzymology*;Pulmonary Artery;RNA, Messenger/metabolism;Swine
12308407;Contraception;Contraceptives, Oral*;Culture;Demography;Disease;Ethnic Groups*;Evaluation Studies as Topic*;Family Planning Services;Gallbladder Diseases*;In Vitro Techniques;Philippines;Population;Population Characteristics;Research
12320922;Asia;Asia, Southeastern;Biology;Delivery of Health Care;Developing Countries;Dietary Supplements*;Disease;Eye*;Health;Health Planning*;Health Services;Indonesia;Nutrition Disorders*;Physiology;Primary Health Care;Vitamin A*;Vitamins
12358094;Age Factors;Chronobiology Phenomena;Diabetes Complications;Electrocardiography;Heart Diseases/complications;Heart Diseases/diagnosis*;Heart Diseases/physiopathology*;Heart Rate/physiology*;Humans;Monitoring, Physiologic/methods*;Posture;Sex Characteristics;Signal Processing, Computer-Assisted*;Sleep/physiology*;Sleep Apnea Syndromes/complications;Wakefulness/physiology*
12365249;Adult;Electromyography/methods;Female;Humans;Male;Movement/physiology*;Muscle Contraction/physiology*;Muscle Fibers, Skeletal/physiology*;Muscle Spindles/physiology;Muscle, Skeletal/physiology*;Proprioception/physiology;Rotation*;Tibia;Time Factors
12368204;Animals;CD4-Positive T-Lymphocytes/immunology*;Chemokine CXCL9;Chemokines, CXC/biosynthesis*;Chemokines, CXC/physiology*;Coronary Disease/immunology*;Coronary Disease/pathology;Heart Transplantation/immunology;Heart Transplantation/pathology*;Intercellular Signaling Peptides and Proteins*;Interferon-gamma/biosynthesis;Mice;Mice, Inbred C57BL;Models, Animal;Postoperative Complications;Time Factors;Transplantation, Homologous/pathology
12370227;Action Potentials*/drug effects;Animals;Arrhythmias, Cardiac/diagnosis;Arrhythmias, Cardiac/etiology;Arrhythmias, Cardiac/physiopathology;Cells, Cultured;Culture Techniques;Dogs;Female;Heart/physiology;Kinetics;Male;Pericardium/drug effects;Pericardium/physiology*;Phenotype;Pinacidil/pharmacology;Sex Factors*;Syndrome;Terfenadine/pharmacology
12371293;Aged;Geriatric Nursing*;Germany;Homes for the Aged;Homosexuality, Male/psychology*;Humans;Male;Middle Aged;Nurse-Patient Relations*;Nursing Homes;Quality of Life/psychology
12378998;Adult;Aged;Blood Flow Velocity/physiology;Brain/blood supply;Brain Damage, Chronic/diagnostic imaging;Brain Damage, Chronic/physiopathology;Brain Damage, Chronic/prevention & control*;Equipment Design;Female;Humans;Hypothermia, Induced/instrumentation;Hypothermia, Induced/methods*;Male;Middle Aged;Oxygen Consumption/physiology;Retrospective Studies;Subarachnoid Hemorrhage/diagnostic imaging;Subarachnoid Hemorrhage/physiopathology;Subarachnoid Hemorrhage/therapy*;Tomography, Emission-Computed/instrumentation;Vasospasm, Intracranial/diagnostic imaging;Vasospasm, Intracranial/physiopathology;Vasospasm, Intracranial/therapy
12381638;Adult;Aged;Aged, 80 and over;Aortic Valve Insufficiency/diagnostic imaging*;Aortic Valve Insufficiency/physiopathology;Blood Flow Velocity;Coronary Circulation/physiology;Echocardiography, Doppler, Color/methods*;Female;Humans;Image Processing, Computer-Assisted/methods;Male;Middle Aged;Stroke Volume/physiology
12389770;Chronic Disease;Drug Therapy/standards*;Family Practice/organization & administration*;Humans;Medical Records Systems, Computerized;Monitoring, Physiologic/methods*;Quality Assurance, Health Care
12396069;Gene Expression Regulation/drug effects;Ginkgo biloba;Oligonucleotide Array Sequence Analysis;Plant Extracts/analysis*;Plant Extracts/chemistry*;Plant Extracts/genetics;Plant Extracts/pharmacology
12397699;Angiotensin Receptor Antagonists*;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Benzimidazoles/therapeutic use*;Chronic Disease;Glomerulonephritis/drug therapy*;Humans;Kidney/drug effects*;Prospective Studies;Tetrazoles/therapeutic use*
12399046;Amino Acid Sequence;Amino Acid Substitution;Carrier Proteins/chemistry;Carrier Proteins/genetics;Carrier Proteins/metabolism*;Conserved Sequence;Escherichia coli/genetics;Escherichia coli/growth & development;Escherichia coli/metabolism*;Molecular Sequence Data;Mutagenesis, Site-Directed;Zinc/metabolism*
12400480;Acquired Immunodeficiency Syndrome*/prevention & control;Community Networks;Female;Financing, Government;Global Health*;Humans;Sex Work;South Africa
12408482;Barrett Esophagus/radiotherapy*;Epithelium/radiation effects;Equipment Design;Hot Temperature;Humans;Microwaves*;Phantoms, Imaging;Polytetrafluoroethylene/chemistry;Radiotherapy/instrumentation*;Radiotherapy/methods*;Temperature
12417150;Amino Acid Sequence;Base Sequence;DNA Transposable Elements/genetics*;Evolution, Molecular;Gene Expression Regulation, Developmental;Genome, Plant;Magnoliopsida/genetics*;Magnoliopsida/growth & development;Molecular Sequence Data;Mutagenesis, Insertional;Mutation;Phylogeny;Sequence Homology, Amino Acid
12422412;Animals;Aquaporin 2;Aquaporin 6;Aquaporins/metabolism*;Caveolae/drug effects;Caveolae/metabolism;Caveolae/ultrastructure;Caveolin 1;Caveolins/metabolism;Cell Compartmentation/drug effects;Cell Compartmentation/physiology*;Cell Membrane/drug effects;Cell Membrane/metabolism*;Endosomes/drug effects;Endosomes/metabolism;Endosomes/ultrastructure;Epithelial Cells/cytology;Epithelial Cells/drug effects;Epithelial Cells/metabolism*;Immunohistochemistry;Intracellular Fluid/drug effects;Intracellular Fluid/metabolism;Kidney Tubules, Collecting/cytology;Kidney Tubules, Collecting/drug effects;Kidney Tubules, Collecting/metabolism*;Male;Membrane Proteins/metabolism;Organelles/drug effects;Organelles/metabolism;Protein Transport/drug effects;Protein Transport/physiology*;Rats;Rats, Wistar;Transport Vesicles/drug effects;Transport Vesicles/metabolism;Vasopressins/metabolism;Vasopressins/pharmacology;Vesicular Transport Proteins
12430557;Economics/history*;Family Planning Services/history*;History, 20th Century;Physicians/history*;United States
12444975;Amino Acid Sequence;Bordetella/enzymology*;Chromatography, DEAE-Cellulose;Electrophoresis, Polyacrylamide Gel;Hydrolysis;Molecular Sequence Data;Molecular Weight;Oxygenases/chemistry;Oxygenases/isolation & purification;Oxygenases/metabolism*;Substrate Specificity
12453599;Adolescent;Age of Onset;Cerebral Cortex/abnormalities*;Cerebral Cortex/physiopathology*;Child;Child, Preschool;Electroencephalography;Epilepsy/epidemiology;Epilepsy/etiology*;Epilepsy/physiopathology*;Female;Functional Laterality/physiology;Humans;Infant;Infant, Newborn;Intellectual Disability/etiology;Intellectual Disability/physiopathology;Male;Movement Disorders/etiology;Movement Disorders/physiopathology;Myoclonus/etiology;Myoclonus/physiopathology;Nervous System Malformations/pathology;Nervous System Malformations/physiopathology*;Predictive Value of Tests;Prognosis;Sleep/physiology;Sleep Disorders, Intrinsic/etiology;Sleep Disorders, Intrinsic/physiopathology;Spasms, Infantile/etiology;Spasms, Infantile/physiopathology
12458828;Amino Acid Sequence;Animals;Base Sequence;Binding Sites;Blotting, Western;Cloning, Molecular;Cysteine/analysis*;DNA, Complementary/genetics;DNA, Complementary/isolation & purification;Electrophoresis, Polyacrylamide Gel;Gene Expression;Gene Library;Genes, Helminth;Helminth Proteins/chemistry*;Helminth Proteins/genetics*;Male;Models, Molecular;Molecular Sequence Data;Oesophagostomum/chemistry*;Oesophagostomum/genetics*;Protein Conformation;Sequence Homology, Amino Acid;Sex Characteristics*;Trypsin Inhibitors/chemistry*;Trypsin Inhibitors/genetics*
12465644;Beginning of Human Life;Cloning, Organism;Commodification;Cryopreservation;Embryo Research/ethics*;Embryo Research/legislation & jurisprudence*;Embryo Transfer;Embryo, Mammalian*;Female;Fertilization in Vitro/ethics;Fertilization in Vitro/legislation & jurisprudence*;Genetic Engineering;Government Regulation;Guidelines as Topic;Human Rights/legislation & jurisprudence;Humans;Internationality*;Preimplantation Diagnosis;Public Policy;Surrogate Mothers
12471510;Animals;Disease Models, Animal;Dogs;Genetic Therapy/methods*;Humans;Mice;Retinal Degeneration/genetics;Retinal Degeneration/therapy*;Sus scrofa
12480296;Administration, Oral;Animals;Antimutagenic Agents/administration & dosage;Antimutagenic Agents/pharmacology*;Bixaceae;Bone Marrow Cells/drug effects*;Carotenoids;Cyclophosphamide/administration & dosage;Cyclophosphamide/toxicity;Diet;Dose-Response Relationship, Drug;Drug Synergism;Food Coloring Agents/toxicity*;Injections, Intraperitoneal;Male;Mice;Micronucleus Tests;Mutagens/administration & dosage;Mutagens/toxicity*;Plant Extracts/administration & dosage;Plant Extracts/toxicity*
12483767;Beauty Culture;Data Interpretation, Statistical*;Hand Dermatoses/epidemiology;Humans;Logistic Models*;Randomized Controlled Trials as Topic/methods*;Risk Factors
12485639;Adolescent;Adult;Finger Joint/physiology*;Fingers/physiology;Friction;Hand Strength/physiology;Humans;Isotonic Contraction/physiology*;Male;Middle Aged;Movement/physiology*;Muscle, Skeletal/physiology*;Physical Exertion/physiology;Reproducibility of Results;Sensitivity and Specificity;Sports;Stress, Mechanical;Tendons/physiology*;Weight-Bearing/physiology*;Wrist Joint/physiology
12495156;Data Interpretation, Statistical*;Humans;Likelihood Functions;Randomized Controlled Trials as Topic/methods*;Treatment Outcome
12499093;Carcinoma, Non-Small-Cell Lung/diagnosis;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/metabolism;Carcinoma, Non-Small-Cell Lung/pathology;Cisplatin/pharmacology*;Cisplatin/therapeutic use*;Drug Resistance, Neoplasm*;Female;Gene Expression Regulation, Neoplastic;Humans;Lung Neoplasms/diagnosis;Lung Neoplasms/drug therapy*;Lung Neoplasms/metabolism;Lung Neoplasms/pathology;Male;Middle Aged;Neoplasm Staging;Prognosis;Proto-Oncogene Proteins c-bcl-2/metabolism*;Retinoblastoma Protein/metabolism*;Smoking;Tumor Suppressor Protein p53/metabolism*
12503590;Child, Preschool;Heart Neoplasms/pathology*;Humans;Male;Rhabdomyoma/pathology*
12504562;Alkaline Phosphatase/genetics*;Cell Line;Gene Products, tat/genetics;Genes, Reporter*;Hepacivirus/genetics*;Humans;Interferon-alpha/pharmacology;RNA, Viral/biosynthesis;Recombinant Proteins;Replicon*;Transfection
12520026;Animals;Binding Sites;Databases, Genetic*;Eukaryotic Cells/metabolism;Gene Expression Profiling;Gene Expression Regulation*;Gene Expression Regulation, Developmental;Humans;Mice;Promoter Regions, Genetic;Saccharomyces/genetics;Saccharomyces/metabolism;Tissue Distribution;Transcription Factors/genetics*;Transcription Factors/metabolism*;Transcription, Genetic*
12536517;Adult;Cardiac Tamponade/etiology;Cardiac Tamponade/surgery;Heart Arrest/complications;Heart Arrest/surgery*;Heart Injuries/complications;Heart Injuries/surgery*;Humans;Hypothermia, Induced*;Male;Resuscitation;Wounds, Penetrating/surgery*
12538135;Adolescent;Adult;Aged;Aged, 80 and over;Brazil/epidemiology;Cardiopulmonary Bypass*/mortality;Cardiopulmonary Bypass*/trends;Cause of Death;Coronary Artery Bypass*/mortality;Coronary Artery Bypass*/trends;Coronary Disease/complications;Coronary Disease/epidemiology;Coronary Disease/surgery;Female;Humans;Male;Middle Aged;Patient Selection*;Postoperative Complications/epidemiology;Postoperative Complications/etiology;Retrospective Studies;Risk Factors;Survival Analysis;Treatment Outcome
12538465;Antigens, Neoplasm/metabolism;DNA, Complementary/metabolism;Gene Library;Humans;Immunohistochemistry;Lymphoma, Non-Hodgkin/metabolism*;Male;Reverse Transcriptase Polymerase Chain Reaction;Testis/metabolism*
12544546;Adolescent;Adult;Age Factors;Aged;Algorithms;Child;Child, Preschool;Chronic Disease/classification;Clinical Pharmacy Information Systems*;Cohort Studies;Drug Costs*;Drug Prescriptions/economics;Economics, Medical;Female;Forecasting;Health Care Costs;Health Expenditures*;Health Maintenance Organizations;Humans;Male;Middle Aged;Models, Econometric;Outpatients;Regression Analysis;Retrospective Studies;Risk Adjustment*;Sex Factors;United States
12548449;Adolescent;Adult;Arthroscopy/methods*;Child;Female;Follow-Up Studies;Humans;Knee Joint/diagnostic imaging;Knee Joint/physiopathology;Knee Joint/surgery*;Male;Osteochondritis Dissecans/classification;Osteochondritis Dissecans/diagnostic imaging;Osteochondritis Dissecans/physiopathology;Osteochondritis Dissecans/surgery*;Radiography;Retrospective Studies;Treatment Outcome;Wound Healing/physiology*
12550039;Adolescent;Adult;Age Distribution;Age Factors;Aged;Anti-Bacterial Agents/pharmacology*;Blood/microbiology;Cefotaxime/pharmacology;Cerebrospinal Fluid/microbiology;Child;Child, Preschool;Drug Resistance, Bacterial;Erythromycin/pharmacology;Hospitals/statistics & numerical data;Humans;Microbial Sensitivity Tests;Middle Aged;Penicillin Resistance;Penicillins/pharmacology;Product Surveillance, Postmarketing;Quality Control;Spain;Streptococcus pneumoniae/drug effects*;Streptococcus pneumoniae/isolation & purification
12566234;Animals;Antibodies, Protozoan/analysis;Chronic Disease;Enzyme-Linked Immunosorbent Assay;Epilepsy/blood;Epilepsy/parasitology*;Humans;Immunoglobulin G/analysis;Toxoplasma/immunology;Toxoplasma/isolation & purification;Toxoplasmosis, Cerebral/parasitology*
12572099;Communication;Dental Health Surveys;Dentist-Patient Relations*;Humans;Informed Consent*/legislation & jurisprudence;Legislation, Dental;Netherlands;Patient Satisfaction*;Surveys and Questionnaires
12572450;Animals;Bacterial Infections/prevention & control;Bacterial Infections/veterinary;Breeding/methods*;Female;Male;Mycoses/prevention & control;Mycoses/veterinary;Reproductive Techniques;Turtles/anatomy & histology*;Turtles/growth & development*
12573423;Adult;Ethics, Medical*;Female;Humans;Male;Practice Guidelines as Topic;Professional Misconduct/ethics*;Professional-Family Relations/ethics*;Sexual Behavior/ethics*
12574968;Azure Stains;Bone Marrow Examination;Humans;Immunoglobulin A;Immunohistochemistry;Inclusion Bodies/pathology*;Inclusion Bodies/ultrastructure;Male;Microscopy, Electron;Middle Aged;Multiple Myeloma/pathology*;Multiple Myeloma/ultrastructure;Plasma Cells/pathology;Plasma Cells/ultrastructure
12575014;Abortion, Eugenic;Adult;Biomarkers, Tumor/analysis;Brain Neoplasms/chemistry;Brain Neoplasms/diagnosis*;Female;Fetal Diseases/diagnosis*;Humans;Immunohistochemistry;Magnetic Resonance Imaging;Pregnancy;Pregnancy Trimester, Second;Prognosis;Teratoma/chemistry;Teratoma/diagnosis*;Ultrasonography, Prenatal
12579524;Animals;Antioxidants/metabolism*;Glutathione Peroxidase/metabolism;Hippocampus/metabolism*;Lipid Peroxidation*;Male;Rats;Rats, Sprague-Dawley;Receptors, N-Methyl-D-Aspartate/metabolism*;Smoke*;Superoxide Dismutase/metabolism;Tobacco/metabolism*
12579695;Adolescent;Adult;Amnion/transplantation*;Burns, Chemical/surgery*;Child;Child, Preschool;Conjunctiva/surgery*;Eye Burns/chemically induced;Eye Burns/surgery*;Female;Follow-Up Studies;Humans;Male;Middle Aged;Reconstructive Surgical Procedures/methods;Stevens-Johnson Syndrome/surgery
12587795;Adolescent;Adult;Aged;Aged, 80 and over;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Brachytherapy*;Brain Neoplasms/drug therapy;Brain Neoplasms/radiotherapy*;Brain Neoplasms/surgery;Case-Control Studies;Combined Modality Therapy;Female;Follow-Up Studies;Glioblastoma/drug therapy;Glioblastoma/radiotherapy*;Glioblastoma/surgery;Humans;Male;Middle Aged;Radiosurgery;Survival Rate;Treatment Outcome
12591344;Adult;Female;Follow-Up Studies;Histocompatibility Testing;Humans;Immunosuppressive Agents/therapeutic use;Kidney*;Kidney Transplantation/immunology;Kidney Transplantation/physiology*;Living Donors*;Male;Middle Aged;Reoperation;Retrospective Studies;Spouses;Time Factors;Treatment Outcome
12591619;Chickenpox/epidemiology;Chickenpox/transmission*;Disease Transmission, Infectious;Epidemiologic Methods*;Herpes Zoster/epidemiology;Herpes Zoster/transmission*;Herpesvirus 3, Human*;Humans;Models, Biological*;Population Dynamics
12592236;Double-Blind Method;Drug Combinations;Endometrial Hyperplasia/chemically induced;Endometrial Hyperplasia/epidemiology;Endometrial Hyperplasia/pathology;Endometrium/drug effects*;Endometrium/pathology;Estradiol Congeners/adverse effects*;Ethinyl Estradiol/adverse effects*;Female;Humans;Incidence;Middle Aged;Norethindrone/adverse effects*;Norethindrone/analogs & derivatives*;Placebos/therapeutic use;Safety;Severity of Illness Index
12593249;Female;Humans;Postmenopause/drug effects*;Practice Guidelines as Topic*;Selective Estrogen Receptor Modulators/therapeutic use*
12605175;Adolescent;Adult;Aged;Digestive System Surgical Procedures/trends*;Digestive System Surgical Procedures/utilization*;Gastroesophageal Reflux/surgery*;Health Policy;Humans;Laparoscopy/trends*;Laparoscopy/utilization*;Middle Aged;New England
12609930;Exercise*;Female;Humans;Time Factors;United Kingdom;Women's Health*;Women, Working
12610642;Anger/physiology*;Brain/physiology*;Brain Diseases/physiopathology*;Brain Diseases/psychology;Humans;Violence*
12627341;Adolescent;Adult;Age Factors;Aged;Diagnosis, Differential;Female;Humans;Hyperthyroidism/diagnosis*;Iodine/deficiency*;Iodine/therapeutic use;Male;Mass Screening;Middle Aged;Pregnancy;Pregnancy Complications/diagnosis;Pregnancy Complications/prevention & control;Radionuclide Imaging;Thyroid Gland/diagnostic imaging;Thyroiditis, Autoimmune/diagnosis;Thyrotropin/blood*;Ultrasonography
12639064;Adolescent;Adult;Aged;Aged, 80 and over;Female;Foot Diseases/physiopathology;Foot Diseases/therapy*;Health Services Research;Humans;Male;Middle Aged;Outcome Assessment (Health Care)/methods*;Podiatry/standards*;Self Efficacy;Surveys and Questionnaires*;Treatment Outcome;United Kingdom/epidemiology
12639876;Cohort Studies;Developmental Disabilities/etiology*;Female;Heart Defects, Congenital/surgery*;Humans;Infant;Infant, Newborn;Male;Neurologic Examination;Postoperative Care/methods;Postoperative Complications/etiology*;Prospective Studies;Psychomotor Disorders/etiology*
12639968;Capsid/chemistry*;Capsid/metabolism*;Dimerization;Dose-Response Relationship, Drug;Escherichia coli/metabolism;Guanidine/pharmacology;Hepatitis B Core Antigens/chemistry;Hepatitis B virus/chemistry*;Kinetics;Light;Scattering, Radiation;Thermodynamics;Time Factors;Tryptophan/pharmacology;Urea/pharmacology;Viral Core Proteins/chemistry;Virion/physiology;Virus Assembly*
12643538;Chromatography, High Pressure Liquid;Cysteine/analogs & derivatives*;Iodoacetamide/metabolism;Mass Spectrometry;Peptides/analysis*;Peptides/metabolism;Peptides, Cyclic/analysis;Peptides, Cyclic/chemical synthesis*;Peptides, Cyclic/metabolism
12650373;Contract Services/organization & administration*;Contract Services/trends;Decision Making, Organizational;Health Care Sector;Health Maintenance Organizations/economics*;Health Maintenance Organizations/trends;Health Services Accessibility/economics*;Health Services Accessibility/trends;Health Services Research;Humans;Longitudinal Studies;Medicare/economics*;Medicare/trends;Organizational Policy;Risk Sharing, Financial*;United States
12650722;Adult;Dehydroepiandrosterone/analysis*;Dehydroepiandrosterone/metabolism;Dietary Supplements;Doping in Sports*;Estranes/urine;Hormones/urine;Humans;Male;Mass Spectrometry;Middle Aged;Physical Endurance;Sports*;Substance Abuse Detection/methods*;Time Factors
12660016;Aged;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carboplatin/administration & dosage;Carcinoma, Small Cell/drug therapy*;Clinical Trials as Topic;Etoposide/administration & dosage;Humans;Lung Neoplasms/drug therapy*;Treatment Outcome
12662947;Bone Diseases/diagnosis;Child;Child, Preschool;Diabetes Insipidus/etiology;Diagnosis, Differential;Histiocytosis, Langerhans-Cell/diagnosis*;Humans;Infant;Liver Diseases/diagnosis;Magnetic Resonance Imaging/methods;Male;Nervous System Diseases/diagnosis;Prognosis;Tomography, X-Ray Computed/methods
12674010;Adaptation, Psychological*;Burnout, Professional/prevention & control*;Burnout, Professional/psychology*;Humans;Nursing Staff/psychology*;Occupational Health;Self Care/methods;Self Care/psychology;Spirituality*
12687327;Abdominal Wall;Adiponectin;Adipose Tissue/anatomy & histology*;Adipose Tissue/physiology;Adult;Aged;Aging/physiology*;Body Composition;Cohort Studies;Demography;Female;Humans;Insulin Resistance/ethics*;Insulin Resistance/physiology;Intercellular Signaling Peptides and Proteins*;Leptin/blood;Lipoproteins/blood*;Lipoproteins/physiology;Male;Middle Aged;Phenotype;Proteins/chemistry*;Proteins/physiology;Sex Characteristics*
12714644;Adolescent;Adult;Aged;Aging/physiology*;Calcium/metabolism*;Cataract/metabolism*;Child;Crystallins/metabolism*;Diabetes Mellitus/metabolism*;Humans;Lens, Crystalline/metabolism*;Light;Membrane Lipids/metabolism*;Middle Aged;Scattering, Radiation;Spectrophotometry, Atomic
12714983;Animals;Cytogenetic Analysis*;DNA, Ribosomal;Female;Grasshoppers/genetics*;In Situ Hybridization, Fluorescence;Male;Microsatellite Repeats
12715115;Animals;Brain Ischemia/physiopathology*;Brain Ischemia/prevention & control;Enzyme Inhibitors/pharmacology;Hippocampus/physiology;Ischemic Preconditioning/methods*;Male;NG-Nitroarginine Methyl Ester/pharmacology*;Nitric Oxide/physiology*;Nitric Oxide Synthase/antagonists & inhibitors*;Rats;Rats, Wistar
12728003;Animals;Anopheles/genetics*;Cell Line;Genetic Vectors/genetics*;Green Fluorescent Proteins;Luminescent Proteins/genetics;Microscopy, Fluorescence;RNA Interference*;RNA, Double-Stranded/genetics*
12730571;Foundations*;Genetic Research/economics*;Genomics;Research Support as Topic*;Universities/economics*;Washington
12735366;Animals;Behavior, Animal*;Deception*;Locomotion;Macaca;Male;Social Behavior;Social Dominance
12749277;Anti-Ulcer Agents/therapeutic use*;Diterpenes/therapeutic use*;Diterpenes, Abietane*;Drug Therapy, Combination;Female;Helicobacter Infections/drug therapy;Helicobacter pylori;Humans;Male;Middle Aged;Peptic Ulcer/drug therapy*;Peptic Ulcer/microbiology;Prospective Studies;Ranitidine/therapeutic use*;Secondary Prevention
12750918;Adult;Aged;Deglutition Disorders/diagnosis;Deglutition Disorders/drug therapy;Deglutition Disorders/etiology*;Diagnostic Techniques, Digestive System;Enzyme Inhibitors/therapeutic use;Female;Gastroesophageal Reflux/complications*;Gastroesophageal Reflux/diagnosis;Gastroesophageal Reflux/drug therapy;Gastroesophageal Reflux/physiopathology;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Omeprazole/therapeutic use;Sensation Disorders/diagnosis;Sensation Disorders/drug therapy;Sensation Disorders/etiology*
12771189;5' Untranslated Regions;Animals;Cell Membrane/metabolism;Cell Nucleus/metabolism;Cell Nucleus/ultrastructure;Cytoplasm/metabolism;Dinoflagellida/metabolism;Dinoflagellida/ultrastructure*;Genes, Plant;Golgi Apparatus/metabolism;Immunohistochemistry;In Vitro Techniques;Luciferases/metabolism;Models, Biological;Phylogeny;Plant Proteins/metabolism;Plastids/metabolism;Plastids/ultrastructure*;Protein Biosynthesis;Protein Sorting Signals;Protein Structure, Tertiary;Protein Transport
12776594;Anemarrhena*/chemistry;Animals;Astragalus membranaceus*/chemistry;Blood Pressure/drug effects;Cardiotonic Agents/pharmacology;Drug Synergism;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Heart Failure/etiology;Heart Failure/physiopathology*;Heart Rate/drug effects;Hypertension, Renovascular/complications;Hypertension, Renovascular/physiopathology*;Male;Plants, Medicinal/chemistry;Rats;Rats, Wistar
12804002;Animals;CD4-CD8 Ratio;CD4-Positive T-Lymphocytes/virology*;CD8-Positive T-Lymphocytes/virology*;DNA, Viral/blood;Flow Cytometry;Lymphocyte Activation;Lymphocyte Count;Macaca mulatta;Simian Acquired Immunodeficiency Syndrome/immunology*;Simian Acquired Immunodeficiency Syndrome/virology;Simian Immunodeficiency Virus/physiology*
12804996;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Arm;Cyclophosphamide/administration & dosage;Dermatomyositis/complications*;Dermatomyositis/pathology;Diagnosis, Differential;Doxorubicin/administration & dosage;Hand;Hepatitis C/complications*;Hepatitis C/drug therapy;Hepatitis C/pathology;Humans;Interferon-alpha/therapeutic use;Lymphoma, Non-Hodgkin/complications*;Lymphoma, Non-Hodgkin/drug therapy;Lymphoma, Non-Hodgkin/pathology;Male;Middle Aged;Porphyria Cutanea Tarda/diagnosis*;Porphyria Cutanea Tarda/etiology;Porphyria Cutanea Tarda/pathology;Prednisone/administration & dosage;Vincristine/administration & dosage
12808040;Alu Elements/genetics;Cell Nucleus/metabolism*;HeLa Cells;Humans;Polypyrimidine Tract-Binding Protein/metabolism*;RNA/metabolism;RNA Polymerase III/biosynthesis;RNA Polymerase III/genetics*;RNA, Messenger/metabolism;RNA, Small Interfering;Signal Recognition Particle/genetics
12809793;Animals;Biocompatible Materials/chemistry*;Calcification, Physiologic*;Calcium Carbonate/chemistry*;Mathematics;Microscopy, Electron;Shellfish;Tensile Strength
12813873;Aged;Aged, 80 and over;Alzheimer Disease/diagnosis;Dementia/diagnosis*;Female;Geriatric Assessment*;Humans;Neuropsychological Tests;Physician's Role*;Primary Health Care
12816339;Adolescent;Adult;Child Abuse, Sexual/diagnosis*;Child Abuse, Sexual/statistics & numerical data;Crime Victims/psychology;Female;Humans;Male;Medical History Taking;Middle Aged;Prevalence;Surveys and Questionnaires*;Truth Disclosure
12817533;Attitude of Health Personnel;Drug Prescriptions/standards*;Drug Therapy, Computer-Assisted/standards*;Humans;Medication Errors/prevention & control*
12819104;Amino Acid Sequence;Apoptosis*;Caspase 8;Caspase 9;Caspase Inhibitors*;Caspases/physiology;Cells, Cultured;Humans;Mitochondria/physiology*;Molecular Sequence Data;NF-kappa B/antagonists & inhibitors;NF-kappa B/physiology*;Poly(ADP-ribose) Polymerases/metabolism;Rickettsia rickettsii;Rocky Mountain Spotted Fever/drug therapy;Rocky Mountain Spotted Fever/pathology*;Rocky Mountain Spotted Fever/physiopathology
12821269;Adult;Aged;Female;Follow-Up Studies;Humans;Lung Neoplasms/epidemiology;Male;Middle Aged;Neoplasms/complications*;Neoplasms/epidemiology;Nutrition Surveys;Periodontitis/complications*;Periodontitis/epidemiology;Risk Factors
12821654;Animals;Biological Transport;Calcium/metabolism*;Calcium Channels/metabolism*;Calcium-Calmodulin-Dependent Protein Kinase Type 2;Calcium-Calmodulin-Dependent Protein Kinases/metabolism;Calcium-Calmodulin-Dependent Protein Kinases/physiology*;Electrophysiology;Ion Channel Gating;Kinetics;Microscopy, Confocal;Oocytes/metabolism;Phosphorylation;Receptors, Serotonin/metabolism;Time Factors;Xenopus laevis
12827006;Adolescent;Age Distribution;Analysis of Variance;Ascorbic Acid/analysis;Ascorbic Acid/blood*;Child;Child, Preschool;Endoscopy;Female;Gastric Juice/chemistry*;Helicobacter Infections/blood*;Helicobacter Infections/diagnosis;Helicobacter Infections/microbiology;Helicobacter pylori/enzymology;Helicobacter pylori/isolation & purification*;Humans;Hydrogen-Ion Concentration;Korea;Male;Pyloric Antrum/microbiology;Pyloric Antrum/pathology;Urease/analysis
12833875;Arachnoid/blood supply;Central Nervous System Vascular Malformations/complications*;Central Nervous System Vascular Malformations/therapy;Cerebral Hemorrhage/etiology*;Cerebral Hemorrhage/therapy;Cranial Sinuses;Drainage;Embolization, Therapeutic*;Humans;Male;Middle Aged;Pia Mater/blood supply;Varicose Veins/complications*;Varicose Veins/therapy;Veins/surgery
12841511;Abortion, Criminal/legislation & jurisprudence;Female;Humans;India;Women's Rights/legislation & jurisprudence*
12850383;Animals;Endothelin-1/blood*;Enzyme-Linked Immunosorbent Assay;Humans;Hypertension/blood*;Male;Models, Animal;Rats;Rats, Wistar
12870653;Adenosine Triphosphatases/chemistry;Amino Acids/chemistry;Animals;Antioxidants/pharmacology;Calcium/metabolism;Calcium-Transporting ATPases/chemistry*;Calcium-Transporting ATPases/metabolism;Dose-Response Relationship, Drug;Edetic Acid/pharmacology;Free Radicals*;Kinetics;Lipid Metabolism;Lipid Peroxidation;Lysine/chemistry;Myocardium/metabolism*;Oxidative Stress;Oxygen/metabolism;Rats;Sarcoplasmic Reticulum/metabolism;Spectrometry, Fluorescence;Time Factors;Tryptophan/chemistry;Tyrosine/analogs & derivatives*;Tyrosine/chemistry
12873672;Adult;Aged;Antimetabolites, Antineoplastic/therapeutic use*;Capecitabine;Combined Modality Therapy;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/therapeutic use*;Dose-Response Relationship, Drug;Female;Fluorouracil/analogs & derivatives;Humans;Male;Middle Aged;Rectal Neoplasms/therapy*
12875030;Anti-Infective Agents/chemistry*;Anti-Infective Agents/toxicity;Decarboxylation;Electron Transport;Electrons;Fluorescence;Fluorine/chemistry;Fluoroquinolones;Hydrogen-Ion Concentration;Ions;Molecular Structure;Photochemistry;Protons;Reactive Oxygen Species/chemistry;Singlet Oxygen/chemistry;Superoxides/chemistry
12888529;Base Sequence;DNA (Cytosine-5-)-Methyltransferase 1;DNA (Cytosine-5-)-Methyltransferases/biosynthesis;DNA (Cytosine-5-)-Methyltransferases/genetics;Doxycycline/pharmacology;Genetic Vectors*;Humans;Nucleic Acid Conformation;Plasmids*;Promoter Regions, Genetic;RNA Interference*;RNA, Small Interfering/biosynthesis;RNA, Small Interfering/chemistry;RNA, Small Interfering/genetics*;RNA, Small Nuclear/genetics;Sequence Alignment;Transcription, Genetic;Tumor Cells, Cultured
12901225;Animals;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology;Enzyme Inhibitors/therapeutic use*;Forecasting;Humans;Neoplasms/drug therapy*;Neoplasms/enzymology;Technology, Pharmaceutical/methods;Technology, Pharmaceutical/trends*;Telomerase/antagonists & inhibitors*;Telomerase/metabolism;Telomere/drug effects;Telomere/metabolism
12902553;Analgesia;Back Pain/prevention & control;Bone Cements*;Fluoroscopy;Humans;Hypnotics and Sedatives;Needles;Polymethyl Methacrylate*;Radiography, Interventional*;Spinal Fractures/surgery*;Tomography, X-Ray Computed
12906317;Angiogenesis Inhibitors/pharmacology;Angiogenesis Inhibitors/therapeutic use*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Humans;Hypoxia;Intercellular Signaling Peptides and Proteins/physiology;Neoplasms/blood supply;Neovascularization, Pathologic/drug therapy*;Neovascularization, Pathologic/etiology
12911715;Animals;Animals, Genetically Modified;Disease Models, Animal;Female;Mice;Mice, Transgenic;Neoplasms, Experimental*;Ovarian Neoplasms/etiology*;Ovarian Neoplasms/pathology;Research Design;Rodentia;Sensitivity and Specificity;Transplantation, Heterologous
12928126;Adult;Aged;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Area Under Curve;Carboplatin/administration & dosage;Carboplatin/pharmacokinetics;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/pathology;Carcinoma, Non-Small-Cell Lung/radiotherapy*;Cisplatin/administration & dosage;Dose-Response Relationship, Drug;Drug Administration Schedule;Esophagitis/chemically induced;Female;Humans;Infusions, Intravenous;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Lung Neoplasms/radiotherapy*;Male;Middle Aged;Paclitaxel/administration & dosage;Survival Analysis;Treatment Outcome
12951150;Animals;Binding Sites;Calmodulin/metabolism;Enzyme Inhibitors/chemical synthesis*;Enzyme Inhibitors/pharmacology;Evaluation Studies as Topic;Humans;Inhibitory Concentration 50;Neurons/drug effects;Neurons/metabolism;Nitric Oxide Synthase/antagonists & inhibitors*;Protein Isoforms/metabolism;Rats;Structure-Activity Relationship;Thiazoles/chemical synthesis*;Thiazoles/pharmacology;Thiourea/analogs & derivatives*;Thiourea/pharmacology
12952234;Bone Marrow Cells;Bone Marrow Transplantation*;Costs and Cost Analysis;Female;Fluorometry;Follow-Up Studies;Humans;Linear Models;Male;Nucleic Acid Amplification Techniques/economics;Nucleic Acid Amplification Techniques/methods*;Nucleic Acid Amplification Techniques/standards*;Reagent Kits, Diagnostic;Reproducibility of Results;Sensitivity and Specificity;Tandem Repeat Sequences*;Time Factors;Transplantation Chimera/genetics*;Transplantation, Homologous
12953901;Computer Simulation;Dose Fractionation*;Radiometry/methods*;Radiotherapy Dosage;Radiotherapy Planning, Computer-Assisted/methods*;Radiotherapy, Conformal/methods*;Reproducibility of Results;Sensitivity and Specificity
12955858;Animals;Cell Differentiation/physiology;Humans;Joints/embryology*;Joints/physiology*;Morphogenesis/physiology;Organogenesis/physiology*
12957904;Antigens, Bacterial/analysis*;Antigens, Bacterial/chemistry*;Antigens, Bacterial/isolation & purification;Enterotoxins/analysis*;Enterotoxins/chemistry*;Enterotoxins/isolation & purification;Enzyme-Linked Immunosorbent Assay/methods;Sensitivity and Specificity;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods;Staphylococcus
12961810;Biomedical Research/economics;Biomedical Research/legislation & jurisprudence*;Child;Child Welfare/legislation & jurisprudence;Clinical Trials as Topic/methods;Continental Population Groups/legislation & jurisprudence;Ethnic Groups/legislation & jurisprudence;Humans;Minority Groups/legislation & jurisprudence;Minority Groups/statistics & numerical data*;Patient Selection*;Research Subjects*/legislation & jurisprudence;Risk Assessment;Therapeutic Human Experimentation/legislation & jurisprudence*
12969026;Animals;Bass/growth & development;Bass/physiology*;Body Weight;Female;Larva/growth & development;Larva/physiology;Male;Metamorphosis, Biological;Muscle Development*;Muscle, Skeletal/cytology*;Muscle, Skeletal/growth & development;Temperature
12977587;Blood Pressure*;Coronary Circulation*;Coronary Vessels*;Heart/blood supply*;Humans
12978587;Fenestration, Labyrinth*;Leadership*
12981500;Biological Specimen Banks*;Bone Banks*;Bone and Bones*
12986514;Dumping Syndrome*;Gastrectomy*;Humans;Peptic Ulcer/surgery*
12987227;Adenoidectomy*;Adenoids*;Airway Obstruction*;Bronchi*;Bronchial Diseases*;Child;Disease*;Humans;Palatine Tonsil/surgery*;Tonsillectomy*
12991039;Adolescent;Humans;Students*
12993801;Deoxyribonuclease I*;Streptodornase and Streptokinase/therapeutic use*;Streptokinase*;Thrombolytic Therapy*
12994188;Brain*;Brain Diseases*;Cryptococcosis*;Cryptococcus*
12994278;Data Collection*;Delivery, Obstetric*;Female;Humans;Medical Assistance*;Pregnancy
13007835;Child;Child Psychiatry*;Humans;Intellectual Disability*
13012899;Peritoneal Cavity*;Peritonitis*
13020599;Animals;Electrolysis*;Humans;Root Canal Therapy*;Wolves*
13023340;Hospitals*;Humans;Isoniazid*;Tuberculosis/therapy*
13023586;Atmospheric Pressure*;Blood Circulation*;Cell Respiration*;Humans;Pressure*;Respiration*
13032923;Carcinoma*;Choriocarcinoma*;Humans;Male;Stomach Neoplasms*
13036964;Aphasia*;Comprehension*;Humans;Language*
13042811;Animals;Biological Transport;Carcinoma 256, Walker*;Neoplasms, Experimental*;Nitriles/pharmacology*;Rats;Thiocyanates/urine*
13049783;Cerebral Cortex/physiology*;Neoplasms*;Nervous System Physiological Phenomena*;Torso*
13053592;Collapse Therapy*;Thoracoplasty*;Tuberculosis, Pulmonary*
13053693;Adjuvants, Pharmaceutic*;Disease*;Humans;Inferior Colliculi*;Male;Retina*;Retinal Detachment*;Retinal Diseases*;Testis*
13064929;Directories as Topic*;Otolaryngology*;Societies*
13064997;Autoradiography*;Mast Cells/metabolism*;Sulfates*
13070751;Animals;History*;Perciformes*
13085395;Cysts*;Humans;Meninges*;Meningocele*;Meningomyelocele*
13089605;Humans;Spondylolisthesis/etiology*
13094322;Diabetes Mellitus/therapy*;Disease Management*;Humans
13094963;Humans;Neoplasms/statistics & numerical data*;Respiratory System*;Respiratory Tract Neoplasms*;Tuberculosis/statistics & numerical data*
13096174;Biopsy*;Humans;Leprosy/diagnosis*;Peripheral Nerves*
13108613;Awards and Prizes*;General Practitioners*;History, 19th Century;History, 20th Century
13116787;Humans;Perception*;Sensation*;Vestibule, Labyrinth/physiology*;Vision, Ocular*
13122770;Aspergillosis*;Humans;Pulmonary Aspergillosis*
13132788;Bedding and Linens*;Hospital Administration*
13133988;Heart Neoplasms*;Humans
13134332;Animals;Antipyretics*;Chlortetracycline*;Fever*;Humans;Influenza, Human*;Orthomyxoviridae*;Rabbits
13134635;Brain/metabolism*;Metabolic Diseases*;Nervous System/metabolism*;Neurochemistry*;Pituitary Gland*;Pituitary Gland, Anterior/physiology*
13143424;Diet*;Female;Humans;Zinc/metabolism*
13149193;Humans;Insufflation*;Kidney Neoplasms*;Pheochromocytoma*;Pneumoperitoneum*;Pneumoperitoneum, Artificial*;Sympatholytics*
13156791;Aneurysm*;Arteries*;Endocarditis*;Endocarditis, Subacute Bacterial/complications*;Humans;Paralysis*;Pulmonary Artery*
13160859;Humans;Mental Disorders/metabolism*;Occupational Therapy*
13162609;Psychoanalysis/education*;Psychotherapy*
13170557;Criminals*;Water Supply*
13175333;Eye*;Eye Diseases*;Head*;Humans;Plants*
13181078;Anthelmintics*;Cestode Infections/therapy*
13185481;Folic Acid*;Humans;Memory*
13191129;Blood*;Body Fluids*;Coloring Agents*;Humans;Jurisprudence*;Semen*
13192739;Adrenal Glands*;Ascorbic Acid/pharmacology*;Desoxycorticosterone/analysis*;Guinea Pigs;Scurvy*;Vitamins*
13194008;Amino Acids*;Diphtheria*;Diphtheria Toxin*;Formaldehyde/pharmacology*;Glycine*;Glycine Agents*;Psychotherapy*
13201658;Anxiety/psychology*;Anxiety Disorders*;Humans;Manifest Anxiety Scale*;Psychological Tests*
13210617;Alkalies*;Arthritis/therapy*;Biomedical Research*;Bone Marrow*;Dental Materials*;Humans;Malates/therapeutic use*
13218777;Cytomegalovirus Infections*;Humans;Infant, Newborn;Infant, Newborn, Diseases*;Virus Diseases*
13222526;Analgesia*;Anesthesia*;Anesthesia and Analgesia*;Anesthesia, Conduction*;Anesthesiology*;Humans;Nails*;Pain Management*;Paronychia/surgery*;Penicillins/therapeutic use*;Procaine*
13224234;Colon/abnormalities*;Congenital Abnormalities*;Intestinal Obstruction*
13225170;Animals;Coxsackievirus Infections*;Enterovirus*;In Vitro Techniques;Mice;Neoplasms, Experimental*
13226701;Autopsy*;Bone and Bones*;Humans;Skull*
13230513;African Americans*;African Continental Ancestry Group*;Dysentery*;History of Medicine;History, 19th Century*
13231629;Dental Materials*;Root Canal Filling Materials*
13237920;Biomedical Research*;Smallpox/prevention & control*;Vaccination*;Vaccines*;Variola virus*
13243983;Anemia*;Anemia, Hemolytic*;Animals;Bacteriology*;Haemophilus influenzae*;Immune Sera/adverse effects*;Meningitis/microbiology*;Rabbits
13255843;Humans;Intervertebral Disc*;Neurites*;Spine*
13263270;Humans;Pulmonary Ventilation*;Respiratory Function Tests*;Spirometry*
13264521;Thyroid Gland/metabolism*;Thyroxine/analogs & derivatives;Viscera*
13271434;Heme*;Hemin*;Hemoglobins*;Lipid Metabolism*;Lipids*;Oxidation-Reduction*;Porphyrins/pharmacology*
13275653;Humans;Hypertension/therapy*
13289818;Isoniazid*;Niacin*;Nicotinic Acids/therapeutic use*;Tuberculosis*;Tuberculosis, Meningeal/therapy*
13300236;Heart/innervation*;Humans
13307139;Humans;Poisoning*;Salicylates/poisoning*
13314956;Child;Humans;Infant;Surgical Procedures, Operative*
13316714;Gastrointestinal Hemorrhage*;Gastrointestinal Tract*;Hemorrhage/therapy*;Peptic Ulcer*;Peptic Ulcer Hemorrhage*
13327144;Ascariasis/epidemiology*;Disease*;Humans;Intestinal Diseases*;Intestine, Small*;Intestines*;Prisoners*;Prisoners of War*;Veterans*
13331065;Hodgkin Disease*;Humans;Medical Records*;Stomach Neoplasms*
13331767;Humans;Pneumonia*;Pneumonia, Mycoplasma*;Pneumonia, Viral*
13336481;Humans;Oxyuriasis/diagnosis*
13344124;Deafness/complications*;Fetishism (Psychiatric)*;Humans;Hypothalamus*;Paraphilic Disorders*;Puberty*;Puberty, Precocious/complications*;Sexual Behavior/psychology*;Sexual Maturation*
13351977;Balneology*;Baths*;Diabetes Mellitus/therapy*;Humans
13357035;Biometry*;Empiricism*;History of Medicine;Humans;Thinking*
13366316;Ambulatory Care Facilities*;Health Facilities*;Hospitals*;Hospitals, University*;Humans;Muscular Dystrophies/therapy*
13370530;Humans;Metabolism/drug effects*;Sodium Salicylate/pharmacology*
13375044;Brain/surgery*;Brain Diseases*;Child;Hemispherectomy*;Humans;Psychosurgery*;Split-Brain Procedure*
13386856;Humans;Skin*;Skin Diseases*;Subcutaneous Tissue*
13392103;Drug-Related Side Effects and Adverse Reactions*;Fever*;Humans;Hypersensitivity*;Immune System Diseases*
13400441;Female;Humans;Infant;Infant, Newborn;Medical Records*;Pregnancy
13418708;Cardiomegaly/etiology*;Humans
13426302;Child;Chlorpromazine/therapeutic use*;Hepatomegaly*;Humans;Infant;Liver Diseases*;Peptides*;Splenomegaly*
13430142;Endocarditis*;Endocarditis, Bacterial*;Humans;Rheumatic Heart Disease/etiology*
13433609;Animals;Bacteriology/instrumentation*;Caniformia*;Seals, Earless*
13446118;Animals;Brain*;Cattle;Electrophoresis*;Water*
13447762;Adrenal Cortex/drug effects*;Carbohydrate Metabolism*;Carbohydrates*;Propiophenones/pharmacology*
13449390;Biliary Tract*;Biliary Tract Diseases*;Liver Diseases/blood*;Myocardial Infarction/blood*;Transaminases/blood*;Vascular Diseases*
13454352;Air Pollution/adverse effects*;Automobiles*;Humans;Hygiene*
13455970;Colostomy*;Humans;Infant;Plastics*;Urine*;Urine Specimen Collection*
13458514;Humans;Learning*;Reward*;Verbal Learning*
13460275;Autonomic Nervous System*;Heart/physiology*;Humans
13473708;Blood Proteins*;C-Reactive Protein*;Rheumatic Diseases/blood*
13473725;Humans;Leprosy*
13476837;Cardiovascular System*;Dehydration*;Humans;Kidney/blood supply*;Renal Circulation*
13481444;Headache/etiology*;Humans
13483626;Amidines/metabolism*;Arginine*;Butyrates/metabolism*;Guanidines*;gamma-Aminobutyric Acid*
13486295;Child;Humans;Infant;Neuroblastoma*
13490764;Child;Child Welfare*;Health Facilities*;Hospitals*;Humans;Infant;Patient Isolation*;Tuberculosis*;Tuberculosis, Pulmonary*
13491173;Eye Diseases/psychology*;Humans;Nose*;Otorhinolaryngologic Diseases/psychology*;Pharynx*
13501507;Female;Genitalia*;Genitalia, Female/metabolism*;Humans;Ovary/physiology*;Plasmalogens*
13505758;Anemia*;Hematopoiesis*;Hematopoietic System/pathology*
13513065;Blood Transfusion*;Humans;Red Cross*;Social Work*
13521263;Cell Differentiation*;Mycobacterium/metabolism*;Mycobacterium tuberculosis/metabolism*;Niacin/metabolism*;Nicotinic Acids*;Nontuberculous Mycobacteria*
13528844;Cerebellar Diseases*;Cerebellum*;Humans;Myoclonic Cerebellar Dyssynergia*
13547339;Dupuytren Contracture/therapy*;Humans;Hyaluronoglucosaminidase/therapeutic use*
13549636;Humans;Mental Disorders*;Personality*;Personality Disorders*
13553849;Bone Marrow*;Bone Marrow Diseases*;Humans;Osteosclerosis*
13554333;Hemorrhage*;Pneumothorax*;Pneumothorax, Artificial/complications*
13564539;Hot Temperature*;Housing*;Nigeria
13575128;Alcoholic Intoxication/blood*;Alcoholism*;Transaminases/blood*
13582890;Cardiovascular Diseases*;Humans;Myocardial Infarction/statistics & numerical data*
13587509;Coenzymes*;Hydrogen*;Hydroxysteroids*;Lipid Metabolism*;NADP*;Oxidoreductases*;Steroids/metabolism*
13588488;Humans;Neoplasms*;Pleura*;Pleural Neoplasms*;Thorax*
13598517;Carcinogenesis*;Humans;Neoplasms/etiology*
13606280;Humans;Iodides*;Iodine/metabolism*;Thyroid Gland/metabolism*;Viscera*
13611642;Lecithins*;Lysophosphatidylcholines*;Micelles*;Phosphatidylcholines/analogs & derivatives;Refractometry*
13611816;Child;Child Welfare*;Humans;Myanmar
13623557;Asthma/complications*;Humans;Pneumothorax/etiology*
13623813;Biochemical Phenomena*;Fungi*;Humans;Penicillium*
13628381;Electrophoresis*;Muscle Proteins*;Muscles*
13634869;Humans;Hyperoxia*;Oxygen*
13635738;Gambia;Humans;Jordan;Trachoma/epidemiology*
13638823;Diet*;Family Practice*;General Practice*;Hormones/therapeutic use*;Humans;Hypnotics and Sedatives*;Mental Disorders*;Neurotic Disorders/therapy*;Personality Disorders*;Psychiatry*;Psychotherapy*;Recreation*;Rest*;Self Concept*;Substance-Related Disorders*;Tranquilizing Agents/therapeutic use*
13644316;Medicine*;Military Medicine*;Military Personnel*;Naval Medicine*
13646564;Bone Marrow/radiation effects*;Bone Marrow Diseases*;Humans;Hyperplasia*;Radiation/adverse effects*;Radiation Injuries*;Research*
13665969;Ambrosia*;Dermatitis*;Dermatitis, Contact*;Humans
13669988;Bites and Stings*;Cats;Pasteurella Infections*;Pasteurella multocida*
13684828;Hypothyroidism/physiology*
13688391;Humans;Judgment*;Light*;Lighting*;Photic Stimulation*;Vision, Ocular*;Visual Perception*
13690991;Congenital Hypothyroidism/statistics & numerical data*;Disease*;Humans;Thyroid Diseases*;Thyroid Gland*
13699774;Humans;Photofluorography*;Tuberculosis*;Tuberculosis, Pulmonary/diagnostic imaging*
13703038;Gambling*;Humans;Love*;Medical Records*;Neurotic Disorders*;Obsessive-Compulsive Disorder*
13703506;Disease*;Humans;Pancreas*;Pancreatic Diseases*
13707820;Humans;Periodicals as Topic*;Preventive Medicine/history*;Ukraine
13713870;Adrenal Gland Neoplasms*;Adrenal Glands*;Humans;Lung Neoplasms/pathology*;Nevus/complications*;Nevus, Pigmented*;Skin Neoplasms*
13716995;Animals;Ascariasis*;Ascaris*;Child;Humans;Infant
13721165;Bacillus subtilis/metabolism*;Fructans*;Sucrase*;Transferases/metabolism*
13724155;Animals;Female;Humans;Iodine/metabolism*;Pregnancy/metabolism;Primates*
13729379;Glucuronates*;Glucuronidase*;Glycoside Hydrolases/blood;Hepatitis/blood*;Humans;Liver Diseases*;Transaminases/blood*
13733411;Cataract*;Cataract Extraction*;Chymotrypsin/therapy*;Hematologic Tests*
13744112;Disease*;Eyelid Diseases*;Face*;Head*;Humans;Ozone/etiology*;Pain, Intractable*;Thalamus*
13753243;Counseling*;Histamine/therapy*;Humans;Mental Disorders*;Psychotherapy*;Psychotic Disorders/therapy*
13754192;Ascites/surgery*;Humans;Liver Cirrhosis/surgery*
13760766;Humans;Lymphoma*;Lymphoma, Follicular*;Medical Records*;Palatine Tonsil*;Tonsillar Neoplasms*
13766007;Collagen/chemistry*;Collagenases*;Endopeptidases*;Peptide Hydrolases/chemistry*;Peptides/chemistry*
13766879;Humans;Pneumothorax/therapy*
13779092;Animals;Autoradiography*;Female;Humans;Iron/metabolism*;Mice;Pregnancy/metabolism;Radioactivity*;Research*
13781899;Cell Respiration*;Humans;Respiration*;Respiratory Insufficiency*
13784325;Animals;Intestinal Obstruction*;Intestines*;Liver/metabolism*;Nucleosides/metabolism*;Nucleotides/metabolism*;Rats
13785376;Data Collection*;Eyeglasses*;Humans
13787764;Child;Constriction, Pathologic;Esophageal Stenosis*;Humans;Infant
13790909;Pyrrolidinones/chemistry*;Succinimides*
13805740;Diagnosis*;Humans;Laboratories*
13806406;Child;Humans;Infant;Infant, Newborn;Infant, Newborn, Diseases*;Sepsis*;Tetanus*;Tetanus Toxoid*
13811316;Humans;Mental Disorders*;Military Medicine*;Military Personnel*;Tropical Medicine*
13818127;Electrons*;Histological Techniques*;Lung/anatomy & histology*;Microscopy*
13820857;Humans;Mucous Membrane*;Radiography;Stomach/diagnostic imaging*
13856708;Humans;London;Physicians*;Societies*;Societies, Medical*;Universities*
13861012;Child;Child Welfare*;Humans;Mexican Americans*;Mexico
13866018;Humans;Smell*;Taste*;Taste Disorders*
13867018;Antifungal Agents/therapy*;Candida albicans*;Candidiasis*;Endocarditis*;Endocarditis, Subacute Bacterial*;Fungicides, Industrial*;Humans;Medical Records*;Viridans Streptococci*
13869868;Antineoplastic Agents/therapy*;Humans;Tuberculosis*
13878188;Agar*;Antibodies*;Fungi/immunology*;Humans;Mycobacterium/immunology*;Mycoses*;Sarcoidosis/etiology*
13884363;Biochemical Phenomena*;Sulfides/metabolism*;Sulfur/metabolism*
13895953;Androsterone*;Cholesterol/blood*;Humans;Hypercholesterolemia*;Hypothyroidism/metabolism*;Lipids/blood*;Lipoproteins/blood*;Metabolism*;Nitrogen/metabolism*;Testosterone/analogs & derivatives;Thyroid Function Tests*;Thyroid Gland/physiology*;Triiodothyronine*
13896367;Humans;Pneumonectomy*;Pulmonary Surgical Procedures*;Tuberculosis*;Tuberculosis, Pulmonary/surgery*
13898742;Biological Psychiatry*;Electroencephalography*;Mental Disorders*;Psychological Tests*;Thinking*
13899714;Electrocardiography*;Humans
13900436;History of Medicine;Humans;Medicine*;Rare Diseases*
13905354;Cardiac Surgical Procedures*;Constriction, Pathologic;Heart Septal Defects*;Heart Septal Defects, Ventricular*;Heart Septum/abnormalities*;Humans;Prognosis;Pulmonary Surgical Procedures*;Pulmonary Valve Stenosis/surgery*
13909678;Child;Humans;Infant;Urinary Tract Infections*
13916317;Constriction;Environment*;Pupil/physiology*;Vision, Ocular*
13919887;Esophagus/diagnostic imaging*;Humans;Radiography;Radiology*
13920917;Asian Continental Ancestry Group*;Down Syndrome*;Female;Humans;Pregnancy;Pregnancy Complications*;Reproduction*
13921965;Endoscopy*;Humans;Lithiasis*;Ureter*;Urinary Calculi/therapy*
13934721;Coma*;Humans;Hypothyroidism*
13938315;Cesarean Section*;Cicatrix*;Diagnostic Techniques, Obstetrical and Gynecological*;Female;Humans;Hysterosalpingography*;Pregnancy;Uterus*
13942141;Brain*;Cerebral Arterial Diseases*;Humans;Tuberculosis*;Tuberculosis, Meningeal*
13943034;Estradiol Congeners*;Estrogens*;Female;Humans;Labor, Obstetric*;Obstetric Labor, Premature*;Pregnancy;Progesterone*;Progestins*;Relaxin*
13945762;Flicker Fusion*;Humans
13947158;Adrenal Cortex*;Adrenocortical Hyperfunction*;Cushing Syndrome*;Humans;Neoplasms*;Pancreatic Neoplasms*;Paraneoplastic Endocrine Syndromes*;Thymus Neoplasms*
13952682;Alkaline Phosphatase*;Animals;Glycogen*;Nephrectomy*;Parathyroid Glands*;Proteins*;Rats
13984926;Bone Cysts*;Humans;Kidney*;Kidney Diseases, Cystic*
13986728;Fibroma*;Humans;Male;Spermatic Cord*
13990481;Blood Pressure*;Hypothalamus*;Reticular Formation*;Vasomotor System*
13994978;Cerebral Hemorrhage*;Humans;Hypertension*;Intracranial Hemorrhage, Hypertensive*
14011713;Cross Infection*;Humans
14018260;Bone Diseases, Developmental*;Bone Transplantation*;Fibrous Dysplasia of Bone*;Humans;Musculoskeletal Abnormalities*;Osteitis*;Osteitis Fibrosa Cystica*
14019373;Drainage*;Female;Gynecology*;Humans;Obstetrics*
14025217;Animals;Helminths*;Humans;Learning*;Oligochaeta*
14033081;Animals;Cortisone*;Lagomorpha*;Rabbits;Tuberculosis*
14064654;Communicable Diseases*;Diagnosis*;Epidemics*;Hepatitis*;Hepatitis A*;Humans
14066625;Amino Acids*;Ammonium Chloride*;Autopsy*;Brain*;Dogs;Hypoxia*;Pathology*;Pentylenetetrazole*;Pharmacology*;Picrotoxin*;Proteins/metabolism*;Research*;Seizures*
14068038;Animals;Chromatography*;Guinea Pigs;Indoles*;Liver*;Lysergic Acid Diethylamide*;Metabolism*;Microsomes*;Microsomes, Liver*;Rats;Research*
14068680;Aged;Anabolic Agents*;Humans;Methyltestosterone*;Nandrolone*;Nitrogen*;Proteins/metabolism*;Steroids*
14089533;Amino Sugars*;Chemistry Techniques, Analytical*;Chromatography*;Electrophoresis*;Glycosaminoglycans*;Hexosamines*;Hyaluronic Acid*;Nitrogen*;Polysaccharides*;Rats;Research*;Skin*;Tissue Extracts*;Trypsin*;Uronic Acids*
14092935;Barbiturates/toxicity*;Caffeine*;Chemical and Drug Induced Liver Injury*;Chloralose*;Hepatectomy*;Hepatitis*;Hypnotics and Sedatives*;Insulin*;Liver/physiology*;Meperidine*;Muscle Relaxants, Central*;Pentylenetetrazole*;Rats;Research*;Splenectomy*;Theophylline*;Toxicology*;Tranquilizing Agents*;Urethane*
14098349;Biopsy*;Blood Platelets*;Electrons*;Glycogen*;Hepatitis*;Hepatitis A*;Humans;Kidney Glomerulus*;Kidney Tubules*;Leukocytes*;Liver Glycogen*;Macrophages*;Microscopy*;Microscopy, Electron*;Muscles*;Parathyroid Glands*;Peritoneum*;Skin*
14099547;Adenosine Triphosphate*;Animals;Chromatography*;Hepatectomy*;Liver/enzymology*;Liver Regeneration*;Nucleoside-Diphosphate Kinase*;Nucleotides*;Phosphotransferases*;Rabbits;Rats;Research*;Spectrophotometry*
14101839;Animals;Benzimidazoles*;Carcinoma 256, Walker*;Neoplasm Metastasis*;Neoplasms*;Pharmacology*;Rats;Research*;Sarcoma*;Sarcoma, Experimental*;Vitamin B 12*
14116205;Apraxias*;Brain Neoplasms*;Cerebral Hemorrhage*;Corpus Callosum*;Glioblastoma*;Hemiplegia*;Humans;Neoplasms*;Pathology*;Personality*
14130974;Acculturation*;Humans;Psychology, Social*;Transients and Migrants*
14132645;Anemia*;Anemia, Macrocytic*;Anemia, Megaloblastic*;Celiac Disease*;Folic Acid*;Folic Acid Deficiency*;Nitrofurantoin*;Toxicology*
14133114;Hexachlorophene*;Humans;Pharmacology*;Surgical Procedures, Operative*
14136053;History*;Humans;Pharmacies*
14136712;Acetone*;Animals;Cattle;Chemical Phenomena*;Chemistry*;Collagen*;Research*
14143295;Avitaminosis*;Calcification, Physiologic*;Calcium*;Calcium Metabolism Disorders*;Humans;Hyperparathyroidism*;Hypoparathyroidism*;Kidney Diseases*;Minerals/metabolism*;Multiple Myeloma*;Neoplasm Metastasis*;Osteitis Deformans*;Osteomalacia*;Osteoporosis*;Parathyroid Hormone*;Phosphorus*;Phosphorus Metabolism Disorders*;Rickets*;Tetany*;Vitamin D*
14144715;Aneurysm*;Angiography*;Humans;Splenic Artery*;Surgical Procedures, Operative*
14151744;Antigens*;Bacteriophages*;DNA*;DNA, Viral*;Research*
14154303;Biological Clocks*;Electroencephalography*;Epilepsy*;Flicker Fusion*;Humans;Mental Disorders*;Periodicity*;Psychophysiology*;Schizophrenia*
14161988;Analgesics*;Analgesics, Non-Narcotic*;Antipyretics*;Humans;Morphine*;Nitrous Oxide*;Oxygen*;Oxygen Inhalation Therapy*;Pain*;Pain, Postoperative*;Postoperative Care*;Respiratory Function Tests*;Statistics as Topic*
14163315;Carbon Isotopes*;Cell Wall*;Electrophoresis*;Escherichia coli*;Galactose*;Glucosamine*;Glucose*;Glucosyltransferases*;Guanine Nucleotides*;Hexoses*;Isomerases*;Lipopolysaccharides*;Mannose*;Mutation*;Polysaccharides, Bacterial*;Research*;Salmonella typhimurium*;Uracil Nucleotides*
14164602;Adolescent;Back Pain*;Child;Glioma*;Humans;Infant;Meningeal Neoplasms*;Meningioma*;Movement Disorders*;Myelography*;Neoplasms/etiology*;Neuralgia*;Neurilemmoma*;Paralysis*;Paresthesia*;Radiography*;Spinal Canal*;Spinal Cord Compression*;Spinal Cord Neoplasms*;Spinal Injuries*;Spinal Neoplasms*;Spinal Nerves*
14175869;Civil Defense*;Disasters*;Hospitals*;Societies*;Societies, Medical*
14176101;Antibodies*;Fluorescent Antibody Technique*;Humans;Influenza, Human*;Names*;Orthomyxoviridae*;Terminology as Topic*
14183067;Anti-Bacterial Agents*;Antibiotics, Antitubercular*;Dermatologic Agents*;Female;Humans;Inflammation*;Paromomycin*;Pelvic Inflammatory Disease*;Pregnancy;Puerperal Infection*;Rupture, Spontaneous;Sulfates*;Uterine Rupture*;Uterus*
14185990;Chemistry, Pharmaceutical*;Mineralocorticoid Receptor Antagonists*;Pharmacology*;Pregnanes*;Research*;Steroids*
14204758;Blood Circulation*;Blood Pressure*;Cardiac Surgical Procedures*;Diagnosis, Differential*;Heart Function Tests*;Heart Rate*;Hemodynamics*;Humans;Mitral Valve*;Mitral Valve Insufficiency*;Mitral Valve Stenosis*;Physical Exertion*;Pulse*;Thoracic Surgery*
14208109;Antiemetics*;Child;Drug Therapy*;Humans;Infant;Infant, Newborn
14213545;Antigens*;Coombs Test*;Lymphocytes*;Rabbits*;Research*
14214451;Animals;Blood Gas Analysis*;Blood Pressure*;Carbon Dioxide*;Cell Respiration*;Dogs;Heart*;Hemorrhage*;Hydrogen-Ion Concentration*;Hypothermia*;Hypothermia, Induced*;Metabolism*;Physiology*;Research*;Respiration*
14220206;Humans;Vehicle Emissions*
14227257;Kinetics*;Liver/cytology*;Metabolism*;Orotic Acid*;RNA*;Rats*;Research*;Ribosomes*
14232607;Anatomy*;Animals;Canidae*;Dogs;Fractures, Bone*;Mandibular Condyle*;Mandibular Injuries*;Masticatory Muscles*;Radiography*;Research*
14233165;Androgens*;Animals;Antineoplastic Agents*;Biological Assay*;Chemistry, Pharmaceutical*;Estradiol Congeners*;Estrogens*;Mice;Pharmacology*;Poultry*;Pyridazines*;Rats;Research*;Steroids*;Steroids, Heterocyclic*
14235029;Aging*;Alcoholism*;Arteriosclerosis*;Blood Proteins*;Dementia*;Geriatrics*;Humans;Lipids/blood*;Psychotic Disorders*
14241008;Aortic Aneurysm*;Aortic Valve Stenosis*;Arteriosclerosis*;Arteriosclerosis Obliterans*;Cerebrovascular Disorders*;Humans;Statistics as Topic*;Vascular Surgical Procedures*
14243847;Allergy and Immunology*;Animals;Borrelia*;Borrelia Infections*;Mice;Research*;Trypanosoma*;Trypanosomiasis*
14245033;Acetylcholine*;Adrenergic Agents*;Aging*;Animals;Atropine*;Brain/physiology*;Cerebral Cortex*;Chlorpromazine*;Cholinergic Agents*;Dogs;Electrophysiology*;Epinephrine*;Norepinephrine*;Physostigmine*;Research*;Reticular Formation*
14247065;Education, Medical, Graduate*;Europe;Physicians*;Specialization*
14247623;Breast Feeding*;Female;Fluids and Secretions*;Humans;Lactation*;Nitrogen*;Pregnancy;Urine*
14252470;Child;Humans;Infant;Intestinal Neoplasms*;Intestine, Small*;Lymphangioma*;Mesenteric Cyst*;Mesentery*;Suppuration*;Surgical Procedures, Operative*
14257072;Anura*;Calcium*;Choline*;Electric Stimulation*;Electrophysiology*;Ions*;Metals*;Muscle Contraction*;Muscle, Skeletal*;Muscles*;Pharmacology*;Research*
14258312;Adenocarcinoma*;Brain Neoplasms*;Carcinoma, Squamous Cell*;Esophageal Neoplasms*;Female;Glioblastoma*;Humans;Hyperbaric Oxygenation*;Lung Neoplasms*;Mouth Neoplasms*;Neoplasm Metastasis*;Neoplasm Recurrence, Local*;Neoplasms/epidemiology*;Neoplasms/radiotherapy*;Radiation Injuries*;Radiotherapy Dosage*;Retinoblastoma*;Uterine Cervical Neoplasms*
14258596;Humans;Radiography*;Technology, Radiologic*;Television*
14261876;Heart*;Heart, Artificial*;Perfusion*;Solutions*;Tromethamine*;Vascular Surgical Procedures*
14264653;Coronary Artery Disease*;Coronary Disease*;Dietary Fats*;Epidemiology*;Heart*;Humans;Military Medicine*;Naval Medicine*
14271687;Encephalitis Viruses*;Encephalitis Viruses, Tick-Borne*;Encephalitis, Tick-Borne*;Research*;Viral Vaccines*
14272451;Animals;Bacteria*;Bacteriological Techniques*;Insect Control*;Insecta*;Research*
14278425;Arthritis*;Arthritis, Rheumatoid*;Betamethasone*;Drug Therapy*;Humans
14284778;Animals;Astacoidea*;Axons*;Crustacea*;Electrophysiology*;Ganglia*;Interneurons*;Neurons*;Neurophysiology*;Research*
14286897;Biometry*;Humans;Meniere Disease*;Statistics as Topic*;Ultrasonic Therapy*
14299672;Arthroplasty*;Chromium*;Cobalt*;Femoral Neck Fractures*;Femur Neck*;Fracture Fixation*;Geriatrics*;Humans;Molybdenum*;Orthopedic Equipment*;Postoperative Care*;Postoperative Complications*;Prostheses and Implants*;Vitallium*
14303202;Child;Child Development*;Female;Growth*;Humans;Infant;Physiological Phenomena*;Pre-Eclampsia*;Pregnancy;Pregnancy Complications*;Prenatal Exposure Delayed Effects*
14308911;Agar*;Culture Media*;Leptospira*;Research*
14310312;Antigen-Antibody Reactions*;Antigens*;Humans;Leukocytes*;Sarcoidosis*;Skin Tests*;Tissue Extracts*
14315098;Aspergillosis*;Humans;Lung Diseases*;Lung Diseases, Fungal*;Pulmonary Aspergillosis*;Surgical Procedures, Operative*
14318524;Hemostasis*;Humans;Physiology*;Thrombosis*
14323764;Animals;Brain/physiology*;Discrimination Learning*;Memory*;Mollusca*;Nervous System Physiological Phenomena*;Octopodiformes*;Pathology*;Research*;Reversal Learning*;Touch*
14325193;Adolescent;Biometry*;Child;Geriatrics*;Hospitalization*;Hospitals*;Humans;Infant;Infant, Newborn;Statistics as Topic*;United States
14329323;Acclimatization*;Basal Metabolism*;Biomedical Research*;Body Temperature Regulation*;Cold Temperature*;Dihydrotachysterol*;Humans;Shivering*
14340378;Chymotrypsin*;Drug Therapy*;Hematologic Tests*;Humans;Lacrimal Apparatus*;Lacrimal Duct Obstruction*
14343304;Chemistry, Pharmaceutical*;Color*;Coloring Agents*;Coordination Complexes*;Indicators and Reagents*;Metals*;Pharmacy*;Research*
14346215;Accidents*;Accidents, Traffic*;Automobiles*;Humans;Psychology*;Suicide*
14346629;Child;Humans;Psychology, Educational*;Remedial Teaching*
14356990;Humans;Male;Urethra/injuries*;Wounds and Injuries*
14364178;Disease Management*;Gastrectomy*;Humans;Peptic Ulcer Perforation*
14371216;Humans;Hypersensitivity/etiology*;Solanum tuberosum*
14388591;Agglutination Tests*;Arthritis*;Arthritis, Rheumatoid/complications*;Hemagglutination*;Humans;Pneumoconiosis/complications*
14392840;Bile Acids and Salts/administration & dosage*;Calcium/administration & dosage*;Calcium, Dietary*;Cardiovascular System*;Dehydrocholic Acid*;Humans;Portal System/physiology*;Punctures*;Salts*;Spleen*;Veins*
14393629;Anesthesiology/instrumentation*;Humans
14393916;Anesthesia*;Cardiovascular System/drug effects*;Humans;Norepinephrine/pharmacology*;Procaine/pharmacology*;Vasoconstrictor Agents*
14406696;Animals;BCG Vaccine*;Guinea Pigs;Humans;Hypersensitivity*;Immune System Diseases*;Isoniazid/pharmacology*;Streptomycin/pharmacology*
14416076;Hospitalization*;Hospitals, Voluntary*;Humans;Insurance*;Insurance, Hospitalization*
14421644;Gingivitis/complications*;Herpesviridae Infections/complications*;Humans;Meningitis/complications*;Stomatitis/complications*
14431473;Animals;Liver Diseases*;Rats
14441572;Cardiotonic Agents*;Digitalis/therapy*;Digitalis Glycosides*;Diuretics*;Heart Diseases/therapy*
14454178;Histological Techniques*;Humans;Palatine Tonsil/anatomy & histology*
14458357;Dermatologic Agents*;Humans;Sleep*;Sulfur/pharmacology*;Sulfur Compounds*;Urea/pharmacology*
14463978;Embolism*;Extremities*;Humans;Peripheral Vascular Diseases/surgery*;Thromboembolism/surgery*;Thrombosis*
14473604;Egg Yolk*;Growth Substances*;Humans;Intercellular Signaling Peptides and Proteins*;Leptospira/chemistry*;Leptospira interrogans serovar canicola*;Leptospirosis*;Lipids*
14481368;Female;Humans;Kidney*;Nephrectomy*;Pregnancy;Pregnancy Complications*;Tuberculosis*;Tuberculosis, Renal*
14489878;Erythrocytes*;Female;Humans;Phosphorus/blood*;Pre-Eclampsia/blood*;Pregnancy/blood;Radioisotopes*
14490178;Humans;Metabolism*;Postoperative Period;Surgical Procedures, Operative*
14510827;Action Potentials/physiology*;Adolescent;Adult;Electroencephalography/methods*;Epilepsy/physiopathology*;Female;Humans;Magnetic Resonance Imaging/methods*;Male;Middle Aged
14518004;Amino Acid Sequence;Animals;Base Sequence;Blotting, Southern;Bombyx/chemistry*;Bombyx/genetics*;Cloning, Molecular;Conserved Sequence;DNA, Complementary/genetics;Gene Amplification;Genes;Humans;Molecular Sequence Data;Protein Structure, Tertiary;Recombinant Proteins/chemistry;Recombinant Proteins/genetics;Recombinant Proteins/metabolism;Sequence Homology, Amino Acid;Sequence Homology, Nucleic Acid;Transcription Factor TFIIB/chemistry;Transcription Factor TFIIB/genetics*;Transcription Factor TFIIB/metabolism
14526234;Adult;Brain/metabolism;Brain Injuries/complications;Brain Injuries/diagnosis*;Brain Injuries/metabolism*;Cerebrovascular Circulation;Cohort Studies;Energy Metabolism;Female;Glasgow Coma Scale;Glucose/metabolism*;Glycolysis;Humans;Hypotension/diagnosis;Hypotension/etiology;Hypoxia, Brain/diagnosis;Hypoxia, Brain/etiology;Intracranial Pressure;Lactic Acid/metabolism*;Male;Middle Aged;Multivariate Analysis;Oxidative Phosphorylation;Oxygen/metabolism*;Predictive Value of Tests;Prognosis;Pupil Disorders/diagnosis;Pupil Disorders/etiology
14563886;Bacteriophages/genetics*;Bacteriophages/isolation & purification;Base Composition;Genome, Viral*;Molecular Sequence Data;Open Reading Frames;Phylogeny;Salmonella typhimurium/virology*
14565231;Base Pairing;Base Sequence;Calorimetry;Deoxyadenosines/chemistry*;Deoxycytidine/chemistry*;Deoxyguanosine/chemistry*;Drug Stability;Oligodeoxyribonucleotides/chemistry;Pyrazoles/chemistry*;Pyrimidines/chemistry*;Thermodynamics;Thymine/chemistry*
14567020;Adult;Aged;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Biopsy, Needle;Chemotherapy, Adjuvant;Combined Modality Therapy/methods;District of Columbia;Female;Humans;Male;Mesothelioma/mortality;Mesothelioma/pathology*;Mesothelioma/therapy*;Middle Aged;National Institutes of Health (U.S.);Neoplasm Staging;Peritoneal Neoplasms/mortality;Peritoneal Neoplasms/pathology*;Peritoneal Neoplasms/therapy*;Peritoneum/pathology;Peritoneum/surgery*;Prognosis;Prospective Studies;Randomized Controlled Trials as Topic;Risk Assessment;Survival Analysis;Treatment Outcome;United States
14598369;Animals;Humans;Microtubule-Associated Proteins/physiology*;Nerve Regeneration/physiology*;Nervous System/growth & development*;Nervous System/physiopathology*;Nervous System Diseases/physiopathology*;Nervous System Physiological Phenomena
14601015;Birth Weight*;Child;Child Behavior;Child Development*;Child Rearing;Child, Preschool;Cognition;Humans;Maternal Behavior*;Models, Biological*;Predictive Value of Tests*
14601450;Adult;Female;Humans;Rupture;Thyroid Gland/injuries*;Tomography, X-Ray Computed;Wounds, Nonpenetrating/diagnosis;Wounds, Nonpenetrating/etiology;Wounds, Nonpenetrating/surgery*
14602395;Chemical Industry*;Commerce*;Data Collection;Guidelines as Topic;Public Policy*;Risk Assessment;Security Measures*;Ships*;Transportation*;United States;Water Supply
14614076;Afferent Pathways/physiology*;Animals;Dentate Gyrus/drug effects;Dentate Gyrus/physiology*;Dentate Gyrus/ultrastructure;Electric Stimulation/methods;Enzyme Inhibitors/pharmacology;Excitatory Postsynaptic Potentials/physiology;Hydroxamic Acids/pharmacology;Long-Term Potentiation/drug effects;Long-Term Potentiation/physiology;Matrix Metalloproteinase Inhibitors*;Matrix Metalloproteinases/metabolism;Neuronal Plasticity/drug effects;Neuronal Plasticity/physiology;Oligopeptides/pharmacology;Presynaptic Terminals/physiology;Rats;Rats, Sprague-Dawley
14618760;Adolescent;Attitude of Health Personnel;Humans;Job Satisfaction*;Nurse's Role*;Nursing Staff/psychology*;Paris;Psychology, Adolescent*;School Nursing/organization & administration*;Stress, Psychological/prevention & control*;Stress, Psychological/psychology
14630782;Euthanasia;Humans;Netherlands;Oregon;Suicide, Assisted/legislation & jurisprudence*
14641190;Child;Diagnosis, Differential;Embolization, Therapeutic*;Female;Head and Neck Neoplasms/diagnosis*;Head and Neck Neoplasms/surgery;Head and Neck Neoplasms/therapy*;Hemangioma/diagnosis*;Hemangioma/surgery;Hemangioma/therapy*;Humans;Magnetic Resonance Imaging*
14650938;Cell Communication/physiology*;Epidermal Growth Factor/metabolism;Green Fluorescent Proteins;Luminescent Proteins/metabolism;Microscopy, Fluorescence/methods*;Monomeric GTP-Binding Proteins/metabolism;Phosphorylation;Protein Binding;Proto-Oncogene Proteins c-raf/metabolism;Receptor, Epidermal Growth Factor/metabolism
14655599;Adenocarcinoma/classification*;Adenocarcinoma/mortality;Adenocarcinoma/pathology*;Aged;Humans;Male;Middle Aged;Neoplasm Staging;Prognosis;Prostatic Hyperplasia/surgery*;Prostatic Neoplasms/classification*;Prostatic Neoplasms/mortality;Prostatic Neoplasms/pathology*;Transurethral Resection of Prostate*;Treatment Outcome
14672734;Animals;Biphenyl Compounds/chemical synthesis*;Biphenyl Compounds/chemistry;Biphenyl Compounds/metabolism;Biphenyl Compounds/pharmacology*;Breast Neoplasms/drug therapy;Breast Neoplasms/enzymology;Cell Line, Tumor;Enzyme Inhibitors/chemical synthesis*;Enzyme Inhibitors/pharmacology*;Estradiol/metabolism;Estrogen Receptor alpha;Estrone/analogs & derivatives*;Estrone/metabolism;Estrone/pharmacology;Female;Humans;Liver/enzymology;Organ Size;Rats;Rats, Sprague-Dawley;Receptors, Estrogen/metabolism;Steryl-Sulfatase/antagonists & inhibitors*;Steryl-Sulfatase/metabolism;Structure-Activity Relationship;Sulfonic Acids/chemical synthesis*;Sulfonic Acids/chemistry;Sulfonic Acids/metabolism;Sulfonic Acids/pharmacology*;Uterus/enzymology
14672981;Adaptation, Biological*;Animals;Biomechanical Phenomena;Dermis/physiology*;Elasticity;Models, Molecular*;Sea Cucumbers/physiology*
14674561;Accidents;Aluminum/analysis*;Chemical Precipitation;Humans;Hydrogen-Ion Concentration;Metals, Heavy/analysis;Radioactive Waste/analysis*;Sodium Chloride/analysis;Soil Pollutants/analysis*;Solubility;Washington;X-Ray Diffraction
14682545;Animal Welfare*;Animals;Animals, Laboratory*;Humans;Societies, Medical;United Kingdom;Veterinary Medicine
14689207;Aged;Aged, 80 and over;Antigens, CD/analysis;Colonic Neoplasms/diagnosis*;Colonic Neoplasms/surgery;Humans;Immunoglobulin kappa-Chains/analysis;Male;Plasma Cells/immunology;Plasmacytoma/diagnosis*;Plasmacytoma/surgery
14692598;Adipose Tissue/metabolism;Animals;Basal Metabolism/physiology*;Energy Metabolism/physiology*;Exercise/physiology*;Humans;Models, Animal;Muscle, Skeletal/metabolism;Oxygen Consumption;Physical Conditioning, Animal/physiology;Time Factors
14693825;Algorithms*;Amino Acid Sequence;Databases, Protein;False Positive Reactions;Membrane Proteins/chemistry*;Membrane Proteins/classification*;Molecular Sequence Data;Reproducibility of Results;Sensitivity and Specificity;Sequence Alignment/methods*;Sequence Analysis, Protein/methods*;Sequence Homology, Amino Acid*;Software
14695833;Amides/chemical synthesis*;Amides/chemistry;Amides/pharmacology;Animals;Biological Availability;Cytochrome P-450 Enzyme System/metabolism;Diabetes Mellitus, Type 2/drug therapy*;Drug Stability;Female;Humans;In Vitro Techniques;Mice;Microsomes, Liver/metabolism;Oxazines/chemical synthesis*;Oxazines/chemistry;Oxazines/pharmacology;Rats;Receptors, Cytoplasmic and Nuclear/agonists*;Stereoisomerism;Structure-Activity Relationship;Transcription Factors/agonists*
14700465;Antisocial Personality Disorder/diagnosis;Antisocial Personality Disorder/psychology*;Anxiety/diagnosis;Anxiety/psychology;Child, Preschool;Emotions*;Female;Humans;Individuality;Internal-External Control;Longitudinal Studies;Male;Peer Group*;Personality Assessment;Personality Development*;Play and Playthings*;Schools, Nursery;Social Adjustment;Social Behavior;Social Isolation;Socialization*;Sociometric Techniques
14707861;Adolescent;Adult;Aged;Biomarkers, Tumor/analysis;Child;Diagnosis, Differential;Female;Follow-Up Studies;Humans;Immunohistochemistry;Infant;Lymphatic Metastasis/pathology;Male;Melanoma/classification*;Melanoma/pathology*;Middle Aged;Nevus, Blue/pathology*;Sentinel Lymph Node Biopsy;Skin Neoplasms/classification*;Skin Neoplasms/pathology*
14717258;Adaptation, Psychological*;Adolescent;Aspirations (Psychology);Child;Educational Status;Female;Humans;Imitative Behavior;Internal-External Control;Male;Motivation;Parent-Child Relations;Parenting/psychology*;Reinforcement, Social;Social Behavior;Socialization*;Students/psychology*;Teaching*
14729934;Amphotericin B/pharmacology;Amphotericin B/therapeutic use*;Antifungal Agents/pharmacology*;Antifungal Agents/therapeutic use*;Aspergillosis/drug therapy*;Aspergillosis/microbiology;Aspergillus fumigatus/drug effects*;Drug Resistance, Fungal;Humans;Immunocompromised Host*;Itraconazole/pharmacology;Itraconazole/therapeutic use*;Microbial Sensitivity Tests
14735247;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Combined Modality Therapy;Hodgkin Disease/drug therapy*;Hodgkin Disease/mortality;Hodgkin Disease/pathology;Hodgkin Disease/radiotherapy;Humans;Neoplasm Recurrence, Local/drug therapy;Neoplasm Recurrence, Local/radiotherapy;Neoplasm Staging;Radiotherapy, Adjuvant;Survival Rate;Treatment Outcome
14749680;Bacteremia/etiology;Bacteremia/prevention & control*;Catheterization, Central Venous*/adverse effects;Catheterization, Central Venous*/methods;Catheters, Indwelling/adverse effects;Catheters, Indwelling/microbiology;Humans;Physicians/standards*;Practice Patterns, Physicians'/standards*
14760914;Action Potentials/physiology;Algorithms;Animals;Computer Simulation;Electric Conductivity;Electrophysiology;Gap Junctions/physiology;Heart Atria;Models, Biological;Pacemaker, Artificial;Rabbits;Sinoatrial Node/cytology;Sinoatrial Node/physiology*
14762245;Adolescent;Adult;Analysis of Variance;Female;Hospitals, Psychiatric*/statistics & numerical data;Humans;Male;Mental Disorders*;North Carolina;Risk Management/statistics & numerical data;Violence/psychology;Violence/statistics & numerical data*
14772385;Bacteriophage T7*;Bacteriophages*;Siphoviridae*;Sulfanilamides;Sulfonamides*
14778957;Bacillus*;Bacteria*
14783316;Humans;Mycology*
14786215;Humans;Knee Joint*;Popliteal Vein*
14797820;Diabetes Mellitus*;Humans
14801142;Uranium*
14806785;Adrenal Cortex Hormones*;Humans;Steroids*
14807979;Cervix Uteri*;Coloring Agents*;Cytodiagnosis*;Eosine Yellowish-(YS)*;Female;Hematoxylin*;Humans;Neoplasms*;Uterine Cervical Neoplasms*
14809566;Hernia, Inguinal*;Herniorrhaphy*;Humans;Medical Subject Headings*;Prostheses and Implants*;Tantalum*
14816919;Ethnic Groups*;France;Humans;Orthopedics*;Societies*;Societies, Medical*;Traumatology*
14816930;Bone Diseases*;Child;Epiphyses*;Humans;Pain*;Pronation*
14822415;Eugenics*;Humans;Mental Processes*
14827791;General Surgery*;Humans
14829676;Humans;Medical Records Systems, Computerized*;Public Health*;Records as Topic*;School Health Services*;Schools*
14831339;Head*;Humans;Meningeal Neoplasms*;Meningioma*;Plaque, Amyloid*;Skull*
14838607;Diagnosis, Differential*;Humans;Spondylitis*;X-Rays
14840240;Humans;Jurisprudence*;Psychotherapy*
14851434;Drug Industry*;Hospitals*;Poisoning*;Poisons*
14852811;Blue Cross Blue Shield Insurance Plans*;Hospitals*;Insurance, Health*
14876717;Arteriosclerosis/diagnosis*;Atherosclerosis*;Humans;Hypertension/therapy*
14879578;Ganglia*;Herpes Zoster/therapy*;Humans
14888008;Eclampsia/etiology*;Female;Humans;Meteorology*;Pregnancy
14894610;Cataract*;Cataract Extraction*;Humans;Lens, Crystalline*;Sutures*
14897787;Biological Transport;Glucose/pharmacology*;Glycosuria*;Humans;Hyperglycemia*;Kidney Tubules*;Male;Phosphates/metabolism*
14901728;Humans;Public Health*
14902696;Barbiturates/analysis*;Chromatography, Paper*
14904673;Animals;Chromosomes*;Oligochaeta*;Parthenogenesis*
14907081;Fetishism (Psychiatric)*;Paraphilic Disorders*;Sexual Behavior/psychology*
14912209;Humans;Nurses, Public Health*;Public Health Nursing*;Students*
14912525;Breast Neoplasms*;Humans;Patient Care Planning*
14918929;Biliary Tract*;Biliary Tract Diseases*;Gastrointestinal Diseases*;Humans
14921425;Humans;Neurology*;Ophthalmology*
14925148;Aged;Biopsy*;Bone Marrow*;Histoplasma*;Humans;Spleen*
14931457;Diuresis*;Kidney Glomerulus*;Pleurisy/metabolism*;Water/metabolism*
14931912;Crowns*;Dental Abutments*;Denture, Partial*;Humans;X-Rays
14942460;Bacteria*
14942905;Blood Gas Analysis*;Humans;Hypoxia*;Monitoring, Physiologic*;Oxygen*
14943540;Axons*;Humans
14954492;Acacia*;Gum Arabic*;Heart Failure*;Humans
14956557;Heart Failure/therapy*;Humans;Strophanthins/administration & dosage*
14973193;Animals;Cation Transport Proteins/genetics*;Cell Line;Copper/pharmacology*;Gene Expression Regulation/drug effects;Iron/metabolism*;Mice;Phagocytosis/drug effects;RNA, Messenger/genetics
14979164;Humans;Occupational Health*;Substance Abuse Detection*
14982661;Biocompatible Materials/chemistry;Ceramics/chemistry*;Dental Materials/chemistry*;Humans;Inlays*/classification;Inlays*/methods;Treatment Outcome
14996279;Adolescent;Adult;Amelogenesis Imperfecta/pathology*;Amelogenesis Imperfecta/physiopathology*;Analysis of Variance;Calcium/analysis;Case-Control Studies;Dental Enamel/pathology;Dentin/chemistry;Dentin/pathology*;Dentin/ultrastructure;Electron Probe Microanalysis;Humans;Microscopy, Electron, Scanning;Tooth Calcification
14999534;3-Iodobenzylguanidine;Aorta/surgery*;Aortic Diseases/surgery;Blood Vessel Prosthesis Implantation;Cardiac Surgical Procedures*;Cardiopulmonary Bypass;Heart/diagnostic imaging*;Heart/innervation*;Heart Arrest, Induced;Humans;Hypothermia, Induced;Radiopharmaceuticals;Sympathectomy;Tomography, Emission-Computed, Single-Photon*
15013005;Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis*;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Cyclooxygenase 1;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/chemical synthesis*;Cyclooxygenase Inhibitors/pharmacology;Isoenzymes/antagonists & inhibitors;Models, Molecular;Molecular Structure;Prostaglandin-Endoperoxide Synthases;Thiophenes/chemical synthesis*;Thiophenes/pharmacology
15013451;Base Sequence;Capsid Proteins/biosynthesis;Capsid Proteins/genetics*;Capsid Proteins/immunology;Cholera Toxin/biosynthesis;Cholera Toxin/genetics*;Cholera Toxin/immunology;Codon/genetics;Enzyme-Linked Immunosorbent Assay/methods;Epitopes/biosynthesis;Epitopes/genetics*;Foot-and-Mouth Disease Virus/chemistry;Foot-and-Mouth Disease Virus/genetics*;Foot-and-Mouth Disease Virus/immunology;Foot-and-Mouth Disease Virus/metabolism;Fungal Proteins/biosynthesis;Fungal Proteins/genetics;G(M1) Ganglioside/metabolism;Genetic Vectors/genetics;Molecular Sequence Data;Pichia/genetics;Pichia/metabolism*;Plasmids/genetics;Recombinant Fusion Proteins/biosynthesis*;Recombinant Fusion Proteins/genetics;Recombinant Fusion Proteins/immunology;Recombinant Fusion Proteins/metabolism
15017700;Adolescent;Child;Extraoral Traction Appliances*;Humans;Malocclusion, Angle Class II/therapy*;Mandibular Advancement/methods;Orthodontic Appliances, Functional*;Prospective Studies;Treatment Outcome
15042358;Adolescent;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Biomarkers, Tumor/blood*;Bone Neoplasms/blood;Bone Neoplasms/diagnosis*;Bone Neoplasms/pathology;Bone Neoplasms/therapy;Chemotherapy, Adjuvant;Chorionic Gonadotropin, beta Subunit, Human/blood*;Diagnosis, Differential;Female;Humans;Humerus/pathology*;Neoplasm Recurrence, Local/blood;Neoplasm Recurrence, Local/diagnosis*;Neoplasm Recurrence, Local/pathology;Neoplasm Recurrence, Local/therapy;Osteosarcoma/blood;Osteosarcoma/diagnosis*;Osteosarcoma/pathology;Osteosarcoma/therapy;Paraneoplastic Syndromes/blood;Paraneoplastic Syndromes/diagnosis;Pregnancy;Pregnancy Tests*;Radiotherapy, Adjuvant
15048120;Animals;Central Nervous System/cytology;Central Nervous System/growth & development*;Electrophysiology;Evoked Potentials/physiology*;Humans;Models, Neurological;Nervous System Physiological Phenomena;Neural Pathways/cytology;Neural Pathways/growth & development*;Neural Pathways/physiology;Neurons/cytology;Neurons/physiology;Synapses/physiology*;Synaptic Transmission/physiology*
15060201;Animals;Benzhydryl Compounds;Biological Assay;Endocrine System/drug effects*;Estrogens, Non-Steroidal/toxicity;Female;Hazardous Substances/toxicity*;Humans;In Vitro Techniques;Isoflavones/physiology;Isoflavones/toxicity*;Male;Phenols/toxicity;Phytoestrogens;Plant Preparations/toxicity*;Pregnancy;Reproduction/drug effects;Toxicity Tests;Urogenital System/drug effects*;Xenobiotics/toxicity*
15069961;Advisory Committees;Australia/ethnology;Community Participation*;Cultural Diversity;Group Processes;Guidelines as Topic;Health Services Research/ethics*;Health Services Research/standards;Health Services, Indigenous;Health Status;Human Experimentation/ethics*;Human Experimentation/standards;Humans;Minority Groups;New Zealand/ethnology;Oceanic Ancestry Group*
15072814;Adolescent;Adult;Analysis of Variance;Behavior, Addictive/physiopathology;Behavior, Addictive/psychology*;Cognition*/physiology;Cues*;Female;Humans;Male;Marijuana Abuse/physiopathology;Marijuana Abuse/psychology*;Photic Stimulation/methods;Reaction Time/physiology;Street Drugs*
15082695;Communication*;Humans;Informed Consent*;Physician-Patient Relations*;Randomized Controlled Trials as Topic*;Tape Recording*
15084186;Analgesics, Opioid/pharmacology;Animals;Cholestasis/metabolism*;Dose-Response Relationship, Drug;Guinea Pigs;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Male;Mice;Morphine/pharmacology;Narcotic Antagonists/pharmacology;Nitric Oxide/antagonists & inhibitors;Nitric Oxide/physiology*;Receptors, Adrenergic, alpha-2/physiology*;Receptors, Opioid/agonists;Receptors, Opioid/metabolism*;Vas Deferens/drug effects;Vas Deferens/metabolism
15088970;Abortion, Veterinary/etiology*;Animals;Bovine Virus Diarrhea-Mucosal Disease/complications;Bovine Virus Diarrhea-Mucosal Disease/epidemiology*;Cattle;Cattle Diseases/epidemiology*;Cattle Diseases/etiology;Coccidiosis/complications;Coccidiosis/epidemiology;Coccidiosis/veterinary*;Dairying;Diarrhea Viruses, Bovine Viral/isolation & purification;Disease Outbreaks/veterinary*;Enzyme-Linked Immunosorbent Assay/veterinary;Female;Neospora/isolation & purification;New South Wales/epidemiology;Pregnancy;Pregnancy Complications, Infectious/epidemiology;Pregnancy Complications, Infectious/veterinary*;Pregnancy Complications, Parasitic/epidemiology;Pregnancy Complications, Parasitic/veterinary*
15089982;Animals;Dendrites/physiology*;Paraventricular Hypothalamic Nucleus/cytology*;Paraventricular Hypothalamic Nucleus/physiology*;Supraoptic Nucleus/cytology*;Supraoptic Nucleus/physiology*
15093933;Humans;Male;Neoplasm Staging;Prostatic Neoplasms/pathology*;Prostatic Neoplasms/radiotherapy*;Radiation Dosage;Radiotherapy, Conformal/methods*;Rectum*;Retrospective Studies;Tomography, X-Ray Computed
15104633;Animals;Cattle;Female;Goat Diseases/mortality;Goat Diseases/pathology;Goat Diseases/surgery*;Goats;Mastectomy, Radical/veterinary*;Mastitis/surgery;Mastitis/veterinary;Mastitis, Bovine/mortality;Mastitis, Bovine/pathology;Mastitis, Bovine/surgery*;New York/epidemiology;Records as Topic/veterinary;Retrospective Studies;Treatment Outcome
15119223;Delivery of Health Care/organization & administration*;Finland;Health Services Accessibility/organization & administration*;Humans;Program Development;Program Evaluation
15122386;Adult;Aged;Alcohol Drinking/adverse effects;Alcohol Drinking/epidemiology*;Alcohol-Related Disorders/epidemiology*;Alcohol-Related Disorders/etiology;Brazil/epidemiology;Epidemiologic Methods;Female;Humans;Male;Middle Aged;Sex Factors;Smoking/adverse effects
15155985;Cross Infection/prevention & control;Cross Infection/transmission*;DNA Transposable Elements;Humans;Mycobacterium tuberculosis/genetics;Polymorphism, Restriction Fragment Length;Tuberculosis/prevention & control;Tuberculosis/transmission*
15157676;Acetylcysteine/pharmacology;Animals;Cells, Cultured;Ceramides/pharmacology*;Cyclooxygenase 2;Glomerular Mesangium/drug effects;Glomerular Mesangium/enzymology*;NF-kappa B/metabolism;Phospholipases A/biosynthesis*;Phospholipases A2;Prostaglandin-Endoperoxide Synthases/biosynthesis*;Rats;Rats, Sprague-Dawley;Reactive Oxygen Species/metabolism*;Sphingomyelin Phosphodiesterase/metabolism;Sphingomyelins/metabolism;Tumor Necrosis Factor-alpha/pharmacology*
15158207;Animals;Animals, Newborn;Circoviridae Infections/diagnosis;Circoviridae Infections/etiology;Circoviridae Infections/veterinary*;Circovirus/isolation & purification;Swine;Swine Diseases/diagnosis*;Swine Diseases/etiology*;Swine Diseases/pathology;Wasting Syndrome/diagnosis;Wasting Syndrome/etiology;Wasting Syndrome/veterinary*
15158983;Anti-Infective Agents/chemistry*;Chromatography, Micellar Electrokinetic Capillary/methods*;Cinnamates/chemistry;Hesperidin/chemistry;Humans;Hydrogen-Ion Concentration;Niacin/chemistry;Phytotherapy*;Propolis/chemistry*;Reproducibility of Results
15165730;Animals;Guanylate Kinases;Humans;Nucleoside-Phosphate Kinase/physiology*;Pain/etiology*;Receptors, N-Methyl-D-Aspartate/physiology;Spinal Cord/metabolism*
15177280;Aminopeptidases/biosynthesis*;Aminopeptidases/genetics;Aminopeptidases/isolation & purification*;Animals;Baculoviridae/genetics*;Cell Line;Cloning, Molecular;DNA, Complementary/genetics;Genetic Vectors/genetics;Insecta/cytology;Insecta/virology;Male;Protease Inhibitors/pharmacology;RNA, Messenger/metabolism;Rats;Recombinant Proteins/biosynthesis*;Recombinant Proteins/genetics;Recombinant Proteins/isolation & purification;Testis/metabolism
15188409;Amino Acid Sequence;Animals;Antibodies/immunology*;Antibodies/metabolism*;Antibody Specificity;Antigens/immunology;Blotting, Western;Clone Cells;DNA, Complementary/genetics*;Electrophoresis, Polyacrylamide Gel;Enzyme-Linked Immunosorbent Assay;Freund's Adjuvant/immunology;Immunoglobulin G/isolation & purification;Injections, Subcutaneous;Mass Spectrometry;Mice;Mice, Inbred ICR;Molecular Sequence Data;Molecular Weight;Peptide Fragments/chemistry;Peptide Fragments/metabolism;Proteins/chemistry;Proteins/genetics;Proteins/immunology*;Proteins/metabolism*;Rabbits;Recombinant Proteins/metabolism;Reproducibility of Results;Sequence Homology, Amino Acid;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Trypsin
15195223;Antibiotics, Antitubercular/pharmacology*;Humans;Hydrocortisone/blood*;Prospective Studies;Rifampin/pharmacology*;Tuberculosis, Pulmonary/drug therapy*
15199508;Embolectomy*/adverse effects;Embolectomy*/methods;Embolectomy*/mortality;Emergencies;Humans;Postoperative Care;Pulmonary Embolism/diagnosis;Pulmonary Embolism/mortality;Pulmonary Embolism/surgery*;Recurrence;Risk Factors;Survival Rate
15208285;Adult;Aged;Aged, 80 and over;Aging/physiology*;Blood Pressure;Elbow*;Electromyography;Female;Heart Rate;Humans;Isometric Contraction/physiology;Male;Muscle Fatigue/physiology*;Muscle, Skeletal/physiology*;Physical Exertion;Self Concept;Sex Characteristics*;Time Factors;Torque
15210488;Adolescent;Antibodies/blood*;Antigens/immunology;Basal Ganglia/immunology*;Biomarkers/blood;Blotting, Western/methods;Child;Child, Preschool;Chorea/diagnosis;Chorea/immunology;Chorea/microbiology;Cohort Studies;Enzyme-Linked Immunosorbent Assay/methods;Female;Fluorescent Antibody Technique, Indirect/methods;Humans;Infant;Male;Movement Disorders/diagnosis*;Movement Disorders/immunology;Movement Disorders/microbiology;Streptococcal Infections/complications*;Streptococcal Infections/immunology;Tic Disorders/diagnosis;Tic Disorders/immunology;Tic Disorders/microbiology
15211004;Animals;Antimalarials/pharmacology*;Comoros/epidemiology;Drug Resistance, Multiple*;Endemic Diseases;Humans;Malaria, Falciparum/epidemiology*;Malaria, Falciparum/parasitology;Parasitic Sensitivity Tests;Plasmodium falciparum/drug effects*;Prevalence
15212039;Biomedical Research/economics;Biomedical Research/legislation & jurisprudence;Cell Line;Cells*;Germ Cells*;Human Body;Humans;Intention;Legislation, Medical;Ownership/economics;Ownership/legislation & jurisprudence*;Semen Preservation;Tissue Donors/legislation & jurisprudence*;United States
15217927;Adult;Aged;Aged, 80 and over;Base Sequence;CpG Islands;DNA/genetics;DNA/metabolism;DNA Methylation*;Female;Gene Silencing*;Humans;Kidney/pathology;Kidney Neoplasms/genetics*;Logistic Models;Male;Middle Aged;Molecular Sequence Data;Neoplasm Metastasis;Neoplasms/genetics*;Neoplasms/metabolism;Promoter Regions, Genetic;Sulfites/pharmacology;Time Factors
15234521;Chitinases/analysis;Fluorescent Dyes;Hydrogen-Ion Concentration;Hymecromone/analogs & derivatives;Mycology/methods*;Mycology/statistics & numerical data;Mycorrhizae/enzymology*;Phosphoric Monoester Hydrolases/analysis;Reproducibility of Results;Sensitivity and Specificity;Substrate Specificity;beta-Glucosidase/analysis
15240885;Cadherins/metabolism;Catenins;Cell Adhesion/physiology*;Cell Adhesion Molecules/metabolism*;Cells, Cultured;GTP-Binding Protein alpha Subunits, G12-G13/genetics;GTP-Binding Protein alpha Subunits, G12-G13/metabolism*;Gene Expression;Humans;Phosphoproteins/metabolism*;Precipitin Tests;Protein Binding;Recombinant Fusion Proteins/metabolism;rhoA GTP-Binding Protein/metabolism
15242104;Antitrust Laws*;Cardiology Service, Hospital/organization & administration*;Cooperative Behavior;Hospital Planning/legislation & jurisprudence*;Hospital Shared Services/legislation & jurisprudence*;Oncology Service, Hospital/organization & administration*;United States;West Virginia
15252280;Adrenergic beta-Agonists/pharmacology*;Adrenergic beta-Antagonists/pharmacology*;Albuterol/pharmacology;Animals;Animals, Outbred Strains;Atenolol/pharmacology;Avoidance Learning/drug effects;Baclofen/administration & dosage;Baclofen/adverse effects*;Baclofen/antagonists & inhibitors;Dobutamine/pharmacology;Dose-Response Relationship, Drug;Drug Synergism;GABA Agonists/administration & dosage;GABA Agonists/adverse effects*;Injections, Intraperitoneal;Male;Memory Disorders/chemically induced;Memory Disorders/prevention & control*;Mice;Propranolol/pharmacology
15256389;Adrenal Cortex Hormones/administration & dosage;Adrenal Cortex Hormones/therapeutic use;Adult;Albuterol/administration & dosage;Albuterol/adverse effects;Albuterol/analogs & derivatives*;Albuterol/therapeutic use*;Androstadienes/administration & dosage;Androstadienes/adverse effects;Androstadienes/therapeutic use*;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/adverse effects;Anti-Asthmatic Agents/therapeutic use;Asthma/drug therapy;Asthma/prevention & control*;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/adverse effects;Bronchodilator Agents/therapeutic use*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Therapy, Combination;Female;Fluticasone;Forced Expiratory Volume/drug effects;Humans;Male;Practice Guidelines as Topic;Prospective Studies;Quality of Life;Salmeterol Xinafoate;Surveys and Questionnaires;Time Factors;Treatment Outcome
15256547;Cell Wall/chemistry;Cell Wall/enzymology*;Cellulases/genetics;Cellulases/metabolism*;Chitin/metabolism;Chitinases/genetics;Chitinases/metabolism*;Fungi/enzymology*;Fungi/genetics;Fungi/physiology;Gene Expression Regulation, Fungal;Glucans/metabolism
15258459;Animals;Apoptosis;Cell Cycle*;Cell Differentiation;Cell Division;Cell Physiological Phenomena*;Cell Survival;Cell Transformation, Neoplastic;DNA-Binding Proteins/genetics;DNA-Binding Proteins/metabolism*;Helix-Loop-Helix Motifs;Humans;Inhibitor of Differentiation Protein 1;Models, Biological;Neoplasm Staging;Repressor Proteins*/chemistry;Repressor Proteins*/metabolism*;Transcription Factors/chemistry;Transcription Factors/genetics;Transcription Factors/metabolism*;Up-Regulation
15264686;Abnormalities, Multiple*/diagnosis;Abnormalities, Multiple*/therapy;Fatal Outcome;Female;Humans;Infant, Newborn;Intestines/abnormalities*;Intestines/diagnostic imaging;Intestines/physiopathology;Peristalsis;Pregnancy;Syndrome;Ultrasonography, Prenatal;Urinary Bladder/abnormalities*;Urinary Bladder/diagnostic imaging
15270605;Carcinoma/chemistry;Carcinoma/diagnosis;Carcinoma/pathology*;Cell Nucleus/ultrastructure;Diagnosis, Differential;Fatal Outcome;Humans;Jejunal Neoplasms/chemistry;Jejunal Neoplasms/diagnosis;Jejunal Neoplasms/pathology*;Keratin-7;Keratins/analysis;Male;Middle Aged;Mucin-1/analysis;Neoplasm Proteins/analysis;Sarcoma/diagnosis;Vimentin/analysis
15273853;Adolescent;Adult;Aged;Astrocytoma/mortality;Astrocytoma/surgery;Disease-Free Survival;Female;Glioma/mortality;Glioma/surgery*;Humans;Male;Middle Aged;Oligodendroglioma/mortality;Oligodendroglioma/surgery;Retrospective Studies;Supratentorial Neoplasms/mortality;Supratentorial Neoplasms/surgery*
15274592;Acrylic Resins/chemistry*;Adsorption;Light;Molecular Structure;Oligonucleotides/chemistry*;Polymethyl Methacrylate/chemistry*;Scattering, Radiation;Sensitivity and Specificity;Spectrometry, Fluorescence/methods;Surface Properties;Temperature
15278702;Diagnosis, Differential;Humans;Male;Middle Aged;Myocardial Infarction/diagnostic imaging*;Tomography, X-Ray Computed/methods*
15287764;Alkaloids/chemical synthesis*;Alkaloids/chemistry;Cannabinoids/chemical synthesis*;Cannabinoids/chemistry;Molecular Structure;Nuclear Magnetic Resonance, Biomolecular;Organometallic Compounds;Pyridinium Compounds;Stereoisomerism
15293041;Algorithms*;Biomass;Cell Proliferation;Computer Simulation;Energy Metabolism/physiology*;Information Storage and Retrieval/methods*;Models, Biological*;Neural Networks (Computer)*;Online Systems;Oxygen Consumption/physiology;Saccharomyces cerevisiae/growth & development*;Saccharomyces cerevisiae/metabolism*
15302885;Alanine Racemase/metabolism*;Amino Acid Sequence;Anti-Bacterial Agents/biosynthesis*;Cloning, Molecular;Cycloserine/biosynthesis*;Escherichia coli/enzymology;Kinetics;Molecular Sequence Data;Peptide Synthases/metabolism*;Streptomyces/metabolism*
15305354;Adult;Aneuploidy*;Chromosomes, Human, X/genetics;Embryo Implantation/genetics;Female;Genetic Linkage;Humans;In Situ Hybridization, Fluorescence;Logistic Models;Maternal Age;Pregnancy;Preimplantation Diagnosis*;Recurrence;Trisomy
15331862;Affective Symptoms/physiopathology*;Aged;Aged, 80 and over;Brain Damage, Chronic/physiopathology*;Crying/physiology*;Crying/psychology;Female;Humans;Male;Stroke/physiopathology*
15341717;Constipation/therapy*;Female;Humans;Pregnancy;Pregnancy Complications/therapy*
15344349;Animals;Drug Labeling/legislation & jurisprudence;Humans;Legislation, Drug*;Legislation, Veterinary*;Pesticides/standards*;Registries;United States;United States Environmental Protection Agency/legislation & jurisprudence*;Veterinary Medicine/methods*
15345630;Adolescent;Adrenal Cortex Hormones/therapeutic use;Adult;Antiviral Agents/therapeutic use;Bell Palsy*/diagnosis;Bell Palsy*/etiology;Bell Palsy*/therapy;Follow-Up Studies;Herpes Simplex/complications;Humans;Middle Aged;Physical Examination;Physical Therapy Modalities;Treatment Outcome
15359533;Alleles;Analysis of Variance;France;Gene Frequency;Genetic Heterogeneity;Genetic Markers;Genetic Variation;Genetics, Population*;Humans;Language;Polymorphism, Genetic;Tandem Repeat Sequences/genetics*
15363933;Altruism*;Biological Evolution*;Cooperative Behavior*;Humans;Interpersonal Relations;Models, Psychological*
15366832;Alkaloids/analysis*;Chromatography, Liquid;Flavonoids/analysis*;Glucosinolates/analysis*;Plant Leaves/chemistry;Plant Roots/chemistry;Plant Stems/chemistry;Salvadoraceae;Seeds/chemistry;Spectrometry, Mass, Electrospray Ionization
15369689;Acid Etching, Dental/methods;Cementation;Dental Etching/methods*;Dentin/chemistry*;Dentin/ultrastructure*;Dentin-Bonding Agents/chemistry*;Elasticity;Hardness;Humans;In Vitro Techniques;Materials Testing;Molar, Third/chemistry*;Surface Properties;Tissue Adhesions;Water/chemistry*
15375414;Adaptation, Psychological*;Anger;Attitude;Emotions*;Expressed Emotion;Female;Frustration;Hate;Health Behavior;Humans;Intelligence*;Interpersonal Relations;Interviews as Topic;Male;Self-Assessment;Social Behavior;Stress, Psychological/psychology*;Students, Dental/psychology*;Time Management
15380218;Acetamides/chemical synthesis;Acetamides/pharmacokinetics*;Acetamides/toxicity;Administration, Oral;Animals;Benzofurans/chemical synthesis;Benzofurans/pharmacokinetics*;Benzofurans/toxicity;Biological Availability;Cyclic AMP/antagonists & inhibitors;Cyclic AMP/biosynthesis;Dose-Response Relationship, Drug;Humans;In Vitro Techniques;Mice;Muscle Contraction/drug effects;Muscle, Smooth, Vascular/drug effects;Muscle, Smooth, Vascular/physiology;NIH 3T3 Cells;Radioligand Assay;Rats;Receptor, Melatonin, MT1/agonists*;Receptor, Melatonin, MT2/agonists*;Structure-Activity Relationship
15383643;Acute Disease;Adult;Cetirizine/adverse effects*;Chemical and Drug Induced Liver Injury/etiology;Chemical and Drug Induced Liver Injury/physiopathology*;Histamine H1 Antagonists, Non-Sedating/adverse effects*;Humans;Male;Recurrence;Rhinitis/drug therapy
15393816;Face*;Humans
15396166;Meninges*;Tuberculosis*;Tuberculosis, Meningeal*
15397694;Adult;Chronic Disease*;Humans;Otitis Media*
15402265;Animals;Fallopian Tubes*;Female;Humans;Insufflation*;Uterus*
15403860;Anaphylaxis*;Humans;Hypersensitivity*;Immune System Diseases*
15414442;Animals;Body Fluids*;Bufonidae*;California;Female;Humans;Pregnancy
15415397;Aerospace Medicine*;Altitude*;Aviation*;Humans;Sports*
15418965;Autopsy*;Cardiovascular Diseases*;Heart*;Heart Diseases*;Humans
15421563;Humans;Motion Sickness*;Travel*
15423410;Blood*;Ethanol*;Humans
15427236;Brucellosis*;Chlortetracycline*;Streptomycin*
15436780;Anemia*;Humans;Kidney*;Kidney Failure, Chronic*;Renal Insufficiency, Chronic*
15449602;Base Sequence;DNA, Fungal/genetics;DNA, Ribosomal Spacer/genetics;Ecosystem;Fungi/classification;Fungi/genetics;Fungi/isolation & purification*;Genetic Variation;Lithuania;Molecular Sequence Data;Mycelium/isolation & purification;Mycorrhizae/classification;Mycorrhizae/genetics;Mycorrhizae/isolation & purification;Phylogeny;Plant Roots/microbiology;Plant Stems/microbiology;Sequence Homology, Nucleic Acid;Sweden;Trees
15457110;Adult;Age Factors;Ambulatory Care*;Comorbidity;Diagnosis, Dual (Psychiatry);Humans;Male;Middle Aged;Personality/classification;Personality Disorders/diagnosis*;Personality Disorders/epidemiology;Personality Disorders/psychology;Personality Inventory/statistics & numerical data*;Psychiatric Status Rating Scales;Psychometrics;Schizophrenia/diagnosis*;Schizophrenia/epidemiology;Schizophrenic Psychology;Substance-Related Disorders/diagnosis*;Substance-Related Disorders/epidemiology;Substance-Related Disorders/psychology
15465489;Animals;Binding Sites;Cell Line;Cell Nucleus/metabolism;DNA/metabolism;DNA-Binding Proteins/biosynthesis*;Gene Expression Regulation, Developmental*;Homeodomain Proteins/biosynthesis*;Homeodomain Proteins/chemistry;Homeodomain Proteins/metabolism;In Situ Hybridization;In Vitro Techniques;Mice;Mice, Transgenic;Mutation;Nerve Tissue Proteins;Neural Crest/embryology;Neuropeptides/biosynthesis*;Neuropeptides/chemistry;PAX3 Transcription Factor;POU Domain Factors;Paired Box Transcription Factors;Plasmids/metabolism;Promoter Regions, Genetic;Protein Binding;Protein Structure, Tertiary;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Time Factors;Trans-Activators/biosynthesis*;Trans-Activators/chemistry;Transcription Factors/biosynthesis*;Transcription Factors/metabolism;Transfection;Tretinoin/pharmacology;beta-Galactosidase/metabolism
15466898;Administration, Inhalation;Aerosols;Alcoholism/prevention & control*;Analysis of Variance;Animals;Cannabinoid Receptor Antagonists*;Ethanol/administration & dosage*;Ethanol/blood;Male;Piperidines/pharmacology*;Pyrazoles/pharmacology*;Rats;Rats, Wistar;Receptors, Drug/antagonists & inhibitors*;Self Administration;Substance Withdrawal Syndrome
15469436;Candida albicans/growth & development;Candida albicans/pathogenicity*;Cells, Cultured;Cytokines/genetics;Cytokines/metabolism*;Humans;Interleukin-6/genetics;Interleukin-6/metabolism;Interleukin-8/genetics;Interleukin-8/metabolism;Mouth Mucosa/immunology*;Mouth Mucosa/microbiology;Streptococcus/pathogenicity*;Tumor Necrosis Factor-alpha/genetics;Tumor Necrosis Factor-alpha/metabolism;Up-Regulation*
15473992;Adolescent;Adult;Alzheimer Disease/complications;Alzheimer Disease/pathology*;Amyloid beta-Peptides/analysis;Amyloid beta-Protein Precursor/analysis;Apolipoproteins E/analysis;Biomarkers/analysis;Brain Injuries/complications;Brain Injuries/pathology*;Brain Injuries/surgery;Female;Humans;Immunohistochemistry;Male;Middle Aged;Neuropil/pathology;Peptide Fragments/analysis;Plaque, Amyloid/pathology;Risk;Temporal Lobe/chemistry;Temporal Lobe/pathology*
15473996;Animals;Brain/metabolism*;Brain Chemistry;Cattle;Cell Survival/drug effects;Cells, Cultured;Creutzfeldt-Jakob Syndrome/cerebrospinal fluid;Creutzfeldt-Jakob Syndrome/metabolism*;Dose-Response Relationship, Drug;Encephalopathy, Bovine Spongiform/cerebrospinal fluid;Encephalopathy, Bovine Spongiform/metabolism*;Humans;Microglia/metabolism;Microglia/pathology;Microglia/secretion;Neurons/drug effects;Neurons/metabolism;Neurons/pathology;Peptide Fragments/antagonists & inhibitors;Peptide Fragments/pharmacology;PrPSc Proteins/biosynthesis;Prions/antagonists & inhibitors;Prions/pharmacology;Uric Acid/analysis;Uric Acid/metabolism*;Uric Acid/pharmacology
15474117;Epidemiologic Measurements;Humans;Mortality*;Refugees/statistics & numerical data*;Sudan/epidemiology;Violence/statistics & numerical data*;Warfare*
15474472;Arachidonic Acids/pharmacology*;Blotting, Western;Brain Neoplasms/metabolism;Cell Line;Cell Line, Tumor;Ceramides/metabolism;Cholesterol/metabolism;Cyclooxygenase 2;Dinoprostone/metabolism;Dose-Response Relationship, Drug;Glioma/metabolism*;Humans;Isoenzymes/biosynthesis*;MAP Kinase Signaling System;Membrane Microdomains/metabolism*;Membrane Proteins;Mitogen-Activated Protein Kinase 1/metabolism;Mitogen-Activated Protein Kinase 3/metabolism;Phosphorylation;Prostaglandin-Endoperoxide Synthases/biosynthesis*;Prostaglandins/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction;beta-Cyclodextrins/pharmacology;p38 Mitogen-Activated Protein Kinases/metabolism
15481705;Adolescent;Child;Child, Preschool;Disaster Planning/organization & administration*;Environmental Exposure;Female;Humans;Infant;Infant, Newborn;Iodine Radioisotopes/adverse effects*;Italy;Male;Neoplasms, Radiation-Induced/etiology;Neoplasms, Radiation-Induced/prevention & control*;Potassium Iodide/administration & dosage;Potassium Iodide/therapeutic use*;Power Plants;Practice Guidelines as Topic;Radiation Dosage;Radioactive Hazard Release;Risk;Thyroid Neoplasms/etiology;Thyroid Neoplasms/prevention & control*
15489436;Amino Acid Sequence;Carboxylic Ester Hydrolases*/antagonists & inhibitors;Carboxylic Ester Hydrolases*/chemistry;Carboxylic Ester Hydrolases*/genetics;Carboxylic Ester Hydrolases*/metabolism;Hydroxybutyrates/metabolism*;Molecular Sequence Data;Periplasm/enzymology*;Polyesters/metabolism*;Rhodospirillum rubrum/enzymology*;Rhodospirillum rubrum/genetics;Rhodospirillum rubrum/growth & development;Solubility;Substrate Specificity
15503976;Algorithms;Cell Count/methods;Corneal Transplantation*;Endothelium, Corneal/cytology*;Eye Banks;Fourier Analysis;Humans;Image Processing, Computer-Assisted/methods;Tissue Donors*
15505431;Adult;Aged;Antigens, Bacterial/analysis*;Feces/microbiology*;Female;Helicobacter Infections/diagnosis*;Helicobacter Infections/drug therapy;Helicobacter pylori/isolation & purification*;Humans;Immunoenzyme Techniques;Male;Middle Aged;Predictive Value of Tests;Sensitivity and Specificity
15512973;Decision Making*/ethics;Decision Theory*;Ethical Theory*;Ethics, Clinical;Ethics, Medical;Health Policy;Humans;Male;Mass Screening/ethics;Prostate-Specific Antigen/blood;Prostatic Neoplasms/prevention & control;Risk Assessment
15514039;Arabidopsis/genetics*;Chromosome Mapping*;Chromosomes, Plant/genetics*;Expressed Sequence Tags*;Genes, Plant;Genome, Plant;Oryza/genetics*;Ploidies*;Sequence Alignment;Triticum/genetics*
15514674;Apoptosis/drug effects*;Apoptosis/physiology;Apoptosis Regulatory Proteins;Humans;Membrane Glycoproteins/pharmacology*;Mitochondria/drug effects;Mitochondria/physiology;TNF-Related Apoptosis-Inducing Ligand;Thymus Gland/cytology*;Tumor Necrosis Factor-alpha/pharmacology*
15516448;Adenocarcinoma/diagnosis*;Adenocarcinoma/surgery;Adult;Blood Transfusion;Combined Modality Therapy;Conization/adverse effects*;Conization/methods;Diagnosis, Differential;Embolization, Therapeutic;Factor XI Deficiency/diagnosis*;Factor XI Deficiency/therapy;Female;Follow-Up Studies;Humans;Hysterectomy/methods;Postoperative Hemorrhage/diagnosis*;Postoperative Hemorrhage/therapy;Risk Assessment;Severity of Illness Index;Time Factors;Treatment Outcome;Uterine Cervical Neoplasms/diagnosis*;Uterine Cervical Neoplasms/surgery
15522086;Animals;Base Sequence;Chromosomes, Bacterial;Cosmids/genetics;Cosmids/metabolism;Exons*;Leishmania donovani/genetics*;Leishmania major/genetics*;Leishmania major/pathogenicity*;Leishmaniasis, Cutaneous;Leishmaniasis, Visceral;Mice;Mice, Inbred BALB C;Molecular Sequence Data;Phenotype;Selection, Genetic*;Sequence Alignment
15522407;Aminoglycosides/chemistry*;Antibiotics, Antineoplastic/chemistry*;Circular Dichroism;Copper/chemistry*;Electron Spin Resonance Spectroscopy;Models, Molecular;Molecular Conformation;Naphthoquinones/chemistry*;Spectrophotometry
15527070;Administration, Oral;Animals;Antioxidants/administration & dosage;Antioxidants/pharmacology*;Chromans/metabolism;Chromans/urine;Kidney/drug effects;Kidney/metabolism*;Male;Potassium/urine;Propionates/metabolism;Propionates/urine;Random Allocation;Rats;Rats, Sprague-Dawley;Sodium/urine*;Sodium Chloride, Dietary/administration & dosage;Sodium Chloride, Dietary/pharmacokinetics*;Urine/physiology;gamma-Tocopherol/administration & dosage;gamma-Tocopherol/pharmacology*
15532075;Berberine/analogs & derivatives*;Berberine/analysis;Berberine/chemistry*;Berberine Alkaloids/analysis;Berberine Alkaloids/chemistry*;Coptis/chemistry*;Drugs, Chinese Herbal/chemistry*;Plant Roots/chemistry;Spectrometry, Mass, Electrospray Ionization*
15540504;Adolescent;Adult;Female;Humans;Male;Punishment;Reinforcement (Psychology)*
15540584;Air Pollutants/analysis*;Air Pollution/prevention & control;Cities;Environmental Monitoring;Models, Theoretical*;Oxidants, Photochemical/analysis*;Ozone/analysis*;Photochemistry;Smog*;Thailand
15563496;Butyrylcholinesterase/deficiency*;Butyrylcholinesterase/genetics*;Child, Preschool;Electrophoresis, Agar Gel;Humans;Male;Mutagenesis, Insertional;Polymerase Chain Reaction
15573385;Aged;Aged, 80 and over;Bedding and Linens/economics;Fecal Incontinence/economics*;Fecal Incontinence/nursing;Geriatric Nursing/economics;Health Care Costs*;Health Expenditures;Health Services for the Aged/economics;Humans;Incontinence Pads/economics;Rehabilitation Centers/economics;Subacute Care/economics*;Urinary Incontinence/economics*;Urinary Incontinence/nursing
15578448;Animals;Biopsy;Bone Marrow/pathology*;Cell Transformation, Neoplastic/pathology;Humans;Polycythemia Vera/diagnosis*;Polycythemia Vera/pathology*
15595190;Adolescent;Adult;Body Height;Child;Child, Preschool;Growth Disorders/complications*;Human Growth Hormone/therapeutic use;Humans;Personality*
15604240;Androgens/physiology;Arachidonic Acids/antagonists & inhibitors;Arachidonic Acids/biosynthesis;Arachidonic Acids/metabolism;Arachidonic Acids/physiology*;Cell Line, Tumor;Cyclic AMP-Dependent Protein Kinases/metabolism;Cyclohexanones/pharmacology;Endocannabinoids;Glycerides/antagonists & inhibitors;Glycerides/biosynthesis;Glycerides/metabolism;Glycerides/physiology*;Humans;Hydrolysis;Lipoprotein Lipase/antagonists & inhibitors;Male;Neoplasm Invasiveness;Neoplasms, Hormone-Dependent/metabolism;Neoplasms, Hormone-Dependent/pathology*;Prostatic Neoplasms/metabolism;Prostatic Neoplasms/pathology*;Receptor, Cannabinoid, CB1/agonists;Receptor, Cannabinoid, CB1/antagonists & inhibitors;Receptor, Cannabinoid, CB1/biosynthesis;Receptor, Cannabinoid, CB1/physiology
15606843;Diagnosis, Differential;Eyelids/pathology;Eyelids/surgery;Humans;Lymphoma, T-Cell, Cutaneous/diagnosis*;Lymphoma, T-Cell, Cutaneous/pathology;Lymphoma, T-Cell, Cutaneous/surgery*;Male;Middle Aged;Skin Neoplasms/diagnosis*;Skin Neoplasms/pathology;Skin Neoplasms/surgery*
15631821;Angioplasty/methods*;Angioplasty, Balloon, Coronary/methods*;Brain Ischemia/therapy*;Humans;Myocardial Ischemia/therapy*;Stents;Stroke/therapy
15642665;Adult;Anemia, Hemolytic/genetics*;Base Sequence;Child, Preschool;Chromosomes/chemistry;Chronic Disease;Exons;Female;Gene Expression Regulation, Enzymologic;Globins/genetics;Humans;Infant, Newborn;Male;Pedigree;Point Mutation/physiology;Polymerase Chain Reaction;Pregnancy;Pyruvate Kinase/deficiency;Pyruvate Kinase/genetics*;Severity of Illness Index;Vietnam
15664749;Clinical Trials as Topic/standards*;Spectroscopy, Near-Infrared/methods*;Tablets, Enteric-Coated/analysis;Tablets, Enteric-Coated/classification*;Tablets, Enteric-Coated/standards*
15673393;Algorithms*;Attention Deficit and Disruptive Behavior Disorders/diagnosis*;Attention Deficit and Disruptive Behavior Disorders/drug therapy;Central Nervous System Stimulants/adverse effects*;Central Nervous System Stimulants/therapeutic use;Child;Diagnosis, Computer-Assisted/methods*;Electrocardiography/methods*;Female;Humans;Long QT Syndrome/chemically induced*;Long QT Syndrome/diagnosis*;Male;Reproducibility of Results;Sensitivity and Specificity;Sex Factors
15681813;Animals;Animals, Newborn;Apoptosis/drug effects*;Blotting, Western/methods;Caspase 3;Caspases/metabolism;Cell Count/methods;DNA Fragmentation/drug effects;Dopamine/metabolism*;Dose-Response Relationship, Drug;Enzyme Activation/drug effects;Enzyme Inhibitors/pharmacology;Enzyme-Linked Immunosorbent Assay/methods;Flow Cytometry/methods;Immunoprecipitation/methods;Mesencephalon/cytology*;Mutation/physiology;Neurons/drug effects*;Neurons/metabolism;Organometallic Compounds/pharmacology*;Protein Kinase C-delta/metabolism*;Rats;Reactive Oxygen Species/metabolism;Systole;Transfection/methods
15682561;Adult;Age of Onset;Cohort Studies;Disease Progression;Female;Hispanic Americans*;Humans;Incidence;Los Angeles/ethnology;Male;Middle Aged;Presbyopia/diagnosis;Presbyopia/ethnology*;Prevalence;Retrospective Studies
15685010;Administration, Oral;Anticoagulants/administration & dosage*;Aspirin/administration & dosage;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy*;Azetidines/administration & dosage;Benzylamines;Case Management*;Humans;Risk Factors;Stroke/etiology;Stroke/prevention & control*;Venous Thrombosis/prevention & control*;Warfarin/administration & dosage
15685112;Animals;Diagnosis, Differential;Disease Models, Animal;Dogs;Humans;Immunosuppressive Agents/therapeutic use;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors;Intracellular Signaling Peptides and Proteins/pharmacology*;Narcolepsy/drug therapy*;Narcolepsy/etiology*;Narcolepsy/physiopathology;Neuropeptides/antagonists & inhibitors;Neuropeptides/pharmacology*;Orexins;Polysomnography
15685841;Delusions/psychology*;Delusions/therapy;Humans;Professional-Patient Relations*
15687220;Bacterial Proteins/metabolism*;Bacterial Proteins/physiology*;Gene Expression Regulation, Bacterial*;Genes, Bacterial;Host Factor 1 Protein/biosynthesis;Host Factor 1 Protein/metabolism*;Legionella pneumophila/physiology*;Pigmentation/genetics;Protein Binding;RNA, Bacterial;RNA, Messenger/analysis;Repressor Proteins/metabolism*;Sequence Deletion;Sigma Factor/physiology*;Transcription, Genetic;Virulence/genetics
15695410;Antibodies, Neoplasm/biosynthesis;Antibodies, Neoplasm/immunology*;Antibody Affinity;Antibody Specificity;Breast Neoplasms/immunology;Breast Neoplasms/therapy;Cancer Vaccines/immunology*;Cancer Vaccines/pharmacology;Female;Humans;MAP Kinase Signaling System/immunology*;Ovarian Neoplasms/immunology;Ovarian Neoplasms/therapy;Peptide Fragments/immunology;Phosphorylation;Receptor, ErbB-2/immunology*;Receptor, ErbB-2/metabolism*
15714489;China/epidemiology;DNA, Viral/analysis;Genetic Variation;Genotype;Hepacivirus/classification*;Hepacivirus/genetics*;Hepatitis C/epidemiology*;Hepatitis C/virology;Humans;Molecular Sequence Data;Phylogeny;RNA, Viral/blood;Reverse Transcriptase Polymerase Chain Reaction;Sequence Analysis, DNA;Viral Proteins/genetics
15719101;Bacterial Proteins/chemistry*;Bacterial Proteins/genetics*;Cloning, Molecular;Cyclization;Diterpenes/chemistry*;Escherichia coli/genetics;Molecular Structure;Mycobacterium tuberculosis/enzymology*;Mycobacterium tuberculosis/genetics*
15724349;Adult;Allergens/adverse effects;Betaine/adverse effects*;Betaine/analogs & derivatives*;Cosmetics/adverse effects*;Cross Reactions;Dermatitis, Allergic Contact/etiology*;Diamines/adverse effects*;Drug Synergism;Female;Hair Preparations/adverse effects*;Humans;Propylamines/adverse effects*;Surface-Active Agents/adverse effects*
15731939;Adult;Esophagus*;Female;Fundoplication/methods*;Gastric Acid/secretion*;Gastroesophageal Reflux/complications;Gastroesophageal Reflux/metabolism;Gastroesophageal Reflux/surgery*;Gastroscopy*;Heartburn/etiology;Heartburn/metabolism*;Heartburn/surgery;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Pilot Projects;Treatment Outcome
15740670;Animals;Cytokines/biosynthesis;Genetic Therapy*;Hantavirus/immunology*;Immunoglobulin G/blood;Immunophenotyping;Interleukin-12/genetics*;Lymphocyte Activation;Male;Mice;Mice, Inbred BALB C;Nucleocapsid/genetics;Nucleocapsid/immunology*;Vaccines, DNA/immunology*;Viral Vaccines/immunology*
15742954;Aging;Animal Feed/analysis*;Animals;Chickens/blood;Chickens/physiology*;Diet/veterinary*;Feeding Behavior/physiology;Oviposition
15743333;Aged;Blood-Brain Barrier/physiology;Electroencephalography;Electromyography;Female;Ferritins/cerebrospinal fluid*;Humans;Iron/cerebrospinal fluid*;Male;Polysomnography;Restless Legs Syndrome/cerebrospinal fluid*;Restless Legs Syndrome/diagnosis;Restless Legs Syndrome/epidemiology;Sleep Initiation and Maintenance Disorders/epidemiology;Sleep Initiation and Maintenance Disorders/physiopathology;Transferrin/cerebrospinal fluid*
15754444;African Americans*;Breast Neoplasms/ethnology*;Breast Neoplasms/metabolism*;Breast Neoplasms/secondary;Cell Cycle*;Cell Cycle Proteins/metabolism*;Female;Humans
15766556;Adenoviridae/genetics*;Administration, Rectal;Animals;Apoptosis;Body Weight/genetics;Cell Proliferation;Colitis/chemically induced;Colitis/genetics*;Colitis/pathology;Colitis/therapy*;Female;Gene Expression;Genetic Therapy*;Hepatocyte Growth Factor/administration & dosage;Hepatocyte Growth Factor/genetics*;Hepatocyte Growth Factor/metabolism*;Mice;Mice, Inbred BALB C;Trinitrobenzenesulfonic Acid/administration & dosage;Trinitrobenzenesulfonic Acid/pharmacology*
15767052;Adult;Aged;Basement Membrane/surgery;Diabetic Retinopathy/diagnosis;Diabetic Retinopathy/surgery*;Epiretinal Membrane/surgery*;Female;Fluorescein Angiography;Follow-Up Studies;Humans;Laser Coagulation;Macular Edema/diagnosis;Macular Edema/surgery*;Male;Middle Aged;Prognosis;Prospective Studies;Tomography, Optical Coherence;Visual Acuity;Vitrectomy*
15767568;Biomedical Engineering*;Escherichia coli/genetics;Escherichia coli/physiology;Escherichia coli Proteins/physiology;Feedback;Heat-Shock Proteins/physiology;Heat-Shock Response;Models, Biological*;Protein Biosynthesis;Sigma Factor/physiology
15770577;Adolescent;Adult;Age Factors;Child;Child, Preschool;Exercise Test;Foot/growth & development*;Gait/physiology;Humans;Male;Reference Values;Running/physiology;Shoes;Signal Processing, Computer-Assisted;Sports/physiology*;Walking/physiology;Weight-Bearing/physiology*
15776224;Adult;Afferent Pathways/physiology;Aged;Aging/physiology*;Ankle Joint/innervation;Ankle Joint/physiology*;Female;Humans;Male;Movement/physiology*;Muscle Contraction/physiology;Muscle Spindles/physiology;Muscle, Skeletal/innervation;Muscle, Skeletal/physiology;Physical Fitness/physiology;Postural Balance/physiology;Proprioception/physiology*;Reaction Time/physiology
15776604;Adult;Age Factors;Aged;Blood Gas Analysis;Exercise/physiology*;Humans;Male;Middle Aged;Oxygen/blood;Oxygen/metabolism*;Rest/physiology*;Retrospective Studies;Smoking/metabolism*
15784131;Basophils/cytology*;Cell Count;Humans;Leukocyte Count;Microscopy
15811855;Animals;Apoptosis*;Blotting, Western;Brain/metabolism;Caspase 8;Caspase 9;Caspases/metabolism;Cell Survival;Cytokines/chemistry*;Cytokines/metabolism;Cytosol/metabolism;DNA Damage;DNA Glycosylases/chemistry*;DNA, Mitochondrial/chemistry*;DNA, Mitochondrial/metabolism;Electrophoresis, Polyacrylamide Gel;Humans;Inflammation;Interferon-gamma/metabolism;Mitochondria/metabolism*;Multiple Sclerosis/metabolism;Multiple Sclerosis/pathology;Neuroglia/metabolism;Nitric Oxide/metabolism*;Nitric Oxide Synthase/metabolism;Nitric Oxide Synthase Type II;Oligodendroglia/metabolism;RNA/metabolism;Rats;Recombinant Proteins/chemistry;Time Factors;Transfection;Tumor Necrosis Factor-alpha/metabolism
15820162;Antibiotic Prophylaxis;Cardiovascular Surgical Procedures/adverse effects;Cardiovascular Surgical Procedures/methods*;Decision Making;Endocarditis, Bacterial/complications*;Heart Septal Defects, Ventricular/etiology*;Heart Septal Defects, Ventricular/surgery*;Hemodynamics;Humans;Prognosis;Recurrence;Risk Factors
15824855;Analysis of Variance;Animals;Biomechanical Phenomena/methods;Bone and Bones/metabolism;Female;Genetic Variation*;Lumbar Vertebrae/pathology*;Mice;Mice, Inbred C3H;Mice, Inbred C57BL;Mice, Inbred Strains;Models, Anatomic;Models, Biological;Models, Genetic;Multivariate Analysis;Phenotype;Species Specificity;Stress, Mechanical;Structure-Activity Relationship;Tensile Strength;Tomography, X-Ray Computed
15826322;Advertising as Topic*;Affect;Communication*;Gestures*;Helping Behavior*;Humans;Imagination*;Surveys and Questionnaires;Television*;Verbal Behavior*;Videotape Recording;Visual Perception
15842032;Adolescent;Adult;Female;Humans;Male;Prospective Studies;Social Support;Somatoform Disorders/diagnosis;Somatoform Disorders/psychology;Surveys and Questionnaires;Transsexualism/psychology;Transsexualism/surgery*;Treatment Outcome
15917632;Cell-Free System/enzymology*;Cytosol/enzymology*;Endoplasmic Reticulum/chemistry*;Molecular Chaperones/metabolism;Proteasome Endopeptidase Complex/metabolism*;Protein Transport;Saccharomyces cerevisiae/enzymology*
15920754;Animals;Benzoquinones/toxicity*;Carcinogens/toxicity*;Catalase/metabolism;Chelating Agents/pharmacology;Chromatography, Gel;Comet Assay;Culture Media;DNA Adducts;DNA Damage;Deferoxamine/pharmacology;Dose-Response Relationship, Drug;Electrons;Flow Cytometry;Fluoresceins/pharmacology;Humans;Iron/pharmacology;Leukocytes, Mononuclear/drug effects;Mitochondria/metabolism;Molecular Weight;NAD(P)H Dehydrogenase (Quinone)/metabolism;Oxygen/chemistry;Oxygen/metabolism*;Peroxides/chemistry;Rats;Reactive Oxygen Species*;Superoxide Dismutase/metabolism;Xanthine Oxidase/metabolism
15931632;Administration, Oral;Adult;Aged;Busulfan/administration & dosage*;Disease-Free Survival;Female;Follow-Up Studies;Hematopoietic Stem Cell Transplantation*;Humans;Immunosuppressive Agents/administration & dosage*;Leukemia, Myeloid/mortality;Leukemia, Myeloid/therapy*;Male;Middle Aged;Retrospective Studies;Transplantation Conditioning*/methods;Transplantation, Homologous;Vidarabine/administration & dosage;Vidarabine/analogs & derivatives*
15933219;Adenosine/metabolism*;Animals;Base Sequence;Biological Transport;Molecular Sequence Data;Sequence Homology, Nucleic Acid;Trypanosoma brucei brucei/metabolism*
15935388;Animals;Computer Simulation*;Electric Fish/physiology*;Electric Stimulation;Models, Neurological*;Neurons, Afferent/physiology*;Sensory Receptor Cells/physiology;Sensory Thresholds;Stochastic Processes
15936986;Anthropometry;Bandages;Breast Neoplasms/complications*;Clinical Competence/standards;Exercise Therapy/methods;Female;Health Services Needs and Demand;Humans;London;Lymphedema/etiology;Lymphedema/prevention & control*;Male;Massage/methods;Nursing Assessment;Nursing Audit;Nursing Evaluation Research;Oncology Nursing/organization & administration*;Patient Care Planning/organization & administration;Patient Education as Topic/organization & administration;Self Care/methods;Severity of Illness Index;Skin Care/methods;Treatment Outcome
15942230;Acrospiroma/pathology*;Biopsy, Needle;Follow-Up Studies;Foot Dermatoses/pathology;Humans;Immunohistochemistry;Male;Middle Aged;Severity of Illness Index;Sweat Gland Neoplasms/pathology*
15942240;Brain Edema/complications;Brain Edema/pathology*;Disease Progression;Female;Humans;Hypercalcemia/complications;Hypercalcemia/pathology*;Hypertensive Encephalopathy/complications;Hypertensive Encephalopathy/pathology*;Image Processing, Computer-Assisted;Magnetic Resonance Imaging/methods;Middle Aged;Neurologic Examination
15942770;Adaptation, Physiological/physiology;Adult;Age Factors;Aged;Aging/physiology*;Algorithms;Diagnosis, Computer-Assisted/methods*;Electrocardiography/methods*;Entropy;Female;Heart/innervation*;Heart/physiology*;Heart Rate/physiology*;Humans;Middle Aged;Models, Cardiovascular;Models, Statistical;Sympathetic Nervous System/physiology*;Vagus Nerve/physiology*
15959657;Adolescent;Aggression/psychology;Anxiety/diagnosis;Anxiety/epidemiology;Child;Child, Preschool;Depression/diagnosis;Depression/epidemiology;Female;Humans;Male;Mass Screening/methods*;Mental Disorders/diagnosis*;Mental Disorders/epidemiology*;Observer Variation;Severity of Illness Index;Sex Distribution;Somatoform Disorders/diagnosis;Somatoform Disorders/epidemiology;Surveys and Questionnaires
15962649;Adolescent;Adult;Aged;Aged, 80 and over;Breast Neoplasms/pathology*;Breast Neoplasms/therapy;Coloring Agents/administration & dosage;Female;Humans;Injections, Intradermal;Lymphatic Metastasis;Middle Aged;Neoplasm Staging;Predictive Value of Tests;Rosaniline Dyes/administration & dosage;Sentinel Lymph Node Biopsy/statistics & numerical data*;Treatment Outcome
15981277;Animals;Bacterial Proteins/genetics;Base Sequence;Cell Culture Techniques;Cell Line;Cell Proliferation/drug effects;Cell Survival/drug effects;Cytomegalovirus/genetics;Dose-Response Relationship, Drug;Gene Expression Regulation/drug effects*;Humans;Mammals;Molecular Chaperones/genetics;Molecular Chaperones/metabolism;Molecular Sequence Data;Promoter Regions, Genetic;Protein Engineering/methods*;Recombinant Proteins/drug effects;Recombinant Proteins/genetics*;Recombinant Proteins/metabolism;Tetracycline/pharmacology*;Time Factors;Trans-Activators/genetics;Transferrin/drug effects;Transferrin/genetics;Transferrin/metabolism
15986916;Acute Disease;Animal Nutritional Physiological Phenomena*;Animals;Cattle;Cattle Diseases/blood;Cattle Diseases/prevention & control*;Female;Hemoglobinuria/prevention & control;Hemoglobinuria/veterinary*;Lactation/physiology;Phosphorus/blood;Phosphorus/deficiency*;Postpartum Period/physiology;Pregnancy;Pregnancy, Animal/physiology;Randomized Controlled Trials as Topic;Seasons
15987077;Carcinogens/adverse effects;Carcinogens/metabolism;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism;Environmental Pollutants/adverse effects;Environmental Pollutants/metabolism*;Genetic Predisposition to Disease/genetics;Genotype;Glutathione Transferase/genetics*;Glutathione Transferase/metabolism;Humans;Polymorphism, Genetic*;Risk Factors;Smoking/genetics;Smoking/metabolism;Toxicogenetics*;Toxins, Biological/adverse effects;Toxins, Biological/metabolism*;Xenobiotics/adverse effects;Xenobiotics/metabolism*
15994791;Amino Acid Sequence;Antiviral Agents/physiology*;Carrier Proteins/chemistry*;Carrier Proteins/physiology*;HIV-1/physiology;HeLa Cells;Humans;Leukemia Virus, Murine/physiology;Molecular Sequence Data;Retroviridae Infections/prevention & control*;Structure-Activity Relationship
15995831;Adult;Brain Stem/pathology;Female;Humans;Machado-Joseph Disease/complications*;Machado-Joseph Disease/pathology;Magnetic Resonance Imaging/methods;Multiple Sclerosis/complications*;Multiple Sclerosis/pathology
16003053;Adult;Aged;Bronchoalveolar Lavage Fluid/microbiology;Cross Infection/diagnosis*;Cross Infection/etiology*;Cross Infection/microbiology;Female;Hospital Bed Capacity, 500 and over;Hospitals, Teaching;Humans;Intensive Care Units;Male;Middle Aged;Pneumonia, Bacterial/diagnosis*;Pneumonia, Bacterial/etiology*;Pneumonia, Bacterial/microbiology;Polymerase Chain Reaction/methods;Prospective Studies;Respiration, Artificial/adverse effects*
16006767;Anti-Bacterial Agents/pharmacology*;Cell Culture Techniques;Cell Survival;Clarithromycin/pharmacology*;Eosinophils/drug effects*;Eosinophils/physiology;Humans;Inflammation;Mast Cells/drug effects*;Mast Cells/physiology;Neutrophils/drug effects*;Neutrophils/physiology;Respiratory Burst
16009186;Adult;Female;Humans;Leydig Cell Tumor/blood;Leydig Cell Tumor/diagnosis*;Ovarian Neoplasms/blood;Ovarian Neoplasms/diagnosis*;Ovary/blood supply*;Veins
16010579;Actins/analysis;Adult;Aged;Brain Edema/epidemiology;Brain Edema/pathology;Carcinoembryonic Antigen/analysis;Cell Movement;Cell Proliferation;Female;Humans;Immunohistochemistry;Incidence;Keratins/analysis;Ki-67 Antigen/analysis;Male;Mast Cells/chemistry*;Mast Cells/pathology*;Mast Cells/physiology;Meningeal Neoplasms/chemistry*;Meningeal Neoplasms/epidemiology;Meningeal Neoplasms/immunology*;Meningeal Neoplasms/pathology;Meningioma/chemistry*;Meningioma/epidemiology;Meningioma/immunology*;Meningioma/pathology;Middle Aged;Mucin-1/analysis;Pericytes/pathology;Vimentin/analysis
16021854;Estradiol/pharmacology*;Fallopian Tubes/cytology;Fallopian Tubes/drug effects;Female;Humans;Mucous Membrane/cytology;Mucous Membrane/drug effects;Organ Culture Techniques;Protein Isoforms;RNA, Messenger/analysis;RNA, Messenger/metabolism;Receptors, Progesterone/genetics;Receptors, Progesterone/metabolism;Vascular Endothelial Growth Factor A/genetics;Vascular Endothelial Growth Factor A/metabolism*;Vascular Endothelial Growth Factor Receptor-1/genetics;Vascular Endothelial Growth Factor Receptor-1/metabolism*;Vascular Endothelial Growth Factor Receptor-2/genetics;Vascular Endothelial Growth Factor Receptor-2/metabolism*
16023748;Adult;Alpha Rhythm*;Evoked Potentials, Visual/physiology*;Female;Form Perception/physiology*;Humans;Male;Photic Stimulation;Reference Values;Space Perception/physiology*;Time Factors
16024829;Adolescent;Adult;Aged;Female;Heart Failure/complications;Heart Failure/etiology;Heart Failure/therapy*;Humans;Kidney Failure, Chronic/complications;Kidney Failure, Chronic/etiology;Kidney Failure, Chronic/physiopathology;Male;Middle Aged;Peritoneal Dialysis*;Water-Electrolyte Balance/physiology
16027551;Benchmarking;Cooperative Behavior;Decision Making, Organizational;Forms and Records Control;Guidelines as Topic;Hospital Information Systems/organization & administration;Humans;Interprofessional Relations;Leadership*;Medical Records Systems, Computerized/standards*;Minnesota;Needs Assessment;Nurse Clinicians/organization & administration*;Nurse's Role*;Patient Care Team/organization & administration;Professional Competence;Professional Staff Committees/organization & administration*;Total Quality Management
16027704;Airway Obstruction/surgery*;Female;Humans;Infant;Infant, Newborn;Male;Mandible/surgery*;Osteogenesis, Distraction*;Pierre Robin Syndrome/surgery*;Pilot Projects
16027760;Adult;Age Factors;Aged;Alcohol Drinking/prevention & control*;Female;Guidelines as Topic*;Health Behavior*;Health Status;Humans;Male;Middle Aged;New Zealand
16037970;Animals;Antibodies/pharmacology;Antibodies, Neoplasm/pharmacology*;Binding Sites, Antibody/physiology*;Biomarkers, Tumor/pharmacokinetics*;Computer Simulation;Fluorescent Antibody Technique*;Models, Biological;Neoplasms/diagnosis*
16039727;Analysis of Variance;Animals;Corpus Striatum/drug effects;Corpus Striatum/physiology*;Discrimination Learning/drug effects;Discrimination Learning/physiology;Dopamine Antagonists/pharmacology;Dopamine D2 Receptor Antagonists;Hippocampus/physiology*;Male;Maze Learning/drug effects;Maze Learning/physiology*;Memory/drug effects;Memory/physiology;Neural Pathways/drug effects;Neural Pathways/physiology*;Rats;Rats, Long-Evans;Space Perception/drug effects;Space Perception/physiology*;Spatial Behavior/drug effects;Spatial Behavior/physiology;Sulpiride/pharmacology;Theta Rhythm
16042596;Protein Kinases/metabolism;Pyruvate Dehydrogenase Complex/metabolism;Thiamine Pyrophosphate/analogs & derivatives*;Thiamine Pyrophosphate/metabolism*
16051761;Animal Migration;Animals;Animals, Wild/physiology;Animals, Wild/virology;Birds/physiology;Birds/virology*;China/epidemiology;Disease Outbreaks/veterinary*;Indonesia/epidemiology;Influenza A virus/genetics;Influenza A virus/isolation & purification*;Influenza in Birds/epidemiology*;Influenza in Birds/mortality;Influenza in Birds/transmission;Influenza in Birds/virology;Orthomyxoviridae Infections/epidemiology;Orthomyxoviridae Infections/transmission;Orthomyxoviridae Infections/virology;World Health Organization*
16055993;Animals;Disease Models, Animal;Femoral Vein/transplantation;Locomotion;Nerve Regeneration/physiology*;Neural Conduction;Polytetrafluoroethylene*;Prosthesis Implantation*;Rats;Rats, Wistar;Sciatic Nerve/injuries;Sciatic Nerve/physiology*;Sciatic Nerve/surgery;Transplantation, Autologous
16098689;Animals;Ascomycota/pathogenicity;Ascomycota/physiology*;Chymotrypsin/genetics;Culture Media;Esterases/genetics;Fungal Proteins/biosynthesis;Fungal Proteins/genetics;Moths/microbiology;Polymerase Chain Reaction;Serine Endopeptidases/genetics;Trypsin/genetics;Virulence Factors/biosynthesis
16112473;Anabolic Agents/administration & dosage*;Animals;Animals, Newborn;Blotting, Western/methods;Calbindin 2;Calbindins;Cell Count/methods;Dose-Response Relationship, Radiation;Electric Stimulation/methods;Female;Gene Expression/drug effects*;Immunohistochemistry/methods;In Vitro Techniques;Indoles/metabolism;Male;Membrane Potentials/drug effects;Membrane Potentials/physiology;Membrane Potentials/radiation effects;Methyltestosterone/administration & dosage*;Mice;Mice, Inbred C57BL;Neural Inhibition/drug effects;Neural Inhibition/physiology;Neural Inhibition/radiation effects;Neurons/drug effects;Neurons/physiology*;Patch-Clamp Techniques/methods;Prosencephalon/cytology;Prosencephalon/physiology;Protein Subunits/genetics;Protein Subunits/metabolism;RNA, Messenger/biosynthesis;Receptors, GABA-A/genetics;Receptors, GABA-A/metabolism*;Reverse Transcriptase Polymerase Chain Reaction/methods;S100 Calcium Binding Protein G/metabolism;Sex Characteristics*
16122086;Altitude*;Disease Outbreaks*;Ethiopia/epidemiology;Humans;Malaria/epidemiology*;Retrospective Studies;Topography, Medical*
16132044;Animals;Chromatin/genetics*;Epigenesis, Genetic*;Gene Expression Regulation*;Gene Silencing;Histones/genetics;Histones/metabolism;Humans;RNA/genetics*
16135504;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carboplatin/therapeutic use*;Carcinoma, Non-Small-Cell Lung/drug therapy*;Cisplatin/therapeutic use*;Clinical Trials as Topic;Humans;Lung Neoplasms/drug therapy*;Meta-Analysis as Topic;Survival Analysis;Treatment Outcome
16142262;Bone Marrow Cells/cytology*;Cell Adhesion*/physiology;Cell Communication/physiology;Cells, Cultured;Hematopoietic Stem Cells/physiology*;Humans;Myelodysplastic Syndromes/physiopathology*;Stromal Cells/physiology
16142831;Carbon Isotopes;Ligands;Lipid Bilayers/chemistry*;Magnetic Resonance Spectroscopy/methods*;Magnetic Resonance Spectroscopy/standards;Membrane Fluidity*;Molecular Structure;Phosphorylcholine/chemistry;Polymers/chemistry*;Protons;Reference Standards
16147743;Acute Disease;Adult;Cesarean Section/adverse effects*;Colonic Pseudo-Obstruction/etiology*;Female;Humans;Pregnancy;Pregnancy, Multiple*;Triplets
16149495;Biomarkers/blood;Biomarkers/cerebrospinal fluid;Diagnostic Techniques, Endocrine;Humans;Radioimmunoassay;Reference Values;Specimen Handling;Thyroid Diseases/diagnosis*;Thyrotoxicosis/diagnosis;Thyrotropin-Releasing Hormone/blood*;Thyrotropin-Releasing Hormone/cerebrospinal fluid
16155875;1-Methyl-3-isobutylxanthine/pharmacology;3T3-L1 Cells;Adipocytes/cytology;Adipocytes/drug effects*;Adipocytes/metabolism*;Adrenocorticotropic Hormone/pharmacology;Animals;Cells, Cultured;Hydrolysis/drug effects;Lipolysis/drug effects*;Mice;Nitrobenzoates/metabolism;Phenotype;Protein Kinases/metabolism;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptor, Melanocortin, Type 2/genetics;Receptors, Corticotropin/genetics;Receptors, Melanocortin;Signal Transduction/drug effects*;alpha-MSH/pharmacology*
16156471;Achilles Tendon/injuries*;Achilles Tendon/surgery;Cadaver;Humans;Materials Testing;Reconstructive Surgical Procedures/methods*;Rupture;Suture Techniques*;Sutures;Tensile Strength;Treatment Outcome
16159274;Adsorption;Benzene Derivatives/chemical synthesis;Benzene Derivatives/chemistry;Catalysis;Electron Spin Resonance Spectroscopy/methods;Molecular Structure;Particle Size;Photochemistry;Porosity;Surface Properties;Titanium/chemistry*
16160109;Biomechanical Phenomena;Cervical Vertebrae/diagnostic imaging*;Cervical Vertebrae/injuries*;Humans;Neck Injuries/diagnostic imaging*;Spinal Fractures/diagnostic imaging*;Tomography, X-Ray Computed*
16161483;Administration, Oral;Animals;Blood Glucose/drug effects*;Cells, Cultured;Diabetes Mellitus, Experimental/drug therapy;Gluconeogenesis/drug effects*;Hepatocytes/drug effects*;Hepatocytes/metabolism;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacology*;Hypoglycemic Agents/therapeutic use;Male;Mice;Mice, Inbred C57BL;Naphthalenes/administration & dosage;Naphthalenes/pharmacology*;Naphthalenes/therapeutic use;Rats
16168080;Base Sequence;Cluster Analysis;Computational Biology;Cyanobacteria/genetics*;Genes, Bacterial/genetics;Genome, Bacterial/genetics*;Molecular Sequence Data;Nucleic Acid Conformation;RNA, Untranslated/chemistry;RNA, Untranslated/genetics*;Research Design;Sequence Alignment
16171380;Bacterial Proteins/metabolism;Cysteine/chemistry*;Cysteine/genetics;Disulfides/chemistry*;Escherichia coli Proteins;Histidine Kinase;Membrane Proteins/metabolism;Methyl-Accepting Chemotaxis Proteins;Models, Molecular;Mutagenesis, Site-Directed;Protein Structure, Secondary;Protein Structure, Tertiary;Receptors, Amino Acid/chemistry*;Receptors, Amino Acid/genetics;Receptors, Amino Acid/metabolism
16183240;Animal Feed/analysis*;Anti-Bacterial Agents/analysis*;Chromatography, High Pressure Liquid/methods;Lincomycin/analysis*;Mass Spectrometry;Pyrroles;Reproducibility of Results;Spectrophotometry, Ultraviolet;Vinyl Compounds
16189968;Adult;Algorithms;Artificial Intelligence*;Biomechanical Phenomena/methods;Computer Simulation;Diagnosis, Computer-Assisted/methods*;Discriminant Analysis;Female;Foot/physiopathology*;Foot Dermatoses/diagnosis*;Foot Dermatoses/physiopathology*;Gait;Humans;Keratoderma, Palmoplantar/diagnosis*;Keratoderma, Palmoplantar/physiopathology*;Leg/physiopathology;Male;Middle Aged;Models, Biological*;Pattern Recognition, Automated/methods;Pressure Ulcer/diagnosis;Pressure Ulcer/physiopathology;Reproducibility of Results;Sensitivity and Specificity
16203285;Astrocytoma/diagnosis;Astrocytoma/genetics;Astrocytoma/pathology*;Biomarkers, Tumor;Brain Neoplasms/diagnosis;Brain Neoplasms/genetics;Brain Neoplasms/pathology*;Genes, p53;Genetic Markers;Glial Fibrillary Acidic Protein/analysis;Humans;Immunohistochemistry;In Situ Hybridization, Fluorescence;Loss of Heterozygosity;Mutation;Oligodendroglioma/diagnosis;Oligodendroglioma/genetics;Oligodendroglioma/pathology*;Receptor, Epidermal Growth Factor/genetics
16212626;Animals;Apoptosis/drug effects;Collagenases/pharmacokinetics;Collagenases/pharmacology*;Humans;Insulin/secretion;Islets of Langerhans/cytology;Islets of Langerhans/drug effects;Islets of Langerhans/physiology*;Islets of Langerhans/ultrastructure;Islets of Langerhans Transplantation/pathology;Islets of Langerhans Transplantation/physiology*;Mice;Mice, Inbred BALB C;Mice, SCID;Microscopy, Confocal;Microscopy, Immunoelectron;Proto-Oncogene Proteins c-bcl-2/metabolism;Thermolysin/pharmacokinetics;Thermolysin/pharmacology*;bcl-2-Associated X Protein/metabolism
16217070;Acute Disease;Antigens, Viral/immunology;Autoantibodies/immunology*;Capsid Proteins/immunology;Cerebellar Ataxia/blood;Cerebellar Ataxia/immunology*;Cerebellar Ataxia/virology*;Cerebellum/immunology;Cerebellum/physiopathology;Cerebellum/virology;Epstein-Barr Virus Infections/complications*;Epstein-Barr Virus Infections/immunology*;Epstein-Barr Virus Infections/virology;Humans;Immunoglobulin M/blood;Immunoglobulin M/immunology;Nerve Tissue Proteins/immunology;Triose-Phosphate Isomerase/immunology
16241494;Action Potentials*;Animals;Arrhythmias, Cardiac/physiopathology*;Computer Simulation;Heart Conduction System/physiopathology*;Humans;Models, Cardiovascular*;Models, Neurological*
16254247;Cell Cycle Proteins/metabolism;Cell Cycle Proteins/physiology*;Cell Line;Centrosome/metabolism*;Cytoskeletal Proteins;Down-Regulation/physiology*;Dynactin Complex;Dyneins/metabolism;Dyneins/physiology*;GTP-Binding Proteins/metabolism;GTP-Binding Proteins/physiology;Golgi Apparatus/metabolism;HeLa Cells;Humans;Lysosomes/metabolism;Microtubule-Associated Proteins/biosynthesis;Microtubule-Associated Proteins/genetics;Microtubule-Associated Proteins/metabolism*;Microtubule-Associated Proteins/physiology*;Nuclear Proteins/biosynthesis;Nuclear Proteins/genetics;Nuclear Proteins/metabolism*;Phosphorylation;Protein Binding/physiology;Protein Kinases/metabolism;Protein Kinases/physiology*;Protein Structure, Tertiary/physiology;Protein Transport/physiology;Protein-Serine-Threonine Kinases;Proto-Oncogene Proteins/metabolism;Proto-Oncogene Proteins/physiology*;Serine Endopeptidases/metabolism*;Transfection
16264139;Arthroplasty, Replacement*;Bone Density/drug effects*;Bone Density Conservation Agents/pharmacology*;Diphosphonates/pharmacology*;Humans;Joint Prosthesis
16283767;Amylose/chemistry*;Anisotropy;Biocompatible Materials/chemistry*;Chemistry, Pharmaceutical/methods*;Cross-Linking Reagents/pharmacology;Diffusion;Drug Carriers*;Kinetics;Macromolecular Substances/chemistry*;Magnetic Resonance Spectroscopy;Models, Statistical;Protons;Solubility;Starch/chemistry*;Tablets*;Temperature;Time Factors;Water/chemistry
16302448;Adult;Aged;Brain/pathology;Brain/radiation effects*;Female;Humans;Male;Middle Aged;Nasopharyngeal Neoplasms/mortality;Nasopharyngeal Neoplasms/radiotherapy*;Nasopharynx/pathology;Nasopharynx/radiation effects;Necrosis;Neoplasm Staging;Radiation Injuries/etiology;Radiotherapy/adverse effects*;Radiotherapy Dosage;Retrospective Studies;Survival Rate;Time Factors;Treatment Outcome
16304375;Angiogenesis Inhibitors/therapeutic use;Antilymphocyte Serum/therapeutic use;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Blood Transfusion;Cyclosporine/therapeutic use;Granulocyte Colony-Stimulating Factor/therapeutic use;Growth Substances/therapeutic use*;Hemoglobins/metabolism;Humans;Immunosuppressive Agents/therapeutic use;Myelodysplastic Syndromes/drug therapy*;Myelodysplastic Syndromes/genetics*;Myelodysplastic Syndromes/therapy;Quality of Life;Risk Assessment;Thalidomide/analogs & derivatives;Thalidomide/therapeutic use
16304775;Animals;Bone Marrow/radiation effects*;Bone Marrow/ultrastructure;Chromosomes*;Dose-Response Relationship, Drug;Gamma Rays*;Humans;Lymphocytes/radiation effects*;Lymphocytes/ultrastructure;Mice;Mice, Inbred C57BL;Mice, Inbred CBA;Neutrons*;Thymus Gland/cytology;Thymus Gland/radiation effects*
16310428;Aged;Coronary Angiography;Coronary Vessels;Electrocardiography*;Female;Follow-Up Studies;Humans;Injections, Intra-Arterial;Male;Middle Aged;Myocardial Infarction/diagnostic imaging;Myocardial Infarction/drug therapy*;Myocardial Infarction/physiopathology;Peptides/administration & dosage*;Peptides/therapeutic use;Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors*;Retrospective Studies;Thrombolytic Therapy/methods*;Treatment Outcome
16316479;Animals;Hippocampus/drug effects*;Hippocampus/physiology;Long-Term Potentiation/drug effects*;Long-Term Potentiation/physiology;Male;Maze Learning/drug effects;Maze Learning/physiology;Memory/drug effects*;Memory/physiology;Memory Disorders/drug therapy;Nicotine/pharmacology*;Nicotine/therapeutic use;Rats;Rats, Wistar;Space Perception/drug effects*;Space Perception/physiology;Stress, Psychological/drug therapy*;Stress, Psychological/physiopathology
16317356;Eye Movements/physiology*;Humans;Psychomotor Performance/physiology*;Space Perception/physiology*;Visual Perception/physiology*
16318295;Personality/classification*;Vocabulary*
16318697;Adult;Anti-Bacterial Agents/pharmacology;Anti-Infective Agents, Local/adverse effects*;Bacteria/drug effects;Bacteria/isolation & purification;Child, Preschool;Drug Resistance, Bacterial*;Family Characteristics*;Hand/microbiology;Hand Disinfection;Household Products/adverse effects*;Humans;Logistic Models;Male;Microbial Sensitivity Tests;Triclosan/adverse effects*
16320527;Adult;Buffers;Cross-Sectional Studies;DMF Index;Dental Caries/etiology;Dental Prosthesis;Female;Fluorosis, Dental/etiology;Food Industry*;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Occupational Diseases/classification;Occupational Diseases/etiology*;Saliva/physiology;Saliva/secretion;Secretory Rate/physiology;Tooth Discoloration/etiology;Tooth Erosion/classification;Tooth Erosion/etiology*;Wine*/adverse effects
16322464;Communicable Disease Control/history;Communicable Disease Control/organization & administration;Communicable Diseases/history;Communicable Diseases/therapy;Financing, Organized/history;Global Health*;History, 20th Century;Humans;Immunization Programs/history;Immunization Programs/organization & administration;International Cooperation/history;Primary Health Care/history;Primary Health Care/organization & administration;Public Health/economics;Public Health/history*;World Health Organization/economics;World Health Organization/history*;World Health Organization/organization & administration
16324809;Acoustic Stimulation;Animals;Auditory Cortex/physiology*;Evoked Potentials, Auditory/physiology*;Guinea Pigs;Male;Models, Animal;Reaction Time/physiology*
16325787;Bacillus/enzymology*;Carbohydrate Sequence;Chromatography, Thin Layer;Glucose/chemistry;Glucose/metabolism;Glucosyltransferases/chemistry*;Glucosyltransferases/metabolism*;Glycosides/biosynthesis*;Glycosides/chemistry;Molecular Sequence Data;Polysaccharides/biosynthesis*;Polysaccharides/chemistry
16327305;Aged;Aged, 80 and over;Alleles;Biopsy, Needle;Cadherins/blood;Cadherins/genetics*;DNA, Neoplasm/genetics*;Disease Progression;Follow-Up Studies;Genotype;Humans;Male;Middle Aged;Neoplasm Staging;Polymerase Chain Reaction;Polymorphism, Genetic*;Prostatic Neoplasms/blood;Prostatic Neoplasms/genetics*;Prostatic Neoplasms/pathology
16329039;Antigens, CD34/analysis;Ataxia Telangiectasia Mutated Proteins;Breast Neoplasms/blood supply;Breast Neoplasms/chemistry;Breast Neoplasms/genetics*;Breast Neoplasms/pathology;Carcinoma, Ductal, Breast/blood supply;Carcinoma, Ductal, Breast/chemistry;Carcinoma, Ductal, Breast/genetics*;Carcinoma, Ductal, Breast/pathology;Cell Cycle Proteins/genetics*;Cell Cycle Proteins/physiology;Cell Differentiation;DNA Damage;DNA-Binding Proteins/genetics*;DNA-Binding Proteins/physiology;Disease Progression;Down-Regulation;Female;Gene Expression Regulation, Neoplastic/physiology*;Humans;Immunohistochemistry;Neovascularization, Pathologic/genetics*;Neovascularization, Pathologic/physiopathology;Protein-Serine-Threonine Kinases/genetics*;Protein-Serine-Threonine Kinases/physiology;Tumor Suppressor Proteins/genetics*;Tumor Suppressor Proteins/physiology
16344643;Evidence-Based Medicine;Humans;Leadership;Nurse Administrators*;Nursing Research/organization & administration*;Research Support as Topic/organization & administration*
16353270;Abortion, Induced/psychology*;Adolescent;Adult;Anxiety;Cross-Sectional Studies;Depression;Educational Status;Female;Fetus/abnormalities*;Humans;Male;Mental Health;Middle Aged;Parents/psychology*;Pregnancy;Regression Analysis;Retrospective Studies;Risk Factors;Sex Factors;Stress, Psychological/etiology*;Surveys and Questionnaires
16362187;Adult;Autonomic Nervous System Diseases/epidemiology;Autonomic Nervous System Diseases/physiopathology*;Blepharoptosis/etiology;Blepharoptosis/physiopathology;Cluster Headache/physiopathology*;Conjunctiva/blood supply;Conjunctiva/innervation;Conjunctiva/physiopathology;Edema/etiology;Edema/physiopathology;Female;Humans;Hyperhidrosis/etiology;Hyperhidrosis/physiopathology;Lacrimal Apparatus Diseases/etiology;Lacrimal Apparatus Diseases/physiopathology;Male;Middle Aged;Miosis/etiology;Miosis/physiopathology;Nasal Mucosa/innervation;Nasal Mucosa/physiopathology;Nasal Mucosa/secretion;Parasympathetic Nervous System/physiopathology*;Prevalence;Principal Component Analysis;Sympathetic Nervous System/physiopathology*
16362950;Adult;Cause of Death;China/epidemiology;Cohort Studies;Dose-Response Relationship, Immunologic;Dust*;Female;Humans;Lung Neoplasms/etiology;Lung Neoplasms/mortality*;Male;Mining*;Occupational Exposure/adverse effects*;Quality Assurance, Health Care;Retrospective Studies;Risk Assessment;Risk Factors;Silicon Dioxide/toxicity*;Silicosis/complications;Silicosis/mortality*;Tin/toxicity*
16365085;Amino Acids/pharmacology*;Animals;Glucose/metabolism;Growth Hormone/pharmacology*;Humans;Insulin/pharmacology*;Insulin-Like Growth Factor I/pharmacology*;Muscle, Skeletal/metabolism*;Proteins/metabolism*
16371193;Anticoagulants/administration & dosage;Case-Control Studies;Digestive System Surgical Procedures/adverse effects*;Endoscopy, Digestive System/adverse effects*;Heparin/administration & dosage;Humans;Middle Aged;Pulmonary Embolism/prevention & control;Retrospective Studies;Risk Factors;Ultrasonography;Venous Thrombosis/diagnostic imaging;Venous Thrombosis/etiology;Venous Thrombosis/prevention & control*
16381974;Chromosome Mapping;Databases, Nucleic Acid*;Genetic Markers;Genome, Plant*;Genomics;Genotype;Internet;Phenotype;Polymorphism, Single Nucleotide*;Software;User-Computer Interface;Zea mays/genetics*
16383045;Dental Care/economics*;Health Services Accessibility/economics*;Humans;Medicaid/economics*;Social Welfare/economics*;United States
16384897;Catechin/analysis;Chromatography, High Pressure Liquid;Flavonoids/genetics;Flavonoids/metabolism*;Flowers/anatomy & histology;Flowers/growth & development;Flowers/metabolism;Gene Expression Regulation, Plant;Plant Proteins/physiology*;Plants, Genetically Modified/anatomy & histology;Plants, Genetically Modified/genetics;Plants, Genetically Modified/metabolism;Proto-Oncogene Proteins c-myb/physiology*;Tobacco/genetics;Vitis/genetics;Vitis/growth & development;Vitis/metabolism*
16388343;Adult;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Conjunctival Diseases/complications*;Conjunctival Diseases/diagnosis*;Diagnosis, Differential;Headache/complications*;Headache/diagnosis*;Headache/drug therapy;Humans;Indomethacin/therapeutic use;Magnetic Resonance Imaging;Male;Syndrome
16402226;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/therapeutic use;Ceftazidime/pharmacology;Ceftazidime/therapeutic use;Cystic Fibrosis/complications*;Cystic Fibrosis/microbiology;Drug Resistance, Multiple/drug effects;Drug Synergism;Drug Therapy, Combination;Humans;Microbial Sensitivity Tests/methods;Microbial Sensitivity Tests/standards*;Pseudomonas Infections/complications*;Pseudomonas Infections/drug therapy;Pseudomonas Infections/microbiology;Pseudomonas aeruginosa/drug effects*;Pseudomonas aeruginosa/isolation & purification;Reproducibility of Results;Thienamycins/pharmacology;Thienamycins/therapeutic use;Tobramycin/pharmacology;Tobramycin/therapeutic use
16409767;Animals;Female;Intraocular Pressure/physiology*;Male;Microscopy, Electron;Rabbits;Retina/ultrastructure*;Suction/adverse effects*;Vacuum
16419170;Cell Line, Tumor/drug effects*;Cell Movement/drug effects;Colorectal Neoplasms*;Dose-Response Relationship, Drug;Female;Humans;Male;Matrix Metalloproteinase 2/genetics;Matrix Metalloproteinase 2/metabolism;NG-Nitroarginine Methyl Ester/pharmacology*;Neoplasm Invasiveness*;Nitric Oxide/metabolism;Nitric Oxide Synthase/antagonists & inhibitors*;Tissue Inhibitor of Metalloproteinase-2/genetics;Tissue Inhibitor of Metalloproteinase-2/metabolism
16429100;17-Hydroxysteroid Dehydrogenases/deficiency;17-Hydroxysteroid Dehydrogenases/genetics;Child;Disorders of Sex Development/enzymology;Disorders of Sex Development/genetics;Disorders of Sex Development/surgery*;Female;Genitalia, Male/surgery*;Humans;Male;Penis/surgery;Surgery, Plastic/methods;Surgical Flaps;Urogenital Surgical Procedures/methods
16430992;Aged;Alzheimer Disease/diagnosis*;Alzheimer Disease/physiopathology*;Brain/physiopathology*;Cognition*;Diagnosis, Computer-Assisted/methods*;Discriminant Analysis;Discrimination Learning*;Electroencephalography/methods*;Evoked Potentials, Visual*;Female;Humans;Male;Reproducibility of Results;Sensitivity and Specificity
16436684;Adaptation, Physiological/physiology*;Adolescent;Adult;Data Interpretation, Statistical;Face*;Female;Humans;Magnetoencephalography*;Male;Photic Stimulation;Recognition (Psychology)/physiology*;Visual Cortex/physiology*
16437025;Absorptiometry, Photon/methods;Bone Density/physiology*;Child;Humans;Osteoporosis/diagnosis;Reproducibility of Results;Tomography, X-Ray Computed/methods*
16441439;Adenosine Triphosphate/metabolism;Cells, Cultured;Chemokine CXCL10;Chemokines, CXC/metabolism;Flagellin/metabolism*;Flagellin/pharmacology;Humans;In Vitro Techniques;Interferon-gamma/secretion*;Interleukin-12/secretion*;Interleukin-18/secretion*;Leukocytes, Mononuclear/drug effects;Leukocytes, Mononuclear/metabolism*;Ligands;NF-kappa B/metabolism;Nigericin/pharmacology;Purinergic P2 Receptor Agonists;Receptors, Purinergic P2X7;Recombinant Proteins/pharmacology;Salmonella/metabolism;Toll-Like Receptor 5/metabolism*;Up-Regulation
16446119;Adult;Anticonvulsants/therapeutic use;Electroencephalography;Epilepsies, Myoclonic/complications;Epilepsies, Myoclonic/diagnosis*;Epilepsies, Myoclonic/drug therapy;Epilepsy, Absence/complications;Epilepsy, Absence/drug therapy;Eyelids/physiopathology;Female;Humans;Intellectual Disability/complications;Magnetic Resonance Imaging
16450413;Body Mass Index;Humans;Myocardial Infarction/etiology*;Risk Assessment/methods;Waist-Hip Ratio/adverse effects*
16452729;Androstenedione/pharmacology*;Animals;Corpus Luteum/metabolism*;Female;Ganglia, Sympathetic/drug effects*;Injections;Luteolysis/drug effects*;Norepinephrine/pharmacology;Ovary/innervation;Pregnancy;Progesterone/blood;Rats;Rats, Inbred Strains;Time Factors
16469225;Adult;Equipment Failure;Follow-Up Studies;Foreign-Body Migration/diagnosis;Foreign-Body Migration/surgery*;Gastroplasty/adverse effects*;Gastroplasty/instrumentation*;Humans;Jejunal Diseases/etiology;Jejunal Diseases/surgery*;Laparoscopy/adverse effects;Laparoscopy/methods;Male;Obesity, Morbid/diagnosis;Obesity, Morbid/surgery;Postoperative Complications/diagnosis;Postoperative Complications/surgery*;Reoperation;Risk Assessment;Treatment Outcome
16472385;Analysis of Variance;Animals;Anopheles/classification;Anopheles/drug effects;Anopheles/physiology*;Bedding and Linens/standards*;Burkina Faso;Cattle;Diet/veterinary;Enzyme-Linked Immunosorbent Assay/methods;Enzyme-Linked Immunosorbent Assay/veterinary;Genotype;Housing*;Humans;Insecticide Resistance/genetics;Insecticides*/pharmacology;Mosquito Control/methods;Mosquito Control/standards*;Mutation/genetics;Nitriles/pharmacology;Permethrin/pharmacology;Polymerase Chain Reaction/methods;Polymerase Chain Reaction/veterinary;Pyrethrins/pharmacology
16481078;Adult;Animals;CD4-Positive T-Lymphocytes/immunology*;Cytotoxicity, Immunologic;Epitopes/immunology*;Epitopes, T-Lymphocyte/immunology;HLA-A2 Antigen/genetics;HLA-DR1 Antigen/genetics;Hepacivirus/immunology*;Hepatitis C/immunology;Humans;Immunologic Memory*;Interferon-gamma/biosynthesis;Mice;Mice, Transgenic;Middle Aged;Recombinant Proteins/administration & dosage;Recombinant Proteins/genetics;Recombinant Proteins/immunology;T-Lymphocytes, Cytotoxic/immunology*;Viral Hepatitis Vaccines/immunology*;Viral Nonstructural Proteins/administration & dosage;Viral Nonstructural Proteins/genetics;Viral Nonstructural Proteins/immunology*
16488879;Computer Simulation;Cues;Humans;Motion Perception;Optical Illusions;Psychophysics;Space Perception*;User-Computer Interface;Vision, Binocular
16500142;Borates/chemistry*;Diffusion;Electron Spin Resonance Spectroscopy*;Electrons*;Imidazoles/chemistry*;Oxidation-Reduction;Paraquat/chemistry*;Solutions/chemistry
16500876;Adolescent;African Continental Ancestry Group*;Beverages/classification*;Child;Energy Intake;European Continental Ancestry Group*;Female;Food/classification*;Humans;Male;Mental Recall;Photography;Reproducibility of Results;Size Perception*;South Africa;Weights and Measures
16507323;Adult;Aged;Cardiac Surgical Procedures*;Cardiomyopathy, Hypertrophic/diagnostic imaging;Cardiomyopathy, Hypertrophic/surgery*;Catheter Ablation*/methods;Echocardiography;Female;Heart Septum/diagnostic imaging;Heart Septum/surgery*;Heart Ventricles/surgery;Humans;Male;Middle Aged;Sensitivity and Specificity;Treatment Outcome
16507532;Biological Evolution*;Computer Simulation;Genetic Speciation;Genetic Variation;Models, Biological;Phenotype*;Phylogeny;Time Factors
16508086;Archaeal Proteins/chemistry*;Archaeal Proteins/isolation & purification;Archaeal Proteins/metabolism*;Crystallization;Nickel/pharmacology;Pyrococcus horikoshii/metabolism*;Recombinant Proteins/chemistry;Recombinant Proteins/isolation & purification;Recombinant Proteins/metabolism;Repressor Proteins/chemistry*;Repressor Proteins/isolation & purification;Repressor Proteins/metabolism*;X-Ray Diffraction
16510226;Adolescent;Adult;Anxiety/psychology*;Attention*;Cues;Facial Expression*;Female;Fixation, Ocular*;Humans;Imitative Behavior*;Male;Middle Aged;Orientation*;Reference Values;Space Perception
16511019;CD8-Positive T-Lymphocytes/immunology;Cloning, Molecular;Crystallization;Humans;Major Histocompatibility Complex*;Protein Conformation;Protein Denaturation;Protein Folding;Receptors, Antigen, T-Cell/chemistry*;Receptors, Antigen, T-Cell/isolation & purification;Receptors, Antigen, T-Cell/metabolism;Recombinant Proteins/chemistry;Recombinant Proteins/isolation & purification;Recombinant Proteins/metabolism
16512592;Accounting;Family Practice/economics*;Fee-for-Service Plans*;Financing, Personal;Humans;Insurance Claim Reporting;Patient Credit and Collection/methods*;Practice Management, Medical/economics*;United States
16525054;Action Potentials/physiology;Adaptation, Physiological/physiology*;Analysis of Variance;Animals;Behavior, Animal;Color Perception/physiology;Conditioning (Psychology)/physiology;Decision Making/physiology*;Discrimination (Psychology)/physiology*;Humans;Macaca fascicularis;Male;Neurons/classification;Neurons/physiology*;Neuropsychological Tests*;Pattern Recognition, Visual/physiology;Photic Stimulation/methods;Prefrontal Cortex/cytology*;Statistics as Topic
16525228;Adult;Anticholesteremic Agents/therapeutic use*;Cerebrovascular Disorders/mortality;Cerebrovascular Disorders/prevention & control;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Coronary Disease/blood;Coronary Disease/mortality;Coronary Disease/prevention & control*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Pravastatin/therapeutic use*;Risk Factors
16526453;Acetaminophen/analysis*;Acetaminophen/chemistry;Acetates/chemistry;Calibration;Chemistry Techniques, Analytical/methods*;Chemistry, Pharmaceutical/methods*;Dose-Response Relationship, Drug;Humans;Hydrogen-Ion Concentration;Iron/chemistry;Kinetics;Models, Chemical;Phenanthrolines/chemistry;Salicylamides/analysis*;Spectrophotometry/methods*;Temperature;Time Factors
16526815;Amino Acids/chemistry*;Carbamates/chemistry*;Carbonates/chemistry*;Molecular Structure;Stereoisomerism
16538788;Child;Graft Rejection;Heart Transplantation/adverse effects*;Humans;Incidence;Lymphoproliferative Disorders/epidemiology;Lymphoproliferative Disorders/etiology*;Multicenter Studies as Topic;Retrospective Studies;Risk Factors
16540491;Activities of Daily Living;Aged;Aged, 80 and over;Aging/pathology*;Catchment Area (Health);Comorbidity*;Female;Forms and Records Control;Geriatric Assessment*;Hospitals;Humans;Male;Medical Records/standards*;Scandinavian and Nordic Countries
16540630;Adult;Aluminum/blood;Aluminum/poisoning*;Ataxia/chemically induced;Chelation Therapy*;Deferoxamine/therapeutic use*;Dysarthria/chemically induced;Humans;Male;Methadone*;Poisoning/drug therapy;Seizures/chemically induced;Substance Abuse, Intravenous*
16542731;Bacterial Proteins/analysis;Bacterial Proteins/immunology;Child, Preschool;Chlamydiales/classification*;Chlamydiales/genetics;Chlamydiales/isolation & purification*;DNA, Bacterial/chemistry;DNA, Bacterial/genetics;DNA, Ribosomal/chemistry;DNA, Ribosomal/genetics;Female;Gram-Negative Bacterial Infections/epidemiology*;Gram-Negative Bacterial Infections/microbiology*;Humans;Immunoassay;Infant;Israel;Male;Molecular Epidemiology;Nasopharynx/microbiology;Pneumonia, Bacterial/microbiology;Polymerase Chain Reaction;RNA, Ribosomal, 16S/genetics;Sequence Analysis, DNA;Water Microbiology*;Water Supply*
16550624;Amino Acids/chemical synthesis;Amino Acids/chemistry*;Base Pairing;Butyrates/chemistry;Catalysis;Dimerization;HIV Protease/chemistry*;Models, Molecular;Nucleotides/chemistry*;Protein Conformation;Protein Engineering*/methods;Protein Folding;Protein Structure, Tertiary
16567518;Aging;Animals;Body Weight;Energy Intake;Interleukin-1/deficiency*;Interleukin-1/genetics;Interleukin-6/deficiency*;Interleukin-6/genetics;Mice;Mice, Knockout;Obesity/genetics*;Obesity/immunology;Phenotype;Receptors, Interleukin-1/antagonists & inhibitors;Thinness/genetics;Thinness/immunology;Weight Gain
16574582;Adult;Anisotropy;Brain/anatomy & histology*;Brain/pathology;Brain Mapping*;Diffusion Magnetic Resonance Imaging*;Female;Humans;Image Processing, Computer-Assisted/methods*;Imaging, Three-Dimensional;Models, Neurological;Neoplasms/diagnosis;Neoplasms, Neuroepithelial/diagnosis;Neurons/cytology*;Visual Perception/physiology
16582567;Endpoint Determination;Growth Disorders/drug therapy*;Growth Disorders/etiology;Hormone Replacement Therapy;Human Growth Hormone/therapeutic use*;Humans;Quality of Life*;Recombinant Proteins/therapeutic use
16583606;Forecasting/methods;Humans;Leadership;Nurse Administrators/trends*;Planning Techniques;Safety Management/trends*;United States
16585825;Facial Muscles/abnormalities*;Humans;Infant, Newborn;Klippel-Feil Syndrome*;Male;Metacarpal Bones/abnormalities*;Radius/abnormalities*;Thumb/abnormalities*
16600721;Adult;Aged;Aged, 80 and over;Carcinoma, Transitional Cell/pathology*;Carcinoma, Transitional Cell/surgery*;Cystectomy*;Female;Humans;Male;Middle Aged;Neoplasm Staging;Treatment Outcome;Urinary Bladder Neoplasms/pathology*;Urinary Bladder Neoplasms/surgery*
16618210;Animals;Cell Differentiation/physiology*;Cells, Cultured;Coculture Techniques;Fetus/anatomy & histology;Fetus/physiology;Fibroblasts/cytology;Fibroblasts/physiology*;Muscle, Skeletal/cytology*;Muscle, Skeletal/embryology;Muscle, Skeletal/metabolism;Myoblasts/cytology;Myoblasts/physiology*;Osteopontin;Rats;Rats, Wistar;Sialoglycoproteins/metabolism*
16637278;Chromosomes, Bacterial/genetics*;Crossing Over, Genetic/genetics*;DNA Repair/genetics*;DNA Replication/genetics*;Escherichia coli/genetics*;Gene Expression Regulation, Bacterial/genetics*;Repetitive Sequences, Nucleic Acid/genetics
16639050;Academic Medical Centers/standards;Aged;Angina, Unstable/therapy*;Cardiac Care Facilities/standards*;Cardiology/standards;Cardiology Service, Hospital/standards*;Female;Guideline Adherence/statistics & numerical data*;Hospital Mortality;Humans;Male;Middle Aged;Outcome and Process Assessment (Health Care)*;Practice Guidelines as Topic;Risk Assessment;United States
16646318;Aedes/parasitology*;Animals;Apicomplexa/physiology*;Digestive System/parasitology;Larva/parasitology;Oocysts/physiology
16649061;Arctic Regions;Bacteria/genetics*;Base Sequence;DNA Primers;DNA, Bacterial;Genes, Bacterial*;Oxidoreductases/genetics*;Plants/microbiology*;Polymorphism, Restriction Fragment Length
16651572;Bone Nails*;Bone Wires;Child;Follow-Up Studies;Fracture Fixation/methods*;Fracture Healing;Humans;Humeral Fractures/diagnostic imaging;Humeral Fractures/surgery*;Radiography;Range of Motion, Articular;Retrospective Studies;Treatment Outcome
16652215;Adult;Aneurysm, False/diagnostic imaging;Aneurysm, False/etiology;Aneurysm, False/therapy*;Angiography;Angioplasty, Balloon*;Arterial Occlusive Diseases/diagnostic imaging;Arterial Occlusive Diseases/etiology*;Arterial Occlusive Diseases/therapy*;Celiac Artery*/diagnostic imaging;Female;Humans;Mesenteric Artery, Superior*/diagnostic imaging;Stents*;Tomography, X-Ray Computed;Wounds and Injuries/complications*
16682291;Aged;Antineoplastic Agents/therapeutic use;Benzamides;Blood Platelets/drug effects;Bone Marrow Cells/cytology;Cells, Cultured;Chromosomes, Human, Pair 22;Chromosomes, Human, Pair 9;Chronic Disease;Dose-Response Relationship, Drug;Female;Fibrinolytic Agents/therapeutic use;Fusion Proteins, bcr-abl/analysis*;Humans;Hydroxyurea/therapeutic use;Imatinib Mesylate;In Situ Hybridization, Fluorescence;Karyotyping;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy;Leukocytes/drug effects;Piperazines/therapeutic use;Pyrimidines/therapeutic use;Quinazolines/therapeutic use;Thrombocythemia, Essential/complications*;Thrombocythemia, Essential/diagnosis;Thrombocythemia, Essential/drug therapy;Time Factors;Translocation, Genetic;Treatment Outcome
16700164;Belgium;Clinical Competence;Databases, Factual;Disinfection/statistics & numerical data;Equipment Contamination/prevention & control;Guideline Adherence/statistics & numerical data;Health Services Research;Hemodialysis Units, Hospital/organization & administration;Humans;Nurse's Role;Nursing Staff, Hospital/education;Nursing Staff, Hospital/organization & administration;Personnel Staffing and Scheduling/statistics & numerical data;Practice Guidelines as Topic;Renal Dialysis/methods*;Renal Dialysis/nursing;Renal Dialysis/standards;Renal Dialysis/statistics & numerical data*;Sanitary Engineering;Scotland;Surveys and Questionnaires;Water Purification/methods
16712467;Animals;Antineoplastic Agents/chemical synthesis*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/toxicity;Cell Proliferation/drug effects;Choline Kinase/antagonists & inhibitors*;Enzyme Inhibitors/chemical synthesis*;Enzyme Inhibitors/pharmacology;Enzyme Inhibitors/toxicity;Humans;Lethal Dose 50;Pyridinium Compounds/chemical synthesis;Pyridinium Compounds/pharmacology;Pyridinium Compounds/toxicity;Quantitative Structure-Activity Relationship;Quinolinium Compounds/chemical synthesis;Quinolinium Compounds/pharmacology;Quinolinium Compounds/toxicity
16724771;Concept Formation*;Humans;Internet*;Metaphor*;Paired-Associate Learning*;Psycholinguistics*;Semantics;Writing*
16738584;Animal Care Committees;Animal Welfare/ethics*;Animal Welfare/legislation & jurisprudence;Animals;Clinical Trials as Topic/ethics;Clinical Trials as Topic/legislation & jurisprudence;Clinical Trials as Topic/veterinary*;Consent Forms/standards*;Dogs;Male;Mandatory Reporting/ethics*;United States;United States Department of Agriculture
16757605;Antifungal Agents/pharmacology*;Candida/classification;Candida/drug effects*;Candida/isolation & purification;Candida albicans/drug effects;Candida albicans/isolation & purification;Candidiasis/microbiology;Drug Resistance, Fungal;Fungemia/microbiology;Humans;Microbial Sensitivity Tests/methods;Microbial Sensitivity Tests/standards;Triazoles/pharmacology*
16770471;Animals;Apoptosis;Bromodeoxyuridine;Cell Proliferation*;DNA/metabolism;Endothelial Cells/pathology;Hindlimb Suspension;Male;Mice;Muscle, Skeletal/metabolism;Muscle, Skeletal/pathology*;Muscular Atrophy/metabolism;Muscular Atrophy/pathology*;Proteins/metabolism;Satellite Cells, Skeletal Muscle/pathology;Time Factors
16778338;Antihypertensive Agents/therapeutic use;Blood Pressure Determination;Blood Pressure Monitoring, Ambulatory;Female;Humans;Hypertension/diagnosis*;Hypertension/drug therapy;Hypertension/epidemiology;Hypertension/psychology;Male;Office Visits*;Prevalence;Self Care
16786069;Carboxylic Acids/chemistry;Crystallization;Electronics;Europium/chemistry*;Hydrogen-Ion Concentration;Ligands;Light;Luminescence;Models, Chemical;Models, Molecular;Photochemistry/methods*;Spectrometry, Fluorescence;Spectrophotometry, Ultraviolet;Time Factors;Zinc/chemistry*
16794424;Anabolic Agents/therapeutic use;Androgens/therapeutic use;Female;Hormone Replacement Therapy;Humans;Menopause*;Methyltestosterone/therapeutic use;Sexual Behavior*/drug effects;Testosterone/blood*;Testosterone/therapeutic use
16802974;Biological Clocks/physiology*;Biological Clocks/radiation effects;Cell Membrane/physiology*;Cell Membrane/radiation effects;Computer Simulation;Dose-Response Relationship, Radiation;Electromagnetic Fields;Ion Channel Gating/physiology;Ion Channel Gating/radiation effects;Membrane Potentials/physiology*;Membrane Potentials/radiation effects;Membrane Proteins/metabolism;Models, Biological*;Proton Pumps/physiology*;Proton Pumps/radiation effects;Radiation Dosage;Saccharomyces cerevisiae/physiology*;Saccharomyces cerevisiae/radiation effects;Saccharomyces cerevisiae Proteins/metabolism*
16809942;Animals;Genetic Diseases, Inborn/genetics*;Genetic Diseases, Inborn/physiopathology*;Humans;Mice;Pancreatic Diseases/genetics*;Pancreatic Diseases/physiopathology*
16810108;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/therapeutic use;Administration, Oral;Administration, Topical;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use*;Genetic Predisposition to Disease;Macaca mulatta;Organophosphonates/administration & dosage;Organophosphonates/therapeutic use*;Prodrugs/administration & dosage;Prodrugs/therapeutic use;Simian Acquired Immunodeficiency Syndrome/drug therapy*;Simian Acquired Immunodeficiency Syndrome/prevention & control*;Simian Immunodeficiency Virus/drug effects;Simian Immunodeficiency Virus/pathogenicity*;Tenofovir;Virulence
16826122;Animals;Cell Proliferation/drug effects;Disease Models, Animal;Dose-Response Relationship, Drug;Drug Administration Schedule;Follow-Up Studies;Growth Substances/administration & dosage*;Male;Rats;Rats, Sprague-Dawley;Tendon Injuries/drug therapy*;Tendon Injuries/pathology;Tendons/pathology*;Time Factors;Treatment Outcome;Wound Healing/drug effects*
16845930;Animals;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/therapeutic use*;Anxiety/etiology;Anxiety/prevention & control*;Benzimidazoles/administration & dosage;Benzimidazoles/therapeutic use*;Brain Ischemia/complications*;GABA Agonists/administration & dosage;GABA Agonists/therapeutic use*;Infarction, Middle Cerebral Artery/physiopathology;Maze Learning/drug effects;Morpholines/administration & dosage;Morpholines/therapeutic use*;Rats;Rats, Inbred Strains
16847055;Apoptosis*;Cell Line, Tumor;Enzyme Activation;Epidermal Growth Factor/physiology*;Gene Expression Regulation, Neoplastic*;Humans;Male;Models, Biological;Phosphorylation;Prostatic Neoplasms/metabolism;Prostatic Neoplasms/pathology*;Proto-Oncogene Proteins c-raf/metabolism;Signal Transduction*;bcl-Associated Death Protein/metabolism*
16851051;Base Pairing;Cations/chemistry;Cytosine/chemistry*;Electrons;Energy Transfer;Guanine/chemistry*;Hydrogen Bonding;Lithium/chemistry*;Models, Chemical;Molecular Structure;Oxidation-Reduction;Sensitivity and Specificity;Spectrophotometry, Infrared/methods
16854201;5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/biosynthesis;Chi-Square Distribution;Child;Chromosome Deletion*;Chromosome Disorders/enzymology;Chromosome Disorders/genetics*;Chromosomes, Human, Pair 22/genetics*;Cleft Palate/complications*;Cystathionine beta-Synthase/biosynthesis;Ethnic Groups;Female;Ferredoxin-NADP Reductase/biosynthesis;Humans;Male;Methylenetetrahydrofolate Reductase (NADPH2)/biosynthesis;Palate, Hard/abnormalities*;Phenotype;Polymorphism, Single Nucleotide;Sex Factors;Syndrome;Velopharyngeal Insufficiency/etiology;Velopharyngeal Insufficiency/genetics*
16862308;Animals;Brazil;Female;Fisheries;Male;Mortality;Penaeidae/anatomy & histology;Penaeidae/growth & development*;Seawater;Shellfish*
16865110;Dentists, Women*;Female;Humans;United Kingdom
16865676;Adult;Aged;Aged, 80 and over;Amino Acid Sequence;Base Sequence;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/pathology*;DNA Primers;Evolution, Molecular;Female;Humans;Hypoxia-Inducible Factor 1, alpha Subunit/genetics*;Immunohistochemistry;Loss of Heterozygosity;Male;Middle Aged;Molecular Sequence Data;Polymerase Chain Reaction;Polymorphism, Genetic*;Polymorphism, Restriction Fragment Length;Sequence Homology, Amino Acid;Ulcer/pathology*
16874816;Adenoviruses, Human/genetics;Adult;Aged;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Breast Neoplasms/immunology;Breast Neoplasms/surgery;Breast Neoplasms/therapy*;Combined Modality Therapy;Doxorubicin/administration & dosage;Female;Gene Transfer Techniques;Genes, p53*;Genetic Therapy*;Genetic Vectors;Humans;Lymphocytes, Tumor-Infiltrating/immunology;Middle Aged;Survival Rate;Taxoids/administration & dosage;Transgenes
16876167;Animals;Emotions;Female;Gonadal Steroid Hormones/physiology;Gonads/physiology;Hormones/physiology*;Humans;Hypothalamo-Hypophyseal System/physiopathology;Limbic System/pathology;Limbic System/physiopathology;Male;Mood Disorders/pathology;Mood Disorders/physiopathology*;Mood Disorders/psychology;Neurosecretory Systems/physiopathology*;Pituitary-Adrenal System/physiopathology;Schizophrenia/physiopathology*;Schizophrenic Psychology;Sex Characteristics*;Sex Differentiation
16891399;Animals;DNA Primers;Granulocyte-Macrophage Colony-Stimulating Factor/genetics*;Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology*;Hyperoxia/physiopathology*;Immunity, Innate;Lung/immunology;Lung/physiopathology*;Mice;Mice, Inbred C57BL;Reverse Transcriptase Polymerase Chain Reaction
16895047;Chi-Square Distribution;Clinical Trials as Topic/ethics;Clinical Trials as Topic/standards*;Comprehension*;Cultural Characteristics;Developing Countries;Female;Humans;Informed Consent*;Malaria/prevention & control*;Malaria Vaccines/therapeutic use*;Male;Mali;Rural Population;Suburban Population;Surveys and Questionnaires;Translations
16899094;Adenine;Adult;Alveolar Bone Loss/classification;Codon/genetics;Cytosine;Exons/genetics;Female;Gene Frequency;Genetic Predisposition to Disease/genetics;Genotype;Guanine;Haplotypes/genetics;Homozygote;Humans;Introns/genetics;Male;Periodontal Attachment Loss/classification;Periodontitis/classification;Periodontitis/genetics*;Polymorphism, Genetic/genetics;Polymorphism, Single Nucleotide/genetics;Receptors, Calcitriol/genetics*;Risk Factors;Thymine
16907772;Age Factors;Aged;Alveolar Process/blood supply*;Alveolar Process/surgery;Alveolar Ridge Augmentation/methods*;Female;Humans;Mandible/blood supply*;Mandible/surgery;Middle Aged;Osteogenesis/physiology;Osteogenesis, Distraction/methods*;Statistics, Nonparametric
16916281;Desiccation;Euryarchaeota/growth & development;Euryarchaeota/metabolism*;Exobiology;Extraterrestrial Environment/chemistry*;Mars*;Methane/biosynthesis;Methanobacteriaceae/growth & development;Methanobacteriaceae/metabolism;Methanobacterium/growth & development;Methanobacterium/metabolism;Methanosarcina barkeri/growth & development;Methanosarcina barkeri/metabolism
16916596;Analysis of Variance;Animals;Body Weight/drug effects;Carbon Isotopes/metabolism;Chromatography, Gas/methods;Dose-Response Relationship, Drug;Embryo, Nonmammalian/drug effects*;Embryo, Nonmammalian/metabolism;Ethanol/metabolism*;Ethanol/pharmacology*;Radiometry/methods;Time Factors;Zebrafish
16919591;Adult;Analysis of Variance;Attention/physiology*;Decision Making/physiology*;Female;Humans;Judgment/physiology;Male;Random Allocation;Students/psychology
16925049;Australia;Disasters*;Humans;Nurse's Role*;Pakistan;Relief Work/organization & administration*;Volunteers/organization & administration
16930048;Antibiotics, Antineoplastic/chemical synthesis*;Chemistry, Organic/methods*;Heterocyclic Compounds, 4 or More Rings/chemical synthesis*;Heterocyclic Compounds, 4 or More Rings/chemistry;Magnetic Resonance Spectroscopy;Molecular Structure;Stereoisomerism
16949719;Cardiopulmonary Resuscitation*;Emergency Medical Services*;Humans;Monitoring, Physiologic/methods*;Respiratory Physiological Phenomena*
16954334;AMP-Activated Protein Kinases;Aminoimidazole Carboxamide/administration & dosage;Aminoimidazole Carboxamide/analogs & derivatives*;Aminoimidazole Carboxamide/pharmacology;Animals;Biomarkers/metabolism;Blood Glucose/drug effects;Body Weight/drug effects;Drug Administration Schedule;Eating/drug effects;Female;Gene Expression;Glucose Transporter Type 4/metabolism*;Hexokinase/metabolism*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacology;Male;Mice;Mice, Knockout;Mitochondria, Muscle/enzymology;Mitochondrial Proteins/metabolism*;Multienzyme Complexes/genetics;Multienzyme Complexes/physiology*;Muscles/drug effects;Muscles/metabolism*;Physical Conditioning, Animal/physiology*;Protein Subunits/metabolism;Protein-Serine-Threonine Kinases/genetics;Protein-Serine-Threonine Kinases/physiology*;Ribonucleotides/administration & dosage;Ribonucleotides/pharmacology*;Running
16960657;3-Hydroxybutyric Acid/metabolism*;Animals;Cells, Cultured;Enzyme Activation;Extracellular Signal-Regulated MAP Kinases/metabolism;Glucose/metabolism*;Humans;Insulin/metabolism*;Insulin Receptor Substrate Proteins;Ketone Bodies/metabolism*;Male;Myocytes, Cardiac/cytology;Myocytes, Cardiac/metabolism*;Phosphatidylinositol 3-Kinases/metabolism*;Phosphoproteins/metabolism;Phosphorylation;Protein Subunits/metabolism;Proto-Oncogene Proteins c-akt/metabolism;Rats;Rats, Sprague-Dawley;Receptor, Insulin/metabolism;Signal Transduction/physiology;Vanadates/metabolism*;p38 Mitogen-Activated Protein Kinases/metabolism
16962029;Humans;Immune System;Immunologic Techniques*;Sensitivity and Specificity
16966785;Disease Notification;Humans;Influenza, Human/epidemiology;Internationality*;Italy;Poison Control Centers/statistics & numerical data;Population Surveillance*/methods;Sentinel Surveillance;Sports*
16969799;Atlantic Ocean;Cyanobacteria/cytology;Flow Cytometry*/instrumentation;Flow Cytometry*/methods;Phytoplankton/cytology*;Seawater*;Syringes
16990816;Animals;Caenorhabditis elegans/genetics*;Chromosomes, Artificial, Bacterial/genetics;Cloning, Molecular/methods;Genetic Engineering/methods*;Genomics/methods*;Green Fluorescent Proteins/genetics;Phenotype;RNA Interference;Transgenes
17001356;Adult;Atracurium*;Cholinesterase Inhibitors/administration & dosage*;Female;Humans;Male;Middle Aged;Neostigmine/administration & dosage*;Nerve Block*;Neuromuscular Nondepolarizing Agents*;Vecuronium Bromide*
17001534;Aging;Animals;Ants/physiology*;Body Weight;Female;Gas Chromatography-Mass Spectrometry;Heteroptera/metabolism*;Male;Organic Chemicals/analysis;Organic Chemicals/chemistry;Organic Chemicals/metabolism*;Predatory Behavior/physiology*;Solid Phase Microextraction;Volatilization
17006646;Animals;Disaccharides/analysis;Disaccharides/chemistry;Female;Heparin Lyase;Heparitin Sulfate/chemistry*;Heparitin Sulfate/isolation & purification*;Magnetic Resonance Spectroscopy;Male;Mice;Mice, Inbred ICR;Molecular Structure;Tissue Distribution
17006679;Centrifugation/methods;Crystallization;Filtration/methods;Glucocorticoids/analysis;Glucocorticoids/chemistry;Glucocorticoids/isolation & purification*;Particle Size;Pharmaceutical Preparations/analysis;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/isolation & purification;Reproducibility of Results;Suspensions;Triamcinolone Acetonide/analysis;Triamcinolone Acetonide/chemistry;Triamcinolone Acetonide/isolation & purification*
17010025;Adult;Female;Health Care Surveys;Health Services Accessibility/organization & administration;Hospitals, Rural/organization & administration*;Humans;Male;Massachusetts;Medically Underserved Area;Medicine/organization & administration*;Middle Aged;Personnel Staffing and Scheduling/organization & administration*;Rural Health Services/organization & administration*;Specialization*
17011381;Administration, Cutaneous;Clinical Trials, Phase II as Topic;Clinical Trials, Phase III as Topic;Humans;Mandelic Acids/administration & dosage*;Mandelic Acids/adverse effects;Muscarinic Antagonists/administration & dosage*;Muscarinic Antagonists/adverse effects;Urinary Bladder, Overactive/etiology*
17014935;Adjuvants, Immunologic/pharmacology*;Adsorption;Aluminum Compounds/pharmacology*;Animals;Antibody Formation;Antigens/chemistry;Antigens/immunology*;Caseins/chemistry;Caseins/immunology;Female;Mice;Mice, Inbred BALB C;Microscopy, Confocal;Muramidase/chemistry;Muramidase/immunology;Ovalbumin/chemistry;Ovalbumin/immunology;Phosphates/pharmacology*;Phosphorylation;Vaccines/chemistry;Vaccines/immunology*
17025330;Plants/chemistry;Sugar Acids/chemical synthesis*;Thioglycosides/chemical synthesis;Xylose/analogs & derivatives*;Xylose/chemical synthesis
17065908;Adult;Catheterization, Central Venous/adverse effects;Catheterization, Central Venous/instrumentation;Catheterization, Central Venous/methods*;Central Venous Pressure;Female;Humans;Jugular Veins;Male;Subclavian Vein
17067212;Adaptation, Physiological/physiology;Adaptation, Physiological/radiation effects*;Animals;Chromosome Inversion/radiation effects*;Dose-Response Relationship, Radiation;Male;Mice;Mice, Inbred C57BL;Prostate/physiology*;Prostate/radiation effects*;Radiation Dosage;Radiation Tolerance/physiology*;Radiation Tolerance/radiation effects*;X-Rays
17067755;Glycosides/chemistry;Humans;Magnetic Resonance Spectroscopy;Phenols/chemistry;Phytotherapy*;Plant Components, Aerial;Plant Extracts/chemistry*;Solidago*
17076183;Adolescent;Anxiety/psychology;Female;Humans;Korea/epidemiology;Male;Mental Health*;Only Child/psychology*;Psychology, Adolescent*;Self Concept;Social Support;Stress, Psychological/psychology;Urban Population*
17083870;Adult;Cutaneous Fistula/etiology*;Edema/etiology;Humans;Male;Oral Fistula/etiology*;Periapical Periodontitis/complications*;Periapical Periodontitis/diagnosis;Tooth, Unerupted/complications
17085275;Cooperative Behavior*;Health Planning Guidelines*;Hospice Care*;Humans;Program Evaluation/methods*;United States;United States Department of Veterans Affairs*
17086504;Adult;Employment;Female;Health Care Costs;Health Status;Humans;Male;Middle Aged;Northern Territory;Occupational Diseases/psychology*;Occupational Diseases/rehabilitation*;Personality*;Personality Disorders*;Rehabilitation, Vocational*/economics;Treatment Outcome;Wounds and Injuries/psychology*;Wounds and Injuries/rehabilitation*
17090381;Calcium Sulfate/chemistry*;Drugs, Chinese Herbal/pharmacology*;Granulation Tissue/drug effects*;Plant Preparations/pharmacology;Random Allocation;Skin Ulcer/physiopathology;Wound Healing/drug effects
17094870;Administration, Inhalation;Animals;Blood Pressure/drug effects;Dose-Response Relationship, Drug;Guanidines/pharmacology;Isothiuronium/analogs & derivatives;Isothiuronium/pharmacology;Lipopolysaccharides/toxicity*;Lung/drug effects*;Lung/metabolism;Nitrates/metabolism*;Nitric Oxide/administration & dosage;Nitric Oxide/pharmacology*;Nitric Oxide Synthase Type II/physiology;Nitrites/metabolism*;Perfusion;Rats;Rats, Sprague-Dawley
17096186;Animals;DNA, Viral/genetics;DNA-Binding Proteins/genetics*;Gene Deletion*;Genes, Viral*;Genetic Vectors;Nucleopolyhedrovirus/genetics*;Nucleopolyhedrovirus/physiology;Spodoptera;Viral Proteins/genetics*;Virus Replication
17099125;Centers for Medicare and Medicaid Services (U.S.);Current Procedural Terminology;Fee Schedules/legislation & jurisprudence;Health Care Surveys/methods*;Humans;Medicare Part B/legislation & jurisprudence;Operating Rooms/economics;Operating Rooms/utilization*;Relative Value Scales;Surgical Procedures, Operative/classification*;Surgical Procedures, Operative/economics;Time and Motion Studies*;United States
17111907;Budgets/legislation & jurisprudence*;Education, Continuing;Fraud/prevention & control*;Guideline Adherence*;Medicaid/economics;Medicaid/legislation & jurisprudence;United States
17114908;Apoptosis/drug effects;Carcinoma, Small Cell/metabolism*;Cell Line, Tumor;Cell Membrane/metabolism;Cell Proliferation/drug effects;Gene Expression;Ghrelin;Humans;Lung Neoplasms/metabolism*;Nerve Tissue Proteins/metabolism;Neuropeptides/metabolism*;Neuropeptides/pharmacology;Peptide Hormones/metabolism*;Peptide Hormones/pharmacology;Peptides, Cyclic/pharmacology;Protein Binding;Receptors, G-Protein-Coupled/metabolism*;Receptors, Ghrelin;Receptors, Neuropeptide/metabolism;Receptors, Somatostatin/metabolism*;Somatostatin/analogs & derivatives;Somatostatin/pharmacology
17115086;Animals;Anti-Anxiety Agents/adverse effects*;Benzodiazepines/adverse effects*;Brain/drug effects*;Brain/physiopathology*;Cognition/drug effects*;Humans;Memory Disorders/chemically induced*;Memory Disorders/physiopathology*
17117435;Animals;Cycloheximide/pharmacology;Hepatocyte Growth Factor/metabolism;Mice;Mice, Inbred mdx;Mice, Transgenic;Muscle Fibers, Skeletal/metabolism*;Muscle, Skeletal/metabolism*;Nitric Oxide/metabolism*;Nitric Oxide Synthase/antagonists & inhibitors;PAX7 Transcription Factor/metabolism;Proto-Oncogene Proteins c-met/metabolism;Satellite Cells, Skeletal Muscle/metabolism*;Stem Cells/metabolism*
17127689;Animals;Blastocyst/physiology*;Blastocyst/ultrastructure;Blastomeres/physiology*;Blastomeres/ultrastructure;Body Patterning/physiology*;Carbocyanines;Cell Polarity/physiology;Female;Mice;Pregnancy;Zona Pellucida/physiology*;Zona Pellucida/ultrastructure;Zygote/physiology;Zygote/ultrastructure
17134584;Aged;Ankle/blood supply*;Blood Flow Velocity/physiology;Brachial Artery/physiopathology*;Coronary Artery Disease/physiopathology*;Endothelium, Vascular/physiopathology*;Female;Humans;Male;Middle Aged;Vasodilation
17135216;Acalculous Cholecystitis/parasitology*;Acute Disease;Child;Diagnosis, Differential;Humans;Malaria, Falciparum/complications*;Malaria, Vivax/complications*;Male
17140902;Adult;Aged;Aged, 80 and over;Colonoscopy/utilization*;Colorectal Neoplasms/diagnosis*;Colorectal Neoplasms/epidemiology;Female;Follow-Up Studies;Health Services Needs and Demand*;Humans;Incidence;Male;Middle Aged;Population Surveillance*;Retrospective Studies;Risk Factors;Western Australia/epidemiology
17156868;Coronary Artery Disease*/complications;Coronary Artery Disease*/surgery;Coronary Artery Disease*/therapy;Diabetes Complications*;Humans;Myocardial Revascularization*
17186980;Adult;Aged;Brugada Syndrome/diagnosis*;Brugada Syndrome/physiopathology*;Case-Control Studies;Electric Stimulation;Electrocardiography*;Female;Humans;Male;Middle Aged;Prognosis;Retrospective Studies;Risk Factors;Sensitivity and Specificity;Tachycardia, Ventricular/physiopathology;Ventricular Fibrillation/physiopathology
17190948;Arrhythmias, Cardiac/diagnosis*;Asphyxia Neonatorum/complications;Asphyxia Neonatorum/diagnosis*;Diagnosis, Computer-Assisted/methods*;Electrocardiography/methods*;Electroencephalography/methods*;Female;Heart Rate*;Humans;Infant, Newborn;Male;Reproducibility of Results;Seizures/diagnosis*;Seizures/etiology;Sensitivity and Specificity
17191812;Antioxidants/isolation & purification;Antioxidants/pharmacology*;Copper/pharmacology*;Dietary Fats, Unsaturated/isolation & purification;Dietary Fats, Unsaturated/pharmacology;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Humans;Lipoproteins, LDL/drug effects*;Lipoproteins, LDL/metabolism;Olea;Olive Oil;Oxidation-Reduction/drug effects;Phenols/isolation & purification;Phenols/pharmacology*;Plant Extracts/isolation & purification;Plant Extracts/pharmacology;Plant Leaves;Plant Oils/isolation & purification;Plant Oils/pharmacology;Reactive Oxygen Species/isolation & purification;Reactive Oxygen Species/pharmacology*
17193712;Amino Acid Sequence;Base Sequence;Blotting, Northern;Chromosome Mapping;Cloning, Molecular;DNA, Complementary/genetics*;DNA, Plant/genetics*;Epitopes/genetics*;Molecular Sequence Data;Nitrate Reductase/genetics*;Nucleic Acid Hybridization/genetics;RNA, Messenger/genetics*;RNA, Plant/genetics;Sequence Alignment;Tobacco/enzymology;Tobacco/genetics
17197283;Adult;Behavioral Risk Factor Surveillance System;Centers for Disease Control and Prevention (U.S.)/statistics & numerical data*;Female;Humans;Male;Middle Aged;Obesity/epidemiology*;Obesity, Morbid/epidemiology;Overweight;Prevalence;United States/epidemiology
17214350;Adolescent;Adult;Cell Transformation, Neoplastic;Female;Humans;Middle Aged;Precancerous Conditions/microbiology*;Precancerous Conditions/pathology;Ureaplasma Infections/pathology*;Ureaplasma urealyticum;Uterine Cervical Diseases/microbiology*;Uterine Cervical Diseases/pathology;Uterine Cervical Neoplasms/microbiology*;Uterine Cervical Neoplasms/pathology;Vaginal Diseases/microbiology*;Vaginal Diseases/pathology;Vaginal Neoplasms/microbiology*;Vaginal Neoplasms/pathology
17214926;Facial Pain/diagnosis;Facial Pain/epidemiology;Facial Pain/etiology;Facial Pain/therapy*;Humans;Migraine Disorders/complications;Temporomandibular Joint Disorders/diagnosis;Temporomandibular Joint Disorders/epidemiology;Temporomandibular Joint Disorders/etiology;Temporomandibular Joint Disorders/therapy*;Tooth Diseases/complications
17223523;Attitude of Health Personnel;Face/surgery*;Humans;Reconstructive Surgical Procedures/psychology*;Skin Transplantation/standards*
17240369;Animals;Basement Membrane/metabolism*;Cell Differentiation;Cell Line;Embryonic Development;Epidermis/embryology;Epidermis/physiology;Epithelial Cells/metabolism;Extracellular Matrix Proteins/genetics;Extracellular Matrix Proteins/metabolism*;Eyelids/embryology;Eyelids/physiology;Gene Expression Regulation, Developmental*;Humans;Mesoderm/cytology;Mesoderm/metabolism*;Mice;Mice, Knockout;Molecular Sequence Data;Tissue Distribution;Transfection
17245079;Diabetic Retinopathy/complications;Diabetic Retinopathy/pathology;Diabetic Retinopathy/surgery*;Humans;Laser Coagulation*;Macular Edema/etiology;Macular Edema/pathology;Macular Edema/surgery*;Severity of Illness Index;Treatment Outcome;Vitrectomy*;Vitreoretinopathy, Proliferative/etiology;Vitreoretinopathy, Proliferative/pathology;Vitreoretinopathy, Proliferative/surgery*
17245624;Cyclin-Dependent Kinase Inhibitor p21/genetics*;Cyclin-Dependent Kinase Inhibitor p21/metabolism;DNA Damage*;Gamma Rays;Genes, p53*;Humans;Membrane Proteins/metabolism;Meningeal Neoplasms/genetics*;Meningeal Neoplasms/metabolism;Meningeal Neoplasms/pathology;Meningioma/genetics*;Meningioma/metabolism;Meningioma/pathology;PTEN Phosphohydrolase/metabolism;Signal Transduction*/radiation effects;Tumor Cells, Cultured;Tumor Suppressor Protein p53/metabolism;Ultraviolet Rays
17259607;Acetyl-CoA C-Acyltransferase/genetics;Acetyl-CoA C-Acyltransferase/metabolism;Acyl Coenzyme A/metabolism*;Aerobiosis;Bacterial Proteins/genetics;Bacterial Proteins/metabolism;Culture Media;Escherichia coli/genetics;Escherichia coli/growth & development;Escherichia coli/metabolism*;Gene Expression Regulation, Bacterial;Phenylacetates/metabolism*;Pseudomonas putida/genetics;Pseudomonas putida/growth & development;Pseudomonas putida/metabolism*
17275721;Data Collection/history;Evidence-Based Medicine;Existentialism/history*;History, 20th Century;History, 21st Century;Humans;Interviews as Topic;Nursing Methodology Research/history*;Philosophy, Nursing/history*;Postanesthesia Nursing/history*;Prejudice;Psychology/history;Qualitative Research*;Researcher-Subject Relations
17285284;Child, Preschool;Diagnosis, Differential;Disease Progression;Dyspnea/diagnosis;Fatal Outcome;Female;Follow-Up Studies;Humans;Lung Neoplasms/diagnosis*;Magnetic Resonance Imaging;Male;Neoplasm Recurrence, Local/pathology;Pleural Effusion/diagnosis;Pleural Neoplasms/diagnosis*;Pneumothorax/diagnosis;Pulmonary Atelectasis/diagnosis;Pulmonary Blastoma/diagnosis*;Retrospective Studies;Tomography, X-Ray Computed
17289241;Animals;Animals, Newborn;Body Weight/drug effects;Cholinergic Antagonists/toxicity*;Cyclopentanes/toxicity*;Female;Fetal Development/drug effects*;Litter Size/drug effects;Male;Mice;Mice, Inbred Strains;Organ Size/drug effects;Pregnancy;Quinuclidines/toxicity*;Random Allocation;Sex Ratio;Sperm Count;Sperm Motility/drug effects
17292549;Chronic Disease;Fibromyalgia/complications*;Fibromyalgia/diagnosis;Humans;Pain/diagnosis;Pain/etiology*;Pain Measurement
17293768;Age Factors;Continental Population Groups;Disabled Persons/legislation & jurisprudence;Humans;Interviews as Topic/methods*;Job Application*;Marital Status;Nurse Administrators/legislation & jurisprudence;Nursing Staff/legislation & jurisprudence*;Personnel Selection*/legislation & jurisprudence;Personnel Selection*/methods;Prejudice*;Religion;Residence Characteristics;Sex Factors;United States
17303186;Behavior;Disease Outbreaks/statistics & numerical data*;Humans;Infection/epidemiology;Infection/psychology;Mathematics;Models, Statistical*;Nonlinear Dynamics
17304671;Alberta/epidemiology;Athletic Injuries/epidemiology;Athletic Injuries/physiopathology*;Athletic Injuries/psychology;Attitude to Health*;Humans;Male;Selection Bias;Sports*/physiology;Sports*/psychology;Whiplash Injuries/epidemiology;Whiplash Injuries/physiopathology*;Whiplash Injuries/psychology
17309935;Aged;Calcium Carbonate/adverse effects*;Calcium Carbonate/therapeutic use;Cardiovascular Diseases/epidemiology*;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Cerebrovascular Disorders/epidemiology*;Cerebrovascular Disorders/etiology;Cerebrovascular Disorders/prevention & control;Dietary Supplements;Female;France/epidemiology;Humans;Middle Aged;Postmenopause;Vitamin D/adverse effects*;Vitamin D/therapeutic use
17311465;Chromatography, Gas/instrumentation;Chromatography, Gas/methods;Electrodes;Equipment Design;Heating/instrumentation*;Heating/methods;Sensitivity and Specificity;Silicon/chemistry*;Temperature*;Time Factors
17334360;Adaptor Proteins, Signal Transducing/genetics;Adaptor Proteins, Signal Transducing/metabolism*;Animals;Cell Nucleolus/drug effects;Cell Nucleolus/metabolism*;Cells, Cultured;Disks Large Homolog 4 Protein;Embryo, Mammalian;Enzyme Inhibitors/pharmacology;Excitatory Amino Acid Agonists/pharmacology;Green Fluorescent Proteins/metabolism;Humans;Immunoprecipitation;Intracellular Signaling Peptides and Proteins/metabolism;Membrane Proteins/metabolism;N-Methylaspartate/pharmacology;Neurons/drug effects;Neurons/physiology*;Neurons/ultrastructure*;Phosphoproteins/metabolism;Protein Biosynthesis/drug effects;Protein Biosynthesis/physiology*;Protein Structure, Tertiary;Protein Transport/drug effects;RNA, Small Interfering/pharmacology;Rats;Signal Transduction/physiology*;Synapses/metabolism;Transfection/methods;Zonula Occludens-1 Protein
17340145;Azospirillum/metabolism*;DNA Transposable Elements/genetics*;Gene Expression Regulation, Plant*;Gene Library;Glucuronidase/chemistry;Lipid Bilayers/chemistry;Lipopolysaccharides/chemistry;Mutagenesis*;Mutation;Plasmids/metabolism;Polysaccharides/chemistry;Promoter Regions, Genetic;Salts/chemistry*;Sodium Chloride/chemistry;Time Factors
17341406;Aged;Bradycardia/physiopathology;Bundle-Branch Block/physiopathology*;Electrocardiography;Female;Heart Rate;Humans;Tachycardia, Atrioventricular Nodal Reentry/physiopathology*
17369164;China;Communication*;Counseling;Educational Status;Genetic Counseling/psychology*;Genetic Testing*;Health Education*;Humans;Internet;Patient Education as Topic
17388056;Consumer Product Safety;Food Contamination/prevention & control*;Food Handling/methods*;Food Microbiology;Food Services/standards*;Gloves, Protective/utilization*;Hand Disinfection/methods;Hand Disinfection/standards*;Humans;Hygiene;Restaurants
17406290;Calcium;Cell Nucleus/metabolism;Chloroquine;Endosomes/metabolism*;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/radiation effects;HeLa Cells;Humans;Peptide Nucleic Acids/chemistry*;Peptide Nucleic Acids/metabolism*;Photochemistry
17411555;Breast Neoplasms/mortality;Breast Neoplasms/prevention & control*;Cost-Benefit Analysis;Early Diagnosis;Female;Humans;Magnetic Resonance Imaging/economics;Magnetic Resonance Imaging/methods;Magnetic Resonance Imaging/utilization*;Mammography/economics;Mammography/methods;Mammography/utilization;Mass Screening/standards*;Mass Screening/trends;Risk Assessment;Sensitivity and Specificity;United States
17411885;Clinical Competence*;Credentialing/trends;Diagnostic Imaging/standards*;Education, Medical, Continuing;Female;Forecasting;Humans;Male;Practice Guidelines as Topic*;Quality Control;Radiology/education*;Radiology/standards;Radiology Department, Hospital/standards;Radiology, Interventional/education*;Radiology, Interventional/standards;Reference Standards;Societies, Medical;Technology, Radiologic/education*;Technology, Radiologic/standards;United States
17417780;Adenocarcinoma/prevention & control*;Adenomatous Polyposis Coli/genetics;Amidines/administration & dosage;Amidines/pharmacology*;Animals;Colitis/chemically induced;Colitis/complications*;Colonic Neoplasms/prevention & control*;Cyclooxygenase 2/metabolism;Dextran Sulfate;Dose-Response Relationship, Drug;Heterocyclic Compounds, 2-Ring/administration & dosage;Heterocyclic Compounds, 2-Ring/pharmacology;Interleukin-1beta/metabolism;Intestinal Mucosa/metabolism;Male;Mice;Mice, Inbred C57BL;Nitric Oxide Synthase Type II/antagonists & inhibitors*;RNA, Messenger/analysis;Reverse Transcriptase Polymerase Chain Reaction;Triglycerides/blood;Tumor Necrosis Factor-alpha/metabolism
17426099;Adult;Age of Onset;Asian Continental Ancestry Group/genetics*;Diabetes Mellitus, Type 2/ethnology*;Diabetes Mellitus, Type 2/genetics*;Female;Genotype;Homeodomain Proteins/genetics*;Humans;Male;Middle Aged;Paired Box Transcription Factors/genetics*;Pedigree;Point Mutation;Polymorphism, Single-Stranded Conformational;Thailand
17434266;Algorithms;Animals;Calcium Channels/physiology*;Calcium Channels, T-Type/physiology;Cloning, Molecular;Electrophysiology;Extracellular Space/chemistry;Extracellular Space/physiology*;Humans;Hydrogen-Ion Concentration;Ion Channel Gating/physiology;Membrane Potentials/physiology;Models, Neurological;Neurons/physiology*;Rats;Tissue Culture Techniques;Transfection
17435177;Animals;Anti-Bacterial Agents/pharmacology;Apoptosis/drug effects;Autocrine Communication;Blotting, Western;Caspases/metabolism;Cell Differentiation/drug effects;Cell Proliferation/drug effects;Cells, Cultured;Endoplasmic Reticulum/metabolism*;Enzyme Inhibitors/pharmacology;Mesoderm/cytology;Mesoderm/drug effects;Mesoderm/metabolism;Muscle Fibers, Skeletal/physiology*;Muscle, Skeletal/cytology;Muscle, Skeletal/metabolism*;Myoblasts/cytology;Myoblasts/metabolism*;Oxidative Stress*;Thapsigargin/pharmacology;Tunicamycin/pharmacology
17445655;Adult;Aged;Female;Follow-Up Studies;Humans;Middle Aged;Patient Satisfaction*;Retrospective Studies;Suburethral Slings*;Surveys and Questionnaires;Time Factors;Urinary Incontinence, Stress/surgery*
17448121;Amlodipine/pharmacology*;Animals;Antihypertensive Agents/pharmacology*;Aorta, Thoracic/drug effects;Aorta, Thoracic/physiopathology;Arginine/pharmacology;Drug Antagonism;Drug Therapy, Combination;Heart Ventricles/drug effects;Heart Ventricles/physiopathology;In Vitro Techniques;Lipopolysaccharides/pharmacology*;Male;Myocardial Contraction/drug effects*;Norepinephrine/pharmacology;Protective Agents/pharmacology*;Rats;Rats, Wistar;Salmonella typhimurium/immunology;Ventricular Function/drug effects
17455406;Analysis of Variance;Animals;Biomarkers/blood;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology*;Cardiac Output/drug effects;Cardiotonic Agents/pharmacology*;Coronary Stenosis/complications;Coronary Stenosis/drug therapy*;Coronary Stenosis/metabolism*;Coronary Stenosis/physiopathology;Diltiazem/pharmacology;Disease Models, Animal;Heart Rate/drug effects;Lactic Acid/blood;Milrinone/pharmacology*;Myocardial Contraction/drug effects;Myocardial Reperfusion;Myocardial Stunning/drug therapy*;Myocardial Stunning/etiology;Myocardial Stunning/metabolism*;Myocardial Stunning/physiopathology;Phosphodiesterase Inhibitors/pharmacology*;Research Design;Swine;Time Factors;Vascular Resistance/drug effects;Ventricular Function, Left/drug effects;Ventricular Pressure/drug effects
17456042;Arachidonic Acid/metabolism;Enzyme Inhibitors/chemistry*;Humans;Inflammation/drug therapy*;Molecular Structure;Phospholipases A/antagonists & inhibitors*;Phospholipases A2;Snake Venoms/toxicity*;Structure-Activity Relationship
17462117;Aged;Alfentanil/pharmacology;Anesthesia, General*;Anesthetics, Combined/pharmacology*;Anesthetics, Inhalation/pharmacology*;Anesthetics, Intravenous/pharmacology*;Blood Pressure/drug effects;Cardiopulmonary Bypass;Consciousness/drug effects;Coronary Artery Bypass*;Electroencephalography*;Evoked Potentials, Auditory/drug effects*;Female;Heart Rate/drug effects;Humans;Isoflurane/pharmacology;Male;Memory/drug effects;Middle Aged;Monitoring, Intraoperative/methods*;Propofol/pharmacology;Reaction Time/drug effects;Time Factors
17467539;Diagnostic Techniques, Ophthalmological;Glaucoma, Angle-Closure/diagnosis*;Humans;Intraocular Pressure;Iridectomy;Laser Therapy;Optic Disk/pathology*;Optic Nerve Diseases/diagnosis*;Photography
17473102;Academies and Institutes/standards*;Academies and Institutes/trends;Circumcision, Male/methods;Circumcision, Male/standards*;Circumcision, Male/trends;Guideline Adherence/standards*;Guideline Adherence/trends;HIV Infections/epidemiology;HIV Infections/prevention & control*;Humans;Male;Pediatrics/methods;Pediatrics/standards;Pediatrics/trends;United States
17485925;Animals;Bottle-Nosed Dolphin/blood;Bottle-Nosed Dolphin/immunology*;Bottle-Nosed Dolphin/psychology;Cell Survival/immunology;Female;Hydrocortisone/blood;Leukocyte Count/veterinary;Neutrophils/immunology*;Phagocytosis/immunology;Stress, Physiological/blood;Stress, Physiological/immunology;Stress, Physiological/veterinary*;Superoxides/blood;Transportation*
17486241;Adult;African Continental Ancestry Group/statistics & numerical data;Anemia/diagnosis;Anemia/epidemiology*;Anemia/ethnology;Brazil/epidemiology;Epidemiologic Methods;European Continental Ancestry Group/statistics & numerical data;Female;Hemoglobins/analysis*;Humans;Middle Aged;Socioeconomic Factors
17507221;Animals;Humans;Luminescent Proteins/chemistry;Luminescent Proteins/pharmacology*;Rats;Receptors, Somatostatin/antagonists & inhibitors*;Recombinant Proteins/antagonists & inhibitors;Structure-Activity Relationship
17509583;Adult;Blastocyst/cytology*;Cell Nucleus/physiology;Cleavage Stage, Ovum/physiology*;Embryo Implantation/physiology*;Embryo Transfer*;Female;Humans;Infertility, Female/diagnosis;Infertility, Female/therapy;Mitosis/physiology;Pregnancy;Pregnancy Outcome;Pregnancy Rate;Sperm Injections, Intracytoplasmic*;Time Factors
17511565;Animals;Biocompatible Materials*;Cell Differentiation/physiology;Cell Line;Embryonic Stem Cells/pathology;Embryonic Stem Cells/transplantation*;Humans;Liver/cytology;Liver/pathology;Mice;Mice, SCID;Neurons/cytology;Neurons/pathology;Pancreas/cytology;Pancreas/pathology;Prostheses and Implants*/adverse effects;Teratoma/etiology*;Teratoma/pathology;Tissue Engineering*
17511567;Animals;Cell Culture Techniques/methods;Cell Culture Techniques/trends;Clinical Medicine*;Embryonic Stem Cells/transplantation;Humans;Stem Cell Transplantation*/methods;Stem Cell Transplantation*/trends;Stem Cells/physiology*;Tissue Banks/trends
17535022;Aged;Brain Neoplasms/mortality;Brain Neoplasms/secondary*;Brain Neoplasms/surgery*;Female;Humans;Karnofsky Performance Status;Male;Middle Aged;Multivariate Analysis;Prognosis;Radiosurgery*;Survival Analysis;Treatment Outcome
17551981;Animals;Anti-Inflammatory Agents/pharmacology*;Brain/drug effects*;Cell Proliferation/drug effects;Deuterium Oxide*;Drug Evaluation, Preclinical/methods*;Encephalomyelitis, Autoimmune, Experimental/drug therapy;Female;Flow Cytometry;Inflammation/drug therapy*;Lipopolysaccharides/toxicity;Mice;Mice, Inbred C57BL;Microglia/drug effects;Microglia/metabolism*;Reproducibility of Results;Sensitivity and Specificity
17562615;ADAM Proteins/blood*;ADAM Proteins/immunology*;ADAMTS13 Protein;Antibodies, Monoclonal*/immunology;Antibody Specificity;Biomarkers/blood;Humans;Immunoenzyme Techniques/methods*;Neutralization Tests;Purpura, Thrombotic Thrombocytopenic/blood;Purpura, Thrombotic Thrombocytopenic/diagnosis*;Sensitivity and Specificity
17562886;Animals;Ants/physiology*;Behavior, Animal/physiology;Memory/physiology*;Motor Activity/physiology
17565033;Capillaries/pathology;Clubfoot/etiology;Connective Tissue Diseases/complications*;Connective Tissue Diseases/diagnosis;Diagnosis, Differential;Fever/etiology;Hemoptysis/etiology;Humans;Lung/blood supply;Lung Diseases, Interstitial/complications*;Lung Diseases, Interstitial/diagnosis;Male;Middle Aged;Pneumonia/complications;Pneumonia/diagnosis;Respiratory Insufficiency/etiology*
17574337;Air Pollutants/analysis*;Cities;Environmental Monitoring;Korea;Organic Chemicals/analysis*;Refuse Disposal*;Volatilization
17575982;Animals;Anticoagulants/isolation & purification*;Cricetinae/parasitology*;Feeding Behavior/physiology*;Gastrointestinal Tract/chemistry;Insect Proteins/pharmacology;RNA Interference/physiology*;Sequence Analysis/methods;Thrombin/antagonists & inhibitors*;Thrombin/metabolism;Triatoma/physiology*
17578784;Bacteremia/diagnosis*;Bacteremia/epidemiology;Blood-Borne Pathogens/isolation & purification;Comorbidity;Cross Infection/epidemiology;Cross Infection/microbiology*;Female;Fungemia/diagnosis*;Fungemia/epidemiology;Humans;Immunocompromised Host*;Incidence;Male;Neoplasms/epidemiology;Neoplasms/immunology*;Neoplasms/therapy;Neutropenia/epidemiology;Neutropenia/immunology*;Prognosis;Risk Assessment;Survival Analysis
17615978;Aged;Carcinoma, Verrucous/diagnosis;Carcinoma, Verrucous/pathology*;Carcinoma, Verrucous/surgery;Follow-Up Studies;Humans;Male;Middle Aged;Penile Neoplasms/diagnosis;Penile Neoplasms/pathology*;Penile Neoplasms/surgery
17617081;Adult;Blood Platelets/drug effects;Blood Platelets/physiology*;Epinephrine/pharmacology*;Female;Humans;Platelet Aggregation/drug effects*;Pregnancy/blood*;Pregnancy Trimester, Second/blood;Pregnancy Trimester, Third/blood
17617175;Arabidopsis/genetics;Aspartic Acid/metabolism;Carbon-Oxygen Lyases/genetics;Carbon-Oxygen Lyases/metabolism;Gene Expression;Gene Expression Regulation, Plant;Hydro-Lyases/genetics;Hydro-Lyases/metabolism;Lysine/biosynthesis*;Methionine/biosynthesis*;Methionine Adenosyltransferase/genetics;Methionine Adenosyltransferase/metabolism*;Plants, Genetically Modified/metabolism;RNA, Messenger/metabolism;Tobacco/genetics;Tobacco/metabolism*
17632091;Analgesics, Non-Narcotic/pharmacology*;Animals;Capsaicin/pharmacology*;Cells, Cultured;Dose-Response Relationship, Drug;Dose-Response Relationship, Radiation;Drug Interactions;Electric Stimulation;Membrane Potentials/drug effects;Membrane Potentials/physiology;Membrane Potentials/radiation effects;Mice;Mice, Inbred C57BL;Mice, Knockout;Neurons/drug effects*;Neurons/physiology;Patch-Clamp Techniques/methods;Sodium Channel Blockers/pharmacology;Sodium Channels/drug effects*;TRPV Cation Channels/deficiency*;Tetrodotoxin/pharmacology;Trigeminal Ganglion/cytology
17651243;Eye Diseases/genetics*;Genomics/trends*;Genotype;Humans
17681719;Animals;Cecum/drug effects;Cecum/metabolism;Chickens;Cytokines/genetics*;Dose-Response Relationship, Drug;Female;Gene Expression Regulation/drug effects;Palatine Tonsil/drug effects;Palatine Tonsil/metabolism*;Palatine Tonsil/microbiology;Poultry Diseases/drug therapy*;Poultry Diseases/genetics*;Poultry Diseases/immunology;Poultry Diseases/microbiology;Probiotics/pharmacology*;Probiotics/therapeutic use;Salmonella Infections, Animal/drug therapy*;Salmonella Infections, Animal/genetics*;Salmonella Infections, Animal/immunology;Salmonella typhimurium/physiology*
17687251;Biological Evolution*;Genetics, Population*;Oleaceae/genetics*;Oleaceae/growth & development;Phylogeny*;Plastids/genetics
17690577;Adolescent;Adult;Circumcision, Male/statistics & numerical data*;Developing Countries;Epidemiologic Methods;Female;HIV Infections/epidemiology;HIV Infections/prevention & control*;HIV Infections/transmission;Humans;Male;Sexual Behavior;Uganda/epidemiology;Zimbabwe/epidemiology
17698267;Air Pollutants/analysis*;Air Pollution, Indoor/analysis*;China;Environmental Monitoring/methods;Humans;Inhalation Exposure;Naphthalenes/analysis;Naphthalenes/toxicity;Particulate Matter/analysis;Polycyclic Aromatic Hydrocarbons/analysis*;Risk;Tobacco Smoke Pollution;Volatilization
17704241;Animals;Binding, Competitive;Cell Line, Tumor;Chelating Agents/chemistry*;Female;Heterocyclic Compounds, 1-Ring/chemical synthesis;Heterocyclic Compounds, 1-Ring/chemistry*;Heterocyclic Compounds, 1-Ring/pharmacokinetics*;Humans;Indium Radioisotopes*;Mice;Mice, Nude;Neoplasm Transplantation;Oligopeptides/chemistry*;Peptides/chemical synthesis;Peptides/chemistry;Peptides/pharmacokinetics*;Radiopharmaceuticals/chemical synthesis;Radiopharmaceuticals/chemistry;Radiopharmaceuticals/pharmacokinetics*;Tissue Distribution;Transplantation, Heterologous
17710957;Adult;Age of Onset;Animals;Birth Weight;Causality;Chronic Disease;Coronary Artery Disease/epidemiology;Coronary Artery Disease/etiology*;Diabetes Mellitus/epidemiology;Diabetes Mellitus/etiology*;Disease Models, Animal;Fetal Nutrition Disorders/diagnosis;Fetal Nutrition Disorders/epidemiology*;Fetal Nutrition Disorders/prevention & control;Humans;Infant Nutritional Physiological Phenomena;Infant, Newborn;Morbidity;Nutrition Assessment;Nutrition Surveys;Nutritional Status;Obesity/epidemiology;Obesity/etiology*;Weight Gain
17712395;Adult;Aged;Biopsy;Breath Tests*;Dyspepsia/etiology;Female;Helicobacter Infections/complications;Helicobacter Infections/diagnosis*;Helicobacter Infections/microbiology*;Helicobacter pylori*;Hospitals;Humans;Male;Middle Aged;Peru;Stomach/pathology*;Urease*
17712409;Animals;Botulinum Toxins, Type A/antagonists & inhibitors*;Carrier Proteins/chemistry;Carrier Proteins/metabolism;Catalytic Domain;Computer Simulation;Drug Design*;Endopeptidases/chemistry;Endopeptidases/metabolism*;Models, Molecular;Molecular Dynamics Simulation;Molecular Structure;Protease Inhibitors/chemical synthesis;Protease Inhibitors/chemistry*;Protease Inhibitors/metabolism
17713853;Animals;Antiparkinson Agents/metabolism;Antiparkinson Agents/toxicity*;Benzazepines/pharmacology;Brain Chemistry/drug effects;Catecholamines/metabolism;Cell Survival/drug effects;Chromatography, High Pressure Liquid;Dopamine/metabolism;Dopamine/physiology;Dopamine Antagonists/pharmacology;Dopamine Plasma Membrane Transport Proteins/metabolism;Levodopa/metabolism;Levodopa/toxicity*;Male;Membrane Potentials/drug effects;Mitochondrial Membranes/drug effects;Motor Activity/drug effects;PC12 Cells;Rats;Rats, Sprague-Dawley;Reactive Oxygen Species/metabolism;Receptors, Dopamine D1/drug effects;Synaptic Transmission/physiology;Tyrosine/analogs & derivatives*;Tyrosine/metabolism;Tyrosine/toxicity
17715535;Anti-HIV Agents/supply & distribution*;Anti-HIV Agents/therapeutic use;Guidelines as Topic;HIV Infections/drug therapy*;Humans;Refugees*
17715978;Animals;Benzoates/chemistry*;Benzoates/isolation & purification;Benzoates/pharmacology;Crystallography, X-Ray;Diterpenes/chemistry*;Diterpenes/isolation & purification;Diterpenes/pharmacology;Humans;Magnetic Resonance Spectroscopy;Models, Molecular;Molecular Structure;Phenols/chemistry*;Phenols/isolation & purification;Phenols/pharmacology;Rhodophyta/chemistry*
17721865;Adult;Apgar Score;Echocardiography;Female;Heart Septal Defects, Ventricular/complications;Heart Septal Defects, Ventricular/diagnosis*;Humans;Infant, Newborn;Lymphedema/complications;Lymphedema/congenital;Lymphedema/diagnosis*;Pregnancy;Pregnancy Trimester, Third*;Syndrome;Ultrasonography, Prenatal*
17726358;Aged;Aged, 80 and over;Chi-Square Distribution;Diagnostic Tests, Routine;Disability Evaluation;Female;Hip Fractures/blood*;Hip Fractures/physiopathology*;Hip Fractures/rehabilitation;Humans;Linear Models;Male;Predictive Value of Tests;Retrospective Studies;Serum Albumin/analysis*;Treatment Outcome
17765044;Abdominal Pain/etiology;Aged;Cholelithiasis/complications*;Cholelithiasis/diagnostic imaging;Humans;Ileus/diagnostic imaging;Ileus/etiology*;Ileus/surgery;Male;Sigmoid Diseases/diagnostic imaging;Sigmoid Diseases/etiology*;Sigmoid Diseases/surgery;Tomography, X-Ray Computed
17785770;Animals;Autoantibodies/metabolism;Autoantibodies/physiology;Autoimmune Diseases/immunology;Autoimmune Diseases/metabolism*;Autoimmune Diseases/physiopathology*;Female;Humans;Pre-Eclampsia/immunology*;Pre-Eclampsia/metabolism*;Pre-Eclampsia/pathology;Pregnancy;Receptor, Angiotensin, Type 1/immunology*;Receptor, Angiotensin, Type 1/metabolism;Receptor, Angiotensin, Type 1/physiology
17786339;Angiopoietins/genetics;Angiopoietins/metabolism*;Animals;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Apoptosis/drug effects*;Carcinoma, Hepatocellular/blood supply*;Drug Synergism;Female;Fluorouracil/administration & dosage;Humans;Immunoenzyme Techniques;Interferon-alpha/administration & dosage;Liver Neoplasms/blood supply*;Mice;Mice, Inbred BALB C;Mice, Nude;Neovascularization, Pathologic/drug therapy*;RNA, Messenger/genetics;RNA, Messenger/metabolism;RNA, Neoplasm/genetics;RNA, Neoplasm/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Vascular Endothelial Growth Factor A/genetics;Vascular Endothelial Growth Factor A/metabolism*
17824428;Age Factors;Aging/physiology*;Animals;Bayes Theorem;Butterflies/growth & development;Butterflies/physiology*;Circadian Rhythm;Ecosystem*;Environment;Female;Finland;Life Cycle Stages/physiology*;Male;Models, Biological;Population Dynamics;Probability;Sex Factors;Species Specificity;Survival*;Temperature
17845672;Aged;Arthroplasty, Replacement, Hip;Constriction, Pathologic/etiology;Humans;Hypotension/etiology*;Intraoperative Complications*;Male;Posture;Venae Cavae*
17876395;Adult;Aged;Aged, 80 and over;Chi-Square Distribution;Cross-Sectional Studies;Educational Status;Female;Headache/etiology;Health Knowledge, Attitudes, Practice*;Hemiplegia/etiology;Humans;Hyperlipidemias/complications;Hypertension/complications;Income;Male;Middle Aged;Risk Factors;Sex Factors;Stroke*/diagnosis;Stroke*/etiology;Stroke*/therapy;Urban Population*
17892982;Adrenergic beta-Antagonists/therapeutic use*;Adult;Angiotensin II Type 1 Receptor Blockers/therapeutic use*;Atenolol/therapeutic use*;Humans;Losartan/therapeutic use*;Marfan Syndrome/complications;Marfan Syndrome/drug therapy*;Outcome Assessment (Health Care);Research Design
17926006;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/therapeutic use;Bacterial Typing Techniques;Cefotaxime/administration & dosage;Cefotaxime/therapeutic use;Child, Preschool;Haemophilus Vaccines/administration & dosage;Haemophilus influenzae/classification;Haemophilus influenzae/immunology;Haemophilus influenzae/isolation & purification*;Humans;Male;Meningitis, Haemophilus/drug therapy;Meningitis, Haemophilus/immunology;Meningitis, Haemophilus/microbiology*;Meningitis, Haemophilus/prevention & control;Recurrence
17929854;Benzopyrans/metabolism;Cysteine/chemistry;False Positive Reactions;Furans/metabolism;Image Processing, Computer-Assisted;Ketones/metabolism;Krypton/chemistry;Mass Spectrometry/methods*;Models, Chemical;Models, Statistical;Peptides/chemistry;Proteins/chemistry;Proteomics/instrumentation*;Proteomics/methods*;Reproducibility of Results;Spectrometry, Fluorescence/methods;Tryptophan/chemistry
17934007;Biomarkers/blood;C-Reactive Protein/analysis*;Female;Humans;Male;Middle Aged;Myocardial Ischemia/mortality*;Prognosis;Rheumatoid Factor/blood
17958548;Antibodies/blood*;Antigens;Clinical Laboratory Techniques;Female;Humans;Pregnancy;Prenatal Care/methods*;Prenatal Diagnosis/methods
17958920;Female;Fetus/parasitology*;Humans;Infectious Disease Transmission, Vertical*;Pregnancy;Pregnancy Complications, Parasitic/parasitology*;Time Factors
17959665;Animals;Body Weight;Cell Line;Female;Immunity, Innate/genetics*;Immunity, Innate/immunology;Leishmania major/immunology;Leishmaniasis, Cutaneous/immunology*;Liver/virology;Lymph Nodes/immunology;Lymphocyte Subsets/immunology;Male;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, Transgenic;Ovary/virology;Parasitemia;RNA-Binding Proteins/biosynthesis*;RNA-Binding Proteins/genetics;Spleen/immunology;Spleen/virology;T-Lymphocytes/immunology;Tail/pathology;Vaccinia/immunology*;Vaccinia virus/immunology;Viral Proteins/biosynthesis*;Viral Proteins/genetics
17960811;Aged;Deep Brain Stimulation/instrumentation*;Electrodes, Implanted*;Female;Follow-Up Studies;Humans;Male;Middle Aged;Parkinson Disease/therapy*;Retrospective Studies;Subthalamic Nucleus/physiology*
17961160;Adult;Female;Humans;Hysterectomy;Rhabdomyosarcoma, Alveolar/diagnosis*;Rhabdomyosarcoma, Alveolar/pathology;Rhabdomyosarcoma, Alveolar/surgery;Uterine Cervical Neoplasms/diagnosis*;Uterine Cervical Neoplasms/pathology;Uterine Cervical Neoplasms/surgery
17991251;Aged;Colony Count, Microbial;Dental Implants/adverse effects*;Dental Implants/microbiology;Dental Prosthesis, Implant-Supported/adverse effects*;Dental Prosthesis, Implant-Supported/microbiology;Denture, Overlay/adverse effects*;Denture, Overlay/microbiology;Female;Follow-Up Studies;Gingival Crevicular Fluid/immunology;Gingival Crevicular Fluid/microbiology;Gingival Crevicular Fluid/physiology;Humans;Interleukin-1beta/analysis;Jaw, Edentulous/microbiology;Jaw, Edentulous/rehabilitation;Jaw, Edentulous/surgery;Male;Observer Variation;Oral Hygiene;Periodontal Index*;Periodontitis/diagnosis;Periodontitis/etiology*;Periodontitis/immunology;Periodontitis/microbiology;Prospective Studies;Reproducibility of Results;Sensitivity and Specificity;Statistics, Nonparametric
17997680;Acoustic Stimulation/methods;Adult;Attention/physiology*;Auditory Perception/physiology*;Eye Movements/physiology;Fixation, Ocular/physiology;Functional Laterality/physiology;Humans;Information Theory;Linear Models;Male;Nature;Photic Stimulation/methods;Probability;Sound Localization/physiology;Visual Fields;Visual Perception/physiology*
18025305;Adenoviridae/genetics;Apoptosis*/genetics;Apoptosis*/physiology;Apoptosis Regulatory Proteins/metabolism*;Benzimidazoles;Carbocyanines;Cell Line;Cell Line, Tumor;Cell Membrane Permeability;Cytochromes c/secretion;Fluorescent Dyes;HCT116 Cells;Humans;Kidney/cytology;Male;Membrane Proteins/metabolism*;Mitochondria/physiology;Models, Biological;Myeloid Cell Leukemia Sequence 1 Protein;Neoplasm Proteins/metabolism*;Prostatic Neoplasms/pathology;Proto-Oncogene Proteins c-bcl-2/metabolism*;Transgenes;bcl-2 Homologous Antagonist-Killer Protein/genetics;bcl-2 Homologous Antagonist-Killer Protein/metabolism*;bcl-2-Associated X Protein/genetics;bcl-2-Associated X Protein/metabolism*
18030938;Adult;Advertising as Topic/legislation & jurisprudence;Child;Developing Countries*;Female;Humans;Infant, Newborn;Lebanon;Male;Pregnancy;Pregnancy Complications/prevention & control*;Public Policy*;Smoking/adverse effects*;Tobacco Use Disorder/prevention & control*
18039029;Animals;Disease Models, Animal*;Drosophila/immunology;Drosophila/microbiology*;Hemolymph/microbiology;Host-Pathogen Interactions/physiology*;Immunohistochemistry;Intestines/microbiology*;Microscopy, Electron, Transmission;Microscopy, Fluorescence;Reverse Transcriptase Polymerase Chain Reaction;Serratia Infections/immunology;Serratia Infections/physiopathology*;Serratia marcescens/immunology;Serratia marcescens/pathogenicity*
18053657;Animals;Cell Line, Tumor;Cell Survival/drug effects;Cholera Toxin/pharmacology;Cholesterol Side-Chain Cleavage Enzyme/antagonists & inhibitors;Cholesterol Side-Chain Cleavage Enzyme/genetics;Cholesterol Side-Chain Cleavage Enzyme/metabolism;Chorionic Gonadotropin/metabolism;Colforsin/pharmacology;Cyclic AMP/metabolism*;Cyclic GMP/analogs & derivatives;Cyclic GMP/pharmacology;Dose-Response Relationship, Drug;Enzyme Inhibitors/toxicity*;Hydroxycholesterols/metabolism;Insecticides/toxicity*;Leydig Cell Tumor/metabolism*;Leydig Cell Tumor/pathology;Male;Mice;Nitriles/toxicity*;Phosphoproteins/genetics;Phosphoproteins/metabolism;Pregnenolone/metabolism;Progesterone/metabolism*;Pyrethrins/toxicity*;RNA, Messenger/metabolism;Signal Transduction/drug effects*
18055810;Acute Disease;Animals;Antibodies, Viral/blood;Blepharitis/prevention & control;Blepharitis/virology;Cytokines/metabolism;Enzyme-Linked Immunosorbent Assay;Female;Freund's Adjuvant/therapeutic use;Herpes Simplex Virus Vaccines/therapeutic use*;Herpesvirus 1, Human/physiology*;Keratitis, Dendritic/mortality;Keratitis, Dendritic/prevention & control*;Keratitis, Dendritic/virology;Macrophages/physiology*;Mannitol/analogs & derivatives;Mannitol/therapeutic use;Mice;Mice, Inbred BALB C;Vaccination;Vaccines, DNA/therapeutic use*;Viral Envelope Proteins/genetics;Viral Envelope Proteins/immunology;Virus Latency;Virus Replication/physiology
18057701;Aminoglycosides/pharmacology*;Anti-Bacterial Agents/pharmacology*;Humans;Japan;Methicillin Resistance;Microbial Sensitivity Tests;Models, Molecular;Staphylococcal Infections/microbiology*;Staphylococcus aureus/drug effects*
18058353;Adult;Aged;Diagnostic Techniques, Ophthalmological*;Female;Graves Ophthalmopathy/diagnosis;Graves Ophthalmopathy/physiopathology*;Humans;Infrared Rays;Magnetics;Male;Middle Aged;Oculomotor Muscles/pathology;Saccades/physiology*
18059998;Adult;Clinical Protocols;Exercise Therapy/methods*;Humans;Lower Extremity;Massage/methods;Motor Activity;Muscle Strength*;Muscle Stretching Exercises;Pain/diagnostic imaging;Pain/etiology;Pain Management*;Randomized Controlled Trials as Topic;Tendinopathy/complications;Tendinopathy/diagnostic imaging;Tendinopathy/physiopathology;Tendinopathy/therapy*;Treatment Outcome;Ultrasonography
18063379;Antibodies/pharmacology;Cell Line, Transformed;Dose-Response Relationship, Drug;Ear, Middle/pathology;Ear, Middle/secretion*;Epithelial Cells/pathology;Epithelial Cells/secretion*;Hearing Loss/metabolism;Hearing Loss/pathology;Humans;Inflammation/metabolism;Inflammation/pathology;Interleukin 1 Receptor Antagonist Protein/pharmacology;Interleukin-1beta/antagonists & inhibitors;Interleukin-1beta/metabolism;Interleukin-1beta/pharmacology*;Mucins/secretion*;Time Factors;Tumor Necrosis Factor-alpha/antagonists & inhibitors;Tumor Necrosis Factor-alpha/metabolism;Tumor Necrosis Factor-alpha/pharmacology*;Up-Regulation/drug effects
18064931;Airway Obstruction/therapy*;Caregivers;Child;Family Practice/trends*;Home Care Services/trends*;Humans;Intubation, Intratracheal*/adverse effects;Intubation, Intratracheal*/trends;Laryngeal Diseases/complications;Laryngeal Diseases/therapy;Respiration, Artificial/adverse effects;Tracheotomy/methods;Tracheotomy/trends*
18068905;Adolescent;Adult;Aged;Cocaine-Related Disorders/rehabilitation*;Counseling;Female;HIV Infections/prevention & control*;Heroin Dependence/rehabilitation*;Humans;Male;Methadone/therapeutic use*;Middle Aged;Narcotics/therapeutic use*;Reward*;Risk Factors;Substance Abuse Treatment Centers;Substance Abuse, Intravenous/rehabilitation
18079070;Apoptosis*;Apoptosis Regulatory Proteins/analysis*;Carcinoma, Squamous Cell/chemistry*;Carcinoma, Squamous Cell/enzymology;Carcinoma, Squamous Cell/immunology;Carcinoma, Squamous Cell/pathology;Caspase 3/analysis;Cell Cycle Proteins/analysis*;Cell Differentiation;Cell Proliferation*;Diagnosis, Differential;Humans;Immunohistochemistry;Keratoacanthoma/enzymology;Keratoacanthoma/immunology;Keratoacanthoma/metabolism*;Keratoacanthoma/pathology;Ki-67 Antigen/analysis;Proliferating Cell Nuclear Antigen/analysis;Proto-Oncogene Proteins c-bcl-2/analysis;Skin Neoplasms/chemistry*;Skin Neoplasms/enzymology;Skin Neoplasms/immunology;Skin Neoplasms/pathology;Tumor Suppressor Protein p53/analysis
18084196;Humans;Sepsis/etiology*;Sepsis/prevention & control;Tooth Diseases/complications*;Tooth Diseases/mortality
18093580;Air Pollutants/adverse effects*;Air Pollutants/analysis;Ambrosia/adverse effects;Asthma/epidemiology*;Asthma/etiology;Asthma/prevention & control;Child;Child Welfare;Child, Preschool;Databases, Factual;Emergency Service, Hospital/utilization*;Female;Humans;Infant;Infant, Newborn;Male;Poaceae/adverse effects;Pollen/adverse effects*;Pollen/chemistry;Quebec/epidemiology
18094109;Animals;Animals, Newborn;Antibodies, Viral/immunology*;Circoviridae Infections/immunology;Circoviridae Infections/prevention & control;Circoviridae Infections/veterinary*;Circoviridae Infections/virology;Circovirus/immunology;Circovirus/pathogenicity*;Immunity, Maternally-Acquired/immunology*;Specific Pathogen-Free Organisms;Swine;Swine Diseases*/immunology;Swine Diseases*/prevention & control;Swine Diseases*/virology;Treatment Outcome;Vaccination/veterinary;Viral Vaccines/administration & dosage;Viral Vaccines/therapeutic use*;Viremia/immunology;Viremia/prevention & control;Viremia/veterinary;Viremia/virology
18094602;Alleles;Genotype;HLA-A Antigens/genetics*;HLA-B Antigens/genetics*;HLA-C Antigens/genetics*;Histocompatibility Testing/methods*;Humans;Polymerase Chain Reaction/methods*;Reagent Kits, Diagnostic
18098389;Airway Resistance*;Animals;Disease Models, Animal;Elasticity;Electric Impedance;Lung/pathology;Lung/physiopathology*;Lung Compliance;Lung Diseases/pathology;Lung Diseases/physiopathology*;Lung Volume Measurements;Models, Biological;Pressure;Reproducibility of Results;Respiratory Function Tests;Respiratory Mechanics*
18118854;Brain*;Brain Injuries*
18123679;Ascomycota*;Cavernous Sinus*;Cavernous Sinus Thrombosis*;Coma*;Diabetes Mellitus*;Diabetic Coma*;Humans;Sinus Thrombosis, Intracranial*
18131250;Cell Respiration*;Extremities*;Humans;Range of Motion, Articular*;Respiration*
18134505;Anesthesia*;Anesthesiology*;Humans;Thoracic Surgery*;Thoracic Surgical Procedures*;Thorax/surgery*
18136988;Foreign Bodies*;Gastrointestinal Tract*;Humans;Jaw*
18149712;Ethylamines/toxicity;Humans
18151657;Humans;Meninges*;Tuberculosis*
18160122;Blood Banks/economics*;Blood Banks/organization & administration*;Computer Simulation;Cost-Benefit Analysis;Efficiency, Organizational/economics*;Humans;Policy Making;State Medicine/organization & administration;United Kingdom
18171947;Animals;Animals, Genetically Modified;Behavior, Animal/physiology*;Circadian Rhythm/physiology;Drosophila;Drosophila Proteins/genetics;Drosophila Proteins/metabolism*;Embryo, Nonmammalian;Gene Expression Regulation, Developmental/physiology*;Green Fluorescent Proteins/genetics;Green Fluorescent Proteins/metabolism;Membrane Potentials/physiology;Microscopy, Electron, Transmission/methods;Motor Activity;Mutation/physiology;Neuromuscular Junction/physiology*;Neuromuscular Junction/ultrastructure;Protein Isoforms/genetics;Protein Isoforms/metabolism*;Sexual Behavior, Animal/physiology;Tumor Suppressor Proteins/genetics;Tumor Suppressor Proteins/metabolism*
18174076;Adolescent;Adult;Cephalometry/standards*;Computer Simulation;Dental Models;Humans;Incisor/physiology*;Lasers;Maxilla;Maxillofacial Development*;Middle Aged;Palate, Hard/anatomy & histology*;Palate, Hard/growth & development;Reference Standards;Retrospective Studies;Statistics, Nonparametric;Subtraction Technique;Vertical Dimension*
18180647;Humans;Multiple Sclerosis/complications*;Multiple Sclerosis/pathology;Nerve Fibers/pathology;Optic Neuritis/complications*;Optic Neuritis/pathology;Retina/pathology;Vision Disorders/etiology;Visual Cortex/pathology;Visual Cortex/physiopathology;Visual Pathways/pathology;Visual Pathways/physiopathology
18182833;Anesthetics, Intravenous/pharmacology*;Drug Delivery Systems*;Humans;Pain/drug therapy*;Pain/physiopathology;Propofol/pharmacology;Receptors, Glycine/drug effects*;Receptors, Glycine/metabolism;Strychnine/pharmacology;Synaptic Transmission/physiology
18197866;Adult;Age Factors;Aging*/physiology;Aging*/psychology;Attitude of Health Personnel*;Australia;Female;Health Status*;Humans;Job Satisfaction;Middle Aged;Nursing Staff*/ethics;Nursing Staff*/psychology;Qualitative Research;Risk Management;Self Care*/psychology
18205202;Africa, Western/epidemiology;African Americans/genetics*;African Continental Ancestry Group/genetics*;Breast Neoplasms/ethnology;Breast Neoplasms/genetics*;Female;Genetic Predisposition to Disease;Humans;Mid-Atlantic Region/epidemiology;Phylogeny
18205620;Amino Acid Sequence;Amino Acid Substitution;Amino Acids/chemistry;Amino Acids/genetics*;Amino Acids/metabolism*;Computational Biology;Evolution, Molecular*;Humans;Phylogeny*;Proteins/chemistry;Proteins/metabolism;Software
18218037;Adult;Biomarkers/blood;Blood Glucose/analysis;Carotid Arteries/metabolism;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/genetics;Fasting/blood;Female;Gene Frequency;Humans;Inflammation Mediators/blood;Insulin/blood;Interleukin-10/genetics*;Obesity/blood;Obesity/genetics;Polycystic Ovary Syndrome/blood;Polycystic Ovary Syndrome/genetics*;Polymorphism, Single Nucleotide*;Tunica Intima/metabolism
18235066;Adolescent;Adult;Cross-Sectional Studies;Educational Status*;Female;Health Surveys;Humans;India;Interviews as Topic;Male;Middle Aged;Risk Factors;Socioeconomic Factors;Spouse Abuse/statistics & numerical data*;Spouses*
18235069;Adult;Asian Americans*;Cross-Sectional Studies;Epidemiologic Studies;Female;Health Status*;Health Surveys;Humans;Male;Middle Aged;Occupational Diseases/epidemiology*;Occupational Health*;Philippines/ethnology;Prejudice*;Psychological Tests;Psychometrics;Surveys and Questionnaires;United States/epidemiology;Workplace*
18235496;Colloids/chemistry;Crystallization/methods*;DNA, Single-Stranded/chemistry*;Gold/chemistry;Metal Nanoparticles/chemistry*;Nucleic Acid Conformation;Scattering, Radiation;Thermodynamics;Transition Temperature;X-Ray Diffraction
18240658;Affect*;Female;Humans;Laryngectomy/psychology*;Male;Middle Aged;Quality of Life/psychology*;Social Behavior;Surveys and Questionnaires;Tongue/surgery*
18243443;Radiation Monitoring/instrumentation*;Radiation Monitoring/methods*;Radioactivity;Reproducibility of Results
18255213;1-Methyl-4-phenylpyridinium/toxicity;Animals;Apoptosis/drug effects*;Caspase 3/metabolism;Cell Differentiation/drug effects;Cell Survival/drug effects;Cells, Cultured;DNA Fragmentation/drug effects;Dopamine/metabolism;Dose-Response Relationship, Drug;Iron/metabolism;Iron Chelating Agents/pharmacology*;Mesencephalon/cytology;Mesencephalon/metabolism;Neuroprotective Agents/pharmacology*;Parkinson Disease*/metabolism;Phytic Acid/pharmacology*;Rats
18256934;Adult;Cholestasis, Intrahepatic/diagnosis;Cholestasis, Intrahepatic/drug therapy;Cholestasis, Intrahepatic/physiopathology;Diagnosis, Differential;Fatty Liver/diagnosis;Fatty Liver/drug therapy;Fatty Liver/physiopathology;Female;HELLP Syndrome/diagnosis;HELLP Syndrome/drug therapy;HELLP Syndrome/physiopathology;Humans;Hyperemesis Gravidarum/diagnosis;Hyperemesis Gravidarum/drug therapy;Hyperemesis Gravidarum/physiopathology;Liver Diseases/diagnosis;Liver Diseases/drug therapy;Liver Diseases/physiopathology*;Pregnancy;Pregnancy Complications/diagnosis;Pregnancy Complications/drug therapy;Pregnancy Complications/physiopathology*
18259822;Adenocarcinoma/genetics*;Adenocarcinoma/metabolism;Adenocarcinoma/secondary;Aged;Biomarkers, Tumor/genetics;Biomarkers, Tumor/metabolism;Bone Morphogenetic Protein 7;Bone Morphogenetic Proteins/genetics*;Bone Morphogenetic Proteins/metabolism;Case-Control Studies;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/metabolism;Colorectal Neoplasms/pathology;Female;Gene Expression Regulation, Neoplastic;Humans;Immunoenzyme Techniques;Liver Neoplasms/genetics*;Liver Neoplasms/metabolism;Liver Neoplasms/secondary;Lymphatic Metastasis;Male;Neoplasm Invasiveness;Neoplasm Staging;Prognosis;RNA, Messenger/genetics;RNA, Messenger/metabolism;RNA, Neoplasm/genetics;RNA, Neoplasm/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Survival Rate;Transforming Growth Factor beta/genetics*;Transforming Growth Factor beta/metabolism
18269218;Animals;Axons/physiology*;Axons/secretion;Cell Differentiation/physiology;Cell Movement/physiology;Humans;Neuroglia/physiology*;Neuroglia/secretion
18271782;Administration, Topical;Adult;Conjunctivitis, Allergic/diagnosis;Conjunctivitis, Allergic/drug therapy;Conjunctivitis, Allergic/etiology*;Diagnosis, Differential;Humans;Keratomileusis, Laser In Situ/adverse effects*;Male;Steroids/administration & dosage;Surgical Flaps
18276004;Acrylic Resins/chemistry*;Animals;Binding Sites;Cattle;Chitosan/chemistry*;Cross-Linking Reagents/chemistry;Hemoglobins/chemistry*;Hemoglobins/ultrastructure;Microscopy, Electron, Scanning;Molecular Imprinting;Serum Albumin/chemistry*;Serum Albumin/ultrastructure;X-Ray Diffraction
18283983;Animal Diseases/diagnostic imaging;Animals;Computer Communication Networks/instrumentation*;Radiographic Image Enhancement/instrumentation*;Veterinary Medicine/instrumentation
18287804;Abnormalities, Multiple*;Bronchiectasis*/diagnosis;Bronchiectasis*/surgery;Child;Ear Canal/abnormalities*;Female;Humans;Pneumonectomy
18288720;Adult;Aged;Coal Mining*;Humans;Micronuclei, Chromosome-Defective*;Micronucleus Tests;Occupational Exposure/adverse effects*;Pneumoconiosis/epidemiology;Pneumoconiosis/genetics*;Sister Chromatid Exchange*;Turkey/epidemiology
18291098;3T3-L1 Cells;Adipocytes/drug effects;Adipocytes/metabolism*;Animals;Anti-Inflammatory Agents/administration & dosage;Chemokine CCL2/metabolism*;Dose-Response Relationship, Drug;Inflammation/chemically induced;Inflammation/metabolism*;Inflammation/prevention & control*;Mice;Stilbenes/administration & dosage*;Tumor Necrosis Factor-alpha/administration & dosage*
18294005;Enzyme Stability;Erythrocytes/enzymology;Heme/analysis*;Heme/biosynthesis;Heme/chemistry*;Hot Temperature;Humans;Hydroxymethylbilane Synthase/metabolism*;Molecular Structure;Porphyrias/diagnosis*;Porphyrias/metabolism*;Tandem Mass Spectrometry/methods*
18295135;Adolescent;Adolescent Behavior*;Adult;Age Distribution;Causality;Cohort Studies;Comorbidity;Crime Victims/statistics & numerical data*;Female;Humans;Logistic Models;Longitudinal Studies;Male;Multivariate Analysis;Odds Ratio;Prevalence;Sex Offenses/statistics & numerical data*;Smoking/epidemiology*;Socioeconomic Factors;United States/epidemiology;Violence/statistics & numerical data*
18300555;Ambulatory Care/economics;Ambulatory Care/standards*;Centers for Medicare and Medicaid Services (U.S.);Disclosure*;Humans;Observation;Organizational Policy;Prospective Payment System/legislation & jurisprudence*;Quality Assurance, Health Care/economics*;United States
18311630;Computer-Aided Design;Databases, Factual*;Drug Design*;Internet;Molecular Structure
18323761;Animals;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use;Brain/physiopathology;Deep Brain Stimulation;Dopamine/physiology*;Dopamine Agents/adverse effects;Dopamine Agents/therapeutic use;Humans;Iatrogenic Disease;Parkinson Disease/diagnosis;Parkinson Disease/epidemiology;Parkinson Disease/physiopathology*;Parkinson Disease/therapy;Sleep Disorders, Intrinsic/diagnosis;Sleep Disorders, Intrinsic/epidemiology;Sleep Disorders, Intrinsic/physiopathology*;Subthalamic Nucleus/physiopathology;Surveys and Questionnaires*
18330485;Campanulaceae/genetics*;Chromosome Inversion;Chromosome Mapping;DNA, Plant/chemistry;Evolution, Molecular*;Gene Order;Genome, Chloroplast*;Genomics;RNA, Transfer/genetics*;Repetitive Sequences, Nucleic Acid*
18336388;Adult;Case-Control Studies;Cohort Studies;European Continental Ancestry Group;Female;Fetal Death/genetics;Gene Frequency;Humans;Infant, Newborn;Infant, Small for Gestational Age;Interleukin-6/genetics*;Polymorphism, Single Nucleotide/genetics*;Pre-Eclampsia/genetics;Pregnancy;Pregnancy Complications/genetics*;Premature Birth/genetics;Promoter Regions, Genetic/genetics*;Prospective Studies;Risk Factors
18354144;Animals;Anterior Cruciate Ligament/surgery*;Bone Development;Epiphyses/cytology;Epiphyses/diagnostic imaging;Epiphyses/growth & development*;Epiphyses/surgery;Femur/diagnostic imaging;Femur/growth & development;Mesenchymal Stem Cell Transplantation*;Orthopedic Procedures/adverse effects;Rabbits;Radiography;Reconstructive Surgical Procedures;Tibia/diagnostic imaging;Tibia/growth & development
18358238;Animals;Axons/metabolism;Axons/physiology*;Cell Differentiation*;Cells, Cultured;Guanine Nucleotide Exchange Factors/analysis;Guanine Nucleotide Exchange Factors/genetics;Guanine Nucleotide Exchange Factors/metabolism*;Hippocampus/chemistry;Hippocampus/cytology;Hippocampus/metabolism;Humans;Mice;Mice, Knockout;Neurons/cytology*;Neurons/metabolism;Neurons/physiology*;Pinocytosis*/genetics;Pseudopodia/chemistry;Pseudopodia/metabolism
18375485;Amino Acids/blood*;Carnitine/analogs & derivatives*;Carnitine/blood;Heptanoates/blood*;Humans;Infant, Newborn;Neonatal Screening/methods*;Tyrosinemias/diagnosis*
18376595;Carnitine/analysis*;Chromatography, Liquid/methods*;Infant Formula/chemistry*;Tandem Mass Spectrometry/methods*
18378893;Arabidopsis/microbiology*;Arabidopsis Proteins/biosynthesis;Fungi/immunology*;Gene Expression Regulation, Plant/immunology*;MAP Kinase Signaling System/immunology*;Mitogen-Activated Protein Kinase 3/metabolism;Mitogen-Activated Protein Kinase 6/metabolism;Plant Diseases/immunology;Sesquiterpenes;Terpenes/metabolism*
18379940;Administration, Oral;Adolescent;Female;Fluorescein Angiography;Humans;Inflammation/microbiology;Macular Edema/microbiology;Pharyngitis/microbiology;Radiography;Retinal Vessels*;Scarlet Fever;Steroids/administration & dosage;Steroids/therapeutic use;Streptococcal Infections*;Uveitis/microbiology;Vasculitis/diagnosis;Vasculitis/drug therapy;Vasculitis/microbiology*;Venules/diagnostic imaging;Vitreous Body
18388750;Brachial Plexus Neuropathies/physiopathology;Brachial Plexus Neuropathies/surgery*;Elbow Joint/innervation;Elbow Joint/physiopathology*;Humans;Muscle, Skeletal/anatomy & histology;Muscle, Skeletal/transplantation*;Range of Motion, Articular/physiology*;Surgical Flaps/innervation*
18389925;Antipsychotic Agents/metabolism;Antipsychotic Agents/pharmacology*;Cytochrome P-450 Enzyme System/drug effects*;Drug Interactions*;Humans;Polypharmacy;Professional Competence;Schizophrenia/drug therapy
18390505;Confidentiality*;Health Personnel*;Humans
18394897;Chromosomal Proteins, Non-Histone/metabolism;DNA Replication/physiology*;Heterochromatin/metabolism*;Histones/metabolism*;Hot Temperature;RNA Interference;S Phase/physiology*;Schizosaccharomyces/metabolism*;Schizosaccharomyces pombe Proteins/metabolism
18397547;Aged;Amnesia/diagnosis*;Amnesia/epidemiology;Amnesia/psychology;Attention*;Cognition Disorders/diagnosis*;Cognition Disorders/epidemiology;Cognition Disorders/psychology;Comorbidity;Cross-Sectional Studies;Depressive Disorder/diagnosis*;Depressive Disorder/epidemiology;Depressive Disorder/psychology;Female;Humans;Inhibition (Psychology)*;Male;Mass Screening;Memory, Short-Term;Middle Aged;Neuropsychological Tests/statistics & numerical data*;Problem Solving*;Psychometrics/statistics & numerical data;Quebec;Reproducibility of Results;Retention (Psychology);Verbal Learning
18409188;Cardiomyopathy, Hypertrophic/diagnosis*;Cardiomyopathy, Hypertrophic/genetics;Cardiomyopathy, Hypertrophic, Familial/diagnosis;DNA Mutational Analysis;Humans;Mutation;Oligonucleotide Array Sequence Analysis/economics;Oligonucleotide Array Sequence Analysis/methods*
18409807;Humans;Microcomputers*;Occupational Health*;Risk Assessment/methods*;Software*;Workload/statistics & numerical data*
18419457;Adult;Aged;CD4-Positive T-Lymphocytes/immunology;CD4-Positive T-Lymphocytes/metabolism;CD4-Positive T-Lymphocytes/pathology;China;Cross-Sectional Studies;Disease Progression;Female;HIV Infections/immunology*;HIV Infections/pathology;Humans;Lymphocyte Count;Male;Middle Aged;Receptors, Antigen, T-Cell, gamma-delta/immunology*;Receptors, Antigen, T-Cell, gamma-delta/metabolism;T-Lymphocyte Subsets/immunology*;T-Lymphocyte Subsets/metabolism;T-Lymphocyte Subsets/pathology
18422759;Adoptive Transfer;Animals;Cells, Cultured;Central Nervous System/drug effects*;Central Nervous System/immunology;Central Nervous System/physiopathology;Chemokine CXCL11/antagonists & inhibitors;Chemokine CXCL11/genetics;Chemokine CXCL11/immunology;Chemokine CXCL12/antagonists & inhibitors;Chemokine CXCL12/genetics;Chemokine CXCL12/immunology;Chemokines/agonists;Chemokines/genetics;Chemokines/immunology;Chemotaxis, Leukocyte/drug effects;Chemotaxis, Leukocyte/immunology;Disease Models, Animal;Encephalomyelitis, Autoimmune, Experimental/drug therapy*;Encephalomyelitis, Autoimmune, Experimental/immunology;Encephalomyelitis, Autoimmune, Experimental/physiopathology;Female;Immunologic Factors/pharmacology*;Immunologic Factors/therapeutic use;Immunosuppression/methods;Mice;Molecular Sequence Data;Peptides/genetics;Peptides/immunology;Peptides/pharmacology;Receptors, CXCR3/antagonists & inhibitors*;Receptors, CXCR3/immunology;Receptors, CXCR4/antagonists & inhibitors*;Receptors, CXCR4/immunology;Sequence Homology, Amino Acid;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;Treatment Outcome
18426815;Case-Control Studies;Chemokine CCL5/blood;Chemokine CCL5/genetics*;Cohort Studies;Diabetes Mellitus, Type 2/epidemiology*;Diabetes Mellitus, Type 2/genetics*;Female;Follow-Up Studies;Genetic Predisposition to Disease/epidemiology;Germany/epidemiology;Haplotypes;Humans;Incidence;Male;Middle Aged;Polymorphism, Single Nucleotide*;Prospective Studies
18429986;Adult;Dermatomycoses/diagnosis*;Dermatomycoses/drug therapy;Humans;Malassezia/isolation & purification*;Male;Tinea Versicolor/drug therapy*
18435388;Age Factors;Aged;Aged, 80 and over;Exercise*/physiology;Female;Health Promotion*;Health Status;Humans;Male;Middle Aged;Motor Activity*;Program Development*;Program Evaluation*;Residence Characteristics*;Saskatchewan;Socioeconomic Factors
18436234;Animals;Animals, Newborn;Cell Membrane/drug effects;Cell Membrane/enzymology*;Collagen Type I/metabolism;Collagen Type III/metabolism;Enzyme Activation/drug effects;Extracellular Space/drug effects;Extracellular Space/enzymology;Fibroblasts/cytology;Fibroblasts/drug effects*;Fibroblasts/enzymology*;Gelatin/metabolism;Gene Expression Regulation, Enzymologic/drug effects;Intracellular Space/drug effects;Intracellular Space/enzymology;Leptin/pharmacology*;Matrix Metalloproteinase 14/genetics;Matrix Metalloproteinase 14/metabolism*;Matrix Metalloproteinase 2/metabolism*;Matrix Metalloproteinase Inhibitors;Mice;Myocardium/cytology;Myocardium/enzymology*;Proline/metabolism;Protein Transport/drug effects;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley
18440719;Adaptation, Physiological/physiology*;Adult;Analysis of Variance;Biological Clocks/physiology;Eye Movements/physiology;Feedback;Female;Head Movements/physiology;Humans;Male;Movement/physiology*;Postural Balance/physiology*;Posture;Visual Acuity/physiology*;Visual Perception
18442380;Aged;Arthroplasty, Replacement, Hip/methods*;Arthroplasty, Replacement, Hip/rehabilitation*;Arthroplasty, Replacement, Knee/methods*;Arthroplasty, Replacement, Knee/rehabilitation*;Female;Follow-Up Studies;Humans;Length of Stay*;Male;Middle Aged;Perioperative Care/methods*;Prospective Studies;Randomized Controlled Trials as Topic/methods
18450331;Aldehydes/chemistry*;Anti-Bacterial Agents/cerebrospinal fluid;Anti-Bacterial Agents/chemistry*;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Drug Design*;Ketones/chemical synthesis;Ketones/chemistry*;Ketones/pharmacology*;Structure-Activity Relationship
18451009;Antipsychotic Agents/adverse effects;Antipsychotic Agents/economics*;Antipsychotic Agents/therapeutic use*;Clinical Trials as Topic*;Cost-Benefit Analysis;Drug Administration Schedule;Humans;Metabolic Syndrome/chemically induced;Metabolic Syndrome/prevention & control;Schizophrenia/drug therapy*;Schizophrenia/economics*
18462140;Canada;Cost-Benefit Analysis;Cross Infection/transmission;Disposable Equipment/economics*;Disposable Equipment/standards;Equipment Reuse/economics;Health Care Costs;Humans;Infection Control/economics*;Sterilization/economics
18467016;Antioxidants/chemistry*;Antioxidants/metabolism*;Area Under Curve;Benzothiazoles/analysis*;Benzothiazoles/metabolism;Drug Interactions;Drug Synergism;Flavonoids/chemistry*;Fluorescein/analysis*;Fluorescein/metabolism;Free Radical Scavengers;Indicators and Reagents;Molecular Weight;Oxidation-Reduction;Sulfonic Acids/analysis*;Sulfonic Acids/metabolism
18468428;Adult;Albumins/therapeutic use;Diuretics/therapeutic use;Dopamine/therapeutic use;Female;Hepatorenal Syndrome/mortality*;Hepatorenal Syndrome/therapy*;Humans;Lypressin/analogs & derivatives;Lypressin/therapeutic use;Male;Middle Aged;Paracentesis;Renal Dialysis;Treatment Outcome
18474307;Efficiency, Organizational;History, 20th Century;History, 21st Century;Humans;Organizational Objectives;Radiation Oncology*/history;Radiation Oncology*/trends;Research*/history;Research*/trends;Research Support as Topic;Societies, Medical*/history;United States
18480267;Animals;Cell Movement;Endothelial Cells/cytology;Female;Gene Expression Regulation, Developmental*;Germ Cells/cytology;Gonads/embryology*;Male;Mice;Mice, Transgenic;Neovascularization, Physiologic*;Organ Culture Techniques/methods;Ovary/blood supply*;Ovary/embryology*;Testis/blood supply*;Testis/embryology*;Time Factors
18495226;Adenylate Kinase/antagonists & inhibitors;Adenylate Kinase/metabolism;Antineoplastic Combined Chemotherapy Protocols/pharmacology;Blotting, Western;Cell Growth Processes/drug effects;Cell Line, Tumor;Cisplatin/administration & dosage;Cisplatin/pharmacology;Dose-Response Relationship, Drug;Drug Screening Assays, Antitumor;Drug Synergism;Female;Humans;Metformin/administration & dosage;Metformin/pharmacology*;Ovarian Neoplasms/drug therapy*;Ovarian Neoplasms/enzymology;Ovarian Neoplasms/pathology;Phosphorylation/drug effects;Pyrazoles/pharmacology;Pyrimidines/pharmacology;Ribosomal Protein S6 Kinases/metabolism;Ribosomal Protein S6 Kinases, 70-kDa/metabolism
18496070;Birth Injuries/prevention & control*;Dystocia/nursing*;Education, Nursing, Continuing/methods*;Female;Health Plan Implementation;Humans;Infant, Newborn;Manikins*;Patient Care Team;Pregnancy;Risk Management;Shoulder*/innervation;Shoulder Injuries
18506827;Ceramics*;Crowns*;Finite Element Analysis;Glass;Imaging, Three-Dimensional;Materials Testing;Stress, Mechanical
18510270;Gloves, Surgical/economics;Gloves, Surgical/standards*;Occupational Health*;Physician's Role*
18524389;Computers;Humans;Magnetic Resonance Imaging;Phantoms, Imaging;Positron-Emission Tomography/methods*;Radiography, Thoracic;Reproducibility of Results;Software;Tomography, X-Ray Computed/methods*;Whole Body Imaging/methods*
18536167;Animals;Carcinogens/administration & dosage;Carcinogens/toxicity*;DNA/drug effects;DNA/metabolism;Dose-Response Relationship, Drug;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Male;Mice;Ochratoxins/administration & dosage;Ochratoxins/toxicity*;Phyllanthus emblica/chemistry*;Plant Extracts/pharmacology*;Proteins/drug effects;Proteins/metabolism;RNA/drug effects;RNA/metabolism
18538810;Animals;Female;Gene Expression Regulation, Developmental/drug effects;Gene Expression Regulation, Developmental/physiology;Protein Subunits/physiology*;Pyrethrins/chemistry*;Pyrethrins/pharmacology*;Sodium Channels/physiology*;Xenopus laevis
18541576;Adolescent;Adult;Alcohol Drinking/epidemiology;Cohort Studies;Exercise*;Feeding Behavior*;Female;Fruit;Humans;Interviews as Topic;Parity;Pregnancy/physiology*;Pregnancy Complications/epidemiology;Pregnancy Complications/physiopathology;Prenatal Care;Puerto Rico;Smoking/epidemiology*;Substance-Related Disorders/epidemiology;Vegetables;Weight Gain
18545035;Humans;National Institute for Occupational Safety and Health (U.S.);Occupational Exposure*;Occupational Health;Radiation Dosage*;Radiation Injuries;Radiation Monitoring/methods*;Radioactive Pollutants/analysis*;Radioactive Pollutants/toxicity;Radiography*;Risk Assessment/methods*;United States;X-Rays/adverse effects*
18547382;Animals;Antifungal Agents/adverse effects*;Dog Diseases/chemically induced*;Dogs;Female;Ketoconazole/adverse effects*;Male;Retrospective Studies
18548255;Carcinoma, Squamous Cell*/genetics;Carcinoma, Squamous Cell*/virology;Humans;Male;Penile Neoplasms*/genetics;Penile Neoplasms*/virology;Prognosis;Tumor Suppressor Protein p53/biosynthesis
18550387;Achievement*;Educational Status;Female;Humans;Magnetic Resonance Imaging/methods*;Male;Motivation*;Putamen/physiology*;Reward*;Task Performance and Analysis*;Young Adult
18551251;Animals;Antimalarials/pharmacology*;B7-1 Antigen/metabolism;B7-2 Antigen/metabolism;Chloroquine/pharmacology*;Cinnamates/pharmacology*;Drug Resistance, Multiple*;Drug Therapy, Combination;Female;Glycosides/pharmacology*;Immunoglobulin G/blood;Immunologic Factors/pharmacology*;Lymphocyte Activation/drug effects;Macrophages/drug effects;Macrophages/metabolism;Malaria/drug therapy*;Malaria/immunology;Malaria/parasitology;Mice;Mice, Inbred BALB C;Ovalbumin/immunology;Plasmodium yoelii/drug effects*;Plasmodium yoelii/immunology;Reactive Oxygen Species/metabolism;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;Time Factors;Up-Regulation;Vanillic Acid/pharmacology*
18560115;Computational Biology*;Computer Simulation;Computer Systems*;Databases as Topic;Databases, Protein*;Dicarboxylic Acid Transporters/genetics;Humans;Italy;Program Development;Protein Structure, Tertiary/genetics*;Saccharomyces cerevisiae/genetics;Software
18568228;Aluminum Oxide/chemistry;Composite Resins/chemistry*;Dental Bonding/methods*;Dental Cements/chemistry;Dental Etching/methods;Dental Materials/chemistry*;Dental Veneers;Humans;Light-Curing of Dental Adhesives/methods;Materials Testing;Self-Curing of Dental Resins/methods*;Silanes/chemistry;Stress, Mechanical;Surface Properties;Tensile Strength;Titanium/chemistry*
18575485;Animals;Anti-Retroviral Agents/therapeutic use*;Child;Child, Preschool;Female;Follow-Up Studies;HIV Infections/complications;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1/genetics*;Humans;Incidence;Infant;Malaria/complications*;Malaria/epidemiology;Malaria/parasitology;Male;Parasitemia/complications*;Parasitemia/epidemiology;Parasitemia/parasitology;Plasmodium falciparum/isolation & purification;Prevalence;Prospective Studies;RNA, Viral/analysis*;Treatment Outcome
18596056;Aged;Aged, 80 and over;Aortic Valve/surgery*;Atrial Fibrillation/complications;Atrial Fibrillation/surgery*;Catheter Ablation*;Coronary Artery Bypass*;Coronary Artery Disease/complications;Coronary Artery Disease/surgery*;Female;Heart Valve Diseases/complications;Heart Valve Diseases/surgery*;Heart Valve Prosthesis Implantation*;Humans;Male;Middle Aged;Time Factors;Treatment Outcome
18602048;Adult;Algorithms;Feasibility Studies;Female;Humans;Hysteroscopy;Intrauterine Devices*;Pilot Projects;Prosthesis Implantation/methods*;Retrospective Studies;Sterilization, Tubal/instrumentation;Sterilization, Tubal/methods*
18613738;Algorithms;Animals;Bacterial Adhesion;Bacterial Physiological Phenomena*;Biofilms*;Cell Adhesion;Cell Proliferation;Computer Simulation;Developmental Biology;Mathematics*;Models, Theoretical;Software
18618603;Image Processing, Computer-Assisted;Karyotyping;Microscopy, Atomic Force;Plant Structures/genetics*;Plant Structures/ultrastructure*;Saponaria/classification;Saponaria/genetics*;Saponaria/ultrastructure*
18619484;Alkaloids/administration & dosage*;Alkaloids/metabolism*;Alkaloids/pharmacokinetics;Alkaloids/pharmacology;Animals;Cell Proliferation/drug effects;Drug Carriers/administration & dosage*;Drug Carriers/chemistry;Drug Carriers/metabolism*;Drug Carriers/pharmacokinetics;Galactosides/chemistry;Injections, Intravenous;Lipids/chemistry*;Liver/cytology;Liver/drug effects;Liver/metabolism*;Mice;Nanoparticles/chemistry*
18625859;Adult;Axons/pathology*;Cross-Sectional Studies;Female;Humans;Lasers*/standards;Male;Microscopy, Confocal/methods;Microscopy, Confocal/standards;Middle Aged;Multiple Sclerosis/complications;Multiple Sclerosis/diagnosis;Multiple Sclerosis/pathology*;Nerve Degeneration/complications;Nerve Degeneration/diagnosis;Nerve Degeneration/pathology*;Nerve Fibers/pathology;Optic Disk/pathology;Retina/pathology*;Retinal Ganglion Cells/pathology;Tomography, Optical Coherence/methods*;Tomography, Optical Coherence/standards;Visual Acuity/physiology
18662923;Alcoholic Intoxication/mortality*;Alcoholic Intoxication/prevention & control;Alcoholism/mortality*;Alcoholism/prevention & control;Ethanol;Government Regulation;Health Policy*;Health Promotion*;Humans;Russia;Social Marketing;USSR
18666266;Animals;CHO Cells;Cerebrospinal Fluid/chemistry;Cerebrospinal Fluid/enzymology;Cricetinae;Cricetulus;DNA/chemistry*;Deoxyribonucleases/chemistry;Drug Carriers/chemical synthesis*;Drug Carriers/chemistry;Drug Carriers/pharmacology;Fatty Acids, Unsaturated/chemical synthesis*;Fatty Acids, Unsaturated/chemistry;Fluorescent Dyes/chemistry;Green Fluorescent Proteins/biosynthesis;Green Fluorescent Proteins/chemistry;Green Fluorescent Proteins/genetics;Humans;Ligands;Lipids/chemistry*;Luciferases/chemistry;Molecular Structure;Oximes/chemical synthesis;Oximes/chemistry*;Oximes/pharmacology;Stereoisomerism;Transfection/methods
18670393;Drainage/instrumentation*;Humans;Minimally Invasive Surgical Procedures/instrumentation*;Pericardial Effusion/surgery*;Thoracotomy*
18671910;Aged;Aged, 80 and over;Alzheimer Disease/cerebrospinal fluid*;Alzheimer Disease/enzymology;Amyloid beta-Peptides/cerebrospinal fluid;Biomarkers/cerebrospinal fluid;Case-Control Studies;Cognition Disorders/cerebrospinal fluid*;Cognition Disorders/enzymology;Dementia/cerebrospinal fluid;Dementia/classification;Dementia/enzymology;Dementia/pathology;Female;Frontal Lobe/enzymology;Frontal Lobe/pathology;Humans;Lewy Body Disease/cerebrospinal fluid*;Lewy Body Disease/enzymology;Male;Peptide Fragments/cerebrospinal fluid;Phosphopyruvate Hydratase/cerebrospinal fluid*;Reference Values;Temporal Lobe/enzymology;Temporal Lobe/pathology;tau Proteins/cerebrospinal fluid
18675353;Fluorescence Resonance Energy Transfer;Protein Conformation;Protein Denaturation;Proteins/chemistry*;Spectrometry, Fluorescence
18676527;Administration, Oral;Alberta;Child;Child, Preschool;Common Cold/diagnosis;Common Cold/drug therapy;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Follow-Up Studies;Humans;Male;Maximum Tolerated Dose;Panax*;Phytotherapy/methods*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Probability;Reference Values;Respiratory Tract Infections/diagnosis;Respiratory Tract Infections/drug therapy*;Risk Assessment;Treatment Outcome
18677335;Adult;Castleman Disease/diagnosis*;Diagnosis, Differential;Humans;Lymphoma/diagnosis;Male;Retroperitoneal Neoplasms/diagnosis;Retroperitoneal Space/diagnostic imaging*;Sarcoma/diagnosis;Tomography, X-Ray Computed
18678735;Adolescent;Art Therapy*;Criminal Psychology;Humans;Male;Needs Assessment;Prisoners/psychology*;Virginia;Young Adult
18694637;Adult;Asthma/metabolism*;Asthma/physiopathology;Biomarkers/analysis;Breath Tests/instrumentation;Electrochemistry;Equipment Design;Exhalation/physiology;Female;Humans;Luminescent Measurements/instrumentation*;Luminescent Measurements/methods;Male;Middle Aged;Nitric Oxide/analysis*;Patient Selection;Practice Guidelines as Topic;Young Adult
18699513;Amplifiers, Electronic;Carbon/chemistry;Electric Capacitance;Electric Conductivity;Electric Power Supplies;Electrodes;Electronics, Medical/instrumentation;Equipment Design;Quartz;Radio Waves*;Reproducibility of Results;Transducers
18701322;Adolescent;Adult;Aged;Attitude to Health;Child;Epilepsy/therapy*;Ethiopia;Female;Health Services Accessibility*;Humans;Male;Middle Aged;Outpatient Clinics, Hospital/utilization*;Patient Compliance;Patient-Centered Care;Primary Health Care/methods*;Rural Health;Rural Health Services/utilization*;Rural Population;Surveys and Questionnaires
18708149;Adolescent;Aging/physiology*;Aging/psychology*;Attention/physiology*;Brain/physiology*;Brain Mapping;Child;Cognition/physiology*;Female;Humans;Male;Nerve Net/physiology*;Time;Time Perception/physiology*
18709283;Adolescent;Adult;Attitude*;Female;Honduras;Humans;Male;Risk Factors;Street Drugs;Students, Nursing/statistics & numerical data*;Substance-Related Disorders*
18719125;Biofilms/growth & development*;DNA Breaks, Double-Stranded;DNA Repair/genetics*;DNA, Bacterial/genetics;Genetic Variation*;Models, Genetic;Mutation;Oxidative Stress/genetics*;Pseudomonas aeruginosa/genetics*;Selection, Genetic*
18726132;Cholangiopancreatography, Endoscopic Retrograde*;Evidence-Based Medicine;Gallstones/complications*;Humans;Meta-Analysis as Topic;Pancreatitis/diagnostic imaging*;Pancreatitis/etiology;Randomized Controlled Trials as Topic
18751344;Adolescent;Child;Child, Preschool;Esotropia/surgery*;Female;Humans;Male
18755376;Acne Vulgaris/drug therapy*;Acne Vulgaris/pathology;Clinical Trials, Phase III as Topic*;Dermatitis, Atopic/drug therapy*;Dermatitis, Atopic/pathology;Dermatitis, Seborrheic/drug therapy*;Dermatitis, Seborrheic/pathology;Humans;Seasons*;Treatment Outcome
18756961;Abdominal Neoplasms/diagnosis*;Abdominal Neoplasms/therapy;Hemangioma/diagnosis*;Hemangioma/therapy;Humans;Lymphoma/diagnosis*;Lymphoma/therapy
18757150;Chemical Phenomena*;Chemistry, Pharmaceutical*;Cyclodextrins/chemistry*;Genistein/chemistry*;Models, Molecular;Molecular Structure;Solubility;Spectrophotometry, Ultraviolet;beta-Cyclodextrins/chemistry*
18759153;Aged;Aged, 80 and over;Endoscopy, Gastrointestinal;Female;Gastrointestinal Hemorrhage/mortality*;Gastrointestinal Hemorrhage/therapy*;Hospital Mortality;Humans;Male;Middle Aged;Recurrence;Treatment Outcome
18759250;Case-Control Studies;Data Interpretation, Statistical;Female;Genetic Predisposition to Disease;Genetics, Population/statistics & numerical data*;Genotype;Humans;Male;Models, Genetic;Models, Statistical;Molecular Epidemiology/statistics & numerical data*;Mothers;Parents;Risk Factors
18764847;Double-Blind Method;Editorial Policies*;Humans;Nursing*;Peer Review, Research/standards*;Periodicals as Topic/standards*;Professional Competence/standards*
18765176;Adult;Aged;Aged, 80 and over;Echocardiography, Three-Dimensional/methods*;Female;Humans;Image Interpretation, Computer-Assisted/methods*;Magnetic Resonance Imaging/methods*;Male;Middle Aged;Organ Size;Reproducibility of Results;Sensitivity and Specificity;Ventricular Dysfunction, Left/diagnosis*;Young Adult
18769804;AIDS-Related Opportunistic Infections/epidemiology;AIDS-Related Opportunistic Infections/mortality*;Adult;CD4 Lymphocyte Count;Chile/epidemiology;Female;HIV Infections/epidemiology;HIV Infections/mortality*;Humans;Male;Multivariate Analysis;Prevalence;Retrospective Studies;Tuberculosis/epidemiology;Tuberculosis/mortality*;Viral Load
18769820;Biomedical Research/ethics*;Cholesterol/physiology*;Humans
18782933;Cities/economics;Cities/ethnology;Cities/history;Cities/legislation & jurisprudence;City Planning*/economics;City Planning*/education;City Planning*/history;City Planning*/legislation & jurisprudence;History, 17th Century;History, 18th Century;Local Government*;London/ethnology;Politics;Power (Psychology);Public Opinion;Public Policy*;Social Change*/history;Social Control Policies*/economics;Social Control Policies*/history;Social Control Policies*/legislation & jurisprudence;Urban Health*/history;Urban Population/history
18803542;Age Factors;Community Health Services/organization & administration*;Delivery of Health Care/organization & administration*;Hospitalization;Humans;New South Wales;Rehabilitation/organization & administration*;Victoria
18811551;Carcinoma, Transitional Cell/surgery*;Cystectomy/methods*;Humans;Kidney Neoplasms/surgery*;Male;Middle Aged;Nephrostomy, Percutaneous/methods*;Urinary Diversion/methods*
18817414;Animal Feed/analysis*;Animals;Desiccation/methods*;Digestion;Food Handling/methods*;Freeze Drying;Hot Temperature;Lysine/chemistry*;Swine;Zea mays/chemistry*
18824090;Acetates/chemistry*;Administration, Oral;Crystallization;Drug Stability;Magnetic Resonance Spectroscopy/methods*;Solubility;Spectrophotometry, Infrared/methods*;Stereoisomerism;Temperature;Thermodynamics;Thiazoles/chemistry*
18827160;Adolescent;Asthma/etiology*;Bronchial Hyperreactivity/complications*;Bronchial Hyperreactivity/diagnosis;Bronchial Provocation Tests;Health Surveys;Humans;Hypersensitivity/etiology*;Inflammation;Spirometry
18828993;Adult;Aged;Caregivers/education*;Female;Home Nursing/education;Humans;Male;Middle Aged;Problem Solving*;Psychometrics;Spinal Cord Injuries/nursing*;Videoconferencing*
18831965;Amino Acid Sequence;Bacteriophages/enzymology*;Bacteriophages/genetics;Genes, Viral;Hot Temperature*;Mercaptoethanol/chemistry;Molecular Sequence Data;Molecular Weight;Muramidase/chemistry*;Muramidase/genetics;Muramidase/isolation & purification;Substrate Specificity;Thermus/virology*;Viral Proteins/chemistry*;Viral Proteins/genetics;Viral Proteins/isolation & purification
18843402;Alkenes/chemistry;Alkylation;Catalysis;Indoles/chemical synthesis*;Indoles/chemistry;Iridium/chemistry*;Stereoisomerism;Substrate Specificity;Tryptamines/chemical synthesis*;Tryptamines/chemistry
18844834;Adult;Diseases in Twins;Female;Follow-Up Studies;Glomerulonephritis/drug therapy*;Glomerulonephritis/surgery;Humans;Immunosuppressive Agents/therapeutic use*;Kidney Failure, Chronic/drug therapy*;Kidney Failure, Chronic/surgery;Kidney Transplantation*;Male;Time Factors;Treatment Refusal;Withholding Treatment
18852512;Amino Acid Sequence;Amylases/chemistry*;Amylases/genetics;Amylases/isolation & purification;Amylases/metabolism*;Ascomycota/enzymology*;Ascomycota/genetics;Avena/metabolism;Biocatalysis;Cations, Divalent/pharmacology;Chromatography;Hydrogen-Ion Concentration;Kinetics;Metals/pharmacology;Peptide Mapping;Sequence Analysis, Protein;Sequence Homology, Amino Acid;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Starch/metabolism;Substrate Specificity;Temperature;alpha-Amylases/chemistry*;alpha-Amylases/genetics;alpha-Amylases/isolation & purification;alpha-Amylases/metabolism*
18861038;Anatomy/education*;Humans
18863021;Anesthesia*;Anesthesiology*;Humans;Injections, Intravenous*;Liver*
18863659;Agglutination/blood*;Agglutinins/blood*;Animals;Arthritis*;Arthritis, Rheumatoid*;Erythrocytes*;Humans;Rheumatology*;Sheep;Sheep, Domestic*
18870259;Biopsy*;Dermatology/pathology*;Humans
18888093;Humans
18902612;Alcoholism/diagnosis*;Alcohols*;Blood*;Humans;Occupational Health*
18913299;Aged;Electrocardiography*;Humans
18915732;Humans
18919656;Aged;Heart Diseases*;Heart Rate*;Humans;Tachycardia, Paroxysmal*
18950943;Aged;Aged, 80 and over;Arthritis/epidemiology*;Australia/epidemiology;Comorbidity;Depression/epidemiology*;Female;Frail Elderly/statistics & numerical data*;Humans;Incidence;Male;Pain/diagnosis;Pain/epidemiology*;Risk Assessment/methods*;Risk Factors
18975328;Adult;Aged;Aged, 80 and over;Antigens, CD/analysis;Antigens, CD/immunology*;B7 Antigens;Blotting, Western;CD8-Positive T-Lymphocytes/chemistry;Dermatomyositis/metabolism;Female;Flow Cytometry;Humans;Immunohistochemistry;Male;Middle Aged;Muscle Cells/chemistry;Muscle Cells/immunology*;Muscle Neoplasms/metabolism;Muscular Diseases/metabolism;Myositis, Inclusion Body/metabolism;Polymyositis/metabolism;RNA, Small Interfering/analysis;Receptors, Immunologic/analysis;Receptors, Immunologic/immunology*;Rhabdomyosarcoma/metabolism
18984890;Adult;Aged;Breast Implants/adverse effects*;Breast Neoplasms/epidemiology*;Breast Neoplasms/etiology*;Breast Neoplasms/pathology;Case-Control Studies;Female;Humans;Logistic Models;Lymphoma, Large-Cell, Anaplastic/epidemiology*;Lymphoma, Large-Cell, Anaplastic/etiology*;Lymphoma, Large-Cell, Anaplastic/pathology;Middle Aged;Netherlands/epidemiology;Risk;Silicone Gels/adverse effects*
18987562;Adult;Antidepressive Agents, Second-Generation/metabolism;Antidepressive Agents, Second-Generation/therapeutic use;Base Sequence;DNA Primers/genetics;Depressive Disorder, Major/diagnostic imaging;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/genetics*;Depressive Disorder, Major/metabolism;Diencephalon/diagnostic imaging;Diencephalon/metabolism;Female;Genotype;Humans;Male;Mesencephalon/diagnostic imaging;Mesencephalon/metabolism;Middle Aged;Paroxetine/metabolism*;Paroxetine/therapeutic use*;Pharmacogenetics;Polymorphism, Genetic*;Promoter Regions, Genetic*;Serotonin Plasma Membrane Transport Proteins/genetics*;Serotonin Plasma Membrane Transport Proteins/metabolism*;Serotonin Uptake Inhibitors/metabolism;Serotonin Uptake Inhibitors/therapeutic use;Tomography, Emission-Computed, Single-Photon
18990010;Adult;Aged;Chi-Square Distribution;Combined Modality Therapy;Disease-Free Survival;Endometrial Neoplasms/mortality*;Endometrial Neoplasms/pathology*;Endometrial Neoplasms/therapy;Female;Humans;Immunohistochemistry;Kaplan-Meier Estimate;Middle Aged;Neoplasm Invasiveness/pathology;Neoplasm Staging;Neoplasms, Multiple Primary/mortality*;Neoplasms, Multiple Primary/pathology*;Neoplasms, Multiple Primary/therapy;Ovarian Neoplasms/mortality*;Ovarian Neoplasms/pathology;Ovarian Neoplasms/secondary*;Ovarian Neoplasms/therapy;Probability;Prognosis;Registries;Retrospective Studies;Risk Assessment;Statistics, Nonparametric;Survival Analysis;Thailand
18990169;Adolescent;Adult;Aged;Child;Child, Preschool;Gynecomastia/etiology;Humans;Leydig Cell Tumor/pathology;Leydig Cell Tumor/surgery*;Luteinizing Hormone/metabolism;Male;Middle Aged;Orchiectomy/methods*;Testicular Neoplasms/pathology;Testicular Neoplasms/surgery*;Testis/pathology;Testis/surgery*;Treatment Outcome;Young Adult
18997461;Antibody Formation/drug effects*;Cross-Over Studies;Humans;Immunity, Cellular/drug effects*;Lymphocytes/drug effects;Lymphocytes/metabolism;Male;Neutrophils/drug effects;Neutrophils/metabolism;Phagocytosis/drug effects*;Respiratory Burst/drug effects;Trans Fatty Acids/administration & dosage*;Trans Fatty Acids/blood;Trans Fatty Acids/immunology*;Young Adult
18998065;Adult;Aged;Aged, 80 and over;Female;Humans;Lymph Nodes/pathology*;Lymph Nodes/surgery;Lymphatic Metastasis;Male;Middle Aged;Neoplasm Invasiveness;Neoplasm Staging/standards*;Prognosis;SEER Program;Stomach Neoplasms/classification*;Stomach Neoplasms/pathology*;Survival Rate;United States;Young Adult
19007509;Analgesics, Opioid/analysis*;Gas Chromatography-Mass Spectrometry;Humans;Immunoenzyme Techniques/methods*;Vitreous Body/chemistry*
19015169;Aged;Bicarbonates/blood*;Chronic Disease;Cohort Studies;Humans;Kidney Diseases/blood*;Kidney Diseases/mortality*;Male;Middle Aged;Proportional Hazards Models;Renal Dialysis
19015595;Adiponectin/blood;Aged;Angina Pectoris*/diagnostic imaging;Angina Pectoris*/metabolism;Angina Pectoris*/pathology;Biomarkers/blood;Cholesterol, LDL/blood;Coronary Artery Disease*/diagnostic imaging;Coronary Artery Disease*/metabolism;Coronary Artery Disease*/pathology;Coronary Vessels/diagnostic imaging;Coronary Vessels/metabolism;Coronary Vessels/pathology*;Female;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Retrospective Studies;Ultrasonography, Interventional*;Ventricular Remodeling/physiology*
19018851;Adenocarcinoma/mortality;Adenocarcinoma/pathology;Adenocarcinoma/surgery;Adolescent;Adult;Carcinoma, Squamous Cell/mortality;Carcinoma, Squamous Cell/pathology;Carcinoma, Squamous Cell/therapy;Chemotherapy, Adjuvant/utilization;Esophageal Neoplasms/mortality*;Esophageal Neoplasms/pathology*;Esophageal Neoplasms/therapy;Female;Gastrostomy/utilization;Humans;Male;Radiotherapy, Adjuvant/utilization;Retrospective Studies;Sex Distribution;Stents;Survival Rate
19029306;RNA Splicing/physiology*;RNA, Catalytic/metabolism;RNA, Small Nuclear/chemistry;RNA, Small Nuclear/metabolism*;Ribonucleoproteins/metabolism;Spliceosomes/metabolism
19036352;Humans;Immunohistochemistry;Salivary Gland Neoplasms/classification*;Salivary Gland Neoplasms/diagnosis;Salivary Gland Neoplasms/pathology*;Salivary Glands/pathology*;World Health Organization
19059651;Adolescent;Adult;Delusions/diagnosis;Delusions/psychology;Female;Humans;Male;Perceptual Distortion*;Personality Inventory/statistics & numerical data;Phobic Disorders/diagnosis*;Phobic Disorders/psychology;Psychometrics/statistics & numerical data;Reproducibility of Results;Schizotypal Personality Disorder/diagnosis*;Schizotypal Personality Disorder/psychology;Social Perception*;Thinking*;Young Adult
19061712;Adult;Aged;Chronic Disease;Double-Blind Method;Female;Granulocyte Colony-Stimulating Factor/therapeutic use*;Humans;Infusions, Intra-Arterial;Male;Middle Aged;Myocardial Ischemia/therapy*;Stem Cell Transplantation*
19073764;Animals;Diabetes Mellitus, Type 1/surgery*;Dipeptidyl Peptidase 4/metabolism*;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Graft Rejection/prevention & control;Graft Survival/drug effects*;Graft Survival/immunology*;Islets of Langerhans Transplantation/immunology*;Male;Mice;Mice, Inbred NOD;Pyrazines/pharmacology*;Sitagliptin Phosphate;T-Lymphocytes/immunology*;Transplantation, Isogeneic/physiology;Triazoles/pharmacology*
19074054;Anticoagulants/antagonists & inhibitors*;Factor VIIa/therapeutic use*;Heart Valve Prosthesis Implantation;Humans;Male;Middle Aged;Mitral Valve;Recombinant Proteins/therapeutic use;Review Literature as Topic;Safety;Shock/chemically induced;Shock/drug therapy;Warfarin/antagonists & inhibitors*
19082840;Alleles;Animals;Continental Population Groups/genetics;Genetic Variation*;Humans;Male;Pan troglodytes/genetics*;Polymerase Chain Reaction;Sequence Analysis, DNA;Tandem Repeat Sequences*;X Chromosome*
19086685;Adult;Anxiety*/diagnosis;Anxiety*/epidemiology;Depression*/diagnosis;Depression*/epidemiology;Disability Evaluation*;Female;Humans;Male;Middle Aged;Socioeconomic Factors;Young Adult
19086916;Adult;Humans;Influenza A Virus, H1N1 Subtype/immunology;Influenza A Virus, H1N1 Subtype/isolation & purification;Influenza A Virus, H3N2 Subtype/immunology;Influenza A Virus, H3N2 Subtype/isolation & purification;Influenza A virus/classification;Influenza A virus/immunology;Influenza A virus/isolation & purification;Influenza B virus*/immunology;Influenza B virus*/isolation & purification;Influenza Vaccines*/administration & dosage;Influenza Vaccines*/therapeutic use;Influenza, Human/epidemiology*;Influenza, Human/prevention & control*;Influenza, Human/virology;Middle Aged;Population Surveillance/methods*;Vaccination/statistics & numerical data;Young Adult
19103013;Anti-Infective Agents, Local/therapeutic use*;Bandages;Burns/drug therapy*;Humans;Skin Transplantation;Skin, Artificial;Wound Healing
19110234;Antineoplastic Agents/pharmacology*;Apoptosis/drug effects*;Azacitidine/pharmacology*;Carboplatin/pharmacology*;Cell Line, Tumor;Drug Resistance, Neoplasm/drug effects*;Female;Humans;Ovarian Neoplasms
19119268;Nanotechnology/ethics;Nanotechnology/trends*
19119707;Acetates/administration & dosage;Acetates/therapeutic use;Adrenergic beta-Agonists/administration & dosage*;Adrenergic beta-Agonists/therapeutic use;Anti-Asthmatic Agents/administration & dosage*;Anti-Asthmatic Agents/therapeutic use;Asthma/physiopathology*;Asthma/prevention & control*;Child, Preschool;Cough/physiopathology;Drug Administration Schedule;Humans;Multivariate Analysis;Prognosis;Quinolines/administration & dosage;Quinolines/therapeutic use;Remission, Spontaneous;Respiratory Sounds/physiopathology;Severity of Illness Index
19121509;Cephalometry;Dental Arch/pathology*;Humans;Lip;Mandible/pathology*;Orthodontic Appliance Design*;Orthodontic Appliances*;Orthodontics, Corrective/instrumentation;Prospective Studies;Randomized Controlled Trials as Topic;Retrospective Studies
19122728;Acoustics;Algorithms;Animals;Electrons;Gelatin/chemistry;Laser Therapy/instrumentation*;Laser Therapy/methods;Lasers*;Light;Models, Statistical;Models, Theoretical;Optics and Photonics;Skin/radiation effects;Swine;Time Factors;Water/chemistry
19130898;Arachidonic Acid/metabolism*;Carbamates/pharmacology;Cells, Cultured;Enzyme Inhibitors/pharmacology;Exocytosis/drug effects;Fluoroimmunoassay;Glucuronidase/metabolism;Group IV Phospholipases A2/antagonists & inhibitors;Group IV Phospholipases A2/physiology*;Humans;Immunoblotting;Indolizines/pharmacology;Ionophores/pharmacology;Lipopolysaccharides/pharmacology;Macrophages, Alveolar/drug effects;Macrophages, Alveolar/enzymology*;Platelet Activating Factor/biosynthesis*;Polymerase Chain Reaction
19131472;Carnosine/metabolism*;Humans;Magnetic Resonance Spectroscopy;Male;Muscle Fibers, Fast-Twitch/metabolism;Muscle Fibers, Slow-Twitch/metabolism;Muscle, Skeletal/metabolism*;Time Factors;Young Adult;beta-Alanine/pharmacokinetics*
19139364;Age Factors;Aged;Atrophy/chemically induced;Atrophy/pathology;Atrophy/physiopathology;Brain/drug effects*;Brain/pathology*;Brain/physiopathology;Causality;Cognition Disorders/chemically induced;Cognition Disorders/pathology;Cognition Disorders/physiopathology;Dementia/chemically induced;Dementia/pathology;Dementia/physiopathology;Estrogen Replacement Therapy/adverse effects*;Estrogens/adverse effects;Estrogens, Conjugated (USP)/adverse effects*;Female;Hippocampus/drug effects;Hippocampus/pathology;Hippocampus/physiopathology;Humans;Magnetic Resonance Imaging;Neuropsychological Tests;Prefrontal Cortex/drug effects;Prefrontal Cortex/pathology;Prefrontal Cortex/physiopathology
19143478;Administration, Intranasal;Animals;Capsid Proteins/administration & dosage;Capsid Proteins/genetics;Capsid Proteins/immunology*;Female;Humans;Immunity, Humoral;Immunization;Male;Mice;Mice, Inbred BALB C;Rotavirus/genetics;Rotavirus/immunology*;Rotavirus Infections/immunology*;Rotavirus Infections/virology;Vaccines, DNA/administration & dosage;Vaccines, DNA/genetics;Vaccines, DNA/immunology;Viral Vaccines/administration & dosage;Viral Vaccines/genetics;Viral Vaccines/immunology*
19162476;Anti-Infective Agents/isolation & purification;Anti-Infective Agents/pharmacology*;Ascomycota/chemistry*;Ascomycota/classification;Ascomycota/isolation & purification;Microbial Sensitivity Tests;Seawater/microbiology;Siderophores/isolation & purification;Siderophores/pharmacology*;Vibrio/drug effects*;Vibrio/growth & development;Yeasts/chemistry*;Yeasts/classification;Yeasts/isolation & purification
19166402;Adiponectin/blood*;Adipose Tissue/metabolism*;Animals;Cardiovascular Diseases/blood*;Disease Progression;Humans;Prognosis
19169121;Adolescent;Adult;Ambulatory Care/statistics & numerical data;Antipsychotic Agents/therapeutic use*;Cohort Studies;Comorbidity;Continuity of Patient Care/statistics & numerical data;Dose-Response Relationship, Drug;Female;Florida;Healthcare Disparities/trends*;Hospitalization/statistics & numerical data;Humans;Long-Term Care/statistics & numerical data;Male;Managed Care Programs/statistics & numerical data;Medicaid/statistics & numerical data;Middle Aged;Probability;Quality of Health Care/standards;Quality of Health Care/trends*;Reference Standards;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Schizophrenia/epidemiology;Substance-Related Disorders/epidemiology;United States;Young Adult
19181112;Animals;DNA Repair*;DNA-Binding Proteins/physiology*;Disease Models, Animal;Endonucleases/physiology*;Humans
19185803;Contraceptives, Oral, Hormonal/administration & dosage;Estrogen Replacement Therapy;Estrogens/metabolism;Female;Humans;Pancreatic Neoplasms/epidemiology*;Pancreatic Neoplasms/metabolism;Pregnancy;Reproductive History*
19190697;Actinobacteria/classification;Actinobacteria/genetics;Actinobacteria/isolation & purification*;Antarctic Regions;Bacteroidetes/classification;Bacteroidetes/genetics;Bacteroidetes/isolation & purification*;Cold Temperature;Colony Count, Microbial;DNA, Bacterial/genetics;Fresh Water/microbiology;Polymorphism, Restriction Fragment Length;Proteobacteria/classification;Proteobacteria/genetics;Proteobacteria/isolation & purification*;Water/analysis;Water Microbiology*
19197275;Academies and Institutes*;Biomedical Research*;Research Support as Topic;United States
19197314;3T3 Cells;Alkylating Agents/pharmacology;Animals;Biosensing Techniques/instrumentation;Biosensing Techniques/methods*;Cells/drug effects*;Cytotoxins/pharmacology;DNA Damage/drug effects;DNA, Single-Stranded/drug effects;Infrared Rays;Luminescence;Luminescent Agents/analysis;Luminescent Agents/radiation effects;Luminescent Measurements/instrumentation;Luminescent Measurements/methods*;Mice;Nanotechnology/methods;Nanotubes, Carbon/chemistry*;Reactive Oxygen Species/pharmacology;Sensitivity and Specificity;Spectrophotometry, Infrared/instrumentation;Spectrophotometry, Infrared/methods;Static Electricity
19208057;Humans;Journalism, Medical*;Periodicals as Topic
19222296;Elastomers/chemistry*;Mechanical Phenomena;Models, Molecular;Molecular Biology;Proteins/chemistry
19222875;Adaptor Proteins, Signal Transducing/analysis;Antioxidants/pharmacology*;Aorta;Apoptosis Regulatory Proteins/analysis;Biomarkers/analysis;Carthamus tinctorius;Cell Adhesion/drug effects;Cell Movement/drug effects;Chromatography, High Pressure Liquid;Coculture Techniques;Depression, Chemical;Endothelial Cells/metabolism*;Glucose/metabolism*;Humans;Monocytes/drug effects*;Monocytes/physiology;NF-kappa B/analysis;NF-kappa B/metabolism;Reactive Oxygen Species/metabolism;Serotonin/analogs & derivatives*;Serotonin/chemistry;Serotonin/pharmacology;U937 Cells;Vascular Cell Adhesion Molecule-1/analysis
19223280;Adult;Budd-Chiari Syndrome/blood;Budd-Chiari Syndrome/enzymology;Budd-Chiari Syndrome/genetics*;Female;Humans;Janus Kinase 2/genetics*;Mutation*;Prothrombin/genetics*;Thrombocythemia, Essential/enzymology;Thrombocythemia, Essential/genetics*
19227628;Anxiety/psychology;Fantasy*;Humans;Patient Satisfaction*;Physician-Patient Relations;Reality Testing;Surgical Procedures, Operative/psychology*;Television*
19232661;Cell Line;Genes, env*;HIV-1/genetics*;HIV-1/metabolism;Humans;Male;RNA, Viral/genetics;Reassortant Viruses/genetics;Reassortant Viruses/metabolism;Receptors, CXCR4/metabolism;Semen/virology;Sequence Alignment;Transfection;env Gene Products, Human Immunodeficiency Virus/genetics;env Gene Products, Human Immunodeficiency Virus/metabolism*
19236616;Adult;Aged;Aged, 80 and over;Coronary Disease/epidemiology*;Diabetes Mellitus, Type 2/epidemiology*;Female;Finland/epidemiology;Humans;Male;Middle Aged;Myocardial Infarction/epidemiology*;Risk Factors;United Kingdom/epidemiology;United States/epidemiology
19252283;Antioxidants/isolation & purification;Antioxidants/pharmacology*;Cell Cycle/drug effects;Dipeptides/isolation & purification;Dipeptides/pharmacology*;Diploidy;Fibroblasts/cytology;Fibroblasts/drug effects*;Fibroblasts/metabolism;Free Radical Scavengers/isolation & purification;Free Radical Scavengers/pharmacology*;Humans;Hydrogen Peroxide/pharmacology*;Hydrolysis;Oxidative Stress/drug effects*;Protamines/chemistry*;Reactive Oxygen Species/metabolism
19257837;DNA, Viral/blood*;DNA, Viral/isolation & purification*;Hepatitis Viruses/classification*;Hepatitis Viruses/genetics;Hepatitis Viruses/isolation & purification*;Humans;Prevalence;Serum/virology*
19260292;Acer/chemistry*;Drugs, Chinese Herbal/analysis;Drugs, Chinese Herbal/isolation & purification;Ethanol/chemistry;Flavonoids/analysis;Flavonoids/isolation & purification*;Microwaves*;Phenols/analysis;Phenols/isolation & purification*;Plant Leaves/chemistry;Plants, Medicinal/chemistry*;Polyphenols;Solvents;Spectrophotometry, Ultraviolet;Technology, Pharmaceutical/methods*;Temperature;Time Factors;Ultrasonics
19262148;Animals;Cadherins/chemistry;Cadherins/classification;Cadherins/genetics;Cadherins/metabolism*;Cell Adhesion;Gene Expression Regulation, Developmental;Humans;Neural Crest/cytology*;Neural Crest/metabolism*
19270833;Adult;Aortic Aneurysm, Abdominal/diagnosis;Aortic Aneurysm, Abdominal/pathology;Aortic Aneurysm, Abdominal/surgery*;Blood Vessel Prosthesis Implantation/methods;Graft Survival;Humans;Kidney/blood supply;Kidney Transplantation*;Male;Reperfusion Injury/prevention & control;Tomography, X-Ray Computed;Transplantation, Homologous
19272842;Biomarkers, Tumor/genetics*;Biomarkers, Tumor/metabolism;Bystander Effect*;Culture Media, Conditioned/pharmacology*;Gene Expression Profiling*;Gene Expression Regulation, Neoplastic/radiation effects*;Humans;Melanoma/genetics*;Melanoma/radiotherapy;Oligonucleotide Array Sequence Analysis;RNA, Messenger/genetics;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Tumor Cells, Cultured;X-Rays*
19275116;Child Welfare*;Child, Preschool;Data Collection;Female;Humans;Job Satisfaction*;Male;Salaries and Fringe Benefits;Social Work*/economics
19275657;Animals;Cardiovascular Agents/pharmacology*;Cardiovascular Diseases/diagnostic imaging;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/physiopathology;Clinical Trials as Topic;Drug Delivery Systems;Drug Design*;Humans;Radioisotopes/chemistry;Radionuclide Imaging;Radiopharmaceuticals/chemistry;Technology, Pharmaceutical/methods;Treatment Outcome
19282306;Acute Disease;Adult;Aged;Aged, 80 and over;Cholangiopancreatography, Endoscopic Retrograde;Drainage;Endoscopy*;Female;Follow-Up Studies;Humans;Male;Middle Aged;Necrosis/surgery;Pancreas/pathology;Pancreas/surgery*;Pancreatitis/mortality;Pancreatitis/pathology;Pancreatitis/surgery*;Postoperative Complications/mortality;Postoperative Complications/pathology;Retrospective Studies;Stents;Treatment Outcome;Young Adult
19289045;Algorithms;DNA/metabolism;DNA-Directed RNA Polymerases/metabolism*;Diffusion;Models, Genetic*;RNA/biosynthesis*;Transcription, Genetic/physiology*
19294883;Asian Continental Ancestry Group/ethnology;Case-Control Studies;Cerebral Infarction/epidemiology;Cerebral Infarction/genetics*;Databases, Factual/statistics & numerical data;Female;Genetic Predisposition to Disease*;Humans;Male;Peptidyl-Dipeptidase A/genetics*;Polymorphism, Genetic*;Statistics as Topic
19300363;Adolescent;Adult;Child;Child, Preschool;Face/abnormalities*;Female;Humans;Male;Mandibulofacial Dysostosis/diagnosis*;Mouth Abnormalities/diagnosis*;Phenotype;Young Adult
19303269;Adult;Anesthesia, General;Animals;Disease Models, Animal;Fracture Fixation, Internal/methods*;Fracture Fixation, Internal/veterinary;Humans;Male;Mandibular Fractures/diagnostic imaging;Mandibular Fractures/physiopathology;Mandibular Fractures/surgery;Mandibular Fractures/veterinary*;Sheep;Sheep Diseases/pathology*;Temporomandibular Joint Disorders/pathology*;Temporomandibular Joint Disorders/veterinary*;Tomography, X-Ray Computed
19305284;Adolescent;Antifibrinolytic Agents/administration & dosage;Antifibrinolytic Agents/therapeutic use*;Blood Loss, Surgical/prevention & control;Blood Transfusion;Child;Dose-Response Relationship, Drug;Female;Humans;Male;Perioperative Care;Retrospective Studies;Scoliosis/surgery*;Spinal Fusion/methods*;Tranexamic Acid/administration & dosage;Tranexamic Acid/therapeutic use*
19307751;Animals;Cell Proliferation;Cells, Cultured;Indoleamine-Pyrrole 2,3,-Dioxygenase/antagonists & inhibitors;Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism;Interleukin-10/biosynthesis*;Lymphocyte Activation*;Lymphokines/pharmacology;Mesenchymal Stromal Cells/cytology;Mesenchymal Stromal Cells/metabolism*;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Receptors, Interleukin-10/metabolism;T-Lymphocytes/cytology;T-Lymphocytes/immunology*;T-Lymphocytes/metabolism;Tryptophan/analogs & derivatives;Tryptophan/pharmacology
19324928;Amino Acid Motifs;Arabidopsis/genetics*;Arabidopsis/metabolism;Arabidopsis Proteins/genetics;Arabidopsis Proteins/metabolism*;Conserved Sequence;Gene Expression Regulation, Plant;Plants, Genetically Modified/genetics;Plants, Genetically Modified/metabolism;Repressor Proteins/genetics;Repressor Proteins/metabolism*;Transcription Factors/genetics;Transcription Factors/metabolism*;Transcription, Genetic
19325106;Animals;Female;Genetic Variation;Genotype;Heterozygote;Homozygote;Isoptera/genetics;Isoptera/physiology*;Male;Microsatellite Repeats;Parthenogenesis*;Reproduction;Social Behavior
19325351;Cadaver;Dissection;Heel/anatomy & histology*;Heel/blood supply;Humans;Pressure Ulcer/physiopathology*
19331811;Animals;Antibiotics, Antineoplastic/pharmacology;Calcium/metabolism;Cell Death/physiology;Cells, Cultured;Connectin;Doxorubicin/pharmacology;Extracellular Signal-Regulated MAP Kinases/metabolism;Female;GATA4 Transcription Factor/metabolism;Male;Mice;Mitochondria/metabolism;Muscle Proteins/metabolism;Myocardial Contraction/drug effects;Myocardial Contraction/physiology;Myocytes, Cardiac/cytology;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/metabolism*;Myocytes, Cardiac/pathology*;Myofibrils/metabolism*;Myofibrils/ultrastructure;Protein Kinase Inhibitors/metabolism*;Protein Kinase Inhibitors/pharmacology;Proto-Oncogene Proteins c-akt/metabolism;Rats;Rats, Wistar;Receptor, Epidermal Growth Factor/metabolism;Receptor, ErbB-2/antagonists & inhibitors*;Receptor, ErbB-2/metabolism;Receptor, ErbB-4;Signal Transduction/physiology
19332522;Biomedical Research/methods*;Communication Disorders*;Continental Population Groups*;Ethnic Groups*;Humans
19333416;Animals;Humans;Microscopy/methods*;Molecular Imaging/instrumentation;Molecular Imaging/methods*;Molecular Imaging/trends;Nanoparticles/chemistry;Quantum Dots*
19333661;Carcinoma, Hepatocellular/surgery*;Hepatectomy*;Humans;Liver Cirrhosis/surgery*;Liver Neoplasms/surgery*;Liver Transplantation*
19339279;GTP Phosphohydrolases/metabolism;Mitochondria/metabolism*;Mitochondrial Proteins/biosynthesis*;Models, Biological;Mutation/genetics;Protein Binding;Protein Biosynthesis*;Protein Stability;Protein Structure, Tertiary;Ribosomal Proteins/chemistry;Ribosomal Proteins/metabolism*;Ribosomes/metabolism;Saccharomyces cerevisiae/cytology;Saccharomyces cerevisiae/growth & development;Saccharomyces cerevisiae/metabolism*;Saccharomyces cerevisiae Proteins/chemistry;Saccharomyces cerevisiae Proteins/metabolism*;Solubility
19339472;DNA Primers/genetics;Disease Outbreaks*;Gastroenteritis/epidemiology*;Gastroenteritis/virology*;Humans;Netherlands/epidemiology;Polymerase Chain Reaction/methods*;Prevalence;Sensitivity and Specificity;Virus Diseases/epidemiology*;Virus Diseases/virology*;Viruses/classification;Viruses/genetics;Viruses/isolation & purification*
19349178;Acetals/chemistry;Analgesics, Opioid/chemical synthesis*;Chemistry, Organic/methods;Chemistry, Pharmaceutical/methods*;Drug Design;Kinetics;Ligands;Models, Chemical;Molecular Conformation;Morphinans/chemistry;Morphine/chemistry;Receptors, Opioid, delta/chemistry;Receptors, Opioid, kappa/agonists*;Receptors, Opioid, kappa/chemistry;Receptors, Opioid, mu/chemistry;Spiro Compounds/chemistry
19363981;Bicuspid/anatomy & histology;Clinical Competence*;Composite Resins*;Dental Articulators;Dental Materials*;Dental Models;Dental Occlusion;Dental Polishing/instrumentation;Dental Restoration, Permanent/methods*;Dentistry, Operative/education*;Humans;Jaw Relation Record/instrumentation;Molar/anatomy & histology
19364376;Amino Acids/chemistry;Amino Acids/pharmacology*;Animal Feed/analysis;Animal Nutritional Physiological Phenomena;Animals;Animals, Suckling;Diet/veterinary;Dietary Supplements;Female;Intestines/anatomy & histology*;Intestines/microbiology;Lactation;Lipopolysaccharides/toxicity;Methionine/analogs & derivatives*;Methionine/chemistry;Methionine/pharmacology;Minerals/metabolism*;Nutritional Status;Organometallic Compounds/chemistry;Organometallic Compounds/pharmacology*;Swine/physiology*;Weaning;Zinc/chemistry;Zinc/pharmacology*
19373164;Blood Glucose/metabolism*;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Humans;Hypoglycemic Agents/therapeutic use*;Postprandial Period*;Thiazolidinediones/therapeutic use*
19376252;Apoptosis;Cell Line, Tumor;Cytochromes c/metabolism;Humans;Membrane Potentials/physiology;Microscopy, Confocal;Mitochondria/metabolism*;Oxidative Stress*;Reactive Oxygen Species/metabolism*;Signal Transduction
19388495;Clinical Trials as Topic/standards*;Clinical Trials as Topic/statistics & numerical data*;Humans;Risk;Sample Size
19408734;Argentina;General Surgery/history*;History, 19th Century;History, 20th Century
19408916;DNA/analysis;Models, Theoretical;Polymerase Chain Reaction/methods*;Polymerase Chain Reaction/standards;Quantum Dots*;Sensitivity and Specificity;Temperature
19412800;Congenital Abnormalities/diagnostic imaging*;Female;Fetus/abnormalities;Humans;Mass Screening;Midwifery*;Pregnancy;Pregnancy Complications/diagnostic imaging*;Pregnancy Trimester, Second;Retrospective Studies;Ultrasonography, Prenatal*
19416293;Automation;Bacterial Typing Techniques/methods*;DNA Fingerprinting;DNA, Bacterial/genetics*;Electrophoresis, Gel, Pulsed-Field;Escherichia coli Infections/diagnosis*;Humans;Polymerase Chain Reaction/methods*;Repetitive Sequences, Nucleic Acid*;Sensitivity and Specificity;Sequence Analysis, DNA;United Kingdom;Uropathogenic Escherichia coli/genetics;Uropathogenic Escherichia coli/isolation & purification*
19422923;Algorithms;Computational Biology/methods*;Models, Genetic;Phylogeny*;Sequence Analysis, DNA/methods*;Software*
19423109;Adiponectin/blood;Aged;Apolipoprotein A-I/blood;Apolipoproteins B/blood;Biomarkers/blood;C-Reactive Protein/metabolism;Cardiovascular Diseases/blood;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control*;Cholesterol Ester Transfer Proteins/blood;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Cholesterol, VLDL/blood;Corn Oil/administration & dosage*;Corn Oil/adverse effects;Cross-Over Studies;Double-Blind Method;Fasting/blood;Female;Humans;Hydrogenation;Hypercholesterolemia/blood;Hypercholesterolemia/complications;Hypercholesterolemia/diet therapy*;Insulin/blood;Middle Aged;Postmenopause*;Serum Albumin/metabolism;Severity of Illness Index;Soybean Oil/administration & dosage*;Soybean Oil/adverse effects;Sterol O-Acyltransferase/blood;Time Factors;Treatment Outcome;Triglycerides/blood
19433276;Adolescent;Brain Neoplasms/diagnosis*;Brain Neoplasms/physiopathology*;Child;Child, Preschool;Female;Follow-Up Studies;Humans;Infant;Magnetic Resonance Imaging;Male;Neurofibromatosis 1/diagnosis;Neurofibromatosis 1/physiopathology;Observation;Optic Chiasm/pathology;Optic Nerve Glioma/diagnosis*;Optic Nerve Glioma/physiopathology*;Retrospective Studies;Visual Pathways/pathology
19437617;Administration, Topical;Aged;Aged, 80 and over;Anesthetics, Local/administration & dosage*;Cataract Extraction/methods*;Cyclopentolate/administration & dosage*;Double-Blind Method;Eye;Female;Humans;Injections;Lidocaine/administration & dosage*;Male;Mydriatics/administration & dosage*;Phacoemulsification*;Preoperative Care*;Pupil/drug effects;Treatment Outcome
19437879;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Capsid Proteins/genetics;Capsid Proteins/metabolism*;Cell Line, Tumor;Coumarins/metabolism;Cytochrome P-450 CYP2A6;Hepatitis E virus/metabolism*;Humans;Imidazoles/metabolism;Immunoprecipitation;Protein Binding;Recombinant Proteins/genetics;Recombinant Proteins/metabolism*;Reverse Transcriptase Polymerase Chain Reaction
19456361;Animals;Immunohistochemistry;Larva/enzymology;Rana esculenta/metabolism*;Steroids/metabolism*;Sulfatases/metabolism*;Sulfotransferases/metabolism*
19457679;Animals;Bone Regeneration/physiology*;Female;Nasal Bone/anatomy & histology;Nasal Bone/physiology;Nasal Bone/surgery*;Osteogenesis/physiology;Osteogenesis, Distraction/methods*;Osteotomy;Periodicity*;Rabbits;Random Allocation;Statistics, Nonparametric
19465202;Humans;Skin Transplantation/methods*;Surgical Flaps*;Wound Healing;Wounds and Injuries/surgery*
19473991;Binding Sites/genetics;Calmodulin/metabolism;Catalysis;Ferrous Compounds/metabolism;Flavin Mononucleotide/metabolism;Flavin-Adenine Dinucleotide/metabolism;Heme/metabolism*;Kinetics;Mutant Proteins/metabolism;NADP/metabolism;Nitric Oxide/metabolism*;Nitric Oxide Synthase Type I/chemistry;Nitric Oxide Synthase Type I/genetics;Nitric Oxide Synthase Type I/metabolism*;Oxidation-Reduction;Oxygen/metabolism*;Point Mutation;Temperature;Time Factors
19481437;Biotechnology/methods*;Lignin/chemistry*;Lignin/metabolism*
19486742;Anesthesia/adverse effects;Humans;Nasal Obstruction/etiology;Nasal Septum/surgery*;Postoperative Complications*;Preoperative Care;Rhinoplasty;Treatment Outcome
19488015;Dyspnea/etiology;Echocardiography;Female;Heart Neoplasms/blood*;Heart Neoplasms/complications;Heart Neoplasms/diagnostic imaging;Hematopoiesis, Extramedullary*;Humans;Middle Aged;Myxoma/blood*;Myxoma/complications;Myxoma/diagnostic imaging;beta-Thalassemia/complications*
19490359;Animals;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/therapeutic use*;Aortic Valve/drug effects*;Aortic Valve/pathology;Aortic Valve/surgery;Catheterization*;Drug Delivery Systems;Drug-Eluting Stents*;Feasibility Studies;Paclitaxel/administration & dosage;Paclitaxel/therapeutic use*;Swine
19496444;Animals;Bacterial Proteins/chemistry;Bacterial Proteins/genetics;DNA, Bacterial/chemistry;Germany;Hedgehogs/parasitology;Molecular Sequence Data;Phylogeny;Polymerase Chain Reaction;Rickettsia felis/genetics;Rickettsia felis/isolation & purification*;Sequence Analysis, DNA;Siphonaptera/classification;Siphonaptera/microbiology*
19500824;Administration, Sublingual;Humans;Immunotherapy*;Meta-Analysis as Topic*;Publication Bias*;Respiratory Hypersensitivity/therapy*
19502193;Antineoplastic Agents/adverse effects*;Diarrhea/etiology;Diarrhea/prevention & control;Diarrhea/therapy*;Evidence-Based Practice*;Humans;Radiotherapy/adverse effects*
19514061;Abnormalities, Multiple/genetics*;Humans;Mutation*;Proteins/genetics*;Syndrome
19517327;Antirheumatic Agents/administration & dosage*;Antirheumatic Agents/therapeutic use;Arthritis/complications*;Arthritis/drug therapy*;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Collagen Diseases/drug therapy;Humans;Immunosuppressive Agents/therapeutic use;Neoplasms/etiology;Rheumatology/trends*;Risk Factors;Tobacco Use Disorder/complications;Vasculitis/drug therapy
19525905;Bandages;Chronic Disease;Honey;Humans;Matrix Metalloproteinases/physiology;State Medicine;United Kingdom;Wound Healing*;Wounds and Injuries/therapy*
19527732;Amino Acid Sequence;Models, Biological;Models, Molecular;Monte Carlo Method;Nuclear Magnetic Resonance, Biomolecular;Platelet Glycoprotein GPIIb-IIIa Complex/chemistry*;Platelet Glycoprotein GPIIb-IIIa Complex/metabolism*;Protein Multimerization*;Protein Structure, Quaternary
19532904;DNA/chemistry*;Kinetics;Nanostructures/chemistry*;Nanotechnology;Nucleic Acid Conformation
19536923;Drug Approval;Drug Labeling*;Europe;Humans;Macular Degeneration/drug therapy*;Photochemotherapy*;Porphyrins/administration & dosage;Porphyrins/adverse effects;Porphyrins/therapeutic use*;Randomized Controlled Trials as Topic
19537552;Brazil;Ecosystem*;Fires*;Plant Bark;Plant Stems;Population Dynamics;Trees/physiology*
19540617;Adult;Aged;Circadian Rhythm*;Exercise;Female;Humans;Male;Middle Aged;Protein Stability;Pulmonary Surfactant-Associated Protein D/blood*;Pulmonary Surfactant-Associated Protein D/metabolism*
19541127;Acute Disease;Child;Chronic Disease;Creatine Kinase/blood*;Humans;Metabolic Diseases/blood*;Metabolic Diseases/diagnosis*
19549956;Breast Neoplasms/diagnostic imaging*;Early Detection of Cancer;False Positive Reactions;Female;Humans;Information Dissemination;Mammography/adverse effects*;Mass Screening/adverse effects*;Mass Screening/methods;Mass Screening/standards*;National Health Programs;Truth Disclosure;United Kingdom;Unnecessary Procedures
19555368;Base Sequence;DNA, Mitochondrial;Genetic Markers;Genome, Fungal*;Genome, Mitochondrial*;Glomeromycota/genetics*;Introns;Mycorrhizae/genetics*;Phylogeny;Polymorphism, Genetic
19577203;Anesthesia, Intravenous/methods;Anesthesia, Intravenous/nursing*;Anesthetics, Intravenous/therapeutic use;Clinical Competence;Emergencies;Emergency Nursing/methods*;Emergency Treatment/methods;Emergency Treatment/nursing;Humans;Intubation, Intratracheal/methods;Intubation, Intratracheal/nursing;Monitoring, Physiologic/methods;Monitoring, Physiologic/nursing;Nurse's Role;Nursing Assessment;Oxygen Inhalation Therapy/nursing;Patient Selection;Posture;Practice Guidelines as Topic;Risk Assessment
19579781;Animals;Bison/parasitology*;Cattle/parasitology;Coccidiosis/epidemiology;Coccidiosis/parasitology*;Coccidiosis/veterinary*;Eimeria/classification;Eimeria/physiology*;Feces/parasitology;Host-Parasite Interactions*;Oocysts;Poland/epidemiology;Species Specificity;Trees/parasitology*
19580451;Animals;Cattle;Communication*;Disease Outbreaks/prevention & control;Escherichia coli Infections/epidemiology;Escherichia coli Infections/microbiology;Escherichia coli Infections/prevention & control*;Escherichia coli O157/isolation & purification*;Feces/microbiology;Food Inspection/legislation & jurisprudence;Legislation, Food*;Meat/microbiology*;Peer Review;Periodicals as Topic;Risk Factors;Safety/legislation & jurisprudence;United States;United States Department of Agriculture
19588263;Animals;Aquaculture/economics;Aquaculture/trends*;Asia;Europe;Fishes;Latin America
19596641;Adult;Antibodies, Antinuclear/blood*;Biomarkers/blood;Centromere/immunology;Female;Forearm/pathology;Humans;Leg/pathology;Lichen Sclerosus et Atrophicus/complications;Lichen Sclerosus et Atrophicus/immunology*;Lichen Sclerosus et Atrophicus/pathology*;Scleroderma, Localized/complications;Scleroderma, Localized/immunology*;Scleroderma, Localized/pathology*;Scleroderma, Systemic/complications;Scleroderma, Systemic/immunology*;Scleroderma, Systemic/pathology*
19608044;Anti-Bacterial Agents/therapeutic use;Bacteria/isolation & purification;Bacterial Infections/diagnosis;Bacterial Infections/drug therapy;Bacterial Infections/microbiology*;Bacterial Typing Techniques;Humans;Parotitis/diagnosis;Parotitis/drug therapy;Parotitis/microbiology;Sialadenitis/diagnosis;Sialadenitis/drug therapy;Sialadenitis/microbiology*
19627243;Adult;Aged;Attitude to Health/ethnology*;California/epidemiology;Cultural Characteristics;Delivery of Health Care/utilization*;Emigration and Immigration/statistics & numerical data*;Female;Hispanic Americans/statistics & numerical data*;Humans;Insurance Coverage/statistics & numerical data*;Insurance, Health/statistics & numerical data*;Medically Uninsured/ethnology;Middle Aged;Patient Acceptance of Health Care/ethnology*;Patient Compliance/ethnology;Socioeconomic Factors;Women's Health;Young Adult
19653154;Adult;Caregivers/ethics*;Decision Making/ethics*;Delivery of Health Care/ethics*;Germany;Humans;Patient Rights/ethics*;Physician-Patient Relations/ethics*;Practice Patterns, Physicians'/ethics*;Switzerland;Terminal Care/ethics*
19656153;Adolescent;Anticoagulants/administration & dosage;Child;Drug Administration Schedule;Humans;Infant, Newborn;Risk Factors;Thrombophilia/complications;Thrombophilia/diagnosis*;Thrombophilia/genetics;Thrombosis/etiology;Thrombosis/therapy;Venous Thromboembolism/etiology
19657163;Aerobiosis;Bacteria/isolation & purification;Bacteria/metabolism*;Biodegradation, Environmental;Biofilms/growth & development*;Bioreactors/microbiology*;Color;Flocculation;Industrial Waste/analysis*;Microscopy, Electron, Scanning;Oxygen/isolation & purification;Phylogeny;Textiles*;Waste Disposal, Fluid;Water Purification
19665063;Adult;Base Sequence;DNA Primers;Genes, p53;Humans;Hybrid Cells;Loss of Heterozygosity;Magnetic Resonance Imaging;Male;Mutation;Nerve Sheath Neoplasms/diagnosis*;Nerve Sheath Neoplasms/pathology;Neurofibromatosis 1/diagnosis*;Neurofibromatosis 1/pathology;Reverse Transcriptase Polymerase Chain Reaction;Spinal Neoplasms/diagnosis*;Spinal Neoplasms/pathology
19665580;Bile Acids and Salts/biosynthesis*;Bile Acids and Salts/toxicity*;Diarrhea/chemically induced*;Feedback, Physiological;Fibroblast Growth Factors/blood*;Humans;Malabsorption Syndromes/pathology*;Models, Biological
19669685;Adult;Female;Humans;Pregnancy;Pregnancy Complications/etiology*;Suburethral Slings/adverse effects*;Urinary Retention/etiology*
19681754;Cells, Cultured;Cellular Senescence*;DNA Damage*;Endothelial Cells/enzymology*;Gene Knockdown Techniques;Humans;MAP Kinase Signaling System*;Membrane Glycoproteins/genetics;Membrane Glycoproteins/metabolism;NADPH Oxidase 2;NADPH Oxidase 4;NADPH Oxidases/genetics;NADPH Oxidases/metabolism*;Oxidation-Reduction;Superoxides/metabolism;Telomere/genetics;Telomere/metabolism*
19686640;Cryptococcus neoformans/chemistry*;Cryptococcus neoformans/physiology*;Elastic Modulus/physiology;Optical Tweezers;Polysaccharides/chemistry*;Polysaccharides/physiology*;Stress, Mechanical
19687625;Animals;Biomarkers/blood;Dog Diseases/drug therapy*;Dogs;Doxycycline/therapeutic use*;Female;Hyaluronic Acid/blood;Joints/drug effects;Lameness, Animal/drug therapy;Male;Osteoarthritis, Hip/drug therapy;Osteoarthritis, Hip/veterinary*;Time Factors;Treatment Outcome
19688680;Angiography*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Aspirin/therapeutic use;Carotid Artery Diseases/diagnosis*;Carotid Artery Diseases/drug therapy;Carotid Artery, Common*/pathology;Carotid Stenosis/diagnosis*;Carotid Stenosis/drug therapy;Diagnosis, Differential;Female;Follow-Up Studies;Humans;Magnetic Resonance Angiography*;Middle Aged;Neck Pain/diagnosis*;Neck Pain/drug therapy;Neck Pain/etiology;Tomography, X-Ray Computed*;Ultrasonography, Doppler, Duplex*
19689985;Adult;Female;Financing, Government/economics*;Health Care Surveys;Humans;Income;Insurance Coverage/economics*;Male;Medicaid*/economics;Medically Uninsured;Public Opinion*;United States
19698129;Amino Acid Sequence;Angiotensinogen/genetics;Animals;Fishes/genetics;Introns*;Molecular Sequence Data;Sequence Alignment;Serpins/genetics*;Spliceosomes/genetics*;Vertebrates/genetics
19698935;Anticholesteremic Agents/administration & dosage*;Bezafibrate/administration & dosage;Bezafibrate/adverse effects;Cardiovascular Diseases/etiology;Cardiovascular Diseases/mortality*;Cardiovascular Diseases/prevention & control*;Cholesterol, LDL/drug effects;Clofibric Acid/administration & dosage*;Clofibric Acid/adverse effects;Female;Fenofibrate/administration & dosage;Fenofibrate/adverse effects;Gemfibrozil/administration & dosage;Gemfibrozil/adverse effects;Humans;Hyperlipidemias/blood;Hyperlipidemias/complications;Hyperlipidemias/drug therapy*;Prognosis;Randomized Controlled Trials as Topic;Risk Assessment;Survival Analysis;Treatment Outcome
19699160;Advertising as Topic;Affect;Anxiety;Body Image*;Eating/physiology;Eating/psychology*;Female;Humans;Imitative Behavior*;Students/psychology;Surveys and Questionnaires;Television;Thinness/psychology*;Young Adult
19700550;Bacteria/genetics*;Base Sequence;Cucumis sativus/growth & development;Cucumis sativus/microbiology*;DNA Primers/genetics;DNA, Plant/genetics;Ecosystem;Genes, Bacterial;Genes, Plant;Oxalobacteraceae/genetics;Oxalobacteraceae/physiology;Plant Roots/microbiology*;Polymerase Chain Reaction;RNA, Bacterial/genetics;RNA, Ribosomal, 16S/genetics;Soil/analysis;Soil Microbiology;Streptomyces/genetics;Streptomyces/physiology;Symbiosis
19701975;Adult;Aged;Body Weight*;Female;Graft Survival/drug effects*;Humans;Immunosuppressive Agents/pharmacology*;Liver Transplantation*;Living Donors*;Male;Middle Aged;Organ Size;Tacrolimus/pharmacology*;Treatment Outcome;Young Adult
19709944;Adult;Female;Humans;Male;Orthodontic Anchorage Procedures/instrumentation*;Palate, Hard/physiology*;Thermosensing/physiology*
19715026;Anger*;Delivery of Health Care;Humans;Physicians/psychology*;Politics
19738040;Animals;Bronchioles/enzymology;Bronchioles/pathology*;Carcinoma, Non-Small-Cell Lung/enzymology*;Carcinoma, Non-Small-Cell Lung/genetics;Carcinoma, Non-Small-Cell Lung/pathology;Cell Transformation, Neoplastic/drug effects;Cell Transformation, Neoplastic/genetics;Cell Transformation, Neoplastic/metabolism*;Cell Transformation, Neoplastic/pathology;Genes, ras/drug effects;Gold Sodium Thiomalate/pharmacology;Humans;Isoenzymes/deficiency;Isoenzymes/genetics*;Isoenzymes/metabolism;Lung Neoplasms/enzymology*;Lung Neoplasms/genetics;Lung Neoplasms/pathology;Male;Mice;Mice, Transgenic;Protein Kinase C/deficiency;Protein Kinase C/genetics*;Protein Kinase C/metabolism;Pulmonary Alveoli/enzymology;Pulmonary Alveoli/pathology*;Stem Cells/enzymology;Stem Cells/pathology*
19752578;Animals;Animals, Newborn;Aorta/physiology;Blood Pressure/physiology;Carbon Dioxide/blood*;Cardiac Output/physiology*;Models, Animal;Models, Cardiovascular*;Monitoring, Physiologic/methods*;Monitoring, Physiologic/standards;Pulmonary Circulation/physiology;Reproducibility of Results;Respiration, Artificial*;Sheep
19755056;Adolescent;Adult;Carpal Bones/diagnostic imaging;Humans;Lunate Bone/surgery*;Middle Aged;Osteonecrosis/diagnostic imaging;Osteonecrosis/surgery*;Pisiform Bone/transplantation*;Radiography;Young Adult
19758804;Agaricales/genetics;Agaricales/metabolism*;Biological Products/biosynthesis*;Biological Products/genetics;Biotechnology/methods;Glycosylation;Models, Biological;Organisms, Genetically Modified/genetics;Organisms, Genetically Modified/metabolism*;Recombinant Proteins/biosynthesis*;Recombinant Proteins/genetics;Technology, Pharmaceutical/methods
19789185;Acoustic Stimulation*;Adult;Attention/physiology*;Auditory Perception/physiology*;Brain Mapping/methods;Cerebral Cortex/anatomy & histology;Cerebral Cortex/physiology*;Dichotic Listening Tests/methods*;Dichotic Listening Tests/psychology;Dominance, Cerebral/physiology;Evoked Potentials, Auditory/physiology;Executive Function/physiology;Female;Functional Laterality/physiology;Humans;Magnetoencephalography/methods;Male;Nerve Net/anatomy & histology;Nerve Net/physiology;Random Allocation;Reaction Time/physiology*;Young Adult
19796868;Anaerobiosis*;Bioreactors;Hydrogen-Ion Concentration*;Nitrates/isolation & purification*;Nitrates/metabolism;Sulfides/isolation & purification*;Sulfides/metabolism
19802670;Adult;Cartilage, Articular/injuries;Cartilage, Articular/surgery*;Chondrocytes/transplantation*;Collagen/therapeutic use*;Female;Follow-Up Studies;Humans;Knee Injuries/complications;Knee Injuries/surgery;Male;Orthopedic Procedures/methods*;Osteoarthritis/surgery;Osteochondritis Dissecans/surgery;Recovery of Function;Tissue Engineering/methods;Tissue Scaffolds*;Transplantation, Autologous
19806942;Adult;Catheter Ablation*;Combined Modality Therapy;Female;Humans;Male;Middle Aged;Patient Satisfaction;Polyethylene Glycols/therapeutic use;Saphenous Vein/diagnostic imaging;Saphenous Vein/surgery*;Sclerosing Solutions/therapeutic use;Sclerotherapy;Time Factors;Treatment Outcome;Ultrasonography, Doppler;Varicose Veins/diagnostic imaging;Varicose Veins/surgery*;Venous Insufficiency/diagnostic imaging;Venous Insufficiency/surgery*
19825910;Adrenergic beta-Antagonists/pharmacology;Adrenergic beta-Antagonists/therapeutic use*;Aged;Angiotensin II Type 1 Receptor Blockers/pharmacology;Angiotensin II Type 1 Receptor Blockers/therapeutic use*;Atenolol/pharmacology;Atenolol/therapeutic use*;Double-Blind Method;Female;Fibrinolysis/drug effects*;Humans;Hypertension/blood;Hypertension/complications;Hypertension/drug therapy*;Hypertrophy, Left Ventricular/blood;Hypertrophy, Left Ventricular/drug therapy*;Hypertrophy, Left Ventricular/etiology;Losartan/pharmacology;Losartan/therapeutic use*;Male;Middle Aged;Plasminogen Activator Inhibitor 1/analysis;Renin-Angiotensin System/physiology;Thrombophilia/etiology;Thrombophilia/physiopathology;Tissue Plasminogen Activator/analysis;von Willebrand Factor/analysis*
19835231;Blood Glucose;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/diagnosis*;Diabetes Mellitus, Type 2/etiology;Diabetes Mellitus, Type 2/prevention & control*;Humans;Male;Medical History Taking;Middle Aged;Morbidity;Nurse's Role*;Nursing Assessment;Nursing Diagnosis;Overweight/complications;Patient Care Planning;Patient Education as Topic;Physical Examination;Referral and Consultation;Risk Assessment;Risk Factors
19865680;Isomerism;Kinetics;Models, Molecular;Quinones/chemistry*
19897654;Animals;Bacterial Proteins/chemistry;Bacterial Proteins/genetics*;Bacterial Proteins/metabolism*;Bacterial Proteins/pharmacology;CHO Cells/drug effects;Cricetinae;Cricetulus;Hemolysin Proteins/chemistry*;Hemolysin Proteins/genetics;Hemolysin Proteins/metabolism*;Hemolysin Proteins/pharmacology;L-Lactate Dehydrogenase/metabolism;Mutagenesis;Mutagenesis, Site-Directed;Mutation;Phenylalanine/chemistry*;Phenylalanine/genetics;Protein Multimerization;Structure-Activity Relationship;Vibrio vulnificus/genetics;Vibrio vulnificus/metabolism*
19902093;Animals;Anti-Anxiety Agents/pharmacology*;Benzimidazoles/pharmacology*;Cell Line, Transformed;Fluorescent Antibody Technique;Hippocampus/cytology;Hippocampus/drug effects;Humans;Jurkat Cells;Mice;Morpholines/pharmacology*;Neuroprotective Agents/pharmacology*;Radioligand Assay;Receptors, sigma/drug effects*
19912653;Animals;Bone Morphogenetic Protein 2/biosynthesis;Bone Morphogenetic Protein 2/drug effects*;Drug Carriers/administration & dosage;Gels;Gene Expression/drug effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Intervertebral Disc/drug effects*;Intervertebral Disc/injuries;Intervertebral Disc Degeneration/drug therapy*;Lactic Acid/administration & dosage;Polyethylene Glycols/administration & dosage;Polyglycolic Acid/administration & dosage;RNA, Messenger/analysis;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/administration & dosage*
19938354;Absorptiometry, Photon;Adult;Alleles*;Bone Density/genetics;Bone Diseases, Metabolic/genetics*;C-Reactive Protein/metabolism;Chromosomes, Human, Pair 12/genetics;Female;Genetic Carrier Screening;Genotype;Homozygote;Humans;Male;Middle Aged;Osteoporosis/genetics*;Polymerase Chain Reaction;Polymorphism, Genetic/genetics;Receptors, Calcitriol/genetics*;Sex Factors;Spondylitis, Ankylosing/diagnosis;Spondylitis, Ankylosing/genetics*;Spondylitis, Ankylosing/immunology
19939561;Acrylates/chemical synthesis*;Acrylates/chemistry;Acrylonitrile/chemical synthesis*;Acrylonitrile/chemistry;Adsorption*;Emulsions;Hydrogen-Ion Concentration;Hydroxylamine/chemistry;Ions;Kinetics;Metals/chemistry;Microscopy, Electron, Scanning/methods;Models, Chemical;Oximes/chemistry*;Polymers/chemistry;Porosity;Spectroscopy, Fourier Transform Infrared
19942630;Attitude to Health;Complementary Therapies/trends*;Humans;Politics;United States
19942722;Acupuncture Therapy/methods*;Adult;Combined Modality Therapy;Feasibility Studies;Female;Humans;Male;Massage/methods*;Middle Aged;Music Therapy/methods;Reproducibility of Results;Sleep*;Sleep Initiation and Maintenance Disorders/therapy*;Surveys and Questionnaires;Treatment Outcome
19957324;Aged;Aged, 80 and over;Antibodies, Bacterial/biosynthesis*;BCG Vaccine/immunology;BCG Vaccine/therapeutic use*;Biomarkers/analysis;Carcinoma, Transitional Cell/immunology;Carcinoma, Transitional Cell/therapy*;Heat-Shock Proteins/analysis;Heat-Shock Proteins/immunology*;Humans;Male;Middle Aged;Mycobacterium bovis/metabolism;Treatment Outcome;Urinary Bladder Neoplasms/immunology;Urinary Bladder Neoplasms/therapy*
19958613;Anastomosis, Surgical*;Arteries/surgery*;Cadaver;Endoscopy;Epistaxis/pathology;Epistaxis/therapy*;Ethmoid Sinus/blood supply;Ethmoid Sinus/diagnostic imaging;Ethmoid Sinus/surgery*;Humans;Monitoring, Intraoperative;Prospective Studies;Tomography, X-Ray Computed*;Treatment Outcome
20005350;Alanine Transaminase/blood;Animals;Antioxidants/pharmacology*;Ascorbic Acid/pharmacology*;Hydroxyl Radical/metabolism;L-Lactate Dehydrogenase/blood;Lycium*;Male;Methylguanidine/metabolism;Oxidative Stress/drug effects;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Reperfusion Injury/prevention & control*
20007983;Anesthesiology/education*;Congresses as Topic*;Education, Medical, Continuing/methods;Humans;International Cooperation;Review Literature as Topic*
20029175;Animals;Gene Expression Regulation/physiology*;Humans;Kidney/physiology*;Kidney Diseases/genetics*;Kidney Diseases/metabolism;Kidney Diseases/physiopathology*;Protein Biosynthesis/physiology*;Signal Transduction/physiology
20045957;Amino Acid Sequence*;Models, Molecular;Protein Conformation;Proteins/chemistry*;Sequence Alignment/methods*;Software*;Structural Homology, Protein*
20090084;Anecdotes as Topic*;Humans;Literature;Physician-Patient Relations*
20096183;Adolescent;Child;Child, Preschool;Female;Humans;Infant;Kidney Diseases/surgery*;Laparoscopy*/methods;Male;Nephrectomy/methods*;Video-Assisted Surgery*
20122116;Cost-Benefit Analysis;Decision Support Techniques;Environmental Monitoring/economics;Environmental Monitoring/legislation & jurisprudence;Government Regulation;Humans;Interdisciplinary Communication*;Models, Theoretical;Nanostructures*;Nanotechnology/legislation & jurisprudence*;Nanotechnology/trends;Organizational Case Studies;Resource Allocation*;Risk Assessment;Silver*;Technology Assessment, Biomedical/economics;Technology Assessment, Biomedical/methods*;United States
20123038;Antineoplastic Agents/therapeutic use;Carcinoma, Hepatocellular/drug therapy*;Carcinoma, Hepatocellular/mortality;Carcinoma, Hepatocellular/physiopathology;Humans;Liver Diseases/physiopathology*;Liver Neoplasms/drug therapy*;Liver Neoplasms/mortality;Liver Neoplasms/physiopathology;Prognosis;Risk Adjustment*;Severity of Illness Index;Survival Analysis
20126971;Antineoplastic Agents/pharmacology;Carcinoma, Squamous Cell/genetics*;Cell Proliferation;Disease Progression;Gene Expression Profiling;Gene Expression Regulation, Neoplastic*;Genes, Tumor Suppressor;Head and Neck Neoplasms/genetics*;Humans;Models, Biological;Neoplasm Invasiveness;Neoplasm Metastasis;Neovascularization, Pathologic;Receptor, Epidermal Growth Factor/chemistry
20127947;Animals;Antibodies, Monoclonal/administration & dosage*;Antibodies, Monoclonal, Humanized;Antigens, CD20/immunology*;Humans;Immunoconjugates/therapeutic use;Indium Radioisotopes;Lymphoma, Non-Hodgkin/radiotherapy*;Mice;Mice, Nude;Radioimmunotherapy/methods*
20131660;Aerospace Medicine*;Humans;Nanoparticles/toxicity*
20132971;Air Pollution, Indoor/adverse effects*;Allergens/immunology*;Asthma/epidemiology*;Asthma/etiology;Asthma/immunology;Child;Child, Preschool;Environmental Exposure/adverse effects*;Female;Fungi/immunology;Humans;Male;Morbidity;Multicenter Studies as Topic;Randomized Controlled Trials as Topic;Spores, Fungal/immunology*;Urban Health;Urban Population
20141679;Counseling*;Humans;Male;Prostatectomy;Prostatic Neoplasms/radiotherapy*;Radiotherapy, Adjuvant;Salvage Therapy*;Survival Rate
20153901;Adult;Aged;Amantadine/adverse effects*;Antiparkinson Agents/adverse effects*;Cell Count;Corneal Diseases/chemically induced*;Corneal Diseases/pathology;Cross-Sectional Studies;Dose-Response Relationship, Drug;Endothelium, Corneal/drug effects*;Endothelium, Corneal/pathology;Female;Humans;Male;Middle Aged;Parkinson Disease/drug therapy*
20162486;Ceramics/standards*;Equipment Design*;Escherichia coli/isolation & purification;Filtration/instrumentation*;Filtration/methods;Filtration/standards;Fresh Water/analysis*;Fresh Water/microbiology;Household Articles/standards*;Quality Control;Water Microbiology/standards;Water Purification/instrumentation*;Water Purification/methods;Water Purification/standards
20164598;Amyloid beta-Peptides/chemistry;Amyloid beta-Peptides/drug effects*;Amyloid beta-Peptides/metabolism*;Amyloid beta-Protein Precursor/metabolism;Anesthetics, Inhalation/administration & dosage*;Anesthetics, Intravenous/administration & dosage*;Biophysics;Diazepam/administration & dosage*;Drug Interactions;Halothane/administration & dosage*;Humans;Magnetic Resonance Spectroscopy/methods;Models, Biological
20173192;Adolescent;Awareness*;Female;Health Behavior*;Humans;Learning*;Male;Young Adult
20176996;Adult;Age Factors;Aged;Atherosclerosis/diagnostic imaging;Atherosclerosis/epidemiology*;Blood Pressure/physiology*;Calcinosis/diagnostic imaging;Calcinosis/epidemiology;Chi-Square Distribution;Female;Humans;Hypertension/diagnostic imaging;Hypertension/epidemiology*;Male;Middle Aged;Population Surveillance;Prevalence;Radiography;Regression Analysis;Surveys and Questionnaires;Vascular Diseases/diagnostic imaging;Vascular Diseases/epidemiology*
20186502;Ammonia/chemistry*;Biomass;Bioreactors;Ethanol/chemistry*;Fermentation*;Furaldehyde/chemistry;Hydrolysis;Lignin/metabolism;Saccharomyces cerevisiae/metabolism;Sorghum*/chemistry;Sorghum*/metabolism
20192874;Algorithms*;Auditory Threshold*;Computer Simulation;Female;Hearing Aids*;Hearing Loss, Sensorineural/rehabilitation*;Humans;Male;Perceptual Masking*;Prosthesis Design;Signal Processing, Computer-Assisted*;Social Environment;Sound Localization*;Sound Spectrography;Speech Acoustics;Speech Perception*
20199627;Darkness*;Humidity*;Photosynthesis;Plant Stomata/physiology*;Plant Transpiration*;Temperature*;Tradescantia/physiology;Water/physiology
20211144;Adult;Anti-Bacterial Agents/therapeutic use;Biopsy;Borrelia burgdorferi Group/cytology;Borrelia burgdorferi Group/isolation & purification*;Brazil/epidemiology;Doxycycline/therapeutic use;Female;Humans;Immunohistochemistry;Lyme Disease/diagnosis*;Lyme Disease/drug therapy;Lyme Disease/microbiology;Male;Microscopy;Middle Aged;Skin/microbiology*;Skin/pathology;Treatment Outcome
20231941;Adolescent;Bone Cysts, Aneurysmal/pathology*;Female;Humans;Pubic Bone*
20236188;Animals;DNA, Protozoan/genetics*;Eukaryota/classification;Eukaryota/genetics;Eukaryota/isolation & purification;Geologic Sediments/parasitology;Kinetoplastida/classification;Kinetoplastida/genetics*;Kinetoplastida/isolation & purification;Molecular Probe Techniques;Molecular Probes/genetics*;Molecular Sequence Data;Phylogeny;RNA, Ribosomal/genetics;Sequence Analysis, DNA;Water/parasitology
20245266;Academies and Institutes*;Humans;New Zealand
20250561;Humans;Physicians*;Public Health*;United Kingdom
20267133;Humans
20267542;Documentation*;Humans;Paper*;Science*
20289772;Female;Hemorrhage*;Humans;Menstruation*;Metrorrhagia*;Puberty*;Sexual Maturation*;Single Person*;Uterine Hemorrhage*;Uterus*
20299690;Aged;Aortic Valve Stenosis/metabolism*;Aortic Valve Stenosis/pathology;Aortic Valve Stenosis/physiopathology;Case-Control Studies;Cell Degranulation*;Cell Hypoxia;Cells, Cultured;Culture Media, Conditioned/metabolism;Endostatins/metabolism;Female;Fibroblasts/metabolism*;Humans;Immunohistochemistry;Male;Mast Cells/metabolism*;Middle Aged;Neovascularization, Pathologic/metabolism*;Neovascularization, Pathologic/pathology;Neovascularization, Pathologic/physiopathology;Smoke/adverse effects;Time Factors;Tobacco;Tryptases/metabolism;Vascular Endothelial Growth Factor A/metabolism*
20353336;Animals;Electrons*;Humans;Neoplasm Invasiveness/diagnostic imaging*;Neoplasm Invasiveness/physiopathology;Neoplasms*/diagnostic imaging;Neoplasms*/radiotherapy;Radionuclide Imaging;Radiopharmaceuticals*/therapeutic use;Radiotherapy/methods*;Technetium*/therapeutic use
20365558;Kinetics;Molecular Dynamics Simulation*;Particle Size*
20368637;Adult;Atrophy/genetics;Atrophy/pathology;Brain Stem/pathology;Brain Stem/physiopathology;Cerebellum/metabolism;Cerebellum/pathology;Cerebellum/physiopathology;DNA Mutational Analysis;Diagnosis, Differential;Female;Genes, Dominant/genetics;Genes, Recessive/genetics;Genetic Predisposition to Disease/genetics*;Genetic Testing;Genotype;Heat-Shock Proteins/genetics*;Humans;Inheritance Patterns/genetics*;Magnetic Resonance Imaging;Male;Multiple Sclerosis/genetics;Muscle Spasticity/genetics*;Muscle Spasticity/physiopathology;Mutation/genetics;Nerve Fibers, Myelinated/pathology;Pedigree;Phenotype;Spinocerebellar Degenerations/genetics*;Spinocerebellar Degenerations/physiopathology;Young Adult
20386458;Acetylcholine;Action Potentials/drug effects;Animals;Anti-Arrhythmia Agents/pharmacology*;Atrial Fibrillation/drug therapy*;Atrial Fibrillation/physiopathology;Azabicyclo Compounds/pharmacology*;Carbamates/pharmacology*;Disease Models, Animal;Dogs;Electrophysiological Phenomena/drug effects;Female;Heart Atria/drug effects;Heart Atria/metabolism;Heart Ventricles/drug effects;Heart Ventricles/metabolism;Male;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/metabolism;Patch-Clamp Techniques;Sodium Channel Blockers/pharmacology
20387055;Arabidopsis/drug effects*;Arabidopsis/metabolism*;Biological Assay;Molecular Biology/methods*;Osmosis/drug effects*;Proline/metabolism*;Seedlings/drug effects;Seedlings/metabolism;Solutions;Stress, Physiological/drug effects*;Water/pharmacology*
20395677;Animals;Collagen/chemistry;Cystathionine beta-Synthase/metabolism;Down-Regulation;Homocysteine/metabolism*;Hydrogen Sulfide/metabolism*;Hyperhomocysteinemia/metabolism;Inflammation;Kidney/pathology;Kidney Diseases/etiology*;Kidney Diseases/metabolism*;Male;Matrix Metalloproteinase 2/metabolism;Matrix Metalloproteinase 9/metabolism;Mice;Mice, Inbred C57BL
20397268;Adult;Aged;Aged, 80 and over;Carcinoma, Pancreatic Ductal/diagnosis*;Carcinoma, Pancreatic Ductal/mortality;Carcinoma, Pancreatic Ductal/pathology;Female;Follow-Up Studies;Humans;Male;Medical Oncology/methods;Middle Aged;Pancreatic Neoplasms/diagnosis*;Pancreatic Neoplasms/mortality;Pancreatic Neoplasms/pathology;Prognosis;Treatment Outcome
20397866;Clinical Competence/standards;Emergency Medical Services*;Emergency Medical Technicians/education*;Emergency Medical Technicians/organization & administration;Humans;Intubation, Intratracheal/methods*;Intubation, Intratracheal/standards*;Medical Audit;Middle Aged;Physicians*;Program Evaluation;Retrospective Studies;Time Factors
20399857;Adult;Amyotrophic Lateral Sclerosis*/genetics;Amyotrophic Lateral Sclerosis*/pathology;Amyotrophic Lateral Sclerosis*/physiopathology;Analysis of Variance;Brain/metabolism*;Brain/pathology;Case-Control Studies;Female;Fibroblasts/metabolism;Fibroblasts/pathology;Genetic Testing/methods;Humans;Lymphocytes/metabolism;Male;Middle Aged;Nervous System/metabolism;Nervous System/pathology;RNA, Messenger/metabolism*;Spinal Cord/metabolism*;Spinal Cord/pathology;Superoxide Dismutase/genetics*;Superoxide Dismutase/metabolism;Superoxide Dismutase-1
20410153;Adult;Atorvastatin Calcium;Chemokine CXCL9/blood*;Chemokines/blood;Disease Progression;Female;Heptanoic Acids/therapeutic use*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Interferons/immunology*;Lupus Erythematosus, Systemic*/blood;Lupus Erythematosus, Systemic*/drug therapy;Lupus Erythematosus, Systemic*/immunology;Pyrroles/therapeutic use*;Severity of Illness Index
20416963;Adolescent;Adult;Aged;Aged, 80 and over;Brachytherapy*;Choroid Neoplasms/mortality;Choroid Neoplasms/pathology;Choroid Neoplasms/radiotherapy*;Combined Modality Therapy;Female;Humans;Hyperthermia, Induced;Male;Melanoma/mortality;Melanoma/pathology;Melanoma/radiotherapy*;Middle Aged;Neoplasm Metastasis;Prognosis;Ruthenium Radioisotopes/therapeutic use*;Treatment Outcome
20430407;Humans;Male;Patient Satisfaction*;Prostatectomy/adverse effects;Suburethral Slings*;Urinary Incontinence/etiology;Urinary Incontinence/surgery*
20447785;Aged;Aged, 80 and over;Biomarkers/metabolism;Case-Control Studies;Elder Abuse/diagnosis*;Endothelial Cells/metabolism;Endothelium/metabolism;Female;Forensic Pathology;Humans;Immunohistochemistry;Injury Severity Score;Interleukin-8/metabolism;Kidney/metabolism;Kidney/pathology;Liver/metabolism;Liver/pathology;Lung/metabolism;Lung/pathology;Macrophages/metabolism;Male;Multiple Organ Failure/metabolism;Myocardium/metabolism;Myocardium/pathology;Neutrophils/metabolism*;P-Selectin/metabolism;Peroxidase/metabolism
20452149;Adult;Apgar Score;Asphyxia Neonatorum/epidemiology*;Extraction, Obstetrical/standards*;Female;France;Hospitals, Maternity/statistics & numerical data;Humans;Infant, Newborn;Labor, Obstetric*;Practice Guidelines as Topic;Pregnancy;Prospective Studies;Time Factors;Young Adult
20469603;Animals;Anticonvulsants/administration & dosage*;Anticonvulsants/isolation & purification;Bridged-Ring Compounds/administration & dosage;Chloride Channels/antagonists & inhibitors*;Disease Models, Animal*;Drug Discovery;Epilepsy, Temporal Lobe/chemically induced*;Epilepsy, Temporal Lobe/physiopathology*;GABA Antagonists/administration & dosage*;Humans;Kindling, Neurologic/drug effects;Norbornanes/administration & dosage
20479230;Arabidopsis/genetics;Arabidopsis/metabolism*;Arabidopsis Proteins/genetics;Arabidopsis Proteins/metabolism*;Base Sequence;Basic-Leucine Zipper Transcription Factors/genetics;Basic-Leucine Zipper Transcription Factors/metabolism*;Conserved Sequence;DNA, Plant/genetics;Genes, Plant;Genetic Complementation Test;Humans;Mutagenesis, Insertional;Mutation;Phenotype;Plants/genetics;Plants, Genetically Modified;Promoter Regions, Genetic;Two-Hybrid System Techniques;Zinc/metabolism*
20488468;Ampicillin/therapeutic use;Analysis of Variance;Anti-Infective Agents, Urinary/therapeutic use*;Chi-Square Distribution;Child;Child, Preschool;Drug Combinations;Drug Therapy, Combination;Escherichia coli Infections/drug therapy;Female;Humans;Infant;Male;Microbial Sensitivity Tests;Prospective Studies;Sulfamethoxazole/therapeutic use*;Treatment Outcome;Trimethoprim/therapeutic use*;Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use*;United States;Urinary Tract Infections/drug therapy*;Urinary Tract Infections/microbiology
20509947;Fabry Disease/diagnosis;Fabry Disease/genetics;Fabry Disease/pathology;Female;Genetic Diseases, X-Linked/classification;Genetic Diseases, X-Linked/diagnosis*;Genetic Diseases, X-Linked/genetics*;Genetic Diseases, X-Linked/pathology;Humans;Mucopolysaccharidosis II/diagnosis;Mucopolysaccharidosis II/genetics;Mucopolysaccharidosis II/pathology
20510144;Animals;Anti-Mullerian Hormone/physiology;Artiodactyla;Disorders of Sex Development/genetics;Female;Forkhead Box Protein L2;Forkhead Transcription Factors/physiology*;Gonadal Steroid Hormones/physiology;Humans;Male;Mice;Mice, Knockout;Mice, Transgenic;Models, Biological;Ovary/embryology*;Ovary/metabolism;SOX9 Transcription Factor/physiology;Sex Chromosomes/genetics;Sex Differentiation/genetics;Sex Differentiation/physiology*;Testis/embryology;Testis/metabolism
20510321;CD56 Antigen/genetics;CD56 Antigen/metabolism;Cell Differentiation/drug effects*;Down-Regulation/drug effects;Flow Cytometry;Humans;Interferon-gamma/genetics;Interferon-gamma/metabolism;Interleukin-15/pharmacology*;Interleukins/genetics;Interleukins/metabolism;Killer Cells, Natural/cytology;Killer Cells, Natural/drug effects;Killer Cells, Natural/metabolism;Lymphoid Tissue/cytology;Lymphoid Tissue/metabolism;Lymphotoxin-alpha/genetics;Lymphotoxin-alpha/metabolism;Nuclear Receptor Subfamily 1, Group F, Member 3/genetics;Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism;OX40 Ligand/genetics;OX40 Ligand/metabolism*;Proto-Oncogene Proteins c-kit/genetics;Proto-Oncogene Proteins c-kit/metabolism*;Reverse Transcriptase Polymerase Chain Reaction
20515382;Clinical Clerkship;Clinical Medicine/education*;Educational Measurement/methods*;Pilot Projects;Schools, Medical*;United States
20516438;Age Factors;Aged;Aged, 80 and over;Breast Neoplasms/drug therapy*;Chemotherapy, Adjuvant;Data Collection/methods;Female;Follow-Up Studies;Humans;Interviews as Topic;Outcome Assessment (Health Care)/methods*;Patient Preference;Physician-Patient Relations;Risk Factors
20524851;Animals;Bone Marrow Cells/cytology*;Bone Marrow Cells/drug effects;Bone Marrow Cells/physiology*;Cytokines/genetics*;Dendritic Cells/cytology;Dendritic Cells/drug effects;Dendritic Cells/physiology*;Enzyme Activation;Enzyme-Linked Immunosorbent Assay;Extracellular Signal-Regulated MAP Kinases/metabolism;Female;Flow Cytometry;Interleukin-12/genetics;Interleukin-6/genetics;Mice;Mice, Inbred BALB C;Myeloid Differentiation Factor 88/physiology*;Recombinant Proteins/pharmacology;Toll-Like Receptor 3/physiology;Toll-Like Receptors/physiology*;p38 Mitogen-Activated Protein Kinases/metabolism
20564514;Adult;Bronchiolitis Obliterans/epidemiology;California/epidemiology;Cross-Sectional Studies;Diacetyl/therapeutic use*;Female;Flavoring Agents/adverse effects*;Humans;Industry/statistics & numerical data*;Lung Diseases/epidemiology*;Male;Mass Screening;Middle Aged;Occupational Diseases/epidemiology*;Occupational Exposure/adverse effects*;Occupational Health/statistics & numerical data*;Odds Ratio;Population Surveillance;Prevalence;Risk Factors;Spirometry;Surveys and Questionnaires;Young Adult
20571676;Chemistry Techniques, Analytical/instrumentation*;Fluorescent Dyes/chemical synthesis;Fluorescent Dyes/chemistry*;Molecular Imaging/methods*;Spectrometry, Fluorescence
20592101;C-Reactive Protein/analysis;CD4 Antigens/blood;Copper/blood;Female;Glutathione Peroxidase/metabolism;Humans;Iron/blood;Kidney Failure, Chronic/immunology*;Kidney Failure, Chronic/therapy;Lipid Peroxidation;Lymphocytes/immunology*;Male;Middle Aged;Oxidative Stress/immunology*;Peritoneal Dialysis;Receptors, IgE/blood;Renal Dialysis*;Selenium/blood;T-Lymphocyte Subsets/immunology;Thiobarbituric Acid Reactive Substances/analysis;Trace Elements/blood*;Zinc/blood
20601910;Abdominal Pain/epidemiology;Adolescent;Anorexia/etiology;Child;Enteral Nutrition;Female;Growth*;Humans;Intestinal Obstruction/surgery;Male;Prospective Studies;Satiation;Superior Mesenteric Artery Syndrome/complications;Superior Mesenteric Artery Syndrome/physiopathology;Superior Mesenteric Artery Syndrome/surgery;Superior Mesenteric Artery Syndrome/therapy*;Treatment Outcome;Vomiting/epidemiology
20605912;Gene Expression Regulation, Plant;Gene Knockout Techniques;Genes, Plant/genetics*;Homeodomain Proteins/genetics;Homeodomain Proteins/metabolism*;Leucine Zippers/genetics*;Lipid Metabolism/genetics;Oligonucleotide Array Sequence Analysis;Organ Specificity/genetics;Plant Epidermis/genetics*;Plant Leaves/cytology;Plant Leaves/genetics;Plant Proteins/genetics;Plant Proteins/metabolism*;Reproducibility of Results;Transcription Factors/genetics;Transcription Factors/metabolism*;Transcriptional Activation/genetics;Transformation, Genetic;Waxes/metabolism;Zea mays/genetics*;Zea mays/immunology
20619241;Adult;Angioplasty, Balloon, Coronary*/adverse effects;Angioplasty, Balloon, Coronary*/instrumentation;Chi-Square Distribution;Employment*;Female;France;Humans;Logistic Models;Male;Middle Aged;Myocardial Infarction/rehabilitation;Myocardial Infarction/therapy*;Platelet Aggregation Inhibitors/therapeutic use;Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors;Retrospective Studies;Risk Assessment;Risk Factors;Sick Leave*;Stents;Time Factors;Treatment Outcome
20620666;Age Factors;Aged;Aged, 80 and over;Alzheimer Disease/pathology*;Atrophy;Cognition Disorders/pathology*;Disease Progression*;Female;Follow-Up Studies;Humans;Longitudinal Studies;Magnetic Resonance Imaging/methods*;Male;Middle Aged;Prospective Studies;Sex Characteristics*
20632120;Analgesics/therapeutic use*;Analgesics, Opioid/therapeutic use;Chronic Disease/drug therapy;Chronic Disease/epidemiology;Complementary Therapies;Humans;Low Back Pain/drug therapy;Pain/drug therapy*;Pain/epidemiology;Pain Measurement*;Practice Guidelines as Topic;United States/epidemiology
20635028;Aged;Blood Platelets;Coronary Disease;Gingival Crevicular Fluid*;Humans;Periodontal Pocket;Periodontitis;Platelet Activating Factor*;Risk Factors;Saliva
20635849;Austria/epidemiology;Blood Platelet Disorders/diagnosis*;Blood Platelet Disorders/epidemiology;Child;Data Collection;Germany/epidemiology;Humans;Pediatrics;Platelet Count;Platelet Function Tests/methods*;Registries;Surveys and Questionnaires;Switzerland/epidemiology
20653888;Biomass;Nitrates/metabolism*;Nitrogen Fixation*;Photosynthesis*;Plant Leaves/growth & development*;Plant Leaves/metabolism;Plant Root Nodulation;Plant Shoots/growth & development;Soybeans/growth & development;Soybeans/metabolism*
20656722;Adult;Chlamydia Infections/epidemiology*;Chlamydia trachomatis;Gonorrhea/epidemiology*;HIV Seronegativity*;HIV-1*;Homosexuality, Male/statistics & numerical data*;Humans;Kenya/epidemiology;Male;Neisseria gonorrhoeae;Prevalence;Rectal Diseases/epidemiology;Urethral Diseases/epidemiology;Young Adult
20674895;Adolescent;Adult;Combined Modality Therapy;Embryo Transfer*/methods;Fallopian Tube Diseases/complications;Fallopian Tube Diseases/diagnostic imaging;Fallopian Tube Diseases/therapy*;Female;Fertilization in Vitro*/methods;Humans;Infertility, Female/diagnostic imaging;Infertility, Female/etiology;Infertility, Female/therapy;Pregnancy;Pregnancy Rate;Sclerotherapy/methods*;Time Factors;Ultrasonography, Interventional/methods*;Young Adult
20698165;Adult;Algorithms;Biopsy, Fine-Needle/methods;Cell Biology/trends;Child;Child Health Services*;Cytodiagnosis/methods;Health Services*;Humans;Infection/pathology;Lymph Nodes/pathology;Physicians, Family;Research/trends;Research Design
20698833;Animals;Electric Stimulation Therapy*;Glucose Transporter Type 4/metabolism*;Heart Failure/complications*;Heart Failure/physiopathology;Hemodynamics;Male;Muscle, Skeletal/blood supply;Muscle, Skeletal/metabolism*;Muscle, Skeletal/pathology;Muscular Diseases/etiology;Muscular Diseases/metabolism;Muscular Diseases/pathology;Muscular Diseases/therapy*;Myocardial Infarction/complications;Rats;Rats, Wistar
20713968;Animals;Biomechanical Phenomena;Electrophysiological Phenomena;Female;Mechanoreceptors/physiology;Mechanotransduction, Cellular/physiology*;Myometrium/physiology;Rats;Uterine Contraction/physiology*
20729175;Feedback;JNK Mitogen-Activated Protein Kinases/metabolism*;MAP Kinase Signaling System*;Models, Biological*;Molecular Dynamics Simulation*;Receptor Cross-Talk*;Signal Transduction;p38 Mitogen-Activated Protein Kinases/metabolism*
20735066;Acetone/chemistry*;Alkenes/chemistry*;Amines/chemistry*;Catalysis;Copper/chemistry*;Cyclization;Molecular Structure;Oxidation-Reduction
20735655;Animals;Georgia;Models, Biological;Perciformes/growth & development*;Rivers*;Seasons;Water Movements*
20736460;Clinical Trials as Topic/standards*;Internationality*;Investigational New Drug Application*;Quality Control;United States;United States Food and Drug Administration*
20736660;Canada;Clinical Clerkship;Curriculum*;Education, Medical, Undergraduate*;Health Care Surveys;Humans;Internal Medicine/education*;Medical Errors/prevention & control;Practice Guidelines as Topic;Safety Management*;United States
20814602;Adult;Alveolar Process/surgery*;Bone Transplantation;Female;Humans;Male;Malocclusion, Angle Class II/surgery*;Microsurgery/instrumentation;Microsurgery/methods*;Minimally Invasive Surgical Procedures;Oral Surgical Procedures/instrumentation;Oral Surgical Procedures/methods*;Orthodontics, Corrective/methods;Young Adult
20822277;Adolescent;Child;Educational Status;Humans;Intelligence;Parents/psychology;Prevalence;Psychometrics;Reference Values;United States;Wechsler Scales/standards*;Wechsler Scales/statistics & numerical data
20825786;Academic Medical Centers/methods;Academic Medical Centers/statistics & numerical data;Disease Outbreaks*/statistics & numerical data;Emergency Service, Hospital*/statistics & numerical data;Humans;Influenza A Virus, H1N1 Subtype*;Influenza, Human/diagnosis;Influenza, Human/epidemiology*;Population Surveillance/methods;Seasons
20826502;Cohort Studies;Confounding Factors (Epidemiology);England;Female;Humans;Likelihood Functions;Male;Models, Theoretical*;Multivariate Analysis;Probability;Wales
20839179;Humans;Neurology/manpower;Risk Factors;Spain/epidemiology;Stroke/epidemiology;Stroke/mortality*;Stroke/prevention & control
20841947;Acute Disease;Aged;Amino Acids, Branched-Chain/therapeutic use;Chemotherapy, Adjuvant;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/therapeutic use;Female;Hepatic Encephalopathy/chemically induced*;Hepatic Encephalopathy/drug therapy;Hepatitis B/complications*;Humans;Lactulose/therapeutic use;Liver/injuries*;Pancreatic Neoplasms/complications;Pancreatic Neoplasms/drug therapy*;Pancreatic Neoplasms/pathology;Pancreatic Neoplasms/surgery;Tomography, X-Ray Computed
20845251;Adult;Aged;Anticoagulants/administration & dosage;Combined Modality Therapy;Cooperative Behavior;Humans;Interdisciplinary Communication;Intraocular Pressure/drug effects;Massage;Middle Aged;Retinal Artery Occlusion/diagnosis*;Retinal Artery Occlusion/etiology;Retinal Artery Occlusion/therapy*;Risk Factors;Thrombolytic Therapy
20863022;Constipation*/etiology;Constipation*/nursing;Constipation*/psychology;Emotions*;Humans;Parkinson Disease*/complications;Parkinson Disease*/nursing;Parkinson Disease*/psychology;Quality of Life;Social Behavior*;Specialties, Nursing/methods*
20864172;Animals;Cell Culture Techniques/methods*;Cells, Cultured;Chondrocytes/cytology*;Chondrocytes/ultrastructure;Chromatography, Gel;Circular Dichroism;Cryoelectron Microscopy;Extracellular Matrix/chemistry;Hydrogel, Polyethylene Glycol Dimethacrylate;Hydrogels/chemistry;Immunohistochemistry;Magnetic Resonance Spectroscopy;Mice;Mice, Nude;Microscopy, Electron, Transmission;Peptides/chemical synthesis;Peptides/chemistry*;Rabbits;Reverse Transcriptase Polymerase Chain Reaction;Tissue Engineering/methods*;Tissue Scaffolds/chemistry
20883085;Animals;Antineoplastic Agents, Phytogenic/administration & dosage*;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics;Hydrogels*;Inhibitory Concentration 50;Lactic Acid*;Mice;Mice, Inbred BALB C;Micelles;Neoplasm Transplantation;Polyethylene Glycols*;Polyglycolic Acid*;Powder Diffraction;Rheology;Solubility;Taxoids/administration & dosage*;Taxoids/blood;Taxoids/pharmacokinetics;X-Ray Diffraction
20890156;Arrhythmias, Cardiac/etiology;Arrhythmias, Cardiac/prevention & control*;Catheter Ablation;Endoscopy*;Esophagogastric Junction/surgery*;Female;Gastroesophageal Reflux/complications;Gastroesophageal Reflux/surgery*;Humans;Middle Aged
20922866;Adult;Animals;Charcot-Marie-Tooth Disease*/therapy;Female;Humans;Infant, Newborn;Obstetric Labor Complications*/therapy;Pregnancy;Pregnancy Complications*/therapy
20956275;Animals;Biocompatible Materials;Bioprosthesis;Endothelium, Corneal/cytology*;Endothelium, Corneal/drug effects;Endothelium, Corneal/growth & development;Epithelium, Corneal/cytology*;Epithelium, Corneal/drug effects;Epithelium, Corneal/growth & development;Extracellular Matrix/ultrastructure*;Materials Testing;Rabbits;Sodium Dodecyl Sulfate/pharmacology;Surface-Active Agents/pharmacology;Swine;Tissue Engineering/methods*;Tissue Scaffolds*
20956463;Adult;Ciliary Body/pathology;Female;Humans;Lupus Erythematosus, Systemic/complications*;Myopia/etiology*;Myopia/pathology*
20959109;Base Sequence;Chromosomal Puffs/chemistry;Chromosomal Puffs/metabolism*;Diffusion;HeLa Cells;Humans;Microscopy;Movement;Protein Binding;RNA/chemistry;RNA/genetics;RNA/metabolism;RNA Probes/genetics;RNA Probes/metabolism;Ribonucleoproteins/metabolism*;Spectrometry, Fluorescence;Time Factors
20968151;Diagnosis, Differential;Europe;Hematologic Neoplasms/classification*;Hematologic Neoplasms/diagnosis*;Humans;Leukemia/classification;Leukemia/diagnosis;Lymphoma/classification;Lymphoma/diagnosis;Manuals as Topic*;Medical Records/standards*
20969653;Age Factors;Animals;Disease Models, Animal;Dopamine/metabolism;Female;Glial Cell Line-Derived Neurotrophic Factor/genetics;Glial Cell Line-Derived Neurotrophic Factor/immunology;Glial Cell Line-Derived Neurotrophic Factor/metabolism*;Heterozygote;Lipopolysaccharides/immunology;Male;Mice;Mice, Knockout;Neostriatum/immunology;Neostriatum/metabolism;Neostriatum/pathology;Neurodegenerative Diseases/immunology;Neurodegenerative Diseases/metabolism;Neurodegenerative Diseases/pathology*;Neurons/immunology;Neurons/metabolism;Neurons/pathology;Pregnancy;Prenatal Exposure Delayed Effects/immunology*;Substantia Nigra/immunology*;Substantia Nigra/metabolism;Tumor Necrosis Factor-alpha/metabolism;Tyrosine 3-Monooxygenase/metabolism*
20987452;Arachidonic Acid*;Calcium/metabolism*;Humans;Thiamine*;Urea*
20995966;Amino Acids/chemistry*;Proteins/chemistry*
20996403;Ear Auricle*;Keloid*
21000154;Animals;Dental Occlusion*;Dentition*;Humans;Periodontal Ligament*;Tooth*
21004429;Goiter*;Humans;Pyrimidines*;Thiourea/pharmacology*;Thyroid Gland/drug effects*
21022626;Humans;Meningitis*
21026575;Anatomy/education*;Humans;Organizations*;Work*
21027146;Constriction, Pathologic;Pyloric Stenosis*;Pylorus*
21034649;Adult;Aged;Aged, 80 and over;Carotid Stenosis/etiology*;Carotid Stenosis/physiopathology*;Eye Diseases/etiology*;Female;Hemodynamics;Humans;Hyperlipidemias/physiopathology;Hypertension/physiopathology;Ischemia/etiology*;Male;Middle Aged;Retrospective Studies;Risk Factors;Smoking/adverse effects
21038821;Efficiency, Organizational/economics*;Health Facilities/economics*;Insurance Claim Reporting/standards*;Internet*;Medicare*;United States
21057200;DNA Damage;DNA Repair;Exodeoxyribonucleases/metabolism;Exodeoxyribonucleases/physiology*;Fanconi Anemia/genetics;Fanconi Anemia/metabolism;Fanconi Anemia Complementation Group D2 Protein/metabolism;Fanconi Anemia Complementation Group D2 Protein/physiology;Fanconi Anemia Complementation Group Proteins/metabolism*;Fanconi Anemia Complementation Group Proteins/physiology;Humans;S Phase;Ubiquitination
21098835;History, 21st Century;Humans;Periodicals as Topic/history;Ultrasonography/history
21115739;Aurora Kinases;Cyclin B/genetics;Cyclin B/metabolism;Gene Knock-In Techniques;Genes, Protozoan*;Genetic Engineering;Genetic Markers;Genetic Vectors;Giardia lamblia/genetics*;Giardia lamblia/metabolism;Protein-Serine-Threonine Kinases/genetics;Protein-Serine-Threonine Kinases/metabolism
21122693;Calcium/analysis*;Coronary Angiography;Coronary Disease/diagnostic imaging*;Coronary Disease/etiology;Humans;Myocardial Infarction/diagnostic imaging;Myocardial Infarction/etiology;Risk Factors;Tomography, X-Ray Computed
21130622;AIDS Serodiagnosis*;Adolescent;Child;Child, Preschool;Cote d'Ivoire;Cross-Sectional Studies;Female;Humans;Infant;Male;Parents*;Patient Acceptance of Health Care/statistics & numerical data*
21137625;Aminoglycosides/adverse effects;Aminoglycosides/pharmacology;Aminoglycosides/therapeutic use*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/therapeutic use*;Drug Resistance, Bacterial;Humans;Randomized Controlled Trials as Topic;Skin Diseases, Infectious/drug therapy*;Skin Diseases, Infectious/microbiology
21152699;Aspartate Aminotransferases/blood;Biomarkers/blood;Body Mass Index;C-Reactive Protein/analysis*;Case-Control Studies;Creatine Kinase, MB Form/blood;Electrocardiography;Female;Follow-Up Studies;Humans;Male;Middle Aged;Myocardial Infarction/blood*;Myocardial Infarction/physiopathology;Prospective Studies
21169151;Aged;Coronary Artery Bypass/methods*;Coronary Stenosis/complications;Coronary Stenosis/pathology*;Coronary Stenosis/surgery*;Endoscopy/methods*;Heart Arrest/etiology;Heart Arrest/pathology*;Heart Arrest/surgery*;Humans;Male;Robotics/methods*;Treatment Outcome
21187853;Age Distribution;Economics/statistics & numerical data*;Employment/statistics & numerical data*;Female;Health Status*;Humans;Longitudinal Studies;Male;Middle Aged;Residence Characteristics/statistics & numerical data*;Sex Distribution;Socioeconomic Factors*;United Kingdom
21196670;Cardiac Surgical Procedures/methods*;Child;Child, Preschool;Extracorporeal Membrane Oxygenation*/adverse effects;Heart Defects, Congenital/surgery*;Humans;Infant;Infant, Newborn;Transposition of Great Vessels/surgery
21205195;Animals;Chromatography, High Pressure Liquid;Mass Spectrometry;Planarians/chemistry*;Polysaccharides/chemistry*
21242526;Animals;Cancer Vaccines/administration & dosage;Cancer Vaccines/immunology*;Cancer Vaccines/secretion;Carcinoma, Lewis Lung/immunology;Carcinoma, Lewis Lung/prevention & control*;Carcinoma, Lewis Lung/secretion;Cell Line, Tumor;Cells, Cultured;Chemokines/administration & dosage;Chemokines/immunology;Chemokines/secretion*;Coculture Techniques;Dendritic Cells/immunology;Dendritic Cells/metabolism;Dendritic Cells/secretion;Exosomes/immunology;Exosomes/metabolism;Exosomes/secretion*;Heat Stress Disorders/immunology;Heat Stress Disorders/metabolism;Heat Stress Disorders/prevention & control*;Hot Temperature;Male;Melanoma, Experimental/immunology;Melanoma, Experimental/prevention & control*;Melanoma, Experimental/secretion;Membrane Microdomains/immunology*;Membrane Microdomains/metabolism;Membrane Microdomains/secretion;Mice;Mice, Inbred C57BL;Signal Transduction/immunology*;T-Lymphocyte Subsets/immunology;T-Lymphocyte Subsets/metabolism
21244857;Amino Acid Oxidoreductases/genetics;Amino Acid Oxidoreductases/metabolism*;Animals;Body Patterning/genetics;Cartilage/embryology*;Cartilage/metabolism;Cell Death;Cell Differentiation/genetics;Cell Proliferation;Cell Shape/genetics;Chondrocytes/cytology;Chondrocytes/metabolism;Cloning, Molecular;Extracellular Matrix/genetics;Extracellular Matrix/ultrastructure;Gene Silencing;Head/embryology*;Mesoderm/embryology;Mesoderm/metabolism;Neural Crest/cytology;Neural Crest/metabolism;Phenotype;Phylogeny;Stem Cells/cytology;Zebrafish/embryology*;Zebrafish/metabolism;Zebrafish Proteins/genetics;Zebrafish Proteins/metabolism*
21257298;Alternaria/drug effects*;Alternaria/genetics*;DNA, Complementary/metabolism*;Drug Resistance, Fungal*;Expressed Sequence Tags;Fungicides, Industrial/metabolism*;Gene Expression Regulation, Fungal/drug effects*;Genes, Fungal;Isothiocyanates/metabolism*;Sequence Analysis, DNA;Sequence Homology
21265363;Abdominal Wall*;Debridement;Drainage;Humans;Male;Middle Aged;Pancreatic Pseudocyst/complications*;Pancreatic Pseudocyst/diagnostic imaging;Pancreatic Pseudocyst/surgery;Tomography, X-Ray Computed
21274842;Advanced Practice Nursing/trends*;Clinical Competence;Forecasting;Germany;Health Services Needs and Demand/trends*;Humans;National Health Programs/trends*;Nurse's Role;Professional Autonomy;Quality of Health Care/trends*
21281302;Adolescent;Adult;Cultural Characteristics*;Developing Countries;Ethics, Nursing*;Female;Ghana;Health Knowledge, Attitudes, Practice;Humans;Middle Aged;Professional Autonomy;Professional Competence;Surveys and Questionnaires
21287819;Contracts*;General Practice/standards*;General Practitioners/standards*;Health Care Reform;Hospitals, Public;Humans;Organizational Case Studies;State Medicine/organization & administration*;United Kingdom
21288169;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Blood Coagulation Tests;Clinical Laboratory Techniques*;Humans
21300256;Acrocephalosyndactylia/complications*;Blepharoptosis/etiology;Blepharoptosis/surgery;Cephalometry;Child, Preschool;Facial Bones/abnormalities*;Female;Humans;Malocclusion, Angle Class III/etiology;Malocclusion, Angle Class III/surgery*;Malocclusion, Angle Class III/therapy;Maxilla/surgery*;Micrognathism/etiology;Micrognathism/surgery*;Orthognathic Surgical Procedures;Osteogenesis, Distraction*
21310230;8,11,14-Eicosatrienoic Acid/analysis*;8,11,14-Eicosatrienoic Acid/chemistry;8,11,14-Eicosatrienoic Acid/metabolism;Anti-Inflammatory Agents/metabolism;Antineoplastic Agents/metabolism;Arachidonic Acid/analysis;Arachidonic Acid/chemistry;Arachidonic Acid/metabolism;Catalysis;Cell Line, Tumor;Chromatography, Liquid;Colonic Neoplasms/chemistry;Colonic Neoplasms/enzymology*;Electron Spin Resonance Spectroscopy;Free Radicals/metabolism;Humans;Mass Spectrometry;Oxidation-Reduction;Peroxides/metabolism*;Prostaglandin-Endoperoxide Synthases/metabolism*;Prostaglandins/analysis*;Prostaglandins/chemistry;Pyridines/metabolism;Spin Trapping
21314868;Aged;Aged, 80 and over;Fasting/blood*;Female;Hospital Mortality*;Hospitalization/statistics & numerical data*;Humans;Hyperglycemia/mortality*;Italy/epidemiology;Kaplan-Meier Estimate;Male;Prevalence;Prospective Studies;Spain/epidemiology
21324896;Alkaline Phosphatase/genetics;Alkaline Phosphatase/metabolism;Animals;Cell Differentiation/physiology*;Chromones/pharmacology;Class Ia Phosphatidylinositol 3-Kinase/genetics;Class Ia Phosphatidylinositol 3-Kinase/metabolism*;Cyclin D/genetics;Cyclin D/metabolism;Cyclin E/genetics;Cyclin E/metabolism;Enzyme Inhibitors/pharmacology;Flavonoids/pharmacology;MAP Kinase Signaling System/physiology*;Mice;Mice, Knockout;Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors;Mitogen-Activated Protein Kinase Kinases/genetics;Mitogen-Activated Protein Kinase Kinases/metabolism;Morpholines/pharmacology;Osteoblasts/cytology;Osteoblasts/enzymology*;Proto-Oncogene Proteins c-akt/antagonists & inhibitors;Proto-Oncogene Proteins c-akt/genetics;Proto-Oncogene Proteins c-akt/metabolism
21330976;Artifacts;Fluorodeoxyglucose F18;Head/diagnostic imaging*;Humans;Imaging, Three-Dimensional;Magnetic Resonance Imaging/methods*;Motion;Phantoms, Imaging;Positron-Emission Tomography/methods*;Radiosurgery/methods*;Time Factors;Tomography, X-Ray Computed/methods*
21348783;Bipolar Disorder/genetics;Epigenomics;Genetic Predisposition to Disease/genetics*;Genome-Wide Association Study;Humans;Mental Disorders/genetics*;Molecular Biology;Psychiatry/methods*;Psychiatry/trends;Schizophrenia/genetics
21353845;Adenoma/diagnosis*;Colonic Polyps/diagnosis*;Colonoscopy/instrumentation*;Colonoscopy/methods;Colorectal Neoplasms/diagnosis*;False Negative Reactions;Humans;Randomized Controlled Trials as Topic
21359940;Angiography;Colostomy*;Contrast Media;Embolization, Therapeutic/methods*;Epigastric Arteries/injuries*;Extravasation of Diagnostic and Therapeutic Materials;Hemorrhage/diagnostic imaging;Hemorrhage/etiology*;Hemorrhage/therapy*;Humans;Iatrogenic Disease;Male;Middle Aged;Tomography, X-Ray Computed
21367408;Fusarium/isolation & purification*;Humans;Male;Middle Aged;Mycetoma/diagnosis*;Mycetoma/microbiology*;Mycetoma/pathology;Mycetoma/therapy
21372827;Animals;Carcinoma, Hepatocellular/genetics*;Carcinoma, Hepatocellular/metabolism;Carcinoma, Hepatocellular/pathology*;Cell Line, Tumor;Cell Proliferation;Genetic Vectors;Hep G2 Cells;Humans;Liver Neoplasms/genetics*;Liver Neoplasms/metabolism;Liver Neoplasms/pathology*;Mediator Complex/genetics;Mediator Complex/physiology*;Mice;Mice, Nude;Neoplasm Transplantation;RNA, Small Interfering/genetics
21384111;Acid Phosphatase/metabolism;Animals;Blotting, Western;Cathepsin K/genetics;Cathepsin K/metabolism;Cell Differentiation/drug effects*;Cell Line;Computational Biology;Dibenzazepines/pharmacology;Electrophoretic Mobility Shift Assay;Isoenzymes/metabolism;Mice;NFATC Transcription Factors;Osteoclasts/cytology*;Osteoclasts/drug effects*;Osteogenesis/drug effects;RANK Ligand/pharmacology;Receptors, Retinoic Acid/agonists;Receptors, Retinoic Acid/antagonists & inhibitors;Receptors, Retinoic Acid/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Tartrate-Resistant Acid Phosphatase;Tretinoin/pharmacology*
21386579;Arsenic/chemistry*;Germanium/chemistry*;Glass/chemistry*;Models, Chemical*;Tellurium/chemistry*;X-Ray Diffraction*
21398204;Aged;Biopsy;Carcinoma, Verrucous/complications*;Carcinoma, Verrucous/diagnosis*;Carcinoma, Verrucous/pathology;Condylomata Acuminata/complications*;Condylomata Acuminata/virology;Genital Neoplasms, Male/complications*;Genital Neoplasms, Male/diagnosis*;Genital Neoplasms, Male/pathology;Humans;Immunohistochemistry;Male;Paget Disease, Extramammary/complications*;Paget Disease, Extramammary/diagnosis*;Paget Disease, Extramammary/pathology;Papillomavirus Infections/complications;Skin/pathology
21401899;Adolescent;Adult;Aged;Aged, 80 and over;Biomarkers, Tumor/blood*;Case-Control Studies;Enzyme-Linked Immunosorbent Assay;Female;Humans;Intracellular Signaling Peptides and Proteins/blood*;Male;Middle Aged;Oncogene Proteins/blood*;Pancreatic Neoplasms/blood;Pancreatic Neoplasms/diagnosis*;Pancreatitis, Chronic/blood*;Prognosis;Protein Deglycase DJ-1;Young Adult
21425096;Genotype;Punicaceae/genetics*;Random Amplified Polymorphic DNA Technique;Turkey
21429197;Autoantibodies/blood;C-Peptide/blood;Child;Cohort Studies;Diabetes Mellitus, Type 1/complications;Diabetes Mellitus, Type 1/genetics*;Diabetic Ketoacidosis/etiology;Diabetic Ketoacidosis/genetics*;Enzyme-Linked Immunosorbent Assay;Female;Genetic Predisposition to Disease/genetics*;Humans;Male;Polymorphism, Single Nucleotide/genetics;Proinsulin/genetics*;Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics*;Regression Analysis;Time Factors
21432817;Adult;Chromosome Aberrations*;Delayed Diagnosis;Heart Neoplasms/diagnosis*;Heart Neoplasms/genetics;Heart Neoplasms/surgery*;Humans;Male;Sarcoma/diagnosis*;Sarcoma/genetics;Sarcoma/surgery*
21448157;Animals;Cells, Cultured;Chromosome Segregation/physiology*;Epithelial Cells/cytology;Genomic Instability*;Intestinal Mucosa/cytology*;Intestine, Small/cytology*;Male;Mice;Mice, Inbred C57BL;Monte Carlo Method;Stem Cells/cytology*
21467828;Diagnostic Imaging;Humans;Liver Neoplasms/pathology*;Myocardial Infarction/pathology*;Paraffin Embedding*;Terahertz Spectroscopy/methods*
21476440;Blotting, Western;Cell Differentiation*;Cells, Cultured;Humans;Keratinocytes/cytology*;Keratinocytes/enzymology;Protein Kinases/metabolism*;Signal Transduction*
21476821;Brain Neoplasms/surgery*;Cost-Benefit Analysis;Cranial Irradiation;Humans;Quality-Adjusted Life Years;Radiosurgery/economics*
21497694;Biomedical Research*/ethics;Humans;Infant, Newborn;Informed Consent*;Pain Management*;Pain Measurement
21518348;Humans;Language*;Language Disorders/diagnosis*;Memory Disorders/etiology;Reading*;Vocabulary*
21555087;Adolescent;Adult;Africa South of the Sahara;Delivery, Obstetric/statistics & numerical data;Female;Health Services Accessibility/economics;Humans;Maternal Health Services/economics*;Middle Aged;Private Sector/economics*;Public Sector/economics*;Quality of Health Care/statistics & numerical data*;Reproductive Health Services/economics*;Reproductive Health Services/utilization*;Sexually Transmitted Diseases/diagnosis;Sexually Transmitted Diseases/therapy;Women's Health;Young Adult
21562189;Action Potentials/physiology;Animals;Hippocampus/physiology*;Humans;Memory/physiology*;Psychomotor Performance/physiology*;Theta Rhythm/physiology*
21563247;Aged;Diffusion;Embolization, Therapeutic/adverse effects;Female;Humans;Image Processing, Computer-Assisted;Leiomyoma/diagnosis*;Leiomyoma/etiology*;Magnetic Resonance Imaging/methods;Middle Aged;Necrosis;ROC Curve;Retrospective Studies;Sensitivity and Specificity;Uterine Artery/pathology*;Uterine Artery Embolization/adverse effects*
21592496;Breast Feeding/statistics & numerical data*;Female;Humans;Infant Formula*;Infant Nutritional Physiological Phenomena/physiology*;Male;Milk, Human*;Nutrition Surveys/methods*;Nutritional Status/physiology*
21594863;Adolescent;Female;Headache/cerebrospinal fluid;Headache/etiology*;Humans;Lymphocytosis/cerebrospinal fluid*;Lymphocytosis/etiology*;Nervous System Diseases/cerebrospinal fluid*;Nervous System Diseases/complications;Nervous System Diseases/etiology*;Papilledema/cerebrospinal fluid*;Papilledema/complications*;Syndrome
21613815;Animals;Humans;Kidney/cytology*;Kidney/physiology*;Regeneration/physiology*;Stem Cells/cytology*
21620153;Coloring Agents;Female;Fluorescein Angiography*;Humans;Indocyanine Green;Mammaplasty*;Surgical Flaps/blood supply*
21640217;Acute Coronary Syndrome/diagnostic imaging;Acute Coronary Syndrome/drug therapy;Acute Coronary Syndrome/therapy*;Aged;Angioplasty, Balloon, Coronary*/adverse effects;Coronary Angiography;Female;Humans;Male;Middle Aged;Platelet Aggregation Inhibitors/administration & dosage*;Stents/adverse effects;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*
21664413;Age Factors;Aging;Biological Transport;Calcium/metabolism*;Estrogens/blood;Female;Glucocorticoids/pharmacology;Homeostasis;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Intestines/metabolism*;Lactation/metabolism;Pregnancy;Prolactin/blood;Vitamin D/metabolism*
21675264;Bronchi/pathology;Disease Progression;Endothelium, Vascular/pathology*;Free Radicals/metabolism*;Humans;Nitric Oxide/metabolism;Oxidation-Reduction;Pulmonary Disease, Chronic Obstructive/physiopathology*;Risk Factors
21677498;Abdominal Wall/pathology*;Adenocarcinoma/complications;Adenocarcinoma/pathology;Adenocarcinoma/surgery*;Cecal Neoplasms/complications;Cecal Neoplasms/pathology;Cecal Neoplasms/surgery*;Crohn Disease/complications;Crohn Disease/surgery*;Fatal Outcome;Humans;Ileal Neoplasms/complications;Ileal Neoplasms/pathology;Ileal Neoplasms/surgery*;Male;Middle Aged;Neoplasm Invasiveness;Recurrence;Tomography, X-Ray Computed
21709443;Animals;Annexin A5/biosynthesis;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Cell Cycle/drug effects;Cell Death/drug effects;Cell Line, Tumor/drug effects;Cyclin-Dependent Kinase Inhibitor p21/biosynthesis;Humans;Male;Mice;Mice, Nude;Mitochondria/enzymology;Prostatic Neoplasms/drug therapy*;Prostatic Neoplasms/metabolism;Prostatic Neoplasms/pathology;Topotecan/administration & dosage;Topotecan/pharmacology;Topotecan/therapeutic use*;Tumor Suppressor Protein p53/biosynthesis
21712694;Adolescent;Femoral Nerve/pathology;Femoral Nerve/surgery*;Humans;Male;Motor Neurons;Nerve Transfer/methods*;Obturator Nerve/transplantation*;Peripheral Nervous System Neoplasms/surgery*
21741572;Clinical Medicine/education*;Emergency Nursing/education*;Humans;Maine;Nursing Staff, Hospital/education*
21751229;Female;Humans;Likelihood Functions;Models, Statistical*;Patient Compliance/statistics & numerical data;Randomized Controlled Trials as Topic/statistics & numerical data*;Smoking Cessation/statistics & numerical data;Treatment Outcome
21762632;Exercise Test/methods*;Humans;Lung Neoplasms/surgery*;Pneumonectomy;Respiratory Function Tests
21778008;Adult;Community-Based Participatory Research;Emigration and Immigration/legislation & jurisprudence*;Fear/psychology*;Female;Focus Groups;Health Services Accessibility;Health Status*;Humans;Law Enforcement;Male;Massachusetts;Middle Aged;Perception;Stress, Psychological;Transients and Migrants/legislation & jurisprudence;Transients and Migrants/psychology*;Transients and Migrants/statistics & numerical data;United States;United States Government Agencies/organization & administration*
21781002;Acute-Phase Proteins/analysis;Acute-Phase Proteins/metabolism;Acute-Phase Proteins/urine*;Adult;Case-Control Studies;Early Diagnosis;Female;Health;Humans;Infant, Extremely Low Birth Weight*/metabolism;Infant, Extremely Low Birth Weight*/urine;Infant, Newborn;Kidney Failure, Chronic/diagnosis*;Kidney Failure, Chronic/urine;Lipocalin-2;Lipocalins/analysis;Lipocalins/metabolism;Lipocalins/urine*;Male;Metabolomics/methods*;Proto-Oncogene Proteins/analysis;Proto-Oncogene Proteins/metabolism;Proto-Oncogene Proteins/urine*;Urinalysis/methods;Young Adult
21788134;Antineoplastic Agents/chemical synthesis;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacology*;Cell Death/drug effects;Cell Line, Tumor;Cell Membrane Permeability/drug effects*;Cell Proliferation/drug effects;Dose-Response Relationship, Drug;Drug Design;Drug Screening Assays, Antitumor;Humans;Ligands;Models, Molecular;Molecular Structure;Molecular Weight;STAT3 Transcription Factor/antagonists & inhibitors*;STAT3 Transcription Factor/metabolism;Salicylic Acid/chemical synthesis;Salicylic Acid/chemistry;Salicylic Acid/pharmacology*;Small Molecule Libraries;Stereoisomerism;Structure-Activity Relationship;src Homology Domains/drug effects*
21795810;Amino Acid Sequence;Catalase/chemistry*;Humans;Models, Molecular;Molecular Sequence Data;Peroxisomes/enzymology*;Pichia/enzymology*;Protein Structure, Quaternary;Protein Structure, Tertiary;Sequence Alignment
21800240;Aged;Aged, 80 and over;Chronic Disease/epidemiology;Chronic Disease/rehabilitation;Delivery of Health Care/trends;Female;Forecasting;Germany;Health Policy/trends;Health Services Needs and Demand/trends;Health Services for the Aged/trends*;Humans;Male;National Health Programs/trends*;Patient Participation/trends;Population Dynamics*;Prejudice*;Stereotyping*
21808952;Adenocarcinoma/drug therapy;Adenocarcinoma/secondary*;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Axilla;Biomarkers, Tumor/blood;Fatal Outcome;Humans;Male;Middle Aged;Neoplasms, Unknown Primary/drug therapy;Neoplasms, Unknown Primary/pathology*;Palliative Care;Skin Neoplasms/drug therapy;Skin Neoplasms/secondary*
21826380;Disinfectants*/chemistry;Disinfectants*/toxicity;Environment;European Union;Food Industry;Government Agencies;Legislation, Drug*;Public Health;Public Policy;Registries*;Spain
21827790;Animals;Antibodies, Viral/immunology;Area Under Curve;Cloning, Molecular;Enzyme-Linked Immunosorbent Assay/methods*;Enzyme-Linked Immunosorbent Assay/veterinary;Immune Sera/immunology;Immunoglobulin M/immunology;Livestock/virology;Nucleocapsid Proteins/immunology*;Recombinant Proteins/immunology;Reproducibility of Results;Rift Valley Fever/diagnosis*;Rift Valley Fever/immunology;Rift Valley Fever/veterinary;Rift Valley Fever/virology;Rift Valley fever virus/immunology;Rift Valley fever virus/isolation & purification*;Rift Valley fever virus/pathogenicity;Ruminants/immunology;Ruminants/virology*;Sensitivity and Specificity
21834608;Cerebral Palsy/prevention & control;Ductus Arteriosus, Patent/epidemiology;Female;Gestational Age;Humans;Infant Mortality;Infant, Newborn;Infant, Premature*/blood;Infant, Premature, Diseases/chemically induced;Infant, Premature, Diseases/epidemiology*;Magnesium/blood;Magnesium Sulfate/administration & dosage*;Magnesium Sulfate/adverse effects*;Neuroprotective Agents/administration & dosage*;Pregnancy;Retinopathy of Prematurity/epidemiology;Retrospective Studies;Treatment Outcome
21849321;Animal Fins/anatomy & histology;Animals;Eels/anatomy & histology;Eels/classification*;Female;Fossils;Gills/anatomy & histology;Palau;Phylogeny*
21862084;Electromyography/methods*;Female;Humans;Male;Urinary Bladder/physiopathology*;Urination Disorders/diagnosis*;Urodynamics/physiology*
21884278;Animals;Female;Insemination, Artificial/veterinary;Male;Pregnancy;Semen Preservation/methods;Semen Preservation/veterinary*;Specimen Handling/methods;Specimen Handling/veterinary*;Spermatozoa/physiology*;Swine/physiology*
21893814;Algorithms;Behavior;Decision Support Systems, Clinical*;Diagnosis, Computer-Assisted/methods*;Hospitalization;Humans;Patient Compliance;Patient Readmission;Program Development/methods;Recurrence;Remote Consultation/methods*;Schizophrenia/diagnosis*;Schizophrenia/prevention & control;Schizophrenic Psychology;Software;Telemedicine/methods*;Text Messaging;Time Factors
21894070;Colonialism/history;History, 19th Century;History, 20th Century;Humans;Korea;Malaria/diagnosis;Malaria/drug therapy;Malaria/history*;Malaria, Vivax/diagnosis;Malaria, Vivax/drug therapy;Malaria, Vivax/history;Microscopy, Polarization;Plasmodium malariae/isolation & purification;Plasmodium ovale/isolation & purification;Plasmodium vivax/isolation & purification;Quinine/history;Quinine/therapeutic use
21899490;Analgesics*/chemical synthesis;Analgesics*/chemistry;Analgesics*/pharmacology;Animals;Anti-Inflammatory Agents, Non-Steroidal*/chemical synthesis;Anti-Inflammatory Agents, Non-Steroidal*/chemistry;Anti-Inflammatory Agents, Non-Steroidal*/pharmacology;Female;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry;Mice;Oxadiazoles*/chemical synthesis;Oxadiazoles*/chemistry;Oxadiazoles*/pharmacology;Spectroscopy, Fourier Transform Infrared;Stomach Ulcer/chemically induced*;Thiazoles*/chemical synthesis;Thiazoles*/chemistry;Thiazoles*/pharmacology
21909936;Agrobacterium/genetics;Naphthoquinones/immunology*;Naphthoquinones/metabolism*;Plant Roots/metabolism;Plants, Genetically Modified;Plumbaginaceae;Recombinant Proteins/genetics;Recombinant Proteins/metabolism;Single-Chain Antibodies/genetics*
21915146;Animals;Drosophila Proteins/metabolism*;Gene Expression Regulation, Developmental*;Glycoproteins/metabolism*;Protein Interaction Mapping*;Receptor Protein-Tyrosine Kinases/metabolism*;Signal Transduction*;Wnt Proteins/metabolism*
21918455;Adult;Age Factors;Bias*;Child;Cohort Studies*;Denmark/epidemiology;Disease/etiology;Female;Humans;Logistic Models;Male;Maternal Age;Patient Dropouts/statistics & numerical data*;Registries;Young Adult
21925624;Adhesiveness;Animals;Biocompatible Materials/chemistry*;Dimethylpolysiloxanes/chemistry*;Materials Testing;Microscopy, Atomic Force;Microscopy, Electron, Scanning;Nanostructures;Surface Properties
21928150;Biodiversity;Conservation of Natural Resources;Ecosystem;Environmental Monitoring;Forestry/methods;Forestry/statistics & numerical data*;Pennsylvania;Statistics as Topic;Trees/growth & development*
21947764;Animals;Female;Humans;Mastitis/epidemiology*;Mastitis/etiology*
21948562;Amino Acids/chemistry*;Amino Acids/metabolism*;Cell Line, Tumor;Gold/chemistry*;Gold/metabolism*;Humans;Metal Nanoparticles/chemistry*;Peptides/chemistry*;Peptides/metabolism*;Surface Properties
21963692;Adult;Attention;Case-Control Studies;Cognition Disorders/diagnosis;Cognition Disorders/epidemiology*;Cognition Disorders/psychology;Comorbidity;Depressive Disorder/epidemiology*;Depressive Disorder/psychology;Female;Humans;Longitudinal Studies;Male;Memory, Short-Term;Neuropsychological Tests;Psychomotor Performance;Reaction Time;Schizophrenia/epidemiology*;Schizophrenic Psychology;Slovenia/epidemiology;Trail Making Test;Verbal Learning;Young Adult
21976345;Adolescent;Adult;Aged;Aged, 80 and over;Child;Child, Preschool;Emigrants and Immigrants/statistics & numerical data*;Female;Forecasting;Health Care Reform/legislation & jurisprudence*;Humans;Infant;Infant, Newborn;Insurance Coverage/statistics & numerical data;Insurance Coverage/trends*;Male;Medically Uninsured/statistics & numerical data*;Middle Aged;Patient Protection and Affordable Care Act;Private Sector;Public Sector;Socioeconomic Factors;United States;Young Adult
22014287;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use*;Aripiprazole;Bipolar Disorder/drug therapy*;Female;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/therapeutic use;Male;Piperazines/adverse effects;Piperazines/therapeutic use*;Practice Guidelines as Topic;Quinolones/adverse effects;Quinolones/therapeutic use*
22018440;Anesthesia, Epidural/methods*;Anesthesia, Local/methods*;Anesthetics/administration & dosage*;Female;Follow-Up Studies;Humans;Infusions, Parenteral/utilization;Infusions, Spinal/utilization;Laparotomy/methods*;Male;Middle Aged;Pain Measurement;Pain, Postoperative/therapy*;Retrospective Studies;Treatment Outcome
22031703;Adolescent;Adult;Aged;Aged, 80 and over;Bacteremia/diagnosis*;Bacteremia/microbiology;Bacteriological Techniques/methods*;Blood/microbiology*;Humans;Middle Aged;Mycobacterium tuberculosis/genetics;Mycobacterium tuberculosis/isolation & purification*;Real-Time Polymerase Chain Reaction/methods*;Sensitivity and Specificity;Specimen Handling/methods*;Tuberculosis/diagnosis*;Tuberculosis/microbiology;Young Adult
22032655;Acculturation*;Adaptation, Psychological*;Breast Neoplasms/psychology*;China/ethnology;Female;Humans;United States
22038856;Beverages*;Camellia sinensis*;Drinking*;Female;Humans;Plant Extracts/administration & dosage*;Urinary Incontinence/prevention & control*
22041966;Adrenal Cortex Hormones/therapeutic use;Dermatitis, Atopic*/complications;Dermatitis, Atopic*/diagnosis;Dermatitis, Atopic*/prevention & control;Dermatitis, Atopic*/therapy;Diagnosis, Differential;Drugs, Chinese Herbal/therapeutic use;Emollients/therapeutic use;Humans;Patient Education as Topic
22045771;Antineoplastic Agents/administration & dosage*;Female;Hematologic Neoplasms/therapy*;Hematopoietic Stem Cell Transplantation*;Humans;Male;Transplantation Conditioning*;Vidarabine/administration & dosage;Vidarabine/analogs & derivatives*;Whole-Body Irradiation*
22047642;Antineoplastic Agents/chemical synthesis;Antineoplastic Agents/chemistry*;Antineoplastic Agents/pharmacology*;Cell Line, Tumor;Cell Survival/drug effects;Chelating Agents/chemical synthesis;Chelating Agents/chemistry;Chelating Agents/pharmacology;Coordination Complexes/chemical synthesis;Coordination Complexes/chemistry*;Coordination Complexes/pharmacology*;Crystallography, X-Ray;Humans;Ligands;Models, Molecular;Neoplasms/drug therapy;Nickel/chemistry*;Nickel/pharmacology*;Pyrazoles/chemical synthesis;Pyrazoles/chemistry;Pyrazoles/pharmacology
22066820;Animals;Choroid Diseases/drug therapy*;Glucocorticoids/administration & dosage*;Glucocorticoids/adverse effects;Humans;Intravitreal Injections;Retinal Diseases/drug therapy*;Risk Assessment;Risk Factors;Treatment Outcome;Triamcinolone Acetonide/administration & dosage*;Triamcinolone Acetonide/adverse effects
22075837;Alveolar Process/surgery*;Child, Preschool;Cicatrix/surgery;Cleft Lip/surgery*;Cleft Palate/surgery*;Esthetics;Female;Humans;Infant;Male;Reconstructive Surgical Procedures/methods*;Surgical Flaps*;Treatment Outcome
22095334;Conflict of Interest;Industry*;Medicine*;Public Health*
22098646;Acute Disease;Humans;Magnetic Resonance Imaging;Tomography, X-Ray Computed;Vertigo/diagnosis*;Vertigo/etiology
22108907;Absorbable Implants*;Aged;Australia;Cardiovascular Agents/administration & dosage*;Coronary Angiography;Coronary Artery Disease/diagnostic imaging;Coronary Artery Disease/pathology;Coronary Artery Disease/therapy*;Coronary Vessels/diagnostic imaging*;Coronary Vessels/pathology;Europe;Everolimus;Female;Fibrosis;Humans;Male;Middle Aged;Necrosis;New Zealand;Percutaneous Coronary Intervention/adverse effects;Percutaneous Coronary Intervention/instrumentation*;Plaque, Atherosclerotic*;Predictive Value of Tests;Prosthesis Design;Sirolimus/administration & dosage;Sirolimus/analogs & derivatives*;Time Factors;Tissue Scaffolds*;Treatment Outcome;Ultrasonography, Interventional*
22126606;Adsorption;Benzenesulfonates/chemistry;Chromium/chemistry*;Graphite/chemistry*;Iron;Magnetics*;Nanoparticles/chemistry*;Waste Disposal, Fluid;Water Pollutants, Chemical/chemistry;Water Purification
22144388;Animals;Data Collection;Decision Making;Ecosystem*;Humans;Models, Theoretical*;Social Behavior*
22150672;Biological Transport, Active;Caco-2 Cells/metabolism*;Cell Membrane Permeability/physiology*;Flavanones/metabolism*;Humans;Hydrogen-Ion Concentration;Membranes, Artificial*;Models, Theoretical;Permeability;Pharmaceutical Preparations
22151914;Adult;Algorithms;Biomechanical Phenomena;Data Interpretation, Statistical;Electromyography/statistics & numerical data*;Female;Fuzzy Logic*;Gait/physiology;Humans;Locomotion/physiology*;Male;Middle Aged;Models, Statistical;Muscle, Skeletal/physiology;Parkinson Disease/physiopathology;Parkinson Disease/rehabilitation;Reflex/physiology;Reproducibility of Results;Spinal Cord Injuries/physiopathology;Spinal Cord Injuries/rehabilitation;Walking/physiology
22153755;Carcinoma, Renal Cell/surgery*;Carcinoma, Renal Cell/therapy;Clinical Trials as Topic;Combined Modality Therapy;Humans;Kidney Neoplasms/surgery*;Kidney Neoplasms/therapy;Nephrectomy;Patient Selection;Time Factors;Tomography, X-Ray Computed;Treatment Outcome
22155574;Aged;Aged, 80 and over;Ambulatory Care;California;Female;Humans;Inappropriate Prescribing/statistics & numerical data*;Male;Medicare Part D/statistics & numerical data*;Polypharmacy;United States
22168139;Animals;Animals, Genetically Modified;Blood Platelets/immunology*;Galactosyltransferases/genetics;Galactosyltransferases/metabolism;Humans;Liver Transplantation/immunology*;Liver Transplantation/pathology;Papio/immunology*;Platelet Aggregation/immunology;Swine/immunology*;Thrombocytopenia/immunology*;Transplantation, Heterologous/immunology*;Transplantation, Heterologous/pathology
22187960;Carcinosarcoma/genetics;DEAD-box RNA Helicases/genetics*;Female;Gene Expression;Gene Expression Profiling;Germ-Line Mutation;Humans;MicroRNAs/metabolism;Mutation, Missense*;Neoplasms, Germ Cell and Embryonal/genetics;Ovarian Neoplasms/genetics*;Rhabdomyosarcoma/genetics;Ribonuclease III/genetics*;Sequence Analysis, DNA;Sertoli-Leydig Cell Tumor/genetics*
22200917;Aged;Autoimmune Diseases/diagnostic imaging*;Autoimmune Diseases/pathology;Autoimmune Diseases/therapy;Bile Duct Neoplasms/diagnostic imaging*;Bile Duct Neoplasms/pathology;Bile Duct Neoplasms/therapy;Bile Ducts, Extrahepatic*;Cholangiocarcinoma/diagnostic imaging*;Cholangiocarcinoma/pathology;Cholangiocarcinoma/therapy;Contrast Media;Diagnosis, Differential;Female;Humans;Male;Middle Aged;Pancreatitis/diagnostic imaging*;Pancreatitis/pathology;Pancreatitis/therapy;Radiographic Image Interpretation, Computer-Assisted;Retrospective Studies;Tomography, X-Ray Computed/methods*
22206064;Adult;Diabetes Mellitus, Type 2/ethnology*;Diabetes Mellitus, Type 2/genetics*;Female;Genetics, Population;Haplotypes/genetics;Humans;KCNQ1 Potassium Channel/genetics*;Malaysia;Male;Middle Aged;Polymorphism, Single Nucleotide/genetics;Sequence Analysis, DNA
22210396;Adaptation, Physiological;Adolescent;Age Factors;Blood Pressure/physiology*;Cardiovascular Physiological Phenomena;Carotid Arteries/anatomy & histology;Energy Metabolism/physiology;Exercise Test;Female;Heart Rate;Humans;Male;Reference Values;Sex Factors;Stress, Psychological/pathology;Stress, Psychological/physiopathology*;Tunica Intima/anatomy & histology*;Tunica Media/anatomy & histology*
22210766;Biotin/biosynthesis*;Carbon-Nitrogen Ligases/genetics*;Carbon-Nitrogen Ligases/metabolism*;DNA, Bacterial/genetics;DNA, Bacterial/metabolism;Electrophoretic Mobility Shift Assay;Escherichia coli/genetics*;Escherichia coli/metabolism*;Escherichia coli Proteins/genetics*;Escherichia coli Proteins/metabolism*;Gene Expression Regulation, Bacterial*;Models, Biological;Operator Regions, Genetic;Protein Binding;Repressor Proteins/genetics*;Repressor Proteins/metabolism*;Suppression, Genetic*;Transcription, Genetic
22211942;Adult;Algorithms*;Anisotropy;Data Interpretation, Statistical;Diffusion;Diffusion Tensor Imaging/methods*;Epilepsy, Temporal Lobe/pathology*;Female;Humans;Image Enhancement/methods;Image Interpretation, Computer-Assisted/methods*;Imaging, Three-Dimensional/methods*;Male;Middle Aged;Reproducibility of Results;Sensitivity and Specificity
22215839;Biomarkers/metabolism*;Female;Humans;Hydrocortisone/metabolism*;Male;Saliva/chemistry*;Shock, Septic/metabolism*
22216119;Animals;Apoptosis;Blotting, Western;Cell Nucleus/metabolism*;Cell Proliferation*;Cyclin-Dependent Kinase Inhibitor p21/antagonists & inhibitors*;Humans;Insulin/secretion*;Islets of Langerhans/cytology*;Islets of Langerhans/secretion;Mice;Microscopy, Confocal;Phosphorylation;Protein Kinase C-delta/metabolism*
22220502;Administration, Intranasal;Adolescent;Age of Onset;Analgesics, Opioid/administration & dosage*;Female;Health Surveys;Humans;Male;Massachusetts;Opioid-Related Disorders/diagnosis*;Opioid-Related Disorders/therapy;Oxycodone/administration & dosage*;Young Adult
22237435;Apoptosis/genetics;Autoimmune Lymphoproliferative Syndrome/diagnosis;Autoimmune Lymphoproliferative Syndrome/genetics*;Cell Line;Fas Ligand Protein/metabolism;Gene Expression;Gene Frequency;Gene Order;Genetic Association Studies;Haploinsufficiency;Humans;Mutation*;Penetrance*;Protein Binding;Protein Structure, Tertiary/genetics;RNA Stability;T-Lymphocytes/metabolism;fas Receptor/chemistry;fas Receptor/genetics*;fas Receptor/metabolism
22251615;Adult;Aged;Analysis of Variance;Body Mass Index;Bone Density/drug effects*;Bone Density Conservation Agents/adverse effects*;Breast Neoplasms/chemically induced*;Breast Neoplasms/surgery;Double-Blind Method;Estrogen Replacement Therapy;Female;Humans;Middle Aged;Neoplasm Recurrence, Local/chemically induced*;Norpregnenes/adverse effects*;Osteoporosis/prevention & control*;Selective Estrogen Receptor Modulators/adverse effects*;Survivors
22262456;Animals;Cells, Cultured;Focal Adhesion Protein-Tyrosine Kinases/metabolism;Integrin alphaV/metabolism*;Integrin beta Chains/metabolism*;Phagocytosis*;Proto-Oncogene Proteins/metabolism;Rats;Receptor Protein-Tyrosine Kinases/metabolism;Retinal Pigment Epithelium/cytology*;Retinal Pigment Epithelium/metabolism;c-Mer Tyrosine Kinase;rac1 GTP-Binding Protein/metabolism*
22271229;Abatacept;Antibodies, Monoclonal, Humanized/therapeutic use*;Antirheumatic Agents/therapeutic use;Arthritis, Rheumatoid/therapy*;Cost-Benefit Analysis;Decision Making;England;Guidelines as Topic;Health Care Costs;Health Services Accessibility;Humans;Immunoconjugates/therapeutic use*;National Health Programs;Outcome Assessment (Health Care);Rheumatology/methods*;Treatment Outcome;Wales
22282650;Adult;Aged;Female;Genetic Predisposition to Disease;Glucosylceramidase/genetics*;Humans;Male;Middle Aged;Mutation;Parkinson Disease/genetics*;Penetrance;Phenotype
22303464;Animals;Ceratitis capitata/genetics*;Ceratitis capitata/growth & development*;Female;Gene Expression Profiling/methods*;Gene Expression Regulation, Developmental;Genes, Insect/genetics;Immunity/genetics;Male;Mediterranean Region;Oligonucleotide Array Sequence Analysis;RNA, Messenger/genetics;RNA, Messenger/metabolism;Real-Time Polymerase Chain Reaction;Reproducibility of Results;Sexual Behavior, Animal/physiology*;Sexual Maturation/genetics*;Transcription, Genetic;Transcriptome/genetics
22304841;Female;Humans;Insulin Resistance/genetics*;Polymorphism, Genetic/genetics*;Receptors, Calcitriol/genetics*;Vitamin D/pharmacology*;Vitamins/pharmacology*
22307863;Anatomic Landmarks/blood supply*;Anatomic Landmarks/innervation;Endoscopy/adverse effects;Endoscopy/methods*;Epiglottis/surgery*;Female;Humans;Larynx/blood supply;Larynx/surgery*;Male;Microsurgery/adverse effects;Microsurgery/methods*;Postoperative Hemorrhage/epidemiology;Postoperative Hemorrhage/etiology*;Surgical Instruments/adverse effects*
22323126;Animals;Azoxymethane/pharmacology;Blotting, Western;Carcinogens/pharmacology;Colitis/chemically induced;Colitis/pathology;Colonic Neoplasms/pathology*;Dextran Sulfate;Diet, High-Fat/adverse effects;Glucagon-Like Peptide 2/pharmacology*;Imidazoles/pharmacology;Immunohistochemistry;Inflammation/pathology;Male;Mice;Mice, Inbred C57BL;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Rats;Rats, Inbred F344;Real-Time Polymerase Chain Reaction;beta Catenin/biosynthesis
22325051;Adult;Follow-Up Studies;Graft Rejection/diagnostic imaging;Graft Rejection/etiology*;Graft Rejection/pathology;Hand Injuries/complications;Hand Injuries/surgery*;Hand Transplantation*;Humans;Male;Middle Aged;Postoperative Complications*;Prognosis;Ultrasonography;Vascular Diseases/diagnostic imaging;Vascular Diseases/etiology*;Vascular Diseases/pathology
22341612;Adult;Female;Gastrointestinal Stromal Tumors/blood supply;Gastrointestinal Stromal Tumors/pathology;Gastrointestinal Stromal Tumors/secondary*;Gastrointestinal Stromal Tumors/surgery*;Hepatectomy/methods*;Humans;Liver Neoplasms/blood supply;Liver Neoplasms/pathology;Liver Neoplasms/secondary*;Liver Neoplasms/surgery*;Portal Vein*;Therapeutic Occlusion*;Tourniquets*
22344993;Angioplasty, Balloon, Coronary/adverse effects*;Cardiovascular Diseases/etiology*;Coronary Occlusion/therapy*;Female;Humans;Male
22352661;Animals;Chickens;Electroretinography/methods*;Evoked Potentials, Visual/physiology*;Retina/physiology*;Signal Processing, Computer-Assisted*;Tomography, Optical Coherence/methods*
22352741;Culture;Ethics, Professional;Humans;Morals;Professional Competence*;Psychology/ethics*;Self-Assessment;Social Responsibility*
22362840;Adolescent;Adult;Aged;Aged, 80 and over;Child;Cyclic AMP/metabolism*;Cyclic GMP/metabolism*;Female;Humans;Male;Middle Aged;Mucus/metabolism*;Olfaction Disorders/diagnosis;Olfaction Disorders/metabolism*;Olfactory Mucosa/metabolism*;Olfactory Mucosa/pathology;Reference Values;Taste Disorders/diagnosis;Taste Disorders/metabolism*;Young Adult
22364968;Adult;Age Factors;Aged;Aortic Valve/surgery*;Bioprosthesis*;Female;Heart Valve Prosthesis*;Humans;Male;Middle Aged;Mitral Valve/surgery*;Monitoring, Physiologic;Prospective Studies;Young Adult
22372852;Adult;Angiography/methods;Biopsy, Needle;Cardiac Surgical Procedures/methods*;Disease Progression;Dyspnea/diagnosis;Dyspnea/etiology;Echocardiography/methods;Embolectomy/methods*;Female;Follow-Up Studies;Heart Atria/pathology;Heart Atria/surgery;Heart Neoplasms/complications*;Heart Neoplasms/diagnosis;Heart Neoplasms/surgery;Humans;Immunohistochemistry;Myxoma/complications*;Myxoma/diagnosis;Myxoma/surgery;Pulmonary Embolism/diagnosis;Pulmonary Embolism/etiology*;Pulmonary Embolism/surgery;Rare Diseases;Risk Assessment;Tomography, X-Ray Computed/methods;Treatment Outcome
22374820;Coordination Complexes/chemistry;Electron Transport;Ligands;Metals/chemistry*;Organic Chemicals/chemistry*;Temperature;X-Rays
22384716;Beta Particles*;Cell Line;Cesium Radioisotopes/chemistry;Chromatin/chemistry;Chromatin/radiation effects;DNA/radiation effects*;Dose-Response Relationship, Radiation;Endothelial Cells/drug effects*;Endothelial Cells/metabolism;Gamma Rays;HeLa Cells;Humans;Nitric Oxide/biosynthesis*;Superoxides/metabolism*;Thymidine/chemistry;Tritium/chemistry
22387714;Adolescent;Adult;Feeding Behavior*;Female;Food Contamination*;Humans;Interpersonal Relations*;Male;Sexual Partners;Social Behavior*;Social Desirability*;Social Perception*;Videotape Recording;Young Adult
22395053;Animals;Calcium Channel Blockers/pharmacology*;Cotinine/blood;Disease Models, Animal;Male;Nifedipine/pharmacology;Rats;Rats, Wistar;Reperfusion Injury/blood;Reperfusion Injury/drug therapy*;Sciatic Nerve/blood supply;Sciatic Nerve/drug effects*;Smoking/adverse effects*;Vasodilator Agents/pharmacology*;Verapamil/pharmacology
22409279;Ablation Techniques;Animals;Axons/physiology*;Disease Models, Animal;Humans;Male;Motor Neurons/physiology*;Nerve Regeneration*;Peripheral Nerve Injuries/physiopathology*;Peroneal Nerve/physiology*;Rats;Rats, Sprague-Dawley;Sensory Receptor Cells/physiology*;Spinal Nerve Roots/physiology;Spinal Nerve Roots/surgery;Tibial Nerve/physiology*
22412099;Anticholesteremic Agents/administration & dosage*;Azetidines/administration & dosage*;Cholesterol, Dietary/pharmacokinetics*;Female;Humans;Hypercholesterolemia/drug therapy*;Lipid Metabolism/drug effects*;Male;Phytosterols/administration & dosage*
22425025;Animals;Biodegradation, Environmental;Blotting, Western;Cell Death;Chondrogenesis*;Coated Materials, Biocompatible/chemistry;Core Binding Factor Alpha 1 Subunit/genetics;Core Binding Factor Alpha 1 Subunit/metabolism*;Female;Gene Expression Regulation;Gene Transfer Techniques*;Humans;Lactic Acid/chemistry*;Light;Mesenchymal Stromal Cells/cytology;Mesenchymal Stromal Cells/drug effects;Mesenchymal Stromal Cells/metabolism;Mice;Mice, Inbred BALB C;Nanoparticles/chemistry*;Nanoparticles/ultrastructure;Particle Size;Polyglycolic Acid/chemistry*;RNA, Small Interfering/metabolism*;Real-Time Polymerase Chain Reaction;SOX9 Transcription Factor/genetics*;SOX9 Transcription Factor/metabolism;Scattering, Radiation;Transfection
22434819;Adolescent;Adult;Aged;Algorithms;Atherosclerosis/diagnosis*;Atherosclerosis/pathology;Child;Databases, Factual;Diagnostic Techniques, Cardiovascular*;Early Diagnosis;Female;Humans;Internet;Male;Medical Informatics/methods*;Middle Aged;Risk Factors
22445157;Female;HIV Infections*;Health Knowledge, Attitudes, Practice*;Homosexuality;Humans;Interviews as Topic;Los Angeles;Male;Qualitative Research;Religion and Medicine*;Risk-Taking;Social Stigma*;Social Values*;Substance Abuse, Intravenous;Urban Population
22468845;Antibodies, Monoclonal, Humanized/administration & dosage;Antibodies, Monoclonal, Humanized/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Cell Line, Tumor;Cell Proliferation/drug effects;Cyclopentanes/pharmacology*;Dose-Response Relationship, Drug;Female;Gene Expression Regulation/drug effects*;Genes, fos;Humans;Quinolines/pharmacology*;Receptors, Estrogen/agonists*;Receptors, G-Protein-Coupled/agonists*;Trastuzumab
22488866;Chemical and Drug Induced Liver Injury/diagnosis*;Chemical and Drug Induced Liver Injury/etiology;Colitis, Ulcerative/complications;Colitis, Ulcerative/drug therapy*;Female;Glucocorticoids/adverse effects*;Glucocorticoids/therapeutic use;Humans;Middle Aged;Prednisolone/adverse effects*;Prednisolone/therapeutic use
22490195;Carbon/analysis;China;Chromatography, Gas/methods;Disinfectants/analysis*;Disinfection/methods;Environmental Monitoring/methods*;Iodine/analysis;Nitrogen/analysis;Plants;Water Pollutants, Chemical/analysis*;Water Supply*
22490541;Animals;Diabetes Mellitus/metabolism;Diabetes Mellitus/pathology*;Glycation End Products, Advanced/metabolism;Rats;Skin/metabolism;Skin/pathology*;Skin Ulcer/pathology;Wound Healing
22511458;Animals;Annexin A1/analysis;Annexin A1/genetics;Annexin A1/physiology*;Blotting, Western;Cell Adhesion/genetics;Cell Adhesion/physiology;Cell Movement/genetics;Cell Movement/physiology*;Cells, Cultured;Comet Assay;DNA Damage*;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/physiology;Female;Humans;Hydrogen Peroxide/pharmacology;Isotope Labeling/methods;Mammary Glands, Animal/cytology;Mammary Glands, Animal/metabolism*;Mass Spectrometry;Mice;Mice, Inbred C57BL;Mice, Knockout;Oxidants/pharmacology;Peptides/analysis;Peptides/genetics;Proteome/analysis;Proteome/genetics;Proteomics/methods*;Reverse Transcriptase Polymerase Chain Reaction
22521755;Aged;Early Diagnosis*;Female;Health Knowledge, Attitudes, Practice*;Humans;Male;Middle Aged;Mouth Neoplasms/diagnosis*;Outcome Assessment (Health Care);Patient Education as Topic/methods*;Pilot Projects;Program Evaluation;Risk Factors;Surveys and Questionnaires
22541905;Adult;Aged;Female;Humans;Language;Male;Middle Aged;Surveys and Questionnaires*;Translating;Urinary Bladder Neoplasms*/diagnosis
22575165;Animals;Chickens;Diarrhea, Infantile/drug therapy*;Diarrhea, Infantile/virology;Female;Fluid Therapy;Humans;Immunoglobulins/therapeutic use*;Infant;Male;Mice;Rotavirus;Rotavirus Infections/drug therapy*;Rotavirus Infections/virology;Virus Shedding
22579138;Authorship;Career Choice;Career Mobility;Case-Control Studies;Clinical Trials as Topic/statistics & numerical data;Federal Government*;Female;Humans;Leadership*;Male;Odds Ratio;Physicians, Women/statistics & numerical data;Prejudice*;Publishing/statistics & numerical data;Research Personnel/statistics & numerical data*;Research Support as Topic/statistics & numerical data;Sex Ratio;United States;United States Department of Veterans Affairs/statistics & numerical data;Women, Working/statistics & numerical data*
22587963;Benzene/chemical synthesis*;Benzene/chemistry*;Chemistry Techniques, Synthetic/methods*;Crystallography, X-Ray;Nanotechnology/methods*;Nanotubes, Carbon/chemistry*;Stereoisomerism
22606300;Animals;Bacteriophage P22/physiology;Gene Expression Regulation, Bacterial;Genes, Bacterial*;Macrophages/microbiology;Mice;Mutagenesis, Site-Directed;O Antigens/chemistry;O Antigens/genetics*;Promoter Regions, Genetic;RNA, Bacterial/genetics;Salmonella Infections, Animal/etiology;Salmonella typhimurium/genetics*;Salmonella typhimurium/immunology;Salmonella typhimurium/pathogenicity;Salmonella typhimurium/virology;Virulence/genetics;Virulence/immunology
22609366;Adult;Analysis of Variance;Anisotropy;Brain/pathology*;Brain-Derived Neurotrophic Factor/genetics;Depressive Disorder, Major/genetics*;Depressive Disorder, Major/pathology*;Diffusion Tensor Imaging;Female;Genotype;Humans;Image Processing, Computer-Assisted;Male;Middle Aged;Nerve Fibers, Myelinated/pathology*;Polymorphism, Single Nucleotide/genetics*;Psychiatric Status Rating Scales;Receptor, trkB/genetics*;Young Adult
22613191;Aminolevulinic Acid/administration & dosage;Aminolevulinic Acid/therapeutic use*;Animals;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Apoptosis/drug effects;Apoptosis/radiation effects;Cell Death/drug effects;Cell Death/radiation effects;Cell Line, Tumor;Combined Modality Therapy;Doxorubicin/administration & dosage;Drug Resistance, Neoplasm/drug effects;Drug Resistance, Neoplasm/radiation effects;Leukemia/drug therapy*;Leukemia/pathology;Mice;Necrosis/chemically induced;Necrosis/etiology;Oxidative Stress/drug effects;Oxidative Stress/physiology;Oxidative Stress/radiation effects;Photochemotherapy*/methods;Photosensitizing Agents/administration & dosage;Photosensitizing Agents/therapeutic use*;Vincristine/administration & dosage
22691251;Adolescent;Asthma/immunology*;Asthma/physiopathology;Child;Female;Forced Expiratory Volume;Humans;Interleukin-10/blood;Interleukin-23/blood*;Interleukin-4/blood;Male
22698811;Animals;Choline O-Acetyltransferase/genetics;Choline O-Acetyltransferase/metabolism;Female;Galanin/deficiency;Galanin/metabolism*;Mice;Mice, Knockout;Pilocarpine/pharmacology;Sweat Glands/innervation*;Sweat Glands/metabolism*;Sweat Glands/pathology;Sweating/drug effects;Sweating/genetics*
22723132;Attention*;Attention Deficit Disorder with Hyperactivity/psychology*;Child;Cognition*;Female;Humans;Leadership*;Male;Retrospective Studies;Social Behavior*
22726981;Aged;Angioedema/chemically induced*;Angioedema/diagnostic imaging;Colectomy/methods;Colonic Neoplasms/diagnostic imaging*;Colonic Neoplasms/pathology;Colonic Neoplasms/surgery;Contrast Media/adverse effects*;Cough/chemically induced;Cough/diagnostic imaging;Follow-Up Studies;Humans;Iothalamate Meglumine/adverse effects;Jejunal Diseases/chemically induced*;Jejunal Diseases/pathology;Male;Motion;Multidetector Computed Tomography/adverse effects;Multidetector Computed Tomography/methods*;Neoplasm Staging;Preoperative Care/methods;Risk Assessment;Treatment Outcome
22734030;Aged;Breast Neoplasms/secondary*;Female;Humans;Inflammatory Breast Neoplasms/pathology*;Middle Aged
22746015;Anesthesiology;Authorship*;Biomedical Research;Ethics, Research;Periodicals as Topic;Research/standards*;Research Design
22748108;Animals;Area Under Curve;Arousal/drug effects;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/cerebrospinal fluid;Calcium Channel Blockers/pharmacokinetics*;Dogs;Dose-Response Relationship, Drug;Heart Rate/drug effects;Infusions, Parenteral/methods*;Injections, Spinal/methods*;Male;Motor Activity/drug effects;Nociception/drug effects;Pharmacokinetics;Skin/innervation;Time Factors;omega-Conotoxins/administration & dosage*;omega-Conotoxins/blood;omega-Conotoxins/cerebrospinal fluid;omega-Conotoxins/pharmacokinetics*
22761940;Animals;Calcium/metabolism*;Calcium Channels/metabolism;Calcium Signaling;Cerebellum/cytology;Cerebellum/metabolism*;Interneurons/metabolism*;Rats;Rats, Sprague-Dawley;Receptors, N-Methyl-D-Aspartate/metabolism*
22774390;Adolescent;Carcinoma, Papillary/pathology*;Carcinoma, Papillary/surgery;Female;Humans;Thyroglossal Cyst/pathology*;Thyroglossal Cyst/surgery;Thyroid Neoplasms/pathology*;Thyroid Neoplasms/surgery;Thyroidectomy
22776782;Adult;Creatinine/blood;Dialysis Solutions/therapeutic use;Female;Humans;Hyperphosphatemia/blood;Hyperphosphatemia/therapy*;Kidney Failure, Chronic/blood;Kidney Failure, Chronic/therapy*;Male;Middle Aged;Phosphates/blood*;Renal Dialysis/instrumentation*;Renal Dialysis/methods*;Time Factors;Treatment Outcome;Urea/blood;Uremia/blood;Uremia/therapy
22789625;Antibodies/immunology;Antibodies/pharmacology;Cell Proliferation/drug effects;Cell Survival/drug effects;Disease Progression;Endothelial Cells/drug effects;Endothelial Cells/immunology*;Endothelial Cells/metabolism*;Histocompatibility Antigens Class I/immunology*;Histocompatibility Antigens Class I/metabolism*;Humans;Integrin beta4/metabolism*;Neoplasms/immunology;Neoplasms/metabolism;Neurons/immunology;Neurons/metabolism;Signal Transduction*/drug effects
22790592;Acetabulum/abnormalities;Acetabulum/surgery*;Clinical Competence;Curriculum;Education, Medical, Graduate*/standards;Fellowships and Scholarships;Femoracetabular Impingement/surgery*;Hip Dislocation, Congenital/surgery*;Hip Joint/abnormalities;Hip Joint/surgery*;Humans;Internship and Residency;Orthopedic Procedures/education*;Orthopedic Procedures/standards
22801776;B-Lymphocytes;Cell Nucleus/ultrastructure*;Chromosome Mapping;Chromosomes, Human, Pair 15/genetics;Chromosomes, Human, Pair 15/ultrastructure*;Female;Fibroblasts;Humans;Imaging, Three-Dimensional/methods*;In Situ Hybridization, Fluorescence/methods*;Male;Microscopy, Confocal;Receptors, GABA-A/genetics;Receptors, GABA-A/ultrastructure*;Ubiquitin-Protein Ligases/genetics;Ubiquitin-Protein Ligases/ultrastructure*;snRNP Core Proteins/genetics;snRNP Core Proteins/ultrastructure*
22823958;Allergens/analysis*;Allergens/immunology;Animals;Antibody Specificity;Calibration;Electrophoresis, Polyacrylamide Gel;Enzyme-Linked Immunosorbent Assay;Food Hypersensitivity/etiology*;Gadus morhua/immunology*;Gelatin/adverse effects*;Gelatin/analysis;Humans;Limit of Detection;Parvalbumins/analysis*;Parvalbumins/immunology
22825286;Blood Glucose Self-Monitoring/psychology;Child;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/psychology*;Diabetes Mellitus, Type 1/therapy*;Female;Glycated Hemoglobin A/metabolism;Humans;Interview, Psychological*;Longitudinal Studies;Male;Patient Compliance/psychology;Psychometrics/statistics & numerical data;Reproducibility of Results;Risk Factors;Self Care/psychology*
22828343;Actins/chemistry*;Microscopy, Electron, Transmission/methods*;Molecular Imaging/methods*;Water/chemistry*
22834015;Delayed-Action Preparations;Drug Delivery Systems*;Humans;Micelles;Nanotechnology*;Neoplasms/drug therapy*;Polymers/chemistry*
22835085;Computer Simulation;Computer-Aided Design;Heart-Assist Devices*;Hemorheology;Humans;Hydrodynamics;Models, Cardiovascular;Models, Chemical;Prosthesis Design
22843401;Actinomycetales/enzymology*;Biofuels;Biomass;Biotechnology/methods*;Blotting, Western;Chemistry Techniques, Analytical/methods;Fluorescent Dyes/metabolism;Glycoside Hydrolases/genetics;Glycoside Hydrolases/metabolism*;Lignin/metabolism*;Tobacco/chemistry;Tobacco/metabolism*;Trichoderma/enzymology*;Zea mays/chemistry;Zea mays/metabolism*
22847646;Aorta/metabolism;Aorta/pathology;Cells, Cultured;Endothelial Cells/metabolism;Endothelial Cells/pathology*;Humans;Inflammation/metabolism;Inflammation/pathology*;Lab-On-A-Chip Devices*;Microfluidic Analytical Techniques/instrumentation;Microfluidic Analytical Techniques/methods*;Phenotype;Tumor Necrosis Factor-alpha/metabolism
22850163;Afghan Campaign 2001-*;Iraq War, 2003-2011*;Military Medicine/trends*;Traumatology/trends*;United States
22882416;Administration, Intranasal;Brain/diagnostic imaging;Humans;Infant;Male;Oxygen Inhalation Therapy/adverse effects*;Pneumocephalus/diagnostic imaging;Pneumocephalus/etiology*;Tomography, X-Ray Computed
22917080;Blood Glucose;Cohort Studies;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/complications*;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/complications*;Diabetes Mellitus, Type 2/drug therapy;Follow-Up Studies;Humans;Hypoglycemic Agents/therapeutic use;Incidence;Israel/epidemiology;Neoplasms/complications*;Neoplasms/epidemiology*;Risk
22928837;Animals;Anti-Inflammatory Agents/pharmacology*;Antioxidants/pharmacology;Cell Line;Dose-Response Relationship, Drug;Heme Oxygenase-1/metabolism*;Inflammation*/drug therapy;Inflammation*/metabolism;Inflammation Mediators/metabolism*;JNK Mitogen-Activated Protein Kinases/metabolism;Lipids/pharmacology;Lipopolysaccharides;Macrophages/drug effects;Macrophages/metabolism;Mice;Nitric Oxide/biosynthesis*;Phenols/pharmacology;Phosphatidylinositol 3-Kinases/metabolism;Phytotherapy;Pistacia*;Plant Extracts/pharmacology*;Proto-Oncogene Proteins c-akt/metabolism;RNA, Messenger/metabolism;Signal Transduction/drug effects
22929410;Bronchi/immunology*;CD4-Positive T-Lymphocytes/immunology*;CD4-Positive T-Lymphocytes/metabolism;CD8-Positive T-Lymphocytes/immunology*;CD8-Positive T-Lymphocytes/metabolism;Epithelial Cells/immunology;Epithelial Cells/metabolism;Female;Humans;Inflammation/immunology;Inflammation/therapy;Interferon-gamma/biosynthesis*;Lymphocyte Count;Male;Middle Aged;Pulmonary Disease, Chronic Obstructive/immunology*;Pulmonary Disease, Chronic Obstructive/metabolism;Pulmonary Disease, Chronic Obstructive/therapy;Respiratory Mucosa/immunology;Respiratory Mucosa/metabolism;Smoking/immunology;Trachea/immunology*;Tumor Necrosis Factor-alpha/biosynthesis*
22936755;Atmosphere/chemistry*;Carbon Dioxide/analysis*;Climate Change*
22940575;Animals;Anticonvulsants/adverse effects;Anticonvulsants/therapeutic use;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use;Depression/chemically induced;Depression/complications*;Depression/etiology;Depression/therapy;Disease Models, Animal*;Drug Interactions;Epilepsy/complications*;Epilepsy/etiology;Epilepsy/psychology;Epilepsy/therapy;Humans;Rats
22952845;Bacterial Proteins/chemistry;Bacterial Proteins/genetics;Bacterial Proteins/metabolism*;Base Sequence;Binding Sites;DNA, Bacterial/genetics;Deoxyribonuclease I/metabolism;Gene Expression Regulation, Bacterial;Methicillin Resistance/genetics*;Molecular Sequence Data;Mutagenesis, Site-Directed;Mutation;Operon/genetics;Penicillin-Binding Proteins/genetics*;Penicillin-Binding Proteins/metabolism*;Promoter Regions, Genetic/genetics;Protein Multimerization;Protein Structure, Quaternary;RNA, Messenger/genetics;RNA, Messenger/metabolism;Staphylococcus aureus/genetics*;Staphylococcus aureus/metabolism*;Transcription Factors/chemistry;Transcription Factors/genetics;Transcription Factors/metabolism*;Transcription, Genetic
22953859;Animals;Benzhydryl Compounds/analysis*;Chromatography, Liquid/methods*;Epoxy Compounds/analysis*;Fish Products/analysis*;Fishes;Food, Preserved/analysis*;Seafood/analysis;Tandem Mass Spectrometry/methods*
22967192;Adolescent;Adult;Aged;Aged, 80 and over;Female;Femur Neck/anatomy & histology*;Humans;Imaging, Three-Dimensional/methods*;Male;Middle Aged;Models, Anatomic;Models, Statistical*;Regression Analysis;Young Adult
22969146;Administration, Oral;Animal Feed/analysis*;Animals;Animals, Outbred Strains;Chromatography, High Pressure Liquid;Drug Combinations;Drug Delivery Systems/methods*;Drug Delivery Systems/veterinary;Female;Fluoxetine/administration & dosage;Fluoxetine/analogs & derivatives;Fluoxetine/analysis*;Fluoxetine/blood;Male;Pharmaceutical Preparations/administration & dosage*;Pilot Projects;Rats*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/analysis*;Serotonin Uptake Inhibitors/blood;Species Specificity;Time Factors
22983965;Bacterial Load/methods*;Desiccation*;Lactobacillus plantarum/physiology*;Mass Screening/methods;Microbial Viability*;Microscopy, Fluorescence/methods;Stress, Physiological
22985130;Equipment Design;Escherichia coli/genetics;Escherichia coli/isolation & purification*;Filtration/economics;Filtration/instrumentation;Lab-On-A-Chip Devices*/economics;Nucleic Acids/genetics;Nucleic Acids/isolation & purification*;Saccharomyces cerevisiae/genetics;Saccharomyces cerevisiae/isolation & purification*;Self-Sustained Sequence Replication/economics;Self-Sustained Sequence Replication/instrumentation*;Staphylococcus aureus/genetics;Staphylococcus aureus/isolation & purification*;Water Microbiology
22988927;Adult;Aged;Carcinoma/chemistry*;Carcinoma/pathology*;Chi-Square Distribution;Cholelithiasis/chemistry;Cholelithiasis/pathology;Female;Gallbladder Neoplasms/chemistry*;Gallbladder Neoplasms/pathology*;Humans;Male;Middle Aged;Neoplasm Grading;Nicotine/analysis*;Smoking;Statistics, Nonparametric;Young Adult
22994264;Fluoroscopy/methods*;Humans;Injections, Epidural/methods*;Spinal Cord/diagnostic imaging*;Spinal Cord Stimulation/methods*
23010333;Acoustic Stimulation;Animals;Auditory Pathways/injuries*;Auditory Pathways/pathology;Auditory Pathways/physiopathology*;Auditory Threshold/physiology;Avoidance Learning/physiology;Behavior, Animal/physiology;Conditioning (Psychology)/physiology;Inferior Colliculi/injuries*;Inferior Colliculi/pathology;Inferior Colliculi/physiopathology*;Male;Psychoacoustics;Rats;Rats, Wistar
23011375;Adult;Aged;Female;Humans;Intraoperative Complications*;Laryngoscopy/methods*;Laryngostenosis/diagnosis;Laryngostenosis/etiology;Laryngostenosis/physiopathology;Laryngostenosis/rehabilitation*;Male;Middle Aged;Prognosis;Spirometry/methods;Thyroidectomy/adverse effects*;Time Factors;Tomography, X-Ray Computed/methods;Treatment Outcome;Vocal Cord Paralysis/etiology*;Vocal Cord Paralysis/physiopathology
23013215;Amides/chemistry*;Macrocyclic Compounds/chemistry*;Magnetic Resonance Spectroscopy;Models, Molecular;Thiophenes/chemical synthesis*;Thiophenes/chemistry;Ultrasonics/methods*
23027213;Cicatrix/drug therapy;Cicatrix/prevention & control*;Dermatologic Surgical Procedures/instrumentation;Dermatologic Surgical Procedures/methods*;Face;Humans;Neck;Occlusive Dressings;Reconstructive Surgical Procedures/instrumentation;Reconstructive Surgical Procedures/methods*;Wound Healing*/drug effects
23027491;Adult;Aged;Aged, 80 and over;Cadaver;Cervical Vertebrae/pathology*;Cervical Vertebrae/surgery*;Decompression, Surgical/methods*;Female;Humans;Male;Middle Aged;Spinal Fusion/methods*;Treatment Outcome;Young Adult
23035191;DNA, Protozoan/genetics;DNA, Ribosomal/genetics;Humans;Malaria/diagnosis*;Malaria/parasitology*;Molecular Diagnostic Techniques/methods*;Molecular Diagnostic Techniques/standards;Multiplex Polymerase Chain Reaction/methods*;Multiplex Polymerase Chain Reaction/standards;Parasitology/methods*;Parasitology/standards;Plasmodium/classification*;Plasmodium/genetics;Plasmodium/isolation & purification*;RNA, Ribosomal, 18S/genetics;Reference Standards
23044263;Acetylcysteine/pharmacology*;Animals;Bile Ducts/surgery*;Cognition Disorders/complications*;Cognition Disorders/drug therapy*;Hepatic Encephalopathy/complications*;Hepatic Encephalopathy/drug therapy*;Male;Oxidative Stress/drug effects*;Rats;Rats, Wistar
23068906;Athletic Tape*;Biomechanical Phenomena;Chronic Disease;Female;Health Status Indicators;Humans;Low Back Pain/diagnostic imaging;Low Back Pain/pathology;Low Back Pain/rehabilitation*;Pain Measurement;Pelvis*;Radiography;Sacroiliac Joint/diagnostic imaging;Sacroiliac Joint/pathology*;Sacrum/diagnostic imaging;Sacrum/pathology*;Swimming/injuries*;Young Adult
23072684;Aged;Aged, 80 and over;Communication;Counseling;Female;Focus Groups;Health Knowledge, Attitudes, Practice;Humans;Independent Living;Interviews as Topic;Male;Maryland;Middle Aged;Motivation;Motor Activity*;Perception;Physician's Role*;Physician-Patient Relations*;Qualitative Research;Reproducibility of Results;Surveys and Questionnaires
23073619;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Asparaginase/therapeutic use;Carboplatin/therapeutic use;Chemoradiotherapy/methods;Clinical Trials as Topic;DNA, Viral/blood;Dexamethasone/therapeutic use;Epstein-Barr Virus Infections/blood;Epstein-Barr Virus Infections/pathology;Epstein-Barr Virus Infections/therapy;Etoposide/therapeutic use;Female;Herpesvirus 4, Human;Humans;Ifosfamide/therapeutic use;Lymphoma, Extranodal NK-T-Cell/blood;Lymphoma, Extranodal NK-T-Cell/pathology;Lymphoma, Extranodal NK-T-Cell/therapy*;Male;Neoplasm Staging;Nose Neoplasms/blood;Nose Neoplasms/pathology;Nose Neoplasms/therapy*
23084435;Animals;Benzofurans/chemical synthesis;Benzofurans/chemistry*;Benzofurans/pharmacology*;Cell Line;Humans;Ligands;Radioligand Assay;Receptors, sigma/antagonists & inhibitors;Receptors, sigma/metabolism*;Structure-Activity Relationship
23100509;Aged;Animals;Bronchi/enzymology*;Catalase/metabolism*;Disease Models, Animal;Epithelium/enzymology*;Female;Gene Expression Regulation, Enzymologic;Humans;Immunohistochemistry;In Situ Hybridization;Lung/enzymology;Male;Mice;Mice, Inbred C57BL;Middle Aged;Oligonucleotide Array Sequence Analysis;Oxidation-Reduction;Oxidative Stress;Pulmonary Disease, Chronic Obstructive/enzymology*;Pulmonary Disease, Chronic Obstructive/physiopathology*;RNA, Messenger/metabolism;Smoking/adverse effects*;Time Factors
23104759;Adult;Coinfection;Female;HIV Antibodies/blood;HIV Seropositivity/blood;HIV Seropositivity/epidemiology*;HIV Seropositivity/virology;Hepatitis C/blood;Hepatitis C/epidemiology*;Hepatitis C/virology;Hepatitis C Antibodies/blood;Humans;India/epidemiology;Male;Middle Aged;Prevalence
23119101;Adult;Analysis of Variance;Cognition/physiology*;Humans;Knowledge;Learning/physiology*;Mathematics*;Problem Solving/physiology;Problem-Based Learning/methods*;Psychomotor Performance/physiology
23132290;Adult;Aged;Aged, 80 and over;Clinical Trials as Topic*;Dyspnea;Fatigue;Female;Hospitalization;Humans;Male;Middle Aged;Neoplasms/therapy*;Palliative Care;Patient Dropouts*;Young Adult
23133443;Animals;Atherosclerosis/epidemiology;Atherosclerosis/etiology;Cardiovascular Diseases/epidemiology;Cardiovascular Diseases/etiology*;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/physiopathology*;Diabetes, Gestational/blood;Diabetes, Gestational/physiopathology*;Disease Susceptibility;Family Health*;Female;Fetal Development*;Humans;Hyperglycemia/embryology*;Hyperglycemia/etiology;Hyperglycemia/physiopathology;Male;Maternal-Fetal Exchange;Obesity/epidemiology;Obesity/etiology;Obesity/physiopathology;Pregnancy;Pregnancy in Diabetics/blood;Pregnancy in Diabetics/physiopathology*;Risk
23165785;Humans;Japan;Myocardial Infarction/prevention & control*
23190579;Animals;Bivalvia/anatomy & histology*;Bivalvia/chemistry*;Brazil;Cilia/chemistry;Collagen/chemistry;Endothelial Cells/chemistry;Epithelium/chemistry;Gills/chemistry;Gills/ultrastructure*;Hemocytes/chemistry;Hemolymph/chemistry;Histocytochemistry/methods*;Microscopy, Electron, Scanning;Species Specificity
23193417;Adult;Case-Control Studies;Female;Genotype;Graves Disease/enzymology;Graves Disease/genetics*;Humans;Iodide Peroxidase/genetics*;Male;Middle Aged;Polymorphism, Single Nucleotide;Thyrotoxicosis/enzymology;Thyrotoxicosis/genetics
23196359;Ascomycota*/classification;Ascomycota*/genetics;Ascomycota*/growth & development;Bursitis/diagnosis;Bursitis/microbiology*;DNA, Bacterial;Humans;Kidney Transplantation*/adverse effects;Knee Injuries/microbiology*;Magnetic Resonance Imaging;Male;Middle Aged;Molecular Sequence Data;Mycoses/diagnosis;Mycoses/microbiology*;Phylogeny;Ultrasonography
23210105;Administration, Topical;Aged;Dermatomyositis/complications*;Dermatomyositis/diagnosis;Dermatomyositis/drug therapy;Diagnosis, Differential;Exanthema/diagnosis;Exanthema/drug therapy;Exanthema/etiology*;Glucocorticoids/administration & dosage*;Humans;Immunosuppressive Agents/administration & dosage;Male;Muscle Weakness/diagnosis;Muscle Weakness/drug therapy;Muscle Weakness/etiology*;Tacrolimus/administration & dosage*
23213802;Construction Industry*/standards;Construction Materials*/standards;Humans;Occupational Health
23216263;Bullying*;Global Health*;Health Care Sector*/statistics & numerical data;Health Personnel*/statistics & numerical data;Humans;Turkey;Violence*/statistics & numerical data;Workplace*/statistics & numerical data
23222657;Adult;Brain Mapping/methods;Corpus Callosum/physiology*;Face/physiology*;Functional Laterality/physiology*;Humans;Image Processing, Computer-Assisted/methods;Magnetic Resonance Imaging;Pattern Recognition, Visual/physiology*;Photic Stimulation/methods;Visual Cortex/physiology*;Visual Fields/physiology*;Visual Perception/physiology;Young Adult
23245499;Anxiety/psychology;Bullying/psychology*;Child;Crime Victims/psychology*;Depression/psychology;Female;Humans;Male;Peer Group*;Schools;Self Concept*;Self Report;Social Adjustment*;Students/psychology
23246152;Aged;Aged, 80 and over;Female;Geriatric Assessment*;Health Resources/utilization*;Hip Fractures/complications*;Humans;Male;Patient Discharge;Social Welfare
23261004;Adipose Tissue*;Adult;Aged;Body Mass Index;Confidence Intervals;Coronary Disease/complications;Coronary Disease/mortality*;Coronary Disease/rehabilitation;Exercise Therapy;Follow-Up Studies;Humans;Middle Aged;Obesity/classification*;Obesity/complications;Obesity/rehabilitation;Odds Ratio;Retrospective Studies;Risk Factors;Survival Rate/trends;United States/epidemiology;Young Adult
23292166;Base Sequence;Child, Preschool;Congenital Hypothyroidism/genetics*;Exons;Female;Heterozygote;Humans;Male;Membrane Proteins/genetics*;Mutagenesis, Insertional;Mutation;Pedigree;Point Mutation
23297433;Adult;Child;Child Health Services/economics;Child Health Services/legislation & jurisprudence;Child Health Services/statistics & numerical data;Dental Health Services/economics;Dental Health Services/legislation & jurisprudence;Dental Health Services/statistics & numerical data;Economics, Hospital;Emergency Medical Services/economics;Emergency Medical Services/legislation & jurisprudence;Emergency Medical Services/statistics & numerical data;Federal Government;Health Care Reform/economics;Health Care Reform/legislation & jurisprudence;Health Services/economics;Health Services/legislation & jurisprudence*;Health Services/statistics & numerical data;Home Care Services/economics;Home Care Services/legislation & jurisprudence;Home Care Services/statistics & numerical data;Humans;Insurance Benefits/economics;Insurance Benefits/legislation & jurisprudence*;Insurance Benefits/statistics & numerical data;Long-Term Care/economics;Long-Term Care/legislation & jurisprudence;Long-Term Care/statistics & numerical data;Medicaid/economics;Medicaid/legislation & jurisprudence*;Medicaid/statistics & numerical data;Mental Health Services/economics;Mental Health Services/legislation & jurisprudence;Mental Health Services/statistics & numerical data;Occupational Therapy/economics;Occupational Therapy/legislation & jurisprudence;Occupational Therapy/statistics & numerical data;Patient Protection and Affordable Care Act;Pharmaceutical Services/economics;Pharmaceutical Services/legislation & jurisprudence;Pharmaceutical Services/statistics & numerical data;Physical Therapy Modalities/economics;Physical Therapy Modalities/legislation & jurisprudence;Physical Therapy Modalities/statistics & numerical data;Preventive Health Services/economics;Preventive Health Services/legislation & jurisprudence;Preventive Health Services/statistics & numerical data;Reproductive Health Services/economics;Reproductive Health Services/legislation & jurisprudence;Reproductive Health Services/statistics & numerical data;Smoking Cessation/economics;Smoking Cessation/legislation & jurisprudence;Smoking Cessation/statistics & numerical data;State Government;Transportation of Patients/economics;Transportation of Patients/legislation & jurisprudence;Transportation of Patients/statistics & numerical data;United States;Vision Tests/economics;Vision Tests/statistics & numerical data
23301375;Adult;Cesarean Section/psychology*;Cross-Sectional Studies;Fear/psychology;Female;Hospitals, Private/statistics & numerical data*;Hospitals, Public/statistics & numerical data*;Humans;Iran;Pain/psychology;Parturition/psychology*;Patient Preference/psychology*;Pregnancy;Socioeconomic Factors
23333803;Cells, Cultured;Endothelial Cells/enzymology*;Endothelial Cells/immunology;Endothelial Cells/metabolism;Gene Expression;Gene Knockdown Techniques;Humans;I-kappa B Kinase/metabolism*;Intercellular Adhesion Molecule-1/genetics;Intercellular Adhesion Molecule-1/metabolism;Isoenzymes/genetics;Isoenzymes/metabolism;Isoenzymes/physiology;Lipopolysaccharides/pharmacology*;Lung/blood supply;MAP Kinase Kinase Kinases/genetics;MAP Kinase Kinase Kinases/metabolism;Membrane Glycoproteins/genetics;Membrane Glycoproteins/metabolism;Membrane Glycoproteins/physiology*;Microvessels/cytology*;NADPH Oxidase 2;NADPH Oxidase 4;NADPH Oxidases/genetics;NADPH Oxidases/metabolism;NADPH Oxidases/physiology*;Phosphoproteins/metabolism;Phosphorylation;Protein Phosphatase 2/metabolism;Protein Phosphatase 2/physiology;Protein Processing, Post-Translational*;Protein Transport;RNA, Small Interfering/genetics;Superoxides/metabolism
23334392;Animals;Capillaries/metabolism;Capillaries/pathology;Capillaries/ultrastructure;Cell Differentiation/physiology;Centrosome/enzymology;Centrosome/pathology;Centrosome/ultrastructure;Female;Golgi Apparatus/enzymology;Golgi Apparatus/pathology;Golgi Apparatus/ultrastructure;Isoenzymes/genetics;Isoenzymes/metabolism*;Kidney Glomerulus/blood supply;Kidney Glomerulus/cytology;Kidney Glomerulus/enzymology;Male;Mice;Mice, Knockout;Microscopy, Electron;Podocytes/enzymology*;Podocytes/pathology*;Podocytes/ultrastructure;Protein Kinase C/genetics;Protein Kinase C/metabolism*;Proteinuria/metabolism;Proteinuria/pathology;Proteinuria/physiopathology*;Signal Transduction/physiology;Tight Junctions/enzymology;Tight Junctions/pathology;Tight Junctions/ultrastructure
23353870;Absorbable Implants*;Animals;Bis-Trimethylammonium Compounds/chemistry;Bis-Trimethylammonium Compounds/pharmacokinetics;Carbocyanines/chemistry*;Carbocyanines/pharmacokinetics;Fluorescent Dyes/chemistry*;Fluorescent Dyes/pharmacokinetics;Gelatin/chemistry;Materials Testing;Mice;Mice, Nude;Optical Imaging;Spectroscopy, Near-Infrared;Tissue Distribution;Tissue Engineering;Tissue Scaffolds*/chemistry
23357829;Amyloid/analysis*;Amyloid/metabolism;Antibodies/metabolism;Biosensing Techniques/methods*;Biotechnology;Escherichia coli/metabolism;Escherichia coli Proteins/chemistry;Escherichia coli Proteins/metabolism;High-Throughput Screening Assays;Intracellular Space/chemistry;Intracellular Space/metabolism;Membrane Transport Proteins/chemistry;Membrane Transport Proteins/metabolism;Models, Molecular;Molecular Probe Techniques;Protein Binding;Protein Folding
23364386;Administration, Oral;Administration, Topical;Anti-Bacterial Agents/administration & dosage;Child, Preschool;Drainage;Emergency Medicine;Female;Humans;Male;Middle Ear Ventilation*;Otitis Media/therapy*;Otolaryngology;Practice Patterns, Physicians'/statistics & numerical data*;Suction;Surveys and Questionnaires;Therapeutic Irrigation
23366293;Bicycling/physiology*;Electricity*;Exercise/physiology*;Exercise Test;Humans;Male;Oxygen Consumption/physiology;Young Adult
23370826;Adult;Blood Gas Analysis/standards*;Blood Gas Analysis/statistics & numerical data;Humans;Positive-Pressure Respiration/methods;Prospective Studies;Pulmonary Gas Exchange/physiology;Respiratory Distress Syndrome, Adult/blood;Respiratory Distress Syndrome, Adult/classification*;Respiratory Distress Syndrome, Adult/diagnosis;Severity of Illness Index
23371469;Biomarkers, Tumor/biosynthesis*;Biomarkers, Tumor/genetics;Carcinoma, Squamous Cell/enzymology*;Carcinoma, Squamous Cell/pathology*;Cell Adhesion Molecules/biosynthesis*;Cell Line, Tumor;Cell Movement/genetics;Cell Proliferation;Down-Regulation;Humans;Kallikreins/biosynthesis*;Kallikreins/genetics;Lymphatic Metastasis;Mouth Neoplasms/enzymology*;Mouth Neoplasms/pathology*;Neoplasm Invasiveness;RNA Interference;RNA, Small Interfering/genetics
23382253;Beriberi/epidemiology;Beriberi/prevention & control*;HIV Infections/epidemiology;HIV Infections/prevention & control*;Health Care Reform;Health Services Accessibility;Humans;Malaria/epidemiology;Malaria/prevention & control*;Myanmar/epidemiology;Tuberculosis/epidemiology;Tuberculosis/prevention & control*
23394388;Adult;Aged;Angioedema/chemically induced*;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Cough/chemically induced*;Female;Humans;Male;Middle Aged;Peptidyl-Dipeptidase A/genetics*;Pharmacogenetics*;Polymorphism, Genetic;Receptor, Bradykinin B2/genetics
23395836;Adult;Antipsychotic Agents/adverse effects*;Bone Density/drug effects;Bone Resorption/chemically induced*;Bone Resorption/complications*;Bone Resorption/metabolism;Cross-Sectional Studies;Estradiol/blood;Female;Humans;Hyperprolactinemia/etiology*;Hyperprolactinemia/metabolism;Hypogonadism/etiology;Hypogonadism/metabolism;Male;Menopause;Middle Aged;Risperidone/adverse effects*;Schizophrenia/drug therapy*;Sex Characteristics;Sex Factors;Testosterone/blood
23398870;Anti-Bacterial Agents/therapeutic use*;Community-Acquired Infections/drug therapy;Community-Acquired Infections/immunology;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Immunologic Factors/therapeutic use*;Immunomodulation;Macrolides/therapeutic use;Pneumonia/drug therapy*;Pneumonia/immunology;Steroids/therapeutic use*
23404758;Animals;Copepoda/anatomy & histology*;Copepoda/classification*;Female;Japan;Pacific Ocean;Perciformes/parasitology*;Species Specificity
23428915;CD4-CD8 Ratio/methods*;CD4-Positive T-Lymphocytes/immunology*;CD8-Positive T-Lymphocytes/immunology*;Case-Control Studies;Computer Simulation;Flow Cytometry;Gene Rearrangement, beta-Chain T-Cell Antigen Receptor*;Genes, T-Cell Receptor beta*;High-Throughput Nucleotide Sequencing*;Humans;Likelihood Functions;Models, Genetic;Multiple Sclerosis/diagnosis*;Multiple Sclerosis/genetics;Multiple Sclerosis/immunology;Predictive Value of Tests;Reproducibility of Results
23451263;Adult;Antitubercular Agents/therapeutic use*;Cohort Studies;Female;Follow-Up Studies;Government;Hospitals;Humans;Male;Middle Aged;Retrospective Studies;Taiwan;Tuberculosis, Multidrug-Resistant/drug therapy*;Tuberculosis, Pulmonary/drug therapy*
23453092;Acute Coronary Syndrome/diagnosis*;Aged;Biomarkers/analysis;Clinical Trials as Topic;Female;Humans;Male;Middle Aged;Multicenter Studies as Topic;Myocardial Infarction/diagnosis*;Retrospective Studies;Troponin/blood*
23457918;Animals;Antiprotozoal Agents/therapeutic use;Babesia/isolation & purification;Babesiosis/diagnosis;Babesiosis/drug therapy;Babesiosis/epidemiology;Babesiosis/veterinary*;Diagnosis, Differential;Horse Diseases/diagnosis*;Horse Diseases/drug therapy;Horse Diseases/epidemiology;Horses;Netherlands/epidemiology;Polymerase Chain Reaction/veterinary*;Prevalence;Theileria/isolation & purification;Theileriasis/diagnosis*;Theileriasis/drug therapy;Theileriasis/epidemiology;Tick-Borne Diseases/diagnosis;Tick-Borne Diseases/drug therapy;Tick-Borne Diseases/epidemiology;Tick-Borne Diseases/veterinary*;Ticks/parasitology*
23462219;Adult;Africa South of the Sahara;Anti-HIV Agents/economics*;Anti-HIV Agents/therapeutic use;Cohort Studies;Cost-Benefit Analysis/economics;Female;HIV Infections/drug therapy;HIV Infections/economics*;Humans;Male;Models, Theoretical;Patient Compliance;Point-of-Care Systems/economics*;Quality-Adjusted Life Years;Randomized Controlled Trials as Topic;Viral Load/drug effects
23472062;Humans;Light*;Neoplasms/diagnosis*;Neoplasms/therapy*;Phototherapy/methods*
23479716;Abdominal Neoplasms/radiotherapy*;Artifacts*;Diagnostic Imaging/methods*;Humans;Pelvic Neoplasms/radiotherapy*;Radiation Injuries/diagnosis*;Radiation Injuries/etiology*;Radiotherapy/adverse effects*
23485238;Adsorption;Boron/chemistry;Fluorescence;Industrial Waste*;Iron;Metalloids/analysis*;Metalloids/chemistry;Metalloids/isolation & purification;Metallurgy;Oxidation-Reduction;Steel;Waste Disposal, Fluid/methods*;Water Pollutants, Chemical/analysis*;Water Pollutants, Chemical/chemistry;Water Pollutants, Chemical/isolation & purification;X-Ray Diffraction
23487228;Behavioral Symptoms/complications;Behavioral Symptoms/pathology;Brain Infarction/etiology*;Brain Infarction/pathology;Cognition Disorders/complications;Corpus Striatum/pathology*;Female;Humans;Magnetic Resonance Imaging;Mental Disorders/complications*;Middle Aged;Nerve Fibers, Myelinated/pathology;Neuropsychological Tests
23517578;Animals;Apoptosis;Base Sequence;Blotting, Western;CD8-Positive T-Lymphocytes/cytology;CD8-Positive T-Lymphocytes/immunology*;Carcinoma, Lewis Lung/immunology*;Cell Differentiation;Cells, Cultured;DNA Primers;Enzyme-Linked Immunosorbent Assay;Flow Cytometry;Gene Expression Profiling;Lung Neoplasms/immunology*;Lymphocyte Activation;Mice;MicroRNAs/genetics*;Oligonucleotide Array Sequence Analysis;Real-Time Polymerase Chain Reaction
23531732;Female;Humans;Magnetic Resonance Imaging*;Middle Aged;Multimodal Imaging*;Neoplasm Staging;Neuroendocrine Tumors/diagnosis*;Neuroendocrine Tumors/diagnostic imaging;Neuroendocrine Tumors/pathology;Organometallic Compounds*;Positron-Emission Tomography*;Spinal Neoplasms/diagnosis*;Spinal Neoplasms/diagnostic imaging;Spinal Neoplasms/pathology;Tomography, X-Ray Computed*
23532689;Adult;Aged;Aged, 80 and over;Biomarkers, Tumor/genetics;Biomarkers, Tumor/metabolism;Cell Adhesion Molecules/metabolism;Cell Cycle Proteins/metabolism;Colorectal Neoplasms/genetics;Colorectal Neoplasms/metabolism*;Colorectal Neoplasms/pathology;DNA Repair Enzymes/metabolism;DNA-Binding Proteins/metabolism;Female;Gene Expression Regulation, Neoplastic;Humans;Intestinal Mucosa/metabolism*;Lymphatic Metastasis;MRE11 Homologue Protein;Male;Middle Aged;NF-kappa B/metabolism;Nuclear Proteins/genetics;Nuclear Proteins/metabolism*;Transcription Factors/genetics;Transcription Factors/metabolism*
23541871;Aluminum Silicates/metabolism*;Microscopy, Electron;Nanocomposites/radiation effects*;Nanocomposites/ultrastructure*;Polymerization/radiation effects*;Polymethyl Methacrylate/metabolism*;Temperature
23552530;Biomedical Research*;Humans;Pakistan;Randomized Controlled Trials as Topic*;Research Design*
23578015;Adolescent;Adrenergic Uptake Inhibitors/administration & dosage;Adrenergic Uptake Inhibitors/adverse effects;Adrenergic Uptake Inhibitors/therapeutic use*;Atomoxetine Hydrochloride;Attention Deficit Disorder with Hyperactivity/complications;Attention Deficit Disorder with Hyperactivity/drug therapy*;Child;Child Development Disorders, Pervasive/complications*;Double-Blind Method;Female;Humans;Male;Propylamines/administration & dosage;Propylamines/adverse effects;Propylamines/therapeutic use*;Psychiatric Status Rating Scales;Time Factors
23596088;Acrylamides*/chemistry;Acrylamides*/pharmacology;Animals;Cell Adhesion/drug effects;Coated Materials, Biocompatible*/chemistry;Coated Materials, Biocompatible*/pharmacology;Cochlear Implants*;Extracellular Matrix/chemistry;Humans;Mice;NIH 3T3 Cells;Oxazoles*/chemistry;Oxazoles*/pharmacology;Polymers*/chemistry;Polymers*/pharmacology
23601467;Adult;Aged;Alleles;Case-Control Studies;Diabetes Mellitus, Type 2/genetics;Diabetes Mellitus, Type 2/pathology;Diabetic Retinopathy/genetics*;Diabetic Retinopathy/pathology*;Female;Gene Deletion;Genotype;Humans;Male;Middle Aged;Mutagenesis, Insertional;Peptidyl-Dipeptidase A/genetics*;Polymorphism, Genetic;Sequence Deletion
23601836;Aorta/abnormalities*;Aorta/diagnostic imaging;Cardiac Catheterization/instrumentation*;Child, Preschool;Echocardiography, Doppler, Color;Echocardiography, Three-Dimensional;Equipment Design;Heart Atria/abnormalities*;Heart Atria/diagnostic imaging;Heart Defects, Congenital/diagnosis;Heart Defects, Congenital/therapy*;Humans;Male;Treatment Outcome
23620807;Apoptosis/drug effects;Checkpoint Kinase 1;Comet Assay;DNA Damage*;Endocytosis/drug effects;Flow Cytometry;G2 Phase Cell Cycle Checkpoints/drug effects*;Human Umbilical Vein Endothelial Cells/drug effects;Human Umbilical Vein Endothelial Cells/enzymology*;Human Umbilical Vein Endothelial Cells/pathology*;Humans;Hydrodynamics;Intracellular Space/drug effects;Intracellular Space/metabolism;Membrane Potential, Mitochondrial/drug effects;Nanoparticles/chemistry;Nanoparticles/toxicity*;Nanoparticles/ultrastructure;Necrosis;Oxidative Stress/drug effects;Particle Size;Protein Kinases/metabolism*;Reactive Oxygen Species/metabolism;Silicon Dioxide/toxicity*;Static Electricity;Subcellular Fractions/drug effects;Subcellular Fractions/metabolism
23631297;Animals;Antilymphocyte Serum/therapeutic use*;Humans;Immunosuppressive Agents/chemistry;Immunosuppressive Agents/therapeutic use*;Kidney Transplantation/immunology*;Signal Transduction/physiology;T-Lymphocytes/drug effects;T-Lymphocytes/metabolism;TOR Serine-Threonine Kinases/antagonists & inhibitors*
23665829;Asthma/drug therapy*;Bronchodilator Agents/adverse effects*;Budesonide/adverse effects*;Child, Preschool;Dermatitis, Allergic Contact/etiology*;Female;Humans;Male;Patch Tests
23673957;Agriculture;Animals;Carbon Dioxide*;Manure;Nitrogen;Soil*;Swine
23679148;Anthropometry/history;Biometry/history;Congresses as Topic/history;History, 17th Century;History, 18th Century;History, 19th Century;History, 20th Century;Humans;Internationality;Kinesiology, Applied/history;Kinesiology, Applied/methods;Kinesiology, Applied/organization & administration;Kinesiology, Applied/standards;Kinesiology, Applied/trends*;Physical Education and Training/history;Physical Education and Training/methods;Physical Education and Training/organization & administration;Physical Education and Training/standards;Physical Education and Training/trends*;Societies, Scientific/history;Sports Medicine/history;Sports Medicine/methods;Sports Medicine/organization & administration;Sports Medicine/standards;Sports Medicine/trends*
23686434;Active Transport, Cell Nucleus/genetics;Basic Helix-Loop-Helix Transcription Factors/genetics*;Computer Simulation;Dimerization;Gene Regulatory Networks/genetics*;Homeodomain Proteins/genetics*;Humans;Models, Genetic*;Signal Transduction/genetics*;Stochastic Processes;Transcription Factor HES-1
23701731;Age Factors;Animals;Canada;Child;Child, Preschool;Diet;Dietary Supplements;Emigrants and Immigrants*;Female;Health Status Disparities*;Humans;Infant;Male;Milk;Seasons;Skin Pigmentation;Vitamin D/analogs & derivatives*;Vitamin D/blood;Vitamin D Deficiency/blood*
23702597;Child;Dyslexia/psychology*;Female;Humans;Male;Phonetics;Speech Perception/physiology*;Vocabulary
23720250;Analgesics, Opioid/pharmacology*;Anesthetics, General/pharmacology*;Animals;Carotid Body/drug effects;Chemoreceptor Cells/drug effects;Dose-Response Relationship, Drug;Humans;Hypnotics and Sedatives/pharmacology*;Ion Channels/drug effects;Models, Animal;Motor Neurons/drug effects;Respiratory Center/drug effects;Respiratory Center/physiology;Respiratory Mechanics/drug effects*;Respiratory Mechanics/physiology;Synaptic Transmission/drug effects
23743293;Acetaminophen/administration & dosage;Animals;Benzoquinones/administration & dosage;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/pathology;Gene Expression Regulation/drug effects;Glutathione/metabolism*;Glycogen/genetics;Glycogen/metabolism;Hepatocytes/drug effects;Hepatocytes/metabolism;Imines/administration & dosage;Inactivation, Metabolic/genetics*;Lipogenesis/drug effects;Lipogenesis/genetics;Liver/drug effects;Liver/metabolism;Mice;Thioredoxin Reductase 1/genetics;Thioredoxin Reductase 1/metabolism*;Thioredoxins/genetics;Thioredoxins/metabolism*
23759252;Disease Eradication*;Endemic Diseases;Global Health;Humans;Incidence;Poliomyelitis/epidemiology*;Poliomyelitis/prevention & control*;Poliovirus Vaccine, Oral/administration & dosage*;Poliovirus Vaccine, Oral/immunology*;Vaccination/methods*
23769709;Animals;Apoptosis;Cholesterol Side-Chain Cleavage Enzyme;Embryonic Development/physiology*;Female;Fertilization/physiology;Gonadal Hormones/biosynthesis;Gonadal Hormones/metabolism;Humans;Male;Mitochondria/enzymology*;Mitochondria/metabolism*;Oogenesis/physiology*;Reproduction/physiology;Spermatogenesis/physiology*
23786211;Animals;Diabetes Mellitus, Type 2/metabolism;Diabetes Mellitus, Type 2/physiopathology;Energy Metabolism;Exercise;Humans;Mitochondria, Muscle/metabolism;Mitochondria, Muscle/physiology*;Muscle, Skeletal/metabolism;Muscle, Skeletal/physiopathology*;Obesity/metabolism;Obesity/physiopathology;Obesity/therapy*;Oxidative Phosphorylation;Protons;Weight Gain;Weight Loss
23804445;Algorithms*;Animals;Feeding Behavior/physiology*;Humans;Models, Biological*;Walking/physiology*
23810172;Health Policy;Health Status Disparities*;Humans;Models, Theoretical*;Social Class;United Kingdom
23832341;Amino Acid Sequence;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacology*;Apoptosis/drug effects;Base Sequence;Cell Cycle Checkpoints/drug effects;Cell Proliferation/drug effects;Cloning, Molecular;HL-60 Cells;Humans;Jurkat Cells;Molecular Sequence Data;Pleurotus/enzymology*;Pleurotus/genetics;Ribonuclease T1/chemistry;Ribonuclease T1/genetics;Ribonuclease T1/pharmacology*
23890808;B-Lymphocyte Subsets/immunology;B-Lymphocyte Subsets/metabolism;Biomarkers/cerebrospinal fluid;Humans;Multiple Sclerosis/cerebrospinal fluid*;Multiple Sclerosis/immunology*;Multiple Sclerosis/metabolism;Oligoclonal Bands/biosynthesis*;Oligoclonal Bands/cerebrospinal fluid*
23896636;Adult;Aged, 80 and over;Breast Neoplasms/pathology;Esophageal Neoplasms/pathology;Female;Gastrectomy*;Gastrointestinal Hemorrhage/etiology;Gastrointestinal Hemorrhage/prevention & control;Humans;Male;Middle Aged;Ovarian Neoplasms/pathology;Stomach Neoplasms/diagnosis;Stomach Neoplasms/secondary*;Stomach Neoplasms/surgery*;Time Factors;Treatment Outcome
23900412;Animals;Cell Compartmentation/physiology*;Dendrites/metabolism*;Humans;Nerve Tissue Proteins/biosynthesis;Nerve Tissue Proteins/metabolism*;Neurons/metabolism*;Neurons/ultrastructure;Prions/metabolism*;Synapses/metabolism*
23901791;Bacteriophage lambda/chemistry;Bismuth/chemistry*;Copper/chemistry;DNA, Viral/chemistry*;Electrochemical Techniques;Microscopy, Atomic Force;Microscopy, Electrochemical, Scanning;Nanowires/chemistry*;Nanowires/ultrastructure;Nickel/chemistry;Silver/chemistry;Tellurium/chemistry*
23915118;Cell Membrane/chemistry;Gold/chemistry*;Lipid Bilayers/chemistry;Metal Nanoparticles/chemistry*;Particle Size
23915593;Aged;Esophagectomy/adverse effects*;Esophagectomy/mortality*;Frail Elderly;Humans;Retrospective Studies;Risk Factors;Severity of Illness Index
23925392;Animals;Bone Density/drug effects*;Bone and Bones/drug effects*;Fractures, Bone/chemically induced*;Humans;Thiophenes/adverse effects*
23939039;Animals;Antioxidants/pharmacology;Cattle;Cell Cycle Checkpoints/drug effects;Cell Division/drug effects;Cell Line;Cell Proliferation/drug effects*;Curcumin/pharmacology*;Endothelial Cells/drug effects*;Endothelial Cells/metabolism;Heme Oxygenase-1/genetics;Heme Oxygenase-1/metabolism;Microtubules/drug effects;Microtubules/metabolism;Mitosis/drug effects*;Tubulin/metabolism*
23944941;Antioxidants/analysis;Antioxidants/pharmacology*;Carotenoids/analysis;Carotenoids/pharmacology*;Color;Diet;Food Handling*;Humans;Lutein/analysis;Lutein/pharmacology*;Phenols/analysis;Phenols/pharmacology*;Polyphenols/analysis;Polyphenols/pharmacology;Seeds/chemistry*;Triticum/chemistry*;Xanthophylls/analysis;Xanthophylls/pharmacology;Zeaxanthins
23953825;Adipocytes/cytology;Adipocytes/metabolism;Adipogenesis/drug effects*;Adipose Tissue/cytology*;Adipose Tissue/physiology;Adult Stem Cells/drug effects*;Adult Stem Cells/metabolism;Cell Differentiation;Cytochalasin D/metabolism;Cytoskeleton/metabolism;Extracellular Matrix/metabolism*;Humans;Microscopy, Atomic Force;Tissue Engineering/methods;Up-Regulation
23970259;Ceremonial Behavior*;Child;Circumcision, Female/adverse effects*;Comprehension;Culture;Female;Health Education*;Humans;Tanzania/ethnology
23982556;Adolescent;Biopsy;Diabetes Mellitus/pathology*;Diagnosis, Differential;Female;Humans;Hyperlipidemias/pathology*;Hypertriglyceridemia/pathology*;Retinal Diseases/pathology*;Xanthomatosis/pathology*
23999702;Animals;Disorders of Sex Development/veterinary*;Female;Ovary/anatomy & histology;Ovary/physiology;Turtles*
24004673;Carcinoma, Squamous Cell/genetics*;Chromosomes, Human, Pair 3*;Gene Amplification*;Genomics*;Humans;Lung Neoplasms/genetics*;Oncogenes*
24028963;Animals;Behavior, Animal;Cognition;Memory*
24035312;Education, Nursing;Humans;Lebanon;Students, Nursing*;Thinking*
24048289;Animals;Humans;Neurogenesis;Neuronal Plasticity*;Neurons/physiology*;Olfactory Bulb/cytology;Olfactory Bulb/physiology*;Olfactory Perception
24064260;Acetates/pharmacology*;Ascorbate Peroxidases/metabolism;Cadmium/toxicity*;Capsicum/drug effects*;Capsicum/growth & development;Capsicum/metabolism;Catalase/metabolism;Chlorophyll/metabolism;Cyclopentanes/metabolism;Cyclopentanes/pharmacology*;Hydrogen Peroxide/metabolism;Lipid Peroxidation/drug effects;Oxylipins/metabolism;Oxylipins/pharmacology*;Plant Leaves/drug effects;Plant Leaves/growth & development;Plant Leaves/metabolism;Seedlings/drug effects;Seedlings/growth & development;Seedlings/metabolism;Soil Pollutants/toxicity*;Stress, Physiological
24121124;Adaptor Proteins, Signal Transducing/genetics;Adaptor Proteins, Signal Transducing/immunology*;Adaptor Proteins, Signal Transducing/metabolism;Animals;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Carcinoma, Lewis Lung/immunology;Carcinoma, Lewis Lung/therapy;Cell Transformation, Neoplastic/metabolism;Disease Models, Animal;Female;Genetic Vectors/genetics;Genetic Vectors/immunology;Genetic Vectors/pharmacology;Humans;Male;Mammary Glands, Human/metabolism;Mammary Glands, Human/pathology;Mammary Neoplasms, Experimental/immunology;Mammary Neoplasms, Experimental/therapy;Melanoma, Experimental/immunology;Melanoma, Experimental/therapy;Mice;Mice, Inbred C57BL;Sequestosome-1 Protein;Vaccines, DNA/genetics;Vaccines, DNA/immunology*;Vaccines, DNA/pharmacology*
24135248;Acetylation;Animals;Cell Hypoxia;Epigenesis, Genetic;Epithelial-Mesenchymal Transition*;Histone Deacetylases/metabolism;Histones/metabolism*;Humans;Lung Neoplasms/metabolism*;Lung Neoplasms/pathology;Protein Processing, Post-Translational*;Signal Transduction;Transforming Growth Factor beta/physiology
24141756;Child;Child, Preschool;Craniosynostoses/complications*;Craniosynostoses/diagnosis;Diagnosis, Differential;Eye Movements*;Female;Humans;Ocular Motility Disorders/diagnosis;Ocular Motility Disorders/etiology*;Ocular Motility Disorders/physiopathology;Oculomotor Muscles/innervation;Oculomotor Muscles/physiopathology*;Tomography, X-Ray Computed;Trochlear Nerve Diseases/complications*;Trochlear Nerve Diseases/diagnosis;Visual Acuity
24161510;Animals;Female;Humans;Male;Sweetening Agents/adverse effects*
24168193;Carcinogenesis/pathology*;Epithelial-Mesenchymal Transition/physiology*;Humans;Neoplasms/pathology;Signal Transduction/physiology
24176402;Angiomyolipoma/etiology;Birt-Hogg-Dube Syndrome/complications;Carcinoma, Papillary/etiology;Carcinoma, Renal Cell/etiology;Humans;Kidney Neoplasms/etiology*;Leiomyomatosis/complications;Leiomyomatosis/genetics;Renal Insufficiency, Chronic/etiology;Tuberous Sclerosis/complications;Tuberous Sclerosis/genetics;von Hippel-Lindau Disease/complications;von Hippel-Lindau Disease/genetics
24244189;Animals;Caenorhabditis elegans/genetics*;Caenorhabditis elegans/growth & development;Chromosomes/genetics;Dopamine/genetics;Dopamine/metabolism;GABAergic Neurons/metabolism*;Gene Expression Regulation, Developmental;Gene Knockdown Techniques;Genes, Essential*;Nervous System/growth & development;Nervous System/metabolism;RNA Interference*;gamma-Aminobutyric Acid/genetics*
24248692;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Biomarkers, Tumor/metabolism*;Clinical Trials as Topic/methods*;Clinical Trials as Topic/standards;Clinical Trials as Topic/trends;Colorectal Neoplasms/drug therapy*;Colorectal Neoplasms/metabolism*;Evidence-Based Medicine;Humans;Molecular Targeted Therapy/methods*;Neoplasms/drug therapy*;Neoplasms/metabolism*;Neoplasms/pathology;Predictive Value of Tests;Prognosis;Research Design/trends*;Sample Size;Treatment Outcome
24261157;Accidental Falls*;Child Abuse/diagnosis*;Child Abuse/legislation & jurisprudence*;Child Advocacy/legislation & jurisprudence*;Female;Humans;Infant;Skull Fractures/diagnosis*;Skull Fractures/etiology*;Skull Fractures/therapy
24262055;Adult;Contrast Media;Echocardiography/methods*;Embolism, Air/diagnostic imaging*;Embolism, Air/etiology*;Female;Foramen Ovale, Patent/complications*;Foramen Ovale, Patent/diagnostic imaging*;Humans;Image Interpretation, Computer-Assisted/methods*;Male;Microbubbles*;Reproducibility of Results;Sensitivity and Specificity;Young Adult
24268472;Acids/chemistry;Alkalies/chemistry;Biofuels*;Ethanol/chemical synthesis*;Microwaves;Models, Chemical;Musa/chemistry*;Pressure;Steam;Ultrasonics/methods;Waste Products/analysis*
24301232;Acne Vulgaris/drug therapy*;Acne Vulgaris/microbiology;Acne Vulgaris/pathology;Anti-Bacterial Agents/therapeutic use*;Dermatology/methods;Drug Resistance, Bacterial;Humans;Practice Patterns, Physicians'
24320265;Monte Carlo Method;Quantum Theory*
24330692;Acceleration;Adult;Aged;Blood Pressure;Cardiac Output;Cardiography, Impedance*;Case-Control Studies;Exercise Test*;Exercise Tolerance*;Feasibility Studies;Female;Hemodynamics*;Humans;Hypertension, Pulmonary/diagnosis*;Hypertension, Pulmonary/physiopathology;Male;Middle Aged;Predictive Value of Tests;Prospective Studies;Telemetry;Time Factors;Walking*
24336070;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/physiopathology*;Aging, Premature/chemically induced*;Aging, Premature/pathology;Antiretroviral Therapy, Highly Active/adverse effects*;Humans;Laminin/metabolism;Mitochondrial Diseases/chemically induced;Oxidative Stress/drug effects*;Reverse Transcriptase Inhibitors/adverse effects;Telomerase/antagonists & inhibitors;Telomere Shortening/drug effects*
24337576;Carboxy-Lyases/genetics;Carboxy-Lyases/metabolism*;Chorismic Acid/chemistry;Chorismic Acid/metabolism;Escherichia coli/genetics;Escherichia coli/metabolism;Evolution, Molecular;Oxo-Acid-Lyases/genetics;Oxo-Acid-Lyases/metabolism*;Parabens/chemistry;Parabens/metabolism;Photosynthesis/genetics;Phylogeny;Plastoquinone/metabolism*;Recombinant Fusion Proteins/chemistry;Recombinant Fusion Proteins/genetics;Recombinant Fusion Proteins/metabolism;Synechocystis/enzymology*;Synechocystis/genetics;Synechocystis/growth & development;Ubiquinone/metabolism
24341112;Computer Security*;Confidentiality*;Electronic Health Records*;Hospitals, Public;United Kingdom
24343858;Adult;Analysis of Variance;Brachiocephalic Veins/anatomy & histology;Brachiocephalic Veins/pathology*;Feasibility Studies;Female;Humans;Jugular Veins/anatomy & histology;Jugular Veins/pathology*;Magnetic Resonance Angiography/methods*;Male;Observer Variation;Reproducibility of Results;Retrospective Studies;Sensitivity and Specificity;Signal-To-Noise Ratio;Subclavian Vein/pathology*;Vascular Diseases/pathology*;Vena Cava, Superior/anatomy & histology;Vena Cava, Superior/pathology*
24360359;Adolescent;Adult;Brain Mapping/methods;Female;Humans;Image Processing, Computer-Assisted/methods;Magnetic Resonance Imaging*/methods;Male;Occipital Lobe/physiology*;Pattern Recognition, Visual/physiology*;Photic Stimulation/methods;Transcranial Magnetic Stimulation*/methods;Visual Perception/physiology*;Young Adult
24366552;Adult;Aged;Aged, 80 and over;Female;Humans;Imaging, Three-Dimensional/methods*;Male;Middle Aged;Retrospective Studies;Tibial Fractures/diagnostic imaging*;Tibial Fractures/surgery;Tomography, X-Ray Computed/methods*;Trauma Centers;Young Adult
24374494;Bacteria/metabolism*;Biofilms*;Calcium/analysis;Iron/metabolism*;Ligands;Manganese/analysis;Microscopy, Electron, Scanning;Silicon/analysis;Solutions
24384115;Antiparkinson Agents/therapeutic use*;Combined Modality Therapy;Disease Management;Disease Progression;Early Diagnosis;Humans;Parkinson Disease/diagnosis*;Parkinson Disease/drug therapy;Parkinson Disease/epidemiology;Parkinson Disease/therapy*;Patient Participation;Practice Guidelines as Topic;United States/epidemiology
24388313;Adult;Bone Demineralization, Pathologic/genetics*;Claudins/genetics*;Humans;Hypercalciuria/genetics*;Hypocalcemia/genetics;Hypoparathyroidism/congenital;Hypoparathyroidism/genetics;Kidney Failure, Chronic/genetics;Male;Mutation*;Nephrocalcinosis/genetics*;Renal Tubular Transport, Inborn Errors/genetics*
24407064;Allergens/adverse effects*;Allergens/chemistry;Benzophenones/adverse effects*;Benzophenones/chemistry;Dermatitis, Allergic Contact/etiology*;Dermatitis, Photoallergic/etiology;Humans;Sunscreening Agents/adverse effects*;Sunscreening Agents/chemistry
24423597;Cluster Analysis;Data Mining*;Humans;Influenza Vaccines/immunology;Interferon-gamma/metabolism;Longitudinal Studies;Neural Networks (Computer);Principal Component Analysis;T-Lymphocytes/immunology;T-Lymphocytes/metabolism
24423637;Adult;Aged;Aged, 80 and over;Aromatase/metabolism;Brain/drug effects;Brain/metabolism*;Cytokines/genetics;Cytokines/metabolism;Estrogens/genetics;Estrogens/metabolism*;Female;Humans;Male;Middle Aged;Multiple Sclerosis/pathology*;Nerve Fibers, Myelinated/metabolism;Nerve Fibers, Myelinated/pathology;Postmortem Changes;Progesterone/genetics;Progesterone/metabolism*;Receptors, Estrogen/genetics;Receptors, Estrogen/metabolism;Sex Characteristics*;Signal Transduction/drug effects;Signal Transduction/physiology*
24429442;Anti-HIV Agents/therapeutic use*;HIV Infections/prevention & control*;Humans
24429942;Adolescent;Adult;Age of Onset;Cognition;Cognition Disorders/complications;Cognition Disorders/psychology*;Female;Humans;Male;Psychotic Disorders/complications;Psychotic Disorders/psychology*;Schizoid Personality Disorder/complications;Schizoid Personality Disorder/psychology*;Social Perception;Wit and Humor as Topic;Young Adult
24438523;Anti-HIV Agents/chemistry*;Anti-HIV Agents/pharmacology*;Drug Design;HIV Infections/drug therapy*;HIV Infections/enzymology;HIV Infections/virology;HIV-1/drug effects;HIV-1/enzymology*;Humans;Models, Molecular;Ribonuclease H, Human Immunodeficiency Virus/antagonists & inhibitors*;Ribonuclease H, Human Immunodeficiency Virus/chemistry;Ribonuclease H, Human Immunodeficiency Virus/metabolism;Structure-Activity Relationship
24442687;Axilla/surgery;Breast Neoplasms/epidemiology*;Breast Neoplasms/pathology;Breast Neoplasms/surgery*;Clinical Trials as Topic;Female;Humans;Lymph Node Excision*;Lymphatic Metastasis;Mastectomy, Segmental*;Medicare;Neoplasm Staging;SEER Program;Sentinel Lymph Node Biopsy;United States
24460027;Angiostatins/genetics;Angiostatins/therapeutic use*;Animals;Cornea/blood supply;Cornea/pathology;Cornea/surgery;Corneal Neovascularization/surgery;Corneal Neovascularization/therapy*;Corneal Opacity;Corneal Transplantation;Endostatins/genetics;Endostatins/therapeutic use*;Genetic Therapy*;Genetic Vectors/metabolism*;Green Fluorescent Proteins/metabolism;Humans;Infectious Anemia Virus, Equine/genetics*;Primates;Rabbits;Transduction, Genetic*
24468877;Animals;Extracellular Fluid/metabolism*;Humans;Lewy Body Disease/genetics;Lewy Body Disease/metabolism*;Lewy Body Disease/pathology*;Models, Molecular;Neurons/pathology*;Neurons/ultrastructure;alpha-Synuclein/metabolism*
24476222;Animals;Aorta/metabolism;Calcinosis/metabolism;Calcinosis/prevention & control*;Coronary Artery Disease/metabolism;Coronary Artery Disease/prevention & control*;Dietary Supplements/analysis*;Disease Models, Animal;Female;Humans;Mice;Oxygen/metabolism*;Stilbenes/administration & dosage*;Uremia/metabolism;Uremia/prevention & control*
24505715;Algorithms;Brain/anatomy & histology*;Brain/growth & development*;Female;Humans;Image Enhancement/methods;Image Interpretation, Computer-Assisted/methods*;Imaging, Three-Dimensional/methods*;Infant, Newborn;Infant, Premature;Magnetic Resonance Imaging/methods*;Male;Morphogenesis/physiology*;Pattern Recognition, Automated/methods*;Reproducibility of Results;Sensitivity and Specificity
24522003;Acupuncture Therapy/instrumentation*;Needles/standards*;Stainless Steel/chemistry;Stainless Steel/standards;Surface Properties
24530743;Animals;Antigens, Bacterial/chemistry;Antigens, Bacterial/genetics;Antigens, Bacterial/immunology*;Bordetella pertussis/genetics;Bordetella pertussis/immunology*;Epitopes, T-Lymphocyte/chemistry;Epitopes, T-Lymphocyte/genetics;Epitopes, T-Lymphocyte/immunology*;Humans;Immunity/physiology;Major Histocompatibility Complex/immunology;Pertussis Vaccine/immunology*;Whooping Cough/immunology*;Whooping Cough/prevention & control*
24549077;Arthralgia/diagnosis*;Cardiomyopathy, Dilated/diagnosis*;Child, Preschool;Diagnosis, Differential;Eosinophilia/complications;Eosinophilia/diagnosis*;Eosinophilia/parasitology;Female;Heart Diseases/complications;Hip Joint;Humans;Hypereosinophilic Syndrome/diagnosis;Myocarditis/diagnosis*;Rheumatic Diseases/diagnosis;Thrombosis/complications
24553968;Bioreactors/microbiology*;Biota*;Cluster Analysis;Molecular Sequence Data;Nitrites/analysis;Oxidoreductases/genetics;Phylogeny;Sequence Analysis, DNA;Waste Water/chemistry;Waste Water/microbiology*;Water Purification*
24569282;Aluminum Oxide/chemistry*;Anti-Bacterial Agents/chemistry*;Hydrogen-Ion Concentration;Tetracycline/chemistry*;Time Factors;Ultrasonics*;Waste Disposal, Fluid/methods;Water/chemistry*;Water Pollutants, Chemical
24583045;Data Collection;Electronic Health Records/utilization*;Female;Humans;Interviews as Topic;Male;Medical Informatics;Online Systems/standards*;Software;User-Computer Interface*;Utilization Review*
24583743;Animals;Female;Intervertebral Disc/physiopathology*;Intervertebral Disc Displacement/physiopathology*;Lumbar Vertebrae/physiology*;Range of Motion, Articular/physiology*
24590961;Afghanistan;Fee-for-Service Plans;Health Services Accessibility;Humans;Pilot Projects;Primary Health Care/economics*;Primary Health Care/standards;Primary Health Care/utilization;Quality of Health Care/economics*
24597009;Adult;Cross-Sectional Studies;Educational Measurement*;Emotional Intelligence*;Female;Humans;Male;Middle Aged;Nurse Anesthetists/education*;School Admission Criteria*;Students, Nursing/psychology*;Young Adult
24599029;Catalysis;Cyclohexanones/chemical synthesis;Cyclohexanones/chemistry*;Molecular Conformation
24618195;Adult;Aged;Bursitis/complications*;Catheterization;Embolization, Therapeutic*;Female;Humans;Male;Middle Aged;Neovascularization, Pathologic/etiology;Neovascularization, Pathologic/therapy*;Pilot Projects;Prospective Studies;Range of Motion, Articular;Recovery of Function;Shoulder Joint/blood supply;Shoulder Pain/etiology;Shoulder Pain/therapy*
24663169;Animals;Cattle/physiology*;Dinoprost;Estrus Synchronization/methods;Female;Gonadotropin-Releasing Hormone;Insemination, Artificial/methods;Insemination, Artificial/veterinary*;Pregnancy;Pregnancy Rate*;Semen/physiology*;Sex Preselection/veterinary*
24667374;Breast Neoplasms/metabolism*;Female;Humans;Interleukin-6/metabolism*;MicroRNAs/metabolism*;NF-kappa B/metabolism*;Neoplasm Proteins/metabolism*;RNA, Neoplasm/metabolism*;STAT3 Transcription Factor/metabolism*;Signal Transduction*
24694783;Cell Line, Tumor;Cell Separation/methods;Hodgkin Disease/pathology*;Humans;Reed-Sternberg Cells/pathology*;Sentinel Lymph Node Biopsy
24695690;Biomarkers, Tumor/analysis*;Colorectal Neoplasms/metabolism*;Colorectal Neoplasms/mortality;Humans;Immunohistochemistry;Multidrug Resistance-Associated Proteins/analysis;Multidrug Resistance-Associated Proteins/biosynthesis;NAD(P)H Dehydrogenase (Quinone)/analysis;NAD(P)H Dehydrogenase (Quinone)/biosynthesis;NF-E2-Related Factor 2/analysis;NF-E2-Related Factor 2/biosynthesis*;Prognosis;Survival Rate;Tumor Suppressor Protein p53/analysis;Tumor Suppressor Protein p53/biosynthesis
24714945;Adult;Age Distribution;Aged;Brazil/epidemiology;Humans;Information Systems;Male;Middle Aged;Mortality/trends;Prostatic Neoplasms/mortality*;Space-Time Clustering;Time Factors
24751149;Animal Diseases/microbiology*;Animals;Bacterial Proteins/genetics*;Methicillin-Resistant Staphylococcus aureus/genetics*;Spain;Staphylococcal Infections/veterinary*;Urban Health;Waste Water/microbiology*
24758757;Animals;Coronary Vessels*;Nickel;Nitrogen;Random Allocation;Stainless Steel/chemistry;Stents*;Swine;Swine, Miniature
24769347;Anti-Infective Agents/chemical synthesis*;Anti-Infective Agents/chemistry;Anti-Infective Agents/metabolism;Anti-Infective Agents/pharmacology*;Bacteria/drug effects;Bacteria/enzymology;Candida albicans/drug effects;Chemistry Techniques, Synthetic;DNA Gyrase/chemistry;DNA Gyrase/metabolism;DNA, Superhelical/metabolism;Drug Design*;Drug Resistance, Bacterial/drug effects*;Flavonoids/chemistry*;Fluoroquinolones/chemistry*;Microbial Sensitivity Tests;Molecular Docking Simulation;Protein Conformation;Structure-Activity Relationship
24773432;Animals;Disease Models, Animal;Female;Humans;Male;Mice;Mice, Inbred C57BL;Mice, Transgenic;Parkinson Disease/genetics;Parkinson Disease/physiopathology*;Vocalization, Animal/physiology*;alpha-Synuclein/genetics*
24773481;Administration, Cutaneous;Anesthetics, Local/therapeutic use*;Dosage Forms;Health Care Surveys;Hospitals, Teaching;Humans;Lidocaine/therapeutic use*;Neuralgia/drug therapy*;Neuralgia/physiopathology;Neuralgia/psychology;Pain/drug therapy;Pain Measurement;Patient Satisfaction/statistics & numerical data*;Recovery of Function*;Self Report;Treatment Outcome
24774858;Animals;Disease Reservoirs;Euplotes/parasitology*;Host-Parasite Interactions;Macronucleus*;Phylogeny;RNA, Ribosomal, 18S/genetics;Trypanosomatina/classification;Trypanosomatina/genetics;Trypanosomatina/isolation & purification*
24783255;Adolescent;Ambulatory Care/methods*;Anorexia Nervosa/diagnosis*;Anorexia Nervosa/psychology;Anorexia Nervosa/therapy*;Female;Germany;Humans;Psychotherapy/methods*
24796226;Adolescent;Adult;Age Factors;Automobile Driving/psychology*;Automobile Driving/statistics & numerical data;Biomarkers/blood;C-Reactive Protein/analysis;Cross-Sectional Studies;Homocysteine/blood;Humans;Inflammation/blood;Inflammation/epidemiology;Inflammation/etiology*;Male;Middle Aged;Motor Vehicles;Occupational Diseases/blood;Occupational Diseases/epidemiology;Occupational Diseases/etiology;Surveys and Questionnaires;Work Schedule Tolerance/physiology;Work Schedule Tolerance/psychology;Young Adult
24803441;Australia;Capacity Building;Family*;Health Promotion*;Humans;Leadership*;Oceanic Ancestry Group*/psychology;Personal Satisfaction*;Power (Psychology)*;Program Development
24808581;Algorithms;Animals;Computer Simulation;Models, Neurological*;Neurotransmitter Agents/metabolism;Stochastic Processes*;Synapses/physiology*;Synaptic Transmission/physiology*
24813828;Adult;Electroencephalography*;Female;Humans;Male;Middle Aged;Monitoring, Ambulatory*;Polysomnography*;Sensitivity and Specificity;Sleep/physiology*
24845655;Acute Pain/psychology*;Central Nervous System Sensitization*;Chronic Pain/psychology*;Humans;Male;Pain Threshold/psychology*;Stress Disorders, Post-Traumatic/psychology*
24873770;Anastomosis, Surgical;Duodenum/pathology;Duodenum/surgery;Enterocolitis, Necrotizing/diagnosis*;Enterocolitis, Necrotizing/diagnostic imaging;Enterocolitis, Necrotizing/pathology;Enterocolitis, Necrotizing/surgery*;Humans;Ileum/pathology;Ileum/surgery;Intestine, Small/pathology*;Intestine, Small/surgery*;Male;Middle Aged;Radiography;Reoperation;Risk Factors;Treatment Outcome
24874701;Carbonated Beverages/statistics & numerical data;Child;Cross-Sectional Studies;DMF Index;Dental Caries Activity Tests*;Educational Status;Feeding Behavior;Female;Humans;Male;Molar/physiology*;Mothers/education;Periodontal Index;Population Surveillance;Risk Assessment;Social Class;Tooth Crown/pathology;Tooth Eruption/physiology*;Tooth Remineralization*;Toothbrushing/statistics & numerical data
24898414;Adult;Circadian Rhythm;Female;Fluoroimmunoassay;Health Surveys;Humans;Hydrocortisone/metabolism*;Longitudinal Studies;Male;Philippines/epidemiology;Premature Birth/metabolism*;Prevalence;Saliva/chemistry*;Sex Factors;Young Adult
24898552;Antihypertensive Agents/therapeutic use;Blood Pressure/drug effects;Body Weight/physiology;Catheter Ablation/methods*;Drug Resistance;Female;Heart Rate/drug effects;Humans;Hypertension/drug therapy;Hypertension/surgery*;Male;Middle Aged;Sympathectomy/adverse effects;Sympathectomy/methods*;Treatment Outcome
24898820;Animals;Biological Evolution;Brain/physiology;Evolution, Molecular*;Humans;Mammals/genetics*;Mammals/physiology;Microcephaly/genetics*;Phylogeny;Primates/genetics*;Primates/physiology;Selection, Genetic
24911293;Antimycin A/pharmacology;Electron Transport;Electron Transport Complex III/antagonists & inhibitors;Electron Transport Complex III/metabolism*;Membrane Potential, Mitochondrial;Mitochondrial Membranes/metabolism;Models, Theoretical*;Reactive Oxygen Species/metabolism;Superoxides/metabolism*
24935937;Animals;Blood Pressure/physiology*;Female;Inflammation/pathology;Inflammation/physiopathology*;Kidney/immunology;Kidney/physiology;Mice, Knockout;Models, Animal;Placenta/immunology;Placenta/physiology;Pregnancy;Pregnancy, Animal/physiology*;Receptors, Angiotensin/deficiency;Receptors, Angiotensin/genetics;Receptors, Angiotensin/physiology*;T-Lymphocytes/parasitology;T-Lymphocytes/pathology
24938354;Adolescent;Age Factors;Child;Child, Preschool;Humans;Infant;Male;Reproducibility of Results;Speech Production Measurement/methods*;Speech Production Measurement/statistics & numerical data;Stuttering/classification;Stuttering/diagnosis*
24939250;Dental Cements;Dental Implant-Abutment Design*;Dental Implants*;Dental Prosthesis Retention;Dental Prosthesis, Implant-Supported*;Humans;Image Processing, Computer-Assisted/methods;Photography, Dental/methods
24939469;Aged;Aging/drug effects*;Clinical Trials as Topic;Humans;Patient Selection;Randomized Controlled Trials as Topic
24979260;Adolescent;Adult;Collagen/therapeutic use*;Cornea/innervation*;Cornea/physiopathology;Cross-Linking Reagents/therapeutic use*;Female;Follow-Up Studies;Humans;Keratoconus/drug therapy*;Keratoconus/pathology;Keratoconus/physiopathology;Male;Microscopy, Confocal;Nerve Fibers/pathology;Ophthalmic Nerve/pathology*;Ophthalmic Nerve/physiopathology;Photochemotherapy/methods*;Prospective Studies;Sensation/physiology*;Treatment Outcome;Young Adult
24982471;Appointments and Schedules;Checklist;Forecasting;General Practice/methods;General Practice/trends;Health Services Accessibility/standards;Humans;Telemedicine/methods*;Telemedicine/trends;Telephone*;Triage/methods*;Triage/trends
24994492;Antidepressive Agents/therapeutic use*;Combined Modality Therapy/methods;Combined Modality Therapy/statistics & numerical data;Exercise Therapy/methods*;Exercise Therapy/statistics & numerical data;Germany/epidemiology;Humans;Prevalence;Psychotherapy/methods*;Psychotherapy/statistics & numerical data;Relaxation Therapy/methods*;Relaxation Therapy/statistics & numerical data;Risk Factors;Tension-Type Headache/diagnosis*;Tension-Type Headache/epidemiology;Tension-Type Headache/therapy*
24994564;Diet*;Environmental Exposure*;Gold*;Humans;Metals, Heavy/toxicity*;Mining*;Peru;Risk Assessment;Rural Population*
24997339;Animals;Basement Membrane/metabolism;Cell Culture Techniques;Collagen/administration & dosage*;Collagen/chemistry;Collagen/metabolism;Drug Combinations;Extracellular Matrix/metabolism*;Humans;Laminin/administration & dosage*;Laminin/chemistry;Laminin/metabolism;Models, Biological;Neoplasms/metabolism*;Proteoglycans/administration & dosage*;Proteoglycans/chemistry;Proteoglycans/metabolism;Xenograft Model Antitumor Assays/methods
25003897;Female;Humans;Sexual Behavior/statistics & numerical data*
25005468;Animals;Bacterial Shedding;Female;Longitudinal Studies;Male;Midwestern United States/epidemiology;Prevalence;Risk Factors;Salmonella Infections, Animal/epidemiology*;Salmonella Infections, Animal/microbiology;Salmonella enterica/isolation & purification*;Swine;Swine Diseases/epidemiology*;Swine Diseases/microbiology
25014297;Delivery of Health Care, Integrated;Health Equity;Health Services Accessibility;Health Services for Persons with Disabilities;Hearing Loss/therapy*;Humans
25036592;Cholesterol/metabolism*;Cytoplasm/metabolism;Cytoplasm/pathology;Host-Pathogen Interactions*;Humans;Infection/etiology;Infection/metabolism*;Infection/pathology;Lipid Metabolism;Membrane Microdomains/metabolism*;Membrane Microdomains/pathology;MicroRNAs/genetics;MicroRNAs/metabolism;Prions/metabolism;Prions/pathogenicity
25048534;Fee Schedules/economics*;Humans;Medicare Part B/economics;Medicare Part B/organization & administration*;Models, Econometric;Practice Patterns, Physicians'/economics;Reimbursement Mechanisms/economics;Reimbursement Mechanisms/organization & administration*;United States
25059036;Animals;Antineoplastic Agents, Phytogenic/pharmacology;Blotting, Western;Diabetes Complications/etiology;Diabetes Complications/pathology;Diabetes Complications/prevention & control;Diabetes Mellitus, Experimental/complications;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/metabolism;Diabetes Mellitus, Type 2/complications;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/metabolism;Dyslipidemias/drug therapy*;Dyslipidemias/etiology;Dyslipidemias/pathology;Glucokinase/metabolism;Glucose/metabolism*;Glucose Transporter Type 2/genetics;Glucose-6-Phosphatase/metabolism;Glycogen/metabolism;Hyperglycemia/complications;Kidney Diseases/etiology;Kidney Diseases/pathology;Kidney Diseases/prevention & control;Male;Mice;Mice, Inbred ICR;Mice, Inbred NOD;Polymers/metabolism*;RNA, Messenger/genetics;Real-Time Polymerase Chain Reaction;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction/drug effects*;Triterpenes/pharmacology*
25076108;Burkina Faso/epidemiology;Child, Preschool;Cross-Sectional Studies;Environment*;Female;Humans;Infant;Malaria/diagnosis;Malaria/epidemiology*;Male;Socioeconomic Factors*
25079356;Animals;Cell Lineage/genetics*;Core Binding Factor Alpha 2 Subunit/genetics;Core Binding Factor Alpha 2 Subunit/metabolism;Diploidy*;Embryo, Mammalian/cytology;Embryo, Mammalian/embryology;Embryo, Mammalian/metabolism*;Gene Expression Regulation, Developmental;Megakaryocyte Progenitor Cells/cytology;Megakaryocyte Progenitor Cells/metabolism*;Megakaryocytes/cytology;Megakaryocytes/metabolism*;Mice, Inbred C57BL;Mice, Knockout;Mice, Transgenic;Microscopy, Confocal;Oligonucleotide Array Sequence Analysis;Polyploidy*;Time Factors;Transcriptome;Yolk Sac/cytology;Yolk Sac/embryology;Yolk Sac/metabolism
25087358;Adolescent;Australia;Belgium;Brain/growth & development;Decision Making*;Female;Humans;Male;Mental Competency/legislation & jurisprudence*;Minors/legislation & jurisprudence*;Netherlands;Psychological Tests;Treatment Refusal/legislation & jurisprudence*
25087370;Adult;Australia;Decision Making;Humans;Medical Futility/legislation & jurisprudence;Mental Competency/legislation & jurisprudence*;Quality of Life;Right to Die/ethics;Right to Die/legislation & jurisprudence*;Withholding Treatment/ethics;Withholding Treatment/legislation & jurisprudence*
25089941;Attention*;Cognition*;Humans;Individuality;Memory, Short-Term;Models, Psychological;Motivation;Task Performance and Analysis*;Thinking
25100403;Animals;Brain/pathology*;Cell Transplantation*;Genetic Therapy*;Humans;Neurodegenerative Diseases/genetics*;Neurodegenerative Diseases/therapy*;Synthetic Biology*;Transcription Factors/metabolism
25159676;Alzheimer Disease/drug therapy*;Alzheimer Disease/physiopathology*;Animals;Brain/drug effects;Brain/physiopathology;Estrogen Receptor alpha/agonists;Estrogen Receptor alpha/genetics;Estrogen Receptor alpha/metabolism*;Humans;Neuroprotective Agents/pharmacology;Neuroprotective Agents/therapeutic use*;Protein Isoforms
25159930;Autoantibodies/blood*;Guillain-Barre Syndrome;Humans;Paraproteinemias*/complications;Paraproteinemias*/genetics;Paraproteinemias*/immunology;Paraproteins/immunology*;Peripheral Nervous System Diseases*/complications;Peripheral Nervous System Diseases*/genetics;Peripheral Nervous System Diseases*/immunology;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
25175765;Activation, Metabolic;Animals;Anti-Inflammatory Agents/metabolism;Anti-Inflammatory Agents/pharmacology*;Caffeic Acids/metabolism;Caffeic Acids/pharmacology;Cytochrome P-450 Enzyme System/metabolism;Cytokines/metabolism*;Glycosides/metabolism;Glycosides/pharmacology;Harpagophytum*/chemistry;Humans;Inflammation/drug therapy;Inflammation/metabolism*;Inflammation Mediators/metabolism*;Interleukin-6/metabolism;Interleukin-8/metabolism;Lipopolysaccharides;Liver/enzymology*;Monocytes/drug effects;Monocytes/metabolism;Phytotherapy;Plant Extracts/metabolism;Plant Extracts/pharmacology*;Plant Tubers;Pyrans/metabolism;Pyrans/pharmacology;Rats;Tumor Necrosis Factor-alpha/metabolism
25199884;Animals;Bird Diseases/diagnostic imaging*;Calcinosis/veterinary*;Diagnosis, Differential;Palaeognathae/anatomy & histology*;Tomography, X-Ray Computed/veterinary*;Whole Body Imaging/veterinary;Yolk Sac/diagnostic imaging*
25204131;Light;Panax notoginseng/growth & development;Panax notoginseng/metabolism*;Panax notoginseng/radiation effects*;Photosynthesis/radiation effects*;Plant Extracts/analysis*;Plant Extracts/metabolism
25220246;Anthocyanins/metabolism*;Antioxidants/metabolism*;Carotenoids/metabolism*;Gene Expression;Ipomoea batatas/genetics*;Ipomoea batatas/metabolism;Organ Specificity;Oxidation-Reduction;Plant Leaves/genetics;Plant Leaves/metabolism;Plant Proteins/genetics*;Plant Proteins/metabolism;Plant Roots/genetics;Plant Roots/metabolism;Plants, Genetically Modified;Promoter Regions, Genetic/genetics;Tobacco/genetics;Tobacco/physiology;Transcription Factors/genetics;Transcription Factors/metabolism
25256761;Animals;Brain/metabolism*;Eating/physiology*;Energy Metabolism/physiology*;Feeding Behavior/physiology;Humans;Insulin Resistance/physiology*;Nutritional Status;Rodentia;Weight Gain/physiology*
25275345;Adult;African Americans/ethnology*;African Americans/psychology;Cognition*;Cross-Sectional Studies;Female;Health Status*;Humans;Mental Disorders/diagnosis;Mental Disorders/ethnology*;Mental Disorders/psychology;Perception;Poverty/ethnology*;Poverty/psychology;Self Report;Stress, Psychological/diagnosis;Stress, Psychological/ethnology*;Stress, Psychological/psychology
25286811;Amniotic Fluid;Anthropometry;Biomarkers/blood;Body Composition;Female;Fetal Growth Retardation/blood;Fetal Growth Retardation/diagnosis*;Fetal Growth Retardation/etiology*;Fetus/blood supply;Humans;Laser-Doppler Flowmetry;Pregnancy;Risk Factors;Ultrasonography, Prenatal
25287915;Adult;Aged;Aged, 80 and over;Colorectal Neoplasms/pathology*;Disease-Free Survival;Female;Hepatectomy/adverse effects*;Humans;Liver Neoplasms/pathology*;Liver Neoplasms/secondary;Liver Neoplasms/surgery*;Male;Middle Aged;Neoplasm Staging;Postoperative Complications/etiology;Postoperative Complications/mortality;Retrospective Studies;Risk Factors;Survival Rate;Treatment Outcome;Young Adult
25289648;Adaptor Proteins, Signal Transducing/physiology*;Endopeptidases/metabolism;HeLa Cells;Humans;Jurkat Cells;MCF-7 Cells;Protein Biosynthesis;Protein Transport;RNA Interference*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Transcription, Genetic;Vimentin/genetics;Vimentin/metabolism
25318088;Adult;Case-Control Studies;Cross-Sectional Studies;Female;Hand/physiopathology*;Humans;Male;Middle Aged;Reference Values;Scleroderma, Systemic/physiopathology*;Skin/physiopathology;Somatosensory Disorders/physiopathology*;Statistics, Nonparametric;Touch Perception/physiology*
25318284;Home Health Aides/economics*;Lobbying;Politics;Salaries and Fringe Benefits/legislation & jurisprudence*;United States
25318820;Animals;Erythrocyte Aggregation*;Erythrocyte Deformability*;Female;Hemorheology*;Male;Rats/genetics;Rats/physiology*
25339724;Aggression*;Animals;Behavior, Animal*;Biological Evolution;Cues;Female;Insecta/anatomy & histology;Insecta/genetics;Insecta/physiology*;Male;Phenotype;Reproduction;Sex Characteristics;Sexual Behavior, Animal;Species Specificity;Wings, Animal/anatomy & histology*
25344414;Animals;Antibodies/administration & dosage*;Arthritis, Experimental/drug therapy*;Arthritis, Rheumatoid/drug therapy*;Arthritis, Rheumatoid/metabolism;Collagen Type II/antagonists & inhibitors*;Etanercept/therapeutic use;Humans;Mice;Mice, Knockout;Mice, Transgenic;Tumor Necrosis Factor-alpha/antagonists & inhibitors*
25348780;Adult;Aged;Aged, 80 and over;Female;Fluorescent Dyes/administration & dosage;Fluorescent Dyes/therapeutic use*;Follow-Up Studies;Humans;Injections, Intralesional;Lymphatic Metastasis;Male;Melanoma/drug therapy*;Melanoma/mortality;Melanoma/pathology;Middle Aged;Neoplasm Recurrence, Local/drug therapy*;Neoplasm Recurrence, Local/mortality;Neoplasm Recurrence, Local/pathology;Neoplasm Staging;Prognosis;Rose Bengal/administration & dosage;Rose Bengal/therapeutic use*;Skin Neoplasms/drug therapy*;Skin Neoplasms/mortality;Skin Neoplasms/secondary;Survival Rate
25365906;Adolescent;Cartilage, Articular/injuries*;Child;Epiphyses/diagnostic imaging;Epiphyses/injuries;Female;Femur Head Necrosis/etiology*;Humans;Male;Multivariate Analysis;Radiography;Retrospective Studies;Risk Factors;Severity of Illness Index;Slipped Capital Femoral Epiphyses/complications*;Slipped Capital Femoral Epiphyses/surgery
25399700;Estrogen Replacement Therapy/adverse effects*;Female;Humans;Menopause*;Patient Education as Topic*;Physician's Role*;Risk Assessment
25424469;Adult;Animals;Anxiety/psychology*;Avoidance Learning*;Child;Fear*;Female;Humans;Male;Mothers/psychology*;Phobic Disorders/diagnosis*;Phobic Disorders/psychology;Spiders*
25447234;Adult;Aging/genetics;Aging/metabolism*;Biomarkers/metabolism;Case-Control Studies;Datasets as Topic;Humans;Middle Aged;Parkinson Disease/genetics;Parkinson Disease/metabolism*;Pars Compacta/metabolism*;Polymorphism, Single Nucleotide;Tissue Array Analysis;Transcriptome*;Young Adult
25449146;Animals;Association Learning*;Avoidance Learning*;Maze Learning*;Models, Animal*;Zebrafish
25450978;DNA, Bacterial/chemistry;DNA, Bacterial/genetics;DNA, Bacterial/metabolism;Gene Expression Regulation, Bacterial;Iron/metabolism*;Iron-Sulfur Proteins/chemistry;Iron-Sulfur Proteins/metabolism*;Models, Molecular;Nucleic Acid Conformation;Protein Binding;Protein Structure, Tertiary;Response Elements*
25466129;Chitosan/chemistry;Coated Materials, Biocompatible/chemistry;Fatty Acids, Nonesterified/analysis;Food Additives/chemistry*;Food Technology;Glycerol/chemistry;Liposomes/chemistry*;Milk Proteins/chemistry*;Particle Size;Solubility;Water/analysis;Whey Proteins
25466395;Age Factors;Aged;Aged, 80 and over;Clinical Competence*;Delirium/etiology;Delirium/nursing*;Education, Nursing, Continuing/organization & administration*;Evaluation Studies as Topic*;Female;Geriatric Assessment;Hospitalization;Humans;Inpatients/psychology*;Male;Narration;Nurse-Patient Relations;Quality Improvement;Risk Assessment;Sex Factors
25467358;Anniversaries and Special Events*;History of Nursing*;History, 19th Century;United Kingdom
25468660;Aged;Bicycling;Blood Gas Analysis;Cardiac Catheterization;Case-Control Studies;Diastole;Echocardiography, Doppler;Exercise*;Exercise Test;Exercise Tolerance*;Female;Heart Failure/blood;Heart Failure/diagnosis;Heart Failure/physiopathology*;Humans;Hypertension/diagnosis;Hypertension/physiopathology;Male;Middle Aged;Myocardium/metabolism*;Oxygen/blood*;Oxygen Consumption*;Pulmonary Wedge Pressure;Stroke Volume*;Time Factors;Ventricular Function, Left*
25495115;Aged;Aged, 80 and over;Angiodysplasia/diagnosis*;Angiodysplasia/surgery;Argon Plasma Coagulation;Endoscopes, Gastrointestinal*;Endoscopy, Gastrointestinal/instrumentation*;Feasibility Studies;Female;Fluoroscopy;Humans;Image-Guided Biopsy;Intestinal Diseases/diagnosis*;Intestinal Diseases/surgery;Intestinal Polyps/diagnosis*;Intestinal Polyps/surgery;Magnetic Resonance Imaging, Interventional/instrumentation*;Male;Middle Aged;Outcome Assessment (Health Care);Prospective Studies
25525948;Bile Duct Neoplasms/blood supply;Bile Duct Neoplasms/pathology;Bile Duct Neoplasms/surgery*;Blood Vessel Prosthesis Implantation/methods;Embolization, Therapeutic;Hepatectomy/methods*;Hepatic Artery/pathology;Hepatic Artery/surgery;Humans;Klatskin Tumor/blood supply;Klatskin Tumor/pathology;Klatskin Tumor/surgery*;Liver Function Tests;Liver Transplantation/methods;Margins of Excision*;Portal Vein/pathology;Portal Vein/surgery;Postoperative Complications/etiology;Postoperative Complications/prevention & control;Preoperative Care;Prognosis;Retrospective Studies;Risk Assessment;Risk Factors
25533802;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control*;Health Promotion/methods;Humans;Life Style;Risk Factors
25536223;Adult;Aged;Allografts;Antibodies, Viral/blood;Antibodies, Viral/immunology;BK Virus/physiology*;Cord Blood Stem Cell Transplantation*;DNA, Viral/blood;DNA, Viral/immunology;Female;Follow-Up Studies;Hematologic Neoplasms*/blood;Hematologic Neoplasms*/immunology;Hematologic Neoplasms*/therapy;Humans;Male;Middle Aged;Polyomavirus Infections*/blood;Polyomavirus Infections*/immunology;Tumor Virus Infections*/blood;Tumor Virus Infections*/immunology;Virus Activation/immunology*
25540943;Anaerobiosis;Biofuels;Biological Oxygen Demand Analysis;Bioreactors;Electrochemical Techniques;Hydrogen Sulfide/analysis;Nitrogen/analysis;Phosphorus/analysis;Recycling;Waste Disposal, Fluid/methods*
25542049;Anti-Bacterial Agents/metabolism;Anti-Bacterial Agents/pharmacology;Bacterial Proteins/analysis*;Bacterial Proteins/antagonists & inhibitors;Bacterial Proteins/classification;Bacterial Proteins/genetics;Bacteriological Techniques*;Body Fluids/microbiology;Carbapenems/metabolism;Carbapenems/pharmacology;Carrier State/microbiology;Community-Acquired Infections/epidemiology;Community-Acquired Infections/microbiology;Cross Infection/epidemiology;Cross Infection/microbiology;Drug Resistance, Multiple, Bacterial/genetics;Enterobacteriaceae/drug effects;Enterobacteriaceae/enzymology*;Enterobacteriaceae/genetics;Enterobacteriaceae/isolation & purification;Enterobacteriaceae Infections/drug therapy;Enterobacteriaceae Infections/epidemiology;Enterobacteriaceae Infections/microbiology*;Humans;Laboratories, Hospital;Microbial Sensitivity Tests;Phenotype;Proteomics/methods;beta-Lactam Resistance/genetics;beta-Lactamases/analysis*;beta-Lactamases/classification;beta-Lactamases/genetics
25542688;Automatic Data Processing*;Humans;Neuropharmacology*;Neuropsychology*;Periodicals as Topic*
25552470;Administration, Oral;Aged;Anticoagulants/administration & dosage*;Atrial Appendage/diagnostic imaging*;Atrial Fibrillation/complications*;Dose-Response Relationship, Drug;Echocardiography, Transesophageal;Electric Countershock/methods;Female;Humans;Pyrazoles/administration & dosage*;Pyridones/administration & dosage*;Recurrence;Risk Factors;Thrombosis/diagnostic imaging*;Thrombosis/drug therapy*;Treatment Outcome;Vitamin K
25568955;Asparagine/genetics;Cytoplasm;Glutamine/genetics;Molecular Chaperones/genetics;Prion Diseases/genetics*;Prion Diseases/pathology;Prions/genetics*;Prions/metabolism;Protein Aggregates/genetics*;Protein Conformation;Saccharomyces cerevisiae;Vacuoles/genetics*;Vacuoles/metabolism
25582375;Animals;Antioxidants/administration & dosage*;Antioxidants/chemistry;Antioxidants/therapeutic use;Diabetes Mellitus/drug therapy*;Diabetes Mellitus/physiopathology;Drug Carriers/chemistry;Drug Delivery Systems*;Humans;Hypoglycemic Agents/therapeutic use;Mitochondria/metabolism;Oxidative Stress/drug effects;Solubility
25583184;Arm/physiology*;Biomechanical Phenomena;Humans;Leg/physiology*;Male;Motor Skills/physiology*;Sports Equipment*;Swimming/physiology*;Task Performance and Analysis;Video Recording;Young Adult
25599663;Antibiotics, Antineoplastic/chemistry;Antibiotics, Antineoplastic/toxicity;Cell Line, Tumor;Cell Survival/drug effects;Cell-Penetrating Peptides/chemistry;Cell-Penetrating Peptides/metabolism;DNA/chemistry*;Doxorubicin/chemistry;Doxorubicin/toxicity;Drug Carriers;Gold/chemistry;Humans;Metal Nanoparticles/chemistry*;Microscopy, Confocal;Nucleic Acid Amplification Techniques;Quantum Dots/chemistry
25603316;Animals;Association Learning*/physiology;Brain/physiopathology;Chronic Pain/physiopathology;Chronic Pain/psychology*;Discrimination (Psychology)*/physiology;Discrimination Learning*/physiology;Fear*/physiology;Humans;Models, Psychological
25613243;Dental Care/ethics*;Dental Plaque/prevention & control*;Humans;Practice Guidelines as Topic*
25617491;Animals;Collagen Type I/chemistry;Collagen Type I/metabolism*;Collagen Type III/chemistry;Collagen Type III/metabolism*;Gene Expression Regulation, Enzymologic;Gene Knockout Techniques;Humans;Hypertension, Pulmonary/enzymology;Keloid/enzymology;Metalloendopeptidases/genetics;Metalloendopeptidases/metabolism*;Mice;Procollagen/metabolism*;Tensile Strength
25619660;Animals;Cells, Cultured;Corpus Striatum/metabolism*;Disease Models, Animal;Down-Regulation/genetics*;Female;Gene Expression/genetics*;Gene Expression Regulation/genetics*;Humans;Huntingtin Protein;Huntington Disease/genetics*;Huntington Disease/metabolism;Male;Mice, Inbred C57BL;Mutation*;Nerve Tissue Proteins/genetics*;Neuroprotective Agents*;Nuclear Proteins/genetics*;RNA, Small Interfering/genetics;RNA, Untranslated/genetics*;RNA, Untranslated/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Serine Proteases/genetics*;Serine Proteases/metabolism
25622392;Adult;Diabetes Mellitus, Type 2/diagnosis*;Diabetes Mellitus, Type 2/mortality*;Humans;Insurance, Disability*;Insurance, Life*;Male;Risk Assessment
25636033;Alzheimer Disease/metabolism;Alzheimer Disease/pathology*;BRCA1 Protein/metabolism*;DNA Damage;DNA Repair;Humans;Neurons/metabolism;Signal Transduction;Tumor Suppressor Protein p53/metabolism*
25647153;Animals;Antigens, CD/metabolism*;Colitis/chemically induced;Colitis/immunology;Colitis/microbiology;Colitis/prevention & control*;Dendritic Cells/cytology;Dendritic Cells/immunology*;Dendritic Cells/metabolism;Dextran Sulfate/toxicity;Disease Models, Animal;Epithelial Cells/immunology;Epithelial Cells/metabolism;Epithelial Cells/microbiology;Escherichia coli/physiology;Escherichia coli Infections/complications;Escherichia coli Infections/pathology;Female;Flow Cytometry;Inflammation/etiology;Inflammation/metabolism;Inflammation/prevention & control*;Integrin alpha Chains/metabolism*;Intestines/immunology*;Intestines/metabolism;Intestines/microbiology;Male;Mice;Mice, Inbred C57BL;Mice, Knockout;Toll-Like Receptor 2/physiology*;Toll-Like Receptor 4/physiology*
25656027;Factor Analysis, Statistical;Humans;Liver Cirrhosis*;Morbidity;Postoperative Complications*;Retrospective Studies;Risk Factors;Stomach Neoplasms*
25679446;Cell Phone;Humans;Information Systems;Mobile Applications*;Neoplasms/therapy*;Palliative Care/methods*;Palliative Medicine/instrumentation*;Palliative Medicine/methods;Telemedicine/methods*
25679475;Adolescent;Adult;Aged;Algorithms;Electroencephalography;Female;Humans;Male;Middle Aged;Models, Statistical;Polysomnography/methods*;Signal Processing, Computer-Assisted*;Sleep/physiology*;Young Adult
25688649;Animal Feed/analysis;Animal Nutritional Physiological Phenomena;Animals;Bixaceae/metabolism*;Carotenoids/analysis;Carotenoids/metabolism*;Chickens;Dietary Supplements/analysis;Egg Yolk/chemistry;Egg Yolk/metabolism*;Female;Plant Extracts/analysis;Plant Extracts/metabolism*;Tocotrienols/analysis;Tocotrienols/metabolism*;alpha-Tocopherol/analysis;alpha-Tocopherol/metabolism*
25695450;Acellular Dermis*;Actins/metabolism*;Animals;Biomarkers/metabolism;Cattle;Collagen/therapeutic use*;Fetus;Guided Tissue Regeneration/methods*;Humans;Skin/injuries*;Skin/metabolism;Skin Transplantation/methods*;Soft Tissue Injuries/metabolism;Soft Tissue Injuries/therapy*;Tissue Scaffolds;Wound Healing/physiology
25701522;Cell Membrane Permeability*;Cells, Cultured;Humans;Reproducibility of Results;Ultrasonics/methods*
25716483;Adaptation, Psychological/physiology*;Humans;Mental Disorders/physiopathology*;Mental Disorders/psychology*;Motivation*;Reward
25739105;Arterial Occlusive Diseases/diagnosis*;Arterial Occlusive Diseases/physiopathology;Arterial Occlusive Diseases/surgery;Blood Flow Velocity/physiology;Celiac Artery/diagnostic imaging*;Female;Humans;Middle Aged;Respiration*;Syndrome;Tomography, X-Ray Computed;Ultrasonography, Doppler
25741709;Animals;Apoptosis/genetics;Ependymoglial Cells/metabolism;Ependymoglial Cells/pathology*;Gene Expression Profiling;Mice;Mice, Transgenic;MicroRNAs/genetics;MicroRNAs/metabolism*;Retinal Degeneration/genetics;Retinal Degeneration/metabolism*;Retinal Degeneration/pathology;Signal Transduction/genetics
25747293;Adult;Biomedical Research*;Female;Focus Groups;Health Knowledge, Attitudes, Practice*;Hispanic Americans*;Humans;Male;Mexico/ethnology;Middle Aged;Motivation;Perception;Qualitative Research;Research Subjects*;Trust;United States
25752126;Child;Face;Goiter;Hair Diseases/diagnosis;Hair Diseases/pathology*;Humans;Male;Pilomatrixoma/diagnosis;Pilomatrixoma/pathology*;Skin;Skin Neoplasms/diagnosis;Skin Neoplasms/pathology*
25766512;Acute Coronary Syndrome/mortality*;Acute Coronary Syndrome/pathology;Acute Coronary Syndrome/therapy*;Age Factors;Aged;Cardiac Catheterization/statistics & numerical data;Disease Management;Evidence-Based Medicine/statistics & numerical data;Female;Heart Failure/complications;Heart Failure/epidemiology*;Hospital Mortality;Hospitalization;Humans;Male;Middle Aged;Percutaneous Coronary Intervention/statistics & numerical data;Prognosis;Registries;Sex Factors
25783419;Adolescent;Adult;Aged;Anxiety/complications;Anxiety Disorders/complications;Chronic Disease;Dementia/complications;Diabetes Mellitus, Type 1/complications*;Diabetes Mellitus, Type 2/complications*;Female;Humans;Hypertension/complications*;Logistic Models;Longitudinal Studies;Male;Mental Disorders/complications*;Middle Aged;Obesity/complications*;Obesity/psychology;Obesity, Morbid/complications;Obesity, Morbid/psychology;Primary Health Care;Spain;Substance-Related Disorders/complications;Weight Loss*;Young Adult
25817306;Aged, 80 and over;Aortic Valve/diagnostic imaging;Aortic Valve/surgery;Female;Hemodynamics;Humans;Kaplan-Meier Estimate;Male;Mitral Valve/diagnostic imaging;Mitral Valve Insufficiency/diagnostic imaging*;Postoperative Complications/diagnostic imaging*;Retrospective Studies;Severity of Illness Index;Systole;Transcatheter Aortic Valve Replacement*;Treatment Outcome;Ultrasonography
25817927;Adult;Antipsychotic Agents/therapeutic use;California;Female;Forensic Psychiatry/standards;Guidelines as Topic*;Hospitals, Psychiatric/standards*;Humans;Male;Middle Aged;Schizophrenia/drug therapy;Schizophrenia/therapy;Violence/psychology*;Young Adult
25823631;Alcoholism/drug therapy*;Alcoholism/genetics*;Cocaine-Related Disorders/drug therapy*;Cocaine-Related Disorders/genetics*;Humans;Opioid-Related Disorders/drug therapy*;Opioid-Related Disorders/genetics*;Polymorphism, Genetic;Receptors, Opioid/genetics*;Treatment Outcome
25824818;Analysis of Variance;Animals;Body Weight/drug effects;Dose-Response Relationship, Drug;Endothelin-1/genetics;Endothelin-1/metabolism*;Female;Gene Expression Regulation, Developmental/drug effects;Halogenated Diphenyl Ethers/toxicity*;Male;Nitric Oxide Synthase Type III/genetics;Nitric Oxide Synthase Type III/metabolism*;Placenta/drug effects;Placenta/metabolism*;Pregnancy;Prenatal Exposure Delayed Effects/chemically induced*;Prenatal Exposure Delayed Effects/physiopathology*;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley
25826474;Adult;Exercise Movement Techniques*;Female;Health Status*;Humans;Libido/physiology*;Middle Aged;Prospective Studies;Quality of Life;Sexual Behavior/psychology*;Sexual Dysfunction, Physiological/prevention & control;Sexual Dysfunctions, Psychological/prevention & control;Women's Health;Young Adult
25850073;Adult;Aged;Cystostomy/methods;Endometriosis/surgery*;Feasibility Studies;Female;Follow-Up Studies;Humans;Iatrogenic Disease;Laparoscopy*;Middle Aged;Postoperative Complications/surgery*;Retrospective Studies;Treatment Outcome;Ureter/injuries;Ureter/surgery*;Ureteral Diseases/surgery*;Ureteral Obstruction/surgery;Urologic Surgical Procedures/instrumentation;Urologic Surgical Procedures/methods*
25857031;Adenocarcinoma, Mucinous*;Cysts;Humans;Neoplasm Grading;Neoplasm Invasiveness;Pancreatic Neoplasms/pathology*
25857873;Alkaloids/chemistry*;Chromatography, Liquid/methods*;Indoles/chemistry*;Mass Spectrometry/methods*;Mitragyna/chemistry*;Molecular Structure;Plant Leaves/chemistry
25862375;Animals;Brain Diseases/metabolism*;Exosomes/metabolism*;Extracellular Vesicles/metabolism;Humans;MicroRNAs/metabolism*;RNA Transport;Toll-Like Receptors/metabolism*
25877269;Aged;Aged, 80 and over;Cardiovascular Diseases/mortality;Cause of Death;Cold Temperature*;Environmental Exposure/adverse effects*;Female;Frail Elderly/statistics & numerical data*;Hot Temperature*;Humans;London/epidemiology;Male;Mortality*;Regression Analysis;Respiratory Tract Infections/mortality;Weather*
25880583;Aged;Angiography/methods;Angioplasty, Balloon/methods*;Chronic Disease;Cohort Studies;Contrast Media*;Female;Hospitals, University;Humans;Hypertension, Pulmonary/complications;Hypertension, Pulmonary/diagnosis*;Hypertension, Pulmonary/therapy*;Japan;Kidney Function Tests;Male;Middle Aged;Pulmonary Embolism/complications;Pulmonary Embolism/diagnostic imaging;Pulmonary Embolism/therapy*;Radiographic Image Enhancement*;Retrospective Studies;Severity of Illness Index;Statistics, Nonparametric;Tomography, X-Ray Computed/methods;Treatment Outcome
25908538;Attention*;Autistic Disorder/psychology;Autistic Disorder/therapy*;Child, Preschool;Communication*;Education, Special/methods*;Humans;Male;Reinforcement (Psychology)*;Task Performance and Analysis;Time Factors
25919850;Antidepressive Agents/therapeutic use*;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Treatment-Resistant/drug therapy*;Female;Humans;Male;Patient Acceptance of Health Care/psychology*
25946283;Aged;Conjunctiva/pathology*;Conjunctival Neoplasms/pathology*;Female;Humans;Melanoma/pathology*
25948228;Chromosomes, Human, Pair 22*;Epigenesis, Genetic;Humans;Leukemia, Myeloid, Acute*;Translocation, Genetic
25957564;Aldehyde Dehydrogenase/genetics;Aldehyde Dehydrogenase/metabolism*;Bacterial Proteins/genetics;Bacterial Proteins/metabolism;Fermentation;Klebsiella pneumoniae/enzymology*;Klebsiella pneumoniae/genetics;Lactic Acid/analogs & derivatives;Lactic Acid/metabolism;Propylene Glycols/metabolism*
25957756;Adult;Female;Humans;Lower Extremity/anatomy & histology*;Lower Extremity/blood supply*;Male;Muscle, Skeletal/anatomy & histology*;Muscle, Skeletal/blood supply*;Surgical Flaps*
25965001;Adolescent;Cotinine;Environmental Exposure/statistics & numerical data*;Female;Humans;Male;Middle Aged;Tobacco Smoke Pollution/analysis*
25965018;Acclimatization/genetics*;Animals;Buffaloes;Cattle;Heat-Shock Proteins/blood;Heat-Shock Proteins/genetics*;Heat-Shock Proteins/metabolism*;Heat-Shock Response/genetics;RNA, Messenger/metabolism;Seasons*;Transcriptome;Tropical Climate*
25970809;Accidents, Occupational;Adult;Combined Modality Therapy;Crush Syndrome/physiopathology;Crush Syndrome/prevention & control*;Emergency Treatment/methods*;Follow-Up Studies;Humans;Injury Severity Score;Lower Extremity;Male;Multiple Trauma/diagnosis;Multiple Trauma/therapy*;Reperfusion Injury/prevention & control*;Risk Assessment;Tourniquets/utilization*;Treatment Outcome;Wounds and Injuries/diagnosis;Wounds and Injuries/therapy
26008859;Hepatitis, Alcoholic*/diagnosis;Hepatitis, Alcoholic*/genetics;Hepatitis, Alcoholic*/physiopathology;Hepatitis, Alcoholic*/therapy;Humans;Research*
26023797;AMP-Activated Protein Kinases/genetics;AMP-Activated Protein Kinases/metabolism*;Age Factors;Animals;Brain/metabolism;Down-Regulation;Gene Expression;Hypertension/genetics;Hypertension/metabolism*;Hypertension/urine;Ion Channels/biosynthesis;Ion Channels/genetics;Ion Channels/metabolism*;Kidney/metabolism;Male;Mitochondrial Proteins/biosynthesis;Mitochondrial Proteins/genetics;Mitochondrial Proteins/metabolism*;Myocardium/metabolism;PPAR alpha/genetics;PPAR alpha/metabolism*;Proteinuria/genetics;Proteinuria/metabolism;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Rats, Inbred SHR;Signal Transduction;Uncoupling Protein 2
26045219;Adult;Female;Femur Head/diagnostic imaging;Femur Head/pathology*;Hip Joint/diagnostic imaging;Hip Joint/pathology*;Humans;Joint Diseases/complications;Joint Diseases/diagnostic imaging;Joint Diseases/pathology*;Lupus Erythematosus, Systemic/complications;Lupus Erythematosus, Systemic/diagnostic imaging;Lupus Erythematosus, Systemic/pathology*;Magnetic Resonance Imaging;Radiography
26058788;Brachypodium/metabolism*;Cell Wall/metabolism*;Proteomics/methods*
26061760;Adipose Tissue/metabolism*;Animals;Cell Hypoxia;Energy Metabolism;Humans;Lipid Metabolism;Oxidative Stress*;Oxygen Consumption*
26081461;Animal Feed/analysis*;Animal Nutritional Physiological Phenomena;Animals;Animals, Newborn/physiology;Diet/veterinary*;Dietary Supplements/analysis;Digestion/physiology;Feeding Behavior*;Fruit*;Male;Mexico;Sheep/physiology*;Trees*;Tropical Climate;Weight Gain
26085296;Female;Humans;Male;Sleep/physiology*;Sleep Wake Disorders/etiology*;Sleep Wake Disorders/psychology*;Workload/psychology*;Workload/statistics & numerical data*
26086387;Adult;Female;Humans;Hypertension/etiology;Hypertriglyceridemia/etiology;Logistic Models;Male;Mental Disorders/etiology*;Mental Disorders/psychology;Metabolic Syndrome/complications;Metabolic Syndrome/diagnosis*;Middle Aged;Occupational Injuries/etiology*;Occupational Injuries/psychology;Odds Ratio;Proportional Hazards Models;Risk Factors;Stress, Psychological*;Surveys and Questionnaires;Workplace
26086449;Aniline Compounds/chemical synthesis;Aniline Compounds/chemistry;Aniline Compounds/pharmacology*;Carbolines/chemical synthesis;Carbolines/chemistry;Carbolines/pharmacology*;Cell Size/drug effects;DNA Fragmentation/drug effects;Membrane Potential, Mitochondrial/drug effects;Mitochondria/metabolism*;Phosphatidylserines/metabolism;Reactive Oxygen Species/metabolism;Singlet Oxygen/metabolism;Trypanocidal Agents/chemical synthesis;Trypanocidal Agents/chemistry;Trypanocidal Agents/pharmacology*;Trypanosoma cruzi/drug effects*;Trypanosoma cruzi/metabolism
26092760;Animals;Antioxidants/pharmacology;Berberine/adverse effects;Berberine/pharmacokinetics;Berberine/pharmacology*;Drug Interactions;Enzyme Inhibitors/pharmacology;Humans;Immunologic Factors/pharmacology;Molecular Targeted Therapy;Neurotransmitter Agents/pharmacology
26094763;Adolescent;Adult;Aged;Aged, 80 and over;Analgesia, Patient-Controlled*;Emergency Service, Hospital;Emergency Treatment*;Female;Humans;Male;Middle Aged;Pain/etiology*;Pain Management/methods*;Wounds and Injuries/complications*;Young Adult
26097630;Adult;Biopsy;Carcinoma, Squamous Cell/therapy*;Chemoradiotherapy/adverse effects;Combined Modality Therapy;Female;Humans;Lymph Node Excision;Lymphangioma/diagnosis;Lymphangioma/etiology*;Lymphedema/etiology;Neoplasms, Second Primary/diagnosis;Neoplasms, Second Primary/etiology*;Postoperative Complications/etiology;Uterine Cervical Neoplasms/therapy*;Vulvar Neoplasms/diagnosis;Vulvar Neoplasms/etiology*
26108808;Arrhythmias, Cardiac/complications;Arrhythmias, Cardiac/diagnosis*;Arrhythmias, Cardiac/therapy*;Asia;Cardio-Renal Syndrome/diagnosis*;Cardio-Renal Syndrome/therapy;Cardiology/standards;Clinical Decision-Making/methods;Defibrillators, Implantable/standards*;Europe;Humans;Kidney Function Tests/standards;Practice Guidelines as Topic;Renal Insufficiency, Chronic/complications;Renal Insufficiency, Chronic/diagnosis*;Renal Insufficiency, Chronic/therapy*
26173897;Epidemics*;Humans;Influenza A Virus, H1N1 Subtype/isolation & purification;Influenza, Human/epidemiology;Influenza, Human/virology;Models, Biological*
26174954;Alcoholics/statistics & numerical data*;Brain Injuries/mortality;Brain Injuries/pathology;Cohort Studies;Female;Forensic Pathology;Hematoma, Subdural/mortality;Hematoma, Subdural/pathology*;Humans;Male;New York City/epidemiology;Retrospective Studies;Sex Distribution
26194183;Adult;Brain/physiopathology;Brain Diseases;Brain Mapping/methods;Broca Area/physiopathology*;Cytokines/analysis*;Cytokines/blood;Female;Humans;Image Processing, Computer-Assisted/methods;Intelligence Tests;Language;Magnetic Resonance Imaging/methods;Male;Middle Aged;Psychiatric Status Rating Scales;Psychotic Disorders/physiopathology;Schizophrenia/metabolism;Schizophrenia/physiopathology*;Verbal Behavior/physiology*
26195157;Diagnosis, Differential;Female;Humans;Lung Neoplasms/pathology*;Middle Aged;Solitary Fibrous Tumors/pathology*
26195526;Asian Continental Ancestry Group;Electrophoresis, Gel, Pulsed-Field;Escherichia coli/enzymology*;Escherichia coli/genetics;Humans;Microbial Sensitivity Tests;beta-Lactamases/genetics*
26227663;Addison Disease/complications*;Addison Disease/drug therapy;Adult;Aged;Anti-Inflammatory Agents/metabolism*;Anti-Inflammatory Agents/therapeutic use;Cognition Disorders/drug therapy;Cognition Disorders/etiology*;Female;Fludrocortisone/metabolism*;Fludrocortisone/therapeutic use;Humans;Male;Middle Aged;Mood Disorders/drug therapy;Mood Disorders/etiology*;Neuropsychological Tests;Psychiatric Status Rating Scales
26231773;Animals;Dairying/methods*;Environment;Eutrophication;Netherlands;Nitrogen;Nitrogen Cycle*;Phosphorus*;Water Pollution/prevention & control*
26245120;Ancylostomiasis;Animals;Child;Enzyme-Linked Immunosorbent Assay;Helminthiasis*;Humans;Immunoglobulin E;Interleukin-4;Interleukin-9;Intestinal Diseases, Parasitic*;Trichuriasis
26250233;Animal Distribution;Animal Structures/anatomy & histology;Animal Structures/growth & development;Animals;Body Size;Ecosystem;Female;Male;Organ Size;Queensland;Snakes/anatomy & histology;Snakes/classification*;Snakes/growth & development
26255417;Alcoholism/nursing*;Community Health Nursing/organization & administration;Female;Humans;Middle Aged;Nurse's Role*;Nurse-Patient Relations*;Nursing Diagnosis/methods*;Women's Health
26267595;Adult;African Americans/statistics & numerical data;Age Factors;Aged;Exercise Test;Female;Forced Expiratory Volume;Humans;Kaplan-Meier Estimate;Lung Diseases/mortality;Lung Diseases/physiopathology;Lung Diseases/surgery;Lung Transplantation*;Male;Middle Aged;Multivariate Analysis;Occupational Diseases/mortality;Occupational Diseases/physiopathology;Occupational Diseases/surgery;Proportional Hazards Models;Retrospective Studies;Silicosis/mortality;Silicosis/physiopathology;Silicosis/surgery*;Survival Rate;Tissue Donors/statistics & numerical data;United States;Vital Capacity
26296402;Education*;Education, Medical;Humans;Interpersonal Relations*
26297339;Hernia, Ventral/surgery*;Herniorrhaphy/methods*;Humans;Surgical Mesh*
26311526;Chemoradiotherapy, Adjuvant/methods*;Deglutition/radiation effects;Humans;Neck Dissection/methods;Oral Surgical Procedures/methods*;Oropharyngeal Neoplasms/pathology;Oropharyngeal Neoplasms/therapy;Oropharyngeal Neoplasms/virology*;Papillomavirus Infections/pathology;Papillomavirus Infections/therapy*;Prospective Studies;Quality of Life;Radiation Dosage;Radiotherapy, Adjuvant/methods*;Survival Analysis;Treatment Outcome
26311620;Adult;Endoplasmic Reticulum/metabolism;Endoplasmic Reticulum/ultrastructure;Fascia Lata/cytology*;Fascia Lata/ultrastructure*;Humans;Male;Microscopy, Electron*;Mitochondria/metabolism;Mitochondria/ultrastructure;Telocytes/cytology;Telocytes/ultrastructure*;Telopodes/ultrastructure
26323240;Delivery of Health Care/methods*;Drug-Related Side Effects and Adverse Reactions/epidemiology*;Female;Humans;Male
26324495;Age Factors;Anti-Bacterial Agents/therapeutic use*;Child, Preschool;Female;Humans;Inappropriate Prescribing*/prevention & control;Inappropriate Prescribing*/statistics & numerical data;Infant;Infection*/diagnosis;Infection*/drug therapy;Infection*/epidemiology;Logistic Models;Male;Practice Patterns, Physicians'/statistics & numerical data*;Predictive Value of Tests;Primary Health Care/methods;Prospective Studies;Symptom Assessment/methods;Symptom Assessment/statistics & numerical data;Wales/epidemiology
26327230;Animals;Catalysis;Cattle;Colorimetry/methods;Gold/chemistry*;Hydrogen Sulfide/analysis*;Hydrogen Sulfide/blood*;Limit of Detection;Models, Molecular;Nanoshells/chemistry*;Nanoshells/ultrastructure;Platinum/chemistry*;Reproducibility of Results;Water/analysis*
26330387;Adult;Aged;Bayes Theorem;CCCTC-Binding Factor;Carcinoma, Endometrioid/genetics*;Carcinoma, Endometrioid/pathology;DNA Copy Number Variations*;Disease-Free Survival;Endometrial Neoplasms/genetics*;Female;Gene Deletion;Homeodomain Proteins/genetics*;Humans;Loss of Heterozygosity;Microsatellite Instability;Middle Aged;Mutation*;Odds Ratio;Polymorphism, Single Nucleotide*;Prognosis;Repressor Proteins/genetics*
26344490;Acetonitriles/chemistry*;Acetophenones/chemistry*;Aminopyridines/chemistry*;Catalysis;Copper/chemistry*;Imidazoles/chemical synthesis*;Imidazoles/chemistry;Molecular Structure;Pyridines/chemical synthesis*;Pyridines/chemistry
26350566;Acute-Phase Proteins/pharmacology*;Animals;Cell Proliferation/drug effects*;Cells, Cultured;Disease Models, Animal;Enzyme Activation;Humans;Hypertension, Pulmonary/chemically induced;Hypertension, Pulmonary/enzymology;Hypertension, Pulmonary/pathology;Lipocalin-2;Lipocalins/metabolism;Lipocalins/pharmacology*;Male;Monocrotaline;Muscle, Smooth, Vascular/drug effects*;Muscle, Smooth, Vascular/enzymology;Muscle, Smooth, Vascular/pathology;Myocytes, Smooth Muscle/drug effects*;Myocytes, Smooth Muscle/enzymology;Myocytes, Smooth Muscle/pathology;Phosphatidylinositol 3-Kinase/antagonists & inhibitors;Phosphatidylinositol 3-Kinase/metabolism*;Phosphorylation;Protein Kinase Inhibitors/pharmacology;Proto-Oncogene Proteins/pharmacology*;Proto-Oncogene Proteins c-akt/metabolism*;Pulmonary Artery/drug effects*;Pulmonary Artery/enzymology;Pulmonary Artery/pathology;Rats, Sprague-Dawley;Signal Transduction/drug effects;Up-Regulation;Vascular Remodeling/drug effects*
26361763;Asthma/diagnosis*;Asthma/genetics;Environmental Monitoring*;Epigenesis, Genetic;Humans;Time Factors
26362076;Female;Humans;Hysterectomy/adverse effects*;Hysterectomy/methods;Incidence;Lower Urinary Tract Symptoms/epidemiology;Lower Urinary Tract Symptoms/etiology*;Lower Urinary Tract Symptoms/physiopathology;Lower Urinary Tract Symptoms/therapy;Urodynamics;Uterine Cervical Neoplasms/surgery
26369653;Amylases/blood;Blood Glucose/drug effects;Body Fat Distribution;Body Weight/drug effects;Diabetes Mellitus, Type 2/complications*;Diabetes Mellitus, Type 2/diagnostic imaging;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/pathology;Drug Administration Schedule;Female;Glycated Hemoglobin A/metabolism;Humans;Hypoglycemic Agents/pharmacology;Hypoglycemic Agents/therapeutic use;Insulin Resistance;Insulin-Secreting Cells/cytology;Insulin-Secreting Cells/drug effects*;Insulin-Secreting Cells/enzymology*;Lipase/blood;Liraglutide/pharmacology*;Liraglutide/therapeutic use;Male;Metformin/pharmacology*;Metformin/therapeutic use;Middle Aged;Obesity/complications*;Obesity/drug therapy;Organ Size/drug effects;Overweight/complications*;Overweight/drug therapy;Radiography;Treatment Outcome
26389154;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Colorectal Neoplasms/mortality*;Colorectal Neoplasms/pathology*;Female;Humans;Male
26395494;Animals;Brain/cytology;Brain/metabolism;Cell Lineage;Cell Proliferation;DNA-Binding Proteins/metabolism;Drosophila/cytology*;Drosophila/genetics;Drosophila/growth & development;Drosophila/physiology*;Drosophila Proteins/metabolism;Larva/metabolism;MicroRNAs/metabolism*;Nerve Tissue Proteins/metabolism;Neural Stem Cells/cytology;Neural Stem Cells/metabolism;Nuclear Proteins/metabolism;Transcription Factors/metabolism
26409910;Adult;Ankle Joint/physiology*;Electric Stimulation Therapy/methods*;Female;Healthy Volunteers;Humans;Male;Muscle Contraction/physiology*;Muscle Fatigue/physiology;Muscle, Skeletal/physiology*
26411135;Adult;Cross-Sectional Studies;Female;Forced Expiratory Volume/physiology*;Humans;Incidence;Lung Diseases/epidemiology*;Lung Diseases/etiology;Male;Middle Aged;Occupational Diseases/epidemiology*;Pakistan;Population Surveillance*;Reference Values;Spirometry;Textiles*
26421301;Adult Stem Cells/cytology;Adult Stem Cells/metabolism*;Animals;Biomarkers/metabolism*;Embryonic Stem Cells/cytology;Embryonic Stem Cells/metabolism*;Humans;Neural Stem Cells/cytology;Neural Stem Cells/metabolism*;Neurogenesis*
26460083;Child;Chromosomes, Human, Pair 18;Female;Humans;Karyotyping;Mouth Abnormalities/genetics*;Phenotype;Survival;Trisomy/physiopathology*;Trisomy 18 Syndrome
26475436;Anatomy/education*;Anatomy/ethics*;Education, Medical, Undergraduate/ethics*;Guidelines as Topic*;Humans;Schools, Medical/ethics*;Students, Medical/psychology*
26478003;Animals;Cypriniformes/genetics*;DNA, Mitochondrial/genetics;Genes, Mitochondrial/genetics*;Genes, rRNA/genetics;Genome, Mitochondrial/genetics*;Phylogeny;RNA, Transfer/genetics;Sequence Analysis, DNA/methods
26491122;Adolescent;Anthropometry;Blood Glucose/analysis;Blood Pressure;Body Composition;Brazil/epidemiology;Breast Feeding;C-Reactive Protein/analysis;Child;Counseling*;Energy Intake;Female;Follow-Up Studies;Health Promotion/methods*;Humans;Infant;Infant Nutritional Physiological Phenomena*;Infant, Newborn;Lipids/blood;Male;Metabolic Diseases*/prevention & control;Micronutrients/administration & dosage;Nutrition Policy;Risk;Sex Factors;Weight Gain*
26498764;Adult;Female;Hernias, Diaphragmatic, Congenital/diagnostic imaging*;Hernias, Diaphragmatic, Congenital/surgery;Humans;Infant, Newborn;Kidney/abnormalities*;Magnetic Resonance Imaging;Pregnancy;Prenatal Diagnosis*
26521092;Femur/diagnostic imaging;Femur/physiology*;Finite Element Analysis*;Humans;Patient-Specific Modeling*;Stress, Mechanical*;Tomography, X-Ray Computed;Weight-Bearing
26528871;Acute Disease;Adhesives/adverse effects*;Adolescent;Adult;Aged;Female;Humans;Male;Middle Aged;Prevalence;Prospective Studies;Skin/injuries*;Young Adult
26541926;Global Health;Humans;Incidence;Myocardial Ischemia/epidemiology*;Myocardial Ischemia/etiology*;Postoperative Complications*;Risk Assessment*;Risk Factors;Surgical Procedures, Operative/adverse effects*
26571564;Animals;Humans;MAP Kinase Kinase Kinase 5/metabolism;Oxidative Stress/physiology;Phosphorylation/physiology*;Signal Transduction/physiology*;Ubiquitin/metabolism*;Ubiquitination/physiology*
26572496;Aged;Body Height*;Female;Fractures, Bone/epidemiology*;Humans;Middle Aged;Postmenopause*;Risk Factors;United Kingdom/epidemiology
26575059;Humans;Male;Prostate-Specific Antigen/blood*;Prostatic Neoplasms/blood*;Prostatic Neoplasms/diagnosis*;Prostatic Neoplasms/epidemiology*
26575695;Biometry*;Cluster Analysis*;Computer Simulation;Data Interpretation, Statistical*;Humans;Periodontal Attachment Loss;Sample Size;Statistics, Nonparametric*;Tooth
26586777;Adolescent;Adult;Aged;Analysis of Variance;Cervix Uteri/pathology;Condoms/utilization;Cross-Sectional Studies;Female;Gentian Violet;Humans;Middle Aged;Multiplex Polymerase Chain Reaction;Multivariate Analysis;New South Wales/epidemiology;Phenazines;Sexually Transmitted Diseases/epidemiology;Sexually Transmitted Diseases/etiology*;Uterine Cervicitis/epidemiology;Uterine Cervicitis/etiology*;Vaginal Discharge;Young Adult
26587822;Humans;Organ Transplantation/standards*;Organ Transplantation/trends*;Tissue and Organ Procurement/trends*;Transplants/standards*
26598610;Animals;Cell Size*;Humans;Mitosis*
26603806;Bronchoscopes*;Bronchoscopy/instrumentation*;Female;Fiber Optic Technology*;Humans;Intubation, Intratracheal/instrumentation*;Male
26610043;Animals;Antioxidants/pharmacology;Apoptosis/drug effects;Creatine Kinase/metabolism;Disease Models, Animal;Drugs, Chinese Herbal/pharmacology*;Glutathione/metabolism;L-Lactate Dehydrogenase/metabolism;Male;Malondialdehyde/metabolism;Myocardial Ischemia/drug therapy*;Myocardial Ischemia/metabolism;Myocardial Reperfusion Injury/drug therapy*;Myocardial Reperfusion Injury/metabolism;Myocardium/metabolism;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/metabolism;Nitric Oxide Synthase Type II/metabolism;Paeonia;Plant Extracts/pharmacology*;Protective Agents/pharmacology*;RNA, Messenger/metabolism;Rats;Rats, Wistar;Superoxide Dismutase/metabolism;bcl-2-Associated X Protein/metabolism
26612673;Adolescent;Child;Child, Preschool;Female;Humans;Infant;Male;Prospective Studies;Regression Analysis;Time Factors;Transportation of Patients/standards*;Trauma Centers*;Trauma Severity Indices
26626253;Acetylcholine/metabolism;Aging;Animals;Brain/drug effects;Brain/metabolism;Choline/metabolism;Choline O-Acetyltransferase/metabolism;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacology*;Drug Interactions;Hippocampus/drug effects;Hippocampus/metabolism;Indans/administration & dosage;Indans/pharmacology*;Male;Microdialysis;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/pharmacology*;Piperidines/administration & dosage;Piperidines/pharmacology*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley
26626310;Adolescent;Adult;Divorce*;Family Characteristics;Female;HIV Infections/epidemiology*;HIV Infections/transmission*;HIV-1*;Humans;Lesotho/epidemiology;Male;Middle Aged;Risk Factors;Sexual Behavior*
26631734;Acyl Carrier Protein/chemistry*;Acyl Carrier Protein/genetics;Acyl Carrier Protein/metabolism*;Crystallography, X-Ray;Enterococcus faecalis/chemistry;Enterococcus faecalis/genetics;Enterococcus faecalis/metabolism*;Hot Temperature;Hydrogen Bonding;Models, Molecular;Nuclear Magnetic Resonance, Biomolecular;Protein Stability;Protein Structure, Secondary
26643587;Humans;Perception;Professional Role/psychology;Rheumatic Diseases/psychology*
26645878;Adult;Age Factors;Aged;Female;Forecasting;Health Status Disparities*;Hong Kong/epidemiology;Humans;Male;Middle Aged;Myocardial Ischemia/etiology;Myocardial Ischemia/mortality*;Risk Factors;Sex Factors;Socioeconomic Factors
26671508;Adolescent;Child;Echocardiography/methods*;Exercise/physiology*;Exercise Test/methods*;Female;Healthy Volunteers;Heart Ventricles/diagnostic imaging;Hemodynamics/physiology*;Humans;Male;Retrospective Studies;Systole;Ventricular Function, Left
26684047;Adult;Asian Continental Ancestry Group/ethnology;Cross-Sectional Studies;Dry Eye Syndromes/diagnosis;Dry Eye Syndromes/ethnology;Dry Eye Syndromes/physiopathology*;Female;Humans;Menstruation Disturbances/diagnosis;Menstruation Disturbances/ethnology;Menstruation Disturbances/physiopathology*;Middle Aged;Nutrition Surveys;Republic of Korea/epidemiology;Risk Factors;Surveys and Questionnaires;Young Adult
26720814;Adolescent;Adult;Female;Humans;Interpersonal Relations*;Male;Personal Satisfaction*;Power (Psychology)*;Self Concept*;Social Desirability*;Surveys and Questionnaires;Young Adult
26758119;Hemangioendothelioma/complications*;Humans;Infant, Newborn;Kasabach-Merritt Syndrome/complications*;Sarcoma, Kaposi/complications*
26769511;Antioxidants;Bentonite/chemistry*;Biopolymers;Food Packaging;Fruit/chemistry*;Nanocomposites;Pectins/chemistry*;Permeability;Polysaccharides;Punicaceae/chemistry*
26781378;Ascomycota/classification*;Ascomycota/genetics;Ascomycota/isolation & purification*;DNA Barcoding, Taxonomic;Fungal Proteins/genetics;Humans;Molecular Sequence Data;Mycoses/microbiology*;Phylogeny
26794515;Animals;Axonal Transport/physiology*;Axons/metabolism*;Decapodiformes/metabolism*;Intermediate Filaments/metabolism;Kinesin/metabolism*;Phosphorylation
26797316;Aneurysm;Decompression, Surgical;Humans;Popliteal Artery/surgery*
26829651;Atlantic Ocean;Cells, Cultured;Chromatography, High Pressure Liquid;Clone Cells;Dinoflagellida/chemistry;Dinoflagellida/cytology;Dinoflagellida/growth & development;Dinoflagellida/metabolism*;Harmful Algal Bloom;Heterocyclic Compounds, 3-Ring/chemistry;Heterocyclic Compounds, 3-Ring/isolation & purification;Heterocyclic Compounds, 3-Ring/metabolism;Heterocyclic Compounds, 4 or More Rings/chemistry;Heterocyclic Compounds, 4 or More Rings/isolation & purification;Heterocyclic Compounds, 4 or More Rings/metabolism*;Hydrocarbons, Cyclic/chemistry;Hydrocarbons, Cyclic/isolation & purification;Hydrocarbons, Cyclic/metabolism*;Imines/chemistry;Imines/isolation & purification;Imines/metabolism;Marine Toxins/chemistry;Marine Toxins/isolation & purification;Marine Toxins/metabolism*;Methylation;Molecular Structure;Nuclear Magnetic Resonance, Biomolecular;Spectrometry, Mass, Electrospray Ionization;Stereoisomerism;Sweden;Tandem Mass Spectrometry
26838160;Adenosine Diphosphate/metabolism*;Administration, Oral;Animals;Carps/urine;Chickens/urine;Chromatography, Liquid;Liver/chemistry*;Mass Spectrometry;Rats/urine;Swine/urine;Tissue Distribution;Trimethoprim/administration & dosage;Trimethoprim/analogs & derivatives*;Trimethoprim/pharmacokinetics;Trimethoprim/urine
26849914;Bays/chemistry;China;Environmental Monitoring*;Geologic Sediments/chemistry;Lead/analysis;Mercury;Metals, Heavy/analysis*;Water Pollutants, Chemical/analysis*
26850003;Antiviral Agents/chemical synthesis;Antiviral Agents/chemistry*;Antiviral Agents/pharmacology*;Dose-Response Relationship, Drug;Drug Discovery*;Genotype;Hepacivirus/drug effects*;Hepacivirus/genetics*;Microbial Sensitivity Tests;Molecular Structure;Proline/analogs & derivatives*;Silanes/chemistry*;Silanes/pharmacology;Structure-Activity Relationship;Viral Nonstructural Proteins/antagonists & inhibitors*;Viral Nonstructural Proteins/genetics;Virus Replication/drug effects
26856450;Bacillus/chemistry*;Bacillus/genetics;Bacillus/physiology*;Bacillus/ultrastructure;Bacterial Proteins/analysis*;Bacterial Proteins/genetics;Flagella/chemistry;Flagella/ultrastructure;Gene Knockout Techniques;Locomotion*;Membrane Proteins/analysis;Membrane Proteins/genetics;Microscopy, Electron, Scanning;Microscopy, Electron, Transmission;Microscopy, Immunoelectron
26856509;Blood Glucose/analysis;Communication;Diabetes Mellitus, Type 2*;Humans;Prisoners*;Research Design*
26857210;Animals;Bile Duct Neoplasms/etiology*;Bile Duct Neoplasms/metabolism;Carcinogenesis;Cell Line, Tumor;Cholangiocarcinoma/etiology*;Cholangiocarcinoma/metabolism;Down-Regulation;Drug Resistance, Neoplasm;Female;Forkhead Box Protein O3/physiology*;Gene Expression Regulation;Humans;Kelch-Like ECH-Associated Protein 1/metabolism*;Mice, Nude;NF-E2-Related Factor 2/metabolism*;Oxidative Stress;Proto-Oncogene Proteins c-akt/metabolism;Random Allocation;Receptor Cross-Talk;Signal Transduction;Tumor Necrosis Factor-alpha/metabolism
26857938;Case-Control Studies*;Humans;Patient Selection*;Research Design*
26883966;Adult;Arizona;Female;Focus Groups;Food Assistance*;Health Education*;Humans;Male;Middle Aged;Nutritionists/statistics & numerical data;Nutritive Value*;Young Adult
26892406;Analgesics, Opioid/therapeutic use;Anticonvulsants/therapeutic use;Cannabinoids/therapeutic use;Humans;Neuralgia/diagnosis*;Neuralgia/therapy*;Pain Management/methods;Pain Management/standards*;Practice Guidelines as Topic/standards*
26896385;Humans;Professional-Patient Relations*;Psychoanalytic Therapy*;Transference (Psychology)*;Unconscious (Psychology)
26899975;Animals;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/chemistry;Antipsychotic Agents/pharmacokinetics;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Dopamine Antagonists/administration & dosage;Dopamine Antagonists/blood;Dopamine Antagonists/chemistry;Dopamine Antagonists/pharmacokinetics;Drug Compounding;Drug Liberation;Lactic Acid/chemistry;Male;Microspheres;Particle Size;Polyglycolic Acid/chemistry;Rats, Sprague-Dawley;Risperidone/administration & dosage*;Risperidone/blood;Risperidone/chemistry;Risperidone/pharmacokinetics;Serotonin Antagonists/administration & dosage;Serotonin Antagonists/blood;Serotonin Antagonists/chemistry;Serotonin Antagonists/pharmacokinetics
26910643;Animals;Cartilage, Articular/diagnostic imaging;Cartilage, Articular/pathology*;Femur/diagnostic imaging;Femur/pathology*;Histological Techniques;Immobilization/adverse effects*;Male;Rats;Rats, Wistar;Stifle/diagnostic imaging;Stifle/pathology*;X-Ray Microtomography
26923320;Female;Humans;Midwifery/organization & administration*;Nurse Midwives/organization & administration*;Personnel Staffing and Scheduling/organization & administration*;Pregnancy
26928050;Animals;Base Sequence;DNA, Protozoan/chemistry;DNA, Protozoan/genetics;HSP72 Heat-Shock Proteins/chemistry;HSP72 Heat-Shock Proteins/genetics*;Humans;Leishmania/chemistry;Leishmania/genetics;Leishmania/isolation & purification*;Leishmaniasis;Mice;Mice, Inbred BALB C;Molecular Sequence Data;Protozoan Proteins/chemistry;Protozoan Proteins/genetics*;Real-Time Polymerase Chain Reaction/methods*;Sequence Analysis, DNA;Transition Temperature
26937492;Antineoplastic Agents/therapeutic use*;Clinical Trials as Topic;Female;Humans;Ovarian Neoplasms/drug therapy*;Phthalazines/adverse effects;Phthalazines/pharmacokinetics;Phthalazines/pharmacology;Phthalazines/therapeutic use*;Piperazines/adverse effects;Piperazines/pharmacokinetics;Piperazines/pharmacology;Piperazines/therapeutic use*;Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use*
26941006;Animals;Estradiol/blood;Female;Gonadotropin-Releasing Hormone/metabolism;Hypothalamo-Hypophyseal System/drug effects*;Hypothalamo-Hypophyseal System/metabolism;Hypothalamus/metabolism;Lipopolysaccharides/pharmacology*;Luteinizing Hormone/blood;Male;Maternal Exposure*;Pregnancy;Prenatal Exposure Delayed Effects/metabolism*;Rats;Testosterone/pharmacology
26945538;Adipose Tissue/drug effects;Adipose Tissue/metabolism;Administration, Oral;Animals;Body Weight/drug effects;Diet, High-Fat/adverse effects;Energy Metabolism/drug effects;Female;Glucose/metabolism;Lipids/blood;Maternal Nutritional Physiological Phenomena*;Metabolic Diseases/prevention & control*;Mice;Mice, Inbred C57BL;Obesity/metabolism*;Osteocalcin/administration & dosage*;Osteocalcin/metabolism;Pregnancy;Weaning
26948059;Biomarkers, Tumor/genetics*;Gene Expression;Humans;Lymphoma, T-Cell/diagnosis*;Lymphoma, T-Cell/pathology;Male;Middle Aged;Proto-Oncogene Proteins pp60(c-src)/genetics*;Recurrence
26954442;Actins/metabolism*;Animals;Endoplasmic Reticulum/metabolism;GTP Phosphohydrolases/metabolism;Microtubule-Associated Proteins/metabolism;Mitochondria;Mitochondrial Dynamics*;Mitochondrial Proteins/metabolism
26969962;Aged;Deltoid Muscle/diagnostic imaging*;Deltoid Muscle/pathology;Glomus Tumor/diagnostic imaging*;Glomus Tumor/pathology*;Glomus Tumor/surgery;Humans;Magnetic Resonance Imaging;Male;Margins of Excision;Soft Tissue Neoplasms/diagnostic imaging*;Soft Tissue Neoplasms/pathology*;Soft Tissue Neoplasms/surgery
26977629;Child;Child, Preschool;Creatine Kinase/blood;DNA Mutational Analysis;Electromyography;Female;Humans;Infant;Lamin Type A/genetics*;Male;Muscular Dystrophies, Limb-Girdle/blood;Muscular Dystrophies, Limb-Girdle/diagnosis*;Muscular Dystrophies, Limb-Girdle/genetics*;Mutation;Russia
26992329;Aged;Aged, 80 and over;Antibodies/blood;Antibodies/immunology;Antigens, Neoplasm/immunology;Biomarkers, Tumor*;Case-Control Studies;Colorectal Neoplasms/blood*;Colorectal Neoplasms/diagnosis*;Female;Humans;Hydrogel, Polyethylene Glycol Dimethacrylate;Male;Middle Aged;Neoplasm Staging;Polysaccharides/immunology;Protein Array Analysis*/methods;ROC Curve;Sensitivity and Specificity
26996647;Adult;Brazil;Female;Health Status;Humans;Male;Middle Aged;Quality of Life*;Students, Medical/psychology*;Surveys and Questionnaires
27001548;Adult;Aged;Audiovisual Aids*;Chronic Disease/psychology*;Female;Humans;Male;Middle Aged;Prospective Studies;Psychometrics/instrumentation*;Quality of Life/psychology*;Self Report;Severity of Illness Index;Socioeconomic Factors;Surveys and Questionnaires;Tinnitus/psychology*
27003542;Biomedical Research/standards*;Humans;Leadership;Publishing/standards
27007929;Adult;Electrodes, Implanted;Female;Humans;Leg;Male;Middle Aged;Nerve Block;Neuralgia/therapy*;Pain Management/instrumentation;Pain Management/methods;Spinal Cord;Transcutaneous Electric Nerve Stimulation/methods*
27009899;Europe;Health Policy*;Health Status Disparities;Health Surveys/economics*;Humans;Public Health*
27015560;ATP Citrate (pro-S)-Lyase/metabolism*;Acetyl Coenzyme A/metabolism*;Breast Neoplasms/genetics;Breast Neoplasms/metabolism*;Cell Line, Tumor;Class I Phosphatidylinositol 3-Kinases/genetics;Female;Humans;Lipogenesis/physiology*;Mechanistic Target of Rapamycin Complex 2/metabolism;Receptor, ErbB-2/genetics;TOR Serine-Threonine Kinases/metabolism*
27017858;Hepatectomy/methods*;Humans;Liver/anatomy & histology;Liver/surgery;Liver Neoplasms/surgery*
27023212;Aldehydes/chemistry;Alkenes/chemistry;Araceae/drug effects*;Araceae/growth & development;Flowers/drug effects*;Flowers/growth & development;Oxylipins/chemical synthesis*;Oxylipins/isolation & purification;Oxylipins/pharmacology;Plant Growth Regulators/chemical synthesis*;Plant Growth Regulators/isolation & purification;Plant Growth Regulators/pharmacology;Stereoisomerism
27024171;Emotions*;Heart*;Humans
27031226;Apoptosis*;Caspase 3/metabolism*;Caspase 7/metabolism*;Hep G2 Cells;Humans;Magnetic Resonance Imaging*;Magnetite Nanoparticles/chemistry*;Neoplasm Proteins/metabolism*;Neoplasms*/diagnostic imaging;Neoplasms*/enzymology
27037200;Aged;Ampulla of Vater/pathology;Ampulla of Vater/surgery*;Chi-Square Distribution;Common Bile Duct Neoplasms/mortality;Common Bile Duct Neoplasms/pathology;Common Bile Duct Neoplasms/surgery*;Female;Hospital Mortality;Hospitals, High-Volume*;Hospitals, Low-Volume*;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Netherlands;Odds Ratio;Pancreatic Neoplasms/mortality;Pancreatic Neoplasms/pathology;Pancreatic Neoplasms/surgery*;Pancreaticoduodenectomy*/adverse effects;Pancreaticoduodenectomy*/mortality;Proportional Hazards Models;Registries;Risk Factors;Time Factors;Treatment Outcome
27065428;Aged;Blindness/etiology*;Blindness/physiopathology;Female;Humans;Orbital Fractures/surgery*;Orbital Implants/adverse effects*;Postoperative Complications*;Recovery of Function*;Visual Acuity/physiology*
27088766;Adult;Autistic Disorder/physiopathology*;Child;Disabled Children*;Humans;Language*;Parent-Child Relations*;Parents
27094096;Action Potentials/physiology;Animals;Entorhinal Cortex/physiology*;Environment;Grid Cells/physiology*;Humans;Models, Neurological;Motion;Space Perception/physiology
27105959;Humans;Patient Protection and Affordable Care Act*;United States
27115694;Animals;Chromosomes, Human, X/metabolism*;Dosage Compensation, Genetic;Gene Silencing;Humans;Protein Interaction Maps*;RNA, Long Noncoding/genetics;RNA, Long Noncoding/metabolism*;X Chromosome Inactivation*
27118687;Cardiovascular Diseases/etiology*;Cardiovascular Diseases/mortality;Disease Progression;Female;Heart Diseases/etiology;Humans;Kidney Failure, Chronic/etiology;Male;Middle Aged;Prospective Studies;Renal Insufficiency, Chronic/complications*;Smoking/adverse effects*
27131070;Adult;Age Factors;Brugada Syndrome*/chemically induced;Brugada Syndrome*/diagnosis;Brugada Syndrome*/epidemiology;Dose-Response Relationship, Drug;Drug Administration Routes;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*/diagnosis;Drug-Related Side Effects and Adverse Reactions*/epidemiology;Electrocardiography/methods;Female;Heart Conduction System/drug effects;Heart Diseases/epidemiology;Humans;Male;Mass Screening/methods;Middle Aged;Risk Factors;Sex Factors
27140334;Adaptor Proteins, Signal Transducing/metabolism;Animals;Aortic Valve Stenosis/complications*;Cardiomyopathy, Hypertrophic/diagnostic imaging*;Cardiomyopathy, Hypertrophic/etiology;Cardiomyopathy, Hypertrophic/metabolism;Collagen/ultrastructure*;Disease Models, Animal;Echocardiography;Heart Failure/pathology*;Heart Ventricles/diagnostic imaging*;Heart Ventricles/metabolism;Humans;Male;Mice;Microscopy, Electron, Scanning;Ventricular Remodeling
27180936;Aged;Bilirubin/blood*;Blood Glucose/analysis;Blood Glucose/metabolism*;Cross-Sectional Studies;Diabetes Mellitus, Type 2/blood*;Female;Humans;Male;Middle Aged;Monitoring, Physiologic;Sex Factors
27187628;Aged;Cognition*;Cognition Disorders*;Denmark;Humans;Middle Aged
27209223;Adult;Alcohol Drinking/epidemiology*;Alcohol Drinking/psychology;Alcoholism/epidemiology*;Alcoholism/psychology;Ambulatory Care Facilities*;Female;HIV Infections/epidemiology*;HIV Infections/psychology;Humans;Male;Mass Screening*;Middle Aged;Psychometrics/statistics & numerical data;Reproducibility of Results;Risk-Taking;Surveys and Questionnaires*
27215901;Amyloid/chemistry*;Animals;Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry*;Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism;Humans;Neurodegenerative Diseases/metabolism*;Protein Aggregates*;Protein Denaturation;Protein Processing, Post-Translational
27220057;Aged;Aged, 80 and over;Anxiety/therapy*;Bibliotherapy/methods;Cognitive Therapy/methods*;Depression/therapy*;Evidence-Based Practice;Feasibility Studies;Female;Geriatric Assessment;Humans;Male;Middle Aged;Pilot Projects;Self Report
27249773;BRCA1 Protein/genetics;BRCA2 Protein/genetics;DNA Repair/genetics;Female;Genetic Predisposition to Disease*;Genetic Testing*;Humans;Mutation;Neoplasm Proteins/biosynthesis;Neoplasms/genetics*;Neoplasms/pathology;Neoplasms/therapy;Prognosis;Transcriptome*
27251870;Adolescent;Adult;Child;Child Development*;Female;Health Insurance Portability and Accountability Act*/legislation & jurisprudence;Health Insurance Portability and Accountability Act*/trends;Health Personnel*/legislation & jurisprudence;Health Personnel*/trends;Humans;Longitudinal Studies;Middle Aged;Multicenter Studies as Topic/methods;National Institute of Child Health and Human Development (U.S.)*/legislation & jurisprudence;National Institute of Child Health and Human Development (U.S.)*/trends;Patient Selection*;Pregnancy;Sampling Studies;United States/epidemiology;Young Adult
27286234;Animals;Biological Evolution*;Gene Expression Profiling;Host Specificity;Phylogeny;Seeds;Transcriptome*;Wasp Venoms/genetics*;Wasps/physiology*
27319741;Bacteria/metabolism*;Bacteria/virology;Bacteriophages/genetics;Bacteriophages/metabolism*;DNA Modification Methylases/metabolism;Genes, Viral;Nucleotides/biosynthesis*
27322481;Acyltransferases/immunology;Acyltransferases/metabolism;Adult;Antigens, Bacterial/immunology;Antigens, Bacterial/metabolism;BCG Vaccine/administration & dosage*;BCG Vaccine/adverse effects;BCG Vaccine/immunology*;Bacterial Proteins/immunology;Bacterial Proteins/metabolism;Bacterial Toxins/immunology;Bacterial Toxins/metabolism;Dose-Response Relationship, Drug;Healthy Volunteers;Hemolysin Proteins/immunology;Hemolysin Proteins/metabolism;Herpesvirus 3, Human/physiology*;Humans;Male;Vaccines, Synthetic/administration & dosage*;Vaccines, Synthetic/adverse effects;Vaccines, Synthetic/immunology*;Virus Activation;Young Adult
27386948;Aged;Aged, 80 and over;Area Under Curve;Carcinoma, Squamous Cell/mortality*;Carcinoma, Squamous Cell/pathology;Humans;Lymphocyte Count;Male;Middle Aged;Neoplasm Staging;Neutrophils/cytology*;Penile Neoplasms/mortality*;Penile Neoplasms/pathology;Prognosis;ROC Curve;Survival Analysis
27410496;Adolescent;Adolescent Behavior/psychology*;African Americans/psychology*;African Americans/statistics & numerical data;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use*;Cross-Sectional Studies;Female;HIV Infections/drug therapy*;HIV Infections/ethnology;HIV Infections/psychology*;Humans;Male;Marijuana Smoking;Medication Adherence/ethnology;Medication Adherence/psychology*;Mental Health;Motivation;Professional-Patient Relations;Self Report;Social Support;Substance-Related Disorders/complications;United States;Young Adult
27422213;Aged;Amputation;Ankle Brachial Index*;Cohort Studies;Diabetes Mellitus/mortality*;Diabetes Mellitus/surgery;Female;Humans;Lower Extremity/surgery;Male;Middle Aged;Pulse Wave Analysis*
27457051;Algorithms*;Anthropometry/methods*;Body Size/physiology*;Computer Simulation;Finite Element Analysis*;Humans;Models, Biological*;Reproducibility of Results;Sensitivity and Specificity
27469622;Adsorption;Amino Acid Sequence;Cecropins/chemistry*;Gold/chemistry*;Melitten/chemistry*;Metal Nanoparticles/chemistry;Molecular Dynamics Simulation*;Protein Binding;Protein Conformation;Surface Properties
27490757;Biomimetic Materials*/chemical synthesis;Biomimetic Materials*/chemistry;Ferrosoferric Oxide*/chemical synthesis;Ferrosoferric Oxide*/chemistry;Humans;Magnetosomes/chemistry*;Magnetosomes/ultrastructure;Nanoparticles/chemistry*
27490958;Animals;Biological Evolution;Dinosaurs/anatomy & histology*;Dinosaurs/physiology;Eating/physiology*;Fossils;Jaw/anatomy & histology*;Jaw/physiology
27497490;Axons;Humans;Neuroaxonal Dystrophies*;Neuroglia*
27497712;Administration, Intravenous;Adolescent;Adult;Adverse Drug Reaction Reporting Systems;Age Factors;Aged;Aged, 80 and over;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects*;Antiviral Agents/therapeutic use;Cyclopentanes/administration & dosage;Cyclopentanes/adverse effects*;Cyclopentanes/therapeutic use;Disease Progression;Female;Guanidines/administration & dosage;Guanidines/adverse effects*;Guanidines/therapeutic use;Humans;Influenza A virus/isolation & purification;Influenza B virus/isolation & purification;Influenza, Human/drug therapy*;Influenza, Human/virology;Inpatients;Japan/epidemiology;Male;Middle Aged;Neuraminidase/antagonists & inhibitors*;Pregnancy;Risk Factors;Treatment Outcome;Young Adult
27503511;Animals;Culex/virology;Culicidae/virology*;Female;Host-Pathogen Interactions;Insect Vectors/virology;Passeriformes/virology;Seasons;Seroepidemiologic Studies;United States/epidemiology;West Nile Fever/epidemiology*;West Nile Fever/veterinary;West Nile virus/isolation & purification*
27518198;Electric Power Supplies*;Electricity;Electrodes;Salinity*;Seawater
27519944;Adolescent;Adult;Anemia, Sickle Cell/complications*;Blood Specimen Collection;Brain/pathology;Case-Control Studies;Cells, Cultured;Child;Endothelial Cells/chemistry;Female;Gene Expression Regulation;Humans;Lipoproteins, LDL;Male;Middle Aged;Scavenger Receptors, Class E/blood;Scavenger Receptors, Class E/genetics;Scavenger Receptors, Class E/physiology*;Vascular Diseases/etiology*
27523598;Alleles*;Death, Sudden, Cardiac/etiology*;Death, Sudden, Cardiac/pathology;Diphosphates;Exome/genetics;Female;Gene Deletion;Genes, Essential/genetics;Genetic Complementation Test;Heterozygote;Humans;Infant;Inorganic Pyrophosphatase/genetics*;Inorganic Pyrophosphatase/metabolism;Male;Membrane Potential, Mitochondrial/genetics;Microbial Viability;Mitochondria/enzymology;Mitochondria/metabolism;Mitochondria/pathology;Mitochondrial Proteins/genetics*;Mitochondrial Proteins/metabolism;Mutation/genetics*;Mutation, Missense;Proton Pumps/deficiency;Proton Pumps/genetics;Proton Pumps/metabolism;Saccharomyces cerevisiae/cytology;Saccharomyces cerevisiae/enzymology;Saccharomyces cerevisiae/genetics;Saccharomyces cerevisiae Proteins/genetics;Saccharomyces cerevisiae Proteins/metabolism
27552213;Athletes;Autonomic Nervous System/physiology*;Baroreflex/physiology;Cardiac Output/physiology;Compression Bandages*;Exercise/physiology*;Heart Rate/physiology;Hemodynamics/physiology*;Humans;Male;Swimming/physiology;Vascular Resistance/physiology;Young Adult
27582262;Humans;Male;Muscle Contraction/physiology*;Muscle, Skeletal/physiology*;NF-kappa B/metabolism*;Physical Conditioning, Human/methods*;Resistance Training/methods*;Sedentary Lifestyle;Signal Transduction/physiology;Stress, Physiological/physiology;Young Adult
27587466;Animals;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Disease Models, Animal;Drug Discovery;Enhancer of Zeste Homolog 2 Protein/antagonists & inhibitors*;Epigenesis, Genetic/drug effects*;Humans;Lung Neoplasms/drug therapy;Lung Neoplasms/genetics*;Lung Neoplasms/metabolism*;Lung Neoplasms/pathology;Mice;Molecular Targeted Therapy*;Xenograft Model Antitumor Assays
27614159;Bone and Bones/metabolism*;Bone and Bones/pathology*;Cell Differentiation;Cells, Cultured;Cellular Reprogramming*;Female;Fibrosis;Fibrous Dysplasia of Bone/metabolism*;Fibrous Dysplasia of Bone/pathology*;Glycolysis*;Humans;Induced Pluripotent Stem Cells/metabolism;Induced Pluripotent Stem Cells/pathology;Mesenchymal Stromal Cells/metabolism;Mesenchymal Stromal Cells/pathology;Phosphofructokinase-2/metabolism*
27614627;Animals;Bone and Bones/metabolism*;Calcification, Physiologic*;Extracellular Matrix Proteins/chemistry*;Extracellular Matrix Proteins/metabolism*;Immunohistochemistry;Male;Phosphoproteins/chemistry*;Phosphoproteins/metabolism*;Phosphorylation;Protein-Serine-Threonine Kinases/metabolism*;Rats;Rats, Wistar
27696576;Aged;Breast Neoplasms/diagnostic imaging*;Breast Neoplasms/pathology;Contrast Media*;Female;Humans;Image Enhancement;Mammography/methods*;Middle Aged
27702649;Animals;Genome, Helminth/genetics*;Genome, Mitochondrial/genetics*;Nucleic Acid Conformation;Phylogeny;RNA, Transfer/genetics;Trematoda/classification*;Trematoda/genetics*
27707760;Aged;Biopsy;Carcinoma, Neuroendocrine/secondary*;Carcinoma, Small Cell/secondary*;Fatal Outcome;Humans;Liver Neoplasms/diagnosis;Liver Neoplasms/secondary*;Male;Pelvic Neoplasms/diagnosis;Pelvic Neoplasms/secondary*;Prostate-Specific Antigen/blood;Prostatic Neoplasms/pathology*;Tomography, X-Ray Computed
27721187;Adult;Aged;Aged, 80 and over;Carrier Proteins/genetics;Circadian Rhythm/genetics;Cryptochromes/genetics*;Depressive Disorder, Major/genetics*;Dysthymic Disorder/genetics*;Female;Genotype;Humans;Intracellular Signaling Peptides and Proteins/genetics*;Male;Middle Aged;Polymorphism, Single Nucleotide
27723504;Alternative Splicing/genetics*;Amino Acid Motifs;Arachis/genetics*;Arachis/physiology*;Cell Nucleolus/metabolism;Droughts*;Exons/genetics;Gene Expression Regulation, Plant;Introns/genetics;Plant Leaves/metabolism;Plant Proteins/genetics;Plant Proteins/metabolism*;Protein Domains;Protein Isoforms/chemistry;Protein Isoforms/genetics;Protein Isoforms/metabolism;Protein Transport;Real-Time Polymerase Chain Reaction;Stress, Physiological*;Tobacco/cytology;Tobacco/metabolism;Transcription Factors/chemistry;Transcription Factors/genetics;Transcription Factors/metabolism
27725571;Adult;Cerebrovascular Circulation;Cerebrum/blood supply;Cerebrum/physiology*;Electrooculography;Eye Movements/physiology*;Eyelids/physiology*;Female;Humans;Male;Models, Biological*;Motor Activity;Rest;Subtraction Technique;Young Adult
27727462;Adult;Aged;Aged, 80 and over;American Cancer Society;Decision Making*;Early Detection of Cancer*;Humans;Male;Middle Aged;Prostate-Specific Antigen/blood*;Prostatic Neoplasms/blood*;Prostatic Neoplasms/epidemiology;Prostatic Neoplasms/pathology
27738107;Allosteric Regulation;Cyclic AMP*/analogs & derivatives;Cyclic AMP*/chemistry;Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors;Cyclic AMP-Dependent Protein Kinases/chemistry*;Cyclic AMP-Dependent Protein Kinases/metabolism;Plasmodium falciparum/enzymology*;Protozoan Proteins/antagonists & inhibitors;Protozoan Proteins/chemistry*;Protozoan Proteins/metabolism
27743839;Algorithms;Carbon Dioxide/metabolism*;Computer Simulation;Exercise/physiology*;Humans;Hypoxia;Kinetics;Lung/metabolism;Lung/physiology;Models, Theoretical*;Oxygen/metabolism*;Respiratory Mechanics/physiology*;Time Factors
27801754;Female;Humans;Hysterectomy;Leiomyoma/blood supply;Leiomyoma/drug therapy*;Leiomyoma/surgery;Menorrhagia/complications;Middle Aged;Necrosis;Telangiectasia, Hereditary Hemorrhagic/complications;Tranexamic Acid/adverse effects*;Tranexamic Acid/therapeutic use;Uterine Hemorrhage/etiology;Uterine Neoplasms/blood supply;Uterine Neoplasms/drug therapy*;Uterine Neoplasms/surgery;Uterus/blood supply;Uterus/pathology;Vasculitis/chemically induced*
27815490;Animals;Congresses as Topic;Drug-Related Side Effects and Adverse Reactions/etiology;Education, Medical, Continuing;Humans;Pathology, Clinical/education;Pathology, Clinical/methods*;Toxicological Phenomena;Toxicology/education;Toxicology/methods*
27820709;Anesthesia Recovery Period;Cholinesterase Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Electric Stimulation/methods;Humans;Monitoring, Physiologic/methods*;Muscle Weakness/chemically induced;Neuromuscular Blockade/methods*;Neuromuscular Nondepolarizing Agents/antagonists & inhibitors*;Paralysis/chemically induced;Perioperative Care/methods*;Postoperative Complications/prevention & control*
27822606;Animals;Disease Models, Animal;Female;Flow Cytometry;Graves Disease/genetics*;Graves Disease/immunology*;Graves Disease/pathology;Immunoglobulins, Thyroid-Stimulating/immunology;Interleukin-17/genetics*;Mice;Mice, Inbred BALB C;RNA, Messenger/genetics*;Real-Time Polymerase Chain Reaction;Receptors, Thyrotropin/administration & dosage;Receptors, Thyrotropin/immunology;T-Lymphocytes, Regulatory/immunology*
27825939;Aged;Aged, 80 and over;Ankle Joint/diagnostic imaging*;Arthroplasty, Replacement, Knee*;Female;Humans;Male;Middle Aged;Observer Variation;Osteoarthritis, Knee/diagnostic imaging*;Osteoarthritis, Knee/surgery*;Reproducibility of Results;Retrospective Studies;Tomography, X-Ray Computed*
27829665;Autoimmune Diseases/immunology*;Autoimmune Diseases/prevention & control*;HLA-DRB1 Chains/immunology*;Humans;Protective Agents/administration & dosage*
27835672;Acute Lung Injury/etiology;Acute Lung Injury/metabolism;Adult;Aged;Aged, 80 and over;Aquaporin 1/metabolism*;Aquaporin 3/metabolism;Aquaporin 5/metabolism*;Autopsy;Epithelial Sodium Channels/metabolism*;Female;Humans;Immunohistochemistry;Influenza A Virus, H1N1 Subtype/physiology;Influenza, Human/complications;Influenza, Human/virology;Leptospirosis/complications;Male;Middle Aged;Pulmonary Alveoli/metabolism*;Pulmonary Alveoli/pathology;Respiration Disorders/etiology;Respiration Disorders/metabolism;Sepsis/complications;Sodium-Potassium-Exchanging ATPase/metabolism*;Young Adult
27854497;Computer Communication Networks/instrumentation*;Computer Communication Networks/standards*;Computer Security/instrumentation;Computer Security/standards*;Confidentiality/standards*;Guidelines as Topic;Product Labeling/methods;Product Labeling/standards*;Reference Standards;United States;United States Food and Drug Administration;Unithiol;Wireless Technology/instrumentation*;Wireless Technology/standards*
27856230;Adipose Tissue/cytology*;Administration, Intravenous;Animals;Cells, Cultured;Echocardiography;Male;Microbubbles;Myocardial Infarction/diagnostic imaging;Myocardial Infarction/therapy*;Rats, Wistar;Stromal Cells/transplantation;Time Factors
27858862;Adult;China;Female;Humans;Interferon-gamma Release Tests*;Leukocytes, Mononuclear;Tertiary Care Centers;Tuberculosis, Female Genital/blood;Tuberculosis, Female Genital/diagnosis*
27862294;Animals;Conservation of Natural Resources*;Ecosystem;Fisheries;Motivation;Natural Resources*;Ownership*;South Africa
27862955;Food Analysis/methods*;Limit of Detection;Physalis/chemistry*;Temperature;Volatile Organic Compounds/analysis*;Volatile Organic Compounds/isolation & purification
27873050;Female;Humans;Interferon beta-1a/therapeutic use*;Meningeal Neoplasms/pathology*;Meningioma/pathology*;Middle Aged;Multiple Sclerosis/drug therapy*;Neoplasm Regression, Spontaneous/pathology*
27883994;Age Factors;Female;Geography;Humans;Huntington Disease/mortality*;Male;Registries;Sex Factors;Spain;Time Factors
27884016;Adult;Aged;Aged, 80 and over;Cell Division/genetics*;Cell Proliferation/genetics;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/metabolism;Colorectal Neoplasms/pathology*;Epithelial-Mesenchymal Transition/genetics*;Female;Gene Expression Profiling;Genes, Switch/genetics*;Humans;Male;Margins of Excision;Middle Aged;Neoplasm Invasiveness;Phenotype;Tissue Array Analysis;Transcriptome*
27916981;Forkhead Transcription Factors;Humans;Neoplasms*;T-Lymphocytes, Regulatory*
27927718;Biosimilar Pharmaceuticals/therapeutic use*;Drug Substitution/standards;Gastrointestinal Agents/therapeutic use*;Humans;Inflammatory Bowel Diseases/drug therapy*;Infliximab/therapeutic use;Treatment Outcome
27928716;Burnout, Professional/etiology;Humans;Physicians/psychology*;Problem Behavior;Substance-Related Disorders/epidemiology;Suicide
27931580;Adult;Aged;Female;Forced Expiratory Volume;Hand Strength;Humans;Knee/physiopathology;Liver Cirrhosis/physiopathology*;Liver Cirrhosis/rehabilitation;Liver Cirrhosis/surgery;Liver Transplantation/methods;Liver Transplantation/rehabilitation*;Living Donors*;Male;Middle Aged;Muscle Strength*/physiology;Physical Fitness/physiology;Postoperative Period;Preoperative Period;Retrospective Studies;Severity of Illness Index;Vital Capacity;Walk Test*
27996991;Aspirin/therapeutic use*;Cardiovascular Diseases/prevention & control*;Humans;Neoplasms/prevention & control*;Platelet Aggregation Inhibitors/therapeutic use;Primary Prevention/methods;United States
28025992;Animals;Animals, Newborn;Cell Differentiation*/genetics;Cell Proliferation;Cell Separation;Cells, Cultured;Ear, Inner/cytology*;Gene Expression Regulation;Mice, Inbred C57BL;MicroRNAs/genetics;MicroRNAs/metabolism*;Neural Stem Cells/cytology*;Neural Stem Cells/metabolism;Neurites/metabolism;Neurons/cytology*;Neurons/metabolism;Real-Time Polymerase Chain Reaction;Receptor, trkB/metabolism;Spheroids, Cellular/cytology;Transfection;Tubulin/metabolism;Up-Regulation;cdc42 GTP-Binding Protein/metabolism
28071070;Cholesteatoma/surgery*;Ear Diseases/surgery*;Ear, Inner*;Fistula/surgery*;Humans
28081193;Ammonium Chloride/pharmacology;DNA, Fungal/isolation & purification;DNA, Fungal/metabolism;DNA, Mitochondrial/genetics*;DNA, Mitochondrial/metabolism;Environment*;Genes, Mating Type, Fungal/genetics;Genotype;Hybridization, Genetic/drug effects;Hybridization, Genetic/genetics;Inheritance Patterns/genetics*;Mitochondria/drug effects;Mitochondria/genetics;Mitochondria/metabolism;Osmotic Pressure;Saccharomyces/genetics*;Saccharomyces cerevisiae/genetics;Stress, Physiological;Ubiquitination/drug effects
28108451;Genetic Predisposition to Disease;Genetics, Population/methods*;Genome-Wide Association Study/statistics & numerical data*;Genomics/methods;Humans;Hypertension/genetics;Meta-Analysis as Topic*;Models, Genetic*;Polymorphism, Single Nucleotide;Software*;Statistics as Topic
28120356;Animals;Antineoplastic Agents/therapeutic use*;Breast Neoplasms/drug therapy*;Breast Neoplasms/genetics;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Cell Adhesion/drug effects;Cell Differentiation/drug effects;Cell Movement/drug effects;Cell Proliferation/drug effects;Cell Survival/drug effects;Drug Discovery/methods*;Female;Gene Expression Profiling*;Gene Expression Regulation, Neoplastic;Humans;Integrins/antagonists & inhibitors*;Integrins/chemistry;Integrins/genetics;Integrins/metabolism;Molecular Structure;Molecular Targeted Therapy*;Signal Transduction/drug effects;Structure-Activity Relationship
28121708;Anti-Retroviral Agents/therapeutic use*;Brain/diagnostic imaging;Cerebrovascular Circulation*;Cognition*;Cohort Studies;Cross-Sectional Studies;HIV Infections/drug therapy*;HIV Infections/pathology*;HIV Infections/virology;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Sustained Virologic Response*
28123016;Animals;COS Cells;Cells, Cultured;Cercopithecus aethiops;Female;Guanine Nucleotide Exchange Factors/physiology*;Mice;Mice, Inbred ICR;Neuronal Outgrowth/physiology*;Phosphorylation;Phosphotransferases/physiology*;Pregnancy;Rats;Signal Transduction/physiology;rab GTP-Binding Proteins/metabolism*
28159122;Belgium;Child;Decision Making*;Family*;Family Characteristics*;Fathers;Female;Homosexuality, Female*;Humans;Insemination, Artificial*;Male;Mothers*;Sexual and Gender Minorities*;Social Norms;Social Support;Spermatozoa;Tissue Donors
28169123;Erectile Dysfunction/prevention & control;Humans;Laparoscopy*;Male;Prostatectomy/adverse effects;Prostatectomy/methods*;Prostatic Neoplasms/surgery;Robotic Surgical Procedures*;Urinary Incontinence/prevention & control
28177978;Adult;Aged;Breast Neoplasms/surgery*;Catchment Area (Health)/statistics & numerical data*;Female;Health Policy;Health Services Accessibility/statistics & numerical data*;Healthcare Disparities/statistics & numerical data*;Humans;Mammaplasty/statistics & numerical data;Mammaplasty/utilization*;Mastectomy;Medically Underserved Area;Middle Aged;Retrospective Studies;Surgeons/supply & distribution*;Surgery, Plastic/manpower*;United States
28204531;Binding Sites;Biocatalysis;Calcium/metabolism*;Crystallography, X-Ray;Glycoside Hydrolases/chemistry*;Glycoside Hydrolases/metabolism*;Models, Molecular;Xylosidases/chemistry*;Xylosidases/metabolism*
28210985;Absorptiometry, Photon/methods;Adult;Aged;Bone Density*;China/epidemiology;Female;Humans;Intervertebral Disc*/diagnostic imaging;Intervertebral Disc*/pathology;Intervertebral Disc Degeneration*/diagnosis;Intervertebral Disc Degeneration*/epidemiology;Intervertebral Disc Degeneration*/pathology;Lumbar Vertebrae*/diagnostic imaging;Lumbar Vertebrae*/pathology;Magnetic Resonance Imaging/methods;Male;Middle Aged;Osteoarthritis*/diagnosis;Osteoarthritis*/epidemiology;Osteoarthritis*/pathology;Pelvic Bones*/diagnostic imaging;Pelvic Bones*/pathology;Radiography/methods;Regression Analysis;Zygapophyseal Joint*/diagnostic imaging;Zygapophyseal Joint*/pathology
28232072;Animals;DNA Helicases/genetics;DNA Helicases/metabolism*;Electrocardiography;Gene Expression Profiling;Gene Expression Regulation;Heart Conduction System*;Heart Failure/diagnosis;Heart Failure/genetics;Heart Failure/metabolism;Heart Failure/physiopathology;Humans;Mice;Mice, Transgenic;Mutation;Myocardial Contraction*/genetics;Myocytes, Cardiac/metabolism*;Nuclear Proteins/genetics;Nuclear Proteins/metabolism*;Protein Binding;Proto-Oncogene Proteins c-myc/genetics;Proto-Oncogene Proteins c-myc/metabolism*;Transcription Factors/genetics;Transcription Factors/metabolism*
28234916;Aged;Antigens/blood;Antigens/immunology;Coronary Artery Bypass/adverse effects*;Female;Heart Failure/blood*;Heart Failure/physiopathology;Heart Failure/surgery;Heart-Assist Devices/adverse effects;Humans;Male;Middle Aged;Perioperative Period/adverse effects;Postoperative Hemorrhage/blood*;Postoperative Hemorrhage/etiology;Postoperative Hemorrhage/physiopathology;von Willebrand Diseases/blood*;von Willebrand Diseases/etiology;von Willebrand Diseases/immunology;von Willebrand Diseases/physiopathology;von Willebrand Factor/immunology;von Willebrand Factor/metabolism*
28238839;Adolescent;Adult;Cohort Studies;Contraception/methods;Contraceptive Agents, Female*;Desogestrel/administration & dosage*;Drug Implants;Female;Humans;Obesity/complications;Obesity/drug therapy*;Overweight/complications;Overweight/drug therapy*;Pilot Projects;Postpartum Period*;Pregnancy;Pregnancy Complications;Prospective Studies;Subcutaneous Tissue/drug effects;Weight Loss*;Young Adult
28244817;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/chemistry;Cell Proliferation/drug effects;HeLa Cells;Humans;Liposomes/administration & dosage*;Liposomes/chemistry;MCF-7 Cells;Neoplasms/drug therapy*;Phospholipids/administration & dosage*;Phospholipids/chemistry;Podophyllotoxin/administration & dosage*;Podophyllotoxin/chemistry
28283685;Aged;Aged, 80 and over;Chronic Disease/epidemiology*;Female;Germany/epidemiology;Humans;Insurance, Health/statistics & numerical data;Life Expectancy*;Male;Middle Aged;Multimorbidity*;Polypharmacy
28285660;Amino Acid Sequence;Animals;Anti-Bacterial Agents/chemistry;Anti-Bacterial Agents/metabolism*;Bacteriocins/chemistry;Bacteriocins/genetics*;Bacteriocins/metabolism*;Biosynthetic Pathways/genetics;Cattle;Gene Order;Genes, Bacterial;Genome, Bacterial;Gram-Positive Bacteria/drug effects;Microbial Sensitivity Tests;Milk/microbiology;Molecular Sequence Data;Molecular Weight;Multigene Family;Sequence Analysis, DNA;Staphylococcus hyicus/genetics*;Staphylococcus hyicus/isolation & purification;Staphylococcus hyicus/metabolism*
28291946;Animals;Antioxidants/metabolism;Intestines/metabolism;Larva/growth & development;Larva/metabolism*;Liver/metabolism;Malondialdehyde/metabolism;Nitriles/chemistry*;Nitriles/metabolism*;Pesticides/chemistry*;Pesticides/metabolism*;Ranidae/growth & development*;Ranidae/metabolism;Stereoisomerism;Tissue Distribution;Triazoles/chemistry*;Triazoles/metabolism*
28298342;Animals;Ants/physiology*;French Guiana;Fungi/physiology*;Herbivory;Plants*;Symbiosis*
28317274;Aged;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Atrial Fibrillation/drug therapy*;Atrial Fibrillation/epidemiology;Female;Finland/epidemiology;Follow-Up Studies;Hemorrhage/chemically induced;Hemorrhage/mortality*;Humans;International Normalized Ratio/trends;Male;Middle Aged;Mortality/trends;Registries*;Risk Factors;Stroke/drug therapy*;Stroke/mortality*;Treatment Outcome;Warfarin/administration & dosage*;Warfarin/adverse effects
28337681;Acanthocephala/anatomy & histology;Acanthocephala/classification*;Acanthocephala/genetics;Animals;Atlantic Ocean;Brachyura/parasitology*;Electron Transport Complex IV/genetics;Host Specificity;Pacific Ocean;Phylogeny;South America;Species Specificity
28338195;Autophagy/drug effects*;Cell Line, Tumor;Cell Movement/drug effects;Humans;Neoplasm Invasiveness;Stomach Neoplasms;Transforming Growth Factor beta1/metabolism*
28338599;Allied Health Personnel;Blood Donors*;Blood Transfusion/instrumentation;Blood Transfusion/methods*;Blood Volume Determination/methods;Emergency Medical Services/methods;Humans;Military Medicine/methods
28353670;Aged;Aged, 80 and over;China;Community Health Services/organization & administration;Community Health Services/utilization*;Cross-Sectional Studies;Female;General Practitioners/organization & administration;General Practitioners/utilization*;Health Services Needs and Demand/statistics & numerical data*;Health Services for the Aged/organization & administration;Health Services for the Aged/utilization*;Humans;Logistic Models;Male;Multivariate Analysis
28392290;Dermatitis, Atopic/immunology*;Dermatitis, Contact/immunology*;Humans
28425692;Antitrust Laws;Efficiency, Organizational/legislation & jurisprudence;Geography;Health Care Sector/legislation & jurisprudence*;Health Facility Merger/legislation & jurisprudence*;Humans;United States
28442537;Adult;Aged, 80 and over;Aging/physiology*;Humans;Male;Memory/physiology*;Mental Recall/physiology*;Middle Aged;Neural Inhibition/physiology*;Neuronal Plasticity/physiology;Prefrontal Cortex/physiology*;Recruitment, Neurophysiological/physiology*;Task Performance and Analysis
28448758;Alkaline Phosphatase/metabolism;Humans;Hypercalcemia/complications;Hypercalcemia/metabolism;Hyperparathyroidism, Primary/complications*;Hyperparathyroidism, Primary/diagnosis;Hyperparathyroidism, Primary/metabolism;Male;Middle Aged;Osteitis Deformans/complications*;Osteitis Deformans/diagnostic imaging;Osteitis Deformans/metabolism;Pelvic Bones/diagnostic imaging;Radiography;Radionuclide Imaging;Radiopharmaceuticals;Technetium Tc 99m Medronate;Vitamin D Deficiency/complications;Vitamin D Deficiency/metabolism
28449361;Adult;Colitis, Ulcerative/diagnosis;Colitis, Ulcerative/epidemiology;Colitis, Ulcerative/pathology*;Colitis, Ulcerative/therapy;Disease Progression;Europe;Humans;Prognosis;Risk Factors
28463596;Amino Acid Sequence;Animals;Baculoviridae/genetics;Baculoviridae/metabolism;Bees;Cattle;Chymases/antagonists & inhibitors;Chymases/chemistry*;Chymases/genetics;Cloning, Molecular;Escherichia coli/genetics;Escherichia coli/metabolism;Gene Expression*;Insect Proteins/antagonists & inhibitors;Insect Proteins/chemistry*;Insect Proteins/genetics;Kinetics;Leucine/chemistry;Oligopeptides/chemistry;Peptide Fragments/chemistry*;Phenylalanine/chemistry;Protease Inhibitors/chemistry;Recombinant Proteins/chemistry;Recombinant Proteins/genetics;Serum Albumin, Bovine/chemistry;Sf9 Cells;Spodoptera;Substrate Specificity;Tyrosine/chemistry
28526535;Arteritis/complications*;Arteritis/diagnosis;Child, Preschool;Coronary Artery Disease/complications*;Coronary Artery Disease/diagnosis;Female;Humans;Immunoglobulins, Intravenous/therapeutic use*;Inflammation Mediators/blood*;Male;Mucocutaneous Lymph Node Syndrome/blood*;Mucocutaneous Lymph Node Syndrome/complications;Mucocutaneous Lymph Node Syndrome/drug therapy*;Prognosis;Treatment Outcome;Tumor Necrosis Factor-alpha/blood*
28532048;Cations;Durapatite;Europium;Metals;Methacrylates;Phosphorylcholine/analogs & derivatives;Polymerization;Surface Properties;Theranostic Nanomedicine*
28532086;Apatites;Lactic Acid/chemistry*;Polyglycolic Acid/chemistry*;Porosity;Tissue Engineering;Tissue Scaffolds
28535407;Adult;Affect*;Bipolar Disorder/psychology*;Cyclothymic Disorder/psychology;Female;Humans;Inhibition (Psychology)*;Male;Prospective Studies;Regression Analysis;Risk Factors;Self Report;Surveys and Questionnaires
28539067;Activities of Daily Living;Dyspnea/physiopathology*;Fatigue;Humans;Pulmonary Disease, Chronic Obstructive/physiopathology*;Reproducibility of Results
28544336;Controlled Substances*;Drug Prescriptions*;Drug and Narcotic Control/legislation & jurisprudence*;Federal Government;Female;Government Regulation*;Humans;Midwifery/legislation & jurisprudence*;Nurse Midwives/legislation & jurisprudence*;Pregnancy;Professional Practice/legislation & jurisprudence*;State Government;United States
28550180;AMP-Activated Protein Kinases/chemistry;AMP-Activated Protein Kinases/genetics*;AMP-Activated Protein Kinases/metabolism;Adenosine Monophosphate/metabolism;Cardiomyopathy, Hypertrophic/drug therapy;Cardiomyopathy, Hypertrophic/enzymology;Cardiomyopathy, Hypertrophic/genetics*;Cardiomyopathy, Hypertrophic/physiopathology;Carrier Proteins/metabolism;Case-Control Studies;DNA Mutational Analysis;Enzyme Activation;Fibroblasts/enzymology;Fibroblasts/pathology;Genetic Predisposition to Disease;HEK293 Cells;Humans;Infant, Newborn;Models, Molecular;Mutation, Missense*;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/enzymology*;Myocytes, Cardiac/pathology;Phenformin/pharmacology;Phenotype;Phosphoproteins/metabolism;Phosphorylation;Protein Conformation;Protein Kinase Inhibitors/pharmacology;Ribosomal Protein S6 Kinases, 70-kDa/metabolism;Signal Transduction*/drug effects;Sirolimus/pharmacology;Structure-Activity Relationship;TOR Serine-Threonine Kinases/antagonists & inhibitors;TOR Serine-Threonine Kinases/metabolism;Transfection
28555952;Animal Husbandry*/ethics;Animal Welfare*/ethics;Animals;Attitude*;Australia;Clinical Competence;Euthanasia, Animal;Female;Humans;Internet;Male;New Zealand;Pets;Schools, Veterinary;Sex Distribution;Sterilization, Reproductive/psychology;Sterilization, Reproductive/veterinary;Students/psychology*;Surveys and Questionnaires
28577304;Adult;Blood Glucose/metabolism;Carcinoma, Hepatocellular/blood;Carcinoma, Hepatocellular/epidemiology*;Cohort Studies;Diabetes Mellitus/blood;Female;Humans;Lipids/blood;Liver Cirrhosis/blood;Liver Cirrhosis/epidemiology*;Liver Neoplasms/blood;Liver Neoplasms/epidemiology*;Male;Metabolic Syndrome/blood;Metabolic Syndrome/epidemiology*;Middle Aged;Obesity/blood;Obesity/epidemiology;Sweden/epidemiology;Triglycerides/blood
28580604;Disorders of Sex Development/epidemiology*;Disorders of Sex Development/physiopathology;Humans;Parents/education*;Patient Education as Topic*;Sexual Development/genetics*
28611284;Activating Transcription Factor 2/metabolism*;Animals;Brain/metabolism;Cell Line, Tumor;Cell Survival/drug effects;Cyclic AMP Response Element-Binding Protein/metabolism*;Disease Models, Animal;Dopaminergic Neurons/drug effects*;Dopaminergic Neurons/metabolism*;Gene Expression Regulation/drug effects;Humans;Male;Metformin/pharmacology*;Mice;Mitochondria/metabolism;Neuroprotective Agents/pharmacology;Parkinson Disease/metabolism;Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism*;Proteomics/methods;Signal Transduction/drug effects*;Substantia Nigra/metabolism
28692928;Abortion, Spontaneous/chemically induced;Abortion, Spontaneous/epidemiology;Abortion, Therapeutic;Adult;Arsenic/toxicity*;Arsenic/urine;Bangladesh/epidemiology;Child;Child Mortality*;Child, Preschool;Cohort Studies;Female;Humans;Infant;Infant, Newborn;Maternal Exposure/adverse effects*;Odds Ratio;Pregnancy;Pregnancy Outcome*;Prenatal Exposure Delayed Effects/chemically induced;Prenatal Exposure Delayed Effects/epidemiology*;Proportional Hazards Models;Stillbirth/epidemiology;Water Pollutants, Chemical/toxicity*;Water Pollutants, Chemical/urine
28703790;Animals;Genes, Reporter*;Image Processing, Computer-Assisted/methods;Luminescent Proteins/analysis;Luminescent Proteins/genetics;Mice;Mice, Transgenic;Microscopy, Confocal;Microscopy, Fluorescence/methods*;Mitochondrial Degradation*;Recombinant Proteins/analysis;Recombinant Proteins/genetics;Staining and Labeling/methods*
28708042;Cauda Equina/surgery;Diskectomy;Humans;Intervertebral Disc Displacement/surgery*;Lumbar Vertebrae/surgery;Polyradiculopathy/surgery*
28717044;Alternative Splicing;Animals;Myotonic Dystrophy*;RNA*;RNA Splicing;RNA-Binding Proteins/genetics
28750321;Amino Acid Substitution;Animals;CD4 Lymphocyte Count;Cercocebus atys/virology*;Evolution, Molecular*;HIV-2/genetics*;HIV-2/growth & development*;Humans;Mice;Mice, SCID;Models, Biological;Serial Passage;Simian Immunodeficiency Virus/genetics*;Simian Immunodeficiency Virus/growth & development*;Viral Load;Viral Proteins/genetics
28904219;Diagnostic Techniques, Ophthalmological/history*;Germany;History, 19th Century;History, 20th Century;Ophthalmology/history*
28914613;Brachytherapy/instrumentation*;Brachytherapy/methods*;Catheters;Humans;Neoplasms/radiotherapy*;Phantoms, Imaging*;Radiotherapy Dosage;Radiotherapy Planning, Computer-Assisted/methods*;Reproducibility of Results;Software
28964317;Acoustics;Child;Child, Preschool;Cochlear Implantation/methods*;Cochlear Implants;Deafness/surgery*;Female;Humans;Language;Male;Phonetics;Speech Intelligibility*;Speech Perception/physiology*;Speech Production Measurement
29141315;Bronchi;Bronchoscopy;Child;Child, Preschool;Female;Humans;Infant;Intubation, Intratracheal;Lung;Male;One-Lung Ventilation*;Pulmonary Atelectasis/therapy*;Respiration, Artificial;Retrospective Studies;Thorax;Trachea;Treatment Outcome
29157742;Adult;Aged;Aged, 80 and over;Equipment Design;Female;Humans;Lung Neoplasms/surgery*;Male;Middle Aged;Pneumonectomy/methods*;Prospective Studies;Pulmonary Artery/surgery*;Thoracic Surgery, Video-Assisted*;Ultrasonic Therapy*/adverse effects;Ultrasonic Therapy*/instrumentation;Vascular Surgical Procedures/adverse effects;Vascular Surgical Procedures/instrumentation;Vascular Surgical Procedures/methods
29222549;Fluorescein Angiography;Geographic Atrophy*;Humans;Retinal Drusen;Retinal Pigment Epithelium;Tomography, Optical Coherence*
29232394;Asia;Europe;Exostoses/pathology*;Fossils*;History, Ancient;Humans;Skull/anatomy & histology*
29301972;Age Factors;Aged;Aneurysm, Ruptured;Anterior Cerebral Artery/diagnostic imaging*;Cerebral Angiography/methods;Female;Humans;Intracranial Aneurysm/diagnostic imaging;Intracranial Aneurysm/etiology*;Middle Aged
29317241;Acanthamoeba/drug effects*;Amebiasis/drug therapy*;Amebiasis/metabolism;Animals;Artemisia annua/chemistry*;Brain/metabolism*;Brain/pathology;Gene Expression;Immunohistochemistry;Mice;Mice, Inbred BALB C;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;RNA, Messenger/metabolism;Real-Time Polymerase Chain Reaction;Toll-Like Receptor 2/drug effects;Toll-Like Receptor 2/genetics;Toll-Like Receptor 2/metabolism;Toll-Like Receptor 4/drug effects;Toll-Like Receptor 4/genetics;Toll-Like Receptor 4/metabolism;Toll-Like Receptors/drug effects*;Toll-Like Receptors/genetics;Toll-Like Receptors/metabolism
29356888;Adult;Aged;Aged, 80 and over;Complementary Therapies/statistics & numerical data*;Female;Germany/epidemiology;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/epidemiology*;Neoplasms/therapy*;Physician-Patient Relations;Prevalence;Primary Health Care/statistics & numerical data*;Risk Assessment;Surveys and Questionnaires;Young Adult
29329092;Animals;Aspirin/pharmacokinetics*;Aspirin/pharmacology;Cell Membrane/drug effects;Dogs;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions;Limit of Detection;Linear Models;Madin Darby Canine Kidney Cells;Panax notoginseng/chemistry*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Saponins/blood*;Saponins/chemistry;Saponins/pharmacokinetics*;Saponins/pharmacology
29268027;Animals;Biological Availability;Herb-Drug Interactions*;Humans;Medicine, African Traditional/methods;Pharmaceutical Preparations/metabolism;Plant Preparations/administration & dosage*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry*
29258478;Adolescent;Adult;Cross-Sectional Studies;Female;Herb-Drug Interactions*;Humans;Nonprescription Drugs*/adverse effects;Nonprescription Drugs*/therapeutic use;Phytotherapy/statistics & numerical data;Plant Extracts*/adverse effects;Plant Extracts*/therapeutic use;Pregnancy;Prescription Drugs*/adverse effects;Prescription Drugs*/therapeutic use;Surveys and Questionnaires;Young Adult
29237435;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Female;Herb-Drug Interactions/immunology;Humans;Kaplan-Meier Estimate;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/epidemiology;Pilot Projects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Programmed Cell Death 1 Receptor/antagonists & inhibitors*;Programmed Cell Death 1 Receptor/immunology;Viscum album*
29196903;Age Factors;Aged;Aged, 80 and over;Female;Herb-Drug Interactions;Humans;Male;Phytotherapy;Plant Preparations/administration & dosage*;Prescription Drugs/administration & dosage*
29174652;Anti-Bacterial Agents/pharmacology*;Antioxidants/pharmacology;Antioxidants/therapeutic use;Biological Products/therapeutic use;Drug Therapy, Combination/methods*;Herb-Drug Interactions;Humans;Phenols/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology;Plants, Medicinal/chemistry*;Terpenes/pharmacology*
29154055;Age Factors;Aged;Aged, 80 and over;Chronic Disease/therapy*;Complementary Therapies/statistics & numerical data;Complementary Therapies/utilization*;Cross-Sectional Studies;Ethiopia;Female;Herb-Drug Interactions;Hospitals, Teaching;Humans;Male;Motivation;Patient Acceptance of Health Care*;Patient Satisfaction;Phytotherapy;Socioeconomic Factors;Spiritual Therapies
29145840;Animals;Dopamine/metabolism;Glycyrrhiza*;Herb-Drug Interactions;Locomotion/drug effects;Male;Methanol;Nicotine/pharmacology*;Nucleus Accumbens/chemistry;Nucleus Accumbens/drug effects*;Nucleus Accumbens/metabolism;Oxidative Stress/drug effects*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley
29073478;Animals;Chromatography, High Pressure Liquid/methods*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics;Flavonoids/blood*;Flavonoids/chemistry;Flavonoids/pharmacokinetics;Ginsenosides/blood*;Ginsenosides/chemistry;Ginsenosides/pharmacokinetics;Herb-Drug Interactions;Injections, Intravenous;Linear Models;Rats;Reproducibility of Results;Sensitivity and Specificity;Spectrometry, Mass, Electrospray Ionization/methods;Tandem Mass Spectrometry/methods*
29027684;Chromatography, Liquid/methods*;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/metabolism;Herb-Drug Interactions;Liliaceae/chemistry*;Limit of Detection;Linear Models;Reproducibility of Results;Tandem Mass Spectrometry/methods*
28905437;Adult;Asian Continental Ancestry Group*;Diabetes Mellitus/drug therapy;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Herbal Medicine*;Humans;Male;Medicine, Ayurvedic*;Middle Aged;Phytotherapy*;Plants, Medicinal;Skin Diseases/drug therapy;Surveys and Questionnaires;United Kingdom;Young Adult
28885074;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme System/drug effects;Depression/drug therapy;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Pharmacokinetics;Phloroglucinol/analogs & derivatives;Phloroglucinol/isolation & purification;Phloroglucinol/pharmacology;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Terpenes/isolation & purification;Terpenes/pharmacology
28846866;Animals;Behavior, Animal/drug effects;Benzofurans/blood*;Benzofurans/chemistry;Benzofurans/pharmacokinetics*;Choline/chemistry;Choline/pharmacokinetics;Choline/toxicity;Chromatography, High Pressure Liquid/methods;Female;Glycerol/chemistry;Glycerol/pharmacokinetics;Glycerol/toxicity;Herb-Drug Interactions*;Limit of Detection;Linear Models;Male;Mass Spectrometry/methods;Mice;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Solvents/chemistry;Solvents/pharmacokinetics*;Solvents/toxicity;Water
28833680;11-beta-Hydroxysteroid Dehydrogenases/metabolism;Animals;Cell Line, Tumor;Enzyme Inhibitors;Glycyrrhiza/toxicity*;Glycyrrhizic Acid/toxicity*;Herb-Drug Interactions;Humans;Hypertension;Mutagenicity Tests;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/toxicity;Plants, Medicinal/toxicity*;Toxicity Tests
28807159;Animals;Databases, Bibliographic/statistics & numerical data;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional*
28797065;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Randomized Controlled Trials as Topic;Thromboembolism/prevention & control;Treatment Outcome;Warfarin/pharmacokinetics*;Warfarin/therapeutic use
28784133;Animals;Antipsychotic Agents/pharmacology;Antipsychotic Agents/therapeutic use*;Apomorphine;Asteraceae*;Behavior, Animal/drug effects;Catalepsy;Chlorpromazine/pharmacology;Chlorpromazine/therapeutic use;Disease Models, Animal;Haloperidol/pharmacology;Haloperidol/therapeutic use;Herb-Drug Interactions;Hypnotics and Sedatives/pharmacology;Hypnotics and Sedatives/therapeutic use;Mice, Inbred BALB C;Mice, Inbred ICR;Motor Activity/drug effects*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Psychotic Disorders/drug therapy*
28762712;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Risk Factors
28755953;Dietary Supplements/standards;Dietary Supplements/toxicity*;Herb-Drug Interactions;Humans;Kidney/drug effects;Kidney Diseases/epidemiology;Kidney Diseases/etiology*;Plant Extracts/analysis;Plant Extracts/toxicity*;United States/epidemiology
28698304;Cells, Cultured;Hepatocytes/cytology;Hepatocytes/metabolism*;Herb-Drug Interactions*;Humans;Lignans/pharmacokinetics;Lignans/pharmacology;Midazolam/pharmacokinetics*;Midazolam/pharmacology;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Schisandra/chemistry*
28640225;Animals;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Liver/drug effects*;Liver/pathology;Male;Medicine, Chinese Traditional/methods*;Niacinamide/analogs & derivatives*;Niacinamide/blood;Niacinamide/pharmacokinetics;Niacinamide/pharmacology;Niacinamide/toxicity;Phenylurea Compounds/blood;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/pharmacology*;Phenylurea Compounds/toxicity;Rats;Rats, Sprague-Dawley
28621744;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Isoenzymes/metabolism*;Xanthenes/chemistry;Xanthones/chemistry*
28603119;Administration, Oral;Animals;Area Under Curve;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics*;Half-Life;Herb-Drug Interactions*;Indans/administration & dosage;Indans/blood;Indans/pharmacokinetics*;Male;Medicine, Korean Traditional*;Metabolic Clearance Rate;Phytotherapy;Piperidines/administration & dosage;Piperidines/blood;Piperidines/pharmacokinetics*;Plant Extracts/administration & dosage*;Plants, Medicinal;Rats, Sprague-Dawley
28585285;Anti-Infective Agents;Antineoplastic Agents, Phytogenic;Antioxidants/analysis;Beverages;Biflavonoids/analysis;Camellia sinensis/chemistry;Catechin/analysis;Drug Synergism;Flavonoids/analysis;Flavonols/analysis;Glutamates/analysis;Health Promotion*;Herb-Drug Interactions;Humans;Hypoglycemic Agents;Phytochemicals/analysis;Plant Extracts/chemistry;Plants, Medicinal*/adverse effects;Plants, Medicinal*/chemistry;Polyphenols/analysis;Proanthocyanidins/analysis;Sensation;Tea*/chemistry;gamma-Aminobutyric Acid/analysis
28573249;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Female;Garlic;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/surgery;Nurses;Physicians;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts*/adverse effects;Plant Extracts*/therapeutic use;Plants, Medicinal;Professional-Patient Relations;Urtica dioica;Young Adult
28570472;Anticoagulants/adverse effects;Anticoagulants/therapeutic use;Cosmetic Techniques/adverse effects;Cosmetic Techniques/nursing;Herb-Drug Interactions*;Herbal Medicine/trends*;Humans;Nursing Assessment/methods*;Nursing Assessment/standards;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use
28533679;Adult;Area Under Curve;Catechin/analogs & derivatives*;Catechin/isolation & purification;Catechin/pharmacology;Female;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Rosuvastatin Calcium/administration & dosage;Rosuvastatin Calcium/pharmacokinetics*;Tea/chemistry*;Young Adult
28526079;Adult;Aged;Aged, 80 and over;Communication;Complementary Therapies/psychology;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patients/psychology*;Physicians/psychology;Surveys and Questionnaires;Young Adult
28473993;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Carboxylesterase/genetics;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/pathology;Catechol O-Methyltransferase/genetics;Cytochrome P-450 Enzyme System/genetics;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/therapeutic use*;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Humans;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/genetics;Salvia miltiorrhiza/chemistry*
28466663;Animals;Area Under Curve;Chromatography, High Pressure Liquid;Diterpenes, Abietane/administration & dosage;Diterpenes, Abietane/pharmacokinetics;Diterpenes, Abietane/pharmacology*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Inhibitory Concentration 50;Isoenzymes;Phenanthrenes/administration & dosage;Phenanthrenes/pharmacokinetics;Phenanthrenes/pharmacology*;Rats;Salvia miltiorrhiza/chemistry*
28419964;Animals;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Carbamazepine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P450 Family 2/metabolism*;Drugs, Chinese Herbal/pharmacology*;Half-Life;Herb-Drug Interactions/physiology;Liver/metabolism*;Male;Paeonia/chemistry*;Rats;Rats, Wistar;Steroid 16-alpha-Hydroxylase/metabolism*
28344076;Cyclooctanes/pharmacology*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dioxoles/pharmacology*;Herb-Drug Interactions;Humans;Hydroxylation;Lignans/pharmacology*;Midazolam/pharmacology;Molecular Structure;Nifedipine/pharmacology;Oxidation-Reduction;Schisandra/chemistry*;Testosterone/pharmacology
28342858;Animals;Artocarpus/chemistry*;Cardiotonic Agents/administration & dosage;Cardiotonic Agents/isolation & purification;Cardiotonic Agents/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Isoproterenol/toxicity;Male;Myocardial Contraction/drug effects;Myocardial Infarction/prevention & control*;Myocardium/pathology;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Leaves;Rats;Rats, Sprague-Dawley
28299812;Animals;Chromatography, Liquid;Glucosides/chemistry;Glucosides/pharmacokinetics*;Herb-Drug Interactions*;Losartan/blood;Losartan/chemistry;Losartan/pharmacokinetics*;Male;Mass Spectrometry;Microsomes, Liver/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tablets;Tripterygium/chemistry*
28288489;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Flavonoids/pharmacology*;Herb-Drug Interactions/physiology;Liver/metabolism;Plants, Medicinal;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Simvastatin/pharmacokinetics
28282295;Acute Disease;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Chronic Pain/drug therapy*;Disease Models, Animal;Drug Therapy, Combination;Formaldehyde;Herb-Drug Interactions;Hot Temperature;Luteolin/pharmacology;Luteolin/therapeutic use*;Mice;Morphine/pharmacology;Morphine/therapeutic use*;Nociceptive Pain/drug therapy*;Pain/drug therapy;Pain Management;Peripheral Nerve Injuries/complications;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Sciatic Nerve;Sciatic Neuropathy/drug therapy*;Sciatica/drug therapy
28260629;Administration, Oral;Animals;Biological Availability;Chromatography, High Pressure Liquid/methods*;Erlotinib Hydrochloride/blood;Erlotinib Hydrochloride/pharmacokinetics*;Herb-Drug Interactions*;Limit of Detection;Linear Models;Plant Extracts/blood;Plant Extracts/pharmacokinetics*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Rats;Reproducibility of Results;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry/methods;Tea*
28257666;Administration, Oral;Animals;Aspirin/adverse effects*;Blood Volume/drug effects*;Drugs, Chinese Herbal/pharmacokinetics*;Ginsenosides/pharmacokinetics*;Herb-Drug Interactions;Homeostasis/drug effects*;Male;Rats;Rats, Sprague-Dawley;Saponins/adverse effects*;Saponins/pharmacokinetics*
28252553;Adult;Aged;Antineoplastic Agents/therapeutic use*;Complementary Therapies*;Drugs, Chinese Herbal/administration & dosage*;Female;Follow-Up Studies;Herb-Drug Interactions*;Humans;Male;Melanoma/drug therapy*;Melanoma/pathology;Middle Aged;Prognosis;Surveys and Questionnaires
28250272;Binding Sites*;Herb-Drug Interactions;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Protein Binding;Seeds;Serum Albumin/chemistry*;Silymarin/chemistry*;Silymarin/pharmacokinetics;Static Electricity;Thermodynamics
28238155;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Antineoplastic Combined Chemotherapy Protocols/pharmacology;Carboplatin/administration & dosage;Carboplatin/pharmacology;Cell Line, Tumor;Drug Screening Assays, Antitumor;Endometrial Neoplasms/drug therapy;Female;HEK293 Cells;Herb-Drug Interactions;Humans;Middle Aged;Ovarian Neoplasms/drug therapy*;Paclitaxel/administration & dosage;Paclitaxel/pharmacology;Phytotherapy/adverse effects;Phytotherapy/statistics & numerical data;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Uterine Cervical Neoplasms/drug therapy
28219593;Adult;Areca/adverse effects*;Case-Control Studies;Female;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Liver Transplantation*;Male;Mastication;Middle Aged;Retrospective Studies;Tacrolimus/pharmacokinetics*;Taiwan;Transplant Recipients;Young Adult
28176623;Administration, Oral;Animals;Area Under Curve;Biological Availability;Biomarkers/blood;Blood Glucose/drug effects*;Blood Glucose/metabolism;Cinnamomum/chemistry;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Cytochrome P-450 CYP3A Inhibitors/toxicity;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Herb-Drug Interactions*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Male;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/toxicity;Rabbits;Rats, Sprague-Dawley;Thiazolidinediones/administration & dosage;Thiazolidinediones/pharmacokinetics*;Weight Loss/drug effects
28152355;Adult;Australia;Awareness;Child, Preschool;Dietary Supplements/adverse effects*;Dietary Supplements/toxicity;Female;Garcinia cambogia/adverse effects;Garcinia cambogia/toxicity;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Herbal Medicine/methods*;Humans;Male;Massive Hepatic Necrosis/chemically induced;Massive Hepatic Necrosis/surgery;Metals, Heavy/toxicity;Middle Aged;Plant Preparations/therapeutic use;Plant Preparations/toxicity;Plants, Toxic/adverse effects*;Plants, Toxic/toxicity;Risk;Social Control, Formal
28144968;Acute Kidney Injury/chemically induced*;Cytochrome P-450 CYP2C9/physiology;Cytochrome P-450 CYP3A/physiology;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/adverse effects*;Protein Binding;Saponins/adverse effects*;Triterpenes/adverse effects*
28058783;Animals;Female;Herb-Drug Interactions;Humans;Larrea/chemistry*;Lignans/chemistry*;Lignans/pharmacology;Liver/metabolism*;Microsomes, Liver/drug effects*;Rats
28039696;Animals;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/therapeutic use*;Cachexia/drug therapy*;Cachexia/etiology;Ginger/chemistry*;Herb-Drug Interactions;Humans;Neoplasms/complications;Neoplasms/drug therapy*;Neoplasms/mortality;Neoplasms/pathology;Phytotherapy;Plant Extracts/adverse effects;Plant Extracts/isolation & purification;Plant Extracts/therapeutic use*;Plants, Medicinal;Risk Factors;Treatment Outcome
27996361;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/chemistry*;Amino Acid Sequence;Animals;Binding Sites;Computational Biology/methods*;Flavonoids/chemistry;Flavonoids/toxicity*;Herb-Drug Interactions;Humans;Ligands;Mice;Molecular Docking Simulation;Molecular Dynamics Simulation;Protein Binding;Protein Interaction Domains and Motifs;Sequence Alignment;Structural Homology, Protein
27925507;Anemia/blood;Anemia/chemically induced;Anemia/drug therapy*;Angelica sinensis/chemistry*;Animals;Biomarkers/blood;Disease Models, Animal;Erythrocyte Indices;Erythrocytes/drug effects*;Erythrocytes/metabolism;Erythropoietin/pharmacology;Hematinics/isolation & purification;Hematinics/pharmacology*;Hematinics/toxicity;Hematocrit;Hematopoiesis/drug effects*;Hemoglobins/metabolism;Herb-Drug Interactions;Lisinopril*;Male;Phytotherapy;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/toxicity;Plant Root Cap/chemistry*;Plants, Medicinal;Polysaccharides/isolation & purification;Polysaccharides/pharmacology*;Polysaccharides/toxicity;Rats, Wistar;Time Factors
27925249;Administration, Oral;Biological Availability;Biotransformation;Buprenorphine/administration & dosage;Buprenorphine/blood;Buprenorphine/metabolism*;Buprenorphine/pharmacokinetics;Caco-2 Cells;Dietary Supplements*/adverse effects;Glucuronides/metabolism*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestines/drug effects*;Intestines/metabolism;Liver/drug effects*;Liver/metabolism;Models, Biological;Oxidation-Reduction;Phytochemicals/toxicity*;Protein Binding
27923318;Animals;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Complementary Therapies/trends;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/trends;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry
27919190;Animals;Area Under Curve;Caco-2 Cells;Chromatography, Liquid;Glycyrrhizic Acid/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Mass Spectrometry;Metabolic Clearance Rate;Microsomes, Liver;Random Allocation;Rats;Rats, Sprague-Dawley;Triterpenes/pharmacokinetics*
27916843;Drugs, Chinese Herbal;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Protein Isoforms/antagonists & inhibitors;Sapogenins/pharmacokinetics*;Sapogenins/pharmacology*;Saponins/pharmacokinetics*;Saponins/pharmacology*;Triterpenes/pharmacokinetics*;Triterpenes/pharmacology*
27904048;Animals;Cell Line;Citrus*;Flavanones/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Hesperidin/pharmacology*;Humans;Hymecromone/pharmacology;Insecta;Recombinant Proteins/metabolism;Trifluoperazine/pharmacology
27903949;Aged;Anti-Retroviral Agents/pharmacology;Anti-Retroviral Agents/therapeutic use*;Equisetum/chemistry*;Female;HIV Infections/drug therapy*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
27902536;Herb-Drug Interactions/physiology*;Humans;Mental Disorders/drug therapy*;Mental Disorders/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/metabolism;Monoamine Oxidase Inhibitors/therapeutic use;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Plant Preparations/therapeutic use*;Psychotropic Drugs/adverse effects;Psychotropic Drugs/metabolism;Psychotropic Drugs/therapeutic use*
27890005;Animals;Chemical and Drug Induced Liver Injury/etiology*;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Phytochemicals/adverse effects*;Phytochemicals/pharmacology;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Risk
27878352;Anesthetics/adverse effects;Anticoagulants/adverse effects*;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Fibrinolytic Agents/adverse effects;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Hypnotics and Sedatives/adverse effects;Intraoperative Complications/chemically induced*;Male;Middle Aged;Phytotherapy/adverse effects;Platelet Aggregation Inhibitors/adverse effects;Prospective Studies
27847337;Administration, Oral;Andrographis/chemistry*;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Arthritis, Experimental/blood;Arthritis, Experimental/chemically induced;Arthritis, Experimental/drug therapy*;Arthritis, Experimental/physiopathology;Chromatography, High Pressure Liquid;Diterpenes/administration & dosage*;Diterpenes/isolation & purification;Edema/chemically induced;Edema/prevention & control;Female;Freund's Adjuvant;Half-Life;Herb-Drug Interactions*;Hyperalgesia/chemically induced;Hyperalgesia/physiopathology;Hyperalgesia/prevention & control;Metabolic Clearance Rate;Naproxen/administration & dosage;Naproxen/blood;Naproxen/pharmacokinetics*;Nociception/drug effects;Nociceptive Pain/chemically induced;Nociceptive Pain/physiopathology;Nociceptive Pain/prevention & control;Pain Threshold/drug effects;Phytotherapy;Plant Extracts/administration & dosage*;Plant Extracts/isolation & purification;Plants, Medicinal;Rats, Wistar
27847211;Anesthetics/metabolism*;Animals;Herb-Drug Interactions/physiology*;Herbal Medicine/methods;Humans;Phytotherapy*/methods;Plants, Medicinal/metabolism*
27845750;Aspalathus/chemistry*;Chalcones/pharmacology;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology;Hypolipidemic Agents/pharmacology*;Phenylpropionates/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*
27789327;Animals;Blood Glucose/drug effects*;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/metabolism;Diabetic Retinopathy/drug therapy*;Diabetic Retinopathy/metabolism;Ethanol/chemistry;Female;Herb-Drug Interactions;Hyperglycemia/drug therapy;Hyperglycemia/metabolism;Hypoglycemic Agents/pharmacology;Insulin/metabolism;Male;Moringa oleifera/chemistry*;Plant Extracts/administration & dosage*;Plant Extracts/chemistry;Plant Leaves/chemistry*;Rats;Rats, Wistar;Retina/drug effects;Retina/metabolism;Sitagliptin Phosphate/pharmacology*
27487816;Animals;Ginkgo biloba/chemistry*;Herb-Drug Interactions/immunology*;Male;Plant Extracts/chemistry*;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/metabolism;Ticlopidine/pharmacokinetics
27804869;Animals;Anxiety/drug therapy*;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Plants, Medicinal*
27766890;Animals;Apigenin/pharmacokinetics*;Biological Availability;Drug Interactions*;Herb-Drug Interactions;Humans;Plant Extracts/pharmacokinetics*
27470545;Anticoagulants/therapeutic use;Herb-Drug Interactions*;Humans;Plants, Medicinal/chemistry*;Treatment Outcome;Warfarin/chemistry;Warfarin/therapeutic use*
27765363;Alkaloids;Animals;Antimetabolites, Antineoplastic/pharmacology;Antimetabolites, Antineoplastic/therapeutic use;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Colchicine/analogs & derivatives*;Colchicine/pharmacology;Colchicine/therapeutic use;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacology;Deoxycytidine/therapeutic use;Disease Models, Animal;Female;Glycosides;Herb-Drug Interactions;Humans;Liliaceae/chemistry*;Mice, Inbred C57BL;Pancreas/drug effects*;Pancreatic Neoplasms/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Seeds
27759172;Academic Medical Centers;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/statistics & numerical data*;Humans;Inpatients*;Israel;Male;Middle Aged;Prospective Studies
27751754;Acquired Immunodeficiency Syndrome/diagnosis;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/virology;Anti-Retroviral Agents/adverse effects*;Antiretroviral Therapy, Highly Active/adverse effects;Decision Support Techniques*;Drug Interactions*;Food-Drug Interactions;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/virology;Herb-Drug Interactions;Humans;Risk Assessment;Risk Factors;Software Design*;User-Computer Interface
27748172;Aspalathus/adverse effects;Cardiovascular Diseases/therapy*;Drug-Related Side Effects and Adverse Reactions*;Garcinia mangostana/adverse effects;Herb-Drug Interactions*;Humans;Lycium/adverse effects;Plants, Medicinal/adverse effects*;Portugal;Tea/adverse effects
27721546;Animals;Carbon Monoxide/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/metabolism*;Plant Extracts/pharmacology*;Rats;Tinospora*
27714886;Andrographis/chemistry*;Animals;Butanones/chemistry*;Butanones/pharmacology;Diterpenes/chemistry*;Diterpenes/pharmacokinetics*;Female;Herb-Drug Interactions;Plant Extracts/chemistry*;Plant Extracts/pharmacology;Rats;Rats, Wistar
27709322;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/trends;Humans;Israel;Logistic Models;Male;Middle Aged;Plant Preparations/adverse effects*;Prospective Studies;Surveys and Questionnaires
27693910;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Dietary Supplements;Food-Drug Interactions*;Fruit and Vegetable Juices*;Herb-Drug Interactions*;Humans;Hypericum*;Micronutrients/administration & dosage;Pharmacovigilance;Solute Carrier Organic Anion Transporter Family Member 1b1/antagonists & inhibitors;Warfarin/pharmacology
27671273;Clinical Competence*;Communication;Community Pharmacy Services*;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Dietary Supplements*/adverse effects;Drug-Related Side Effects and Adverse Reactions/etiology;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Medicine, Traditional/adverse effects;Medicine, Traditional/methods*;Patient Education as Topic;Pharmacists*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Professional Role*;Professional-Patient Relations;Risk Factors
27631192;Antineoplastic Agents/pharmacology*;Apoptosis/drug effects;Cell Cycle/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Cytochrome P-450 CYP1A2/drug effects*;Cytochrome P-450 CYP2C19/drug effects*;Cytochrome P-450 CYP2C9/drug effects*;Herb-Drug Interactions*;Humans;Isoenzymes;Lettuce/chemistry*;Pharmacogenomic Testing;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal;Recombinant Proteins
27558587;Animals;Bicuculline/pharmacology;Conditioning (Psychology)/drug effects*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Fear/drug effects*;Female;Flumazenil/pharmacology;Herb-Drug Interactions;Immobility Response, Tonic/drug effects*;Ovariectomy*;Rats;Social Isolation*
27544221;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Hospitalization/trends*;Humans;Inpatients/statistics & numerical data*;Phytotherapy/utilization*;Prospective Studies
27516439;Adult;Aged;Communication*;Complementary Therapies/utilization*;Cross-Sectional Studies;Dietary Supplements*;Evidence-Based Medicine;Family Practice;Female;Herb-Drug Interactions;Hospitalization;Hospitals;Humans;Inpatients/psychology*;Inpatients/statistics & numerical data;Israel;Male;Middle Aged;Patient-Centered Care;Physician-Patient Relations*;Physicians, Primary Care*;Prospective Studies;Truth Disclosure*
27507204;Animals;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Glucuronosyltransferase/chemistry*;Glucuronosyltransferase/metabolism;Glycyrrhizic Acid/chemistry;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions*;Intestines/chemistry;Intestines/drug effects;Intestines/enzymology*;Kinetics;Liver/chemistry;Liver/drug effects;Liver/enzymology*;Male;Rats;Rats, Sprague-Dawley
27485257;Animals;Biological Transport;Cytochrome P-450 CYP1A2/metabolism*;Dogs;Herb-Drug Interactions*;Herbal Medicine;Humans;Madin Darby Canine Kidney Cells;Models, Biological*;Organic Anion Transport Protein 1/metabolism*;Transfection
27468556;Animals;Drugs, Chinese Herbal/chemistry*;Enzymes/chemistry*;Enzymes/metabolism;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/chemistry*
27467225;Antidepressive Agents, Second-Generation/administration & dosage;Apium graveolens/adverse effects*;Bipolar Disorder*/chemically induced;Bipolar Disorder*/diagnosis;Bipolar Disorder*/therapy;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Female;Herb-Drug Interactions;Humans;Hypericum*;Menopause/drug effects;Middle Aged;Phytotherapy*/adverse effects;Phytotherapy*/methods;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Roots/adverse effects;Psychiatric Status Rating Scales;Treatment Outcome;Venlafaxine Hydrochloride/administration & dosage*;Withholding Treatment
27459888;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Activation, Metabolic;Administration, Oral;Animals;Area Under Curve;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/toxicity;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism;Dogs;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions*;Madin Darby Canine Kidney Cells;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/toxicity;Rats, Sprague-Dawley;Risk Assessment;Tandem Mass Spectrometry;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Ticlopidine/toxicity;Transfection
27457692;Alkaloids/pharmacology;Benzodioxoles/pharmacology;Berberine/pharmacology;Chemistry, Pharmaceutical/methods;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions/physiology*;Humans;Medicine, Ayurvedic;Microsomes, Liver/metabolism*;Pharmaceutical Preparations/metabolism*;Piperidines/pharmacology;Plant Extracts/metabolism*;Plant Extracts/pharmacology*;Polyunsaturated Alkamides/pharmacology;Saponins/pharmacology;Stilbenes/pharmacology;Triterpenes/pharmacology;Withanolides/pharmacology
27444983;Contraceptives, Oral, Combined/adverse effects*;Contraceptives, Oral, Hormonal/adverse effects*;Depression/drug therapy;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Hypericum/chemistry*;Metrorrhagia/chemically induced;Ovulation/drug effects;Plant Extracts/adverse effects*;Randomized Controlled Trials as Topic;Risk Assessment
27427263;Aged;Aged, 80 and over;Dietary Supplements*/adverse effects;Evidence-Based Medicine;Female;Herb-Drug Interactions;Humans;Male;Plants, Medicinal*/adverse effects;Polypharmacy;Practice Guidelines as Topic/standards*
27416488;Administration, Oral;Animals;Biological Availability;Chemistry, Pharmaceutical/methods;Cohort Studies;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions;Hibiscus/chemistry*;Humans;Hydroxocobalamin/pharmacokinetics*;Hydroxocobalamin/therapeutic use*;Intestines/metabolism;Male;Mice;Mice, Inbred C57BL;Middle Aged;Nervous System Diseases/drug therapy;Nervous System Diseases/metabolism;Teas, Herbal;Vitamin B 12 Deficiency/drug therapy*;Vitamin B 12 Deficiency/metabolism;Vitamin B Complex/pharmacokinetics*;Vitamin B Complex/therapeutic use*
27401301;Animals;Anti-HIV Agents/pharmacology*;Anti-HIV Agents/therapeutic use;Antiretroviral Therapy, Highly Active*;Ascorbic Acid/pharmacology;Chemotherapy, Adjuvant/methods;HIV Infections/drug therapy*;Herb-Drug Interactions*;Hypoxis/chemistry*;Lamivudine/pharmacology;Lamivudine/therapeutic use;Male;Nevirapine/pharmacology;Nevirapine/therapeutic use;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Seminiferous Tubules/drug effects;Seminiferous Tubules/pathology;Sperm Count;Sperm Motility/drug effects;Spermatozoa/drug effects*;Stavudine/pharmacology;Stavudine/therapeutic use
27399660;Biological Availability;Cassia/chemistry*;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors/chemistry*;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Enzyme Activation/drug effects;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kinetics;Lamiales/chemistry*;Mass Spectrometry;Molecular Structure;Plant Extracts/chemistry*;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Tissue Distribution
27357588;Aconitum/chemistry*;Alkaloids/pharmacokinetics*;Animals;Anthraquinones/pharmacology;Area Under Curve;Chromatography, High Pressure Liquid/methods;Diterpenes/pharmacokinetics*;Drugs, Chinese Herbal/pharmacokinetics*;Female;Half-Life;Herb-Drug Interactions/physiology;Male;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rheum/adverse effects*;Tandem Mass Spectrometry/methods
27352447;Cytochrome P-450 Enzyme System/metabolism*;Fruit*;Herb-Drug Interactions*;Humans;Lycium*;Metabolic Detoxication, Phase I*;Oxygenases/metabolism*;Plant Extracts/pharmacology*;Plant Preparations
27288758;Administration, Intravenous;Administration, Oral;Alkaloids/pharmacokinetics*;Animals;Area Under Curve;Benzodioxoles/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Stability;Herb-Drug Interactions;Male;Piper;Piperidines/pharmacokinetics*;Plant Preparations/pharmacokinetics*;Polyunsaturated Alkamides/pharmacokinetics*;Quality Control;Rats;Rats, Sprague-Dawley;Reference Standards;Reproducibility of Results;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Taxoids/pharmacokinetics*
27240333;Animals;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions;Kidney Function Tests;Liver Function Tests;Male;Rats;Schizophrenia/drug therapy;Tissue Distribution
27223851;Drugs, Chinese Herbal;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Magnoliopsida/chemistry*;Molecular Structure;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/chemistry;Saponins/chemistry*
27208893;Computer Simulation;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Glucuronides/metabolism;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Inactivation, Metabolic;Kinetics;Models, Molecular;Molecular Structure;Phytosterols/chemistry;Phytosterols/pharmacology*;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Quantitative Structure-Activity Relationship;Saponins/chemistry;Saponins/pharmacology;Static Electricity;Tamoxifen/metabolism;Trifluoperazine/metabolism
27171366;Animals;Dietary Supplements/adverse effects;Dietary Supplements/standards;European Union;Herb-Drug Interactions;Humans;Legislation, Drug;Medicine, Traditional/methods;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/standards;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*;Russia
27164071;Antipsychotic Agents/pharmacology*;Chromatography, High Pressure Liquid;Clozapine/analogs & derivatives;Clozapine/analysis;Clozapine/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;In Vitro Techniques;Microsomes, Liver/chemistry;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
27157958;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions/epidemiology;Female;Herb-Drug Interactions*;Humans;Male;Phytotherapy/statistics & numerical data*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use*;Turkey/epidemiology
27145339;Furans/pharmacology*;Glucosides/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Kinetics;Lignans/pharmacology*
27142346;Animals;Cell Proliferation/drug effects*;Cognition/drug effects*;Cognition Disorders/chemically induced;Cognition Disorders/pathology;Cognition Disorders/prevention & control*;Herb-Drug Interactions;Hippocampus/drug effects;Hippocampus/pathology;Male;Neuroprotective Agents/administration & dosage;Plant Extracts/administration & dosage;Plant Preparations/administration & dosage*;Rats;Rats, Sprague-Dawley;Treatment Outcome;Valproic Acid*;Zingiberaceae/chemistry*
27125594;Aged;Complementary Therapies/adverse effects*;Female;Herb-Drug Interactions;Humans;Male;Middle East;Neoplasms/drug therapy*;Surveys and Questionnaires
27105957;Benzyl Compounds/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Phytolaccaceae/chemistry*;Plant Extracts/pharmacology*;Sulfides/pharmacology*
27090799;Adult;Aged;Aged, 80 and over;Comorbidity;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Drugs, Chinese Herbal/therapeutic use;Female;Formularies, Homeopathic;Germany/epidemiology;Herb-Drug Interactions;Humans;Male;Melanoma/epidemiology*;Melanoma/therapy*;Middle Aged;Surveys and Questionnaires;Vitamins/therapeutic use
27071286;Animals;Anticholesteremic Agents/pharmacology;Antioxidants/pharmacology;Atorvastatin Calcium/pharmacology*;Cynara scolymus*;Disease Models, Animal;Drug Monitoring;Drug Synergism;Herb-Drug Interactions;Hypercholesterolemia/drug therapy*;Hypercholesterolemia/metabolism;Oxidative Stress/drug effects*;Phytotherapy/methods;Plant Extracts/pharmacology*;Plant Leaves;Rats;Treatment Outcome
27061296;Albuterol/pharmacology*;Animals;Bronchodilator Agents/pharmacology*;Dose-Response Relationship, Drug;Drug Synergism;Flavonoids/pharmacology*;Guinea Pigs;Herb-Drug Interactions*;In Vitro Techniques;Ipratropium/pharmacology*;Male;Muscle Relaxation/drug effects*;Muscle, Smooth/drug effects*;Trachea/drug effects*
27057621;Amodiaquine/pharmacology*;Animals;Antimalarials/pharmacology*;Chloroquine/pharmacology;Disease Models, Animal;Drug Resistance;Drug Therapy, Combination;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Malaria/drug therapy*;Malaria/parasitology;Mice;Parasitic Sensitivity Tests;Plant Extracts/pharmacology*;Plasmodium berghei/drug effects*;Time Factors
27054913;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Alkaloids/pharmacology*;Animals;Benzophenanthridines/pharmacology;Berberine Alkaloids/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dioxoles/pharmacology;Dogs;Eschscholzia/chemistry*;Hep G2 Cells/drug effects;Herb-Drug Interactions;Humans;Madin Darby Canine Kidney Cells/drug effects;Plant Extracts/pharmacology;Receptors, Steroid/genetics;Receptors, Steroid/metabolism*
27023460;Adult;Antitussive Agents/blood;Antitussive Agents/pharmacokinetics*;Antitussive Agents/urine;Asian Continental Ancestry Group/genetics;Cytochrome P-450 CYP2D6/genetics*;Dextromethorphan/blood;Dextromethorphan/pharmacokinetics*;Dextromethorphan/urine;Drugs, Chinese Herbal/pharmacology*;Female;Genotype;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Young Adult
27003511;Animals;Biomedical Research;Clinical Studies as Topic;Herb-Drug Interactions*;Humans;Mice;Plant Preparations*;Rats
27000164;Administration, Oral;Antineoplastic Agents*/administration & dosage;Antineoplastic Agents*/adverse effects;Clinical Competence*;Community Pharmacy Services;Cross-Sectional Studies;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Pharmacists/psychology*
26990021;Animals;Berberine Alkaloids/pharmacokinetics*;Berberine Alkaloids/therapeutic use;Chromatography, High Pressure Liquid/methods*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme System/metabolism*;Dogs;Herb-Drug Interactions;Humans;Isoenzymes/chemistry*;Male
26959552;Animals;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Enzyme Induction/drug effects*;Herb-Drug Interactions;Male;Microsomes, Liver/enzymology*;Pentacyclic Triterpenes/pharmacology*;Rats;Triterpenes/pharmacology*
26954426;Adult;Child, Preschool;Female;Herb-Drug Interactions*;Humans;Male;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Pregnancy
26953389;Adolescent;Adult;Age Factors;Aged;Alcoholism/complications;Child;Child, Preschool;Dose-Response Relationship, Drug;Ethanol/administration & dosage;Ethanol/adverse effects*;Herb-Drug Interactions*;Humans;Infant;Phytotherapy/adverse effects*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Preservatives, Pharmaceutical/administration & dosage;Preservatives, Pharmaceutical/adverse effects*;Risk Factors
26941093;Adult;Aged;Anticoagulants/therapeutic use*;Brazil/epidemiology;Female;Follow-Up Studies;Heart Diseases/drug therapy*;Heart Diseases/epidemiology;Herb-Drug Interactions*;Humans;International Normalized Ratio/methods;Male;Middle Aged;Outpatient Clinics, Hospital*;Pharmacists*;Plants, Medicinal*;Professional Role
26931616;Ampicillin/pharmacology*;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Caffeic Acids/pharmacology;Drug Synergism;Escherichia coli/drug effects;Flavones/pharmacology;Glucosides/pharmacology;Herb-Drug Interactions*;Iridoids/pharmacology;Medicine, Traditional;Olea/chemistry*;Phenols/pharmacology*;Phenylethyl Alcohol/analogs & derivatives;Phenylethyl Alcohol/pharmacology;Plant Extracts/metabolism;Plant Extracts/pharmacology*;Plant Leaves/chemistry;Staphylococcus aureus/drug effects
26926393;Anticoagulants/metabolism;Anticoagulants/pharmacology;Binding Sites;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Humans;Molecular Docking Simulation;Protein Binding;Salvia miltiorrhiza/chemistry;Salvia miltiorrhiza/metabolism*;Serum Albumin/metabolism*;Warfarin/metabolism;Warfarin/pharmacology
26915920;Animals;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/methods
26908268;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Caco-2 Cells;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Indinavir/pharmacokinetics;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Ritonavir/pharmacology;Sophora/chemistry*;Up-Regulation
26891872;Administration, Oral;Adrenergic beta-1 Receptor Antagonists/pharmacokinetics;Adrenergic beta-1 Receptor Antagonists/pharmacology;Animals;Area Under Curve;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;In Vitro Techniques;Inhibitory Concentration 50;Male;Metoprolol/pharmacokinetics*;Metoprolol/pharmacology;Microsomes, Liver/metabolism;Plant Bark;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Terminalia/chemistry*
26891286;Antiretroviral Therapy, Highly Active;Benzoxazines/pharmacology;Cytochrome P-450 CYP2B6/genetics;Cytochrome P-450 CYP2B6/metabolism;Cytochrome P-450 CYP2B6 Inhibitors/chemistry;Cytochrome P-450 CYP2B6 Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Magnoliopsida/chemistry;Nevirapine/pharmacology;Plant Extracts/chemistry*;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*
26887532;Female;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods*;Plant Extracts/adverse effects*
26874879;Animals;Benzylamines/administration & dosage;Benzylamines/blood*;Biological Availability;Chromatography, High Pressure Liquid/methods;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacology*;Epimedium/chemistry*;Herb-Drug Interactions*;Limit of Detection;Male;Naphthalenes/administration & dosage;Naphthalenes/blood*;Rats;Rats, Sprague-Dawley;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/blood*;Tandem Mass Spectrometry/methods
26872133;Administration, Oral;Animals;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Liver/drug effects;Liver/metabolism;Male;Metoprolol/blood;Metoprolol/pharmacokinetics;Midazolam/blood;Midazolam/pharmacokinetics;Omeprazole/blood;Omeprazole/pharmacokinetics;Phenacetin/blood;Phenacetin/pharmacokinetics;Quinazolines/pharmacology*;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
26837208;Adult;Aged;Aged, 80 and over;Cohort Studies;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/trends;Humans;Inpatients*;Male;Middle Aged;Prospective Studies;Surveys and Questionnaires
26800424;Alkaloids/administration & dosage;Alkaloids/pharmacology*;Animals;Area Under Curve;Drug Interactions;Glycyrrhizic Acid/administration & dosage;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions;Male;Quinolizines/administration & dosage;Quinolizines/pharmacology*;Rats;Rats, Sprague-Dawley;Ribavirin/administration & dosage;Ribavirin/pharmacokinetics*;Silymarin/administration & dosage;Silymarin/pharmacology*
26776959;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control*;Dietary Supplements*;Functional Food;Gastrointestinal Microbiome/drug effects;Herb-Drug Interactions;Humans;Inflammation/drug therapy;Polyphenols/administration & dosage;Polyphenols/pharmacology*;Randomized Controlled Trials as Topic
26776752;Animals;Biological Assay;Biotransformation;Dietary Supplements/adverse effects*;Dietary Supplements/standards;Dose-Response Relationship, Drug;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Pharmacovigilance;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Plant Preparations/standards;Polypharmacy;Quality Control;Risk Assessment;Toxicity Tests/methods*;Toxicity Tests/standards
26771134;Animals;Chromatography, High Pressure Liquid/methods;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Male;Medicine, Chinese Traditional;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry/methods*
26762235;Animals;Area Under Curve;Biological Availability;Cytochrome P-450 CYP3A/metabolism;Diabetes Mellitus, Experimental*/drug therapy;Diterpenes/pharmacology*;Glyburide*/pharmacokinetics;Glyburide*/pharmacology;Herb-Drug Interactions*;Hypoglycemic Agents*/pharmacokinetics;Hypoglycemic Agents*/pharmacology;Liver/drug effects;Liver/metabolism;Male;Phytotherapy;Plant Extracts/pharmacology*;Rats, Wistar;Reference Values;Triterpenes/pharmacology*
26760391;Dietary Supplements/adverse effects*;Emergency Service, Hospital;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy*;Plant Preparations/adverse effects*;Serotonin Uptake Inhibitors/therapeutic use
26743226;Animals;Benzamides/pharmacology;Carbachol/pharmacology;Cats;Cells, Cultured;Domperidone/pharmacology;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Esophageal Sphincter, Lower/drug effects;Gastric Emptying/drug effects;Gastrointestinal Motility/drug effects*;Gastrointestinal Transit/drug effects;Herb-Drug Interactions;Indoles/pharmacology;Lonicera*;Male;Morpholines/pharmacology;Muscle Contraction/drug effects;Muscle, Smooth/drug effects;Ondansetron/pharmacology;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Rats;Sulfonamides/pharmacology
26721197;Alkaloids/blood*;Alkaloids/pharmacology;Animals;Chromatography, High Pressure Liquid;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Gymnema sylvestre/chemistry*;Herb-Drug Interactions*;Hypoglycemic Agents/blood*;Hypoglycemic Agents/pharmacology;Male;Plant Extracts/blood*;Plant Extracts/pharmacology;Rats, Wistar;Streptozocin;Sulfonylurea Compounds/blood*;Sulfonylurea Compounds/pharmacology;Tandem Mass Spectrometry
26712778;Animals;Cells, Cultured/drug effects*;Cytochrome P-450 CYP3A/drug effects*;Enzyme Inhibitors/metabolism*;Glycyrrhetinic Acid/metabolism*;Glycyrrhetinic Acid/therapeutic use;Hepatitis, Chronic/drug therapy*;Herb-Drug Interactions;Humans;Male;Mice;Mice, Inbred C57BL;Microsomes, Liver/metabolism*;Plant Extracts/metabolism*;Plant Extracts/therapeutic use;Tandem Mass Spectrometry
26692465;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use*;Apoptosis/drug effects;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Synergism;Herb-Drug Interactions*;Humans;K562 Cells;Leukemia/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Viscum album*
26690396;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Anti-HIV Agents/pharmacology*;Biological Transport;Caco-2 Cells;Cell Line, Tumor;Crotalid Venoms/pharmacology*;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions*;Humans;Indinavir/pharmacology*;Ketoconazole/pharmacology;Plant Extracts/pharmacology*;Verapamil/pharmacology
26680654;Adult;Area Under Curve;Chlorzoxazone/pharmacokinetics*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2E1/metabolism*;Enzyme Inhibitors/pharmacology*;Fasting;Half-Life;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Stilbenes/pharmacology*;Young Adult
26670091;Animals;Antineoplastic Agents/therapeutic use*;Female;Herb-Drug Interactions*;Humans;Male;Medical Oncology*;Neoplasms/drug therapy*;Phytotherapy/utilization*;Plant Preparations/adverse effects*
26657265;Animals;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/chemistry;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions/physiology;India;Inhibitory Concentration 50;Ketoconazole/metabolism;Ketoconazole/pharmacology;Male;Medicine, Traditional/methods;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Plant Extracts/chemistry*;Plant Extracts/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Swertia/chemistry*;Triterpenes/chemistry;Triterpenes/metabolism;Triterpenes/pharmacology
26656228;Cardiovascular Diseases/drug therapy*;Commiphora;Crataegus;Garlic;Herb-Drug Interactions;Humans;Medicine, Traditional/methods;Phytotherapy/methods*;Plant Extracts/pharmacology*;Plant Gums/pharmacology;Plants, Medicinal*;Terminalia
26634927;Animals;Anticonvulsants/chemistry;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Benzodiazepines;Citrullus colocynthis/chemistry*;Flavonoids;Flumazenil;Fruit/chemistry;Herb-Drug Interactions;Male;Medicine, Arabic;Mice;Naloxone;Pentylenetetrazole;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Receptors, Opioid/metabolism*;Seizures/chemically induced;Seizures/drug therapy*
26633237;Administration, Oral;Adult;Area Under Curve;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Diclofenac/pharmacokinetics*;Half-Life;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Stilbenes/pharmacology*;Young Adult
26630907;Animals;Biomarkers/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacokinetics;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/methods*;Time Factors
26619825;Acetaminophen/pharmacokinetics*;Animals;Anisoles/pharmacokinetics;Caffeine/pharmacokinetics*;Fruit/chemistry;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Male;Mice;Oils, Volatile/pharmacokinetics*;Parasympatholytics;Pimpinella/chemistry;Plant Oils/pharmacokinetics
26599199;Adult;Allied Health Personnel;Animals;Antineoplastic Agents/therapeutic use*;Arum;Camelus;Curcuma;Daucus carota;Female;Garlic;Herb-Drug Interactions*;Herbal Medicine/statistics & numerical data;Honey;Humans;Male;Medical Oncology*;Middle Aged;Middle East;Milk;Neoplasms/drug therapy*;Nigella sativa;Physicians;Phytotherapy/utilization*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Research Personnel;Surveys and Questionnaires;Urtica dioica
26593212;Administration, Oral;Andrographis/chemistry*;Animals;Anti-Inflammatory Agents/pharmacokinetics;Anti-Inflammatory Agents/pharmacology;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Arthritis/drug therapy;Arthritis/metabolism;Chromatography, High Pressure Liquid;Diterpenes/pharmacokinetics*;Diterpenes/pharmacology;Female;Herb-Drug Interactions*;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Plants, Medicinal/chemistry;Pyridines/pharmacokinetics*;Pyridines/pharmacology;Rats;Rats, Wistar;Sulfones/pharmacokinetics*;Sulfones/pharmacology
26577109;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/economics;Acquired Immunodeficiency Syndrome/immunology*;Anti-Retroviral Agents/therapeutic use;Drugs, Chinese Herbal/therapeutic use;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*/economics;Pilot Projects
26561312;Animals;Cytochrome P-450 Enzyme System/metabolism;Disease Models, Animal;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Isoflavones/pharmacology*;Phytoestrogens/pharmacology;Phytotherapy*;Plants, Medicinal/chemistry;Prescription Drugs/pharmacology*
26526838;Animals;Anti-Retroviral Agents/chemistry;Anti-Retroviral Agents/pharmacokinetics*;Citrus paradisi/metabolism;Garlic/metabolism;Ginkgo biloba/metabolism;Herb-Drug Interactions/physiology*;Humans;Hypericum/metabolism;Panax/metabolism;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism*
26498206;Animals;Cantharidin/pharmacology*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9 Inducers;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inducers/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/drug effects*;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
26482404;Adverse Drug Reaction Reporting Systems/legislation & jurisprudence;Biotransformation;Consumer Product Safety/legislation & jurisprudence*;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Health Policy/legislation & jurisprudence*;Herb-Drug Interactions*;Humans;Pharmacovigilance;Plant Preparations/adverse effects*;Policy Making;Risk Assessment;Risk Factors
26474329;Activation, Metabolic;Animals;Carcinogenesis*;Carcinogens/history;Carcinogens/metabolism;Cytochrome P-450 Enzyme System/history;Cytochrome P-450 Enzyme System/metabolism;Diet*;Drug Interactions;Exercise;Herb-Drug Interactions;History, 20th Century;History, 21st Century;Humans;Lipectomy;Microsomes, Liver/enzymology;Neoplasms/chemically induced;Neoplasms/prevention & control;Xenobiotics/metabolism*
26470816;Adult;Aged;Aged, 80 and over;Databases, Factual*;Drug-Related Side Effects and Adverse Reactions*;Female;Herb-Drug Interactions*;Humans;Male;Medicine, Chinese Traditional*;Middle Aged;Research;Taiwan;Young Adult
26444365;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism*;Animals;Antineoplastic Agents/pharmacology;Cells, Cultured;Diketopiperazines/pharmacology;Drug Resistance, Multiple;Drug Resistance, Neoplasm;Herb-Drug Interactions/physiology*;Heterocyclic Compounds, 4 or More Rings/pharmacology;Humans;Hydrocharitaceae*;Lethal Dose 50;Mice;Mitoxantrone/pharmacology;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism*;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Plant Leaves
26441065;Animals;Consumer Product Safety;Echinacea*/adverse effects;Female;Herb-Drug Interactions*;Humans;Phytotherapy;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Pregnancy
26438626;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Milk Thistle/adverse effects;Pharmaceutical Preparations/metabolism*;Plant Extracts/pharmacokinetics*
26400418;ATP-Binding Cassette Transporters/metabolism*;Biological Transport/drug effects;Enterocytes/drug effects*;Enterocytes/metabolism;Flavonoids/pharmacology*;Glucuronides/pharmacology;Hepatocytes/drug effects*;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans
26366963;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/pharmacokinetics;Antiparkinson Agents/pharmacology;Benserazide/administration & dosage;Benserazide/pharmacokinetics;Benserazide/pharmacology*;Biological Availability;Capsules;Carbidopa/administration & dosage;Carbidopa/pharmacokinetics;Carbidopa/pharmacology*;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Levodopa/pharmacokinetics*;Levodopa/pharmacology;Male;Middle Aged;Motor Skills/drug effects;Mucuna/chemistry*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Phytotherapy/methods*;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Seeds/chemistry
26339628;Computer Simulation;Databases, Factual;Gene Expression;Herb-Drug Interactions/genetics*;Humans;Inactivation, Metabolic/genetics;Models, Molecular;Molecular Docking Simulation*;Plants, Medicinal/chemistry*;Receptors, Steroid/agonists;Receptors, Steroid/chemistry*;Receptors, Steroid/genetics
26318744;Animals;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Isoenzymes/drug effects;Isoenzymes/metabolism;Limit of Detection;Male;Medicine, Chinese Traditional;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Tandem Mass Spectrometry
26311243;Animals;Herb-Drug Interactions*;Herbal Medicine;Humans;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plants, Medicinal/adverse effects*
26285764;Binding Sites/physiology;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 Enzyme Inhibitors/analysis*;Cytochrome P-450 Enzyme Inhibitors/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology;Cytochrome P-450 Enzyme System/analysis;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions/physiology*;Glycyrrhiza/chemistry;Glycyrrhiza/metabolism*;Herb-Drug Interactions/physiology*;High-Throughput Screening Assays/methods*;Humans;Isoenzymes/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Tandem Mass Spectrometry/methods
26264198;Animals;Dietary Supplements;Drug Interactions;Herb-Drug Interactions*;Humans;Liver Diseases/prevention & control;Membrane Transport Proteins/metabolism*;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Plants, Medicinal/chemistry
26253491;Acetaminophen/metabolism;Animals;Area Under Curve;Cytochrome P-450 CYP1A2;Cytochromes/metabolism*;Fruit;Herb-Drug Interactions*;Liver/drug effects;Male;Microsomes, Liver;Phenacetin/metabolism;Phenacetin/pharmacokinetics*;Plant Extracts/pharmacology*;Rats, Sprague-Dawley;Ziziphus*
26223121;Biological Products;Biological Transport;Cytochrome P-450 Enzyme System/physiology*;Drugs, Chinese Herbal;Ginkgo biloba;Glucuronosyltransferase/physiology*;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/physiology*;Oxidation-Reduction;Panax;Plants, Medicinal;Pueraria
26186450;Administration, Oral;Adult;Antitubercular Agents/therapeutic use;CD4 Lymphocyte Count;Drug Administration Schedule;Fabaceae/chemistry*;Female;HIV Infections/blood;HIV Infections/diet therapy;HIV Infections/immunology;HIV Infections/virology*;HIV-1/immunology;Herb-Drug Interactions;Humans;Isoniazid/adverse effects*;Male;Opportunistic Infections/immunology;Opportunistic Infections/prevention & control*;Patient Safety;Plant Leaves/chemistry*;T-Lymphocytes/immunology;T-Lymphocytes/virology;Tuberculosis, Pulmonary/immunology;Tuberculosis, Pulmonary/prevention & control*;Viral Load/immunology
26179835;Cytochrome P-450 CYP1A2 Inducers/administration & dosage;Cytochrome P-450 CYP1A2 Inducers/pharmacology*;Cytochrome P-450 CYP2C9 Inducers/adverse effects*;Epilepsy/chemically induced;Epilepsy/drug therapy*;Fruit and Vegetable Juices/adverse effects*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Morinda/adverse effects*;Phenytoin/administration & dosage;Phenytoin/pharmacology*
26162600;Chronic Disease/drug therapy*;Chronic Disease/epidemiology*;Cross-Sectional Studies;Female;Herb-Drug Interactions*;Humans;Male;Middle East/epidemiology;Phytotherapy/statistics & numerical data*;Plants, Medicinal
26159784;Adolescent;Adult;Adverse Drug Reaction Reporting Systems*;Aged;Anaphylaxis/chemically induced;Anti-Bacterial Agents/adverse effects;Child;Child, Preschool;China;Databases, Factual*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions*;Humans;Infant;Injections;Male;Middle Aged;Penicillin G/administration & dosage*;Penicillin G/adverse effects*;Young Adult
26108148;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood*;Anti-Bacterial Agents/urine*;Area Under Curve;Cephalosporins/administration & dosage;Cephalosporins/adverse effects;Cephalosporins/blood*;Cephalosporins/urine*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Kidney/drug effects*;Kidney Function Tests;Limit of Detection;Rats, Sprague-Dawley
26102010;Animals;Curcumin/analogs & derivatives*;Curcumin/pharmacology;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1B1/genetics;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;Diet, High-Fat/adverse effects*;Fructose/adverse effects;Gene Expression Regulation, Enzymologic/drug effects;Herb-Drug Interactions;Inactivation, Metabolic;Liver/drug effects*;Liver/enzymology;Liver/pathology;Male;Membrane Proteins/genetics;Membrane Proteins/metabolism;Mice, Inbred ICR
26100226;Chalcones/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism;Glycyrrhiza*;Herb-Drug Interactions;Humans;Microsomes, Liver/metabolism
26084208;Animals;Cyclooctanes;Dioxoles;Drugs, Chinese Herbal/pharmacology;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Lignans;Plant Extracts/pharmacology*;Polycyclic Compounds;Rats;Schisandra*/chemistry;Structure-Activity Relationship
26052873;Aged;Aged, 80 and over;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Cross-Sectional Studies;Diabetes Mellitus, Type 2/epidemiology;Diabetes Mellitus, Type 2/therapy*;Female;Herb-Drug Interactions;Humans;Hypoglycemic Agents/therapeutic use;Israel/epidemiology;Male;Middle Aged;Surveys and Questionnaires
26036354;Absorption, Physiological;Animals;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/pharmacokinetics;Biotransformation;Comorbidity;Complementary Therapies/adverse effects*;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/epidemiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Polypharmacy;Risk Assessment;Risk Factors;Treatment Outcome
26006029;Animals;Asparagus Plant*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Gymnema sylvestre*;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Plant Extracts/pharmacology*;Rats;Rats, Wistar
25980420;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/toxicity;Area Under Curve;Cell Line;Chromatography, Liquid;Gastric Mucosa/drug effects;Gastric Mucosa/pathology;Herb-Drug Interactions*;Inflammation/drug therapy;Inflammation/pathology;Macrophages/drug effects;Macrophages/metabolism;Male;Mefenamic Acid/pharmacokinetics;Mefenamic Acid/pharmacology*;Mefenamic Acid/toxicity;Mice;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
25943187;Diabetes Mellitus, Type 2/drug therapy;Diabetes Mellitus, Type 2/metabolism;Drug Interactions;Herb-Drug Interactions;Humans;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*;Metformin/pharmacokinetics*;Metformin/pharmacology*
25938343;Azabicyclo Compounds/adverse effects;Female;Herb-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Methemoglobin/analysis*;Middle Aged;Oximetry/methods*;Piperazines/adverse effects;Plant Preparations/adverse effects;Spectrophotometry;Sulfhemoglobin/analysis*;Sulfhemoglobinemia/diagnosis*;Wine/adverse effects
25938222;Centella*;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions/physiology;Humans;In Vitro Techniques;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology;Plants, Medicinal;Withania*
25936586;Aryl Hydrocarbon Hydroxylases/metabolism;Chromatography, Liquid;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C8/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Hydroxylation;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Moraceae/chemistry;Plant Roots/chemistry;Tandem Mass Spectrometry;Xanthones/pharmacology*
25920220;Averrhoa/chemistry*;Cytochrome P-450 CYP2D6 Inhibitors/isolation & purification*;Cytochrome P-450 CYP3A Inhibitors/isolation & purification*;Herb-Drug Interactions;Plants, Medicinal/chemistry
25908622;Animals;Anticoagulants/pharmacokinetics*;Chromatography, Liquid;Drug Administration Schedule;Herb-Drug Interactions;Injections, Intraperitoneal;Isoflavones/administration & dosage;Isoflavones/pharmacology*;Male;Platelet Aggregation Inhibitors/pharmacokinetics*;Rats;Rats, Wistar;Tandem Mass Spectrometry;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacology*;Warfarin/pharmacokinetics*
25891082;Administration, Oral;Animals;Biotransformation;Caffeic Acids/administration & dosage;Caffeic Acids/isolation & purification;Caffeic Acids/pharmacokinetics*;Caffeic Acids/toxicity;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/isolation & purification;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/toxicity;Catechol O-Methyltransferase/metabolism;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions;Humans;Injections, Intravenous;Kidney Tubules/metabolism;Liver/enzymology*;Male;Mass Spectrometry;Membrane Transport Proteins/metabolism;Methylation;Microsomes, Liver/enzymology;Organic Anion Transport Protein 1/metabolism;Phytotherapy;Plant Roots;Plants, Medicinal;Rats, Sprague-Dawley;Renal Elimination;Salvia miltiorrhiza/chemistry*;Sulfates/metabolism
25872596;Adolescent;Adult;Alcohol Drinking/epidemiology*;Alcoholic Intoxication/epidemiology;Driving Under the Influence/statistics & numerical data;Female;Herb-Drug Interactions*;Humans;Male;Marijuana Abuse/epidemiology*;Middle Aged;Prevalence;Self-Injurious Behavior/epidemiology;Surveys and Questionnaires*;United States/epidemiology;Young Adult
25858254;Biological Products/pharmacology*;Blotting, Western;Chromatography, Liquid;Drugs, Chinese Herbal/pharmacology*;Estrone/analogs & derivatives*;Estrone/metabolism;Fluorescent Antibody Technique;HEK293 Cells;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Substrate Specificity;Tandem Mass Spectrometry;Transfection
25834921;Alcohol Oxidoreductases/antagonists & inhibitors*;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P450 Family 2;Cytochromes/antagonists & inhibitors*;Ginsenosides/administration & dosage;Ginsenosides/isolation & purification;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Male;Panax notoginseng/chemistry;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/blood*;Rats, Wistar;Steroid 16-alpha-Hydroxylase/antagonists & inhibitors*;Substrate Specificity
25756365;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/blood;Dose-Response Relationship, Drug;Drug Hypersensitivity Syndrome/blood;Drug Hypersensitivity Syndrome/diagnosis;Eosinophilia/blood;Eosinophilia/chemically induced*;Eosinophilia/diagnosis;Herb-Drug Interactions*;Humans;Male;Panax/adverse effects*;Panax/metabolism;Triazines/adverse effects*;Triazines/blood
25753317;Animals;Chromatography, High Pressure Liquid/methods*;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics;Flavonoids/blood*;Flavonoids/pharmacokinetics;Herb-Drug Interactions;Male;Metoprolol/analogs & derivatives;Metoprolol/blood*;Metoprolol/pharmacokinetics;Rats;Rats, Wistar;Tandem Mass Spectrometry/methods*
25729835;Adult;Anti-HIV Agents/adverse effects*;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Biotransformation;Ginkgo biloba*;HIV Infections/diagnosis;HIV Infections/drug therapy*;Herb-Drug Interactions*;Humans;Middle Aged;Patient Safety;Plant Extracts/adverse effects*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Risk Assessment;Risk Factors;Viral Load
25710938;Animals;Biological Transport/drug effects;Biological Transport/physiology;Caffeic Acids/metabolism*;Cell Line;Food;HEK293 Cells;Herb-Drug Interactions/physiology*;Humans;Kidney Tubules/drug effects;Kidney Tubules/metabolism*;Male;Membrane Transport Proteins/metabolism;Organic Anion Transport Protein 1/metabolism;Probenecid/pharmacology;Rats;Rats, Sprague-Dawley
25705905;Animals;Area Under Curve;Biological Transport/drug effects;Enzymes/metabolism;Half-Life;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/metabolism;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry;Prescription Drugs/pharmacokinetics*
25686904;Catalytic Domain;Computer Simulation;Cytochrome P-450 CYP2C19/chemistry;Cytochrome P-450 CYP2C19/metabolism*;Cytochrome P-450 CYP2C19 Inhibitors/chemistry;Cytochrome P-450 CYP2C19 Inhibitors/metabolism;Cytochrome P-450 CYP2C19 Inhibitors/pharmacology*;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Ethanol;Herb-Drug Interactions;Humans;Hydroxylation;Kinetics;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Molecular Docking Simulation;Phenanthrenes/chemistry;Phenanthrenes/metabolism;Phenanthrenes/pharmacology;Salvia miltiorrhiza/chemistry*
25684704;Centella/chemistry;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kaempferols/pharmacology;Microsomes, Liver/drug effects*;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry;Quercetin/pharmacology;Triterpenes/pharmacology*;Withania/chemistry
25658125;Animals;Drug Discovery;Herb-Drug Interactions*;Humans;Medicine, Traditional*;Phytotherapy;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plants, Medicinal;Risk Assessment
25653502;Animals;Biological Transport;Dose-Response Relationship, Drug;Glucosides/metabolism*;Glucosides/pharmacology;HEK293 Cells;Herb-Drug Interactions;Humans;Kinetics;LLC-PK1 Cells;Models, Biological;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors;Organic Anion Transporters, Sodium-Independent/genetics;Organic Anion Transporters, Sodium-Independent/metabolism*;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Swine
25647717;China;Consumer Product Safety*/legislation & jurisprudence;Dose-Response Relationship, Drug;Drug Contamination;Drug-Related Side Effects and Adverse Reactions/etiology*;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/standards*;Government Regulation;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*/standards;Medicine, Chinese Traditional*/trends;Taiwan;United States
25640094;Animals;Carthamus tinctorius/chemistry;Clinical Trials as Topic;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Ginger/chemistry;Ginkgo biloba/chemistry;Glycyrrhiza/chemistry;Herb-Drug Interactions*;Humans;Lycium/chemistry;Medicine, Chinese Traditional/methods*;Panax/chemistry;Prunus persica/chemistry;Salvia miltiorrhiza/chemistry;Singapore;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
25623616;Adult;Benzylisoquinolines/blood;Berberine/blood;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP3A/metabolism;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Male;Microsomes, Liver/metabolism;Midazolam/pharmacology*;Milk Thistle*;Plant Extracts/pharmacology*;Silymarin/blood;Tolbutamide/pharmacology*;Young Adult
25618121;Adult;Aged;Aged, 80 and over;Diabetes Mellitus, Type 2/drug therapy*;Diet;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Health Care Surveys;Herb-Drug Interactions;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Nutrition Assessment;Nutritional Status;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Assessment;Risk Factors;Surveys and Questionnaires
25614104;Animals;Anti-HIV Agents/pharmacokinetics*;Atazanavir Sulfate/administration & dosage;Atazanavir Sulfate/pharmacokinetics*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Drug Combinations;Drugs, Chinese Herbal/pharmacokinetics*;Gene Expression Regulation, Enzymologic/drug effects;HIV Infections/drug therapy*;HIV Protease;Herb-Drug Interactions*;Humans;Male;Rats;Rats, Sprague-Dawley;Thailand
25600201;Cytochrome P-450 CYP2C19/metabolism*;Cytochrome P-450 CYP2C19 Inhibitors/isolation & purification;Cytochrome P-450 CYP2C19 Inhibitors/pharmacology*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Hepatocytes/drug effects;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Kalanchoe*/chemistry;Kinetics;Liver/drug effects*;Liver/enzymology;Methanol/chemistry;Microsomes, Liver/enzymology;Models, Biological;NADP/metabolism;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Recombinant Proteins/metabolism;Risk Assessment;Solvents/chemistry;Testosterone/metabolism
25567192;Animals;Area Under Curve;Chromatography, High Pressure Liquid;Flavones/pharmacology*;Flavonoids/pharmacology;Herb-Drug Interactions*;Male;Piperazines/blood;Piperazines/pharmacokinetics*;Plant Extracts/pharmacology*;Purines/blood;Purines/pharmacokinetics;Rats, Wistar;Sildenafil Citrate;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Zingiberaceae/chemistry*
26958257;Anticoagulants/pharmacology*;Ginkgo biloba/chemistry*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Statistics as Topic;United States;United States Department of Veterans Affairs;Warfarin/pharmacology*
25533650;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Integrative Medicine*;Medicine, Chinese Traditional*;Membrane Transport Proteins/metabolism
25485843;Adult;Aged;Antineoplastic Agents, Hormonal*/adverse effects;Breast Neoplasms/drug therapy;Drugs, Chinese Herbal*/adverse effects;Endometrial Neoplasms/epidemiology*;Endometrial Neoplasms/etiology*;Female;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Middle Aged;Neoplasms, Second Primary*;Odds Ratio;Population Surveillance;Practice Patterns, Physicians'*;Risk;Risk Factors;Taiwan;Tamoxifen*/adverse effects;Young Adult
25475096;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*
25472767;Animals;Coix*;Cytochrome P-450 Enzyme Inducers/isolation & purification;Cytochrome P-450 Enzyme Inducers/metabolism;Cytochrome P-450 Enzyme Inducers/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/isolation & purification;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions/physiology;Male;Rats;Rats, Sprague-Dawley
25451570;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Inhibitors/chemistry;Herb-Drug Interactions;Humans;Kinetics
25447838;Animals;Apigenin/pharmacology*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism*;Cytochrome P450 Family 2;Cytochromes/metabolism;Herb-Drug Interactions;Liver/drug effects;Liver/enzymology;Male;Midazolam/pharmacokinetics*;Phenacetin/pharmacokinetics*;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Steroid 16-alpha-Hydroxylase/metabolism;Tolbutamide/pharmacokinetics*
25428336;Biomedical Research/legislation & jurisprudence*;Clinical Trials as Topic;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Humans;Plants, Medicinal/adverse effects;United States
25413939;Aged;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Female;Herb-Drug Interactions;Humans;Paroxetine/adverse effects*;Paroxetine/therapeutic use*;Phytotherapy*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use*;Rhodiola*;Self Medication;Serotonin Syndrome/chemically induced*;Serotonin Syndrome/diagnosis*;Serotonin Syndrome/psychology;Somatoform Disorders/diagnosis;Somatoform Disorders/drug therapy*;Somatoform Disorders/psychology
25408261;Adolescent;Adult;Asian Continental Ancestry Group*;Biological Availability;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Fruit;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Young Adult
25392581;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Diclofenac/metabolism;Euphorbiaceae;Herb-Drug Interactions*;Humans;Hydroxylation;Liliaceae;Magnoliopsida;Mephenytoin/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pharmaceutical Preparations/metabolism*;Phenacetin/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal*;South Africa;Testosterone/metabolism
25377539;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biocatalysis/drug effects;Cell Death/drug effects;Cell Survival/drug effects;Cytochrome P-450 CYP1A2/genetics*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Echinacea/chemistry*;Genes, Reporter;Hep G2 Cells;Herb-Drug Interactions;Humans;Luciferases/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptors, Steroid/metabolism*;Time Factors;Transcriptional Activation/drug effects;Transcriptional Activation/genetics;Up-Regulation/drug effects*
25343287;Administration, Oral;Amlodipine/administration & dosage;Amlodipine/pharmacokinetics*;Animals;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Half-Life;Herb-Drug Interactions*;Hypertension/drug therapy;Male;Panax/chemistry*;Rats;Rats, Sprague-Dawley;Republic of Korea;Tandem Mass Spectrometry
25339463;Administration, Oral;Animals;Cisplatin/administration & dosage;Cisplatin/blood;Cisplatin/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions*;Injections, Intraperitoneal;Male;Mass Spectrometry;Medicine, Chinese Traditional*;Rats, Sprague-Dawley;Spectrophotometry, Atomic;Ultrafiltration
25336552;Adrenergic alpha-2 Receptor Antagonists/pharmacology*;Antihypertensive Agents/therapeutic use*;Blood Pressure/drug effects;Clonidine/therapeutic use;Emergencies*;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Labetalol/therapeutic use;Male;Middle Aged;Yohimbine/pharmacology*
25319228;Adult;Anti-Anxiety Agents/adverse effects;Anti-Anxiety Agents/pharmacology*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Oral, Combined/pharmacokinetics;Contraceptives, Oral, Combined/pharmacology;Cross-Over Studies;Double-Blind Method;Drug Therapy, Combination;Endometrium/drug effects;Estradiol/blood;Ethinyl Estradiol/adverse effects;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology*;Female;Herb-Drug Interactions;Humans;Levonorgestrel/adverse effects;Levonorgestrel/pharmacokinetics*;Levonorgestrel/pharmacology*;Oils, Volatile/adverse effects;Oils, Volatile/pharmacology*;Ovarian Follicle/drug effects;Patient Compliance;Plant Oils/adverse effects;Plant Oils/pharmacology*;Progesterone/blood;Sex Hormone-Binding Globulin/drug effects;Young Adult
25312732;Cardiovascular Agents/adverse effects*;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Herb-Drug Interactions*;Humans;Nadolol/pharmacokinetics;Simvastatin/pharmacokinetics;Tea/adverse effects*;Warfarin/pharmacology
25307559;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Humans;Risk Assessment
25297453;ATP Binding Cassette Subfamily B Member 11;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/metabolism;Animals;Blood Proteins/metabolism;Female;Ginsenosides/pharmacokinetics*;HEK293 Cells;Herb-Drug Interactions*;Humans;Kidney/metabolism;Liver/metabolism;Male;Multidrug Resistance-Associated Proteins/metabolism;Neoplasm Proteins/metabolism;Organic Anion Transporters/genetics;Organic Anion Transporters, Sodium-Independent/genetics;Rats, Sprague-Dawley;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1
25286744;Administration, Oral;Adult;Cross-Over Studies;Cytochrome P-450 CYP2C19/genetics*;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A Inducers/administration & dosage*;Drug Administration Schedule;Enzyme Induction;Female;Genotype;Germany;Healthy Volunteers;Herb-Drug Interactions*;Humans;Hypericum*;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Pharmacogenetics;Phenotype;Phenylpropionates/administration & dosage;Phenylpropionates/blood;Phenylpropionates/pharmacokinetics*;Plant Extracts/administration & dosage*;Pyridazines/administration & dosage;Pyridazines/blood;Pyridazines/pharmacokinetics*
25256597;Animals;Apigenin/administration & dosage;Apigenin/isolation & purification;Apigenin/pharmacology*;Area Under Curve;Erigeron/chemistry;Glucuronates/administration & dosage;Glucuronates/isolation & purification;Glucuronates/pharmacology*;Herb-Drug Interactions*;Inhibitory Concentration 50;Male;Microsomes, Liver/metabolism;Platelet Aggregation Inhibitors/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
25243874;Administration, Oral;Animals;Area Under Curve;Dogs;Herb-Drug Interactions*;Lepidium sativum/chemistry*;Male;Nigella sativa/chemistry*;Plant Preparations/pharmacology*;Seeds/chemistry;Theophylline/blood;Theophylline/pharmacokinetics*;Trigonella/chemistry*
25233607;Animals;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plants, Medicinal/chemistry*;Warfarin/adverse effects*;Warfarin/pharmacology
25230280;4-Hydroxycoumarins/administration & dosage;4-Hydroxycoumarins/adverse effects*;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Curcuma/adverse effects*;Female;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Indenes/administration & dosage;Indenes/adverse effects*;International Normalized Ratio;Middle Aged;Mitral Valve Insufficiency/drug therapy*;Phenindione/administration & dosage;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Vitamin K/administration & dosage;Vitamin K/adverse effects;Vitamin K/antagonists & inhibitors*
25224345;Administration, Oral;Amiodarone/administration & dosage;Amiodarone/blood;Amiodarone/metabolism;Amiodarone/pharmacokinetics*;Animals;Biological Availability;Carica/chemistry*;Fruit/chemistry;Herb-Drug Interactions*;Injections, Intravenous;Male;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar
25218322;Animals;Benzofurans/chemistry;Cerebrospinal Fluid/metabolism;Diterpenes, Abietane/chemistry;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics*;Ear, Inner;Ginsenosides/chemistry;Guinea Pigs;Herb-Drug Interactions/physiology;Medicine, Chinese Traditional/methods;Panax notoginseng/chemistry;Salvia miltiorrhiza/chemistry
25216634;Animals;Benzofurans/metabolism*;Benzofurans/pharmacology;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/pharmacology;Colon/drug effects;Colon/metabolism*;Coumarins/metabolism*;Coumarins/pharmacology;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Male;Mice;Mice, 129 Strain
25212027;Alkaloids/pharmacology;Coumarins/pharmacology;Flavonoids/pharmacology;Fruit/chemistry;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Morus/chemistry*;Plant Extracts/pharmacology*;Plant Leaves/chemistry;Plant Roots/chemistry;Steroids/pharmacology
25197954;Cell Line, Tumor;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP2C9 Inhibitors/chemistry;Cytochrome P-450 CYP2C9 Inhibitors/isolation & purification;Cytochrome P-450 CYP2C9 Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Isothiocyanates/chemistry;Isothiocyanates/isolation & purification;Isothiocyanates/pharmacology*;RNA, Messenger/metabolism;Receptors, Cytoplasmic and Nuclear/genetics;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/genetics;Receptors, Steroid/metabolism
25196644;Caffeic Acids/pharmacology*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Oxidation-Reduction;Quercetin/pharmacology*
25166453;Dietary Supplements/adverse effects*;Drug Interactions;Estrogen Replacement Therapy/adverse effects;Estrogens/blood;Estrogens/therapeutic use*;Female;Herb-Drug Interactions*;Humans;Melatonin/administration & dosage;Melatonin/blood;Minerals/administration & dosage;Minerals/metabolism;Vitamins/administration & dosage
25158128;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Plants, Medicinal/adverse effects*
25156015;Andrographis/adverse effects*;Andrographis/chemistry;Animals;Cytochrome P-450 Enzyme Inducers/adverse effects*;Cytochrome P-450 Enzyme Inducers/isolation & purification;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/isolation & purification;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Diterpenes/adverse effects*;Diterpenes/isolation & purification;Enzyme Induction;Herb-Drug Interactions*;Humans;Isoenzymes;Liver/drug effects*;Liver/enzymology;Phytotherapy;Plant Extracts/adverse effects*;Plant Extracts/isolation & purification;Plants, Medicinal;Risk Assessment
25153228;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/pharmacology;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism*;Plant Preparations/metabolism*;Plant Preparations/pharmacology;Tamoxifen/metabolism*;Tamoxifen/pharmacology
25141924;Animals;Breast Neoplasms/drug therapy*;Breast Neoplasms/genetics;Breast Neoplasms/pathology*;Cell Transformation, Neoplastic/drug effects*;Cyclin-Dependent Kinase Inhibitor p27/metabolism;Disease Models, Animal;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Luciferases/metabolism;MCF-7 Cells;Mice, Inbred BALB C;Mice, Nude;Microtubule-Associated Proteins/metabolism;Neoplasm Transplantation;Phenols/administration & dosage*;Phenols/adverse effects*;Phenols/pharmacology;Tamoxifen/administration & dosage*;Tamoxifen/adverse effects*;Tamoxifen/pharmacology
25138353;Anti-Retroviral Agents;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/biosynthesis*;Enzyme Induction/drug effects;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Papua New Guinea;Plant Extracts/pharmacology*;Plants, Medicinal*;Receptors, Aryl Hydrocarbon/metabolism;Receptors, Steroid/metabolism
25137576;Alnus/chemistry*;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/chemistry;Antineoplastic Agents, Phytogenic/pharmacology;Antioxidants/chemistry;Antioxidants/pharmacology*;Cell Death/drug effects;Cell Line;Cell Line, Tumor;Cell Proliferation/drug effects;Diarylheptanoids/chemistry;Diarylheptanoids/isolation & purification;Diarylheptanoids/pharmacology*;Doxorubicin/analysis;Doxorubicin/metabolism;Herb-Drug Interactions*;Humans;Mitochondria/drug effects;Mitochondria/ultrastructure;Neoplasms/drug therapy;Neoplasms/metabolism;Plant Bark/chemistry;Reactive Oxygen Species/metabolism;Superoxide Dismutase/genetics;Superoxide Dismutase/metabolism
25099385;Animals;Aryl Hydrocarbon Hydroxylases/analysis;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P450 Family 2;Dose-Response Relationship, Drug;Ferula/adverse effects*;Gene Expression/drug effects*;Herb-Drug Interactions*;Liver/metabolism*;Male;Microsomes, Liver/metabolism;Nigella sativa/adverse effects*;Rats;Steroid 16-alpha-Hydroxylase/analysis;Steroid 16-alpha-Hydroxylase/biosynthesis*;Steroid 16-alpha-Hydroxylase/genetics;Tolbutamide/metabolism;Trigonella/adverse effects*
25091987;Apoptosis/drug effects;Cell Proliferation/drug effects;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/pathology;Dose-Response Relationship, Drug;Fluorouracil/administration & dosage*;HCT116 Cells;HT29 Cells;Herb-Drug Interactions*;Humans;Malaysia;Phytotherapy*;Piper betle*;Plant Extracts/administration & dosage;Plant Leaves
25091466;Animals;Antidepressive Agents/blood;Antidepressive Agents/pharmacokinetics;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics;Isoenzymes/genetics;Isoenzymes/metabolism;Lignans/blood;Lignans/pharmacokinetics;Lignans/pharmacology;Male;Medicine, Chinese Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Rats, Sprague-Dawley;Schisandra*;Sertraline/blood;Sertraline/pharmacokinetics;Tacrolimus/blood;Tacrolimus/pharmacokinetics
25063588;Aged;Aged, 80 and over;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plants, Medicinal
25052959;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism*;Glucuronosyltransferase/metabolism;Hepatocytes/drug effects;Hepatocytes/enzymology*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Lonicera/chemistry;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Sepsis/drug therapy*;Tandem Mass Spectrometry
25048609;Adult;Aged;Antineoplastic Agents, Hormonal/adverse effects*;Breast Neoplasms/diagnosis;Breast Neoplasms/drug therapy*;Breast Neoplasms/epidemiology;Databases, Factual;Drugs, Chinese Herbal/adverse effects*;Endometrial Neoplasms/chemically induced*;Endometrial Neoplasms/diagnosis;Endometrial Neoplasms/epidemiology;Endometrial Neoplasms/prevention & control;Female;Herb-Drug Interactions*;Humans;Logistic Models;Medicine, Chinese Traditional*;Middle Aged;Odds Ratio;Phytotherapy;Plants, Medicinal;Proportional Hazards Models;Protective Factors;Risk Assessment;Risk Factors;Taiwan/epidemiology;Tamoxifen/adverse effects*;Young Adult
25044854;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors*;ATP-Binding Cassette Transporters/genetics;Antineoplastic Agents/chemistry;Biological Availability;Breast Neoplasms/metabolism;Drug Resistance, Neoplasm;Female;Flavanones/chemistry;Flavonoids/chemistry*;Gene Expression Regulation, Neoplastic*;HEK293 Cells;Herb-Drug Interactions;Humans;Humulus/chemistry*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Mitoxantrone/chemistry;Neoplasm Proteins/antagonists & inhibitors*;Neoplasm Proteins/genetics;Phytoestrogens/chemistry;Propiophenones/chemistry;Xanthones/chemistry;Xenobiotics/chemistry
25042570;Administration, Oral;Animals;Area Under Curve;Bridged-Ring Compounds/blood;Bridged-Ring Compounds/pharmacokinetics*;Chromatography, High Pressure Liquid/methods*;Drug Stability;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry;Female;Glucosides/blood;Glucosides/pharmacokinetics*;Half-Life;Herb-Drug Interactions;Isomerism;Limit of Detection;Male;Monoterpenes/blood;Monoterpenes/pharmacokinetics*;Paeonia/chemistry;Rats, Sprague-Dawley;Reproducibility of Results;Tandem Mass Spectrometry/methods*
25039536;Aged, 80 and over;China/epidemiology;Chronic Disease/drug therapy*;Chronic Disease/epidemiology;Cognition Disorders/drug therapy;Cross-Sectional Studies;Drugs, Chinese Herbal/therapeutic use;Educational Status;Female;Herb-Drug Interactions;Humans;Hypertension/drug therapy;Male;Medicine, Chinese Traditional;Neoplasms/drug therapy;Odds Ratio;Osteoarthritis/drug therapy;Polypharmacy*;Prevalence;Respiratory Insufficiency/drug therapy;Rural Population/statistics & numerical data*;Surveys and Questionnaires
25039191;Achyranthes/chemistry*;Animals;Chalcone/administration & dosage;Chalcone/analogs & derivatives*;Chalcone/blood;Chalcone/pharmacokinetics;Chlorogenic Acid/administration & dosage;Chlorogenic Acid/blood;Chlorogenic Acid/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Glucosides/administration & dosage;Glucosides/blood;Glucosides/pharmacokinetics*;Glycosides/administration & dosage;Glycosides/blood;Glycosides/pharmacokinetics*;Glycyrrhizic Acid/administration & dosage;Glycyrrhizic Acid/pharmacokinetics*;Herb-Drug Interactions;Male;Pyrans/administration & dosage;Pyrans/blood;Pyrans/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
25034211;Animals;Cimetidine/pharmacokinetics*;Furosemide/blood;Furosemide/pharmacokinetics*;HEK293 Cells;Herb-Drug Interactions*;Humans;Male;Organic Cation Transport Proteins/antagonists & inhibitors*;Organic Cation Transport Proteins/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley
25029715;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use*;Contraindications;Diet*;Drug-Related Side Effects and Adverse Reactions/prevention & control*;Herb-Drug Interactions;Humans;Vegetables/adverse effects*;Warfarin/adverse effects*;Warfarin/therapeutic use*
25028567;Caffeine/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Dietary Supplements/analysis;Female;Herb-Drug Interactions;Humans;Male;Midazolam/pharmacokinetics;Milk Thistle/chemistry*;Plant Extracts/pharmacology*;Silymarin/analogs & derivatives;Silymarin/blood;Tolbutamide/pharmacokinetics;Young Adult
25026340;Dose-Response Relationship, Drug;Gallic Acid/administration & dosage;Gallic Acid/isolation & purification;Gallic Acid/pharmacology*;HEK293 Cells;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Oleanolic Acid/administration & dosage;Oleanolic Acid/isolation & purification;Oleanolic Acid/pharmacology*;Organic Anion Transporters/antagonists & inhibitors;Organic Cation Transport Proteins/antagonists & inhibitors;Punicaceae/chemistry*;Triterpenes/administration & dosage;Triterpenes/isolation & purification;Triterpenes/pharmacology*
25001901;8-Bromo Cyclic Adenosine Monophosphate/analogs & derivatives;8-Bromo Cyclic Adenosine Monophosphate/pharmacology;Adenosine Diphosphate/pharmacology*;Adenosine Triphosphate/metabolism;Blood Platelets/drug effects;Blood Platelets/metabolism;Calcium/metabolism;Calcium Signaling/drug effects*;Cell Adhesion Molecules/metabolism*;Cordyceps/chemistry;Cyclic AMP/metabolism;Cyclooxygenase 1/metabolism;Deoxyadenosines/pharmacology*;Dose-Response Relationship, Drug;Fibrinogen/metabolism*;Herb-Drug Interactions;Humans;Inositol 1,4,5-Trisphosphate Receptors/metabolism*;Microfilament Proteins/metabolism*;Phosphoproteins/metabolism*;Phosphorylation/drug effects;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/pharmacology;Thionucleotides/pharmacology;Thromboxane A2/metabolism;Thromboxane-A Synthase/metabolism
24997313;Animals;Blueberry Plants/chemistry;Butanones/pharmacology;Camptothecin/administration & dosage;Camptothecin/analogs & derivatives;Camptothecin/pharmacokinetics;Chromatography, Liquid;Fruit/chemistry*;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/genetics*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Ketones/pharmacology*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Rubus/chemistry;Sambucus/chemistry;Tandem Mass Spectrometry;Vaccinium macrocarpon/chemistry;Vaccinium myrtillus/chemistry
24992495;Animals;Area Under Curve;Commiphora/chemistry*;Herb-Drug Interactions/physiology;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry*;Rabbits;Theophylline/pharmacokinetics*;Theophylline/pharmacology
24990552;Animals;Coleus*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacology*;Liver/enzymology*;Male;Mumps Vaccine;Plant Extracts/adverse effects*;Plant Extracts/pharmacology*;Rats, Wistar;Tolbutamide/pharmacology*
24981811;Aged;Creatinine/blood;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male;Peumus*;Phytotherapy;Tacrolimus/pharmacokinetics*;Transplant Recipients;Transplantation, Homologous
24969526;Animals;Antioxidants/metabolism;Antioxidants/pharmacology*;Catalase/metabolism*;Cytochrome P-450 CYP2E1/metabolism*;Cytosol;Drugs, Chinese Herbal/pharmacology*;Glutathione/metabolism*;Glutathione Transferase/metabolism*;Herb-Drug Interactions;Inactivation, Metabolic/drug effects;Liver/drug effects*;Liver/enzymology;Male;Microsomes;Rats, Sprague-Dawley
24969391;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Probiotics/adverse effects*;Probiotics/therapeutic use;Renal Insufficiency, Chronic/drug therapy*;Treatment Outcome
24961584;Animals;Area Under Curve;Biological Availability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Liver/drug effects;Liver/metabolism;Male;Nifedipine/administration & dosage;Nifedipine/metabolism;Nifedipine/pharmacokinetics*;Rats, Wistar
24956073;Antidepressive Agents/therapeutic use;Herb-Drug Interactions*;Humans;Hypericum*;Phytotherapy/adverse effects*;Phytotherapy/methods*;Plant Extracts/administration & dosage*;Plant Extracts/adverse effects*;Prescriptions;Retrospective Studies;United States
24933226;Administration, Oral;Animals;Cytochrome P-450 Enzyme Inducers/administration & dosage;Cytochrome P-450 Enzyme Inducers/pharmacology;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics*;Diterpenes, Kaurane/administration & dosage;Diterpenes, Kaurane/pharmacology*;Dose-Response Relationship, Drug;Gene Expression Regulation, Enzymologic/drug effects*;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred C57BL;RNA, Messenger/metabolism
24929108;Animals;Diabetes Mellitus/drug therapy*;Ethnopharmacology;Herb-Drug Interactions;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacology;Hypoglycemic Agents/therapeutic use;Medicine, African Traditional;Nigeria;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*
24922060;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Caco-2 Cells;Cardiotonic Agents/blood*;Digoxin/blood;Drugs, Chinese Herbal/pharmacology*;Ginsenosides/blood*;Herb-Drug Interactions*;Humans;Rats
24892506;Attitude of Health Personnel*;Complementary Therapies/adverse effects;Complementary Therapies/standards*;England;Evidence-Based Practice/standards*;General Practitioners/psychology*;General Practitioners/standards;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Interviews as Topic;Patient Harm/prevention & control*;Qualitative Research;Referral and Consultation/standards;Social Class
24872678;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Bile/metabolism;Biological Transport;Dogs;Drug Interactions;Herb-Drug Interactions*;Humans;Intestinal Absorption;Madin Darby Canine Kidney Cells;Male;Organic Anion Transporters/physiology*;Rats;Rats, Sprague-Dawley;Saponins/pharmacokinetics*
24851484;Anticholesteremic Agents/adverse effects*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Back Pain/chemically induced;Back Pain/etiology*;Beverages/adverse effects*;Fruit*;Heptanoic Acids/adverse effects*;Heptanoic Acids/therapeutic use;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Male;Middle Aged;Pyrroles/adverse effects*;Pyrroles/therapeutic use;Vaccinium macrocarpon*
24850941;Aromatherapy*/adverse effects;Curriculum;Education, Pharmacy/methods*;Educational Measurement;Herb-Drug Interactions;Humans;Medication Errors/prevention & control;Oils, Volatile/adverse effects;Oils, Volatile/therapeutic use*;Problem-Based Learning;Program Evaluation;Surveys and Questionnaires;Teaching/methods*
24831257;Animals;Biological Transport/drug effects;HIV Infections/drug therapy;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Pharmaceutical Preparations/metabolism;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry
24824478;Beverages;Chrysanthemum;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Glycyrrhiza;Herb-Drug Interactions*;Houttuynia;Humans;Magnoliopsida*;Sirolimus/pharmacokinetics*;Taraxacum
24811814;Animals;Diabetes Mellitus, Type 2/drug therapy;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacokinetics*;Male;Medicine, Chinese Traditional*;Rats;Rats, Wistar;Rehmannia*;Thiazolidinediones/pharmacokinetics*
24797776;Dietary Supplements*;Drug Interactions*;Herb-Drug Interactions*;Humans;Internet;Phytotherapy*
24780924;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Lamivudine/administration & dosage;Lamivudine/pharmacokinetics*;Liver/metabolism;Male;Microdialysis/methods*;Rats;Rats, Sprague-Dawley;Tissue Distribution
24779639;Acetic Acid/chemistry;Animals;Bupleurum/chemistry;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Isoenzymes/metabolism;Male;Mice;Microsomes, Liver;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Saponins/pharmacology*;Time Factors
24769006;Benzofurans/pharmacology*;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP2C9 Inhibitors/pharmacology;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Tandem Mass Spectrometry
24761606;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Transport/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal*/isolation & purification;Drugs, Chinese Herbal*/pharmacokinetics;Drugs, Chinese Herbal*/pharmacology;Evidence-Based Medicine/methods;Gastrointestinal Tract/drug effects;Herb-Drug Interactions*;Humans;Kidney/drug effects;Medicine, Chinese Traditional;Pharmacokinetics*;Phytotherapy;Plants, Medicinal/chemistry*
24747521;Animals;Chromatography, Liquid/methods*;Digoxin/blood*;Digoxin/pharmacokinetics;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics;Ginkgo biloba/chemistry*;Herb-Drug Interactions;Male;Plant Leaves/chemistry;Rats;Rats, Wistar;Spectrometry, Mass, Electrospray Ionization/methods*
24741187;Animals;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/toxicity*;Free Radicals/metabolism;Gentamicins/pharmacology;Gentamicins/toxicity*;Herb-Drug Interactions;Kidney/drug effects*;Kidney/metabolism;Kidney/pathology;Kidney Diseases/blood;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Kidney Diseases/urine;Kidney Function Tests;Male;Mentha piperita/chemistry*;Microbial Sensitivity Tests;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/therapeutic use*;Rabbits
24736980;Animals;Biological Transport;Drugs, Chinese Herbal/pharmacology*;Genotype;HEK293 Cells;Hepatocytes/drug effects*;Hepatocytes/metabolism*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Kinetics;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Phenotype;Polymorphism, Genetic;Rats;Rosuvastatin Calcium/metabolism*;Triterpenes/pharmacology*
24735758;Biological Availability;Caco-2 Cells/drug effects*;Cell Survival;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions*;Humans;Intestinal Absorption
24730468;Aryl Hydrocarbon Hydroxylases/metabolism*;Camellia sinensis*;Complementary Therapies;Coumarins/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Milk Thistle/chemistry*;Plant Extracts/pharmacology*;Silymarin/pharmacology;Tolbutamide/metabolism*
24719213;Animals;Area Under Curve;Dogs;Herb-Drug Interactions*;Lepidium sativum*;Male;Nigella sativa*;Piperazines/pharmacokinetics*;Purines/pharmacokinetics;Sildenafil Citrate;Sulfonamides/pharmacokinetics*;Trigonella*
24710903;Animals;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use;Cell Survival/drug effects;Citrus/chemistry*;Flavanones/pharmacology*;Flavanones/therapeutic use;Fruit/chemistry*;Herb-Drug Interactions;Lycopersicon esculentum/chemistry*;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
24710899;Administration, Intravenous;Administration, Oral;Animals;Area Under Curve;Biological Availability;Buspirone/pharmacokinetics*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Isoflavones/chemistry;Isoflavones/isolation & purification;Isoflavones/pharmacology*;Liver/drug effects;Liver/enzymology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Plant Roots/chemistry;Pueraria/chemistry*;Rats;Rats, Sprague-Dawley
24704041;Animals;Biomarkers/urine;Creatinine/urine;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Glycyrrhiza/chemistry*;Herb-Drug Interactions*;Kidney/drug effects;Kidney Diseases/chemically induced;Kidney Diseases/urine;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Rhizome/chemistry*;Strychnine/adverse effects;Strychnine/analogs & derivatives*;Strychnos/adverse effects;Toxicokinetics;Uric Acid/urine
24690772;Alkenes/pharmacology*;Animals;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Microsomes, Liver/metabolism;Piperidines/pharmacology*;Rats
24686576;Acetaminophen/blood;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/pharmacology;Animals;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacology;Capsules;Diazepam/blood;Diazepam/pharmacokinetics;Diazepam/pharmacology*;Female;Herb-Drug Interactions*;Hypericum/chemistry*;Male;Mice;Motor Activity/drug effects;Pentobarbital/blood;Pentobarbital/pharmacokinetics;Pentobarbital/pharmacology*;Perylene/analogs & derivatives;Perylene/analysis;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Plants, Medicinal;Serbia;Solvents;Tablets
24679099;Angiogenesis Inhibitors/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antineoplastic Agents, Alkylating/therapeutic use;Bevacizumab;Brain Neoplasms/drug therapy*;Camptothecin/analogs & derivatives;Camptothecin/therapeutic use;Chemical and Drug Induced Liver Injury*/etiology;Combined Modality Therapy;Dacarbazine/analogs & derivatives*;Dacarbazine/therapeutic use;Disease Progression;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Female;Glioblastoma/drug therapy*;Herb-Drug Interactions*;Humans;Liver/pathology*;Middle Aged;Phytotherapy/adverse effects
24657955;Dose-Response Relationship, Drug;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions*;Humans;Inpatients/statistics & numerical data*;Italy;Male;Nonprescription Drugs/adverse effects;Pharmacovigilance*;Phytotherapy/adverse effects*;Phytotherapy/statistics & numerical data;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects;Preoperative Period*;Risk Factors
24646483;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Complementary Therapies/adverse effects;Complementary Therapies/methods;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/pathology;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/adverse effects;Plant Preparations/pharmacology*
24642020;Administration, Oral;Animals;Anthraquinones/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage*;Hemostasis/drug effects;Hemostasis/physiology*;Herb-Drug Interactions/physiology*;Rabbits;Random Allocation;Time Factors
24631340;Andrographis*;Diterpenes/chemistry;Diterpenes/metabolism*;Enzyme Repression/drug effects;Glucuronosyltransferase/drug effects;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology
24612940;Adult;Arylamine N-Acetyltransferase/metabolism;Asian Continental Ancestry Group;Caffeine/administration & dosage;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Dextromethorphan/administration & dosage;Furocoumarins/pharmacology*;Healthy Volunteers;Herb-Drug Interactions;Herbal Medicine*;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Male;Medicine, Traditional*;Phytotherapy*;Plants, Medicinal/chemistry;Xanthine Oxidase/metabolism;Young Adult
24583869;Antimetabolites, Antineoplastic/adverse effects*;Antioxidants/pharmacology*;Caco-2 Cells;Catechin/analogs & derivatives*;Catechin/pharmacology;Herb-Drug Interactions;Humans;Hydrogen Peroxide/metabolism;Intestinal Mucosa/drug effects*;Intestinal Mucosa/immunology;Neoplasms/drug therapy;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reactive Oxygen Species/metabolism;Tegafur/adverse effects*;alpha-Defensins/genetics;alpha-Defensins/metabolism*
24575655;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Contraindications;Cytochrome P-450 Enzyme System/drug effects;Drug Monitoring;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Liver/metabolism;Phytotherapy*;Plant Extracts*/administration & dosage
26060475;Anti-HIV Agents/metabolism*;Area Under Curve;Dose-Response Relationship, Drug;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Flavanones/pharmacokinetics*;Flavanones/pharmacology;Herb-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/metabolism*;Predictive Value of Tests;Reverse Transcriptase Inhibitors;Zidovudine/metabolism*;Zidovudine/pharmacology
24566323;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bacopa/chemistry;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions;Humans;Inactivation, Metabolic;Microsomes, Liver/metabolism;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Saponins/administration & dosage;Triterpenes/administration & dosage
24558885;Animals;Cordyceps/chemistry*;Diabetic Nephropathies/drug therapy*;Diabetic Nephropathies/metabolism;Diabetic Nephropathies/physiopathology;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions;Humans;Hyperglycemia/drug therapy*;Hyperglycemia/metabolism;Hyperglycemia/physiopathology;Kidney/drug effects*;Kidney/injuries;Kidney/physiopathology;Male;Metabolic Syndrome/drug therapy*;Metabolic Syndrome/metabolism;Metabolic Syndrome/physiopathology;Rats;Rats, Sprague-Dawley;Rhodiola/chemistry*;Rhus/chemistry*
24533823;Animals;Antibiotics, Antineoplastic/pharmacology;Antibiotics, Antineoplastic/therapeutic use;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Breast Neoplasms/drug therapy*;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Resistance, Multiple/drug effects;Drug Resistance, Neoplasm/drug effects*;Female;Herb-Drug Interactions*;Humans;Ligusticum/chemistry*;MCF-7 Cells;Mice;Mice, Inbred BALB C;Mice, Nude;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Pyrazines/pharmacology;Pyrazines/therapeutic use*
24533750;Adult;Attitude to Health*;Data Collection;Denmark;Female;Follow-Up Studies;Health Personnel;Herb-Drug Interactions*;Herbal Medicine;Humans;Interviews as Topic;Multiple Sclerosis*/drug therapy;Patient Satisfaction;Phytotherapy;Plant Extracts*/therapeutic use;Risk Assessment;Safety;Sensation*;Societies, Medical
24528618;Acupuncture Therapy;Animals;Arrhythmias, Cardiac/drug therapy;Arrhythmias, Cardiac/physiopathology;Arrhythmias, Cardiac/therapy*;Berberis;Cinchona;Complementary Therapies*;Crataegus;Drugs, Chinese Herbal/therapeutic use;Fatty Acids, Omega-3/therapeutic use;Herb-Drug Interactions;Humans;Leonurus;Phytotherapy;Treatment Outcome;Yoga
24525674;Animals;Antineoplastic Agents, Hormonal/administration & dosage;Antineoplastic Agents, Hormonal/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Cycle/drug effects;Cell Proliferation/drug effects;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;Humans;MCF-7 Cells;Mice;Mice, Inbred BALB C;Mice, Nude;Signal Transduction/drug effects;Tamoxifen/administration & dosage;Tamoxifen/pharmacology*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
24525006;Health Personnel;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*
24515579;Autopsy;Cause of Death;DNA, Plant/genetics*;Forensic Toxicology/methods*;Genetic Markers;Herb-Drug Interactions*;Humans;Metabolomics*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/analysis*;Plants, Medicinal*/adverse effects;Plants, Medicinal*/genetics;Plants, Medicinal*/metabolism;Sequence Analysis, DNA*
24510399;Adolescent;Adult;Biotransformation;Curcuma*/chemistry;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP2D6 Inhibitors/chemistry;Cytochrome P-450 CYP2D6 Inhibitors/isolation & purification;Cytochrome P-450 CYP2D6 Inhibitors/pharmacology*;Cytochrome P-450 CYP3A/metabolism*;Dealkylation;Dextromethorphan/analogs & derivatives;Dextromethorphan/pharmacokinetics*;Dextrorphan/pharmacokinetics;Dose-Response Relationship, Drug;Ethanol/chemistry;Healthy Volunteers;Herb-Drug Interactions*;Humans;Linear Models;Liver/drug effects*;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phytotherapy;Plant Extracts/chemistry;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plants, Medicinal;Powders;Rhizome;Saudi Arabia;Solvents/chemistry;Substrate Specificity;Young Adult
24498827;Animals;Dietary Supplements/adverse effects;Drug Interactions*;Food-Drug Interactions;Herb-Drug Interactions;Holistic Health*;Humans;Pharmacokinetics*;Polypharmacy
24493631;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Caco-2 Cells;Digoxin/metabolism*;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestines/microbiology;Male;Panax/chemistry*;Rats;Rats, Sprague-Dawley;Rhodamine 123/metabolism*
24492725;Biological Transport;Biological Transport, Active;Cations/metabolism;Cell Line;Diet;Food-Drug Interactions*;Furocoumarins/pharmacology;Ginkgo biloba/chemistry;HEK293 Cells;Herb-Drug Interactions*;Humans;Kidney/metabolism*;Liver/metabolism*;Organic Cation Transport Proteins/antagonists & inhibitors*;Plant Extracts/pharmacology*;Protons;Quercetin/analogs & derivatives;Quercetin/pharmacology;Tetraethylammonium/metabolism*;Xenobiotics/metabolism
24475926;Africa;Anti-HIV Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;HIV Infections/diagnosis;HIV Infections/drug therapy*;Herb-Drug Interactions*;High-Throughput Screening Assays;Humans;Isoenzymes;Phytotherapy;Plant Preparations/adverse effects*;Plants, Medicinal;Recombinant Proteins/metabolism;Risk Assessment;Risk Factors;Substrate Specificity
24472406;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/physiology;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A/physiology;Herb-Drug Interactions*;Humans;Hypericum*;Male;Middle Aged;Sulfonamides/pharmacokinetics*
24464299;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Plant Extracts/pharmacology*;Risk Assessment;Substrate Specificity
24452064;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Plants, Medicinal/adverse effects*
24427969;Chemical and Drug Induced Liver Injury;Dietary Supplements*/adverse effects;Food Safety*;Ginkgo biloba/adverse effects;Hawaii;Herb-Drug Interactions;Humans;Kava/adverse effects;United States
24420925;Animals;Cyclophosphamide/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Diterpenes/pharmacology*;Epoxy Compounds/pharmacology;Herb-Drug Interactions*;Hydroxytestosterones/metabolism;Immunosuppressive Agents/pharmacokinetics*;Injections, Intravenous;Ketoconazole/pharmacology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Rats, Sprague-Dawley
24399745;Clinical Trials as Topic;Dietary Supplements*/adverse effects;Female;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Plants, Medicinal/adverse effects;Pregnancy/drug effects*
24397864;Apoptosis/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Cisplatin/pharmacology;Cytostatic Agents/pharmacology;Deoxycytidine/analogs & derivatives;Deoxycytidine/pharmacology;Doxorubicin/pharmacology;Herb-Drug Interactions*;Humans;Male;Mitoxantrone/pharmacology;Neoplasms/drug therapy*;Neoplasms/pathology*;Plant Extracts/pharmacology*;Plant Extracts/standards*;Plants, Medicinal/chemistry;Taxoids/pharmacology;Viscum album/chemistry*
24387348;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents/pharmacokinetics*;Clinical Trials as Topic;Complementary Therapies/methods;Cytochrome P-450 Enzyme System/metabolism;Echinacea/chemistry;Garlic/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Neoplasms/drug therapy*;Panax/chemistry;Phytotherapy/methods*;Plant Preparations/pharmacokinetics*
24380838;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism*;Animals;Area Under Curve;Caco-2 Cells;Cell Line, Tumor;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Digoxin/administration & dosage;Diterpenes/adverse effects*;Emodin/adverse effects*;Ginsenosides/adverse effects*;Glycyrrhetinic Acid/adverse effects;Glycyrrhetinic Acid/analogs & derivatives*;Herb-Drug Interactions*;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/pathology;Protein Conformation;Rats;Verapamil/administration & dosage
24373810;Animals;Chalcone/analogs & derivatives*;Chalcone/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Dextromethorphan/blood;Dextromethorphan/pharmacokinetics;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Liver/drug effects;Liver/enzymology;Male;Midazolam/blood;Midazolam/pharmacokinetics;Phenacetin/blood;Phenacetin/pharmacokinetics;Quinones/pharmacology*;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
25954326;Dietary Supplements;Electronic Health Records*;Herb-Drug Interactions*;Humans;Knowledge Bases*;Medical Order Entry Systems*;Medication Errors/prevention & control;Risk Factors
24365638;Angelica sinensis/chemistry*;Animals;Asian Continental Ancestry Group;Clinical Trials as Topic/methods;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Europe;European Continental Ancestry Group;Female;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/methods*;Plant Roots
24365615;Beverages/adverse effects*;Chemistry, Clinical/standards*;Digoxin/analysis;Digoxin/blood*;Drug Monitoring/standards;False Positive Reactions;Female;Flavonoids/adverse effects*;Heart Failure/blood;Heart Failure/drug therapy*;Herb-Drug Interactions*;Hibiscus/chemistry;Humans;Rosa/chemistry
24344037;Adult;Aged;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Chi-Square Distribution;Female;Health Behavior*;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/therapy*;Patient Education as Topic;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Factors;Surveys and Questionnaires;Turkey;Young Adult
24335390;Animals;Computer Simulation;Drug Design;Drug Evaluation, Preclinical/methods;Drug Evaluation, Preclinical/trends;Government Regulation;Herb-Drug Interactions*;Humans;Legislation, Drug;Milk Thistle/chemistry;Models, Biological;Pharmaceutical Preparations/chemistry*;Pharmaceutical Preparations/metabolism;Pharmaceutical Preparations/standards;Pharmacokinetics*;Plant Preparations/chemistry*;Plant Preparations/pharmacokinetics;Plant Preparations/standards;Silymarin/pharmacokinetics;Silymarin/pharmacology;Stilbenes/pharmacokinetics;Stilbenes/pharmacology
24325069;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/pharmacology*;Evaluation Studies as Topic;Herb-Drug Interactions*;Integrative Medicine*
24319132;Complementary Therapies/education*;Credentialing;Curriculum*;Education, Dental*;Faculty;Herb-Drug Interactions;Humans;Phytotherapy;Problem-Based Learning;Schools, Dental*;Teaching/methods;Time Factors;United States
24298594;Anticoagulants/adverse effects*;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Lycium*;Vitamin K/antagonists & inhibitors*
24291054;Aged;Aspirin/pharmacology;Aspirin/therapeutic use*;Cross-Over Studies;Diabetes Mellitus, Type 2/complications;Diabetic Angiopathies/prevention & control*;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Phyllanthus emblica*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Platelet Aggregation Inhibitors/pharmacology;Platelet Aggregation Inhibitors/therapeutic use*;Prospective Studies;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacology;Ticlopidine/therapeutic use
24252494;Animals;Area Under Curve;Chlorzoxazone/pharmacokinetics;Chlorzoxazone/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Escin/pharmacokinetics;Escin/pharmacology*;Gene Expression Regulation, Enzymologic/drug effects*;Half-Life;Herb-Drug Interactions;Hypnotics and Sedatives/pharmacokinetics;Hypnotics and Sedatives/pharmacology;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Liver/drug effects;Liver/enzymology;Male;Midazolam/pharmacokinetics;Midazolam/pharmacology;Muscle Relaxants, Central/pharmacokinetics;Muscle Relaxants, Central/pharmacology;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Tolbutamide/pharmacokinetics;Tolbutamide/pharmacology
24214834;Apiaceae/chemistry*;Coumarins/isolation & purification;Coumarins/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Hep G2 Cells;Herb-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/genetics;Multidrug Resistance-Associated Proteins/metabolism*;RNA, Messenger/metabolism;Real-Time Polymerase Chain Reaction;Receptors, Cytoplasmic and Nuclear/metabolism*;Transfection;Up-Regulation
24201019;Animals;Cytochrome P-450 Enzyme System/metabolism;Glycyrrhiza*/adverse effects;Glycyrrhiza*/toxicity;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional*;Membrane Transport Proteins/metabolism
24185586;Adult;Busulfan/pharmacokinetics*;Hematopoietic Stem Cell Transplantation/methods*;Herb-Drug Interactions*;Humans;Male;Transplantation Conditioning/methods*
24171723;Adult;Aged;Aged, 80 and over;Communication;Cross-Sectional Studies;Drug Therapy, Combination*/psychology;Female;Herb-Drug Interactions;Herbal Medicine;Humans;Male;Middle Aged;Norway;Patients/psychology*;Phytotherapy*/psychology;Plant Extracts/therapeutic use;Surveys and Questionnaires;Young Adult
24168107;Administration, Oral;Adult;Agaricales*/chemistry;Amines/administration & dosage;Amines/pharmacokinetics*;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics;Asian Continental Ancestry Group/genetics;China;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/pharmacokinetics*;Diet*;Ergothioneine/blood*;Genotype;Healthy Volunteers*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Organic Cation Transport Proteins/genetics;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/pharmacokinetics*
24163821;Developing Countries;Herb-Drug Interactions*;Herbal Medicine*;Humans;Pharmacy Administration*/legislation & jurisprudence;Pharmacy Administration*/methods;Pharmacy Administration*/standards;Pharmacy Administration*/trends;Phytotherapy/adverse effects*;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Plants, Medicinal/adverse effects*
24157377;Antineoplastic Agents/metabolism;Antineoplastic Agents/pharmacokinetics;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Gene Expression Regulation, Enzymologic;Hep G2 Cells;Herb-Drug Interactions;Humans;Marsdenia/chemistry*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Recombinant Proteins/genetics;Recombinant Proteins/metabolism
24155255;Absorption;Animals;Caco-2 Cells;Chromatography, High Pressure Liquid/methods;Computer Simulation;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Humans;Intestine, Small/metabolism;Male;Rats;Rats, Sprague-Dawley
24146513;Animals;Cinnamates/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Hypnotics and Sedatives/pharmacology;Liver/drug effects*;Liver/enzymology;Male;Medicine, Traditional;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Pentobarbital/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Sleep/drug effects*;Thailand;Zingiberaceae/chemistry
24146485;Cytochrome P-450 Enzyme System/metabolism*;Female;Herb-Drug Interactions*;Hibiscus*;Humans;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Plant Extracts/pharmacology*;Protein Isoforms/metabolism
24144799;Animals;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Liver/drug effects*;Liver/metabolism;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pharmaceutical Preparations/metabolism*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tripterygium/chemistry*;Triterpenes/pharmacology*
24142885;Adolescent;Adult;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Female;Healthy Volunteers;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Prothrombin Time;Warfarin/blood;Warfarin/pharmacokinetics*;Young Adult
24125938;Adult;Fatal Outcome;Herb-Drug Interactions;Humans;India;Male;Medicine, Traditional/adverse effects*;Phytotherapy/adverse effects*;Phytotherapy/methods;Pulmonary Embolism/chemically induced*;Self Care
24123182;Animals;Bornanes/administration & dosage;Bornanes/pharmacology*;Chromatography, Liquid;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry;Ginsenosides/blood*;Ginsenosides/chemistry;Ginsenosides/pharmacokinetics*;Herb-Drug Interactions*;Linear Models;Male;Mass Spectrometry;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sensitivity and Specificity
24118332;Antineoplastic Agents/therapeutic use*;Beverages/utilization;Communication;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Diet;Dietary Supplements/utilization;Drug Interactions;Drugs, Chinese Herbal/therapeutic use;Female;Health Services Needs and Demand*;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/therapy*;Patient Education as Topic*;Physician-Patient Relations;Radiotherapy*;Vitamins/therapeutic use
24114899;Animals;Blood Glucose/metabolism;Body Weight/physiology;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy;Drug Synergism;Garlic/chemistry*;Glucose Tolerance Test;Glyburide/pharmacology*;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Wistar
24074610;Diabetes Complications/drug therapy;Diabetes Mellitus/drug therapy*;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/therapeutic use*;Phytochemicals/therapeutic use*;Plant Extracts/therapeutic use*
24068654;Adult;Aged;Antidepressive Agents/pharmacology*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Herb-Drug Interactions*;Humans;Hypericum*;Male;Middle Aged;Plant Extracts/pharmacology*;Taxoids/adverse effects;Taxoids/blood;Taxoids/pharmacokinetics*
24022709;Animals;Carbamazepine/pharmacokinetics*;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Female;Herb-Drug Interactions*;Male;Rabbits;Substrate Specificity;Trigonella*
24005963;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Biphenyl Compounds/pharmacology*;Bupropion/metabolism;Drugs, Chinese Herbal/pharmacology;Enzyme Inhibitors/pharmacology*;Ethanolamines/metabolism;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions;Humans;Hydroxylation;Inactivation, Metabolic;Inhibitory Concentration 50;Lignans/pharmacology*;Liver/enzymology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Phenacetin/metabolism
24001154;Adult;Area Under Curve;Cross-Over Studies;Double-Blind Method;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Tetrazoles/adverse effects;Tetrazoles/metabolism;Tetrazoles/pharmacokinetics*;Tetrazoles/pharmacology
24000431;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*
24000430;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Risk Factors
23958198;Animals;Beverages*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit;Herb-Drug Interactions*;Humans;Vaccinium macrocarpon*
23957086;Attitude of Health Personnel;Herb-Drug Interactions;Herbal Medicine*/legislation & jurisprudence;Herbal Medicine*/methods;Humans;Phytotherapy/standards*;Plant Preparations/therapeutic use*;Prescriptions/standards
23920676;Consumer Health Information/classification*;Consumer Health Information/statistics & numerical data;Data Mining/methods;Drug-Related Side Effects and Adverse Reactions/classification*;Herb-Drug Interactions*;Humans;Internet/statistics & numerical data*;Meaningful Use/statistics & numerical data*;Phytotherapy/classification*;Prescription Drugs/classification*;Truth Disclosure
23920278;Animals;Area Under Curve;Camellia sinensis/chemistry*;Catechin/analogs & derivatives*;Catechin/pharmacology;Herb-Drug Interactions*;Intestinal Absorption;Male;Nadolol/blood;Nadolol/pharmacokinetics*;Nadolol/urine;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley
23920226;Acylation;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Caprylates/chemistry;Caprylates/pharmacology;Cinnamates/chemistry;Cinnamates/pharmacology;Cross Infection/microbiology;Escherichia coli/drug effects;Esterification;Flowers;Glycosides/chemistry;Glycosides/pharmacology;Herb-Drug Interactions;Ipomoea/chemistry*;Lactones/chemistry;Lactones/pharmacology*;Methicillin-Resistant Staphylococcus aureus/drug effects;Molecular Structure;Oligosaccharides/chemistry;Oligosaccharides/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Salmonella enterica/drug effects;Shigella flexneri/drug effects
23899130;Dioxoles/administration & dosage*;Herb-Drug Interactions*;Humans;Liposarcoma/drug therapy*;Male;Middle Aged;Photinia/chemistry;Plant Extracts/administration & dosage*;Rhabdomyolysis/etiology*;Tetrahydroisoquinolines/administration & dosage*
23897801;Antidepressive Agents/pharmacology;Antiviral Agents/pharmacology;Depression/drug therapy;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Perylene/analogs & derivatives;Perylene/pharmacokinetics;Phloroglucinol/analogs & derivatives;Phloroglucinol/pharmacokinetics;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry*;Terpenes/pharmacokinetics
23886819;Administration, Oral;Amiodarone/pharmacokinetics*;Animals;Area Under Curve;Body Weight;Citrus/chemistry*;Dose-Response Relationship, Drug;Fruit/chemistry*;Half-Life;Herb-Drug Interactions*;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar
23885542;Attitude to Health;Central Nervous System Agents/administration & dosage*;Central Nervous System Diseases/drug therapy*;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Risk Factors
23867078;Analgesics/chemistry;Analgesics/pharmacokinetics;Animals;Biological Availability;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Flavanones/analysis;Flavanones/pharmacokinetics*;Glucosides/analysis;Glucosides/pharmacokinetics*;Herb-Drug Interactions;Male;Parasympatholytics/chemistry;Parasympatholytics/pharmacokinetics;Pentacyclic Triterpenes/analysis;Pentacyclic Triterpenes/pharmacokinetics*;Rats;Rats, Wistar
23866810;Animals;Anti-Bacterial Agents/pharmacology*;Drug Synergism;Fruit;Garcinia mangostana/chemistry*;Herb-Drug Interactions;Humans;Leptospira/drug effects*;Leptospirosis/microbiology*;Microbial Sensitivity Tests;Penicillin G/pharmacology*;Plant Extracts/pharmacology*;Xanthones/pharmacology*
23865865;Animals;Dietary Supplements;Ginkgo biloba/chemistry*;Herb-Drug Interactions*;Humans;Phytotherapy/methods;Plant Extracts/pharmacokinetics*
23850985;Animals;Cell Line, Tumor;Cell Survival/drug effects;Cells, Cultured;Curcuma;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Humans;Mice;Microsomes, Liver/metabolism;RNA, Messenger/metabolism;Receptors, Aryl Hydrocarbon/metabolism;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/metabolism;Recombinant Proteins/genetics;Recombinant Proteins/metabolism;Sesquiterpenes/pharmacology*;Sesquiterpenes, Germacrane/pharmacology*
23844611;ATP-Binding Cassette Transporters/antagonists & inhibitors;Animals;Cytochrome P-450 Enzyme Inhibitors;Dogs;HEK293 Cells;Herb-Drug Interactions*;Humans;Hypoxis/chemistry*;In Vitro Techniques;LLC-PK1 Cells;Madin Darby Canine Kidney Cells;Medicine, African Traditional;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Pharmaceutical Preparations*;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Substrate Specificity;Swine
23843424;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Equisetum/chemistry;Female;Foeniculum/chemistry;Ginger/chemistry;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Pregnancy;Rosaceae/chemistry;Sambucus/chemistry;Tandem Mass Spectrometry;Vaccinium/chemistry
23835282;Binding, Competitive;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Dextromethorphan/metabolism;Drug Discovery;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacology*;Galactosides/metabolism;Galactosides/pharmacology;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Isoenzymes/metabolism;Kinetics;Methylation/drug effects;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Oenanthe/chemistry;Quercetin/analogs & derivatives*;Quercetin/metabolism;Quercetin/pharmacology;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism
23831483;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/therapeutic use;Biofilms/drug effects*;Cell Movement/drug effects;Ciprofloxacin/pharmacology*;Drug Resistance, Multiple/drug effects;Ginger/chemistry*;Guaiacol/analogs & derivatives*;Guaiacol/pharmacology;Guaiacol/therapeutic use;Herb-Drug Interactions;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Pseudomonas Infections/drug therapy;Pseudomonas Infections/microbiology*;Pseudomonas aeruginosa/drug effects*;Pseudomonas aeruginosa/pathogenicity;Pseudomonas aeruginosa/physiology
23828331;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Beta vulgaris*;Breast Neoplasms/drug therapy*;Cell Line, Tumor;Cell Survival/drug effects;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Combinations;Drug Synergism;Female;Herb-Drug Interactions;Humans;MCF-7 Cells;Male;Pancreatic Neoplasms/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Prostatic Neoplasms/drug therapy*
23820895;Adolescent;Adult;Age Factors;Attitude to Health*;Community Pharmacy Services;Consumer Product Safety*;Dietary Supplements/adverse effects*;Educational Status;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Male;Middle Aged;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Self Care/adverse effects*;Serbia;Surveys and Questionnaires;Young Adult
23813259;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations, Dental/adverse effects*;Phytotherapy/adverse effects;Risk Assessment
23807811;Administration, Oral;Animals;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Blood Coagulation/drug effects;Chromatography, Liquid;Curcuma/chemistry*;Curcumin/pharmacology*;Herb-Drug Interactions;Male;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Random Allocation;Rats;Rats, Wistar;Tandem Mass Spectrometry;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Warfarin/blood;Warfarin/pharmacokinetics*
23801821;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Milk Thistle/chemistry*;Plant Extracts/pharmacology*
23792897;Administration, Oral;Animals;Drugs, Chinese Herbal/administration & dosage*;Epimedium/chemistry*;Herb-Drug Interactions*;Male;Phosphodiesterase 5 Inhibitors/administration & dosage;Phosphodiesterase 5 Inhibitors/chemistry;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Piperazines/administration & dosage;Piperazines/chemistry;Piperazines/pharmacokinetics*;Plant Extracts/administration & dosage*;Plant Extracts/chemistry*;Purines/administration & dosage;Purines/chemistry;Purines/pharmacokinetics;Rats;Sildenafil Citrate;Sulfones/administration & dosage;Sulfones/chemistry;Sulfones/pharmacokinetics*
23794063;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/agonists;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Capsaicin/administration & dosage;Capsaicin/adverse effects;Capsaicin/analogs & derivatives*;Capsaicin/therapeutic use;Capsicum/chemistry;Carrageenan;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/agonists;Diclofenac/therapeutic use*;Disease Models, Animal*;Dose-Response Relationship, Drug;Edema/immunology;Edema/prevention & control*;Female;Fruit/chemistry;Herb-Drug Interactions;Injections, Intramuscular;Injections, Subcutaneous;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Extracts/therapeutic use*;Random Allocation;Rats;Rats, Wistar;Sensory System Agents/administration & dosage;Sensory System Agents/adverse effects;Sensory System Agents/chemistry;Sensory System Agents/therapeutic use*;Transdermal Patch/adverse effects
23791808;Administration, Oral;Animals;China;Chromatography, High Pressure Liquid;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Ethnopharmacology*;Herb-Drug Interactions;Iridoid Glucosides/administration & dosage;Iridoid Glucosides/blood;Iridoid Glucosides/isolation & purification;Iridoid Glucosides/pharmacokinetics*;Molecular Structure;Oleanolic Acid/administration & dosage;Oleanolic Acid/pharmacology*;Pyrones/administration & dosage;Pyrones/blood;Pyrones/isolation & purification;Pyrones/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Solid Phase Extraction;Spectrometry, Mass, Electrospray Ionization;Swertia/chemistry;Tablets
23774247;Animals;Drug Stability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Isoflavones/administration & dosage;Isoflavones/blood;Isoflavones/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Saponins/administration & dosage;Saponins/blood;Saponins/pharmacokinetics*;Spectrometry, Mass, Electrospray Ionization/methods;Tandem Mass Spectrometry/methods
23770559;Aged, 80 and over;Anticoagulants/adverse effects*;Artemisia absinthium*;Atrial Fibrillation/drug therapy;Female;Gastrointestinal Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Plant Preparations/adverse effects*;Warfarin/adverse effects*
23769935;Animals;Antineoplastic Agents, Phytogenic/chemistry;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Antioxidants/chemistry;Antioxidants/isolation & purification;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Biological Products/chemistry;Biological Products/pharmacology;Biological Products/therapeutic use*;Cisplatin/pharmacology;Cisplatin/therapeutic use;Fruiting Bodies, Fungal/chemistry;Ganoderma/chemistry*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Keratinocytes/drug effects*;Keratinocytes/radiation effects;Lanosterol/analogs & derivatives*;Lanosterol/chemistry;Lanosterol/isolation & purification;Lanosterol/pharmacology;Lanosterol/therapeutic use;Male;Molecular Structure;Phytotherapy;Prostatic Neoplasms/drug therapy*;Radiation Injuries, Experimental/drug therapy;Skin Diseases/prevention & control;Xanthine Oxidase/antagonists & inhibitors*
23765408;Adolescent;Antidiarrheals/administration & dosage;Antidiarrheals/blood;Antidiarrheals/pharmacokinetics*;Antidiarrheals/therapeutic use;Berberine/administration & dosage;Berberine/blood;Berberine/pharmacokinetics*;Berberine/therapeutic use;Creatinine/blood;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Nephrotic Syndrome/blood;Nephrotic Syndrome/drug therapy*;Nephrotic Syndrome/immunology;Tacrolimus/administration & dosage;Tacrolimus/blood;Tacrolimus/pharmacokinetics*;Tacrolimus/therapeutic use
23757385;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/metabolism*;Drug Interactions/physiology*;Everolimus;Food-Drug Interactions/physiology*;Herb-Drug Interactions/physiology*;Humans;Pharmacists*/standards;Sirolimus/administration & dosage;Sirolimus/analogs & derivatives*;Sirolimus/metabolism
23742857;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Acanthaceae/chemistry*;Antibodies/metabolism;Caco-2 Cells;Fluorescein;Fluoresceins/metabolism;Herb-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/metabolism*;Naphthoquinones/pharmacology*;Plant Extracts/pharmacology*
23738734;Animals;Area Under Curve;Chlorpheniramine/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Diclofenac/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Limit of Detection;Male;Rats;Rats, Wistar;Tandem Mass Spectrometry/methods;Tissue Distribution
23731657;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Biological Transport/drug effects;Brain/drug effects*;Brain/metabolism;Caco-2 Cells;Digoxin/metabolism;Herb-Drug Interactions*;Humans;Intestines/drug effects*;Intestines/metabolism;Lignans/pharmacology*;Plant Extracts/pharmacology*;Rats;Schisandra/chemistry*;Verapamil/pharmacology;Vincristine/metabolism
23725528;Analgesics/adverse effects;Analgesics/chemistry;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Antitussive Agents/adverse effects;Antitussive Agents/chemistry;Antitussive Agents/pharmacology;Antitussive Agents/therapeutic use;Dietary Supplements*/adverse effects;Ethnopharmacology;Evidence-Based Medicine*;Herb-Drug Interactions;Humans;Mitragyna/adverse effects;Mitragyna/chemistry*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Plant Leaves/adverse effects;Plant Leaves/chemistry*;Psychotropic Drugs/adverse effects;Psychotropic Drugs/chemistry;Psychotropic Drugs/pharmacology;Psychotropic Drugs/therapeutic use;Secologanin Tryptamine Alkaloids/analysis
23722570;Animals;China;Drugs, Chinese Herbal/classification*;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/toxicity*;Herb-Drug Interactions;Humans;Materia Medica/classification*;Materia Medica/pharmacology;Materia Medica/toxicity*;Medicine, Chinese Traditional
23722257;Animals;Chromatography, Liquid/methods*;Drug Stability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Imidazoles/blood;Imidazoles/pharmacokinetics*;Losartan/administration & dosage;Losartan/blood;Losartan/pharmacokinetics*;Male;Mass Spectrometry/methods*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Salvia miltiorrhiza;Sensitivity and Specificity;Tetrazoles/blood;Tetrazoles/pharmacokinetics*
23702042;Animals;Apiaceae/chemistry*;Cell Line;Coumarins/chemistry;Coumarins/pharmacology*;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Gene Expression/drug effects;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Humans;Male;Medicine, Chinese Traditional/methods;Membrane Proteins/genetics*;Membrane Proteins/metabolism;Mice;Mice, Inbred BALB C;Plant Extracts/chemistry;Plant Extracts/pharmacology*;RNA, Messenger/genetics;Receptors, Steroid/genetics;Receptors, Steroid/metabolism*;Transcriptional Activation;Up-Regulation/drug effects
23695160;Antineoplastic Agents/adverse effects;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Antioxidants/pharmacology;Drug Interactions;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/utilization;Plants, Medicinal*/adverse effects;Risk Assessment
23677886;Animals;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics;Herb-Drug Interactions;Humans;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics;Plant Roots*/chemistry;Pueraria*
23671711;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Risk Factors
23628674;Animals;Capsules;Cytochrome P-450 CYP3A Inhibitors;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Immunosuppressive Agents/pharmacokinetics*;Male;Medicine, Chinese Traditional*;Rats;Rats, Sprague-Dawley;Tacrolimus/pharmacokinetics*
23594788;Animals;Biomarkers/metabolism;Cell Line;Cyclosporine/adverse effects*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects*;Kidney Diseases/chemically induced;Kidney Diseases/drug therapy*;Kidney Diseases/pathology;Male;Mice;Oxidative Stress/drug effects*;Panax*;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Random Allocation
23590720;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Area Under Curve;Biological Availability;Cell Line, Tumor;Cell Survival/drug effects;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dose-Response Relationship, Drug;Fruit/chemistry;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics;Male;Morus/chemistry*;Polyphenols/administration & dosage;Polyphenols/pharmacology*;Rats;Rats, Sprague-Dawley
23583485;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2B6;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Gynostemma;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Inhibitory Concentration 50;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology
23582408;Administration, Oral;Animals;Berberine/adverse effects;Berberine/pharmacokinetics;Berberine/therapeutic use*;Cinnamomum aromaticum/chemistry;Diabetes Mellitus, Experimental/drug therapy*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Hypoglycemic Agents/chemistry;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Mice;Phytotherapy;Random Allocation
23249852;Animals;Antiviral Agents/metabolism*;Antiviral Agents/pharmacokinetics;Antiviral Agents/therapeutic use;Carboxylesterase/metabolism;Cell Death/drug effects;Cells, Cultured;Drugs, Chinese Herbal/pharmacology*;Drugs, Chinese Herbal/therapeutic use;Enzyme Activation/drug effects;Glutathione/metabolism;Herb-Drug Interactions*;Humans;Influenza A Virus, H5N1 Subtype*;Influenza, Human/drug therapy*;Lonicera;Oseltamivir/metabolism*;Oseltamivir/pharmacokinetics;Oseltamivir/therapeutic use;Perilla frutescens;Phytotherapy*;Rats
23538078;Cerebrovascular Disorders/drug therapy*;Dementia/drug therapy*;Herb-Drug Interactions;Humans;Intermittent Claudication/drug therapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
23538077;Clinical Trials as Topic;Herb-Drug Interactions;Humans;Hypericum*;Mental Disorders/drug therapy*;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
23538075;Clinical Trials as Topic;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Mental Disorders/prevention & control*;Phytotherapy*
23535538;Animals;Body Weight;Coleus*;Cytochrome P-450 Enzyme System/metabolism*;Diet*;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Dietary Sucrose/pharmacology;Dietary Supplements;Glutathione Transferase/metabolism*;Herb-Drug Interactions*;Liver/drug effects*;Liver/metabolism;Male;Mice;Mice, Inbred ICR;Organ Size;Plant Extracts/pharmacology*;Starch/pharmacology
23510861;Administration, Oral;Animals;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Induction;Glucuronosyltransferase/biosynthesis;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Indole Alkaloids/administration & dosage;Indole Alkaloids/pharmacology*;Liver/drug effects*;Liver/enzymology;Male;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Metabolic Detoxication, Phase I;Metabolic Detoxication, Phase II;Mice;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Quinazolines/administration & dosage;Quinazolines/pharmacology*;Real-Time Polymerase Chain Reaction;Reverse Transcriptase Polymerase Chain Reaction;Substrate Specificity;Sulfotransferases/genetics;Sulfotransferases/metabolism*;Up-Regulation
23458730;Animals;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors*;Dextromethorphan/metabolism*;Dextromethorphan/pharmacokinetics;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology*;Flavonoids/pharmacology*;Herb-Drug Interactions*;Male;Microsomes, Liver/enzymology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis/chemistry
23451885;Adult;Anticholesteremic Agents/pharmacokinetics;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacokinetics*;Simvastatin/analogs & derivatives;Simvastatin/blood;Simvastatin/pharmacokinetics*;Young Adult
23422332;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Astragalus Plant;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Male;Polymorphism, Single Nucleotide;Substrate Specificity;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Therapeutic Equivalency
23409697;Cause of Death;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
23401262;Administration, Oral;Animals;Dogs;Half-Life;Herb-Drug Interactions*;Lepidium sativum/chemistry*;Male;Nigella sativa/chemistry*;Phenytoin/pharmacokinetics*;Seeds/chemistry;Trigonella/chemistry*
23394826;Cytochrome P-450 CYP3A/metabolism*;Enzyme Activation/drug effects;Garlic/chemistry;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Milk Thistle/chemistry;Neoplasms/drug therapy*;Neoplasms/enzymology*;Panax/chemistry;Phytotherapy*;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*
23376044;Acetic Acid/chemistry*;Animals;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2E1*/biosynthesis;Cytochrome P-450 CYP2E1*/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System*/biosynthesis;Cytochrome P-450 Enzyme System*/metabolism;Cytochromes*/biosynthesis;Cytochromes*/metabolism;Dapsone/blood;Dapsone/pharmacokinetics;Dose-Response Relationship, Drug;Drug Compounding;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacokinetics*;Enzyme Induction;Herb-Drug Interactions;Male;RNA, Messenger/biosynthesis;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction;Schisandra/chemistry*;Substrate Specificity;Theophylline/blood;Theophylline/pharmacokinetics
23371804;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Diabetic Neuropathies/drug therapy*;Drug Evaluation, Preclinical;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plant Preparations/therapeutic use
23356591;Advertising as Topic/methods*;Aged;Consumer Health Information/methods*;Dietary Supplements/adverse effects*;Female;Focus Groups;Herb-Drug Interactions*;Humans;Male;Middle Aged;Pilot Projects;Safety*;Surveys and Questionnaires;United States
23344089;Administration, Oral;Animals;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Ciprofloxacin/pharmacokinetics*;Female;Ginger*;Half-Life;Herb-Drug Interactions*;Isoniazid/pharmacokinetics*;Lung/metabolism;Male;Metabolic Clearance Rate;Plant Extracts/pharmacology*;Rats
23340957;Animals;Cytochrome P-450 CYP3A/metabolism*;Drug Combinations;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry*;Enediynes/analysis;Enediynes/pharmacology*;Fatty Alcohols/analysis;Fatty Alcohols/pharmacology*;Herb-Drug Interactions*;Humans;Hydroxylation/drug effects;In Vitro Techniques;Injections;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Midazolam/chemistry;Midazolam/metabolism;Midazolam/pharmacokinetics*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats
23339253;Cyclooctanes/chemistry;Cyclooctanes/pharmacology*;Dioxoles/chemistry;Dioxoles/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Lignans/chemistry;Lignans/pharmacology*;Molecular Structure;Polycyclic Compounds/chemistry;Polycyclic Compounds/pharmacology*;Protein Isoforms
23333907;Anesthetics, Intravenous/metabolism*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Microsomes, Liver;Phenanthrenes/pharmacology*;Plants, Medicinal/chemistry;Propofol/metabolism*;Salvia miltiorrhiza/chemistry
23330543;Drug Interactions;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology*;Receptors, Cytoplasmic and Nuclear/genetics;Receptors, Cytoplasmic and Nuclear/metabolism*
23327826;Administration, Oral;Angiotensin II Type 1 Receptor Blockers/administration & dosage;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Animals;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Female;Herb-Drug Interactions;Imidazoles/metabolism;Losartan/administration & dosage;Losartan/blood;Losartan/pharmacokinetics*;Plant Extracts/administration & dosage*;Rabbits;Rhodiola*;Tetrazoles/metabolism
23306165;Ginsenosides/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Hymecromone/analogs & derivatives;Hymecromone/metabolism;Isoenzymes/antagonists & inhibitors;Panax;Structure-Activity Relationship
23297551;Acquired Immunodeficiency Syndrome/drug therapy*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans
23291634;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Carica/chemistry;Digoxin/metabolism*;Digoxin/pharmacokinetics;Herb-Drug Interactions*;Intestinal Absorption/drug effects;Loranthaceae/chemistry;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Vernonia/chemistry
23286284;Algorithms;Camptothecin/analogs & derivatives*;Camptothecin/chemistry;Camptothecin/pharmacology;Carboxylesterase/antagonists & inhibitors*;Clinical Trials, Phase I as Topic;Diterpenes, Abietane/chemistry;Diterpenes, Abietane/isolation & purification*;Diterpenes, Abietane/pharmacokinetics;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Molecular Structure;Phenanthrolines/pharmacology*;Plant Roots/chemistry;Salvia miltiorrhiza/chemistry*
23285916;Adolescent;Adult;Aged;Aged, 80 and over;Drug Combinations;Drug Therapy;Drugs, Chinese Herbal/administration & dosage*;Female;Herb-Drug Interactions;Hospital Information Systems*;Humans;Male;Middle Aged;Outcome Assessment (Health Care)*;Young Adult
23277336;Anticoagulants/pharmacology*;Contraindications;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Panax/adverse effects*;Phytotherapy/adverse effects*;Randomized Controlled Trials as Topic;Stroke/drug therapy*;Warfarin/pharmacology*
23249200;Anti-HIV Agents/pharmacokinetics;Anticoagulants/pharmacokinetics;Antidepressive Agents/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Diagnostic Techniques and Procedures*;Drugs, Chinese Herbal/pharmacokinetics;Epigenomics;Genomics;Herb-Drug Interactions/genetics*;Humans;Immunosuppressive Agents/pharmacokinetics;Medicine, Chinese Traditional/methods*;Pharmacogenetics;Platelet Aggregation Inhibitors/pharmacokinetics;Polymorphism, Genetic;Proteomics;Randomized Controlled Trials as Topic;Risk Factors;Therapeutics/methods*
23229784;Animals;Benzofurans/pharmacology;CHO Cells;Caffeic Acids/pharmacology;Cinnamates/pharmacology;Cricetulus;Depsides/pharmacology;Drugs, Chinese Herbal/pharmacology*;HEK293 Cells;Herb-Drug Interactions*;Humans;Lactates/pharmacology;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Phenanthrolines/pharmacology*;Salvia miltiorrhiza/chemistry*
23224634;Animals;Anticarcinogenic Agents/adverse effects;Anticarcinogenic Agents/therapeutic use*;Brassica;Case-Control Studies;DNA Damage/drug effects;Feeding Behavior;Glucosinolates/adverse effects;Glucosinolates/therapeutic use;Herb-Drug Interactions;Humans;Isothiocyanates;Mice;Neoplasms/drug therapy*;Neoplasms/prevention & control*;Neoplasms, Experimental/drug therapy;Neoplastic Stem Cells/drug effects;Phytotherapy/methods*;Plant Extracts/therapeutic use*;Thiocyanates/adverse effects;Thiocyanates/therapeutic use*;Transplantation, Heterologous
23209194;ATP Binding Cassette Transporter, Sub-Family B;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Biotransformation;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dogs;Dose-Response Relationship, Drug;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Fabaceae/chemistry*;Female;HEK293 Cells;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Hydroxylation;Isoenzymes;Kinetics;LLC-PK1 Cells;Madin Darby Canine Kidney Cells;Male;Membrane Transport Modulators/isolation & purification;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Midazolam/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors;Organic Anion Transporters, Sodium-Independent/metabolism;Plant Leaves;Plant Preparations/isolation & purification;Plant Preparations/pharmacology*;Plants, Medicinal;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1;Substrate Specificity;Swine;Testosterone/metabolism;Transfection
23207062;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Animals;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme System/metabolism*;Dapsone/pharmacokinetics;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Enzyme Activators/pharmacology;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Isoenzymes/metabolism;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Rheum*;Theophylline/pharmacokinetics;Tolbutamide/pharmacokinetics;Wine
23195128;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Antioxidants/pharmacology;Disease Models, Animal;Fabaceae/chemistry*;Flavonoids/analysis;Fruit/chemistry*;Herb-Drug Interactions*;Male;Naloxone/pharmacology*;Narcotic Antagonists;Pain/chemically induced;Pain/drug therapy*;Pain Measurement/methods;Pharmaceutical Solutions/administration & dosage;Pharmaceutical Solutions/pharmacology;Pharmaceutical Solutions/therapeutic use;Phenols/analysis;Phytotherapy/methods*;Plant Extracts/administration & dosage;Plant Extracts/antagonists & inhibitors;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Rats;Rats, Wistar
23189719;Aconitum/chemistry*;Animals;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage*;Gene Expression/drug effects*;Glycyrrhiza/chemistry*;Herb-Drug Interactions*;Male;Rats;Rats, Sprague-Dawley
23188923;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Plant Preparations/adverse effects;Plant Preparations/pharmacology
23178632;Amiodarone/administration & dosage;Amiodarone/pharmacokinetics*;Amiodarone/pharmacology;Animals;Area Under Curve;Body Weight/drug effects;Drug Administration Schedule;Fucus*;Herb-Drug Interactions*;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Seaweed
23162896;Antineoplastic Agents, Phytogenic/pharmacology;Camptothecin/analogs & derivatives*;Camptothecin/pharmacology;Cell Proliferation/drug effects*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dose-Response Relationship, Drug;Hep G2 Cells;Herb-Drug Interactions*;Humans;Quercetin/administration & dosage;Quercetin/analogs & derivatives*;Quercetin/pharmacology;RNA, Messenger/metabolism;Receptors, Steroid/metabolism;Transcriptional Activation/drug effects;Up-Regulation
23159385;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/antagonists & inhibitors;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology;Adrenergic Agonists/pharmacology;Animals;Aorta, Thoracic/drug effects;Aorta, Thoracic/physiology;Aspidosperma/chemistry;Blood Pressure/drug effects;Blood Pressure/physiology;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology*;Ethanol/chemistry;Heart Rate/drug effects;Heart Rate/physiology;Herb-Drug Interactions/physiology*;In Vitro Techniques;Male;Phenylephrine/antagonists & inhibitors;Phenylephrine/pharmacology;Plant Extracts/antagonists & inhibitors;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Potassium Channel Blockers/pharmacology*;Rats;Rats, Wistar;Vasodilation/drug effects*;Vasodilation/physiology;Vasodilator Agents/antagonists & inhibitors;Vasodilator Agents/chemistry;Vasodilator Agents/pharmacology*
23157874;Adult;Age Distribution;Chronic Disease/drug therapy*;Complementary Therapies/adverse effects;Complementary Therapies/economics;Complementary Therapies/utilization*;Cost Savings/methods;Cross-Sectional Studies;Educational Status;Female;Health Surveys;Herb-Drug Interactions*;Humans;Male;Middle Aged;Polypharmacy;Prescription Drugs/adverse effects;Prescription Drugs/economics;Prescription Drugs/therapeutic use*;Risk Factors;Self Report;Sex Distribution;Socioeconomic Factors;South Australia
23148031;Glucuronosyltransferase/antagonists & inhibitors*;Glycyrrhetinic Acid/pharmacology*;Glycyrrhiza/chemistry;Glycyrrhizic Acid/pharmacology;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Kinetics;Liver/enzymology
23147465;Animals;Cuscuta/chemistry*;Cyclic GMP/physiology;Enzyme Inhibitors/pharmacology;Erectile Dysfunction/drug therapy*;Herb-Drug Interactions;Male;Muscle Relaxation/drug effects*;Muscle, Smooth/drug effects;NG-Nitroarginine Methyl Ester/pharmacology;Penile Erection/drug effects*;Penis/drug effects*;Penis/physiology*;Phytotherapy*;Piperazines/pharmacology;Plant Extracts/pharmacology*;Purines/pharmacology;Rabbits;Sildenafil Citrate;Sulfones/pharmacology
23146043;Animals;Anticoagulants/metabolism;Anticoagulants/pharmacology;Caseins/administration & dosage;Coleus/chemistry*;Colforsin/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Diet;Dietary Proteins/administration & dosage;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Liver/drug effects*;Liver/enzymology;Liver/metabolism;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Plant Extracts/pharmacology*;Warfarin/metabolism*;Warfarin/pharmacology
23122083;Animals;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/chemistry;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism;Fermentation;Herb-Drug Interactions*;Humans;Kinetics;Lactobacillus/metabolism;Male;Microsomes, Liver/chemistry;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley
23121117;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Liver/drug effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects*
23117091;Analgesics/antagonists & inhibitors;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use*;Antipyretics/pharmacology;Antipyretics/therapeutic use*;Artemisia/chemistry*;Caffeine/pharmacology;Carrageenan;Edema/chemically induced;Edema/drug therapy;Female;Fever/drug therapy*;Herb-Drug Interactions*;Male;Methanol/chemistry;Mice;Mice, Inbred BALB C;Naloxone/pharmacology;Pain/chemically induced;Pain/drug therapy;Phytotherapy/methods*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Rats;Rats, Sprague-Dawley;Sodium Glutamate/pharmacology
23104244;Animals;Aryl Hydrocarbon Hydroxylases;Biotransformation;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1B1;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology*;Fermentation;Herb-Drug Interactions*;Liver/drug effects;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
23102508;Cytochrome P-450 Enzyme Inhibitors*;Dextromethorphan;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Kinetics;Microsomes, Liver;Molecular Docking Simulation;Phenacetin;Phenanthrenes/pharmacology*;Salvia miltiorrhiza/chemistry*;Testosterone;Tolbutamide
23092794;Chemical and Drug Induced Liver Injury/enzymology;Chemical and Drug Induced Liver Injury/etiology*;Complementary Therapies/adverse effects;Complementary Therapies/methods;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/therapeutic use;Herb-Drug Interactions*;Humans;Liver/drug effects;Liver/enzymology;Liver/pathology;Male;Middle Aged;Panax/adverse effects*;Pyrrolidinones/adverse effects*;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/therapeutic use;Raltegravir Potassium
23067030;Animals;Clinical Trials as Topic;Contraindications;Dietary Supplements/adverse effects*;Disease Models, Animal;Herb-Drug Interactions*;Humans;Plant Preparations*;Rats;Research Design
23067026;Animals;Contraindications;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations*
23064285;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Anti-Arrhythmia Agents/metabolism*;Biological Transport;Caco-2 Cells;Cell Survival/drug effects;Digoxin/metabolism*;Herb-Drug Interactions*;Humans;Magnoliopsida;Medicine, African Traditional*;Plant Bark;Plant Extracts/pharmacology*;Plant Leaves
23058057;Animals;Area Under Curve;Bornanes/administration & dosage;Bornanes/pharmacology*;Brain/metabolism;Chromatography, High Pressure Liquid;Corpus Striatum/metabolism;Drug Combinations;Drug Delivery Systems;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Emulsions;Half-Life;Herb-Drug Interactions;Male;Microdialysis;Pyrazines/administration & dosage;Pyrazines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tissue Distribution;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacokinetics
23028841;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Aged;Biological Products/adverse effects*;Canada;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Pharmacies;Pharmacists*;Prescription Drugs/adverse effects*;Public Health Surveillance;Surveys and Questionnaires
23028251;Alkaloids/administration & dosage;Alkaloids/pharmacology*;Animals;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/pharmacology*;Benzodioxoles/administration & dosage;Benzodioxoles/pharmacology*;Biological Availability;Curcumin/administration & dosage;Curcumin/pharmacokinetics;Databases, Factual;Dietary Supplements;Drug Compounding/methods;Drug Therapy, Combination/methods;Drug-Related Side Effects and Adverse Reactions/prevention & control;Herb-Drug Interactions;Humans;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics;Piperidines/administration & dosage;Piperidines/pharmacology*;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry*;Polyunsaturated Alkamides/administration & dosage;Polyunsaturated Alkamides/pharmacology*
23026308;Animals;Astragalus Plant;Diabetes Mellitus, Experimental/metabolism;Diabetes Mellitus, Type 2/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacokinetics*;Male;Rats;Rats, Wistar;Thiazolidinediones/pharmacokinetics*
23000442;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Drugs, Chinese Herbal/pharmacology;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology*;Pyrans/pharmacology*;Recombinant Proteins/genetics;Recombinant Proteins/metabolism
22998215;Administration, Oral;Alkaloids/administration & dosage;Alkaloids/adverse effects*;Alkaloids/pharmacokinetics;Animals;Heart Diseases/chemically induced;Heart Diseases/metabolism;Herb-Drug Interactions/physiology*;Humans;Membrane Transport Proteins/metabolism;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Ranunculaceae*;Rhizome*
22996305;Administration, Oral;Animals;Area Under Curve;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Schisandra/chemistry;Tablets
22993742;Adult;Attitude of Health Personnel*;Clinical Competence*;Cross-Sectional Studies;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Herbal Medicine*;Humans;Internal Medicine/methods;Male;Middle Aged;Needs Assessment;Physicians/statistics & numerical data*;Surveys and Questionnaires;United Kingdom
22981724;Angelica;Animals;Benzopyrans/pharmacology*;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Butyrates/pharmacology*;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Theophylline/blood;Theophylline/pharmacokinetics*
22980806;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Availability;Cell Line, Tumor;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Glycyrrhiza/chemistry*;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions;Humans;Male;Plant Extracts/pharmacology*;Plant Roots/chemistry;Rats;Rats, Sprague-Dawley
22975634;Administration, Oral;Animals;Area Under Curve;Brassica/metabolism*;Caffeine/pharmacokinetics;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP2E1/genetics;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Cytochromes/antagonists & inhibitors;Cytochromes/genetics;Cytochromes/metabolism;Dextromethorphan/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Liver/enzymology;Metabolic Clearance Rate;Midazolam/pharmacokinetics*;Omeprazole/pharmacokinetics;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Tolbutamide/pharmacokinetics
22951920;Aged;Drug Labeling/legislation & jurisprudence*;Herb-Drug Interactions*;Humans;Pharmacokinetics;Plant Preparations/pharmacology;Polypharmacy;United States
22947027;Animals;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/therapeutic use;Central Nervous System Diseases/chemically induced;Central Nervous System Diseases/pathology;Central Nervous System Diseases/veterinary*;Food Contamination;Herb-Drug Interactions*;Horse Diseases/chemically induced*;Horse Diseases/pathology;Horses;Ivermectin/administration & dosage;Ivermectin/adverse effects*;Ivermectin/therapeutic use;Plants, Toxic;Solanum/classification;Solanum/toxicity*
22943125;Animals;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/methods*;Medicine, East Asian Traditional/methods*;Pharmaceutical Services/organization & administration;Pharmacists/organization & administration;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Quality Assurance, Health Care;Vietnam
22935233;Drug Interactions;Herb-Drug Interactions;Herbal Medicine/classification;Herbal Medicine/methods;Humans;Medicine, Ayurvedic*;Neoplasms/classification;Neoplasms/therapy;Phytotherapy/methods
22928833;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use*;Benzofurans/pharmacology;Benzofurans/therapeutic use*;Cell Line;Chromones/pharmacology;Chromones/therapeutic use*;Cimicifuga/chemistry*;Cytokines/metabolism;Dose-Response Relationship, Drug;Drug Synergism;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Fibrinolytic Agents/pharmacology;Heparin/pharmacology;Herb-Drug Interactions;Humans;Interferon-beta/metabolism;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Respiratory Syncytial Virus Infections/drug therapy*;Respiratory Syncytial Virus Infections/metabolism;Respiratory Syncytial Virus Infections/virology;Respiratory Syncytial Virus, Human/drug effects*;Respiratory Syncytial Virus, Human/pathogenicity
22926042;Animals;Central Nervous System Agents/chemistry;Central Nervous System Agents/pharmacokinetics*;Herb-Drug Interactions*;Male;Mice;Oils, Volatile/chemistry*;Oils, Volatile/pharmacokinetics*;Pimpinella/chemistry*;Plant Oils/chemistry;Plant Oils/pharmacokinetics*;Seeds/chemistry
22906201;Adolescent;Adult;Age Factors;Aged;Ambulatory Surgical Procedures*;Anesthesia*/classification;Anesthesiology;Chi-Square Distribution;Cough/drug therapy;Cross-Sectional Studies;Data Collection;Female;Health Care Surveys;Herb-Drug Interactions;Herbal Medicine;Humans;Malaria/drug therapy;Male;Marital Status;Middle Aged;Nigeria;Patient Satisfaction;Physician-Patient Relations;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Sex Factors;Surveys and Questionnaires;Urban Population;Young Adult
22889991;Area Under Curve;Beverages;Celiprolol/blood*;Celiprolol/chemistry;Celiprolol/pharmacokinetics;Chromatography, High Pressure Liquid/methods*;Drug Stability;Fruit;Herb-Drug Interactions;Humans;Linear Models;Malus;Reproducibility of Results;Sensitivity and Specificity;Solid Phase Extraction/methods;Spectrometry, Fluorescence/methods*
22876741;Adverse Drug Reaction Reporting Systems/standards*;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Drug-Related Side Effects and Adverse Reactions*/chemically induced;Herb-Drug Interactions*;Humans;Pharmacovigilance*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects;Risk
22875751;Consumer Product Safety;Dietary Supplements*/adverse effects;Food-Drug Interactions*;Health Promotion*;Herb-Drug Interactions*;Humans;Patient Education as Topic;Professional-Patient Relations;Quality of Health Care;United States
22875040;Adult;Aged;Aged, 80 and over;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Cardiotonic Agents/adverse effects;Cardiotonic Agents/therapeutic use*;Chi-Square Distribution;Comorbidity;Digoxin/adverse effects;Digoxin/therapeutic use*;Drug Utilization;Drug Utilization Review;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Female;Health Services/utilization;Herb-Drug Interactions;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Retrospective Studies;Risk Assessment;Risk Factors;Taiwan;Time Factors
22870815;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Furocoumarins/pharmacology*;Herb-Drug Interactions*;Intestinal Absorption/drug effects*;Intestines/drug effects*;Intestines/enzymology;Male;Medicine, Kampo;Metabolic Clearance Rate;Midazolam/blood;Midazolam/pharmacokinetics*;Propanolamines/blood;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar
22869560;Adult;Anti-HIV Agents/therapeutic use;Echinacea/chemistry*;Female;HIV Infections/drug therapy*;Herb-Drug Interactions;Humans;Male;Middle Aged;Plant Extracts/therapeutic use*;Pyridazines/therapeutic use*
22867637;Animals;Anticoagulants/administration & dosage*;Anticoagulants/blood;Anticoagulants/pharmacokinetics;Area Under Curve;Aspirin/administration & dosage*;Aspirin/blood;Aspirin/pharmacokinetics;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics;Herb-Drug Interactions*;Lactates/blood;Male;Prothrombin Time;Rats;Rats, Sprague-Dawley;Salicylic Acid/blood;Warfarin/administration & dosage*;Warfarin/blood;Warfarin/pharmacokinetics
22864989;Drug Labeling/legislation & jurisprudence;Drug Synergism;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Organic Anion Transporters/drug effects*;Pharmacokinetics*;Plant Preparations/pharmacology*;United States;United States Food and Drug Administration/legislation & jurisprudence
22864323;Aged;Anticoagulants/therapeutic use*;Aortic Valve;Atrial Fibrillation/drug therapy;Avena/adverse effects*;Avena/chemistry;Heart Valve Prosthesis;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Panax/adverse effects*;Panax/chemistry;Tribulus/adverse effects*;Tribulus/chemistry;Warfarin/therapeutic use*
22863918;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Antineoplastic Combined Chemotherapy Protocols;Cell Communication/drug effects*;Cell Communication/physiology;Cisplatin/pharmacology;Cisplatin/therapeutic use*;Connexins/metabolism;Dose-Response Relationship, Drug;Drug Synergism;Female;Gap Junctions/drug effects*;Gap Junctions/physiology;HeLa Cells;Herb-Drug Interactions;Humans;Panax notoginseng/chemistry*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Saponins/pharmacology;Saponins/therapeutic use*;Transfection;Uterine Cervical Neoplasms/drug therapy;Uterine Cervical Neoplasms/physiopathology*
22863650;Acupuncture Therapy;Attitude of Health Personnel*;Communication;Complementary Therapies/methods*;Consensus;Cooperative Behavior;Delphi Technique;Exercise;Herb-Drug Interactions;Humans;Internet;Neoplasms/therapy*;Phytotherapy;Quality of Life;Research*
22855269;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Echinacea;Garlic;Ginkgo biloba;Herb-Drug Interactions*;Humans;Hydrastis;Milk Thistle;Panax;Pharmacokinetics*;Plant Preparations/pharmacology*
22854226;Academic Medical Centers;Adult;Aged;Aged, 80 and over;Communication*;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Hospitalization;Humans;Inpatients/psychology*;Inpatients/statistics & numerical data;Internal Medicine;Interviews as Topic;Israel;Male;Middle Aged;Physician-Patient Relations*;Phytotherapy/statistics & numerical data;Phytotherapy/utilization*;Prevalence;Quality of Life;Self Concept;Socioeconomic Factors;Surveys and Questionnaires;Truth Disclosure
22850760;Adult;Asian Continental Ancestry Group/genetics;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Haplotypes;Herb-Drug Interactions/genetics*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Organic Anion Transporters/genetics*;Polymorphism, Single Nucleotide/genetics;Quinolines/pharmacokinetics*;Solute Carrier Organic Anion Transporter Family Member 1b1
22819301;Cytochrome P-450 Enzyme System/metabolism*;Gentianaceae/chemistry*;Herb-Drug Interactions*;Humans;Phenacetin/metabolism;Plant Extracts/pharmacology*;Testosterone/metabolism;Tolbutamide/metabolism;Xanthones/pharmacology*
22814819;Cell Culture Techniques/methods*;Cell Line;Chemistry, Pharmaceutical/standards*;Dietary Supplements/toxicity*;Drug Evaluation, Preclinical/methods*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Liver/metabolism;Pharmacokinetics;Plant Preparations/chemistry*;Plant Preparations/standards;Plant Preparations/toxicity*;Reagent Kits, Diagnostic
22813711;Administration, Oral;Animals;Anticonvulsants/pharmacokinetics;Area Under Curve;Brain/metabolism;Carbamazepine/analogs & derivatives;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Fallopia japonica/chemistry*;Herb-Drug Interactions*;Kidney/metabolism;Liver/metabolism;Male;Multidrug Resistance-Associated Proteins/antagonists & inhibitors;Multidrug Resistance-Associated Proteins/metabolism;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Stilbenes/isolation & purification;Tissue Distribution
22796279;Animals;Bromocriptine/pharmacology;Cell Line;Disease Models, Animal;Dopamine/biosynthesis;Dopamine D2 Receptor Antagonists;Dopamine Plasma Membrane Transport Proteins/metabolism;Dose-Response Relationship, Drug;Estradiol/metabolism;Female;Glycyrrhiza/chemistry*;Haloperidol/pharmacology;Herb-Drug Interactions;Hyperprolactinemia/blood;Hyperprolactinemia/chemically induced;Hyperprolactinemia/drug therapy*;Metoclopramide/adverse effects;PC12 Cells;Paeonia/chemistry*;Phytotherapy/methods*;Plant Extracts/antagonists & inhibitors;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Progesterone/metabolism;Prolactin/biosynthesis;Prolactin/secretion;Rabbits;Rats, Sprague-Dawley;Receptors, Dopamine D2/agonists;Receptors, Dopamine D2/metabolism*
22747079;Complementary Therapies/adverse effects*;Curcuma/chemistry;Drugs, Chinese Herbal/adverse effects*;Garlic/chemistry;Ginger/chemistry;Glycyrrhiza/chemistry;Herb-Drug Interactions;Herbal Medicine*;Phytotherapy/adverse effects*;Tea/chemistry
22741403;Aristolochia/adverse effects;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/adverse effects*;Phytotherapy/adverse effects
22736593;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Panax/chemistry;Sapogenins/pharmacology*
22735598;Alpinia/chemistry*;Anti-Bacterial Agents/pharmacology*;Bacterial Proteins/antagonists & inhibitors;Benzyl Alcohols/isolation & purification;Benzyl Alcohols/pharmacology;Coumarins/isolation & purification;Coumarins/pharmacology;Drug Resistance/drug effects*;Ethidium/pharmacology*;Eugenol/analogs & derivatives;Eugenol/isolation & purification;Eugenol/pharmacology;Herb-Drug Interactions;Microbial Sensitivity Tests;Mycobacterium smegmatis/drug effects*;Phenols/isolation & purification;Phenols/pharmacology*;Phytotherapy;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rhizome;Tuberculosis/drug therapy;Tuberculosis/microbiology
22718621;Animals;Chemistry, Pharmaceutical;Cytochrome P-450 Enzyme System/physiology*;Herb-Drug Interactions*;Humans;Salvia miltiorrhiza*/chemistry
22703874;Adipose Tissue/drug effects*;Adipose Tissue/metabolism;Anthocyanins/pharmacology;Anthocyanins/therapeutic use*;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use;Atorvastatin Calcium;Cells, Cultured;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Fruit;Glucosides/pharmacology;Glucosides/therapeutic use*;Heptanoic Acids/pharmacology;Heptanoic Acids/therapeutic use*;Herb-Drug Interactions;Humans;Inflammation/chemically induced;Inflammation/metabolism;Inflammation/prevention & control*;Interleukin-6/metabolism*;Lipopolysaccharides;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Prunus/chemistry*;Pyrroles/pharmacology;Pyrroles/therapeutic use*;Stem Cells/drug effects
22700632;Adult;Adverse Drug Reaction Reporting Systems*;Aged;Aged, 80 and over;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Comorbidity;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Safety;Pelargonium*;Pharmacovigilance*;Plant Extracts/adverse effects*;Plant Roots;Respiratory System Agents/adverse effects*;Risk Assessment;Risk Factors
22686837;Administration, Oral;Adult;Area Under Curve;Biological Availability;Drug Therapy, Combination/methods;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Schisandra/chemistry*;Sirolimus/blood;Sirolimus/pharmacokinetics;Sirolimus/pharmacology*
22675703;Beverages;Brazil;Caffeine/adverse effects;Caffeine/analysis;Caffeine/therapeutic use*;Fruit/adverse effects;Herb-Drug Interactions;Humans;Paullinia*/adverse effects;Paullinia*/chemistry;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use
22673828;Drug Labeling/legislation & jurisprudence*;Drug and Narcotic Control/legislation & jurisprudence*;Europe;Guidelines as Topic;Herb-Drug Interactions*;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*;Plant Preparations/standards
22670731;Herb-Drug Interactions*;Herbal Medicine/methods;Humans;Plant Preparations*;Plants, Medicinal*
22669039;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Hymecromone/analogs & derivatives;Hymecromone/metabolism;Kinetics;Tripterygium/chemistry*;Triterpenes/chemistry;Triterpenes/pharmacology*
22648787;Animals;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Computer Simulation*;Cytochrome P-450 CYP2D6/metabolism*;Flavonoids/chemistry;Flavonoids/pharmacology*;Heart Rate/drug effects;Herb-Drug Interactions*;Isoflavones/chemistry;Isoflavones/pharmacology;Male;Metoprolol/blood;Metoprolol/pharmacology*;Models, Molecular;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Reference Standards;Systole/drug effects
22643032;Absorption;Animals;Herb-Drug Interactions;Humans;Plant Preparations/pharmacokinetics*;Plants, Medicinal/metabolism*
22642738;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/adverse effects;Adjuvants, Immunologic/therapeutic use;Alanine Transaminase/metabolism;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury/etiology*;Chemical and Drug Induced Liver Injury/physiopathology;Coumarins/administration & dosage;Coumarins/adverse effects*;Drug Combinations;Female;Herb-Drug Interactions;Humans;Injections, Intramuscular;Injections, Subcutaneous;Interferon beta-1b;Interferon-beta/administration & dosage;Interferon-beta/adverse effects*;Interferon-beta/therapeutic use;Multiple Sclerosis/drug therapy;Resins, Plant/administration & dosage;Resins, Plant/adverse effects*;Rutin/administration & dosage;Rutin/adverse effects*;Severity of Illness Index;Young Adult
22612723;Anthelmintics/pharmacokinetics;Anthelmintics/pharmacology;Anti-Retroviral Agents/pharmacokinetics;Anti-Retroviral Agents/pharmacology;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antimalarials/pharmacokinetics;Antimalarials/pharmacology;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Biological Transport/drug effects;Biological Transport/physiology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology;Central Nervous System/drug effects;Herb-Drug Interactions*;Hormones/pharmacokinetics;Hormones/pharmacology;Humans;Immunologic Factors/pharmacokinetics;Immunologic Factors/pharmacology;Plants, Medicinal/chemistry*
22610955;Data Mining/methods*;Drug Combinations;Drug Prescriptions/classification*;Drug Therapy, Combination/methods;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/classification*;Herb-Drug Interactions/physiology;Humans;Medicine, Chinese Traditional/methods*;Respiratory Tract Diseases/drug therapy*;Respiratory Tract Diseases/epidemiology;Review Literature as Topic
22608805;Animals;Chromatography, Liquid/methods*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Flavonoids/blood;Flavonoids/chemistry;Flavonoids/pharmacokinetics;Glucosides/blood;Glucosides/chemistry;Glucosides/pharmacokinetics;Herb-Drug Interactions*;Levofloxacin*;Male;Mass Spectrometry/methods*;Ofloxacin/pharmacology*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Rutin/blood;Rutin/chemistry;Rutin/pharmacokinetics
22607644;Antineoplastic Agents, Phytogenic/pharmacokinetics;Blood Platelets/metabolism;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dietary Supplements/adverse effects;Echinacea*;Etoposide/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/adverse effects;Plant Extracts/pharmacology*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/etiology*
22606944;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Animals;Aryl Hydrocarbon Hydroxylases/biosynthesis;Biotransformation/drug effects;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A/biosynthesis;Enzyme Induction;Herb-Drug Interactions*;Humans;Hypericum*;Pharmacokinetics;Plant Preparations/pharmacology*;Plants, Medicinal;Up-Regulation
22588833;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Herb-Drug Interactions*;Humans;Magnoliopsida*;Phenotype;Phytotherapy/methods*;Plant Extracts/pharmacology*;Substrate Specificity
22578672;Acute Kidney Injury/chemically induced*;Age Factors;Complementary Therapies/adverse effects*;Drug Contamination;Herb-Drug Interactions;Humans;Kidney Failure, Chronic/chemically induced*;Medicine, Traditional/adverse effects*;Plant Preparations/adverse effects*;Renal Insufficiency, Chronic/chemically induced*;Sex Factors
22568242;Animals;Coumaric Acids/blood;Coumaric Acids/metabolism*;Coumaric Acids/urine;Drugs, Chinese Herbal/metabolism*;Gallic Acid/blood;Gallic Acid/metabolism*;Gallic Acid/urine;Herb-Drug Interactions*;Male;Metabolome;Rats;Rats, Sprague-Dawley;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
22565299;Adenosine Triphosphate/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Herb-Drug Interactions*;Humans;Magnoliopsida*;Membrane Transport Proteins/metabolism;Pharmacokinetics*;Plant Preparations/pharmacology*;Transferases/metabolism
22562327;Cognition Disorders/drug therapy;Dementia/drug therapy;Evidence-Based Medicine;Ginkgo biloba*/adverse effects;Herb-Drug Interactions*;Humans;Intermittent Claudication/drug therapy;Macular Degeneration/drug therapy;Phytotherapy/adverse effects;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Stroke/drug therapy;Tinnitus/drug therapy;Treatment Outcome
22549240;Animals;Blood Pressure/drug effects*;Cyclooxygenase 2 Inhibitors/adverse effects;Cyclooxygenase 2 Inhibitors/pharmacokinetics*;Cyclooxygenase 2 Inhibitors/pharmacology;Herb-Drug Interactions*;Hypericum*;Male;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyridines/pharmacology;Rats;Rats, Wistar;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Sulfones/pharmacology
22546220;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Antineoplastic Combined Chemotherapy Protocols/pharmacology;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Apoptosis/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Colorectal Neoplasms/drug therapy*;Colorectal Neoplasms/genetics;Colorectal Neoplasms/metabolism;Drug Synergism;Herb-Drug Interactions*;Humans;Inhibitor of Apoptosis Proteins/genetics;Inhibitor of Apoptosis Proteins/metabolism;Inhibitory Concentration 50;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;RNA, Messenger/metabolism;Stomach Neoplasms/drug therapy*;Stomach Neoplasms/genetics;Stomach Neoplasms/metabolism;Taxoids/administration & dosage;Taxoids/pharmacology;Taxoids/therapeutic use*;Tubulin/genetics;Tubulin/metabolism;Xanthones/administration & dosage;Xanthones/pharmacology;Xanthones/therapeutic use*;tau Proteins/genetics;tau Proteins/metabolism
22541637;Amino Acids/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Dextromethorphan/metabolism;Dextrorphan/metabolism;Diterpenes, Abietane/chemistry;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Kinetics;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Phenanthrolines/chemistry;Phenanthrolines/pharmacology*;Protein Binding;Quinidine/chemistry;Quinidine/pharmacology;Salvia miltiorrhiza/chemistry*
22536985;Acinetobacter/drug effects*;Acinetobacter/growth & development;Acinetobacter Infections/drug therapy;Acinetobacter Infections/microbiology*;Alkaloids/analysis;Alkaloids/pharmacology;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/therapeutic use;Drug Resistance/drug effects*;Drug Synergism;Herb-Drug Interactions;Holarrhena/chemistry*;Humans;Magnoliopsida/chemistry;Medicine, East Asian Traditional;Novobiocin/pharmacology*;Novobiocin/therapeutic use;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry;Tannins/analysis;Tannins/pharmacology;Thailand;Triterpenes/analysis;Triterpenes/pharmacology
22533708;Anti-Bacterial Agents/pharmacology;Ciprofloxacin/pharmacology;Drug Resistance, Bacterial;Escherichia coli/drug effects*;Escherichia coli/enzymology;Escherichia coli/genetics;Herb-Drug Interactions*;Kanamycin/pharmacology;Microbial Sensitivity Tests;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;Polyphenols/chemistry;Polyphenols/pharmacology*;Quercetin/chemistry;Quercetin/pharmacology;beta-Galactosidase/metabolism
22532034;Animals;Antineoplastic Agents/pharmacology;Boronic Acids/pharmacology;Bortezomib;DNA Damage/drug effects;Herb-Drug Interactions;Humans;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Lung Neoplasms/prevention & control;Maximum Tolerated Dose;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Pyrazines/pharmacology;Tea*
22528756;Drug Design;Drug Discovery*/trends;Drug Synergism;Herb-Drug Interactions;Humans;Molecular Targeted Therapy*/trends;Plants, Medicinal
22509899;Absorption;Animals;Biological Availability;Biotransformation/drug effects;Enzymes/metabolism;Herb-Drug Interactions;Humans;Membrane Transport Modulators/isolation & purification;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects;Membrane Transport Proteins/metabolism;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Leaves;Plants, Medicinal;Polyphenols/isolation & purification;Polyphenols/pharmacology*;Tea*/chemistry
22477279;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*
22475333;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional
22475332;Animals;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Plants, Medicinal/metabolism*
22471362;Acetyltransferases/metabolism;Adult;Caffeine/metabolism*;Caffeine/urine;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Dextromethorphan/metabolism*;Dextromethorphan/urine;Drugs, Chinese Herbal/pharmacology*;Drugs, Chinese Herbal/therapeutic use;Estrogens/metabolism;Female;Herb-Drug Interactions*;Humans;Hydrocortisone/metabolism*;Hydrocortisone/urine;Menopause;Phenotype;Phytotherapy/adverse effects;Reference Values;Xanthine Oxidase/metabolism;Young Adult
22465502;Acridines/pharmacology*;Acridones;Alkaloids/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors*;Dextromethorphan/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Indonesia;Liver/drug effects*;Liver/enzymology;Methylation;Microsomes/drug effects;NADP/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry;Rutaceae/chemistry*
22465277;Animals;Area Under Curve;Aspirin/analysis*;Aspirin/blood;Aspirin/pharmacokinetics;Bleeding Time;Brain Chemistry;Drug Stability;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Male;Microdialysis/methods*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Salicylic Acid/analysis*;Salicylic Acid/blood;Salicylic Acid/pharmacokinetics
22459282;Anti-Bacterial Agents/pharmacology*;Benzoxepins/adverse effects;Benzoxepins/pharmacology*;Cell Membrane/drug effects;Depsides/adverse effects;Depsides/pharmacology*;Drug Synergism;Drug Therapy, Combination;Fluoresceins/metabolism;Herb-Drug Interactions;Leukocytes, Mononuclear/drug effects;Lichens/chemistry*;Methicillin-Resistant Staphylococcus aureus/drug effects*;Permeability
22392461;Aged;Beverages*/adverse effects;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/metabolism*;Female;Herb-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Lycium*;Warfarin/adverse effects;Warfarin/blood*
22381135;Administration, Oral;Adult;Atorvastatin Calcium;Cholesterol/blood;Ginkgo biloba/chemistry*;Heptanoic Acids/administration & dosage;Heptanoic Acids/blood*;Heptanoic Acids/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Pyrroles/administration & dosage;Pyrroles/blood*;Pyrroles/pharmacokinetics*;Treatment Outcome
22375948;Animals;Drug Combinations;Drug Interactions;Herb-Drug Interactions;Humans;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
22359586;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Administration, Oral;Animals;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/physiology*;Herb-Drug Interactions*;Herbal Medicine/methods;Indinavir/administration & dosage;Indinavir/blood;Indinavir/pharmacokinetics*;Plant Preparations/blood;Plant Preparations/pharmacokinetics*;RNA, Messenger/analysis;Rats;Sophora*
22339466;Animals;Biological Availability;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Liver/metabolism;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics*;Phyllanthus*;Plant Preparations/administration & dosage*;Plant Preparations/pharmacology;Rats;Rats, Sprague-Dawley
22329195;Anticarcinogenic Agents/adverse effects;Anticarcinogenic Agents/therapeutic use;Camellia sinensis*;Catechin/adverse effects;Catechin/analogs & derivatives;Catechin/therapeutic use;Herb-Drug Interactions*;Neoplasms/drug therapy*;Neoplasms/prevention & control;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Plant Leaves
22322396;Adenosine Triphosphate/metabolism;Animals;Chemistry, Pharmaceutical;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Drug Contamination;Drug Synergism;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/metabolism;Pharmacogenetics;Pharmacokinetics*;Plant Extracts/pharmacology;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Transferases/metabolism
22320169;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adrenal Cortex Hormones/therapeutic use;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Antineoplastic Combined Chemotherapy Protocols;Cell Phone*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Databases, Factual*;Hemorrhage;Herb-Drug Interactions*;Humans;Hypertension;Hypoglycemia;Internet*;Liver/drug effects;Neoplasms/drug therapy;Phytotherapy*;Plant Preparations/therapeutic use*;Serotonin Syndrome;Software
22315916;Adverse Drug Reaction Reporting Systems;Dietary Supplements*;Drug Interactions*;Evidence-Based Medicine;Herb-Drug Interactions;Humans;United States
22313151;Animals;Biotransformation;Chemistry, Pharmaceutical;Dietary Supplements*/adverse effects;Drug Stability;Drug-Related Side Effects and Adverse Reactions;Evidence-Based Medicine;Garlic*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Phytotherapy*/adverse effects;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plants, Medicinal;Risk Assessment;Risk Factors;Solubility
22309869;Adult;Aged;Attitude of Health Personnel*;California;Clinical Competence;Communication;Dental Hygienists/education*;Dietary Supplements*;Education, Continuing;Educational Status;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy*;Professional Practice;Professional-Patient Relations;Self Concept;Surveys and Questionnaires;Young Adult
22300597;Anticoagulants/adverse effects*;Dietary Supplements/adverse effects*;Hemorrhage/epidemiology;Hemorrhage/etiology*;Herb-Drug Interactions*;Homeostasis/drug effects*;Homeostasis/physiology;Humans;Platelet Aggregation Inhibitors/adverse effects
22298448;Animals;Astragalus Plant;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Fabaceae;Herb-Drug Interactions*;Humans;Magnolia;Magnoliopsida*;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Paeonia;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis
22292789;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Plant Preparations/pharmacokinetics*;Plants, Medicinal/metabolism*
22292646;Animals;Benzoates/pharmacology*;Blood Platelets/drug effects;Bone Marrow Cells/drug effects*;Bone Marrow Cells/radiation effects*;Bridged-Ring Compounds/pharmacology*;Chemotherapy, Adjuvant/methods;Cyclophosphamide/pharmacology;Cyclophosphamide/toxicity;Cytarabine/pharmacology;Cytarabine/toxicity;Drug Synergism;Drugs, Chinese Herbal/pharmacology;Female;Glucosides/pharmacology*;Hemoglobins/drug effects;Herb-Drug Interactions;Leukocytes/radiation effects;Male;Mice;Mice, Inbred BALB C;Monoterpenes;Paeonia/chemistry*;Plant Extracts/pharmacology;Plant Roots/chemistry;Rabbits;X-Rays
22283868;Acute Kidney Injury/chemically induced*;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Aristolochia/chemistry*;Cyclophosphamide/administration & dosage;Doxorubicin/administration & dosage;Fatal Outcome;Herb-Drug Interactions;Humans;Lymphoma, Large B-Cell, Diffuse/drug therapy*;Male;Medicine, Traditional/adverse effects*;Middle Aged;Plant Extracts/adverse effects*;Prednisone/administration & dosage;Self Administration;Vincristine/administration & dosage
22275232;Animals;Area Under Curve;Biological Transport;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Half-Life;Herb-Drug Interactions;Intestine, Small/drug effects;Intestine, Small/metabolism*;Male;Molecular Structure;Nitrendipine/blood;Nitrendipine/pharmacokinetics*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Punicaceae/metabolism*;Rats;Rats, Wistar
22257149;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions*;Humans
22236736;Age Factors;Continental Population Groups;Genotype;Herb-Drug Interactions/physiology*;Humans;Patient Education as Topic;Pharmaceutical Preparations*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology*;Sex Factors
22208477;Adult;Aryl Hydrocarbon Hydroxylases/blood*;Aryl Hydrocarbon Hydroxylases/genetics;China;Cross-Over Studies;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2D6/blood*;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP3A/blood*;Cytochrome P-450 CYP3A/genetics;Dextromethorphan/administration & dosage;Dextromethorphan/pharmacokinetics;Drugs, Chinese Herbal/administration & dosage*;Genotype;Herb-Drug Interactions*;Humans;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Omeprazole/administration & dosage;Omeprazole/pharmacokinetics;Placebos
23983383;Acquired Immunodeficiency Syndrome/drug therapy*;Adult;Age Factors;Anti-HIV Agents/therapeutic use*;Cross-Sectional Studies;Female;HIV*;Herb-Drug Interactions;Humans;Male;Medicine, African Traditional/utilization*;Multivariate Analysis;Patient Acceptance of Health Care*;Phytotherapy/utilization*;Rural Population;Sex Factors;Socioeconomic Factors;South Africa;Surveys and Questionnaires;Urban Population
22189672;Adult;Biotransformation/drug effects;Caffeine/blood;Caffeine/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*/adverse effects;Dose-Response Relationship, Drug;Drug Combinations;Enzyme Induction/drug effects;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Female;Ginkgolides/blood;Headache/chemically induced;Herb-Drug Interactions*;Humans;Male;Phenotype;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Young Adult
22181338;Adolescent;Adult;Aged;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Iodine Radioisotopes/adverse effects*;Iodine Radioisotopes/therapeutic use;Lymphocytes/cytology;Lymphocytes/drug effects;Male;Micronuclei, Chromosome-Defective/chemically induced;Middle Aged;Mutagens/analysis;Plant Extracts/therapeutic use*;Radiation Injuries/prevention & control*;Radiopharmaceuticals/adverse effects*;Radiopharmaceuticals/therapeutic use;Thyroid Function Tests;Thyroid Neoplasms/drug therapy*
22164401;Aged;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Factors/therapeutic use;Emergency Service, Hospital*;Evidence-Based Medicine;Female;Hematoma, Subdural/diagnosis;Hematoma, Subdural/diagnostic imaging;Hematoma, Subdural/etiology;Hematoma, Subdural/therapy*;Hemorrhage/diagnosis;Hemorrhage/diagnostic imaging;Hemorrhage/etiology;Hemorrhage/therapy*;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Physical Examination;Plasma;Retroperitoneal Space;Tomography, X-Ray Computed;Warfarin/adverse effects;Warfarin/pharmacology;Warfarin/therapeutic use*
22157964;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Antioxidants/pharmacology;Chronic Disease;Clinical Trials as Topic;Contraindications;Curcumin/pharmacology*;Curcumin/therapeutic use;Herb-Drug Interactions;Humans;Inflammation/complications;Inflammation/drug therapy*;Inflammation/metabolism;Medicine, Ayurvedic;Neoplasms/etiology;Neoplasms/metabolism;Neoplasms/prevention & control*;Plants, Medicinal
22157509;Animals;Anti-Anxiety Agents/pharmacology;Anti-Anxiety Agents/therapeutic use*;Anxiety/drug therapy*;Behavior, Animal/drug effects;Benzodiazepines/metabolism;Binding Sites;Flavanones/pharmacology;Flavanones/therapeutic use*;Herb-Drug Interactions;Male;Maze Learning/drug effects;Mentha/chemistry*;Motor Activity/drug effects*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Prospective Studies;Random Allocation;Rats;Rats, Sprague-Dawley;Receptors, GABA-A/metabolism;gamma-Aminobutyric Acid/metabolism
22157508;Affect;Clinical Competence;Cognition;Cognition Disorders/drug therapy*;Herb-Drug Interactions;Herbal Medicine*;Humans;Mood Disorders/drug therapy*;Nursing;Phytotherapy*;Plant Extracts/therapeutic use*
22139695;Administration, Oral;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects;Allyl Compounds/pharmacology*;Animals;Dietary Supplements/adverse effects;Dietary Supplements/analysis;Dipyridamole/administration & dosage;Dipyridamole/adverse effects;Dipyridamole/blood;Dipyridamole/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Interactions;Garlic/chemistry;Half-Life;Herb-Drug Interactions;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Injections, Intravenous;Intestinal Absorption/drug effects;Jejunum/drug effects;Jejunum/metabolism;Male;Metabolic Clearance Rate/drug effects;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/pharmacology*;Rats;Rats, Sprague-Dawley;Solubility;Sulfides/administration & dosage;Sulfides/adverse effects;Sulfides/pharmacology*
22139686;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Drug Interactions*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;Intestines/drug effects*;Intestines/metabolism;Kidney/drug effects*;Kidney/metabolism;Liver/drug effects*;Liver/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacology
22139685;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestines/drug effects*;Intestines/enzymology*;Intestines/metabolism;Liver/drug effects*;Liver/enzymology*;Liver/metabolism;Pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
22139684;Animals;Biological Availability;Biological Transport/drug effects;Biotransformation/drug effects;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Drug Evaluation, Preclinical/methods;Enzyme Induction/drug effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism
22139678;Animals;Biotransformation;Drug Discovery/economics;Drug Evaluation, Preclinical/economics;Drug Industry/economics;Drug Industry/methods*;Drug Interactions;Drugs, Investigational/adverse effects;Drugs, Investigational/economics;Drugs, Investigational/pharmacokinetics*;Herb-Drug Interactions;Humans
22136282;Animals;Anticoagulants/therapeutic use;Blood Coagulation/drug effects*;Coagulants/therapeutic use;Evidence-Based Medicine;Fibrinolytic Agents/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Risk Factors
22132388;Administration, Oral;Administration, Topical;Aloe*/adverse effects;Aloe*/chemistry;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/administration & dosage*;Plant Extracts/adverse effects;Skin Diseases/drug therapy*
22113252;Adult;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Clozapine/blood;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Drug Resistance;Female;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Plant Preparations/adverse effects*;Schizophrenia, Disorganized/drug therapy*;Schizophrenia, Disorganized/physiopathology;Severity of Illness Index;Treatment Outcome
22108633;Dietary Supplements*/adverse effects;European Union;Food Contamination;Herb-Drug Interactions;Humans;Legislation, Food;Phytotherapy/adverse effects;Plant Preparations/adverse effects*;Plants, Edible*/adverse effects
22106566;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
22101086;Alkaloids/isolation & purification;Alkaloids/pharmacology*;Animals;Annona*/chemistry;Antidepressive Agents/pharmacology*;Behavior, Animal/drug effects;Brain/drug effects;Brain/metabolism;Clomipramine/pharmacology;Dopamine/metabolism;Fluoxetine/pharmacology;Herb-Drug Interactions;Homovanillic Acid/metabolism;Hydroxyindoleacetic Acid/metabolism;Imipramine/pharmacology;Male;Medicine, Traditional;Mexico;Mice;Plant Components, Aerial/chemistry;Plant Extracts/analysis;Plant Extracts/pharmacology*;Serotonin/metabolism;Swimming
22098637;Animals;Anti-Bacterial Agents/pharmacokinetics*;Ceftriaxone/pharmacokinetics*;Drug Interactions;Female;Goats;Herb-Drug Interactions*;Milk/metabolism;Phytotherapy
22097347;Adult;Anticoagulants/pharmacology*;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Warfarin/blood;Warfarin/pharmacology*;Young Adult
22091645;Administration, Oral;Animals;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dogs/blood*;Herb-Drug Interactions*;Hypericum*;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male
22089445;Anti-Retroviral Agents/pharmacokinetics;Anti-Retroviral Agents/pharmacology;Anti-Retroviral Agents/therapeutic use*;Biological Availability;Communicable Diseases;Diet;Food-Drug Interactions*;HIV Infections/complications;HIV Infections/drug therapy*;HIV Infections/metabolism;Health Resources;Herb-Drug Interactions*;Humans;Metabolic Diseases/complications;Micronutrients/pharmacology*;Nutritional Status*;Phytotherapy;Plant Preparations/pharmacology*;Poverty
22083560;Animals;Apiaceae/metabolism;Chromatography, High Pressure Liquid/methods*;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/metabolism;Furocoumarins/analysis;Furocoumarins/metabolism*;Herb-Drug Interactions*;Inhibitory Concentration 50;Liver/drug effects;Liver/metabolism;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Molecular Structure;Nifedipine/chemistry;Nifedipine/pharmacology;Oxidation-Reduction/drug effects;Rats;Rats, Wistar;Time Factors
22079696;Animals;Area Under Curve;Caffeine/blood;Caffeine/pharmacokinetics;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/pharmacology*;Erigeron*;Herb-Drug Interactions*;Metoprolol/blood;Metoprolol/pharmacokinetics;Midazolam/blood;Midazolam/pharmacokinetics;Rats;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
22078631;Adult;Androstenes/administration & dosage;Androstenes/adverse effects;Antioxidants/therapeutic use*;Catechin/analysis;Catechin/therapeutic use;Contraceptives, Oral, Combined/administration & dosage;Contraceptives, Oral, Combined/adverse effects*;Dietary Supplements*/analysis;Double-Blind Method;Estrogens/administration & dosage;Estrogens/adverse effects*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/adverse effects;Female;Herb-Drug Interactions*;Humans;Lipid Peroxidation/drug effects;Menstruation/blood;Menstruation/drug effects;Menstruation/metabolism;Oxidative Stress/drug effects*;Reactive Oxygen Species/antagonists & inhibitors*;Reactive Oxygen Species/blood;Tea/chemistry
22076909;Administration, Oral;Analgesics/pharmacology;Animals;Codeine/pharmacology;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Emulsions/chemistry;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Male;Mentha piperita/chemistry*;Mice;Midazolam/adverse effects;Oils, Volatile/administration & dosage;Oils, Volatile/pharmacology*;Pentobarbital/pharmacology;Plant Leaves/chemistry;Plant Oils/administration & dosage;Plant Oils/pharmacology*;Sleep/drug effects;Time Factors
22066443;Administration, Oral;Animals;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Houttuynia/chemistry*;Injections, Intravenous;Ketones/administration & dosage;Ketones/pharmacokinetics*;Oils, Volatile/administration & dosage;Oils, Volatile/pharmacokinetics*;Plants, Medicinal/chemistry*;Rats
22056022;Animals;Biomarkers/metabolism;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Enzyme Activation;Enzyme Inhibitors/pharmacology*;Ethanol/chemistry;Herb-Drug Interactions;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Phenacetin/pharmacology;Phenanthrolines/chemistry;Phenanthrolines/pharmacology;Plant Roots/chemistry;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Testosterone/pharmacology;Water/chemistry
22039823;Animals;Biological Transport/genetics*;Enzymes/genetics*;Enzymes/metabolism;Genetic Variation;Herb-Drug Interactions/genetics*;Herbal Medicine/methods;Humans;Inactivation, Metabolic/genetics*
22039821;Catalytic Domain;Cytochrome P-450 CYP2D6/chemistry;Cytochrome P-450 CYP2D6/genetics*;Cytochrome P-450 CYP2D6/metabolism*;Drug Evaluation, Preclinical/methods*;Herb-Drug Interactions;Herbal Medicine/methods;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Medicine, Chinese Traditional/methods;Molecular Docking Simulation/methods*;Mutation;Protein Binding;Quantitative Structure-Activity Relationship;Substrate Specificity
22024968;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme System/metabolism;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Plants, Medicinal;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/therapeutic use
22023882;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Angelica*;Animals;Coumarins/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Female;Flavonoids/blood;Flavonoids/metabolism;Flavonoids/pharmacokinetics*;Herb-Drug Interactions;In Vitro Techniques;Intestinal Absorption/drug effects;Intestines/metabolism;Male;Oils, Volatile/pharmacology*;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis*
22010398;Ginkgo biloba*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
21988365;Ajmaline/adverse effects;Anti-Arrhythmia Agents/adverse effects;Antihypertensive Agents/adverse effects*;Bradycardia/chemically induced*;Dietary Supplements/adverse effects;Drug Contamination;Female;Herb-Drug Interactions*;Humans;Hypertension/drug therapy;Hypotension/chemically induced*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Preparations/adverse effects;Reserpine/adverse effects
21969115;Anti-Infective Agents/isolation & purification;Anti-Infective Agents/pharmacology*;Antitubercular Agents/isolation & purification;Antitubercular Agents/pharmacology;Drug Synergism;Escherichia coli/drug effects*;Furans/isolation & purification;Furans/pharmacology*;Herb-Drug Interactions;Lythraceae/chemistry*;Mycobacterium tuberculosis/drug effects*;Nalidixic Acid/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Tetralones/chemistry;Tetralones/isolation & purification;Tetralones/pharmacology*
21963808;Andrographis*;Animals;Binding Sites;Cells, Cultured;Cytochrome P-450 CYP1A1/biosynthesis*;Cytochrome P-450 CYP1A1/genetics;Diterpenes/chemistry;Diterpenes/metabolism*;Enzyme Induction/drug effects;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Ligands;Male;Mice;Mice, Inbred C57BL;Models, Molecular;Molecular Conformation;RNA, Messenger/biosynthesis;Receptors, Aryl Hydrocarbon/chemistry;Receptors, Aryl Hydrocarbon/metabolism*;beta-Naphthoflavone/pharmacology
21959528;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Inactivation, Metabolic*;Nonprescription Drugs;Phytotherapy*;Plants, Medicinal/metabolism*;Prescription Drugs
21946639;Adult;Anticoagulants/adverse effects;Community Pharmacy Services*;Consumer Advocacy*;Consumer Product Safety;Food, Organic*;Health Education*;Herb-Drug Interactions;Humans;Male;New Zealand;Self Medication*;Warfarin/adverse effects
21943317;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adolescent;Adult;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Double-Blind Method;Genistein/pharmacology*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Metabolic Clearance Rate;Midazolam/pharmacokinetics*;Propanolamines/pharmacokinetics*;Protein Kinase Inhibitors/pharmacology*
21939995;Adult;Antirheumatic Agents;Complementary Therapies/adverse effects;Complementary Therapies/utilization;Cross-Sectional Studies;Disclosure;Female;HIV Infections/drug therapy*;Health Care Surveys;Herb-Drug Interactions;Humans;Logistic Models;Male;Middle Aged;Physician-Patient Relations;Phytotherapy/adverse effects;Phytotherapy/utilization*;Socioeconomic Factors;Surveys and Questionnaires
21928376;Animals;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacology;Anti-Inflammatory Agents/administration & dosage;Anti-Inflammatory Agents/chemistry;Anti-Inflammatory Agents/pharmacology;Cat's Claw/chemistry*;Diazepam/administration & dosage;Diazepam/chemistry;Diazepam/pharmacology*;Drug Combinations;Drug Interactions;Eucalyptus/chemistry*;Exploratory Behavior/drug effects;Female;Herb-Drug Interactions*;Male;Mice;Motor Activity/drug effects;Muscle Relaxation;Plant Bark/chemistry;Plant Leaves/chemistry;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology
21925256;Administration, Oral;Caco-2 Cells;Calcitriol/pharmacology;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Diterpenes/administration & dosage;Diterpenes/pharmacology*;Dose-Response Relationship, Drug;Down-Regulation;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Gene Expression Regulation, Enzymologic/drug effects;Herb-Drug Interactions;Humans;Hydroxylation;Intestines/drug effects*;Intestines/enzymology;Medicine, Chinese Traditional;Nifedipine/metabolism;Oxidation-Reduction;Plants, Medicinal;RNA, Messenger/metabolism;Testosterone/metabolism;Time Factors
21920422;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacology;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacology;Berberine/administration & dosage;Berberine/adverse effects;Berberine/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Gene Expression/drug effects*;Herb-Drug Interactions;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacology;Liver/drug effects*;Male;Mice;Mice, Inbred C57BL;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;RNA, Messenger/metabolism
21919844;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Animals;Cytochrome P-450 Enzyme System/metabolism;Garlic/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Panax/chemistry;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Plant Preparations/chemistry;Plant Preparations/metabolism*;Plant Preparations/pharmacokinetics
21910346;Adenocarcinoma/pathology;Cell Differentiation/drug effects*;Cell Line, Tumor;Cell Proliferation/drug effects*;Endometrial Neoplasms/pathology;Female;Fluorouracil/pharmacology*;Herb-Drug Interactions;Humans;Plant Extracts/pharmacology*;Rosa/chemistry
21907570;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacology;Colorectal Neoplasms/drug therapy;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions*;Hyperalgesia/chemically induced;Hyperalgesia/drug therapy;Hyperalgesia/prevention & control;Male;Medicine, Kampo;Mice;Mice, Inbred BALB C;Organoplatinum Compounds/adverse effects*;Organoplatinum Compounds/pharmacology;Pain/chemically induced;Pain/drug therapy;Pain/prevention & control;Peripheral Nervous System Diseases/chemically induced*;Peripheral Nervous System Diseases/drug therapy;Peripheral Nervous System Diseases/prevention & control*;Rats;Rats, Sprague-Dawley;Tumor Cells, Cultured
21906668;Acetaminophen/pharmacology;Administration, Oral;Alkaloids/pharmacology;Animals;Benzodioxoles/pharmacology;Biotransformation;Caco-2 Cells;Catechin/pharmacology;Chromatography, Liquid;Curcumin/administration & dosage;Curcumin/pharmacology*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Flavanones/administration & dosage;Flavanones/blood;Flavanones/pharmacokinetics*;Glucuronides/metabolism;Herb-Drug Interactions*;Humans;Intestinal Absorption*/drug effects;Jejunum/drug effects*;Jejunum/metabolism;Male;Medicine, Chinese Traditional;Perfusion;Piperidines/pharmacology;Plant Roots;Plants, Medicinal;Polyunsaturated Alkamides/pharmacology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis*/chemistry;Sulfates/metabolism;Tandem Mass Spectrometry
21901498;Animals;Biological Availability;Drug Administration Schedule;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Edetic Acid/pharmacology;Herb-Drug Interactions*;Male;Medicine, Kampo;Rats;Rats, Wistar;Tetracycline/pharmacokinetics;Tetracycline/pharmacology*
21892916;Drug Contamination;Drugs, Chinese Herbal/toxicity*;Herb-Drug Interactions;Herbal Medicine;Medicine, Chinese Traditional/adverse effects*;Phytotherapy/adverse effects;Plants, Medicinal/toxicity*
21879526;Anthropology;Chemical and Drug Induced Liver Injury;Ethnopharmacology;Hawaii;Herb-Drug Interactions;Herbal Medicine/standards;Humans;Kava/adverse effects*;Medicine, Traditional*;Phytotherapy/adverse effects*;Risk Assessment
21878380;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/blood;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/pharmacology*;Chromatography, High Pressure Liquid;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Linear Models;Male;Prothrombin Time;Rats;Rats, Wistar;Warfarin/administration & dosage;Warfarin/blood;Warfarin/pharmacokinetics*
21867654;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Legislation, Drug;Liver Failure, Acute/chemically induced;Liver Failure, Acute/diagnosis;Plant Extracts/adverse effects;Plant Preparations/adverse effects*;Risk Factors
21838705;Animals;Antiviral Agents/pharmacokinetics;Biological Transport;Caco-2 Cells;Cardiovascular Agents/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Darunavir;Garlic/chemistry*;Hep G2 Cells;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans;Intestine, Small/drug effects;Intestine, Small/metabolism;Male;Membrane Transport Proteins/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Reproducibility of Results;Sulfonamides/pharmacokinetics
21827497;Animals;Body Weight/drug effects*;Caseins/administration & dosage;Diet, Protein-Restricted*;Dietary Proteins/administration & dosage;Ginkgo biloba*;Herb-Drug Interactions*;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology*;Liver/drug effects;Male;Organ Size/drug effects;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Serum Albumin/metabolism;Tolbutamide/blood;Tolbutamide/pharmacokinetics;Tolbutamide/pharmacology*
21827215;Carbamates/blood;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cross-Over Studies;Cytochrome P-450 Enzyme System/metabolism;Depression/drug therapy*;Genotype;Herb-Drug Interactions/genetics*;Humans;Hypericum*;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Organic Anion Transporters/genetics;Phytotherapy;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Placebos;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Receptors, Steroid/agonists*;Receptors, Steroid/genetics;Receptors, Steroid/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Young Adult
21823195;Acute Coronary Syndrome/complications;Acute Coronary Syndrome/drug therapy;Acute Coronary Syndrome/epidemiology*;Aged;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aspirin/therapeutic use;Cardiovascular Diseases/complications;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/epidemiology;Cohort Studies;Cytochrome P-450 CYP2C19;Databases, Factual;Drug Interactions;Esomeprazole;Female;Herb-Drug Interactions;Hospitalization;Humans;Male;Middle Aged;Omeprazole/adverse effects;Omeprazole/therapeutic use;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Proton Pump Inhibitors/adverse effects*;Proton Pump Inhibitors/therapeutic use;Recurrence;Retrospective Studies;Ticlopidine/adverse effects;Ticlopidine/analogs & derivatives;Ticlopidine/therapeutic use;Treatment Outcome
21804969;Animals;Carcinogens;Dietary Supplements/adverse effects*;Europe;Food Contamination/legislation & jurisprudence;Food Contamination/prevention & control;Food Safety*;Herb-Drug Interactions;Humans;Legislation, Food;Mutagens;Plant Preparations/adverse effects*;Plants, Edible/adverse effects*;Risk Assessment
21804213;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Apiaceae/chemistry;Biological Transport/drug effects;Blood-Brain Barrier/cytology;Blood-Brain Barrier/drug effects*;Blood-Brain Barrier/metabolism;Caco-2 Cells;Cattle;Citrus paradisi/chemistry;Coumarins/pharmacokinetics;Coumarins/pharmacology*;Endothelial Cells/drug effects;Endothelial Cells/metabolism;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Fluoresceins/metabolism;Furans/pharmacokinetics;Furans/pharmacology*;Furocoumarins/pharmacokinetics;Furocoumarins/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Male;Medicine, Kampo;Permeability;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Rutaceae/chemistry;Verapamil/metabolism
21802929;Animals;Anticoagulants/adverse effects*;Blood Coagulation/drug effects;Coagulants/pharmacology;Cyclopentanes/administration & dosage;Cyclopentanes/pharmacology*;Cytochrome P-450 Enzyme System/chemistry*;Cytochrome P-450 Enzyme System/drug effects;Enzyme Induction;Furans/administration & dosage;Furans/pharmacology*;Ginkgo biloba/chemistry*;Ginkgolides/administration & dosage;Ginkgolides/pharmacology*;Herb-Drug Interactions;Lactones/administration & dosage;Lactones/pharmacology;Liver/chemistry;Liver/drug effects;Male;Mice;Mice, Inbred ICR;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Warfarin/administration & dosage;Warfarin/adverse effects*
21802919;Aged;Alanine Transaminase/metabolism;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury/diagnosis*;Chemical and Drug Induced Liver Injury/enzymology*;Chemical and Drug Induced Liver Injury/epidemiology;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions*;Hospitalization;Humans;Liver/drug effects*;Liver/enzymology;Male;Middle Aged;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Pilot Projects;Plants, Medicinal/adverse effects;Plants, Medicinal/metabolism*;Prevalence;Republic of Korea/epidemiology;Retrospective Studies
21796700;Animals;Antineoplastic Agents, Phytogenic/pharmacokinetics*;China;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Male;Paclitaxel/pharmacokinetics*;Phytotherapy;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Schisandra/chemistry*
21756221;Absorption;Africa;Beverages;Genetic Variation;Herb-Drug Interactions*;Humans;Phytotherapy*;Tissue Distribution
21749828;Animals;Bufanolides/pharmacology*;Cattle;Chromatography, High Pressure Liquid;Herb-Drug Interactions*;Humans;Serum Albumin;Serum Albumin, Bovine;Verapamil/pharmacology*
21749392;Animals;Cattle;Cell Survival;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drug-Related Side Effects and Adverse Reactions;Glycosides/pharmacology;Harpagophytum/chemistry*;Herb-Drug Interactions*;Iridoid Glycosides;Luminescent Measurements;Phytotherapy;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry*;Pyrans/pharmacology;Receptors, Steroid/metabolism;Retinoid X Receptors/metabolism
21742280;Adult;Birth Weight/drug effects;Cesarean Section;Female;Health Care Surveys;Herb-Drug Interactions*;Humans;Iron, Dietary/therapeutic use*;Norway;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Polypharmacy;Pregnancy;Pregnancy Complications/drug therapy*;Pregnancy Outcome*;Surveys and Questionnaires
21742023;Action Potentials;Animals;Anti-Anxiety Agents/pharmacology*;CA1 Region, Hippocampal/cytology;CA1 Region, Hippocampal/drug effects*;CA1 Region, Hippocampal/metabolism;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Male;Neurons/drug effects*;Neurons/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley;Receptor, Serotonin, 5-HT1A/drug effects;Receptor, Serotonin, 5-HT1A/metabolism;Receptor, Serotonin, 5-HT2A/drug effects;Receptor, Serotonin, 5-HT2A/metabolism;Serotonin Agents/pharmacology*;Triterpenes/pharmacology*
21729114;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Inhibitory Concentration 50;Isoenzymes;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Republic of Korea
21717139;Animals;Drugs, Chinese Herbal/pharmacology*;Fluorobenzenes/pharmacokinetics*;Herb-Drug Interactions*;Lactates/pharmacology*;Male;Pyrimidines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rosuvastatin Calcium;Solute Carrier Organic Anion Transporter Family Member 1b1/physiology;Sulfonamides/pharmacokinetics*;Triterpenes/pharmacology*
21715270;Aegle/chemistry*;Amides/isolation & purification;Amides/pharmacology*;Animals;Calcium/metabolism;Cell Culture Techniques;Cell Line, Tumor;Dinitrophenols/antagonists & inhibitors;Dinitrophenols/pharmacology;Herb-Drug Interactions*;Histamine Release/drug effects*;Ionomycin/antagonists & inhibitors;Ionomycin/pharmacology;Male;Mast Cells/drug effects*;Mast Cells/metabolism;Rats;Rats, Wistar;Serum Albumin, Bovine/antagonists & inhibitors;Serum Albumin, Bovine/pharmacology;Tetradecanoylphorbol Acetate/antagonists & inhibitors;Tetradecanoylphorbol Acetate/pharmacology;Thapsigargin/antagonists & inhibitors;Thapsigargin/pharmacology;p-Methoxy-N-methylphenethylamine/antagonists & inhibitors;p-Methoxy-N-methylphenethylamine/pharmacology
21704146;Administration, Oral;Animals;Biological Availability;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Carthamus tinctorius;Coumaric Acids/administration & dosage;Coumaric Acids/blood;Coumaric Acids/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Intestinal Absorption/drug effects;Male;Platelet Aggregation Inhibitors/administration & dosage*;Rats;Rats, Sprague-Dawley;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*
21696342;Animals;Body Temperature/drug effects*;Brain/drug effects;Cannabinoids/adverse effects;Cannabis/adverse effects*;Cognition/drug effects*;Conditioning (Psychology)/drug effects*;Herb-Drug Interactions*;Humans;N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage;N-Methyl-3,4-methylenedioxyamphetamine/adverse effects*;Synaptic Transmission/drug effects*
21692140;Canada;Drug Contamination/statistics & numerical data;Drug Industry;Health Communication/methods*;Herb-Drug Interactions;Humans;Information Dissemination/methods;Plant Preparations/adverse effects*;Plant Preparations/metabolism;Plant Preparations/poisoning;Risk Assessment;Risk Management/methods*
21686183;Computational Biology;Crystallography, X-Ray;Cytochrome P-450 CYP1A2/chemistry*;Cytochrome P-450 CYP1A2 Inhibitors/chemistry*;Drug Discovery;Herb-Drug Interactions*;Molecular Conformation;Substrate Specificity
21671861;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antineoplastic Agents, Phytogenic/pharmacology;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy;Plants, Medicinal/chemistry*
21667558;Anxiety Disorders/drug therapy*;Depressive Disorder/drug therapy*;Drug Therapy, Combination;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/therapeutic use*;Somatoform Disorders/drug therapy*
21658754;Aged;Aged, 80 and over;Dietary Supplements/adverse effects*;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Emergency Nursing/methods*;Female;Geriatric Nursing/methods*;Herb-Drug Interactions;Herbal Medicine;Humans;Male;Nonprescription Drugs/adverse effects*;Pharmaceutical Preparations/administration & dosage;Plants, Medicinal/adverse effects*
21657088;Animals;Biomarkers, Pharmacological;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans
21649517;Adolescent;Adult;Age Factors;Aged;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Drug Prescriptions/statistics & numerical data*;Drug Therapy, Combination/adverse effects;Drug Therapy, Combination/trends;Ginkgo biloba*;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Insurance, Health;Middle Aged;Odds Ratio;Phytotherapy/adverse effects*;Plant Extracts;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Retrospective Studies;Risk;Sex Factors;Taiwan;Young Adult
21646440;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors;Drug Monitoring;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Female;Half-Life;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male;Metabolic Clearance Rate/drug effects;Midazolam/blood;Midazolam/pharmacokinetics*;Panax/chemistry*;Plant Roots/chemistry;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Young Adult
21645607;Adolescent;Adult;Age Factors;Aged;Awareness;Communication;Cultural Characteristics;Drug-Related Side Effects and Adverse Reactions;Educational Status;Employment;Female;Health Behavior*/ethnology;Health Care Surveys;Health Knowledge, Attitudes, Practice*/ethnology;Herb-Drug Interactions;Humans;Jamaica;Male;Medicine, Traditional/utilization*;Middle Aged;Pharmaceutical Preparations*;Physician-Patient Relations;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Religion and Medicine;Self Medication;Surveys and Questionnaires;Young Adult
21641521;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use;Commerce/standards*;Consumer Health Information/standards*;Contraindications;Cross-Sectional Studies;Depressive Disorder/therapy;Herb-Drug Interactions*;Humans;Hypericum*;Internet/standards*;Phytotherapy*;Plant Extracts/adverse effects*
21632963;Glucuronides/metabolism*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology*;Trifluoperazine/metabolism*
21619523;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Intestine, Small/drug effects;Intestine, Small/enzymology;Intestine, Small/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plants, Medicinal/chemistry;Species Specificity;Translational Medical Research*/trends
21619521;Animals;Biological Availability;Biotransformation;Gene Knockout Techniques;Herb-Drug Interactions*;Humans;Metabolomics/methods;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
21619520;Animals;Biotransformation;Carcinogens/pharmacokinetics;Carcinogens/toxicity*;Chemical and Drug Induced Liver Injury/metabolism*;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry*;Pyrrolizidine Alkaloids/pharmacokinetics*;Pyrrolizidine Alkaloids/toxicity*
21619519;Animals;Biological Availability;Biotransformation;Ginsenosides/adverse effects;Ginsenosides/analysis;Ginsenosides/pharmacokinetics;Ginsenosides/therapeutic use;Herb-Drug Interactions*;Humans;Panax/chemistry*;Phytotherapy;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use;Plant Roots/chemistry*;Saponins/adverse effects;Saponins/analysis;Saponins/pharmacokinetics;Saponins/therapeutic use
21619518;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Drug Interactions;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestine, Small/drug effects;Intestine, Small/enzymology;Intestine, Small/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry*;Tissue Distribution/drug effects
21614461;Adult;Analysis of Variance;Cross-Over Studies;Fluorides, Topical/adverse effects;Herb-Drug Interactions;Humans;Mouthwashes/adverse effects*;Oils, Volatile/adverse effects*;Phenols/adverse effects*;Plant Oils/adverse effects;Reproducibility of Results;Single-Blind Method;Tea/adverse effects;Tin Fluorides/adverse effects*;Tongue/drug effects*;Tooth Discoloration/chemically induced*
21609190;Animals;Herb-Drug Interactions*;Herbal Medicine*;Humans;Inactivation, Metabolic*;Plant Preparations/pharmacokinetics*;Plants, Medicinal/chemistry*;Plants, Medicinal/toxicity
21567510;Animals;Area Under Curve;Benzofurans/blood;Benzofurans/metabolism;Benzofurans/pharmacokinetics*;Bile/metabolism*;Biological Transport/drug effects;Chromatography, High Pressure Liquid;Chromatography, Liquid;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Male;Mass Spectrometry;Organic Anion Transporters/antagonists & inhibitors*;Plant Extracts/blood;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rifampin/pharmacology*;Salvia miltiorrhiza/chemistry*
21558883;Aged;Aged, 80 and over;Atrial Fibrillation/blood*;Atrial Fibrillation/drug therapy*;Cohort Studies;Follow-Up Studies;Herb-Drug Interactions*/physiology;Humans;International Normalized Ratio/methods;Male;Middle Aged;Plant Preparations/blood;Plant Preparations/therapeutic use*;Surveys and Questionnaires;Time Factors;Warfarin/blood;Warfarin/therapeutic use*
21556089;Adolescent;Adult;Child;Depression/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*;Phytotherapy*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Factors;Treatment Outcome
21545833;Administration, Oral;Animals;Cell Line, Tumor;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Evaluation, Preclinical;Fabaceae*;Formazans;Herb-Drug Interactions*;Humans;Male;Nevirapine/administration & dosage;Nevirapine/metabolism;Nevirapine/pharmacokinetics*;Nevirapine/pharmacology;Plant Extracts/administration & dosage;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/pharmacology;Tetrazolium Salts;Time Factors
21544887;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Humans;Hymecromone/analogs & derivatives*;Hymecromone/metabolism;Isoenzymes;Kinetics;Monoterpenes/pharmacology*;Plant Extracts/pharmacology*;Recombinant Proteins
21542296;Angelica/chemistry*;Animals;Drug Synergism;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Duodenum/metabolism;Flavonoids/isolation & purification;Flavonoids/pharmacokinetics*;Herb-Drug Interactions;Intestinal Absorption/drug effects*;Intestines/metabolism;Male;Perfusion;Permeability;Plants, Medicinal/chemistry;Portal Vein/metabolism;Rats;Rats, Sprague-Dawley;Scutellaria/chemistry*;Verapamil/pharmacology
21538851;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Animals;Cytochrome P-450 Enzyme Inhibitors;Dietary Supplements/adverse effects*;Dietary Supplements/analysis;Glucuronosyltransferase/metabolism;Hepatic Insufficiency/chemically induced;Herb-Drug Interactions;Humans;Kinetics;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/metabolism;Plant Extracts/pharmacology;Tea/chemistry*
21538623;Cell Line;Cytochrome P-450 Enzyme System/metabolism*;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Liver/cytology;Liver/drug effects*;Liver/enzymology;Plant Extracts/pharmacology*;Plant Lectins/pharmacology*;Species Specificity;Viscum/chemistry*;Viscum/classification
21527329;Absorption/drug effects;Animals;Area Under Curve;Capsules;Drugs, Chinese Herbal/pharmacology*;Glyburide/blood;Glyburide/pharmacokinetics*;Herb-Drug Interactions*;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Malvaceae*;Rats;Rats, Sprague-Dawley
21524698;4-Butyrolactone/analogs & derivatives;4-Butyrolactone/pharmacology;Berberine/pharmacology;Cyclooctanes/pharmacology;Cytochrome P-450 CYP3A/metabolism*;Dioxoles/pharmacology;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Genes, Reporter;Hep G2 Cells;Herb-Drug Interactions*;Humans;Lignans/pharmacology;Magnoliopsida/chemistry*;Medicine, Chinese Traditional;Plants, Medicinal/chemistry;Receptors, Steroid/metabolism*;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction/drug effects;Stilbenes/pharmacology
21508758;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Legislation, Food;Physician-Patient Relations;Plant Preparations/adverse effects;United States
21495267;Animals;Anti-Infective Agents/pharmacokinetics*;Antimalarials/pharmacology;Herb-Drug Interactions*;Male;Metronidazole/pharmacokinetics*;Plant Extracts/pharmacology*;Rats;Rats, Wistar
21480802;Animals;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Disease Models, Animal;Female;Herb-Drug Interactions*;Hibiscus/chemistry*;Humans;Hydrochlorothiazide/adverse effects;Hydrochlorothiazide/pharmacokinetics*;Hypertension/drug therapy*;Hypertension/physiopathology;Male;Mice;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics*;Rabbits;Rats;Urination/drug effects
21480130;Aged, 80 and over;Anticoagulants/adverse effects*;Drug Interactions;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Male;Plant Preparations/adverse effects*;Warfarin/adverse effects*
21462089;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adenosine Triphosphatases/metabolism*;Analysis of Variance;Antineoplastic Agents/pharmacology*;Cell Line, Tumor;Cell Survival/drug effects;Colchicine/pharmacology;Daunorubicin/pharmacology;Drug Resistance, Neoplasm;Flavonoids/pharmacology*;Herb-Drug Interactions*;Humans;Verapamil/pharmacology;Vinblastine/pharmacology
21456393;Anti-Inflammatory Agents/therapeutic use;Antineoplastic Agents/therapeutic use*;Bromelains/therapeutic use*;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy
21441484;Animals;Anti-HIV Agents*;Antiretroviral Therapy, Highly Active;Clinical Trials as Topic;Drugs, Chinese Herbal*;Enzyme Inhibitors;HIV-1/enzymology;Herb-Drug Interactions;Humans;Research*
21436933;Counseling/methods*;Counseling/standards;Dietary Supplements*/adverse effects;Health Surveys/methods;Health Surveys/standards;Herb-Drug Interactions;Humans;Patient Education as Topic/methods*;Patient Education as Topic/standards;Pharmacists*/standards;Pilot Projects;Plant Preparations*/adverse effects;Reproducibility of Results
21425377;Alkaloids/pharmacology*;Coptis/chemistry*;Cytochrome P-450 Enzyme System/drug effects*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Isoenzymes/drug effects;Microsomes, Liver/drug effects*;Rhizome/chemistry
21421030;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Infusions, Intravenous;Male;Platelet Aggregation Inhibitors/pharmacokinetics;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry;Taxoids/administration & dosage;Taxoids/pharmacokinetics*;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
21417789;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions/physiology*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology;Intestines/metabolism;Pharmaceutical Preparations/metabolism;Plant Preparations/adverse effects*;Plant Preparations/metabolism*
21397894;Ampicillin/pharmacology;Anti-Bacterial Agents/pharmacology*;Bacteria, Aerobic/drug effects*;Bacteria, Anaerobic/drug effects;Clove Oil/pharmacology*;Colony Count, Microbial;Dental Caries/microbiology;Drug Synergism;Eugenol/pharmacology;Gentamicins/pharmacology;Herb-Drug Interactions;Microbial Sensitivity Tests;Mouth/microbiology*;Periodontitis/microbiology;Sesquiterpenes/pharmacology
21385154;Biological Products/adverse effects;Biological Products/chemistry;Biological Products/metabolism*;Biological Products/pharmacokinetics*;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Herb-Drug Interactions;Humans;Tissue Distribution
21368384;Europe;Herb-Drug Interactions;Humans;Kidney Diseases/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Serenoa/chemistry;Urinary Tract Infections/drug therapy
21359185;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/therapeutic use*;Combined Modality Therapy/adverse effects;Cross-Sectional Studies;Drugs, Chinese Herbal/therapeutic use*;Epidemiologic Studies;Female;Herb-Drug Interactions/physiology*;Humans;Male;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/utilization*;Retrospective Studies;Schizophrenia/drug therapy*;Schizophrenia/epidemiology*;Surveys and Questionnaires;Young Adult
21351298;Animals;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Enzyme Inhibitors/pharmacology*;Glycyrrhiza/chemistry*;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions*;Inhibitory Concentration 50;Ketoconazole/pharmacology;Male;Plant Extracts/pharmacology*;Quinidine/pharmacology;Rats, Wistar;Rhizome
21331509;Animals;Biological Availability;Catechin/analogs & derivatives*;Catechin/blood;Catechin/metabolism;Chemical Precipitation;Herb-Drug Interactions*;Humans;Indoles/blood;Indoles/metabolism*;Indoles/pharmacokinetics*;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry;Mice;Mice, Inbred C57BL;Plant Extracts/metabolism;Pyrroles/blood;Pyrroles/metabolism*;Pyrroles/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tea/chemistry
21309292;Anesthesia;Animals;Cyclooxygenase 2/drug effects;Cyclooxygenase Inhibitors/pharmacology;Dietary Supplements/adverse effects;Dietary Supplements/utilization;Drug Evaluation, Preclinical;Drug Therapy, Combination;Ellagic Acid/adverse effects;Ellagic Acid/pharmacology*;Flow Cytometry*/methods;Hemorrhage/chemically induced;Herb-Drug Interactions/physiology;Ketorolac/pharmacology;Male;P-Selectin*/analysis;P-Selectin*/drug effects;Phytotherapy/adverse effects;Phytotherapy/utilization;Platelet Activation/drug effects*;Rats;Rats, Sprague-Dawley;Thiazines/pharmacology;Thiazoles/pharmacology
21296832;Anticoagulants/chemistry;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Chromatography, Thin Layer;Coumarins/analysis;Hemolysis/drug effects*;Herb-Drug Interactions;Humans;Medicine, African Traditional;Partial Thromboplastin Time;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;Plants, Medicinal/classification;Prothrombin Time;Salicylates/analysis;South Africa;Species Specificity
21296265;Adolescent;Adult;Disclosure/statistics & numerical data*;Drug Prescriptions/statistics & numerical data*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/utilization*;Plants, Medicinal;Prescription Drugs;Self Medication/psychology*;Self Medication/statistics & numerical data*;Self Report;Students/psychology*;Students/statistics & numerical data*;Young Adult
21295405;Animals;Cognition Disorders/etiology*;Disease Models, Animal;Excitatory Amino Acid Antagonists/pharmacology;Excitatory Postsynaptic Potentials/drug effects;Exploratory Behavior/physiology;Fluoroacetates/pharmacology;Glycine/metabolism*;Glycine/pharmacology;Herb-Drug Interactions;Hippocampus/metabolism*;Hippocampus/pathology;Hyperalgesia/drug therapy;Hyperalgesia/etiology;In Vitro Techniques;Male;Membrane Potentials/drug effects;Mice;Mice, Inbred Strains;Motor Activity/drug effects;N-Methylaspartate/pharmacology;Neurons/drug effects;Neurons/physiology;Pain Measurement;Pain Threshold/physiology;Patch-Clamp Techniques;Recognition (Psychology);Sarcosine/analogs & derivatives;Sarcosine/therapeutic use;Sciatic Neuropathy/complications*;Sciatic Neuropathy/drug therapy;Sciatic Neuropathy/pathology*
21294484;Herb-Drug Interactions;Humans;Lycium*;Neoplasms/drug therapy*;Phytotherapy*
21287929;Evidence-Based Practice;Garlic/adverse effects;Ginkgo biloba/adverse effects;Glycyrrhiza/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Medication Reconciliation;NADPH-Ferrihemoprotein Reductase/drug effects;NADPH-Ferrihemoprotein Reductase/metabolism;Nursing Assessment;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;United Kingdom
21287651;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Daunorubicin/pharmacokinetics;Dictamnus/chemistry;Digoxin/antagonists & inhibitors;Digoxin/pharmacokinetics;Genes, MDR/drug effects;Genetic Variation;Herb-Drug Interactions*;Humans;LLC-PK1 Cells;Oocytes/drug effects;Oocytes/metabolism;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Poria/chemistry;Rhus/chemistry;Swine;Xenopus laevis
21281847;Adolescent;Child;Dietary Supplements;Docosahexaenoic Acids/adverse effects;Docosahexaenoic Acids/pharmacology;Eicosapentaenoic Acid/adverse effects;Eicosapentaenoic Acid/pharmacology;Herb-Drug Interactions;Herbal Medicine*;Humans;Hypericum/adverse effects;Kava/adverse effects;Melatonin/adverse effects;Melatonin/pharmacology;Mental Disorders/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Valerian/adverse effects
21220081;Chronic Disease;Complementary Therapies*/adverse effects;Complementary Therapies*/psychology;Complementary Therapies*/trends;Complementary Therapies*/utilization;Culture;Global Health;Herb-Drug Interactions;Humans;Life Style;Pain/etiology;Patient Participation*;Physician-Patient Relations*;Rheumatic Diseases/therapy*;Treatment Outcome
21218728;Adult;Attitude of Health Personnel*;Clinical Competence;Cross-Sectional Studies;Female;Health Knowledge, Attitudes, Practice*;Health Services Needs and Demand;Herb-Drug Interactions;Herbal Medicine*/education;Herbal Medicine*/methods;Herbal Medicine*/statistics & numerical data;Humans;Male;Medicine, Arabic;Motivation;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Pharmacies*/organization & administration;Pharmacists/organization & administration;Pharmacists/psychology*;Safety;Saudi Arabia;Surveys and Questionnaires;Urban Health/statistics & numerical data
21213356;Biotransformation;Cimicifuga/adverse effects;Cimicifuga/chemistry;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Fluorescent Dyes/metabolism;Herb-Drug Interactions;Humans;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Viburnum/adverse effects;Viburnum/chemistry;Vitex/chemistry
22754069;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Counseling*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Patient Education as Topic/methods*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Plant Preparations/pharmacology*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism
21191769;Administration, Oral;Animals;Area Under Curve;Bile/drug effects;Bile/metabolism;Coloring Agents/metabolism*;Coloring Agents/pharmacokinetics;Cyclosporine/metabolism;Cyclosporine/pharmacokinetics;Drug Interactions;Herb-Drug Interactions*;Infusions, Intravenous;Male;Multidrug Resistance-Associated Proteins/metabolism;Phenolsulfonphthalein/metabolism*;Phenolsulfonphthalein/pharmacokinetics;Plant Extracts/metabolism*;Plant Extracts/pharmacokinetics;Plant Extracts/therapeutic use*;Rats;Rats, Sprague-Dawley
21184395;Cytochrome P-450 CYP3A/drug effects;Echinacea/toxicity;Enzyme Induction;Ginkgo biloba/toxicity;Herb-Drug Interactions*;Humans;Hypericum/toxicity;Panax/toxicity;Phytotherapy/adverse effects*;Plant Extracts/toxicity;Plant Preparations/toxicity*;Valerian/toxicity
21178302;Cytochrome P-450 CYP1A1/drug effects*;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1A2/drug effects*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Enzyme Induction/drug effects*;Ginsenosides*/chemistry;Ginsenosides*/metabolism;Ginsenosides*/pharmacology;Glycosylation;Hep G2 Cells;Herb-Drug Interactions;Humans;Panax/metabolism;Plant Extracts/pharmacology;Structure-Activity Relationship
21178301;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP3A*/metabolism;Cytochrome P-450 CYP3A Inhibitors;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Inhibitory Concentration 50;Ketoconazole/pharmacology;Lignans/pharmacology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Phyllanthus/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacology*
21170698;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Biological Availability;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions/physiology*;Humans;Hypericum;Losartan/adverse effects;Losartan/pharmacokinetics;Losartan/therapeutic use;Milk Thistle;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics*;Plant Extracts/therapeutic use
21144332;Antineoplastic Agents/therapeutic use;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy*;Portugal;Risk Factors
21140309;Aged;Aged, 80 and over;Alzheimer Disease/drug therapy*;Attitude of Health Personnel*;Cross-Sectional Studies;Dementia/drug therapy*;Drug Utilization/statistics & numerical data;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use*;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Surveys and Questionnaires;Treatment Outcome;United Kingdom;Vitamins/adverse effects;Vitamins/therapeutic use*
21139236;Animals;Anti-Infective Agents/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System;Furans/isolation & purification;Herb-Drug Interactions*;Humans;Insecta/cytology;Insecta/drug effects;Microsomes/drug effects;Microsomes/metabolism;Myristica fragrans/chemistry*;Phenols/isolation & purification;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Seeds;Spices*;Sulfaphenazole/pharmacology
21134460;Animals;Herb-Drug Interactions*;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*
21132655;Aristolochic Acids/adverse effects;Herb-Drug Interactions;Humans;Kidney Diseases/chemically induced*;Phytotherapy/adverse effects*
21110181;Atrial Fibrillation/physiopathology;Atrial Fibrillation/therapy;Complementary Therapies/methods*;Evidence-Based Medicine/methods*;Heart Rate/physiology;Herb-Drug Interactions;Humans;Integrative Medicine/methods*;Internet;Medicine, Chinese Traditional/methods*;Surveys and Questionnaires*;Treatment Outcome
21093571;Andrographis*/adverse effects;Andrographis*/chemistry;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Centella*/adverse effects;Centella*/chemistry;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacology*;Ethnopharmacology;Flavonoids/adverse effects;Flavonoids/pharmacology;Herb-Drug Interactions;Humans;In Vitro Techniques;Kinetics;Orthosiphon*/adverse effects;Orthosiphon*/chemistry;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry;Recombinant Proteins/antagonists & inhibitors;Triterpenes/adverse effects;Triterpenes/chemistry;Triterpenes/pharmacology
21084768;Aldehyde Oxidase/antagonists & inhibitors*;Animals;Beverages/adverse effects*;Catechin/analogs & derivatives;Catechin/pharmacology;Cytosol/enzymology;Herb-Drug Interactions;Humans;Liver/drug effects;Male;Niacinamide/analogs & derivatives*;Niacinamide/metabolism;Rats;Tea/chemistry*;Xanthine Oxidase/antagonists & inhibitors
21074339;Consumer Health Information*;Drug Monitoring;Female;Herb-Drug Interactions;Humans;Phytoestrogens/adverse effects*;Phytoestrogens/therapeutic use;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Receptors, Estrogen/drug effects
21067427;Administration, Oral;Animals;Biological Transport;Drug-Related Side Effects and Adverse Reactions;Enzyme Induction/drug effects;Enzyme Inhibitors/adverse effects;Gastrointestinal Motility;Herb-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/pharmacology*
21062640;Acorus/chemistry*;Animals;Anisoles/pharmacology*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Rats;Rhizome
21062330;Acute Disease;Adult;Aged;Aged, 80 and over;Anti-Infective Agents/therapeutic use;Ascorbic Acid/adverse effects;Ascorbic Acid/pharmacology;Ascorbic Acid/therapeutic use;Ciprofloxacin/therapeutic use;Disease Progression;Double-Blind Method;Drug Synergism;Echinacea*;Female;Herb-Drug Interactions;Humans;Immunity, Innate/drug effects*;Male;Micronutrients/adverse effects;Micronutrients/pharmacology;Micronutrients/therapeutic use*;Middle Aged;Phytotherapy;Placebos;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Pulmonary Disease, Chronic Obstructive/drug therapy*;Pulmonary Disease, Chronic Obstructive/physiopathology;Respiratory Tract Infections/drug therapy;Respiratory Tract Infections/physiopathology;Selenium/adverse effects;Selenium/pharmacology;Selenium/therapeutic use;Treatment Outcome;Vitamins/adverse effects;Vitamins/pharmacology;Vitamins/therapeutic use*;Zinc/adverse effects;Zinc/pharmacology;Zinc/therapeutic use
21054461;Adult;Aphrodisiacs/pharmacology*;Area Under Curve;Biological Availability;Cross-Over Studies;Eurycoma*;Half-Life;Herb-Drug Interactions*;Humans;Male;Phytotherapy;Plant Extracts/pharmacology*;Plant Roots/chemistry;Propranolol/blood;Propranolol/pharmacokinetics*;Propranolol/pharmacology;Quassins/pharmacology*;Sexual Dysfunction, Physiological/drug therapy;Single-Blind Method;Water;Young Adult
21053788;Complementary Therapies/adverse effects;Depression, Postpartum/drug therapy*;Female;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Lactation/drug effects*;Medicine, Ayurvedic;Medicine, Chinese Traditional;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Pregnancy*;Safety*
21053786;Breast Feeding;Depressive Disorder/drug therapy*;Depressive Disorder, Major/drug therapy;Female;Herb-Drug Interactions;Humans;Hypericum*/adverse effects;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy
21053623;Acupuncture Points*;Drug Incompatibility;Drug Therapy*;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions*;Humans;Seasons*
21049395;Animals;Dietary Supplements*;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic*;Phytotherapy*;Plant Extracts/pharmacology*;Plants, Medicinal*;United States
21036573;Alpinia/chemistry*;Anti-Bacterial Agents/isolation & purification;Anti-Bacterial Agents/pharmacology*;Ceftazidime/pharmacology*;Drug Synergism;Flavanones/isolation & purification;Flavanones/pharmacology;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Herb-Drug Interactions;Kaempferols/isolation & purification;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/isolation & purification;Quercetin/pharmacology;Rhizome;Staphylococcus aureus/drug effects*;Staphylococcus aureus/enzymology;Staphylococcus aureus/ultrastructure;beta-Lactam Resistance/drug effects*;beta-Lactamase Inhibitors
21035317;Cell Culture Techniques;Drug Synergism;Herb-Drug Interactions;Inhibitory Concentration 50;Nitroimidazoles/pharmacology*;Plant Leaves;Sesquiterpenes/pharmacology*;Trypanocidal Agents/pharmacology*;Trypanosoma cruzi/drug effects*;Trypanosoma cruzi/growth & development
20979526;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions;Humans;Middle Aged;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Thrombocytopenia/etiology*
20970932;Aged;Aging/physiology;Consumer Health Information;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*
20966981;Anticoagulants/adverse effects;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Postoperative Hemorrhage/etiology;Risk Factors
20939821;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/pharmacokinetics;Administration, Oral;Biological Availability;Glucuronidase/metabolism;Herb-Drug Interactions;Humans;Oxidation-Reduction;Phytotherapy*;Plant Preparations/chemistry;Plant Preparations/metabolism*;Plant Preparations/pharmacokinetics*;Plant Preparations/toxicity
20930420;Animals;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction;Herb-Drug Interactions;Male;Microsomes, Liver/enzymology*;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley;Sophora/chemistry;Theophylline/metabolism*;Theophylline/pharmacokinetics
20883765;Animals;Antioxidants/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Fruit;Herb-Drug Interactions*;Male;Medicine, Ayurvedic;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phytotherapy*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar
20851588;Alkaloids/isolation & purification;Alkaloids/pharmacology*;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Isoquinolines/isolation & purification;Isoquinolines/pharmacology*;Papaveraceae/chemistry*;Plant Extracts/chemistry;Plant Extracts/pharmacology*
20845605;Adult;Attention/drug effects;Citalopram/adverse effects*;Female;Herb-Drug Interactions*;Humans;Phytotherapy*;Rhodiola/adverse effects*;Serotonin Uptake Inhibitors/adverse effects*
20837659;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Caco-2 Cells;Digoxin/pharmacokinetics;Etoposide/pharmacokinetics;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Humans;Ileum/metabolism;Male;Rats;Rats, Sprague-Dawley;Rhodamine 123/pharmacokinetics;Terfenadine/analogs & derivatives;Terfenadine/pharmacokinetics;Verapamil/pharmacology
20833993;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Capsaicin/pharmacology;Capsaicin/therapeutic use;Carcinoma, Hepatocellular/drug therapy*;Catechin/analogs & derivatives;Catechin/pharmacology;Catechin/therapeutic use;Cell Line, Tumor;Cells, Cultured;Curcumin/pharmacology;Curcumin/therapeutic use;Drug Synergism;Hep G2 Cells;Herb-Drug Interactions*;Humans;Liver Neoplasms/drug therapy*;Lovastatin/pharmacology;Lovastatin/therapeutic use*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
20832765;Antineoplastic Agents/therapeutic use*;Drugs, Chinese Herbal/therapeutic use*;Evidence-Based Medicine/methods;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*
20828605;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Cell Survival/drug effects;Cells, Cultured;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP2C9;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Induction/drug effects;Enzyme Inhibitors/toxicity;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Kinetics;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Milk Thistle/chemistry*;Plant Extracts/chemistry;Plant Extracts/toxicity*;Seeds/chemistry*;Silymarin/chemistry;Silymarin/toxicity*
20813291;Dietary Supplements;Herb-Drug Interactions*;Humans;Plants, Medicinal*;Review Literature as Topic
20813290;Herb-Drug Interactions*;Humans;Plants, Medicinal/metabolism*
20813289;Herb-Drug Interactions*;Humans;Physician-Patient Relations*;Phytotherapy/adverse effects*;Plant Preparations/pharmacology*
20736322;Alkaloids/pharmacology;Cell Line;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/genetics;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction/drug effects;Herb-Drug Interactions;Humans;Quinolizines/pharmacology;Receptors, Steroid/metabolism*;Sophora*
20735354;Animals;Drug Interactions;Drug Synergism;Herb-Drug Interactions;Humans;Oils, Volatile/chemistry;Oils, Volatile/pharmacology;Oils, Volatile/therapeutic use;Phytotherapy*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Plant Preparations/chemistry;Plant Preparations/pharmacology;Plant Preparations/therapeutic use;Plants/chemistry*
20701553;Animals;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/pharmacology;Biological Transport;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Neoplasms/drug therapy*;Plant Extracts/pharmacology
20694770;China;Drugs, Chinese Herbal/pharmacology;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Integrative Medicine*
20690308;Ginkgo biloba*;Herb-Drug Interactions;Humans;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*
20679979;Administration, Oral;Aloe*/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Dietary Supplements/standards;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Osteoarthritis*/complications;Osteoarthritis*/drug therapy;Pain*/etiology;Pain*/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Research Design;Safety
20653549;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Combined Modality Therapy;Complementary Therapies*;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional;Neoplasms/therapy*;Patents as Topic*;Plants, Medicinal
20653355;Adult;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Drug Combinations;Echinacea*;Enzyme Induction/drug effects;Enzyme Induction/physiology;Female;Herb-Drug Interactions*/physiology;Humans;Lopinavir;Male;Middle Aged;Plant Extracts/administration & dosage;Pyrimidinones/administration & dosage*;Ritonavir/administration & dosage*;Young Adult
20651752;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Male;Materia Medica/adverse effects;Medical History Taking/standards*;Middle Aged;Nonprescription Drugs/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects;Postoperative Hemorrhage/chemically induced*;Postoperative Hemorrhage/etiology;Tooth Extraction/adverse effects*
20642555;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bupropion/administration & dosage;Bupropion/analogs & derivatives*;Bupropion/pharmacokinetics*;Cross-Over Studies;Cytochrome P-450 CYP2B6;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Suspensions;Young Adult
20642450;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Animals;Aryl Hydrocarbon Hydroxylases/biosynthesis;Beverages*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Enzyme Induction;Glycyrrhiza*;Herb-Drug Interactions*;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Roots;Rabbits;Verapamil/administration & dosage;Verapamil/blood;Verapamil/pharmacokinetics*
20641061;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Berberine Alkaloids/metabolism;Berberine Alkaloids/pharmacology*;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Time Factors
20638257;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2E1 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Diterpenes, Abietane;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Liver/metabolism*;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Protein Isoforms;Salvia miltiorrhiza/chemistry*
20637580;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Half-Life;Herb-Drug Interactions*;Hypnotics and Sedatives/pharmacokinetics;Hypnotics and Sedatives/pharmacology*;Liver/metabolism;Male;Metabolic Clearance Rate/drug effects;Midazolam/pharmacokinetics;Midazolam/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza*;Sleep/drug effects*
20637575;Analgesics/pharmacology;Analgesics/therapeutic use;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Carrageenan;Drug Synergism;Edema/drug therapy;Edema/etiology;Herb-Drug Interactions;Inflammation/drug therapy*;Male;Monoterpenes/pharmacology;Monoterpenes/therapeutic use*;Naproxen/adverse effects;Naproxen/pharmacology;Naproxen/therapeutic use*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Rats;Rats, Wistar;Stomach Diseases/etiology;Stomach Diseases/pathology;Stomach Diseases/prevention & control*
20636879;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Antioxidants/pharmacology;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Biological Availability;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacology*;Herb-Drug Interactions*;Imidazoles/metabolism*;Losartan/metabolism;Losartan/pharmacokinetics*;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tetrazoles/metabolism*
20633025;Cardiovascular Agents/adverse effects;Cardiovascular Agents/therapeutic use*;Communication;Dietary Supplements*/adverse effects;Drug Contamination;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Physician-Patient Relations;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Assessment;Risk Factors;Treatment Outcome
20617421;Animals;Biological Products/chemistry*;Blood Coagulation/drug effects*;Blood Platelets/cytology*;Blood Platelets/drug effects*;Fibrinolytic Agents/chemistry*;Fibrinolytic Agents/pharmacology*;Herb-Drug Interactions;Humans
20615178;Adverse Drug Reaction Reporting Systems;Argentina;Contraindications;Health Knowledge, Attitudes, Practice*;Health Surveys;Herb-Drug Interactions;Humans;Patient Education as Topic;Phytotherapy*/adverse effects;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Plants, Medicinal/adverse effects*;Self Medication/statistics & numerical data*
20610890;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Darunavir;Duodenum;Garlic*;HIV Protease Inhibitors/pharmacokinetics*;Hep G2 Cells;Herb-Drug Interactions;Humans;Liver/cytology;Liver/drug effects;Male;Membrane Transport Proteins/metabolism*;Multidrug Resistance-Associated Proteins/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Ritonavir/pharmacology;Saquinavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*
20609070;Animals;Aporphines/pharmacology*;Area Under Curve;Cytochrome P-450 CYP1A2 Inhibitors*;Half-Life;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Inhibitory Concentration 50;Male;Nelumbo/chemistry*;Phenacetin/pharmacokinetics*;Plant Leaves;Rats;Rats, Wistar
20609069;Animals;Biological Transport, Active;Caco-2 Cells;Cell Membrane Permeability/drug effects*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Jejunum/drug effects*;Jejunum/metabolism;Male;Mannitol/metabolism;Medicine, Chinese Traditional*;Rats;Rats, Sprague-Dawley;Time Factors;Tolbutamide/pharmacokinetics*
20604832;Animals;Area Under Curve;Berberine/pharmacology*;Biological Availability;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Inactivation, Metabolic;Intestines/metabolism;Liver/metabolism;Magnoliopsida*;Male;Microsomes/metabolism;Rats;Rats, Sprague-Dawley;Verapamil/analogs & derivatives*;Verapamil/blood;Verapamil/metabolism;Verapamil/pharmacokinetics*
20600750;Alanine Transaminase/blood;Animals;Area Under Curve;Aspartate Aminotransferases/blood;Biomarkers/blood;Carbon Tetrachloride;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/prevention & control*;Cytochrome P-450 CYP3A/metabolism*;Dioxoles/pharmacology;Dioxoles/therapeutic use*;Disease Models, Animal;Down-Regulation;Female;Fruit;Herb-Drug Interactions;Lignans/pharmacokinetics*;Lignans/pharmacology;Lignans/therapeutic use;Male;Phytotherapy;Plant Extracts/blood;Plant Extracts/pharmacokinetics*;Plant Extracts/therapeutic use;Protective Agents/pharmacokinetics*;Protective Agents/pharmacology;Protective Agents/therapeutic use;Rats;Rats, Sprague-Dawley;Reference Values;Schisandra/chemistry*
20592321;Adult;Animals;Child;Cholesterol, LDL/blood;Cholesterol, LDL/drug effects;Clinical Trials as Topic;Diabetes Mellitus, Type 2/complications;Dose-Response Relationship, Drug;Dyslipidemias/drug therapy*;Dyslipidemias/physiopathology;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/adverse effects;Hypolipidemic Agents/therapeutic use*;Phytosterols/administration & dosage;Phytosterols/adverse effects;Phytosterols/therapeutic use*
20568597;Curcuma*;Herb-Drug Interactions;Humans;Neoplasms/drug therapy;Phytotherapy*
20567279;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;International Normalized Ratio;Plant Preparations/adverse effects*;Warfarin/adverse effects*;Warfarin/metabolism
20528250;Clinical Trials as Topic;Hematologic Neoplasms/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/chemistry*;Safety;Treatment Outcome
20524938;Alkaloids/isolation & purification;Alkaloids/pharmacokinetics;Alkaloids/pharmacology*;Animals;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Biocatalysis;Blotting, Western;Cell Culture Techniques;Cell Line;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2B1/genetics;Cytochrome P-450 CYP2B1/metabolism*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Structure;Pharmaceutical Preparations/metabolism;Plasmids;Quinolizines/isolation & purification;Quinolizines/pharmacokinetics;Quinolizines/pharmacology*;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction;Sophora/chemistry;Steroid Hydroxylases/genetics;Steroid Hydroxylases/metabolism*;Tandem Mass Spectrometry;Transfection
20523105;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Administration, Oral;Animals;Antineoplastic Agents, Phytogenic/administration & dosage*;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Herb-Drug Interactions*;Injections, Intravenous;Male;Metabolic Clearance Rate/drug effects;Paclitaxel/administration & dosage*;Paclitaxel/blood;Paclitaxel/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology*
20521597;Adult;Biological Availability;Curcuma/adverse effects*;Curcuma/metabolism;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/metabolism;Immunosuppressive Agents/pharmacokinetics;Kidney Transplantation;Male;Tacrolimus/adverse effects*;Tacrolimus/metabolism;Tacrolimus/pharmacokinetics
20516361;Blood Glucose/drug effects;Diabetes Mellitus, Type 2/drug therapy;Glipizide/adverse effects;Glipizide/therapeutic use;Herb-Drug Interactions;Humans;Hypoglycemia/chemically induced*;Hypoglycemic Agents/adverse effects*;Hypoglycemic Agents/therapeutic use;Male;Metformin/adverse effects;Metformin/therapeutic use;Mexican Americans;Middle Aged;Opuntia/chemistry;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use
20509982;Appetite/drug effects;Dietary Supplements;Drug Monitoring;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nutritional Status
20509107;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cell Line;Curcuma/chemistry*;Curcumin/analogs & derivatives;Curcumin/pharmacology*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions*;Humans;Intestines/cytology;Intestines/drug effects*;Intestines/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction
20502012;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/complications*;Atrial Fibrillation/epidemiology;Drug Interactions;Female;Food;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Patient Compliance*;Patient Education as Topic*;Quality of Life;Risk Factors;Stroke/epidemiology;Stroke/prevention & control;Surveys and Questionnaires;Thromboembolism/epidemiology;Thromboembolism/prevention & control*;Warfarin/administration & dosage*;Warfarin/adverse effects
20484172;Adolescent;Adult;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/metabolism;Asian Continental Ancestry Group*;Caffeine/pharmacokinetics;Cross-Over Studies;Curcumin/chemistry;Curcumin/pharmacokinetics*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2A6;Down-Regulation/drug effects;Flavonoids/chemistry;Flavonoids/pharmacokinetics*;Herb-Drug Interactions/physiology;Humans;Male;Phenols/chemistry;Phenols/pharmacokinetics*;Plant Extracts/pharmacokinetics;Polyphenols;Up-Regulation/drug effects;Young Adult
20474062;Aged;Dementia/drug therapy*;England;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Vitamins/therapeutic use*
20457244;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Centella*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dealkylation;Dextromethorphan/metabolism;Dose-Response Relationship, Drug;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Hydroxylation;Kinetics;Methylation;Pentacyclic Triterpenes/isolation & purification;Pentacyclic Triterpenes/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Recombinant Proteins/metabolism;Substrate Specificity;Testosterone/metabolism;Tolbutamide/metabolism;Triterpenes/isolation & purification;Triterpenes/pharmacology
20456830;Antiviral Agents/metabolism*;Biological Products/pharmacology;Chromatography, High Pressure Liquid/methods;Female;Fluorometry;Herb-Drug Interactions*;Humans;Male;Medicine, Chinese Traditional;Microsomes, Liver/metabolism*;Oseltamivir/analogs & derivatives*;Oseltamivir/metabolism;Plant Extracts/pharmacology;Prodrugs;Spectrometry, Mass, Electrospray Ionization/methods
20451336;Animals;Consumer Product Safety;Female;Government Regulation*;Herb-Drug Interactions;Humans;Internationality;Legislation, Drug;Menopause*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use
20446359;Dietary Supplements/adverse effects*;Drug Interactions;Herb-Drug Interactions*;Humans;Nonprescription Drugs/adverse effects*;Prescription Drugs/adverse effects*;Risk Assessment;Self Medication/adverse effects*;Vitamins/adverse effects
20438302;Adolescent;Adrenal Cortex Hormones/adverse effects;Adrenal Cortex Hormones/therapeutic use*;Adult;Aged;Aged, 80 and over;Databases, Factual;Female;Glycyrrhiza*;Herb-Drug Interactions*;Humans;International Classification of Diseases;Male;Medicine, Chinese Traditional*;Middle Aged;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Prescriptions;Taiwan;Young Adult
20423241;Choice Behavior;Clinical Trials as Topic;Female;Herb-Drug Interactions;Humans;Legislation, Drug;Menopause*;Phytoestrogens/therapeutic use;Phytotherapy*
20412155;Drug Contamination;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/poisoning;Forensic Toxicology;Herb-Drug Interactions;Humans;Legislation, Drug;Metals, Heavy/analysis;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Plants, Medicinal/poisoning;Plants, Toxic/toxicity
20406629;Animals;Aorta/drug effects;Atropine Derivatives/pharmacology;Benzene Derivatives/antagonists & inhibitors;Benzene Derivatives/pharmacology*;Bradycardia/chemically induced*;Capsaicin/analogs & derivatives;Capsaicin/pharmacology;Cryptocarya*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Hypotension/chemically induced*;In Vitro Techniques;Male;Oils, Volatile/isolation & purification;Oils, Volatile/pharmacology*;Ondansetron/pharmacology;Phenylephrine/antagonists & inhibitors;Phenylephrine/pharmacology;Rats;Rats, Wistar;Reflex/drug effects*;Vagus Nerve/drug effects*;Vagus Nerve/surgery;Vasoconstriction/drug effects
20399862;Animals;Herb-Drug Interactions*;Herbal Medicine;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*
20388141;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Herb-Drug Interactions;Herbal Medicine/standards;Humans;United States;United States Food and Drug Administration/standards
20379805;Disclosure;Drug Contamination;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/chemistry;Forensic Toxicology*;Herb-Drug Interactions;Humans;Medical Records;Phytotherapy/adverse effects*
20363701;Adrenergic beta-Agonists/pharmacology;Albuterol/pharmacology;Animals;Atropine/pharmacology;Costus*;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Drug Synergism;Female;Herb-Drug Interactions;In Vitro Techniques;Medicine, African Traditional*;Muscarinic Antagonists/pharmacology;Oxytocics/pharmacology*;Oxytocin/antagonists & inhibitors;Oxytocin/pharmacology;Plant Extracts/antagonists & inhibitors;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Leaves/chemistry*;Rats;Rats, Wistar;Uterine Contraction/drug effects;Uterus/drug effects*
20359286;Animals;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism*;Herb-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Risk Factors
23043208;Cardiovascular Agents/administration & dosage*;Cardiovascular Diseases/drug therapy*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Medical History Taking/methods;Phytotherapy/adverse effects*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;United States
20347238;Actaea;Animals;Breast Neoplasms/complications*;Breast Neoplasms/drug therapy;Cimicifuga;Diet;Female;Herb-Drug Interactions;Hot Flashes/complications;Hot Flashes/drug therapy*;Humans;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Soybeans
20345351;Animals;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use*;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use;Enzymes/metabolism;Gene Expression Regulation, Neoplastic/drug effects;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/enzymology;Neoplasms/genetics;Neoplasms/metabolism
20332334;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Benzamides;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Cytochrome P-450 CYP3A/metabolism;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Liver Function Tests;Male;Panax/adverse effects*;Panax/metabolism;Piperazines/administration & dosage;Piperazines/adverse effects*;Piperazines/pharmacokinetics;Piperazines/therapeutic use;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use
20214258;Adult;Age Factors;Aged;Aged, 80 and over;Ambulatory Care Facilities;Antihypertensive Agents/therapeutic use;Female;Herb-Drug Interactions;Humans;Hypertension/drug therapy*;Male;Middle Aged;Nigeria/epidemiology;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Surveys and Questionnaires;Young Adult
20206795;Adult;Asian Continental Ancestry Group;Bleeding Time;Blood Platelets/drug effects*;Chromatography, High Pressure Liquid;Cross-Over Studies;Ginkgo biloba*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Republic of Korea;Ticlopidine/administration & dosage;Ticlopidine/blood;Ticlopidine/pharmacokinetics*;Young Adult
20197523;Cardiovascular Diseases/drug therapy*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Plant Preparations/administration & dosage
20197017;Adolescent;Adult;Area Under Curve;Child;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Liver Function Tests;Liver Transplantation;Male;Middle Aged;Plant Extracts/pharmacology*;Schisandra/chemistry*;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Young Adult
20186406;Asian Continental Ancestry Group;Diazepam/pharmacokinetics*;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Male;Plant Extracts/adverse effects*;Quercetin/blood;Young Adult
20178874;Adolescent;Adult;Aged;Child;Child, Preschool;Drug Utilization;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Jamaica;Male;Middle Aged;Pharmacies;Phytotherapy/utilization*;Plants, Medicinal*;Polypharmacy;Prescription Drugs*/therapeutic use;Prevalence;Self Medication/methods;Self Medication/utilization*;Young Adult
20152556;Cardiovascular Agents/therapeutic use*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/etiology;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;Treatment Outcome
20147772;Commerce;Cyclosporine/adverse effects;Data Collection;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Hypericum/chemistry*;Patient Education as Topic/standards;Pharmacists/standards*;Phytotherapy/adverse effects
20129259;Aged;Attitude of Health Personnel;Biological Products/administration & dosage*;Communication;Cross-Sectional Studies;Dietary Supplements;Female;Health Status;Herb-Drug Interactions;Humans;Male;Minerals/administration & dosage;Ontario;Telephone*;Vitamins/administration & dosage
20112816;Administration, Oral;Animals;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/pharmacology*;Catalase/metabolism;Creatine Kinase, MB Form/metabolism;Disease Models, Animal;Dose-Response Relationship, Drug;Female;Garlic*/chemistry;Heart Diseases/chemically induced;Heart Diseases/enzymology;Heart Diseases/pathology;Heart Diseases/prevention & control*;Herb-Drug Interactions*;Hydrochlorothiazide/administration & dosage;Hydrochlorothiazide/pharmacology*;Isoproterenol;L-Lactate Dehydrogenase/metabolism;Myocardial Reperfusion Injury/enzymology;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/enzymology;Myocardium/pathology*;Oxidative Stress/drug effects;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Roots;Rats;Rats, Wistar;Superoxide Dismutase/metabolism
20106684;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Female;Herb-Drug Interactions*;Humans;Hypericum*;Male;Oxycodone/administration & dosage;Oxycodone/pharmacokinetics*;Pain Threshold/drug effects;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics*
20096675;Andrographis/chemistry*;Animals;Area Under Curve;Cytochrome P-450 CYP1A2/metabolism;Diterpenes/pharmacology*;Half-Life;Herb-Drug Interactions*;Male;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Theophylline/blood*;Theophylline/pharmacokinetics
20089387;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cyclooctanes/isolation & purification;Cyclooctanes/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Dioxoles/isolation & purification;Dioxoles/pharmacology*;Drug Resistance, Multiple;Fruit;Glutathione/metabolism*;Hep G2 Cells;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Lignans/isolation & purification;Lignans/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Schisandra/chemistry*
20077138;Anti-Inflammatory Agents/adverse effects;Biological Products/adverse effects*;Canada;Child;Databases, Factual/statistics & numerical data*;Dexamethasone/adverse effects;Herb-Drug Interactions*;Hospitals, Pediatric;Humans;Pilot Projects
20055162;Animals;Biological Availability;Bornanes/pharmacokinetics*;Herb-Drug Interactions;Intestinal Absorption/drug effects*;Male;Pyrazines/pharmacokinetics*;Rats;Rats, Sprague-Dawley
20047146;Animals;Chemistry, Pharmaceutical;Databases, Factual/statistics & numerical data;Drug Interactions;Drug and Narcotic Control;Herb-Drug Interactions/physiology*;History, 20th Century;History, 21st Century;History, Ancient;Humans;Medicine, Chinese Traditional/history;Medicine, Chinese Traditional/methods*;Medicine, Chinese Traditional/utilization*;Phytotherapy/history;Phytotherapy/methods;Structure-Activity Relationship;Western World*
20040699;Aged;Anticoagulants/pharmacokinetics*;Grifola*;Herb-Drug Interactions*;Humans;International Normalized Ratio*;Male;Warfarin/pharmacokinetics*
20028328;Animals;Cardiovascular Diseases/prevention & control*;Dietary Fiber;Dietary Supplements*;Fatty Acids/pharmacology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Salvia*/chemistry;Seeds/chemistry;alpha-Linolenic Acid/pharmacology
20021292;Clinical Trials as Topic/methods;Cytochrome P-450 Enzyme System/drug effects*;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*
20008216;Adult;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Arsenicals/therapeutic use;Child;Clinical Trials as Topic;Dietary Supplements*;Digestive System Neoplasms/drug therapy;Drug Screening Assays, Antitumor;Drug Synergism;Drugs, Chinese Herbal/therapeutic use;Ganoderma/chemistry;Hematologic Neoplasms/diet therapy;Hematologic Neoplasms/drug therapy*;Herb-Drug Interactions;Humans;Immunologic Factors/pharmacokinetics;Immunologic Factors/therapeutic use*;Mice;Oxides/therapeutic use;Phytotherapy;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology;Plant Preparations/therapeutic use;Polyporus;Thalidomide/therapeutic use;beta-Glucans/isolation & purification;beta-Glucans/therapeutic use
19994614;Anesthesiology*;General Surgery*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy*;Risk Factors
19968403;Chemistry, Pharmaceutical;Drug Compounding;Drugs, Chinese Herbal/history;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;History, 15th Century;History, 21st Century;History, Ancient;History, Medieval;Humans;Medicine, Chinese Traditional/history;Medicine, Chinese Traditional/methods*;Mental Disorders/drug therapy*;Phytotherapy
19952421;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Adenosine Triphosphatases/antagonists & inhibitors*;Adenosine Triphosphate/metabolism;Calcium Channel Blockers/pharmacology;Cell Membrane/drug effects;Glycyrrhiza;Herb-Drug Interactions*;Herbal Medicine;Humans;Hydrolysis;Medicine, Kampo*;Phosphates;Phytotherapy;Plant Extracts/pharmacology*;Plant Roots;Verapamil/pharmacology
19943335;Chemical and Drug Induced Liver Injury/etiology*;Ethanol/adverse effects*;Ethanol/metabolism;Herb-Drug Interactions;Humans;Kava/adverse effects*;Kava/chemistry;Kava/metabolism
19940848;Dietary Supplements*/adverse effects;Dietary Supplements*/standards;Ephedra/adverse effects;Food Industry/legislation & jurisprudence*;Government Regulation;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Legislation, Food/trends*;Pharmacology, Clinical/methods*;United States
19934593;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Curcumin/pharmacology*;Female;Half-Life;Herb-Drug Interactions*;Male;Norfloxacin/blood;Norfloxacin/pharmacokinetics*;Rabbits
19934397;Anticoagulants/chemistry;Anticoagulants/metabolism*;Aryl Hydrocarbon Hydroxylases/metabolism*;Cytochrome P-450 CYP2C9;Herb-Drug Interactions;Humans;Hydroxylation;In Vitro Techniques;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Milk Thistle/chemistry*;Recombinant Proteins/metabolism;Silymarin/analogs & derivatives*;Silymarin/chemistry;Silymarin/pharmacology;Stereoisomerism;Warfarin/chemistry;Warfarin/metabolism*
19919513;Adult;Antioxidants/chemistry*;Antioxidants/pharmacology*;Comet Assay;DNA Damage/drug effects*;Dioscorea;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;Humans;Hydrogen Peroxide/toxicity;Hydroxybenzoates/analysis;Lymphocytes/drug effects;Male;Middle Aged;Oxidative Stress/drug effects;Paeonia;Rhizome
19913311;Cross-Over Studies;Double-Blind Method;Female;Heart Valve Prosthesis;Heart Valve Prosthesis Implantation*;Herb-Drug Interactions/physiology*;Humans;International Normalized Ratio;Male;Middle Aged;Panax/metabolism*;Plant Extracts/blood*;Plant Extracts/therapeutic use;Prospective Studies;Warfarin/blood*;Warfarin/therapeutic use
19893786;Directories as Topic;Herb-Drug Interactions*;Information Storage and Retrieval*;Internet*;Physicians, Family
19889883;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology;Flavonoids/pharmacology*;Ginkgo biloba/chemistry*;Glucuronides/analysis;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Hydrolysis;Immunosuppressive Agents/metabolism*;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Kaempferols/pharmacology;Kinetics;Liver/drug effects;Liver/enzymology;Liver/metabolism;Microsomes/drug effects;Microsomes/enzymology;Microsomes/metabolism;Mycophenolic Acid/analogs & derivatives;Mycophenolic Acid/analysis;Mycophenolic Acid/metabolism*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/pharmacology
19883532;Anti-Anxiety Agents/pharmacology;Anti-Anxiety Agents/therapeutic use*;Anxiety/drug therapy*;Herb-Drug Interactions;Humans;Kava*;Muscle, Skeletal/drug effects;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
19879740;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Caco-2 Cells;Cell Line;Curcuma/chemistry*;Curcumin/analogs & derivatives;Curcumin/pharmacology*;Daunorubicin/pharmacokinetics;Dose-Response Relationship, Drug;Drug Resistance;Fluoresceins/pharmacokinetics;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Rhodamines/pharmacokinetics;Swine
19844860;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Fruit;Herb-Drug Interactions;Humans;Lycium/adverse effects;Lycium/chemistry*;Medicine, Chinese Traditional*;Molecular Structure;Phytotherapy*;Plant Bark;Plant Preparations/chemistry;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*;Plant Roots;Proteoglycans/pharmacology;Proteoglycans/therapeutic use
19830688;Animals;Captopril/pharmacology*;Cardiotonic Agents/pharmacology;Female;Garlic/metabolism*;Herb-Drug Interactions*;Isoproterenol;Myocardial Infarction/drug therapy*;Myocardial Infarction/pathology;Myocardium/pathology;Plant Extracts/pharmacology*;Rats;Rats, Wistar
19825176;Adult;Age Factors;Aged;Complementary Therapies/utilization*;Female;Herb-Drug Interactions*;Humans;Kansas;Male;Medical Records;Middle Aged;Phytotherapy/utilization*;Plant Preparations/administration & dosage*;Preoperative Care*;Retrospective Studies;Self Disclosure;Thoracic Surgical Procedures
19824416;Adult;Anesthesia, General/methods*;Anesthetics, General/administration & dosage;Anesthetics, General/adverse effects*;Catha/chemistry*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects*;Central Nervous System Stimulants/isolation & purification;Contraindications;Female;Hemodynamics/drug effects;Herb-Drug Interactions*;Humans;Ketamine/administration & dosage;Ketamine/adverse effects;Male;Surgical Procedures, Operative/methods;Time Factors
19823793;Age Factors;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme System/physiology;Diagnosis, Differential;Drug Interactions/physiology*;Drug Therapy, Combination/adverse effects*;Drug Tolerance/physiology;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/etiology*;Drug-Related Side Effects and Adverse Reactions/physiopathology;Food-Drug Interactions;Geriatrics*;Herb-Drug Interactions;Humans;Isoenzymes/physiology;Metabolic Clearance Rate/physiology;Pharmacokinetics*;Polypharmacy*
19815591;Animals;Clinical Trials as Topic;Complementary Therapies/adverse effects;Herb-Drug Interactions/physiology*;Herbal Medicine*;Humans
19806896;Animals;Cyclosporine/pharmacology*;Ginkgolides/pharmacokinetics*;Herb-Drug Interactions*;Lactones/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Tissue Distribution
19798943;Alcohols/chemistry;Chemistry, Pharmaceutical;Drugs, Chinese Herbal/chemistry*;Evodia/chemistry*;Herb-Drug Interactions*;Spectroscopy, Fourier Transform Infrared;Water/chemistry
19790032;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Baculoviridae;Caco-2 Cells;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;DNA, Complementary;Digoxin/metabolism;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Ketoconazole/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rhodiola/chemistry*;Structure-Activity Relationship;Testosterone/metabolism;Verapamil/pharmacology
19790031;Alkynes;Amides/analysis*;Amides/pharmacology;Commerce;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Echinacea/chemistry*;Fatty Acids, Unsaturated/analysis;Fatty Acids, Unsaturated/pharmacology*;Herb-Drug Interactions*;Metabolome*;Metabolomics/methods*;Plant Extracts/chemistry*;Plant Extracts/pharmacology
19785729;Anti-Bacterial Agents/pharmacology*;Antifungal Agents/pharmacology*;Bacteria/drug effects*;Candida albicans/drug effects*;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Herbal Medicine;Medicine, Traditional;Microbial Sensitivity Tests;Ocimum*;Phytotherapy;Plant Extracts/pharmacology*;Plant Leaves
19782820;Animals;Cardiovascular System/drug effects;Clinical Competence;Endocrine System/drug effects;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Kidney/drug effects;Liver/drug effects;Lung/drug effects;Maternal-Fetal Exchange;Nervous System/drug effects;Plant Extracts/adverse effects*;Plant Extracts/standards;Plant Extracts/toxicity;Pregnancy
19774504;Animals;Area Under Curve;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Diclofenac/pharmacokinetics;Drug Combinations;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Inactivation, Metabolic*;Inhibitory Concentration 50;Injections;Liver/drug effects*;Liver/metabolism;Male;Midazolam/pharmacokinetics;Ophiopogon*;Panax*;Plant Roots;Rats;Rats, Sprague-Dawley;Theophylline/pharmacokinetics
19771928;Aged;Aged, 80 and over;Confidence Intervals;Dietary Supplements/utilization;Epidemiologic Studies;Female;Health Behavior;Health Care Surveys;Herb-Drug Interactions*;Humans;Male;Middle Aged;Multivariate Analysis;Nonprescription Drugs/therapeutic use*;North Carolina/epidemiology;Phytotherapy/utilization*;Plants, Medicinal;Residence Characteristics*;Rural Health;Rural Population/statistics & numerical data*;Self Medication/statistics & numerical data*
19771443;Adolescent;Adult;Child;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Female;Herb-Drug Interactions;Hospitals, Teaching;Humans;Male;Middle Aged;Otorhinolaryngologic Diseases/therapy*;Phytotherapy/adverse effects;Risk Factors;Specialties, Surgical*;Surveys and Questionnaires;United Kingdom;Utilization Review/statistics & numerical data;Young Adult
19765569;Animals;Antidepressive Agents, Second-Generation/blood;Antidepressive Agents, Second-Generation/pharmacokinetics*;Antioxidants/pharmacology*;Bile/metabolism;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology*;Trazodone/blood;Trazodone/pharmacokinetics*
19760801;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects;Risk Factors
19756775;Alopecia/etiology;Alopecia/prevention & control;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/classification;Combined Modality Therapy;Complementary Therapies*;Data Display;Databases, Factual*;Fatigue Syndrome, Chronic/etiology;Fatigue Syndrome, Chronic/prevention & control;Herb-Drug Interactions*;Humans;Immune System Diseases/etiology;Immune System Diseases/prevention & control;Inflammation/etiology;Inflammation/prevention & control;Internet;Medicine, Chinese Traditional/methods;Nausea/etiology;Nausea/prevention & control;Neoplasms/complications;Neoplasms/therapy*;Pain/etiology;Pain/prevention & control;Palliative Care;Plants, Medicinal/classification;Social Support;User-Computer Interface
19741040;Administration, Oral;Animals;Area Under Curve;Biotransformation;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Administration Schedule;Enzyme Induction;Enzyme Inhibitors/administration & dosage*;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacokinetics;Half-Life;Herb-Drug Interactions*;Hydroxylation;Injections, Intravenous;Intestines/drug effects*;Intestines/enzymology;Lignans/administration & dosage*;Lignans/isolation & purification;Lignans/pharmacokinetics;Liver/drug effects*;Liver/enzymology;Male;Metabolic Clearance Rate;Microsomes/drug effects;Microsomes/enzymology;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Rats;Rats, Sprague-Dawley;Schisandra*/chemistry
19719333;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions/physiology*;Humans
19694739;Administration, Oral;Adult;Antidepressive Agents/pharmacokinetics*;Bupropion/analogs & derivatives*;Bupropion/pharmacokinetics;Chromatography, High Pressure Liquid;Epidemiologic Methods;Ginkgo biloba/metabolism*;Herb-Drug Interactions/physiology;Humans;Male;Plant Extracts/pharmacokinetics*;Young Adult
19685624;Alcohol Deterrents/adverse effects*;Alcohol Deterrents/metabolism;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/metabolism;Risk Factors;Taurine/adverse effects;Taurine/analogs & derivatives*;Taurine/metabolism
19685568;Anticholesteremic Agents/therapeutic use;Antihypertensive Agents/therapeutic use;Dietary Supplements/adverse effects*;Drug Interactions;Heart Diseases/drug therapy*;Herb-Drug Interactions;Humans;Polypharmacy
19679455;Animals;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Cells, Cultured;Cytochrome P450 Family 2;Dose-Response Relationship, Drug;Hepatocytes/metabolism;Herb-Drug Interactions*;Hydroxylation/drug effects;Inactivation, Metabolic;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Mixed Function Oxygenases/antagonists & inhibitors;Models, Animal;Phenanthrenes/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Steroid 16-alpha-Hydroxylase/metabolism*;Tolbutamide/metabolism;Tolbutamide/pharmacokinetics*
19657198;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Depressive Disorder/drug therapy*;Depressive Disorder, Major/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Randomized Controlled Trials as Topic;Risk Factors;Somatoform Disorders/drug therapy
19639535;Apocynaceae/chemistry*;Blood Proteins/metabolism;Caco-2 Cells;Cytochrome P-450 CYP3A Inhibitors*;Gastric Juice/metabolism;Herb-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Liver/metabolism;Microsomes/metabolism;Molecular Structure;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Pregnanediol/analogs & derivatives*;Pregnanediol/chemistry;Pregnanediol/pharmacokinetics;Pregnanediol/pharmacology
19610041;Antineoplastic Agents, Phytogenic/pharmacology*;Cell Survival;DNA Fragmentation;Dose-Response Relationship, Drug;Doxorubicin/pharmacology*;Herb-Drug Interactions*;Humans;Jurkat Cells;Mistletoe/chemistry*;Plant Extracts/pharmacology*
19610027;Angiotensin II Type 1 Receptor Blockers/pharmacology*;Bupleurum/chemistry*;Cells, Cultured;Chemokines/metabolism*;Cytokines/metabolism*;Enzyme-Linked Immunosorbent Assay;Herb-Drug Interactions;Humans;Mesangial Cells/drug effects*;Mesangial Cells/metabolism;Plant Extracts/pharmacology*
19602433;Antifungal Agents/toxicity;Antineoplastic Agents, Phytogenic/toxicity*;Cell Line, Tumor;Computational Biology;Computer Simulation;Cytotoxins/toxicity*;Drug Screening Assays, Antitumor/methods*;Female;Herb-Drug Interactions;Humans;Iran;Plant Extracts/toxicity*;Toxicity Tests
19577456;Animals;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Hydroxylation/drug effects;Inactivation, Metabolic;Male;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Warfarin/metabolism;Warfarin/pharmacokinetics*
19577448;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Blotting, Western;Cell Line;Dose-Response Relationship, Drug;Glycosides/pharmacology*;Harpagophytum/chemistry*;Herb-Drug Interactions*;Humans;Kidney/drug effects;Phytotherapy;Plant Extracts/pharmacology*;Pyrans/pharmacology*;Up-Regulation
19565315;Anesthetics/adverse effects*;Data Collection;Echinacea/adverse effects;Female;Fertilization in Vitro*;Garlic/adverse effects;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Herbal Medicine/statistics & numerical data*;Humans;Infertility, Female*;Ireland;Panax/adverse effects;Plant Extracts/adverse effects;Reproductive Health Services*;Safety;Surveys and Questionnaires
19559714;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism;Dose-Response Relationship, Drug;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Herb-Drug Interactions*;Hypericum/chemistry*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Plant Extracts/adverse effects*;Plant Extracts/isolation & purification;Rats;Rats, Wistar;Time Factors
19552494;Aged;Dietary Supplements/adverse effects*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Male;Mexico;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Phytotherapy/adverse effects*;Polypharmacy*;Prevalence;Risk Factors;Sex Factors;Surveys and Questionnaires;Texas
19551373;Adult;Conscious Sedation/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions/physiology*;Humans;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacology;Male;Middle Aged;Oxazepam/adverse effects*;Oxazepam/pharmacology;Pupil/drug effects;Time Factors;Wakefulness/drug effects*
19545213;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Diet*;Food-Drug Interactions/physiology*;Gene Expression Regulation/physiology*;Herb-Drug Interactions/physiology;Humans
19544697;Dietary Supplements/adverse effects;Herb-Drug Interactions;Humans;Ilex paraguariensis/adverse effects*;Neoplasms/chemically induced*;Plant Leaves/adverse effects;Risk
19533580;Aldehyde Dehydrogenase/metabolism*;Aldehyde Dehydrogenase, Mitochondrial;Animals;Antioxidants/isolation & purification;Antioxidants/pharmacology*;Aorta;Cyclic GMP/metabolism;Drug Tolerance*;Endothelial Cells/drug effects*;Herb-Drug Interactions;Humans;Male;Mitochondrial Proteins/metabolism*;Nitroglycerin/therapeutic use*;Plant Extracts/chemistry;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Reactive Oxygen Species/metabolism;Swertia/chemistry*;Umbilical Veins;Vasodilator Agents;Xanthenes/isolation & purification;Xanthenes/pharmacology*
19480106;Anesthesia, Dental/adverse effects*;Anesthesia, Dental/methods;Anesthetics, Intravenous/adverse effects*;Anesthetics, Intravenous/pharmacokinetics;Binding, Competitive;Biological Availability;Conscious Sedation/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacokinetics;GABA Modulators/adverse effects*;GABA Modulators/pharmacokinetics;Herb-Drug Interactions/physiology*;Humans;Liver/enzymology;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics
19476742;Animals;Drug Hypersensitivity/etiology;Gastrointestinal Tract/drug effects;Herb-Drug Interactions;Humans;Kidney/drug effects;Neoplasms/drug therapy;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*
19476734;Animals;Garcinia mangostana*/chemistry;Herb-Drug Interactions;Humans;Neoplasms/therapy*;Phytotherapy*;Plant Extracts*/pharmacology;Plant Extracts*/therapeutic use;Xanthones/adverse effects;Xanthones/pharmacology
19476272;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Breast Neoplasms/drug therapy*;Cimicifuga*;Complementary Therapies*;Female;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use*;Risk Assessment
19475525;Animals;Antineoplastic Agents/adverse effects;Beverages/adverse effects;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Neoplasms/drug therapy;Self Medication/adverse effects;Vitamins/administration & dosage;Vitamins/adverse effects
19459713;Anti-Obesity Agents/adverse effects*;Drug Contamination;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*
19455923;Complementary Therapies;Dental Care*;Garlic/adverse effects;Ginger/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;North America;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Risk Factors;Safety
19451609;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antimutagenic Agents/pharmacology;Antimutagenic Agents/therapeutic use;Antioxidants/pharmacology;Antioxidants/therapeutic use;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use;Cat's Claw/chemistry*;Herb-Drug Interactions;Humans;Phytotherapy;Plant Extracts*/pharmacology;Plant Extracts*/therapeutic use;Plants, Medicinal
19445319;Antimutagenic Agents/chemistry;Antimutagenic Agents/pharmacokinetics;Antimutagenic Agents/pharmacology;Antioxidants/chemistry;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Aspalathus/chemistry;Beverages*;Biological Availability;Cyclopia Plant/chemistry;Diet*;Herb-Drug Interactions;Phenols/chemistry;Phenols/pharmacokinetics*;Phenols/pharmacology;South Africa
19441067;Adult;Drug Synergism;Herb-Drug Interactions*;Humans;Lorazepam/adverse effects*;Lorazepam/therapeutic use;Male;Passiflora/chemistry*;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Self Medication;Valerian/chemistry*
19441062;Animals;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacology*;Glutathione Transferase/metabolism;Herb-Drug Interactions*;Kidney/enzymology;Liver/enzymology;Lung/enzymology;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Seeds/chemistry;Urticaceae/chemistry*
19425276;Antineoplastic Agents, Phytogenic/adverse effects*;Antineoplastic Agents, Phytogenic/therapeutic use;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Phytotherapy*
19422358;Adult;Angelica/chemistry*;Aryl Hydrocarbon Hydroxylases/metabolism*;Caffeine/pharmacology;Chlorzoxazone/pharmacology;Chromatography, High Pressure Liquid;Chromatography, Liquid;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2E1/metabolism;Dextromethorphan/pharmacology;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Losartan/pharmacology;Male;Midazolam/pharmacology;Omeprazole/pharmacology;Phytotherapy*;Republic of Korea;Scutellaria baicalensis/chemistry*;Tandem Mass Spectrometry;Young Adult
19401473;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adrenergic beta-Antagonists/pharmacokinetics;Adult;Asian Continental Ancestry Group;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects*;Ginkgo biloba/adverse effects*;Herb-Drug Interactions;Humans;Male;Propanolamines/pharmacokinetics*;Time Factors
19390395;Aged;Depression/drug therapy;Fatigue/drug therapy;Herb-Drug Interactions*;Humans;Male;Nurse Practitioners/organization & administration*;Nursing Assessment;Obesity/drug therapy;Patient Education as Topic/methods*;Phytotherapy/adverse effects*;Phytotherapy/nursing;Primary Health Care/methods*;Safety;Sleep Initiation and Maintenance Disorders/drug therapy;United States;United States Food and Drug Administration
19387280;Analgesics, Opioid/pharmacology*;Anesthetics/pharmacology;Animals;Dietary Supplements/adverse effects;Dietary Supplements/utilization;Disease Models, Animal;Drug Evaluation, Preclinical;Herb-Drug Interactions;Kava/adverse effects*;Male;Morphine/pharmacology*;Nurse Anesthetists;Pain/prevention & control*;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/utilization;Prospective Studies;Random Allocation;Rats;Rats, Sprague-Dawley;Receptors, Opioid, mu*/agonists;Receptors, Opioid, mu*/antagonists & inhibitors;Receptors, Opioid, mu*/drug effects;Risk Factors;Single-Blind Method;Time Factors
19381859;Adolescent;Adult;Artemisia/adverse effects*;Child;Child, Preschool;Drug Combinations;Exanthema/chemically induced;Exanthema/epidemiology;Female;Gardenia/adverse effects*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/epidemiology;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Injections;Lonicera/adverse effects*;Male;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Prospective Studies;Risk Factors;Young Adult
19371848;Arnica/adverse effects;Arnica/metabolism;Bromelains/adverse effects;Bromelains/metabolism;Dietary Supplements/adverse effects*;Drug Interactions;Echinacea/adverse effects;Echinacea/metabolism;Ephedra/adverse effects;Ephedra/metabolism;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Perioperative Care*;Plant Preparations/adverse effects*;Plant Preparations/metabolism;Quality Control;Reconstructive Surgical Procedures*;Surgery, Plastic;Valerian/adverse effects;Valerian/metabolism
19371257;Aryl Hydrocarbon Hydroxylases/metabolism*;Cells, Cultured;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2E1/metabolism*;Dietary Supplements;Dose-Response Relationship, Drug;Hepatocytes/drug effects;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Male;Plant Extracts/pharmacology*
19364195;Female;Fibrocystic Breast Disease/drug therapy*;Fruit/chemistry*;Herb-Drug Interactions;Humans;Menstruation Disturbances/drug therapy*;Pain/drug therapy*;Phytotherapy*;Premenstrual Syndrome/drug therapy;Vitex/adverse effects;Vitex/chemistry*
19364194;Herb-Drug Interactions;Olea/chemistry*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Plant Leaves/chemistry*
19353999;Camellia sinensis;Cimicifuga;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dietary Supplements;Herb-Drug Interactions;Humans;Microsomes, Liver/metabolism;Panax;Phytotherapy*;Plant Extracts/pharmacology*;Quinine/metabolism;Reproducibility of Results;Vitis
19326360;Adult;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Maternal Behavior;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Pregnancy;Pregnancy Trimesters;Prescription Drugs/adverse effects;Prevalence;Prognosis;Quebec/epidemiology;Registries/statistics & numerical data;Surveys and Questionnaires;Women's Health
19323340;Anticoagulants/adverse effects;Dental Care*;Dietary Supplements*/adverse effects;Ephedra/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Nonprescription Drugs;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects;Platelet Aggregation Inhibitors/adverse effects
19292027;Clinical Laboratory Techniques*;Dietary Supplements/adverse effects*;Drug Contamination;Herb-Drug Interactions*;Humans;Medicine, Traditional*;Plant Preparations/adverse effects*;Plant Preparations/metabolism
19292026;Animals;Female;Herb-Drug Interactions*;Herbal Medicine*;Humans;Maternal Exposure/adverse effects;Medicine, Traditional*;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/toxicity*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry
19255814;Adult;Aged;Aged, 80 and over;Analgesics/therapeutic use;Anticoagulants/therapeutic use;Antihypertensive Agents/therapeutic use;Attitude of Health Personnel;Complementary Therapies*;Cross-Sectional Studies;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Male;Middle Aged;Ontario;Osteoarthritis/drug therapy*;Patient Education as Topic;Physician-Patient Relations;Plant Preparations/therapeutic use*;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Self Medication*;Surveys and Questionnaires;Truth Disclosure
20690490;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Depression/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*
19247403;Aesculus*;Chronic Disease;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Seeds;Treatment Outcome;Venous Insufficiency/drug therapy*
19245357;Aged;Aged, 80 and over;Aging*/drug effects;Aging*/physiology;Aging*/psychology;Anesthesia/methods;Cardiovascular System/physiopathology;Cognition;Comorbidity;Drug Interactions;Female;General Surgery/methods;Herb-Drug Interactions;Humans;Kidney/physiology;Liver/physiology;Postoperative Complications/prevention & control;Prescription Drugs/adverse effects;Prescription Drugs/pharmacokinetics;Prescription Drugs/therapeutic use*;Surgical Procedures, Operative*;Women's Health
19234997;Aged;Aged, 80 and over;Consumer Product Safety*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Female;Health Behavior;Herb-Drug Interactions;Humans;Idaho;Male;Middle Aged;Nonprescription Drugs/administration & dosage*;Nonprescription Drugs/adverse effects;Patient Satisfaction;Pilot Projects;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Surveys and Questionnaires
19219097;Adult;Child;Contraindications;Female;Herb-Drug Interactions;Humans;Lactation;Male;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy;Recurrence;Urinary Tract Infections/drug therapy*;Vaccinium macrocarpon*/adverse effects
19207805;Adolescent;Adult;Aged;Chi-Square Distribution;Cross-Sectional Studies;Female;Health Care Surveys;Herb-Drug Interactions;Humans;Kidney Failure, Chronic/ethnology*;Kidney Failure, Chronic/therapy;Male;Middle Aged;Nursing Methodology Research;Patient Acceptance of Health Care/ethnology*;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/methods;Phytotherapy/psychology*;Phytotherapy/statistics & numerical data;Renal Dialysis/nursing;Renal Dialysis/psychology*;Self Disclosure;Socioeconomic Factors;Surveys and Questionnaires;Turkey
19203654;Biological Products/adverse effects*;Biological Products/therapeutic use;Complementary Therapies/adverse effects*;Complementary Therapies/ethics;Complementary Therapies/legislation & jurisprudence;Health Personnel/ethics;Health Services Needs and Demand/ethics*;Health Services Needs and Demand/legislation & jurisprudence;Herb-Drug Interactions;Humans;Hypersensitivity/immunology;Hypersensitivity/therapy*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Plants, Medicinal;Treatment Outcome
19200702;Analgesics/therapeutic use*;Animals;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Asteraceae*;Diclofenac/therapeutic use*;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Hot Temperature;Hyperalgesia/drug therapy*;Male;Mice;Mice, Inbred BALB C;Phytotherapy;Plant Extracts/therapeutic use*;Plant Roots
19199376;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Dietary Supplements/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Internet;Neoplasms/drug therapy*;Nonprescription Drugs/adverse effects*;Nonprescription Drugs/therapeutic use;Vitamins/adverse effects;Vitamins/therapeutic use
19186210;1-Methyl-3-isobutylxanthine/pharmacology;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology;Animals;Aorta/drug effects;Calcium/pharmacology;Drug Synergism;Herb-Drug Interactions*;Ligusticum*;Male;Nitric Oxide Donors/pharmacology;Nitroprusside/pharmacology*;Phenylephrine/pharmacology;Phthalic Anhydrides/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Vasoconstrictor Agents/pharmacology;Vasodilator Agents/pharmacology*
19185075;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/therapeutic use*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypericum/adverse effects*;Male;Middle Aged;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use*;Rosuvastatin Calcium;Sulfonamides/pharmacokinetics;Sulfonamides/therapeutic use*
19181175;Adult;Communication*;Complementary Therapies/nursing;Complementary Therapies/psychology*;District of Columbia;HIV Infections/psychology*;HIV Infections/therapy;Herb-Drug Interactions;Holistic Health;Humans;Integrative Medicine;Male;Medical History Taking;Nurse Practitioners/organization & administration;Nurse Practitioners/psychology;Nurse-Patient Relations*;Nursing Assessment;Nursing Methodology Research;Patient Acceptance of Health Care/psychology*;Patient Acceptance of Health Care/statistics & numerical data;Practice Guidelines as Topic;Primary Health Care;Safety
19181163;Drug Prescriptions/nursing*;Evidence-Based Practice;Herb-Drug Interactions*;Humans;Medical History Taking;Nurse Practitioners/organization & administration*;Nursing Assessment;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/nursing;Phytotherapy/psychology;Safety;United States
19174505;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adult;Aged;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Cross-Sectional Studies;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Data Collection;Databases, Factual;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/therapeutic use
19173278;Animals;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacokinetics*;Glycyrrhiza uralensis/chemistry*;Herb-Drug Interactions*;Lidocaine/blood;Lidocaine/pharmacokinetics*;Lidocaine/urine;Male;Medicine, Chinese Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley
19170364;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Dental Care for Chronically Ill*;Drug Administration Schedule;Drug Interactions;Evidence-Based Dentistry*;Hemorrhage/prevention & control;Heparin, Low-Molecular-Weight/administration & dosage;Heparin, Low-Molecular-Weight/therapeutic use;Herb-Drug Interactions;Humans;International Normalized Ratio;Interprofessional Relations;Prothrombin Time;Referral and Consultation;Risk Assessment;Safety;Thromboembolism/prevention & control;Warfarin/pharmacology;Warfarin/therapeutic use*
19158465;Alanine Transaminase/blood;Chemical and Drug Induced Liver Injury/diagnosis*;Complementary Therapies;Guidelines as Topic;Herb-Drug Interactions;Humans;Risk Factors;Severity of Illness Index
19133584;Anti-Inflammatory Agents/therapeutic use;Anticonvulsants/antagonists & inhibitors;Anticonvulsants/therapeutic use;Beverages*/adverse effects;Herb-Drug Interactions*;Humans;Plant Preparations*/adverse effects;Prednisolone/therapeutic use;Tabebuia*/adverse effects
19125771;Adult;Aged;Asia, Southeastern;Blood Glucose/analysis;China;Cognition Disorders/chemically induced*;Drugs, Chinese Herbal;Glyburide/poisoning*;Herb-Drug Interactions*;Humans;Hypoglycemia/chemically induced*;Hypoglycemic Agents/poisoning*;Male;Middle Aged;Retrospective Studies
19122289;Analysis of Variance;Arylsulfotransferase;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Recombinant Proteins/pharmacology;Sulfotransferases/drug effects*
22435411;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism*;Antineoplastic Agents, Phytogenic/therapeutic use;Cognition Disorders/etiology;Dose-Response Relationship, Drug;Ginkgo biloba/adverse effects*;Hepatocytes/drug effects*;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Paclitaxel/adverse effects;Paclitaxel/metabolism*;Paclitaxel/therapeutic use;Plant Preparations/adverse effects*
22435350;Adrenergic alpha-2 Receptor Agonists/pharmacology;Adrenergic alpha-2 Receptor Agonists/therapeutic use;Analgesia*;Analgesics/pharmacology*;Analgesics/therapeutic use;Analysis of Variance;Animals;Berberine Alkaloids/pharmacology*;Berberine Alkaloids/therapeutic use;Corydalis/chemistry*;Dexmedetomidine/pharmacology*;Herb-Drug Interactions*;Hot Temperature;Hypnotics and Sedatives/pharmacology;Male;Pain/drug therapy;Pain Threshold/drug effects;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Rats;Rats, Sprague-Dawley;Receptors, Adrenergic, alpha-2/metabolism*;Yohimbine/pharmacology
20408499;Cuba;Cytochrome P-450 Enzyme System/physiology;Female;Herb-Drug Interactions*/genetics;Humans;Legislation, Drug;Male;Pharmacogenetics;Phytotherapy/adverse effects*
19075623;Cooperative Behavior;Herb-Drug Interactions*;Humans
19075622;Communication;Herb-Drug Interactions*;Humans;Risk Assessment;Risk Management*;Risk Reduction Behavior
19075621;Complementary Therapies*;Herb-Drug Interactions*;Humans;Knowledge
19075620;Animals;Arsenicals/administration & dosage;Benzamides;Drug Discovery;Drug Synergism;Gene Expression Profiling*;Herb-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism;Leukemia, Promyelocytic, Acute/drug therapy*;Leukemia, Promyelocytic, Acute/metabolism;Oxides/administration & dosage;Piperazines/administration & dosage;Proteome*;Pyrimidines/administration & dosage;Tretinoin/administration & dosage
19075619;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Cytochrome P-450 CYP3A/physiology;Enzyme Induction;Herb-Drug Interactions*;Humans;Hypericum*;Perylene/analogs & derivatives;Perylene/pharmacokinetics;Perylene/pharmacology;Photochemotherapy
19075618;Animals;Antineoplastic Agents, Phytogenic/pharmacokinetics;Biological Transport;Blood-Brain Barrier*/drug effects;Blood-Brain Barrier*/physiology;Digoxin/pharmacokinetics;Flavonoids/pharmacokinetics;Herb-Drug Interactions*;Humans;Perylene/analogs & derivatives;Perylene/pharmacology
19075615;Herb-Drug Interactions*;Humans
19067984;Cardiovascular Agents/adverse effects*;Crataegus/adverse effects;Ginkgo biloba/adverse effects;Heart/drug effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/methods;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Ubiquinone/adverse effects;Ubiquinone/analogs & derivatives;Ubiquinone/therapeutic use;Vitamins/adverse effects;Vitamins/therapeutic use
19066872;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/drug effects*;Bupropion/analogs & derivatives*;Bupropion/blood;Bupropion/metabolism*;Bupropion/pharmacokinetics;Cytochrome P-450 CYP2B6;Dopamine Uptake Inhibitors/metabolism;Enzyme Induction/drug effects;Flavonoids/chemistry;Flavonoids/pharmacology*;Glucuronidase/antagonists & inhibitors;Haplotypes;Herb-Drug Interactions;Humans;Hydroxylation/drug effects;Male;Oxidoreductases, N-Demethylating/biosynthesis*;Oxidoreductases, N-Demethylating/drug effects*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Polymorphism, Single Nucleotide;Time Factors
19058404;Herb-Drug Interactions/physiology*;Humans
19053860;Animals;Calcium/metabolism*;Calcium Channel Blockers/pharmacology;Cardiotonic Agents/pharmacology;Crataegus*;Heart Failure/drug therapy;Herb-Drug Interactions;Hypertension/drug therapy;Male;Myocytes, Cardiac/drug effects*;Myocytes, Cardiac/metabolism;Nifedipine/pharmacology;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plant Structures;Rats;Rats, Sprague-Dawley;Sodium-Potassium-Exchanging ATPase/metabolism
19015839;Administration, Oral;Adult;Area Under Curve;Contraceptives, Oral, Combined/administration & dosage;Contraceptives, Oral, Combined/metabolism;Contraceptives, Oral, Combined/pharmacokinetics*;Desogestrel/administration & dosage;Desogestrel/metabolism;Desogestrel/pharmacokinetics*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/metabolism;Ethinyl Estradiol/pharmacokinetics*;Female;Herb-Drug Interactions;Humans;Hypericum;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics*;Tablets
19008635;Animals;Aryl Hydrocarbon Hydroxylases/metabolism;Drug Therapy, Combination*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions/physiology*;Humans
18950251;Animals;Harpagophytum/chemistry*;Herb-Drug Interactions;Low Back Pain/drug therapy*;Osteoarthritis/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Rheumatic Diseases/drug therapy*
18947363;Binding Sites;Coumarins/metabolism;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Echinacea/chemistry*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Inhibitory Concentration 50;Ketoconazole/administration & dosage;Ketoconazole/pharmacology*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology;Quinolines/metabolism;Testosterone/metabolism
18928143;Adolescent;Adult;Child;Child, Preschool;Cross-Sectional Studies;Female;Health Behavior*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nigeria/epidemiology;Phytotherapy/psychology;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Professional-Patient Relations;Self Care/methods;Self Medication/psychology;Self Medication/statistics & numerical data*;Surveys and Questionnaires
18928136;Adult;Aged;Female;Health Behavior*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Mexico/epidemiology;Middle Aged;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Prevalence;Surveys and Questionnaires;United States/epidemiology;Urban Population/statistics & numerical data
18927522;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages/adverse effects;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Enzyme Inhibitors/adverse effects;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Muscular Diseases/chemically induced*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Simvastatin/adverse effects*;Simvastatin/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Tea
18844284;Animals;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Herb-Drug Interactions*;Male;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Plants, Medicinal;Rats;Rats, Wistar;Rhodiola/chemistry*;Theophylline/blood;Theophylline/pharmacokinetics*;Theophylline/pharmacology;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology
18844254;Asteraceae/chemistry;Cytochrome P-450 Enzyme Inhibitors*;Female;Flavonoids/pharmacology;Herb-Drug Interactions;Humans;Hydrocharitaceae/chemistry;Male;Mangifera/chemistry;Medicine, Traditional;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phenols/pharmacology;Phytotherapy;Plant Extracts/pharmacology*;Plants, Medicinal/metabolism;Polyphenols;Polyunsaturated Alkamides/pharmacology
18811084;Anesthesia, Dental*;Conscious Sedation*;Herb-Drug Interactions;Homeopathy*;Humans;Materia Medica;Medical History Taking;Phytotherapy
18776969;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring;Drug Resistance*/genetics;Food-Drug Interactions;Herb-Drug Interactions;Humans;International Normalized Ratio;Mixed Function Oxygenases/genetics;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Vitamin K Epoxide Reductases;Warfarin/administration & dosage*;Warfarin/pharmacokinetics
18765169;Adjuvants, Immunologic/adverse effects;Adjuvants, Immunologic/therapeutic use*;Animals;Cell Proliferation/drug effects;Chemotherapy, Adjuvant*/adverse effects;Herb-Drug Interactions;Injections, Intraperitoneal;Leukopenia/chemically induced;Leukopenia/drug therapy;Leukopenia/immunology;Lymphoma/drug therapy*;Lymphoma/immunology;Lymphoma/pathology;Medicine, Ayurvedic;Mice;Mice, Inbred BALB C;Neoplasm Transplantation;Phagocytosis/drug effects;Phagocytosis/immunology;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Th1 Cells/metabolism;Th1 Cells/pathology
18762932;Administration, Oral;Adult;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/analysis;Bridged Bicyclo Compounds/pharmacology;Cross-Over Studies;Cytochrome P-450 CYP3A/biosynthesis*;Enzyme Induction;Herb-Drug Interactions;Humans;Hypericum*;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/analysis;Phloroglucinol/pharmacology;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Powders;Substrate Specificity;Terpenes/administration & dosage;Terpenes/analysis;Terpenes/pharmacology*;Young Adult
18756649;Anxiety Disorders/drug therapy*;Herb-Drug Interactions;Humans;Kava/adverse effects*;Liver/drug effects*;Phytotherapy*;Plant Extracts/adverse effects*
18712519;Atazanavir Sulfate;Cat's Claw*/adverse effects;Female;HIV Protease Inhibitors*/administration & dosage;HIV Protease Inhibitors*/blood;HIV Protease Inhibitors*/pharmacokinetics;HIV Protease Inhibitors*/therapeutic use;Herb-Drug Interactions*;Humans;Metabolic Clearance Rate;Middle Aged;Oligopeptides/administration & dosage;Oligopeptides/blood;Oligopeptides/pharmacokinetics;Oligopeptides/therapeutic use;Plant Preparations*/administration & dosage;Plant Preparations*/adverse effects;Pyridines/administration & dosage;Pyridines/blood;Pyridines/pharmacokinetics;Pyridines/therapeutic use;Ritonavir/administration & dosage;Ritonavir/blood;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use;Saquinavir/administration & dosage;Saquinavir/blood;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
18711168;Anticholesteremic Agents/adverse effects*;Anticholesteremic Agents/pharmacokinetics;Herb-Drug Interactions;Humans;Male;Middle Aged;Muscle, Skeletal/drug effects*;Pain/chemically induced;Simvastatin/adverse effects*;Simvastatin/pharmacokinetics;Tea*
18698390;Attitude of Health Personnel*;Dietary Supplements*/adverse effects;Drug Interactions;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Legislation, Drug;Patient Education as Topic;Pharmacists*;Plant Preparations*/adverse effects;Professional-Patient Relations;Program Development;Surveys and Questionnaires*
18688789;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Availability;Biological Transport, Active/drug effects*;Caco-2 Cells;Digoxin/pharmacokinetics*;Echinacea/chemistry*;Ethanol/pharmacology;Herb-Drug Interactions;Humans;Plant Extracts/pharmacology*;Verapamil/pharmacology
18673195;Drug Design*;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions*;Hypericum/adverse effects*;Hypericum/chemistry;Molecular Structure;Pharmaceutical Preparations/chemistry;Plant Preparations/adverse effects*;Plant Preparations/isolation & purification
18670318;Adenocarcinoma/diagnostic imaging;Adenocarcinoma/drug therapy;Adenocarcinoma/secondary;Adult;Female;Herb-Drug Interactions*;Herbal Medicine*;Humans;Lung Neoplasms/diagnostic imaging;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Plants, Medicinal/adverse effects*;Protein Kinase Inhibitors/therapeutic use*;Quinazolines/therapeutic use*;Receptor, Epidermal Growth Factor/antagonists & inhibitors;Tomography, X-Ray Computed;Treatment Outcome
18657993;Animals;Binding, Competitive/drug effects;Diterpenes, Abietane;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions;Humans;Male;Phenanthrenes/pharmacology*;Protein Binding/drug effects;Rats;Rats, Sprague-Dawley;Serum Albumin/metabolism*;Spectrometry, Mass, Electrospray Ionization/methods*;Warfarin/administration & dosage;Warfarin/metabolism*;Warfarin/pharmacokinetics
18638690;Antioxidants/adverse effects;Antioxidants/therapeutic use;Cachexia/therapy;Complementary Therapies*;Dietary Supplements*/adverse effects;Dietary Supplements*/utilization;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/therapy;Herb-Drug Interactions;Hot Flashes/therapy;Humans;Lymphedema/therapy;Neoplasms/diet therapy;Neoplasms/drug therapy;Neoplasms/prevention & control;Neoplasms/radiotherapy;Neoplasms/therapy*;Peripheral Nervous System Diseases/chemically induced;Peripheral Nervous System Diseases/therapy;Phytotherapy;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Radiation Injuries/therapy;Radiotherapy/adverse effects;Randomized Controlled Trials as Topic/statistics & numerical data;Risk;Stomatitis/therapy
18637192;Consumer Product Safety/standards;Dietary Supplements/standards*;Herb-Drug Interactions*;Humans;Hypericum*;Plant Extracts*;Product Labeling/methods*;Product Labeling/standards*;United States;United States Food and Drug Administration
18634396;Administration, Oral;Anticoagulants/administration & dosage*;Cytochrome P-450 Enzyme System/genetics;Drug Interactions;Drug Resistance/genetics;Food-Drug Interactions*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Polymorphism, Genetic;Thromboembolism/prevention & control;Warfarin/pharmacology
18624348;Dietary Supplements*;Echinacea;Food, Organic/adverse effects*;Food, Organic/toxicity;Ginkgo biloba;Herb-Drug Interactions;Humans;Research Design*
18623630;Antihypertensive Agents/antagonists & inhibitors*;Benzimidazoles/antagonists & inhibitors*;Blood Pressure/drug effects;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Rhodiola*;Tetrazoles/antagonists & inhibitors*
18619012;Anticoagulants/adverse effects*;Beverages;Herb-Drug Interactions;Humans;International Normalized Ratio;Tea/adverse effects*;Tea/chemistry;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
18618481;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Echinacea/adverse effects*;Herb-Drug Interactions*;Humans;Plants, Medicinal/adverse effects
18618477;Acquired Immunodeficiency Syndrome/drug therapy;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Ethnic Groups/genetics;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Pharmacogenetics/methods*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Polymorphism, Genetic
18584812;Andrographis;Astragalus Plant;Cytochrome P-450 Enzyme System/drug effects*;Echinacea;Eleutherococcus;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Respiratory Tract Infections/drug therapy*
18582555;Animals;Central Nervous System Depressants/administration & dosage;Central Nervous System Depressants/pharmacology*;Dose-Response Relationship, Drug;Drug Synergism;Exploratory Behavior/drug effects;Fruit;Herb-Drug Interactions*;Injections, Intraperitoneal;Male;Medicine, Traditional;Mexico;Mice;Mice, Inbred ICR;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Solvents/chemistry;Theaceae/chemistry*
18570167;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Dietary Supplements/adverse effects*;Dietary Supplements/poisoning;Herb-Drug Interactions;Humans;Poison Control Centers/statistics & numerical data*;Poisoning/epidemiology;Population Surveillance;Prospective Studies;San Francisco/epidemiology;Time Factors
18538093;Antihypertensive Agents/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/therapeutic use;Kidney Diseases*/blood;Kidney Diseases*/metabolism;Plant Preparations/adverse effects
18525278;Diarrhea/chemically induced*;Drug-Related Side Effects and Adverse Reactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/adverse effects*;HIV-1*;Herb-Drug Interactions*;Humans;Lopinavir;Male;Middle Aged;Pyrimidinones/adverse effects*
18516070;Adolescent;Adult;Anticoagulants/pharmacokinetics;Anticoagulants/pharmacology*;Aryl Hydrocarbon Hydroxylases/genetics;Cross-Over Studies;Cytochrome P-450 CYP2C9;Drug Monitoring;Garlic/chemistry*;Genotype;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Mixed Function Oxygenases/genetics;Platelet Aggregation/drug effects;Protein Binding/drug effects;Stereoisomerism;Time Factors;Vaccinium macrocarpon/chemistry*;Vitamin K Epoxide Reductases;Warfarin/pharmacokinetics;Warfarin/pharmacology*
18515463;Commiphora/chemistry*;Depressive Disorder/drug therapy;Female;Herb-Drug Interactions*;Humans;Middle Aged;Phytotherapy;Plant Extracts/adverse effects;Recurrence;Serotonin Uptake Inhibitors/pharmacokinetics*;Serotonin Uptake Inhibitors/therapeutic use;Sertraline/pharmacokinetics*;Sertraline/therapeutic use;Terminalia/chemistry*
18479173;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Clinical Trials as Topic;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism;Drug Evaluation, Preclinical;Enzyme Induction;Herb-Drug Interactions*;Humans;Models, Animal;Models, Biological;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
18433343;Beverages;Clinical Trials as Topic;Cytochrome P-450 Enzyme Inhibitors;Fruit/chemistry*;Herb-Drug Interactions;Humans;Membrane Transport Proteins/physiology;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Plant Extracts/pharmacology*
18429542;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Kava/adverse effects;Nurse's Role*;Patient Education as Topic/organization & administration*;Phytotherapy*/adverse effects;Phytotherapy*/nursing;Plant Extracts/adverse effects
18420532;Administration, Oral;Adult;Area Under Curve;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Female;Forecasting/methods;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Linear Models;Longitudinal Studies;Male;Midazolam/pharmacokinetics*;Middle Aged;Plant Extracts/pharmacology*;Time Factors
18406030;Adult;Antiretroviral Therapy, Highly Active/adverse effects*;Communication;Cross-Sectional Studies;Educational Status;Female;HIV Infections/drug therapy*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Logistic Models;Male;Medicine, African Traditional*;Middle Aged;Physician-Patient Relations*;Phytotherapy/adverse effects*;Uganda
18385029;Dental Care*;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects;Safety;United States
18379627;Adenosine Triphosphate/metabolism;Animals;Brain/drug effects*;Brain/enzymology;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology*;Enzyme Inhibitors/pharmacology*;Ethanol/pharmacology*;Herb-Drug Interactions*;Hydrolysis;Kinetics;Malvaceae*;Nuts;Ouabain/pharmacology;Phosphates/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Wistar;Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors*;Sodium-Potassium-Exchanging ATPase/metabolism
18379623;Alanine Transaminase/metabolism;Animals;Aspartate Aminotransferases/metabolism;Biotransformation;Caffeine/metabolism;Caffeine/toxicity*;Central Nervous System Stimulants/metabolism;Central Nervous System Stimulants/toxicity*;Cocos*;Enzyme Induction;Herb-Drug Interactions*;Liver/drug effects*;Liver/enzymology;Microsomes, Liver/enzymology;Nuts;Plant Preparations/pharmacology*;RNA/metabolism;Rats;Rats, Wistar
18379622;Animals;Brain/drug effects*;Brain/metabolism;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology*;DNA/metabolism;Down-Regulation;Ethanol/pharmacology*;Herb-Drug Interactions*;Malvaceae*;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism*;Neurons/drug effects*;Neurons/metabolism;Nuts;Plant Preparations/pharmacology*;RNA Splicing/drug effects;RNA, Messenger/metabolism;Rats;Rats, Wistar;Transcription, Genetic/drug effects
18367983;Digoxin/blood*;Drug Contamination;Drug Monitoring*;Herb-Drug Interactions*;Humans;Hypericum*;Immunoassay;Phytotherapy;Plant Extracts/adverse effects;Plant Extracts/analysis;Plant Preparations/adverse effects*;Plant Preparations/analysis
18363644;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Beverages/adverse effects;Citrus paradisi*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Induction;Evidence-Based Medicine;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum*;Immunosuppressive Agents/adverse effects*;Kidney Transplantation*;Liver/drug effects*;Liver/enzymology;Plant Preparations/adverse effects;Receptors, Steroid/drug effects;Receptors, Steroid/metabolism;Risk Assessment;Up-Regulation
18356703;Adolescent;Child;Complementary Therapies*/adverse effects;Dietary Supplements/adverse effects;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy*/adverse effects;Psychotropic Drugs/adverse effects;Psychotropic Drugs/therapeutic use*;Treatment Outcome
18346508;Adolescent;Biological Products/therapeutic use*;Canada;Child;Child, Preschool;Drug Interactions*;Drug Therapy/utilization;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions;Female;Health Care Surveys;Herb-Drug Interactions*;Humans;Infant;Male;Pharmaceutical Preparations*;Phytotherapy*/utilization;Vitamins/therapeutic use
18338604;Animals;Cardiotonic Agents/isolation & purification;Cardiotonic Agents/pharmacology*;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Cells, Cultured;Creatine Kinase/blood;Creatine Kinase, MB Form/blood;Doxorubicin/adverse effects*;Doxorubicin/pharmacology;Ginsenosides/isolation & purification;Ginsenosides/pharmacology*;Herb-Drug Interactions;Humans;Lactate Dehydrogenases/blood;Male;Mice;Mice, Inbred ICR;Myocytes, Cardiac/cytology;Myocytes, Cardiac/drug effects*;Panax notoginseng*/chemistry;Plants, Medicinal/chemistry;Random Allocation;Rats
18338596;Amygdalin/chemistry*;Amygdalin/isolation & purification;Calcium Sulfate/chemistry*;Drug Combinations;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/isolation & purification;Ephedra sinica/chemistry*;Ephedrine/analysis*;Glycyrrhiza uralensis/chemistry;Herb-Drug Interactions;Materia Medica/chemistry;Plants, Medicinal/chemistry;Prunus/chemistry
18332740;Aged;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Community Health Nursing/organization & administration*;Comorbidity;Gallstones/complications*;Herb-Drug Interactions;Histamine H1 Antagonists/adverse effects;Home Care Services/organization & administration*;Humans;Kidney Failure, Chronic/complications*;Male;Nonprescription Drugs/adverse effects;Nurse's Role;Nursing Assessment/organization & administration*;Patient Education as Topic;Prednisone/adverse effects;Spider Bites/complications;Spider Bites/drug therapy*;Spider Bites/nursing
18332358;Adult;Aged;Dietary Supplements/statistics & numerical data*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy/statistics & numerical data*;Pilot Projects;Plant Extracts/therapeutic use*;Professional-Patient Relations;Self Medication/statistics & numerical data;United States/epidemiology;Urban Population/statistics & numerical data*
18332357;Adult;Aged;Dietary Supplements/statistics & numerical data*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy/statistics & numerical data*;Pilot Projects;Plant Extracts/therapeutic use*;Professional-Patient Relations;Self Medication/statistics & numerical data;Surveys and Questionnaires;United States/epidemiology;Urban Population/statistics & numerical data*
18332082;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bornanes/pharmacology*;China;Cytochrome P-450 CYP2B6;Herb-Drug Interactions*;Humans;Korea;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Mixed Function Oxygenases/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Phytotherapy;Plant Preparations/pharmacology*;Stroke/drug therapy;Stroke/prevention & control;Suspensions
18331656;Adult;Antineoplastic Agents/administration & dosage;Attitude to Health;Complementary Therapies/utilization*;Female;Head and Neck Neoplasms/drug therapy;Head and Neck Neoplasms/epidemiology;Head and Neck Neoplasms/therapy*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patient Acceptance of Health Care/statistics & numerical data;Phytotherapy/statistics & numerical data*;Plant Preparations*/administration & dosage;Scotland/epidemiology;Surveys and Questionnaires;Young Adult
18331390;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Caco-2 Cells;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Digoxin/metabolism;Herb-Drug Interactions;Humans;Ketoconazole/pharmacology;Plant Extracts/pharmacology;Plant Preparations/pharmacology*;Testosterone/metabolism;Verapamil/pharmacology
18324706;Drug Interactions;Drug Therapy*;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations*;Phytotherapy*/adverse effects;Reproducibility of Results
18310985;Aspirin/adverse effects*;Diffusion Magnetic Resonance Imaging;Female;Fibrinolytic Agents/adverse effects*;Herb-Drug Interactions*;Humans;Intracranial Hemorrhages/chemically induced*;Intracranial Hemorrhages/diagnostic imaging;Ischemic Attack, Transient/prevention & control;Middle Aged;Plant Extracts/adverse effects;Platelet Aggregation Inhibitors/adverse effects*;Self Medication/adverse effects*;Stroke/complications;Subtilisins/adverse effects*;Thrombosis/prevention & control;Tomography, X-Ray Computed
18310083;Amino Acid Sequence;DNA, Complementary/genetics;Flavonoids/chemistry*;Flavonoids/metabolism*;Gene Expression Regulation, Plant;Glycosyltransferases/genetics;Glycosyltransferases/metabolism*;Herb-Drug Interactions/genetics;Molecular Sequence Data;Phylogeny;Plant Proteins/genetics;Plant Proteins/metabolism*;Plasmids;Seeds/enzymology*;Soybeans/enzymology*;Substrate Specificity
18296885;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Ginger;Goats/metabolism*;Herb-Drug Interactions;Pefloxacin/administration & dosage*;Pefloxacin/blood;Pefloxacin/pharmacokinetics*;Phytotherapy/veterinary*;Piper;Piper nigrum;Plant Extracts/pharmacology*
18286859;Drug Contamination/statistics & numerical data;Drug Information Services;Drug and Narcotic Control;Evidence-Based Medicine;Health Knowledge, Attitudes, Practice;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Internet;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods;Phytotherapy/psychology;Phytotherapy/utilization*;Psoriasis/prevention & control*;Psoriasis/psychology;Safety;Self Medication/methods;Self Medication/psychology;Self Medication/statistics & numerical data*;Treatment Outcome;United States;United States Food and Drug Administration
18272627;Acetaminophen/adverse effects;Analgesics, Non-Narcotic/adverse effects;Antioxidants/adverse effects;Antioxidants/therapeutic use*;Chemical and Drug Induced Liver Injury*/etiology*;Hemochromatosis/therapy*;Herb-Drug Interactions*;Humans;Milk Thistle/adverse effects*;Phytotherapy/adverse effects*;Protective Agents/adverse effects;Protective Agents/therapeutic use*;Silymarin/adverse effects;Silymarin/therapeutic use*
18272626;Acetaminophen/adverse effects;Acetaminophen/metabolism;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/metabolism;Aspartame/adverse effects;Aspartame/metabolism;Hemochromatosis/chemically induced*;Hemochromatosis/diagnosis;Herb-Drug Interactions*;Humans;Liver Function Tests*;Milk Thistle/adverse effects*;Milk Thistle/metabolism;Sweetening Agents/adverse effects;Sweetening Agents/metabolism
18269091;Animals;Anti-Bacterial Agents/therapeutic use;Anti-Inflammatory Agents/therapeutic use;Gastrointestinal Agents/therapeutic use;Ginger*/adverse effects;Heart Diseases/prevention & control;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects
18261389;Algorithms;Drug Interactions*;Herb-Drug Interactions*;Humans;Phytotherapy*;Probability;Risk Factors
18260050;Animals;Antibiotics, Antineoplastic/adverse effects;Cardiomyopathies/chemically induced;Cardiomyopathies/drug therapy*;Cardiomyopathies/pathology;Cardiotonic Agents/analysis*;Cell Line, Tumor;Doxorubicin/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Humans;Male;Mice;Mice, Inbred ICR;Myocardium/pathology;Panax notoginseng/chemistry*;Phytotherapy*;Random Allocation;Rhizome/chemistry;Saponins/therapeutic use*
18251040;Adult;Alkaloids/adverse effects*;Anesthesia/methods;Anesthesia Recovery Period*;Anesthesia, Spinal;Catha/adverse effects*;Central Nervous System Stimulants/adverse effects;Disorders of Excessive Somnolence/chemically induced*;Dose-Response Relationship, Drug;Electrocardiography;Female;Herb-Drug Interactions*;Humans;Male;Monitoring, Physiologic/methods;Plant Leaves/adverse effects*;Recovery of Function/drug effects;Smoking
18236826;Anti-Retroviral Agents/pharmacology;Anticoagulants/pharmacology;Cardiovascular Agents/pharmacology;Chronic Disease;Dietary Supplements*;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacology;Phytotherapy*;Risk Factors
18223469;Animals;Bufanolides/blood*;Cross Reactions;Digoxin/blood*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/analysis*;False Negative Reactions;False Positive Reactions;Fluorescence Polarization;Herb-Drug Interactions;Humans;Immunoassay;Mice;Sensitivity and Specificity
18214851;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Ginkgo biloba/adverse effects*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Reproducibility of Results
18214850;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Clarithromycin/pharmacology*;Dietary Supplements;Digoxin/blood*;Digoxin/pharmacokinetics;Echinacea/metabolism*;Flavonoids/pharmacology;Ginkgo biloba;Herb-Drug Interactions*;Hypericum/metabolism*;Rifampin/pharmacology*
18214849;Cimicifuga/metabolism;Cytochrome P-450 CYP2D6/metabolism*;Dietary Supplements;Echinacea/metabolism;Herb-Drug Interactions*;Humans;Hydrastis/adverse effects*;Hydrastis/metabolism;Hypericum/metabolism;Kava/metabolism;Milk Thistle/metabolism;Phytotherapy*;Plant Extracts/pharmacology*
18204476;Adult;Alleles;Area Under Curve;Aryl Hydrocarbon Hydroxylases/genetics*;Blood Glucose/drug effects;Cross-Over Studies;Cytochrome P-450 CYP2C9;Female;Genotype;Gliclazide/pharmacokinetics*;Gliclazide/pharmacology;Half-Life;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Plant Extracts/pharmacology*;Polymerase Chain Reaction;Restriction Mapping
18204358;Anxiety/drug therapy;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Herb-Drug Interactions*;Humans;Phytotherapy;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/therapeutic use;Sleep Initiation and Maintenance Disorders/drug therapy
18204104;Animals;Evidence-Based Medicine;Female;Fetus/drug effects;Herb-Drug Interactions;Humans;Lactation*;Panax*/chemistry;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/toxicity;Pregnancy;Rhizome;Risk Assessment
18204103;Animals;Evidence-Based Medicine;Female;Fruit;Herb-Drug Interactions;Humans;Lactation*;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Pregnancy Complications, Infectious/drug therapy*;Risk Assessment;Urinary Tract Infections/drug therapy*;Vaccinium macrocarpon*/chemistry
18204102;Abortion, Spontaneous/prevention & control;Animals;Evidence-Based Medicine;Female;Fruit;Herb-Drug Interactions;Humans;Lactation/drug effects*;Menstruation/drug effects;Menstruation-Inducing Agents/adverse effects*;Menstruation-Inducing Agents/chemistry;Menstruation-Inducing Agents/toxicity;Oxytocics/adverse effects*;Oxytocics/chemistry;Oxytocics/toxicity;Phytoestrogens/adverse effects*;Phytoestrogens/chemistry;Phytoestrogens/toxicity;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Receptors, Estrogen/drug effects;Receptors, Progesterone/drug effects;Risk Assessment;Uterine Contraction/drug effects;Vitex*/chemistry
18204101;Animals;Caulophyllum*/chemistry;Evidence-Based Medicine;Female;Fetus/drug effects*;Herb-Drug Interactions;Humans;Lactation*;Midwifery;Oxytocics/adverse effects*;Oxytocics/chemistry;Oxytocics/toxicity;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Rhizome;Risk Assessment;United States;Uterine Contraction/drug effects*
18184982;Attitude of Health Personnel*;Canada;Clinical Competence*;Data Collection;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Internship and Residency*;Male;Medical History Taking;Phytotherapy/adverse effects;Phytotherapy/utilization*;Pilot Projects;Plant Preparations/therapeutic use*;Program Evaluation;Students, Medical*;Surveys and Questionnaires
18179003;Adjuvants, Anesthesia/pharmacology;Anesthesia, General;Anesthetics, Inhalation/pharmacology*;Animals;Herb-Drug Interactions*;Isoflurane/pharmacology*;Male;Midazolam/pharmacology;Nurse Anesthetists;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley;Time Factors;Valerian*
22436099;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Curcuma/chemistry*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nifedipine/blood;Nifedipine/pharmacokinetics*;Phytotherapy;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Reference Values;Young Adult
18090773;Adult;Aged;Aged, 80 and over;Aspirin/pharmacology;Blood Coagulation/drug effects*;Blood Coagulation Tests;Blood Platelets/drug effects*;Female;Garlic/adverse effects;Ginkgo biloba/adverse effects;Hemorrhagic Disorders/chemically induced;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Male;Middle Aged;Panax/adverse effects;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Platelet Function Tests;Postoperative Hemorrhage/chemically induced;Serenoa/adverse effects;Single-Blind Method
18081572;Adult;Aged;Alcohol Drinking*;Australia;Complementary Therapies*;Drug Prescriptions*;Drug-Related Side Effects and Adverse Reactions*;Ethanol/pharmacology*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nonprescription Drugs*;Pharmaceutical Preparations;Risk Assessment
18077884;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;United States;United States Food and Drug Administration
20014671;Alcoholic Beverages/adverse effects;Calcium, Dietary/adverse effects;Citrus paradisi/adverse effects;Dietary Fiber/adverse effects;Dietary Proteins/adverse effects;Drug Prescriptions/nursing;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Nurse Practitioners/organization & administration*;Patient Education as Topic/organization & administration;Safety Management;Vitamin K/adverse effects
18045358;Administration, Topical;Complementary Therapies;Cosmetics/pharmacology*;Dermatologic Agents/administration & dosage;Esthetics;Female;Herb-Drug Interactions;Humans;Male;Patient Satisfaction;Phytotherapy/methods*;Plant Extracts/administration & dosage*;Skin Aging/drug effects*;Skin Aging/physiology;Skin Care/methods;Treatment Outcome
18043467;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*
17992210;Dietary Supplements/adverse effects;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Polypharmacy
17978084;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/economics;Acquired Immunodeficiency Syndrome/virology;Adolescent;Adult;Antiretroviral Therapy, Highly Active/methods*;Cross-Sectional Studies;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Middle Aged;Phytotherapy/methods*;Uganda
17971406;Community Pharmacy Services*;Herb-Drug Interactions*;Humans;Pharmacists*;Plant Preparations/adverse effects
17969314;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
17968815;Administration, Oral;Adult;Area Under Curve;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Half-Life;Herb-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/pharmacokinetics*;Silymarin/pharmacology*;Time Factors
17961271;Dietary Supplements/standards*;Drug Interactions;Drug Labeling*;European Union;Herb-Drug Interactions;Humans;Legislation, Drug*;Nutrition Policy*;Quality Control
17941846;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Anticonvulsants/metabolism;Anticonvulsants/pharmacokinetics*;Anticonvulsants/therapeutic use;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Epilepsy/drug therapy*;Epilepsy/metabolism;Herb-Drug Interactions;Humans;Neurotoxins/adverse effects;Neurotoxins/metabolism;Phytotherapy/methods*;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism;Seizures/chemically induced*;Seizures/metabolism
17934030;Acetaminophen/administration & dosage*;Administration, Oral;Aged;Drug Therapy, Combination;Female;Ferritins/blood;Hemochromatosis/blood;Hemochromatosis/chemically induced*;Hemochromatosis/diagnosis;Hemochromatosis/therapy;Herb-Drug Interactions;Humans;Milk Thistle/adverse effects*;Phlebotomy;Phytotherapy/adverse effects*;Treatment Outcome
17925494;Adult;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements;Drug Administration Schedule;Glucocorticoids/blood;Glucocorticoids/pharmacokinetics*;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Male;Plant Preparations/pharmacology*;Plants, Medicinal;Prednisolone/blood;Prednisolone/pharmacokinetics*;Prednisone/blood;Prednisone/metabolism;Prednisone/pharmacokinetics*
17908423;Anticoagulants/adverse effects*;Dental Care for Chronically Ill*;Garlic/adverse effects;Ginger/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Panax/adverse effects;Plant Preparations/adverse effects*;Platelet Aggregation Inhibitors/adverse effects*;Postoperative Hemorrhage/chemically induced*;Postoperative Hemorrhage/prevention & control;Substance Withdrawal Syndrome*
17906915;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Registries
17900071;Aged/psychology*;Aged/statistics & numerical data;Anthropology, Cultural;Communication;Emigration and Immigration;Ethnopharmacology*/methods;Health Knowledge, Attitudes, Practice;Health Services Accessibility;Herb-Drug Interactions;Humans;Nurse's Role;Nurse-Patient Relations;Nursing Methodology Research;Patient Acceptance of Health Care/ethnology*;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods;Phytotherapy/psychology*;Polypharmacy;Qualitative Research;Russia/ethnology;Self Medication/adverse effects;Self Medication/methods;Self Medication/psychology*;Surveys and Questionnaires;Washington
17900036;Antineoplastic Agents/toxicity;Antioxidants/therapeutic use*;Chemotherapy, Adjuvant/adverse effects;Combined Modality Therapy;Dietary Supplements*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/radiotherapy;Radiation-Protective Agents/therapeutic use*;Radiotherapy/adverse effects;Radiotherapy, Adjuvant/adverse effects;Vitamins/therapeutic use*
17883958;2-Pyridinylmethylsulfinylbenzimidazoles/blood;Adult;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/metabolism;Anti-Ulcer Agents/pharmacokinetics;Area Under Curve;Artemisia/chemistry;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Drug Combinations;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Genotype;Herb-Drug Interactions;Humans;Hydroxylation/drug effects;Male;Omeprazole/analogs & derivatives;Omeprazole/blood;Omeprazole/metabolism;Omeprazole/pharmacokinetics*;Plants, Medicinal/chemistry;Safrole/analogs & derivatives;Safrole/metabolism
17877962;Animals;Antineoplastic Agents/metabolism;Antineoplastic Agents/therapeutic use;Breast Neoplasms/drug therapy;Breast Neoplasms/psychology;Breast Neoplasms/therapy*;Complementary Therapies*/adverse effects;Complementary Therapies*/statistics & numerical data;Complementary Therapies*/utilization;Denmark;Female;Herb-Drug Interactions;Humans;Quality of Life;Risk Factors;Treatment Outcome
17876860;Adrenergic beta-Agonists/metabolism*;Arylsulfotransferase/drug effects*;Arylsulfotransferase/metabolism;Beverages*;Biflavonoids/pharmacology;Biological Availability;Catechin/analogs & derivatives;Catechin/pharmacology;Citrus paradisi/chemistry;Citrus sinensis/chemistry;Flavanones/pharmacology;Flavones/pharmacology;Herb-Drug Interactions;Humans;In Vitro Techniques;Phenols/pharmacology;Polyphenols;Quercetin/pharmacology;Sulfotransferases/drug effects*;Sulfotransferases/metabolism;Tea/chemistry
17846096;Dietary Supplements/adverse effects*;Dietary Supplements/utilization;Herb-Drug Interactions;Humans;Palliative Care/methods*;Phytotherapy*;Terminally Ill/psychology
17785609;Aged;Complementary Therapies/adverse effects*;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions*;Female;Hemorrhage/chemically induced;Hemorrhage/epidemiology;Herb-Drug Interactions*/physiology;Humans;Male;Medicare/trends*;Pharmaceutical Preparations/metabolism;Phytotherapy/adverse effects;Plant Extracts/adverse effects;Plant Extracts/metabolism;Plant Preparations/adverse effects;Plant Preparations/metabolism;Retrospective Studies;Risk Factors;Washington
17766652;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Drug Interactions*;Herb-Drug Interactions*;Humans
17761132;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Antioxidants/adverse effects;Antioxidants/therapeutic use*;Clinical Trials as Topic*;Complementary Therapies*;Dietary Supplements*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/diet therapy;Neoplasms/drug therapy*;Plants, Medicinal/adverse effects*
17761130;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Dietary Supplements*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/diet therapy;Neoplasms/drug therapy*;Prevalence;Risk Factors
17723921;Chemical and Drug Induced Liver Injury*;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*
17723077;Acetaminophen/adverse effects;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Canada;Coenzymes/adverse effects;Complementary Therapies/adverse effects*;Diarrhea/complications;Dietary Supplements/adverse effects;Drug Interactions;Ethanol/adverse effects;Female;Ginger/adverse effects;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;International Normalized Ratio;Longitudinal Studies;Male;Middle Aged;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects;Prospective Studies;Risk Factors;Ubiquinone/adverse effects;Ubiquinone/analogs & derivatives;Vitamins/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
17706549;Animals;Drug Design*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Models, Biological;Pharmaceutical Preparations/chemistry;Plant Preparations/adverse effects;Plant Preparations/chemistry;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/trends
17704986;Drug Approval*;Drug Industry*/standards;Germany;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/pharmacology*
17701167;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Aged;Atorvastatin Calcium;Cholesterol/blood;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Female;Heptanoic Acids/pharmacokinetics;Heptanoic Acids/therapeutic use*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypercholesterolemia/blood;Hypercholesterolemia/drug therapy*;Hypericum*;Intestines/drug effects*;Intestines/enzymology;Intestines/metabolism;Liver/drug effects*;Liver/enzymology;Male;Middle Aged;Plant Preparations/pharmacology*;Pyrroles/pharmacokinetics;Pyrroles/therapeutic use*;Time Factors;Treatment Outcome;Triglycerides/blood;Up-Regulation
17684737;Area Under Curve;Drug Interactions*;Herb-Drug Interactions;Humans;Models, Biological;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Pharmacology*;Risk Assessment;Therapeutic Equivalency
17681658;Administration, Oral;Animals;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Ginkgo biloba*;Herb-Drug Interactions;Injections, Intravenous;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
17666620;Anticoagulants/therapeutic use;Female;Gynecologic Surgical Procedures/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Herb-Drug Interactions;Humans;Intermittent Pneumatic Compression Devices;Postoperative Complications/prevention & control*;Pulmonary Embolism/prevention & control*;Stockings, Compression;Venous Thrombosis/prevention & control*
17640426;Anticoagulants/adverse effects*;Blood Coagulation Disorders/chemically induced*;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Humans;Intraoperative Complications/chemically induced*;Male;Otorhinolaryngologic Surgical Procedures*;Patient Education as Topic/methods;Risk Factors
17633503;Echinacea;Ginkgo biloba;Herb-Drug Interactions;Herbal Medicine/education;Herbal Medicine/methods*;Humans;Nonprescription Drugs/therapeutic use;Nurse's Role;Nursing Assessment;Panax;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/nursing*;Safety Management;Self Medication
17616997;Acecainide/pharmacokinetics;Animals;Biological Availability;Female;Herb-Drug Interactions*;Hypericum*;Mice;Perylene/analogs & derivatives;Perylene/pharmacology;Procainamide/pharmacokinetics*
17611934;Cytochrome P-450 Enzyme System/metabolism*;Ginkgo biloba;Herb-Drug Interactions;Humans;Hydrastis;In Vitro Techniques;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Milk Thistle;Panax;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plant Leaves;Plant Roots;Plants, Medicinal*;Rhizome;Seeds;Vitis
17594986;Adult;Biological Transport;Breath Tests;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Erythromycin;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology
17591018;Animals;Chemical and Drug Induced Liver Injury;Complementary Therapies*/adverse effects;Complementary Therapies*/classification;Complementary Therapies*/economics;Costs and Cost Analysis;Drug Evaluation, Preclinical;Global Health;Health Surveys;Hepatitis B, Chronic/therapy*;Hepatitis C, Chronic/therapy*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/economics;Plant Preparations/adverse effects
17581220;Adult;Aged;Blotting, Western;Cells, Cultured;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction/drug effects;Female;Ginkgolides/pharmacology*;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Hydroxylation;Lactones/pharmacology*;Male;Middle Aged;Phenobarbital/pharmacology;Quercetin/pharmacology;Rifampin/pharmacology;Testosterone/metabolism
17578882;Adult;Biological Products/adverse effects*;Biological Products/metabolism;Community Pharmacy Services*/standards;Female;Herb-Drug Interactions*/physiology;Humans;Male;Middle Aged;Pharmacists*/standards
17575287;Animals;Endometriosis/drug therapy*;Female;Herb-Drug Interactions;Humans;Mice;Phytotherapy*;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*
17545337;Asthma/drug therapy;Breast Feeding;Child;Clinical Trials as Topic;Female;Herb-Drug Interactions;Humans;Migraine Disorders/prevention & control;Petasites*;Phytotherapy*;Plant Extracts/therapeutic use*;Pregnancy;Rhinitis, Allergic, Seasonal/drug therapy
17538868;Administration, Oral;Echinacea*;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/blood;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Polyunsaturated Alkamides/administration & dosage;Polyunsaturated Alkamides/blood;Polyunsaturated Alkamides/chemistry;Polyunsaturated Alkamides/pharmacokinetics;Receptors, Cannabinoid/metabolism
17511128;Adult;Aged;Anesthetics/adverse effects;Female;Herb-Drug Interactions*;Humans;Internet;Male;Marketing;Middle Aged;Pharmaceutical Preparations, Dental/adverse effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Surveys and Questionnaires
17495878;Adult;Clarithromycin/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements*;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Kava*;Male;Midazolam/pharmacokinetics*;Models, Biological;Phenotype;Plant Preparations/pharmacology*;Rifampin/pharmacology;Risk Assessment;Substrate Specificity
17480135;Aging;Alzheimer Disease/drug therapy*;Antioxidants/therapeutic use;Biomedical Research/organization & administration;Cognition Disorders/drug therapy;Herb-Drug Interactions;Humans;Phytotherapy/methods*;Plant Extracts/therapeutic use;Plants, Medicinal*
17477088;Acenocoumarol/administration & dosage*;Acenocoumarol/adverse effects;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Chronic Disease;Drug Administration Schedule;Drug Interactions;Educational Measurement;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;International Normalized Ratio;Patient Education as Topic/statistics & numerical data*;Poland;Self Care/psychology;Self Care/statistics & numerical data;Surveys and Questionnaires;Venous Thrombosis/drug therapy*
17464162;Cimicifuga/chemistry*;Female;Herb-Drug Interactions;Humans;Menopause*;Middle Aged;Phytotherapy*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Receptors, Estrogen/drug effects*
17425631;Attitude of Health Personnel;Dietary Supplements/utilization*;Empirical Research;Female;Herb-Drug Interactions;Humans;Inpatients/psychology*;Internal Medicine;Israel;Male;Middle Aged;Phytotherapy/utilization*
17405678;Antineoplastic Agents/toxicity;Antioxidants/therapeutic use*;Chemotherapy, Adjuvant/adverse effects;Combined Modality Therapy;Dietary Supplements*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/radiotherapy;Radiation-Protective Agents/therapeutic use*;Radiotherapy/adverse effects;Radiotherapy, Adjuvant/adverse effects;Randomized Controlled Trials as Topic;Survival Analysis;Vitamins/therapeutic use*
17405676;Adult;Aged;Aged, 80 and over;Female;Herb-Drug Interactions*;Humans;Materia Medica/adverse effects*;Middle Aged;Narration;Nonprescription Drugs/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects*;Surveys and Questionnaires;United States
17400821;Chamomile*;Colic/prevention & control*;Conjunctivitis/chemically induced;Cyclosporine/pharmacology;Dermatitis/prevention & control*;Dermatitis, Contact/etiology;Diarrhea/prevention & control*;Dyspepsia/prevention & control*;Female;Flowers;Herb-Drug Interactions;Humans;Infant;Lactation;Morning Sickness/drug therapy;Phytotherapy*/adverse effects;Plant Extracts/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy;Warfarin/pharmacology
17363091;Angioplasty, Balloon, Coronary;Animals;Cardiovascular Diseases/drug therapy*;Diabetes Complications/prevention & control;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Kidney Diseases/prevention & control;Myocardial Reperfusion Injury/prevention & control;Panax;Peripheral Vascular Diseases/drug therapy;Salvia miltiorrhiza*
17353348;Allyl Compounds/pharmacology*;Animals;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2B1/genetics;Cytochrome P-450 CYP2B6;Cytochrome P450 Family 2;Disulfides/pharmacology;Female;Herb-Drug Interactions;Humans;Liver/drug effects*;Liver/metabolism;Male;Mice;Mice, Inbred C57BL;Mice, Transgenic;NAD(P)H Dehydrogenase (Quinone)/genetics;NADPH Dehydrogenase/genetics;NF-E2-Related Factor 2/deficiency;NF-E2-Related Factor 2/genetics*;Oxidoreductases, N-Demethylating/genetics;RNA, Messenger/metabolism;Rats;Rats, Wistar;Receptors, Cytoplasmic and Nuclear/deficiency;Receptors, Cytoplasmic and Nuclear/genetics*;Steroid Hydroxylases/genetics;Sulfides/pharmacology*;Transcription Factors/deficiency;Transcription Factors/genetics*
17340748;Alopecia/chemically induced;Antineoplastic Agents/adverse effects*;Appetite/drug effects;Brain/drug effects;Complementary Therapies*/adverse effects;Depression/prevention & control;Diarrhea/chemically induced;Diarrhea/prevention & control;Exercise;Fatigue/chemically induced;Fatigue/prevention & control;Herb-Drug Interactions;Humans;Middle Aged;Nausea/chemically induced;Nausea/prevention & control;Oral Ulcer/chemically induced;Oral Ulcer/prevention & control;Vomiting/chemically induced;Vomiting/prevention & control
17312476;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Preparations*/adverse effects;Postoperative Complications/chemically induced*;Surgery, Plastic*;Vitamins*/adverse effects
17299847;Dementia/prevention & control*;Ginkgo biloba*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*
17297618;Adult;Arylamine N-Acetyltransferase/drug effects;Arylamine N-Acetyltransferase/metabolism*;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology;Cytochrome P-450 CYP2D6/drug effects*;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions*;Humans;Male;Xanthine Oxidase/drug effects;Xanthine Oxidase/metabolism*
17290064;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/therapeutic use*;Attitude to Health*;Chicago;Clinical Trials, Phase I as Topic/methods*;Complementary Therapies*;Decision Making*;Dietary Supplements;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/psychology;Neoplasms/therapy;Patient Participation;Patients/psychology*;Plant Preparations/therapeutic use;Prognosis;Quality of Life;Surveys and Questionnaires;Treatment Outcome;Vitamins/therapeutic use
17284505;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Administration Schedule;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Ibuprofen/administration & dosage;Ibuprofen/blood;Ibuprofen/pharmacokinetics*;Male;Plant Preparations/administration & dosage;Plant Preparations/isolation & purification;Plant Preparations/pharmacology*
17270371;Caco-2 Cells;Calcitriol/pharmacology*;Cell Survival/drug effects;Curcuma*/chemistry;Curcumin/analysis;Curcumin/pharmacology*;Curcumin/toxicity;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;Enzyme Induction/drug effects;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Enzyme Inhibitors/toxicity;Herb-Drug Interactions*;Humans;Hydroxylation;Inhibitory Concentration 50;Intestinal Mucosa/drug effects*;Intestinal Mucosa/enzymology;Intestinal Mucosa/pathology;Ketoconazole/pharmacology;Nifedipine/metabolism;Oxidation-Reduction;Plant Extracts/chemistry;Plant Extracts/pharmacology;RNA, Messenger/metabolism;Rhizome;Rifampin/pharmacology;Testosterone/metabolism
17267149;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Antineoplastic Agents, Phytogenic/administration & dosage*;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Genistein/administration & dosage;Genistein/metabolism;Genistein/pharmacology*;Herb-Drug Interactions*;Injections, Intravenous;Male;Metabolic Clearance Rate/drug effects;Nonprescription Drugs*;Paclitaxel/administration & dosage*;Paclitaxel/blood;Paclitaxel/pharmacokinetics*;Phytoestrogens/administration & dosage;Phytoestrogens/metabolism;Phytoestrogens/pharmacology*;Rats;Rats, Sprague-Dawley
17266896;Adverse Drug Reaction Reporting Systems;Drug Information Services*;Drug Interactions*;Drug Labeling*;European Union;Herb-Drug Interactions*;Humans;Hypericum/metabolism;Plants, Medicinal/metabolism;Spain
17243855;Aged;Analgesics, Opioid/therapeutic use;Dizziness/etiology;Herb-Drug Interactions*;Humans;Hypotension, Orthostatic/etiology;Male;Methadone/therapeutic use;Osteoarthritis/drug therapy;Pain/drug therapy;Plants, Medicinal/adverse effects*;Polypharmacy
17243519;Adolescent;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Malaysia;Male;Middle Aged;Patient Acceptance of Health Care/ethnology;Patient Acceptance of Health Care/statistics & numerical data*;Pharmaceutical Preparations;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Surveys and Questionnaires
17240097;Asparagus Plant/growth & development*;Conservation of Natural Resources;Herb-Drug Interactions;Humans;Medicine, Ayurvedic*;Phytotherapy/methods*;Plants, Medicinal;Systems Biology
17225526;Adenosine Triphosphate/pharmacology*;Animals;Ephedrine/pharmacology*;Female;Herb-Drug Interactions;Male;Nasal Mucosa/drug effects*;Rats;Rats, Sprague-Dawley
17169523;Adrenergic beta-Antagonists;Adult;Age Factors;Aged;Anesthetics/pharmacology;Angiotensin II Type 1 Receptor Blockers;Angiotensin-Converting Enzyme Inhibitors;Drug Utilization/statistics & numerical data*;Echinacea;Ephedra;Female;France;Ginkgo biloba;Health Surveys;Herb-Drug Interactions;Humans;Hypericum;Male;Medical History Taking*;Middle Aged;Panax;Phytotherapy/utilization*;Plant Preparations/pharmacology;Platelet Aggregation Inhibitors;Preoperative Care*;Prospective Studies;Sex Factors;Valerian
17168768;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biotransformation;Cytochrome P-450 Enzyme System/metabolism;Drug Design*;Drug Evaluation, Preclinical;Drug Monitoring;Drug-Related Side Effects and Adverse Reactions/prevention & control*;Herb-Drug Interactions*;Humans;Models, Biological;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*
17156416;Adult;Aged;Cross-Sectional Studies;England;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Middle Aged;Narration;Nonprescription Drugs/therapeutic use*;Physician-Patient Relations*;Sampling Studies;Surveys and Questionnaires;Tea;Women's Health*
17125440;Adult;Age Factors;Clinical Trials as Topic/statistics & numerical data*;Complementary Therapies/utilization*;Confounding Factors (Epidemiology);Drug Interactions*;Female;Herb-Drug Interactions;Humans;Male;Minerals/administration & dosage;Plant Preparations/administration & dosage;Prospective Studies;Research Subjects*;Sex Factors;Vitamins/administration & dosage
17116126;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors
17096679;Adult;Aged;Female;Herb-Drug Interactions*;Hospitalization*;Humans;Male;Phytotherapy/adverse effects*
17094523;Anesthetics*/adverse effects;Government Regulation;Herb-Drug Interactions*;Humans;Patient Education as Topic;Phytotherapy*/adverse effects
17093003;Complementary Therapies;Cytochrome P-450 Enzyme Inhibitors*;Dietary Supplements*;Herb-Drug Interactions*
17085776;Animals;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Lactation*;Lethal Dose 50;Plant Leaves;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Plant Preparations*/toxicity;Platelet Aggregation Inhibitors*/adverse effects;Platelet Aggregation Inhibitors*/chemistry;Platelet Aggregation Inhibitors*/pharmacology;Platelet Aggregation Inhibitors*/therapeutic use;Platelet Aggregation Inhibitors*/toxicity;Postpartum Hemorrhage/chemically induced;Pregnancy*;Risk Assessment;Seeds
17085775;Animals;Female;Herb-Drug Interactions;Humans;Hypericum*/adverse effects;Lactation*;Photosensitivity Disorders/chemically induced;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Pregnancy*;Risk Assessment
17085774;Administration, Oral;Animals;Echinacea*/adverse effects;Female;Herb-Drug Interactions;Humans;Lactation*;Lethal Dose 50;Plant Leaves;Plant Preparations*/administration & dosage;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Plant Preparations*/toxicity;Plant Roots;Plant Stems;Pregnancy*;Risk Assessment
17085773;Cimicifuga*;Female;Herb-Drug Interactions;Humans;Lactation*;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Pregnancy*;Receptors, Estrogen/drug effects;Rhizome;Risk Assessment;Uterine Contraction/drug effects;Uterus/drug effects*
17084954;Animals;Antioxidants/administration & dosage;Antioxidants/pharmacology*;Antioxidants/therapeutic use;Beverages*;Carbon Tetrachloride;Chemical and Drug Induced Liver Injury/etiology;Chemical and Drug Induced Liver Injury/prevention & control;Cytochrome P-450 CYP2E1/metabolism;Female;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred BALB C;Phytotherapy*;Salvia officinalis*
17079360;Adult;Cardiotonic Agents/pharmacokinetics*;Clarithromycin/pharmacology;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Digoxin/pharmacokinetics*;Drug Interactions;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Kava*;Male;Rifampin/pharmacology
17077621;Adjuvants, Pharmaceutic;Aluminum;Animals;Biological Availability;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Gastrointestinal Agents/chemistry;Gastrointestinal Agents/pharmacology*;Herb-Drug Interactions*;Levodopa/pharmacokinetics*;Magnesium;Male;Medicine, Kampo;Nonprescription Drugs;Rats;Rats, Wistar
17050802;Adult;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Ginger;Ginkgo biloba;Health;Herb-Drug Interactions/physiology*;Herbal Medicine*;Humans;Hypericum;Male;Models, Biological*;Panax;Plant Extracts/pharmacology;Warfarin/pharmacokinetics*;Warfarin/pharmacology*
17049775;Animals;Carbon Tetrachloride/toxicity*;Carbon Tetrachloride Poisoning/prevention & control;Dose-Response Relationship, Drug;Enzymes/drug effects;Enzymes/metabolism;Female;Gallic Acid/pharmacology*;Glutathione/metabolism;Glycogen/metabolism;Herb-Drug Interactions;Kidney/drug effects;Kidney/metabolism;Kidney/pathology;Lipid Peroxidation/drug effects;Liver/drug effects;Liver/metabolism;Liver/pathology;Medicine, Ayurvedic;Plant Extracts/pharmacology*;Protective Agents/chemistry;Protective Agents/pharmacology*;Proteins/drug effects;Proteins/metabolism;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology;Terminalia/chemistry*
17038845;Dietary Supplements/adverse effects*;Drug Monitoring;Gastroenterology;Guidelines as Topic;Herb-Drug Interactions;Humans;Medical History Taking/methods*;Nonprescription Drugs/adverse effects*;Nurse's Role;Nursing Assessment/methods*;Nutrition Policy;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/nursing;Self Medication/adverse effects;Self Medication/nursing
17036225;Child;Complementary Therapies*;Dietary Supplements;Herb-Drug Interactions;Humans;Mind-Body Therapies;Neoplasms/therapy*;Phytotherapy
17030295;Adult;Antiretroviral Therapy, Highly Active/utilization*;British Columbia/epidemiology;Cohort Studies;Complementary Therapies/utilization*;Cross-Sectional Studies;Female;HIV Infections/drug therapy;HIV Infections/epidemiology;HIV Infections/therapy*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Patient Education as Topic/organization & administration;Socioeconomic Factors;Surveys and Questionnaires
17030294;Adult;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Cross-Sectional Studies;Female;Garlic/adverse effects;Ginkgo biloba/adverse effects;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Malaysia;Male;Middle Aged;Panax/adverse effects;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Platelet Aggregation Inhibitors/administration & dosage*;Surveys and Questionnaires
17023070;Anticoagulants/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Warfarin/adverse effects*
17015952;Animals;Beverages;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors;Herb-Drug Interactions*;Male;Medicine, Kampo*;Nifedipine/pharmacokinetics*;Rats;Schisandra*
17010103;Adult;Aged;Clinical Trials as Topic;Cytochrome P-450 CYP3A/metabolism*;Female;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Male;Middle Aged;Plant Extracts/metabolism*;Plant Extracts/pharmacology*;Prospective Studies
17010102;Cross-Over Studies;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/pharmacology*;Platelet Function Tests/methods*;Tetrazoles/pharmacology*;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacology
17001360;Herb-Drug Interactions*;Humans
16988208;Administration, Oral;Adult;Area Under Curve;Benzazepines/administration & dosage;Benzazepines/blood;Benzazepines/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis;Electrocardiography;Female;Gastrointestinal Tract/metabolism;Half-Life;Headache/chemically induced;Heart Rate/drug effects;Herb-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Hypericum/chemistry*;Male;Metabolic Clearance Rate;Perylene/analogs & derivatives;Perylene/metabolism;Plant Preparations/administration & dosage;Plant Preparations/blood;Plant Preparations/pharmacokinetics*;Tablets
16983620;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Anti-Retroviral Agents/pharmacokinetics*;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacokinetics;Plants, Medicinal*
16979090;Aged;Alkaloids;Cholinesterase Inhibitors/adverse effects;Dementia/therapy;Evidence-Based Medicine;Galantamine/adverse effects;Geriatric Assessment/methods*;Geriatrics/education;Geriatrics/methods;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Medical History Taking/methods*;Neuroprotective Agents/adverse effects;Nootropic Agents/adverse effects;Phytotherapy/adverse effects*;Phytotherapy/utilization;Sesquiterpenes/adverse effects
16935738;Androgen Antagonists/adverse effects;Dietary Supplements/adverse effects*;Dietary Supplements/utilization;Echinacea/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Isoflavones/adverse effects;Medical History Taking;Nurse's Role;Nursing Assessment;Panax/adverse effects;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic/organization & administration*;Perioperative Care/nursing*;Perioperative Care/psychology;Phytotherapy/adverse effects*;Phytotherapy/nursing*;Phytotherapy/psychology;Phytotherapy/utilization;Plant Extracts/adverse effects;Postanesthesia Nursing/organization & administration;Risk Factors;Soybean Oil/adverse effects;United States
16926962;Aged;Aged, 80 and over;Drug Interactions*;Female;Health Care Surveys;Herb-Drug Interactions;Humans;Male;Nova Scotia;Osteoarthritis/drug therapy*;Primary Health Care/statistics & numerical data;Risk Assessment;Self Care
16918318;Animals;Anticarcinogenic Agents/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Gene Expression Regulation, Enzymologic;Glucuronosyltransferase/metabolism;Glutathione Transferase/metabolism;Herb-Drug Interactions*;Humans;Neoplasms/prevention & control;Pharmaceutical Preparations/metabolism*;Plant Preparations/pharmacology*
16907661;Evidence-Based Medicine*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
16905502;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16905501;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16903853;Action Potentials/drug effects;Action Potentials/physiology;Animals;Antidepressive Agents/pharmacology*;Cell Culture Techniques/methods;Cells, Cultured;Cerebral Cortex/cytology;Cerebral Cortex/drug effects*;Cerebral Cortex/physiology;Drug Evaluation, Preclinical/instrumentation;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions/physiology;Hypericum/chemistry;Mice;Microarray Analysis/instrumentation*;Microarray Analysis/methods;Microelectrodes/standards;Nerve Net/cytology;Nerve Net/drug effects*;Nerve Net/physiology;Neural Inhibition/drug effects;Neural Inhibition/physiology;Neurons/drug effects*;Neurons/physiology;Passiflora/chemistry;Plant Extracts/pharmacology*;Receptors, GABA/drug effects;Receptors, GABA/metabolism;Receptors, Serotonin/drug effects;Receptors, Serotonin/metabolism;Serotonin/metabolism;Synaptic Transmission/drug effects;Synaptic Transmission/physiology;Valerian/chemistry;gamma-Aminobutyric Acid/metabolism
16880233;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Medical Oncology*;Neoplasms/therapy*;Plants, Medicinal/adverse effects*
16880232;Complementary Therapies/utilization*;Decision Making;Health Planning Guidelines;Herb-Drug Interactions;Humans;Neoplasms/therapy*
16877262;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Anti-Retroviral Agents/administration & dosage;Anti-Retroviral Agents/metabolism*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects;Plant Extracts/metabolism*;Plants, Medicinal/chemistry*
16858951;Animals;Anticonvulsants/administration & dosage*;Centella*;Disease Models, Animal;Drug Therapy, Combination;Herb-Drug Interactions*;Male;Mice;Mice, Inbred ICR;Phytotherapy*;Plant Extracts/administration & dosage;Seizures/drug therapy*
16845946;Cytochrome P-450 Enzyme System/drug effects;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use*
16835538;Attitude to Health;Dissent and Disputes;Evidence-Based Medicine;Female;Health Knowledge, Attitudes, Practice;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Medical History Taking;Menopause*/physiology;Menopause*/psychology;Nurse's Role;Nursing Assessment;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing;Phytotherapy*/psychology;Plants, Medicinal;Risk Factors;Self Medication
16808005;Amides/administration & dosage;Amides/pharmacology;Amides/therapeutic use;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP2D6 Inhibitors;Dose-Response Relationship, Drug;Fruit;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Phytotherapy*;Piper nigrum*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
16796701;Adolescent;Adult;Aged;Child;Child, Preschool;Drug Prescriptions/statistics & numerical data;Family Practice/statistics & numerical data*;Female;Herb-Drug Interactions;Herbal Medicine/statistics & numerical data*;Homeopathy/statistics & numerical data*;Humans;Infant;Infant, Newborn;Male;Middle Aged;Plant Preparations/therapeutic use;Practice Patterns, Physicians'/statistics & numerical data*;Scotland
16791400;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Cathartics/adverse effects;Constipation/chemically induced;Drugs, Chinese Herbal/adverse effects*;Enalapril/adverse effects*;Glycyrrhizic Acid/adverse effects*;Herb-Drug Interactions*;Humans;Hyperaldosteronism/chemically induced*;Hypertension/drug therapy;Male;Potassium/blood;Rhinitis, Allergic, Perennial/drug therapy
16783181;Algorithms;Attitude of Health Personnel*;Audiovisual Aids;Clinical Competence;Decision Trees;Education, Nursing, Continuing/organization & administration*;Focus Groups;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Needs Assessment/organization & administration*;Nursing Assessment;Nursing Education Research;Nursing Methodology Research;Nursing Staff, Hospital*/education;Nursing Staff, Hospital*/psychology;Patient Education as Topic/organization & administration*;Patient Satisfaction;Perioperative Nursing/education;Phytotherapy/adverse effects*;Phytotherapy/nursing;Practice Guidelines as Topic;Preoperative Care;Risk Factors;Surveys and Questionnaires;Total Quality Management/organization & administration
16762125;Aged;Antihypertensive Agents/therapeutic use*;Crataegus*;Diabetes Mellitus, Type 2/complications;Diabetes Mellitus, Type 2/drug therapy*;Double-Blind Method;Female;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Hypertension/etiology;Hypoglycemic Agents/therapeutic use;Male;Middle Aged;Phytotherapy/methods*;Treatment Outcome
16758063;Adolescent;Adult;Aged;Aged, 80 and over;Anesthesia*;Female;Herb-Drug Interactions*;Humans;Intraoperative Complications;Male;Middle Aged;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Preoperative Care*;Surveys and Questionnaires
16755466;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacology*;Cell Line, Tumor;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics;Herb-Drug Interactions;Humans;Hypericum*;Intestine, Small/drug effects;Intestine, Small/enzymology;Liver/drug effects;Liver/enzymology;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;RNA, Messenger/analysis;Reverse Transcriptase Polymerase Chain Reaction
16750959;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Ataxia/chemically induced;Confusion/chemically induced;Drug Synergism;Fever/chemically induced;Headache/chemically induced;Herb-Drug Interactions*;Hospitalization;Humans;Kava/adverse effects*;Male;Medical History Taking;Paroxetine/administration & dosage*;Plant Extracts/adverse effects;Self Medication/adverse effects*;Sleep Stages/drug effects*;Valerian/adverse effects*
16722828;Adaptation, Physiological;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Hypericum*;Plant Preparations/metabolism*
16722827;Cyclosporine/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Heart Transplantation;Herb-Drug Interactions;Humans;Hypericum*;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation;Liver Transplantation;Male;Middle Aged;Models, Chemical;Retrospective Studies
16718375;Aldehyde Reductase/metabolism;Animals;Antioxidants/metabolism;Diabetes Mellitus, Experimental;Female;Glucose/metabolism;Glucosephosphate Dehydrogenase/metabolism;Glutathione Peroxidase/metabolism;Glutathione Reductase/metabolism;Herb-Drug Interactions*;Hexokinase/metabolism;Insulin/metabolism;L-Iditol 2-Dehydrogenase/metabolism;Lens, Crystalline/cytology;Lens, Crystalline/drug effects*;Lens, Crystalline/ultrastructure;Lipid Peroxidation;Plant Extracts/pharmacology;Rats;Rats, Wistar;Retina/drug effects*;Retina/ultrastructure;Sorbitol/metabolism;Time Factors;Trigonella/metabolism*;Vanadates/pharmacology*
16699292;Administration, Oral;Animals;Antitubercular Agents/blood;Antitubercular Agents/pharmacokinetics*;Garlic/chemistry*;Herb-Drug Interactions*;Isoniazid/blood;Isoniazid/pharmacokinetics*;Plant Extracts/pharmacology;Rabbits;Rifampin/blood;Rifampin/pharmacokinetics*
16678003;Aged;Critical Care*;Cytochrome P-450 Enzyme System*/classification;Cytochrome P-450 Enzyme System*/drug effects;Cytochrome P-450 Enzyme System*/physiology;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions;Humans;Isoenzymes*/drug effects;Isoenzymes*/metabolism;Isoenzymes*/physiology;Pharmaceutical Preparations*/classification;Pharmaceutical Preparations*/metabolism
16636327;Aged;Anticoagulants/adverse effects*;Beverages;Female;Herb-Drug Interactions*;Humans;Matricaria/adverse effects*;Ointments;Warfarin/adverse effects*
16610971;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacology*
16594744;Clinical Laboratory Techniques;Herb-Drug Interactions*;Humans;Pathology, Clinical/methods*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/classification
16568876;Aged;Aged, 80 and over;Australia;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Logistic Models;Male;Minerals/pharmacology;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/pharmacology;Vitamins/pharmacology
16557604;Antineoplastic Agents, Phytogenic/therapeutic use;Camellia sinensis;Curcumin/therapeutic use;Drug Synergism*;Genistein/therapeutic use;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Plant Extracts/therapeutic use*;Quercetin/therapeutic use;Signal Transduction
16553520;Aged, 80 and over;Anticoagulants/adverse effects*;Fatty Acids/adverse effects*;Hematuria/chemically induced*;Herb-Drug Interactions*;Humans;Insect Hormones/adverse effects*;Male;Warfarin/adverse effects*
16549570;Adult;Aged;Attitude to Health*;Complementary Therapies/adverse effects;Complementary Therapies/psychology*;Complementary Therapies/utilization;Cross-Sectional Studies;Drug Interactions;Drug Therapy/psychology*;Drug-Related Side Effects and Adverse Reactions;Emergency Service, Hospital;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Victoria
16541172;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Communication;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Female;Food, Organic/adverse effects;Food, Organic/utilization*;Food-Drug Interactions;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/diet therapy;Neoplasms/drug therapy;Neoplasms/therapy*;Norway;Patient Education as Topic;Physician-Patient Relations;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plants, Medicinal*/adverse effects;Surveys and Questionnaires
16538934;Chondroitin Sulfates/adverse effects;Chondroitin Sulfates/therapeutic use;Dietary Supplements*/adverse effects;Dietary Supplements*/utilization;Drug Information Services;Echinacea/adverse effects;Fish Oils/adverse effects;Fish Oils/therapeutic use;Garlic/adverse effects;Ginkgo biloba/adverse effects;Glucosamine/adverse effects;Glucosamine/therapeutic use;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kidney Failure, Chronic/complications;Kidney Failure, Chronic/prevention & control*;Kidney Failure, Chronic/psychology;Panax/adverse effects;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/methods*;Phytotherapy/psychology;Severity of Illness Index
16538644;Antidepressive Agents, Tricyclic/blood;Artifacts;Drug Monitoring/standards*;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Immunoassay;Phytotherapy
16532344;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Areca/adverse effects*;Breast Neoplasms/drug therapy*;Chemotherapy, Adjuvant/adverse effects;Cyclophosphamide/administration & dosage;Cyclophosphamide/adverse effects;Doxorubicin/administration & dosage;Doxorubicin/adverse effects;Female;Fluorouracil/administration & dosage;Fluorouracil/adverse effects;Herb-Drug Interactions*;Humans;Mastication;Methotrexate/administration & dosage;Methotrexate/adverse effects;Middle Aged;Mucositis/chemically induced*;Mucositis/pathology;Taxoids/administration & dosage;Taxoids/adverse effects
16482732;Ambulatory Care/organization & administration*;Communication;Complementary Therapies/organization & administration*;Credentialing/organization & administration;Evidence-Based Medicine;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Internet;Medical History Taking;Medical Oncology/organization & administration*;Neoplasms/psychology;Neoplasms/therapy;Nurse Clinicians/organization & administration*;Nurse Clinicians/psychology;Nurse's Role;Nurse-Patient Relations;Nursing Assessment;Oncology Nursing/organization & administration*;Patient Acceptance of Health Care;Patient Care Planning/organization & administration*;Patient Care Team/organization & administration;Patient Education as Topic/organization & administration;Practice Guidelines as Topic;Referral and Consultation/organization & administration;Safety Management/organization & administration
16477470;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/chemistry;Bridged Bicyclo Compounds/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/chemistry;Phloroglucinol/metabolism;Plants, Medicinal/chemistry;Terpenes/administration & dosage*;Terpenes/chemistry;Terpenes/metabolism
16470916;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Herb-Drug Interactions*;In Vitro Techniques;Kaempferols/pharmacology*;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Sprague-Dawley
16470912;Animals;Anticarcinogenic Agents/pharmacology;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions;Gene Expression Regulation, Enzymologic;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacology*
16459039;Biomedical Research/organization & administration*;Ethnopharmacology/organization & administration*;Herb-Drug Interactions;Humans;Medical History Taking;Physician's Role*
16451764;Adolescent;Adult;Demography;Dentistry*;Disclosure;Female;Health Behavior*;Herb-Drug Interactions;Humans;Internal-External Control;Logistic Models;Male;Middle Aged;Multivariate Analysis;Phytotherapy/psychology*;Plant Preparations/therapeutic use*;Self Medication;Sex Factors;Surveys and Questionnaires
16428919;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Cytochrome P-450 CYP2C9;Diclofenac/pharmacokinetics*;Drug Synergism;Female;Ginkgo biloba*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Plant Extracts/pharmacokinetics;Tolbutamide/pharmacokinetics*
16428030;Antidepressive Agents/adverse effects;Antidepressive Agents/chemical synthesis;Antidepressive Agents/therapeutic use;Depression/drug therapy*;Dermatitis, Phototoxic/etiology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Risk Assessment
16428028;Alcohol Dehydrogenase/antagonists & inhibitors*;Alcohol Dehydrogenase/drug effects;Alcohol Dehydrogenase/metabolism*;Alcohol Drinking;Chemical and Drug Induced Liver Injury/etiology;Herb-Drug Interactions;Kava/chemistry*;Lactones/pharmacology*;Plant Extracts/pharmacology;Pyrans/pharmacology;Pyrazoles/pharmacology;Pyrones/pharmacology;Spectrophotometry/methods
16419414;Anticonvulsants/adverse effects*;Aryl Hydrocarbon Hydroxylases/biosynthesis;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Enzyme Induction/drug effects;Fatal Outcome;Ginkgo biloba/adverse effects*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Mixed Function Oxygenases/biosynthesis;Phenytoin/adverse effects*;Seizures/etiology*;Valproic Acid/adverse effects*
16414224;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Indonesia;NADP/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal*
16396061;Adult;Drug Interactions;Female;HIV Infections/drug therapy*;HIV Infections/ethnology*;Herb-Drug Interactions;Herbal Medicine*;Hispanic Americans/psychology*;Humans;Interviews as Topic;Male;Phytotherapy/utilization*;Prospective Studies;Surveys and Questionnaires;Texas
16370951;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Complementary Therapies;Drug Approval;Herb-Drug Interactions*;Humans;Public Health;United States;United States Food and Drug Administration
16370950;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Communication;Data Collection;Decision Making;Herb-Drug Interactions*;Humans;Nonprescription Drugs;Physician-Patient Relations;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Quality Control;Reproducibility of Results
16341856;Adult;Area Under Curve;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/pharmacology;Cytochrome P-450 CYP3A/biosynthesis*;Herb-Drug Interactions*;Humans;Hypericum*;Male;Midazolam/pharmacokinetics*;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/pharmacology;Plant Extracts/pharmacology;Tablets;Terpenes/administration & dosage;Terpenes/pharmacology*
16337563;Clinical Trials as Topic/standards;Drug Information Services;Drug Labeling/standards;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Internet;Pain/diagnosis;Pain/drug therapy*;Pain Measurement;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Phytotherapy/adverse effects*;Phytotherapy/economics;Phytotherapy/standards*;Research Design/standards;Safety;Treatment Outcome
16329453;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents, Hormonal/administration & dosage*;Antineoplastic Agents, Hormonal/adverse effects;Aromatase Inhibitors/administration & dosage;Breast Neoplasms/drug therapy*;Contraceptives, Oral, Hormonal/administration & dosage*;Contraceptives, Oral, Hormonal/adverse effects;Female;Herb-Drug Interactions*;Hormone Replacement Therapy*/adverse effects;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors;Surveys and Questionnaires;Tamoxifen/administration & dosage
16329452;Attitude to Health;Documentation;Drug Utilization;Drug and Narcotic Control;Herb-Drug Interactions*;Humans;Informed Consent;Medical Records;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors;Surveys and Questionnaires
16329448;Antineoplastic Agents/administration & dosage*;Breast Neoplasms/drug therapy*;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors
16328317;Drug Utilization;Female;Herb-Drug Interactions*;Hospitalization/statistics & numerical data;Humans;Phytotherapy/adverse effects*;Product Surveillance, Postmarketing
16317661;Anti-Obesity Agents/adverse effects;Aristolochic Acids/adverse effects*;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Nephritis/chemically induced*
16294617;Dietary Supplements/adverse effects*;Drug Monitoring/methods;Drug Monitoring/nursing;Herb-Drug Interactions;Humans;Kidney/drug effects*;Kidney Diseases*/chemically induced;Kidney Diseases*/prevention & control;Medical History Taking;Nurse's Role;Nursing Assessment;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/nursing;Risk Factors;United States;United States Food and Drug Administration
16291709;Angina Pectoris/drug therapy;Animals;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Diterpenes, Abietane;Drugs, Chinese Herbal*/adverse effects;Drugs, Chinese Herbal*/chemistry;Drugs, Chinese Herbal*/pharmacology;Drugs, Chinese Herbal*/therapeutic use;Fibrinolytic Agents*/adverse effects;Fibrinolytic Agents*/chemistry;Fibrinolytic Agents*/pharmacology;Fibrinolytic Agents*/therapeutic use;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Lactates/pharmacokinetics;Lactates/pharmacology;Phenanthrenes/pharmacokinetics;Phenanthrenes/pharmacology;Phenanthrolines*/adverse effects;Phenanthrolines*/chemistry;Phenanthrolines*/pharmacology;Phenanthrolines*/therapeutic use;Plant Extracts;Randomized Controlled Trials as Topic;Salvia miltiorrhiza;Stroke/drug therapy
16287339;Androgen Antagonists/therapeutic use*;Complementary Therapies;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/therapeutic use*;Prostatic Hyperplasia/drug therapy*;Serenoa
16263432;Child;Consumer Product Safety*;Drug Contamination;Female;Government Regulation;Herb-Drug Interactions;Herbal Medicine*/legislation & jurisprudence;Herbal Medicine*/standards;Humans;Hypersensitivity;Internationality;Medicine, Traditional;Phytotherapy/adverse effects*;Plant Extracts*/administration & dosage;Plant Extracts*/adverse effects;Plant Extracts*/pharmacology;Plants, Medicinal*;Pregnancy
16260410;Adult;Biomedical Research;Child;Dose-Response Relationship, Drug;Echinacea*;Evidence-Based Medicine*;Female;Herb-Drug Interactions;History, 19th Century;Humans;Leukopenia/drug therapy;Male;Phytotherapy/history;Phytotherapy/standards*;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plant Extracts/standards;Plants, Medicinal*;Pregnancy;Radiation Injuries/drug therapy;Randomized Controlled Trials as Topic;Research Design;Respiratory Tract Infections/prevention & control;Safety
16255656;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Arthritis/drug therapy;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects;Plant Extracts/therapeutic use
16227061;Ephedra/chemistry;Ephedra/toxicity*;Herb-Drug Interactions;Humans;Hypericum/chemistry;Hypericum/toxicity*;Phytotherapy*
16221754;Administration, Oral;Adult;Area Under Curve;Cimicifuga*;Clarithromycin/administration & dosage;Clarithromycin/pharmacokinetics;Dietary Supplements;Digoxin/antagonists & inhibitors;Digoxin/blood;Digoxin/pharmacokinetics*;Drug Administration Schedule;Female;Genes, MDR/genetics;Half-Life;Haplotypes/genetics;Herb-Drug Interactions;Humans;Male;Milk Thistle*;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Rifampin/administration & dosage;Rifampin/pharmacokinetics;Rifampin/urine
16209856;Antiviral Agents/therapeutic use;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Complementary Therapies/standards*;Europe;Herb-Drug Interactions;Herpes Genitalis/drug therapy*;Humans;Plants, Medicinal;United States
16209114;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Herb-Drug Interactions;Humans;Neoplasms/therapy*
16181542;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biotransformation/physiology*;Cytochrome P-450 CYP3A/physiology*;Drug Interactions/physiology;Drugs, Chinese Herbal/metabolism*;Herb-Drug Interactions/physiology*;Humans;Intestines/metabolism*;Receptors, Cytoplasmic and Nuclear/metabolism
16175124;Clinical Trials as Topic*;Garlic;Ginkgo biloba;Herb-Drug Interactions*;Hypericum;Panax;Phytotherapy*
16168817;Anticoagulants/therapeutic use*;Ginsenosides/adverse effects;Hemorrhage/chemically induced;Herb-Drug Interactions*;Herbal Medicine*;Humans;Panax*/adverse effects;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Warfarin/therapeutic use*
16168502;Animals;Cardiotonic Agents/therapeutic use*;Digoxin/therapeutic use*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/metabolism*
16162912;Antirheumatic Agents/adverse effects*;Arthritis/therapy;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*
16158798;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Binding, Competitive;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypnotics and Sedatives/metabolism;Liver/metabolism;Oxidation-Reduction
16156004;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/psychology;Anti-HIV Agents/therapeutic use*;Evidence-Based Medicine;HIV Infections/drug therapy*;HIV Infections/psychology;Herb-Drug Interactions;Herbal Medicine;Humans;Phytotherapy*;Plants, Medicinal*;Quality of Life;Randomized Controlled Trials as Topic;Treatment Outcome
16153141;Aged;Anxiety/drug therapy;Ethanol/adverse effects;Herb-Drug Interactions*;Humans;Kava*;Middle Aged;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Sleep Wake Disorders/drug therapy
16131821;Administration, Oral;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chickens/metabolism*;Dose-Response Relationship, Drug;Female;Half-Life;Herb-Drug Interactions*;Oxytetracycline/blood;Oxytetracycline/pharmacokinetics*;Piper*
16125735;Animals;Antidepressive Agents/pharmacology*;Area Under Curve;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Herb-Drug Interactions;Hypericum;Injections, Intraperitoneal;Liver/drug effects*;Liver/enzymology;Male;Midazolam/pharmacokinetics;Perfusion;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Tolbutamide/pharmacokinetics
16117219;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Nursing Assessment
16115117;Evidence-Based Medicine;Garlic*/adverse effects;Herb-Drug Interactions;Humans;Hypertension/prevention & control*;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/methods*;Phytotherapy/standards;Phytotherapy/utilization;Treatment Outcome;United States
16114489;Anti-Bacterial Agents/isolation & purification;Anti-Bacterial Agents/pharmacology*;Apiaceae*;Cresols/isolation & purification;Cresols/pharmacology*;Drug Resistance, Bacterial;Herb-Drug Interactions;In Vitro Techniques;Microbial Sensitivity Tests;Monoterpenes/isolation & purification;Monoterpenes/pharmacology*;Oils, Volatile/isolation & purification;Oils, Volatile/pharmacology;Plant Oils/isolation & purification;Plant Oils/pharmacology*;Salmonella enteritidis/drug effects*;Salmonella typhimurium/drug effects*
16114078;Administration, Oral;Area Under Curve;Computer Simulation;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Injections, Intravenous;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics*;Plants, Medicinal*;Predictive Value of Tests
16108248;Anticoagulants*/agonists;Anticoagulants*/antagonists & inhibitors;Drug Interactions;Herb-Drug Interactions*;Humans;Panax;Salvia miltiorrhiza;Warfarin*/agonists;Warfarin*/antagonists & inhibitors
16100357;Antirheumatic Agents/adverse effects*;Drug Contamination*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*
16062162;Adrenal Cortex Hormones/therapeutic use;Analgesics, Opioid/therapeutic use;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/drug therapy*;Neoplasms/surgery;Practice Guidelines as Topic*;Preoperative Care
16046518;Beverages*;Biopsy;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Female;Follow-Up Studies;Graft Rejection/blood;Graft Rejection/pathology;Graft Rejection/prevention & control*;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Kidney Transplantation*;Middle Aged;Plant Extracts/therapeutic use*
16044851;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Dental Care for Chronically Ill*;Drug Interactions;Herb-Drug Interactions;Humans;Ibuprofen/pharmacology
16037651;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Dietary Supplements*/standards;Drug Labeling;European Union;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Humans;Italy;Legislation, Drug*;Legislation, Food*;Minerals/standards;Minerals/therapeutic use;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/standards;Plant Preparations*/therapeutic use;Plants, Medicinal;Vitamins/standards;Vitamins/therapeutic use
16037648;Abortion, Spontaneous/chemically induced;Adolescent;Adult;Adverse Drug Reaction Reporting Systems/organization & administration;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Anaphylaxis/chemically induced;Anaphylaxis/epidemiology;Beverages/adverse effects;Child;Child, Preschool;Dietary Supplements/adverse effects*;Drug Hypersensitivity/epidemiology;Drug Hypersensitivity/etiology;Female;Government Agencies/organization & administration;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Italy;Male;Middle Aged;Pilot Projects;Plant Preparations/adverse effects*;Pregnancy;Pregnancy Complications/chemically induced;Self Medication;Telefacsimile
16010646;Complementary Therapies;Dietary Supplements;Herb-Drug Interactions*;Humans;Kidney Diseases/drug therapy*;Phytotherapy*;Warfarin/pharmacology*
16005588;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Kava/adverse effects*
16004184;Europe;Herb-Drug Interactions*;Humans;Legislation, Drug;Materia Medica/adverse effects*;Plant Preparations/adverse effects*;United States
15999084;Anticoagulants/adverse effects;Antioxidants/therapeutic use;Cardiovascular Diseases/prevention & control;Case Management/organization & administration;Chondroitin/therapeutic use;Clinical Trials as Topic*;Evidence-Based Medicine;Glucosamine/therapeutic use;Herb-Drug Interactions;Humans;National Institutes of Health (U.S.);Osteoarthritis/drug therapy;Phytotherapy/standards*;United States
15997009;Clinical Trials as Topic*;Herb-Drug Interactions*;Humans;Pediatrics;Pharmacokinetics
15984360;Aloe/adverse effects;Ephedra/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;Nurse Practitioners;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/nursing;Phytotherapy/psychology
15983535;Aged;Consumer Product Safety*;Dietary Supplements/utilization*;Drug Interactions;Female;Health Behavior;Health Services for the Aged/standards*;Herb-Drug Interactions;Humans;Male;Nonprescription Drugs/administration & dosage;Patient Satisfaction*;Plant Preparations/administration & dosage*;Surveys and Questionnaires
15974642;Administration, Oral;Aged;Allyl Compounds/chemistry;Caffeine/administration & dosage;Caffeine/blood;Caffeine/pharmacology;Chlorzoxazone/administration & dosage;Chlorzoxazone/blood;Chlorzoxazone/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*;Drug Administration Schedule;Female;Ginkgo biloba/chemistry;Herb-Drug Interactions;Humans;Hypericum/chemistry;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Isoenzymes/metabolism;Male;Midazolam/administration & dosage;Midazolam/blood;Midazolam/pharmacology;Panax/chemistry;Phenotype;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Sulfides/chemistry
15960738;Aged;Arthroplasty, Replacement, Hip*;Ginkgo biloba*;Herb-Drug Interactions;Humans;Male;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Postoperative Hemorrhage/chemically induced*
15942431;Gastrointestinal Diseases/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*
15936791;Administration, Oral;Animals;Area Under Curve;Asthenia/chemically induced;Chromatography, High Pressure Liquid;Half-Life;Herb-Drug Interactions*;Injections, Intravenous;Isoflavones/analysis;Isoflavones/chemistry;Male;Methotrexate/administration & dosage;Methotrexate/blood;Methotrexate/pharmacokinetics*;Molecular Structure;Piloerection/drug effects;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Roots/chemistry*;Pueraria/chemistry*;Rats;Rats, Sprague-Dawley
15935039;Aged;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Cystitis/complications;Cystitis/drug therapy;Fruit;Herb-Drug Interactions*;Humans;Hypertension/complications;Hypertension/drug therapy;International Normalized Ratio;Male;Medical History Taking/methods*;Medication Errors/prevention & control;Phytotherapy/methods*;Plant Preparations;Vaccinium macrocarpon*;Warfarin/blood;Warfarin/therapeutic use*
15916450;Animals;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics*
15915310;Complementary Therapies/standards*;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Evidence-Based Medicine*;Food-Drug Interactions;Herb-Drug Interactions;Herbal Medicine/standards*;Humans;Practice Guidelines as Topic;Self Medication
15914127;Adult;Contraceptives, Oral, Synthetic/pharmacokinetics*;Contraceptives, Oral, Synthetic/pharmacology;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/pharmacology;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology;Female;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Metrorrhagia;Norethindrone/pharmacokinetics*;Norethindrone/pharmacology;Ovulation/drug effects*
15900291;Drug Contamination/legislation & jurisprudence;Drug Contamination/statistics & numerical data;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Herbal Medicine/standards;Herbal Medicine/statistics & numerical data;Humans;Malaysia/ethnology;Plant Preparations/classification;Plant Preparations/therapeutic use*;Plants, Medicinal
15900287;Adult;Aryl Hydrocarbon Hydroxylases/drug effects*;Aryl Hydrocarbon Hydroxylases/genetics*;Caffeine/pharmacology;Capsules;Cimicifuga/chemistry;Cimicifuga/metabolism*;Dietary Supplements;Drug Administration Schedule;Female;Herb-Drug Interactions/physiology;Humans;Hydrastis/chemistry;Hydrastis/metabolism*;Kava/chemistry;Kava/metabolism*;Male;Midazolam/pharmacology;Patient Selection;Phenotype*;Time Factors;Valerian/chemistry*;Valerian/metabolism
15898829;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Phytotherapy*/adverse effects;Plants, Medicinal/adverse effects;Plants, Medicinal/metabolism*
15884474;Anxiety/drug therapy*;Cimicifuga;Depression/drug therapy*;Evidence-Based Medicine;Ginkgo biloba;Herb-Drug Interactions;Humans;Hypericum;Kava;Nurse's Role;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/nursing;Phytotherapy/standards;Sleep Wake Disorders/drug therapy*;Valerian
15856334;Adult;Aged;Demography;Dietary Supplements/classification;Dietary Supplements/utilization*;Female;Health Care Surveys;Herb-Drug Interactions;Hospitals, Community/utilization*;Humans;Illinois;Male;Middle Aged;Neoplasm Staging;Neoplasms/drug therapy;Neoplasms/pathology;Neoplasms/therapy*;Oncology Service, Hospital/utilization*;Self Care*;Surveys and Questionnaires
15835425;Communication*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Oral Health*;Vitamins/adverse effects
15834065;Antirheumatic Agents/adverse effects*;England;Herb-Drug Interactions*;Humans;Outpatient Clinics, Hospital;Phytotherapy/utilization*
15829016;Adolescent;Adult;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Ascorbic Acid/pharmacokinetics;Ascorbic Acid/therapeutic use*;Clinical Trials as Topic/standards;Drug Interactions*;Female;HIV Infections/drug therapy*;HIV-1/drug effects;Herb-Drug Interactions;Humans;Male;Middle Aged;Phytotherapy;Plant Extracts/pharmacokinetics;Plant Extracts/therapeutic use*
15824968;Animals;Blood Glucose/drug effects;Drugs, Chinese Herbal/pharmacology*;Fructose/pharmacology;Glucose Intolerance/drug therapy*;Glucose Tolerance Test;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology;Insulin Resistance*;Male;Panax*;Rats;Rats, Wistar;Tolbutamide/pharmacology
15823059;Aged;Complementary Therapies;Drug Prescriptions*;Drug-Related Side Effects and Adverse Reactions*;Ginkgo biloba/adverse effects*;Herb-Drug Interactions*;Humans
15816268;Adolescent;Adult;Age Factors;Community Health Centers;Diabetes Mellitus/drug therapy*;Drug Prescriptions/statistics & numerical data*;Female;Gastrointestinal Diseases/drug therapy*;Health Care Surveys;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Male;Middle Aged;Pharmacies;Pharmacy Service, Hospital;Phytotherapy/adverse effects;Phytotherapy/utilization*;Pilot Projects;Polypharmacy*;Self Medication/utilization*;Surveys and Questionnaires
15814041;Anticoagulants/antagonists & inhibitors*;Commiphora*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Thrombosis/prevention & control;Warfarin/antagonists & inhibitors*
15807986;Animals;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Area Under Curve;Camellia sinensis;Clozapine/blood;Clozapine/pharmacokinetics*;Cytochrome P-450 CYP1A2/biosynthesis;Half-Life;Herb-Drug Interactions*;Liver/metabolism;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tea*
15801937;Administration, Oral;Adult;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Ginger/metabolism*;Ginkgo biloba/metabolism*;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Platelet Aggregation/drug effects;Protein Binding/drug effects;Warfarin/pharmacokinetics*;Warfarin/pharmacology
15794726;Adult;Aged;Animals;Child;Herb-Drug Interactions*;Humans;Middle Aged;Pharmaceutical Preparations/classification*;Plants, Medicinal/classification*;Risk Assessment
15779134;Acetaminophen/adverse effects;Aged;Analgesics, Non-Narcotic/adverse effects*;Anticoagulants/adverse effects*;Blood Coagulation/drug effects;Female;Ginger/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Warfarin/adverse effects
15742918;Aged;Herb-Drug Interactions;Humans;Hypericum;Male;Phytotherapy*/adverse effects;Plants, Medicinal*/adverse effects
15732155;Antineoplastic Agents/therapeutic use*;Benzamides;Herb-Drug Interactions*;Humans;Hypericum*;Imatinib Mesylate;Phytotherapy*;Piperazines/therapeutic use*;Pyrimidines/therapeutic use*
15703370;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;African Americans;Asian Continental Ancestry Group;Cytochrome P-450 CYP3A/biosynthesis*;European Continental Ancestry Group;Female;Genotype;Herb-Drug Interactions/ethnology*;Hispanic Americans;Humans;Hypericum*;Male;Midazolam/blood;Midazolam/pharmacokinetics*;Middle Aged;Phenotype;Plant Preparations/pharmacology*;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
15676159;Anticoagulants/pharmacology;Antihypertensive Agents/pharmacology;Biological Availability;Blood Coagulation/drug effects;Cardiotonic Agents/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/blood;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/epidemiology;Clinical Trials as Topic;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology;Phytotherapy;Plant Preparations/pharmacology*;Plants, Medicinal*/metabolism;Platelet Aggregation Inhibitors/pharmacology;Risk Factors
15667753;Angelica;Cimicifuga;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions;Hot Flashes/drug therapy*;Humans;Menopause*;Oenothera;Phytotherapy*;Plants, Medicinal*;Trifolium
15663295;Animals;Beverages*;Biological Availability;Bronchodilator Agents/blood;Cassia*;Chromatography, High Pressure Liquid/methods;Herb-Drug Interactions*;Male;Plant Preparations/pharmacology*;Rats;Rats, Wistar;Sapindaceae;Theophylline/blood*
15663291;Beverages/analysis;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/physiology*;Enzyme Inhibitors/analysis;Food-Drug Interactions/physiology*;Fruit/chemistry;Herb-Drug Interactions/physiology*;Humans
15660956;Anti-Allergic Agents/pharmacokinetics;Anti-Allergic Agents/pharmacology;Anti-Asthmatic Agents/pharmacokinetics;Anti-Asthmatic Agents/pharmacology;Anti-Infective Agents/pharmacokinetics;Anti-Infective Agents/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology;Central Nervous System Agents/pharmacokinetics;Central Nervous System Agents/pharmacology;Clinical Trials as Topic;Contraceptives, Oral/pharmacokinetics;Contraceptives, Oral/pharmacology;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Immunosuppressive Agents/pharmacokinetics;Immunosuppressive Agents/pharmacology
15656716;Anxiety/drug therapy;Herb-Drug Interactions;Phytotherapy*/adverse effects;Sleep Initiation and Maintenance Disorders/drug therapy;Spasm/drug therapy;Valerian*/adverse effects;Valerian*/chemistry
15656714;Angelica sinensis*/adverse effects;Angelica sinensis*/chemistry;Cardiovascular Diseases/drug therapy;Dysmenorrhea/drug therapy;Female;Herb-Drug Interactions;Hot Flashes/drug therapy;Humans;Male;Nephrotic Syndrome/drug therapy;Phytotherapy*/adverse effects
15655860;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Herb-Drug Interactions*;Humans;Panax/adverse effects*;Warfarin/administration & dosage;Warfarin/adverse effects*
15647404;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Risk Factors;Stereoisomerism;Thrombosis/metabolism;Thrombosis/prevention & control;Warfarin/chemistry;Warfarin/metabolism;Warfarin/pharmacology*
15638066;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Plants, Medicinal*/adverse effects
15630483;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Platelets/drug effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*
15627040;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Anti-Retroviral Agents/metabolism*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP3A;Fabaceae*;Herb-Drug Interactions*;Humans;Hypoxis*;Oxidoreductases, N-Demethylating/metabolism;Phytotherapy/methods*;Plant Extracts/adverse effects*;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/metabolism;Verapamil/metabolism
15625927;Blood Glucose/metabolism*;Cinnamomum zeylanicum*/adverse effects;Complementary Therapies*/adverse effects;Contraindications;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plants, Medicinal*/adverse effects
15617217;Dietary Supplements*/adverse effects;Dietary Supplements*/standards;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Phytotherapy*/standards;Self Medication/adverse effects;United States;United States Food and Drug Administration
15608563;Adult;Aryl Hydrocarbon Hydroxylases/blood;Aryl Hydrocarbon Hydroxylases/metabolism*;Asian Continental Ancestry Group;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Mixed Function Oxygenases/blood;Mixed Function Oxygenases/metabolism*;Omeprazole/analogs & derivatives*;Omeprazole/blood;Omeprazole/pharmacokinetics;Omeprazole/pharmacology*;Omeprazole/urine;Pharmacogenetics*;Plant Extracts/pharmacology;Time Factors
15581442;Drug Contamination;Drug Prescriptions/standards*;Drug and Narcotic Control;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans;Physician's Role*;Phytotherapy/adverse effects*;Phytotherapy/economics;Phytotherapy/standards*;Plant Preparations/adverse effects;Plant Preparations/economics;Plant Preparations/standards;United States
15570327;Beverages;Drug Labeling;Europe;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans;Kava/adverse effects*;Liver Failure/chemically induced*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use
15551196;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adenosine Triphosphate/metabolism;Amitriptyline/pharmacology;Animals;Antidepressive Agents/pharmacology;Brain/cytology;Bridged Bicyclo Compounds/pharmacology;Cells, Cultured;Dose-Response Relationship, Drug;Drug Interactions;Endothelial Cells/drug effects*;Fluoresceins/metabolism;Fluoxetine/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Leukemia;Models, Biological;Phloroglucinol/analogs & derivatives*;Phloroglucinol/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/pharmacology;Swine;Terpenes/pharmacology
15523104;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Antioxidants/therapeutic use*;Combined Modality Therapy;Delivery of Health Care, Integrated;Diet;Dietary Supplements*;Female;Herb-Drug Interactions;Humans;Male;Micronutrients/administration & dosage;Neoplasms/mortality;Neoplasms/prevention & control*;Neoplasms/therapy*;Oxidative Stress/drug effects*;Radiotherapy, Adjuvant;Risk Assessment;Sensitivity and Specificity;Survival Analysis
15520476;Anti-HIV Agents/therapeutic use*;Complementary Therapies*;Focus Groups;HIV Infections/psychology;HIV Infections/therapy*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Information Dissemination;Male;Patient Education as Topic*/methods;Phytotherapy
15508430;Area Under Curve;Cytochrome P-450 Enzyme System/pharmacokinetics*;Ginkgo biloba/metabolism*;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Liver/metabolism;Milk Thistle/metabolism*;Risk Factors
15503544;Echinacea/adverse effects;Ephedra/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Kava/adverse effects;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Serenoa
15500490;Adolescent;Ambulatory Surgical Procedures/methods*;Anesthesia/methods*;Child;Child, Preschool;Herb-Drug Interactions;Herbal Medicine/methods;Herbal Medicine/statistics & numerical data*;Humans;Infant;Surveys and Questionnaires
15493382;Chemistry, Pharmaceutical;Drug Contamination;Drug Overdose;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*
15477727;Dietary Supplements/adverse effects*;Food, Organic*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
15467212;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;Animals;Apocynum*;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Cytochrome P-450 CYP3A;Herb-Drug Interactions;Hypericum;In Vitro Techniques;Intestinal Absorption;Male;Methylprednisolone/pharmacokinetics;Nifedipine/pharmacokinetics;Oxidoreductases, N-Demethylating/biosynthesis*;Plant Extracts/pharmacology;Rats;Rats, Wistar
15386721;Child;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Kava/adverse effects*;Male;Middle Aged;Pharmacoepidemiology*
15386186;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/metabolism*;Plant Extracts/pharmacokinetics;Plants, Medicinal*
15369000;Chondroitin;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Garlic;Ginger;Ginkgo biloba;Glucosamine;Herb-Drug Interactions*;Herbal Medicine;Humans;Hypericum;Kava;Orthopedics*;Panax;Perioperative Care;Phytotherapy/adverse effects;Valerian
15368996;Dose-Response Relationship, Drug;Drug Administration Schedule;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Herbal Medicine;Humans;Perioperative Care;Phytotherapy/adverse effects;Risk Factors
15350672;Animals;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2E1/drug effects;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/toxicity*;Enzyme Induction/drug effects;Gene Expression Regulation, Enzymologic/drug effects*;Health Surveys;Herb-Drug Interactions*;Humans;Korea;Male;Obesity/drug therapy;Plant Extracts/toxicity*;Rats;Rats, Sprague-Dawley
15341976;Child;Complementary Therapies*;Dietary Supplements;Herb-Drug Interactions;Humans;Mind-Body Therapies;Neoplasms/therapy*;Phytotherapy
15341178;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing
15339595;Anti-Bacterial Agents/therapeutic use;Combined Modality Therapy;Drug Therapy, Combination;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*;Respiration, Artificial;Severe Acute Respiratory Syndrome/therapy*;Treatment Outcome
15339586;Antibiotics, Antineoplastic/pharmacology;Cell Proliferation/drug effects*;Chromatography, High Pressure Liquid;Daunorubicin/pharmacology;Drugs, Chinese Herbal/pharmacology*;Electrophoresis, Gel, Two-Dimensional;Female;Herb-Drug Interactions;Humans;Male;Neoplasms/drug therapy;Neoplasms/pathology;Plant Extracts/isolation & purification;Plant Extracts/pharmacology;Polygonaceae*;Tumor Cells, Cultured
15330011;Asthma/immunology*;Asthma/therapy*;Clinical Trials as Topic;Complementary Therapies*/classification;Herb-Drug Interactions;Humans;Hypersensitivity/immunology;Hypersensitivity/therapy;Phytotherapy/classification;Plant Preparations/classification;Plants, Medicinal/classification;United States
15316539;Attitude to Health;Complementary Therapies*/classification;Dental Care;Dentistry*;Herb-Drug Interactions;Humans;Nonprescription Drugs/therapeutic use;Phytotherapy/adverse effects;United States
15310261;Acupuncture Therapy;Complementary Therapies*;Herb-Drug Interactions*;Humans;Risk;Risk Management;Safety
15307350;Drug Monitoring;Herb-Drug Interactions;Humans;Nursing Assessment;Patient Acceptance of Health Care;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/utilization
15303543;Animals;Antioxidants/adverse effects;Antioxidants/pharmacokinetics;Antioxidants/pharmacology*;Clinical Trials as Topic;Flavonoids/adverse effects;Flavonoids/pharmacokinetics;Flavonoids/pharmacology*;Herb-Drug Interactions;Humans;Phytotherapy/methods;Plants, Medicinal*
15270047;Herb-Drug Interactions;Humans;Nursing Assessment/methods;Phytotherapy/adverse effects*;Phytotherapy/nursing
15266321;Complementary Therapies/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/therapy*;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects
15266218;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Animals;Biological Transport;Cell Membrane Permeability;Cells, Cultured;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;HIV Protease Inhibitors/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Microsomes, Liver/metabolism;RNA, Messenger/biosynthesis;Rats;Rats, Sprague-Dawley;Ritonavir/pharmacokinetics*
15261327;Anesthesia*;Antidepressive Agents/adverse effects*;Cardiovascular Diseases/chemically induced;Herb-Drug Interactions*;Humans;Kava/adverse effects*;Perioperative Care;Plant Extracts/administration & dosage;Plant Extracts/adverse effects
15260917;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions/genetics*;Humans;Hypericum/chemistry;Hypericum/drug effects;Hypericum/metabolism*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Randomized Controlled Trials as Topic
15260514;Aged;Aged, 80 and over;Dietary Supplements/utilization*;Drug Utilization;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Pharmaceutical Preparations/administration & dosage;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Surveys and Questionnaires;United Kingdom
15234747;Anti-Anxiety Agents/adverse effects*;Anti-Anxiety Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacology;Cytochrome P-450 Enzyme System/drug effects;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Kava*;Phytotherapy*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology
15231618;Area Under Curve;Clinical Trials as Topic/standards;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Observer Variation;Pharmacokinetics
15197212;Antineoplastic Agents/pharmacology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;United States
15189680;False Positive Reactions;Herb-Drug Interactions*;Humans;Plant Preparations/urine*;Street Drugs/urine*;Substance Abuse Detection/methods*
15187203;Dietary Supplements*/adverse effects;Drug Utilization;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Primary Health Care*;Self Medication;Surveys and Questionnaires;Urologic Diseases*/chemically induced
15182880;Aged;Aged, 80 and over;Attitude to Health;Dose-Response Relationship, Drug;Female;Follow-Up Studies;Geriatric Assessment;Herb-Drug Interactions;Humans;Male;Patient Education as Topic*;Phytotherapy/methods*;Plants, Medicinal*;Risk Assessment;Treatment Outcome
15180581;Animals;Evidence-Based Medicine/methods*;Herb-Drug Interactions*;Herbal Medicine/classification;Humans;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Randomized Controlled Trials as Topic
15176651;Adult;Aged;Anti-Arrhythmia Agents/blood*;Antidiarrheals/blood*;Apocynaceae/chemistry*;Digitoxin/blood;Digoxin/blood;False Positive Reactions;Female;Glycosides/blood*;Half-Life;Herb-Drug Interactions;Humans;Male;Pilot Projects;Plant Extracts/blood;Plant Roots/chemistry
15145962;Beverages/adverse effects*;Citrus*;Dietary Supplements;Drug Interactions*;Drug Labeling/legislation & jurisprudence;Female;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Male;Pharmacogenetics;Sex Factors
15120451;Administration, Oral;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Biological Availability;Carrageenan;Diclofenac/administration & dosage;Diclofenac/blood;Diclofenac/pharmacokinetics;Diclofenac/pharmacology*;Edema/chemically induced;Edema/prevention & control;Fruit;Ginger*;Herb-Drug Interactions;Male;Medicine, Ayurvedic;Phytotherapy*;Piper*;Plant Extracts/pharmacology*;Rabbits;Rats;Rats, Wistar
15114493;Chemical and Drug Induced Liver Injury/etiology*;Herb-Drug Interactions;Humans;Kava*;Phytotherapy*;Plant Extracts/adverse effects*
15090899;Aged;Food-Drug Interactions/physiology*;Herb-Drug Interactions/physiology*;Humans;Nutritional Status/physiology
15089812;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Herb-Drug Interactions;Humans;Hypericum*;International Normalized Ratio;Male;Panax*;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Prothrombin Time;Warfarin/analogs & derivatives*;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology;Warfarin/urine
15072439;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Herb-Drug Interactions*;Humans;Phytotherapy;Plants, Medicinal/metabolism*
15061327;Consumer Product Safety;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal*;United States;United States Food and Drug Administration
15056330;Aged;Attitude to Health;Community Health Nursing/methods;Complementary Therapies/utilization;Cross-Sectional Studies;Female;Health Behavior;Health Status;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Socioeconomic Factors;Turkey
15049433;Adult;Area Under Curve;Depressive Disorder/drug therapy;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Organ Transplantation;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Serotonin Uptake Inhibitors/therapeutic use
15037491;Dietary Supplements*;Drug Interactions*;Female;Health Surveys;Herb-Drug Interactions;Humans;Male;Middle Aged;Primary Health Care;United States
15022662;Attitude of Health Personnel*;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Family Practice;Female;Herb-Drug Interactions;Humans;Male;Medical History Taking;Middle Aged;Physician-Patient Relations;Self Medication/adverse effects
15018694;Aged;Aged, 80 and over;Alzheimer Disease/diagnosis;Alzheimer Disease/drug therapy*;Alzheimer Disease/psychology;Caregivers/education;Caregivers/psychology;Comorbidity;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Dietary Supplements*/adverse effects;Drug Utilization/statistics & numerical data;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Educational Status;Herb-Drug Interactions;Hospitals, Veterans;Humans;Male;Mental Status Schedule;Michigan;Patient Education as Topic;Phytotherapy/utilization*;Veterans/psychology*
15017578;Child;Child, Preschool;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Surgical Procedures, Operative/statistics & numerical data*;Surveys and Questionnaires
14999364;Acute Kidney Injury/chemically induced*;Cyclooxygenase 1;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/adverse effects*;Cyclooxygenase Inhibitors/pharmacokinetics;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Membrane Proteins;Nonprescription Drugs;Plant Preparations;Prostaglandin-Endoperoxide Synthases;Risk Factors
14991387;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects*;Attitude to Health;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/psychology;Patient Compliance;Patient Education as Topic/methods;Phytotherapy/adverse effects*;Pilot Projects;Plants, Medicinal/adverse effects*;Professional-Patient Relations;Surveys and Questionnaires;Time Factors;Washington
14984852;Adolescent;Child;Child, Preschool;Complementary Therapies/utilization*;Data Collection;Female;Herb-Drug Interactions;Humans;Infant;Male;Phytotherapy/utilization*;Plant Preparations*;Surgical Procedures, Operative*
14980009;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Bridged Bicyclo Compounds;Flow Cytometry;Genes, MDR;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Mice;NIH 3T3 Cells;Perylene/analogs & derivatives*;Perylene/pharmacology*;Phloroglucinol/analogs & derivatives;Terpenes/pharmacology*
14766022;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/prevention & control*;Calcium Channel Blockers/administration & dosage;Carnitine/administration & dosage;Coenzymes;Dietary Supplements*/adverse effects;Digoxin/administration & dosage;Electrolytes/administration & dosage*;Electrolytes/adverse effects;Fatty Acids, Omega-3/administration & dosage;Free Radical Scavengers/administration & dosage;Glycosides/administration & dosage;Glycosides/adverse effects;Herb-Drug Interactions;Herbal Medicine*;Humans;Ubiquinone/administration & dosage;Ubiquinone/analogs & derivatives*;Vitamins/administration & dosage*
14765834;Anticoagulants/adverse effects*;Aortic Valve*;Heart Valve Diseases/complications;Heart Valve Diseases/etiology*;Heart Valve Prosthesis*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Myocardial Infarction/etiology*;Plants, Medicinal/adverse effects*;Postoperative Complications/etiology*;Thrombosis/complications;Thrombosis/etiology*;Warfarin/adverse effects*
14749695;Administration, Oral;Adult;Area Under Curve;Caffeine/administration & dosage;Caffeine/pharmacokinetics;Cytochrome P-450 Enzyme System/drug effects*;Dextromethorphan/administration & dosage;Dextromethorphan/pharmacokinetics;Echinacea*;Female;Herb-Drug Interactions;Humans;Infusions, Intravenous;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Roots;Reference Values;Tolbutamide/administration & dosage;Tolbutamide/pharmacokinetics
14749688;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
14702801;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
14674921;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Drug Eruptions/etiology*;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions;Humans;Japan;Middle Aged;Patch Tests;Plant Preparations/adverse effects*
14670163;Dietary Supplements/classification;Dietary Supplements/utilization*;Female;Herb-Drug Interactions;Hot Flashes/drug therapy;Humans;Isoflavones/classification;Isoflavones/therapeutic use;Menopause/drug effects;Physician-Patient Relations;Phytoestrogens;Phytotherapy/classification;Phytotherapy/utilization*;Plant Preparations/classification;Plant Preparations/therapeutic use;Treatment Outcome;Women's Health*
14664751;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions/physiology*;Humans;Neoplasms/drug therapy*;Neoplasms/enzymology*
14640772;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*
14631731;Complementary Therapies/adverse effects*;Herb-Drug Interactions;Humans;Meningioma/drug therapy;Meningioma/surgery;Nutrition Therapy;Phytotherapy;Quality of Life
14596440;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Panax*;Phytotherapy*;Plant Preparations/pharmacology*
14595964;Drug Administration Schedule;Drug Interactions*;Food-Drug Interactions;Herb-Drug Interactions;Humans;Intestinal Absorption/drug effects;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism;Pharmacokinetics
14522595;Albendazole/administration & dosage;Albendazole/analogs & derivatives*;Albendazole/analysis;Albendazole/pharmacokinetics*;Animals;Anthelmintics/administration & dosage;Anthelmintics/analysis;Anthelmintics/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Drug Therapy, Combination;Herb-Drug Interactions;Injections, Intravenous;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Jejunum/drug effects*;Jejunum/metabolism;Male;Metabolic Clearance Rate/drug effects;Metabolic Clearance Rate/physiology;Panax*/chemistry;Perfusion;Plant Extracts/pharmacology*;Rats;Rats, Wistar
14506083;Aged;Geriatric Psychiatry/methods*;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy/adverse effects*;Plants, Medicinal*
14503986;Drugs, Chinese Herbal;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Herbal Medicine/methods*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/toxicity;Risk Factors
12911685;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Isoenzymes/metabolism;Medicine, Kampo*;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology
12856855;Animals;Dose-Response Relationship, Drug;Drug Interactions*;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions;Humans
12832592;Depressive Disorder/drug therapy*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy*
12784545;Animals;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Central Nervous System Diseases/chemically induced;Dermatitis, Phototoxic/pathology;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Pharmacokinetics;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics
12635815;Animals;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Plants, Medicinal/chemistry*;Plants, Medicinal/metabolism*
12597263;Anticoagulants/pharmacology;Cardiovascular Agents/pharmacology*;Digoxin/pharmacology;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum;Hypertension/chemically induced;Hypokalemia/chemically induced;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
12568285;Animals;Blood Cell Count;Cassia/toxicity*;Diet;Drug Interactions;Eating/drug effects;Enteritis/chemically induced;Enteritis/pathology;Enzymes/blood;Growth/drug effects;Herb-Drug Interactions;Intestinal Mucosa/pathology;Male;Nerium/toxicity*;Rats;Rats, Wistar;Saudi Arabia;Weight Gain/drug effects
12472978;Analgesics/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anticoagulants/adverse effects;Aspirin/adverse effects;Dietary Supplements/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
12429683;Adolescent;Adult;Anti-Bacterial Agents*;Contraceptives, Oral*;Drug Interactions*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Hypericum*;Surveys and Questionnaires
12428996;Aged;Drug Interactions*;Drug Prescriptions;Drug-Related Side Effects and Adverse Reactions*;Female;Health Services for the Aged*;Herb-Drug Interactions;Hospitals, University;Humans;Male;Memory Disorders/drug therapy*;Nonprescription Drugs/adverse effects;Ontario;Plants, Medicinal/adverse effects*
12426769;Animals;Anticoagulants/adverse effects*;Drug Interactions;Food-Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal;Warfarin/adverse effects*
12424801;Albumins/metabolism;Binding, Competitive;Digoxin/analysis;Digoxin/blood;Digoxin/chemistry;Dose-Response Relationship, Drug;Drug Interactions*;Drugs, Chinese Herbal*;Enzyme Inhibitors/analysis;Enzyme Inhibitors/blood;Enzyme Inhibitors/chemistry;Enzyme Multiplied Immunoassay Technique;Herb-Drug Interactions;Humans;In Vitro Techniques;Medicine, Chinese Traditional;Phenanthrolines/antagonists & inhibitors*;Phenanthrolines/pharmacology;Plant Extracts/antagonists & inhibitors*;Plant Extracts/pharmacology;Salicylates/pharmacology*
12419960;Animals;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Drug Interactions/physiology;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Female;Herb-Drug Interactions;Herbal Medicine;Medicine, Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Protein Binding/drug effects;Protein Binding/physiology;Rats;Rats, Sprague-Dawley
12404705;Adult;Cognition/drug effects*;Cognition/physiology;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Male;Mathematics;Nootropic Agents/pharmacology*;Panax*;Plant Extracts/pharmacology;Psychomotor Performance/drug effects*;Psychomotor Performance/physiology
12397870;Animals;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology
12392581;Contraceptives, Oral/metabolism;Cyclosporine/metabolism;Digoxin/metabolism;Drug Interactions*;HIV Protease Inhibitors/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism*;Plant Extracts/adverse effects;Plant Extracts/metabolism*;Serotonin Uptake Inhibitors/metabolism;Theophylline/metabolism;Warfarin/metabolism
12378978;Beverages/adverse effects*;Biological Availability;Biotransformation/drug effects*;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions*;Garlic/adverse effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Mixed Function Oxygenases/antagonists & inhibitors;Phytotherapy/adverse effects*;Substance P/antagonists & inhibitors
12362826;Controlled Clinical Trials as Topic;Drug Interactions*;Evidence-Based Medicine;Garlic/adverse effects;Garlic/metabolism;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Panax/adverse effects;Panax/metabolism;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics;Plants, Medicinal/adverse effects*;Plants, Medicinal/metabolism;Practice Guidelines as Topic;Valerian/adverse effects;Valerian/metabolism
12235448;Adult;Allyl Compounds/pharmacokinetics;Analysis of Variance;Cytochrome P-450 CYP2E1/genetics*;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions/genetics;Female;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/metabolism;Male;Mixed Function Oxygenases/genetics*;Mixed Function Oxygenases/metabolism;Panax/metabolism;Phenotype;Phytotherapy/methods;Plant Preparations/administration & dosage*;Plant Preparations/pharmacokinetics;Predictive Value of Tests;Sex Factors;Sulfides/pharmacokinetics
12175708;Animals;Binding, Competitive/drug effects;CHO Cells;Cells, Cultured;Cricetinae;Cyclic AMP/metabolism;Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology;Herb-Drug Interactions;Humulus/chemistry*;Plant Extracts/pharmacology;Purinergic P1 Receptor Antagonists;Radioligand Assay;Receptor, Adenosine A2A;Receptors, Purinergic P1/drug effects*;Valerian/chemistry*
12169403;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Synergism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Injections, Intravenous;Male;Mice;Prothrombin Time;Rats;Rats, Wistar;Warfarin/administration & dosage;Warfarin/blood;Warfarin/pharmacokinetics*
12160480;Animals;Cytochrome P-450 Enzyme System/biosynthesis;Drug Interactions;Herb-Drug Interactions;Humans;Pharmacokinetics*;Phytotherapy*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Xenobiotics/metabolism
12125624;Anxiety/drug therapy;Depression/drug therapy;Drug Interactions;Female;HIV Infections/drug therapy;HIV Infections/psychology;HIV Protease Inhibitors/pharmacology*;HIV Seronegativity;Herb-Drug Interactions;Humans;Hypericum*;Indinavir/pharmacology*;Male
12125178;Alcoholic Beverages/adverse effects*;Biological Availability;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Risk Factors
12125177;Drug Contamination;Drug Hypersensitivity/etiology;Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Switzerland
12110997;Antidepressive Agents/chemistry;Antidepressive Agents/pharmacology*;Biogenic Amines/metabolism;Biological Transport;Drug Evaluation, Preclinical;Flavonoids/chemistry;Flavonoids/pharmacology*;GTP-Binding Proteins/metabolism*;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Membrane Transport Proteins/metabolism*;Plant Extracts/chemistry;Radioligand Assay;Receptors, Biogenic Amine/drug effects*;Receptors, Biogenic Amine/metabolism
12100483;Amino Acid Sequence;Arabidopsis/drug effects;Arabidopsis/embryology;Arabidopsis/genetics*;Arabidopsis/metabolism*;Base Sequence;Cholestadienols/pharmacology;DNA, Plant/genetics;Enzyme Inhibitors/pharmacology;Gas Chromatography-Mass Spectrometry;Genes, Plant*;Herb-Drug Interactions;Methyltransferases/genetics;Models, Biological;Mutation;Oxidoreductases/antagonists & inhibitors;Oxidoreductases/genetics;Phenotype;Phytosterols/biosynthesis*;Steroid Isomerases/genetics
12020172;Clinical Trials as Topic;Databases, Bibliographic;Drug Interactions;Female;Herb-Drug Interactions;Humans;Male;Panax/adverse effects*
11995940;Animals;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Drug Interactions/physiology;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Male;Paeonia/metabolism*;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Roots/metabolism;Rats;Rats, Sprague-Dawley
11883051;Dose-Response Relationship, Drug;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Self Medication
11849198;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/blood;Analysis of Variance;Drug Interactions/physiology;Female;HIV Protease Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Lymphocytes/drug effects;Lymphocytes/metabolism;Male;Ritonavir/pharmacology;Single-Blind Method;Statistics, Nonparametric
11786229;Binding Sites;Carbohydrate Sequence;Deuterium Oxide;Drug Design;Galectin 1;Hemagglutinins/chemistry*;Herb-Drug Interactions;Lactose/analogs & derivatives;Lactose/chemistry*;Lectins/chemistry*;Magnetic Resonance Spectroscopy/methods*;Mistletoe;Models, Molecular;Molecular Conformation;Molecular Sequence Data;Plant Lectins;Plant Preparations*;Plant Proteins*;Ribosome Inactivating Proteins, Type 2;Solutions;Surface Properties;Toxins, Biological/chemistry;Xylose/chemistry*
11772128;Drug Interactions*;Drug Prescriptions*;Echinacea/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Serenoa
11736868;Adult;Aged;Aged, 80 and over;Cycadopsida*;Databases as Topic;Drug Interactions*;Female;Herb-Drug Interactions;Humans;Magnoliopsida*;Male;Middle Aged;Phytotherapy*/adverse effects
11714999;Cardiovascular Agents/pharmacology*;Drug Interactions;Herb-Drug Interactions;Humans;Plants, Medicinal*
11695885;Cannabis;Clinical Trials as Topic;Drug Interactions*;Drug Synergism*;Flavonoids;Ginkgo biloba;Glycyrrhiza;Herb-Drug Interactions;Humans;Hypericum;Kava;Oils, Volatile;Panax;Phytotherapy*;Valerian
11556915;Anti-Infective Agents, Local/chemistry;Anti-Infective Agents, Local/pharmacology*;Candida albicans/drug effects;Escherichia coli/drug effects;Herb-Drug Interactions;Magnoliopsida/chemistry*;Microbial Sensitivity Tests;Monoterpenes*;Oils, Volatile/chemistry;Oils, Volatile/pharmacology;Plant Oils/chemistry;Plant Oils/pharmacology*;Plants, Medicinal/chemistry*;Pseudomonas aeruginosa/drug effects;Solubility;Staphylococcus aureus/drug effects;Tea/chemistry;Terpenes/chemistry;Trees/chemistry
11554427;Animals;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology*;Biotransformation;Blood Proteins/metabolism;Carbamazepine/pharmacokinetics*;Carbamazepine/pharmacology*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;In Vitro Techniques;Liver/drug effects;Liver/enzymology;Male;Medicine, Kampo;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Protein Binding;Rats;Rats, Wistar
11542535;Animals;Capsicum/drug effects;Capsicum/growth & development*;Capsicum/metabolism;Capsicum/radiation effects;Carbon Dioxide/pharmacology*;Carbon Dioxide/toxicity;Cell Respiration/drug effects;Darkness;Drosophila melanogaster;Ecosystem;Environment, Controlled*;Hemiptera;Herb-Drug Interactions;Insecta/drug effects*;Insecta/physiology;Insecticides/pharmacology*;Light;Malathion/pharmacology*;Photosynthesis/drug effects;Plants, Medicinal*
11407242;Adult;Contraceptives, Oral, Combined/adverse effects;Depressive Disorder/drug therapy*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Nonprescription Drugs/adverse effects*;Plants, Medicinal*
11315759;Antidepressive Agents/adverse effects*;Clinical Trials as Topic;Contraindications;Dermatitis, Phototoxic/epidemiology;Dermatitis, Phototoxic/etiology;Drug Interactions;Epidemiologic Studies;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Incidence;Perylene/analogs & derivatives*;Perylene/pharmacology;Photosensitizing Agents/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Plants, Medicinal*/adverse effects;Radiation-Sensitizing Agents/pharmacology
11213066;Adult;Dietary Supplements*;Drug Interactions;Drugs, Chinese Herbal/pharmacology;Female;Graft Rejection/drug therapy;Graft Rejection/prevention & control;Herb-Drug Interactions;Humans;Kidney Transplantation/immunology;Pancreas Transplantation/immunology;Phytotherapy*
11212424;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects*;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Contraceptives, Oral/administration & dosage;Contraceptives, Oral/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects
11155496;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Depressive Disorder/drug therapy*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Plants, Medicinal*;Risk Factors
11144706;Anticoagulants/pharmacology;Dietary Supplements;Drug Interactions;Drugs, Chinese Herbal/pharmacology*;Garlic/chemistry;Ginger/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions;Humans;Panax/chemistry;Plant Extracts/pharmacology;Plants, Medicinal;Warfarin/pharmacology*
11095377;Antiviral Agents/pharmacology;Contraceptives, Oral;Drug Interactions;Female;Hepatitis C/therapy;Herb-Drug Interactions;Humans;Hypericum*;Interferons/pharmacology;Male;Plants, Medicinal*;Pregnancy
11029865;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Pharmacists;Plants, Medicinal/adverse effects
10985130;Adverse Drug Reaction Reporting Systems;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plants, Medicinal*;South Africa
10953464;Drug Interactions*;Herb-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Plants, Medicinal/adverse effects*
10917398;Contraceptives, Oral/adverse effects*;Drug Interactions;Estrogen Replacement Therapy/adverse effects*;Female;Herb-Drug Interactions;Humans;Magnoliopsida/adverse effects*;Middle Aged
10906369;Adverse Drug Reaction Reporting Systems;Anti-Ulcer Agents/adverse effects*;Cisapride/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Induction;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Mixed Function Oxygenases/metabolism*;Plants, Medicinal*;Product Surveillance, Postmarketing;Psychotropic Drugs/adverse effects*;Referral and Consultation*
10902065;Adult;Anticoagulants/adverse effects*;Complementary Therapies*;Herb-Drug Interactions;Humans;Magnoliopsida/adverse effects;Phytotherapy;Vitamins/adverse effects;Warfarin/adverse effects*
10872032;Cyclosporine/blood;Drug Interactions;Graft Rejection/blood;Herb-Drug Interactions;Humans;Hypericum*;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacology;Tremor/chemically induced;Warfarin/pharmacology
10815528;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/chemistry;Hypericum/metabolism*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/chemistry;Serotonin Uptake Inhibitors/metabolism*
10800553;Anticoagulants/pharmacology;Antiviral Agents/pharmacology;Contraceptives, Oral/pharmacology;Drug Interactions;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/enzymology;Plants, Medicinal*
10784267;Depression/therapy;Drug Interactions;Drug and Narcotic Control*;European Union;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/therapeutic use;Ireland;Phytotherapy*;Plants, Medicinal*;United Kingdom;United States
10737289;Beverages/adverse effects*;Cardiovascular Agents/pharmacology*;Drug Interactions;Herb-Drug Interactions;Humans;Hypokalemia/etiology*;Phytotherapy;Plants, Medicinal/adverse effects*;Plants, Medicinal/therapeutic use;United States
10721388;Benzodiazepines/adverse effects;Beverages/adverse effects*;Calcium Channel Blockers/adverse effects;Cisapride/adverse effects;Citrus/adverse effects*;Cyclosporine/adverse effects;Cytochrome P-450 Enzyme Inhibitors;Drug Prescriptions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Terfenadine/adverse effects
10715935;Antidepressive Agents/adverse effects*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal*
10702779;Adipose Tissue, Brown/drug effects;Adipose Tissue, Brown/metabolism*;Animals;Body Temperature Regulation/drug effects*;Caffeine/pharmacology*;Catechin/pharmacology;Central Nervous System Stimulants/pharmacology*;Culture Techniques;Ephedrine/pharmacology;Flavonoids*;Herb-Drug Interactions;Male;Norepinephrine/metabolism;Obesity/metabolism*;Oxygen Consumption;Phenols/pharmacology;Plant Extracts/pharmacology;Polymers/pharmacology;Rats;Rats, Sprague-Dawley;Sympathectomy;Sympathetic Nervous System/drug effects;Sympathetic Nervous System/physiology;Tea*
10682937;Animals;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/pharmacology*;Cattle;Chromatography, High Pressure Liquid;Drug Interactions;Electron Transport Complex I;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Furans/isolation & purification;Furans/pharmacology*;Herb-Drug Interactions;Lactones/isolation & purification;Lactones/pharmacology*;Mitochondria, Heart/drug effects;Mitochondria, Heart/enzymology*;Multienzyme Complexes/antagonists & inhibitors*;NADH, NADPH Oxidoreductases/antagonists & inhibitors*;Phytotherapy;Plant Extracts/chemistry;Seeds/chemistry
10675182;Anticoagulants/therapeutic use;Drug Contamination;Drug Interactions*;Herb-Drug Interactions;Humans;Plants, Medicinal*
11122556;Aged;Dementia/therapy*;Drug Interactions*;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;MEDLINE;Panax/adverse effects;Plants, Medicinal/adverse effects*;Valerian/adverse effects
10543025;Animals;Birth Weight/drug effects;Body Weight/drug effects;Carcinoma, Hepatocellular/genetics;Carcinoma, Hepatocellular/metabolism;Diet;Embryonic and Fetal Development/drug effects*;Estrogen Receptor alpha;Estrogen Receptor beta;Female;Genistein/toxicity*;Growth/drug effects*;Growth Inhibitors/toxicity*;Herb-Drug Interactions;Humans;Isoflavones/toxicity*;Litter Size/drug effects;Liver Neoplasms/genetics;Liver Neoplasms/metabolism;Male;Ovum/drug effects;Pregnancy;Rats;Rats, Sprague-Dawley;Receptors, Estrogen/agonists*;Receptors, Estrogen/genetics;Receptors, Estrogen/physiology;Sexual Maturation/drug effects;Soybeans;Transfection;Tumor Cells, Cultured
10533874;Anesthetics*;Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal/adverse effects*;Risk Factors;Surgical Procedures, Operative*
10531760;Adult;Aged;Anticoagulants/adverse effects*;Complementary Therapies*;Dietary Supplements/adverse effects*;Drug Interactions;Estrogens, Non-Steroidal/adverse effects*;Estrogens, Non-Steroidal/classification*;Estrogens, Non-Steroidal/therapeutic use;Female;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Isoflavones*;Male;Middle Aged;Panax/adverse effects;Phytoestrogens;Phytotherapy;Plant Preparations;Plants, Medicinal;Warfarin/adverse effects*
10499304;Animals;Drug Antagonism;Drug Interactions;Drug Synergism;Drugs, Chinese Herbal/history;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;History, Ancient;Humans;Medicine, Chinese Traditional*/history;Reproducibility of Results;Yin-Yang
10493330;Drug Interactions;Herb-Drug Interactions;Humans;Plants, Medicinal/adverse effects*
10447148;Aged;Aged, 80 and over;Antidepressive Agents/metabolism*;Antidepressive Agents/therapeutic use;Depressive Disorder/drug therapy;Drug Interactions;Ericales/adverse effects;Ericales/chemistry*;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry*
10417980;Animals;Anisotropy;Biflavonoids*;Cell Line;Cell Membrane/metabolism;Chamomile;Dimerization;Diphenylhexatriene/analogs & derivatives*;Flavonoids/chemistry;Flavonoids/metabolism*;Fluorescent Dyes*;Herb-Drug Interactions;Liposomes/metabolism;Mice;Molecular Structure;Oils, Volatile/chemistry;Oils, Volatile/metabolism*;Phospholipids/metabolism;Plants, Medicinal;Spectrometry, Fluorescence
10394636;Abscisic Acid/pharmacology;Base Sequence;Cloning, Molecular;DNA Primers/genetics;DNA, Plant/genetics;Ethylenes/pharmacology;Fabaceae/drug effects;Fabaceae/enzymology*;Fabaceae/genetics;Gene Expression Regulation, Developmental/drug effects;Gene Expression Regulation, Plant/drug effects;Genes, Plant*/drug effects;Genes, Reporter;Glucuronidase/genetics;Glucuronidase/metabolism;Herb-Drug Interactions;Histocytochemistry;Indoleacetic Acids/pharmacology;Lyases/genetics*;Molecular Sequence Data;Plants, Genetically Modified;Plants, Medicinal*;Plants, Toxic;Promoter Regions, Genetic/drug effects;Tobacco/genetics
10381780;Animals;Calcium/metabolism;Calcium-Transporting ATPases/antagonists & inhibitors*;Calcium-Transporting ATPases/metabolism;Catechols;Cyclic AMP-Dependent Protein Kinases/metabolism;Dogs;Ellagic Acid/pharmacology*;Fatty Alcohols/pharmacology*;Herb-Drug Interactions;In Vitro Techniques;Kinetics;Microsomes/drug effects;Microsomes/enzymology;Muscle, Skeletal/drug effects;Muscle, Skeletal/enzymology;Muscle, Skeletal/ultrastructure;Myocardium/enzymology*;Myocardium/metabolism;Myocardium/ultrastructure;Phosphates/metabolism;Phosphorylation;Plants, Medicinal;Rabbits;Sarcoplasmic Reticulum/drug effects;Sarcoplasmic Reticulum/enzymology*
10375176;Analysis of Variance;Animals;Anticonvulsants/pharmacokinetics*;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacology;Carbamazepine/pharmacokinetics*;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Male;Medicine, Chinese Traditional;Phytotherapy;Protein Binding/drug effects;Rats;Rats, Wistar
10088878;Drug Interactions;Ephedrine/adverse effects;Ericales/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Kava;Panax/adverse effects;Patient Education as Topic;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects*;Teaching Materials;United States;United States Food and Drug Administration
9924842;Adult;Brazil;Drug Interactions;Fluoxetine/adverse effects;Herb-Drug Interactions;Humans;Male;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Serotonin Syndrome/chemically induced*;Serotonin Syndrome/psychology;Serotonin Uptake Inhibitors/adverse effects*
9818800;Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/pharmacology*;Plants, Medicinal/therapeutic use*
9565737;Age Factors;Animals;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus/chemistry*;Coumarins/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavonoids/chemistry;Food-Drug Interactions*;Furocoumarins;Herb-Drug Interactions;Humans;Intestine, Small/drug effects;Intestine, Small/enzymology;Male;Mixed Function Oxygenases/metabolism;Risk Assessment;Sex Factors
9395786;Antiviral Agents/pharmacology*;CCAAT-Enhancer-Binding Proteins;DNA, Viral/metabolism;DNA-Binding Proteins/metabolism;Enhancer Elements, Genetic*;Hepatitis B virus/drug effects*;Hepatitis B virus/genetics;Herb-Drug Interactions;Humans;Nuclear Proteins/metabolism;Plants, Medicinal*;Simian virus 40/genetics;Transcription Factors/metabolism*;Tumor Cells, Cultured
9292409;Animals;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/drug therapy*;Benzoates*;Bridged-Ring Compounds*;Calcium Channels/drug effects;Glucosides/metabolism;Glucosides/pharmacology*;Glucosides/therapeutic use;Heart Atria/drug effects;Heart Atria/metabolism;Herb-Drug Interactions;In Vitro Techniques;Male;Monoterpenes;Myocardial Contraction/drug effects*;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Plants, Medicinal*/metabolism;Plants, Medicinal*/therapeutic use;Rats;Rats, Wistar;Sodium Channels/drug effects;Time Factors;Veratrine/metabolism;Veratrine/toxicity*
9260034;Anti-Anxiety Agents/metabolism;Beverages*;Biological Availability;Calcium Channel Blockers/metabolism;Central Nervous System Stimulants/metabolism;Citrus/metabolism*;Controlled Clinical Trials as Topic;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Estrogens/metabolism;Flavonoids/metabolism;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/metabolism;In Vitro Techniques;Midazolam/metabolism;Mixed Function Oxygenases/metabolism
9050093;Animals;Anti-Anxiety Agents/pharmacology*;Carbolines/pharmacology*;Diazepam/pharmacology*;Drug Interactions;Ginkgo biloba;Herb-Drug Interactions;Male;Motor Activity/drug effects;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Social Behavior*
8665388;Animals;Disease Vectors*;Drug Evaluation, Preclinical;Herb-Drug Interactions;Larva;Lethal Dose 50;Medicine, African Traditional*;Molluscacides*;Pest Control/methods;Plant Extracts*;Schistosoma haematobium/drug effects*;Schistosoma mansoni/drug effects*;Snails/parasitology*;Water Microbiology;Zimbabwe
7487701;Aged;Drug Combinations;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Male;Phenanthrolines/adverse effects*;Plant Extracts*;Salicylates/adverse effects*;Self Medication;Warfarin/adverse effects*;Warfarin/therapeutic use
7882725;Adolescent;Adult;Cell Communication/drug effects;Cell Fusion/drug effects;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/pharmacology*;Lymphocytes/ultrastructure*;Macrophages/ultrastructure*;Male;Microscopy, Electron;Phagocytosis;Semen/cytology;Semen/drug effects*;Tripterygium
8202566;Animals;Erythrocytes/drug effects*;Erythrocytes/metabolism;Ginsenosides;Glucose/metabolism;Herb-Drug Interactions;In Vitro Techniques;Monosaccharide Transport Proteins/drug effects*;Monosaccharide Transport Proteins/metabolism;Panax*;Plants, Medicinal*;Saponins/pharmacology*;Sheep;Structure-Activity Relationship;Triterpenes/pharmacology*
8026706;Animals;Baclofen/metabolism;Bridged Bicyclo Compounds/metabolism;Bridged Bicyclo Compounds, Heterocyclic*;Carbohydrate Sequence;Flunitrazepam/metabolism;Ginsenosides;Herb-Drug Interactions;Ligands;Male;Molecular Sequence Data;Muscimol/metabolism;Panax;Plants, Medicinal;Rats;Rats, Sprague-Dawley;Receptors, GABA-A/drug effects;Receptors, GABA-A/metabolism*;Receptors, GABA-B/drug effects;Receptors, GABA-B/metabolism*;Saponins/pharmacology*;Sulfur Radioisotopes;Tritium
11537706;Cell Polarity/drug effects;Cell Polarity/physiology*;Colchicine/pharmacology;Cytochalasin D/pharmacology;Cytoskeleton/drug effects;Cytoskeleton/physiology*;Cytoskeleton/ultrastructure;Endoplasmic Reticulum/chemistry;Endoplasmic Reticulum/ultrastructure;Gravitation;Herb-Drug Interactions;Immunohistochemistry;Microscopy, Electron;Organelles/metabolism;Organelles/physiology;Organelles/ultrastructure*;Paclitaxel/pharmacology;Peptides/analysis;Peptides/physiology;Phalloidine/pharmacology;Plant Cells;Plant Physiological Phenomena;Plant Proteins/analysis;Plant Proteins/physiology;Plants/ultrastructure*;Plastids/chemistry;Plastids/physiology;Plastids/ultrastructure*;Rotation
8218717;Animals;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal*
1509690;Animal Feed;Animals;Body Weight/drug effects*;Cassia*;Chickens;Drug Combinations;Female;Hematologic Tests;Herb-Drug Interactions;Liver Function Tests;Male;Plants, Medicinal*;Plants, Toxic*;Poultry Diseases/chemically induced*;Poultry Diseases/metabolism;Poultry Diseases/pathology
1357129;Adrenergic beta-Agonists/adverse effects;Albuterol/adverse effects;Albuterol/analogs & derivatives;Butylamines/adverse effects;Clozapine/adverse effects;Contraceptives, Oral/pharmacology;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Flecainide/adverse effects;Herb-Drug Interactions;Humans;Medicine, East Asian Traditional;Noscapine/toxicity;Omeprazole/adverse effects;Parasympatholytics/adverse effects;Plants, Toxic;Salmeterol Xinafoate
1323854;Alginates/pharmacology;Animals;Dialysis;Dietary Fiber/pharmacology*;Herb-Drug Interactions;In Vitro Techniques;Intestines/drug effects;Niacin/pharmacology*;Pentoxifylline/pharmacology*;Psyllium/pharmacology;Rats;Viscosity
2052849;Animals;Biomphalaria/growth & development;Biomphalaria/parasitology*;Biomphalaria/physiology;Chemotaxis;Ecdysteroids;Ecdysterone/pharmacology*;Female;Herb-Drug Interactions;Host-Parasite Interactions/drug effects;Host-Parasite Interactions/physiology;Invertebrate Hormones/pharmacology;Invertebrate Hormones/physiology*;Oviposition/drug effects;Plant Extracts/pharmacology*;Schistosoma mansoni/drug effects;Schistosoma mansoni/physiology*
2001408;Adult;Cell Adhesion*/drug effects;Disulfides/pharmacology;Extracellular Matrix/physiology*;Fibronectins/pharmacology;Fibronectins/physiology*;Garlic;Herb-Drug Interactions;Humans;In Vitro Techniques;Kinetics;Luminescent Measurements;Luminol;N-Formylmethionine Leucyl-Phenylalanine/pharmacology;Neutrophils/cytology;Neutrophils/drug effects;Neutrophils/physiology*;Oligopeptides/pharmacology;Plant Extracts/pharmacology;Plants, Medicinal;Receptors, Immunologic/drug effects;Tetradecanoylphorbol Acetate/pharmacology
1793770;Animals;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/adverse effects*;Plants, Medicinal*
2397548;Antihypertensive Agents*;Drug Compounding;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Hydralazine/administration & dosage;Hydralazine/pharmacology*;Hydrochlorothiazide/administration & dosage;Hydrochlorothiazide/pharmacology*
3390207;Animals;Cell Survival/drug effects;Colchicine/analogs & derivatives*;Colchicine/metabolism;Colchicine/pharmacology;Colchicum/analysis*;Guanosine Triphosphate/metabolism;Herb-Drug Interactions;Hydrolysis;Mice;Mitosis/drug effects*;Plants, Medicinal/analysis*;Structure-Activity Relationship;Tubulin/metabolism*
3434801;Agglutinins/analysis*;Carbohydrate Sequence;Chromatography, High Pressure Liquid;Concanavalin A/analysis*;Datura stramonium/analysis;Glycoside Hydrolases/metabolism*;Herb-Drug Interactions;Lectins/analysis*;Molecular Sequence Data;Oligosaccharides/analysis*;Phytohemagglutinins/analysis*;Plant Extracts/analysis;Plant Lectins;Plants, Medicinal;Plants, Toxic
493123;Cholesterol;DNA, Bacterial/metabolism*;DNA, Circular/metabolism;Deoxyribonucleases/pharmacology;Fabaceae/metabolism;Herb-Drug Interactions;Liposomes*/metabolism;Phosphatidylcholines;Plants, Medicinal;Plasmids;Protoplasts/metabolism*
418440;Animals;Body Temperature/drug effects;Cannabis*;Copper/pharmacology*;Drug Interactions;Drug Tolerance;Female;Herb-Drug Interactions;Hypnotics and Sedatives;Magnesium/pharmacology;Male;Mice;Penicillamine/pharmacology;Pentobarbital/pharmacology;Rats;Zinc/pharmacology
830703;Appetite/drug effects;Benzothiadiazines;Diuretics;Drug Administration Schedule;Drug Interactions;Folic Acid/metabolism;Food*;Glycyrrhiza;Herb-Drug Interactions;Humans;Hypertension/chemically induced;Hypokalemia/chemically induced;Intestinal Absorption/drug effects;Monoamine Oxidase Inhibitors/adverse effects;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/urine;Plants, Medicinal;Sodium/adverse effects;Sodium Chloride Symporter Inhibitors/adverse effects;Taste/drug effects;Tyramine/adverse effects;Vitamin D/metabolism
1238886;Animals;Cannabidiol/therapeutic use*;Cannabis/therapeutic use*;Dronabinol/therapeutic use*;Drug Synergism;Herb-Drug Interactions;Humans;Male;Morphine;Phytotherapy*;Rats;Substance Withdrawal Syndrome/drug therapy*
1202312;Aedes*;Alkaloids/analysis;Animals;Anthraquinones/analysis;Cardiac Glycosides/analysis;Flavonoids/analysis;Herb-Drug Interactions;Insecticides*/analysis;Larva;Minnesota;North Dakota;Phenols/analysis;Phytosterols/analysis;Plant Extracts;Saponins/analysis
1097148;Adult;Benzopyrans/administration & dosage;Benzopyrans/pharmacology;Cannabidiol/administration & dosage;Cannabidiol/pharmacology*;Cannabis/administration & dosage;Cannabis/pharmacology*;Clinical Trials as Topic;Dronabinol/administration & dosage;Dronabinol/pharmacology*;Drug Interactions;Eye/drug effects;Herb-Drug Interactions;Humans;Male;Phytotherapy;Pulse/drug effects;Time Factors;Time Perception/drug effects
234681;Benzothiadiazines;Diet;Diuretics;Drug-Related Side Effects and Adverse Reactions*;Food*;Glycyrrhiza;Herb-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Malabsorption Syndromes/chemically induced;Monoamine Oxidase Inhibitors/adverse effects;Nutritional Physiological Phenomena/drug effects*;Pharmaceutical Preparations/metabolism*;Plants, Medicinal;Potassium/metabolism;Sodium Chloride Symporter Inhibitors/adverse effects;Vitamins/adverse effects
4850601;Animals;Cannabis/administration & dosage;Cannabis/pharmacology*;Depression, Chemical;Dose-Response Relationship, Drug;Drug Combinations;Drug Interactions;Electroshock;Herb-Drug Interactions;Injections, Intraperitoneal;Male;Mice;Pentylenetetrazole/pharmacology;Phenobarbital/pharmacology;Phenytoin/pharmacology*;Phytotherapy;Seizures/chemically induced;Seizures/drug therapy*;Stimulation, Chemical
4300950;Acacia;Alcohols;Aluminum;Calcium Carbonate;Calcium Hydroxide;Chemistry, Pharmaceutical;Citrates;Herb-Drug Interactions;Hydroxides;Iron*;Kaolin;Lactose;Magnesium;Magnesium Oxide;Oxides;Pharmaceutical Vehicles*;Phosphates;Polyethylenes;Potassium Iodide;Silicon Dioxide;Sodium Chloride;Spectrum Analysis;Stearic Acids;Sulfates;Zinc
4389856;Anesthetics/pharmacology*;Benzothiadiazines/adverse effects;Cortisone/adverse effects;Drug Antagonism*;Ganglionic Blockers/adverse effects;Herb-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Plants, Medicinal;Preoperative Care*;Rauwolfia/adverse effects;Sympatholytics/adverse effects;Sympathomimetics/adverse effects;Tranquilizing Agents/adverse effects;Vasodilator Agents/adverse effects
29503428;Administration, Oral;Food Additives/adverse effects*;Food-Drug Interactions*;Humans;Inositol/analogs & derivatives;Magnesium Oxide;Solubility;Tablets/administration & dosage*
29345156;Adult;Animals;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics;Catechol O-Methyltransferase Inhibitors/administration & dosage;Catechol O-Methyltransferase Inhibitors/pharmacokinetics;Dose-Response Relationship, Drug;Drug Therapy, Combination;Food-Drug Interactions;Half-Life;Humans;Levodopa/administration & dosage;Levodopa/pharmacokinetics;Oxadiazoles/administration & dosage*;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics;Parkinson Disease/drug therapy*;Parkinson Disease/physiopathology
29220436;Computational Biology;Data Mining;Databases, Pharmaceutical*;Databases, Protein*;Food-Drug Interactions*;Humans;Plants, Edible*;User-Computer Interface
29191726;Basic Helix-Loop-Helix Transcription Factors/agonists*;Basic Helix-Loop-Helix Transcription Factors/antagonists & inhibitors*;Cell Line, Tumor;Cell Survival/drug effects;Cooking;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Food-Drug Interactions;Gene Expression Regulation/drug effects;Humans;Laurus;Myristica fragrans;Oils, Volatile/pharmacology*;Origanum;Plant Oils/pharmacology*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptors, Aryl Hydrocarbon/agonists*;Receptors, Aryl Hydrocarbon/antagonists & inhibitors*;Spices/analysis*;Thymus Plant
29092729;Adult;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Benzopyrans/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Propionates/pharmacokinetics*;Therapeutic Equivalency;Young Adult
29086063;Adolescent;Adult;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use*;Biological Availability;Female;Food Analysis;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/therapeutic use*;Proton Pump Inhibitors/therapeutic use*;Young Adult
29076384;Adolescent;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Child;Drug Monitoring;Food-Drug Interactions;Fusion Proteins, bcr-abl;Humans;Imatinib Mesylate/pharmacokinetics;Imatinib Mesylate/pharmacology;Imatinib Mesylate/therapeutic use*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Medication Adherence;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/pharmacology;Protein Kinase Inhibitors/therapeutic use
28980319;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport;Catechin/chemistry;Cell Line;Cyclodextrins/chemistry*;Digoxin/administration & dosage;Digoxin/chemistry;Digoxin/pharmacokinetics;Food-Drug Interactions*;Intestinal Absorption;Intestine, Small/metabolism;Male;Quinidine/administration & dosage;Quinidine/chemistry;Quinidine/pharmacokinetics;Rats;Rats, Sprague-Dawley;Rhodamine 123/administration & dosage;Rhodamine 123/chemistry;Rhodamine 123/pharmacokinetics;Solubility;Swine;Tea/chemistry*
28948482;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Fasting;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Hydrocodone/administration & dosage*;Hydrocodone/pharmacokinetics;Male;Naltrexone/administration & dosage*
28941798;Animals;Cytochrome P-450 Enzyme Inhibitors/toxicity*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxylation;Inhibitory Concentration 50;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Naphthoquinones/toxicity*;Rats;Rats, Sprague-Dawley
28933336;Adolescent;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Chromatography, Liquid/methods*;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Oxycodone/administration & dosage*;Oxycodone/adverse effects;Oxycodone/pharmacokinetics;Tablets;Tandem Mass Spectrometry/methods*;Therapeutic Equivalency;Young Adult
28892755;Binding Sites;Binding, Competitive;Blood Proteins/chemistry;Blood Proteins/metabolism*;Circular Dichroism;Flavonoids/chemistry;Flavonoids/metabolism*;Food-Drug Interactions;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Kinetics;Molecular Docking Simulation;Protein Binding;Protein Structure, Tertiary;Pyridines/chemistry;Pyridines/metabolism*;Rutin/chemistry;Rutin/metabolism;Serum Albumin/chemistry;Serum Albumin/metabolism;Spectrophotometry, Ultraviolet;Thermodynamics
28776077;Abiraterone Acetate/administration & dosage*;Abiraterone Acetate/adverse effects;Abiraterone Acetate/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Liberation;Food-Drug Interactions*;Humans;Male;Middle Aged;Solubility
28655386;Adult;Citrus;Female;Food-Drug Interactions*;Fruit and Vegetable Juices;Humans;Interferon-beta/adverse effects*;Multiple Sclerosis/drug therapy;Rhabdomyolysis/chemically induced*
28635328;Administration, Oral;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Diet;Dietary Supplements;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Stroke/etiology;Stroke/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage*;Vitamin K/antagonists & inhibitors;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacology
28622592;Animals;Ethanol/metabolism*;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism*;Humans
28622205;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy*;Caffeine/adverse effects;Caffeine/blood;Coffee/adverse effects*;Coffee/metabolism;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use*;Male;Middle Aged
28585857;Chronic Disease/drug therapy;Chronic Disease/therapy*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Polypharmacy*
28450226;Acyl Coenzyme A/metabolism*;Alcohol Oxidoreductases/antagonists & inhibitors*;Alcohol Oxidoreductases/genetics;Alcohol Oxidoreductases/metabolism;Binding Sites;Binding, Competitive;Cell Line, Tumor;Drug Resistance, Neoplasm;Fatty Acids, Nonesterified/metabolism*;Food-Drug Interactions;Humans;Intestinal Mucosa/enzymology*;Mutation;Myristic Acid/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Oxidoreductases/antagonists & inhibitors;Oxidoreductases/genetics;Oxidoreductases/metabolism;Palmitic Acid/metabolism;Palmitoyl Coenzyme A/metabolism;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Stearic Acids/metabolism;Sugar Alcohol Dehydrogenases/antagonists & inhibitors;Sugar Alcohol Dehydrogenases/genetics;Sugar Alcohol Dehydrogenases/metabolism
28414144;Beverages;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Intestinal Absorption/physiology;Intestines/metabolism*;Organic Anion Transporters/metabolism*;Pharmaceutical Preparations/metabolism*
28409410;Animals;Aorta/drug effects;Aorta/metabolism;Aorta/pathology;Atorvastatin Calcium/agonists*;Atorvastatin Calcium/therapeutic use;Biomarkers/blood;Biomarkers/metabolism;C-Reactive Protein/agonists;C-Reactive Protein/genetics;C-Reactive Protein/metabolism;Cardiotonic Agents/agonists;Cardiotonic Agents/therapeutic use;Chromium/agonists;Chromium/therapeutic use*;Combined Modality Therapy;Dietary Supplements*;Disease Models, Animal*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Heart Ventricles/drug effects;Heart Ventricles/metabolism;Heart Ventricles/pathology;Hyperlipidemias/diet therapy*;Hyperlipidemias/drug therapy;Hyperlipidemias/metabolism;Hyperlipidemias/pathology;Hypolipidemic Agents/chemistry;Hypolipidemic Agents/therapeutic use*;Lipoproteins, LDL/blood;Male;Octoxynol;Picolinic Acids/administration & dosage;Random Allocation;Rats, Sprague-Dawley;Serum Albumin, Human;Serum Amyloid P-Component/agonists;Serum Amyloid P-Component/genetics;Serum Amyloid P-Component/metabolism
28399577;Clinical Trials as Topic;Diarrhea/drug therapy*;Dietary Supplements*;Drug Interactions;Food-Drug Interactions;Humans;Nutrition Policy;Risk Factors;Zinc/administration & dosage*;Zinc/deficiency*;Zinc/pharmacokinetics
28349328;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pyridones/pharmacokinetics*;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir/pharmacokinetics;Triazoles/pharmacokinetics*
28339328;Administration, Oral;Adolescent;Adult;Antimetabolites, Antineoplastic/administration & dosage*;Child;Child, Preschool;Dairy Products;Drug Administration Schedule;Drug Monitoring/methods;Erythrocytes/metabolism;Female;Food-Drug Interactions;Humans;Male;Medication Adherence*;Mercaptopurine/administration & dosage*;Methyltransferases/genetics;Methyltransferases/metabolism;Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*;Thioguanine/blood*;Thionucleotides/blood*;Young Adult
28286289;Administration, Oral;Adolescent;Adult;Animals;Biological Availability;Cell Line, Tumor;Cross-Over Studies;Drug Liberation;Fasting/blood;Fasting/metabolism*;Female;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/chemistry;Hypnotics and Sedatives/pharmacokinetics*;Intestinal Absorption;Male;Milk;Models, Biological;Pyridines/blood;Pyridines/chemistry;Pyridines/pharmacokinetics*;Serum Albumin, Bovine;Software;Young Adult
28247011;Adult;Aged;Aged, 80 and over;Albumins/metabolism;BRCA1 Protein/genetics*;BRCA2 Protein/genetics*;Benzamides/administration & dosage;Benzamides/pharmacokinetics*;Benzamides/therapeutic use;Biological Availability;Body Weight;Fallopian Tube Neoplasms/drug therapy*;Fallopian Tube Neoplasms/genetics*;Female;Food-Drug Interactions;Heterozygote;Humans;Intestinal Absorption;Male;Middle Aged;Models, Biological;Mutation;Neoplasms/drug therapy*;Neoplasms/genetics*;Ovarian Neoplasms/drug therapy*;Ovarian Neoplasms/genetics*;Peritoneal Neoplasms/drug therapy*;Peritoneal Neoplasms/genetics*;Poly(ADP-ribose) Polymerase Inhibitors/pharmacokinetics*;Population;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use
28243685;Antitussive Agents/administration & dosage;Antitussive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Chromatography, High Pressure Liquid/methods*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Male;Morphinans/administration & dosage;Morphinans/pharmacokinetics*;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
28234656;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Mental Disorders/drug therapy;Mental Disorders/metabolism*;Nootropic Agents/pharmacokinetics*;Nootropic Agents/therapeutic use;Polypharmacy*;Psychotropic Drugs/pharmacokinetics*;Psychotropic Drugs/therapeutic use
28204912;Adolescent;Adult;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclin-Dependent Kinase 4/antagonists & inhibitors;Cyclin-Dependent Kinase 6/antagonists & inhibitors;Cyclin-Dependent Kinase Inhibitor Proteins/adverse effects;Cyclin-Dependent Kinase Inhibitor Proteins/pharmacokinetics*;Energy Intake;Fasting/metabolism;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Intestinal Absorption;Male;Meals;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Young Adult
28196633;Animals;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Drug Interactions*;Food-Drug Interactions;Herbal Medicine/methods;Humans;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry;Vitamin K/antagonists & inhibitors
28191610;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Antithrombins/pharmacology;Antithrombins/therapeutic use;Atrial Fibrillation/drug therapy;Clinical Competence/standards*;Consensus;Dabigatran/pharmacology;Dabigatran/therapeutic use;Drug-Related Side Effects and Adverse Reactions;Factor Xa Inhibitors/therapeutic use;Food-Drug Interactions;Humans;Internal Medicine/methods*;Italy;Liver Diseases/etiology;Perioperative Period/methods;Pyrazoles/pharmacology;Pyrazoles/therapeutic use;Pyridines/pharmacology;Pyridines/therapeutic use;Pyridones/pharmacology;Pyridones/therapeutic use;Rivaroxaban/pharmacology;Rivaroxaban/therapeutic use;Stroke/drug therapy;Thiazoles/pharmacology;Thiazoles/therapeutic use;Time Factors;Venous Thromboembolism/prevention & control
28177427;Carbonated Beverages*;Drug Interactions;Drug Monitoring;Erlotinib Hydrochloride/administration & dosage*;Erlotinib Hydrochloride/pharmacokinetics;Food-Drug Interactions;Humans;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/pharmacokinetics;Proton Pump Inhibitors/administration & dosage*
28167545;Administration, Oral;Adult;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Body Mass Index;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Drug Dosage Calculations;Fasting;Female;Food-Drug Interactions*;Gram-Positive Bacterial Infections/drug therapy;Gram-Positive Bacterial Infections/microbiology;Healthy Volunteers;Humans;Linezolid/blood;Linezolid/pharmacokinetics*;Male;Models, Statistical*;Oxazolidinones/blood;Oxazolidinones/pharmacokinetics*;Patient Safety;Pyridones/blood;Pyridones/pharmacokinetics*
28163162;Administration, Oral;Biological Availability;Chemistry, Pharmaceutical/methods;Ciprofloxacin/metabolism*;Food-Drug Interactions/physiology*;Gastrointestinal Absorption/physiology*;Humans;Hydrogen-Ion Concentration;Malvaceae/adverse effects*;Postprandial Period;Solubility;Tablets/metabolism*;Viscosity
28142160;Acetaldehyde/blood;Adult;Attention;Cross-Over Studies;Double-Blind Method;Ethanol/administration & dosage;Ethanol/blood;Ethanol/metabolism*;Ethanol/pharmacology;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Orphan Drug Production;Tiopronin/administration & dosage;Tiopronin/adverse effects;Tiopronin/pharmacology*;Young Adult
28134229;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/therapeutic use*;Citrus paradisi;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans;Neoplasms/drug therapy*
28104136;Acute Disease;Calcineurin Inhibitors/adverse effects*;Creatinine/blood;Curcuma/adverse effects*;Edema/etiology;Food-Drug Interactions*;Humans;Liver Transplantation;Male;Middle Aged;Postoperative Complications/chemically induced*;Tacrolimus/adverse effects*;Tacrolimus/blood
28101841;Administration, Oral;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Female;Food-Drug Interactions*;Humans;Ketoprofen/administration & dosage;Ketoprofen/blood;Ketoprofen/pharmacokinetics*;Male;Sex Characteristics*;Stereoisomerism*
28091956;Acetylcholinesterase/blood;Animals;Antioxidants/pharmacology*;Brain Chemistry/drug effects;Caffeine/pharmacology*;Central Nervous System Stimulants/pharmacology*;Cholinesterase Inhibitors/pharmacology*;Drug Interactions;Food-Drug Interactions;Free Radical Scavengers/pharmacology;In Vitro Techniques;Indans/pharmacology*;Iron Chelating Agents/pharmacology;Lipid Peroxidation/drug effects;Nootropic Agents/pharmacology*;Piperidines/pharmacology*;Rats
28077306;Animals;Anti-Anxiety Agents/pharmacology;Antidepressive Agents/pharmacology;Anxiety/psychology;Behavior, Animal/drug effects*;Brain/drug effects*;Brain/metabolism;Brain-Derived Neurotrophic Factor/metabolism*;Depression/psychology;Diet;Estradiol/adverse effects;Estradiol/pharmacology*;Female;Food-Drug Interactions*;Isoflavones/administration & dosage*;Maze Learning/drug effects;Motor Activity/drug effects;Ovariectomy;Rats, Sprague-Dawley
28073144;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Drug Labeling;Food-Drug Interactions*;Humans;Intestinal Absorption
28069114;Adult;Antioxidants/analysis;Antioxidants/metabolism*;Coffee/chemistry;Coffee/metabolism*;Female;Food, Fortified/analysis;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Nutritive Value/immunology*;Phenols/analysis;Phenols/metabolism*;Plant Extracts/analysis;Plant Extracts/metabolism;Soy Milk/chemistry;Soy Milk/metabolism*;Young Adult
28057550;Administration, Oral;Adult;Antirheumatic Agents/adverse effects;Antirheumatic Agents/blood;Antirheumatic Agents/pharmacokinetics*;Antirheumatic Agents/urine;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Platelet Membrane Glycoproteins/antagonists & inhibitors;Receptors, G-Protein-Coupled/antagonists & inhibitors;Young Adult
28050783;Animals;Azoxymethane/pharmacology*;Carcinogenesis/metabolism*;Carcinogens/pharmacology;Cell Transformation, Neoplastic/metabolism;Colon/drug effects;Colon/metabolism;Colon/pathology;Colonic Neoplasms*/metabolism;Colonic Neoplasms*/pathology;Complex Mixtures;Dextran Sulfate/pharmacology*;Diet, High-Fat*/adverse effects;Diet, High-Fat*/methods;Disease Models, Animal;Dose-Response Relationship, Drug;Food-Drug Interactions;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Lysophospholipids/pharmacology*;Rats;Soybeans*;Statistics as Topic
28043125;ATP Binding Cassette Transporter, Sub-Family G, Member 2/antagonists & inhibitors*;Animals;Biological Products/pharmacology*;Biological Transport/drug effects;Breast Neoplasms/diet therapy*;Breast Neoplasms/metabolism;Cell Line;DNA, Complementary/metabolism;Flavonoids/chemistry;Flavonoids/pharmacology;Food-Drug Interactions/physiology;Gallic Acid/analogs & derivatives;Gallic Acid/chemistry;Humans;Masoprocol/chemistry;Membrane Transport Proteins/metabolism;Multidrug Resistance-Associated Proteins/antagonists & inhibitors*;Neoplasm Proteins/antagonists & inhibitors*;Sf9 Cells
28032362;Animals;Cells, Cultured;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry*;Computer Simulation;Dogs;Estrone/analogs & derivatives;Estrone/metabolism;Flavanones/pharmacology;Flavones/pharmacology;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Furocoumarins/pharmacology;Hesperidin/pharmacology;Humans;Inhibitory Concentration 50;Models, Biological;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism
28028768;Absorption, Physiological;Achlorhydria/chemically induced;Achlorhydria/metabolism*;Achlorhydria/prevention & control;Administration, Oral;Adult;Atazanavir Sulfate/administration & dosage;Atazanavir Sulfate/pharmacokinetics*;Betaine/administration & dosage;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Proton Pump Inhibitors/adverse effects;Proton Pump Inhibitors/pharmacokinetics*;Rabeprazole/adverse effects;Rabeprazole/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Young Adult
27939244;Animals;Anticholesteremic Agents/pharmacology;Atorvastatin Calcium/administration & dosage;Atorvastatin Calcium/pharmacology*;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Dietary Supplements*;Docosahexaenoic Acids/administration & dosage;Docosahexaenoic Acids/pharmacology*;Drug Combinations;Eicosapentaenoic Acid/administration & dosage;Eicosapentaenoic Acid/analogs & derivatives*;Eicosapentaenoic Acid/pharmacology*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Hypercholesterolemia/drug therapy;Male;Metabolic Syndrome/blood;Metabolic Syndrome/metabolism*;Rats;Rats, Inbred Strains
27933871;Apigenin/pharmacology*;Arachidonic Acid/metabolism*;Cytochrome P450 Family 4/antagonists & inhibitors;Cytochrome P450 Family 4/metabolism*;Food-Drug Interactions;Humans;Hydroxyeicosatetraenoic Acids/metabolism;Hydroxylation;Inhibitory Concentration 50;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Microsomes/drug effects;Microsomes/metabolism;Polyphenols/pharmacology*;Vasoconstrictor Agents/pharmacology*
27914234;Administration, Oral;Aged;Biological Availability;Food-Drug Interactions*;Gastrointestinal Tract/metabolism*;Humans;Hydrogen-Ion Concentration*;Pharmacokinetics;Solubility
27909943;Chemistry, Pharmaceutical/methods;Computer Simulation;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/chemistry*;Delayed-Action Preparations/metabolism*;Drug Liberation/physiology;Food-Drug Interactions/physiology;Gastrointestinal Tract/metabolism;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Models, Biological;Pediatrics;Solubility;Valproic Acid/administration & dosage;Valproic Acid/chemistry*;Valproic Acid/metabolism*
27890698;Adult;Animals;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/metabolism;Cell Line, Tumor;Citrus*;Citrus paradisi*;Citrus sinensis*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices*/adverse effects;HEK293 Cells;Humans;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/metabolism;Mice;Rifampin/adverse effects;Rifampin/metabolism;Tacrolimus/adverse effects;Tacrolimus/metabolism*
27883269;Administration, Oral;Animals;Antimalarials/administration & dosage*;Antimalarials/pharmacokinetics;Area Under Curve;Biological Availability;Child, Preschool;Ethanolamines/administration & dosage*;Ethanolamines/pharmacokinetics;Female;Fluorenes/administration & dosage*;Fluorenes/pharmacokinetics;Food-Drug Interactions*;Humans;Infant;Malaria, Falciparum/drug therapy*;Male;Milk;Plant Oils/administration & dosage;Tablets;Time Factors;Treatment Outcome;Uganda;Zea mays
27863806;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects*;Antiviral Agents/blood*;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Hepatitis/drug therapy;Humans;Male;Middle Aged;Placebo Effect;Quinoxalines/administration & dosage;Quinoxalines/adverse effects*;Quinoxalines/blood*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/blood*
27639080;Administration, Oral;Adult;Appetite Stimulants/administration & dosage*;Appetite Stimulants/pharmacokinetics*;Appetite Stimulants/therapeutic use;Biological Availability;Cachexia/drug therapy;Cross-Over Studies;Drug Delivery Systems/methods;Drug Dosage Calculations;Eating;Fasting;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Megestrol Acetate/administration & dosage*;Megestrol Acetate/pharmacokinetics*;Megestrol Acetate/therapeutic use;Models, Biological*;Nanoparticles;Republic of Korea;Young Adult
27799203;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/chemistry;Antiviral Agents/therapeutic use*;Body Mass Index;Food-Drug Interactions;Glucuronides/administration & dosage;Glucuronides/chemistry;Glucuronides/therapeutic use*;HIV Infections/drug therapy;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
27785737;Adolescent;Adult;B-Lymphocytes/drug effects;Basophils/drug effects;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Syk Kinase/antagonists & inhibitors*;Tetraspanin 30/biosynthesis;Tetraspanin 30/drug effects;Vanadates/pharmacology;Young Adult
27530469;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antiviral Agents/administration & dosage*;Antiviral Agents/pharmacokinetics;Antiviral Agents/pharmacology;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Food-Drug Interactions*;Hepatitis C, Chronic/drug therapy*;Humans;Organic Anion Transporters/metabolism
27781421;Adolescent;Adult;Area Under Curve;Carbohydrate Metabolism/drug effects;Female;Food-Drug Interactions*;Humans;Hydrocortisone/blood;Male;Middle Aged;Organophosphates/pharmacokinetics*;Phenanthrenes/pharmacokinetics*;Receptors, Glucocorticoid/agonists*
27770845;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*
27757923;Amiodarone*/chemistry;Amiodarone*/pharmacokinetics;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics;Biological Availability;Calorimetry, Differential Scanning/methods;Drug Compounding/methods;Food-Drug Interactions;Freeze Drying/methods;Humans;Solubility;Spectroscopy, Fourier Transform Infrared/methods;X-Ray Diffraction/methods;beta-Cyclodextrins*/chemistry;beta-Cyclodextrins*/pharmacokinetics
27749255;Administration, Oral;Alcohol Drinking/adverse effects*;Alcohol Drinking/blood;Alcohol Drinking/metabolism;Alcoholic Beverages/adverse effects;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/chemistry;Antioxidants/pharmacokinetics*;Biological Availability;Dose-Response Relationship, Drug;Ethanol/adverse effects;Food-Drug Interactions*;Half-Life;Injections, Intravenous;Intestinal Absorption*;Kaempferols/administration & dosage;Kaempferols/agonists;Kaempferols/blood;Kaempferols/pharmacokinetics*;Male;Metabolic Clearance Rate;Random Allocation;Rats, Sprague-Dawley
27738922;Cholinergic Antagonists/adverse effects;Cholinergic Antagonists/metabolism*;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices*;Humans;Treatment Outcome;Urinary Bladder, Overactive/drug therapy*;Urinary Bladder, Overactive/metabolism*
27720220;5-alpha Reductase Inhibitors/administration & dosage*;Adrenergic alpha-Antagonists/administration & dosage*;Alcoholic Beverages*;Drug Interactions;Food-Drug Interactions*;Humans;Male;Prostatic Hyperplasia/drug therapy
27719743;Adolescent;Adult;Aminobutyrates/pharmacokinetics*;Angiotensin Receptor Antagonists/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neprilysin/antagonists & inhibitors*;Tetrazoles/pharmacokinetics*;Valsartan/pharmacokinetics*
27709656;Area Under Curve;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans
27704550;Administration, Oral;Adolescent;Beverages*;Biological Availability;Child;Child, Preschool;Dosage Forms;Drug Compounding;Food*;Food-Drug Interactions/physiology;Humans;Infant;Infant, Newborn;Pediatrics/methods*;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism
27693678;Administration, Oral;Area Under Curve;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions;Gastric Juice/chemistry;Gastrointestinal Contents/drug effects*;Gastrointestinal Tract/drug effects*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Healthy Volunteers;Humans;Hydrogen-Ion Concentration;Indinavir/administration & dosage*;Indinavir/chemistry;Indinavir/pharmacokinetics;Intestinal Absorption/drug effects*;Male;Membranes, Artificial;Micelles;Solubility;Tandem Mass Spectrometry
27654926;Colorectal Neoplasms/diet therapy;Colorectal Neoplasms/drug therapy;Colorectal Neoplasms/prevention & control;Colorectal Neoplasms/therapy;Combined Modality Therapy;Complementary Therapies*/trends;Dietary Supplements*;Evidence-Based Medicine*;Food-Drug Interactions;Gastritis/diet therapy;Gastritis/drug therapy;Gastritis/prevention & control;Gastritis/therapy;Gastrointestinal Agents/therapeutic use*;Gastrointestinal Diseases/diet therapy*;Gastrointestinal Diseases/drug therapy;Gastrointestinal Diseases/prevention & control;Gastrointestinal Diseases/therapy;Healthy Diet;Healthy Lifestyle;Helicobacter Infections/diet therapy;Helicobacter Infections/drug therapy;Helicobacter Infections/prevention & control;Helicobacter Infections/therapy;Humans;Inflammatory Bowel Diseases/diet therapy;Inflammatory Bowel Diseases/drug therapy;Inflammatory Bowel Diseases/prevention & control;Inflammatory Bowel Diseases/therapy;Nutritional Support*/trends
27638335;Clinical Trials as Topic*/methods;Drug Compounding;Food-Drug Interactions/physiology*;Humans;Models, Biological*;Receptors, Lysosphingolipid/physiology*;Thiazoles/chemistry;Thiazoles/pharmacokinetics*
27618606;Animals;Area Under Curve;Beverages;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Glycyrrhiza*;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Punicaceae*;Rats;Rats, Sprague-Dawley;Reproducibility of Results
27592195;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/pharmacokinetics;Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage*;Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/pharmacokinetics*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;Humans;Individuality;Male;Retrospective Studies
27582329;Cell Line, Tumor;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;Fruit and Vegetable Juices*;Humans;Hydroxytestosterones/antagonists & inhibitors*;Hydroxytestosterones/metabolism;Recombinant Proteins/metabolism;Vegetables
27581964;Animals;Clinical Trials as Topic;Drug Resistance, Neoplasm;Food-Drug Interactions;Humans;Kidney Function Tests;Thalidomide/adverse effects;Thalidomide/analogs & derivatives*;Thalidomide/chemistry;Thalidomide/pharmacokinetics;Thalidomide/pharmacology
27581475;Aged;Angiotensin Receptor Antagonists/adverse effects;Angiotensin Receptor Antagonists/therapeutic use*;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Diet;Feeding Behavior;Female;Food-Drug Interactions;Humans;Hyperkalemia/blood*;Hyperkalemia/etiology;Hypertension/blood;Hypertension/drug therapy*;Male;Middle Aged;Potassium/administration & dosage*;Potassium/blood;Potassium/pharmacology;Renin-Angiotensin System/drug effects*;Risk Factors
27558232;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics*;Bridged Bicyclo Compounds, Heterocyclic/therapeutic use;Cohort Studies;Dietary Fats/administration & dosage;Dietary Fats/metabolism*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism*;Lymphoma, Non-Hodgkin/drug therapy;Lymphoma, Non-Hodgkin/metabolism*;Male;Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors*;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use
27539539;Adult;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Fasting/physiology;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Tetracyclines/pharmacokinetics*;Time Factors
27514506;Adult;Angiotensin II Type 1 Receptor Blockers/administration & dosage;Angiotensin II Type 1 Receptor Blockers/adverse effects;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Chlorthalidone/administration & dosage*;Chlorthalidone/adverse effects;Chlorthalidone/pharmacokinetics;Cohort Studies;Dietary Fats/administration & dosage;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Oxadiazoles/administration & dosage*;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics;Tablets;Young Adult
27503364;Adult;Area Under Curve;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Double-Blind Method;Female;Food-Drug Interactions;Fruit and Vegetable Juices*;Furocoumarins/administration & dosage;Furocoumarins/pharmacology*;Healthy Volunteers;Humans;Male;Midazolam/pharmacokinetics*;Prospective Studies
27497726;Animals;Food*;Food Additives/chemistry;Food Additives/toxicity*;Food Safety*;Food-Drug Interactions*;Gastrointestinal Absorption/drug effects*;Humans;Nanoparticles/chemistry;Nanoparticles/toxicity*;Oxidative Stress/drug effects;Particle Size;Solubility;Surface Properties
27488574;Administration, Oral;Adult;Amphetamine*/administration & dosage;Amphetamine*/adverse effects;Amphetamine*/chemistry;Amphetamine*/pharmacokinetics;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/chemistry;Central Nervous System Stimulants/pharmacokinetics;Cross-Over Studies;Dosage Forms*;Drug Compounding/methods;Drug-Related Side Effects and Adverse Reactions*/diagnosis;Drug-Related Side Effects and Adverse Reactions*/etiology;Female;Food-Drug Interactions*;Half-Life;Humans;Isomerism;Male;Middle Aged;Therapeutic Equivalency
27481881;Adult;Aged;Area Under Curve;Arterial Pressure/drug effects*;Caffeine/administration & dosage;Caffeine/adverse effects;Caffeine/blood;Caffeine/pharmacokinetics*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Coffee*/adverse effects;Cross-Over Studies;Felodipine/administration & dosage;Felodipine/blood;Felodipine/pharmacokinetics*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Vascular Resistance/drug effects;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
27458288;Active Transport, Cell Nucleus/drug effects*;Administration, Oral;Adolescent;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Biopsy;Canada;Capsules;Disease Progression;Drug Administration Schedule;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions;Humans;Hydrazines/administration & dosage*;Hydrazines/adverse effects;Hydrazines/pharmacokinetics;Male;Middle Aged;New York City;Pharmaceutical Solutions;Postprandial Period;Sarcoma/drug therapy*;Sarcoma/metabolism;Sarcoma/pathology;Soft Tissue Neoplasms/drug therapy*;Soft Tissue Neoplasms/metabolism;Soft Tissue Neoplasms/pathology;Tablets;Time Factors;Tomography, X-Ray Computed;Treatment Outcome;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/pharmacokinetics;Young Adult
27453391;Beverages/analysis;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*
27444380;Animals;Anticarcinogenic Agents/chemistry;Anticarcinogenic Agents/metabolism;Anticarcinogenic Agents/pharmacology*;Binding, Competitive;Catalytic Domain;Citrus paradisi/chemistry*;Cytochrome P-450 CYP1A1/antagonists & inhibitors*;Cytochrome P-450 CYP1A1/chemistry;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 Enzyme Inhibitors/chemistry;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Flavanones/chemistry;Flavanones/metabolism;Flavanones/pharmacology;Food-Drug Interactions;Fruit and Vegetable Juices/analysis*;Furocoumarins/chemistry;Furocoumarins/metabolism;Furocoumarins/pharmacology;Humans;Ligands;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Molecular*;Molecular Conformation;Molecular Docking Simulation;Molecular Dynamics Simulation;Rats;Rats, Wistar;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism
27444313;Acetamides*/administration & dosage;Acetamides*/adverse effects;Acetamides*/pharmacokinetics;Administration, Oral;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/pharmacokinetics;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Monitoring;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Piperidines*/administration & dosage;Piperidines*/adverse effects;Piperidines*/pharmacokinetics;Pyridines*/administration & dosage;Pyridines*/adverse effects;Pyridines*/pharmacokinetics;Stomach Ulcer/drug therapy;Tablets;Tandem Mass Spectrometry
27435452;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Cytochrome P-450 CYP3A/metabolism;Drug Interactions*;Factor Xa Inhibitors/administration & dosage*;Factor Xa Inhibitors/adverse effects;Factor Xa Inhibitors/pharmacology;Food-Drug Interactions;Humans;Warfarin/administration & dosage;Warfarin/adverse effects
27422208;Animals;Drug Compounding;Food-Drug Interactions*;Humans;In Vitro Techniques;Stomach/drug effects*;Stomach/physiology
27418571;Adult;Benzhydryl Compounds/blood*;Benzhydryl Compounds/chemistry*;Cross-Over Studies;Diet, High-Fat*;Drug Compounding;Fasting/blood*;Female;Food-Drug Interactions/physiology*;Glucosides/blood*;Glucosides/chemistry*;Hot Temperature*/adverse effects;Humans;Male;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
27418392;Acrylates/chemistry*;Administration, Oral;Animals;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology*;Chemistry, Pharmaceutical*;Eating;Fasting;Food-Drug Interactions*;In Vitro Techniques;Male;Polymers/chemistry*;Rats;Rats, Wistar;Risedronate Sodium/chemistry;Risedronate Sodium/pharmacokinetics;Risedronate Sodium/pharmacology*;Stomach/drug effects*
27406858;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use;Case-Control Studies;Constipation/epidemiology;Constipation/etiology*;Cross-Sectional Studies;Energy Intake*;Feeding Behavior*;Female;Food-Drug Interactions;Healthy Diet*;Hospitals, Special;Humans;Italy/epidemiology;Levodopa/administration & dosage;Levodopa/adverse effects;Levodopa/therapeutic use;Male;Malnutrition/epidemiology;Malnutrition/etiology*;Middle Aged;Outpatient Clinics, Hospital;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology*;Patient Compliance*;Prevalence;Risk;Severity of Illness Index
27402726;Administration, Oral;Aged;Area Under Curve;Biological Availability;Biphenyl Compounds/administration & dosage;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Middle Aged;Postmenopause*
27348971;Animals;Area Under Curve;Blotting, Western;Capsaicin/administration & dosage;Capsaicin/pharmacology*;Chromatography, Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Glucuronosyltransferase/genetics*;Liver/drug effects;Liver/enzymology;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/pharmacokinetics*;Tandem Mass Spectrometry;Up-Regulation/drug effects
27345284;Administration, Intravenous;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Nitriles/administration & dosage;Nitriles/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Stomach/chemistry;Triazoles/administration & dosage;Triazoles/pharmacokinetics*
27339904;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Antineoplastic Agents/pharmacology*;Antioxidants/metabolism;Apoptosis/drug effects*;Apoptosis Regulatory Proteins/agonists;Apoptosis Regulatory Proteins/genetics;Apoptosis Regulatory Proteins/metabolism;Ascorbic Acid/metabolism*;Carcinoma/diet therapy;Carcinoma/drug therapy;Carcinoma/metabolism;Colonic Neoplasms/diet therapy;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Combined Modality Therapy;Dietary Supplements;Drug Resistance, Neoplasm;Food-Drug Interactions;Gene Expression Regulation, Neoplastic/drug effects;HCT116 Cells;Humans;Osmolar Concentration;Oxidants/metabolism;Proto-Oncogene Proteins/agonists;Proto-Oncogene Proteins/genetics;Proto-Oncogene Proteins/metabolism;RNA Interference;Reactive Oxygen Species/agonists*;Reactive Oxygen Species/metabolism;Sulindac/pharmacology*;Tumor Suppressor Protein p53/agonists*;Tumor Suppressor Protein p53/antagonists & inhibitors;Tumor Suppressor Protein p53/genetics;Tumor Suppressor Protein p53/metabolism
27324506;Adult;Aminobutyrates/pharmacokinetics*;Angiotensin Receptor Antagonists/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Double-Blind Method;Food-Drug Interactions/physiology;Healthy Volunteers;Humans;Male;Neprilysin/pharmacokinetics*;Receptors, Angiotensin/metabolism;Tetrazoles/pharmacokinetics*;Valsartan/pharmacokinetics*;Young Adult
27322002;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacology*;Delayed-Action Preparations;Dosage Forms*;Food-Drug Interactions*;Humans;Nifedipine/administration & dosage;Nifedipine/pharmacology*;Solubility
27316629;Administration, Oral;Antineoplastic Agents/administration & dosage*;Food-Drug Interactions*;Humans;Plants, Edible*;Plants, Medicinal*
27310331;Administration, Oral;Adult;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Indoleacetic Acids/administration & dosage*;Indoleacetic Acids/adverse effects;Indoleacetic Acids/pharmacokinetics;Male;Middle Aged;Pyridines/administration & dosage*;Pyridines/adverse effects;Pyridines/pharmacokinetics;Receptors, Immunologic/antagonists & inhibitors*;Receptors, Prostaglandin/antagonists & inhibitors*
27310148;Acute Disease;Chronic Disease;Cluster Headache/drug therapy*;Cluster Headache/prevention & control;Drug Interactions*;Food-Drug Interactions;Humans;Secondary Prevention/methods;Time Factors;Xenobiotics/administration & dosage*;Xenobiotics/adverse effects;Xenobiotics/pharmacokinetics
27301503;Adult;Biological Availability;Citrus paradisi*/adverse effects;Connective Tissue Diseases/blood*;Connective Tissue Diseases/drug therapy;Drug Administration Schedule;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood*;Immunosuppressive Agents/therapeutic use;Male;Tacrolimus/administration & dosage;Tacrolimus/blood*;Tacrolimus/therapeutic use;Young Adult
27294349;Adult;Area Under Curve;Benzylamines/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices/adverse effects*;Half-Life;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate/physiology;Midazolam/pharmacokinetics*;Middle Aged;Naphthalenes/pharmacokinetics*;Punicaceae/adverse effects*
27292282;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Drug Stability;Factor Xa Inhibitors/pharmacokinetics*;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pyrazoles/pharmacokinetics*;Pyridones/pharmacokinetics*;Tablets;Therapeutic Equivalency
27213447;Adult;Belgium;Biological Availability;Biomarkers/blood;Breakfast;Calcifediol/blood*;Cholecalciferol/administration & dosage*;Cholecalciferol/blood;Cholecalciferol/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Dietary Supplements*;Female;Food-Drug Interactions*;Gastrointestinal Absorption;Humans;Male;Middle Aged;Postprandial Period;Young Adult
27183705;Administration, Oral*;Beverages;Biological Availability;Capsules;Chemistry, Pharmaceutical;Child;Dosage Forms;Food*;Food-Drug Interactions*;Humans;Pharmaceutical Vehicles;Surface Tension;Suspensions;Tablets;Taste;Viscosity
27178739;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Body Fluids/chemistry;Body Fluids/metabolism;Catheterization;Cross-Over Studies;Delayed-Action Preparations;Drug Compounding;Duodenum/metabolism;Fasting;Female;Food-Drug Interactions;Gastrointestinal Tract/metabolism*;Healthy Volunteers;Humans;Intestinal Absorption;Jejunum/metabolism;Male;Stomach/metabolism;Triazoles/analysis;Triazoles/pharmacokinetics*;Young Adult
27173501;Aged, 80 and over;Antirheumatic Agents/adverse effects;Arthritis, Rheumatoid/drug therapy;Carbonated Beverages/adverse effects*;Electrocardiography;Female;Food-Drug Interactions;Humans;Hydroxychloroquine/adverse effects;Long QT Syndrome/chemically induced*;Muscle Cramp/drug therapy;Muscle Relaxants, Central/adverse effects*;Quinine/adverse effects*
27163498;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Ketoprofen/administration & dosage*;Ketoprofen/pharmacokinetics;Male;Sex Factors;Young Adult
27163497;Administration, Oral;Adolescent;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors/administration & dosage*;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Dietary Fats;Fasting;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage*;Imidazoles/adverse effects;Imidazoles/pharmacokinetics;Least-Squares Analysis;Male;Middle Aged;Naphthalenes/administration & dosage*;Naphthalenes/adverse effects;Naphthalenes/pharmacokinetics;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors;Young Adult
27162173;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adamantane/pharmacology;Adolescent;Adult;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Janus Kinase Inhibitors/adverse effects;Janus Kinase Inhibitors/pharmacokinetics*;Janus Kinase Inhibitors/pharmacology*;Male;Middle Aged;Niacinamide/adverse effects;Niacinamide/analogs & derivatives*;Niacinamide/pharmacokinetics;Niacinamide/pharmacology;Young Adult
27155921;Administration, Oral;Animals;Atherosclerosis/blood;Atherosclerosis/etiology*;Atherosclerosis/metabolism;Biomarkers/blood;Choline/administration & dosage;Choline/metabolism*;Deuterium;Dietary Fats/metabolism;Environmental Pollutants/administration & dosage;Environmental Pollutants/toxicity*;Enzyme Induction/drug effects;Food-Drug Interactions;Liver/drug effects*;Liver/enzymology;Liver/metabolism;Male;Methylamines/administration & dosage;Methylamines/blood*;Methylamines/metabolism;Mice, Inbred C57BL;Oxygenases/chemistry;Oxygenases/genetics;Oxygenases/metabolism*;Phosphatidylcholines/administration & dosage;Phosphatidylcholines/metabolism;Polychlorinated Biphenyls/administration & dosage;Polychlorinated Biphenyls/toxicity*;Random Allocation;Up-Regulation/drug effects
27138025;Adolescent;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage*;Benzhydryl Compounds/pharmacokinetics;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Glucosides/administration & dosage*;Glucosides/pharmacokinetics;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/pharmacokinetics;Male;Metformin/administration & dosage*;Metformin/pharmacokinetics;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
27137147;Administration, Oral;Adult;Age Factors;Aged;Antiemetics/administration & dosage*;Antiemetics/adverse effects;Antiemetics/blood;Antiemetics/pharmacokinetics*;Cross-Over Studies;Fasting/blood;Female;Food-Drug Interactions*;Germany;Healthy Volunteers;Humans;Isoquinolines/administration & dosage*;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Male;Middle Aged;Postprandial Period;Pyridines/administration & dosage*;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Quinuclidines/administration & dosage*;Quinuclidines/adverse effects;Quinuclidines/blood;Quinuclidines/pharmacokinetics*;Young Adult
27137146;Administration, Oral;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biotransformation;Capsules;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Naltrexone/administration & dosage;Naltrexone/adverse effects;Naltrexone/analogs & derivatives;Naltrexone/blood;Naltrexone/pharmacokinetics*;Narcotic Antagonists/administration & dosage;Narcotic Antagonists/adverse effects;Narcotic Antagonists/blood;Narcotic Antagonists/pharmacokinetics*;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/blood;Oxycodone/pharmacokinetics*;Postprandial Period;Young Adult
27136912;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Breakfast;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Administration Schedule;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Janus Kinase 2/antagonists & inhibitors*;Janus Kinase 2/metabolism;Janus Kinase Inhibitors/administration & dosage;Janus Kinase Inhibitors/adverse effects;Janus Kinase Inhibitors/blood;Janus Kinase Inhibitors/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Tennessee;Young Adult
27136908;Administration, Oral;Adolescent;Adult;Area Under Curve;Belgium;Canagliflozin/administration & dosage*;Canagliflozin/adverse effects;Canagliflozin/blood;Canagliflozin/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Kidney Tubules/drug effects*;Kidney Tubules/metabolism;Linear Models;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Sodium-Glucose Transporter 2/metabolism;Therapeutic Equivalency;United States;Young Adult
27120703;Acquired Immunodeficiency Syndrome/complications;Animals;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/therapeutic use;Drug Interactions;Drug Resistance, Multiple, Bacterial;Food-Drug Interactions;Global Health*;Half-Life;Humans;Medication Adherence;Public Health;Tissue Distribution;Tuberculosis, Multidrug-Resistant/drug therapy*;Tuberculosis, Multidrug-Resistant/epidemiology
27067239;Administration, Oral;Amiodarone/metabolism*;Biological Availability;Biopharmaceutics/methods;Chemistry, Pharmaceutical/methods;Danazol/metabolism*;Food-Drug Interactions;High-Throughput Screening Assays/methods;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Ivermectin/metabolism*;Models, Biological;Pharmaceutical Preparations/metabolism*;Solubility;Stomach/metabolism;Therapeutic Equivalency
27061460;Abiraterone Acetate/pharmacokinetics*;Adult;Animals;Bile/metabolism;Biological Availability;Duodenum/metabolism;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Postprandial Period;Rats;Solubility;Steroid Synthesis Inhibitors/pharmacokinetics;Stomach/metabolism;Young Adult
27061346;Antacids/adverse effects*;Antacids/chemistry;Deoxyribose/chemistry;Dietary Supplements/adverse effects*;Electron Spin Resonance Spectroscopy;Ferrous Compounds/adverse effects;Ferrous Compounds/chemistry;Food-Drug Interactions*;Humans;Hydrogen Peroxide/agonists;Hydrogen Peroxide/analysis;Hydrogen Peroxide/chemistry;Hydrogen-Ion Concentration;Hydroxyl Radical/agonists;Hydroxyl Radical/analysis;Hydroxyl Radical/chemistry;Iron, Dietary/adverse effects*;Lactates/adverse effects;Lactates/chemistry;Magnesium Compounds/adverse effects*;Magnesium Compounds/chemistry;Netherlands;Nonprescription Drugs/adverse effects;Osmolar Concentration;Peroxides/adverse effects*;Peroxides/chemistry;Reactive Oxygen Species/analysis;Reactive Oxygen Species/chemistry*;Self Care/adverse effects*;Self Medication/adverse effects
27052517;Animals;Anticholesteremic Agents/metabolism*;Biological Transport;Catechin/analogs & derivatives*;Catechin/metabolism;Female;Food-Drug Interactions*;HEK293 Cells;Humans;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Simvastatin/analogs & derivatives;Simvastatin/metabolism*
27049053;Adult;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Mesalamine/adverse effects;Mesalamine/pharmacokinetics*;Spectrometry, Mass, Electrospray Ionization;Tablets, Enteric-Coated;Tandem Mass Spectrometry;Therapeutic Equivalency
27043608;Acetaldehyde/blood;Alanine Transaminase/blood;Alcohol Dehydrogenase/metabolism;Alcoholic Intoxication/therapy;Aldehyde Oxidoreductases/metabolism;Animals;Aspartate Aminotransferases/blood;Chemical and Drug Induced Liver Injury/prevention & control;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Fruit*/adverse effects;Functional Food*/adverse effects;Liver/drug effects;Liver/metabolism;Male;Malondialdehyde/metabolism;Mice;Superoxide Dismutase/metabolism
27039386;Administration, Oral;Adult;Aged;Angiogenesis Inhibitors/administration & dosage*;Angiogenesis Inhibitors/adverse effects;Angiogenesis Inhibitors/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gene Expression Regulation, Neoplastic/drug effects;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/pharmacology;Integrin alpha2/genetics;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;RNA, Messenger/metabolism;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacology;Treatment Outcome
27033456;ATP Binding Cassette Transporter, Sub-Family G, Member 2/biosynthesis;ATP Binding Cassette Transporter, Sub-Family G, Member 2/drug effects*;ATP Binding Cassette Transporter, Sub-Family G, Member 2/genetics;Antineoplastic Agents/pharmacology;Breast Neoplasms/drug therapy*;Breast Neoplasms/genetics;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Dose-Response Relationship, Drug;Doxorubicin/pharmacology;Drug Resistance, Multiple/drug effects*;Drug Resistance, Neoplasm/drug effects*;Female;Food-Drug Interactions;Gene Expression Regulation, Neoplastic;Genistein/toxicity*;Humans;MCF-7 Cells;MicroRNAs/genetics;MicroRNAs/metabolism;Mitoxantrone/pharmacology;Multidrug Resistance-Associated Proteins/biosynthesis;Multidrug Resistance-Associated Proteins/drug effects*;Multidrug Resistance-Associated Proteins/genetics;Neoplasm Proteins/biosynthesis;Neoplasm Proteins/drug effects*;Neoplasm Proteins/genetics;Phytoestrogens/toxicity*;Protein Biosynthesis;Protein Synthesis Inhibitors/pharmacology;Risk Assessment;Up-Regulation
27029823;Adult;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Bridged Bicyclo Compounds, Heterocyclic/blood*;Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics;Cross-Over Studies;Diet, Fat-Restricted*/methods;Diet, High-Fat*/methods;Dietary Fats/blood*;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors*;Sulfonamides/blood*;Sulfonamides/pharmacokinetics
27022718;Administration, Oral;Calibration;Chromatography, High Pressure Liquid/methods*;Drug Stability;Fasting;Female;Flavanones/administration & dosage*;Flavanones/blood*;Flavanones/pharmacokinetics;Flavonoids/blood*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Humans;Liquid-Liquid Extraction;Male;Reproducibility of Results;Sensitivity and Specificity;Spectrometry, Mass, Electrospray Ionization;Tablets;Tandem Mass Spectrometry/methods*
27019158;Administration, Oral;Adult;Antiviral Agents/administration & dosage*;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Healthy Volunteers;Hepacivirus/drug effects*;Hepacivirus/enzymology;Humans;Male;Metabolic Clearance Rate;Middle Aged;Oligopeptides/administration & dosage*;Oligopeptides/pharmacokinetics*;Omeprazole/administration & dosage*;Omeprazole/adverse effects;Protease Inhibitors/administration & dosage*;Protease Inhibitors/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/adverse effects;Risk Factors;Thiazoles/administration & dosage*;Thiazoles/pharmacokinetics*;Viral Nonstructural Proteins/antagonists & inhibitors*;Viral Nonstructural Proteins/metabolism;Young Adult
26995510;Adrenergic alpha-Agonists/therapeutic use*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Central Nervous System Stimulants/therapeutic use*;Depressive Disorder/drug therapy*;Dietary Supplements*;Dopamine Agonists/therapeutic use*;Double-Blind Method;Drug Interactions;Drug Resistance;Drug Therapy, Combination;Excitatory Amino Acid Antagonists/therapeutic use*;Fatty Acids, Omega-3/therapeutic use;Folic Acid/therapeutic use;Food-Drug Interactions;Humans;Ketamine/therapeutic use*;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Randomized Controlled Trials as Topic;S-Adenosylmethionine/therapeutic use
26995271;Administration, Oral;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology*;Humans;Intestinal Absorption/drug effects*;Neoplasms/metabolism*;Proton Pump Inhibitors/pharmacology*
26970526;Adult;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*/methods;Dietary Fats/administration & dosage;Dietary Fats/blood*;Drug Administration Schedule;Drug Compounding;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/blood*;Piperidines/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage;Pyrimidines/blood*;Pyrimidines/pharmacokinetics;Pyrroles/administration & dosage;Pyrroles/blood*;Pyrroles/pharmacokinetics
26943820;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26934925;Administration, Oral;Animals;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/pharmacology*;Drinking Water;Food-Drug Interactions;Intestinal Absorption;Magnesium/pharmacology*;Male;Mineral Waters*;Rats, Wistar;Risedronate Sodium/pharmacokinetics*;Risedronate Sodium/urine
26932305;Adamantane/administration & dosage;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/pharmacokinetics*;Nitriles/administration & dosage;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/pharmacokinetics*;Tablets;Therapeutic Equivalency
26929637;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Blood Coagulation/drug effects*;Drug Administration Schedule;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Medication Adherence;Patient Satisfaction;Patient Selection;Practice Guidelines as Topic;Recurrence;Risk Factors;Time Factors;Treatment Outcome;Venous Thromboembolism/blood;Venous Thromboembolism/diagnosis;Venous Thromboembolism/drug therapy*
26921120;Adolescent;Adult;Biopharmaceutics;Cell Membrane/metabolism;Computer Simulation;Fasting;Female;Food-Drug Interactions*;Gastric Emptying;Humans;Intestinal Absorption;Intestines/metabolism*;Ketoconazole/chemistry;Ketoconazole/pharmacokinetics;Male;Middle Aged;Triazoles/chemistry;Triazoles/pharmacokinetics;Young Adult
26918279;Aged;Anemia/chemically induced;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Japan;Leukopenia/chemically induced;Male;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy*;Neoplasms/metabolism*;Neoplasms/pathology;Neutropenia/chemically induced;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics;Pyrrolidines/pharmacology;Pyrrolidines/therapeutic use;Thymine/adverse effects;Thymine/pharmacokinetics;Thymine/pharmacology;Thymine/therapeutic use;Trifluridine/adverse effects;Trifluridine/pharmacokinetics*;Trifluridine/pharmacology*;Trifluridine/therapeutic use;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Uracil/pharmacology;Uracil/therapeutic use
26902828;Antineoplastic Agents/pharmacokinetics*;Asian Continental Ancestry Group;Chemistry, Pharmaceutical;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Protein Kinase Inhibitors/pharmacokinetics*
26895020;ATP-Binding Cassette Transporters/metabolism;Animals;Animals, Genetically Modified;Area Under Curve;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Enterocytes/enzymology;Food-Drug Interactions;Glucuronosyltransferase/metabolism;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology*;Intestinal Mucosa/metabolism;Metabolic Clearance Rate;Models, Animal;Models, Biological*;Pharmacokinetics;Sulfotransferases/metabolism
26872892;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Boron Compounds/adverse effects;Boron Compounds/pharmacokinetics*;Cross-Over Studies;Diet, High-Fat*;Female;Food-Drug Interactions;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/pharmacokinetics;Humans;Intestinal Absorption;Lymphoma/metabolism*;Male;Meals*;Middle Aged;Neoplasms/metabolism*;Proteasome Inhibitors/adverse effects;Proteasome Inhibitors/pharmacokinetics*
26858332;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Carcinoma, Non-Small-Cell Lung/blood;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/pathology;Cross-Over Studies;Drug Monitoring;Erlotinib Hydrochloride/administration & dosage;Erlotinib Hydrochloride/blood;Erlotinib Hydrochloride/pharmacokinetics*;Esomeprazole/administration & dosage;Female;Food-Drug Interactions*;Gastrointestinal Absorption*;Humans;Hydrogen-Ion Concentration;Lung Neoplasms/blood;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Male;Middle Aged;Netherlands;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage
26854426;Animals;Biological Availability;Chemistry, Pharmaceutical;Drug Delivery Systems*;Emulsions;Ethylene Glycols/administration & dosage;Ethylene Glycols/chemistry;Fasting/metabolism;Food-Drug Interactions;Gastrointestinal Tract/metabolism;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics;Intestinal Absorption/drug effects;Linoleic Acids/administration & dosage;Linoleic Acids/chemistry;Male;Nelfinavir/administration & dosage*;Nelfinavir/blood;Nelfinavir/chemistry;Nelfinavir/pharmacokinetics;Permeability/drug effects;Polysorbates/administration & dosage;Polysorbates/chemistry;Rabbits;Rats;Solubility;Surface-Active Agents/administration & dosage;Surface-Active Agents/chemistry
26843482;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antiphospholipid Syndrome/complications;Antiphospholipid Syndrome/drug therapy*;Antithrombins/administration & dosage;Antithrombins/adverse effects;Breast Feeding;Factor Xa Inhibitors/administration & dosage;Factor Xa Inhibitors/adverse effects;Female;Food-Drug Interactions/physiology;Hemorrhage/chemically induced;Humans;Kidney Diseases/complications;Liver Diseases/complications;Lupus Coagulation Inhibitor/blood;Pregnancy;Pregnancy Complications/drug therapy;Thrombosis/complications;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors
26843267;Biological Availability;Dietary Supplements*;Energy Metabolism/physiology*;Food-Drug Interactions;Humans;Intestinal Absorption;Malnutrition/metabolism;Micronutrients/metabolism*;Nutritional Requirements
26830519;Aged;Dietary Supplements/adverse effects*;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/metabolism;Female;Food-Drug Interactions*/physiology;Humans;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/diagnosis*;Rhabdomyolysis/metabolism;Rosuvastatin Calcium/adverse effects*;Rosuvastatin Calcium/metabolism
26821227;Adipose Tissue/drug effects;Adipose Tissue/metabolism;Dexamethasone/adverse effects*;Docosahexaenoic Acids/pharmacology;Eicosapentaenoic Acid/pharmacology;Fatty Acids, Nonesterified/blood;Fish Oils/administration & dosage;Fish Oils/pharmacology*;Food-Drug Interactions;Glycerol/blood;Humans;Insulin Resistance*;Lipid Metabolism/drug effects;Lipolysis/drug effects*;Male;Oils/pharmacology;Paraffin/pharmacology;Young Adult
26821071;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Anthocyanins/administration & dosage*;Anthocyanins/metabolism;Dietary Supplements*;Dose-Response Relationship, Drug;Fluoresceins/administration & dosage*;Fluoresceins/metabolism;Food-Drug Interactions*/physiology;Humans;Swine;Verapamil/administration & dosage;Verapamil/metabolism
26801658;Aged;Combined Modality Therapy/adverse effects;Enteral Nutrition/adverse effects*;Fever/chemically induced*;Food-Drug Interactions;Humans;Levodopa/adverse effects*;Male;Substance Withdrawal Syndrome
26798646;Animals;Food*;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena*
26797810;Adolescent;Adult;Asian Continental Ancestry Group;China;Dose-Response Relationship, Drug;Drug Administration Schedule*;Female;Fibrosis/drug therapy;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Pyridones/administration & dosage*;Pyridones/adverse effects;Pyridones/blood;Pyridones/pharmacokinetics*;Sex Characteristics;Young Adult
26795834;Evidence-Based Nursing/organization & administration*;Food-Drug Interactions*;Humans;Nurse Practitioners*;Primary Care Nursing*
26775868;Administration, Oral;Adolescent;Adult;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Cinnarizine/administration & dosage*;Cinnarizine/blood;Cinnarizine/pharmacokinetics;Cross-Over Studies;Drug Delivery Systems*;Emulsions;Fasting;Food-Drug Interactions*;Gastric Emptying;Healthy Volunteers;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics;Humans;Intestinal Absorption;Male;Tablets;Young Adult
26755336;Adult;Bile/metabolism*;Biological Availability;Celecoxib/pharmacokinetics*;Diet, High-Fat/methods;Fasting/metabolism*;Food;Food-Drug Interactions/physiology;Gastrointestinal Tract/metabolism*;Humans;Models, Biological;Solubility
26748446;Adjuvants, Pharmaceutic*/chemistry;Adjuvants, Pharmaceutic*/pharmacology;Animals;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/chemistry*;Biological Availability;Delayed-Action Preparations;Dogs;Food-Drug Interactions*;Microscopy, Electron, Scanning;Phospholipids*/chemistry;Phospholipids*/pharmacology;Piperazines/administration & dosage;Piperazines/blood;Piperazines/chemistry*;Solubility;Spectroscopy, Fourier Transform Infrared;Technology, Pharmaceutical/methods*;Thiazoles/administration & dosage;Thiazoles/blood;Thiazoles/chemistry*;X-Ray Diffraction
26728536;Aged;Antibodies/pharmacology;Antibodies/therapeutic use;Bone Density/drug effects;Bone Density Conservation Agents*/pharmacology;Bone Density Conservation Agents*/therapeutic use;Bone Morphogenetic Proteins/immunology;Bone Resorption/prevention & control;Cathepsin K/antagonists & inhibitors;Clinical Trials as Topic;Diphosphonates*/pharmacology;Diphosphonates*/therapeutic use;Drug Discovery/trends*;Enzyme Inhibitors/pharmacology;Enzyme Inhibitors/therapeutic use;Female;Food-Drug Interactions;Genetic Markers/immunology;Humans;Osteogenesis/drug effects;Osteoporosis/drug therapy*;Osteoporosis/metabolism;Parathyroid Hormone-Related Protein*/pharmacology;Parathyroid Hormone-Related Protein*/therapeutic use
26725427;Administration, Oral;Animals;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/blood;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Food Deprivation;Food-Drug Interactions;Half-Life;Rats;Rifampin/administration & dosage;Rifampin/blood;Rifampin/pharmacokinetics*
26721731;Administration, Oral;Alcoholic Beverages;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/chemistry;Capsules;Citrus sinensis;Drug Liberation;Food-Drug Interactions*;Fruit and Vegetable Juices;Gastric Juice/metabolism*;Hydrodynamics;Hydrogen-Ion Concentration;Nifedipine/administration & dosage*;Nifedipine/chemistry;Solubility;Water/administration & dosage
26709596;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Urea/adverse effects;Urea/analogs & derivatives*;Urea/pharmacokinetics
26689566;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics;Aurora Kinase A/antagonists & inhibitors*;Azepines/administration & dosage*;Azepines/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/pharmacokinetics*;Pyrimidines/administration & dosage*;Pyrimidines/pharmacokinetics*
26677899;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chemistry, Pharmaceutical;Computer Simulation;Delayed-Action Preparations;Excipients/chemistry;Fasting;Food-Drug Interactions*;Gastric Absorption;Humans;Intestinal Absorption;Models, Biological*;Models, Chemical*;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/chemistry;Nifedipine/pharmacokinetics*;Numerical Analysis, Computer-Assisted;Postprandial Period;Solubility
26632187;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport;Caco-2 Cells;Dioxoles/pharmacology*;Drug Interactions*;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Lignans/pharmacology*;Male;Plant Extracts/pharmacology;Rats, Wistar;Rhodamine 123/pharmacokinetics*;Seeds/chemistry*;Sesamum/chemistry*;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
26630906;Animals;Biological Availability;Biological Transport;Drug Interactions;Food-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Liver/metabolism;Membrane Transport Proteins/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
26604072;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Eating/physiology;Fasting;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Middle Aged;Mineralocorticoid Receptor Antagonists/adverse effects*;Mineralocorticoid Receptor Antagonists/pharmacokinetics*;Mineralocorticoid Receptor Antagonists/therapeutic use;Naphthyridines/adverse effects*;Naphthyridines/pharmacokinetics*;Naphthyridines/therapeutic use;Pharmaceutical Solutions/adverse effects;Pharmaceutical Solutions/pharmacokinetics;Pharmaceutical Solutions/therapeutic use;Tablets/adverse effects;Tablets/pharmacokinetics;Tablets/therapeutic use;Young Adult
26590950;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Biotransformation;Cross-Over Studies;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/blood;Cyclooxygenase Inhibitors/chemistry;Cyclooxygenase Inhibitors/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/analysis;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Drug Compounding*;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Ketoprofen/administration & dosage;Ketoprofen/blood;Ketoprofen/chemistry;Ketoprofen/pharmacokinetics*;Male;Metabolic Clearance Rate;Molecular Structure;Sex Characteristics;Stereoisomerism;Tablets, Enteric-Coated;Young Adult
26589308;Biopharmaceutics/classification*;Carrier Proteins/metabolism;Drug Interactions;Environment;Food-Drug Interactions;Humans;Pharmaceutical Preparations/classification*;Pharmaceutical Preparations/metabolism;Pharmacogenetics;Pharmacokinetics*;Solubility;Tissue Distribution
26581327;Administration, Oral;Adolescent;Adult;Age Factors;Aged;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage*;Double-Blind Method;Fasting;Female;Fluoroquinolones/blood;Fluoroquinolones/pharmacokinetics;Fluoroquinolones/pharmacology*;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Sex Factors;Young Adult
26566368;Cobicistat/adverse effects;Cobicistat/therapeutic use*;Cytochrome P-450 CYP3A Inhibitors/adverse effects;Cytochrome P-450 CYP3A Inhibitors/therapeutic use*;Darunavir/adverse effects;Darunavir/pharmacokinetics;Darunavir/therapeutic use*;Drug Combinations;Drug Interactions;Food-Drug Interactions;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use*;Humans;Risk Factors;Treatment Outcome
26526067;Administration, Oral;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/metabolism;Antineoplastic Agents/toxicity*;Bacteria/drug effects;Bacteria/enzymology;Bacterial Proteins/antagonists & inhibitors;Bacterial Proteins/metabolism;Camptothecin/administration & dosage;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/toxicity;Cefixime/pharmacology;Diarrhea/chemically induced*;Diarrhea/metabolism;Diarrhea/microbiology;Diarrhea/prevention & control;Enzyme Inhibitors/pharmacology;Female;Flavonoids/pharmacology;Food-Drug Interactions;Fruit and Vegetable Juices;Gastrointestinal Microbiome;Gene Transfer Techniques;Glucuronidase/antagonists & inhibitors;Glucuronidase/metabolism;Hydrogen-Ion Concentration;Intestinal Absorption*;Intestines/drug effects*;Intestines/metabolism;Intestines/microbiology;Kinetics;Malus;Mice, Inbred C57BL;Oocytes;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Xenopus laevis
26502357;Adult;Aged;Castration/methods*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Gonadotropin-Releasing Hormone/antagonists & inhibitors*;Humans;Luteinizing Hormone/blood;Male;Middle Aged;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/therapeutic use*;Prostatic Neoplasms/drug therapy*;Pyrimidinones/adverse effects;Pyrimidinones/pharmacokinetics;Pyrimidinones/therapeutic use*;Testosterone/blood;Treatment Outcome;Young Adult
26478276;Administration, Oral;Animals;Antimalarials/administration & dosage*;Antimalarials/pharmacokinetics;Antimalarials/pharmacology;Biological Availability;Chemistry, Pharmaceutical/methods;Chloroquine/pharmacology;Disease Models, Animal;Drug Stability;Ethanolamines/administration & dosage*;Ethanolamines/pharmacokinetics;Ethanolamines/pharmacology;Fluorenes/administration & dosage*;Fluorenes/pharmacokinetics;Fluorenes/pharmacology;Food-Drug Interactions*;Malaria/drug therapy*;Male;Mice;Mice, Inbred C57BL;Solubility;Technology, Pharmaceutical/methods
26467069;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics;Anticholesteremic Agents/therapeutic use;Biological Availability;Flavonoids/administration & dosage*;Flavonoids/adverse effects;Flavonoids/pharmacology;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypercholesterolemia/diet therapy;Hypercholesterolemia/drug therapy*
26457956;Adolescent;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Child;Child, Preschool;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infant;Maintenance Chemotherapy;Male;Medication Adherence*;Mercaptopurine/administration & dosage*;Mercaptopurine/adverse effects;Mercaptopurine/pharmacokinetics;Methotrexate/administration & dosage*;Methotrexate/adverse effects;Methotrexate/pharmacokinetics;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*;Risk Factors;Surveys and Questionnaires
26446005;Adolescent;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cross-Over Studies;Diet, High-Fat/methods;Dietary Fats/metabolism*;Fasting/metabolism;Food-Drug Interactions/physiology*;Healthy Volunteers;Histamine H1 Antagonists, Non-Sedating/metabolism*;Humans;Loratadine/analogs & derivatives*;Loratadine/metabolism;Male;Phenotype*;Prevalence;Young Adult
26407124;Beverages*;Citrus paradisi/chemistry*;Demography;Diet*;Food*;Food-Drug Interactions*;Healthy Volunteers*;Humans;Male;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency;Young Adult
26391972;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Liberation;Food-Drug Interactions*;Humans;Mesalamine/administration & dosage*;Mesalamine/chemistry;Mesalamine/pharmacokinetics;Solubility
26382728;Administration, Oral;Adolescent;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbon Isotopes;Citrus paradisi/chemistry*;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*;Healthy Volunteers;Humans;Injections, Intravenous;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Time Factors;Young Adult
26375734;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Biopharmaceutics/classification*;Case-Control Studies;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/chemistry;Diclofenac/metabolism*;Female;Food-Drug Interactions/physiology*;Gastrointestinal Contents/drug effects;Gastrointestinal Contents/enzymology;Gastrointestinal Transit/drug effects;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Male
26369919;Aged;Anticonvulsants/administration & dosage*;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Biological Availability;Child;Delayed-Action Preparations;Drug Administration Schedule;Epilepsy/drug therapy*;Food-Drug Interactions;Humans;Medication Adherence*;Neuralgia, Postherpetic/drug therapy;Restless Legs Syndrome/drug therapy
26355866;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355864;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355863;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355003;Animals;Appetite Regulation/drug effects*;Appetite Stimulants/administration & dosage;Appetite Stimulants/pharmacology*;Chickens;Crosses, Genetic;Dietary Carbohydrates/administration & dosage;Dietary Proteins/administration & dosage*;Dose-Response Relationship, Drug;Energy Intake/drug effects;Food Preferences;Food-Drug Interactions*;Gene Expression Regulation, Developmental/drug effects*;Hypothalamus/drug effects*;Hypothalamus/growth & development;Hypothalamus/metabolism;Injections, Intraventricular;Neurons/drug effects;Neurons/metabolism;Neuropeptide Y/agonists;Neuropeptide Y/genetics;Neuropeptide Y/metabolism;Prolactin-Releasing Hormone/administration & dosage;Prolactin-Releasing Hormone/pharmacology*;Random Allocation;Rats;Weight Gain/drug effects
26352940;Acetaminophen/pharmacokinetics*;Adolescent;Adult;Cross-Over Studies;Female;Food-Drug Interactions;Gastric Emptying/physiology*;Humans;Male;Postprandial Period;Young Adult
26352868;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Medication Adherence;Thromboembolism/prevention & control*
26346860;Anticoagulants/adverse effects*;Databases, Bibliographic;Eating*;Food-Drug Interactions*;Humans;Recommended Dietary Allowances*;Soy Foods/adverse effects;Vegetables;Vitamin K/administration & dosage*;Vitamin K/adverse effects*;Warfarin/adverse effects*
26334219;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Area Under Curve;Benzamides;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/therapeutic use*;Pyrazines;Sulfonamides
26325166;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Capsules/metabolism;Capsules/pharmacokinetics;Cross-Over Studies;Eating;Fasting;Female;Food/adverse effects*;Food-Drug Interactions*;Healthy Volunteers;Humans;Indoles/metabolism*;Indoles/pharmacokinetics*;Pyrroles/metabolism*;Pyrroles/pharmacokinetics*;Young Adult
26304780;Antioxidants;Dietary Supplements;Digestion/drug effects;Food, Fortified*;Food-Drug Interactions;Gastrointestinal Tract/metabolism;Humans;Light;Nutritive Value/drug effects*;Onions/chemistry*;Phaseolus/metabolism*;Phenols/administration & dosage*;Plant Extracts/chemistry*
26294172;Administration, Oral;Area Under Curve;Asian Continental Ancestry Group;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food/adverse effects*;Food-Drug Interactions;Half-Life;Healthy Volunteers;Humans;Male;Tablets/administration & dosage;Tablets/pharmacokinetics;Triazoles/administration & dosage*;Triazoles/pharmacokinetics*
26293519;Adolescent;Adult;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/pharmacokinetics*;Biological Availability;Energy Intake;Fasting;Food;Food-Drug Interactions*;Humans;Male;Quinolines/pharmacokinetics*;Young Adult
26293237;Acetamides/administration & dosage*;Acetates/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*
26293236;Acetamides/administration & dosage*;Acetates/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*
26288994;Antifungal Agents/chemistry*;Biological Availability;Carbohydrates/chemistry;Drug Liberation*;Fats/chemistry;Food-Drug Interactions*;Hydrogen-Ion Concentration;Ketoconazole/chemistry*;Models, Biological*;Proteins/chemistry;Solubility
26283447;Administration, Oral;Animal Feed/analysis;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dogs;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions*;Half-Life;Male;Minocycline/administration & dosage;Minocycline/blood;Minocycline/pharmacokinetics*
26276738;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Biological Availability;Cytostatic Agents;Eating;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic
26272586;Administration, Oral;Adult;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Receptor Protein-Tyrosine Kinases/antagonists & inhibitors;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics*;Young Adult
26264792;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26264233;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Drug Monitoring;Food-Drug Interactions;Graft Rejection/immunology;Graft Rejection/prevention & control;Graft Survival/drug effects;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/chemistry;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation*/adverse effects;Medication Adherence;Practice Guidelines as Topic;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects;Tacrolimus/chemistry;Tacrolimus/pharmacokinetics;Time Factors;Treatment Outcome
26242220;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Chemistry, Pharmaceutical;Cross-Over Studies;Diet, High-Fat/adverse effects;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Neoplasm Metastasis/drug therapy;Neoplasms/blood;Neoplasms/drug therapy*;Phthalazines/adverse effects;Phthalazines/chemistry;Phthalazines/pharmacokinetics*;Phthalazines/therapeutic use;Piperazines/adverse effects;Piperazines/chemistry;Piperazines/pharmacokinetics*;Piperazines/therapeutic use;Poly(ADP-ribose) Polymerase Inhibitors/adverse effects;Poly(ADP-ribose) Polymerase Inhibitors/chemistry;Poly(ADP-ribose) Polymerase Inhibitors/pharmacokinetics*;Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use;Tablets
26234524;Administration, Oral;Animals;Dipeptidyl Peptidase 4/genetics;Dipeptidyl Peptidase 4/metabolism*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use*;Dose-Response Relationship, Drug;Drug Therapy, Combination;Food-Drug Interactions;Glucagon-Like Peptide 1/agonists*;Glucagon-Like Peptide 1/blood;Glucose Intolerance/blood;Glucose Intolerance/drug therapy*;Glucose Intolerance/metabolism;Injections, Intraperitoneal;Insulin/agonists;Insulin/blood;Insulin/secretion;Insulin-Secreting Cells/drug effects;Insulin-Secreting Cells/secretion;Male;Mice, Inbred C57BL;Piperazines/administration & dosage;Piperazines/therapeutic use;Piperidines/administration & dosage;Piperidines/therapeutic use;Pyridines/administration & dosage;Pyridines/therapeutic use;Receptor, Serotonin, 5-HT1B/chemistry;Receptor, Serotonin, 5-HT1B/metabolism*;Serotonin 5-HT1 Receptor Agonists/administration & dosage;Serotonin 5-HT1 Receptor Agonists/therapeutic use*;Up-Regulation/drug effects*;Uracil/administration & dosage;Uracil/analogs & derivatives;Uracil/therapeutic use
26215636;Animals;Biological Availability;Computational Biology;Cross-Over Studies;Drug Compounding;Drug Liberation;Excipients/chemistry;Expert Systems;Fenofibrate/blood;Fenofibrate/chemistry;Fenofibrate/metabolism;Fenofibrate/pharmacokinetics*;Food-Drug Interactions;Hypolipidemic Agents/blood;Hypolipidemic Agents/chemistry;Hypolipidemic Agents/metabolism;Hypolipidemic Agents/pharmacokinetics*;Intestinal Absorption;Male;Olive Oil/chemistry*;Pharmaceutical Vehicles/chemistry*;Polyethylene Glycols/chemistry*;Polysorbates/chemistry*;Povidone/chemistry*;Random Allocation;Solubility;Surface-Active Agents/chemistry*;Sus scrofa
26213156;Adult;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Area Under Curve;Beverages*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Stereoisomerism;Terfenadine/analogs & derivatives*;Terfenadine/chemistry;Terfenadine/pharmacokinetics;Young Adult
26210682;Adult;Aged;Aged, 80 and over;Biological Availability;Drug Administration Schedule;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Imidazolines/administration & dosage;Imidazolines/pharmacokinetics;Imidazolines/pharmacology*;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Postprandial Period;Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors*;Young Adult
26181186;Academic Medical Centers;Animals;Antineoplastic Agents/pharmacology*;Biomarkers/blood;Camptothecin/analogs & derivatives;Camptothecin/pharmacology;Cell Line, Tumor;Cisplatin/pharmacology;Dietary Supplements*;Dose-Response Relationship, Drug;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fish Oils/pharmacokinetics;Fishes*;Food-Drug Interactions*;Health Care Surveys;Humans;Mice, Inbred BALB C;Neoplasms/blood;Neoplasms/drug therapy*;Neoplasms/pathology;Netherlands;Organoplatinum Compounds/pharmacology;Seafood*;Surveys and Questionnaires;Tumor Burden;Up-Regulation
26179237;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats;Drug Antagonism*;Energy Intake;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacokinetics;Quinazolinones/administration & dosage;Quinazolinones/pharmacokinetics*;Rabeprazole/administration & dosage;Rabeprazole/pharmacokinetics*;Young Adult
26149619;Animals;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/toxicity;Capsules;Chemistry, Pharmaceutical;Excipients;Food-Drug Interactions;Humans;Intestinal Absorption;Nifedipine/administration & dosage*;Nifedipine/pharmacokinetics;Nifedipine/toxicity;Solubility;Tablets
26140311;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26138369;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26135230;Administration, Oral;Area Under Curve;Biological Availability;Capsules/administration & dosage*;Capsules/chemistry*;Capsules/metabolism;Chemistry, Pharmaceutical/methods;Cross-Over Studies;Eating/physiology;Food;Food-Drug Interactions;Humans;Piperazines/administration & dosage*;Piperazines/chemistry*;Piperazines/metabolism;Thiazoles/administration & dosage*;Thiazoles/chemistry*;Thiazoles/metabolism
26133712;Administration, Oral;Amiodarone/administration & dosage;Amiodarone/analogs & derivatives*;Amiodarone/blood;Amiodarone/chemistry;Amiodarone/pharmacokinetics;Animals;Anti-Arrhythmia Agents/administration & dosage*;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics*;Castor Oil/analogs & derivatives;Castor Oil/chemistry;Dogs;Drug Delivery Systems*;Emulsions;Food-Drug Interactions*;Glycerides/chemistry;Glycerol/analogs & derivatives;Glycerol/chemistry;Intestinal Absorption;Male;Polyethylene Glycols/chemistry;Polysorbates/chemistry;Surface-Active Agents/chemistry
26119520;Animals;Binding, Competitive;Brain/drug effects*;Brain/metabolism;Dietary Supplements/adverse effects*;Dietary Supplements/classification;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions*;Humans;Kinetics;Male;Muscarinic Antagonists/adverse effects*;Muscarinic Antagonists/classification;Muscarinic Antagonists/metabolism;Protein Binding;Radioimmunoassay;Rats, Inbred WKY;Receptors, Muscarinic/drug effects*;Receptors, Muscarinic/metabolism;Risk Assessment;Risk Factors
26101174;4-Aminopyridine/adverse effects;4-Aminopyridine/analogs & derivatives*;4-Aminopyridine/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Eating/physiology*;Fasting/metabolism;Female;Food-Drug Interactions/physiology*;Half-Life;Healthy Volunteers;Humans;Male;Middle Aged;Phosphates/pharmacokinetics;Therapeutic Equivalency;Young Adult
26096139;Abiraterone Acetate/adverse effects;Abiraterone Acetate/blood;Abiraterone Acetate/pharmacokinetics*;Adult;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/blood;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Dietary Fats/pharmacology*;Drug Therapy, Combination;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Prednisone/adverse effects;Prostatic Neoplasms, Castration-Resistant/blood;Prostatic Neoplasms, Castration-Resistant/metabolism*
26095990;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Humans;Organic Anion Transporters/antagonists & inhibitors*;Tea*/adverse effects
26056407;Attitude of Health Personnel;Attitude to Computers;Computer Simulation*;Computer-Assisted Instruction/methods*;Counseling*;Curriculum;Education, Pharmacy/methods*;Food-Drug Interactions;Health Knowledge, Attitudes, Practice;Humans;Medication Adherence*;Professional-Patient Relations*;Students, Pharmacy/psychology*;Surveys and Questionnaires;Teaching/methods*
26048185;Adult;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood*;Benzhydryl Compounds/therapeutic use;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions/physiology*;Glucosides/administration & dosage;Glucosides/adverse effects;Glucosides/blood*;Glucosides/therapeutic use;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood*;Hypoglycemic Agents/therapeutic use;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/blood*;Metformin/therapeutic use;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
26048134;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Cross-Over Studies;Female;Food-Drug Interactions*;Gastrointestinal Absorption;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Phthalazines/pharmacokinetics*;Phthalazines/therapeutic use;Piperazines/pharmacokinetics*;Piperazines/therapeutic use
26047551;Antioxidants/chemistry;Antioxidants/pharmacology*;Bone Marrow Transplantation*;Catechin/analogs & derivatives*;Catechin/chemistry;Catechin/pharmacology;Food-Drug Interactions;Humans;Tea/chemistry*;Uric Acid/blood
26028419;Antacids;Drug Liberation*;Food Additives/adverse effects*;Food-Drug Interactions*;Immersion;Laxatives;Magnesium Oxide/chemistry*;Polysaccharides, Bacterial/adverse effects*;Solubility;Tablets;Time Factors
26026989;Animals;Antitussive Agents/pharmacokinetics*;Food-Drug Interactions;Humans;Intestines/metabolism*;Liver/metabolism*;Male;Mice;Noscapine/pharmacokinetics*
26022074;Animals;Antidepressive Agents/administration & dosage;Antidepressive Agents/therapeutic use*;Behavior, Animal/drug effects;CA1 Region, Hippocampal/drug effects;CA1 Region, Hippocampal/metabolism;CA1 Region, Hippocampal/pathology;Combined Modality Therapy;Depression/blood;Depression/metabolism;Depression/pathology;Depression/prevention & control*;Dietary Supplements*;Disease Models, Animal*;Estradiol/administration & dosage;Estradiol/analogs & derivatives*;Estradiol/therapeutic use;Estrogen Replacement Therapy;Estrogens/administration & dosage;Estrogens/blood;Estrogens/therapeutic use*;Fatty Acids, Omega-3/administration & dosage;Fatty Acids, Omega-3/therapeutic use*;Female;Food-Drug Interactions;Injections, Subcutaneous;Nerve Tissue Proteins/agonists;Nerve Tissue Proteins/antagonists & inhibitors;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism;Ovariectomy/adverse effects;Random Allocation;Rats, Wistar;Serotonergic Neurons/drug effects;Serotonergic Neurons/metabolism;Serotonergic Neurons/pathology;Serotonin/blood
26011141;Administration, Oral;Adult;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenytoin/administration & dosage;Phenytoin/analogs & derivatives*;Phenytoin/pharmacokinetics
26006702;Adult;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions*;Gonanes/blood;Gonanes/pharmacokinetics*;Humans;Intestinal Absorption;Molecular Structure;Young Adult
26004270;Animals;Antiviral Agents/pharmacokinetics;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Genotype;Hepacivirus/drug effects;Hepacivirus/genetics;Hepatitis C/drug therapy*;Hepatitis C/virology;Humans;Oligopeptides/pharmacokinetics;Oligopeptides/pharmacology;Oligopeptides/therapeutic use*
25995169;Administration, Oral;Adult;Age Factors;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Asian Continental Ancestry Group/genetics*;China/epidemiology;Cross-Over Studies;Crown Ethers/administration & dosage;Crown Ethers/blood;Crown Ethers/pharmacokinetics*;Cytochrome P-450 CYP2C19/genetics*;Cytochrome P-450 CYP2C19/metabolism;Food-Drug Interactions*;Gastrointestinal Absorption*;Healthy Volunteers;Humans;Models, Biological*;Nonlinear Dynamics*;Pharmacogenetics;Polymorphism, Genetic*;Protein Binding;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Quinazolines/administration & dosage;Quinazolines/blood;Quinazolines/pharmacokinetics*;Serum Albumin/metabolism;Serum Albumin, Human;Young Adult
25994853;Adult;Aged;Carcinoma, Non-Small-Cell Lung/drug therapy;Carcinoma, Non-Small-Cell Lung/metabolism*;Cohort Studies;Cross-Over Studies;Erlotinib Hydrochloride;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Lung Neoplasms/drug therapy;Lung Neoplasms/metabolism*;Male;Middle Aged;Postprandial Period*;Protein Kinase Inhibitors/pharmacokinetics*;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
25975016;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/chemistry;Food*;Food-Drug Interactions;Humans;Isoenzymes/metabolism;Liver/drug effects;Liver/enzymology*;Pyrazoles/metabolism*;Pyrimidines/metabolism*
25963981;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Antimalarials/therapeutic use;Area Under Curve;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Artemisinins/therapeutic use;Biological Availability;Dietary Fats;Drug Combinations;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Infant, Newborn;Malaria, Falciparum/drug therapy;Malaria, Falciparum/metabolism;Models, Statistical;Papua New Guinea/epidemiology;Pregnancy;Pregnancy Outcome;Pyrimethamine/adverse effects*;Pyrimethamine/pharmacokinetics*;Pyrimethamine/therapeutic use;Quinolines/adverse effects*;Quinolines/pharmacokinetics*;Quinolines/therapeutic use;Sulfadoxine/adverse effects*;Sulfadoxine/pharmacokinetics*;Sulfadoxine/therapeutic use;Young Adult
25963481;Acetates/administration & dosage*;Acetates/blood*;Administration, Oral;Adolescent;Adult;Aminopyridines/administration & dosage*;Aminopyridines/blood*;Biological Availability;Diacylglycerol O-Acyltransferase/antagonists & inhibitors*;Diacylglycerol O-Acyltransferase/blood*;Diet, High-Fat/methods;Dietary Fats/blood*;Dose-Response Relationship, Drug;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Middle Aged;Young Adult
25947916;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Antioxidants/adverse effects;Antioxidants/pharmacology;Apoptosis/drug effects;Apoptosis Regulatory Proteins/metabolism;Breast Neoplasms/drug therapy*;Breast Neoplasms/metabolism;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Dose-Response Relationship, Drug;Doxorubicin/pharmacology*;Doxorubicin/therapeutic use;Female;Food-Drug Interactions;Humans;Luteolin/adverse effects*;Luteolin/pharmacology;MCF-7 Cells;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Proto-Oncogene Proteins c-bcl-2/metabolism;Reactive Oxygen Species/metabolism;Receptors, Estrogen/metabolism;Vegetables/chemistry
25933598;Animals;Area Under Curve;Computer Simulation*;Dogs;Fasting;Food-Drug Interactions*;Humans;Male;Models, Biological*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Solubility;Species Specificity
25917876;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Biotransformation;Dose-Response Relationship, Drug;Drug Administration Schedule;Food-Drug Interactions;Humans;Male;Middle Aged;Phenylthiohydantoin/administration & dosage;Phenylthiohydantoin/analogs & derivatives*;Phenylthiohydantoin/blood;Phenylthiohydantoin/pharmacokinetics;Prostatic Neoplasms, Castration-Resistant/blood;Prostatic Neoplasms, Castration-Resistant/drug therapy*;Prostatic Neoplasms, Castration-Resistant/metabolism
25894658;Adult;Communication*;Dietary Supplements/adverse effects*;Female;Food-Drug Interactions*;Humans;Internet;Japan;Male;Middle Aged;Physicians*;Self Medication/adverse effects*;Surveys and Questionnaires;Trace Elements/administration & dosage;Vitamins/administration & dosage;Young Adult
25894564;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/chemistry;Blood Platelets/drug effects;Blood Platelets/metabolism;Cells, Cultured;Colony-Forming Units Assay;Dietary Supplements;Drug Evaluation, Preclinical;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/chemistry;Food-Drug Interactions;Hematopoiesis/drug effects*;Humans;Leukocytes, Mononuclear/cytology;Leukocytes, Mononuclear/drug effects;Leukocytes, Mononuclear/metabolism;Leukocytes, Mononuclear/pathology;Macaca fascicularis;Male;Megakaryocytes/cytology;Megakaryocytes/drug effects*;Megakaryocytes/metabolism;Megakaryocytes/pathology;Mice;Molecular Structure;Niacin/metabolism*;Niacin/therapeutic use;Nicotinamide Phosphoribosyltransferase/antagonists & inhibitors*;Nicotinamide Phosphoribosyltransferase/genetics;Nicotinamide Phosphoribosyltransferase/metabolism;Pentosyltransferases/genetics;Pentosyltransferases/metabolism;Rats, Sprague-Dawley;Thrombocytopenia/chemically induced*;Thrombocytopenia/metabolism;Thrombocytopenia/prevention & control
25893430;Administration, Oral;Animals;Antineoplastic Agents, Hormonal/administration & dosage*;Antineoplastic Agents, Hormonal/pharmacokinetics;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Dogs;Emulsions;Food-Drug Interactions*;Male;Megestrol Acetate/administration & dosage*;Megestrol Acetate/chemistry;Megestrol Acetate/pharmacokinetics;Nanoparticles*;Random Allocation;Solubility;Tandem Mass Spectrometry
25880707;Adult;Blood Coagulation Tests;Drug Monitoring/methods;Factor Xa Inhibitors/blood;Factor Xa Inhibitors/pharmacokinetics*;Food-Drug Interactions*;Humans;Job Description;Male;Meals*;Medication Adherence;Personnel Staffing and Scheduling;Predictive Value of Tests;Pulmonary Embolism/blood;Pulmonary Embolism/diagnosis;Pulmonary Embolism/drug therapy*;Recurrence;Risk Factors;Rivaroxaban/blood;Rivaroxaban/pharmacokinetics*;Venous Thromboembolism/blood;Venous Thromboembolism/diagnosis;Venous Thromboembolism/drug therapy*;Venous Thrombosis/blood;Venous Thrombosis/diagnosis;Venous Thrombosis/drug therapy*
25850750;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/pharmacokinetics;Acetates/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/adverse effects;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*;Young Adult
25828628;Adult;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Anticoagulants/blood;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Diet/adverse effects;Drug Monitoring;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/therapeutic use;Female;Food-Drug Interactions*;Hematuria/chemically induced;Humans;International Normalized Ratio;Male;Middle Aged;Nutritional Status/drug effects*;Republic of Korea;Retrospective Studies;Vitamin K/adverse effects;Vitamin K/antagonists & inhibitors*;Vitamin K/blood;Vitamin K/therapeutic use;Vitamin K Deficiency/chemically induced*;Vitamin K Deficiency/prevention & control;Vitamin K Epoxide Reductases/antagonists & inhibitors;Vitamin K Epoxide Reductases/metabolism;Warfarin/adverse effects*;Warfarin/blood;Warfarin/pharmacokinetics;Warfarin/therapeutic use
25812749;Acetaldehyde Dehydrogenase Inhibitors/adverse effects*;Adult;Antitrichomonal Agents/adverse effects*;Disulfiram/adverse effects*;Food-Drug Interactions*;Humans;Male;Ornidazole/adverse effects*;Wine*
25807927;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects*;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Delayed-Action Preparations;Drug Therapy, Combination;Food-Drug Interactions;Glucuronates/blood;Glucuronates/metabolism;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects*;Hydromorphone/analogs & derivatives;Hydromorphone/blood;Hydromorphone/metabolism;Hydromorphone/pharmacokinetics*;Male;Middle Aged;Young Adult
25792182;Food-Drug Interactions*;Humans
25791157;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Cyclooxygenase Inhibitors/adverse effects;Dietary Fiber/adverse effects;Dietary Fiber/therapeutic use;Dinoprostone/therapeutic use;Enterobacteriaceae;Food-Drug Interactions;Gastrointestinal Motility/drug effects;Intestinal Diseases/chemically induced*;Intestinal Diseases/pathology;Intestinal Diseases/prevention & control;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Intestine, Small/drug effects*;Intestine, Small/microbiology;Intestine, Small/pathology;Mice;Nitric Oxide/metabolism;Nitric Oxide Synthase/metabolism;Pre-Exposure Prophylaxis/methods;Prostaglandins/biosynthesis;Proton Pump Inhibitors/adverse effects;Rats
25784216;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/administration & dosage;Aspirin/pharmacokinetics*;Biological Availability;Dipyrone/administration & dosage;Dipyrone/pharmacokinetics*;Drug Liberation;Food-Drug Interactions*;Humans
25769525;Administration, Oral;Colon/physiology*;Fasting/physiology*;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit;Humans;Intestine, Small/physiology*;Tablets/pharmacokinetics*
25762793;Antitubercular Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Rifampin/pharmacokinetics*;Tuberculosis, Pulmonary/drug therapy*
25762792;Antitubercular Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Rifampin/pharmacokinetics*;Tuberculosis, Pulmonary/drug therapy*
25748293;Administration, Oral;Adult;Aged;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Chromatography, Liquid;Diphosphonates/administration & dosage;Diphosphonates/adverse effects;Diphosphonates/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Middle Aged;Tablets;Tandem Mass Spectrometry/methods;Young Adult
25747454;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Administration, Oral;Adult;Biotransformation;Chemistry, Pharmaceutical;Cross-Over Studies;Drug Stability;Duodenum/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Intestinal Absorption*;Intestinal Secretions/metabolism;Male;Phosphorous Acids/administration & dosage;Phosphorous Acids/blood;Phosphorous Acids/pharmacokinetics*;Postprandial Period;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Technology, Pharmaceutical;Young Adult
25744000;Animals;Bone Density/drug effects;Bone Density Conservation Agents/pharmacology;Bone Density Conservation Agents/therapeutic use*;Bone Resorption/metabolism;Bone Resorption/pathology;Bone Resorption/prevention & control*;Bone and Bones/drug effects;Bone and Bones/metabolism;Bone and Bones/pathology;Calcium Channels/genetics;Calcium Channels/metabolism;Calcium, Dietary/metabolism;Calcium, Dietary/therapeutic use*;Cell Proliferation/drug effects;Cells, Cultured;Combined Modality Therapy;Food-Drug Interactions*;Male;Mice, Inbred C57BL;Osteoblasts/drug effects*;Osteoblasts/metabolism;Osteoblasts/pathology;Osteogenesis/drug effects*;Parathyroid Hormone/analogs & derivatives*;Parathyroid Hormone/pharmacology;Parathyroid Hormone/therapeutic use*;Peptide Fragments/pharmacology;Peptide Fragments/therapeutic use;Receptors, Calcium-Sensing/agonists;Receptors, Calcium-Sensing/genetics;Receptors, Calcium-Sensing/metabolism;Receptors, Parathyroid Hormone/agonists;Receptors, Parathyroid Hormone/genetics;Receptors, Parathyroid Hormone/metabolism;TRPV Cation Channels/agonists;TRPV Cation Channels/genetics;TRPV Cation Channels/metabolism;Up-Regulation/drug effects
25724156;Administration, Oral;Adult;Aged;Aged, 80 and over;Case-Control Studies;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/blood;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism*;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*
27140799;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/adverse effects;1-Deoxynojirimycin/analogs & derivatives*;1-Deoxynojirimycin/blood;1-Deoxynojirimycin/pharmacokinetics;Administration, Oral;Adolescent;Adult;Aged;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Administration Schedule;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Meals*;Metabolic Clearance Rate;Middle Aged;Pharmaceutical Solutions;Postprandial Period;Texas;Therapeutic Equivalency;Young Adult
25720525;Adult;Area Under Curve;Beverages/adverse effects;Citrus paradisi/adverse effects;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions;Fruit and Vegetable Juices/adverse effects*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Punicaceae/adverse effects*;Simvastatin/pharmacokinetics*;Young Adult
25712830;Administration, Oral;Animals;Biopharmaceutics/classification;Computer Simulation;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Intestinal Absorption;Mouth Mucosa/metabolism*
25694412;Drug Administration Schedule;Food-Drug Interactions;Humans;Hypothyroidism/drug therapy*;Quality of Life;Thyroxine/administration & dosage*;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use
25673087;Administration, Oral;Adult;Amidines/administration & dosage*;Amidines/blood;Amidines/pharmacokinetics*;Amidines/urine;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Antithrombins/blood;Antithrombins/pharmacokinetics*;Antithrombins/urine;Biomarkers, Pharmacological/blood;Biomarkers, Pharmacological/urine;Blood Coagulation/drug effects*;Cross-Over Studies;Dipeptides/administration & dosage*;Dipeptides/blood;Dipeptides/pharmacokinetics*;Dipeptides/urine;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology*;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
25668218;Animals;Computational Biology/methods*;Databases, Factual;Diet;Disease;Food-Drug Interactions*;Gene Expression Profiling;Humans;Mice;Models, Molecular*;Phytochemicals*
25658756;Administration, Oral;Age Factors;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Blood Coagulation/drug effects;Food-Drug Interactions;Hemorrhage/drug therapy;Humans;Liver Diseases/metabolism;Platelet Aggregation Inhibitors/adverse effects;Renal Insufficiency, Chronic/metabolism;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use
25656645;Binding Sites;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Models, Molecular;Nifedipine/pharmacology*;Rutin/pharmacology*;Serum Albumin/chemistry*;Thermodynamics
25648347;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Area Under Curve;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Capsules;Cross-Over Studies;Disease-Free Survival;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Protein-Tyrosine Kinases/antagonists & inhibitors;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Quinolones/therapeutic use;Tablets
25636978;Beverages;Dietary Supplements;Food-Drug Interactions*;Fruit;Humans;Internal Medicine*;Intestines/metabolism;Vegetables;Vitamins
25633078;Biological Availability;Biotransformation;Digestion/physiology*;Flavonoids/chemistry*;Flavonoids/metabolism;Flavonoids/pharmacokinetics*;Flavonoids/pharmacology;Food-Drug Interactions*;Gastrointestinal Absorption;Gastrointestinal Tract/metabolism*;Humans;Hydroxylation;Molecular Structure;Structure-Activity Relationship;Tissue Distribution
25615879;Administration, Oral;Animals;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/analysis;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics;Calcium Compounds/chemistry*;Chemical Phenomena;Chemistry, Pharmaceutical;Drug Carriers/administration & dosage*;Drug Carriers/analysis;Drug Carriers/chemistry;Drug Carriers/pharmacokinetics;Drug Liberation;Drug Stability;Drug Storage;Emulsions;Food-Drug Interactions*;Intestinal Absorption;Male;Nifedipine/administration & dosage*;Nifedipine/analysis;Nifedipine/chemistry;Nifedipine/pharmacokinetics;Particle Size;Porosity;Powders;Rats, Wistar;Silicates/chemistry*;Silicon Dioxide/chemistry*;Surface Properties
25609481;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions/physiology;Gastrointestinal Absorption/physiology;Humans;Hydrogen-Ion Concentration;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/pharmacokinetics
25573904;Administration, Oral;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Fasting;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Infant Formula/administration & dosage*;Male;Middle Aged;Powders;Ritonavir/blood;Ritonavir/pharmacokinetics*;Solutions;Therapeutic Equivalency;Water
25557052;Activation, Metabolic/drug effects;Beverages/adverse effects*;Blood Platelets/drug effects;Citrus paradisi/adverse effects*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/metabolism;Platelet Aggregation Inhibitors/pharmacokinetics;Platelet Aggregation Inhibitors/pharmacology;Prasugrel Hydrochloride/blood;Prasugrel Hydrochloride/metabolism;Prasugrel Hydrochloride/pharmacokinetics*;Prasugrel Hydrochloride/pharmacology;Prodrugs/metabolism*;Prodrugs/pharmacokinetics;Young Adult
25552402;Administration, Sublingual;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Healthy Volunteers;Heterocyclic Compounds, 4 or More Rings/administration & dosage;Heterocyclic Compounds, 4 or More Rings/blood;Heterocyclic Compounds, 4 or More Rings/pharmacokinetics*;Humans;Male;Middle Aged;Models, Biological;Young Adult
25549790;Animals;Biological Availability;Carbamates/chemistry*;Carbamates/pharmacokinetics;Food-Drug Interactions*;Hypoglycemic Agents/chemistry*;Hypoglycemic Agents/pharmacokinetics;Male;Nanoparticles*;Piperidines/chemistry*;Piperidines/pharmacokinetics;Rats;Rats, Wistar
25547640;Acetaminophen/pharmacokinetics*;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carbamazepine/pharmacokinetics;Citrus paradisi/adverse effects*;Diclofenac/pharmacokinetics;Eating;Food-Drug Interactions*;Male;Rats;Rats, Sprague-Dawley
25546166;Administration, Oral;Adolescent;Adult;Area Under Curve;Canagliflozin;Cross-Over Studies;Drug Combinations;Fasting/blood;Female;Food-Drug Interactions*;Glucosides/administration & dosage*;Glucosides/adverse effects;Glucosides/blood;Glucosides/pharmacokinetics*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Metabolic Clearance Rate;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/blood;Metformin/pharmacokinetics*;Middle Aged;Postprandial Period;Tablets;Therapeutic Equivalency;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Young Adult
25546165;Administration, Oral;Adolescent;Adult;Area Under Curve;Biotransformation;Capsules;China;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting/blood;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Postprandial Period;Salicylates/administration & dosage;Salicylates/blood;Salicylates/pharmacokinetics*;Therapeutic Equivalency;Young Adult
25541407;Adipokines/blood;Adipose Tissue/drug effects;Adipose Tissue/metabolism;Animals;Biomarkers/blood;Blood Glucose/drug effects*;Blood Glucose/metabolism;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/etiology;Diabetes Mellitus, Type 2/genetics;Diabetes Mellitus, Type 2/prevention & control*;Dichlorodiphenyl Dichloroethylene/pharmacology*;Dichlorodiphenyl Dichloroethylene/toxicity;Diet, Fat-Restricted;Diet, High-Fat*;Disease Models, Animal;Dyslipidemias/blood;Dyslipidemias/etiology;Dyslipidemias/prevention & control*;Environmental Pollutants/pharmacology*;Environmental Pollutants/toxicity;Fatty Liver/blood;Fatty Liver/etiology;Fatty Liver/prevention & control;Food-Drug Interactions;Glucose Intolerance/blood;Glucose Intolerance/etiology;Glucose Intolerance/prevention & control;Glucose Transporter Type 4/genetics;Glucose Transporter Type 4/metabolism;Hyperinsulinism/blood;Hyperinsulinism/etiology;Hyperinsulinism/prevention & control;Insecticides/pharmacology*;Insecticides/toxicity;Insulin/blood;Insulin Resistance;Lipids/blood*;Liver/drug effects;Liver/metabolism;Male;Mice, Inbred C57BL;Muscle, Skeletal/drug effects;Muscle, Skeletal/metabolism;RNA, Messenger/metabolism;Time Factors
25525635;Drug Interactions;Food-Drug Interactions;Humans;Lactones/adverse effects;Lactones/pharmacokinetics;Lactones/pharmacology;Lactones/therapeutic use*;Platelet Aggregation Inhibitors/therapeutic use*;Pyridines/adverse effects;Pyridines/pharmacokinetics;Pyridines/pharmacology;Pyridines/therapeutic use*;Receptor, PAR-1/antagonists & inhibitors*;Thrombosis/prevention & control*
25511575;Androstenes/pharmacokinetics*;Antineoplastic Agents/pharmacokinetics*;Clinical Trials as Topic;Computer Simulation*;Food-Drug Interactions;Gastrointestinal Absorption;Humans;Metabolic Clearance Rate;Models, Biological;Pyrimidines/pharmacokinetics*;Randomized Controlled Trials as Topic/methods*;Sampling Studies
25510602;Animals;Bile Acids and Salts/analysis;Fasting/metabolism;Food-Drug Interactions*;Humans;Ileum/metabolism;In Vitro Techniques;Intestinal Absorption*;Intestinal Secretions/metabolism*;Male;Permeability;Pharmaceutical Preparations/metabolism*;Phospholipids/analysis;Postprandial Period/physiology;Rats, Wistar;Solvents
25499666;Adult;Analysis of Variance;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects*;Diclofenac/blood;Diclofenac/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Pennsylvania;Tablets;Young Adult
25486915;Administration, Oral;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use*;Dermatologic Surgical Procedures*;Dermatology;Dietary Supplements;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Platelet Aggregation Inhibitors/pharmacology*;Platelet Aggregation Inhibitors/therapeutic use*;Practice Guidelines as Topic;Risk Assessment
25486333;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Citrus paradisi;Cross-Over Studies;Dietary Supplements;Dosage Forms;Dose-Response Relationship, Drug;Female;Flavanones/administration & dosage*;Flavanones/pharmacology;Food-Drug Interactions;Humans;Male;Organic Anion Transporters/genetics;Polymorphism, Single Nucleotide;Propanolamines/blood;Propanolamines/pharmacokinetics*;Propanolamines/urine;Young Adult
25476894;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Carbamates/administration & dosage;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Antagonism;Famotidine/pharmacology;Female;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;raf Kinases/antagonists & inhibitors
25470100;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Organic Anion Transporters/antagonists & inhibitors*;Psychotropic Drugs/antagonists & inhibitors*
25466133;Amines/chemistry*;Biogenic Amines/analysis;Chromatography, High Pressure Liquid;Fermentation*;Food-Drug Interactions;Histamine/analysis;Monoamine Oxidase Inhibitors/administration & dosage;Phenethylamines/analysis;Risk Assessment;Soy Foods/analysis*;Spain;Tyramine/analysis
25449994;Administration, Oral;Adult;Area Under Curve;Calcium Carbonate/pharmacology*;Cross-Over Studies;Dietary Supplements*;Drug Antagonism;Fasting;Female;Ferrous Compounds/pharmacology*;Food-Drug Interactions;HIV Integrase Inhibitors/pharmacokinetics*;Half-Life;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate
25438724;Administration, Oral;Adult;Biological Availability;Capsules;Cognition/drug effects;Cross-Over Studies;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Nicotinic Agonists/administration & dosage;Nicotinic Agonists/adverse effects;Nicotinic Agonists/pharmacokinetics*;Quinuclidines/administration & dosage;Quinuclidines/adverse effects;Quinuclidines/pharmacokinetics*;Receptors, Nicotinic;Sex Factors;Therapeutic Equivalency;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/pharmacokinetics*
25418395;Depression/complications;Depression/diagnosis;Diagnosis, Differential;Dietary Proteins/administration & dosage;Energy Intake;Food-Drug Interactions;Gastrointestinal Diseases/diagnosis;Gastrointestinal Diseases/etiology;Humans;Inflammation/diagnosis;Inflammation/etiology;Micronutrients/administration & dosage;Micronutrients/deficiency;Protein-Energy Malnutrition/diagnosis*;Protein-Energy Malnutrition/etiology;Weight Loss
25418056;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/genetics;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors*;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/metabolism;Animals;Antineoplastic Agents/chemistry;Antineoplastic Agents/metabolism*;Antineoplastic Agents/pharmacology;Beverages/analysis;Biological Transport/drug effects;Cell Line;Coumarins/analysis;Coumarins/chemistry;Coumarins/pharmacology;Dasatinib;Dogs;Flavonoids/analysis;Flavonoids/chemistry;Flavonoids/pharmacology;Food-Drug Interactions;Fruit/chemistry;Humans;Madin Darby Canine Kidney Cells;Membrane Transport Modulators/analysis;Membrane Transport Modulators/chemistry;Membrane Transport Modulators/pharmacology*;Neoplasm Proteins/antagonists & inhibitors*;Neoplasm Proteins/genetics;Neoplasm Proteins/metabolism;Phytochemicals/analysis;Phytochemicals/chemistry;Phytochemicals/pharmacology*;Protein Kinase Inhibitors/chemistry;Protein Kinase Inhibitors/metabolism*;Protein Kinase Inhibitors/pharmacology;Protein-Tyrosine Kinases/antagonists & inhibitors;Protein-Tyrosine Kinases/metabolism;Pyrimidines/antagonists & inhibitors;Pyrimidines/metabolism*;Pyrimidines/pharmacology;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Sus scrofa;Thiazoles/antagonists & inhibitors;Thiazoles/metabolism*;Thiazoles/pharmacology
25417837;Administration, Oral;Animals;Animals, Inbred Strains;Beverages;Breakfast;Denmark;Dogs;Drug Evaluation, Preclinical/methods*;Drugs, Investigational/administration & dosage;Drugs, Investigational/chemistry;Drugs, Investigational/pharmacokinetics*;Energy Intake;Food-Drug Interactions*;Gastric Emptying/drug effects;Humans;Male;Models, Animal*;Oral Mucosal Absorption*;Solubility;Species Specificity;Swine;Swine, Miniature/physiology*
25417766;Acetaminophen/antagonists & inhibitors;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Acetaminophen/poisoning;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/chemistry;Analgesics, Non-Narcotic/pharmacokinetics*;Analgesics, Non-Narcotic/poisoning;Animals;Antipyretics/antagonists & inhibitors;Antipyretics/blood;Antipyretics/pharmacokinetics;Antipyretics/poisoning;Biological Availability;Biotransformation;Carbohydrate Conformation;Catalytic Domain;Chemical and Drug Induced Liver Injury/blood;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/prevention & control;Cytochrome P-450 CYP2E1/chemistry;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP2E1 Inhibitors/chemistry;Cytochrome P-450 CYP2E1 Inhibitors/metabolism;Cytochrome P-450 CYP2E1 Inhibitors/therapeutic use*;Databases, Protein;Dietary Supplements*;Female;Food-Drug Interactions*;Glucosamine/chemistry;Glucosamine/metabolism;Glucosamine/therapeutic use*;Humans;Ligands;Liver/drug effects;Liver/enzymology;Liver/metabolism*;Molecular Docking Simulation;Protein Conformation;Rats, Sprague-Dawley
25381051;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biological Availability;Cohort Studies;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Leukemia, Lymphocytic, Chronic, B-Cell/blood;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism;Lymphoma, Mantle-Cell/blood;Lymphoma, Mantle-Cell/drug therapy*;Lymphoma, Mantle-Cell/metabolism;Male;Middle Aged;Models, Biological*;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/therapeutic use;Protein-Tyrosine Kinases/antagonists & inhibitors*;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrazoles/therapeutic use;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use
25377158;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biotransformation;Dose-Response Relationship, Drug;Drugs, Investigational/administration & dosage;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Drugs, Investigational/therapeutic use;Female;Food-Drug Interactions;Half-Life;Humans;Hydroxylation;Intestinal Absorption;Male;Metabolic Clearance Rate;Methylation;Middle Aged;Models, Biological*;Neoplasms/blood;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Tablets
25365914;Administration, Oral;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*
25361167;Animals;Brazil;Cytochrome P-450 Enzyme Inhibitors/chemistry*;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme System/chemistry*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Kinetics;Male;Propolis/chemistry*;Propolis/metabolism;Rats;Rats, Wistar
27129123;Administration, Oral;Adolescent;Adult;Amlodipine, Valsartan Drug Combination/administration & dosage*;Amlodipine, Valsartan Drug Combination/adverse effects;Amlodipine, Valsartan Drug Combination/blood;Amlodipine, Valsartan Drug Combination/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/administration & dosage*;Angiotensin II Type 1 Receptor Blockers/adverse effects;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Combinations;Drug Monitoring;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Hydrochlorothiazide/administration & dosage*;Hydrochlorothiazide/adverse effects;Hydrochlorothiazide/blood;Hydrochlorothiazide/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Tablets;Young Adult
27129119;Adolescent;Adult;Aged;Antiviral Agents/administration & dosage*;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Boronic Acids/administration & dosage*;Boronic Acids/adverse effects;Boronic Acids/pharmacokinetics*;Double-Blind Method;Female;Food-Drug Interactions;Genotype;Hepacivirus/drug effects*;Hepacivirus/enzymology;Hepacivirus/genetics;Hepatitis C, Chronic/blood;Hepatitis C, Chronic/diagnosis;Hepatitis C, Chronic/drug therapy*;Hepatitis C, Chronic/genetics;Humans;Interleukins/genetics;Male;Middle Aged;Phenotype;Protease Inhibitors/administration & dosage*;Protease Inhibitors/adverse effects;Protease Inhibitors/pharmacokinetics;RNA, Viral/blood;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Treatment Outcome;United States;Viral Load;Viral Nonstructural Proteins/antagonists & inhibitors*;Viral Nonstructural Proteins/metabolism;Young Adult
25350242;Aged;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/therapeutic use;Biopsy;Celiac Disease/chemically induced*;Celiac Disease/diagnosis*;Celiac Disease/epidemiology*;Celiac Disease/pathology;Chronic Disease;Diagnosis, Differential;Diarrhea/chemically induced*;Diarrhea/epidemiology;Diarrhea/etiology*;Diarrhea/pathology;Female;Food-Drug Interactions;Humans;Ileum/drug effects;Ileum/pathology;Imidazoles/adverse effects*;Imidazoles/therapeutic use;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use
25344090;Abiraterone Acetate;Adult;Androstenes/administration & dosage;Androstenes/adverse effects;Androstenes/blood;Androstenes/pharmacokinetics*;Antineoplastic Agents, Hormonal/administration & dosage;Antineoplastic Agents, Hormonal/adverse effects;Antineoplastic Agents, Hormonal/blood;Antineoplastic Agents, Hormonal/pharmacokinetics*;Asian Americans;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors/administration & dosage;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/blood;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics*;Dose-Response Relationship, Drug;European Continental Ancestry Group;Food-Drug Interactions*/ethnology;Half-Life;Humans;Japan/ethnology;Male;Meals;Metabolic Clearance Rate;Middle Aged;Prostatic Neoplasms/drug therapy;Prostatic Neoplasms/ethnology;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors*;Tablets;United States;Young Adult
25337649;Animals;Anticonvulsants/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Intestinal Absorption;Membrane Transport Proteins/physiology*;Vigabatrin/pharmacokinetics*
25326286;Aldehyde Oxidase/antagonists & inhibitors*;Aldehyde Oxidase/metabolism*;Catechin/adverse effects;Catechin/analogs & derivatives;Catechin/metabolism;Cytochrome P-450 Enzyme System/metabolism;Diet/adverse effects*;Enzyme Inhibitors/metabolism;Food-Drug Interactions/physiology*;Guanine/analogs & derivatives;Guanine/metabolism;Humans;Ligands;Oxidation-Reduction;Quantitative Structure-Activity Relationship;Tea/adverse effects;Xenobiotics/metabolism
25312344;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Humans;Models, Biological*;Retrospective Studies;Therapeutic Equivalency
25288354;Chemistry, Pharmaceutical;Drug Stability;Enteral Nutrition/methods*;Food-Drug Interactions*;Gastrostomy/adverse effects;Gastrostomy/methods*;Humans;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/methods*;Prescription Drugs/administration & dosage*;Prescription Drugs/chemistry;Prescription Drugs/pharmacokinetics
25274605;Area Under Curve;Beverages;Citrus;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/blood;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics*;Drug Interactions*;Food-Drug Interactions;Humans;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Predictive Value of Tests;Regression Analysis;Substrate Specificity
25268237;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Biological Availability;Computer Simulation;Fasting/physiology;Felodipine/blood;Felodipine/pharmacokinetics*;Food-Drug Interactions/physiology*;Gastric Emptying/physiology;Gastrointestinal Tract/physiopathology;Gastrointestinal Transit/physiology;Humans;Intestinal Absorption/physiology;Intestines/physiology;Models, Statistical*;Postprandial Period/physiology;Precision Medicine;Solubility;User-Computer Interface*
25253884;Adult;Beverages*;Biomarkers/blood;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Female;Food-Drug Interactions/physiology*;Forecasting;Humans;Loperamide/administration & dosage;Loperamide/blood*;Male;Microsomes/drug effects;Microsomes/enzymology;Middle Aged;Prospective Studies;Substrate Specificity/drug effects;Substrate Specificity/physiology;Young Adult
25251944;Dietary Supplements/adverse effects*;Drug-Related Side Effects and Adverse Reactions*/epidemiology;Drug-Related Side Effects and Adverse Reactions*/etiology;Food-Drug Interactions;Humans;Plant Preparations/adverse effects*;Plants, Medicinal*/adverse effects;Plants, Medicinal*/classification
25238825;Drug Interactions*;Enteral Nutrition*;Food-Drug Interactions*;Humans
25231186;Adamantane/analogs & derivatives;Adamantane/pharmacology;Adolescent;Adult;Appetite Regulation/drug effects;Cross-Over Studies;Dietary Fats/metabolism*;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Double-Blind Method;Energy Intake/drug effects;Energy Metabolism/drug effects*;Food-Drug Interactions*;Gastric Inhibitory Polypeptide/agonists*;Gastric Inhibitory Polypeptide/blood;Gastric Inhibitory Polypeptide/secretion;Glucagon/blood;Glucagon/secretion;Glucagon-Like Peptide 1/agonists*;Glucagon-Like Peptide 1/blood;Glucagon-Like Peptide 1/secretion;Humans;Hyperglycemia/blood;Hyperglycemia/metabolism;Hyperglycemia/prevention & control*;Insulin/blood;Insulin/secretion;Male;Middle Aged;Nitriles/pharmacology;Peptide Fragments/blood;Peptide Fragments/secretion;Peptide YY/blood;Peptide YY/secretion;Postprandial Period;Pyrrolidines/pharmacology;Young Adult
25224876;Adult;Aged;Analgesics/pharmacokinetics*;Area Under Curve;Benzenesulfonates/pharmacokinetics*;Chromatography, High Pressure Liquid;Colonoscopy;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Least-Squares Analysis;Male;Middle Aged;Pain/drug therapy;Tandem Mass Spectrometry
25224007;Adolescent;Adult;Anti-HIV Agents/therapeutic use;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/therapeutic use;Area Under Curve;Comorbidity;Diabetes Mellitus/drug therapy;Diabetes Mellitus/epidemiology;Diabetes Mellitus/pathology;Dietary Fats/metabolism;Dietary Fats/pharmacokinetics*;Drug Administration Schedule;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/epidemiology;HIV Infections/pathology;Humans;Hypoglycemic Agents/therapeutic use;Isoniazid/pharmacokinetics*;Isoniazid/therapeutic use;Male;Middle Aged;Peru/epidemiology;Rifampin/pharmacokinetics*;Rifampin/therapeutic use;Sex Factors;Treatment Outcome;Tuberculosis, Pulmonary/drug therapy*;Tuberculosis, Pulmonary/epidemiology;Tuberculosis, Pulmonary/pathology
25213388;Adult;Child;Cyclosporine/adverse effects;Cyclosporine/pharmacokinetics;Cyclosporine/therapeutic use*;Dermatitis, Atopic/drug therapy;Disease Susceptibility;Drug Administration Schedule;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics;Immunosuppressive Agents/therapeutic use*;Infection/etiology;Kidney Diseases/chemically induced;Kidney Diseases/diagnosis;Neoplasms/etiology;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications/drug therapy;Pregnancy Complications/prevention & control;Psoriasis/drug therapy;Quality of Life;Skin Diseases/drug therapy*
25207548;Adult;Citrus paradisi*;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans;Male;Phenylpropionates/adverse effects;Phenylpropionates/pharmacokinetics*;Pyridazines/adverse effects;Pyridazines/pharmacokinetics*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
25204404;Adult;Aged;Aged, 80 and over;Androstenes/blood;Androstenes/pharmacokinetics*;Androstenes/therapeutic use;Antineoplastic Agents/therapeutic use;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Double-Blind Method;Fasting/metabolism;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Models, Biological*;Prostatic Neoplasms, Castration-Resistant/drug therapy;Prostatic Neoplasms, Castration-Resistant/metabolism*;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors;Taxoids/therapeutic use;Young Adult
25199774;Administration, Oral;Adult;Aged;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics;Antifungal Agents/therapeutic use*;Female;Food-Drug Interactions;Gastrointestinal Absorption;Humans;Leukemia/microbiology;Liver/pathology;Male;Middle Aged;Mycoses/complications;Mycoses/drug therapy*;Mycoses/prevention & control*;Suspensions/adverse effects;Tablets/adverse effects;Triazoles/adverse effects;Triazoles/pharmacokinetics;Triazoles/therapeutic use*
25193431;Administration, Oral;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Biological Availability;Capsules;Cross-Over Studies;Dietary Fats/adverse effects*;Female;Food Analysis/methods;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasm Staging;Neoplasms*/drug therapy;Neoplasms*/pathology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Therapeutic Equivalency;Treatment Outcome
25186833;Adolescent;Adult;Biological Availability;Clinical Trials, Phase I as Topic;Dose-Response Relationship, Drug;Factor Xa Inhibitors/administration & dosage;Factor Xa Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Models, Biological*;Nonlinear Dynamics;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Sex Factors;Thiazoles/administration & dosage;Thiazoles/pharmacokinetics*;Young Adult
25173560;Animals;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Catechin/analogs & derivatives*;Catechin/metabolism;Drug Synergism;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/metabolism;Tea/metabolism*
27129014;Adult;Area Under Curve;Belgium;Cross-Over Studies;Drug Compounding;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Metabolic Clearance Rate;Middle Aged;Models, Biological;Postprandial Period;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/adverse effects;Proton Pump Inhibitors/chemistry;Proton Pump Inhibitors/pharmacokinetics*;Rabeprazole/administration & dosage*;Rabeprazole/adverse effects;Rabeprazole/chemistry;Rabeprazole/pharmacokinetics*;Tablets;Therapeutic Equivalency;United States;Young Adult
27129006;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Darunavir/administration & dosage*;Darunavir/adverse effects;Darunavir/blood;Darunavir/pharmacokinetics*;Fasting/blood;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Netherlands;Pharmaceutical Solutions;Postprandial Period;Ritonavir/administration & dosage*;Tablets;Young Adult
25170252;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Analgesics/administration & dosage;Analgesics/pharmacokinetics;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxycodone/administration & dosage;Oxycodone/pharmacokinetics*;Tablets;Young Adult
25165009;Administration, Oral;Animals;Area Under Curve;Biological Availability;Chromatography, Reverse-Phase/methods;Drug Stability;Fasting/blood;Female;Food-Drug Interactions*;Ginkgo biloba*/chemistry;Ginkgolides/administration & dosage*;Ginkgolides/blood;Ginkgolides/isolation & purification;Ginkgolides/pharmacokinetics*;Half-Life;Lactones/administration & dosage*;Lactones/blood;Lactones/isolation & purification;Lactones/pharmacokinetics*;Male;Plant Extracts/administration & dosage*;Plant Extracts/blood;Plant Extracts/isolation & purification;Plant Extracts/pharmacokinetics*;Postprandial Period;Rats, Sprague-Dawley;Reproducibility of Results;Sex Factors;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry
25148900;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Hyperkalemia/chemically induced;Hypotension/chemically induced;Kidney Function Tests;Renal Insufficiency/chemically induced;Renal Insufficiency, Chronic/drug therapy*;Renal Insufficiency, Chronic/physiopathology;Renin-Angiotensin System/drug effects*
25142999;Adult;Cytochrome P-450 CYP3A Inducers/adverse effects*;Cytochrome P-450 CYP3A Inhibitors/blood;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics*;Dietary Supplements/adverse effects*;Drug Combinations;Female;Food-Drug Interactions*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Immunologic Factors/adverse effects;Lopinavir/blood;Lopinavir/pharmacokinetics*;Male;Maryland;Metabolic Clearance Rate;National Institute of Allergy and Infectious Diseases (U.S.);Nootropic Agents/adverse effects;Panax/adverse effects*;Plant Roots/adverse effects;Ritonavir/blood;Ritonavir/pharmacokinetics*;United States;Young Adult
25118080;Cheese/adverse effects*;Food-Drug Interactions*;Humans;Male;Monoamine Oxidase Inhibitors/adverse effects*;Myocardial Infarction/chemically induced*;Phenelzine/adverse effects*;Young Adult
25112306;Anticoagulants/pharmacology*;Food-Drug Interactions*;Fruit/chemistry*;Humans;International Normalized Ratio;Warfarin/pharmacology*
25078976;Adult;Analgesics/administration & dosage;Analgesics/adverse effects;Analgesics/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Energy Intake/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pregabalin;Therapeutic Equivalency;Time Factors;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
25055080;Animals;Antioxidants/metabolism;Antioxidants/pharmacology*;Aorta/metabolism;Camellia sinensis*;Diet;Diet, High-Fat;Dietary Fats/metabolism;Dietary Fats/pharmacology*;Duodenum/metabolism;Ferrous Compounds/pharmacology;Food-Drug Interactions;Gene Expression/drug effects*;Iron/metabolism;Iron/pharmacology*;Lactates/pharmacology;Liver/metabolism;Male;Mice, Inbred C57BL;Mitogen-Activated Protein Kinase 1/genetics;Mitogen-Activated Protein Kinase 1/metabolism;Myocardium/metabolism*;NF-kappa B/genetics;NF-kappa B/metabolism;Plant Extracts/pharmacology*;Polymerase Chain Reaction;RNA, Messenger/genetics;RNA, Messenger/metabolism;Tea;Trace Elements/pharmacology
25051813;Alcoholic Beverages/adverse effects;Beverages/adverse effects*;Food-Drug Interactions;Humans;Quinine/adverse effects*
25044357;Benzilates/blood;Benzilates/chemistry;Benzilates/pharmacokinetics*;Biological Availability;Computer Simulation;Dose-Response Relationship, Drug;Fasting/metabolism*;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastrointestinal Absorption/drug effects*;Humans;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Models, Biological*;Nortropanes/blood;Nortropanes/chemistry;Nortropanes/pharmacokinetics*;Solubility;Time Factors;Urological Agents/blood;Urological Agents/chemistry;Urological Agents/pharmacokinetics*
25030115;Chemistry, Pharmaceutical;Colloids;Danazol/chemistry*;Digestion;Drug Carriers*;Drug Stability;Emulsions;Fasting;Food-Drug Interactions;Humans;Intestinal Secretions/enzymology;Kinetics;Lipids/chemistry*;Lipolysis;Nanoparticles;Oils/chemistry*;Postprandial Period;Solubility;Solvents/chemistry;Technology, Pharmaceutical/methods;Water/chemistry
25029747;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications*;Benzimidazoles/therapeutic use;Dabigatran;Food-Drug Interactions;Humans;Morpholines/therapeutic use;Pyrazoles/therapeutic use;Pyridones/therapeutic use;Rivaroxaban;Stroke/etiology;Stroke/prevention & control*;Thiophenes/therapeutic use;Warfarin/therapeutic use;beta-Alanine/analogs & derivatives;beta-Alanine/therapeutic use
25026202;Chromatography, Liquid;Citrus/chemistry*;Food-Drug Interactions*;Fruit/chemistry;Furocoumarins/analysis*;Humans;Mass Spectrometry;Methoxsalen/analogs & derivatives*;Methoxsalen/analysis;Plant Extracts/chemistry*;Plant Extracts/standards
25008160;Centers for Disease Control and Prevention (U.S.);Dose-Response Relationship, Radiation;Drug Interactions;Evidence-Based Medicine*/methods;Food-Drug Interactions;Humans;Iodine Radioisotopes/administration & dosage;Iodine Radioisotopes/adverse effects*;Iodine Radioisotopes/pharmacokinetics;Iodine Radioisotopes/therapeutic use;Radionuclide Imaging;Radiopharmaceuticals/administration & dosage;Radiopharmaceuticals/adverse effects*;Radiopharmaceuticals/pharmacokinetics;Radiopharmaceuticals/therapeutic use;Sodium Iodide/administration & dosage;Sodium Iodide/adverse effects*;Sodium Iodide/pharmacokinetics;Sodium Iodide/therapeutic use;Thyroid Diseases/diagnostic imaging;Thyroid Diseases/metabolism;Thyroid Diseases/physiopathology;Thyroid Diseases/radiotherapy*;Thyroid Gland/diagnostic imaging;Thyroid Gland/metabolism;Thyroid Gland/physiopathology;Thyroid Gland/radiation effects*;Thyrotropin/blood;Tissue Distribution;Toxicology/methods;United States
24990113;Administration, Oral;Adult;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Fasting/metabolism;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyrazoles/adverse effects;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Therapeutic Equivalency;Young Adult
24982396;Administration, Oral;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects*;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Biological Availability;Biopharmaceutics/ethics*;Biopharmaceutics/methods;Cohort Studies;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Neoplasms/drug therapy;Neoplasms/metabolism;Risk Assessment;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics
27128838;Adolescent;Adult;Anti-Inflammatory Agents/administration & dosage;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents/blood;Anti-Inflammatory Agents/pharmacokinetics*;Antioxidants/administration & dosage;Antioxidants/adverse effects;Antioxidants/pharmacokinetics*;Drug Monitoring;Fasting/blood;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Models, Biological;Oleanolic Acid/administration & dosage;Oleanolic Acid/adverse effects;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/blood;Oleanolic Acid/pharmacokinetics;Postprandial Period;Risk Assessment;Wisconsin;Young Adult
24973432;Color;Diltiazem/poisoning*;Drug Overdose*;Fat Emulsions, Intravenous/poisoning*;Female;Food-Drug Interactions;Hemolysis;Humans;Hyperlipidemias/chemically induced;Middle Aged;Off-Label Use;Plasma;Poisoning/blood;Tetrazoles/poisoning;Valine/analogs & derivatives;Valine/poisoning;Valsartan
24970101;Absorption;Animals;Chemistry, Pharmaceutical/methods;Diffusion;Drug Delivery Systems*;Food-Drug Interactions*;Humans;Osmolar Concentration;Particle Size;Permeability;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmacopoeias as Topic;Solubility;Tablets
24966255;Aged;Anticoagulants*/pharmacology;Dietary Supplements;Drug Interactions*;Female;Flavonoids/pharmacology;Food-Drug Interactions;Fruit/chemistry*;Humans;International Normalized Ratio;Quercetin*/pharmacology;Vitis/chemistry*;Warfarin*/pharmacology
24965573;Adolescent;Adult;Azetidines*/adverse effects;Azetidines*/blood;Azetidines*/pharmacokinetics;Azetidines*/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Janus Kinase 1/antagonists & inhibitors;Janus Kinase 2/antagonists & inhibitors;Male;Middle Aged;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/blood;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;STAT3 Transcription Factor/antagonists & inhibitors;Sulfonamides*/adverse effects;Sulfonamides*/blood;Sulfonamides*/pharmacokinetics;Sulfonamides*/pharmacology;Young Adult
24952640;Community Pharmacy Services*;Databases, Factual;Food-Drug Interactions*;Greece;Humans;Internet*;Pharmaceutical Services*;Pharmacists*;Software
24938126;Calcineurin Inhibitors/metabolism*;Cooking*;Diet*;Flavonoids/metabolism*;Food-Drug Interactions*;Humans
24935561;Analgesics/blood;Analgesics/pharmacokinetics;Analgesics/pharmacology;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Fluoroquinolones/adverse effects;Fluoroquinolones/blood;Fluoroquinolones/pharmacokinetics;Fluoroquinolones/pharmacology;Food-Drug Interactions;Humans;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism*;Models, Biological*;Morpholines/blood;Morpholines/pharmacokinetics;Morpholines/pharmacology;Pyrazoles/blood;Pyrazoles/pharmacokinetics;Pyrazoles/pharmacology
24918555;Acne Vulgaris/drug therapy*;Acne Vulgaris/pathology;Adolescent;Adult;Child;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/therapeutic use*;Double-Blind Method;Drugs, Generic/administration & dosage;Drugs, Generic/adverse effects;Drugs, Generic/therapeutic use*;Female;Food-Drug Interactions;Humans;Isotretinoin/administration & dosage;Isotretinoin/adverse effects;Isotretinoin/therapeutic use*;Male;Middle Aged;Severity of Illness Index;Treatment Outcome;Young Adult
24903351;Adult;Animals;Anti-Allergic Agents/blood;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics;Anti-Allergic Agents/urine;Area Under Curve;Beverages*;Cross-Over Studies;Eating;Female;Food-Drug Interactions*;Fruit*;Histamine H1 Antagonists, Non-Sedating/blood;Histamine H1 Antagonists, Non-Sedating/chemistry;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics;Histamine H1 Antagonists, Non-Sedating/urine;Humans;Intestinal Absorption;Male;Malus*;Oocytes/metabolism;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;RNA, Complementary/genetics;Stereoisomerism;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/chemistry;Terfenadine/pharmacokinetics;Terfenadine/urine;Xenopus laevis;Young Adult
24898424;Administration, Oral;Beverages*/adverse effects;Biological Availability;Citrus paradisi/adverse effects;Citrus paradisi/metabolism*;Food-Drug Interactions/physiology*;Forecasting;Humans;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*
24875052;Deamino Arginine Vasopressin/administration & dosage;Deamino Arginine Vasopressin/chemistry;Drug Delivery Systems*;Eating;Excipients;Fasting/metabolism*;Fatty Acids/chemistry;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/chemistry;Lipase/chemistry;Lipids/chemistry*;Lipolysis;Oleic Acid/chemistry;Peptides/administration & dosage*;Proteins/administration & dosage*
24852093;Administration, Oral;Biological Availability;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Delayed-Action Preparations;Drug Carriers/chemistry*;Drug Delivery Systems/trends;Drug Stability;Emulsions;Food-Drug Interactions;Humans;Lipids/chemistry*;Nanoparticles/chemistry*;Solutions;Suspensions
24834535;Benzodiazepines/administration & dosage;Beverages/adverse effects*;Calcium Channel Blockers/administration & dosage;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage
24818771;Adult;Diet, High-Fat;Fasting/metabolism;Ferric Compounds/chemistry;Food-Drug Interactions*;Gastrointestinal Transit;Humans;Hypromellose Derivatives/chemistry*;Hypromellose Derivatives/pharmacokinetics*;Intestine, Large/metabolism;Intestine, Small/metabolism;Magnetic Phenomena;Male;Molecular Weight;Postprandial Period;Solubility;Stomach/metabolism;Tablets
24817647;Angiogenesis Inhibitors/administration & dosage;Angiogenesis Inhibitors/metabolism;Angiogenesis Inhibitors/pharmacokinetics*;Angiogenesis Inhibitors/pharmacology;Animals;Benzofurans/administration & dosage;Benzofurans/metabolism;Benzofurans/pharmacokinetics*;Benzofurans/pharmacology;Bile/chemistry;Biological Availability;Caco-2 Cells;Cells, Cultured;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Drug Interactions;Drugs, Investigational/administration & dosage;Drugs, Investigational/metabolism;Drugs, Investigational/pharmacokinetics*;Drugs, Investigational/pharmacology;Female;Food-Drug Interactions;Humans;Inactivation, Metabolic;Intestinal Absorption*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Models, Biological*;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/metabolism;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/pharmacology;Quinazolines/administration & dosage;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Quinazolines/pharmacology;Random Allocation;Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors*
24817413;Animals;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Arrhythmias, Cardiac/chemically induced;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Hepacivirus/drug effects*;Hepacivirus/enzymology;Hepatitis C/diagnosis;Hepatitis C/drug therapy*;Hepatitis C/enzymology;Humans;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Proline/adverse effects;Proline/analogs & derivatives*;Proline/pharmacokinetics;Risk Assessment;Risk Factors;Serine Proteinase Inhibitors/adverse effects;Serine Proteinase Inhibitors/pharmacokinetics*
24813475;Cardiovascular Diseases/prevention & control;Cognition/drug effects;Diet;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;United States
24813412;Beverages/adverse effects*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Male;Punicaceae/adverse effects*;Risk Factors
24810181;Administration, Oral;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biological Availability;Circadian Rhythm*;Cross-Over Studies;Drug Administration Schedule;Fatigue/chemically induced;Fatigue/physiopathology;Female;Food-Drug Interactions*;Half-Life;Hand-Foot Syndrome/physiopathology;Humans;Hypertension/chemically induced;Hypertension/physiopathology;Indazoles/adverse effects;Indazoles/blood;Indazoles/pharmacokinetics*;Indazoles/therapeutic use;Male;Neoplasms/blood;Neoplasms/drug therapy;Phenylurea Compounds/adverse effects;Phenylurea Compounds/blood;Phenylurea Compounds/pharmacokinetics*;Phenylurea Compounds/therapeutic use;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/therapeutic use;Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors*;Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors*;Severity of Illness Index
24802019;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/pharmacology;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Deoxycytidine/administration & dosage;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacokinetics;Diet, High-Fat;Drug Administration Schedule;Emtricitabine;Food-Drug Interactions*;Half-Life;Humans;Male;Phosphorous Acids/administration & dosage;Phosphorous Acids/pharmacology*;Young Adult
24798770;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics;Cross-Over Studies;Dideoxynucleosides/administration & dosage;Dideoxynucleosides/blood;Dideoxynucleosides/pharmacokinetics*;Dietary Fats;Drug Combinations;Female;Food-Drug Interactions*;Heterocyclic Compounds, 3-Ring/administration & dosage;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Lamivudine/administration & dosage;Lamivudine/blood;Lamivudine/pharmacokinetics*;Male;Therapeutic Equivalency;Vaginal Creams, Foams, and Jellies;Young Adult
24791577;Analysis of Variance;Antihypertensive Agents/therapeutic use*;Blood Pressure/drug effects*;Body Mass Index;China;Cohort Studies;Factor Analysis, Statistical;Female;Follow-Up Studies;Food-Drug Interactions/physiology*;Health Surveys/methods;Health Surveys/statistics & numerical data;Humans;Hypertension/complications;Hypertension/drug therapy*;Male;Middle Aged;Obesity/complications;Riboflavin/administration & dosage*
27128606;Administration, Oral;Adolescent;Adult;Area Under Curve;Atrioventricular Block/chemically induced;Atrioventricular Block/physiopathology;Australia;Biological Availability;Bradycardia/chemically induced;Bradycardia/physiopathology;Cross-Over Studies;Drug Compounding;Female;Food-Drug Interactions;Half-Life;Healthy Volunteers;Heart Rate/drug effects;Humans;Indoles/administration & dosage;Indoles/adverse effects;Indoles/pharmacokinetics*;Linear Models;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*;Receptors, Lysosphingolipid/drug effects*;Receptors, Lysosphingolipid/metabolism;Single-Blind Method;Young Adult
24768728;Administration, Oral;Age Factors;Animals;Chemistry, Pharmaceutical;Child;Child, Preschool;Delayed-Action Preparations;Drug Carriers*;Drug Stability;Excipients/chemistry;Food-Drug Interactions;Humans;Hypnotics and Sedatives/administration & dosage*;Hypnotics and Sedatives/chemistry*;Infant;Kinetics;Lipids/chemistry*;Melatonin/administration & dosage*;Melatonin/chemistry*;Milk/chemistry;Particle Size;Solubility;Technology, Pharmaceutical/methods;Yogurt
24757719;Antineoplastic Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Indoles/pharmacokinetics*;Male;Melanoma/metabolism*;Protein Kinase Inhibitors/pharmacokinetics*;Sulfonamides/pharmacokinetics*
24756141;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Labeling;Drug Therapy;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/enzymology;Neoplasms/metabolism;Risk Factors
24755124;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Combinations;Female;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage*;Linagliptin;Male;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/chemistry;Metformin/pharmacokinetics;Middle Aged;Purines/administration & dosage*;Purines/adverse effects;Purines/chemistry;Purines/pharmacokinetics;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/chemistry;Quinazolines/pharmacokinetics;Solubility;Tablets
24752831;Adult;Anticholesteremic Agents/administration & dosage*;Anticholesteremic Agents/pharmacokinetics;Anticholesteremic Agents/pharmacology;Area Under Curve;Asian Continental Ancestry Group;Azetines/administration & dosage*;Azetines/pharmacokinetics;Azetines/pharmacology;Cholesterol, LDL/blood*;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/pharmacology;Food-Drug Interactions;Half-Life;Humans;Male;Young Adult
24751672;Administration, Oral;Atenolol/administration & dosage;Atenolol/chemistry;Atenolol/metabolism*;Atenolol/pharmacokinetics;Food/adverse effects*;Food-Drug Interactions*;Furosemide/administration & dosage;Furosemide/chemistry;Furosemide/metabolism*;Furosemide/pharmacokinetics;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects*;Metformin/administration & dosage;Metformin/chemistry;Metformin/metabolism*;Metformin/pharmacokinetics;Permeability;Reproducibility of Results;Solubility;Viscosity
24739447;Adrenergic beta-Antagonists/pharmacokinetics*;Catechin/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Nadolol/pharmacokinetics*;Tea/chemistry*
24734908;Administration, Oral;Adolescent;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/pharmacokinetics;Male;Naphthalenes/administration & dosage*;Naphthalenes/adverse effects;Naphthalenes/pharmacokinetics;Receptors, Immunologic/antagonists & inhibitors*;Receptors, Prostaglandin/antagonists & inhibitors*;Young Adult
24730660;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Global Health;HIV Infections/drug therapy*;Humans;Patient Compliance;Pharmacogenetics;Quality of Life*
24723311;Aged;Aged, 80 and over;Cohort Studies;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic/methods*;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/therapeutic use*;Treatment Failure
24721651;Animals;Diet*;Diuretics/pharmacology*;Food-Drug Interactions*;Homeostasis/drug effects;Large-Conductance Calcium-Activated Potassium Channels/metabolism*;Mice;Mice, Knockout;Potassium/metabolism*
24713083;Acculturation;Aged;Aging*;Alcohol Drinking/epidemiology*;Alcohol Drinking/ethnology;Alcohol Drinking/psychology;Alcoholic Beverages/adverse effects;Alcoholism/epidemiology*;Alcoholism/ethnology;Alcoholism/psychology;Boston/epidemiology;Cohort Studies;Contraindications;Cross-Sectional Studies;Ethanol;Female;Food-Drug Interactions;Health Surveys;Hispanic Americans;Humans;Longitudinal Studies;Male;Middle Aged;Patient Compliance;Prevalence;Puerto Rico/ethnology;Risk;Sex Factors;Urban Health*/ethnology
24703329;Age Factors;Constipation/diet therapy*;Dietary Supplements;European Union;Female;Food-Drug Interactions;Humans;Laxatives/adverse effects;Laxatives/therapeutic use;Legislation, Drug/organization & administration;Legislation, Food*/organization & administration;Plants, Medicinal/adverse effects*;Pregnancy
24676073;Adolescent;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Enteral Nutrition*;Female;Food-Drug Interactions*;Humans;Intensive Care Units;Male;Middle Aged;Retrospective Studies;Young Adult
24670091;Administration, Oral;Biological Availability;Capsules/chemistry;Chemical Precipitation;Chemistry, Pharmaceutical;Crystallization;Drug Delivery Systems/methods*;Drug Stability;Drug Storage;Emulsions/chemistry*;Emulsions/pharmacokinetics;Food-Drug Interactions;In Vitro Techniques;Intestinal Absorption;Particle Size;Solubility;Surface-Active Agents/chemistry;Technology, Pharmaceutical/methods*;Triglycerides/chemistry
24670024;Acetaldehyde Dehydrogenase Inhibitors/adverse effects*;Administration, Intravenous;Adult;Alcoholic Beverages/adverse effects*;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Cephalosporins/administration & dosage;Cephalosporins/adverse effects*;Disulfiram/adverse effects*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Retrospective Studies
24660518;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Clinical Competence*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Hospitals, Teaching/manpower;Hospitals, Teaching/standards;Humans;Nursing Care/standards*;Nursing Staff, Hospital/standards;Nutritive Value;Patient Education as Topic/standards*;Potassium/physiology*;Southeastern United States
24657141;Chemistry, Pharmaceutical;Digestion;Duodenum/metabolism;Food-Drug Interactions*;Humans;Hydrochlorothiazide/chemistry*;Hydrophobic and Hydrophilic Interactions;Models, Biological*;Solubility;Stomach/metabolism*;Tablets
24637348;Administration, Oral;Animals;Biopharmaceutics/methods*;Chemistry, Pharmaceutical;Excipients/chemistry*;Food-Drug Interactions*;Gastrointestinal Motility;Gastrointestinal Tract/metabolism*;Humans;Intestinal Absorption*;Models, Animal;Models, Biological;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Reproducibility of Results;Species Specificity
24619146;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics;Benzodiazepines/adverse effects;Benzodiazepines/pharmacokinetics;Biotransformation;Checklist;Comorbidity;Dose-Response Relationship, Drug;Drug Information Services;Drug Interactions*;Drug Monitoring;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Humans;Inactivation, Metabolic;Metabolic Clearance Rate/physiology;Polypharmacy;Prescription Drugs/adverse effects*;Prescription Drugs/pharmacokinetics;Substance-Related Disorders/blood;Xenobiotics/adverse effects*;Xenobiotics/pharmacokinetics
24618639;Animals;Area Under Curve;Brain Chemistry;Drug Evaluation, Preclinical;Food-Drug Interactions;Glucuronosyltransferase/blood;Isoenzymes/blood;Male;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Soybeans/chemistry*;Valproic Acid/analogs & derivatives*;Valproic Acid/blood;Valproic Acid/pharmacokinetics*;gamma-Aminobutyric Acid/metabolism
24615728;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics;Asian Continental Ancestry Group;Beverages;Carbamates/blood;Carbamates/pharmacokinetics*;Cobicistat;Cross-Over Studies;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Dietary Proteins/pharmacology*;Drug Combinations;Emtricitabine;Food-Drug Interactions*;Humans;Male;Middle Aged;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Quinolones/blood;Quinolones/pharmacokinetics*;Tenofovir;Thiazoles/blood;Thiazoles/pharmacokinetics*;Young Adult
24598049;Acaricides/administration & dosage;Acaricides/blood;Acaricides/pharmacokinetics;Administration, Oral;Animals;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/blood;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Body Weight;Dogs/metabolism*;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions*;Gastrointestinal Absorption;Insecticides/administration & dosage;Insecticides/blood;Insecticides/pharmacokinetics;Isoxazoles/administration & dosage;Isoxazoles/blood;Isoxazoles/pharmacokinetics*;Male;Safety;Tablets
24594059;Adult;Aged;Antitubercular Agents/pharmacokinetics*;Arylamine N-Acetyltransferase/genetics;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Tuberculosis/drug therapy*
24583387;Amlodipine/pharmacology;Animals;Antihypertensive Agents/pharmacology*;Blood Pressure;Food-Drug Interactions*;Heart/drug effects;Indapamide/pharmacology;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Male;Nutritional Status*;Perindopril/pharmacology;Rats;Rats, Inbred SHR;Spleen/drug effects;Spleen/metabolism
24583386;Biological Availability;Dietary Supplements/adverse effects;Food-Drug Interactions*;Fruit/chemistry;Humans;Intestinal Absorption/drug effects;Intestines/drug effects;Intestines/metabolism;Nutritional Status;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Risk Factors;Vegetables/chemistry
24582998;Calcium, Dietary/administration & dosage;Dietary Fats/administration & dosage;Dietary Fiber/administration & dosage;Dietary Proteins/administration & dosage;Energy Intake;Evidence-Based Practice*;Food-Drug Interactions*;Humans;Medicaid;Medicare;Motor Activity;Nutrition Assessment;Nutritionists*;Phosphorus, Dietary/administration & dosage;Renal Insufficiency, Chronic/diagnosis;Renal Insufficiency, Chronic/diet therapy*;Renal Insufficiency, Chronic/drug therapy;Sodium, Dietary/administration & dosage;United States
24553283;Adrenergic beta-Antagonists/pharmacokinetics*;Catechin/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Nadolol/pharmacokinetics*;Tea/chemistry*
24552005;Citrus paradisi*;Drug-Related Side Effects and Adverse Reactions/etiology*;Food-Drug Interactions*;Humans
24549825;Animals;Beverages*;Binding Sites/physiology;Cells, Cultured;Citrus paradisi/metabolism*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Oocytes;Organic Anion Transporters/metabolism*;Pravastatin/metabolism*;Pravastatin/pharmacology;Substrate Specificity;Terfenadine/analogs & derivatives*;Terfenadine/metabolism;Terfenadine/pharmacology;Xenopus laevis
24548978;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Phenylurea Compounds/administration & dosage;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Protein Kinase Inhibitors/pharmacokinetics*;Quinolines/administration & dosage;Quinolines/adverse effects;Quinolines/pharmacokinetics*
24535888;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Humans;Male;Middle Aged;Nitroimidazoles/administration & dosage*;Nitroimidazoles/adverse effects;Nitroimidazoles/pharmacokinetics;Prodrugs;Suspensions;Tablets;Trypanocidal Agents/administration & dosage*;Trypanocidal Agents/adverse effects;Trypanocidal Agents/pharmacokinetics;Trypanosomiasis, African/drug therapy;Young Adult
24517573;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Antioxidants/adverse effects;Antioxidants/metabolism;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Curcumin/adverse effects*;Curcumin/metabolism;Cytochrome P-450 CYP2C9/chemistry;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP2C9 Inhibitors/adverse effects;Cytochrome P-450 CYP2C9 Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P450 Family 2;Diclofenac/metabolism;Dietary Supplements/adverse effects*;Food-Drug Interactions;Humans;Kinetics;Male;Metabolic Detoxication, Phase I;Microsomes, Liver/enzymology*;Microsomes, Liver/metabolism;NADP/metabolism;Rats, Sprague-Dawley;Species Specificity;Steroid 16-alpha-Hydroxylase/antagonists & inhibitors*;Steroid 16-alpha-Hydroxylase/metabolism
24495314;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Metabolic Clearance Rate;Metformin/administration & dosage;Metformin/adverse effects;Metformin/blood;Metformin/pharmacokinetics*;Piperidones/administration & dosage;Piperidones/adverse effects;Piperidones/blood;Piperidones/pharmacokinetics*;Postprandial Period;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Republic of Korea;Sex Factors;Tablets;Young Adult
24490434;Dietary Supplements*;Evidence-Based Medicine;Food-Drug Interactions;Humans;Nutritional Status;Primary Prevention/methods*;Randomized Controlled Trials as Topic;Research Design
24488324;Adult;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Crown Ethers/administration & dosage*;Crown Ethers/adverse effects;Crown Ethers/blood;Crown Ethers/pharmacokinetics*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Xenograft Model Antitumor Assays;Young Adult
24453847;Drug Therapy/methods*;Food-Drug Interactions*;Humans;Nutritive Value*;Parenteral Nutrition Solutions/adverse effects;Parenteral Nutrition Solutions/pharmacokinetics*;Parenteral Nutrition Solutions/therapeutic use*;Parenteral Nutrition, Home*
24447534;Administration, Oral;Aged;Cross-Over Studies;Diet, High-Fat/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Male;Middle Aged;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Piperazines/pharmacokinetics*;Purines/pharmacokinetics;Sildenafil Citrate;Sulfones/pharmacokinetics*;Tablets/adverse effects*;Therapeutic Equivalency
24442773;Animals;Chemistry, Pharmaceutical*;Dogs;Food-Drug Interactions*;Humans;Solubility
24442146;Animals;Bile/metabolism;Biomarkers/blood;Biomarkers/urine;Chemical and Drug Induced Liver Injury/etiology*;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/pathology;Citric Acid Cycle;Diet, High-Fat*;Disease Models, Animal;Fatty Acids, Nonesterified/metabolism;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Liver/metabolism;Liver/pathology;Male;Metabolomics/methods;Mitochondria, Liver/metabolism;Non-alcoholic Fatty Liver Disease/etiology*;Non-alcoholic Fatty Liver Disease/metabolism;Non-alcoholic Fatty Liver Disease/pathology;Rats, Sprague-Dawley;Risk Factors;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Valproic Acid*
24435225;Alkalies/chemistry;Food-Drug Interactions*;Models, Chemical*;Permeability;Solubility
24419562;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/pharmacology;Adult;Area Under Curve;Blood Pressure/drug effects;Catechin/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;HEK293 Cells;Humans;Inhibitory Concentration 50;Intestines/metabolism;Male;Nadolol/pharmacokinetics*;Nadolol/pharmacology;Organic Anion Transporters/metabolism;Tea/chemistry*;Young Adult
24399453;Administration, Oral;Adult;Asian Continental Ancestry Group*/ethnology;Cohort Studies;Dose-Response Relationship, Drug;Fasting/metabolism*;Fatigue/chemically induced;Fatigue/diagnosis;Follow-Up Studies;Food-Drug Interactions/physiology*;Humans;Male;Piperazines/adverse effects*;Piperazines/pharmacokinetics*;Piperidines/adverse effects*;Piperidines/pharmacokinetics*;Postprandial Period/drug effects;Postprandial Period/physiology*;Young Adult
24383939;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Blood Coagulation/drug effects;Diet;Food-Drug Interactions;Humans;Male;Taiwan;Vegetables;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
24382706;Animals;Area Under Curve;Benzamides/administration & dosage;Benzamides/pharmacokinetics;Biological Availability;Caco-2 Cells;Capsules;Cell Membrane Permeability;Chemistry, Pharmaceutical/methods*;Delayed-Action Preparations/chemistry*;Drug Carriers;Enzyme Activators/administration & dosage;Enzyme Activators/pharmacokinetics;Excipients;Female;Food-Drug Interactions;Humans;Hypromellose Derivatives;Male;Methylcellulose/analogs & derivatives;Models, Biological;Solubility;Sulfones/administration & dosage;Sulfones/pharmacokinetics;Swine/physiology*;Swine, Miniature/physiology*;Tablets
24374975;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Melanoma/drug therapy;Melanoma/genetics;Melanoma/metabolism*;Middle Aged;Mutation;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Proto-Oncogene Proteins B-raf/antagonists & inhibitors;Proto-Oncogene Proteins B-raf/genetics;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
24374821;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/urine;Dose-Response Relationship, Drug;Fasting/metabolism;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/urine;Single-Blind Method;Thymidine/adverse effects;Thymidine/analogs & derivatives*;Thymidine/blood;Thymidine/pharmacokinetics;Thymidine/urine;Young Adult
24374798;Administration, Oral;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/blood;Antimetabolites, Antineoplastic/chemistry;Antimetabolites, Antineoplastic/pharmacokinetics*;Azacitidine/administration & dosage;Azacitidine/blood;Azacitidine/chemistry;Azacitidine/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Delayed-Action Preparations/pharmacokinetics;Female;Food-Drug Interactions*;Hematologic Neoplasms/metabolism;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Stomach/chemistry;Tablets
24371039;Animals;Cell Line;Cell Line, Tumor;Cell Membrane/drug effects*;Cell Membrane/metabolism;Cell Membrane/secretion;Dose-Response Relationship, Drug;Enteroendocrine Cells/drug effects*;Enteroendocrine Cells/metabolism;Enteroendocrine Cells/secretion;Food-Drug Interactions*;Glucagon-Like Peptide 1/secretion*;Glucose/metabolism*;Grape Seed Extract/pharmacology*;Linoleic Acid/metabolism*;Membrane Potential, Mitochondrial;Membrane Potentials;Mice;Proanthocyanidins/pharmacology*;Proline/metabolism*;Time Factors
24346280;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics;Receptor, ErbB-2/metabolism
24343538;Amantadine/administration & dosage;Amantadine/adverse effects;Amantadine/therapeutic use;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/classification;Antiparkinson Agents/therapeutic use*;Cardiovascular Diseases/chemically induced;Catechol O-Methyltransferase;Catechol O-Methyltransferase Inhibitors;Clinical Trials as Topic;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/classification;Dopamine Agonists/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/therapeutic use;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Indoles/therapeutic use;Levodopa/administration & dosage;Levodopa/therapeutic use;Mental Disorders/chemically induced;Mental Disorders/prevention & control;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Multicenter Studies as Topic;Parkinson Disease/drug therapy*;Serotonin Syndrome/etiology;Serotonin Syndrome/prevention & control;Treatment Outcome
24338453;Administration, Oral;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Blood Coagulation/drug effects*;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Treatment Outcome;Venous Thrombosis/blood;Venous Thrombosis/diagnosis;Venous Thrombosis/drug therapy*
24332774;Aged;Antiparkinson Agents/therapeutic use*;Food-Drug Interactions*;Humans;Levodopa/therapeutic use*;Male;Parkinson Disease/drug therapy*;Plants, Medicinal;Vicia faba/adverse effects*
24325365;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Models, Biological;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/pharmacokinetics*;Succinates/administration & dosage;Succinates/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
24316176;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Artemisia annua*;Artemisinins/administration & dosage;Artemisinins/pharmacokinetics*;Biological Availability;Capsules;Dietary Supplements;Digestion;Edible Grain;Flavonoids/administration & dosage;Flavonoids/pharmacokinetics*;Food-Drug Interactions;Intestines/metabolism;Malaria/drug therapy;Malaria/metabolism;Plant Leaves*;Plant Oils;Stomach/metabolism;Sucrose
24303901;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Biological Transport/drug effects;Biological Transport/physiology;Cell Line, Tumor;Citrus paradisi*;Doxorubicin/metabolism;Doxorubicin/pharmacology;Food-Drug Interactions/physiology*;Freeze Drying/methods;Humans;Male;Pharmaceutical Preparations/metabolism*;Plant Extracts/isolation & purification;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Rabbits
24301077;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Arthritis, Rheumatoid/drug therapy;Biological Availability;Biopharmaceutics;Caco-2 Cells;Chemistry, Pharmaceutical;Excipients;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Piroxicam/administration & dosage*;Piroxicam/pharmacokinetics;Piroxicam/therapeutic use;Rats;Solubility;Stereoisomerism;Therapeutic Equivalency;Tissue Distribution
24292052;Adult;Beverages*;Celiprolol/blood;Celiprolol/pharmacokinetics*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Food-Drug Interactions;Humans;Male;Midazolam/blood;Midazolam/pharmacokinetics*;Organic Anion Transporters/antagonists & inhibitors*;Young Adult
24272966;Administration, Oral;Adult;Blood Glucose/analysis;Cross-Over Studies;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology*;Double-Blind Method;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Insulin/blood;Male;Middle Aged;Ribose/adverse effects;Ribose/pharmacokinetics*;Ribose/pharmacology*;Solutions;Uric Acid/blood;Young Adult
24262730;Adult;Anemia, Iron-Deficiency/complications;Anemia, Iron-Deficiency/etiology*;Female;Food;Food-Drug Interactions*;Humans;Iron/administration & dosage;Iron/pharmacokinetics*;Iron/therapeutic use;Pica/complications*;Polyphenols/chemistry;Trace Elements/administration & dosage;Trace Elements/therapeutic use;Vitis/adverse effects*;Vitis/chemistry
24259961;Analgesics, Opioid/adverse effects;Exocrine Pancreatic Insufficiency/etiology;Exocrine Pancreatic Insufficiency/metabolism;Exocrine Pancreatic Insufficiency/physiopathology;Food-Drug Interactions;Gastrointestinal Motility;Humans;Intestinal Absorption*/drug effects;Intestines/drug effects;Intestines/metabolism*;Intestines/microbiology;Intestines/physiopathology;Life Style;Malnutrition/etiology;Malnutrition/metabolism;Malnutrition/physiopathology;Nutritional Status;Pancreatitis, Chronic/complications;Pancreatitis, Chronic/diagnosis;Pancreatitis, Chronic/metabolism*;Pancreatitis, Chronic/physiopathology;Pancreatitis, Chronic/therapy;Pharmacokinetics*;Polypharmacy
24256019;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions;Fibric Acids/adverse effects;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hypolipidemic Agents/adverse effects*;Rhabdomyolysis/chemically induced
24252529;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/therapeutic use;Anti-Infective Agents/pharmacokinetics;Anticonvulsants/pharmacokinetics;Contraceptives, Oral/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inducers/pharmacokinetics*;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Gastrointestinal Agents/pharmacokinetics;HIV Infections/drug therapy;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Intestinal Absorption;Nitriles/administration & dosage;Nitriles/blood;Nitriles/pharmacokinetics*;Nitriles/therapeutic use;Proton Pump Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/therapeutic use;Rilpivirine
24252527;Adenine/administration & dosage;Adenine/analogs & derivatives;Adult;Aged;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology*;Anti-HIV Agents/therapeutic use;Biological Availability;Child;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inducers/pharmacology;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives;Drug Administration Routes;Drug Combinations;Drug Interactions;Drug Therapy, Combination;Emtricitabine;Food-Drug Interactions;HIV Infections/drug therapy;HIV Reverse Transcriptase/antagonists & inhibitors*;HIV-1/drug effects*;HIV-1/enzymology;Half-Life;Humans;Intestinal Absorption;Molecular Structure;Nanoparticles;Nitriles/administration & dosage;Nitriles/pharmacokinetics;Nitriles/pharmacology*;Nitriles/therapeutic use;Organophosphonates/administration & dosage;Proton Pump Inhibitors/pharmacology;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics;Pyrimidines/pharmacology*;Pyrimidines/therapeutic use;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/pharmacology;Reverse Transcriptase Inhibitors/therapeutic use;Rilpivirine;Tenofovir
24242999;Administration, Oral;Adolescent;Adult;Aged;Antimalarials*/administration & dosage;Antimalarials*/adverse effects;Antimalarials*/blood;Antimalarials*/pharmacokinetics;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Heterocyclic Compounds, 1-Ring*/administration & dosage;Heterocyclic Compounds, 1-Ring*/adverse effects;Heterocyclic Compounds, 1-Ring*/blood;Heterocyclic Compounds, 1-Ring*/pharmacokinetics;Humans;Male;Middle Aged;Peroxides*/administration & dosage;Peroxides*/adverse effects;Peroxides*/blood;Peroxides*/pharmacokinetics;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/blood;Spiro Compounds*/pharmacokinetics;Young Adult
24239996;Administration, Intravenous;Administration, Oral;Animals;Biological Availability;Biopharmaceutics/methods;Capsules;Chemistry, Pharmaceutical;Cinnarizine/administration & dosage*;Cinnarizine/blood;Cinnarizine/chemistry;Cinnarizine/pharmacokinetics*;Dietary Proteins/administration & dosage;Dogs;Drug Carriers*;Fasting/blood;Food-Drug Interactions*;Intestinal Absorption;Male;Nanotechnology;Postprandial Period;Solubility;Tablets;Technology, Pharmaceutical/methods
24224449;Adult;Aged;Antineoplastic Agents/therapeutic use;Antioxidants/analysis*;Ascorbic Acid/administration & dosage*;Carcinoma, Non-Small-Cell Lung/blood*;Carcinoma, Non-Small-Cell Lung/drug therapy*;Dietary Supplements;Female;Food-Drug Interactions;Humans;Lung Neoplasms/blood*;Lung Neoplasms/drug therapy*;Male;Middle Aged;Vitamin A/administration & dosage;Vitamin A/blood;Vitamin E/administration & dosage;Vitamin E/blood;Vitamins/blood*
24219078;Administration, Oral*;Drug Compounding;Drug Stability;Female;Food*;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Humans;Pediatric Nursing*;Practice Patterns, Nurses'*;Scotland;Surveys and Questionnaires
24216238;Child;Drug Industry;Europe;Excipients;Food-Drug Interactions;Government Regulation;Guidelines as Topic*;Humans;Legislation, Drug*
24166743;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Carrier Proteins/genetics;Carrier Proteins/metabolism*;Digoxin*;Drug Interactions;Food-Drug Interactions;Humans;Pharmaceutical Preparations/metabolism
24166669;Animals;Caffeic Acids/pharmacology*;Citrus paradisi;DNA, Complementary/genetics;Food-Drug Interactions;Kidney/drug effects;Kidney/metabolism*;Male;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/genetics;Pharmaceutical Preparations/metabolism;Rats;Rats, Wistar;Xenopus laevis
24152604;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;Glucosides/administration & dosage;Glucosides/adverse effects;Glucosides/pharmacokinetics*;Healthy Volunteers;Humans;Male;Middle Aged;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Young Adult
24142299;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacokinetics;Drug Combinations;Emtricitabine;Fasting/metabolism;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;Humans;Male;Middle Aged;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Organophosphonates/administration & dosage;Organophosphonates/adverse effects;Organophosphonates/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rilpivirine;Tablets;Tenofovir;Young Adult
24132705;Administration, Oral;Adult;Amlodipine/administration & dosage*;Amlodipine/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Female;Food;Food-Drug Interactions*;Humans;Imidazoles/pharmacokinetics;Losartan/administration & dosage*;Losartan/pharmacokinetics*;Male;Tablets/administration & dosage;Tablets/pharmacokinetics;Tetrazoles/pharmacokinetics;Young Adult
24126567;Administration, Oral;Adult;Area Under Curve;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Bridged Bicyclo Compounds/administration & dosage*;Bridged Bicyclo Compounds/adverse effects;Bridged Bicyclo Compounds/pharmacokinetics;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Calcium Channels, L-Type/drug effects*;Calcium Channels, T-Type/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Humans;Male;Prospective Studies;Young Adult
24123095;Administration, Oral;Adult;Breakfast;Coffee/adverse effects*;Cohort Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Hypothyroidism/metabolism;Intestinal Absorption;Italy;Male;Middle Aged;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use;Time Factors;Triiodothyronine/blood
24120730;Aspartame/pharmacology;Cell Line, Tumor;Cells, Cultured;Cyclamates/pharmacology;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism*;Food-Drug Interactions*;Hepatocytes/drug effects;Hepatocytes/metabolism;Humans;Receptors, Aryl Hydrocarbon/metabolism*;Receptors, Glucocorticoid/metabolism*;Saccharin/pharmacology;Sweetening Agents/pharmacology*;Thiazines/pharmacology
24117531;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Lactams/pharmacokinetics*;Male;Meals;Neuropeptides/pharmacology*;Omeprazole/pharmacology;Ranitidine/pharmacology;Ritonavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*;Young Adult
24099279;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food-Drug Interactions;Healthy Volunteers;Hydrogen-Ion Concentration;Indazoles/pharmacokinetics*;Proton Pump Inhibitors/adverse effects*;Rabeprazole/adverse effects*;Solubility;Sulfonamides/pharmacokinetics*
24090732;Administration, Oral;Animals;Area Under Curve;Dogs;Fasting/metabolism*;Food-Drug Interactions*;Gastric Acid/secretion;Gastric Emptying/drug effects;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Gastric Mucosa/secretion;Humans;Hydrogen-Ion Concentration;Male;Models, Animal;Pentagastrin/administration & dosage*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/blood;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Reproducibility of Results;Species Specificity
24087843;Animals;Anticarcinogenic Agents/administration & dosage*;Anticarcinogenic Agents/pharmacokinetics;Antineoplastic Agents/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics;Chemoprevention;Diet;Disease Models, Animal;Drug Evaluation, Preclinical;Food-Drug Interactions*;Humans;Isothiocyanates/administration & dosage*;Isothiocyanates/chemistry;Isothiocyanates/pharmacokinetics;Neoplasms/drug therapy;Neoplasms/prevention & control;Randomized Controlled Trials as Topic
24067745;Adult;Area Under Curve;Beverages/adverse effects*;Biotransformation/drug effects*;Citrus paradisi/adverse effects*;Confidence Intervals;Cross-Over Studies;Female;Food-Drug Interactions*;Genotype;Half-Life;Humans;Male;Platelet Aggregation Inhibitors/metabolism*;Platelet Function Tests;Receptors, Purinergic P2Y12/genetics;Ticlopidine/analogs & derivatives*;Ticlopidine/metabolism;Young Adult
24063896;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Antiviral Agents/chemistry;Antiviral Agents/pharmacology*;Antiviral Agents/therapeutic use;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Therapy, Combination;Food-Drug Interactions;Genotype;Hepacivirus/drug effects;Hepacivirus/enzymology;Hepacivirus/genetics;Hepatitis C/drug therapy;Humans;Inactivation, Metabolic;Interferons/administration & dosage;Interferons/therapeutic use;Interleukins/genetics;Intestinal Absorption;Oligopeptides/chemistry;Oligopeptides/pharmacology*;Oligopeptides/therapeutic use;Polyethylene Glycols/administration & dosage;Polyethylene Glycols/therapeutic use;Protease Inhibitors/chemistry;Protease Inhibitors/pharmacology*;Protease Inhibitors/therapeutic use;Ribavirin/administration & dosage;Ribavirin/therapeutic use;Viral Nonstructural Proteins/antagonists & inhibitors*;Virus Replication/drug effects
24062180;Adolescent;Adult;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;PPAR alpha/agonists*;Phenylpropionates/adverse effects;Phenylpropionates/pharmacokinetics*;Phenylpropionates/pharmacology;Placebos;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Pyrroles/pharmacology;Sex Factors;Young Adult
24060671;Administration, Oral;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Computer Simulation;Fasting/blood;Food-Drug Interactions*;Gastrointestinal Motility;Gastrointestinal Tract/physiology;Humans;Intestinal Absorption;Models, Biological*;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/chemistry;Nifedipine/classification;Nifedipine/pharmacokinetics*;Permeability;Postprandial Period;Reproducibility of Results;Solubility;Technology, Pharmaceutical/methods
24056057;Biological Availability;Chemistry, Pharmaceutical/methods*;Computer Simulation;Diclofenac/blood*;Diclofenac/chemistry*;Dosage Forms;Fasting;Female;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Kinetics;Male;Pharmaceutical Preparations;Software;Solubility;Tablets/pharmacokinetics;Tablets, Enteric-Coated/chemistry*;Technology, Pharmaceutical/methods*
24056027;Administration, Oral;Animals;Biological Availability;Chemistry, Pharmaceutical;Cinnarizine/administration & dosage;Cinnarizine/chemistry;Cinnarizine/pharmacokinetics*;Computer Simulation;Dogs;Drug Carriers*;Excipients/chemistry;Fasting/metabolism*;Food-Drug Interactions*;Hydrogen-Ion Concentration;Intestines/metabolism*;Lipolysis*;Models, Biological;Nanotechnology;Postprandial Period*;Reproducibility of Results;Solubility;Stomach/metabolism*;Tablets;Technology, Pharmaceutical/methods
24053714;Animals;Biological Availability;Food*;Food-Drug Interactions*;Functional Food*;Humans;Pharmaceutical Preparations/administration & dosage*
24051217;Administration, Oral;Biopharmaceutics/instrumentation;Biopharmaceutics/methods*;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/chemistry*;Diclofenac/metabolism;Equipment Design;Food-Drug Interactions*;Gastric Emptying*;Humans;Peristalsis*;Postprandial Period*;Pressure;Solubility;Stomach/physiology*;Tablets;Time Factors
24048240;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Food-Drug Interactions*;Humans
24040848;Absorption;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat/methods;Eating/physiology*;Fasting/physiology;Food;Food-Drug Interactions*;Humans;Male;Tablets/adverse effects;Tablets/metabolism;Tablets/pharmacokinetics;Tamoxifen/adverse effects;Tamoxifen/analogs & derivatives*;Tamoxifen/metabolism;Tamoxifen/pharmacokinetics;Young Adult
24036846;Administration, Oral;Adult;Antacids/adverse effects*;Antacids/therapeutic use;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Calcium Carbonate/adverse effects*;Calcium Carbonate/therapeutic use;Calcium, Dietary/adverse effects;Calcium, Dietary/therapeutic use;Cross-Over Studies;Dietary Supplements/adverse effects*;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Gastritis/chemically induced;Gastritis/prevention & control;Half-Life;Humans;Intestinal Absorption;Male;Protein-Tyrosine Kinases/administration & dosage;Protein-Tyrosine Kinases/adverse effects;Protein-Tyrosine Kinases/blood;Protein-Tyrosine Kinases/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*
24036239;Benzilates/chemistry*;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Diffusion;Food-Drug Interactions*;Gastric Juice/chemistry;Gastrointestinal Motility*;Gastrointestinal Tract/physiology*;Humans;Hydrodynamics;Kinetics;Models, Chemical;Nortropanes/chemistry*;Osmolar Concentration;Postprandial Period*;Solubility;Tablets, Enteric-Coated;Technology, Pharmaceutical/methods;Viscosity;Water/chemistry*
24030706;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use*;Consumer Health Information/methods*;Dabigatran;Drug Interactions;Fibrinolytic Agents/administration & dosage;Fibrinolytic Agents/adverse effects;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions;Humans;Patient Safety;Perception*;Social Media*;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/therapeutic use
24021514;Administration, Oral;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/physiology;Mental Disorders/blood;Mental Disorders/drug therapy*;Randomized Controlled Trials as Topic;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/adverse effects;Thyroxine/pharmacokinetics*
24014143;Adult;Cross-Over Studies;Female;Food-Drug Interactions/physiology*;Humans;Isoindoles/administration & dosage*;Isoindoles/blood*;Lurasidone Hydrochloride;Male;Middle Aged;Schizophrenia/blood*;Schizophrenia/drug therapy*;Thiazoles/administration & dosage*;Thiazoles/blood*
24013073;ATP Binding Cassette Transporter, Sub-Family B/genetics;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Availability;Capsaicin/pharmacology*;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Dexamethasone/pharmacology;Dietary Supplements;Dose-Response Relationship, Drug;Food-Drug Interactions*;Ketoconazole/pharmacology;Male;Rats, Sprague-Dawley
24003188;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24003187;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23994640;Administration, Oral;Biopharmaceutics/methods*;Dosage Forms;Fasting/metabolism;Food-Drug Interactions;Humans;Intestinal Absorption;Intestinal Secretions/chemistry;Intestinal Secretions/metabolism*;Intestine, Small/metabolism*;Models, Biological*;Permeability;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Postprandial Period;Solubility
23989967;Administration, Oral;Adolescent;Biological Availability;Child;Cross-Over Studies;Deamino Arginine Vasopressin/administration & dosage*;Deamino Arginine Vasopressin/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Freeze Drying*;Humans;Male;Metabolic Clearance Rate/physiology;Nocturnal Enuresis/blood*;Nocturnal Enuresis/drug therapy*;Tablets;Therapeutic Equivalency
23979737;Administration, Oral;Adult;Antitubercular Agents/blood;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Nitroimidazoles/blood;Nitroimidazoles/pharmacokinetics*
23955148;Administration, Oral;Animals;Cross-Over Studies;Dogs;Food-Drug Interactions*;Humans;In Vitro Techniques;Models, Biological*;Pharmacokinetics;Solubility
23939880;Adult;Bile Acids and Salts/metabolism;Body Fluids/metabolism*;Eating;Fasting/metabolism;Female;Food-Drug Interactions;Gastrointestinal Contents;HIV Protease Inhibitors/metabolism*;Humans;Hydrogen-Ion Concentration;Intestines/metabolism*;Male;Micelles;Postprandial Period;Ritonavir/metabolism;Solubility;Young Adult
23939537;Administration, Sublingual;Adult;Area Under Curve;Cross-Over Studies;Diet, High-Fat*;Fasting/blood*;Female;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Middle Aged;Pyridines/administration & dosage;Pyridines/blood;Pyridines/pharmacokinetics*;Solubility;Tablets;Young Adult
23934742;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Clinical Trials as Topic;Depression/drug therapy*;Depression/enzymology;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Tyramine/pharmacology
23928870;Adult;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Cytochrome P-450 CYP2C9/genetics;Cytochrome P-450 CYP2C9/metabolism;Female;Food-Drug Interactions/genetics*;Genotype*;Humans;Male;Middle Aged;Pharmacogenetics/methods;Polymorphism, Single Nucleotide*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Vitamin K Epoxide Reductases/genetics*;Vitamin K Epoxide Reductases/metabolism;Warfarin/administration & dosage*;Warfarin/adverse effects
23927483;Adolescent;Adult;Analysis of Variance;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Energy Intake;Epoprostenol/analogs & derivatives*;Epoprostenol/pharmacokinetics;Female;Food;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Middle Aged;Nutritive Value;Tandem Mass Spectrometry;Young Adult
23926628;Adverse Drug Reaction Reporting Systems;Angiotensin II Type 1 Receptor Blockers/therapeutic use;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Anti-Arrhythmia Agents/therapeutic use;Beverages*;Cardiotonic Agents/therapeutic use;Cardiovascular Agents/therapeutic use*;Cardiovascular Diseases/drug therapy*;Dietary Supplements*;Drug Interactions;Food;Food-Drug Interactions*;Humans;Vitamins*
23926058;Administration, Oral;Adolescent;Adult;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions*/physiology;Humans;Male;Middle Aged;Organophosphates/administration & dosage*;Organophosphates/pharmacokinetics*;Oxazoles/administration & dosage*;Oxazoles/pharmacokinetics*;Prodrugs/administration & dosage*;Prodrugs/chemistry;Prodrugs/pharmacokinetics*;Young Adult
23917982;Critical Care/methods;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions*;Humans;Intensive Care Units;Nutritional Support/adverse effects;Nutritional Support/methods;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods*
23893461;Administration, Oral;Adult;Aged;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Diet, High-Fat;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;MAP Kinase Kinase 1/antagonists & inhibitors;MAP Kinase Kinase 2/antagonists & inhibitors;Male;Middle Aged;Neoplasms/metabolism*;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyridones/blood;Pyridones/pharmacokinetics*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*
23888935;Adult;Analysis of Variance;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Ethnic Groups;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Imidazoles/pharmacokinetics*;Male;Middle Aged;Pyridazines/pharmacokinetics*;Sex Characteristics;Tandem Mass Spectrometry;Young Adult
23888632;Citrus paradisi*;Evidence-Based Medicine;Food-Drug Interactions*;United Kingdom
23878024;Adult;Animals;Anti-Allergic Agents/blood;Anti-Allergic Agents/pharmacokinetics*;Beverages*/analysis;COS Cells;Cercopithecus aethiops;Citrus paradisi*;Coumarins/analysis;Cross-Over Studies;Estrone/analogs & derivatives;Estrone/metabolism;Female;Flavonoids/analysis;Food-Drug Interactions*;Fruit;HEK293 Cells;Humans;Male;Middle Aged;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Young Adult
23870611;Administration, Oral;Adult;Asian Continental Ancestry Group;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Tolerance;Food*;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Succinates/administration & dosage;Succinates/pharmacokinetics*;Tablets, Enteric-Coated
23849436;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Phenoxyacetates/adverse effects;Phenoxyacetates/pharmacokinetics*;Tablets
23832397;Administration, Oral;Adult;Aged;Aged, 80 and over;Aurora Kinase A/antagonists & inhibitors*;Cohort Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasm Metastasis;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Norbornanes/administration & dosage*;Norbornanes/adverse effects;Norbornanes/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics;Treatment Outcome;Young Adult
27024600;Beverages;Citrus paradisi*;Food-Drug Interactions*;Heart;Humans
23794501;Animals;Beverages/analysis*;Citrus paradisi/chemistry*;Citrus sinensis/chemistry*;Estrone/analogs & derivatives;Estrone/pharmacokinetics;Flavonoids/chemistry;Flavonoids/isolation & purification;Flavonoids/metabolism;Food-Drug Interactions*;Gene Expression;Intestinal Absorption/drug effects;Malus/chemistry*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Xenopus
23789936;Administration, Oral;Aged;Aged, 80 and over;Biological Availability;Capsules;Disease Progression;Dose-Response Relationship, Drug;Dyspnea/chemically induced;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glycine/administration & dosage;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/therapeutic use;Humans;Male;Middle Aged;Myelodysplastic Syndromes/blood;Myelodysplastic Syndromes/drug therapy*;Myelodysplastic Syndromes/enzymology;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/therapeutic use*;Remission Induction;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics;Sulfones/therapeutic use*;Treatment Outcome;Urologic Diseases/chemically induced
23789798;Administration, Oral;Administration, Topical;Adult;Airway Obstruction/prevention & control;Algorithms;Deglutition Disorders/physiopathology*;Dosage Forms*;Drug Prescriptions*;Food-Drug Interactions;Guideline Adherence;Hospitals, Urban/organization & administration;Humans;Pharmaceutical Preparations/classification;Pharmacy Service, Hospital*;Powders;Practice Guidelines as Topic*
23773634;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/pharmacokinetics;Arthritis, Rheumatoid/drug therapy*;Arthritis, Rheumatoid/enzymology;Calcineurin/metabolism;Calcineurin Inhibitors;Citrus paradisi;Enzyme Inhibitors/adverse effects;Folic Acid/adverse effects;Folic Acid/metabolism;Food-Drug Interactions*;Fruit/adverse effects;Humans;Isoniazid/adverse effects;Methotrexate/adverse effects;Risk Factors;Seafood/adverse effects
23773631;Animals;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents/therapeutic use*;Dietary Proteins/adverse effects;Dietary Supplements*/adverse effects;Food-Drug Interactions;Humans;Meat/adverse effects;Plant Preparations/therapeutic use*;Rheumatic Diseases/drug therapy*;Rheumatic Diseases/epidemiology;Rheumatic Diseases/immunology;Risk Factors;Treatment Outcome;Vitamin D/adverse effects;Vitamin D/therapeutic use*;Vitamin D Deficiency/drug therapy*;Vitamin D Deficiency/epidemiology;Vitamin D Deficiency/immunology
23757819;Aged;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Middle Aged
23750707;Animals;Benzilates/metabolism;Benzilates/pharmacokinetics*;Bile Acids and Salts/metabolism*;Caco-2 Cells;Cattle;Food-Drug Interactions;Glycochenodeoxycholic Acid/pharmacology;Humans;Intestinal Absorption/drug effects;Magnetic Resonance Spectroscopy;Male;Nortropanes/metabolism;Nortropanes/pharmacokinetics*;Rats;Rats, Wistar;Taurodeoxycholic Acid/pharmacology
23745231;Acne Vulgaris/drug therapy*;Administration, Oral;Dermatologic Agents/administration & dosage*;Dermatologic Agents/pharmacokinetics;Dermatologic Agents/therapeutic use;Food-Drug Interactions;Humans;Isotretinoin/administration & dosage*;Isotretinoin/pharmacokinetics;Isotretinoin/therapeutic use;Tablets
23740680;Drug-Related Side Effects and Adverse Reactions/etiology;Food;Food-Drug Interactions/physiology*;Humans;Medicine, Ayurvedic*;Treatment Outcome
23736966;Adolescent;Adult;Calcineurin Inhibitors*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/adverse effects;Cyclosporine/pharmacokinetics*;Diet, Fat-Restricted*;Diet, High-Fat*;Double-Blind Method;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
23735880;Adult;Anthocyanins/chemistry;Anthocyanins/toxicity*;Cell Survival/drug effects;Cytochrome P-450 CYP1A1/metabolism*;Dietary Supplements;Enzyme Inhibitors/toxicity;Female;Food-Drug Interactions;Gene Expression Regulation, Enzymologic/drug effects;Glucosides/chemistry;Glucosides/toxicity;Hep G2 Cells;Hepatocytes/drug effects*;Hepatocytes/metabolism;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Middle Aged;Protein Binding;Receptors, Aryl Hydrocarbon/drug effects*;Receptors, Aryl Hydrocarbon/metabolism;Signal Transduction/drug effects
23720136;Administration, Oral;Adult;Biological Availability;Breakfast;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Sucrose;Fasting/metabolism*;Female;Food, Formulated*;Food-Drug Interactions*;HIV Reverse Transcriptase/antagonists & inhibitors;Humans;Male;Meals;Middle Aged;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Proteins/administration & dosage;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics*;Rilpivirine;Young Adult
23719876;Anti-Retroviral Agents/administration & dosage*;Anti-Retroviral Agents/pharmacokinetics;Biological Availability*;Dosage Forms;Enteral Nutrition/methods;Enteral Nutrition/standards*;Food-Drug Interactions*;Humans;Intubation, Gastrointestinal
23715233;Antihypertensive Agents*/administration & dosage;Antihypertensive Agents*/adverse effects;Antihypertensive Agents*/therapeutic use;Colombia;Comorbidity;Cross-Sectional Studies;Culture;Drug Administration Schedule;Drug Interactions;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Humans;Hypertension/complications;Hypertension/drug therapy;Hypertension/physiopathology;Hypertension/psychology*;Male;Medication Adherence*/statistics & numerical data;Middle Aged;Patient Education as Topic;Patient Medication Knowledge*/statistics & numerical data;Physician-Patient Relations;Socioeconomic Factors;Urban Population
23711557;Adult;Anticoagulants/therapeutic use*;Cardiovascular Nursing/standards*;Drug Interactions;Europe;Female;Food-Drug Interactions;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Humans;International Normalized Ratio/nursing;Male;Middle Aged;Self Administration;Thrombosis/drug therapy;Thrombosis/nursing*;Thrombosis/prevention & control;Warfarin/therapeutic use
23710968;Food*;Food-Drug Interactions/physiology*;Humans;Nutritional Status/physiology;Pharmaceutical Preparations/metabolism*
23706685;Biotransformation/genetics;Carrier Proteins/genetics;Carrier Proteins/metabolism;Clinical Trials as Topic/methods;Confounding Factors (Epidemiology);Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical/methods;Drug Interactions*;Food-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Kidney/metabolism;Patient Selection;Pharmacokinetics;Plant Preparations/pharmacokinetics;Research Design*
23696038;Beverages/analysis;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood*;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/metabolism*;Citrus paradisi*/metabolism;Computer Simulation;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Models, Biological;Nifedipine/administration & dosage;Nifedipine/blood*;Nifedipine/chemistry;Nifedipine/metabolism*;Solubility
23686349;Absorption;Animals;Biological Transport;Drug Interactions;Food-Drug Interactions;Genotype;Humans;Membrane Transport Modulators/metabolism;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Permeability;Phenotype
23680730;Administration, Oral;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/chemistry*;Anti-Bacterial Agents/pharmacokinetics;Biological Availability;Cephalexin/blood;Cephalexin/chemistry*;Cephalexin/pharmacokinetics;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Dogs;Drug Compounding;Drug Delivery Systems*;Fasting/metabolism;Female;Food-Drug Interactions;Intestinal Absorption;Male;Tablets
23677858;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Adrenergic beta-Antagonists/pharmacokinetics;Adrenergic beta-Antagonists/therapeutic use;Adult;Area Under Curve;Beverages/adverse effects*;Blood Pressure/drug effects;Citrus paradisi*;Cross-Over Studies;Drug Interactions;Food-Drug Interactions;Half-Life;Heart Rate/drug effects;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology*;Male;Nadolol/pharmacokinetics*;Nadolol/pharmacology*;Rifampin/pharmacokinetics;Rifampin/pharmacology*;Young Adult
23674575;Disease Management*;Food-Drug Interactions*;Humans
23673492;Animals;Anti-Anxiety Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages*;Buspirone/pharmacokinetics;Caco-2 Cells;Calcium Channel Blockers/pharmacokinetics;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Evaluation, Preclinical;Drug Interactions*;Flurbiprofen/pharmacokinetics;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/pharmacokinetics;Hypoglycemic Agents/pharmacokinetics;Midazolam/pharmacokinetics;Nitrendipine/pharmacokinetics;Punicaceae/chemistry*;Tolbutamide/pharmacokinetics;Triazolam/pharmacokinetics
23669408;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Biotransformation;Canthaxanthin/adverse effects;Canthaxanthin/metabolism;Carotenoids/adverse effects;Carotenoids/metabolism*;Cryptoxanthins;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism*;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Isoenzymes/metabolism;Kinetics;Lutein/adverse effects;Lutein/metabolism;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Xanthophylls/adverse effects;Xanthophylls/metabolism;Xenobiotics/metabolism*;Zeaxanthins
23665448;Absorption;Administration, Oral;Adult;Biopharmaceutics/methods*;Biopharmaceutics/trends;Chemistry, Pharmaceutical/methods;Chemistry, Pharmaceutical/trends;Child;Computer Simulation;Drug Delivery Systems;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Pediatrics;Permeability;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemical synthesis;Solubility;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/trends
23637051;Adolescent;Benzoates/administration & dosage*;Beverages*;Blood Transfusion;Child;Child, Preschool;Female;Food*;Food-Drug Interactions*;Hematologic Diseases/therapy;Hemosiderosis/drug therapy*;Hemosiderosis/etiology;Humans;Iron Chelating Agents/administration & dosage*;Male;Triazoles/administration & dosage*
23636154;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug Interactions*;Drug Monitoring;Female;Food-Drug Interactions;Humans;Internet;Male;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Patient Education as Topic/methods*;Prescription Drugs/administration & dosage;Prescription Drugs/adverse effects*;Sex Factors;Surveys and Questionnaires;United States
23634851;Animals;Carcinogenesis/drug effects;Carcinogenesis/metabolism;Carcinogens/metabolism*;Chemoprevention;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Diet;Disease Models, Animal;Food-Drug Interactions/physiology;Humans;Inactivation, Metabolic/physiology;Phytochemicals/pharmacology*
23612358;Alcoholic Beverages;Chemistry, Pharmaceutical;Delayed-Action Preparations/administration & dosage;Drug Delivery Systems;Food;Food-Drug Interactions*;Gastrointestinal Tract/physiology*;Humans;Pharmaceutical Preparations/administration & dosage
23611558;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Dietary Supplements*;Everolimus;Fish Oils/administration & dosage;Food;Food-Drug Interactions*;Fruit/chemistry;Humans;Immunosuppression;Immunosuppressive Agents/pharmacology*;Patient Education as Topic;Plants, Medicinal/chemistry;Sirolimus/analogs & derivatives;Sirolimus/pharmacology;Tacrolimus/pharmacology;Transplantation*
23588449;Aged;Anticoagulants/pharmacology*;Chronic Disease;Coumarins/pharmacology*;Diet*;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vitamin K/administration & dosage*
23588433;Adrenergic alpha-Antagonists;Adrenergic beta-Antagonists;Antihypertensive Agents*/pharmacokinetics;Antihypertensive Agents*/pharmacology;Calcium Channel Blockers;Citrus paradisi;Diet;Diuretics;Food-Drug Interactions*;Humans
23558602;Adult;Area Under Curve;Capsules;Delayed-Action Preparations;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Omeprazole/administration & dosage;Omeprazole/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacokinetics*;Tablets, Enteric-Coated;Time Factors;Young Adult
23556334;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood*;Antifungal Agents/pharmacokinetics*;Area Under Curve;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions;Humans;Indicators and Reagents;Limit of Detection;Mass Spectrometry;Quality Control;Reproducibility of Results;Triazoles/administration & dosage;Triazoles/blood*;Triazoles/pharmacokinetics*
23553850;Adult;Aged;Aged, 80 and over;Anilides/administration & dosage;Anilides/adverse effects;Anilides/pharmacokinetics*;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasm Staging;Neoplasms/drug therapy*;Neoplasms/pathology*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Treatment Outcome
23550055;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23550054;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23536972;Administration, Oral;Animals;Area Under Curve;Dogs;Eating*;Fasting;Food-Drug Interactions*;Intestinal Absorption;Male;Models, Theoretical;Succinates/administration & dosage*;Succinates/blood;Succinates/metabolism;Succinates/pharmacokinetics*
23529727;Administration, Oral;Adult;Amidohydrolases/antagonists & inhibitors*;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male;Tablets;Treatment Outcome;Young Adult
23520584;Adolescent;Adult;Aged;Bacterial Infections/classification;Bacterial Infections/immunology;Bacterial Infections/prevention & control*;Child, Preschool;Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage*;Female;Food-Drug Interactions/immunology*;Humans;Immunization Schedule;Infant, Newborn;Male;Mass Vaccination*/methods;Mass Vaccination*/organization & administration;Mass Vaccination*/trends;Meningococcal Vaccines/administration & dosage*;Organizational Innovation;Pneumococcal Vaccines/administration & dosage*;Pregnancy;Vaccines, Conjugate/administration & dosage*;Viral Vaccines/administration & dosage*;Virus Diseases/classification;Virus Diseases/immunology;Virus Diseases/prevention & control*
23503449;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Food-Drug Interactions/physiology*;Humans;Male;Suspensions;Taiwan/epidemiology;Triazoles/administration & dosage*;Triazoles/pharmacokinetics*;Young Adult
23501043;Aged;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Glucagon-Like Peptide 2/administration & dosage*;Glucagon-Like Peptide 2/pharmacology;Humans;Infusions, Subcutaneous;Intestinal Absorption/drug effects;Male;Middle Aged;Short Bowel Syndrome/drug therapy*;Short Bowel Syndrome/physiopathology
23497885;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/chemistry*;ATP-Binding Cassette Transporters/metabolism;Biological Transport;Cell Line;Dietary Supplements/analysis;Down-Regulation*;Food-Drug Interactions;Humans;Neoplasm Proteins/chemistry*;Neoplasm Proteins/metabolism;Plant Extracts/chemistry*;Protein Binding
23497763;Acetanilides/administration & dosage;Acetanilides/adverse effects;Acetanilides/blood;Acetanilides/pharmacokinetics*;Administration, Oral;Adrenergic beta-Agonists/administration & dosage;Adrenergic beta-Agonists/adverse effects;Adrenergic beta-Agonists/blood;Adrenergic beta-Agonists/pharmacokinetics*;Adult;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Reference Values;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*
23495418;Cardiovascular Agents/adverse effects*;Citrus paradisi*;Food-Drug Interactions*;Humans
23480875;Administration, Oral;Adult;Animals;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Combinations;Ethanolamines/pharmacokinetics*;Female;Fluorenes/pharmacokinetics*;Food-Drug Interactions;Humans;Male;Milk*;Plant Oils/pharmacology*;Uganda;Zea mays*
23478684;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/therapeutic use;Beverages;Biological Availability;Citrus paradisi;Diet;Dietary Fiber;Feeding Behavior;Food-Drug Interactions/physiology*;Humans;Plants, Medicinal
23466046;Animals;Deficiency Diseases/chemically induced*;Deficiency Diseases/diet therapy;Deficiency Diseases/epidemiology;Deficiency Diseases/prevention & control;Dietary Supplements;Food-Drug Interactions*;Humans;Micronutrients/administration & dosage;Micronutrients/deficiency;Micronutrients/metabolism*;Micronutrients/therapeutic use;Prescription Drugs/adverse effects*;Risk
23458226;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics*;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Models, Statistical;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Postprandial Period;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/chemistry;Thiophenes/pharmacokinetics*;Young Adult
23456771;Abnormalities, Drug-Induced/physiopathology;Abnormalities, Drug-Induced/prevention & control;Adult;Animals;Anticonvulsants/administration & dosage*;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Biotransformation;Body Temperature;Child;Circadian Rhythm/physiology;Drug Chronotherapy*;Drug Delivery Systems;Epilepsy/drug therapy;Epilepsy/physiopathology;Epilepsy/prevention & control;Epilepsy/therapy;Food-Drug Interactions;Gene Expression Regulation;Humans;Hydrocortisone/secretion;Intestinal Absorption;Melatonin/secretion;Melatonin/therapeutic use;Mice;Phototherapy;Prospective Studies;Randomized Controlled Trials as Topic;Retrospective Studies;Sleep Stages/physiology
23447089;Administration, Oral;Animals;Area Under Curve;Chromatography, Liquid;Dietary Fats;Dogs;Fluorobenzenes/administration & dosage;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Models, Biological*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Tandem Mass Spectrometry;Tissue Distribution
23444432;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
23444431;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
23442116;Arsenic/pharmacokinetics*;Bile Acids and Salts/chemistry;Bile Acids and Salts/metabolism*;Computer Simulation;Digestion;Fatty Acids/chemistry;Fatty Acids/metabolism*;Food-Drug Interactions*;Gastrointestinal Tract/metabolism*;Humans;Hydrogen-Ion Concentration;Models, Biological;Oryza/chemistry;Reference Standards;Risk Assessment;Soil Pollutants/pharmacokinetics*;Trace Elements/analysis
23434923;Administration, Oral;Animals;Buffers;Calibration;Chromatography, High Pressure Liquid;Dogs;Drug Evaluation, Preclinical;Fasting*;Food-Drug Interactions;Gastric Juice/drug effects;Gastrointestinal Contents/chemistry;Gastrointestinal Tract/drug effects*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Osmolar Concentration;Phospholipids/chemistry;Solubility;Surface Tension
23420518;Administration, Oral;Antineoplastic Agents*/administration & dosage;Antineoplastic Agents*/chemistry;Antineoplastic Agents*/pharmacokinetics;Biological Availability;Drug Stability;Food-Drug Interactions;Humans;Solubility
23419230;Administration, Cutaneous;Administration, Oral;Caregivers/education;Cognitive Therapy;Combined Modality Therapy;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Food-Drug Interactions;Humans;Medication Adherence*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Motivational Interviewing;Patient Education as Topic;Treatment Failure
23417765;Administration, Oral;Adolescent;Adult;Asian Continental Ancestry Group*;Eating/drug effects;Eating/physiology*;Female;Food-Drug Interactions/physiology*;Humans;Male;Piperazines/administration & dosage*;Piperazines/blood*;Piperazines/pharmacokinetics;Piperidines/administration & dosage*;Piperidines/blood*;Piperidines/pharmacokinetics;Young Adult
23412805;Adult;Aged;Aged, 80 and over;Antineoplastic Agents, Hormonal/therapeutic use*;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism;Breast Neoplasms/drug therapy*;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Coffee*;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C8;Female;Food-Drug Interactions*;Genotype;Humans;Middle Aged;Receptors, Estrogen/metabolism*;Tamoxifen/therapeutic use*
23405822;Aged;Aged, 80 and over;Food-Drug Interactions*;Humans;Long-Term Care;Middle Aged;Nursing Homes;Risk Assessment
23402972;Animals;Body Fluids/drug effects*;Body Fluids/metabolism;Caco-2 Cells;Food*;Food-Drug Interactions;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage;Indinavir/chemistry;Indinavir/pharmacokinetics*;Intestinal Absorption/drug effects*;Intestines/drug effects*;Intestines/metabolism;Male;Mice;Solubility
23399607;Citrus paradisi;Diabetes Mellitus, Type 2/drug therapy*;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Male;Middle Aged;Musculoskeletal Pain/chemically induced*;Myositis/chemically induced*;Quality of Life;Simvastatin/adverse effects*;Simvastatin/therapeutic use
23384079;Dietary Supplements*;Food-Drug Interactions;Humans;Preventive Medicine;Science*
23373097;Beverages;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
23362039;Aging*;Alcohol Drinking/adverse effects;Alcohol Drinking/epidemiology*;Alcoholism/epidemiology;Australia/epidemiology;Binge Drinking/epidemiology;Disease Susceptibility;Europe/epidemiology;Food-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/therapeutic use*;North America/epidemiology;Patient Compliance;Prevalence;Substance-Related Disorders/epidemiology
23356842;Animals;Area Under Curve;Beverages*;Ciprofloxacin/pharmacology*;Citrus paradisi*;Cytochrome P-450 CYP1A2 Inhibitors;Drug Interactions;Food-Drug Interactions;Intestinal Absorption/physiology;Male;Permeability;Rats;Rats, Wistar;Riluzole/pharmacokinetics*
23340477;Food Labeling*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Patient Safety*;Protein Kinase Inhibitors/therapeutic use*;Protein-Tyrosine Kinases/antagonists & inhibitors*
23331476;Beverages/adverse effects;Blood Glucose/analysis;Caffeine/adverse effects*;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Diabetes Mellitus, Type 2/blood*;Diabetes Mellitus, Type 2/metabolism;Diabetes, Gestational/blood;Diabetes, Gestational/metabolism;Evidence-Based Medicine*;Female;Food-Drug Interactions;Humans;Hyperglycemia/chemically induced*;Hyperinsulinism/chemically induced;Hypoglycemia/chemically induced;Hypoglycemic Agents/therapeutic use;Insulin/therapeutic use;Insulin Resistance*;Male;Pregnancy;Randomized Controlled Trials as Topic
23329786;Diarrhea/etiology;Diarrhea/pathology;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intubation, Gastrointestinal/adverse effects;Nutritional Status;Osmolar Concentration;Pharmaceutical Preparations/administration & dosage*
23297175;Beverages*;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/adverse effects;Furocoumarins/analysis;Humans;Organic Anion Transporters/metabolism;Pharmacokinetics*
23282066;Animals;Beverages;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;Humans;Hydroxylation;Kinetics;Male;Mice;Mice, Inbred BALB C;Microsomes/metabolism;Midazolam/blood;Midazolam/pharmacokinetics*;Models, Animal;Oxidoreductases, N-Demethylating/metabolism;Rats;Rats, Sprague-Dawley;Species Specificity;Tandem Mass Spectrometry;Triazolam/blood;Triazolam/pharmacokinetics*
23279674;Adrenergic beta-Antagonists/adverse effects;Angiotensin Receptor Antagonists/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Antihypertensive Agents/adverse effects*;Calcium Channel Blockers/adverse effects;Food-Drug Interactions;Humans;Hypertension/drug therapy;Risk Factors;Sodium Chloride Symporter Inhibitors/adverse effects;Trace Elements/deficiency;Trace Elements/metabolism*;Zinc/deficiency;Zinc/metabolism*
23278367;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Eating;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Phosphorous Acids/adverse effects;Phosphorous Acids/blood;Phosphorous Acids/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Tenofovir
24937393;Acetylcholine/pharmacology;Animals;Carbachol/pharmacology;Cholinergic Agonists/pharmacology;Diet*;Dose-Response Relationship, Drug;Food-Drug Interactions;Gastrointestinal Motility*/drug effects;Gastrointestinal Transit;Honey*;Ileum/drug effects;Ileum/physiology*;Male;Muscle, Smooth/drug effects;Muscle, Smooth/physiology*;Rats, Wistar
23264447;Absorption;Animals;Beverages*;Binding Sites;Binding, Competitive;Biological Transport;Citrus paradisi*;Citrus sinensis*;Estrone/analogs & derivatives*;Estrone/metabolism;Food-Drug Interactions*;Fruit;Kinetics;Malus*;Oocytes;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Terfenadine/analogs & derivatives*;Terfenadine/metabolism;Xenopus laevis
23248072;Adolescent;Adult;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacology*;Antiparkinson Agents/urine;Catechol O-Methyltransferase/metabolism;Catechol O-Methyltransferase Inhibitors*;Cross-Over Studies;Double-Blind Method;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacology*;Enzyme Inhibitors/urine;Erythrocytes/drug effects;Erythrocytes/enzymology;Food-Drug Interactions;Humans;Male;Middle Aged;Models, Biological;Oxadiazoles/blood;Oxadiazoles/pharmacology*;Oxadiazoles/urine;Young Adult
23230999;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Doxylamine/administration & dosage;Doxylamine/adverse effects;Doxylamine/analogs & derivatives*;Doxylamine/pharmacokinetics;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics*;Tablets, Enteric-Coated;Young Adult
23220613;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Capsaicin/administration & dosage*;Capsaicin/pharmacokinetics;Capsicum/chemistry;Chromatography, Liquid;Cytochrome P-450 CYP3A/metabolism;Dexamethasone/administration & dosage;Female;Food-Drug Interactions*;Ketoconazole/administration & dosage;Mass Spectrometry;Rats;Rats, Sprague-Dawley;Simvastatin/administration & dosage;Simvastatin/pharmacokinetics*
23211396;Administration, Oral;Adult;Azepines/pharmacokinetics*;Benzamides/pharmacokinetics*;Cross-Over Studies;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male
23200637;Adult;Beverages*;Cytochromes/blood;Food-Drug Interactions*;Fruit;Heart Transplantation;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacology*;Male;Punicaceae*;Tacrolimus/blood;Tacrolimus/pharmacology*
23190017;Administration, Oral;Adolescent;Adult;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Middle Aged;Oxazines/administration & dosage;Oxazines/pharmacokinetics*;Pharmaceutical Solutions;Prodrugs;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Tyrosine Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Suspensions;Syk Kinase;Tablets;Young Adult
23184849;Acute Kidney Injury/chemically induced;Beverages/adverse effects*;Biological Availability;Breast Neoplasms/chemically induced;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Fruit/metabolism;Furocoumarins/metabolism;Humans;Metabolic Detoxication, Phase I*;Pharmaceutical Preparations/metabolism;Rhabdomyolysis/chemically induced;Risk Factors;Torsades de Pointes/chemically induced
23184666;Adolescent;Adult;Analysis of Variance;Area Under Curve;Arrhythmias, Cardiac/chemically induced*;Arrhythmias, Cardiac/diagnosis;Arrhythmias, Cardiac/physiopathology;Biotransformation;Caffeine/administration & dosage;Caffeine/adverse effects*;Chi-Square Distribution;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Drug Interactions;Electrocardiography;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heart Rate/drug effects*;Hematologic Agents/administration & dosage;Hematologic Agents/adverse effects*;Hematologic Agents/blood;Hematologic Agents/pharmacokinetics*;Humans;Hydroxylation;Intestinal Absorption;London;Male;Metabolic Clearance Rate;Postprandial Period;Quinazolines/administration & dosage;Quinazolines/adverse effects*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Young Adult
23167572;Adolescent;Adult;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/chemistry;Antiprotozoal Agents/pharmacokinetics*;China;Chromatography, High Pressure Liquid/methods*;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Humans;Male;Ornidazole/administration & dosage;Ornidazole/chemistry;Ornidazole/pharmacokinetics*;Stereoisomerism;Young Adult
23165864;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2C19;Female;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Sex Characteristics;Thalidomide/adverse effects;Thalidomide/pharmacokinetics*
23157216;Aged;Food-Drug Interactions*;Humans;Nutritional Status;Polypharmacy*
23156527;Economics, Pharmaceutical;Folic Acid/metabolism;Food-Drug Interactions*;Humans;Minerals/metabolism;Pharmacokinetics;Trace Elements/metabolism;Vitamin D/metabolism;Vitamin K/metabolism
23146039;Amodiaquine/analogs & derivatives;Amodiaquine/metabolism*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Honey*;Inhibitory Concentration 50;Kinetics;Recombinant Proteins/metabolism
23146034;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Furocoumarins/pharmacology*;Hep G2 Cells;Humans;Ketoconazole/pharmacology;Models, Biological*;NADPH-Ferrihemoprotein Reductase/antagonists & inhibitors*;Nifedipine/metabolism*;Plant Extracts/pharmacology;RNA, Messenger/metabolism
23139017;Animals;Biopharmaceutics/classification*;Computer Simulation*;Dogs;Drug Discovery*;Food-Drug Interactions*;Humans;Mice;Rats
23132664;Animals;Beverages*;Citrus paradisi*;Citrus sinensis*;Dose-Response Relationship, Drug;Estrone/analogs & derivatives*;Estrone/metabolism;Flavanones/pharmacology;Flavonoids/pharmacology*;Food-Drug Interactions*;Fruit;Hesperidin/pharmacology;Humans;Kinetics;Least-Squares Analysis;Malus*;Models, Biological;Nonlinear Dynamics;Oocytes;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Osmolar Concentration;Phlorhizin/pharmacology;Quercetin/pharmacology;Xenopus laevis
23126367;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adenosine/analogs & derivatives*;Adenosine/pharmacokinetics;Adult;Area Under Curve;Beverages*;Blood Platelets;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/pharmacokinetics*;Purinergic P2Y Receptor Antagonists/pharmacokinetics*;Young Adult
23117668;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use;Blood Coagulation/drug effects*;Blood Coagulation Tests;Dabigatran;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring*;Food-Drug Interactions;Hemostasis/drug effects;Humans;Morpholines/adverse effects;Morpholines/pharmacokinetics;Morpholines/therapeutic use;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics;Pyrazoles/therapeutic use;Pyridones/adverse effects;Pyridones/pharmacokinetics;Pyridones/therapeutic use;Rivaroxaban;Switzerland;Thiophenes/adverse effects;Thiophenes/pharmacokinetics;Thiophenes/therapeutic use;Thromboembolism/blood;Thromboembolism/drug therapy*;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
23104241;Administration, Oral;Adult;Anticonvulsants/adverse effects;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood*;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Caffeine/adverse effects;Case-Control Studies;Central Nervous System Stimulants/adverse effects;Chi-Square Distribution;Chromatography, High Pressure Liquid;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/blood*;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Cross-Sectional Studies;Drug Interactions;Drug Monitoring/methods;Drug Resistance*;Female;Food-Drug Interactions;Humans;Least-Squares Analysis;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Psychiatric Status Rating Scales;Risk Factors;Schizophrenia/blood;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Schizophrenic Psychology;Spectrophotometry, Ultraviolet;Treatment Failure;Valproic Acid/adverse effects
23102570;Antineoplastic Agents/therapeutic use*;Energy Drinks/adverse effects*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*
23101976;Absorption;Acetaldehyde/metabolism;Alcohol Dehydrogenase/classification;Alcohol Dehydrogenase/genetics;Alcohol Dehydrogenase/metabolism;Alcoholism/metabolism;Cytochrome P-450 CYP2E1/metabolism;Electron Transport;Ethanol/blood;Ethanol/metabolism*;Female;Food-Drug Interactions;Humans;Kinetics;Liver/metabolism;Male;NAD/metabolism;Oxidation-Reduction;Tissue Distribution
23097095;Coffee/adverse effects*;Drug Carriers/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Thyroxine/pharmacokinetics*
23065939;Algorithms;Food-Drug Interactions*;Intestinal Absorption*;Intestines/metabolism;Micelles;Models, Biological*;Molecular Dynamics Simulation;Pharmaceutical Preparations/metabolism
23065713;Flavanones/chemistry*;Food-Drug Interactions*;Glucosides/chemistry*;Glucuronosyltransferase/metabolism*;Glycyrrhiza/chemistry;Humans;Hymecromone/metabolism;Isoenzymes/metabolism;Kinetics
23052407;Administration, Oral;Adolescent;Adult;Biological Availability;Breakfast;Cannabidiol/administration & dosage;Cannabidiol/blood;Cannabidiol/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage;Dronabinol/administration & dosage;Dronabinol/blood;Dronabinol/pharmacokinetics*;Drug Combinations;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged;Mouth Mucosa/metabolism*;Oral Sprays;Young Adult
23047652;Adult;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Beverages*;Cytochrome P-450 CYP2C9;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Humans;In Vitro Techniques;Inhibitory Concentration 50;Male;Middle Aged;Plant Extracts/pharmacology;Punicaceae/chemistry*;Young Adult
23033114;Administration, Oral;Animals;Beverages*;Biological Availability;Food-Drug Interactions*;Fruit*;Humans;Organic Anion Transporters/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism
23027198;Adolescent;Adult;Aged;Antifungal Agents/administration & dosage;Antifungal Agents/therapeutic use*;Biological Availability;Chromatography, High Pressure Liquid;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Diseases/metabolism;Hematopoietic Stem Cell Transplantation;Humans;Immunosuppressive Agents/adverse effects;Leukemia, Myeloid, Acute/metabolism*;Male;Middle Aged;Multivariate Analysis;Myelodysplastic Syndromes/metabolism*;Prospective Studies;Spectrophotometry, Ultraviolet;Tacrolimus/adverse effects;Triazoles/administration & dosage;Triazoles/therapeutic use*;Young Adult
23010558;Adult;Aged;Benzamides/administration & dosage;Benzamides/adverse effects;Benzamides/pharmacokinetics;Benzamides/therapeutic use*;Blood Glucose/analysis;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Administration Schedule;Enzyme Activators/administration & dosage;Enzyme Activators/adverse effects;Enzyme Activators/pharmacokinetics;Enzyme Activators/therapeutic use*;Fasting;Female;Food-Drug Interactions*;Glucokinase/metabolism;Half-Life;Humans;Hyperglycemia/prevention & control*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Single-Blind Method;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics;Sulfones/therapeutic use*
22998389;Animals;Antioxidants/adverse effects;Antioxidants/metabolism*;Antioxidants/therapeutic use;Biotransformation;Dietary Supplements*/adverse effects;Enzyme Induction;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/therapeutic use;Flavonoids/adverse effects;Flavonoids/metabolism*;Flavonoids/therapeutic use;Food-Drug Interactions;Glutathione Transferase/antagonists & inhibitors;Glutathione Transferase/biosynthesis*;Glutathione Transferase/chemistry;Glutathione Transferase/metabolism;Humans;Liver/drug effects;Liver/enzymology;Liver/metabolism;Xenobiotics/pharmacokinetics
22951241;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Anxiety Disorders/diagnosis;Anxiety Disorders/drug therapy;Anxiety Disorders/psychology;Bipolar Disorder/diagnosis;Bipolar Disorder/drug therapy;Bipolar Disorder/psychology;Comorbidity;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Medication Adherence;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Primary Health Care*;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology
22951239;Administration, Cutaneous;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Risk Factors;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Tyramine/administration & dosage;Tyramine/adverse effects
22951238;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Serotonin Agents/administration & dosage;Serotonin Agents/adverse effects;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Sympathomimetics/administration & dosage;Sympathomimetics/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects
22951237;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Cross-Cultural Comparison;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy;Depressive Disorder, Major/psychology;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;General Practice;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Practice Guidelines as Topic;Referral and Consultation;Risk Factors;Secondary Prevention;Treatment Outcome
22956350;Administration, Oral;Asian Continental Ancestry Group;Febuxostat;Female;Food-Drug Interactions;Gout Suppressants/administration & dosage;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics*;Humans;Indicators and Reagents;Male;Sex Characteristics;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Xanthine Oxidase/antagonists & inhibitors;Young Adult
22955172;Administration, Oral;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;European Continental Ancestry Group;Food-Drug Interactions*;Half-Life;Humans;Japan;Male;Stereoisomerism;Thalidomide/administration & dosage;Thalidomide/analogs & derivatives*;Thalidomide/pharmacokinetics;Time Factors;Young Adult
22953828;2-Pyridinylmethylsulfinylbenzimidazoles/chemistry*;Animals;Cattle;Food-Drug Interactions*;Protein Binding;Serum Albumin, Bovine/chemistry;Serum Albumin, Bovine/metabolism;Spectrum Analysis/methods*
22951980;Acetates/pharmacokinetics*;Adult;Anti-Asthmatic Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Prospective Studies;Quinolines/pharmacokinetics*;Young Adult
22950522;Administration, Oral;Adolescent;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Methotrexate/administration & dosage;Middle Aged;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Serine-Threonine Kinases/antagonists & inhibitors*;Young Adult
22943970;Administration, Oral;Adult;Area Under Curve;Blood Glucose/drug effects;Dipeptidyl Peptidase 4/drug effects;Dipeptidyl Peptidase 4/metabolism;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Glucagon-Like Peptide 1/drug effects;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Insulin/blood;Linear Models;Male;Piperazines/administration & dosage*;Piperazines/pharmacokinetics;Piperazines/pharmacology;Republic of Korea;Young Adult
22943633;Adult;Anthocyanins/analysis;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages/adverse effects*;Beverages/analysis;Blueberry Plants/adverse effects*;Blueberry Plants/chemistry;Buspirone/pharmacokinetics*;Citrus paradisi/adverse effects;Citrus paradisi/chemistry;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Furocoumarins/analysis;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Middle Aged;Phenols/analysis
22943121;Animals;Depression/drug therapy*;Depression/physiopathology;Drug Design*;Drug Interactions;Food-Drug Interactions;Heart Failure/drug therapy;Heart Failure/physiopathology;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neurodegenerative Diseases/drug therapy;Neurodegenerative Diseases/physiopathology;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology
22943117;Administration, Oral;Animals;Chronic Disease;Dermatologic Agents/administration & dosage*;Dermatologic Agents/pharmacokinetics;Dermatologic Agents/pharmacology;Drug Interactions;Eczema/drug therapy*;Eczema/pathology;Food-Drug Interactions;Hand Dermatoses/drug therapy;Hand Dermatoses/pathology;Humans;Tretinoin/administration & dosage*;Tretinoin/pharmacokinetics;Tretinoin/pharmacology
22940371;Adolescent;Adult;Beverages;Citrus/chemistry*;Citrus paradisi/chemistry*;Colchicine/adverse effects;Colchicine/pharmacokinetics*;Drug Labeling;Female;Food-Drug Interactions*;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics;Humans;Male;Middle Aged;Time Factors;Young Adult
22937625;Adult;Beverages/adverse effects*;Child;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
22932947;Adult;Antithyroid Agents/administration & dosage;Antithyroid Agents/blood;Antithyroid Agents/pharmacokinetics;Antithyroid Agents/therapeutic use;Capsules;Chemistry, Pharmaceutical;Coffee/adverse effects*;Cross-Over Studies;Drug Carriers/administration & dosage;Drug Carriers/pharmacokinetics*;Drug Carriers/therapeutic use;Female;Food-Drug Interactions*;Gels;Goiter, Nodular/drug therapy;Hormone Replacement Therapy;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy;Hypothyroidism/metabolism;Intestinal Absorption*;Male;Middle Aged;Neoplasm Recurrence, Local/drug therapy;Thyroid Gland/drug effects;Thyroid Gland/secretion;Thyroid Nodule/drug therapy;Thyrotropin/blood;Thyrotropin/secretion;Thyroxine/administration & dosage;Thyroxine/blood;Thyroxine/pharmacokinetics*;Thyroxine/therapeutic use
22931521;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Clinical Trials as Topic;Drug Discovery;Drug Interactions;Food-Drug Interactions;Glomerular Filtration Rate;Humans;Inactivation, Metabolic;Kidney Diseases/complications*;Kidney Diseases/metabolism;Thromboembolism/blood;Thromboembolism/complications;Thromboembolism/drug therapy*;Treatment Outcome
22927137;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Alkaloids/administration & dosage*;Animals;Benzodioxoles/administration & dosage*;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/metabolism;Diltiazem/pharmacokinetics*;Food-Drug Interactions;Gene Expression/drug effects;Hep G2 Cells;Humans;Male;Piperidines/administration & dosage*;Polyunsaturated Alkamides/administration & dosage*;Rats;Rats, Sprague-Dawley;Receptors, Steroid/metabolism*
22926611;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/therapeutic use;Caffeine/isolation & purification;Caffeine/pharmacology*;Carbonated Beverages;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Schizophrenia, Paranoid/drug therapy;Young Adult
22908106;Child, Preschool;Congenital Hypothyroidism/blood;Congenital Hypothyroidism/drug therapy*;Female;Food-Drug Interactions*;Humans;Infant, Newborn;Lactose Intolerance;Soy Milk/administration & dosage*;Thyrotropin/blood;Thyroxine/administration & dosage*
22897361;Biological Availability*;Cacao/metabolism;Citrus/metabolism;Coffee/metabolism;Fatty Acids, Unsaturated/pharmacokinetics;Fish Oils/pharmacokinetics;Food*;Food Industry;Food-Drug Interactions/physiology;Humans;Intestinal Absorption/physiology;Plant Preparations/pharmacokinetics;Tea/metabolism
22893357;Acute-Phase Reaction/chemically induced;Aged;Bone Density/drug effects*;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/adverse effects;Bone Density Conservation Agents/pharmacology*;Bone Remodeling/drug effects;Calcium, Dietary/administration & dosage;Calcium, Dietary/pharmacology*;Diphosphonates/administration & dosage;Diphosphonates/adverse effects;Diphosphonates/pharmacology*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Hip Joint/physiopathology;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacology*;Lumbar Vertebrae/physiopathology;Middle Aged;Osteoporosis, Postmenopausal/blood;Osteoporosis, Postmenopausal/drug therapy;Osteoporosis, Postmenopausal/physiopathology;Randomized Controlled Trials as Topic;Vitamin D/analogs & derivatives*;Vitamin D/blood
22892338;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/toxicity*;Biotransformation;Citrus paradisi;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Diclofenac/metabolism;Diclofenac/pharmacokinetics;Diclofenac/toxicity*;Female;Food-Drug Interactions;Glutathione/metabolism;Humans;In Vitro Techniques;Intestinal Diseases/chemically induced*;Intestinal Diseases/pathology*;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Intestine, Small/enzymology*;Intestine, Small/pathology*;Male;Mice;Mice, Knockout;Microsomes/drug effects;Microsomes/enzymology;Middle Aged;Ulcer/chemically induced;Ulcer/pathology
22884524;Animals;Arylsulfotransferase/physiology;Beverages;Biological Transport;Citrus paradisi;Cytochrome P-450 CYP3A/physiology;Food-Drug Interactions*;Glucuronosyltransferase/physiology;Humans;Intestines/metabolism*
22877817;Food-Drug Interactions*;Humans;Hydroxybenzoates/pharmacology*;Inhibitory Concentration 50;Organic Anion Transporters/classification;Organic Anion Transporters/drug effects*
22874769;Adenocarcinoma/diet therapy;Adenocarcinoma/drug therapy*;Adenocarcinoma/metabolism;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Apoptosis/drug effects*;Camptothecin/analogs & derivatives;Camptothecin/pharmacology;Camptothecin/therapeutic use;Cell Line, Tumor;Cell Survival/drug effects;Colonic Neoplasms/diet therapy;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Combined Modality Therapy;Dietary Supplements;Drug Resistance, Neoplasm*;Emulsions;Fatty Acids, Omega-3/metabolism;Fatty Acids, Omega-3/therapeutic use;Fish Oils/metabolism*;Fish Oils/therapeutic use;Fluorouracil/pharmacology;Fluorouracil/therapeutic use;Food-Drug Interactions;Humans;Membrane Potential, Mitochondrial/drug effects;Mitochondria/drug effects*;Mitochondria/metabolism;Organoplatinum Compounds/pharmacology;Organoplatinum Compounds/therapeutic use;bcl-2-Associated X Protein/metabolism
22866966;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Drug Interactions;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Medication Adherence;Pharmacogenetics*
22856466;Animals;Biomarkers/metabolism;Cell Proliferation/drug effects;Cell Shape/drug effects;Dietary Supplements/adverse effects;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/pathology;Estrogen Replacement Therapy/methods*;Female;Flax/adverse effects;Flax/chemistry*;Food-Drug Interactions*;Hyperplasia;Menopause*/metabolism;Ovariectomy/adverse effects;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Powders;Proliferating Cell Nuclear Antigen/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Seeds/adverse effects;Seeds/chemistry*;Uterus/drug effects*;Uterus/metabolism;Uterus/pathology
22849770;Adult;Area Under Curve;Blood Pressure/drug effects;Cyclopropanes/administration & dosage;Cyclopropanes/pharmacokinetics;Cyclopropanes/pharmacology*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Enalapril/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Male;Midazolam/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/pharmacokinetics;Pyridines/pharmacology*;Renin/antagonists & inhibitors*;Time Factors;Young Adult
22833934;Administration, Oral;Biological Availability*;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Solubility;Technology, Pharmaceutical*
22829430;Adult;Dietary Supplements/adverse effects*;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Lung Neoplasms/blood*;Lung Neoplasms/mortality*;Male;Middle Aged;Nutrition Surveys;Proportional Hazards Models;Risk Factors;United States/epidemiology;Vitamin A/blood*;Vitamin D/analogs & derivatives*;Vitamin D/blood;beta Carotene/blood
22818558;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Dabigatran;Drug Contamination;Drug Monitoring/methods*;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Heparin/administration & dosage;Heparin/adverse effects*;Humans;Hypersensitivity/etiology;Hypersensitivity/prevention & control;Injections, Subcutaneous/adverse effects;Necrosis/etiology;Necrosis/prevention & control;Osteoporosis/chemically induced;Osteoporosis/prevention & control;Skin Diseases/chemically induced;Skin Diseases/prevention & control;Subcutaneous Tissue/drug effects;Thrombocytopenia/chemically induced;Thrombocytopenia/prevention & control;Warfarin*/administration & dosage;Warfarin*/adverse effects;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*
22792553;Aged;Chronic Disease/drug therapy*;Chronic Disease/epidemiology;Combined Modality Therapy;Comorbidity;Drug Interactions;Drug Therapy, Combination;Evidence-Based Medicine;Family Practice*;Female;Food-Drug Interactions;Guideline Adherence;Humans;Specialization*;Switzerland
22788578;Animals;Anticarcinogenic Agents/adverse effects;Cardiotonic Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Stilbenes/adverse effects*;Vasodilator Agents/adverse effects;Wine/adverse effects;Wine/analysis
22782559;Benzilates;Biopharmaceutics/methods*;Buffers;Chemistry, Pharmaceutical;Computer Simulation;Food;Food-Drug Interactions*;Galactans/chemistry;Gastrointestinal Tract/metabolism*;Humans;Hypromellose Derivatives;Mannans/chemistry;Methylcellulose/analogs & derivatives;Methylcellulose/chemistry;Models, Biological*;Nortropanes/chemistry*;Nortropanes/pharmacokinetics;Permeability;Plant Gums/chemistry;Solubility;Tablets;Viscosity
22773284;Antibody Formation/drug effects;Antibody Formation/immunology;Breast Feeding*;Child Development/physiology*;Communicable Diseases/immunology*;Drug Contamination;Environmental Pollutants/adverse effects;Food-Drug Interactions/immunology;Health Promotion;Humans;Immunity, Cellular/drug effects;Immunity, Cellular/immunology;Infant, Newborn;Infection Control/methods*;Milk, Human/immunology*;Nervous System/growth & development;Vaccination/methods;Vaccines*/classification;Vaccines*/immunology;Vaccines*/pharmacology
22769968;Adsorption;Cyclic GMP/physiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/physiopathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/physiopathology;Hearing/drug effects;Heart/drug effects;Heart/physiopathology;Heart Diseases/chemically induced;Heart Diseases/physiopathology;Humans;Nervous System Diseases/chemically induced;Nervous System Diseases/physiopathology;Nitric Oxide/physiology;Phosphodiesterase 5 Inhibitors/adverse effects*;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Reproduction/drug effects;Tissue Distribution
22759198;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Double-Blind Method;Factor Xa Inhibitors*;Fasting;Fibrinolytic Agents/pharmacokinetics*;Fibrinolytic Agents/pharmacology;Food-Drug Interactions/physiology*;Half-Life;Humans;Male;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology;Pyridones/pharmacokinetics*;Pyridones/pharmacology;Time Factors;Young Adult
22759078;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Peroxides/adverse effects*;Peroxides/pharmacokinetics*;Young Adult
22735461;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Energy Intake;Factor Xa Inhibitors*;Fasting;Food-Drug Interactions*;Humans;Male;Partial Thromboplastin Time/statistics & numerical data;Prothrombin Time/statistics & numerical data;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Pyridones/pharmacology*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Pyrrolidines/pharmacology*
22718404;Administration, Oral;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Anticoagulants/classification;Anticoagulants/economics;Anticoagulants/therapeutic use;Atrial Fibrillation/complications*;Cross-Sectional Studies;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Humans;Medication Adherence;Middle Aged;Patient Preference*;Prescription Fees;Stroke/etiology;Stroke/prevention & control*;Thrombophilia/drug therapy*;Thrombophilia/etiology;Time Factors;Vitamin K/antagonists & inhibitors
22717418;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naltrexone/pharmacology;Narcotic Antagonists/pharmacology;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
22717215;Biological Availability;Dietary Supplements/adverse effects;Dietetics*;Energy Metabolism/drug effects;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Nutritional Status;Pharmacokinetics;Risk Factors
22715076;Circadian Rhythm;Drug Chronotherapy;Drug Therapy, Combination;Food-Drug Interactions*;General Practice;Germany;Humans;Pharmacokinetics;Risk Factors
22697192;Administration, Cutaneous;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Aged;Depressive Disorder/drug therapy*;Drug Eruptions/etiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Female;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Selegiline/administration & dosage*;Selegiline/adverse effects;Self-Injurious Behavior/chemically induced;Tyramine/adverse effects*;United States
22669570;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Sirolimus/adverse effects;Sirolimus/analogs & derivatives*;Sirolimus/pharmacokinetics;Stomatitis/chemically induced;Time Factors;Tonsillitis/chemically induced;Young Adult
22668071;Animals;Capsaicin/pharmacology*;Capsicum*;Cholinesterase Inhibitors/pharmacokinetics*;Food-Drug Interactions*;Galantamine/pharmacokinetics*;Rats;Sensory System Agents/pharmacology*
22660441;Adult;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacology*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacology*;Blood Pressure/drug effects*;Circadian Rhythm;Cross-Over Studies;Diet, High-Fat;Food-Drug Interactions;Humans;Male;Middle Aged;Models, Biological*;Pyrimidines/blood;Pyrimidines/pharmacology*;Tetrazoles/blood;Tetrazoles/pharmacology*;Young Adult
22652546;Administration, Oral;Caco-2 Cells;Chemical Precipitation;Computer Simulation*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Male;Models, Biological*;Permeability;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Solubility
22650326;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group*;China;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Least-Squares Analysis;Linear Models;Male;Metabolic Clearance Rate;Models, Biological;Postprandial Period;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/blood;Quinolones/pharmacokinetics*;Young Adult
22649154;Animals;Antioxidants/metabolism;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Atherosclerosis/metabolism;Atherosclerosis/physiopathology;Atherosclerosis/prevention & control*;Atherosclerosis/therapy;Combined Modality Therapy;Dietary Supplements;Disease Progression;Evidence-Based Medicine*;Food-Drug Interactions;Humans;Oxidative Stress/drug effects
22648626;Animals;CCAAT-Enhancer-Binding Protein-beta/genetics*;CCAAT-Enhancer-Binding Protein-beta/metabolism;Capsaicin/pharmacology*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions;Gene Expression Regulation/drug effects;Hep G2 Cells;Humans;Inactivation, Metabolic;Liver/drug effects;Liver/metabolism;Male;Nifedipine/analogs & derivatives;Nifedipine/blood;Nifedipine/pharmacokinetics;Promoter Regions, Genetic/drug effects;Proto-Oncogene Proteins c-akt/genetics;Proto-Oncogene Proteins c-akt/metabolism;Rats;Rats, Sprague-Dawley;Receptors, Steroid/genetics*;Receptors, Steroid/metabolism;Signal Transduction/drug effects;TRPV Cation Channels/metabolism;Up-Regulation
22648492;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Drug Administration Schedule;Drug Design*;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Humans;Time Factors;Venous Thromboembolism/drug therapy*;Venous Thromboembolism/pathology;Vitamin K/antagonists & inhibitors
22645121;Brain Injuries/therapy;Calcium/blood;Enteral Nutrition/methods;Evidence-Based Medicine*;Food-Drug Interactions;Humans;Hypocalcemia/diagnosis;Hypocalcemia/drug therapy;Hypocalcemia/physiopathology;Insulin/administration & dosage;Obesity/diet therapy;Pancreatitis/physiopathology;Pancreatitis/therapy;Phosphorus/administration & dosage;Renal Insufficiency, Chronic/drug therapy;Research*;Treatment Outcome;Warfarin/administration & dosage
22644797;Adult;Aged;Cross-Over Studies;Diarrhea/chemically induced;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Energy Intake*;Fasting;Fatigue/chemically induced;Female;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Indazoles/adverse effects;Indazoles/pharmacokinetics*;Male;Middle Aged;Nausea/chemically induced;Tablets;Young Adult
22634362;Alcoholic Intoxication/metabolism;Alcoholic Intoxication/prevention & control*;Animals;Anxiety/etiology;Anxiety/prevention & control*;Behavior, Animal/drug effects;Brain/drug effects*;Brain/metabolism;Dietary Supplements;Disease Models, Animal;Dose-Response Relationship, Drug;Ethanol/antagonists & inhibitors*;Ethanol/pharmacokinetics;Ethanol/poisoning;Exploratory Behavior/drug effects;Female;Food-Drug Interactions;Locomotion/drug effects;Male;Neurons/drug effects*;Neurons/metabolism;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/therapeutic use*;Taurine/administration & dosage;Taurine/therapeutic use*;Time Factors;Tissue Distribution/drug effects;Zebrafish
22615291;Adolescent;Adult;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Suspensions;Tablets;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22585285;Administration, Oral;Adult;Antidiuretic Hormone Receptor Antagonists;Asian Continental Ancestry Group;Benzazepines/administration & dosage;Benzazepines/blood;Benzazepines/pharmacokinetics*;Benzazepines/urine;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/blood;Diuretics/pharmacokinetics*;Diuretics/urine;European Continental Ancestry Group;Fasting/metabolism*;Food-Drug Interactions;Humans;Male;Middle Aged;Urine;Young Adult
22581486;Administration, Oral;Animals;Biological Availability;Cell Membrane Permeability;Dose-Response Relationship, Drug;Drug Discovery/methods*;Food-Drug Interactions;Humans;Intestinal Absorption;Models, Biological*;Mouth Mucosa/metabolism*;Nonlinear Dynamics;Permeability;Pharmaceutical Preparations*/administration & dosage;Pharmaceutical Preparations*/chemistry;Pharmaceutical Preparations*/metabolism;Solubility
22574741;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Atenolol/pharmacokinetics*;Beverages*;Cross-Over Studies;Food-Drug Interactions*;Genotype;Humans;Male;Malus*;Middle Aged;Organic Anion Transporters/genetics;Polymorphism, Single Nucleotide
22566187;Animals;Beverages;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Humans;Liver/drug effects;Liver/enzymology;Male;Midazolam/metabolism;Partial Thromboplastin Time;Polyphenols/pharmacology*;Psidium/chemistry*;Rats;Rats, Sprague-Dawley;Warfarin/pharmacology*
22554162;Drug Stability;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Nurses*;Pediatric Nursing*/education
22546295;Animals;Barium/pharmacokinetics;Biological Availability;Cellulose/chemistry;Cellulose/pharmacokinetics;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Diagnostic Imaging;Dogs;Drug Compounding;Energy Intake;Fasting;Food-Drug Interactions;Gastric Emptying*;Hypromellose Derivatives;Lactose/chemistry;Lactose/pharmacokinetics;Male;Metformin/blood;Metformin/chemistry;Metformin/pharmacokinetics*;Methylcellulose/analogs & derivatives;Methylcellulose/chemistry;Methylcellulose/pharmacokinetics;Solubility;Stearic Acids/chemistry;Stearic Acids/pharmacokinetics
22543167;Administration, Oral;Animals;Benzoates/pharmacokinetics*;Bridged-Ring Compounds/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Eating;Female;Food-Drug Interactions;Glucosides/pharmacokinetics*;Male;Monoterpenes;Rats;Rats, Sprague-Dawley;Sex Factors
22530414;Anticoagulants/adverse effects*;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;International Normalized Ratio;Punicaceae/adverse effects*;Warfarin/adverse effects*
22530306;Animals;Area Under Curve;Beverages*;Calibration;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Half-Life;Indicators and Reagents;Isoenzymes/metabolism;Limit of Detection;Male;Mass Spectrometry;Pharmaceutical Preparations/metabolism;Rats;Rats, Wistar;Reference Standards;Regression Analysis
22530299;Algorithms;Area Under Curve;Beverages*;Citrus paradisi*;Data Interpretation, Statistical;Dihydropyridines/chemistry;Dihydropyridines/pharmacology*;Food-Drug Interactions*;Least-Squares Analysis;Models, Statistical;Quantitative Structure-Activity Relationship;Regression Analysis
22528540;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Ascorbic Acid/administration & dosage;Ascorbic Acid/adverse effects*;Dietary Supplements/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypervitaminosis A/chemically induced*;Vitamin A/administration & dosage;Vitamin A/adverse effects*;Vitamin E/administration & dosage;Vitamin E/adverse effects*;beta Carotene/administration & dosage;beta Carotene/adverse effects*
22527288;Adolescent;Adult;Aged;Aged, 80 and over;Ascorbic Acid/administration & dosage;Ascorbic Acid/blood*;Diet;Dietary Supplements*;Female;Folic Acid/administration & dosage;Folic Acid/blood*;Food-Drug Interactions;Gene Expression Regulation;Genotype;Humans;Male;Methylenetetrahydrofolate Reductase (NADPH2)/genetics*;Methylenetetrahydrofolate Reductase (NADPH2)/metabolism;Middle Aged;Nutritional Status*;Polymorphism, Single Nucleotide;Risk Factors;Surveys and Questionnaires;Young Adult
22522225;Administration, Oral;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Drug Combinations;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Lopinavir/administration & dosage;Lopinavir/blood;Lopinavir/pharmacokinetics*;Male;Postprandial Period;Ritonavir/administration & dosage;Ritonavir/blood;Ritonavir/pharmacokinetics*;Sex Factors;Therapeutic Equivalency;Uruguay;Young Adult
22514335;Animals;Benzo(a)pyrene/adverse effects;Charcoal/metabolism*;Clinical Trials as Topic;Coffee*;Food-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Meat/adverse effects;Methylcholanthrene/adverse effects;Mice;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Polycyclic Aromatic Hydrocarbons/adverse effects;Rats;Smoking/adverse effects;Smoking/metabolism*
22504108;Cardiotonic Agents/pharmacology*;Contraindications;Critical Care/methods*;Enteral Nutrition*;Food-Drug Interactions*;Gastrointestinal Tract/blood supply;Gastrointestinal Tract/drug effects;Hemodynamics;Humans;Vasoconstrictor Agents/pharmacology*
22499231;Animals;Beverages*/analysis;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit*/chemistry;Fruit*/growth & development;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Thailand;Up-Regulation
22495943;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use*;Arthroplasty, Replacement, Hip;Arthroplasty, Replacement, Knee;Atrial Fibrillation/blood;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Formularies, Hospital*;Humans;Prothrombin/antagonists & inhibitors;Stroke/blood;Stroke/prevention & control;Thromboembolism/blood;Thromboembolism/etiology;Thromboembolism/prevention & control*
22490669;Blotting, Western;Cell Line, Tumor;Cytochrome P-450 CYP1A1/physiology*;Cytochrome P-450 CYP1A2/physiology;Food-Drug Interactions;Genes, Reporter/drug effects;Hepatocytes/drug effects*;Humans;Intestinal Neoplasms/pathology;Liver Neoplasms/pathology;Male;Middle Aged;Mineral Waters*;Real-Time Polymerase Chain Reaction;Receptors, Aryl Hydrocarbon/physiology*;Signal Transduction/drug effects;Transcription, Genetic/drug effects
22480286;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Benzimidazoles*/pharmacokinetics;Benzimidazoles*/therapeutic use;Clinical Trials as Topic;Dabigatran;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Molecular Structure;Stroke/blood;Stroke/prevention & control*;Thromboembolism/blood;Thromboembolism/prevention & control*;Treatment Outcome;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
22465646;Abdominal Pain/etiology;Citrus paradisi*;Colectomy;Electrocardiography;Female;Food-Drug Interactions*;Humans;Intestines/surgery;Ischemia/chemically induced*;Ischemia/surgery;Middle Aged;Multiple Organ Failure/complications;Piperidines/adverse effects*;Serotonin Agents/adverse effects*;Shock/drug therapy;Shock/etiology;Splanchnic Circulation/physiology*;Tryptamines/adverse effects*
22456303;Administration, Oral;Adolescent;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;GABA Agonists/administration & dosage*;GABA Agonists/adverse effects;GABA Agonists/blood;GABA Agonists/pharmacokinetics*;Humans;Linear Models;Male;Middle Aged;Phosphinic Acids/administration & dosage*;Phosphinic Acids/adverse effects;Phosphinic Acids/blood;Phosphinic Acids/pharmacokinetics*;Propylamines/administration & dosage*;Propylamines/adverse effects;Propylamines/blood;Propylamines/pharmacokinetics*;Young Adult
22456294;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Analysis of Variance;Area Under Curve;Asian Continental Ancestry Group*;Biomarkers/blood;Blood Glucose/drug effects*;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/ethnology;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Administration Schedule;Drug Monitoring;Eating*;Feeding Behavior*;Female;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Humans;Intestinal Absorption;Japan/epidemiology;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Postprandial Period;Pyrrolidines/administration & dosage*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Treatment Outcome
22420652;Acetaminophen/adverse effects;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Fasting;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/prevention & control*;Humans;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects;Nonprescription Drugs/pharmacokinetics
22420520;Biological Availability;Food-Drug Interactions*;Humans;Long-Term Care*;Pharmacokinetics
22417366;Biological Availability;Biological Transport*;Citrus/metabolism;Citrus paradisi/metabolism;Citrus sinensis/metabolism;Food-Drug Interactions*;Fruit/metabolism*;Humans;Inactivation, Metabolic*;Malus/metabolism;Medicine, Traditional;Morus/metabolism;Nutritive Value;Plant Extracts/pharmacokinetics*;Punicaceae/metabolism;Risk Factors;Vegetables/metabolism*;Vitis/metabolism
22417333;Beverages/analysis*;Citrus paradisi/chemistry*;Food Storage/methods*;Food-Drug Interactions;Fruit/chemistry;Furocoumarins/analysis*;Linear Models
22394605;1-Methyl-4-phenylpyridinium/pharmacokinetics;Apigenin/pharmacology;Atorvastatin Calcium;Biological Transport/drug effects;Flavanones/blood;Flavanones/pharmacology;Flavonoids/blood;Flavonoids/pharmacology*;Food-Drug Interactions;HEK293 Cells;Hepatocytes/metabolism*;Heptanoic Acids/pharmacokinetics;Humans;Inhibitory Concentration 50;Kaempferols/blood;Kaempferols/pharmacology;Metformin/pharmacokinetics;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/metabolism;Organic Cation Transporter 1/antagonists & inhibitors*;Organic Cation Transporter 1/metabolism;Pyrroles/pharmacokinetics;Quercetin/blood;Quercetin/pharmacology;Rutin/blood;Rutin/pharmacology;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1;Sulfobromophthalein/pharmacokinetics;Tritium/pharmacokinetics
22390368;Administration, Oral;Aged;Asian Continental Ancestry Group;Delayed-Action Preparations;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/blood;Dopamine Agonists/pharmacokinetics;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Levodopa/administration & dosage;Male;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism*;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics
22375877;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/drug effects;Capsaicin*/administration & dosage;Capsaicin*/analogs & derivatives;Capsaicin*/chemistry;Capsaicin*/pharmacology;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2E1/drug effects;Cytochrome P-450 CYP2E1 Inhibitors;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Inhibitory Concentration 50;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology*;Molecular Structure;Rats;Rats, Wistar
22365344;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22356441;Administration, Oral;Animals;Anti-HIV Agents/chemistry;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology*;Dietary Fats/administration & dosage;Dogs;Food-Drug Interactions;HIV-1/drug effects*;HIV-1/physiology;Haplorhini;Humans;Organophosphates/chemistry;Organophosphates/pharmacokinetics;Organophosphates/pharmacology*;Piperazines/chemistry;Piperazines/pharmacokinetics;Piperazines/pharmacology*;Prodrugs/chemistry;Prodrugs/pharmacokinetics;Prodrugs/pharmacology*;Rats;Solubility;Virus Attachment/drug effects*
22349808;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions*;Headache/chemically induced;Humans;Male;Metabolic Clearance Rate;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Young Adult
22344702;Amino Acid Substitution;Apoenzymes/metabolism;Beverages*;Binding Sites;Chromatography, Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/chemistry;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A Inhibitors*;Electrophoresis, Polyacrylamide Gel;Escherichia coli/genetics;Food-Drug Interactions*;Furocoumarins/metabolism*;Furocoumarins/pharmacology*;Glutathione/metabolism;Humans;Mutagenesis, Site-Directed;Plasmids;Protein Binding;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry
22336488;Administration, Oral;Adolescent;Adult;Benzoates/administration & dosage;Benzoates/blood;Benzoates/pharmacokinetics*;Benzoates/pharmacology;Biological Availability;Calcium/metabolism*;Cross-Over Studies;Female;Food*;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/blood;Hydrazines/pharmacokinetics*;Hydrazines/pharmacology;Male;Middle Aged;Powders;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology;Receptors, Thrombopoietin/agonists;Suspensions;Tablets;Time Factors;Young Adult
22331950;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*
22331942;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*
22324070;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control;Dabigatran;Drug Approval*;Drug Interactions;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
22309266;Animals;Antibiotics, Antineoplastic/pharmacokinetics*;Area Under Curve;Creatine Kinase/blood;Diet, Protein-Restricted*;Doxorubicin/pharmacokinetics*;Drug Combinations;Epirubicin/pharmacokinetics*;Food-Drug Interactions;Heart/drug effects*;Humans;Injections, Intraperitoneal;Male;Models, Animal;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/metabolism;Protein-Energy Malnutrition/metabolism*;Random Allocation;Rats;Risk Factors
22309265;Administration, Oral;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Blood Pressure/drug effects;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;KATP Channels/metabolism*;Male;Propylamines/administration & dosage;Propylamines/adverse effects;Propylamines/pharmacokinetics*;Sex Factors;Young Adult
22308076;Animals;Beverages;Citrus paradisi/chemistry*;Drug Synergism;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Intestinal Absorption;Intestines/drug effects;Lopinavir/administration & dosage;Lopinavir/pharmacokinetics*;Male;Microsomes/drug effects;Rats;Rats, Wistar;Ritonavir/administration & dosage;Ritonavir/chemistry*
22300396;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Transit;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Models, Biological*;Nevirapine/administration & dosage;Nevirapine/pharmacokinetics*;Nonlinear Dynamics;Regression Analysis;South Africa;Young Adult
22294059;Area Under Curve;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Data Interpretation, Statistical;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/adverse effects;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dihydropyridines/administration & dosage*;Dihydropyridines/blood;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Drug Administration Schedule;Drug Labeling*;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pilot Projects;Stereoisomerism;Therapeutic Equivalency;Time Factors
22286159;Adult;Aged;Aryl Hydrocarbon Hydroxylases/metabolism;Beverages*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP2B6;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Humans;Ketamine/administration & dosage;Ketamine/analogs & derivatives;Ketamine/blood;Ketamine/pharmacokinetics*;Male;Middle Aged;Oxidoreductases, N-Demethylating/metabolism;Young Adult
22271001;Animals;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Dogs;Eating;Fasting/metabolism;Female;Food-Drug Interactions*;Intestinal Absorption;Male;Tablets;Time Factors
22265646;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22232462;Administration, Oral;Adult;Antinematodal Agents/administration & dosage;Antinematodal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Macrolides/administration & dosage;Macrolides/pharmacokinetics;Male;Middle Aged;Young Adult
22231999;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Atrial Fibrillation/drug therapy;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Vaccinium macrocarpon/adverse effects*;Warfarin/metabolism;Warfarin/therapeutic use*
22230932;Amlodipine/pharmacology;Antihypertensive Agents/pharmacology*;Biological Availability;Copper/pharmacokinetics;Digestion;Fagopyrum/chemistry*;Food-Drug Interactions*;Indapamide/pharmacology;Iron/pharmacokinetics;Magnesium/pharmacokinetics;Pancreatin/metabolism;Pepsin A/metabolism;Perindopril/pharmacology;Spectrophotometry, Atomic;Trace Elements/pharmacokinetics*;Zinc/pharmacokinetics
22217686;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Breast Neoplasms/drug therapy*;Drug Administration Schedule;Drug Interactions;Drug-Related Side Effects and Adverse Reactions/diagnosis*;Female;Food-Drug Interactions;Humans;Hungary;Medication Adherence*;Molecular Targeted Therapy*
22216470;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
22213574;Amyloid Precursor Protein Secretases/antagonists & inhibitors*;Animals;Area Under Curve;Biological Availability;Biopharmaceutics;Cell Line;Chemistry, Pharmaceutical;Dogs;Food-Drug Interactions*;Nanoparticles/chemistry*;Protease Inhibitors/chemistry*;Protease Inhibitors/pharmacokinetics*;Pyrazoles/chemistry*;Pyrazoles/pharmacokinetics;Quinolines/chemistry*;Quinolines/pharmacokinetics;Solubility;Suspensions;X-Ray Diffraction
22206795;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/urine;Area Under Curve;Biotransformation;Cross-Over Studies;Double-Blind Method;Feces/chemistry;Female;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Metabolomics;Middle Aged;Models, Biological;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/urine;Quinazolines/administration & dosage;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/urine;United Kingdom;Young Adult
22199125;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics*;Animals;Base Sequence;Brassica*;Chromatography, Liquid;DNA Primers;Food-Drug Interactions*;Glucuronosyltransferase/genetics;Male;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction
22183173;Administration, Oral;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/metabolism*;Fasting;Female;Food-Drug Interactions*;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Half-Life;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Intestinal Absorption;Male;Middle Aged;Tandem Mass Spectrometry
22167571;Administration, Oral;Biological Availability;Boswellia*;Cathepsin G/metabolism;Computer Simulation;Cross-Over Studies;Eicosanoids/blood;Fasting/physiology;Food-Drug Interactions*;Humans;Male;Meals;Models, Biological;Plant Extracts/administration & dosage*;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Platelet Aggregation/drug effects;Triterpenes/administration & dosage;Triterpenes/blood;Triterpenes/pharmacokinetics*
22167566;Adenosine A2 Receptor Antagonists/administration & dosage;Adenosine A2 Receptor Antagonists/blood;Adenosine A2 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adult;Biological Availability;Capsules;Cross-Over Studies;Diet, High-Fat*;Energy Intake;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22162540;Adult;Biological Availability;Breakfast;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Tablets;Therapeutic Equivalency;Trimetazidine/administration & dosage;Trimetazidine/blood;Trimetazidine/pharmacokinetics*;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*;Young Adult
22149151;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/analogs & derivatives*;Diclofenac/pharmacokinetics;Dietary Fats;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Republic of Korea;Therapeutic Equivalency;Young Adult
22108488;Dietary Supplements*/adverse effects;Food-Drug Interactions;Humans;Preventive Medicine
22137263;ATP Binding Cassette Transporter 1;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/metabolism;Adenocarcinoma/diet therapy;Adenocarcinoma/drug therapy*;Adenocarcinoma/metabolism;Antineoplastic Agents/agonists;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/agonists;Antineoplastic Agents, Phytogenic/metabolism;Carotenoids/agonists;Carotenoids/metabolism*;Cell Line, Tumor;Cell Proliferation/drug effects;Cholesterol/metabolism;Dietary Supplements;Food-Drug Interactions;Gene Expression Regulation, Neoplastic/drug effects;Humans;Hydrocarbons, Fluorinated/agonists;Hydrocarbons, Fluorinated/pharmacology*;Liver X Receptors;Male;Neoplasm Proteins/agonists;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/genetics;Neoplasm Proteins/metabolism;Orphan Nuclear Receptors/agonists*;Orphan Nuclear Receptors/antagonists & inhibitors;Orphan Nuclear Receptors/genetics;Orphan Nuclear Receptors/metabolism*;Osmolar Concentration;PPAR gamma/antagonists & inhibitors;PPAR gamma/genetics;PPAR gamma/metabolism;Prostatic Neoplasms/diet therapy;Prostatic Neoplasms/drug therapy*;Prostatic Neoplasms/metabolism;RNA Interference;RNA, Messenger/metabolism;RNA, Small Interfering;Sulfonamides/agonists;Sulfonamides/pharmacology*
22137030;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/therapeutic use*;Dietary Supplements*;Fatty Acids, Omega-3/therapeutic use;Fish Oils/therapeutic use*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Haptoglobins/genetics;Haptoglobins/metabolism;Hepatic Insufficiency/etiology;Hepatic Insufficiency/prevention & control;Injections, Intraperitoneal;Liver/drug effects*;Liver/metabolism;Liver/pathology;Liver/physiopathology;Male;NF-kappa B/genetics;NF-kappa B/metabolism;Oxidative Stress/drug effects;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Reperfusion Injury/metabolism;Reperfusion Injury/pathology;Reperfusion Injury/physiopathology;Reperfusion Injury/prevention & control*;Triiodothyronine/administration & dosage;Triiodothyronine/blood;Triiodothyronine/therapeutic use*;Tumor Necrosis Factor-alpha/genetics;Tumor Necrosis Factor-alpha/metabolism
22133697;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Dopamine Antagonists/administration & dosage*;Dopamine Antagonists/adverse effects;Dopamine Antagonists/pharmacokinetics*;Dopamine D2 Receptor Antagonists;Dose-Response Relationship, Drug;Evidence-Based Medicine;Food-Drug Interactions;Humans;Patient Selection;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/diagnosis;Psychotic Disorders/drug therapy*;Psychotic Disorders/metabolism;Psychotic Disorders/psychology;Receptors, Dopamine D2/metabolism;Risk Assessment;Thiazoles/administration & dosage*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Treatment Outcome
22129569;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Republic of Korea;Tetrazoles/administration & dosage*;Tetrazoles/adverse effects;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Therapeutic Equivalency;Young Adult
22129380;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Beverages/adverse effects;Beverages/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Flavonoids/administration & dosage;Flavonoids/analysis;Food-Drug Interactions;Fruit*/chemistry;Functional Food*/adverse effects;Functional Food*/analysis;Humans;Phenols/administration & dosage;Phenols/analysis;Punicaceae*/chemistry
22128201;Adenosine Diphosphate;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/genetics;Breakfast;Cross-Over Studies;Cytochrome P-450 CYP2C19;Diet, High-Fat;Food-Drug Interactions*;Genotype;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/administration & dosage*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Young Adult
22124880;Adult;Amides/adverse effects;Amides/blood;Amides/metabolism;Amides/pharmacokinetics*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics*;Beverages/adverse effects*;Beverages/analysis;Biological Transport/drug effects;Citrus paradisi/chemistry*;Cross-Over Studies;Flavanones/analysis;Flavanones/pharmacology;Food-Drug Interactions*;Fruit/chemistry;Fumarates/adverse effects;Fumarates/blood;Fumarates/metabolism;Fumarates/pharmacokinetics*;HEK293 Cells;Half-Life;Humans;Intestinal Mucosa/enzymology*;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism;Renin/antagonists & inhibitors;Terfenadine/analogs & derivatives;Terfenadine/metabolism;Young Adult
22123127;Animals;Beverages*;Citrus*;Citrus paradisi/metabolism;Curcuma/metabolism*;Food-Drug Interactions/physiology*;Ginger/metabolism*;Male;Plant Extracts/metabolism*;Rats;Rats, Sprague-Dawley;Tacrolimus/metabolism*
22122815;Adolescent;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics;Area Under Curve;Biological Availability;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/blood;Trazodone/administration & dosage*;Trazodone/adverse effects;Trazodone/pharmacokinetics
22120090;Adult;Antidiuretic Hormone Receptor Antagonists*;Area Under Curve;Arginine Vasopressin/blood;Asian Continental Ancestry Group;Benzazepines/blood;Benzazepines/pharmacokinetics*;Benzazepines/pharmacology;Benzazepines/urine;Cross-Over Studies;Diuretics/blood;Diuretics/pharmacokinetics*;Diuretics/pharmacology;Diuretics/urine;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Humans;Male;Potassium/blood;Sodium/blood;Young Adult
22114852;Animals;Clinical Trials as Topic/methods;Contraceptive Agents/administration & dosage;Contraceptive Agents/pharmacokinetics;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/pharmacokinetics*;Drug Interactions/physiology;Female;Food-Drug Interactions/physiology;Humans;Norpregnadienes/administration & dosage*;Norpregnadienes/pharmacokinetics*;Receptors, Progesterone/physiology;Unsafe Sex/drug effects;Unsafe Sex/physiology
22101410;Administration, Oral;Animals;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Half-Life;Male;Nitrendipine/pharmacokinetics*;Punicaceae/chemistry*;Rabbits;Time Factors
22085278;Animals;Beverages;Biological Transport;Caco-2 Cells;Cimetidine/pharmacokinetics*;Dietary Supplements;Food-Drug Interactions*;Fruit/chemistry;Humans;Intestinal Absorption*;Jejunum/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Swine;Vegetables/chemistry;Verapamil
22058101;4-Aminopyridine/administration & dosage;4-Aminopyridine/adverse effects;4-Aminopyridine/pharmacokinetics*;Adolescent;Adult;Analysis of Variance;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Multiple Sclerosis/drug therapy*;Potassium Channel Blockers/administration & dosage;Potassium Channel Blockers/adverse effects;Potassium Channel Blockers/pharmacokinetics;Prospective Studies;Sex Factors;Walking/physiology;Young Adult
22057852;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Drug Administration Schedule;Eating;Fasting;Fatigue/chemically induced;Female;Food*;Food-Drug Interactions;Histone Deacetylase Inhibitors/administration & dosage;Histone Deacetylase Inhibitors/adverse effects;Histone Deacetylase Inhibitors/pharmacokinetics*;Humans;Hydroxamic Acids/administration & dosage;Hydroxamic Acids/adverse effects;Hydroxamic Acids/pharmacokinetics*;Indoles;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Treatment Outcome;Vomiting/chemically induced
22040889;Adult;Area Under Curve;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics*;Ascorbic Acid/urine;Beverages;Dose-Response Relationship, Drug;Flavonoids/pharmacology;Food-Drug Interactions*;Fruit/chemistry*;Humans;Intestinal Absorption*;Japan;Male;Malpighiaceae/chemistry*;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Reference Values;Vitamins/blood;Vitamins/pharmacokinetics*;Vitamins/urine;Young Adult
22039822;Area Under Curve;Beverages;Calcium Channel Blockers/chemistry*;Calcium Channel Blockers/pharmacology*;Citrus paradisi*;Cytochrome P-450 CYP3A/chemistry;Cytochrome P-450 CYP3A/metabolism;Dihydropyridines/chemistry*;Dihydropyridines/pharmacology*;Food-Drug Interactions*;Humans;Intestines/metabolism;Quantitative Structure-Activity Relationship
22031686;Adult;Aged;Calcium Channel Blockers/adverse effects;Citrus paradisi/adverse effects*;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions*;Emergency Medical Services;Female;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Male;Middle Aged;Pharmacovigilance;Risk
22031621;Adult;Biological Availability;Cross-Over Studies;Female;Food;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/blood;Piperidines/pharmacokinetics*;Pyrroles/administration & dosage*;Pyrroles/blood;Pyrroles/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors;Receptor, ErbB-2/antagonists & inhibitors;Triazines/administration & dosage*;Triazines/blood;Triazines/pharmacokinetics*;Vascular Endothelial Growth Factor A/antagonists & inhibitors
22029224;Adult;Benzilates/blood*;Benzilates/pharmacokinetics*;Calibration;Chemistry, Pharmaceutical;Cholinergic Antagonists/blood*;Cholinergic Antagonists/pharmacokinetics*;Chromatography, High Pressure Liquid;Delayed-Action Preparations;Female;Food-Drug Interactions;Half-Life;Humans;Male;Quality Control;Reference Standards;Reproducibility of Results;Sex Characteristics;Solutions;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
22020317;Administration, Oral;Adult;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/therapeutic use;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Oxonic Acid/administration & dosage;Oxonic Acid/adverse effects;Oxonic Acid/pharmacokinetics*;Oxonic Acid/therapeutic use;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacology*;Proton Pump Inhibitors/therapeutic use;Tegafur/administration & dosage;Tegafur/adverse effects;Tegafur/pharmacokinetics*;Tegafur/therapeutic use;Treatment Outcome
22016977;Contraindications;Documentation*;Drug Administration Schedule;Drug Compounding/standards*;Drug Dosage Calculations;Drug Prescriptions/standards;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/standards*;Female;Food-Drug Interactions;Humans;Pregnancy;Terminology as Topic
22001672;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cell Line, Tumor;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/toxicity*;Food-Drug Interactions*;Humans;Limonins/toxicity*;Microsomes, Liver;Tandem Mass Spectrometry
23251982;Drug Administration Routes*;Drug Interactions;Enteral Nutrition*;Food-Drug Interactions;United Kingdom
21973269;Administration, Oral;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/pharmacology;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Carbonated Beverages;Cross-Over Studies;Drug Interactions;Esomeprazole/administration & dosage;Esomeprazole/pharmacology;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Male;Triazoles/administration & dosage;Triazoles/blood;Triazoles/chemistry;Triazoles/pharmacokinetics*;Young Adult
21967645;Adenosine/analogs & derivatives*;Adenosine/pharmacokinetics;Administration, Oral;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Least-Squares Analysis;Male;Middle Aged;Purinergic P2Y Receptor Antagonists/pharmacokinetics*;Time Factors;Young Adult
21961887;Absorption/physiology;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Age Factors;Antipyretics/administration & dosage;Antipyretics/pharmacokinetics*;Area Under Curve;Biological Availability;Child;Child, Preschool;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Food-Drug Interactions;Humans;Infant;Male;Suspensions/administration & dosage;Suspensions/pharmacokinetics*;Therapeutic Equivalency;Young Adult
21959701;Acenocoumarol/administration & dosage;Administration, Oral;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Case-Control Studies;Diet*;Female;Food-Drug Interactions;Humans;International Normalized Ratio/statistics & numerical data*;Male;Middle Aged;Retrospective Studies;Seasons;Single Person;Spouses*;Vitamin K/administration & dosage*;Vitamins/administration & dosage*;Warfarin/administration & dosage
23256289;Alcohol Drinking/adverse effects;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Aripiprazole;Combined Modality Therapy;Depressive Disorder/drug therapy;Dietary Supplements/adverse effects*;Food*;Food-Drug Interactions*;Humans;Male;Malnutrition/chemically induced*;Malnutrition/diagnosis;Malnutrition/prevention & control;Middle Aged;Piperazines/adverse effects;Piperazines/therapeutic use;Prescription Drugs/adverse effects*;Quinolones/adverse effects;Quinolones/therapeutic use
21942630;ATP-Binding Cassette Transporters/metabolism;Animals;Biological Transport;Carrier Proteins/metabolism*;Diet;Drug Design;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Models, Animal;Multidrug Resistance-Associated Proteins/metabolism;Pharmaceutical Preparations/metabolism;Pharmacogenetics;Polymorphism, Genetic
21936891;Animals;Atherosclerosis/prevention & control;Cholesterol/blood;Cholesterol/metabolism;Cholesterol, Dietary/adverse effects;Cholesterol, HDL/blood*;Cholic Acid/adverse effects;Combined Modality Therapy;Dietary Supplements*;Fluorobenzenes/antagonists & inhibitors*;Fluorobenzenes/therapeutic use;Food-Drug Interactions*;Globulins/isolation & purification;Globulins/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypercholesterolemia/blood;Hypercholesterolemia/diet therapy*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Lipoproteins/metabolism;Liver/metabolism;Male;Pyrimidines/antagonists & inhibitors*;Pyrimidines/therapeutic use;Rats;Rats, Wistar;Risk Factors;Rosuvastatin Calcium;Soybean Proteins/isolation & purification;Soybean Proteins/therapeutic use*;Sulfonamides/antagonists & inhibitors*;Sulfonamides/therapeutic use;Triglycerides/metabolism
21931020;Abiraterone Acetate;Androstadienes/administration & dosage;Androstadienes/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Drug Labeling/standards;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*;Prostatic Neoplasms/metabolism;United States;United States Food and Drug Administration
21910510;Administration, Oral;Adult;Angiotensin I/blood;Angiotensin II/blood;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/urine;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Biphenyl Compounds/adverse effects*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Biphenyl Compounds/urine;Blood Pressure/drug effects;Dizziness/chemically induced;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidines/adverse effects*;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/urine;Renin/blood;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Tetrazoles/urine;Young Adult
21909143;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation*;Humans;Myocardial Infarction/blood;Myocardial Infarction/drug therapy*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/drug therapy*;Thrombosis/blood;Thrombosis/drug therapy*;Transplantation, Homologous
21898126;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/analogs & derivatives*;Blood Glucose/metabolism;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use*;Drug Administration Schedule;Drug Therapy, Combination;Female;Food-Drug Interactions;Glucagon/blood;Glucagon-Like Peptide 1/blood*;Humans;Hypoglycemic Agents/therapeutic use*;Insulin/blood;Male;Middle Aged;Postprandial Period;Pyrazines/administration & dosage*;Sitagliptin Phosphate;Triazoles/administration & dosage*
21896619;Addison Disease/blood*;Addison Disease/drug therapy;Adult;Aged;Beverages*;Citrus paradisi/physiology*;Cortisone/analogs & derivatives*;Cortisone/metabolism;Cortisone/therapeutic use;Female;Food-Drug Interactions/physiology*;Glycyrrhiza/physiology*;Humans;Hydrocortisone/biosynthesis;Hydrocortisone/blood*;Male;Middle Aged;Up-Regulation/physiology
21874525;Administration, Oral;Animals;Biological Availability;Blood Glucose/drug effects;Chenodeoxycholic Acid/analogs & derivatives;Cholic Acids/administration & dosage;Cholic Acids/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/metabolism;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Drug Therapy, Combination;Food-Drug Interactions;Gliclazide/administration & dosage;Gliclazide/pharmacokinetics*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Injections, Intravenous;Male;Probiotics/pharmacology*;Random Allocation;Rats;Rats, Wistar
21872931;Administration, Oral;Adolescent;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/therapeutic use;Biological Availability;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions*;HIV Infections/blood;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1/isolation & purification*;Humans;Male;Medication Adherence;Middle Aged;Nevirapine/administration & dosage;Nevirapine/blood;Nevirapine/pharmacokinetics*;Nevirapine/therapeutic use;Young Adult
21856591;Adult;Carica/adverse effects*;Food-Drug Interactions;Goiter, Nodular/surgery;Humans;Hypothyroidism/complications*;Hypothyroidism/drug therapy*;Intestinal Absorption;Male;Thyroidectomy;Thyrotropin/blood;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*;Triiodothyronine/blood
21853290;Adolescent;Adult;Antidiuretic Hormone Receptor Antagonists;Benzazepines/blood;Benzazepines/pharmacokinetics*;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Diuretics/blood;Diuretics/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Young Adult
21852006;Adolescent;Adult;Beverages/adverse effects;Caffeine/adverse effects;Caffeine/blood*;Coffee*/adverse effects;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Warfarin/blood*
21843611;Acetaminophen/administration & dosage*;Acetaminophen/chemistry;Administration, Oral;Capsules;Carrageenan/chemistry;Excipients/chemistry*;Fasting;Food-Drug Interactions;Humans;Hypromellose Derivatives;In Vitro Techniques;Methylcellulose/analogs & derivatives*;Methylcellulose/chemistry;Models, Biological*;Polysaccharides, Bacterial/chemistry;Radionuclide Imaging/methods;Solubility
21831129;Acute Coronary Syndrome/drug therapy*;Acute Coronary Syndrome/physiopathology;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Thrombosis/prevention & control*;Vitamin K/antagonists & inhibitors
21819239;Administration, Oral;Anticoagulants/pharmacology*;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Factor Xa Inhibitors;Food-Drug Interactions;Hemostatics/metabolism;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Pharmacogenetics;Prothrombin/antagonists & inhibitors;Thrombin/therapeutic use;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors;Warfarin/adverse effects;Warfarin/therapeutic use*
21819160;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Cross-Over Studies;Delayed-Action Preparations;Dipeptides/administration & dosage;Dipeptides/adverse effects;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Combinations;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
21812328;Antioxidants/analysis;Beverages/adverse effects*;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Female;Flavanones/analysis;Food-Drug Interactions/physiology*;Forecasting;Furocoumarins/analysis;Humans;In Vitro Techniques;Linear Models;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Statistical;Oxidation-Reduction;Testosterone/metabolism
21805622;Esterification;Flavones/chemistry;Flavones/metabolism;Flavonoids/chemistry*;Flavonoids/metabolism*;Flavonols/chemistry;Flavonols/metabolism;Food-Drug Interactions;Free Radical Scavengers/chemistry*;Free Radical Scavengers/metabolism*;Glucosides/chemistry;Glucosides/metabolism;Glycosylation;Hydrogenation;Hydroxylation;Kinetics;Methylation;Milk Proteins/metabolism*;Polyphenols/chemistry;Polyphenols/metabolism;Protein Binding;Stilbenes/chemistry*;Stilbenes/metabolism*;Structure-Activity Relationship
21803422;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Linagliptin;Male;Middle Aged;Purines/adverse effects;Purines/pharmacokinetics*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
21803144;Computer Simulation*;Drug Compounding*;Drugs, Generic*/chemistry;Drugs, Generic*/pharmacokinetics;Food-Drug Interactions*;Humans;Pharmaceutical Preparations*/metabolism;Therapeutic Equivalency;United States;United States Food and Drug Administration
21797170;Antineoplastic Agents/metabolism;Antineoplastic Agents/pharmacology*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Nutritional Status*;Oxidoreductases/metabolism
21796375;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Diet*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/metabolism*
21793725;Anticarcinogenic Agents/pharmacology*;Antioxidants/pharmacology*;Apoptosis/drug effects;Beverages/analysis;Chemoprevention;Food-Drug Interactions;Fruit/chemistry;Humans;Inflammation/drug therapy;Neoplasms/drug therapy;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Punicaceae/chemistry*
21733905;Adolescent;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation/methods;Humans;Male;Mycoses/prevention & control;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Suspensions;Triazoles/pharmacokinetics*;Triazoles/therapeutic use;Voriconazole
21732691;2-Pyridinylmethylsulfinylbenzimidazoles;Animals;Benzimidazoles/chemistry*;Binding Sites;Cattle;Flavonoids/chemistry*;Food-Drug Interactions*;Molecular Structure;Protein Binding;Serum Albumin, Bovine/chemistry*;Sulfoxides/chemistry*
21724950;Aged;Alanine/administration & dosage;Alanine/analogs & derivatives*;Alanine/blood;Alanine/pharmacokinetics;Alanine/pharmacology;Amyloid Precursor Protein Secretases/antagonists & inhibitors*;Amyloid beta-Peptides/blood;Azepines/administration & dosage*;Azepines/blood;Azepines/pharmacokinetics;Azepines/pharmacology;Biological Availability;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nootropic Agents/administration & dosage*;Nootropic Agents/blood;Nootropic Agents/pharmacokinetics;Nootropic Agents/pharmacology;Patient Dropouts;Peptide Fragments/blood;Tablets
21721019;Animals;Arylsulfotransferase/biosynthesis*;Arylsulfotransferase/genetics;Caffeine/administration & dosage*;Caffeine/adverse effects;Central Nervous System Stimulants/administration & dosage;Enzyme Induction*;Female;Food-Drug Interactions;Intestinal Mucosa/enzymology*;Intestinal Mucosa/metabolism;Intestine, Small/enzymology*;Intestine, Small/metabolism;Liver/enzymology*;Liver/metabolism;Male;Organ Specificity;Phosphodiesterase Inhibitors/administration & dosage;Purinergic P1 Receptor Antagonists/administration & dosage;RNA, Messenger/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Sex Characteristics;Sulfotransferases/biosynthesis*;Sulfotransferases/genetics
21720234;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Carbonated Beverages/adverse effects*;Cola*/adverse effects;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use;Male;Middle Aged
21718067;Animals;Cattle;Dietary Supplements/analysis*;Food-Drug Interactions*;Glycosylation;Hemoglobins/chemistry*;Hydrophobic and Hydrophilic Interactions;Hydroxylation;Models, Biological;Molecular Structure;Polyphenols/chemistry*;Protein Binding;Structure-Activity Relationship
21715058;Acenocoumarol/adverse effects*;Acenocoumarol/pharmacokinetics;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Ethanol/pharmacokinetics;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food Labeling;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Internet;Legislation, Drug;Patient Education as Topic;Spain;United States;United States Food and Drug Administration;Vitamin K/antagonists & inhibitors;Vomiting/etiology
21712497;Administration, Oral;Area Under Curve;Biological Availability;Capsules/administration & dosage;Confidence Intervals;Cross-Over Studies;Deglutition Disorders;Female;Food-Drug Interactions*;Humans;Male;Malus*;Middle Aged;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Therapeutic Equivalency;Yogurt*
21705359;Antihypertensive Agents/therapeutic use;Blood Pressure/physiology;Cost-Benefit Analysis;Diet/adverse effects;Diet, Sodium-Restricted/methods;Dose-Response Relationship, Drug;Food-Drug Interactions;Health Promotion/economics;Health Promotion/methods;Heart Failure/etiology*;Heart Failure/physiopathology;Heart Failure/prevention & control;Humans;Hypertension/etiology*;Hypertension/physiopathology;Hypertension/prevention & control;Hypertrophy, Left Ventricular/etiology;Hypertrophy, Left Ventricular/physiopathology;Life Style;Obesity/prevention & control;Risk Factors;Sodium Chloride, Dietary/adverse effects*;Ventricular Dysfunction, Left/etiology;Ventricular Dysfunction, Left/physiopathology;Weight Loss
21704241;Administration, Oral;Adolescent;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting;Female;Fenofibrate/administration & dosage;Fenofibrate/adverse effects;Fenofibrate/analogs & derivatives*;Fenofibrate/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Prodrugs;Tablets;Therapeutic Equivalency;Young Adult
21704240;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Sulfhydryl Compounds/administration & dosage;Sulfhydryl Compounds/adverse effects;Sulfhydryl Compounds/pharmacokinetics*;Time Factors;Young Adult
21697612;Acyclovir/analogs & derivatives;Acyclovir/metabolism;Animals;Caffeic Acids/pharmacology*;Chlorogenic Acid/pharmacology;Coffee/chemistry;Estrone/analogs & derivatives;Estrone/metabolism;Food-Drug Interactions*;Fruit/chemistry;Humans;Inhibitory Concentration 50;Methotrexate/metabolism;Oocytes/drug effects;Oocytes/metabolism;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/genetics;Quinic Acid/pharmacology;RNA, Complementary/pharmacology;Vegetables/chemistry;Xenopus laevis;p-Aminohippuric Acid/metabolism
21692829;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Beverages;Carcinoma, Squamous Cell/drug therapy;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Esophageal Neoplasms/drug therapy;Female;Food-Drug Interactions*;Humans;Middle Aged;Taxoids/pharmacokinetics*;Taxoids/therapeutic use
21692649;Administration, Intranasal/methods*;Animals;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Brain/metabolism*;Cattle;Cefotaxime/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Male;Meningitis, Bacterial/metabolism;Rats;Rats, Sprague-Dawley
21691746;Adolescent;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Proto-Oncogene Proteins c-abl/antagonists & inhibitors;Quinolines/administration & dosage*;Quinolines/adverse effects;Quinolines/pharmacokinetics;Tandem Mass Spectrometry;Tissue Distribution;Young Adult;src-Family Kinases/antagonists & inhibitors
21682192;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Flavonoids/adverse effects;Food-Drug Interactions*;Furocoumarins/adverse effects;Humans;Intestinal Absorption/drug effects*;Intestines/metabolism*
21680781;Adult;Alleles;China;Cross-Over Studies;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dietary Supplements*;Enzyme Induction;Food-Drug Interactions;Gene Frequency;Genetic Association Studies;Half-Life;Humans;Male;Metabolic Detoxication, Phase I;Midazolam/analogs & derivatives;Midazolam/blood;Midazolam/pharmacokinetics*;Polymorphism, Single Nucleotide*;Quercetin/metabolism*;Young Adult
21676011;Adult;Body Temperature/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Middle Aged;TRPV Cation Channels/antagonists & inhibitors*;Young Adult
21675289;Analgesics/pharmacology;Analgesics/therapeutic use;Capsaicin/metabolism;Capsaicin/pharmacology*;Capsaicin/therapeutic use;Capsicum*;Food-Drug Interactions;Humans;Pain/drug therapy;Substance P/antagonists & inhibitors;Substance P/metabolism*
21674263;Area Under Curve;Biological Availability;Dopamine Antagonists/pharmacokinetics*;Dopamine Antagonists/pharmacology;Excipients/chemistry*;Fasting;Food-Drug Interactions;Humans;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Solubility;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
21671821;Administration, Oral;Animals;Delayed-Action Preparations/pharmacokinetics;Drug Combinations;Drug Delivery Systems*;Food-Drug Interactions;Gastric Emptying;Humans;Stomach/physiology*;Technology, Pharmaceutical*
21666065;Acetaminophen/metabolism;Acetaminophen/pharmacokinetics*;Acetaminophen/urine;Adult;Alleles;Cross-Over Studies;Diet;Female;Food-Drug Interactions*;Fruit*;Genotype;Glucuronides/metabolism;Glucuronosyltransferase/genetics*;Glucuronosyltransferase/metabolism;Half-Life;Humans;Male;Polymorphism, Genetic;Saliva/metabolism;Vegetables*
21663428;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/pharmacokinetics;Methylphenidate/therapeutic use*;Treatment Outcome
21650079;Biological Availability;Chemistry, Pharmaceutical/standards;Drug Design;Drug Interactions;Drugs, Generic/pharmacokinetics;Drugs, Generic/standards*;Europe;European Union;Food-Drug Interactions;Guidelines as Topic;Therapeutic Equivalency*;United States;United States Food and Drug Administration
21633025;Administration, Oral;Adolescent;Adult;Aminoquinolines/pharmacokinetics*;Amphotericin B/pharmacokinetics*;Antiprotozoal Agents/pharmacokinetics*;Area Under Curve;Cohort Studies;Cross-Over Studies;Fasting;Female;Food;Food-Drug Interactions*;Half-Life;Humans;India;Leishmaniasis, Visceral/drug therapy*;Leishmaniasis, Visceral/pathology;Male;Middle Aged;Prospective Studies;Young Adult
21628600;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use*;Brain/drug effects*;Brain/enzymology;Dietary Proteins/adverse effects;Dietary Proteins/metabolism*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/etiology;Hypertension/prevention & control;Indans/adverse effects;Indans/therapeutic use*;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/enzymology;Patient Safety;Risk Assessment;Risk Factors;Treatment Outcome;Tyramine/adverse effects;Tyramine/metabolism*
21617593;Beverages*;Food-Drug Interactions*;Fruit*;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Humans;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
21615244;Animals;Biological Availability;Caco-2 Cells;Female;Food;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Male;Models, Animal;Pharmaceutical Preparations/metabolism*;Predictive Value of Tests;Rats;Rats, Wistar;Regression Analysis
21610201;Adolescent;Adult;Area Under Curve;Benzofurans/adverse effects*;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Blood Glucose/drug effects*;C-Peptide/secretion;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Insulin/secretion;Male;Middle Aged;Receptors, G-Protein-Coupled/agonists*;Sulfones/adverse effects*;Sulfones/pharmacokinetics;Sulfones/pharmacology;Young Adult
21607954;Acetamides/blood;Acetamides/pharmacokinetics;Acetamides/urine;Adult;Animals;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Area Under Curve;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Milk*;Oseltamivir/blood;Oseltamivir/pharmacokinetics*;Oseltamivir/urine;Reference Values
21593283;Administration, Oral;Adrenergic beta-1 Receptor Antagonists/administration & dosage;Adrenergic beta-1 Receptor Antagonists/pharmacokinetics*;Adult;Area Under Curve;Atenolol/administration & dosage;Atenolol/pharmacokinetics;Beverages;Celiprolol/administration & dosage;Celiprolol/pharmacokinetics*;Citrus paradisi/chemistry;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Organic Anion Transporters/genetics*;Pharmacogenetics;Polymorphism, Genetic;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives;Terfenadine/pharmacokinetics;Young Adult
21553459;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans
21551317;Adult;Analysis of Variance;Area Under Curve;Benzilates/administration & dosage;Benzilates/blood;Benzilates/chemistry;Benzilates/pharmacokinetics*;Biological Availability;Biotransformation;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Fasting/blood;Female;Food-Drug Interactions*;Germany;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Muscarinic Antagonists/administration & dosage;Muscarinic Antagonists/blood;Muscarinic Antagonists/chemistry;Muscarinic Antagonists/pharmacokinetics*;Oxidation-Reduction;Postprandial Period;Young Adult
21548660;Adult;Area Under Curve;Benzopyrans/adverse effects;Benzopyrans/blood;Benzopyrans/metabolism;Benzopyrans/pharmacokinetics*;Biotransformation/physiology;Cross-Over Studies;Dopamine beta-Hydroxylase/antagonists & inhibitors;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics;Food Deprivation/physiology;Food-Drug Interactions/physiology*;Humans;Imidazoles/adverse effects;Imidazoles/blood;Imidazoles/metabolism;Imidazoles/pharmacokinetics*;Male;Therapeutic Equivalency;Young Adult
21545633;Antimetabolites, Antineoplastic;Biological Transport/drug effects;Carbonated Beverages/adverse effects*;Cola/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Kidney/metabolism;Liver/metabolism;Lymphoma/drug therapy;Lymphoma/urine;Male;Methotrexate/pharmacokinetics*;Methotrexate/therapeutic use;Middle Aged;Urine/chemistry
21544521;Animal Feed/adverse effects;Animals;Behavior, Animal/drug effects*;Body Temperature/drug effects;Body Weight/drug effects*;Dietary Fats*/administration & dosage;Dietary Fats*/adverse effects;Dopamine Agonists/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Male;Quinpirole/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Dopamine/metabolism*;Yawning/drug effects
21535728;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects*;Animals;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Dietary Supplements/adverse effects*;Food-Drug Interactions;Garlic/chemistry;Half-Life;Male;Metabolic Clearance Rate;Nifedipine/blood;Nifedipine/pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Roots/chemistry;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects*;Random Allocation;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sulfides/administration & dosage;Sulfides/adverse effects*;Time Factors;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
21532276;Administration, Oral;Alendronate/administration & dosage;Alendronate/pharmacokinetics*;Alendronate/urine;Animals;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/analysis;Food-Drug Interactions;Male;Mineral Waters/adverse effects*;Mineral Waters/analysis;Rats;Rats, Wistar;Time Factors
21527341;Administration, Oral;Adolescent;Adult;Area Under Curve;Chemical Precipitation;Computer Simulation;Cross-Over Studies;Fasting/metabolism*;Food-Drug Interactions*;Gastric Emptying;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Humans;Intestinal Absorption/physiology;Intestine, Small/metabolism*;Male;Models, Biological;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics*;Solubility;Tablets/administration & dosage;Tablets/pharmacokinetics;Young Adult
21517925;Administration, Oral;Adult;Asian Continental Ancestry Group;China;Chromatography, Liquid/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Isoindoles/administration & dosage;Isoindoles/adverse effects;Isoindoles/pharmacokinetics*;Male;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
21511277;Antidiuretic Agents/pharmacokinetics;Antidiuretic Agents/pharmacology*;Antidiuretic Agents/therapeutic use*;Chemistry, Pharmaceutical;Child;Deamino Arginine Vasopressin/pharmacokinetics;Deamino Arginine Vasopressin/pharmacology*;Deamino Arginine Vasopressin/therapeutic use*;Female;Food-Drug Interactions*;Humans;Male;Nocturnal Enuresis/drug therapy*;Tablets;Therapeutic Equivalency
21501216;Aged;Analysis of Variance;Anticholesteremic Agents/blood*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cohort Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Heptanoic Acids/blood*;Heptanoic Acids/therapeutic use;Humans;Lipid Metabolism/drug effects;Lipid Metabolism Disorders/blood;Lipid Metabolism Disorders/drug therapy*;Male;Middle Aged;Pyrroles/blood*;Pyrroles/therapeutic use;Time Factors
21500482;Beverages/analysis*;Citrus paradisi/chemistry*;Flavanones/analysis;Flavonoids/analysis*;Food-Drug Interactions;Fruit/chemistry;Humans
21497708;Administration, Oral;Adult;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Humans;Japan;Male;Metabolic Clearance Rate;Midazolam/blood;Midazolam/pharmacokinetics*;Midazolam/urine;Punicaceae/chemistry*;Tandem Mass Spectrometry;Young Adult
21490128;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Availability;Cytochrome P-450 CYP3A/metabolism*;Drug Design;Drug Interactions;Drug Synergism;Food-Drug Interactions;Humans;Mice;Mice, Knockout;Mice, Transgenic;Models, Animal;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*
21474786;Administration, Oral;Adult;Androgens/administration & dosage*;Androgens/blood;Androgens/pharmacokinetics*;Biotransformation;Chromatography, Liquid;Cross-Over Studies;Dihydrotestosterone/blood;Drug Administration Schedule;Emulsions;Estradiol/blood;Fasting/blood;Food-Drug Interactions;Humans;Hypogonadism/blood;Hypogonadism/drug therapy*;Male;Middle Aged;Postprandial Period;Tandem Mass Spectrometry;Testosterone/administration & dosage;Testosterone/analogs & derivatives*;Testosterone/blood;Testosterone/pharmacokinetics;Treatment Outcome;United States
21474406;Administration, Oral;Aged;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hospital Units*;Humans;Inpatients/psychology*;International Normalized Ratio;Knowledge;Middle Aged;Patient Education as Topic*;Physical and Rehabilitation Medicine*;Prospective Studies;Rehabilitation*;Self Medication;Surveys and Questionnaires;Vitamin K/antagonists & inhibitors
21473341;Diet*;Food-Drug Interactions*;Humans;Patient Education as Topic*;United Kingdom
21457137;Acetates;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Food-Drug Interactions*;Fruit;Male;Plant Extracts/pharmacology*;Rabbits;Verapamil/pharmacokinetics*
21453201;Animals;Clinical Trials as Topic/methods;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions/chemically induced*;Drug-Related Side Effects and Adverse Reactions/metabolism;Drug-Related Side Effects and Adverse Reactions/prevention & control;Food-Drug Interactions/physiology;Humans;Indans/adverse effects;Indans/pharmacokinetics;Indans/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Serotonin Agents/adverse effects;Serotonin Agents/pharmacokinetics;Serotonin Agents/therapeutic use;Treatment Outcome
21443600;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/blood*;Fasting/blood;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tretinoin/administration & dosage;Tretinoin/adverse effects;Tretinoin/blood*;Young Adult
21441285;Animals;Anti-Inflammatory Agents, Non-Steroidal/toxicity*;Disease Models, Animal;Dose-Response Relationship, Drug;Enterocytes/drug effects;Enterocytes/pathology;Escherichia coli/metabolism*;Female;Food-Drug Interactions;Gastric Mucosa/drug effects;Gastric Mucosa/microbiology;Gastric Mucosa/pathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/microbiology;Gastrointestinal Tract/pathology*;Indomethacin/toxicity*;Probiotics/administration & dosage*;Swine
21435141;Adolescent;Adult;Benzhydryl Compounds;Biological Availability;Diet;Dietary Fats*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Glucosides/administration & dosage;Glucosides/pharmacokinetics*;Humans;Male;Middle Aged;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Young Adult
21434835;ATP Binding Cassette Transporter, Sub-Family B/drug effects;Alkaloids/pharmacokinetics*;Benzodioxoles/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Piper nigrum/chemistry*;Piperidines/pharmacokinetics*;Polyunsaturated Alkamides/pharmacokinetics*
21432599;Attention Deficit Disorder with Hyperactivity/diagnosis;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/therapeutic use*;Female;Food Deprivation;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/therapeutic use*;Single-Blind Method
21422239;Administration, Oral;Adolescent;Adult;Biological Availability;Blood Cell Count;Butyrates/administration & dosage;Butyrates/adverse effects*;Butyrates/analysis;Butyrates/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Fetal Hemoglobin/analysis;Food-Drug Interactions;Half-Life;Hematinics/administration & dosage;Hematinics/adverse effects*;Hematinics/analysis;Hematinics/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate;Plasma/chemistry;Reticulocytes/drug effects;Urine/chemistry;Young Adult
21398067;Animal Feed*/analysis;Animals;Antineoplastic Agents/analysis;Antineoplastic Agents/blood;Antineoplastic Agents/metabolism*;Antineoplastic Agents/urine;Biotransformation;Carbon Radioisotopes/metabolism;Chromatography, High Pressure Liquid/instrumentation;Chromatography, High Pressure Liquid/methods;Dogs;Feces/chemistry;Female;Food-Drug Interactions*;Humans;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry/instrumentation;Mass Spectrometry/methods;Molecular Structure;Pyrrolidines/analysis;Pyrrolidines/blood;Pyrrolidines/metabolism*;Pyrrolidines/urine;Rats;Species Specificity
21372392;Administration, Oral;Caco-2 Cells;Dose-Response Relationship, Drug;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption*;Permeability;Pharmaceutical Preparations/analysis*;Postprandial Period;Solubility;Technology, Pharmaceutical/methods*;Tetrazoles/pharmacokinetics*;Water
21364039;Anticoagulants/metabolism;Anticoagulants/pharmacology*;Beverages*;Drug Interactions;Female;Food-Drug Interactions*;Fruit*;Humans;International Normalized Ratio;Middle Aged;Vaccinium macrocarpon*;Warfarin/metabolism;Warfarin/pharmacology*
21359645;Administration, Oral;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Food/adverse effects*;Food-Drug Interactions*;Humans;Warfarin*/adverse effects;Warfarin*/pharmacokinetics;Warfarin*/therapeutic use
21356148;Adult;Aged;Anticholesteremic Agents/administration & dosage*;Cholesterol/blood;Female;Follow-Up Studies;Food, Fortified*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hypercholesterolemia/drug therapy;Linear Models;Longitudinal Studies;Male;Margarine/analysis*;Middle Aged;Multivariate Analysis;Phytosterols/administration & dosage*;Retrospective Studies;Surveys and Questionnaires
21355446;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adult;Blood Cell Count;Blood Chemical Analysis;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Organophosphonates/administration & dosage;Organophosphonates/adverse effects;Organophosphonates/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics*;Spectrometry, Fluorescence;Tablets;Tenofovir;Therapeutic Equivalency;Young Adult
21349922;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Beverages;Biological Availability;Citrus paradisi/chemistry;Female;Food-Drug Interactions;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology*;Intestine, Small/drug effects;Intestine, Small/enzymology*;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics*;Mice;Mice, Knockout;NADPH-Ferrihemoprotein Reductase/genetics;NADPH-Ferrihemoprotein Reductase/metabolism;NADPH-Ferrihemoprotein Reductase/physiology*
21341419;Caffeine/pharmacokinetics;Citrus paradisi;Dairy Products;Food-Drug Interactions*;Humans;Vitamin K/pharmacokinetics;Vitamins/pharmacokinetics
21301274;Beverages/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vaccinium macrocarpon*;Warfarin/adverse effects*
21298205;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics;Anti-Arrhythmia Agents/therapeutic use*;Beverages*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Citrus paradisi*;Food-Drug Interactions;Humans
21268318;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
21257798;Adolescent;Adult;Area Under Curve;Biological Availability;Double-Blind Method;Female;Food-Drug Interactions;Humans;Janus Kinases/antagonists & inhibitors;Male;Middle Aged;Neutropenia/chemically induced;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology*;STAT3 Transcription Factor/blood;Young Adult
21254874;Animals;Beverages*/adverse effects;Beverages*/analysis;Citrus paradisi*/adverse effects;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans;Pharmacokinetics*
21248612;Administration, Oral;Adolescent;Adult;Antifibrinolytic Agents/administration & dosage;Antifibrinolytic Agents/adverse effects;Antifibrinolytic Agents/therapeutic use*;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions;Humans;Menorrhagia/drug therapy*;Middle Aged;Tablets;Time Factors;Tranexamic Acid/administration & dosage;Tranexamic Acid/adverse effects;Tranexamic Acid/therapeutic use;Treatment Outcome;Young Adult
21238588;Administration, Oral;Animals;Anticoagulants*/administration & dosage;Anticoagulants*/blood;Anticoagulants*/pharmacokinetics;Area Under Curve;Biological Availability;Drug Delivery Systems;Duodenum/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions*;Haplorhini;Naphthalenes/blood;Naphthalenes/pharmacokinetics*;Propionates/blood;Propionates/pharmacokinetics*;Solubility;Tablets, Enteric-Coated;Time Factors
21235125;Anti-Allergic Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/pharmacokinetics;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi/adverse effects*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Risk Factors
21219314;Animals;Anticonvulsants*;Behavior, Animal/drug effects;Cell Death/drug effects;Convulsants*;Cyclooxygenase 2/metabolism;Cyclooxygenase 2 Inhibitors/pharmacology*;Diet;Dose-Response Relationship, Drug;Eating;Extinction, Psychological/drug effects;Food-Drug Interactions;Immunohistochemistry;Kainic Acid/pharmacology;Kindling, Neurologic/drug effects*;Lactones/pharmacology*;Male;Mice;Pentylenetetrazole*;Seizures/chemically induced;Seizures/prevention & control*;Sulfones/pharmacology*
21207216;Absorption/physiology*;Algorithms;Anticonvulsants/chemistry;Anticonvulsants/pharmacokinetics;Capsules;Carbamazepine/chemistry;Carbamazepine/pharmacokinetics;Chemistry, Pharmaceutical;Computer Simulation;Dosage Forms;Drug Design*;Fasting/metabolism;Food-Drug Interactions;Humans;Intestinal Absorption/physiology;Models, Biological*;Models, Statistical*;Pharmacokinetics;Quality Improvement*;Solubility;Suspensions;Tablets;Therapeutic Equivalency
21204914;Adult;Amides/blood*;Antihypertensive Agents/blood*;Beverages*;Citrus sinensis*;Female;Food-Drug Interactions*;Fumarates/blood*;Humans;Male;Malus*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/physiology;Renin/blood;Young Adult
21194458;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Critical Care*;Drug Monitoring;Food-Drug Interactions;Humans;Hypoalbuminemia/drug therapy;Hypoalbuminemia/therapy;Parenteral Nutrition*/adverse effects
21189136;Administration, Oral;Animals;Biological Availability;Biological Transport;Biotransformation;Food-Drug Interactions*;Humans;Intestinal Absorption;Intestinal Mucosa/enzymology;Intestinal Mucosa/metabolism;Intestines/enzymology;Intestines/metabolism*;Membrane Transport Proteins/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics;Research Design
21185864;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy*;Clinical Trials as Topic;Food-Drug Interactions;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Thromboembolism/drug therapy*;Thromboembolism/etiology;Thromboembolism/prevention & control;Venous Thrombosis/complications;Venous Thrombosis/drug therapy*;Venous Thrombosis/prevention & control;Warfarin/therapeutic use
21173898;Administration, Oral;Calcium Carbonate/blood;Calcium Carbonate/therapeutic use;Calcium Citrate/blood;Calcium Citrate/therapeutic use;Calcium Gluconate/blood;Calcium Gluconate/therapeutic use;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Therapy, Combination;Food-Drug Interactions;Half-Life;Hormone Replacement Therapy/methods*;Humans;Hypocalcemia/blood;Hypocalcemia/drug therapy*;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Infusions, Intravenous;Iodine/administration & dosage;Iodine/blood;Parathyroid Diseases/blood;Parathyroid Diseases/surgery*;Parathyroid Hormone/blood;Parathyroid Hormone/therapeutic use;Parathyroidectomy*;Postoperative Complications/blood;Postoperative Complications/drug therapy*;Recombinant Proteins/therapeutic use;Thyroid Diseases/blood;Thyroid Diseases/surgery*;Thyroid Neoplasms/blood;Thyroid Neoplasms/surgery*;Thyroidectomy*;Thyrotropin/blood;Thyroxine/blood;Thyroxine/therapeutic use;Treatment Outcome;Triiodothyronine/blood;Triiodothyronine/therapeutic use;Vitamin D/blood;Vitamin D/therapeutic use
21163558;Antioxidants/analysis;Combined Modality Therapy;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/diet therapy*;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/enzymology;Dyslipidemias/prevention & control;Female;Food-Drug Interactions*;Glyburide/adverse effects;Glyburide/therapeutic use*;Glycated Hemoglobin A/analysis;Humans;Hyperglycemia/prevention & control;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Oxidoreductases/blood;Sesame Oil/adverse effects;Sesame Oil/therapeutic use*;Severity of Illness Index
21162177;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/metabolism*;Beverages/adverse effects;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Food-Drug Interactions*;Fruit;Health Knowledge, Attitudes, Practice*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Patient Education as Topic
21155809;Animals;Biological Availability;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Food/standards*;Food-Drug Interactions*;Humans;Legislation, Food
21148046;Administration, Oral;Adult;Biological Availability;Biotransformation;Body Mass Index;Cytochrome P-450 CYP3A/metabolism*;Female;Flavonoids/analysis;Food-Drug Interactions;Half-Life;Honey*/analysis;Humans;Injections, Intravenous;Intestines/enzymology*;Liver/enzymology*;Male;Metabolic Clearance Rate;Midazolam/administration & dosage;Midazolam/analogs & derivatives;Midazolam/blood;Midazolam/pharmacokinetics;Midazolam/urine;Single-Blind Method;Young Adult
21147941;Administration, Cutaneous;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Blood Pressure/drug effects*;Cheese;Depressive Disorder, Major/drug therapy;Feeding Behavior;Food-Drug Interactions;Humans;Hypertension/chemically induced*;Hypertension/prevention & control;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Myocardium;Risk Factors;Selegiline/adverse effects;Selegiline/pharmacokinetics;Selegiline/therapeutic use*;Tyramine
21142260;Animals;Beverages;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 Enzyme System/adverse effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
21138349;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Transport/drug effects;Darunavir;Drug Interactions;Food-Drug Interactions*;Garlic/chemistry;Garlic/metabolism*;HIV Protease Inhibitors/pharmacokinetics*;Hep G2 Cells;Humans;Liver/drug effects;Liver/metabolism;Models, Biological;Multidrug Resistance-Associated Proteins/metabolism;Permeability;Plant Extracts/pharmacokinetics*;Saquinavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*
21125816;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions;Ganciclovir/pharmacokinetics;Guanine/administration & dosage;Guanine/adverse effects;Guanine/analogs & derivatives*;Guanine/pharmacokinetics;Humans;Male;Mass Spectrometry;Reproducibility of Results;Tablets;Young Adult
21124269;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Beverages/adverse effects*;Food-Drug Interactions*;Gastrointestinal Hemorrhage/etiology;Gastrointestinal Hemorrhage/prevention & control;Health Knowledge, Attitudes, Practice;Humans;Vaccinium macrocarpon*;Warfarin/administration & dosage*;Warfarin/adverse effects
21120480;Adult;Aged;Area Under Curve;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use*;Tomography, X-Ray Computed;Treatment Outcome;Young Adult
21118913;Adenine/analogs & derivatives*;Adenine/pharmacology;Adenine/therapeutic use;Chemoprevention;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacology;Deoxycytidine/therapeutic use;Drug Interactions;Emtricitabine;Female;Food-Drug Interactions;HIV Infections/drug therapy;HIV Infections/prevention & control*;Humans;Male;Organophosphonates/pharmacology;Organophosphonates/therapeutic use*;Tenofovir
21098692;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical/methods;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/adverse effects;Hydromorphone/chemistry;Hydromorphone/pharmacokinetics*;Male;Naltrexone/administration & dosage;Therapeutic Equivalency
21085831;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Pregnancy Complications/drug therapy;Tuberculosis/drug therapy*;Tuberculosis, Multidrug-Resistant/drug therapy
21085830;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Brazil;Chemical and Drug Induced Liver Injury;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Risk Factors;Tuberculosis/drug therapy*;Tuberculosis/metabolism
21073557;Biomedical Research/history;Cheese;Drug Interactions*/genetics;Drug Therapy/history*;Food-Drug Interactions*;History, 20th Century;Humans
21058190;Antineoplastic Agents, Phytogenic/metabolism*;Cell Adhesion;Cell Cycle/drug effects*;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Cyclin B1/metabolism;Food-Drug Interactions;G2 Phase/drug effects;Humans;Microtubules/drug effects;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Neoplasms/prevention & control;Nocodazole/antagonists & inhibitors*;Nocodazole/pharmacology;Osmolar Concentration;Paclitaxel/antagonists & inhibitors*;Paclitaxel/pharmacology;Quercetin/metabolism*;Time Factors;Tubulin/metabolism;Tubulin Modulators/antagonists & inhibitors*;Tubulin Modulators/pharmacology;Tumor Suppressor Protein p53/genetics;Tumor Suppressor Protein p53/metabolism
21055466;Carbamates/administration & dosage*;Carbamates/pharmacokinetics*;Fasting;Food-Drug Interactions;Gastrointestinal Tract/metabolism*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Magnetic Resonance Imaging;Organophosphates/administration & dosage*;Organophosphates/pharmacokinetics*;Postprandial Period;Solubility;Sulfonamides/administration & dosage*;Sulfonamides/pharmacokinetics*;Tablets
21048420;Antipsychotic Agents*/chemistry;Catechin/analogs & derivatives*;Catechin/chemistry;Dimethyl Sulfoxide;Food-Drug Interactions*;Hydrogen;Magnetic Resonance Spectroscopy;Models, Molecular;Molecular Conformation;Risperidone*/chemistry;Solubility;Solutions;Tea*;Water
21039758;Administration, Oral;Anti-Allergic Agents/pharmacokinetics*;Beverages*;Biological Availability;Citrus*;Citrus paradisi*;Food-Drug Interactions/physiology*;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Humans;Organic Anion Transporters/metabolism;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
22834058;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/drug therapy*;Diet;Dose-Response Relationship, Drug;Food-Drug Interactions*;Health Behavior;Health Education;Humans;Risk Factors;Vegetables*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
20980999;Administration, Oral;Adult;Aged;Cohort Studies;Cross-Over Studies;Dietary Fats/metabolism*;Fatigue/chemically induced;Female;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics*
20974993;Acetates/administration & dosage;Acetates/blood;Acetates/pharmacokinetics*;Adolescent;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/blood;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Asthma/drug therapy*;Asthma/metabolism;Asthma/physiopathology;Beverages*;Citrus paradisi*;Citrus sinensis*;Cross-Over Studies;Female;Florida;Food-Drug Interactions*;Fruit;Heterozygote;Homozygote;Humans;Isotonic Solutions;Leukotriene Antagonists/administration & dosage;Leukotriene Antagonists/blood;Leukotriene Antagonists/pharmacokinetics*;Male;Models, Biological;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Phenotype;Polymorphism, Genetic;Quinolines/administration & dosage;Quinolines/blood;Quinolines/pharmacokinetics*
20972517;Beverages;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism;Diabetes Mellitus/drug therapy*;Flavanones/pharmacology;Food-Drug Interactions*/physiology;Humans;Intestines/metabolism;Metabolic Syndrome/drug therapy*;Metabolic Syndrome/metabolism;Phytotherapy*
20970282;Aged, 80 and over;Amiodarone/adverse effects*;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/therapy;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Electric Countershock;Electrocardiography;Emergency Service, Hospital;Female;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced;Torsades de Pointes/therapy
20959524;Adult;Benzothiazoles/administration & dosage;Benzothiazoles/adverse effects*;Benzothiazoles/analysis;Benzothiazoles/pharmacokinetics*;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects*;Dopamine Agonists/analysis;Dopamine Agonists/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Plasma/chemistry;Urine/chemistry
20952061;Antineoplastic Agents/economics*;Antineoplastic Agents/therapeutic use;Benzamides;Beverages*;Citrus*;Drug Costs*;Food-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Piperazines/economics*;Piperazines/therapeutic use;Pyrimidines/economics*;Pyrimidines/therapeutic use
20949341;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats;Drug-Related Side Effects and Adverse Reactions;Fasting;Feeding Behavior*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Morphine/administration & dosage;Morphine/pharmacology*;Naltrexone/administration & dosage;Naltrexone/pharmacokinetics*
20928982;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/history*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/drug therapy;History, 20th Century;History, 21st Century;Humans;International Normalized Ratio;Mixed Function Oxygenases/antagonists & inhibitors;Patient Education as Topic;Thrombophilia/drug therapy;Thrombosis/prevention & control;Vitamin K/metabolism;Vitamin K/therapeutic use;Vitamin K Epoxide Reductases;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/history*;Warfarin/pharmacokinetics;Warfarin/therapeutic use
20926751;Adenosine A1 Receptor Antagonists/administration & dosage;Adenosine A1 Receptor Antagonists/adverse effects;Adenosine A1 Receptor Antagonists/blood;Adenosine A1 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Aged;Biological Availability;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/adverse effects;Diuretics/blood;Diuretics/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Sex Characteristics;Xanthines/administration & dosage;Xanthines/adverse effects;Xanthines/blood;Xanthines/pharmacokinetics*;Young Adult
20883117;Aged;Amitriptyline/administration & dosage;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Amitriptyline/therapeutic use;Animals;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions;Humans;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/pharmacokinetics*;Muscle Relaxants, Central/therapeutic use;Randomized Controlled Trials as Topic;Spasm/drug therapy*
20869315;Antacids/adverse effects;Anti-Infective Agents/adverse effects;Anticonvulsants/adverse effects;Antiemetics/adverse effects;Antineoplastic Agents/adverse effects;Child;Complementary Therapies/adverse effects;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasms/drug therapy*
20864621;Administration, Oral;Adolescent;Adult;Biotransformation;Cytochrome P-450 CYP2D6/metabolism;Dizziness/chemically induced;Double-Blind Method;Drug Administration Schedule;Electrocardiography;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Heart Rate/drug effects;Humans;Intestinal Absorption;Male;Models, Biological;Nausea/chemically induced;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine;Vomiting/chemically induced;Young Adult
20854805;Antineoplastic Agents/antagonists & inhibitors*;Antineoplastic Agents/pharmacology;Apoptosis/drug effects;Carcinoma, Non-Small-Cell Lung/drug therapy*;Cell Line, Tumor;Cell Survival/drug effects;Drug Interactions;Enzyme Activation/drug effects;Flavonoids/pharmacology*;Food-Drug Interactions;Free Radical Scavengers/pharmacology*;Humans;Indoles/antagonists & inhibitors*;Indoles/pharmacology;JNK Mitogen-Activated Protein Kinases/metabolism;MAP Kinase Signaling System/drug effects;Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors;Osmolar Concentration;Phosphorylation/drug effects;Protein Kinase Inhibitors/pharmacology;Reactive Oxygen Species/metabolism*
20852003;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Acetamides/therapeutic use;Adult;Biological Availability;Capsules;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/therapeutic use;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/therapeutic use;Male;Orexin Receptors;Reaction Time/drug effects;Receptors, G-Protein-Coupled/antagonists & inhibitors*;Receptors, Neuropeptide/antagonists & inhibitors*;Tablets;Task Performance and Analysis;Therapeutic Equivalency;Wakefulness/drug effects;Young Adult
20736331;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Drug Labeling/standards*;Fasting;Food;Food-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage*
20736327;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Drug Delivery Systems;Drug Labeling/standards*;Drug Labeling/statistics & numerical data;Fasting;Food;Food-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage*;United States;United States Food and Drug Administration
20717876;Beverages;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Fruit;Humans;Intestines/drug effects*;Intestines/enzymology;Microsomes/drug effects;Midazolam/metabolism*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Recombinant Proteins;Triterpenes/isolation & purification;Triterpenes/pharmacology*;Vaccinium macrocarpon/chemistry*
20701327;Animals;Biological Availability;Chemistry, Pharmaceutical/instrumentation;Chemistry, Pharmaceutical/methods*;Dosage Forms;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Pharmacokinetics*;Solubility
20694287;Dietary Fiber*;Food-Drug Interactions*;Humans
20686214;Aged;Aged, 80 and over;Child, Preschool;Day Care, Medical/statistics & numerical data*;Drug Interactions;Drug Utilization;Food, Organic/utilization*;Food-Drug Interactions;Humans;Japan/epidemiology;Nonprescription Drugs*;Parents*;Schools, Nursery/statistics & numerical data*;Self Medication;Surveys and Questionnaires
20678294;Appetite/drug effects;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Gastrointestinal Diseases/etiology;Humans;Nutrition Assessment;Nutritional Status*
20664534;Adult;Amides/pharmacokinetics*;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Female;Food-Drug Interactions;Fumarates/pharmacokinetics*;Half-Life;Humans;Male;Organic Anion Transporters/antagonists & inhibitors*;Renin/antagonists & inhibitors;Young Adult
20662310;1-Naphthylisothiocyanate;Administration, Oral;Animals;Biological Availability;Carbon Tetrachloride;Cholestasis/chemically induced;Cholestasis/metabolism*;Food-Drug Interactions;Immunosuppressive Agents/pharmacokinetics*;Intestinal Absorption/physiology*;Male;Rats;Rats, Sprague-Dawley;Ribonucleosides/pharmacokinetics*
20660294;Administration, Oral;Bone Density Conservation Agents/administration & dosage*;Bone Density Conservation Agents/pharmacokinetics;Bone Resorption/drug therapy;Calcitonin/administration & dosage*;Calcitonin/pharmacokinetics;Food-Drug Interactions;Gastric Emptying/drug effects;Humans;Osteoporosis/drug therapy*;Osteoporosis/metabolism;Peptide Fragments/administration & dosage;Peptide Fragments/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
20653797;Antiparkinson Agents/therapeutic use*;Catechol O-Methyltransferase Inhibitors;Dopamine Agonists/therapeutic use;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy*;Practice Guidelines as Topic
20653361;Animals;Antifungal Agents/therapeutic use*;Azoles/therapeutic use*;Disease Management;Drug Interactions*/physiology;Food-Drug Interactions*/physiology;Humans;Mycoses/drug therapy*;Mycoses/etiology;Transplantation*/adverse effects
20652662;Adult;Cheese/adverse effects*;Chest Pain/drug therapy;Chest Pain/etiology;Chest Pain/physiopathology;Electrocardiography;Female;Food-Drug Interactions*;Heart/drug effects;Heart/physiopathology;Humans;Injections, Intravenous;Monoamine Oxidase Inhibitors/adverse effects*;Morphine/therapeutic use;Myocardial Infarction/blood;Myocardial Infarction/chemically induced*;Myocardial Infarction/physiopathology;Nitroprusside/therapeutic use;Phenelzine/adverse effects*;Treatment Outcome;Troponin I/blood;Vasodilator Agents/therapeutic use
20642557;Aged;Aged, 80 and over;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Cardiovascular Diseases/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacology*;Warfarin/therapeutic use
20630973;Aged;Anticoagulants/adverse effects*;Brassica/adverse effects*;Diet/adverse effects;Dyspnea/chemically induced;Female;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Pulmonary Embolism/drug therapy;Recurrence;Vitamin K Deficiency/etiology*;Warfarin/adverse effects*
20628041;Antiparkinson Agents/adverse effects*;Carbidopa/administration & dosage;Drug Therapy, Combination;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Intensive Care Units;Length of Stay;Levodopa/adverse effects*;Male;Middle Aged;Neuroleptic Malignant Syndrome/etiology*;Parkinson Disease/drug therapy
20584229;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects*;Benzimidazoles/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Morpholines/administration & dosage;Morpholines/adverse effects*;Morpholines/metabolism;Pyrazoles/administration & dosage;Pyrazoles/adverse effects*;Pyrazoles/metabolism;Pyridones/administration & dosage;Pyridones/adverse effects*;Pyridones/metabolism;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects*;Thiophenes/metabolism;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/metabolism
20576487;Absorption;Administration, Oral;Chemistry, Pharmaceutical;Computer Simulation*;Fasting;Female;Food-Drug Interactions;Forecasting;Gastric Emptying;Humans;Intestinal Absorption*;Male;Models, Biological*;Morpholines/administration & dosage;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Nanoparticles*;Permeability;Postprandial Period;Randomized Controlled Trials as Topic;Software;Solubility
20566446;Adolescent;Adult;Area Under Curve;Biological Availability;Child;Child, Preschool;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
20554023;Absorption;Administration, Oral;Animals;Chemistry, Pharmaceutical;Computer Simulation*;Dogs;Eating;Fasting;Food-Drug Interactions;Gastrointestinal Transit;Intestinal Absorption;Models, Biological*;Particle Size;Permeability;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/chemistry;Platelet Aggregation Inhibitors/pharmacokinetics*;Reproducibility of Results;Solubility;Tetrazoles/administration & dosage;Tetrazoles/blood;Tetrazoles/chemistry;Tetrazoles/pharmacokinetics*
20550762;Antacids/pharmacology*;Antitubercular Agents/administration & dosage;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions*;Humans
20538908;Anticoagulants/therapeutic use*;Drug Monitoring;Enteral Nutrition*;Food, Formulated*/analysis;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Middle Aged;Thromboembolism/prevention & control;Treatment Outcome;Vitamin K/administration & dosage*;Vitamin K/therapeutic use;Warfarin/therapeutic use*
20538051;Administration, Oral;Animals;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Circadian Rhythm*;Diet*;Drug Administration Schedule;Eating*;Food-Drug Interactions*;Male;Milk;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/pharmacokinetics*;Oleic Acid/administration & dosage;Rats;Rats, Sprague-Dawley;Sodium Chloride, Dietary/administration & dosage;Taurocholic Acid/administration & dosage
20534818;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Area Under Curve;Asian Continental Ancestry Group;Blood Coagulation/drug effects*;Body Mass Index;Chromatography, Liquid;Cross-Over Studies;Dietary Fats*;European Continental Ancestry Group;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Models, Biological;Partial Thromboplastin Time;Prothrombin Time;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Pyridines/urine;Tandem Mass Spectrometry;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/urine;Young Adult
20529767;Antineoplastic Agents/therapeutic use;Benzamides;Drug Eruptions/prevention & control;Drug Interactions;Drug Resistance, Neoplasm;Erythropoietin/therapeutic use;Fertility/drug effects;Food-Drug Interactions;France;Granulocyte Colony-Stimulating Factor/therapeutic use;Heart Diseases/chemically induced;Heart Diseases/prevention & control;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Metabolic Diseases/chemically induced;Metabolic Diseases/prevention & control;Neutropenia/chemically induced;Neutropenia/prevention & control;Piperazines/therapeutic use;Protein Kinase Inhibitors/adverse effects*;Protein-Tyrosine Kinases/antagonists & inhibitors;Pyrimidines/adverse effects*;Pyrimidines/therapeutic use;Recombinant Proteins
20520305;Fabaceae/adverse effects*;Fabaceae/metabolism;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Hypertension/metabolism;Levodopa/adverse effects;Levodopa/metabolism;Tyramine/adverse effects;Tyramine/metabolism
20512335;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Beverages/adverse effects;Biological Availability;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Labeling;Female;Food-Drug Interactions*;Humans;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Midazolam/metabolism;Middle Aged;Neoplasms/drug therapy;Neoplasms/pathology;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
20511734;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Biomedical Research;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Drug Evaluation;Drug Monitoring;Drugs, Investigational/administration & dosage;Drugs, Investigational/pharmacokinetics*;Energy Intake;Fasting/physiology;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Postprandial Period/physiology;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/pharmacokinetics*;Treatment Outcome;Young Adult
20503933;ATP Binding Cassette Transporter, Sub-Family B/biosynthesis;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents/pharmacology;Antioxidants/pharmacology*;Blotting, Western;Cell Line, Tumor;Cell Survival/drug effects;Drug Resistance, Neoplasm/drug effects*;Fluoresceins/pharmacology;Food-Drug Interactions;Glutathione Transferase/biosynthesis;Glutathione Transferase/metabolism;Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism;Humans;Kaempferols/pharmacology*;Multidrug Resistance-Associated Proteins/metabolism;Reverse Transcriptase Polymerase Chain Reaction
20503932;Animals;Area Under Curve;Beverages;Calcium Channel Blockers/pharmacokinetics*;Citrus paradisi/chemistry*;Felodipine/pharmacokinetics*;Food-Drug Interactions*;Humans;MEDLINE;Publication Bias*
20495471;Age Factors;Anti-Bacterial Agents/therapeutic use;Beverages*;Evidence-Based Medicine;Female;Food-Drug Interactions;Fruit;Humans;Male;Phytotherapy*;Recurrence;Sex Factors;Treatment Outcome;Urinary Tract Infections/microbiology;Urinary Tract Infections/therapy*;Vaccinium macrocarpon*;Women's Health
20492299;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Alkaloids/pharmacology*;Animals;Benzodioxoles/pharmacology*;Biological Availability;Chromatography, High Pressure Liquid;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Histamine H1 Antagonists, Non-Sedating/administration & dosage;Histamine H1 Antagonists, Non-Sedating/blood;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Intestinal Absorption/drug effects*;Male;Piper nigrum/chemistry*;Piperidines/pharmacology*;Polyunsaturated Alkamides/pharmacology*;Rats;Rats, Sprague-Dawley;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
20490472;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Confounding Factors (Epidemiology);Cross-Over Studies;Drug Administration Schedule;Eating*;Fasting*;Female;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/blood;Piperazines/pharmacology*;Piperidines/administration & dosage*;Piperidines/blood;Piperidines/pharmacology*;Postprandial Period;Reference Values;Research Design;Time Factors
20486464;Biotransformation;Drug Therapy;Europe;Fasting;Food-Drug Interactions;Guidelines as Topic*;Humans;Patient Selection;Pharmaceutical Preparations/analysis;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/standards*;Pharmacokinetics*;Solubility;Therapeutic Equivalency*
20484610;Adult;Amines/administration & dosage;Amines/adverse effects;Amines/blood;Amines/pharmacokinetics*;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/adverse effects;Cyclohexanecarboxylic Acids/blood;Cyclohexanecarboxylic Acids/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Stomach/metabolism*;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics*
20481649;Animals;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Antifungal Agents/pharmacology;Area Under Curve;Biological Availability;Drug Interactions;Drug Resistance, Fungal;Food-Drug Interactions;Fungi/drug effects;Humans;Mycoses/drug therapy*;Mycoses/microbiology;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Triazoles/pharmacology
20472816;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Amiodarone/analogs & derivatives*;Amiodarone/pharmacokinetics;Amiodarone/pharmacology;Amiodarone/therapeutic use;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacology;Anti-Arrhythmia Agents/therapeutic use;Atrial Fibrillation/drug therapy*;Biological Availability;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Food-Drug Interactions;Half-Life;Humans
20458565;Food-Drug Interactions;Pharmacokinetics;Pharmacology*;Solubility
20457591;Adolescent;Adult;Cross-Over Studies;Dietary Fats/administration & dosage*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Pyrrolidinones/adverse effects;Pyrrolidinones/blood;Pyrrolidinones/pharmacokinetics*;Raltegravir Potassium;Young Adult
20457501;Animals;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Caseins/metabolism*;Cattle;Ciprofloxacin/chemistry;Ciprofloxacin/pharmacokinetics*;Food-Drug Interactions*;Milk/adverse effects*;Solubility;Tablets
20449528;Beverages;Citrus paradisi;Fatty Acids;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hyperlipidemias/blood;Hyperlipidemias/drug therapy*;Phytosterols
20432867;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Bacteria/metabolism;Bifidobacterium;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Intestines/microbiology;Lactobacillus rhamnosus;Probiotics/administration & dosage*;Probiotics/adverse effects;Vitamin K/biosynthesis;Vitamin K/metabolism;Warfarin/administration & dosage*
20422948;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions;Humans;Itraconazole/administration & dosage;Itraconazole/pharmacokinetics*;Male;Reference Standards;Reproducibility of Results;Tandem Mass Spectrometry;Therapeutic Equivalency;Young Adult
20406214;Administration, Oral;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Beverages*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Oxycodone/administration & dosage;Oxycodone/blood;Oxycodone/pharmacokinetics*
20400647;Adult;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Beverages/analysis*;Biological Availability;Biotransformation;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Itraconazole/adverse effects;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Miconazole/blood;Miconazole/chemistry;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
20384552;Animals;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/pharmacology;Dietary Fiber/pharmacology;Dietary Proteins/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Levodopa/pharmacokinetics*;Levodopa/pharmacology;Parkinson Disease/drug therapy
20374180;Amlodipine/administration & dosage*;Amlodipine/blood*;Beverages/adverse effects;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/blood;Hypertension/drug therapy*;Hypertension/physiopathology;Japan;Male;Middle Aged;Nifedipine/administration & dosage*;Nifedipine/blood*
20372991;Adult;Area Under Curve;Azithromycin/administration & dosage*;Azithromycin/blood;Azithromycin/pharmacokinetics*;Biological Availability;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Dosage Forms;Fasting;Female;Food-Drug Interactions*;Humans;Male;Molecular Structure
20221896;Administration, Oral;Aminoquinolines/administration & dosage;Aminoquinolines/chemistry;Aminoquinolines/pharmacokinetics*;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/chemistry;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/administration & dosage;Carbamates/chemistry;Carbamates/pharmacokinetics*;Cholesterol Ester Transfer Proteins/antagonists & inhibitors*;Chromatography, High Pressure Liquid;Dogs;Food-Drug Interactions;Half-Life;Injections, Intravenous;Intestinal Absorption/physiology*;Intestines/metabolism*;Lipids/chemistry;Lymphatic System/metabolism*;Male;Mass Spectrometry;Molecular Weight;Quinolines/administration & dosage;Quinolines/chemistry;Quinolines/pharmacokinetics*;Solubility;Triglycerides/chemistry
20208387;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis*;Drug Evaluation/methods*;Drug Interactions*;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology;Food-Drug Interactions;Humans;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism*;Models, Statistical*
20206791;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Biopterin/administration & dosage;Biopterin/analogs & derivatives*;Biopterin/blood;Biopterin/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Energy Intake;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Models, Biological;Postprandial Period;Solubility;Tablets;Young Adult
20197487;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Tablets;Tandem Mass Spectrometry;Young Adult
20183991;Belgium;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/analysis;Capsules;Chromatography, High Pressure Liquid;Delayed-Action Preparations;Drug Utilization;Food-Drug Interactions;Nifedipine/administration & dosage*;Nifedipine/analysis;Reproducibility of Results;Solubility;Spectrophotometry, Ultraviolet;Tablets
20180933;Acute Disease;Africa;Antimalarials*/administration & dosage;Antimalarials*/pharmacokinetics;Artemisinins*/administration & dosage;Artemisinins*/pharmacokinetics;Biological Availability;Child;Child, Preschool;Diet;Drug Combinations;Ethanolamines/administration & dosage;Ethanolamines/pharmacokinetics*;Female;Fluorenes/administration & dosage;Fluorenes/pharmacokinetics*;Food-Drug Interactions*;Humans;Malaria, Falciparum/blood;Malaria, Falciparum/drug therapy*;Male;Time Factors
20166442;Administration, Oral;Area Under Curve;Asian Continental Ancestry Group;China;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Fluorobenzenes/administration & dosage;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Half-Life;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Young Adult
20160155;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Adult;Beverages;China;Chromatography, High Pressure Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A Inhibitors;DNA/genetics;Ethnic Groups;Female;Food-Drug Interactions;Genotype;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Phenotype;Polymorphism, Genetic;Reverse Transcriptase Polymerase Chain Reaction;Young Adult
20150522;Adamantane/analogs & derivatives*;Adamantane/blood;Adamantane/pharmacokinetics;Adult;Area Under Curve;Cross-Over Studies;Dietary Fats*;Dipeptides/blood;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/blood;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
20147618;Administration, Oral;Adult;Analgesics/blood;Analgesics/pharmacokinetics*;Analgesics/urine;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Anticonvulsants/urine;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Metabolic Clearance Rate;Middle Aged;Pregabalin;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics;gamma-Aminobutyric Acid/urine
20144318;Adult;Diabetes Mellitus, Type 2/genetics*;Diabetes Mellitus, Type 2/metabolism*;Diet*;Food-Drug Interactions/genetics;Genetic Predisposition to Disease;Humans;Metabolic Syndrome/genetics;Nutrigenomics*;Research Design
20140680;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Caco-2 Cells;Cardiovascular Agents/analysis;Cardiovascular Agents/pharmacokinetics*;Cell Membrane Permeability;Dietary Supplements*/analysis;Food-Drug Interactions*;Garlic/chemistry*;Humans;Hypoglycemic Agents/analysis;Hypoglycemic Agents/pharmacokinetics*;Intestinal Absorption;Intestine, Small/metabolism;Male;Monocarboxylic Acid Transporters/metabolism;Multidrug Resistance-Associated Proteins/metabolism;Organic Anion Transporters/metabolism;Peptide Transporter 1;Plant Extracts*/chemistry;Plant Roots/chemistry*;Rats;Rats, Wistar;Symporters/metabolism;Transcytosis
20137869;Adolescent;Alcoholic Intoxication/psychology;Alcoholism/psychology;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Computer Simulation;Decision Making*;Eating;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans
20137768;Adolescent;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Liquid/methods;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/adverse effects;Nifedipine/pharmacokinetics*;Osmosis;Tablets;Tandem Mass Spectrometry/methods;Therapeutic Equivalency;Young Adult
20137764;Adult;Amines/pharmacokinetics;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/pharmacokinetics;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prodrugs;Young Adult;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
20132652;Amino Acids, Aromatic/pharmacokinetics;Binding, Competitive;Chronotherapy;Diet, Mediterranean;Diet, Protein-Restricted*;Food-Drug Interactions;Humans;Levodopa/pharmacokinetics;Levodopa/therapeutic use;Parkinson Disease/diet therapy*
20110012;Adolescent;Adult;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benzothiazoles/administration & dosage*;Benzothiazoles/adverse effects;Benzothiazoles/pharmacokinetics*;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats;Food-Drug Interactions;Humans;Male;Reproducibility of Results;Young Adult
20101064;Administration, Oral;Adult;Area Under Curve;Benzoxazines/administration & dosage*;Benzoxazines/blood;Benzoxazines/pharmacokinetics*;Biological Availability;Capsules;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Reverse Transcriptase Inhibitors/administration & dosage*;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Taste;Therapeutic Equivalency
20095789;Aldehyde Oxidase/antagonists & inhibitors;Aldehyde Oxidase/metabolism*;Animals;Drug Interactions;Flavonoids/metabolism*;Flavonoids/pharmacology;Flavonoids/therapeutic use;Food-Drug Interactions;Humans;Metalloproteins/antagonists & inhibitors;Metalloproteins/metabolism*;Molybdenum/metabolism*;Oxidation-Reduction;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Structure-Activity Relationship;Xanthine Oxidase/antagonists & inhibitors;Xanthine Oxidase/metabolism*;Xenobiotics/metabolism
20081065;Administration, Oral;Adolescent;Adult;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics*;Area Under Curve;Bleeding Time;Dose-Response Relationship, Drug;Factor Xa/metabolism;Factor Xa Inhibitors*;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Male;Middle Aged;Partial Thromboplastin Time;Prothrombin Time;Pyridines/adverse effects*;Pyridines/pharmacokinetics*;Single-Blind Method;Tablets;Thiazoles/adverse effects*;Thiazoles/pharmacokinetics*;Young Adult
20067711;Animals;Biotransformation;Clinical Trials as Topic/standards;Dietary Supplements*;Dosage Forms;Food-Drug Interactions*;Functional Food*;Humans;Pharmacokinetics;Risk Assessment
20065263;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Arecaceae/chemistry*;Beverages/adverse effects*;Blood Coagulation/drug effects;Fatty Acids/adverse effects;Food-Drug Interactions*;Fruit/chemistry*;Humans;United States;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
20053516;Animals;Anti-Infective Agents/chemistry*;Anti-Infective Agents/metabolism;Biological Availability;Calcium/chemistry;Caseins/chemistry;Chromatography, High Pressure Liquid;Ciprofloxacin/chemistry*;Ciprofloxacin/metabolism;Food-Drug Interactions*;Hydrogen-Ion Concentration;Kinetics;Lipids/chemistry;Milk/adverse effects*;Reproducibility of Results;Solid Phase Extraction;Solubility;Spectrometry, Mass, Electrospray Ionization;Tablets
20044363;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Practice Guidelines as Topic*;Prescription Drugs*
21819799;Adult;Anticonvulsants/poisoning*;Benzodiazepines/poisoning*;Beverages/poisoning*;Codeine/poisoning;Fatal Outcome;Food-Drug Interactions*;Humans;Male;Morphine/poisoning;Papaver/chemistry*;Plant Extracts;Seeds/chemistry;Thebaine/poisoning
20040339;Administration, Oral;Adult;Area Under Curve;Cimetidine/pharmacokinetics;Cimetidine/pharmacology;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacokinetics;Histamine H2 Antagonists/pharmacology;Humans;Hypoglycemic Agents/pharmacology;Male;Metformin/pharmacokinetics;Metformin/pharmacology;Middle Aged;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Young Adult
20029019;Anticoagulants/therapeutic use*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Hematoma/diagnosis;Hematoma/etiology*;Humans;International Normalized Ratio;Middle Aged;Punicaceae/adverse effects*;Warfarin/therapeutic use*
20001610;Anti-HIV Agents/chemistry;Anti-HIV Agents/therapeutic use*;Benzoxazines/adverse effects;Benzoxazines/chemistry;Benzoxazines/metabolism;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Chemistry, Pharmaceutical;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1;Humans;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/chemistry;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*
19948946;Adolescent;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions*;Fusion Proteins, bcr-abl/metabolism;Headache/chemically induced;Humans;Male;Middle Aged;Protein-Tyrosine Kinases/metabolism;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Vomiting/chemically induced;Young Adult
19947351;Antineoplastic Agents/pharmacology*;Antioxidants/pharmacology*;DNA Damage/drug effects;Dietary Supplements*;Edible Grain;Food-Drug Interactions/physiology*;Fruit;Humans;Neoplasms/drug therapy*;Oxidative Stress/drug effects;Vegetables
19945772;Adenocarcinoma/drug therapy;Adenocarcinoma/pathology;Adenocarcinoma/physiopathology*;Antimetabolites, Antineoplastic/pharmacology;Apoptosis*;Cell Count;Cell Cycle;Cell Survival*;Colorectal Neoplasms/drug therapy;Colorectal Neoplasms/pathology;Colorectal Neoplasms/physiopathology*;Drug Combinations;Fat Emulsions, Intravenous/administration & dosage*;Fat Emulsions, Intravenous/chemistry;Fatty Acids/analysis;Fish Oils/chemistry;Fluorouracil/pharmacology;Food-Drug Interactions;HT29 Cells;Humans;Osmolar Concentration;Phospholipids/administration & dosage;Phospholipids/chemistry;S Phase/drug effects*;Sorbitol/administration & dosage;Sorbitol/chemistry;Soybean Oil/chemistry;Triglycerides/administration & dosage;Triglycerides/chemistry
19925488;Adult;Anaphylaxis/etiology*;Anaphylaxis/immunology;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Exercise*;Female;Food-Drug Interactions;Humans;Immunoglobulin E/analysis;Male;Skin Tests;Wheat Hypersensitivity/complications*;Wheat Hypersensitivity/immunology
19925256;Adult;Alginates/administration & dosage*;Alginates/pharmacokinetics;Antacids/administration & dosage*;Antacids/pharmacokinetics;Chemistry, Pharmaceutical/instrumentation*;Chemistry, Pharmaceutical/methods;Cross-Over Studies;Drug Combinations;Food-Drug Interactions/physiology;Gastroesophageal Reflux/diagnostic imaging;Gastroesophageal Reflux/drug therapy;Glucuronic Acid/administration & dosage;Glucuronic Acid/pharmacokinetics;Hexuronic Acids/administration & dosage;Hexuronic Acids/pharmacokinetics;Humans;Male;Radionuclide Imaging;Stomach/diagnostic imaging*;Stomach/drug effects;Stomach/metabolism*;Young Adult
19924121;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions*;Fusion Proteins, bcr-abl/administration & dosage;Fusion Proteins, bcr-abl/pharmacokinetics*;Humans;Leukocyte Count;Male;Middle Aged;Protein-Tyrosine Kinases/administration & dosage;Protein-Tyrosine Kinases/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Solubility;Young Adult
19922894;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions;Gelatin;Humans;Intestinal Absorption;Male;Young Adult
19908637;Anti-Bacterial Agents/pharmacology*;Food-Drug Interactions*;Humans
19902529;Antioxidants/metabolism*;Circular Dichroism;Dietary Supplements;Food-Drug Interactions*;Humans;Magnetic Resonance Spectroscopy;Protein Binding;Quercetin/metabolism*;Serum Albumin/metabolism*;Warfarin/metabolism*
19895490;Anti-Bacterial Agents/pharmacology*;Bacillus subtilis/drug effects;Dietary Carbohydrates;Dietary Fats;Dietary Proteins;Drug Synergism;Edetic Acid/pharmacology*;Escherichia coli/drug effects;Food Microbiology*;Food Preservatives/pharmacology;Food-Drug Interactions*;Laurates/pharmacology*;Microbial Sensitivity Tests;Monoglycerides/pharmacology*;Nisin/pharmacology*;Propionates/pharmacology;Pyrones/pharmacology*;Sodium Lactate/pharmacology;Staphylococcus aureus/drug effects
19881206;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/metabolism;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/metabolism;Benzoates/administration & dosage;Benzoates/metabolism;Camptothecin/administration & dosage;Camptothecin/adverse effects;Camptothecin/analogs & derivatives;Camptothecin/metabolism;Coumaric Acids;Cyclohexanes/administration & dosage;Cyclohexanes/metabolism*;Drug Interactions;Flavonoids;Food-Drug Interactions;Functional Food;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/metabolism*;Intestinal Absorption*;Monocarboxylic Acid Transporters/physiology;Phenols;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/metabolism;Polyphenols
19891943;Absorptiometry, Photon;Accidental Falls/prevention & control;Aged;Algorithms;Biomarkers/blood;Bone Density*;Bone Density Conservation Agents/therapeutic use*;Calcium/therapeutic use*;Congresses as Topic;Diphosphonates/therapeutic use;Drug Interactions;Drug Therapy, Combination;Estrogen Replacement Therapy/methods;Female;Food-Drug Interactions;Hip Fractures/diagnosis;Hip Fractures/physiopathology;Hip Fractures/prevention & control*;Humans;Life Style;Mass Screening/methods;Middle Aged;Osteoporosis, Postmenopausal/blood;Osteoporosis, Postmenopausal/complications;Osteoporosis, Postmenopausal/diagnosis*;Osteoporosis, Postmenopausal/physiopathology;Osteoporosis, Postmenopausal/prevention & control*;Osteoporotic Fractures/blood;Osteoporotic Fractures/diagnosis*;Osteoporotic Fractures/etiology;Osteoporotic Fractures/physiopathology;Osteoporotic Fractures/prevention & control*;Osteoprotegerin/blood;Practice Guidelines as Topic;RANK Ligand/blood;Risk Assessment;Risk Factors;Treatment Outcome;Vitamin D/therapeutic use*
19843830;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Influenza Vaccines/adverse effects*;Influenza Vaccines/pharmacokinetics;Intracranial Hemorrhages/chemically induced*;Intracranial Hemorrhages/metabolism;Warfarin/adverse effects*;Warfarin/pharmacokinetics
19830413;Administration, Oral;Adolescent;Adult;Beverages*;Biological Availability;Body Mass Index;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Fruit*;Half-Life;Humans;Jordan;Male;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Purines/administration & dosage;Purines/blood;Purines/pharmacokinetics;Sildenafil Citrate;Statistics as Topic;Sulfones/administration & dosage;Sulfones/blood;Sulfones/pharmacokinetics*;Young Adult
19822208;Administration, Oral;Dosage Forms*;Electromagnetic Phenomena;Ferrosoferric Oxide/chemistry;Food-Drug Interactions;Humans;Imaging, Three-Dimensional/methods*;Magnetic Resonance Imaging/methods*;Particle Size;Stomach*;Technology, Pharmaceutical/methods;Time Factors
19804821;Animals;Biological Availability;Cross-Over Studies;Flavonols/administration & dosage*;Flavonols/blood;Flavonols/pharmacokinetics*;Food-Drug Interactions/physiology*;Male;Quercetin/administration & dosage*;Quercetin/blood;Quercetin/pharmacokinetics*;Simvastatin/blood;Simvastatin/pharmacokinetics*;Swine
19789373;Beverages*;Biological Availability;Clinical Trials as Topic;Food-Drug Interactions*;Fruit*;Humans;Organic Anion Transporters/metabolism*;Pharmacokinetics*
19779132;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Adrenergic beta-1 Receptor Antagonists;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*/adverse effects;Biological Transport/drug effects;Cell Culture Techniques;Cell Membrane Permeability/drug effects;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Flavanones/adverse effects;Flavanones/isolation & purification;Food-Drug Interactions*;Humans;Intestinal Absorption*;LLC-PK1 Cells;Oocytes/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/biosynthesis;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar;Species Specificity;Swine;Transfection;Xenopus laevis
19766437;Absorption;Anticoagulants/adverse effects*;Anticoagulants/metabolism*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Drug Overdose;Female;Food-Drug Interactions;Humans;Middle Aged;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Phenindione/metabolism;Severity of Illness Index;Vitamin K/antagonists & inhibitors*
19749487;Animals;Catalysis;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/physiology*;Environment;Food-Drug Interactions;Humans;Liver/enzymology;Oxidation-Reduction;Pharmaceutical Preparations/metabolism*;Pharmacogenetics;Polymorphism, Genetic;Species Specificity;Substrate Specificity
19746411;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Data Interpretation, Statistical;Dogs;Drug Combinations;Drug Evaluation, Preclinical;Food-Drug Interactions;HIV Infections/drug therapy;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Lopinavir;Models, Biological;Pyrimidinones/administration & dosage;Pyrimidinones/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Tablets;Therapeutic Equivalency
19730804;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Colitis, Ulcerative/drug therapy;Crohn Disease/drug therapy;Double-Blind Method;Drug Administration Schedule;Drug Monitoring;Food-Drug Interactions;Humans;Japan;Male;Mesalamine/administration & dosage;Mesalamine/metabolism;Mesalamine/pharmacokinetics*;Metabolic Clearance Rate;Middle Aged;Safety*;Tablets;Time Factors
19728565;Adolescent;Adult;Amodiaquine/administration & dosage;Amodiaquine/adverse effects;Amodiaquine/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Spectrometry, Mass, Electrospray Ionization;Young Adult
19721907;Anticholesteremic Agents/pharmacology*;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control*;Diet*;Follow-Up Studies;Food-Drug Interactions;Humans;Hypercholesterolemia/complications;Hypercholesterolemia/etiology*;Male;Middle Aged;Olive Oil;Plant Oils*;Risk Factors;Simvastatin/pharmacology*;Sunflower Oil
19721898;Antineoplastic Agents/pharmacology*;Food-Drug Interactions*;Humans
19694738;Administration, Oral;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/pharmacokinetics*;Cytochrome P-450 CYP2C9;Diclofenac/administration & dosage;Diclofenac/pharmacokinetics*;Drug Monitoring;Epidemiologic Methods;Female;Food-Drug Interactions/physiology;Humans;Male;Microsomes, Liver/metabolism*;Plant Extracts/metabolism*;Vaccinium macrocarpon/metabolism*;Young Adult
19694184;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Beverages/analysis*;Budesonide/administration & dosage*;Budesonide/pharmacokinetics*;Capsules;Chromatography, High Pressure Liquid;Citrus paradisi*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Injections, Intravenous;Male;Mass Spectrometry;Young Adult
19682087;Administration, Oral;Animals;Biological Availability;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Male;Omeprazole/blood;Omeprazole/pharmacokinetics*;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics;Rats;Rats, Wistar;Seeds/metabolism;Soybeans*
19669631;Administration, Oral;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/pharmacology;Biological Availability;Bipolar Disorder/drug therapy;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Monitoring;Energy Intake*;Food-Drug Interactions*;Humans;Injections, Intramuscular;Intestinal Absorption;Piperazines/administration & dosage*;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Safety;Schizophrenia/drug therapy;Thiazoles/administration & dosage*;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology;Treatment Outcome
19667002;Drug Incompatibility;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19663740;ATP-Binding Cassette Transporters/metabolism;Absorption;Amino Acid Transport Systems/metabolism;Animals;Brain/metabolism;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans;Membrane Transport Proteins/physiology*;Pharmaceutical Preparations/metabolism;Pharmaceutical Preparations/urine;Pharmacokinetics;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Subcellular Fractions/metabolism;Tissue Distribution
19663632;Animals;Biological Availability;Cytochrome P-450 Enzyme System/metabolism;Dietary Fats/pharmacology*;Fatty Acids/pharmacology;Food-Drug Interactions;Humans;Isoenzymes/metabolism;Lipids/pharmacology*;Lipoproteins/physiology*;Pharmaceutical Preparations/metabolism*
19663519;Adolescent;Adult;Age Factors;Aged;Dosage Forms;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Evaluation;Electrocardiography/drug effects;Female;Food-Drug Interactions;Glycation End Products, Advanced/antagonists & inhibitors*;Humans;Male;Middle Aged;Pyridinium Compounds/administration & dosage*;Pyridinium Compounds/adverse effects;Pyridinium Compounds/pharmacokinetics;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics;Therapeutic Equivalency
19660444;Animals;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology*;Area Under Curve;Blood Pressure;Dose-Response Relationship, Drug;Electrocardiography;Electrolytes/urine;Female;Food-Drug Interactions*;Garlic*;Hydrochlorothiazide/pharmacokinetics;Hydrochlorothiazide/pharmacology*;Rats;Rats, Wistar
19660002;Adult;Aged;Area Under Curve;Cross-Over Studies;Erectile Dysfunction/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphodiesterase Inhibitors/therapeutic use;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Sulfonamides;Young Adult
19646718;Adult;Atrial Fibrillation/chemically induced;Autoimmune Diseases/epidemiology;Comorbidity;Contraindications;Dose-Response Relationship, Drug;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/physiology;Female;Food-Drug Interactions;Gastritis/epidemiology;Heart Diseases/epidemiology;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/drug effects;Male;Middle Aged;Osteoporosis/chemically induced;Pregnancy;Pregnancy Complications/epidemiology;Thyrotropin/blood;Thyroxine/administration & dosage;Thyroxine/adverse effects;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*
19644845;Adult;Female;Food;Food-Drug Interactions/physiology;Gastric Juice/metabolism*;Humans;Male;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Satiation/physiology*;Solubility;Stomach/metabolism*
19637955;Anticoagulants/pharmacokinetics*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Middle Aged;Punicaceae/adverse effects*;Venous Thrombosis/drug therapy;Warfarin/pharmacokinetics*
19634639;Animals;Anti-Bacterial Agents/pharmacokinetics;Beverages;Biological Availability;Fluoroquinolones/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/physiology*;Kinetics;Milk
19627745;Adult;Anti-Allergic Agents/therapeutic use;Child;Dietary Sucrose/adverse effects;Food/adverse effects*;Food Additives/adverse effects;Food Hypersensitivity/diet therapy;Food Hypersensitivity/drug therapy;Food Hypersensitivity/epidemiology;Food Hypersensitivity/etiology;Food-Drug Interactions;Foodborne Diseases/epidemiology;Foodborne Diseases/etiology;Humans;Lactose Intolerance/diagnosis;Lactose Intolerance/diet therapy;Lactose Intolerance/drug therapy;Lactose Intolerance/epidemiology;Metabolism, Inborn Errors/complications;Prevalence;beta-Galactosidase/therapeutic use
19619649;Administration, Oral;Amoxicillin/blood;Amoxicillin/pharmacokinetics;Amoxicillin-Potassium Clavulanate Combination/pharmacokinetics;Chemistry, Pharmaceutical/methods;Dosage Forms*;Drug Delivery Systems;Electromagnetic Phenomena;Female;Food-Drug Interactions;Gastrointestinal Motility;Gastrointestinal Tract/physiology*;Humans;Imaging, Three-Dimensional/methods*;Male;Molecular Probe Techniques*;Molecular Probes*/chemistry;Solubility;Tablets, Enteric-Coated/analysis;Tablets, Enteric-Coated/chemistry;Technology, Pharmaceutical/methods*
19617468;Administration, Oral;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Drug Administration Schedule;Food-Drug Interactions;Gastric Mucosa/metabolism;Humans;Mycoses/drug therapy*;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics
19601724;Animals;Anti-Allergic Agents*/administration & dosage;Anti-Allergic Agents*/adverse effects;Anti-Allergic Agents*/pharmacokinetics;Anti-Allergic Agents*/therapeutic use;Carrier Proteins/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Diet*;Dose-Response Relationship, Drug;Drug Interactions*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Models, Biological
19594405;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Humans;Oxidation-Reduction;Polymorphism, Genetic*;Xenobiotics/metabolism*
19591515;Administration, Oral;Adolescent;Adult;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Cross-Over Studies;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged
19589874;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Acridines/pharmacology;Administration, Oral;Animals;Biological Transport/physiology*;Caco-2 Cells;Colchicine/pharmacokinetics*;Drug Interactions;Epithelium/drug effects;Epithelium/physiology;Food-Drug Interactions;Humans;Ileum/drug effects;Ileum/pathology;Indoles/administration & dosage;Indoles/pharmacology;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Intestine, Small/drug effects;Intestine, Small/pathology;Intestine, Small/physiology;Jejunum/drug effects;Jejunum/pathology;Male;Multidrug Resistance-Associated Proteins/physiology*;Oxotremorine/analogs & derivatives;Oxotremorine/pharmacokinetics;Oxotremorine/pharmacology;Permeability;Rats;Rats, Wistar;Tetrahydroisoquinolines/pharmacology;Verapamil/administration & dosage;Verapamil/pharmacology;p-Aminohippuric Acid/pharmacokinetics;p-Aminohippuric Acid/pharmacology
19585717;Arrhythmias, Cardiac/chemically induced*;Clinical Trials as Topic;Drug Approval;Drug Interactions;Exercise Tolerance/drug effects;Food-Drug Interactions;France;Humans;Intermittent Claudication/drug therapy*;Mortality;Pentoxifylline/administration & dosage;Pentoxifylline/adverse effects;Pentoxifylline/therapeutic use;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use;Randomized Controlled Trials as Topic;Risk;Tetrazoles/administration & dosage;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use;Walking
19585468;Anthocyanins/pharmacology*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/pharmacology*;Fluvoxamine/pharmacology;Food-Drug Interactions;Fruit/chemistry;Humans;Inhibitory Concentration 50;Luminescent Measurements;Proanthocyanidins/pharmacology
19581528;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*;Reference Values;Risk Assessment
19572422;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use;Child;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Fasting;Female;Food-Drug Interactions;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;HIV Infections/drug therapy*;HIV Integrase Inhibitors/administration & dosage;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/pharmacology*;HIV Integrase Inhibitors/therapeutic use;Humans;Inactivation, Metabolic;Intestinal Absorption;Male;Microsomes, Liver/enzymology;Polypharmacy;Pregnancy;Pregnancy Complications, Infectious/drug therapy;Pyrrolidinones/administration & dosage;Pyrrolidinones/adverse effects;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/pharmacology*;Pyrrolidinones/therapeutic use;Raltegravir Potassium
19559560;Animals;Butylene Glycols/metabolism*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Estradiol/metabolism;Estradiol/pharmacology*;Female;Flax/metabolism*;Food-Drug Interactions;Insulin-Like Growth Factor I/analysis;Insulin-Like Growth Factor I/metabolism;Intestine, Small/enzymology;Intestine, Small/metabolism;Lignans/metabolism*;Liver/enzymology;Liver/metabolism;Organ Size;Ovariectomy;Phytoestrogens/metabolism*;RNA/chemistry;RNA/genetics;Random Allocation;Reverse Transcriptase Polymerase Chain Reaction/veterinary;Sheep/metabolism*;Stomach/enzymology;Stomach/metabolism;Thyroxine/analysis;Thyroxine/metabolism;Triiodothyronine/analysis;Triiodothyronine/metabolism
19553405;Adult;Aged;Aged, 80 and over;Anticoagulants/pharmacokinetics*;Beverages/adverse effects*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacokinetics*
19548857;Animals;Food-Drug Interactions/physiology;HIV Infections/drug therapy;HIV Infections/enzymology;HIV Reverse Transcriptase/antagonists & inhibitors*;HIV Reverse Transcriptase/metabolism;Humans;Nitriles/chemistry*;Nitriles/pharmacokinetics;Nitriles/therapeutic use*;Pyrimidines/chemistry*;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/chemistry*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Rilpivirine
19480806;Dietetics/education;Enteral Nutrition/adverse effects;Enteral Nutrition/methods;Enteral Nutrition/standards;Evidence-Based Medicine;Feeding Behavior;Food Preservation/standards;Food Service, Hospital/standards;Food, Formulated/adverse effects;Food, Formulated/standards;Food-Drug Interactions;Humans;Malnutrition/diagnosis;Malnutrition/prevention & control;Malnutrition/therapy;Mass Screening/methods;Mass Screening/standards;Medical Records/standards;Nutrition Assessment;Nutritional Support/standards*;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods;Parenteral Nutrition/standards;Parenteral Nutrition Solutions/administration & dosage;Parenteral Nutrition Solutions/chemistry;Parenteral Nutrition Solutions/standards;Patient Care Planning;Quality Assurance, Health Care;Risk Factors;Spain;Surveys and Questionnaires
19476741;Adjuvants, Immunologic/pharmacology;Adjuvants, Immunologic/therapeutic use;Animals;Diabetes Mellitus/therapy;Food-Drug Interactions;Grifola*/chemistry;Humans;Neoplasms/therapy;beta-Glucans/analysis
19473600;Adolescent;Adult;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Muscarinic Antagonists/adverse effects;Muscarinic Antagonists/blood;Muscarinic Antagonists/pharmacokinetics*
19465123;Adult;Animals;Biological Availability;Celecoxib;Cross-Over Studies;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Milk/metabolism*;Models, Biological*;Predictive Value of Tests;Pyrazoles/chemistry;Pyrazoles/pharmacokinetics*;Solubility;Sulfonamides/chemistry;Sulfonamides/pharmacokinetics*
19458055;Abdominal Pain/chemically induced;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Diarrhea/chemically induced;Drug Administration Schedule;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Organoplatinum Compounds/administration & dosage;Organoplatinum Compounds/adverse effects;Organoplatinum Compounds/pharmacokinetics*;Vomiting/chemically induced
19446149;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Area Under Curve;Benzoates/administration & dosage;Benzoates/adverse effects;Benzoates/pharmacokinetics*;Biological Availability;Calcium, Dietary/pharmacology;Capsules;Cross-Over Studies;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/adverse effects;Hydrazines/pharmacokinetics*;Magnesium/pharmacology;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Receptors, Thrombopoietin/agonists;Tablets;Young Adult
19445995;Adult;Antitussive Agents/pharmacokinetics*;Antitussive Agents/urine;Beverages*/analysis;Biotransformation;Calibration;Chromatography, High Pressure Liquid;Citrus paradisi*/chemistry;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Dextromethorphan/pharmacokinetics*;Dextromethorphan/urine;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Indicators and Reagents;Male;Middle Aged;Reproducibility of Results;Tandem Mass Spectrometry;Young Adult
19439487;Administration, Oral;Animals;Animals, Newborn;Antiviral Agents/administration & dosage;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Biological Transport;Brain/metabolism;Caco-2 Cells;Caseins/metabolism;Dipeptides/pharmacology;Female;Food-Drug Interactions*;HeLa Cells;Humans;Intestinal Absorption*/drug effects;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism*;Male;Milk/metabolism*;Oseltamivir/administration & dosage;Oseltamivir/blood;Oseltamivir/pharmacokinetics*;Peptide Transporter 1;Rats;Rats, Wistar;Symporters/antagonists & inhibitors;Symporters/genetics;Symporters/metabolism*;Temperature;Transfection
19398716;Abdominal Pain/chemically induced;Aged;Aged, 80 and over;Biotransformation;Dose-Response Relationship, Drug;Female;Fever/chemically induced;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glutathione/administration & dosage;Glutathione/adverse effects;Glutathione/analogs & derivatives*;Glutathione/pharmacokinetics;Glutathione/therapeutic use;Humans;Male;Maximum Tolerated Dose;Middle Aged;Myelodysplastic Syndromes/drug therapy*;Neutropenia/chemically induced;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/therapeutic use*;Tablets
19373300;Antidepressive Agents/adverse effects*;Beverages;Drug Interactions;Food-Drug Interactions;Humans;Isocarboxazid/adverse effects;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Phenelzine/adverse effects;Risk Factors;Serotonin Syndrome/chemically induced;Tranylcypromine/adverse effects
19369574;Administration, Oral;Adult;Cross-Over Studies;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Purines/administration & dosage*;Ribavirin/administration & dosage;Ribavirin/pharmacokinetics*
19357792;Anthocyanins/administration & dosage;Anthocyanins/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors*;Flavonoids/administration & dosage;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit/chemistry;Humans;Inhibitory Concentration 50;Luminescent Measurements/methods;Phenols/administration & dosage;Phenols/pharmacology*;Polyphenols;Vegetables/chemistry
19356393;Adult;Amitriptyline/administration & dosage;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Humans;Male;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/pharmacokinetics*;Tablets;Young Adult
19328861;Aged;Antacids/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biotransformation;Double-Blind Method;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Linear Models;Male;Middle Aged;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency
19319690;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Biological Transport, Active;Caco-2 Cells;Calcium Channel Blockers/pharmacology;Cell Membrane Permeability/drug effects;Dose-Response Relationship, Drug;Drug Interactions;Epithelial Cells/metabolism*;Food-Drug Interactions;Histamine H2 Antagonists/metabolism*;Humans;Intestines/cytology;Intestines/metabolism*;Kinetics;Multidrug Resistance-Associated Proteins/antagonists & inhibitors;Multidrug Resistance-Associated Proteins/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Nizatidine/metabolism*;Spectrophotometry, Ultraviolet;Verapamil/pharmacology
19318633;Calcium/pharmacology;Clinical Trials as Topic;Folic Acid/pharmacology;Food-Drug Interactions;Humans;Micronutrients/pharmacology*;Neoplasms/prevention & control*;Research Design;Selenium/pharmacology;Trace Elements/pharmacology;Treatment Failure;Vitamin B 12/pharmacology;Vitamin B 6/pharmacology;Vitamin D/pharmacology;Vitamin E/pharmacology;Vitamins/pharmacology;beta Carotene/pharmacology
19293342;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Ghrelin/agonists*;Human Growth Hormone/metabolism;Humans;Indoles;Insulin-Like Growth Factor I/metabolism;Male;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Oligopeptides/pharmacology*;Tryptophan/analogs & derivatives
19284184;Aluminum/toxicity;Autistic Disorder/chemically induced*;Autistic Disorder/metabolism;Cadmium/toxicity;Child;Child Welfare;Cytokines/metabolism;Environmental Pollutants/toxicity*;Fluorides/toxicity;Food Additives/toxicity*;Food-Drug Interactions;Glutamic Acid/metabolism;Humans;Immune System Diseases/metabolism;Lead/toxicity;Metals, Heavy/toxicity*;Mitochondria/metabolism;Neurotoxins/toxicity*;Risk Factors
19281729;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Neoplasms/drug therapy*;Therapeutic Equivalency;Topotecan/adverse effects;Topotecan/pharmacokinetics*;Topotecan/therapeutic use*
19277401;Anticoagulants/administration & dosage*;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Medication Adherence;Oligosaccharides/administration & dosage*;Secondary Prevention;Thromboembolism/drug therapy*;Thromboembolism/economics;Thromboembolism/prevention & control;Warfarin/administration & dosage*
19267186;Diet;Duodenum/physiology*;Female;Food-Drug Interactions;Gastrointestinal Contents/chemistry*;Humans;Linear Models;Male;Models, Biological;Pharmaceutical Preparations/analysis*;Pharmaceutical Preparations/chemistry;Postprandial Period*;Solubility;Time Factors
19255348;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Patient Education as Topic/methods*;Practice Guidelines as Topic*;Rheumatic Heart Disease/drug therapy;Therapeutic Equivalency;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
19253346;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Biological Availability;Blood Coagulation/drug effects;Drug Design;Factor Xa Inhibitors;Food-Drug Interactions*;Humans;Rats;Thrombin/antagonists & inhibitors;Vitamin K/antagonists & inhibitors;Vitamin K/pharmacokinetics*;Vitamin K Deficiency/blood
19243357;2-Pyridinylmethylsulfinylbenzimidazoles/blood;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacokinetics*;Adolescent;Adult;Cross-Over Studies;Delayed-Action Preparations;Dexlansoprazole;Dietary Fats/pharmacokinetics*;Fasting;Female;Food-Drug Interactions*;Humans;Lansoprazole;Male;Middle Aged;Proton Pump Inhibitors/blood;Proton Pump Inhibitors/pharmacokinetics*;Young Adult
19243207;Adult;Amitriptyline/administration & dosage;Amitriptyline/adverse effects;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/adverse effects;Antidepressive Agents, Tricyclic/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Sample Size;Young Adult
19226652;Animals;Area Under Curve;Caco-2 Cells;Fasting;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption*;Male;Permeability;Pharmaceutical Preparations/metabolism*;Postprandial Period/physiology;Rats;Rats, Wistar;Solubility
19225452;Biological Transport, Active/drug effects;Biological Transport, Active/physiology;Food-Drug Interactions/physiology*;Humans;Metabolic Networks and Pathways/drug effects;Metabolic Networks and Pathways/physiology;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/standards;Practice Guidelines as Topic/standards*;Transplantation/physiology*
19222985;Chronic Disease;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Drug Interactions;Drug Resistance;Electroconvulsive Therapy;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Risk Factors
19206053;Adult;Aged;Arrhythmias, Cardiac/chemically induced;Biological Availability;Biotransformation;Citrus paradisi/metabolism;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Intestinal Absorption;Male;Membrane Transport Proteins/physiology*;Middle Aged;Muscular Diseases/chemically induced;Pharmacokinetics*;Xenobiotics/pharmacokinetics
19188677;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Solubility
19184451;Adenocarcinoma/pathology;Animals;Cell Line, Tumor/metabolism;Chemical Precipitation;Chemistry, Pharmaceutical;Colonic Neoplasms/pathology;Computer Simulation*;Dogs;Eating;Fasting;Female;Food-Drug Interactions*;Gastrointestinal Contents;Gastrointestinal Tract/physiology;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Models, Biological*;Morpholines/pharmacokinetics;Pharmacokinetics*;Solubility;Species Specificity;Theophylline/pharmacokinetics
19178019;Antineoplastic Agents/pharmacology;Antioxidants/adverse effects;Antioxidants/therapeutic use;Breast Neoplasms/nursing*;Diet*;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Humans
19169898;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use;Critical Illness;Female;Food-Drug Interactions*;Half-Life;Humans;Infant, Newborn;Male;Netilmicin/pharmacokinetics*;Netilmicin/therapeutic use;Parenteral Nutrition*;Prospective Studies;Sepsis/drug therapy;Tissue Distribution
19167586;Administration, Oral;Adolescent;Adrenergic alpha-2 Receptor Agonists;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/adverse effects;Adrenergic alpha-Agonists/pharmacokinetics*;Adult;Area Under Curve;Asthenia/chemically induced;Biological Availability;Blood Pressure/drug effects;Capsules;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions;Half-Life;Humans;Male;Malus*;Middle Aged;Young Adult
19166632;Cardiovascular Diseases/immunology;Cardiovascular Diseases/therapy;Complementary Therapies*;Dietary Supplements;Fatty Acids, Omega-3/administration & dosage;Food-Drug Interactions*;Glutamine/administration & dosage;Humans;Models, Immunological;Neoplasms/immunology;Neoplasms/therapy
19160441;Administration, Oral;Antibiotics, Antitubercular/administration & dosage*;Antibiotics, Antitubercular/chemistry;Antibiotics, Antitubercular/pharmacokinetics*;Antibiotics, Antitubercular/therapeutic use;Biological Availability;Dosage Forms;Drug Approval;Drug Stability;Excipients;Food-Drug Interactions;Humans;Leprostatic Agents/administration & dosage*;Leprostatic Agents/chemistry;Leprostatic Agents/pharmacokinetics*;Leprostatic Agents/therapeutic use;Permeability;Rifampin/administration & dosage*;Rifampin/chemistry;Rifampin/pharmacokinetics*;Rifampin/therapeutic use;Solubility;Therapeutic Equivalency
19133704;Administration, Oral;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Postprandial Period;Randomized Controlled Trials as Topic;Young Adult
19126824;Aged;Female;Food-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Tea/adverse effects*;Tea/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19116375;Animals;Body Weight;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Eating/drug effects;Food-Drug Interactions;Glucose Tolerance Test;Hypothalamus, Middle/drug effects;Hypothalamus, Middle/metabolism*;Hypothalamus, Middle/pathology;I-kappa B Kinase/metabolism;Injections, Intraventricular;Insulin/blood;Insulin/pharmacology*;Insulin Resistance/physiology*;Leptin/blood;Lipid Metabolism/drug effects;Obesity/blood;Obesity/metabolism*;Obesity/pathology;Rats;Rats, Long-Evans;Satiety Response/physiology;Signal Transduction/drug effects
19088792;Adolescent;Adult;Athletic Performance/physiology*;Caffeine/administration & dosage;Caffeine/pharmacology*;Canada;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacology*;Coffee*;Diet/methods*;Female;Food-Drug Interactions/physiology;Humans;Male;Middle Aged;Motor Activity/physiology*;Sports*;Young Adult
19075617;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/physiology*;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Citrus paradisi;Food-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/physiology;Neoplasm Proteins/physiology
19075045;Administration, Oral;Adult;African Americans/genetics;African Americans/statistics & numerical data;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Carbonated Beverages*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Eating;European Continental Ancestry Group/genetics;European Continental Ancestry Group/statistics & numerical data;Fasting;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;Humans;Hydrogen-Ion Concentration/drug effects;Intestinal Absorption/drug effects;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/adverse effects;Omeprazole/blood;Omeprazole/pharmacokinetics;Suspensions;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
19062482;Animals;Beverages*;Blood Glucose/drug effects;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Drug Synergism;Food-Drug Interactions;Fruit*;Insulin/pharmacokinetics;Insulin/pharmacology*;Male;Morinda*;Phytotherapy/methods*;Random Allocation;Rats;Rats, Sprague-Dawley
19058474;Aged;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Beverages/adverse effects;Fatal Outcome;Flavonoids/adverse effects;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced*;Humans;Male;Pericardial Effusion/chemically induced*;Phytotherapy/adverse effects;Vaccinium macrocarpon/adverse effects*;Vaccinium macrocarpon/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19053875;Acetaminophen/pharmacokinetics*;Animals;Beverages;Citrus paradisi*;Fluorescence Polarization Immunoassay;Food-Drug Interactions*;Half-Life;Mice;Mice, Inbred BALB C;Models, Animal;Plant Preparations/pharmacology*
19053852;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/drug effects;Antioxidants/pharmacology;Beverages;Caco-2 Cells;Colonic Neoplasms/metabolism*;Food-Drug Interactions/physiology*;Gene Expression Regulation/drug effects;Humans;Hydrolyzable Tannins/isolation & purification;Hydrolyzable Tannins/pharmacology*;Intestinal Mucosa/drug effects;Metabolic Detoxication, Phase I;Naphthols/pharmacokinetics;Neoplasm Proteins/drug effects;Plant Preparations*;Punicaceae*;Sulfotransferases/drug effects
19052281;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19048359;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Beverages/adverse effects*;Caco-2 Cells;Cell Polarity;Citrus paradisi*/chemistry;Colchicine/administration & dosage;Colchicine/metabolism*;Dose-Response Relationship, Drug;Flavanones/isolation & purification;Flavanones/pharmacology;Food-Drug Interactions*;Fruit;Furocoumarins/isolation & purification;Furocoumarins/pharmacology;Humans;Ileum/drug effects;Ileum/metabolism*;Intestinal Absorption*/drug effects;Jejunum/drug effects;Jejunum/metabolism*;Male;Permeability;Quinidine/pharmacology;Rats;Rats, Wistar;Risk Assessment;Time Factors;Tubulin Modulators/administration & dosage;Tubulin Modulators/metabolism*;Verapamil/pharmacology
19033220;Brain Injuries/metabolism*;Brain Injuries/therapy*;Energy Intake/physiology;Energy Metabolism/physiology*;Enteral Nutrition/methods*;Enteral Nutrition/standards;Food-Drug Interactions;Humans;Nutrition Assessment;Nutritional Requirements*;Water-Electrolyte Balance/physiology*
19032767;Adult;Africa South of the Sahara;Antimalarials/administration & dosage*;Artemisinins/administration & dosage*;Child;Diet*;Dietary Fats/administration & dosage*;Dietary Fats/analysis;Drug Combinations;Ethanolamines/administration & dosage*;Feeding Behavior;Fluorenes/administration & dosage*;Food-Drug Interactions*;Humans;Infant;Malaria, Falciparum/drug therapy*;Randomized Controlled Trials as Topic
19026256;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/agonists;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Cross-Over Studies;Dietary Fats/metabolism*;Drug Administration Schedule;Energy Intake/physiology*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Young Adult
19014838;Adult;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chemistry, Pharmaceutical;Clarithromycin/administration & dosage*;Clarithromycin/adverse effects;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Half-Life;Humans;Jordan;Male;Metabolic Clearance Rate;Tablets;Therapeutic Equivalency
19014837;Adolescent;Adult;Area Under Curve;Blood Glucose/analysis;Chromatography, High Pressure Liquid;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Glucagon-Like Peptide 1/blood;Half-Life;Humans;Insulin/blood;Korea;Male;Metabolic Clearance Rate;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/pharmacology*;Piperidones;Pyrimidines;Young Adult
19000367;Administration, Oral;Amiodarone/analogs & derivatives*;Amiodarone/pharmacokinetics*;Animals;Area Under Curve;Bile Acids and Salts/administration & dosage;Cholesterol/administration & dosage;Dietary Fats/administration & dosage*;Food-Drug Interactions;Intestines/metabolism*;Lecithins/administration & dosage;Lipase/administration & dosage;Male;Peanut Oil;Plant Oils/administration & dosage;Rats;Rats, Sprague-Dawley;Soybean Oil/administration & dosage;Triglycerides/administration & dosage
18998611;Acetaminophen/adverse effects*;Acetaminophen/pharmacokinetics;Acetaminophen/therapeutic use;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/therapeutic use;Arthritis/drug therapy;Food-Drug Interactions;Humans;Wine/adverse effects*
18997138;Aged;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin*
18990540;Adult;Aged;Anemia, Pernicious/diagnosis;Anemia, Pernicious/drug therapy;Drug-Related Side Effects and Adverse Reactions;Food*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology;Malabsorption Syndromes/complications*;Malabsorption Syndromes/diagnosis;Malabsorption Syndromes/drug therapy;Syndrome;Vitamin B 12/metabolism*;Vitamin B 12/therapeutic use;Vitamin B 12 Deficiency/diagnosis;Vitamin B 12 Deficiency/drug therapy;Vitamin B 12 Deficiency/etiology;Vitamin B Complex/metabolism*;Vitamin B Complex/therapeutic use
18989993;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Data Interpretation, Statistical;Dibenzazepines/administration & dosage;Dibenzazepines/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Stereoisomerism;Tablets;Therapeutic Equivalency;Young Adult
18988456;Biological Availability*;Biopharmaceutics/classification*;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Dosage Forms;Drug Interactions;Food-Drug Interactions*;Humans;Models, Theoretical;Permeability;Pharmaceutical Preparations/classification*;Pharmacology, Clinical/methods;Predictive Value of Tests;Solubility;Technology, Pharmaceutical/methods*;Therapeutic Equivalency
18955941;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Brain/drug effects;Cheese/adverse effects;Depressive Disorder/blood;Depressive Disorder/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/metabolism
18955043;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adenosine Triphosphatases/drug effects*;Adenosine Triphosphatases/metabolism;Antibiotics, Antineoplastic/metabolism;Citrus/chemistry*;Daunorubicin/metabolism;Fluoresceins/metabolism;Food-Drug Interactions*;Humans;KB Cells
18951015;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Biological Availability;Biomarkers, Tumor;Clinical Protocols;Clinical Trials, Phase I as Topic/methods*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Maximum Tolerated Dose;Neoplasms/drug therapy*
18926963;Acenocoumarol/administration & dosage*;Administration, Oral;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Drug Interactions;Educational Status;Family Practice;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Hemorrhage/chemically induced*;Hemorrhage/prevention & control;Humans;Male;Medicine;Middle Aged;Patient Care Team*;Residence Characteristics;Specialization;Surveys and Questionnaires;Young Adult
18855612;Animals;Beverages*;Biological Availability;Citrus paradisi*;Food-Drug Interactions*;Humans;Intestines/metabolism*
18832020;Amino Acids/metabolism;Animals;Antifungal Agents/chemistry*;Antifungal Agents/pharmacokinetics;Bile/chemistry;Biological Availability;Dietary Carbohydrates/metabolism;Dietary Fats/metabolism;Dietary Proteins/metabolism;Food-Drug Interactions*;Gastric Juice/metabolism;Intestinal Secretions/metabolism;Itraconazole/chemistry*;Itraconazole/pharmacokinetics;Milk/metabolism;Solubility
18826865;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Capsules;Chromatography, High Pressure Liquid;Citrus sinensis*;Cross-Over Studies;Delayed-Action Preparations;Diltiazem/administration & dosage;Diltiazem/pharmacokinetics*;Diltiazem/pharmacology;Drug Administration Schedule;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Vitis*
18823217;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting*;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Pyridazines/administration & dosage;Pyridazines/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*;Young Adult
18793577;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/pharmacokinetics*;Therapeutic Equivalency
18793575;Adult;Area Under Curve;Chromatography, Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Endothelin A Receptor Antagonists;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Tandem Mass Spectrometry
18771009;Beverages*;Citrus paradisi*;Color;Cytochrome P-450 CYP3A/metabolism;Data Interpretation, Statistical;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/analysis;Furocoumarins/pharmacokinetics;Furocoumarins/pharmacology;Hot Temperature;Oxidation-Reduction;Pharmacokinetics;Testosterone/metabolism
18768996;Antineoplastic Agents*/adverse effects;Antineoplastic Agents*/pharmacokinetics;Antineoplastic Agents*/pharmacology;Antineoplastic Agents*/therapeutic use;Breast Neoplasms*/drug therapy;Breast Neoplasms*/pathology;Drug Resistance, Neoplasm;Female;Food-Drug Interactions;Humans;Neoplasm Metastasis;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;Protein Kinase Inhibitors*/therapeutic use;Quinazolines*/adverse effects;Quinazolines*/pharmacokinetics;Quinazolines*/pharmacology;Quinazolines*/therapeutic use;Receptor, ErbB-2/metabolism
18758149;Food, Organic*;Food-Drug Interactions*;Glyburide*/pharmacokinetics;Hypoglycemic Agents*/pharmacokinetics;Metformin*/pharmacokinetics
18752268;Adrenergic alpha-1 Receptor Antagonists*;Adult;Azepines/blood;Azepines/chemistry;Azepines/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Drug Carriers/chemistry*;Fasting;Food-Drug Interactions*;Gastrointestinal Tract/diagnostic imaging*;Gastrointestinal Transit/physiology;Humans;Hypromellose Derivatives;Male;Methylcellulose/analogs & derivatives*;Methylcellulose/chemistry;Middle Aged;Postprandial Period;Quinolines/blood;Quinolines/chemistry;Quinolines/pharmacokinetics*;Radioisotopes;Radionuclide Imaging;Samarium
18727015;Anthocyanins/metabolism;Anthocyanins/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions
18724493;Drug Industry*;Drug Interactions;Drug Labeling*;Food-Drug Interactions;HIV Protease Inhibitors/therapeutic use*;Humans;Saquinavir/therapeutic use*
18721117;Biological Availability;Clinical Trials as Topic;Delayed-Action Preparations;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/pharmacokinetics;Renal Insufficiency/complications
18717508;Analgesics, Opioid/therapeutic use*;Chronic Disease;Clinical Trials as Topic;Delayed-Action Preparations;Drug Interactions;Follow-Up Studies;Food-Drug Interactions;Humans;Oxymorphone/adverse effects;Oxymorphone/pharmacokinetics;Oxymorphone/pharmacology;Oxymorphone/therapeutic use*;Pain/drug therapy*
18691989;Antidepressive Agents/chemistry*;Beverages;Drug Stability;Duloxetine Hydrochloride;Food*;Food-Drug Interactions;Fruit;Tablets, Enteric-Coated;Thiophenes/chemistry*
18690864;Administration, Topical;Animals;Clinical Trials as Topic/ethics;Data Interpretation, Statistical;Drugs, Generic;Food-Drug Interactions;Humans;Pharmacokinetics;Therapeutic Equivalency*
18675344;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Emulsions;Fasting/metabolism;Food-Drug Interactions;Freeze Drying;Griseofulvin/administration & dosage;Griseofulvin/chemistry;Griseofulvin/pharmacokinetics*;Humans;Intestinal Absorption;Male;Postprandial Period;Powders;Tablets
18671458;Administration, Oral;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Dietary Fats/administration & dosage*;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tandem Mass Spectrometry
18666368;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi*;Cytochrome P-450 CYP3A/physiology;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans
18663908;Beverages*;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology*
18641203;Adult;Biological Availability;Catechin/administration & dosage;Catechin/analogs & derivatives*;Catechin/chemistry;Catechin/pharmacokinetics;Dietary Fats/pharmacokinetics;Dose-Response Relationship, Drug;Female;Flavonoids/administration & dosage;Flavonoids/chemistry*;Flavonoids/pharmacokinetics*;Food;Food-Drug Interactions;Humans;Ileostomy;Male;Molecular Structure;Tea/chemistry
18624679;Animals;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions*;Food-Drug Interactions;Humans;Intestines/enzymology;Intestines/metabolism*;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
18607579;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Benzofurans/administration & dosage*;Benzofurans/blood;Benzofurans/pharmacokinetics;Biological Availability;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Half-Life;Humans;Male;Niflumic Acid/blood;Niflumic Acid/pharmacokinetics*;Postprandial Period;Prodrugs/administration & dosage*;Prodrugs/pharmacokinetics;Pyridines/administration & dosage*;Pyridines/blood;Pyridines/pharmacokinetics;Young Adult
18589558;Adolescent;Adult;Aged;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Fasting/physiology;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Tandem Mass Spectrometry;Therapeutic Equivalency
18585670;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Biological Availability;Drug Therapy, Combination;Fasting;Female;Food-Drug Interactions*;Humans;Male;Meat*;Middle Aged;Ovum*;Quinolines/administration & dosage;Quinolines/pharmacokinetics*;Vegetables*;Vietnam;Volunteers
18579105;Animals;Anticarcinogenic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antioxidants/pharmacology*;Area Under Curve;Bile/chemistry;Bile/metabolism;Biological Transport/drug effects;Camptothecin/analogs & derivatives*;Camptothecin/pharmacokinetics;Catechin/analogs & derivatives*;Catechin/pharmacology;Chromatography, High Pressure Liquid;Contraindications;Dietary Supplements;Food-Drug Interactions*;Glucuronides/pharmacokinetics*;Injections, Intravenous;Male;Rats;Rats, Sprague-Dawley;Specific Pathogen-Free Organisms
18552451;Blood Pressure/drug effects;Carbolines/administration & dosage*;Carbolines/adverse effects;Carbolines/pharmacokinetics;Carbolines/pharmacology;Cyclic GMP/metabolism;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Male;Muscle Relaxation/drug effects;Muscle, Smooth/metabolism;Penis/blood supply;Penis/metabolism;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage*;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics;Phosphodiesterase Inhibitors/pharmacology;Randomized Controlled Trials as Topic;Tadalafil
18551467;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Folic Acid/administration & dosage;Folic Acid/pharmacokinetics*;Food-Drug Interactions*;Humans;Immunoassay;Luminescent Measurements;Male;Middle Aged;Tea/chemistry*;Vitamin B Complex/administration & dosage;Vitamin B Complex/pharmacokinetics*
18551249;Animals;Biological Availability*;Food-Drug Interactions;Humans;Intestinal Absorption;Therapeutic Equivalency*
18543582;Blood Glucose/analysis;Chlorpropamide/blood;Chlorpropamide/pharmacokinetics*;Chlorpropamide/therapeutic use;Chromatography, High Pressure Liquid;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diet;Dietary Carbohydrates*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/therapeutic use;Middle Aged;Nigeria;Postprandial Period;Time Factors
18538461;Animals;Botulinum Toxins, Type A/chemistry;Botulinum Toxins, Type A/isolation & purification*;Botulinum Toxins, Type A/pharmacokinetics*;Dose-Response Relationship, Drug;Electrophoresis, Polyacrylamide Gel;Food-Drug Interactions;Injections, Intraperitoneal;Intubation, Gastrointestinal;Lethal Dose 50;Mass Spectrometry;Mice
18500565;Drug Design*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations*/administration & dosage;Pharmaceutical Preparations*/chemistry;Pharmaceutical Preparations*/metabolism;Pharmacokinetics
18488812;2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage*;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacokinetics*;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/pharmacokinetics*;Reproducibility of Results
18484490;Administration, Oral;Administration, Rectal;Alendronate/administration & dosage;Alendronate/chemistry;Alendronate/pharmacokinetics*;Animals;Biological Availability;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/chemistry;Bone Density Conservation Agents/pharmacokinetics*;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Diffusion;Food-Drug Interactions;Intestinal Absorption/physiology*;Isotope Labeling;Male;Rabbits;Solubility;Technetium/chemistry
18479171;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Dideoxynucleosides/administration & dosage;Dideoxynucleosides/pharmacokinetics*;Drug Combinations;Drug Interactions;Food-Drug Interactions;Humans;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tissue Distribution
18471347;Adamantane/administration & dosage;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adolescent;Adult;Cross-Over Studies;Diabetes Mellitus, Type 2/drug therapy;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use;Drug Combinations;Female;Food-Drug Interactions*;Humans;Male;Metformin/administration & dosage*;Metformin/pharmacokinetics*;Middle Aged;Nitriles/administration & dosage*;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage*;Pyrrolidines/pharmacokinetics*
18465212;Adult;Colon/physiology*;Drug Delivery Systems*;Fasting/physiology;Food-Drug Interactions/physiology*;Gastric Emptying/physiology;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Ileum/physiology*;Indium Radioisotopes;Kinetics;Male;Polymethacrylic Acids;Tablets, Enteric-Coated;Technetium/pharmacokinetics
18449511;Administration, Oral;Animals;Biological Availability;Biotransformation;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacology*;Drug Interactions;Food-Drug Interactions;Hesperidin/administration & dosage*;Hesperidin/pharmacokinetics*;Intestinal Absorption/drug effects;Male;Models, Biological;Rats;Rats, Sprague-Dawley;Verapamil/administration & dosage*;Verapamil/analogs & derivatives;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/pharmacology
18446504;Animals;Antiparasitic Agents/metabolism;Antiparasitic Agents/pharmacokinetics;Antiparasitic Agents/therapeutic use;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Ivermectin/metabolism;Ivermectin/pharmacokinetics*;Ivermectin/therapeutic use;Parasitic Diseases/drug therapy;Parasitic Diseases/metabolism
18438069;Beverages*;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Humans;Hypertension/chemically induced*;Hypertension/etiology;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/etiology;Tea/adverse effects*
18421804;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*
18382075;Aged;Aged, 80 and over;Biological Availability;Female;Food-Drug Interactions*;Health Status*;Humans;Intestinal Absorption;Male;Nutritional Status/drug effects*;Nutritional Status/physiology*;Pharmaceutical Preparations/administration & dosage*;Pharmacokinetics
18415673;Administration, Oral;Animals;Atorvastatin Calcium;Caffeine/administration & dosage;Caffeine/pharmacology*;Coffee*;Food-Drug Interactions*;Heptanoic Acids/pharmacology*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Myocardial Infarction/pathology;Myocardial Infarction/physiopathology;Myocardial Infarction/prevention & control*;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/physiopathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/metabolism;Myocardium/pathology;Pyrroles/pharmacology*;Rats
18407914;Adsorption;Biological Availability;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Gastrostomy/instrumentation*;Humans;In Vitro Techniques;Iodine Radioisotopes;Thyroxine/pharmacokinetics*
18401778;Cellulose/analogs & derivatives;Cellulose/chemistry;Chemistry, Pharmaceutical;Delayed-Action Preparations;Excipients/chemistry*;Food-Drug Interactions*;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/chemistry;Models, Biological;Neural Networks (Computer)*;Starch/analogs & derivatives;Starch/chemistry;Tablets;Time Factors
18400708;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Area Under Curve;Beverages/analysis;Caco-2 Cells;Citrus/chemistry;Citrus paradisi/chemistry*;Cross-Over Studies;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions;Fruit/chemistry;Furocoumarins/pharmacology*;Humans;Male;Middle Aged
18399711;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacology;Animals;Anti-Ulcer Agents/pharmacology;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Benzimidazoles/pharmacokinetics*;Benzimidazoles/pharmacology*;Biological Availability;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Liver Diseases/metabolism;Prodrugs/pharmacokinetics*;Prodrugs/pharmacology*;Pyridines/pharmacokinetics*;Pyridines/pharmacology*;Thrombin/antagonists & inhibitors*
18386838;Animals;Area Under Curve;Biological Availability;Dogs;Drug Delivery Systems*;Food-Drug Interactions*;Intestine, Small/metabolism*;Male;Pharmacokinetics;Solubility;Tablets
18380401;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food Handling;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Hot Temperature;Humans;In Vitro Techniques;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Testosterone/metabolism
18380396;Adult;Beverages*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Food-Drug Interactions*;Furocoumarins/blood*;Humans;Male;Mass Spectrometry;Radiation-Sensitizing Agents/metabolism*;Reference Standards
18380391;Beverages/adverse effects*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*
18370856;Animals;Carrier Proteins/metabolism;Dietary Supplements*;Drug Interactions;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
18363537;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dietary Carbohydrates/administration & dosage;Dietary Proteins/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacokinetics*
18348745;Attitude of Health Personnel;Communication;Dietary Supplements/utilization*;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;Patient Education as Topic;Prevalence;United States;United States Food and Drug Administration
18348469;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cephalosporins/administration & dosage;Cephalosporins/blood;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Diet*;Diet, Fat-Restricted;Diet, Vegetarian;Dietary Fats/administration & dosage;Fasting;Food-Drug Interactions*;Humans;Male;Tablets
18344215;Animals;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Beverages;Celiprolol/pharmacokinetics*;Chromatography, Liquid;Citrus sinensis/chemistry*;Food-Drug Interactions*;Hesperidin/pharmacology*;Intestinal Absorption;Male;Rats;Rats, Wistar;Spectrometry, Mass, Electrospray Ionization
18343098;Bile Acids and Salts/chemistry*;Capsules;Cholestyramine Resin/chemistry*;Cross-Linking Reagents/chemistry;Food-Drug Interactions*;Gelatin/chemistry*;Humans;Hydrogen-Ion Concentration;Intestine, Small;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Predictive Value of Tests;Solubility;Stomach*;Taurocholic Acid/chemistry
18327703;Administration, Oral;Animals;Atorvastatin Calcium;Blood Pressure/drug effects;Caffeine/administration & dosage;Caffeine/pharmacology*;Coffee*;Disease Models, Animal;Food-Drug Interactions*;Heart Rate/drug effects;Heptanoic Acids/pharmacology*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Male;Myocardial Infarction/pathology;Myocardial Infarction/physiopathology;Myocardial Infarction/prevention & control*;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/physiopathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/metabolism;Myocardium/pathology*;Phosphorylation;Proto-Oncogene Proteins c-akt/metabolism;Pyrroles/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Purinergic P1/drug effects;Receptors, Purinergic P1/metabolism
18294110;Anticoagulants/administration & dosage;Anticoagulants/therapeutic use*;Antifibrinolytic Agents/administration & dosage*;Drug Administration Schedule;Drug Resistance*;Enteral Nutrition*;Female;Food-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Retrospective Studies;Vitamin K/administration & dosage*;Warfarin/administration & dosage;Warfarin/therapeutic use*
18285619;Administration, Oral;Adult;Area Under Curve;Biological Availability;Blood Pressure/drug effects;Capsules;Cross-Over Studies;Dextroamphetamine/administration & dosage;Dextroamphetamine/adverse effects;Dextroamphetamine/chemistry;Dextroamphetamine/metabolism;Dextroamphetamine/pharmacokinetics*;Eating/physiology*;Fasting/physiology*;Female;Flushing/chemically induced;Food-Drug Interactions;Half-Life;Headache/chemically induced;Humans;Hyperkinesis/chemically induced;Lisdexamfetamine Dimesylate;Lysine/chemistry;Lysine/metabolism;Male;Metabolic Clearance Rate;Molecular Structure;Tachycardia/chemically induced
18281442;Adolescent;Adult;Area Under Curve;Benzoates/administration & dosage;Benzoates/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Eating/physiology*;Female;Food;Food-Drug Interactions;Humans;Intestinal Absorption;Iron Chelating Agents/administration & dosage;Iron Chelating Agents/pharmacokinetics*;Iron Overload/metabolism*;Male;Middle Aged;Spectrophotometry, Ultraviolet;Triazoles/administration & dosage;Triazoles/pharmacokinetics*
18272698;Aged;Enteral Nutrition/adverse effects*;Food-Drug Interactions/physiology*;Humans;Levodopa/adverse effects*;Levodopa/pharmacokinetics;Male;Parkinson Disease/metabolism;Parkinson Disease/therapy
18258749;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/administration & dosage;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions*;Half-Life;Humans;Male
18249530;Carbon Dioxide/chemistry;Chemical Phenomena;Chemistry, Physical;Delayed-Action Preparations;Excipients/chemistry*;Food-Drug Interactions;Magnetic Resonance Imaging;Polyvinyls/chemistry*;Propranolol/administration & dosage;Propranolol/chemistry;Stomach;Tablets*;Viscosity;Water/chemistry
18246623;Anticoagulants/chemistry*;Beverages;Food-Drug Interactions*;Vaccinium macrocarpon/chemistry*;Warfarin/chemistry*
18237050;Beverages*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*;Tea/chemistry
18199522;Administration, Oral;Biological Availability;Biological Transport;Dietary Fats/metabolism*;Food-Drug Interactions*;Forecasting;Gastrointestinal Tract/metabolism;Humans;Models, Biological;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/classification;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Solubility
18195466;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Beverages;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Domperidone/blood;Domperidone/pharmacokinetics*;Dopamine Antagonists/blood;Dopamine Antagonists/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Intestinal Absorption;Male;Quinidine/pharmacology*;Rats;Rats, Wistar
18178070;Administration, Oral;Adult;Area Under Curve;Biological Availability;Drug Delivery Systems/methods;Emulsions;Fasting/metabolism*;Food-Drug Interactions*;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male
18176118;Administration, Oral;Adult;Aged;Algorithms;Area Under Curve;Creatine Kinase/blood;Cross-Over Studies;Dose-Response Relationship, Drug;Erlotinib Hydrochloride;Exanthema/chemically induced;Fasting;Food-Drug Interactions*;Glossitis/chemically induced;Hematuria/chemically induced;Humans;Liver/drug effects;Liver/enzymology;Male;Middle Aged;Molecular Structure;Patient Dropouts/statistics & numerical data;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/chemistry;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Time Factors;gamma-Glutamyltransferase/blood
18176062;Antihypertensive Agents/chemistry;Antihypertensive Agents/pharmacokinetics*;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chemical Phenomena;Chemistry, Physical;Citrus paradisi*;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Food-Drug Interactions*;Humans;Structure-Activity Relationship
18175757;Bone Density/drug effects;Bone Density Conservation Agents/administration & dosage*;Calcium, Dietary/administration & dosage*;Diet;Dietary Proteins/pharmacology;Dietary Supplements;Estriol/metabolism*;Estrogens/blood;Estrogens/metabolism*;Estrogens/urine;Female;Food-Drug Interactions;Humans;Steroids/administration & dosage
18174962;Animals;Controlled Clinical Trials as Topic;Cyclohexanes/adverse effects;Cyclohexanes/pharmacology*;Cyclohexanes/therapeutic use;Drug Interactions;Drug Resistance, Viral;Drug Therapy, Combination;Female;Food-Drug Interactions;HIV Fusion Inhibitors/adverse effects;HIV Fusion Inhibitors/pharmacology*;HIV Fusion Inhibitors/therapeutic use;HIV Infections/drug therapy*;HIV-1/drug effects;Humans;Male;Triazoles/adverse effects;Triazoles/pharmacology*;Triazoles/therapeutic use
18172627;Administration, Oral;Adult;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Female;Food-Drug Interactions*;Humans;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Pharmaceutical Solutions;Sex Factors
18162024;Adolescent;Adult;Aged;Aged, 80 and over;Depressive Disorder, Major/drug therapy*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Duloxetine Hydrochloride;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Outpatients;Serotonin Uptake Inhibitors/administration & dosage*;Serotonin Uptake Inhibitors/adverse effects;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Treatment Outcome
18084364;Citrus/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Pharmaceutical Preparations/metabolism*;Punicaceae/adverse effects;Vitis/adverse effects
18082510;Aged;Alcohol Drinking;Coronary Disease/mortality;Coronary Disease/prevention & control;Coronary Disease/therapy*;Cross-Sectional Studies;Ethanol/administration & dosage*;Fatty Acids, Omega-3/administration & dosage*;Fatty Acids, Omega-3/blood*;Female;Fish Oils/administration & dosage;Fish Oils/blood;Follow-Up Studies;Food-Drug Interactions*;Humans;Linear Models;Male;Middle Aged;Multivariate Analysis;Probability;Reference Values;Survival Rate;Treatment Outcome
18082281;Administration, Oral;Animals;Biological Availability;Biological Transport;Drug Carriers/chemistry*;Drug Stability;Food-Drug Interactions;Injections, Intravenous;Lecithins/chemistry*;Lymph/metabolism;Lymphatic Vessels;Male;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, Knockout;Molecular Structure;Mouth Mucosa/metabolism*;Phospholipases A2/genetics;Phospholipases A2/physiology;Postprandial Period;Prodrugs*/administration & dosage;Prodrugs*/pharmacokinetics;Rats;Rats, Wistar;Triglycerides/chemistry*;Valproic Acid/administration & dosage;Valproic Acid/analogs & derivatives*;Valproic Acid/blood;Valproic Acid/pharmacokinetics
18074548;Anaphylaxis/chemically induced;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Arrhythmias, Cardiac/chemically induced;Citrus paradisi;Cystitis/chemically induced;Drug Interactions;Food-Drug Interactions;Histamine/physiology;Histamine H1 Antagonists/adverse effects*;Histamine H1 Antagonists/pharmacology;Humans;Seizures/chemically induced*;Sleep Wake Disorders/chemically induced*
18074531;Adrenergic beta-Antagonists/adverse effects*;Arrhythmias, Cardiac/chemically induced*;Calcium Channel Blockers/adverse effects*;Citrus paradisi;Coronary Vasospasm/chemically induced;Depression/chemically induced;Depression, Chemical;Drug Interactions;Food-Drug Interactions;Heart Rate/drug effects;Humans;Lipid Metabolism Disorders/chemically induced;Myocardial Contraction/drug effects;Sympathetic Nervous System/physiopathology
18069906;Attention Deficit Disorder with Hyperactivity/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Narcolepsy/drug therapy;Parkinson Disease/drug therapy;Phenylketonurias/drug therapy;Stress, Physiological/drug therapy;Tyrosine/adverse effects;Tyrosine/pharmacokinetics;Tyrosine/therapeutic use*
18057881;Animals;Anti-Arrhythmia Agents/pharmacology*;Beverages*;Citrus paradisi;Delayed Rectifier Potassium Channels/antagonists & inhibitors;Dose-Response Relationship, Drug;ERG1 Potassium Channel;Electrocardiography/drug effects;Ether-A-Go-Go Potassium Channels/antagonists & inhibitors*;Ether-A-Go-Go Potassium Channels/metabolism;Female;Flavanones/pharmacology*;Food-Drug Interactions*;In Vitro Techniques;Oocytes/metabolism;Patch-Clamp Techniques;Xenopus
18057745;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/chemistry*;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Biopharmaceutics;Drug Delivery Systems;Emulsions;Excipients;Food-Drug Interactions;Griseofulvin/administration & dosage;Griseofulvin/chemistry*;Griseofulvin/pharmacokinetics*;Male;Particle Size;Rats;Rats, Sprague-Dawley;Solubility;Solvents
18056195;Animals;Camptothecin/analogs & derivatives*;Camptothecin/pharmacology;Camptothecin/toxicity;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Diarrhea/chemically induced*;Diarrhea/prevention & control;Diet;Fatty Acids, Omega-3/administration & dosage*;Female;Food-Drug Interactions*;Glutamine/administration & dosage*;Oligosaccharides/administration & dosage*;Probiotics/administration & dosage;Rats
18045784;Animals;Antimetabolites, Antineoplastic/pharmacokinetics*;Biological Availability;Cattle;Clinical Trials as Topic;Food-Drug Interactions;Humans;Mercaptopurine/pharmacokinetics*;Milk/enzymology*;Patient Education as Topic;Xanthine Oxidase/pharmacology*
18044447;Animals;Anti-Infective Agents/pharmacology*;Capsules;Colony Count, Microbial;Consumer Product Safety;Dose-Response Relationship, Drug;Emulsions;Escherichia coli O157/drug effects*;Escherichia coli O157/growth & development;Eugenol/pharmacology*;Food Microbiology;Food Preservation/methods*;Food-Drug Interactions;Humans;Lipids;Listeria monocytogenes/drug effects*;Listeria monocytogenes/growth & development;Micelles;Microbial Sensitivity Tests;Milk/chemistry;Milk/microbiology*;Time Factors
18042957;Adult;Cohort Studies;Cross-Sectional Studies;Diet;Diet Records;Dietary Supplements/adverse effects;Dietary Supplements/economics*;Dietary Supplements/utilization*;Dietetics;Drug Interactions*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/psychology*;Health Knowledge, Attitudes, Practice;Humans;Male;Middle Aged;Risk Factors
18042475;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;China;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/adverse effects;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Hospitals, University;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Mass Spectrometry;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
18035186;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacology;Antiparkinson Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/adverse effects;Neuroprotective Agents/pharmacology;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Selegiline/administration & dosage;Selegiline/adverse effects;Selegiline/pharmacology;Selegiline/therapeutic use
18024885;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
18024884;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
18024883;Antineoplastic Agents/administration & dosage*;Biological Availability;Drug Administration Schedule;Drug Labeling*;Food-Drug Interactions;Humans;Quinazolines/administration & dosage*;Quinazolines/economics;Quinazolines/pharmacokinetics
18024021;Animals;Anticholesteremic Agents/administration & dosage*;Anticholesteremic Agents/pharmacokinetics;Biological Availability;Caprylates/chemistry;Chemistry, Pharmaceutical;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Dogs;Emulsions;Excipients/chemistry;Food-Drug Interactions*;Glycerides/chemistry;Male;Polyethylene Glycols/chemistry;Polysorbates/chemistry;Quinolines/administration & dosage*;Quinolines/pharmacokinetics;Surface-Active Agents/chemistry*;Triacetin/chemistry;Triglycerides/chemistry
18007569;Absorption;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*
17995858;Antioxidants/analysis*;Antioxidants/chemistry;Biphenyl Compounds/chemistry;Dose-Response Relationship, Drug;Fabaceae/chemistry*;Fabaceae/standards*;Ferric Compounds/chemistry;Flavonoids/analysis;Flavonoids/chemistry;Food Handling/methods*;Food-Drug Interactions;Free Radical Scavengers;Hydrazines/chemistry;Nutritive Value;Phenols/analysis*;Phenols/chemistry;Picrates;Reactive Oxygen Species/metabolism;Solvents/chemistry*;Tannins/analysis;Tannins/chemistry
17995709;Calibration;Chemistry Techniques, Analytical/methods;Chemistry Techniques, Analytical/standards*;Clinical Laboratory Techniques/standards*;Flour/analysis;Folic Acid/analysis;Folic Acid/isolation & purification*;Food Analysis/methods*;Food-Drug Interactions;Infant Food/analysis;Lactobacillus casei/metabolism*;Meat Products/analysis;Pronase/metabolism;Regression Analysis;Reproducibility of Results;Sensitivity and Specificity;Vegetables/chemistry;alpha-Amylases/metabolism;gamma-Glutamyl Hydrolase/metabolism
17982397;Administration, Oral;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/pharmacokinetics*
17978552;Anencephaly/prevention & control;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/pharmacokinetics;Benzodiazepines/administration & dosage;Benzodiazepines/pharmacokinetics;Biomedical Research*;Dietary Supplements;Female;Folic Acid/administration & dosage;Food-Drug Interactions;Health Promotion;Humans;Male;Patient Education as Topic;Pharmaceutical Services*;Pharmacies*;Pharmacists;Pharmacokinetics;Pregnancy;Sex Characteristics;Smoking;Spinal Dysraphism/prevention & control
17976262;Benzoic Acid/metabolism*;Biological Transport;Blotting, Western;Caco-2 Cells;Dose-Response Relationship, Drug;Flavanones/administration & dosage;Flavanones/pharmacology;Flavonoids/administration & dosage;Flavonoids/pharmacology*;Food-Drug Interactions;Gene Expression Regulation/drug effects*;Humans;Inhibitory Concentration 50;Lactic Acid/metabolism;Monocarboxylic Acid Transporters/antagonists & inhibitors*;Quercetin/administration & dosage;Quercetin/pharmacology;Reverse Transcriptase Polymerase Chain Reaction;Silymarin/administration & dosage;Silymarin/pharmacology;Symporters/antagonists & inhibitors*
17971226;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacology;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
17967158;Aged;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Medication Errors/adverse effects;Polypharmacy*
17966839;Adult;Aged;Analysis of Variance;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Farnesyltranstransferase/antagonists & inhibitors;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*
17958008;Beverages/adverse effects;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
17955954;Animals;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Plant Preparations/adverse effects*
17953718;Adult;Antacids/blood;Antacids/pharmacokinetics*;Antacids/pharmacology;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/blood;Dietary Fats/pharmacokinetics*;Drug Interactions/physiology*;Fasting;Febuxostat;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
17937879;Epilepsy/diet therapy*;Epilepsy/metabolism;Food-Drug Interactions;Humans;Ketone Bodies/biosynthesis*
17919554;Aged;Anticoagulants/adverse effects*;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Beverages*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/chemically induced*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
17916059;Antidepressive Agents, Second-Generation/therapeutic use*;Anxiety Disorders/drug therapy*;Biological Availability;Citalopram/adverse effects;Citalopram/pharmacokinetics;Citalopram/therapeutic use*;Depressive Disorder, Major/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans
17910207;Adolescent;Child;Dietary Supplements*;Drug Interactions;Food;Food-Drug Interactions;Humans;Inositol/therapeutic use;Mental Disorders;Minerals;Mood Disorders/therapy;Psychopharmacology*;United States;Vitamins/therapeutic use
17906160;Adult;Area Under Curve;China;Female;Food-Drug Interactions*;Humans;Male;Pulmonary Fibrosis/drug therapy;Pyridones/administration & dosage*;Pyridones/blood;Pyridones/pharmacokinetics*;Pyridones/therapeutic use;Sex Factors
17880476;Brazil;Chemistry, Pharmaceutical;Clinical Nursing Research;Clinical Protocols/standards*;Critical Care/methods;Drug Therapy/nursing;Drug-Related Side Effects and Adverse Reactions;Education, Nursing, Continuing;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/nursing*;Equipment Failure/statistics & numerical data;Evidence-Based Medicine;Female;Food, Formulated/adverse effects;Food-Drug Interactions;Heart Diseases/therapy;Humans;Infusion Pumps/adverse effects;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/nursing*;Male;Nursing Assessment/standards;Nursing Evaluation Research;Nursing Staff, Hospital/education;Patient Care Planning/standards*;Risk Factors;Therapeutic Irrigation/methods;Therapeutic Irrigation/nursing*;Therapeutic Irrigation/standards
17875111;Aged;Aspirin/adverse effects*;Aspirin/pharmacokinetics;Beverages;Citrus*;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Purpura/chemically induced;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics
17720777;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/analogs & derivatives*;1-Deoxynojirimycin/blood;1-Deoxynojirimycin/pharmacokinetics;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Half-Life;Humans;Male;Middle Aged;Sex Factors
17712849;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics;Biological Availability;Cyclodextrins/administration & dosage*;Cyclodextrins/blood;Cyclodextrins/chemistry;Cyclodextrins/pharmacokinetics*;Food-Drug Interactions;Injections, Intravenous;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Solubility;beta-Cyclodextrins/administration & dosage;beta-Cyclodextrins/blood;beta-Cyclodextrins/chemistry;beta-Cyclodextrins/pharmacokinetics
17697908;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyproheptadine/administration & dosage;Cyproheptadine/analogs & derivatives*;Cyproheptadine/pharmacokinetics;Female;Food-Drug Interactions*;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/analogs & derivatives;Loratadine/blood;Loratadine/pharmacokinetics;Male;Tablets
17695563;Atherosclerosis/prevention & control*;Beverages*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*
17691921;Adult;Beverages/analysis;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;DNA/genetics;DNA/isolation & purification;Felodipine/adverse effects;Felodipine/pharmacokinetics*;Felodipine/pharmacology*;Food-Drug Interactions*;Furocoumarins/chemistry;Furocoumarins/pharmacology*;Genotype;Heart Rate/drug effects;Humans;Hydroxylation;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Sequence Data;Polymorphism, Genetic;Testosterone/metabolism
17691590;Adult;Anemia, Iron-Deficiency/drug therapy;Beverages;Citrus sinensis*;Cross-Over Studies;Data Interpretation, Statistical;Erythrocytes/metabolism;Female;Ferric Compounds/pharmacokinetics*;Food-Drug Interactions*;Hemoglobins/metabolism;Humans;Iron/blood;Iron/pharmacokinetics*;Iron Radioisotopes;Male;Tea*;Transferrin/metabolism
17691585;Acetaminophen/chemistry;Anaerobiosis;Ascorbic Acid/chemistry;Aspartic Acid/chemistry;Beverages;Calcium Phosphates/chemistry;Citrus sinensis;Drug Interactions;Ferric Compounds/chemistry*;Food-Drug Interactions;Hydrogen-Ion Concentration;Indicators and Reagents;Methyldopa/chemistry;Salicylic Acid/chemistry;Spectrophotometry, Ultraviolet;Tetracycline/chemistry
17688173;Adult;Anti-Infective Agents/chemistry;Anti-Infective Agents/metabolism*;Anti-Infective Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Calcium Carbonate/adverse effects;Chemistry, Pharmaceutical;Ciprofloxacin/chemistry;Ciprofloxacin/metabolism*;Ciprofloxacin/pharmacokinetics*;Citrus*;Cross-Over Studies;Drug Monitoring;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Linear Models;Male;Metabolic Clearance Rate;Nigeria;Solubility;Spectrophotometry, Ultraviolet;Tablets;Time Factors;Vitis*
17640157;Depressive Disorder/drug therapy;Diet;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Tyramine/metabolism
17656620;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Confidence Intervals;Cross-Over Studies;Dietary Fats*;Dipeptidyl-Peptidase IV Inhibitors*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Models, Statistical;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*
17655512;Absorption;Administration, Oral;Adult;Alprazolam/chemistry;Alprazolam/pharmacokinetics*;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tablets;Tandem Mass Spectrometry
17653140;Administration, Oral;Adolescent;Adult;Aged;Aged, 80 and over;Animals;Biological Availability;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Kidney/metabolism;Male;Middle Aged;Piperidines/blood;Piperidines/pharmacokinetics*;Receptors, Opioid, mu/antagonists & inhibitors;Surgical Procedures, Operative
17639625;Aged;Aspirin/administration & dosage*;Beverages*;Citrus paradisi*;Fibrinolytic Agents/administration & dosage*;Food-Drug Interactions*;Humans
17631915;Amygdala/drug effects;Amygdala/metabolism*;Animals;Behavior, Animal/drug effects;Calcitonin Gene-Related Peptide/metabolism;Cell Count;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Early Growth Response Protein 1/metabolism*;Food-Drug Interactions/radiation effects;Hyperalgesia/chemically induced;Hyperalgesia/metabolism*;Male;Morphine/administration & dosage*;Naloxone;Narcotics/administration & dosage*;Pain Measurement;Proto-Oncogene Proteins c-fos/metabolism*;Rats;Rats, Wistar;Reaction Time/drug effects;Tyrosine 3-Monooxygenase/metabolism
17617289;Adult;Asthenia/chemically induced;Biological Availability;Capsules;Clonidine/administration & dosage;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dietary Fats*;Dosage Forms;Female;Food-Drug Interactions;Humans;Male;Muscle Relaxants, Central/administration & dosage*;Muscle Relaxants, Central/adverse effects;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics*;Tablets
17612708;Administration, Cutaneous;Antidepressive Agents*/adverse effects;Antidepressive Agents*/pharmacology;Antidepressive Agents*/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors*/adverse effects;Monoamine Oxidase Inhibitors*/pharmacology;Monoamine Oxidase Inhibitors*/therapeutic use;Selegiline*/adverse effects;Selegiline*/pharmacology;Selegiline*/therapeutic use
17604610;Administration, Oral;Animals;Area Under Curve;Chlorobenzenes/blood;Chlorobenzenes/metabolism;Chlorobenzenes/pharmacokinetics*;Chylomicrons/chemistry;Chylomicrons/metabolism;DDT;Diazepam/blood;Diazepam/metabolism;Diazepam/pharmacokinetics*;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption/drug effects;Lipoproteins/chemistry*;Lipoproteins/metabolism;Lipoproteins, VLDL/chemistry;Lipoproteins, VLDL/metabolism;Lymph/chemistry;Lymph/metabolism;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/metabolism;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Triglycerides/blood;Triglycerides/metabolism
17571254;Adult;Area Under Curve;Biological Availability;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dietary Fats*;Emulsions;Fasting;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Reference Values;Sex Factors;Therapeutic Equivalency
17549313;Aspirin/pharmacology*;Blood Platelets/drug effects*;Blood Platelets/enzymology;Cyclooxygenase 1/metabolism*;Cyclooxygenase Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Gallic Acid/pharmacology*;Humans;In Vitro Techniques;Platelet Aggregation/drug effects*;Salicylic Acid/pharmacology;Thromboxane B2/metabolism
17545920;Animals;Antineoplastic Agents, Hormonal/pharmacology;Apoptosis/drug effects;Bone Density/drug effects*;Bone Density Conservation Agents/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Line, Tumor;Cell Proliferation/drug effects;Combined Modality Therapy;Food-Drug Interactions*;Lignans/pharmacology*;Mice;Mice, Nude;Ovariectomy;Premenopause;Seeds;Sesamum*;Tamoxifen/antagonists & inhibitors*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
17542349;Administration, Oral;Adolescent;Adult;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/pharmacokinetics*
17542018;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Caco-2 Cells;Citrus paradisi*;Dose-Response Relationship, Drug;Flavanones/pharmacology;Food-Drug Interactions*;Furocoumarins/pharmacology;Humans;Intestinal Absorption/drug effects*;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Membrane Transport Modulators/pharmacology*;Permeability;Propanolamines/metabolism*
17530235;Citrus paradisi*;Drug Overdose;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation;Middle Aged;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects*;Tacrolimus/pharmacokinetics
17510891;Amphetamines/administration & dosage;Amphetamines/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit*;Humans;Models, Biological;Models, Statistical*;Monte Carlo Method;Solubility
17510152;European Union;Food, Organic/standards*;Food-Drug Interactions;Foods, Specialized/standards*;Humans;Legislation, Drug;Marketing;Product Surveillance, Postmarketing
17500086;Drug Interactions;Drug Storage;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Humans;Patient Education as Topic*;Pharmaceutical Preparations*/administration & dosage;Pharmacists*
17499891;Child;Child, Preschool;Environmental Exposure/adverse effects*;Food-Drug Interactions;Humans;Lead Poisoning/blood*;Lead Poisoning/etiology*;Nutritional Status*;Public Health*;Trace Elements/administration & dosage;Vitamins/administration & dosage
17495279;Adolescent;Adult;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Psychotic Disorders;Serotonin 5-HT2 Receptor Agonists*;Tablets;Therapeutic Equivalency;Urea/administration & dosage;Urea/adverse effects;Urea/analogs & derivatives*;Urea/blood;Urea/pharmacokinetics
17468508;Animals;Attitude of Health Personnel;Catechin;Diet;Eating;Food-Drug Interactions;Humans;Hypertension/prevention & control;Milk/adverse effects*;Milk Proteins/adverse effects;Postprandial Period;Swine;Swine, Miniature;Tea*;Vasodilation
17463218;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats;Fasting;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Male;Mass Spectrometry;Middle Aged;Nucleic Acid Synthesis Inhibitors;Rifamycins/administration & dosage;Rifamycins/adverse effects*;Rifamycins/blood;Rifamycins/pharmacokinetics*;Therapeutic Equivalency
17452418;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/blood;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Animals;Beverages/analysis*;Caco-2 Cells;Citrus paradisi*;Dose-Response Relationship, Drug;Enalapril/administration & dosage;Enalapril/pharmacokinetics;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Esterases/antagonists & inhibitors*;Esterases/metabolism;Flavanones/pharmacology;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions*;Fruit;Humans;Hydrolysis;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;In Vitro Techniques;Intestinal Absorption/drug effects;Kaempferols/pharmacology;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Nitrophenols/metabolism;Rats;Rats, Sprague-Dawley
17443397;Administration, Oral;Adult;Carbamates/administration & dosage;Carbamates/blood;Carbamates/chemistry;Carbamates/pharmacokinetics*;Cross-Over Studies;Duodenum/metabolism*;Fasting/metabolism;Feasibility Studies;Female;Food-Drug Interactions*;Gastric Juice/metabolism*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption*;Intestinal Secretions/metabolism*;Male;Organophosphates/administration & dosage;Organophosphates/blood;Organophosphates/chemistry;Organophosphates/pharmacokinetics*;Postprandial Period;Solubility;Sulfonamides/administration & dosage;Sulfonamides/blood;Sulfonamides/chemistry;Sulfonamides/pharmacokinetics*;Tablets
17438537;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Area Under Curve;Beverages*;Carrier Proteins/metabolism;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Organic Anion Transporters/metabolism
17425628;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Eating*;Esomeprazole/administration & dosage;Esomeprazole/blood;Esomeprazole/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged
17414499;Aged;Aging/pathology;Aging/physiology*;Drug Prescriptions;Food-Drug Interactions*;Geriatric Assessment;Health Status*;Humans;Nutrition Assessment;Nutritional Status*;Risk Factors
17397270;Animals;Biotin/pharmacology;Biotin/therapeutic use*;Candidiasis, Vulvovaginal/drug therapy;Dermatitis/drug therapy;Diabetes Mellitus/drug therapy;Dyslipidemias/drug therapy;Female;Food-Drug Interactions;Foot Diseases/drug therapy;Foot Diseases/veterinary;Hoof and Claw;Humans;Male;Multiple Carboxylase Deficiency/drug therapy;Nail Diseases/drug therapy
17392996;Adrenergic beta-Antagonists/pharmacology;Anti-Arrhythmia Agents/pharmacology;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/physiopathology;Citrus paradisi*;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology
17392729;Adult;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages*;Clonidine/analogs & derivatives*;Clonidine/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Midazolam/pharmacokinetics*;Stereoisomerism;Vaccinium macrocarpon*;Warfarin/chemistry;Warfarin/pharmacokinetics*
17392396;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Animals;Beverages*;Caco-2 Cells;Cell Membrane Permeability/drug effects;Citrus paradisi*;Enalapril/pharmacokinetics;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Esterases/antagonists & inhibitors*;Esterases/metabolism;Food-Drug Interactions*;Fruit;Humans;Hydrolysis;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/drug effects;Intestines/enzymology;Liver/drug effects;Liver/enzymology;Lovastatin/pharmacokinetics;Male;Nitrophenols/metabolism;Nitrophenols/pharmacology;Rats;Rats, Sprague-Dawley;Subcellular Fractions/drug effects;Subcellular Fractions/enzymology;Swine
17389562;Acyl Coenzyme A/antagonists & inhibitors;Citrus paradisi/metabolism*;Drug-Related Side Effects and Adverse Reactions;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacokinetics;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
17389557;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Darunavir;Drug Combinations;Fasting;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Seronegativity;Half-Life;Humans;Male;Middle Aged;Ritonavir/administration & dosage;Ritonavir/adverse effects;Ritonavir/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
17389552;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Codon, Nonsense/antagonists & inhibitors*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Immunoblotting;Male;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*
17385020;Area Under Curve;Food-Drug Interactions*;Pharmacokinetics*
17368832;Anticoagulants/antagonists & inhibitors*;Food-Drug Interactions*;Humans;International Normalized Ratio;Tea/adverse effects*;Vegetables*;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
17357375;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects*;Drug Interactions;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/pharmacokinetics*;Histamine H1 Antagonists/pharmacology;Humans;Solute Carrier Organic Anion Transporter Family Member 1b1/drug effects
17346019;Alcohol Drinking/adverse effects*;Alcohol Drinking/epidemiology;Alcohol Drinking/metabolism;Alcohol Drinking/prevention & control*;Alcoholic Beverages/analysis;Attitude to Health;Ethanol/analysis;Food-Drug Interactions;Health Behavior;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration*;Helping Behavior;Humans;Life Style*;Nurse's Role/psychology*;Patient Education as Topic/organization & administration;Social Support;United Kingdom/epidemiology
17331342;Administration, Oral;Animals;Area Under Curve;Chelating Agents/administration & dosage*;Chelating Agents/pharmacokinetics*;Clioquinol/administration & dosage*;Clioquinol/pharmacokinetics*;Cricetinae;Female;Food-Drug Interactions;Tissue Distribution
17328583;Adolescent;Adult;Aged;Antacids/pharmacology;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Azithromycin/administration & dosage;Azithromycin/adverse effects;Azithromycin/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacology;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Humans;Male;Microspheres;Middle Aged;Sample Size
17322161;Anticoagulants/adverse effects*;Aryl Hydrocarbon Hydroxylases;Beverages;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Drug Monitoring;Female;Flavonoids;Food-Drug Interactions*;Hemorrhage/chemically induced;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Vitamin K Deficiency;Warfarin/adverse effects*;Warfarin/pharmacokinetics*
17322140;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Beverages*;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;GABA Modulators/administration & dosage;GABA Modulators/metabolism;GABA Modulators/pharmacokinetics;Humans;Injections, Intravenous;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Midazolam/administration & dosage;Midazolam/metabolism;Midazolam/pharmacokinetics*;Punicaceae/chemistry*;Triazolam/analogs & derivatives;Triazolam/metabolism
17306733;Diet*;Female;Food-Drug Interactions;Genetic Predisposition to Disease;Genomics*;Humans;Male;Nutritional Physiological Phenomena/genetics*;Nutritional Status/genetics;Population Surveillance;Quality Control;Risk Assessment
17300625;Absorption;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Biological Availability;Cross-Over Studies;Dietary Supplements;Dose-Response Relationship, Drug;Drug Combinations;Ethanolamines/administration & dosage;Ethanolamines/pharmacokinetics*;Fasting;Female;Fluorenes/administration & dosage;Fluorenes/pharmacokinetics*;Food-Drug Interactions;Humans;Malaria, Falciparum/prevention & control;Male;Middle Aged;Soy Milk/administration & dosage*
17296276;Administration, Oral;Animals;Brain/metabolism;Chylomicrons/blood;Chylomicrons/metabolism*;DDT/administration & dosage;DDT/blood;DDT/pharmacokinetics*;DDT/toxicity;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Facial Muscles/drug effects;Food-Drug Interactions*;Hyperlipidemias/blood;Hyperlipidemias/etiology;Hyperlipidemias/metabolism*;Infusions, Intravenous;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/adverse effects*;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Tremor/chemically induced;Triglycerides/blood;Triglycerides/metabolism*
17286787;Adult;Area Under Curve;Benzodiazepines/pharmacokinetics*;Benzodiazepines/pharmacology*;Biological Availability;Cross-Over Studies;Diazepam/pharmacokinetics*;Diazepam/pharmacology*;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology*;Male;Nitrazepam/pharmacokinetics*;Nitrazepam/pharmacology*;Psychomotor Performance/drug effects
17270055;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/blood;Hydromorphone/pharmacokinetics*;Male;Middle Aged;Naltrexone/administration & dosage;Narcotic Antagonists/administration & dosage
17269967;Adult;Aged;Aged, 80 and over;Arthritis, Psoriatic/drug therapy*;Caffeine/pharmacology*;Dermatologic Agents/administration & dosage;Dermatologic Agents/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Methotrexate/administration & dosage;Methotrexate/pharmacokinetics*;Middle Aged;Psoriasis/drug therapy*
17269895;Animals;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Intestine, Small/metabolism*;Models, Biological;Prognosis
17253885;Biotransformation;Contraceptives, Oral/pharmacokinetics*;Contraceptives, Oral/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/pharmacology;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology;Food-Drug Interactions;Glucuronides/metabolism;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/metabolism*;Humans;Isoenzymes/metabolism;Membrane Transport Proteins/metabolism;Models, Biological;Oxidation-Reduction;Progestins/pharmacology;Sulfotransferases/antagonists & inhibitors;Sulfotransferases/metabolism*;Sulfuric Acid Esters/metabolism
17253883;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Biological Availability;Biotransformation;Carbamates/administration & dosage;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cyclohexanes/administration & dosage;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Drug Administration Schedule;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Intestinal Absorption;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/pharmacokinetics;Phenylalanine/pharmacology;Piperidines/administration & dosage;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Postprandial Period
17250919;Animals;Biological Availability;Etidronic Acid/administration & dosage;Etidronic Acid/analogs & derivatives*;Etidronic Acid/blood;Etidronic Acid/chemistry;Etidronic Acid/pharmacokinetics;Food-Drug Interactions*;Gastrointestinal Transit;Infusions, Intravenous;Intestinal Absorption*;Intestinal Mucosa/metabolism;Male;Molecular Structure;Naphthalenes/administration & dosage;Naphthalenes/blood;Naphthalenes/chemistry;Naphthalenes/pharmacokinetics*;Propionates/administration & dosage;Propionates/blood;Propionates/chemistry;Propionates/pharmacokinetics*;Rats;Rats, Wistar;Risedronate Sodium;Trientine/administration & dosage;Trientine/blood;Trientine/chemistry;Trientine/pharmacokinetics*
17245831;Food-Drug Interactions;Humans;Hypertension/etiology;Indans/adverse effects;Indans/therapeutic use*;Melanoma/chemically induced;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/adverse effects;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Skin Neoplasms/chemically induced
17233779;Adult;Aged;Dose-Response Relationship, Drug;Double-Blind Method;Erectile Dysfunction/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Satisfaction;Penile Erection/drug effects;Phosphodiesterase Inhibitors/administration & dosage*;Piperazines/administration & dosage*;Purines/administration & dosage;Sildenafil Citrate;Sulfones/administration & dosage*;Treatment Outcome;Vasodilator Agents/administration & dosage*
17224848;Adult;Area Under Curve;Biological Availability;Capsules;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gelatin/chemistry;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Lopinavir;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidinones/administration & dosage;Pyrimidinones/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Tablets
17220050;Adult;Area Under Curve;Biological Availability;Calibration;Cross-Over Studies;Electrocardiography/drug effects;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/pharmacokinetics*;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
17215845;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;Aged;Aged, 80 and over;Beverages/adverse effects*;Biological Availability;Blotting, Western;Carrier Proteins/biosynthesis*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Female;Fluorescent Antibody Technique;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Humans;Immunohistochemistry;Intestines/metabolism*;Male;Middle Aged;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Pharmaceutical Preparations/metabolism*;RNA/biosynthesis;RNA/genetics;Reverse Transcriptase Polymerase Chain Reaction;Terfenadine/analogs & derivatives;Terfenadine/blood
17212251;Aged;Diuretics/adverse effects*;Food-Drug Interactions;Humans;Minerals/adverse effects*;Salts/adverse effects*;Sodium/deficiency*;Sodium Chloride, Dietary/administration & dosage
17209212;Dietary Supplements;Evidence-Based Medicine;Food-Drug Interactions*;Genetic Predisposition to Disease;Humans;Minerals/administration & dosage*;Neoplasms/etiology;Neoplasms/genetics;Neoplasms/prevention & control*;Nutritional Status;Randomized Controlled Trials as Topic;Vitamins/administration & dosage*
17207418;Administration, Oral;Animals;Biological Availability;Drug Administration Schedule;Food-Drug Interactions/physiology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/metabolism;Glucosamine/administration & dosage;Glucosamine/analogs & derivatives*;Glucosamine/blood;Glucosamine/pharmacokinetics;Male;Rats;Rats, Sprague-Dawley
17187315;Animals;Beverages;Cytochrome P-450 Enzyme System/biosynthesis;Drug Interactions*;Enzyme Induction;Food-Drug Interactions;Humans
17176169;Food-Drug Interactions;Tetrahydrofolates/pharmacology;Tetrahydrofolates/therapeutic use*
17146730;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting/blood;Female;Food-Drug Interactions;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Netherlands;Pilot Projects;Postprandial Period;Treatment Outcome;Tubulin Modulators/administration & dosage*;Tubulin Modulators/adverse effects;Tubulin Modulators/blood;Tubulin Modulators/pharmacokinetics*
17143047;Aged;Aging/blood*;Anticoagulants/administration & dosage*;Anticoagulants/therapeutic use;Antifibrinolytic Agents/administration & dosage*;Blood Coagulation/drug effects*;Diet;Food-Drug Interactions*;Humans;Phenprocoumon/administration & dosage;Thrombosis/prevention & control;Vitamin K/administration & dosage*;Warfarin/administration & dosage
17137219;Aldosterone/blood;Animals;Cardiomegaly/physiopathology;Diet, Sodium-Restricted;Echocardiography;Fibrosis/physiopathology;Food-Drug Interactions*;Heart/drug effects;Male;Mineralocorticoid Receptor Antagonists/pharmacology*;Mineralocorticoid Receptor Antagonists/therapeutic use;Myocardial Infarction/physiopathology*;Rats;Rats, Wistar;Sodium Chloride/administration & dosage;Sodium Chloride/pharmacology*;Spironolactone/analogs & derivatives*;Spironolactone/pharmacology;Spironolactone/therapeutic use;Ventricular Remodeling/drug effects*
17132763;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Beverages*;Biological Availability;Cytochrome P-450 CYP2C9;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Punicaceae*;Rats;Rats, Wistar;Tolbutamide/antagonists & inhibitors*;Tolbutamide/pharmacokinetics*
17126638;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Beverages*;Cross-Over Studies;Double-Blind Method;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Time Factors;Vaccinium macrocarpon*;Warfarin/therapeutic use*
17126626;Adolescent;Adult;Dietary Supplements*/adverse effects;Dietary Supplements*/statistics & numerical data;Dietary Supplements*/utilization;Drug Prescriptions/statistics & numerical data;Female;Food-Drug Interactions*;Health Behavior*;Health Knowledge, Attitudes, Practice*;Humans;Interviews as Topic;Male;Middle Aged;Minerals/administration & dosage*;Minerals/adverse effects;Nutrition Surveys;Prevalence;Socioeconomic Factors;United States;Vitamins/administration & dosage*;Vitamins/adverse effects
17126621;Advertising as Topic/legislation & jurisprudence*;Advertising as Topic/methods;Advertising as Topic/standards;Community Participation;Drug Industry;Drug Prescriptions*;Food-Drug Interactions*;Guidelines as Topic;Health Knowledge, Attitudes, Practice;Humans;Legislation, Drug*;Mass Media;Patient Education as Topic;United States;United States Food and Drug Administration
17116021;Administration, Oral;Anticonvulsants/pharmacokinetics*;Carbamates/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Design;Drugs, Investigational;Food-Drug Interactions;Humans;Neurotransmitter Agents/pharmacokinetics*;Placebos
17112309;Aged;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug-Related Side Effects and Adverse Reactions/etiology;Food-Drug Interactions*;Humans
17112297;Area Under Curve;Biological Availability;Computer Simulation;Cross-Over Studies;Fasting/physiology;Food-Drug Interactions/physiology*;Humans;Hydrophobic and Hydrophilic Interactions;Intestinal Absorption/physiology;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Pharmacokinetics*;Software;Solubility
17101740;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Clinical Trials as Topic;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Molecular Structure;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry
17094172;Adult;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/urine;Beverages;Cross-Over Studies;Diclofenac/pharmacokinetics*;Diclofenac/urine;Female;Flowers;Food-Drug Interactions*;Hibiscus*;Humans;Kidney/drug effects*;Kidney/metabolism;Male;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
17077528;Animals;Area Under Curve;Beverages/analysis*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Duodenum/drug effects;Duodenum/metabolism;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/chemistry;Furocoumarins/pharmacology;Hot Temperature*;Hydroxytestosterones/analysis;Hydroxytestosterones/metabolism;Intubation, Gastrointestinal;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Molecular Structure;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics;Rats;Rats, Wistar;Time Factors
17075867;Animals;Atazanavir Sulfate;Biological Availability;Dietary Fats*;Dogs;Drug Evaluation, Preclinical/methods*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Models, Animal*;Oligopeptides/pharmacokinetics;Pentagastrin/pharmacology*;Pravastatin/pharmacokinetics;Pyridines/pharmacokinetics
17065027;Administration, Oral;Adult;Anti-HIV Agents/therapeutic use*;Antiretroviral Therapy, Highly Active;Capsules;Clinical Trials as Topic;Cohort Studies;Didanosine/therapeutic use*;Fasting;Female;Food*;Food-Drug Interactions*;HIV*/isolation & purification;HIV Infections/drug therapy*;HIV Infections/virology;Humans;Male;Patient Compliance;Proportional Hazards Models;Retrospective Studies;Risk Factors;Spain;Treatment Failure;Viral Load
17053894;Administration, Oral;Adult;Algorithms;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Biological Availability;Bread*;Capsules;Chromatography, High Pressure Liquid/methods;Cluster Analysis;Cross-Over Studies;Dose-Response Relationship, Drug;Eating/physiology*;Female;Food-Drug Interactions;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Oryza*;Retrospective Studies;Software*;Time Factors
17046222;Attitude to Health;Diet Records*;Diet Surveys;Diet, Fat-Restricted;Diet, Reducing;Energy Intake*;Evaluation Studies as Topic;Feeding Behavior;Female;Food, Genetically Modified*;Food-Drug Interactions*;Humans;Male;Nutrition Assessment;Sensitivity and Specificity;Surveys and Questionnaires
16995870;Adult;Beverages*;Citrus*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/metabolism*;Drug Interactions;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/metabolism*;Male
16989032;Bacteriuria/prevention & control;Double-Blind Method;Female;Food-Drug Interactions;Fruit;Humans;Phytotherapy;Plant Preparations*/therapeutic use;Randomized Controlled Trials as Topic;Self Care/methods;Urinary Tract Infections*/prevention & control;Urinary Tract Infections*/therapy;Vaccinium macrocarpon*;Warfarin
16988211;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Anticholesteremic Agents/pharmacokinetics;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Disorders of Excessive Somnolence/chemically induced;Dose-Response Relationship, Drug;Drug Combinations;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heptanoic Acids/adverse effects;Heptanoic Acids/pharmacokinetics*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Tablets;Therapeutic Equivalency
16988203;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Administration, Oral;Adult;Aminopyridines/administration & dosage;Aminopyridines/blood;Aminopyridines/metabolism;Aminopyridines/pharmacokinetics*;Area Under Curve;Benzamides/administration & dosage;Benzamides/blood;Benzamides/metabolism;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclopropanes/administration & dosage;Cyclopropanes/blood;Cyclopropanes/metabolism;Cyclopropanes/pharmacokinetics;Dietary Fats/administration & dosage*;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Half-Life;Headache/diagnosis;Headache/epidemiology;Humans;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
16945054;Anticoagulants/adverse effects*;Beverages*;Food-Drug Interactions;Humans;International Normalized Ratio;Vaccinium macrocarpon*;Warfarin/adverse effects*
16909484;Administration, Cutaneous;Depression/drug therapy*;Drug Approval;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Selegiline/administration & dosage*
16903052;Animal Feed/adverse effects;Animal Feed/analysis*;Animals;Chironomidae/growth & development*;Ecosystem;Food-Drug Interactions;Geologic Sediments/chemistry*;Larva/growth & development*;Water Pollutants, Chemical/toxicity*
16900909;Alcoholic Beverages/adverse effects*;Analgesics, Opioid/adverse effects*;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Intestinal Absorption;Oxycodone/adverse effects*;Patient Education as Topic
16872553;Animals;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Drug Interactions;Food-Drug Interactions*;Furocoumarins/pharmacology;Humans;In Vitro Techniques;Intestines/metabolism;Male;Microsomes/metabolism;Microsomes, Liver/metabolism;Nifedipine/pharmacokinetics*;Oxidation-Reduction;Rats;Rats, Wistar;Vaccinium macrocarpon*
16871472;Adult;Alprazolam/therapeutic use;Animals;Antidepressive Agents, Second-Generation/therapeutic use;Antidepressive Agents, Tricyclic/adverse effects*;Anxiety/complications;Anxiety/drug therapy;Clomipramine/adverse effects*;Drug Eruptions/pathology*;Female;Food-Drug Interactions*;Gadus morhua*;Humans;Hypnotics and Sedatives/therapeutic use;Meat/adverse effects*;Obsessive-Compulsive Disorder/complications;Obsessive-Compulsive Disorder/drug therapy;Paroxetine/therapeutic use;Urticaria/chemically induced*;Urticaria/pathology*
16870316;Animals;Antibiotics, Antineoplastic/toxicity*;Blood Pressure/drug effects;Deoxyguanosine/analogs & derivatives;Deoxyguanosine/metabolism;Doxorubicin/toxicity*;Food-Drug Interactions*;Hypertension/chemically induced*;Hypertension/enzymology;Hypertension/pathology;Immunoenzyme Techniques;Kidney/drug effects*;Kidney/enzymology;Kidney/pathology;Male;Nitric Oxide Synthase Type III/metabolism*;Oxidative Stress*;Rats;Rats, Sprague-Dawley;Sodium, Dietary/administration & dosage*;Up-Regulation
16863482;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Interactions;Food-Drug Interactions*;Gastric Acid/secretion;Gastric Acidity Determination;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Histamine H2 Antagonists/pharmacology*;Humans;Intestinal Absorption/drug effects;Male;Pilot Projects;Ranitidine/pharmacology*;Reference Values;Saquinavir/blood;Saquinavir/pharmacokinetics*;Scotland
16863458;Animals;Drug Interactions;Food-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/metabolism;Immunosuppressive Agents/therapeutic use*;Mycophenolic Acid/adverse effects;Mycophenolic Acid/analogs & derivatives*;Mycophenolic Acid/metabolism;Mycophenolic Acid/therapeutic use;Organ Transplantation*;Transplantation Immunology
16863430;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Biological Availability;Cytochrome P-450 CYP3A/physiology*;Drug Design;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Liver/metabolism;Pharmaceutical Preparations/metabolism*;Pharmacogenetics
16863427;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/analysis;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/physiology*;Absorption;Area Under Curve;Blood-Brain Barrier;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasm Proteins/analysis;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/genetics;Neoplasm Proteins/physiology*;Pharmacokinetics*;Polymorphism, Genetic
16862703;Anticholesteremic Agents/metabolism;Atorvastatin Calcium;Beverages*;Cytochrome P-450 CYP3A Inhibitors*;Female;Food-Drug Interactions*;Heptanoic Acids/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Punicaceae*;Pyrroles/metabolism
16856145;Administration, Oral;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Therapy, Combination;Female;Food-Drug Interactions*;Heart Rate/drug effects*;Humans;Indans/administration & dosage;Indans/adverse effects*;Levodopa/administration & dosage;Levodopa/adverse effects;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Parkinson Disease/drug therapy*;Risk Factors;Tyramine*/administration & dosage
16855078;Administration, Cutaneous;Administration, Oral;Adolescent;Adult;Blood Pressure/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Heart Rate/drug effects;Humans;Hypertension/chemically induced*;Hypertension/physiopathology;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Reference Values;Selegiline/administration & dosage;Selegiline/adverse effects*;Time Factors;Tranylcypromine/administration & dosage;Tranylcypromine/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects*
16850557;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism
16850428;Algorithms;Biopharmaceutics;Body Fluids/chemistry;Caco-2 Cells;Chromatography, High Pressure Liquid;Danazol/administration & dosage;Danazol/chemistry;Danazol/pharmacokinetics;Electric Conductivity;Emulsions;Estrogen Antagonists/administration & dosage;Estrogen Antagonists/chemistry;Estrogen Antagonists/pharmacokinetics;Food-Drug Interactions*;Humans;Intestinal Absorption;Permeability;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Polyethylene Glycols;Predictive Value of Tests;Solubility
16815131;Adult;Antiretroviral Therapy, Highly Active/adverse effects;Diabetes, Gestational/diet therapy*;Dietetics/organization & administration*;Female;Food-Drug Interactions;HIV Infections/complications;HIV Infections/therapy*;Home Care Services/organization & administration*;Humans;Maternal Nutritional Physiological Phenomena;Nutrition Therapy*;Nutritional Sciences/education;Patient Care Team;Patient Education as Topic;Pregnancy;Pregnancy Complications, Infectious/therapy*;Pregnancy Outcome;Prenatal Nutritional Physiological Phenomena;United States
16814135;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/drug therapy*;Intestines/enzymology
16808323;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Area Under Curve;Beverages*;Biological Availability*;Citrus paradisi*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*
16804094;Animals;Beverages*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Punicaceae*
16803818;Anti-Anxiety Agents/administration & dosage*;Benzodiazepines/administration & dosage*;Citrus paradisi;Conscious Sedation/methods*;Food-Drug Interactions*;Humans
16802061;Anti-Anxiety Agents;Beverages*;Calcium Channel Blockers*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors
16789588;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
16773618;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Combined Modality Therapy;Cross-Over Studies;Diet, Protein-Restricted*/adverse effects;Drug Therapy, Combination;Female;Food-Drug Interactions*;Humans;Levodopa/administration & dosage;Levodopa/adverse effects*;Male;Middle Aged;Neurologic Examination*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology;Patient Satisfaction;Pilot Projects;Postprandial Period*/physiology;Single-Blind Method
16772772;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Drug Synergism;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Hypoprothrombinemias/chemically induced*;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
16758223;Adolescent;Adult;Alcohol Drinking/adverse effects;Antioxidants/therapeutic use;Biomarkers;Case-Control Studies;Child;Controlled Clinical Trials as Topic;Dermatologic Agents/administration & dosage;Dermatologic Agents/therapeutic use;Diet, Vegetarian;Energy Intake;Fasting;Fatty Acids, Omega-3/therapeutic use;Female;Fish Oils;Food-Drug Interactions;Glutens/adverse effects;Homocysteine/blood;Humans;Male;Methotrexate/administration & dosage;Methotrexate/therapeutic use;Nutritional Status*;Psoriasis/blood;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology;Psoriasis/metabolism;Sex Factors;Vitamin D/therapeutic use
16756539;Enteral Nutrition*;Food-Drug Interactions*;Humans
16755036;Animals;Beverages/radiation effects*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Citrus paradisi/radiation effects;Drug Interactions;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/pharmacology*;Furocoumarins/radiation effects;Male;Nifedipine/blood;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar;Ultraviolet Rays*
16741856;Anticoagulants/pharmacology*;Drug Resistance;Female;Food-Drug Interactions*;Humans;Lettuce*;Middle Aged;Warfarin/pharmacology*
16732136;Administration, Cutaneous;Animals;Depressive Disorder/drug therapy*;Diet*;Food-Drug Interactions;Guinea Pigs;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/pharmacokinetics*;Selegiline/administration & dosage*;Selegiline/pharmacokinetics*;Tyramine/metabolism*
16722829;Adult;Antimalarials/pharmacokinetics*;Beverages*;Citrus paradisi*;Female;Food-Drug Interactions;Humans;Male;Primaquine/pharmacokinetics*;Sex Characteristics
16715357;Animals;Bile Acids and Salts/analysis;Buffers;Dipyridamole/chemistry*;Dogs;Duodenum*;Fasting;Female;Food-Drug Interactions*;Gastrointestinal Contents/chemistry*;Humans;Hydrogen-Ion Concentration;Jejunum*;Ketoconazole/chemistry*;Lipids/analysis;Male;Polyethylene Glycols;Solubility;Species Specificity;Vitamin K/administration & dosage
16702731;Adult;Bayes Theorem;Beverages;Citrus paradisi/chemistry*;Female;Food-Drug Interactions*;Half-Life;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Liver Transplantation/physiology*;Phosphoric Monoester Hydrolases/metabolism;Tacrolimus/blood;Tacrolimus/pharmacokinetics*
16699355;Anticoagulants/therapeutic use*;Cross-Sectional Studies;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Heart Valve Prosthesis Implantation*/adverse effects;Humans;International Normalized Ratio;Male;Middle Aged;Patient Education as Topic/methods;Population Surveillance;Thromboembolism/etiology;Thromboembolism/prevention & control;Vitamin K/metabolism;Warfarin/therapeutic use*
16674636;Blood Platelets/physiology*;Diet*;Food-Drug Interactions*;Humans;Platelet Function Tests/methods;Preoperative Care/methods;Research Design
16669846;Administration, Oral;Adult;Area Under Curve;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Dihydropyridines/blood;Dihydropyridines/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Stereoisomerism;Time Factors
16669845;Beverages*;Biological Availability;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Dihydropyridines/pharmacokinetics*;Enzyme Inhibitors/pharmacokinetics;Food-Drug Interactions*;Herbal Medicine;Humans;Intestines/drug effects;Intestines/enzymology;Liver/drug effects;Liver/enzymology;Stereoisomerism
16638738;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Factor Xa Inhibitors;Fasting/metabolism;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology;Humans;Intestinal Absorption/drug effects;Magnesium Hydroxide/pharmacology;Male;Morpholines/adverse effects;Morpholines/blood;Morpholines/pharmacokinetics*;Morpholines/pharmacology;Prothrombin Time;Ranitidine/pharmacology*;Rivaroxaban;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Thiophenes/pharmacology
16628990;Anticoagulants/pharmacology*;Dietary Supplements*;Fish Oils;Food-Drug Interactions*;Fruit;Humans;Seaweed;Soy Milk;Tea;Warfarin/pharmacology*
16613116;Beverages/adverse effects*;Food-Drug Interactions*;Humans;Vaccinium macrocarpon/adverse effects*;Warfarin/adverse effects*
16584288;Administration, Oral;Adult;Biological Availability;Capsules;Delayed-Action Preparations;Dietary Fats/pharmacology;Fasting/metabolism;Female;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male
16569183;Enteral Nutrition*/adverse effects;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pharmacy Service, Hospital;Prospective Studies
16562361;Anti-Retroviral Agents/adverse effects;Anti-Retroviral Agents/classification;Anti-Retroviral Agents/therapeutic use*;CD4 Lymphocyte Count;Food-Drug Interactions;HIV Infections/drug therapy*;Hepatitis C/drug therapy;Humans;Sweden
16552571;Acetylglucosaminidase/blood;Animals;Antioxidants/administration & dosage;Antioxidants/chemistry;Antioxidants/metabolism;Catalase/metabolism;Cell Survival/drug effects;Cisplatin/toxicity*;Creatine/blood;Female;Food-Drug Interactions;Glutathione Peroxidase/metabolism;Humans;Kidney/drug effects*;Kidney/metabolism;Kidney/pathology;Kidney Diseases/chemically induced*;Kidney Diseases/physiopathology;Kidney Diseases/prevention & control;Lipid Peroxidation/drug effects;Male;Rats;Rats, Wistar;Spirulina/chemistry;Spirulina/physiology*;Superoxide Dismutase/metabolism;Tumor Cells, Cultured;Urea/blood
16520665;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Middle Aged;Protein-Tyrosine Kinases/antagonists & inhibitors*;Protein-Tyrosine Kinases/metabolism;Pyrroles/adverse effects;Pyrroles/blood;Pyrroles/pharmacokinetics*
16518091;Adrenergic alpha-1 Receptor Antagonists;Adrenergic alpha-Antagonists/administration & dosage;Adrenergic alpha-Antagonists/pharmacokinetics*;Adult;Aged;Aging/metabolism;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Food-Drug Interactions;Guanosine Triphosphate/physiology;Humans;Indoles/administration & dosage;Indoles/metabolism;Indoles/pharmacokinetics*;Kidney Diseases/metabolism;Male;Orosomucoid/metabolism;Protein Binding
16513449;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Vaccinium macrocarpon*
16513448;Adolescent;Adult;Area Under Curve;Benzodiazepines/pharmacokinetics;Beverages*;Chromatography, Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism*;Female;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Liver/drug effects;Liver/enzymology;Male;Mass Spectrometry;Middle Aged;Ritonavir/pharmacokinetics*
16512094;Anti-Bacterial Agents/adverse effects;Antifungal Agents/adverse effects;Atorvastatin Calcium;Azoles/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dental Care for Chronically Ill*;Drug Interactions;Food-Drug Interactions;Heptanoic Acids/adverse effects;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Macrolides/adverse effects;Pravastatin/adverse effects;Pyrroles/adverse effects;Rhabdomyolysis/chemically induced;Simvastatin/adverse effects
16505889;Beverages;Food-Drug Interactions*;Humans;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Punicaceae*
16502765;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Fasting/blood;Female;Fenofibrate/administration & dosage;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Nanostructures;Reference Values;Tablets
16490807;Adsorption;Adult;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Carbon/pharmacology*;Cross-Over Studies;Dietary Fats;Drug Administration Schedule;Drug Interactions;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Agents/pharmacology*;Humans;Imidazoles/blood;Imidazoles/pharmacokinetics*;Losartan/blood;Losartan/pharmacokinetics*;Male;Oxides/pharmacology*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Time Factors
16490805;Administration, Oral;Adult;Antiemetics/administration & dosage;Antiemetics/blood;Antiemetics/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Monitoring;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Morpholines/administration & dosage;Morpholines/blood;Morpholines/pharmacokinetics*;Neurokinin-1 Receptor Antagonists*
16490803;Absorption;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/pharmacology;Drug Monitoring;Energy Intake;Fasting;Female;Food;Food-Drug Interactions*;Humans;Male;Nucleosides/administration & dosage;Nucleosides/blood;Nucleosides/pharmacokinetics*;Pyrimidinones/administration & dosage;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Thymidine/analogs & derivatives
16454693;Animals;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics*;Diet*;Dietary Fats/pharmacology;Enzyme Induction/physiology;Food-Drug Interactions;Humans;Liver Diseases/metabolism;Nutritional Physiological Phenomena;Oxidation-Reduction;Vitamin A Deficiency/metabolism;Vitamin E/physiology
16430569;Analgesics, Opioid/pharmacokinetics*;Anesthetics/pharmacokinetics*;Animals;Biotransformation;Cytochrome P-450 Enzyme System/physiology*;Drug Interactions;Enzyme Induction/physiology;Enzyme Inhibitors/pharmacology;Food-Drug Interactions/physiology;Humans;Liver/enzymology*;Smoking/metabolism
16430312;Administration, Oral;Adult;Anticoagulants*/administration & dosage;Anticoagulants*/pharmacokinetics;Anticoagulants*/pharmacology;Area Under Curve;Azetidines*/administration & dosage;Azetidines*/pharmacokinetics;Azetidines*/pharmacology;Benzylamines*/administration & dosage;Benzylamines*/pharmacokinetics;Benzylamines*/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Food-Drug Interactions;Humans;Japan;Male;Metabolic Clearance Rate;Thrombin/antagonists & inhibitors*
16425970;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Clinical Chemistry Tests;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage;Eating/drug effects;European Union;Fasting;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Hydrogen-Ion Concentration;Male;Mass Spectrometry;Nifedipine/adverse effects;Nifedipine/blood;Nifedipine/pharmacokinetics*;Solubility;Tablets;Technology, Pharmaceutical/methods;Time Factors
16416305;Adult;Analysis of Variance;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism;Benzodiazepines/blood;Benzodiazepines/metabolism;Benzodiazepines/pharmacokinetics*;Beverages*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/metabolism;Hypnotics and Sedatives/pharmacokinetics*;Male;Metabolic Clearance Rate;Time Factors;Triazolam/blood;Triazolam/metabolism;Triazolam/pharmacokinetics*
16415112;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/enzymology;Midazolam/metabolism;Morus*;Vitis*
16413247;Adult;Algorithms;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Antifungal Agents/blood;Antifungal Agents/pharmacology*;Area Under Curve;Beverages;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Female;Fluconazole/blood;Fluconazole/pharmacology*;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Tea*;Vaccinium macrocarpon*;Vitis*
16412477;Adult;Animals;Beverages;Biological Availability;Blotting, Western;Carrier Proteins/metabolism;Citrus sinensis/chemistry*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Intestines/drug effects;Intestines/metabolism;Male;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Organic Anion Transporters, Sodium-Independent/biosynthesis;Organic Anion Transporters, Sodium-Independent/genetics;Pravastatin/pharmacokinetics*;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/pharmacokinetics
16398269;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Animals;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/pharmacokinetics;Antitubercular Agents/administration & dosage;Antitubercular Agents/pharmacokinetics;Beverages*;Calcium Channel Blockers/pharmacology;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Indinavir/administration & dosage;Indinavir/pharmacokinetics;Intestinal Absorption/drug effects*;Male;Paclitaxel/administration & dosage;Paclitaxel/pharmacokinetics;Permeability;Pharmaceutical Preparations/metabolism*;Rats;Rats, Sprague-Dawley;Rifampin/administration & dosage;Rifampin/pharmacokinetics;Verapamil/pharmacology
16393464;Administration, Oral;Aniline Hydroxylase/metabolism;Animals;Chlorzoxazone/administration & dosage;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics*;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP2B1/metabolism;Cytochrome P-450 CYP2E1/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Fasting/metabolism*;Food-Drug Interactions;Injections, Intravenous;Liver/enzymology;Male;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics;Rats;Rats, Sprague-Dawley
16380358;Animals;Biological Availability;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
16365957;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Male;Piperazines/blood;Purines;Sildenafil Citrate;Sulfones;Vasodilator Agents/blood
16358638;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Drug Administration Schedule;Food-Drug Interactions;Gluconeogenesis/drug effects;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Insulin/administration & dosage;Insulin/adverse effects;Insulin/analogs & derivatives*;Insulin/blood;Insulin/pharmacokinetics;Insulin Lispro;Receptor, Insulin/drug effects
16357446;Antitubercular Agents/adverse effects*;Antitubercular Agents/therapeutic use;Cheese*;Fish Products*;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Risk Factors;Tuberculosis/drug therapy;Wine*
16337049;Anticoagulants/pharmacology*;Aspirin/pharmacology;Azetidines/pharmacology;Benzylamines/pharmacology;Calcium Channel Blockers/pharmacology*;Food Additives/adverse effects*;Food-Drug Interactions*;Honey/adverse effects*;Humans;Soy Foods/adverse effects*
16327247;Administration, Oral;Animals;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Levodopa/administration & dosage;Levodopa/pharmacokinetics*;Male;Musa*;Rats;Rats, Wistar
16326816;Animals;Area Under Curve;Beverages*/adverse effects;Biological Availability;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors*/adverse effects;Food-Drug Interactions*;Fruit*;Male;Metabolic Clearance Rate;Rats;Rats, Wistar
16325363;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Antiretroviral Therapy, Highly Active;Clinical Trials as Topic/methods;Clinical Trials as Topic/statistics & numerical data;Cohort Studies;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/epidemiology;HIV Infections/psychology;Humans;Interdisciplinary Communication;Outcome Assessment (Health Care);Patient Care Team;Physician-Patient Relations;Treatment Refusal*/statistics & numerical data
16321619;Administration, Oral;Adult;Alfentanil/administration & dosage;Alfentanil/pharmacokinetics*;Algorithms;Anesthetics, Intravenous/administration & dosage;Anesthetics, Intravenous/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Injections, Intravenous;Liver/enzymology;Liver/metabolism;Midazolam/administration & dosage;Midazolam/pharmacokinetics*
16306299;Biological Availability;Drug Administration Routes;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/administration & dosage*
16305592;Acebutolol/analogs & derivatives;Acebutolol/blood*;Acebutolol/urine;Adrenergic beta-Antagonists/blood*;Adrenergic beta-Antagonists/urine;Adult;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/urine;Antihypertensive Agents/therapeutic use;Beverages*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male
16305298;Dietary Supplements/adverse effects;Drug Evaluation/methods*;Food-Drug Interactions*;Humans;Intestinal Absorption;Nutritional Status;Pharmaceutical Services;Pharmacokinetics
16302488;Biological Availability;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Risk Factors;Time Factors
16297483;Animals;Antifungal Agents/administration & dosage*;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics;Area Under Curve;Biological Availability;Capsules;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Emulsions;Ethylene Glycols;Food-Drug Interactions;Hydrochloric Acid;Intestinal Absorption;Itraconazole/administration & dosage*;Itraconazole/chemistry;Itraconazole/pharmacokinetics;Male;Oils;Particle Size;Poloxamer;Rats;Rats, Sprague-Dawley;Solubility;Surface-Active Agents;Tocopherols;alpha-Tocopherol/analogs & derivatives
16296740;Animals;Attention Deficit Disorder with Hyperactivity/drug therapy*;Attention Deficit Disorder with Hyperactivity/physiopathology;Biological Availability;Chemistry, Pharmaceutical;Clinical Trials as Topic;Delayed-Action Preparations;Dopamine Agents/therapeutic use*;Food-Drug Interactions*;Humans;Methylphenidate/chemistry;Methylphenidate/pharmacokinetics;Methylphenidate/therapeutic use*;Sex Factors
16291715;Administration, Oral;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics*;Biological Availability;Citalopram/administration & dosage;Citalopram/adverse effects;Citalopram/pharmacokinetics*;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics*
16291710;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Didanosine/adverse effects;Didanosine/blood;Didanosine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir
16288258;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans
16272810;Animals;Beverages;Chromatography, High Pressure Liquid;Citrus*/chemistry;Food-Drug Interactions*;Furocoumarins/analysis;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar
16272808;Beverages/analysis*;Chromatography, High Pressure Liquid/instrumentation;Chromatography, High Pressure Liquid/methods*;Citrus/chemistry*;Food-Drug Interactions;Furocoumarins/analysis*
16268317;Citrus paradisi/adverse effects;Drug Interactions*;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Hypericum/adverse effects
16267709;Drug Administration Routes;Enteral Nutrition/instrumentation;Enteral Nutrition/methods*;Food-Drug Interactions*;Humans;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/methods*;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic;Practice Patterns, Physicians'
16265911;Adult;Dietary Supplements*;Drug Interactions;Drug Labeling;Female;Food Additives*/adverse effects;Food-Drug Interactions;Humans;Legislation, Drug;Legislation, Food;Male;Plant Structures*/adverse effects;Plants, Medicinal*/adverse effects;Russia;Safety
16260103;Absorption;Beverages*/toxicity;Biological Transport/drug effects;Caco-2 Cells;Carbon Radioisotopes;Cell Membrane Permeability/drug effects;Cell Survival/drug effects;Citrus*/classification;Food-Drug Interactions*;Humans;Mannitol/metabolism;Propranolol/metabolism
16247711;Adult;Animals;Body Fluids/chemistry*;Chemical Phenomena;Chemistry, Physical;Chromatography, High Pressure Liquid;Dogs;Female;Food-Drug Interactions*;Humans;Intestines/chemistry;Intestines/metabolism;Kinetics;Lipids/chemistry;Male;Molecular Weight;Pharmaceutical Preparations/chemistry*;Solubility;Thermodynamics
16239358;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adenine/urine;Administration, Oral;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Dietary Fats/pharmacology;Double-Blind Method;Food-Drug Interactions;Humans;Male;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Organophosphonates/urine;Organophosphorus Compounds/blood;Organophosphorus Compounds/pharmacokinetics*;Organophosphorus Compounds/urine;Prodrugs/pharmacokinetics*
16239022;Clinical Trials as Topic*;Dietary Supplements/adverse effects*;Evidence-Based Medicine*;Fibrinolytic Agents/adverse effects*;Food, Organic/adverse effects*;Food-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*;Risk Assessment/methods*;Risk Factors
16236039;Adult;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacokinetics*;Food-Drug Interactions/physiology;Heptanoic Acids/pharmacokinetics*;Humans;Male;Pyrroles/pharmacokinetics*;Quinolines/pharmacokinetics*
16213057;Adult;Algorithms;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Colon/metabolism;Cross-Over Studies;Delayed-Action Preparations*;Felodipine/administration & dosage;Felodipine/blood;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Gastric Emptying;Gastrointestinal Transit/physiology;Humans;Magnetics;Male;Solubility;Spectrophotometry, Ultraviolet;Stomach/metabolism*
16207645;Dietary Supplements*;Drug Interactions*;Drug Prescriptions;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;United States
16199918;Calcium Channel Blockers/adverse effects*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions*;Humans
16198665;3',5'-Cyclic-GMP Phosphodiesterases;Aryl Hydrocarbon Hydroxylases/genetics*;Beverages;Citrus paradisi;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Cytochrome P-450 CYP2C9;Food-Drug Interactions;Genotype;Humans;Male;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism;Piperazines/blood;Piperazines/pharmacokinetics*;Purines;Sildenafil Citrate;Sulfones/blood
16193318;1-Methyl-4-phenylpyridinium/metabolism*;Caco-2 Cells;Caffeine/pharmacology;Catechin/analogs & derivatives;Catechin/pharmacology;Corticosterone/pharmacology;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Organic Cation Transport Proteins/metabolism*;Plant Extracts/pharmacology*;Quinolines/pharmacology;Tea*;Theophylline/pharmacology;Tritium
16192747;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use;Antifungal Agents/adverse effects;Antifungal Agents/therapeutic use*;Clinical Trials as Topic;Cross Infection/prevention & control*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Monitoring;Echinocandins;Food-Drug Interactions;Humans;Immunocompromised Host;Intensive Care Units;Lipopeptides;Liver/drug effects;Liver/enzymology;Mycoses/drug therapy*;Mycoses/prevention & control;Peptides, Cyclic/adverse effects;Peptides, Cyclic/therapeutic use*;Polypharmacy;Pyrimidines/adverse effects;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use;Triazoles/adverse effects;Triazoles/therapeutic use*;Voriconazole
16190498;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio;Phytotherapy/adverse effects*;Urinary Tract Infections/prevention & control*;Vaccinium macrocarpon*;Warfarin*
16187969;Administration, Oral;Adolescent;Adult;Antacids/administration & dosage;Antacids/pharmacokinetics*;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use;Biological Availability;Bismuth/pharmacokinetics*;Bismuth/therapeutic use;Cross-Over Studies;Drug Combinations;Food-Drug Interactions*;Helicobacter Infections/drug therapy*;Helicobacter pylori*;Humans;Male;Metronidazole/pharmacokinetics;Metronidazole/therapeutic use;Middle Aged;Tetracycline/pharmacokinetics;Tetracycline/therapeutic use
16181450;Antioxidants/therapeutic use;Cholecalciferol/therapeutic use;Diet/adverse effects*;Fatty Acids, Unsaturated/therapeutic use;Food-Drug Interactions;Glutens/adverse effects;Humans;Oxidative Stress;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology*;Vitamin B 12/therapeutic use
16169713;Acetaminophen/administration & dosage;Acetaminophen/chemistry*;Acetaminophen/pharmacokinetics;Administration, Oral;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/chemistry*;Analgesics, Non-Narcotic/pharmacokinetics;Biological Availability;Dialysis Solutions/chemistry;Diffusion;Fasting;Female;Food;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Hydrogen-Ion Concentration;In Vitro Techniques;Intestinal Absorption;Male;Models, Biological*;Saliva/chemistry;Saliva/metabolism;Solubility;Tablets*
16164493;Adult;Aged;Area Under Curve;Blood Specimen Collection;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Estradiol/adverse effects;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Hormones/blood;Humans;Mass Spectrometry;Middle Aged;Postmenopause/physiology*;Selective Estrogen Receptor Modulators/adverse effects*;Selective Estrogen Receptor Modulators/pharmacokinetics*
16161934;Beverages*;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions/genetics;Food-Drug Interactions*;Humans;Microsomes, Liver/metabolism*;Pharmaceutical Preparations/metabolism*;Polymorphism, Genetic
16120075;Adult;Beverages;Biological Availability;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Thyroxine/blood;Thyroxine/pharmacokinetics*
16119275;Animals;Antirheumatic Agents/pharmacokinetics*;Beverages*;Biological Transport;Food-Drug Interactions*;Fruit*;Humans;Intestinal Absorption;Intestines/metabolism;Methotrexate/pharmacokinetics*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism
16100300;Adult;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Female;Food-Drug Interactions*;Humans;Ibuprofen/analogs & derivatives*;Ibuprofen/chemistry;Ibuprofen/pharmacokinetics*;Intestinal Absorption;Lysine/analogs & derivatives*;Lysine/pharmacokinetics;Male;Middle Aged;Pharmaceutic Aids;Povidone;Solubility;Tablets;Therapeutic Equivalency
16078151;Adrenergic beta-Agonists/chemistry*;Algorithms;Arylsulfotransferase/chemistry*;Autoradiography;Beverages*;Biological Availability;Citrus;Food-Drug Interactions*;Humans;Isoenzymes/chemistry;Kinetics;Recombinant Proteins/chemistry;Ritodrine/chemistry*;Sulfotransferases/chemistry*;Tea
16076481;Animals;Blood Coagulation/drug effects*;Blood Coagulation/physiology*;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Dietary Supplements/classification*;Evidence-Based Medicine;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/classification;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Hemorrhage/prevention & control;Humans;Risk Assessment/methods;Risk Factors
16055224;Adolescent;Adrenergic beta-Antagonists/administration & dosage*;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Algorithms;Animals;Area Under Curve;Biological Availability;Biological Transport, Active/physiology;Biotransformation;Caco-2 Cells;Cross-Over Studies;Drug Delivery Systems*;Excipients;Female;Food-Drug Interactions;Humans;In Vitro Techniques;Intestinal Absorption;Lactose/analogs & derivatives;Male;Methylcellulose/analogs & derivatives;Middle Aged;Oxazines;Polyethylene Glycols;Propranolol/administration & dosage*;Propranolol/pharmacokinetics*;Rats
16054195;Dietary Supplements*;Fibrinolytic Agents/administration & dosage*;Food-Drug Interactions*;Hemostasis/drug effects*;Hemostasis/physiology*;Humans
16052730;Animals;Calcium/pharmacokinetics*;Dietary Fiber/administration & dosage*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology*;Milk*
16048354;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Animals;Beverages*;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
16048029;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Benzodiazepines/metabolism;Beverages/adverse effects;Biological Availability;Calcium Channel Blockers/metabolism;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects
16043212;Coumarins/administration & dosage;Coumarins/adverse effects;Coumarins/pharmacokinetics;Dietary Supplements*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Pharmacogenetics/methods;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
16035690;Animals;Bleeding Time;Clinical Trials as Topic;Drug Evaluation, Preclinical;Evidence-Based Medicine;Food-Drug Interactions;Garlic*/adverse effects;Garlic*/chemistry;Garlic*/physiology;Humans;Hyperlipidemias/prevention & control;Hypertension/prevention & control;Infection Control;Neoplasms/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Research Design/standards
15999499;Adult;Alcohol Drinking*;Erectile Dysfunction/drug therapy;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Sulfones/adverse effects;Sulfones/pharmacokinetics;Triazines/adverse effects;Triazines/pharmacokinetics;Vardenafil Dihydrochloride
15998360;Adolescent;Adult;Albendazole/pharmacokinetics*;Anthelmintics/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Diet*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Mexico
15991880;Adult;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/adverse effects;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged
15988577;Animals;Atorvastatin Calcium;Blood Glucose/metabolism;Diabetes Mellitus, Type 1/prevention & control*;Female;Food-Drug Interactions;Heptanoic Acids/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Mice;Mice, Inbred C57BL;Mice, Inbred NOD;Pyrroles/therapeutic use*
15983823;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Atenolol/blood;Atenolol/pharmacokinetics*;Atenolol/urine;Beverages*;Biological Availability;Blood Pressure/drug effects;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Heart Rate/drug effects;Humans;Male;Metabolic Clearance Rate
15980352;Adolescent;Adult;Benzoates*/administration & dosage;Benzoates*/adverse effects;Benzoates*/metabolism;Benzoates*/pharmacokinetics;CCR5 Receptor Antagonists*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;HIV Fusion Inhibitors*/administration & dosage;HIV Fusion Inhibitors*/adverse effects;HIV Fusion Inhibitors*/metabolism;HIV Fusion Inhibitors*/pharmacokinetics;Humans;Male;Middle Aged;Piperazines;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/metabolism;Spiro Compounds*/pharmacokinetics
15978308;Administration, Oral;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Enteral Nutrition;Female;Food, Formulated;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Piracetam/analogs & derivatives*;Piracetam/pharmacokinetics
15954427;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Anemia, Aplastic/drug therapy;Autoimmune Diseases/drug therapy;Behcet Syndrome/drug therapy;Calcineurin Inhibitors;Cyclosporine*/administration & dosage;Cyclosporine*/adverse effects;Cyclosporine*/pharmacokinetics;Cyclosporine*/pharmacology;Drug Interactions;Drug Monitoring;Drug Therapy, Combination;Food-Drug Interactions;Graft Rejection/drug therapy;Humans;Immunosuppressive Agents*/administration & dosage;Immunosuppressive Agents*/adverse effects;Immunosuppressive Agents*/pharmacokinetics;Immunosuppressive Agents*/pharmacology;Kidney Transplantation
15951007;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Evidence-Based Medicine;Fatty Acids, Omega-3/adverse effects*;Fatty Acids, Omega-3/therapeutic use*;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Humans;Thrombosis/prevention & control*
15928257;Anticoagulants/administration & dosage*;Anticoagulants/therapeutic use;Diet, Reducing*;Dietary Carbohydrates*;Dietary Proteins*;Drug Monitoring;Food-Drug Interactions;Humans;Vitamin K/administration & dosage;Warfarin/administration & dosage*;Warfarin/therapeutic use
15917540;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/physiology;Female;Food-Drug Interactions;Humans;Male;Quinolines/administration & dosage;Quinolines/pharmacokinetics*
15911722;Anticoagulants/pharmacology*;Clinical Trials as Topic;Food-Drug Interactions*;Humans;Warfarin/pharmacology*
15911222;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Binding, Competitive;Biological Transport/drug effects;Caco-2 Cells;Cell Membrane Permeability/drug effects;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Organic Cation Transport Proteins/metabolism*;Propanolamines/pharmacokinetics*;Radioligand Assay
15903127;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Blotting, Western;Citrus paradisi*;Duodenum/metabolism;Food-Drug Interactions*;Genes, MDR/genetics;Humans;Male;Propanolamines/blood;Propanolamines/pharmacokinetics*;Propanolamines/urine;RNA, Messenger/analysis
15898148;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Azetidines/adverse effects;Azetidines/therapeutic use*;Benzylamines;Drug Approval;Elapid Venoms/chemistry;Food-Drug Interactions;Humans;Liver Failure/chemically induced*;Prodrugs/adverse effects;Prodrugs/therapeutic use*;Thrombosis/prevention & control*;United States;United States Food and Drug Administration
15889002;Absorption;Dietary Fiber/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
15885459;Acetaminophen/administration & dosage;Acetaminophen/blood*;Animals;Dogs;Fasting/metabolism;Food-Drug Interactions/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology*;Gastrointestinal Contents*/drug effects;Male;Milk/metabolism*;Predictive Value of Tests;Solubility;Time Factors
15854203;Animals;Anticholesteremic Agents/metabolism;Anticholesteremic Agents/therapeutic use*;Anticholesteremic Agents/toxicity;Clinical Trials as Topic;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/toxicity;Hypercholesterolemia/drug therapy*;Intestinal Absorption;Liver/metabolism;Quinolines/metabolism;Quinolines/therapeutic use*;Quinolines/toxicity;Treatment Outcome
15832116;Administration, Oral;Deglutition Disorders/drug therapy*;Deglutition Disorders/nursing;Delayed-Action Preparations;Drug Administration Schedule;Enteral Nutrition/adverse effects;Food-Drug Interactions;Humans;Intestinal Absorption
15831782;Adolescent;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Monosaccharides/blood;Monosaccharides/pharmacokinetics*;Monosaccharides/urine;Prodrugs/pharmacokinetics*;Triazoles/blood;Triazoles/pharmacokinetics*;Triazoles/urine
15831779;2-Pyridinylmethylsulfinylbenzimidazoles;Absorption;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Arthroplasty, Replacement, Hip*;Benzimidazoles/pharmacokinetics*;Benzimidazoles/pharmacology;Cross-Over Studies;Dabigatran;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Omeprazole/analogs & derivatives*;Omeprazole/pharmacology;Proton Pump Inhibitors;Pyridines/pharmacokinetics*;Sulfoxides/pharmacology;Thrombin/antagonists & inhibitors*
15831778;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects;Hydromorphone/pharmacokinetics*;Male
15824753;Aged;Aging/physiology;Anticoagulants/administration & dosage*;Anticoagulants/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases/genetics*;Blood Proteins/metabolism;Body Weight/physiology;Cytochrome P-450 CYP2C9;Demography;Drug Interactions;Female;Food-Drug Interactions;Genotype;Heart Valve Prosthesis;Humans;International Normalized Ratio;Male;Polymorphism, Genetic/genetics*;Regression Analysis;Serum Albumin/metabolism;Stereoisomerism;Warfarin/administration & dosage*;Warfarin/pharmacokinetics*
15823765;Administration, Oral;Adult;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions;Half-Life;Humans;Ibuprofen/pharmacokinetics*;Ibuprofen/therapeutic use;Intestinal Absorption;Male;Metabolic Clearance Rate;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Oxycodone/therapeutic use;Pain, Postoperative/drug therapy;Tablets;Therapeutic Equivalency
15811168;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi/chemistry;Citrus paradisi/metabolism*;Drinking;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Half-Life;Humans;Nifedipine/analogs & derivatives;Nifedipine/pharmacokinetics*;Nifedipine/pharmacology;Time Factors
15807982;Biological Availability;Biopharmaceutics/classification*;Biopharmaceutics/legislation & jurisprudence;Drug Approval/legislation & jurisprudence;Drug Evaluation, Preclinical/methods;Food-Drug Interactions;Guidelines as Topic;Humans;Intestinal Absorption;Solubility;Technology, Pharmaceutical/legislation & jurisprudence
15785395;Beverages*;Citrus/chemistry*;Cyclosporine/blood;Cyclosporine/pharmacology*;Food Labeling;Food-Drug Interactions*;Humans;Lung Transplantation
15785394;Adult;Beverages*;Citrus/chemistry;Contraindications;Cyclosporine/blood;Cyclosporine/pharmacology*;Diet;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/analysis;Furocoumarins/blood;Furocoumarins/pharmacology*;Humans;Lung Transplantation*;Male;Transplantation
15776510;Anticholesteremic Agents/metabolism*;Atorvastatin Calcium;Beverages/adverse effects;Citrus paradisi/adverse effects;Citrus paradisi/metabolism*;Food-Drug Interactions*;Heptanoic Acids/metabolism*;Humans;Pyrroles/metabolism*
15762767;Adolescent;Aging/metabolism;Animals;Biotransformation;Female;Food-Drug Interactions;Humans;Indoles/pharmacokinetics*;Indoles/therapeutic use;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Migraine Disorders/complications;Migraine Disorders/drug therapy*;Migraine Disorders/metabolism*;Receptor, Serotonin, 5-HT1B/metabolism*;Serotonin Receptor Agonists/pharmacokinetics*;Serotonin Receptor Agonists/therapeutic use;Sex Characteristics;Tissue Distribution;Tryptamines
15761758;Beverages;Citrus paradisi;Dietary Supplements;Food-Drug Interactions*;Humans;Pharmacokinetics;Pharmacopoeias as Topic/standards*;Spain
15755790;Aged;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/blood;Dietary Proteins/administration & dosage*;Dietary Proteins/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Warfarin/administration & dosage*;Warfarin/blood
15752382;Administration, Oral;Aged;Androstadienes/pharmacokinetics*;Antineoplastic Agents/pharmacokinetics*;Aromatase Inhibitors/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Fasting/metabolism*;Female;Food-Drug Interactions/physiology*;Humans;Middle Aged
15741841;Administration, Oral;Adult;Bicycling/physiology;Blood Glucose/metabolism;Breath Tests;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/metabolism*;Exercise/physiology*;Fatty Acids, Nonesterified/blood;Food-Drug Interactions/physiology*;Fructose/administration & dosage*;Fructose/metabolism*;Humans;Lactic Acid/blood;Male;Oxidation-Reduction;Oxygen Consumption/physiology;Physical Endurance/physiology;Polysaccharides/administration & dosage*;Polysaccharides/metabolism*
15735611;Administration, Oral;Adult;Area Under Curve;Biological Availability;Citrus paradisi/physiology*;Cross-Over Studies;Drinking;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Organic Anion Transporters/chemistry;Organic Anion Transporters/metabolism*;Peptides/chemistry;Peptides/metabolism*;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics*;Water/metabolism;Water/pharmacology
15734296;Adolescent;Adult;Biological Availability;Cross-Over Studies;Danazol/blood*;Danazol/pharmacokinetics;Dietary Fats/pharmacokinetics*;Drinking/physiology*;Eating/physiology*;Food-Drug Interactions/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Humans;Male;Solubility
15706008;Adult;Antitubercular Agents/therapeutic use*;Bacteriological Techniques;Cholesterol/blood;Cholesterol/deficiency*;Colony Count, Microbial;Combined Modality Therapy;Drug Administration Schedule;Drug Therapy, Combination;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Male;Mexico;Middle Aged;Mycobacterium tuberculosis/drug effects*;Sputum/microbiology;Treatment Outcome;Tuberculosis, Pulmonary/blood;Tuberculosis, Pulmonary/diet therapy*;Tuberculosis, Pulmonary/microbiology
15683768;Animals;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Camelus/metabolism*;Chromatography, High Pressure Liquid/veterinary;Cross-Over Studies;Food-Drug Interactions*;Intestinal Absorption;Phenylbutazone/blood;Phenylbutazone/pharmacokinetics*;Poaceae*
15682573;Anticoagulants/agonists;Benzodiazepines/agonists;Beverages/adverse effects*;Calcium Channel Blockers/blood;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Food-Drug Interactions*;Humans;Warfarin/agonists
15673597;Animals;Anticonvulsants/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages*;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Oxidoreductases, N-Demethylating/metabolism*;Punicaceae*;Rats;Rats, Wistar;Spectrophotometry, Ultraviolet
15661483;Acquired Immunodeficiency Syndrome/complications*;Acquired Immunodeficiency Syndrome/drug therapy;Acquired Immunodeficiency Syndrome/epidemiology;Africa South of the Sahara/epidemiology;Antiviral Agents/therapeutic use;Botswana/epidemiology;Food-Drug Interactions;HIV Infections/complications*;HIV Infections/drug therapy;HIV Infections/epidemiology;Humans;Nutrition Disorders/complications*;Nutrition Disorders/epidemiology;Nutritional Physiological Phenomena*;South Africa/epidemiology;Uganda/epidemiology
15658364;Biomarkers/blood;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/blood*;Immunosuppressive Agents/pharmacokinetics;Reference Values;Specimen Handling;Tacrolimus/administration & dosage;Tacrolimus/adverse effects*;Tacrolimus/blood*;Tacrolimus/pharmacokinetics
15658363;Aging/metabolism;Biomarkers/blood;Chromatography, High Pressure Liquid;Cyclosporine/administration & dosage;Cyclosporine/adverse effects;Cyclosporine/blood*;Dosage Forms;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Immunoassay/methods;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/blood*;Kidney Diseases/metabolism;Liver Diseases/metabolism;Specimen Handling
15658353;ATP-Binding Cassette, Sub-Family B, Member 1;Anti-Allergic Agents/administration & dosage*;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/blood*;Anti-Allergic Agents/pharmacokinetics;Aryl Hydrocarbon Hydroxylases;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Specimen Handling;Spectrophotometry
15658352;Aging/metabolism;Asthma/drug therapy;Asthma/metabolism;Biomarkers/blood;Bronchodilator Agents/administration & dosage*;Bronchodilator Agents/blood*;Bronchodilator Agents/pharmacokinetics;Bronchodilator Agents/poisoning;Dosage Forms;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Half-Life;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Placental Lactogen;Reference Values;Smoking/adverse effects;Specimen Handling;Theophylline/administration & dosage*;Theophylline/blood*;Theophylline/poisoning
15658346;Anti-Inflammatory Agents, Non-Steroidal/blood*;Antirheumatic Agents/blood*;Aspirin/blood*;Aspirin/poisoning;Biomarkers/blood;Chromatography, High Pressure Liquid;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Salicylic Acid/blood*;Salicylic Acid/poisoning;Specimen Handling
15658338;Aging/metabolism;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood*;Anticonvulsants/poisoning;Biomarkers/blood;Chromatography, Gas;Chromatography, High Pressure Liquid;Clonazepam/administration & dosage;Clonazepam/adverse effects;Clonazepam/blood*;Clonazepam/poisoning;Diazepam/administration & dosage;Diazepam/adverse effects;Diazepam/blood*;Diazepam/poisoning;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Nitrazepam/administration & dosage;Nitrazepam/adverse effects;Nitrazepam/blood*;Nitrazepam/poisoning;Reference Values;Specimen Handling;Treatment Refusal
15647414;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Delayed-Action Preparations*;Didanosine/administration & dosage;Didanosine/metabolism;Didanosine/pharmacokinetics*;Drug Administration Schedule;Drug Interactions*;Drug Therapy, Combination;Female;Food-Drug Interactions;Half-Life;Healthy Volunteers;Humans;Indinavir/administration & dosage;Indinavir/pharmacokinetics*;Indinavir/pharmacology;Male;Reproducibility of Results;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Ritonavir/pharmacology;Therapeutic Equivalency
15645735;Arteriosclerosis/etiology;Arteriosclerosis/prevention & control;Body Weight;Citrus paradisi/adverse effects;Diet, Protein-Restricted/methods;Exercise Therapy/methods;Exercise Therapy/standards;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Kidney Failure, Chronic/complications*;Kidney Failure, Chronic/therapy*;Kidney Transplantation*;Life Style*;Metabolic Syndrome/complications*;Metabolic Syndrome/therapy;Water-Electrolyte Imbalance/etiology;Water-Electrolyte Imbalance/prevention & control
15643550;Adult;Area Under Curve;Biological Availability;Boswellia*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats*;Eating*;Food-Drug Interactions;Humans;Male;Phytotherapy*;Plant Extracts/pharmacokinetics;Postprandial Period;Reference Values
15640499;Consumer Behavior;Flavonoids/adverse effects*;Food-Drug Interactions;Humans;Phenols/adverse effects*;Polyphenols;Taste/drug effects*;Thiourea/pharmacology;Wine*
15635366;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Blood Pressure/drug effects*;Cheese;Depression/drug therapy;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Nutrition Policy*;Tyramine/administration & dosage*;United States
15635350;Adolescent;Adult;Analysis of Variance;Child;Child Development/drug effects;Child Nutritional Physiological Phenomena;Child, Preschool;Chronic Disease/therapy*;Dietary Supplements/adverse effects*;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Male;Parents;Physician-Patient Relations;Prevalence;Prognosis;Surveys and Questionnaires;Treatment Outcome
15635347;Aged;Dietary Supplements/adverse effects;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Nutrition Surveys;Prevalence
15635346;Aged;Aged, 80 and over;Cohort Studies;Diet;Diet Records;Dietary Supplements/adverse effects;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Linear Models;Male;Middle Aged;Nutrition Surveys;Retrospective Studies;Risk Factors;United States
15635342;Child;Child Health Services;Chronic Disease/therapy;Communication;Complementary Therapies/adverse effects*;Complementary Therapies/methods*;Complementary Therapies/standards;Complementary Therapies/utilization;Dietary Supplements/utilization*;Disabled Children/statistics & numerical data*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Professional-Family Relations*;Treatment Outcome
15621963;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/blood*;Atorvastatin Calcium;Beverages;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Heptanoic Acids/adverse effects;Heptanoic Acids/blood*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/blood*;Rhabdomyolysis/blood*;Rhabdomyolysis/etiology
15605125;Absorption;Animals;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Butter*;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Male;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits
15595979;Beverages/history*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/history;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;History, 20th Century;Humans
15592332;Adult;Area Under Curve;Biological Availability;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology*;Capsules;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Delayed-Action Preparations;Felodipine/pharmacokinetics;Felodipine/pharmacology*;Female;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/pharmacology*;Humans;Male;Spectrophotometry, Ultraviolet
15577230;Administration, Oral;Animals;Dietary Supplements*;Food-Drug Interactions/physiology*;Ginkgo biloba*;Male;Nifedipine/administration & dosage;Nifedipine/pharmacokinetics*;Plant Extracts/metabolism;Plant Leaves;Rats;Rats, Wistar
15577221;Administration, Oral;Adult;Dietary Supplements*;Food-Drug Interactions/physiology*;Ginkgo biloba*;Humans;Male;Middle Aged;Nifedipine/administration & dosage;Nifedipine/metabolism*;Plant Extracts/administration & dosage;Plant Extracts/metabolism;Plant Leaves
15576015;Adult;Appetite Depressants/metabolism;Appetite Depressants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclobutanes/metabolism;Cyclobutanes/pharmacokinetics*;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Male;Middle Aged;Pilot Projects
15571938;Adult;Adverse Drug Reaction Reporting Systems/classification;Adverse Drug Reaction Reporting Systems/organization & administration;Critical Care/methods*;Critical Care/standards;Critical Illness/therapy*;Drug Information Services/organization & administration;Food-Drug Interactions*;Humans;Incidence;Information Dissemination;Intestinal Absorption;Monitoring, Physiologic;Nurse's Role;Nutritional Status;Nutritional Support/methods*;Nutritional Support/standards;Pharmacy and Therapeutics Committee/organization & administration;Primary Prevention
15570603;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Citrus;Food-Drug Interactions/physiology*;Fruit*;Histamine H1 Antagonists/pharmacokinetics*;Intestinal Absorption;Male;Malus;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
15568891;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Drug Resistance, Multiple;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Intestinal Absorption
15561855;Adolescent;Adult;Aged;Aged, 80 and over;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use*;Area Under Curve;Bronchitis/drug therapy;Bronchitis/microbiology;Community-Acquired Infections/drug therapy*;Community-Acquired Infections/metabolism*;Drug Interactions;Female;Fluoroquinolones/pharmacokinetics*;Fluoroquinolones/therapeutic use*;Food-Drug Interactions;Humans;Male;Mass Spectrometry;Middle Aged;Models, Biological;Pneumonia/drug therapy;Pneumonia/microbiology;Population;Reproducibility of Results;Respiratory Tract Infections/drug therapy*;Respiratory Tract Infections/metabolism*;Sinusitis/drug therapy;Sinusitis/microbiology
15542101;Animals;Antimalarials/administration & dosage*;Antimalarials/therapeutic use;Artemisinins/administration & dosage*;Artemisinins/therapeutic use;Beverages;Citrus paradisi*;Cytochrome P-450 Enzyme System/metabolism;Cytochromes b5/metabolism;Food-Drug Interactions*;Liver/enzymology*;Liver/parasitology;Liver/pathology;Liver Function Tests;Male;Mice;Mice, Inbred Strains;Models, Animal;Schistosomiasis mansoni/drug therapy*;Schistosomiasis mansoni/enzymology;Schistosomiasis mansoni/pathology;Sesquiterpenes/administration & dosage*;Sesquiterpenes/therapeutic use
15536460;Administration, Oral;Adult;Alfentanil/administration & dosage*;Alfentanil/pharmacology;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacology;Anti-Bacterial Agents/pharmacokinetics;Antibiotics, Antitubercular/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Biological Availability;Citrus/chemistry;Cross-Over Studies;Cytochrome P-450 CYP3A;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Liver/enzymology*;Male;Mass Spectrometry;Oxidoreductases, N-Demethylating/metabolism*;Pupil/drug effects*;Rifampin/pharmacokinetics;Troleandomycin/pharmacokinetics
15531381;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Blotting, Western;Cell Line, Transformed;Cell Survival/drug effects;Citrus*;Dose-Response Relationship, Drug;Electrophoresis, Polyacrylamide Gel;Flavanones/pharmacology;Fluoresceins/metabolism;Food-Drug Interactions;Humans;Kaempferols/pharmacology;Kidney Tubules, Proximal/cytology;Kidney Tubules, Proximal/drug effects*;Kidney Tubules, Proximal/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction
15531008;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacology;Fasting*;Female;Fenofibrate/administration & dosage;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Middle Aged;Randomized Controlled Trials as Topic;Tablets
15525560;Administration, Oral;Adult;Aminosalicylic Acid/administration & dosage;Antacids/metabolism*;Antitubercular Agents/administration & dosage;Beverages*;Biological Availability;Citrus sinensis;Clofazimine/blood;Clofazimine/pharmacokinetics*;Cross-Over Studies;Cycloserine/administration & dosage;Dietary Fats;Drug Combinations;Drug Interactions;Ethionamide/administration & dosage;Food*;Food-Drug Interactions;Humans;Leprostatic Agents/blood;Leprostatic Agents/pharmacokinetics*;Pyridoxine/administration & dosage
15510379;Diabetes Mellitus/drug therapy*;Drug Interactions;Drug Labeling;Drug Therapy, Combination;Food-Drug Interactions*;Humans;Pharmacies;United States
15509187;Adult;Allylamine/analogs & derivatives*;Allylamine/pharmacology*;Area Under Curve;Colesevelam Hydrochloride;Cross-Over Studies;Drug Administration Schedule;Drug Interactions;Female;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions;Half-Life;Humans;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Time Factors
15508534;Food-Drug Interactions*;Humans;International Normalized Ratio;Soy Milk*;Warfarin*
15504753;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Antineoplastic Agents, Phytogenic/pharmacokinetics;Beverages*;Biological Transport, Active/drug effects;Caco-2 Cells;Calcium Channel Blockers/pharmacology;Citrus/chemistry*;Cyclosporine/pharmacology;Food-Drug Interactions;HIV Protease Inhibitors/pharmacokinetics;Humans;Immunosuppressive Agents/pharmacology;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism*;Multidrug Resistance-Associated Proteins/genetics;Multidrug Resistance-Associated Proteins/metabolism*;Plant Extracts/chemistry;Propionates/pharmacology;Quinolines/pharmacology;Saquinavir/pharmacokinetics;Transfection;Verapamil/pharmacology;Vinblastine/pharmacokinetics
15497788;Acenocoumarol/adverse effects;Acenocoumarol/pharmacokinetics*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Routes;Enteral Nutrition/adverse effects*;Food, Formulated;Food-Drug Interactions*;Humans
15488686;Absorption/drug effects;Administration, Oral;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Area Under Curve;Biological Availability*;Capsules/administration & dosage;Capsules/chemistry;Capsules/pharmacokinetics;Chemistry, Pharmaceutical/methods*;Clinical Trials, Phase I as Topic;Clinical Trials, Phase II as Topic;Dogs;Drug Administration Schedule;Drug Evaluation, Preclinical;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Models, Animal;Morpholines/metabolism;Morpholines/pharmacology*;Morpholines/therapeutic use;Nanostructures/chemistry*;Nausea/chemically induced;Nausea/prevention & control;Substance P/antagonists & inhibitors;Substance P/metabolism;Substance P/pharmacology;Tablets/administration & dosage;Tablets/chemistry;Tablets/pharmacokinetics;Technology, Pharmaceutical/methods;Technology, Pharmaceutical/trends;Upper Gastrointestinal Tract/drug effects;Upper Gastrointestinal Tract/metabolism;Vomiting/chemically induced;Vomiting/prevention & control
15482171;Acetamides/chemistry;Acetamides/pharmacokinetics;Acetamides/pharmacology*;Acetamides/therapeutic use;Animals;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/therapeutic use;Bacteria/drug effects;Clinical Trials as Topic;Food-Drug Interactions;Humans;Linezolid;Methicillin Resistance;Oxazolidinones/chemistry;Oxazolidinones/pharmacokinetics;Oxazolidinones/pharmacology*;Oxazolidinones/therapeutic use;Pneumonia/drug therapy
15475676;Adaptation, Psychological;Adult;Aged;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Therapy, Combination;Feeding Behavior/psychology;Female;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/psychology;Health Knowledge, Attitudes, Practice;Homosexuality, Male/psychology;Humans;Male;Middle Aged;Personality Inventory/statistics & numerical data;Psychometrics;Statistics as Topic;Stress, Psychological/complications;Treatment Refusal/psychology*
15459052;Drug Administration Schedule;Fasting*;Food-Drug Interactions;Humans;Islam*;Pharmaceutical Preparations/administration & dosage*
15456329;Adolescent;Adult;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal*/metabolism;Anti-Inflammatory Agents, Non-Steroidal*/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use;Arthritis, Rheumatoid/drug therapy*;Butanones*/metabolism;Butanones*/pharmacokinetics;Butanones*/therapeutic use;Child;Child, Preschool;Clinical Trials as Topic;Cyclooxygenase Inhibitors*/adverse effects;Cyclooxygenase Inhibitors*/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Osteoarthritis/drug therapy*;Stomach Diseases/chemically induced*
15451546;Administration, Oral;Adult;Biological Availability;Bornanes/administration & dosage*;Bornanes/blood;Bornanes/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Tablets, Enteric-Coated
15449971;Beverages*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Food-Drug Interactions*;Humans
15387721;Animals;Diabetes Complications/drug therapy;Diosmin/therapeutic use*;Food-Drug Interactions;Hemorrhoids/drug therapy;Humans;Lymphedema/drug therapy;Neoplasms/prevention & control;Varicose Veins/drug therapy;Venous Insufficiency/drug therapy
15384254;Administration, Oral;Animals;Body Weight/drug effects;Diet;Dose-Response Relationship, Drug;Female;Fetal Resorption/chemically induced;Fetal Weight/drug effects;Food Deprivation;Food-Drug Interactions;Insecticides/administration & dosage;Insecticides/toxicity*;Maternal Exposure*;Methyl Parathion/administration & dosage;Methyl Parathion/toxicity*;Placenta/drug effects*;Placenta/pathology;Pregnancy;Rats;Rats, Wistar
15383641;Adult;Anticoagulants*/metabolism;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Area Under Curve;Arthroplasty, Replacement, Hip*;Arthroplasty, Replacement, Knee*;Azetidines*/metabolism;Azetidines*/pharmacokinetics;Azetidines*/therapeutic use;Benzylamines;Biological Availability;Clinical Trials as Topic;Food-Drug Interactions;Half-Life;Humans;Male;Venous Thrombosis/drug therapy*
15381495;Anticoagulants/administration & dosage*;Food-Drug Interactions*;Humans;International Normalized Ratio;Vegetables/chemistry;Vitamin K/administration & dosage*;Vitamin K/antagonists & inhibitors;Warfarin/administration & dosage*
15355126;Adult;Aged;Animals;Anti-Inflammatory Agents*/pharmacokinetics;Anti-Inflammatory Agents*/pharmacology;Anti-Inflammatory Agents*/therapeutic use;Area Under Curve;Biological Availability;Budesonide*/pharmacokinetics;Budesonide*/pharmacology;Budesonide*/therapeutic use;Capsules;Crohn Disease/drug therapy*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Randomized Controlled Trials as Topic;Rats
15354763;Appetite/drug effects;Ethanol/pharmacology;Food-Drug Interactions*;Humans;Nutritional Status/drug effects
15346578;Anti-Allergic Agents/adverse effects;Dietary Supplements;Drug Interactions*;Food-Drug Interactions;Polypharmacy*;Terfenadine/adverse effects
15332505;Administration, Oral;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Ibuprofen/pharmacokinetics*;Male;Rabbits
15329598;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/pharmacology*;Antibiotics, Antitubercular/pharmacology;Antiemetics/pharmacology;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Chromatography, High Pressure Liquid;Citrus;Cross-Over Studies;Cytochrome P-450 CYP3A;Drug Interactions;Female;Fentanyl/administration & dosage;Fentanyl/analogs & derivatives*;Fentanyl/blood;Fentanyl/pharmacokinetics*;Fentanyl/pharmacology*;Food-Drug Interactions;Half-Life;Humans;Intestines/enzymology*;Liver/enzymology*;Male;Oxidoreductases, N-Demethylating/metabolism*;Pupil/drug effects;Rifampin/pharmacology;Spectrometry, Mass, Electrospray Ionization;Troleandomycin/pharmacology
15315110;Absorption;Beverages;Citrus paradisi;Ethanol/pharmacology;Fatty Acids/pharmacology;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*
15311686;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/therapeutic use*;Adolescent;Adult;Aged;B-Lymphocytes/drug effects;B-Lymphocytes/immunology;B-Lymphocytes/radiation effects;Benzimidazoles/administration & dosage;Benzimidazoles/therapeutic use*;Child;Combined Modality Therapy;Diet Therapy/methods;Food-Drug Interactions*;Humans;Middle Aged;Psoriasis*/diet therapy;Psoriasis*/drug therapy;Psoriasis*/immunology;Radioactive Pollutants/adverse effects*;Radioisotopes;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;T-Lymphocytes/radiation effects;Treatment Outcome;Ukraine
15309441;Animals;Antineoplastic Agents/administration & dosage*;Apoptosis;Caspase 3;Caspases/metabolism;Colonic Neoplasms/chemically induced;Colonic Neoplasms/epidemiology;Colonic Neoplasms/prevention & control*;Cyclooxygenase 2;Dietary Fats, Unsaturated/administration & dosage*;Disease Models, Animal;Dose-Response Relationship, Drug;Fatty Acids, Unsaturated/analysis;Fatty Acids, Unsaturated/blood;Food-Drug Interactions*;Gene Expression Regulation;Gene Expression Regulation, Enzymologic;Genes, bcl-2;Incidence;Intestinal Mucosa/enzymology;Intestinal Mucosa/pathology;Isoenzymes/metabolism;Liver/chemistry;Male;Olive Oil;Plant Oils/administration & dosage;Plant Oils/chemistry;Prostaglandin-Endoperoxide Synthases/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Soybean Oil/administration & dosage;Soybean Oil/chemistry;Sulindac/administration & dosage*
15291376;Angiotensin II Type 1 Receptor Blockers;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Antihypertensive Agents/therapeutic use;Blood Pressure/drug effects;Clinical Trials as Topic;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/drug therapy*;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazoles/therapeutic use;Olmesartan Medoxomil;Patient Compliance;Receptor, Angiotensin, Type 1/metabolism;Tetrazoles/administration & dosage;Tetrazoles/adverse effects;Tetrazoles/pharmacokinetics*;Tetrazoles/therapeutic use
15230341;Adult;Area Under Curve;Biological Availability;Cefaclor/administration & dosage*;Cefaclor/pharmacokinetics*;Cephalosporins/administration & dosage*;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Fat-Restricted;Diet, Vegetarian;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Linear Models;Male;Oryza;Triticum
15211967;Acenocoumarol/pharmacokinetics;Acenocoumarol/therapeutic use*;Aged;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Monitoring, Physiologic;Protein Binding
15206993;Adult;Anticholesteremic Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Simvastatin/analogs & derivatives*;Simvastatin/metabolism;Simvastatin/pharmacokinetics*
15206986;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Male;Middle Aged;Muscarinic Antagonists/pharmacokinetics*;Quinuclidines/pharmacokinetics*;Solifenacin Succinate;Tetrahydroisoquinolines/pharmacokinetics*
15187690;Anticoagulants/pharmacology*;Food-Drug Interactions;Humans;Tea/chemistry*;Vitamin K/pharmacology*;Warfarin/pharmacology*
15179411;Adult;Area Under Curve;Beverages*;Caco-2 Cells;Citrus paradisi/metabolism*;Confidence Intervals;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Felodipine/pharmacokinetics;Female;Food-Drug Interactions/physiology*;Furocoumarins/pharmacokinetics*;Humans;Male;Plant Extracts/pharmacokinetics
15175418;Acetylcholine;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Animals;Blood Vessels/drug effects*;Blood Vessels/physiology;Food-Drug Interactions;Lisinopril/pharmacology;Prostaglandins/physiology;Rats;Rats, Wistar;Sodium/urine;Sodium, Dietary/pharmacology*;Vasodilation/drug effects*;Vasodilation/physiology
15158901;Animals;Dogs;Food-Drug Interactions/physiology*;Solubility/drug effects;Tablets/chemistry*;Tablets/pharmacokinetics
15151167;Acetaminophen/pharmacokinetics*;Adult;Beverages*;Food-Drug Interactions/physiology;Hibiscus*;Humans;Male;Plant Extracts/isolation & purification;Plant Extracts/pharmacokinetics;Water/metabolism
15142337;Animals;Chemical Phenomena;Chemistry, Physical;Dietary Sucrose;Fasting;Food*;Food, Formulated;Food-Drug Interactions;Hydrogen-Ion Concentration;Milk/chemistry;Pectins/chemistry;Pharmacokinetics;Postprandial Period*;Solubility;Stomach/chemistry*;United States;United States Food and Drug Administration;Viscosity;Vitamin K/chemistry
15134377;Adult;Alcohol Drinking/metabolism*;Cholesterol, HDL/blood*;Cholesterol, LDL/blood*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Glutathione Peroxidase/metabolism;Humans;Male;Oxidative Stress/drug effects*;Postprandial Period*;Time Factors;Wine*
15132100;Anticholesteremic Agents/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Rhabdomyolysis/chemically induced*;Simvastatin/adverse effects*
15124981;Adult;Area Under Curve;CDC2-CDC28 Kinases/antagonists & inhibitors;Cross-Over Studies;Cyclin E/antagonists & inhibitors;Cyclin-Dependent Kinase 2;Dose-Response Relationship, Drug;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Purines/blood;Purines/pharmacokinetics*;Purines/urine;Stereoisomerism;Tissue Distribution
15121498;Administration, Oral;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Diet*;Drug Monitoring;Food-Drug Interactions*;Humans;Phenprocoumon/pharmacology;Vitamin K/chemistry;Vitamin K/pharmacology*;Warfarin/pharmacology
15121490;Administration, Oral;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Case-Control Studies;Cross-Over Studies;Diet*;Drug Monitoring;Female;Food-Drug Interactions*;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Observation;Phenprocoumon/pharmacology;Prospective Studies;Vitamin K/pharmacology*;Warfarin/pharmacology
15118259;Animals;Arteriosclerosis/drug therapy;Arteriosclerosis/prevention & control;Cholesterol/biosynthesis;Cholesterol, VLDL/secretion;Citrus paradisi;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Drug Therapy, Combination;Fenofibrate/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Quinolines/chemistry;Quinolines/pharmacokinetics;Quinolines/pharmacology*;Quinolines/therapeutic use;Receptors, LDL/metabolism;Triglycerides/metabolism
15100064;Carbolines/adverse effects;Carbolines/therapeutic use*;Drug Interactions;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Imidazoles/adverse effects;Imidazoles/therapeutic use*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use*;Piperazines/adverse effects;Piperazines/therapeutic use*;Purines;Sildenafil Citrate;Sulfones;Tadalafil;Triazines;Vardenafil Dihydrochloride
15098799;2-Hydroxypropyl-beta-cyclodextrin;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Cyclodextrins;Female;Food-Drug Interactions*;Humans;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Pharmaceutical Solutions;beta-Cyclodextrins*
15049723;Drug Interactions;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/pharmacology;Fluorobenzenes/therapeutic use*;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hyperlipidemias/drug therapy*;Metabolic Clearance Rate;Pyrimidines/pharmacokinetics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Randomized Controlled Trials as Topic;Rosuvastatin Calcium;Sulfonamides/pharmacokinetics;Sulfonamides/pharmacology;Sulfonamides/therapeutic use*
15036167;Adult;Aged;Area Under Curve;Dietary Proteins/blood*;Female;Food-Drug Interactions/physiology*;Humans;Levodopa/blood*;Levodopa/therapeutic use;Male;Middle Aged;Parkinson Disease/blood*;Parkinson Disease/drug therapy*;Statistics, Nonparametric
15035576;Aged*;Food-Drug Interactions*;Humans;Patient Education as Topic*;Patient Selection*
15033405;Chemistry, Pharmaceutical;Contraceptives, Oral, Combined/administration & dosage*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/adverse effects;Female;Food-Drug Interactions;Humans;Nausea/chemically induced;Norethindrone/administration & dosage;Randomized Controlled Trials as Topic
15017321;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/metabolism;Aryl Hydrocarbon Hydroxylases/genetics;Community Health Nursing/methods;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods;Drug Monitoring/nursing;Food-Drug Interactions;Home Care Services;Humans;International Normalized Ratio;Liver/metabolism;Metabolic Clearance Rate;Patient Education as Topic/methods;Prothrombin Time;Vitamin K*/administration & dosage;Vitamin K*/adverse effects;Warfarin*/administration & dosage;Warfarin*/adverse effects;Warfarin*/metabolism
15011605;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage;Ritonavir/adverse effects
15011592;Acquired Immunodeficiency Syndrome/drug therapy*;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions/physiology*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics;Humans;Multicenter Studies as Topic;Nelfinavir/administration & dosage*;Nelfinavir/pharmacokinetics;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage*;Ritonavir/pharmacokinetics
15001969;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Biological Availability;Celiprolol/antagonists & inhibitors*;Celiprolol/blood;Celiprolol/pharmacokinetics*;Celiprolol/urine;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Receptors, Adrenergic, beta/metabolism;Statistics, Nonparametric
14986824;DNA Methylation*;Diet*;Female;Food-Drug Interactions;Gene Expression Regulation*;Humans;Maternal Nutritional Physiological Phenomena;Neoplasms/genetics*;Pregnancy;S-Adenosylhomocysteine/metabolism;S-Adenosylmethionine/metabolism;Schizophrenia/genetics*
14980003;Animals;Antimalarials/adverse effects;Antimalarials/blood;Antimalarials/metabolism*;Blood Proteins/metabolism*;Electrocardiography/drug effects;Fasting;Food-Drug Interactions;Lipoproteins/metabolism*;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism;Phenanthrenes/adverse effects;Phenanthrenes/blood;Phenanthrenes/metabolism*;Postprandial Period;Protein Binding;Rabbits
14979675;Administration, Oral;Animals;Area Under Curve;Beverages;Citrus*;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dogs/metabolism*;Food-Drug Interactions;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male
14973309;Administration, Oral;Adult;Antiviral Agents/adverse effects;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics;Antiviral Agents/urine;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Ribavirin/adverse effects;Ribavirin/analogs & derivatives*;Ribavirin/blood;Ribavirin/pharmacokinetics*;Ribavirin/urine;Time Factors
14765835;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Beverages*;Food-Drug Interactions*;Humans;Male;Reference Values;Vaccinium macrocarpon*;Warfarin/blood;Warfarin/pharmacology*
14765833;Anticoagulants/administration & dosage;Anticoagulants/metabolism*;Anticoagulants/pharmacology;Anticoagulants/therapeutic use;Continental Population Groups*;Cytochrome P-450 Enzyme System/genetics;Food-Drug Interactions;Humans;Warfarin/administration & dosage;Warfarin/metabolism*;Warfarin/pharmacology;Warfarin/therapeutic use
14758049;Administration, Oral;Adult;Drug Administration Schedule;Drug Combinations;Female;Food-Drug Interactions;Humans;Lopinavir;Male;Middle Aged;Models, Biological;Postprandial Period;Protease Inhibitors/blood;Protease Inhibitors/pharmacokinetics*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Ritonavir/pharmacokinetics*;Time Factors
14748822;Administration, Oral;Adolescent;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Male;Middle Aged;Tablets;Triazoles/blood;Triazoles/pharmacokinetics*
14747426;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/chemistry;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Dexmethylphenidate Hydrochloride*;Fasting;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Methylphenidate/analogs & derivatives*;Methylphenidate/blood;Methylphenidate/chemistry;Methylphenidate/pharmacokinetics*;Postprandial Period;Stereoisomerism;Therapeutic Equivalency
14735231;Administration, Oral;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Hydrogen-Ion Concentration;Male;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits
14734983;Food-Drug Interactions*;Humans;Infusions, Intravenous/adverse effects*;Infusions, Intravenous/nursing;Injections, Intravenous/adverse effects*;Injections, Intravenous/nursing;Parenteral Nutrition, Total/adverse effects*;Parenteral Nutrition, Total/nursing
14706809;Animals;Biological Transport/genetics;Food-Drug Interactions/genetics;Genomics*/methods;Humans;Intestinal Absorption/genetics*;Membrane Transport Proteins/biosynthesis;Membrane Transport Proteins/genetics*;Oligonucleotide Array Sequence Analysis/methods*;Pharmaceutical Preparations/metabolism*
14684645;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Fatal Outcome;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced;Heart Diseases/chemically induced;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Male;Pericardium;Vaccinium macrocarpon*;Warfarin/adverse effects*
14679681;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Food-Drug Interactions*;Garlic/adverse effects*;Humans;International Normalized Ratio;Male;Phenindione/adverse effects*;Phenindione/analogs & derivatives*
14679360;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Beverages*;Biological Availability;Calcium Channel Blockers/metabolism;Central Nervous System Agents/metabolism;Citrus paradisi/chemistry;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects;Pharmacokinetics
14675888;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects*;Diagnosis, Differential;Electrocardiography;Food-Drug Interactions;Heart Block/chemically induced*;Heart Block/diagnosis*;Heart Block/physiopathology;Honey/adverse effects*;Humans;Male;Middle Aged;Verapamil/administration & dosage;Verapamil/adverse effects*
14672861;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Environmental Exposure/adverse effects*;Female;Food-Drug Interactions*;Humans;Lead Poisoning/etiology*;New South Wales;Nutritional Status*;Pregnancy;Pregnancy Complications/etiology;Public Health;Trace Elements/administration & dosage;Vitamins/administration & dosage
14653226;Adult;Benzodiazepines/administration & dosage;Benzodiazepines/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Tolerance;Fasting;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Random Allocation;Therapeutic Equivalency;Time Factors
14644581;Delayed-Action Preparations/metabolism;Dietary Fats/metabolism*;Drug Evaluation, Preclinical/methods;Food-Drug Interactions/physiology*;Polysaccharides/metabolism*;Solubility/drug effects
14641551;ATP Binding Cassette Transporter, Sub-Family B/physiology;Beverages*;Biological Availability;Food-Drug Interactions/physiology*;Fruit*;Humans;Organic Anion Transporters/antagonists & inhibitors;Pharmacokinetics
14629735;Acetaminophen/chemistry*;Adsorption;Analgesics, Non-Narcotic/chemistry*;Charcoal/chemistry*;Chromatography, High Pressure Liquid;Food*;Food-Drug Interactions;Hydrogen-Ion Concentration;Ice Cream;Surface Properties;Yogurt
14616409;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Voriconazole
14606933;Administration, Oral;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/analogs & derivatives*;Tacrolimus/pharmacokinetics*
14587961;Administration, Oral;Animals;Anti-Ulcer Agents/pharmacokinetics;Anti-Ulcer Agents/pharmacology*;Anti-Ulcer Agents/therapeutic use;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions;Gastric Acid/secretion;Humans;Injections, Intravenous;Peptic Ulcer/drug therapy*;Peptic Ulcer/physiopathology;Proton Pump Inhibitors*;Proton Pumps/metabolism
14585065;Antihypertensive Agents/pharmacokinetics*;Antihypertensive Agents/therapeutic use;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions*;Food-Drug Interactions;Humans;Hypertension/drug therapy*;Risk Factors
14576716;Adult;Adverse Drug Reaction Reporting Systems;Age Factors;Aged;California;Diet*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Educational Status;Female;Food-Drug Interactions;Health Maintenance Organizations/statistics & numerical data*;Humans;Male;Middle Aged;Nutrition Surveys;Risk Factors;Sex Factors
14574774;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use*;Netherlands;Phenelzine/adverse effects;Phenelzine/therapeutic use;Secondary Prevention;Time Factors;Tranylcypromine/adverse effects;Tranylcypromine/therapeutic use
14572860;Antitubercular Agents/administration & dosage*;Antitubercular Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Drug Evaluation, Preclinical/methods;Food-Drug Interactions/physiology*;Oils/pharmacokinetics;Rifampin/administration & dosage*;Rifampin/pharmacokinetics*
14571304;Age Factors;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/pharmacology;Azetidines/pharmacokinetics*;Azetidines/pharmacology;Clinical Trials as Topic;Drug Interactions;Ethnic Groups;Ezetimibe;Food-Drug Interactions;Humans;Intestinal Absorption;Sex Factors
14571284;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Honey*;Humans;Male
14564940;Adult;Animals;Area Under Curve;Ascorbic Acid/administration & dosage;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics;Biological Availability;Cross-Over Studies;Dairy Products*;Deficiency Diseases/blood;Deficiency Diseases/prevention & control*;Dietary Supplements*;Female;Folic Acid/administration & dosage;Folic Acid/blood;Folic Acid/pharmacokinetics;Food-Drug Interactions;Humans;Intestinal Absorption;Iron, Dietary/administration & dosage;Iron, Dietary/blood;Iron, Dietary/pharmacokinetics;Micronutrients/administration & dosage;Micronutrients/blood;Micronutrients/pharmacokinetics*;Middle Aged;Zinc/administration & dosage;Zinc/blood;Zinc/pharmacokinetics
14558393;Dietary Supplements*/adverse effects;Drug Interactions;Food-Drug Interactions;Humans;Physician-Patient Relations
14533574;Drug Interactions*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Nurse's Role;Patient Education as Topic;Phytotherapy/adverse effects*;Preoperative Care/methods*;Preoperative Care/nursing;Surgery, Plastic/nursing;Time Factors
14531725;Administration, Oral;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Atorvastatin Calcium;Biological Availability;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions;Gastrointestinal Tract/metabolism;Heptanoic Acids/administration & dosage;Heptanoic Acids/pharmacokinetics*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Liver/metabolism;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
14531721;Beverages;Biological Availability;Biological Transport;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Carriers/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
14531370;Adolescent;Adult;Aged;Anesthetics/administration & dosage;Anesthetics/adverse effects;Anesthetics/metabolism;Dietary Supplements*/adverse effects;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Preanesthetic Medication/adverse effects;Surveys and Questionnaires
14527091;Analysis of Variance;Area Under Curve;Biological Availability;Cefaclor/blood;Cefaclor/pharmacokinetics*;Cross-Over Studies;Diet, Vegetarian*;Dietary Fats/blood;Dietary Fats/pharmacokinetics*;Fasting/blood;Fasting/metabolism*;Food-Drug Interactions/physiology*;Humans;Male;Statistics, Nonparametric
14527090;Adult;Area Under Curve;Biological Availability;Food-Drug Interactions/physiology*;Fruit/metabolism;Humans;Ibuprofen/blood*;Ibuprofen/pharmacokinetics*;Male;Plant Extracts/pharmacokinetics;Tamarindus*
14518700;Adult;Cross-Over Studies;Drug Administration Schedule;Drug Therapy, Combination;Fasting;Food*;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Indinavir/pharmacokinetics;Indinavir/therapeutic use;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Middle Aged;Ritonavir/administration & dosage*;Ritonavir/adverse effects;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use
14517193;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Antiparasitic Agents/therapeutic use*;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Eating;Fasting;Food-Drug Interactions;Humans;Macrolides/adverse effects;Macrolides/pharmacokinetics*;Macrolides/therapeutic use*;Male;Middle Aged;Nausea/chemically induced;Onchocerciasis/drug therapy*;Treatment Outcome;Vomiting/chemically induced
14506878;Adaptation, Physiological*;Animals;Antimalarials/pharmacology*;Antimalarials/therapeutic use;Biological Evolution;Drug Resistance;Erythrocytes/metabolism;Erythrocytes/parasitology;Food-Drug Interactions;Genotype;Humans;Malaria/drug therapy*;Malaria/prevention & control;Oxidation-Reduction;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Plasmodium/drug effects*;Plasmodium/genetics
13679966;Cross Reactions;Dermatitis, Allergic Contact/diagnosis;Dermatitis, Allergic Contact/immunology;Food-Drug Interactions/immunology*;Humans;Latex Hypersensitivity/diagnosis*;Latex Hypersensitivity/immunology*
12973820;Administration, Oral;Adolescent;Adult;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy;Biological Availability*;Capsules;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics*;Dietary Fats/administration & dosage;Dietary Fats/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food*;Food-Drug Interactions/physiology;Humans;Male;Methylphenidate/administration & dosage*;Methylphenidate/blood;Methylphenidate/pharmacokinetics*;Middle Aged;Time Factors
12971031;Adult;Animals;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Beverages;Calcium, Dietary/administration & dosage*;Citrus;Cross-Over Studies;Edible Grain;Fasting;Female;Food, Fortified*;Food-Drug Interactions*;Humans;Levofloxacin*;Male;Middle Aged;Milk;Ofloxacin/administration & dosage;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Therapeutic Equivalency
12952002;Aged;Food-Drug Interactions;Humans;Intestinal Absorption;Prevalence;Vitamin B 12*/blood;Vitamin B 12*/therapeutic use;Vitamin B 12 Deficiency/epidemiology*
12951947;Area Under Curve;Diet;Food-Drug Interactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use*;Humans;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics;Nelfinavir/therapeutic use*
12951939;Advisory Committees*;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use*;Atazanavir Sulfate;Dose-Response Relationship, Drug;Food-Drug Interactions;HIV Infections/drug therapy;Humans;Oligopeptides/administration & dosage;Oligopeptides/therapeutic use*;Pyridines/administration & dosage;Pyridines/therapeutic use*;United States;United States Food and Drug Administration
12945511;Clinical Competence;Diet;Dietary Supplements;Food Preferences*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;Long-Term Care/standards*;Nutritional Sciences/education;Patient Care Team/standards*
12936882;Absorption;Alendronate/administration & dosage*;Alendronate/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Humans;Water Supply/standards*
12936879;Absorption;Beverages*/adverse effects*;Citrus paradisi*/adverse effects;Food-Drug Interactions/physiology*;Humans
12921244;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Digoxin/pharmacokinetics*;Female;Food-Drug Interactions*;Genes, MDR;Genotype;Humans;Intestines/metabolism*;Male
12920426;Adult;Antidepressive Agents, Second-Generation/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Fluvoxamine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male
12875233;Animals;Biological Availability;Digestive System/metabolism;Dosage Forms;Drug Combinations;Food-Drug Interactions;Humans;Intestinal Absorption;Mefenamic Acid/pharmacokinetics*;Phenytoin/pharmacokinetics*;Sulpiride/pharmacokinetics*
12875231;Anti-Anxiety Agents/metabolism*;Anti-Bacterial Agents/pharmacology;Anticonvulsants/pharmacology;Antifungal Agents/pharmacology;Azoles/pharmacology;Benzodiazepines;Calcium Channel Blockers/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/physiology*;Drug Interactions;Food-Drug Interactions;Humans;Macrolides;Rifampin/pharmacology
12860494;Adult;Area Under Curve;Blood Glucose/analysis;Cross-Over Studies;Cyclohexanes/adverse effects;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Double-Blind Method;Food-Drug Interactions*;Gastric Emptying/drug effects*;Half-Life;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Middle Aged;Phenylalanine/adverse effects;Phenylalanine/analogs & derivatives;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology;Time Factors
12852456;Administration, Oral;Animals;Antimalarials/blood*;Antimalarials/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Stability;Food-Drug Interactions;Half-Life;Indicators and Reagents;Male;Primaquine/analogs & derivatives*;Primaquine/blood;Primaquine/metabolism*;Primaquine/pharmacokinetics*;Rabbits;Reproducibility of Results;Spectrophotometry, Ultraviolet
12851659;Administration, Oral;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Honey*;Male;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits;Time Factors
12844325;Age Factors;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Ergolines/administration & dosage*;Ergolines/blood;Ergolines/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Kidney Diseases/metabolism;Levodopa/pharmacokinetics;Liver Diseases/metabolism;Male;Selegiline/pharmacokinetics;Sex Factors
12838962;Animals;Drug Carriers*;Drug Delivery Systems*;Food-Drug Interactions;Humans;Prodrugs;United States;United States Food and Drug Administration
12834283;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Blotting, Western;Catechin/analogs & derivatives*;Catechin/pharmacology;Cell Line;Cyclooxygenase Inhibitors/pharmacology;Dinoprostone/biosynthesis*;Drug Synergism;Food Analysis;Food-Drug Interactions;Genistein/pharmacology;Indicators and Reagents;Indomethacin/pharmacology;Interferon-gamma/pharmacology;Isothiocyanates/chemistry;Isothiocyanates/pharmacology;Lipopolysaccharides/pharmacology;Macrophages/drug effects;Macrophages/metabolism*;Mice;Protein Biosynthesis;Spectrophotometry, Infrared;Sulfonamides/pharmacology;Tumor Necrosis Factor-alpha/biosynthesis*
12831515;Capsules;Chemistry, Pharmaceutical;Crystallization;Dietary Proteins/pharmacology;Food-Drug Interactions/physiology;Hydrogen-Ion Concentration;Indinavir/chemistry*;Ritonavir/chemistry*
12830268;Anticoagulants/administration & dosage;Anticoagulants/antagonists & inhibitors*;Drug Monitoring;Food-Drug Interactions*;Humans;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/antagonists & inhibitors*
12826982;Food-Drug Interactions/genetics*;Humans;Nonprescription Drugs/metabolism*
12820815;Animals;Anti-Ulcer Agents/chemistry*;Beverages*;Capsules;Citrus sinensis;Dairy Products*;Drug Stability;Esomeprazole/chemistry*;Food-Drug Interactions*;Gastric Acid/chemistry;Hydrochloric Acid/chemistry;Malus;Milk;Yogurt
12811362;Adult;Area Under Curve;Beverages*;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Citrus*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Furocoumarins/pharmacology*;Half-Life;Humans;Male;Middle Aged;NADP/metabolism;Radiation-Sensitizing Agents/pharmacology*;Wine*
12807517;11-beta-Hydroxysteroid Dehydrogenases;Adult;Aldosterone/blood;Beverages/adverse effects*;Citrus paradisi*;Depression, Chemical;Edema/etiology*;Edema/metabolism;Female;Food-Drug Interactions*;Humans;Hydroxysteroid Dehydrogenases/antagonists & inhibitors*;Hydroxysteroid Dehydrogenases/metabolism;Mineralocorticoids/metabolism*;Potassium/blood;Renin/blood
12792988;Aflatoxin B1/metabolism;Aflatoxin B1/toxicity*;Animals;Cytochrome P-450 Enzyme System/metabolism;Dietary Sucrose/administration & dosage*;Food-Drug Interactions*;Glutathione Transferase/metabolism;Isoenzymes;Liver/drug effects*;Liver/enzymology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Mutagenesis/drug effects*;Mutagens/metabolism;Mutagens/toxicity*;Rats;Rats, Inbred F344;Salmonella typhimurium/drug effects;Salmonella typhimurium/genetics
12787947;Adult;Catha/chemistry*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacology*;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Food-Drug Interactions;Humans;Lipid Peroxidation/drug effects*;Male;Malondialdehyde/blood;Mastication;Middle Aged;Plant Leaves/chemistry*;Plant Preparations/pharmacology*;Postprandial Period;Smoking;Triglycerides/blood
12771601;APACHE;Administration, Oral;Adolescent;Adult;Aged;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Critical Illness*;Cross-Over Studies;Drug Monitoring/methods;Enteral Nutrition/methods*;Female;Fluoroquinolones*;Food-Drug Interactions;Humans;Infusions, Intravenous;Intubation, Gastrointestinal/methods*;Male;Middle Aged;Prospective Studies
12769668;Animals;Catechin/pharmacology;Enzymes/metabolism*;Food-Drug Interactions;Gallic Acid/analogs & derivatives*;Gallic Acid/pharmacology*;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*
12756216;Brassica*;Caco-2 Cells/enzymology;Caco-2 Cells/metabolism;Chromatography, Liquid;Enterocytes/enzymology;Enterocytes/metabolism;Enterocytes/secretion;Food-Drug Interactions;Gene Expression;Glucuronides/secretion;Glucuronosyltransferase/biosynthesis;Glutathione/analogs & derivatives;Glutathione/secretion;Glutathione Transferase/biosynthesis;Humans;Intestinal Absorption;Isothiocyanates;Jejunum/enzymology;Jejunum/metabolism*;Jejunum/secretion;Mass Spectrometry;Onions*;Plant Extracts/pharmacokinetics;Plant Stems;Plant Tubers;Quercetin/analogs & derivatives;Quercetin/pharmacokinetics*;Quercetin/secretion;RNA, Messenger/biosynthesis;Reverse Transcriptase Polymerase Chain Reaction;Thiocyanates/pharmacokinetics*;beta-Glucosidase/biosynthesis
12751908;Alcohol Dehydrogenase/metabolism;Animals;Dogs;Ethanol/blood;Ethanol/pharmacokinetics*;Food*;Food-Drug Interactions*;Gastric Emptying;Intestinal Absorption;Intestine, Small/enzymology;Monte Carlo Method;Stomach/enzymology;Stomach/metabolism
12751275;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Beverages*;Calcium, Dietary/pharmacology*;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/administration & dosage;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Therapeutic Equivalency
12749182;Administration, Oral;Beverages*;Biological Availability;Citrus paradisi;Estradiol/administration & dosage;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics*;Estrogens, Conjugated (USP)/administration & dosage;Estrogens, Conjugated (USP)/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Progesterone/administration & dosage;Progesterone/pharmacokinetics*
12743672;Administration, Oral;Adult;Analysis of Variance;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Area Under Curve;Azetidines/adverse effects;Azetidines/pharmacokinetics*;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Half-Life;Humans;Male;Metabolic Clearance Rate;Partial Thromboplastin Time;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/pharmacology;Prothrombin Time;Thrombin/antagonists & inhibitors*
12723461;Administration, Oral;Adult;Area Under Curve;Biomarkers;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Half-Life;Humans;Hydrogen-Ion Concentration;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Imidazoles/pharmacology;Male;Mitogen-Activated Protein Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Pyridines/pharmacology;p38 Mitogen-Activated Protein Kinases
12711572;American Heart Association*;Docosahexaenoic Acids/administration & dosage*;Eicosapentaenoic Acid;Fatty Acids, Unsaturated/administration & dosage*;Food-Drug Interactions;Guidelines as Topic*;Heart Diseases/diet therapy*;Humans;United States
12708244;Anticoagulants/pharmacokinetics*;Blood Coagulation/drug effects;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/metabolism;Feeding Behavior*;Food-Drug Interactions*;Humans;International Normalized Ratio
12706777;Administration, Oral;Age Distribution;Aged;Aged, 80 and over;Asthenia/etiology;Carrier Proteins/metabolism*;Cohort Studies;Confusion/etiology;Diagnosis, Differential;Female;Food-Drug Interactions*;France/epidemiology;Humans;Malabsorption Syndromes/complications*;Malabsorption Syndromes/drug therapy;Malabsorption Syndromes/epidemiology;Malabsorption Syndromes/metabolism;Male;Middle Aged;Peripheral Nervous System Diseases/etiology;Retrospective Studies;Schilling Test*;Sex Distribution;Vitamin B 12/metabolism*;Vitamin B 12/therapeutic use*;Vitamin B 12 Deficiency/complications*;Vitamin B 12 Deficiency/diagnosis;Vitamin B 12 Deficiency/drug therapy*;Vitamin B 12 Deficiency/epidemiology
12698990;Administration, Oral;Adult;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/analogs & derivatives*;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Dibenzazepines/blood;Fasting;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Tablets;Therapeutic Equivalency
12698987;Absorption;Acetaminophen/metabolism;Acetaminophen/pharmacokinetics*;Administration, Oral;Algorithms;Area Under Curve;Energy Intake*;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Models, Biological;Postprandial Period
12693698;Administration, Oral;Animals;Area Under Curve;Diltiazem/administration & dosage;Diltiazem/blood;Diltiazem/pharmacokinetics*;Food-Drug Interactions;Half-Life;Honey*;Infusions, Intravenous;Rabbits
12691040;Beverages*;Citrus*;Food-Drug Interactions*;HIV Seronegativity;Humans;Male;Piperazines/pharmacology*;Purines;Sildenafil Citrate;Sulfones
12680887;Administration, Oral;Adult;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/pharmacokinetics*;Anti-Anxiety Agents/pharmacology;Benzodiazepines*;Cross-Over Studies;Eating/physiology*;Fasting/physiology;Fatigue/chemically induced;Food-Drug Interactions/physiology*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology;Male;Psychomotor Performance/drug effects;Thinking/drug effects;Time Factors
12674742;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Biotransformation/genetics*;Drug Interactions/genetics;Drug Resistance, Multiple/genetics*;Food-Drug Interactions/genetics;Gene Expression Regulation/physiology;Humans;Intestinal Absorption/genetics*;Metabolic Clearance Rate/genetics*;Pharmacokinetics*;Risk Factors
12661783;Amphetamines/administration & dosage*;Amphetamines/pharmacokinetics;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Biological Availability;Central Nervous System Stimulants/administration & dosage*;Central Nervous System Stimulants/pharmacokinetics;Delayed-Action Preparations;Drug Administration Schedule*;Eating*;Food-Drug Interactions*;Humans;United States
12653694;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Asthma/complications;Drug Eruptions/drug therapy;Drug Eruptions/etiology*;Food-Drug Interactions/physiology;Humans;Urticaria/chemically induced*;Urticaria/complications;Urticaria/drug therapy
12652372;Anti-HIV Agents/therapeutic use;Antiretroviral Therapy, Highly Active;Delivery of Health Care, Integrated;Food-Drug Interactions;HIV Infections/diet therapy*;HIV Infections/drug therapy;HIV Infections/mortality;Humans;Mass Screening;Nutrition Assessment;Nutritional Physiological Phenomena*;Reproducibility of Results;Treatment Outcome
12648028;Administration, Oral;Adult;Age Factors;Aged;Area Under Curve;Azetidines/pharmacokinetics;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Female;Fibrinolytic Agents/pharmacokinetics;Fibrinolytic Agents/pharmacology*;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/urine;Humans;Infusions, Intravenous;Injections, Subcutaneous;Male;Metabolic Clearance Rate;Middle Aged;Prodrugs/pharmacokinetics;Prodrugs/pharmacology*;Thrombin/antagonists & inhibitors*
12648026;Age Factors;Biological Availability;Breast Neoplasms/drug therapy;Breast Neoplasms/prevention & control;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Kidney Diseases/physiopathology;Liver Diseases/metabolism;Liver Diseases/physiopathology;Osteoporosis/drug therapy;Osteoporosis/prevention & control;Selective Estrogen Receptor Modulators/adverse effects;Selective Estrogen Receptor Modulators/pharmacokinetics*;Selective Estrogen Receptor Modulators/therapeutic use
12638395;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/adverse effects;Cyclooxygenase Inhibitors/pharmacokinetics*;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors*;Male;Membrane Proteins;Middle Aged;Prostaglandin-Endoperoxide Synthases;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Tablets;Time Factors
12638394;3',5'-Cyclic-GMP Phosphodiesterases;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Dietary Fats/administration & dosage*;Drug Administration Schedule;Erectile Dysfunction/drug therapy;Food-Drug Interactions;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism*;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Postprandial Period;Sulfones;Time Factors;Triazines;Vardenafil Dihydrochloride
12634980;Administration, Oral;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Case-Control Studies;Cytochrome P-450 CYP2C9;Dose-Response Relationship, Drug;Drug Interactions;Drug Overdose;Female;Food-Drug Interactions;Genotype;Hemorrhage/chemically induced;Humans;Inpatients;International Normalized Ratio;Male;Mutation;Polymorphism, Genetic;Prospective Studies;Risk Factors;Vitamin K/administration & dosage
12622202;Animals;Anticonvulsants/pharmacokinetics*;Area Under Curve;Carbamazepine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Honey*;Rabbits
12619247;Aged;Aging/physiology;Drug Interactions;Education, Continuing;Emergency Medical Services/organization & administration*;Food-Drug Interactions;Geriatric Assessment*;Humans;Medical History Taking*;Polypharmacy*;Self Administration;United States
12611563;Animals;Arthritis, Rheumatoid/therapy;Asthma/therapy;Cardiomyopathies/therapy;Disease Progression;Food-Drug Interactions;HIV Infections/prevention & control;Humans;Hypothyroidism/therapy;Infertility, Male/therapy;Liver Diseases/blood;Male;Neoplasms/prevention & control;Selenium/adverse effects;Selenium/deficiency;Selenium/therapeutic use*
12611197;Beverages/adverse effects*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
12603801;Adolescent;Causality;Chi-Square Distribution;Child;Child, Preschool;Confidence Intervals;Direct Service Costs;Drug Interactions;Drug Utilization Review*;Drug-Related Side Effects and Adverse Reactions*;Emergency Service, Hospital/economics;Emergency Service, Hospital/utilization*;Female;Food-Drug Interactions;Hospital Costs;Hospitals, Pediatric/utilization;Hospitals, Teaching/utilization;Humans;Male;Medication Errors;Patient Admission/economics;Patient Admission/statistics & numerical data*;Pharmaceutical Preparations/administration & dosage;Probability;Risk Assessment;Risk Factors;Self Medication/adverse effects*;Statistics, Nonparametric;Victoria/epidemiology
12592204;Anti-Infective Agents/blood*;Beverages;Ciprofloxacin/blood*;Citrus sinensis;Food-Drug Interactions*
12578152;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions*;Humans;Ketolides*;Macrolides*;Male;Middle Aged
12554070;Animals;Beverages;Citrus paradisi;Flavanones/pharmacology;Food-Drug Interactions;Furocoumarins/pharmacology*;Hepatocytes/drug effects;Hepatocytes/enzymology;Hepatocytes/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;In Vitro Techniques;Liver/drug effects*;Liver/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Rats;Simvastatin/metabolism*
12551706;Adult;Antiparkinson Agents/adverse effects;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benserazide/adverse effects;Benserazide/blood;Benserazide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions;Half-Life;Humans;Levodopa/adverse effects;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Time Factors;Tyrosine/analogs & derivatives*;Tyrosine/blood
12543606;Beverages*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/metabolism
12520633;Adolescent;Adult;Anti-Infective Agents/pharmacokinetics*;Beverages*;Calcium*;Citrus sinensis*;Female;Fluoroquinolones*;Food, Fortified*;Food-Drug Interactions*;Humans;Male;Therapeutic Equivalency
12520629;Administration, Oral;Adolescent;Adult;Biological Availability;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Sex Factors;Sodium Oxybate/administration & dosage;Sodium Oxybate/adverse effects;Sodium Oxybate/pharmacokinetics*;Solutions
12520628;Aged;Biological Availability;Cross-Over Studies;Estradiol Congeners/pharmacokinetics*;Estrogen Replacement Therapy;Ethinyl Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norethindrone/pharmacokinetics*;Progesterone Congeners/pharmacokinetics*;Tablets
12516078;Animals;Biological Availability;Drug Evaluation, Preclinical/methods;Drug Evaluation, Preclinical/standards;Fasting/physiology*;Food*;Food-Drug Interactions;Gastric Acid/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Hydrogen-Ion Concentration;Macaca fascicularis;Male;Species Specificity;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/standards
12512484;Administration, Oral;Drug Therapy/nursing*;Enteral Nutrition/nursing;Food-Drug Interactions;Gastrostomy/nursing*;Humans;Pharmaceutical Preparations/administration & dosage*
12494789;Buffers*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration*;Models, Biological;Pharmaceutical Preparations/metabolism
12492049;Biological Availability;Carbamates;Dietary Fats/administration & dosage;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use;Vitamin E/administration & dosage
12463728;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Benzodiazepines*;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Fasting;Food-Drug Interactions*;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Time Factors
12452752;Aged;Anticoagulants/administration & dosage;Anticoagulants/pharmacology;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Soybean Proteins/administration & dosage*;Soybean Proteins/pharmacology*;Soybeans*;Warfarin/administration & dosage*;Warfarin/pharmacology*
12451428;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood*;Calcium Channel Blockers/pharmacology;Citrus paradisi*;Cross-Over Studies;Diltiazem/administration & dosage;Diltiazem/blood*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Time Factors
12437338;Animals;Arsenates/administration & dosage;Arsenates/chemistry;Arsenates/metabolism;Arsenicals/administration & dosage;Arsenicals/chemistry;Arsenicals/metabolism*;Arsenites/administration & dosage;Arsenites/chemistry;Arsenites/metabolism;Bile/metabolism*;Food-Drug Interactions;Injections, Intravenous;Male;Organometallic Compounds/pharmacokinetics*;Rabbits;Selenic Acid;Selenium Compounds/administration & dosage;Selenium Compounds/chemistry;Selenium Compounds/metabolism*;Sodium Selenite/administration & dosage;Sodium Selenite/chemistry;Sodium Selenite/metabolism
12435624;Adult;Area Under Curve;Cross-Over Studies;Drug Administration Schedule;Food-Drug Interactions*;Humans;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics*;Reference Values;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*
12434565;Adolescent;Adult;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Mexico;Middle Aged;Ranitidine/blood;Ranitidine/pharmacokinetics*
12432966;Adult;Amphetamine/administration & dosage;Amphetamine/blood;Amphetamine/pharmacokinetics*;Amphetamines/administration & dosage;Amphetamines/blood;Amphetamines/pharmacokinetics*;Analysis of Variance;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism*;Fasting/metabolism*;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged
12429467;Animals;Area Under Curve;Biological Availability;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/metabolism*;Eating/physiology;Food-Drug Interactions/physiology*;Male;Rats;Rats, Sprague-Dawley;Tungsten Compounds/administration & dosage;Tungsten Compounds/blood;Tungsten Compounds/pharmacokinetics*
12426515;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Female;Food-Drug Interactions*;Humans;Male;Phenanthrenes/pharmacokinetics*;Phenanthrenes/pharmacology*
12410622;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Biomarkers;Cardiovascular Diseases/mortality;Cardiovascular Diseases/prevention & control;Cohort Studies;Dietary Supplements;Feeding Behavior;Food-Drug Interactions;Fruit*;Humans;Lung Neoplasms/mortality;Lung Neoplasms/prevention & control;Oxidative Stress;Randomized Controlled Trials as Topic;Smoking*/adverse effects;Smoking*/metabolism;Vegetables*;Vitamin A/administration & dosage;Vitamin A/adverse effects;beta Carotene/administration & dosage*;beta Carotene/adverse effects;beta Carotene/pharmacokinetics
12406936;Beverages;Biological Availability;Cardiovascular Agents/pharmacokinetics*;Citrus paradisi*;Food-Drug Interactions*;Humans
12395977;Adolescent;Adult;Aged;Area Under Curve;Beverages;Citrus paradisi*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male;Middle Aged;Time Factors;Water/administration & dosage
12389876;Antineoplastic Agents/economics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Benzamides;Clinical Trials as Topic;Drug Interactions;Drug Resistance, Neoplasm;Food-Drug Interactions;Gastrointestinal Neoplasms/drug therapy;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Patient Education as Topic;Piperazines/economics;Piperazines/pharmacology;Piperazines/therapeutic use*;Pyrimidines/economics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Sarcoma/drug therapy;Stromal Cells
12389073;Administration, Oral;Adult;Aged;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carcinoma, Small Cell/drug therapy;Chromatography, High Pressure Liquid;Citrus paradisi/adverse effects*;Cross-Over Studies;Etoposide/administration & dosage;Etoposide/adverse effects;Etoposide/blood;Etoposide/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Lung Neoplasms/drug therapy;Male;Middle Aged;Pilot Projects
12387000;Diabetes Mellitus, Type 2/diet therapy*;Dietary Fiber/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Diglycerides/analysis;Food, Organic*/adverse effects;Food, Organic*/analysis;Food-Drug Interactions;Glycoside Hydrolase Inhibitors;Humans;Hypercholesterolemia/diet therapy;Hyperglycemia/diet therapy;Hypertension/drug therapy
12386129;Administration, Oral;Animals;Antinematodal Agents/pharmacokinetics*;Area Under Curve;Benzimidazoles/pharmacokinetics;Biotransformation;Drug Synergism;Feces/chemistry;Fenbendazole/pharmacokinetics*;Food-Drug Interactions;Horses/metabolism*;Injections, Intravenous;Intestinal Absorption;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pesticide Synergists/pharmacology;Piperonyl Butoxide/pharmacology;Stereoisomerism;Sulfates/metabolism;Sulfides/metabolism;Sulfoxides/metabolism
12371493;Animals;Food*;Food-Drug Interactions*;Geologic Sediments/chemistry*;Insecta/growth & development*;Species Specificity;Water Pollutants, Chemical/toxicity*
12371301;Anticholesteremic Agents/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 Enzyme System/metabolism;Drug Synergism*;Food-Drug Interactions*;Humans;Simvastatin/pharmacokinetics*
12369444;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Aging/metabolism;Anti-Ulcer Agents/pharmacokinetics*;Benzimidazoles/pharmacokinetics*;Biological Availability;Child;Clinical Trials as Topic;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Omeprazole/analogs & derivatives;Rabeprazole
12363433;Animal Feed*;Animals;Biological Availability;Digestive System Physiological Phenomena*;Food-Drug Interactions*;Gastrointestinal Transit;Humans;Intestinal Absorption;Solubility;Species Specificity;Veterinary Drugs/administration & dosage;Veterinary Drugs/chemistry;Veterinary Drugs/pharmacokinetics*
12362932;Adult;Beverages;Chromatography, High Pressure Liquid;Citrus*;Citrus paradisi;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions*;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/blood*;Indinavir/pharmacokinetics*;Male
12362927;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Ivermectin/administration & dosage;Ivermectin/adverse effects;Ivermectin/pharmacokinetics*;Male;Middle Aged;Mydriasis/chemically induced;Pupil/drug effects
12362923;Adolescent;Adult;Aged;Butyrophenones/blood;Butyrophenones/pharmacokinetics;Butyrophenones/pharmacology;Butyrophenones/therapeutic use*;Child;Double-Blind Method;Female;Food-Drug Interactions*;Histamine H1 Antagonists/pharmacokinetics;Histamine H1 Antagonists/pharmacology;Histamine H1 Antagonists/therapeutic use*;Humans;Male;Middle Aged;Piperidines/blood;Piperidines/pharmacokinetics;Piperidines/pharmacology;Piperidines/therapeutic use*;Rhinitis, Allergic, Seasonal/blood;Rhinitis, Allergic, Seasonal/drug therapy*;Severity of Illness Index;Treatment Outcome
12235449;Adult;Aryl Hydrocarbon Hydroxylases*;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 CYP2E1/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Europe;European Continental Ancestry Group*/genetics;Female;Food-Drug Interactions/physiology;Humans;Los Angeles;Male;Mexican Americans*/genetics;Midazolam/pharmacokinetics;Middle Aged;Oxidoreductases, N-Demethylating/metabolism*;Statistics, Nonparametric
12207630;Adult;Aged;Biological Availability;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/metabolism*;Hypnotics and Sedatives/pharmacokinetics;Intestines/metabolism;Liver Cirrhosis/enzymology;Male;Midazolam/analogs & derivatives*;Midazolam/blood;Midazolam/metabolism*;Midazolam/pharmacokinetics;Middle Aged
12187774;Biomarkers/urine;Child;Copper/urine*;Drug Administration Schedule;Food-Drug Interactions*;Hepatolenticular Degeneration/drug therapy*;Hepatolenticular Degeneration/genetics;Hepatolenticular Degeneration/urine;Humans;Male;Nuclear Family;Penicillamine/administration & dosage*
12171043;Anti-HIV Agents/adverse effects;Anti-HIV Agents/therapeutic use*;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12171042;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12165187;Adverse Drug Reaction Reporting Systems;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Food-Drug Interactions;Humans;Iatrogenic Disease*;Internet;Interprofessional Relations;Plant Preparations/adverse effects*
12162471;Adolescent;Adult;Area Under Curve;Capsules/administration & dosage;Capsules/pharmacokinetics;Carbamates;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/physiology;Food-Drug Interactions;Health;Humans;Male;Middle Aged;Organophosphates/administration & dosage;Organophosphates/adverse effects;Organophosphates/blood;Organophosphates/pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Suspensions/administration & dosage;Suspensions/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
12161974;Citrus*;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
12154747;Alcohol Drinking;Anti-HIV Agents/therapeutic use*;Diet;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/psychology;Humans;Patient Compliance*
12139218;Adult;Albendazole/administration & dosage;Albendazole/pharmacokinetics*;Anthelmintics/administration & dosage;Anthelmintics/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Cimetidine/administration & dosage*;Citrus*;Drug Interactions;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male
12136744;Adult;Area Under Curve;Capsules;Chemistry, Pharmaceutical;Dietary Fats/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Middle Aged;Saquinavir/blood*;Saquinavir/pharmacokinetics;Statistics, Nonparametric
12115838;Administration, Oral;Animals;Anti-HIV Agents/pharmacology*;Biological Availability;Chemistry, Pharmaceutical;Dogs;Female;Food-Drug Interactions*;Models, Animal;Particle Size;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolinones;Solubility;Tablets/chemistry;Water/chemistry
12115809;Administration, Oral;Animals;Antimalarials/administration & dosage;Antimalarials/chemistry;Antimalarials/pharmacokinetics*;Area Under Curve;Biological Availability;Blood Proteins/metabolism;Cholesterol/blood;Chromatography, High Pressure Liquid;Dietary Fats/pharmacology;Food-Drug Interactions*;Hyperlipidemias/metabolism;Injections, Intravenous;Lipid Metabolism;Lipids/blood*;Lipoproteins/blood*;Male;Peanut Oil;Phenanthrenes/administration & dosage;Phenanthrenes/chemistry;Phenanthrenes/pharmacokinetics*;Plant Oils/pharmacology;Poloxamer/pharmacology;Protein Binding;Rats;Rats, Sprague-Dawley;Stereoisomerism;Triglycerides/blood
12098841;Acetaminophen/administration & dosage*;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Analgesics, Non-Narcotic/administration & dosage*;Analgesics, Non-Narcotic/pharmacokinetics*;Analysis of Variance;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Excipients*;Fasting;Food-Drug Interactions;Humans;Male;Middle Aged;Sodium Bicarbonate*;Solubility;Tablets;Therapeutic Equivalency
12095536;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Antitussive Agents/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases*;Beverages/adverse effects*;Biological Availability;Biotransformation;Citrus*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dealkylation;Dextromethorphan/pharmacokinetics*;Digestive System/enzymology;Digestive System/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Membrane Proteins/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Oxidoreductases, N-Demethylating/metabolism;Phenotype;Reproducibility of Results
12093316;Anti-Infective Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Antihypertensive Agents/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Biological Availability;Dietary Fats;Dietary Fiber;Food-Drug Interactions*;Humans;Practice Guidelines as Topic
12085854;Aged;Beverages/adverse effects;Citrus;Drug Interactions*;Female;Food-Drug Interactions;Humans;Polypharmacy*
12064015;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives;Adenine/pharmacokinetics;Adenine/therapeutic use*;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/nursing;Humans;Organophosphonates*;Organophosphorus Compounds/administration & dosage;Organophosphorus Compounds/adverse effects;Organophosphorus Compounds/pharmacokinetics;Organophosphorus Compounds/therapeutic use*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Tenofovir
12055962;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;Humans
12053901;Animals;Diet*;Disease Models, Animal;Food-Drug Interactions;Hepatitis/complications;Hepatitis/diet therapy*;Hyperlipidemias/complications;Hyperlipidemias/diet therapy*;Obesity/complications;Obesity/diet therapy*;Rats;Rats, Sprague-Dawley;Ursodeoxycholic Acid/pharmacology*
12051573;Administration, Oral;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Thiazoles/administration & dosage;Thiazoles/adverse effects*;Thiazoles/blood;Thiazoles/pharmacokinetics*
12047482;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacokinetics*;Fasting;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Humans;Male;Nifedipine/blood;Nifedipine/pharmacokinetics*;Osmosis;Solubility;Therapeutic Equivalency
12040751;Adult;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Flavanones*;Flavonoids/analysis;Food-Drug Interactions*;Humans;Male;Nifedipine/pharmacokinetics*;Nisoldipine/pharmacokinetics*
12037939;Biological Availability;Food-Drug Interactions*;Humans;Pharmacokinetics
12017348;Administration, Oral;Aged;Area Under Curve;Dietary Fats/administration & dosage;Dietary Fats/pharmacology;Dose-Response Relationship, Drug;Fasting;Feces/chemistry;Food-Drug Interactions;Health;Heterocyclic Compounds, 3-Ring/administration & dosage*;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Heterocyclic Compounds, 3-Ring/urine;Humans;Male;Middle Aged;Pyrimidinones/administration & dosage*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Pyrimidinones/urine
12015791;Animals;Aryl Hydrocarbon Hydroxylases*;Beverages;Biological Availability;Citrus;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Delayed-Action Preparations/pharmacokinetics;Diet;Drug Evaluation, Preclinical/methods*;Food*;Food-Drug Interactions;Humans;Oxidoreductases, N-Demethylating/antagonists & inhibitors;Oxidoreductases, N-Demethylating/metabolism;Pharmacokinetics*
12015789;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/blood;Food-Drug Interactions;Gliclazide/administration & dosage;Gliclazide/blood;Gliclazide/pharmacokinetics*;Half-Life;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Infusions, Intravenous;Tablets
12014354;Aged;Aged, 80 and over;Anacardiaceae*/adverse effects;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Disorders/chemically induced;Food-Drug Interactions*;Fruit/adverse effects;Humans;International Normalized Ratio/adverse effects;Male;Middle Aged;Warfarin/adverse effects;Warfarin/therapeutic use*
12009003;Adolescent;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/therapeutic use;Biotin/blood;Calcium/blood;Carnitine/blood;Carnitine/deficiency;Dietetics;Edema/chemically induced;Folic Acid/blood;Food-Drug Interactions*;Humans;Middle Aged;Seizures/drug therapy*;Serum Albumin/analysis;Serum Albumin/drug effects*;Valproic Acid/adverse effects*;Valproic Acid/therapeutic use;Weight Gain/drug effects
12004838;Anticholesteremic Agents/pharmacology;Beverages/adverse effects*;Calcium Channel Blockers/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans
12001345;Animals;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use*;Bromides/adverse effects;Bromides/pharmacokinetics;Bromides/therapeutic use*;Dog Diseases/drug therapy*;Dogs;Dose-Response Relationship, Drug;Drug Monitoring/veterinary;Epilepsy/drug therapy;Epilepsy/veterinary*;Food-Drug Interactions;Phenobarbital/adverse effects;Phenobarbital/pharmacokinetics;Phenobarbital/therapeutic use*;Potassium Compounds/adverse effects;Potassium Compounds/pharmacokinetics;Potassium Compounds/therapeutic use*
11998345;Administration, Oral;Drug Administration Schedule;Food-Drug Interactions*;Guidelines as Topic;Humans;Pharmaceutical Preparations/administration & dosage*
11996327;Adolescent;Adrenergic alpha-1 Receptor Antagonists;Adrenergic alpha-Antagonists/blood;Adrenergic alpha-Antagonists/pharmacokinetics*;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Fasting/metabolism*;Food*;Food-Drug Interactions*;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Male;Middle Aged;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*
11991343;African Continental Ancestry Group;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Male;Middle Aged;Nifedipine/pharmacokinetics*
11981235;Activities of Daily Living*;Adult;Aged;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Drug Evaluation/methods;Drug Evaluation/statistics & numerical data;Drug Therapy, Combination;Female;Food-Drug Interactions/physiology;Humans;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Middle Aged;Motor Skills/drug effects;Motor Skills/physiology*;Parkinson Disease/blood*;Parkinson Disease/metabolism;Parkinson Disease/physiopathology
11976834;Aged;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dihydrouracil Dehydrogenase (NADP);Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Enzyme Inhibitors/pharmacology*;Female;Fluorouracil/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption;Male;Middle Aged;Models, Biological;Oxidoreductases/antagonists & inhibitors;Population;Therapeutic Equivalency;Uracil/analogs & derivatives*;Uracil/pharmacology*
11971644;Ammonia/toxicity*;Animals;Chlorella/drug effects*;Chlorella/growth & development;Daphnia/drug effects*;Daphnia/growth & development;Dose-Response Relationship, Drug;Food Deprivation;Food-Drug Interactions;Lethal Dose 50;Population Growth;Water Pollutants/toxicity*
11971236;Dietary Supplements/adverse effects*;Food-Drug Interactions;Germany;Humans;Kava/adverse effects*;Liver Diseases/etiology*;United States;United States Food and Drug Administration
11966676;Amlodipine/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Citrus*;Food-Drug Interactions*;Humans
11962300;Chemical Precipitation;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/methods;Enteral Nutrition/nursing*;Equipment Failure;Evidence-Based Medicine;Food-Drug Interactions;Humans;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/methods;Intubation, Gastrointestinal/nursing*;Maintenance;Nursing Evaluation Research;Therapeutic Irrigation/instrumentation;Therapeutic Irrigation/methods;Therapeutic Irrigation/nursing*
11959616;Adult;Anthelmintics/administration & dosage*;Anthelmintics/pharmacokinetics;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Praziquantel/administration & dosage*;Praziquantel/pharmacokinetics
11959608;Administration, Oral;Adult;Beverages*;Carbamates;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics;Humans;Male;Sulfonamides/administration & dosage*;Sulfonamides/pharmacokinetics*
11959071;Acute Disease;Adult;Antidepressive Agents/adverse effects*;Cheese*;Delirium/blood;Delirium/chemically induced*;Delirium/therapy;Food-Drug Interactions;Humans;Hypericum/adverse effects*;Hypertension/blood;Hypertension/chemically induced*;Hypertension/therapy;Male;Monoamine Oxidase Inhibitors/adverse effects*
11957745;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl CoA Reductases/adverse effects;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics*
11956673;Adult;Beverages*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/urine;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavanones*;Flavonoids/blood;Flavonoids/pharmacokinetics;Flavonoids/urine;Food-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Mixed Function Oxygenases/metabolism;Smoking/blood*;Stereoisomerism;Verapamil/adverse effects;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/urine
11953660;Biological Availability;Enteral Nutrition;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Pharmacokinetics;Treatment Outcome
11953654;Aging/physiology*;Antioxidants/therapeutic use;Chronic Disease/therapy*;Food-Drug Interactions;Humans;Kidney Failure, Chronic/complications;Kidney Failure, Chronic/therapy;Nutrition Disorders/etiology;Nutrition Disorders/therapy*;Nutritional Requirements;Nutritional Support/methods*;Parenteral Nutrition;Quality of Life;Treatment Outcome
11936572;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics;Area Under Curve;Beverages*;Calcium/pharmacokinetics*;Ciprofloxacin/blood*;Ciprofloxacin/pharmacokinetics;Citrus/metabolism*;Cross-Over Studies;Female;Food, Fortified*/adverse effects;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Statistics, Nonparametric;Therapeutic Equivalency
11936569;Female;Food, Fortified*/adverse effects;Food, Fortified*/statistics & numerical data;Food-Drug Interactions/physiology*;Humans;Male;United States;United States Food and Drug Administration/legislation & jurisprudence*
11936567;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Didanosine/administration & dosage;Didanosine/adverse effects;Didanosine/blood*;Dietary Fats/blood;Fasting/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Microspheres;Tablets, Enteric-Coated
11927211;Aged;Aged, 80 and over;Alcohol Drinking;Anticoagulants/pharmacokinetics*;Body Mass Index;Case-Control Studies;Coumarins/pharmacokinetics*;Feeding Behavior*;Female;Food-Drug Interactions;Humans;International Normalized Ratio;Life Style*;Male;Middle Aged;Risk Factors
11923060;Adult;Analysis of Variance;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Chemistry, Pharmaceutical;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism*;Dosage Forms;Drug Industry;European Union;Fasting/blood*;Food-Drug Interactions/physiology*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/blood*
11920750;Animals;Antimalarials/blood;Antimalarials/chemistry*;Antimalarials/pharmacokinetics*;Area Under Curve;Chemical Phenomena;Chemistry, Physical;Chromatography, High Pressure Liquid;Dogs;Food-Drug Interactions;Intestinal Absorption/physiology*;Lymph/chemistry;Lymphatic System/metabolism*;Male;Models, Molecular;Phenanthrenes/blood;Phenanthrenes/chemistry*;Phenanthrenes/pharmacokinetics*;Postprandial Period/physiology*;Solubility;Spectrophotometry, Ultraviolet;Spectroscopy, Fourier Transform Infrared
11920745;Administration, Oral;Animals;Area Under Curve;Dogs;Food-Drug Interactions/physiology*;Infusions, Intravenous;Liver/metabolism;Mass Spectrometry;Mineralocorticoid Receptor Antagonists/administration & dosage*;Mineralocorticoid Receptor Antagonists/pharmacokinetics*;Portal Vein;Spironolactone/administration & dosage*;Spironolactone/analogs & derivatives*;Spironolactone/pharmacokinetics*;Spironolactone/pharmacology
11920267;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/toxicity;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Lymphoma, Non-Hodgkin/drug therapy;Male;Middle Aged;Prospective Studies;Treatment Outcome;Vidarabine Phosphate/administration & dosage;Vidarabine Phosphate/analogs & derivatives;Vidarabine Phosphate/pharmacokinetics*;Vidarabine Phosphate/toxicity
11906463;Administration, Oral;Adult;Animals;Chickens;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions/physiology;Humans;Immunoenzyme Techniques;Male;Middle Aged;Muramidase/administration & dosage*;Muramidase/blood*;Rabbits
11904862;Aged;Cost-Benefit Analysis;Dietary Proteins/administration & dosage*;Dietary Proteins/analysis;Dietary Proteins/economics;Drug Therapy/nursing*;Energy Intake*;Food, Formulated*/analysis;Food, Formulated*/economics;Food-Drug Interactions;Humans;Medication Systems, Hospital;Nurse's Role;Nursing Assessment;Nutrition Assessment;Patient Care Team;Patient Selection;Pharmacists;Program Evaluation;Protein-Energy Malnutrition/complications;Protein-Energy Malnutrition/diagnosis;Protein-Energy Malnutrition/economics;Protein-Energy Malnutrition/therapy*;Skilled Nursing Facilities
11899948;Administration, Oral;Area Under Curve;Biological Availability;Estrogen Receptor Modulators/administration & dosage;Estrogen Receptor Modulators/blood;Estrogen Receptor Modulators/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Middle Aged;Norpregnenes/administration & dosage;Norpregnenes/metabolism;Norpregnenes/pharmacokinetics*;Postmenopause/blood;Postmenopause/metabolism
11897422;Administration, Oral;Adult;Bronchodilator Agents/blood;Cross-Over Studies;Digestive System/diagnostic imaging*;Digestive System/metabolism;Food-Drug Interactions/physiology;Gastrointestinal Transit/physiology*;Humans;Linear Models;Male;Monitoring, Physiologic/instrumentation;Monitoring, Physiologic/methods*;Predictive Value of Tests;Radionuclide Imaging;Theophylline/administration & dosage*;Theophylline/blood*;Time Factors
11886184;Aniline Compounds/toxicity*;Animals;Carbamates/toxicity*;Chlorpyrifos/toxicity*;Daphnia/drug effects*;Food Deprivation*;Food-Drug Interactions;Insecticides/toxicity*;No-Observed-Adverse-Effect Level;Phenylcarbamates*;Reproduction/drug effects
11865964;Adult;Analysis of Variance;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacokinetics;Eating/physiology*;Endothelin Receptor Antagonists*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Receptors, Endothelin/physiology;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11865159;Anticonvulsants/pharmacokinetics;Capsules;Delayed-Action Preparations/pharmacokinetics;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics*
11860217;Administration, Oral;Animals;Beverages*;Biological Availability;Citrus*/enzymology;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Food-Drug Interactions*/immunology;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics;Male;Rats;Rats, Sprague-Dawley
11849912;Adult;Anti-Anxiety Agents/administration & dosage*;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Bornanes/administration & dosage*;Bornanes/blood;Bornanes/chemistry;Bornanes/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Fasting/physiology;Food-Drug Interactions*;Gastric Juice/physiology;Humans;Hydrogen-Ion Concentration;Male;Solubility;Tablets, Enteric-Coated
11837383;Adult;Aged;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Isoquinolines/administration & dosage;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/pharmacology*;Kinetics;Male;Middle Aged;Peptidyl-Dipeptidase A/blood;Tetrahydroisoquinolines*
11831543;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions;Half-Life;Humans;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics*;Male;Single-Blind Method
11823754;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Calibration;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions/physiology*;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Purines;Quality Control;Sildenafil Citrate;Sulfones
11823753;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carrier Proteins/metabolism;Citrus;Double-Blind Method;Female;Flavonoids/metabolism;Food-Drug Interactions/physiology*;Fruit*;HeLa Cells;Histamine H1 Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Malus;Membrane Transport Proteins*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Dependent;Symporters;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
11816871;Adult;Beverages/adverse effects*;Citrus*;Clozapine/adverse effects;Clozapine/analogs & derivatives*;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Psychiatric Status Rating Scales;Schizophrenia/blood*;Schizophrenia/drug therapy
11810949;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements*;Food-Drug Interactions*;Garlic*;HIV Infections/drug therapy*;HIV Infections/enzymology;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics;Humans;Saquinavir/blood*;Saquinavir/pharmacokinetics
11796879;Aged;Antihypertensive Agents/adverse effects;Benzopyrans/adverse effects;Beverages;Citrus/adverse effects;Coffee/adverse effects;Diabetes Mellitus, Type 2/complications*;Diabetic Nephropathies/complications*;Ethanolamines/adverse effects;Food-Drug Interactions;Humans;Hyperkalemia/etiology*;Hyperkalemia/therapy;Male;Nebivolol
11794001;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Analysis of Variance;Area Under Curve;Double-Blind Method;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/blood;Hydromorphone/pharmacokinetics*;Male;Middle Aged
11791889;Adult;Antifungal Agents/pharmacology;Antipsychotic Agents/blood*;Antipsychotic Agents/therapeutic use;Beverages*;Citrus*;Clozapine/blood*;Clozapine/therapeutic use;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Enzyme Inhibitors/pharmacology;Food-Drug Interactions;Humans;Ketoconazole/pharmacology;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/physiology;Schizophrenia/blood*;Schizophrenia/drug therapy
11782897;Binding Sites;Carbonates/chemistry;Carbonates/metabolism*;Dose-Response Relationship, Drug;Food;Food-Drug Interactions/physiology;Iron Compounds/chemistry;Iron Compounds/metabolism*;Magnesium Compounds/chemistry;Magnesium Compounds/metabolism*;Metals/chemistry;Metals/metabolism;Phosphates/metabolism*
11777752;Adult;Analysis of Variance;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism;Drug Administration Schedule;Fasting/blood*;Food-Drug Interactions/physiology*;Humans;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives;Isosorbide Dinitrate/blood;Isosorbide Dinitrate/pharmacokinetics*;Male;Middle Aged;Tablets;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics
11768859;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Therapy, Combination;Female;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/therapeutic use;Male;Ritonavir/administration & dosage*;Ritonavir/therapeutic use;United States
11766777;Anti-Bacterial Agents/analysis;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/analysis*;Anticonvulsants/therapeutic use;Capsules;Carbohydrates/analysis*;Cathartics/analysis;Cathartics/therapeutic use;Chemistry, Pharmaceutical;Child;Drug Therapy, Combination;Energy Intake*;Epilepsy/complications;Epilepsy/diet therapy*;Epilepsy/drug therapy*;Food-Drug Interactions;Humans;Ketosis/etiology*;Tablets
11763808;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Diet;Female;Food-Drug Interactions*;Hemostatics/administration & dosage;Hemostatics/adverse effects*;Hemostatics/therapeutic use;Humans;International Normalized Ratio;Seaweed/chemistry*;Vitamin K/administration & dosage;Vitamin K/adverse effects*;Vitamin K/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects*;Warfarin/therapeutic use
11762562;Adult;Breath Tests;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Energy Intake;Ethanol/blood;Ethanol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
11757132;Adolescent;Anti-Infective Agents/adverse effects*;Caffeine/adverse effects*;Enoxacin/adverse effects*;Female;Food-Drug Interactions*;Humans;Psychoses, Substance-Induced/etiology*;Urinary Tract Infections/drug therapy*
11745911;Acetamides/administration & dosage;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacokinetics;Fasting/physiology;Female;Food-Drug Interactions/physiology*;Humans;Injections, Intravenous;Linezolid;Male;Middle Aged;Oxazolidinones/administration & dosage;Oxazolidinones/blood;Oxazolidinones/pharmacokinetics*
11724078;Adult;Aminosalicylic Acid/administration & dosage*;Aminosalicylic Acid/adverse effects;Aminosalicylic Acid/pharmacokinetics*;Antacids/pharmacology;Antitubercular Agents/administration & dosage*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Cross-Over Studies;Dietary Fats/pharmacology;Double-Blind Method;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions;Half-Life;Humans;Male;Powders;Therapeutic Equivalency
11723297;Adolescent;Adult;Cimetidine/administration & dosage;Cimetidine/adverse effects;Dietary Carbohydrates/administration & dosage;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Synergism;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Neurocysticercosis/diagnosis;Neurocysticercosis/drug therapy*;Praziquantel/administration & dosage*;Praziquantel/adverse effects
11722289;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Drug Resistance, Multiple;Food-Drug Interactions;Humans;Intestinal Absorption;Pharmaceutical Preparations/metabolism*;Protein Binding;Xenobiotics/metabolism*
11718495;Administration, Oral;Adult;Aminosalicylic Acid/pharmacology;Antacids/pharmacology*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Clofazimine/pharmacology;Cross-Over Studies;Cycloserine/administration & dosage;Cycloserine/adverse effects;Cycloserine/pharmacokinetics*;Dietary Fats/pharmacology*;Drug Interactions;Electrophoresis, Capillary;Ethionamide/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male
11711263;Administration, Oral;Adult;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics;Cefmenoxime/administration & dosage;Cefmenoxime/analogs & derivatives*;Cefmenoxime/pharmacokinetics;Ceftizoxime/administration & dosage;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Milk/metabolism*;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics*;Time Factors;Urine/chemistry;Water/administration & dosage;Water/metabolism*
11711262;Administration, Oral;Adult;Age Factors*;Aged;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/pharmacokinetics;Ceftizoxime/administration & dosage*;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics*;Diet*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Prodrugs/administration & dosage*;Prodrugs/pharmacokinetics*;Urine/chemistry
11694644;Complementary Therapies/adverse effects;Complementary Therapies/standards*;Dietary Supplements/standards;Drug Interactions;Food-Drug Interactions;Humans;Neoplasms/therapy*;Phytotherapy;Plants, Medicinal/adverse effects;Quality Control;Research/organization & administration*;Research/trends;Research Support as Topic/trends;Treatment Outcome
11693087;Adjuvants, Immunologic/therapeutic use;Anti-HIV Agents*/administration & dosage;Anti-HIV Agents*/adverse effects;Anti-HIV Agents*/classification;Anti-HIV Agents*/therapeutic use;Developing Countries;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;HIV Infections*/complications;HIV Infections*/drug therapy;Hepatitis B/complications;Hepatitis C/complications;Humans;Patient Advocacy
11692301;Aged;Aging/immunology*;Appetite Stimulants/therapeutic use;Dietary Supplements;Food-Drug Interactions;Humans;Infection/diet therapy*;Infection/etiology;Infection/immunology*;Nutrition Disorders/complications;Nutrition Disorders/diagnosis;Nutrition Disorders/epidemiology;Randomized Controlled Trials as Topic;Risk Factors
11684410;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Analysis of Variance;Area Under Curve;Caffeine/administration & dosage;Caffeine/blood;Caffeine/pharmacokinetics;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/pharmacokinetics;Cross-Over Studies;Drug Implants/administration & dosage;Drug Implants/pharmacokinetics;Fasting/blood;Female;Food-Drug Interactions/physiology;Gastric Emptying/physiology*;Humans;Male;Reproducibility of Results;Tablets, Enteric-Coated/administration & dosage;Tablets, Enteric-Coated/pharmacokinetics*
11681271;Area Under Curve;Drug Interactions;Food-Drug Interactions;Humans;Pharmacokinetics*
11673746;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Digoxin/pharmacokinetics*;Food-Drug Interactions*;Genotype;Humans;Polymorphism, Genetic
11605310;Acetaminophen/administration & dosage;Acetaminophen/adverse effects*;Acetaminophen/blood;Adult;Aged;Alanine Transaminase/metabolism;Alcoholism/complications*;Alcoholism/metabolism;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/blood;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury*;Cytochrome P-450 CYP2E1/metabolism;Diagnosis, Differential;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Liver/drug effects*;Liver/enzymology;Liver/metabolism*;Liver Diseases/blood;Liver Diseases/enzymology;Liver Function Tests;Treatment Outcome
11603643;Cardiovascular Diseases/therapy;Chronic Disease/therapy*;Dietary Supplements;Evidence-Based Medicine;Food, Organic*/adverse effects;Food, Organic*/standards;Food-Drug Interactions*;Humans;Safety;Treatment Outcome
11595840;Blood Glucose/metabolism;False Negative Reactions;Fluorodeoxyglucose F18*/metabolism;Food-Drug Interactions*;Humans;Lung Neoplasms/diagnostic imaging*;Lung Neoplasms/metabolism;Male;Middle Aged;Radiopharmaceuticals*/metabolism;Solitary Pulmonary Nodule/diagnostic imaging*;Solitary Pulmonary Nodule/metabolism;Tomography, Emission-Computed*
11587491;Adolescent;Adult;Area Under Curve;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics*;Chromatography, Gas;Cross-Over Studies;Delayed-Action Preparations;Electrochemistry;Female;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/pharmacokinetics*;Middle Aged;Stereoisomerism
11576693;Animals;Drug Carriers;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Intestines/metabolism*;Pharmaceutical Preparations/metabolism*;Rats
11572503;Administration, Oral;Beverages/adverse effects*;Biological Availability;Child;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Flavoring Agents/administration & dosage;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacokinetics;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/enzymology;Liver/enzymology;Midazolam/administration & dosage;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Mixed Function Oxygenases/antagonists & inhibitors;Taste/drug effects
11570093;Beverages;Citrus*;Drug Therapy, Combination;Food-Drug Interactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Ritonavir/therapeutic use;Saquinavir/administration & dosage;Saquinavir/pharmacokinetics*;Saquinavir/therapeutic use
11570085;Anti-HIV Agents/blood*;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use;Female;Food-Drug Interactions*;Garlic*;HIV Infections/blood*;HIV Infections/drug therapy;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Male;Plants, Medicinal*;Saquinavir/blood*;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
11563410;Administration, Oral;Adult;Analysis of Variance;Biological Availability;Blood Glucose/metabolism;Cross-Over Studies;Cyclohexanes/blood;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology*;Cyclohexanes/urine;Dietary Fats/pharmacokinetics*;Fasting/physiology;Food-Drug Interactions*;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*;Hypoglycemic Agents/urine;Insulin/blood;Male;Phenylalanine/analogs & derivatives;Phenylalanine/blood;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology*;Phenylalanine/urine
11563408;Administration, Oral;Adult;Analysis of Variance;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacokinetics*;Confidence Intervals;Cross-Over Studies;Fasting/blood;Food-Drug Interactions*;Ganciclovir/administration & dosage;Ganciclovir/pharmacokinetics*;HIV Seropositivity/blood;HIV Seropositivity/metabolism*;Humans;Least-Squares Analysis;Male;Middle Aged
11552202;Adult;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Biological Availability;Dietary Proteins/adverse effects;Drug Evaluation;Drug Monitoring;Drug Resistance;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food, Formulated/analysis;Food-Drug Interactions*;Humans;Male;Warfarin/blood;Warfarin/pharmacology*
11549099;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/adverse effects;Bronchodilator Agents/pharmacokinetics*;Carboxylic Acids;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclohexanecarboxylic Acids;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Nitriles;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
11531805;Adolescent;Adult;Anaphylaxis/etiology*;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Brachyura;Decapoda (Crustacea);Exercise*;Food Hypersensitivity/etiology*;Food-Drug Interactions*;Humans;Male;Middle Aged;Shellfish/adverse effects;Triticum/adverse effects
11525609;Antioxidants/administration & dosage;Antioxidants/adverse effects;Chemotherapy, Adjuvant;Dietary Supplements/adverse effects*;Food-Drug Interactions;Humans;Micronutrients/adverse effects*;Neoplasm Metastasis/drug therapy*;Neoplasms/drug therapy*;Neoplasms/pathology
11524779;Ethanol;Food-Drug Interactions/physiology*;Humans;Pharmacokinetics*
11524464;Adolescent;Adult;Aged;Analysis of Variance;Anticonvulsants/blood*;Anticonvulsants/pharmacokinetics;Area Under Curve;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption*/physiology;Male;Middle Aged;Phenytoin/blood*;Phenytoin/pharmacokinetics;Therapeutic Equivalency
11510376;Animal Feed;Animals;Anti-Bacterial Agents/administration & dosage*;Cat Diseases/diagnosis*;Cats;Drug Resistance, Microbial;Food-Drug Interactions;Hydrogen-Ion Concentration;Urinalysis;Urinary Tract Infections/diagnosis;Urinary Tract Infections/veterinary*
11509975;Animals;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/metabolism;Anti-Ulcer Agents/pharmacokinetics;Antioxidants/metabolism;Antioxidants/pharmacokinetics;Biological Availability;Carbohydrates/pharmacology*;Citrus/therapeutic use;Drugs, Chinese Herbal;Feces/chemistry;Flavanones*;Flavonoids/blood;Flavonoids/metabolism*;Flavonoids/pharmacokinetics;Food-Drug Interactions;Honey*;Phytotherapy;Rabbits;Sensitivity and Specificity
11509110;Anemia, Iron-Deficiency/prevention & control;Avitaminosis/prevention & control;Embryonic and Fetal Development;Female;Folic Acid Deficiency/prevention & control;Food-Drug Interactions;Humans;Infant, Low Birth Weight;Infant, Newborn;Iodine/deficiency;Magnesium Deficiency/prevention & control;Maternal Welfare*;Micronutrients*;Pregnancy;Pregnancy Complications/prevention & control*;Zinc/deficiency
11509108;Ascorbic Acid/metabolism;Biological Availability;Calcium/metabolism;Child;Child, Preschool;Copper/metabolism;Dietary Supplements*;Food, Fortified*;Food-Drug Interactions*;Humans;Infant;Intestinal Absorption;Iron/metabolism;Manganese/metabolism;Micronutrients/metabolism*;Zinc/metabolism
11488783;Area Under Curve;Beverages;Citrus*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics*;Flavonoids/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Omeprazole/analogs & derivatives;Omeprazole/metabolism;Omeprazole/pharmacokinetics*
11478464;Diet/standards;Dietary Supplements;Food, Organic/adverse effects;Food, Organic/standards*;Food-Drug Interactions;Health Promotion;Humans;Preventive Medicine;Quality Control;Safety;Treatment Outcome
11476118;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Public Health
11452240;Adult;Area Under Curve;Beverages*;Cisapride/analogs & derivatives*;Cisapride/blood;Cisapride/pharmacokinetics*;Cisapride/pharmacology;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Food-Drug Interactions;Gastrointestinal Agents/blood;Gastrointestinal Agents/pharmacokinetics*;Gastrointestinal Agents/pharmacology;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Reference Values;Wine*
11451032;Adult;Colloids;Dietary Fats/pharmacokinetics;Digestive System/metabolism*;Drug Carriers/pharmacokinetics*;Drug Monitoring/methods*;Female;Food-Drug Interactions/physiology;Humans;Liposomes/pharmacokinetics*;Magnetic Resonance Imaging/methods*;Male;Statistics, Nonparametric
11426073;Adult;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/therapeutic use;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Depression/complications;Depression/drug therapy*;Drug Interactions;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions;HIV Infections/complications;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/therapeutic use
11422012;Administration, Oral;Adolescent;Area Under Curve;Child;Child, Preschool;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Genetic Variation;Guanine Nucleotides/analysis*;Guanine Nucleotides/blood;Half-Life;Humans;Infant;Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy;Thioguanine/administration & dosage;Thioguanine/pharmacokinetics*;Thioguanine/therapeutic use;Time Factors
11417077;Animal Feed*;Animals;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Proteins/administration & dosage;Dietary Proteins/adverse effects;Food-Drug Interactions*;Hydrogen-Ion Concentration;Intestinal Absorption;Minerals/administration & dosage;Minerals/adverse effects;Veterinary Drugs/pharmacokinetics*
11405898;Anti-Bacterial Agents/administration & dosage;Anti-Infective Agents, Local/therapeutic use;Bandages*;Burns/therapy;Food-Drug Interactions;Honey*;Humans;Length of Stay;Surgical Wound Infection/therapy;Wound Healing;Wounds and Injuries/therapy*
11405288;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Citrus/chemistry*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions/physiology*;Furocoumarins/pharmacology;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar
11396348;Animals;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
11393692;Administration, Oral;Anti-Bacterial Agents/blood*;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid/methods;Clarithromycin/standards;Food-Drug Interactions;Humans;Mass Spectrometry;Minocycline/administration & dosage;Minocycline/blood*;Minocycline/pharmacokinetics*;Reference Standards;Tablets;Therapeutic Equivalency
11366377;AIDS-Related Opportunistic Infections/drug therapy*;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects*;Drug Interactions*;Drug Resistance, Microbial;Drug Therapy, Combination;Food-Drug Interactions;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects*;Humans;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects*
11365556;Child;Child Nutritional Physiological Phenomena*;Child Welfare;Child, Preschool;Dietary Supplements;Eating;Energy Intake;Female;Fluid Therapy;Food Handling;Food-Drug Interactions;HIV Infections/complications*;HIV Infections/epidemiology;HIV Infections/therapy;Humans;Infant;Infant, Newborn;Male;Nutrition Disorders/complications*;Nutrition Disorders/diet therapy*;Nutritional Requirements*;United States/epidemiology
11361049;Adult;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Half-Life;Headache/chemically induced;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Quinoxalines/adverse effects;Quinoxalines/blood;Quinoxalines/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*
11345788;Food-Drug Interactions*;Humans;Nutritional Sciences/education*;United States
11341034;Animal Feed;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/therapeutic use*;Dietary Supplements;Food-Drug Interactions*;Injections, Intraperitoneal;Inulin/administration & dosage;Inulin/therapeutic use*;Liver Neoplasms, Experimental/diet therapy*;Liver Neoplasms, Experimental/drug therapy*;Male;Mice;Mice, Inbred Strains;Neoplasm Transplantation;Oligosaccharides/administration & dosage;Oligosaccharides/therapeutic use*;Treatment Outcome
11334062;Cyclosporine/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/adverse effects*;Intestinal Absorption/drug effects*;Nutritional Status/drug effects;Organ Transplantation*;Pharmacokinetics;Postoperative Complications;Treatment Outcome
11334060;Cardiovascular Diseases/etiology*;Cardiovascular Diseases/prevention & control;Diabetes Complications;Food-Drug Interactions;Humans;Hyperlipidemias/complications;Hypertension/complications;Immunosuppressive Agents/adverse effects*;Obesity/complications;Organ Transplantation/adverse effects*;Risk Factors;Weight Gain*
11332259;Adult;Antihypertensive Agents/adverse effects*;Diagnostic Errors*;Female;Food-Drug Interactions*;Glycyrrhiza/adverse effects*;Humans;Hydrochlorothiazide/adverse effects;Hypertension/chemically induced*;Hypertension/diagnosis;Hypertension/drug therapy;Hypokalemia/etiology;Medical History Taking;Muscle Cramp;Netherlands;Plants, Medicinal*;Tea/adverse effects*
11327750;Education, Continuing;Enteral Nutrition*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Pharmacokinetics;Risk Factors;Treatment Outcome
11324121;Dental Care*;Dietary Supplements*;Drug Interactions;Food-Drug Interactions;Humans;Plants, Medicinal*
11322025;Anticonvulsants/pharmacokinetics*;Carbamazepine/pharmacokinetics*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged
11304900;Adult;Anti-HIV Agents/therapeutic use*;Beverages*;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;Gastric Juice/metabolism*;Gastric Juice/secretion;HIV Infections/drug therapy;HIV Infections/metabolism*;Half-Life;Humans;Hydrogen-Ion Concentration;Indinavir/pharmacokinetics*;Indinavir/pharmacology;Male;Middle Aged;Models, Biological;Time Factors
11303053;Adult;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Celecoxib;Cross-Over Studies;Dietary Fats/pharmacology;Dogs;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Male;Pyrazoles;Sulfonamides/administration & dosage;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11288420;Anticoagulants/pharmacokinetics;Critical Care*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Monoamine Oxidase Inhibitors/pharmacokinetics;Nutritional Support
11286323;Adult;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Cresols/administration & dosage;Cresols/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Phenylpropanolamine*;Tolterodine Tartrate;Urinary Bladder Diseases/metabolism*
11264638;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Aspergillosis/prevention & control;Carbonated Beverages*;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Itraconazole/administration & dosage;Itraconazole/pharmacokinetics*;Lung Diseases, Fungal/prevention & control;Lung Transplantation*;Opportunistic Infections/prevention & control;Retrospective Studies
11233298;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use;Carbamates;Clinical Trials as Topic;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors*/administration & dosage;HIV Protease Inhibitors*/pharmacology;Humans;Mixed Function Oxygenases/metabolism;Sulfonamides*/administration & dosage;Sulfonamides*/pharmacology
11231102;ATP-Binding Cassette, Sub-Family B, Member 1/pharmacokinetics*;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*;Biological Availability;Caco-2 Cells/metabolism;Citrus*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Male;Propanolamines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Stereoisomerism
11230998;Animals;Cyclooxygenase 1;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/pharmacology*;Eating/drug effects*;Eating/physiology;Female;Food-Drug Interactions*;Glutathione/drug effects;Glutathione/metabolism;Glutathione Peroxidase/drug effects;Glutathione Peroxidase/metabolism;Glutathione Reductase;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Intestinal Mucosa/pathology;Isoenzymes/antagonists & inhibitors;Male;Membrane Proteins;NADH, NADPH Oxidoreductases/drug effects;NADH, NADPH Oxidoreductases/metabolism;Oxidative Stress/drug effects*;Oxidative Stress/physiology;Piroxicam/pharmacology*;Prostaglandin-Endoperoxide Synthases;Rats;Rats, Wistar;Superoxide Dismutase/drug effects;Superoxide Dismutase/metabolism;Thiazines/pharmacology*;Thiazoles/pharmacology*;Ulcer/chemically induced*
11223799;Aged;Aged, 80 and over;Algorithms;Coronary Disease/epidemiology;Coronary Disease/nursing*;Coronary Disease/therapy;Female;Food-Drug Interactions;Humans;Hyperlipidemias/prevention & control;Male;Middle Aged;Nutrition Assessment*;Patient Education as Topic;United States/epidemiology
11216183;Anti-Ulcer Agents/adverse effects*;Anti-Ulcer Agents/pharmacokinetics;Arrhythmias, Cardiac/chemically induced*;Aryl Hydrocarbon Hydroxylases*;Beverages;Cisapride/adverse effects*;Cisapride/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Oxidoreductases, N-Demethylating/drug effects;Oxidoreductases, N-Demethylating/metabolism
11214778;Adult;Area Under Curve;Beverages*;Biotransformation;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Stereoisomerism;Verapamil/pharmacokinetics*;Verapamil/pharmacology
11210400;Adolescent;Adult;Chemistry, Pharmaceutical;Cholinergic Antagonists/chemistry;Cholinergic Antagonists/metabolism;Cholinergic Antagonists/pharmacokinetics;Cross-Over Studies;Delayed-Action Preparations;Female;Food;Food-Drug Interactions*;Humans;Male;Mandelic Acids/chemistry;Mandelic Acids/metabolism;Mandelic Acids/pharmacokinetics*
11210399;Adolescent;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/chemistry;Anticonvulsants/pharmacokinetics;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/chemistry;Carbamazepine/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Food;Food-Drug Interactions*;Humans;Male;Middle Aged
11210398;Administration, Oral;Adult;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*
11206038;3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors*;Aged;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Citrus/chemistry*;Food-Drug Interactions*;Half-Life;Humans;Male;Phosphodiesterase Inhibitors/blood*;Piperazines/blood*;Purines;Reproducibility of Results;Sildenafil Citrate;Spectrophotometry, Ultraviolet;Sulfones
11204334;Biological Availability;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Administration Schedule;Drug Synergism;Food-Drug Interactions*;Humans;Intestinal Mucosa/metabolism;Intestine, Small/metabolism;Liver/metabolism;Metabolic Diseases/etiology*;Metabolic Diseases/metabolism
11204333;Biological Availability;Food-Drug Interactions*/physiology;Humans;Malabsorption Syndromes/etiology*
11201303;Administration, Oral;Animals;Antimalarials/blood;Antimalarials/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cytochrome P-450 Enzyme Inhibitors;Female;Flavonoids/pharmacology*;Food-Drug Interactions*;Half-Life;Least-Squares Analysis;Quinine/administration & dosage;Quinine/blood;Quinine/pharmacokinetics*;Rats;Rats, Wistar
11185672;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions;Glyburide/pharmacokinetics*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Tablets
11185412;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Dietary Fats/pharmacology*;Female;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Middle Aged;Naphthyridines/administration & dosage;Naphthyridines/pharmacokinetics*
11180034;Administration, Oral;Adult;Antihypertensive Agents/pharmacokinetics*;Beverages*/analysis;Biological Availability;Caco-2 Cells/drug effects;Caco-2 Cells/enzymology;Citrus*/chemistry;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;DNA, Complementary/genetics;Enzyme Activation/drug effects;Enzyme Inhibitors/analysis;Enzyme Inhibitors/pharmacology;Felodipine/pharmacokinetics*;Female;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/pharmacology*;Humans;Male;Methoxsalen/analogs & derivatives*;Methoxsalen/analysis;Methoxsalen/pharmacology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/genetics;Mixed Function Oxygenases/metabolism
11170036;Administration, Oral;Animals;Food-Drug Interactions;Gastrointestinal Transit*;Injections, Intravenous;Intestinal Absorption*;Male;Radionuclide Imaging;Rats;Rats, Wistar;Theophylline/pharmacokinetics*
11155630;Creativity;Decision Support Systems, Clinical*;Efficiency, Organizational;Food-Drug Interactions;Hospitals, Community/organization & administration*;Humans;Indiana;Joint Commission on Accreditation of Healthcare Organizations;Medical Errors/prevention & control*;Multi-Institutional Systems/organization & administration;Parenteral Nutrition, Total;Risk Management*;Systems Integration;United States
11150014;Adult;Benzoates/adverse effects*;Female;Food Preservatives/adverse effects*;Food-Drug Interactions;Humans;Rhinitis, Allergic, Perennial/chemically induced*
11142666;Acrylic Resins;Analysis of Variance;Anti-Infective Agents, Local/antagonists & inhibitors*;Cetylpyridinium/antagonists & inhibitors*;Chlorhexidine/antagonists & inhibitors*;Dentifrices/pharmacokinetics;Drug Antagonism;Food-Drug Interactions;Humans;Mouthwashes/pharmacology*;Silicic Acid;Silicon Dioxide*;Sodium Fluoride*;Spectrophotometry;Tea/adverse effects;Tooth Discoloration/etiology;Toothpastes/pharmacology*
11141164;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced*
11135611;Ascorbic Acid/administration & dosage*;Ascorbic Acid/adverse effects;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics;Biological Availability;Citrus*;Food-Drug Interactions;Humans;Intestinal Absorption
11125872;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors;Absorption;Administration, Inhalation;Adult;Benzamides/blood;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Pilot Projects;Pyridines/blood;Pyridines/pharmacokinetics*;Sex Factors
11105574;Animals;Area Under Curve;Citrus*;Cyclosporine/pharmacokinetics;Cyclosporine/poisoning*;Food-Drug Interactions;Swine
11093663;Bornanes/blood*;Bornanes/pharmacokinetics;Calibration;Chromatography, Liquid/methods*;Food-Drug Interactions;Humans;Mass Spectrometry/methods*;Reproducibility of Results;Robotics;Serotonin Agents/blood*
11078178;Age Factors;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Blood Pressure/drug effects*;Blood Pressure/physiology*;Calcium Channel Blockers/pharmacology;Double-Blind Method;Enalapril/pharmacology*;Female;Food-Drug Interactions/physiology;Humans;Hypertension/physiopathology*;Isradipine/pharmacology*;Male;Middle Aged;Patient Compliance;Sex Factors;Sodium Chloride, Dietary/administration & dosage*;Sodium Chloride, Dietary/adverse effects*;Time Factors
11072877;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Bacillus subtilis/drug effects;Biological Availability;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Intestinal Absorption;Mice;Pharmaceutical Vehicles/administration & dosage;Pharmaceutical Vehicles/pharmacology;Poloxamer/pharmacology*;Serum Bactericidal Test;Stomach/metabolism;Tobramycin/administration & dosage;Tobramycin/blood;Tobramycin/pharmacokinetics*
11069440;Administration, Oral;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Middle Aged;Placebos;Pulse;Stereoisomerism
11064378;Animals;Antifungal Agents/pharmacokinetics*;Biological Availability;Caco-2 Cells;Cell Membrane Permeability;Dogs;Echinocandins;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Peptides, Cyclic/pharmacokinetics*
11061578;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Administration Schedule;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hypolipidemic Agents/pharmacokinetics;Male;Mixed Function Oxygenases/metabolism*;Reference Values;Simvastatin/administration & dosage;Simvastatin/blood;Simvastatin/pharmacokinetics*;Time Factors
11056327;Animals;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Hormonal/antagonists & inhibitors*;Antineoplastic Agents, Hormonal/therapeutic use;Female;Flavones*;Flavonoids/pharmacology*;Food-Drug Interactions;Mammary Neoplasms, Experimental/drug therapy*;Mice;Tamoxifen/antagonists & inhibitors*;Tamoxifen/therapeutic use
11054613;Animals;Anti-Arrhythmia Agents/pharmacology*;Anti-Arrhythmia Agents/therapeutic use;Atrial Fibrillation/drug therapy;Atrial Flutter/drug therapy;Clinical Trials as Topic;Drug Administration Schedule;Electrophysiology;Food-Drug Interactions;Heart Conduction System/drug effects*;Humans;Phenethylamines/administration & dosage;Phenethylamines/adverse effects;Phenethylamines/pharmacology*;Phenethylamines/therapeutic use*;Potassium Channel Blockers*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacology*;Sulfonamides/therapeutic use*;Tachycardia/complications;Tachycardia/drug therapy*;Tachycardia/physiopathology;Ventricular Dysfunction/complications
11049012;Adult;Anti-Inflammatory Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Hydrocortisone/blood;Male;Methylprednisolone/blood*
11012470;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Anti-Ulcer Agents/administration & dosage*;Anti-Ulcer Agents/pharmacology*;Cross-Over Studies;Enzyme Inhibitors/administration & dosage*;Enzyme Inhibitors/pharmacology*;Female;Food-Drug Interactions*;Gastric Acid/metabolism*;Gastric Acidity Determination;Humans;Lansoprazole;Male;Manometry;Middle Aged;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives;Omeprazole/pharmacology;Proton Pump Inhibitors*
11002903;Alcohol Drinking/genetics*;Alcohol Drinking/psychology;Animals;Behavior, Addictive/genetics*;Behavior, Addictive/psychology;Breeding;Conditioning, Operant;Food-Drug Interactions;Rats;Rats, Inbred Lew;Rats, Long-Evans;Research Design
10997154;Alkaline Phosphatase/blood;Animal Feed*;Animals;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Calorimetry, Indirect/veterinary;Cholesterol/blood;Diet, Fat-Restricted/veterinary;Diet, Protein-Restricted/veterinary;Dogs/physiology*;Erythrocyte Count/veterinary;Female;Fluorescence Polarization/veterinary;Food-Drug Interactions*;Half-Life;Hematocrit/veterinary;Hemoglobins/analysis;Phenobarbital/blood;Phenobarbital/pharmacokinetics*;Prospective Studies;Random Allocation;Seizures/prevention & control;Seizures/veterinary;Serum Albumin/analysis
10994829;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Beverages/adverse effects*;Beverages/analysis;Biological Availability;Calcium Channel Blockers/metabolism;Citrus/adverse effects*;Citrus/chemistry;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Immunosuppressive Agents/metabolism;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Psychotropic Drugs/metabolism;Tacrolimus/metabolism;Terfenadine/metabolism
10994537;Acute Disease;Adult;Anticoagulants/adverse effects*;Drug Interactions;Drug and Narcotic Control;Female;Food-Drug Interactions;Garlic/adverse effects*;Ginkgo biloba/adverse effects*;Hematoma, Subdural/chemically induced;Humans;Medical History Taking;Nursing Assessment;Phytotherapy*;Plants, Medicinal*;Warfarin/adverse effects*
10993569;Aged;Anticoagulants/administration & dosage*;Bacteria, Anaerobic/drug effects*;Bacteria, Anaerobic/growth & development;Diet;Female;Food-Drug Interactions;Gastritis, Atrophic/drug therapy;Gastritis, Atrophic/microbiology*;Humans;Hydrogen-Ion Concentration;Intestines/microbiology*;Male;Middle Aged;Vitamin K/antagonists & inhibitors*;Vitamin K/biosynthesis;Vitamin K 1/administration & dosage;Vitamin K 1/deficiency;Vitamin K Deficiency/chemically induced;Warfarin/administration & dosage*
10991886;Adult;Antiplatyhelmintic Agents/administration & dosage;Antiplatyhelmintic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Diet;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Middle Aged;Praziquantel/administration & dosage;Praziquantel/pharmacokinetics*;Tablets
10963958;Amines/chemistry;Amines/metabolism;Amines/toxicity*;DNA/drug effects;DNA Damage/drug effects;Escherichia coli/drug effects;Escherichia coli/enzymology;Escherichia coli/genetics;Food Preservatives/chemistry;Food Preservatives/metabolism;Food Preservatives/toxicity*;Food-Drug Interactions*;HeLa Cells/drug effects;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Mutagenicity Tests;Mutagens/chemistry;Mutagens/metabolism;Mutagens/toxicity*;Plasmids/drug effects;Plasmids/genetics;SOS Response (Genetics)/drug effects;Salmonella typhimurium/drug effects;Salmonella typhimurium/genetics;Salmonella typhimurium/metabolism;Sorbic Acid/chemistry;Sorbic Acid/metabolism;Sorbic Acid/toxicity*
10963462;Anticoagulants*;Clinical Competence*;Food-Drug Interactions*;Health Personnel/education*;Health Personnel/standards;Humans;Surveys and Questionnaires;Treatment Outcome;Vitamin K*;Warfarin*
10959308;Beverages*;Citrus*;Food-Drug Interactions*;Humans
10959278;Drug Interactions*;Food-Drug Interactions*;Humans
10954962;Clinical Trials as Topic;Diabetes Mellitus, Type 2/drug therapy*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Hypoglycemic Agents/therapeutic use*;Insulin Resistance;Thiazoles/pharmacology*;Thiazoles/therapeutic use;Thiazolidinediones*;United States
10954012;Administration, Oral;Adult;Appetite/drug effects;Blood Glucose/drug effects;Blood Glucose/metabolism;Calorimetry, Indirect;Cholecystokinin/blood;Cross-Over Studies;Double-Blind Method;Energy Metabolism/drug effects;Epinephrine/blood;Food-Drug Interactions;Fructose/pharmacology;Gastric Inhibitory Polypeptide/blood;Glucagon/blood;Glucagon-Like Peptide 1;Hexoses/blood;Hexoses/pharmacokinetics;Hexoses/pharmacology*;Humans;Male;Norepinephrine/blood;Peptide Fragments/blood;Protein Precursors/blood;Stereoisomerism;Sweetening Agents/pharmacokinetics;Sweetening Agents/pharmacology;Uric Acid/blood*;Uric Acid/urine
10945313;Aged;Aged, 80 and over;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacology*;Area Under Curve;Beverages;Blood Pressure/drug effects*;Citrus*;Diastole/drug effects;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/blood;Felodipine/pharmacology*;Female;Food-Drug Interactions;Half-Life;Heart Rate/drug effects;Humans;Male;Posture;Reference Values;Systole/drug effects;Time Factors
10928402;Administration, Oral;Enteral Nutrition*;Food, Formulated;Food-Drug Interactions*;Humans;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*;Professional Practice;Prospective Studies;Randomized Controlled Trials as Topic;Retrospective Studies
10913925;Adult;Analgesics, Non-Narcotic/administration & dosage*;Analgesics, Non-Narcotic/pharmacokinetics*;Clodronic Acid/administration & dosage*;Clodronic Acid/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Eating*;Food-Drug Interactions;Humans;Intestinal Absorption
10907671;Adult;Alprazolam/blood;Alprazolam/pharmacokinetics*;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Anxiety Disorders/metabolism;Beverages*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism*;Psychomotor Performance/physiology;Smoking/metabolism;Statistics, Nonparametric
10899384;Analgesics, Opioid/pharmacology*;Animals;Body Weight/drug effects;Diet;Female;Food-Drug Interactions*;Male;Morphine/pharmacology*;Pain*;Pain Measurement;Rats;Rats, Long-Evans;Saccharin/pharmacology*;Sex Characteristics*;Sucrose/pharmacology*;Taste
10896460;Anti-Bacterial Agents/pharmacology;Anticonvulsants/pharmacology;Biological Availability;Contraceptives, Oral, Combined/pharmacokinetics*;Contraceptives, Oral, Hormonal/pharmacokinetics*;Drug Interactions;Ethinyl Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Liver/metabolism;Prodrugs/pharmacokinetics;Progestins/pharmacokinetics
10892988;Administration, Oral;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/blood*;Antifungal Agents/pharmacokinetics;Beverages*;Citrus*;Drug Administration Schedule;Food-Drug Interactions*;Male;Mice;Mice, Inbred ICR;Pyrimidines/administration & dosage;Pyrimidines/blood*;Pyrimidines/pharmacokinetics;Triazoles/administration & dosage;Triazoles/blood*;Triazoles/pharmacokinetics;Voriconazole
10890261;Administration, Oral;Aged;Beverages*;Chromatography, High Pressure Liquid;Citrus*/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/blood;Depression/blood;Depression/drug therapy*;Female;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes/drug effects;Microsomes/metabolism;Middle Aged;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/blood;Prospective Studies;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline/administration & dosage;Sertraline/analogs & derivatives;Sertraline/antagonists & inhibitors;Sertraline/metabolism;Sertraline/pharmacokinetics*;Treatment Outcome
10888309;Adult;Amoxicillin/pharmacokinetics*;Capsules;Cross-Linking Reagents;Cross-Over Studies;Digestive System/diagnostic imaging;Digestive System/metabolism*;Excipients;Food-Drug Interactions;Gelatin;Humans;Male;Penicillins/pharmacokinetics*;Radionuclide Imaging;Therapeutic Equivalency
10883418;Biological Availability;Contraceptives, Oral, Synthetic/adverse effects;Contraceptives, Oral, Synthetic/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Estradiol/adverse effects;Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norgestrel/adverse effects;Norgestrel/analogs & derivatives*;Norgestrel/pharmacokinetics*;Postmenopause/metabolism*;Women's Health
10872652;Anticholesteremic Agents/pharmacology*;Area Under Curve;Beverages;Citrus/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Liver/enzymology;Lovastatin/pharmacology*;Mixed Function Oxygenases/antagonists & inhibitors*
10872589;Beverages/analysis*;Calibration;Chromatography, High Pressure Liquid;Citrus*;Coumarins/analysis*;Coumarins/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Mass Spectrometry;Mixed Function Oxygenases/metabolism;Reproducibility of Results;Substrate Specificity
10859150;Aryl Hydrocarbon Hydroxylases*;Beverages*;Citrus*;Coumarins/pharmacokinetics;Coumarins/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions;Humans;Microsomes, Liver/enzymology;Oxidoreductases, N-Demethylating/antagonists & inhibitors*
10851844;Adverse Drug Reaction Reporting Systems;Drug Interactions*;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans
10832939;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/therapeutic use*;Disease*;Drug Interactions;Drug Monitoring;Fever/physiopathology;Food-Drug Interactions;Heart Failure/physiopathology;Humans;Liver Diseases/physiopathology;Safety;Thyroid Diseases/physiopathology;Warfarin/administration & dosage;Warfarin/therapeutic use*
10798570;Body Composition/drug effects;Body Composition/physiology*;Body Water/drug effects;Body Water/metabolism;Central Nervous System Depressants/blood*;Ethanol/blood*;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Humans;Sex Factors
10798569;Alcoholic Beverages*;Animals;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Gastric Emptying/drug effects*;Gastric Emptying/physiology;Humans;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Male;Rats
10798565;Biological Availability;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*
10798564;Alcohol Drinking/metabolism*;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Dose-Response Relationship, Drug;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans;Male
10790445;Alcoholic Beverages*;Analysis of Variance;Bisphenol A-Glycidyl Methacrylate/chemistry;Corn Oil/chemistry;Dental Bonding*;Dentin-Bonding Agents/chemistry*;Dietary Fats;Ethanol/chemistry;Food*;Food-Drug Interactions;Humans;Lactic Acid/chemistry;Materials Testing;Orthodontic Brackets*;Resin Cements/chemistry*;Statistics, Nonparametric;Water/chemistry
10772438;Anti-Bacterial Agents/pharmacology*;Antineoplastic Agents/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions;Erythromycin/pharmacology;Food-Drug Interactions;Humans;Tylosin/analogs & derivatives;Tylosin/pharmacology
10768303;Adolescent;Age Factors;Aged;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology;Anticonvulsants/therapeutic use;Biological Availability;Child;Child, Preschool;Drug Interactions;Epilepsy/drug therapy*;Epilepsy/metabolism;Food-Drug Interactions;Fructose/analogs & derivatives*;Fructose/pharmacokinetics;Fructose/pharmacology;Fructose/therapeutic use;Half-Life;Humans;Intestinal Absorption;Patient Compliance;Pharmacokinetics;Tissue Distribution
10759694;Adult;Amiodarone/analogs & derivatives;Amiodarone/blood;Amiodarone/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases*;Beverages*;Biotransformation;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Electrocardiography/drug effects;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases, N-Demethylating/metabolism
10741622;Adult;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Nisoldipine/adverse effects;Nisoldipine/blood;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology*;Reference Values;Time Factors;Vasodilator Agents/pharmacology
10740993;Aged;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Beverages*;Citrus*;Female;Fluoxetine/adverse effects*;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions*;Humans
10732665;Cheese/adverse effects*;Cheese/analysis;Diet*;Food/adverse effects*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects
10718785;Administration, Oral;Adult;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Eating;Fasting;Food-Drug Interactions;Humans;Hydantoins;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazolidines*;Male;Piperazines/adverse effects;Piperazines/pharmacokinetics*
10709801;Area Under Curve;Data Interpretation, Statistical*;Food-Drug Interactions;Half-Life;Humans;Mathematics;Pharmacokinetics*
10702965;Adult;Area Under Curve;Beverages*;Bronchodilator Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Male;Theophylline/pharmacokinetics*
10688276;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Beverages;Biological Transport, Active;Citrus;Diet*;Digestive System/metabolism*;Flavonoids/metabolism;Food-Drug Interactions;Humans;Pharmaceutical Preparations/metabolism*
10683873;Antimalarials/chemistry;Antimalarials/pharmacokinetics*;Bile Acids and Salts/chemistry*;Caco-2 Cells;Excipients*;Food-Drug Interactions*;Humans;Micelles;Pectins/chemistry*;Permeability;Quinine/chemistry;Quinine/pharmacokinetics*
10681346;Animals;Antifungal Agents/administration & dosage*;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dogs;Dose-Response Relationship, Drug;Food-Drug Interactions;Macaca fascicularis;Male;Mice;Rabbits;Rats;Triazoles/administration & dosage*;Triazoles/blood;Triazoles/pharmacokinetics*
10681341;Adult;Animals;Antimalarials/pharmacokinetics*;Antimalarials/therapeutic use*;Area Under Curve;Artemisinins*;Biological Availability;Child;Double-Blind Method;Drug Therapy, Combination;Electrocardiography;Ethanolamines/pharmacokinetics*;Ethanolamines/therapeutic use*;Fluorenes/pharmacokinetics*;Fluorenes/therapeutic use*;Food-Drug Interactions;Humans;Malaria, Falciparum/drug therapy*;Plasmodium falciparum/isolation & purification;Prospective Studies;Sesquiterpenes/therapeutic use;Treatment Outcome
10664901;Cardiovascular Agents/pharmacology*;Databases as Topic;Drug Interactions;Food-Drug Interactions;Guidelines as Topic;Humans;Internet;Psychotropic Drugs/pharmacology*
10651665;Adult;Erythromycin/administration & dosage*;Erythromycin/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions/physiology*;Gastrointestinal Motility/drug effects*;Humans;Infusions, Intravenous;Intestine, Small/drug effects*;Male;Manometry;Time Factors
10644077;Adamantane/analogs & derivatives;Adamantane/chemistry;Adamantane/pharmacokinetics;Anti-Bacterial Agents/chemistry;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/chemistry;Antimalarials/pharmacokinetics;Atovaquone;Biopharmaceutics*;Chemical Phenomena;Chemistry, Physical;Chromans/chemistry;Chromans/pharmacokinetics;Chromatography, High Pressure Liquid;Food-Drug Interactions;Lactams*;Naphthoquinones/chemistry;Naphthoquinones/pharmacokinetics;Phenylurea Compounds/chemistry;Phenylurea Compounds/pharmacokinetics;Platelet Aggregation Inhibitors/chemistry;Platelet Aggregation Inhibitors/pharmacokinetics;Predictive Value of Tests;Prodrugs/chemistry;Prodrugs/pharmacokinetics;Solubility*;Solvents;Spectrophotometry, Ultraviolet;Thiazoles/chemistry;Thiazoles/pharmacokinetics;Thiazolidinediones*
10640644;Animals;Delayed-Action Preparations;Dogs;Fasting;Food-Drug Interactions;Hydrogels/chemistry;Hydrogels/pharmacokinetics*;Microscopy, Electron, Scanning;Porosity;Stomach/physiology*;Time Factors
11122551;Aging/physiology*;Anorexia;Body Composition;Bone Diseases, Metabolic;Dietary Supplements;Food-Drug Interactions;Geriatric Assessment;Humans;Nutritional Physiological Phenomena*;Quality of Life
10616954;Animals;Biological Availability;Curcumin/administration & dosage*;Diet*;Ferula*;Food-Drug Interactions;Humans;Medicine, Ayurvedic*;Medicine, East Asian Traditional*;Nepal;Phytotherapy;Plants, Medicinal*;Plants, Toxic*
10610011;AIDS-Related Opportunistic Infections/metabolism;AIDS-Related Opportunistic Infections/prevention & control;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects*;Antifungal Agents/pharmacokinetics*;Atovaquone;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects*;Naphthoquinones/pharmacokinetics*;Pneumonia, Pneumocystis/prevention & control;Trimethoprim, Sulfamethoxazole Drug Combination/pharmacokinetics
10606837;Adult;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Computer Simulation;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors/pharmacokinetics*;Felodipine/pharmacokinetics*;Food-Drug Interactions*;Gastrointestinal Transit/physiology;Humans;Intestines/metabolism;Liver/metabolism;Male;Metabolic Clearance Rate;Mixed Function Oxygenases/antagonists & inhibitors;Models, Biological
10604039;Administration, Oral;Animals;Bile/metabolism;Biotransformation;Blood Proteins/metabolism;Dogs;Feces/chemistry;Female;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption;Lymph/metabolism;Macaca fascicularis;Male;Nootropic Agents/pharmacokinetics*;Piperidines/pharmacokinetics*;Proline/analogs & derivatives*;Proline/pharmacokinetics;Protein Binding;Rats;Rats, Sprague-Dawley;Sex Characteristics
10594469;Adult;Aging;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Digestive System/metabolism;Doxazosin/administration & dosage*;Doxazosin/adverse effects;Doxazosin/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Male;Sex Characteristics;Therapeutic Equivalency
10584969;3-Hydroxybutyric Acid/metabolism;Anticonvulsants/metabolism*;Anticonvulsants/therapeutic use;Carnitine/metabolism*;Carnitine/therapeutic use;Dietary Fats/metabolism*;Dietary Fats/therapeutic use;Energy Metabolism/physiology*;Epilepsy/diet therapy;Epilepsy/metabolism*;Fatty Acids/urine;Food-Drug Interactions;Glucagon/blood;Humans;Insulin/blood;Ketone Bodies/metabolism*;Ketosis/chemically induced;Oxidation-Reduction;Patient Selection
10583024;Absorption;Adolescent;Adult;Age Factors;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Etidronic Acid/administration & dosage;Etidronic Acid/adverse effects;Etidronic Acid/analogs & derivatives*;Etidronic Acid/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Humans;Male;Risedronate Sodium;Sex Factors;Time Factors
10579471;Administration, Oral;Adult;Beverages*;Chromatography, High Pressure Liquid;Cisapride/blood;Cisapride/pharmacokinetics*;Cisapride/pharmacology;Citrus*;Cross-Over Studies;Electrocardiography/drug effects;Food-Drug Interactions;Gastrointestinal Agents/blood;Gastrointestinal Agents/pharmacokinetics*;Gastrointestinal Agents/pharmacology;Humans;Male;Time Factors
10579146;Adult;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Patient Dropouts;Sirolimus/blood;Sirolimus/pharmacokinetics*;Time Factors
10573471;Adolescent;Anticonvulsants/administration & dosage;Anticonvulsants/economics*;Anticonvulsants/therapeutic use;Child;Child, Preschool;Cost-Benefit Analysis;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Drug Costs*;Epilepsy/diet therapy*;Epilepsy/drug therapy;Epilepsy/economics*;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Infant;Ketosis*/etiology;Ketosis*/metabolism;Male;Patient Dropouts;Prospective Studies;Treatment Outcome
10548035;Food-Drug Interactions*;Humans
10546925;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/blood;Antimalarials/pharmacokinetics*;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/blood;Antiprotozoal Agents/pharmacokinetics*;Artemisinins*;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Male;Reference Values;Sesquiterpenes/administration & dosage;Sesquiterpenes/blood;Sesquiterpenes/pharmacokinetics*;Time Factors
10546919;Adult;Analysis of Variance;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/administration & dosage;Lovastatin/blood*;Male;Reference Values
10542738;Drug Monitoring;Drug Therapy/nursing;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Intestinal Absorption;Metabolic Clearance Rate;Patient Education as Topic
10538657;Boston;Cost Savings;Decision Support Systems, Clinical*;Drug Interactions;Food-Drug Interactions;Hospitals, General/standards;Hospitals, Teaching/standards;Humans;Hypersensitivity/prevention & control;Iatrogenic Disease/prevention & control*;Medication Errors/prevention & control;Unnecessary Procedures;User-Computer Interface
10511919;Age Factors;Biological Availability*;Clinical Trials as Topic;Food-Drug Interactions*;Forecasting;Humans;Models, Biological;Pharmacokinetics*
10507245;Acetylcholinesterase/blood*;Butyrylcholinesterase/blood*;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics;Cholinesterase Inhibitors/pharmacology*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Humans;Time Factors;Trichlorfon/administration & dosage;Trichlorfon/adverse effects;Trichlorfon/pharmacokinetics;Trichlorfon/pharmacology*
10496300;Animals;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics;Antimalarials/pharmacology*;Artemisinins*;Clinical Trials as Topic;Drug Combinations;Drug Resistance, Microbial;Drug Resistance, Multiple;Ethanolamines/administration & dosage;Ethanolamines/adverse effects;Ethanolamines/pharmacokinetics*;Ethanolamines/pharmacology*;Fluorenes/administration & dosage;Fluorenes/adverse effects;Fluorenes/pharmacokinetics*;Fluorenes/pharmacology*;Food-Drug Interactions;Humans;Malaria/metabolism*;Plasmodium falciparum/physiology*;Sesquiterpenes/pharmacokinetics*
10485080;Adult;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cohort Studies;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/metabolism;Triazoles/pharmacokinetics*
10471981;Adult;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions/physiology*;Humans;Indoles/adverse effects;Indoles/blood*;Male;Models, Statistical;Time Factors
10471070;Adult;Chlorzoxazone/pharmacokinetics*;Citrus;Cohort Studies;Cytochrome P-450 CYP2E1/genetics*;Female;Food-Drug Interactions;Humans;Life Style;Male;Microsomes, Liver/enzymology;Middle Aged;Neuromuscular Agents/pharmacokinetics*;Obesity/metabolism;Phenotype;Solvents
10460103;Adult;Analysis of Variance;Antacids/pharmacokinetics*;Antitubercular Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Interactions;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Regression Analysis;Statistics, Nonparametric
10442206;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions;Half-Life;Humans;Male;Tramadol/administration & dosage*;Tramadol/pharmacokinetics*
10440622;Adolescent;Adult;Animals;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Milk
10431417;Cheese*;Female;Food-Drug Interactions*;Headache/chemically induced*;Humans;Hypertension/chemically induced*;Middle Aged;Monoamine Oxidase Inhibitors/adverse effects*;Tranylcypromine/adverse effects
10431317;Biological Availability;Diuretics/administration & dosage;Diuretics/metabolism*;Diuretics/pharmacokinetics*;Food-Drug Interactions;Heart Failure/drug therapy*;Heart Failure/metabolism*;Humans;Intestinal Absorption;Metabolic Clearance Rate;Solubility
10423213;Anticoagulants/adverse effects*;Beverages*;Citrus*;Food-Drug Interactions;Humans;Male;Middle Aged;Warfarin/adverse effects*
10412889;Albendazole/metabolism*;Animal Feed;Animals;Anthelmintics/metabolism*;Benzimidazoles/analysis;Biotransformation;Chromatography, High Pressure Liquid;Diet/veterinary*;Food-Drug Interactions;Guanidines/metabolism*;In Vitro Techniques;Prodrugs/metabolism;Reproducibility of Results;Rumen/metabolism*;Rumen/microbiology;Sheep/metabolism*
10399135;Animals;Blood Glucose/drug effects*;Body Weight/drug effects;Constriction;Dietary Fats, Unsaturated/pharmacology*;Dose-Response Relationship, Drug;Drinking/drug effects;Eating/drug effects;Fish Oils/chemistry*;Food-Drug Interactions;Hemodynamics/drug effects;Insulin/pharmacology*;Male;Random Allocation;Rats;Rats, Wistar
10391425;Diet, Protein-Restricted/adverse effects;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Epilepsy/diet therapy*;Food-Drug Interactions;Humans;Ketosis*/etiology;Pharmaceutical Services*/standards;Starvation/complications;Starvation/physiopathology*
10367106;Administration, Oral;Adrenergic alpha-1 Receptor Agonists*;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/pharmacokinetics*;Adrenergic alpha-Agonists/urine;Anilides/administration & dosage;Anilides/pharmacokinetics*;Anilides/urine;Animals;Bile/metabolism;Blood Proteins/metabolism;Erythrocytes/metabolism;Feces/chemistry;Female;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption;Lung/metabolism;Male;Protein Binding;Rats;Rats, Sprague-Dawley;Sex Characteristics
10354963;Absorption;Adolescent;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Headache/chemically induced;Humans;Lamivudine/adverse effects;Lamivudine/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Tablets;Therapeutic Equivalency;Zidovudine/adverse effects;Zidovudine/pharmacokinetics*
10351030;Avitaminosis/chemically induced;Digestive System/drug effects;Drug-Related Side Effects and Adverse Reactions*;Education, Pharmacy, Continuing;Electrolytes/blood;Enteral Nutrition;Food-Drug Interactions*;Humans;Nutritional Support*;Parenteral Nutrition;Pharmaceutical Vehicles;Pharmacokinetics;United States
10349562;Chemistry, Pharmaceutical;Eating*;Excipients/chemistry;Felodipine/chemistry;Food-Drug Interactions*;Hydrogen-Ion Concentration;In Vitro Techniques;Nifedipine/chemistry;Solubility;Surface-Active Agents/chemistry;Tablets/metabolism*;Water/chemistry*
10334118;Antitubercular Agents/pharmacokinetics*;Biological Availability;Drug Interactions;Food-Drug Interactions;Humans;Isoniazid/pharmacokinetics*
10326940;Adult;Alcohol Drinking/blood*;Cholesterol/blood;Dietary Fats/administration & dosage*;Drug Synergism;Fasting/blood*;Fatty Acids/blood;Female;Food-Drug Interactions;Humans;Hypertriglyceridemia/blood*;Male;Middle Aged;Triglycerides/blood*
10225572;Administration, Oral;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Ciprofloxacin/administration & dosage;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Suspensions;Tablets;Therapeutic Equivalency
10223170;Administration, Oral;Animals;Chemistry, Pharmaceutical;Delayed-Action Preparations;Digestive System/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Pharmacokinetics*
10220126;Adult;Aged;Beverages;Citrus*;Female;Food-Drug Interactions*;Haloperidol/blood;Haloperidol/pharmacology*;Haloperidol/therapeutic use;Humans;Middle Aged;Psychiatric Status Rating Scales;Schizophrenia/blood;Schizophrenia/drug therapy*;Schizophrenic Psychology
10206085;Adolescent;Adult;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions/physiology*;Humans;Hypoglycemic Agents/blood*;Male;Thiazoles/adverse effects;Thiazoles/blood*;Thiazolidinediones*
10192596;Acute Disease;Bread/analysis;Cheese/analysis;Chromatography, High Pressure Liquid;Diet/adverse effects*;Food Analysis/statistics & numerical data;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/chemistry*;Tyramine/adverse effects*;Tyramine/analysis
10102975;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/pharmacology*;Cross-Over Studies;Double-Blind Method;Famotidine/administration & dosage;Famotidine/pharmacology*;Female;Food-Drug Interactions*;Gastric Acid/secretion*;Humans;Hydrogen-Ion Concentration;Male;Ranitidine/administration & dosage;Ranitidine/pharmacology*
10096315;Administration, Oral;Adult;Age Factors;Aged;Alcohol Drinking/blood*;Area Under Curve;Central Nervous System Depressants/administration & dosage;Central Nervous System Depressants/blood*;Cohort Studies;Cross-Sectional Studies;Ethanol/administration & dosage;Ethanol/blood*;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Male;Middle Aged;Reference Values;Sex Factors;Substance Abuse Detection/standards*;Time Factors
10096255;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Beverages;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacology*;Female;Food-Drug Interactions;Furocoumarins/pharmacology*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Intestinal Mucosa/cytology;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism*;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/metabolism;Reference Values
10090652;Animals;Behavior, Animal/drug effects;Drug Administration Schedule;Drug Interactions;Ethanol/administration & dosage;Ethanol/pharmacology*;Excitatory Amino Acid Antagonists/administration & dosage;Excitatory Amino Acid Antagonists/pharmacology;Food-Drug Interactions;Macaca mulatta;Male;Naltrexone/pharmacology*;Narcotic Antagonists/pharmacology*;Phencyclidine/administration & dosage;Phencyclidine/pharmacology*;Reinforcement (Psychology)*;Saccharin/administration & dosage;Saccharin/pharmacology*;Self Administration
10087023;Animals;Biological Transport, Active;Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology;Cimetidine/metabolism*;Drug Interactions;Food-Drug Interactions;Histamine H2 Antagonists/metabolism*;Hydrogen-Ion Concentration;In Vitro Techniques;Intestinal Absorption*;Intestine, Small/metabolism*;Intestine, Small/ultrastructure;Male;Membrane Potentials;Microvilli/metabolism;Patch-Clamp Techniques;Rats;Rats, Sprague-Dawley;Sodium/metabolism
10049268;Adult;Antacids/pharmacology*;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Double-Blind Method;Drug Interactions;Ethambutol/pharmacokinetics*;Fasting/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Models, Biological
10048159;Alcohol Drinking/adverse effects*;Animals;Cytochrome P-450 CYP2E1/metabolism;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/metabolism;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Hepatitis, Alcoholic/etiology;Hepatitis, Alcoholic/metabolism*;Hepatitis, Alcoholic/pathology;Male;Necrosis;Rats;Rats, Sprague-Dawley
9972685;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacology;Animals;Columbidae;Dose-Response Relationship, Drug;Drug Tolerance;Food-Drug Interactions*;Morphine/administration & dosage*;Morphine/pharmacology
9972684;Analgesia;Analgesics, Opioid/pharmacology*;Animals;Body Weight;Dietary Proteins/pharmacology*;Eating;Food-Drug Interactions;Male;Minerals/pharmacology*;Morphine/pharmacology*;Pain Measurement;Rats;Rats, Long-Evans;Sucrose/pharmacology;Vitamins/pharmacology*
9925057;Adult;Antacids/administration & dosage*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/pharmacokinetics*;Cross-Over Studies;Drug Interactions;Drug Therapy, Combination;Fasting/physiology*;Female;Food-Drug Interactions/physiology*;Humans;Male;Metabolic Clearance Rate/physiology;Rifampin/administration & dosage;Rifampin/pharmacokinetics*
9923580;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Citrus*;Cross-Over Studies;Dihydropyridines/blood;Dihydropyridines/pharmacokinetics*;Dihydropyridines/pharmacology;Food-Drug Interactions/physiology*;Half-Life;Heart Rate/drug effects;Humans;Male
9918208;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage*;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics;Biological Availability;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics
9884817;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antifungal Agents/therapeutic use*;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology;Itraconazole/therapeutic use*;Organ Specificity
9884814;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Cardiovascular Diseases/metabolism;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Mibefradil;Tetrahydronaphthalenes/pharmacokinetics*;Tetrahydronaphthalenes/therapeutic use
9882081;Adolescent;Adult;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Humans;Ketoprofen/analogs & derivatives*;Ketoprofen/pharmacology;Ketoprofen/toxicity;Male;Middle Aged;Tablets;Tromethamine/analogs & derivatives*;Tromethamine/pharmacology;Tromethamine/toxicity
9882026;Animals;Avitaminosis/chemically induced;Biological Availability;Digestive System/drug effects*;Dose-Response Relationship, Drug;Fat Substitutes/adverse effects*;Fat Substitutes/pharmacokinetics;Fatty Acids/adverse effects*;Fatty Acids/pharmacokinetics;Food-Drug Interactions;Humans;Sucrose/adverse effects;Sucrose/analogs & derivatives*;Sucrose/pharmacokinetics
9879808;Air Pollutants, Occupational/metabolism*;Animals;Arsenicals/metabolism*;Chemistry Techniques, Analytical/methods*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Rats
9879571;Biological Transport/drug effects;Electrophoresis, Capillary;Food-Drug Interactions;Micelles;Permeability;Polysaccharides/pharmacology*;Propranolol/metabolism*;Starch/metabolism*
9877005;Amphetamine/pharmacology;Animals;Caffeine/pharmacology*;Central Nervous System Stimulants/pharmacology*;Cocaine/pharmacology;Drinking;Food-Drug Interactions;Male;Nicotine/pharmacology;Rats;Rats, Sprague-Dawley;Reinforcement Schedule*;Substance-Related Disorders
9875172;Beverages/adverse effects*;Citrus/adverse effects*;Complementary Therapies;Female;Food-Drug Interactions*;Humans;Middle Aged;Nifedipine/adverse effects*;Phytotherapy;United States;Vasodilator Agents/adverse effects*
9871430;Adult;Beverages;Buspirone/blood*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mixed Function Oxygenases/drug effects;Reference Values;Serotonin Receptor Agonists/blood*
9855317;Adult;Antacids/pharmacology*;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/pharmacology;Area Under Curve;Cross-Over Studies;Data Interpretation, Statistical;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Pyrazinamide/pharmacokinetics*;Pyrazinamide/pharmacology
9854915;Anesthetics/metabolism*;Cholinesterase Inhibitors/metabolism*;Food-Drug Interactions*;Humans;Solanaceous Alkaloids/metabolism*
9841049;Anesthetics*;Food-Drug Interactions*;Humans;Solanum tuberosum*
9839088;Aged;Animals;Anthraquinones/administration & dosage;Anthraquinones/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Osteoarthritis/drug therapy;Time Factors
9839087;Age Factors;Alcohol Deterrents/pharmacokinetics*;Alcohol Deterrents/pharmacology;Animals;Desipramine/pharmacokinetics;Diazepam/pharmacokinetics;Disulfiram/pharmacokinetics;Dose-Response Relationship, Drug;Drug Interactions;Ethanol/pharmacokinetics;Food-Drug Interactions;Humans;Imipramine/pharmacokinetics;Psychotropic Drugs/pharmacokinetics;Sex Characteristics;Taurine/analogs & derivatives*;Taurine/pharmacokinetics;Taurine/pharmacology
9834039;Adult;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Hypolipidemic Agents/blood*;Male;Reference Values;Simvastatin/analogs & derivatives*;Simvastatin/blood*
9833595;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxazoles/adverse effects;Oxazoles/metabolism;Oxazoles/pharmacokinetics*;Oxazolidinones*;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/metabolism;Serotonin Receptor Agonists/pharmacokinetics*;Tryptamines
9832982;Animals;Dextroamphetamine/administration & dosage;Dextroamphetamine/pharmacology*;Dopamine Agents/administration & dosage;Dopamine Agents/pharmacology*;Drinking;Eating;Female;Food-Drug Interactions;Macaca mulatta;Male;Reinforcement (Psychology)*;Self Administration
9830331;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacology*;Beverages*;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacology;Citrus*;Cyclosporins/blood;Cyclosporins/metabolism;Cyclosporins/pharmacology;Felodipine/blood;Felodipine/metabolism;Felodipine/pharmacology*;Food-Drug Interactions*;Humans;Intestine, Small/metabolism
9829163;Aged;Alzheimer Disease/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/classification;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy;Tyramine/adverse effects
9821810;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antioxidants/pharmacology;Beverages*;Biological Transport/drug effects;Caco-2 Cells/drug effects*;Caco-2 Cells/enzymology;Caco-2 Cells/metabolism*;Cell Survival/drug effects;Citrus*;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Inhibitors/pharmacology;Estrogen Antagonists/pharmacology;Flavanones*;Flavonoids/pharmacology;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Mixed Function Oxygenases/metabolism;Plant Extracts/pharmacology*;Tritium;Vinblastine/pharmacokinetics*
9818297;Adult;Amitriptyline/metabolism*;Eating;Female;Food-Drug Interactions*;Humans;Middle Aged;Nortriptyline/metabolism*
9808916;Antipsychotic Agents/adverse effects*;Child;Feeding and Eating Disorders/chemically induced*;Feeding and Eating Disorders/diet therapy;Food-Drug Interactions;Humans;Male;Risperidone/adverse effects*;Weight Gain/drug effects
9807638;Anorexia Nervosa/drug therapy*;Anorexia Nervosa/genetics;Anorexia Nervosa/physiopathology;Appetite Regulation/physiology;Bulimia/drug therapy*;Bulimia/genetics;Bulimia/physiopathology;Disease Progression;Food-Drug Interactions;Genetic Predisposition to Disease;Humans;Neural Pathways/physiology;Nutritional Physiological Phenomena/physiology;Obsessive Behavior/physiopathology;Serotonin/physiology*;Serotonin Uptake Inhibitors/pharmacology;Serotonin Uptake Inhibitors/therapeutic use*
9805816;Buspirone/pharmacokinetics*;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Humans;Metabolic Clearance Rate;Nifedipine/pharmacokinetics*;Postprandial Period;Theophylline/pharmacokinetics*
9796864;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/pharmacology;Beverages/adverse effects*;Citrus/adverse effects*;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions*;Humans;Infant;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology
9793622;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Dietary Fats;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naproxen/adverse effects*;Naproxen/pharmacokinetics*;Reproducibility of Results;Spectrometry, Fluorescence
9789724;Aged;Aging/metabolism*;Food-Drug Interactions*;Humans;Nutritional Status;Pharmacokinetics*
9786475;Adult;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/adverse effects;Anti-Infective Agents/metabolism;Anti-Infective Agents/pharmacokinetics*;Delayed-Action Preparations;Double-Blind Method;Fluoroquinolones*;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/metabolism;Piperazines/pharmacokinetics*;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/metabolism;Quinolones/pharmacokinetics*;Saliva/chemistry
9784933;Age Factors;Antihypertensive Agents/pharmacokinetics*;Calcium Channel Blockers/pharmacokinetics*;Delayed-Action Preparations;Drug Interactions;Ethnic Groups;Food-Drug Interactions;Humans;Hypertension/metabolism*;Kidney Diseases/metabolism;Liver Diseases/metabolism;Nisoldipine/blood;Nisoldipine/pharmacokinetics*;Stereoisomerism
9784932;Administration, Oral;Administration, Rectal;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Chemistry, Pharmaceutical;Child;Delayed-Action Preparations;Food-Drug Interactions;Humans;Morphine/administration & dosage;Morphine/pharmacokinetics*;Morphine/therapeutic use;Pain/drug therapy*
9775886;Avitaminosis/chemically induced*;Avitaminosis/prevention & control;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans;Nutrition Assessment*;Nutritional Sciences/education;Patient Education as Topic
9764220;Amines/chemistry*;Chromatography, Gas;Food Preservatives/chemistry*;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Magnetic Resonance Spectroscopy;Sorbic Acid/chemistry*
9757923;Adult;Aged;Analysis of Variance;Critical Care/methods*;Enteral Nutrition*;Food-Drug Interactions;Humans;Hypnotics and Sedatives/pharmacokinetics*;Liver/blood supply*;Longitudinal Studies;Middle Aged;Parenteral Nutrition*;Propofol/pharmacokinetics*;Splanchnic Circulation/drug effects;Splanchnic Circulation/physiology;Time Factors
9757152;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Beverages;Carbamazepine/pharmacokinetics*;Citrus/metabolism*;Cross-Over Studies;Drug Administration Schedule;Epilepsy/drug therapy;Epilepsy/metabolism*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Time Factors;Water/metabolism
9757148;Administration, Oral;Adult;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Antioxidants/pharmacology*;Area Under Curve;Beverages;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/pharmacology*;Felodipine/blood;Felodipine/pharmacokinetics*;Flavanones*;Flavonoids/pharmacology*;Food-Drug Interactions;Furocoumarins/pharmacology*;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Reference Values
9737819;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/pharmacology*;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacology*;Female;Food-Drug Interactions*;Gastric Emptying;Humans;Hydrogen-Ion Concentration;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Postprandial Period;Ranitidine/pharmacology;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Tryptamines;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/pharmacokinetics*
9737815;Acrylates/administration & dosage;Acrylates/pharmacokinetics*;Administration, Oral;Adult;Analysis of Variance;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Food-Drug Interactions*;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Injections, Intravenous;Male;Thiophenes*
9725481;Adult;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacokinetics;Dihydropyridines/adverse effects;Dihydropyridines/metabolism;Dihydropyridines/pharmacokinetics*;Double-Blind Method;Food-Drug Interactions*;Humans;Male
9723817;Administration, Oral;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans;Intestine, Small/metabolism;Mixed Function Oxygenases/metabolism;Pharmacokinetics*
9706183;Aged;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Beverages*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prothrombin Time*;Warfarin/blood;Warfarin/pharmacokinetics*
9696960;Administration, Oral;Aged;Aged, 80 and over;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Verapamil/blood;Verapamil/pharmacokinetics*
9682663;Animals;Culture Techniques;Enzyme Inhibitors/pharmacology;Fluoxetine/pharmacology*;Food-Drug Interactions*;Intestinal Absorption/drug effects*;Intestinal Mucosa/metabolism;Jejunum/metabolism;Leucine/pharmacokinetics*;Male;Microvilli/metabolism;Rats;Rats, Wistar;Serotonin Uptake Inhibitors/pharmacology*;Sodium-Potassium-Exchanging ATPase/metabolism;Time Factors
9676346;Adult;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
9676344;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/pharmacokinetics*;Anti-Asthmatic Agents/standards*;Bile Acids and Salts/metabolism;Delayed-Action Preparations;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Quality Control;Reproducibility of Results;Surface-Active Agents/chemistry;Theophylline/administration & dosage;Theophylline/pharmacokinetics*;Theophylline/standards*;Therapeutic Equivalency
9663817;Adolescent;Adult;Anthelmintics/administration & dosage;Anthelmintics/adverse effects;Anthelmintics/pharmacokinetics*;Anthelmintics/therapeutic use;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Child;Cross-Over Studies;Fascioliasis/drug therapy;Fascioliasis/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
9663198;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Diet;Female;Food-Drug Interactions;Heart Valve Prosthesis/adverse effects*;Humans;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications, Cardiovascular/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage;Warfarin/pharmacokinetics;Warfarin/therapeutic use
10185290;Adverse Drug Reaction Reporting Systems*;Centers for Medicare and Medicaid Services (U.S.);Dietary Services/organization & administration;Dietary Services/standards*;Dietetics;Food Service, Hospital/organization & administration;Food Service, Hospital/standards*;Food-Drug Interactions*;Humans;Joint Commission on Accreditation of Healthcare Organizations;United States
10185288;Adverse Drug Reaction Reporting Systems*;Counseling;Dietary Services/organization & administration;Dietary Services/standards*;Food Service, Hospital/organization & administration;Food Service, Hospital/standards*;Food-Drug Interactions*;Guideline Adherence;Humans;Joint Commission on Accreditation of Healthcare Organizations;Patient Education as Topic/standards;Total Quality Management;United States
9650536;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Calcium Channel Blockers/therapeutic use*;Diabetic Nephropathies/drug therapy;Diabetic Nephropathies/metabolism;Diuretics/therapeutic use*;Drug Therapy, Combination;Food-Drug Interactions;Heart Diseases/drug therapy*;Heart Diseases/metabolism;Humans;Hypertension/drug therapy*;Hypertension/metabolism;Myocardial Infarction/drug therapy;Myocardial Infarction/metabolism
9638385;Drug Administration Schedule;Drug Labeling;Education, Pharmacy;Food-Drug Interactions*;Humans;Inpatients*;Patient Education as Topic
9629990;Administration, Oral;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics*
9620116;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Biological Availability;Enteral Nutrition*;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Male;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*
9620100;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Acetaminophen/therapeutic use;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/adverse effects;Analgesics/pharmacokinetics;Analgesics/pharmacology*;Analgesics/therapeutic use;Benzophenones/administration & dosage;Benzophenones/pharmacokinetics;Benzophenones/pharmacology*;Benzophenones/therapeutic use;Biological Availability;Bromobenzenes/administration & dosage;Bromobenzenes/pharmacokinetics;Bromobenzenes/pharmacology*;Bromobenzenes/therapeutic use;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naproxen/adverse effects;Naproxen/pharmacokinetics;Naproxen/pharmacology*;Naproxen/therapeutic use;Orthopedic Procedures*;Pain Measurement;Pain, Postoperative/drug therapy*;Time Factors
9612666;Adult;Aryl Hydrocarbon Hydroxylases*;Beverages*;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Female;Food-Drug Interactions*;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine*;Liver/enzymology;Male;Oxidoreductases, N-Demethylating/metabolism*
9611659;Adult;Antitubercular Agents/adverse effects*;Biogenic Amines/adverse effects*;Cheese/adverse effects*;Female;Food Hypersensitivity/diagnosis;Food Hypersensitivity/etiology;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*
9604126;Administration, Oral;Adult;Analysis of Variance;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Triazoles/adverse effects;Triazoles/pharmacokinetics*
9602956;Administration, Oral;Adult;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Biological Availability;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Humans;Male;Tetrazoles/blood;Tetrazoles/pharmacokinetics*
9590459;Adult;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Blood Specimen Collection/methods*;Cross-Over Studies;Food-Drug Interactions;Humans;Nipecotic Acids/blood;Nipecotic Acids/pharmacokinetics*;Reproducibility of Results;Therapeutic Equivalency
9585793;Acids/blood;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/blood*;Male;Mixed Function Oxygenases/metabolism;Reference Values
9579961;Acetates/analysis;Acetates/blood;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/pharmacokinetics*;Cyclohexanecarboxylic Acids*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacokinetics*;Epilepsy/blood;Epilepsy/drug therapy*;Epilepsy/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Saliva/chemistry;gamma-Aminobutyric Acid*
9579238;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Deamino Arginine Vasopressin/blood;Deamino Arginine Vasopressin/pharmacokinetics*;Eating*;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Renal Agents/blood;Renal Agents/pharmacokinetics*;Single-Blind Method;Sodium/blood;Time Factors
9563888;Administration, Oral;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Capecitabine;Colorectal Neoplasms/metabolism*;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Double-Blind Method;Female;Fluorouracil/analogs & derivatives;Food-Drug Interactions*;Humans;Male;Middle Aged
9578193;Aged;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/therapeutic use;Area Under Curve;Female;Food-Drug Interactions*;Half-Life;Humans;Indoles/adverse effects;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Parkinson Disease/drug therapy;Parkinson Disease/metabolism*
9578182;Adult;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism;Saquinavir/pharmacokinetics*
9563073;Adult;Animals;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/blood;Disopyramide/blood;Disopyramide/pharmacokinetics*;Dogs;Female;Food-Drug Interactions*;Humans;Intestinal Absorption;Liver/metabolism;Male;Piperidines/blood;Piperidines/pharmacokinetics*;Species Specificity;Structure-Activity Relationship
9563071;Adult;Area Under Curve;Biological Availability;Capsules;Colon/diagnostic imaging*;Cross-Over Studies;Eating;Female;Food-Drug Interactions*;Gastric Emptying;Gastrointestinal Transit;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Intestinal Absorption;Intestine, Small/diagnostic imaging*;Male;Radionuclide Imaging;Saquinavir/blood;Saquinavir/pharmacokinetics*;Technetium
9562227;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacology;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Gas;Citrus*;Confidence Intervals;Cross-Over Studies;Flavanones*;Flavonoids/blood;Flavonoids/pharmacology;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male;Nimodipine/administration & dosage;Nimodipine/blood;Nimodipine/pharmacokinetics*;Reference Values;Water
9562133;Acetates/blood;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cyclohexanecarboxylic Acids*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Female;Food-Drug Interactions*;Humans;Male;gamma-Aminobutyric Acid*
9559810;Adult;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Beverages*;Citrus/chemistry*;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Humans;Male;Mixed Function Oxygenases/metabolism
9555149;Anti-Allergic Agents/adverse effects*;Citrus/adverse effects*;Food-Drug Interactions*;Terfenadine/adverse effects*
9555148;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans;Terfenadine/adverse effects*;Terfenadine/pharmacology
9554320;Animals;Antidepressive Agents/metabolism;Antidepressive Agents/pharmacokinetics*;Antidepressive Agents/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions;Genetic Variation;Humans;Polymorphism, Genetic;Serotonin/physiology;Serotonin/poisoning;Serotonin Uptake Inhibitors/metabolism;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology;Stereoisomerism;Syndrome
9550749;Citrus/adverse effects*;Drug Synergism;Food-Drug Interactions*;Humans;Terfenadine/pharmacokinetics*;Terfenadine/therapeutic use
9545149;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/antagonists & inhibitors;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Cyclodextrins/blood;Cyclodextrins/urine;Dose-Response Relationship, Drug;Drug Evaluation;Eating;Fasting;Food/adverse effects*;Food-Drug Interactions/physiology*;Humans;Itraconazole/administration & dosage;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Middle Aged;Pharmaceutical Solutions;beta-Cyclodextrins*
9533066;Acetazolamide/therapeutic use;Anticonvulsants/therapeutic use;Avitaminosis/chemically induced;Child;Child, Preschool;Dehydration/chemically induced;Food, Formulated*/adverse effects;Food-Drug Interactions;Forecasting;Humans;Infant;Phenobarbital/therapeutic use;Seizures/diet therapy*;Seizures/drug therapy
9527781;Adult;Analysis of Variance;Dietary Fats/adverse effects*;Double-Blind Method;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Metabolic Clearance Rate
9523309;Acetaminophen/pharmacokinetics*;Adult;Area Under Curve;Caffeine/pharmacokinetics*;Female;Food-Drug Interactions*;Gastric Emptying*;Humans;Male;Viscosity
9523307;Animals;Anti-Arrhythmia Agents/administration & dosage;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dogs;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Piperidines/administration & dosage;Piperidines/blood;Piperidines/pharmacokinetics*;Viscosity
9522033;Amylases/secretion;Animals;Bicarbonates/metabolism;Dogs;Female;Food-Drug Interactions*;Hormone Antagonists/blood;Hormone Antagonists/pharmacology*;Male;Pancreas/drug effects;Pancreas/enzymology;Pancreas/secretion*;Pancreatic Juice/drug effects;Pancreatic Juice/metabolism;Proglumide/analogs & derivatives*;Proglumide/blood;Proglumide/pharmacology;Receptors, Cholecystokinin/antagonists & inhibitors*;Trypsin/secretion
9510981;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Fasting/metabolism;Food-Drug Interactions*;Half-Life;Humans;Indoles/pharmacokinetics*;Mass Spectrometry;Quinolizines/pharmacokinetics*;Serotonin Antagonists/pharmacokinetics*;Tablets
9503566;Blood Pressure/drug effects*;Diet*;Food-Drug Interactions*;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Substrate Specificity;Tyramine/administration & dosage*;Tyramine/metabolism
9505992;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Area Under Curve;Bilirubin/metabolism*;Cross-Over Studies;Cyclosporins/administration & dosage;Cyclosporins/pharmacokinetics*;Dietary Fats/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*
9505987;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclohexanols/blood;Cyclohexanols/pharmacokinetics*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Serotonin Uptake Inhibitors/blood;Serotonin Uptake Inhibitors/pharmacokinetics*;Venlafaxine Hydrochloride
9494251;Adolescent;Adult;Amino Acids/administration & dosage;Child;Child, Preschool;Diet;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Doping in Sports;Energy Intake;Energy Metabolism;Female;Food-Drug Interactions;Humans;Infant;Male;Middle Aged;Minerals/administration & dosage;Nutritional Physiological Phenomena*;Physical Exertion;Sports*/physiology;Vitamins/administration & dosage;Work/physiology
9475824;Common Cold/drug therapy*;Common Cold/prevention & control;Food-Drug Interactions;Gluconates/administration & dosage;Gluconates/adverse effects;Gluconates/therapeutic use;Humans;Placebo Effect;Randomized Controlled Trials as Topic;Tablets;Zinc/administration & dosage;Zinc/adverse effects;Zinc/therapeutic use*;Zinc Acetate/adverse effects;Zinc Acetate/therapeutic use
9469677;Adult;Area Under Curve;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Female;Food-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Kidney Failure, Chronic/metabolism;Kidney Failure, Chronic/therapy;Kidney Transplantation/physiology*;Male;Middle Aged
9469675;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/pharmacology;Area Under Curve;Attention/drug effects*;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
9465974;Education, Pharmacy/standards*;Food-Drug Interactions*;Georgia;Humans;Joint Commission on Accreditation of Healthcare Organizations;Patient Education as Topic*;Pharmacy Service, Hospital/standards*
9465845;Beverages;Citrus*;Drug Labeling*;Food-Drug Interactions*;Humans;Pharmacy;Practice Guidelines as Topic;Victoria
9455715;Area Under Curve;Biological Availability;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Diet;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Fasting;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intestinal Absorption;Lipid Metabolism;Lipids/chemistry;Male;Tablets;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
9455713;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Male
9450162;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Valproic Acid/pharmacokinetics*
9386217;Contraindications;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/nursing*;Food, Formulated;Food-Drug Interactions;Humans;Parenteral Nutrition;Patient Selection
9423141;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adenine/therapeutic use;Administration, Oral;Animals;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacokinetics*;Antiviral Agents/therapeutic use;Biological Availability;Dogs;Fasting;Food-Drug Interactions;Hydrogen-Ion Concentration;Injections, Intravenous;Male;Organophosphonates*;Pentagastrin/pharmacology;Solubility;Tablets
9390116;Beverages;Citrus*;Food-Drug Interactions;Histamine H1 Antagonists/pharmacokinetics*;Humans;Information Services*;Terfenadine/pharmacokinetics*;United States
9357093;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Citrus*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Pectins/pharmacology*;Valproic Acid/pharmacokinetics*
9354216;2-Pyridinylmethylsulfinylbenzimidazoles;Amoxicillin/therapeutic use;Anti-Bacterial Agents/administration & dosage*;Anti-Ulcer Agents/administration & dosage*;Clarithromycin/therapeutic use;Drug Therapy, Combination;Food-Drug Interactions*;Helicobacter Infections/drug therapy*;Helicobacter pylori*;Humans;Lansoprazole;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives*
9353575;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Diet, Fat-Restricted;Dietary Fats/administration & dosage;Food-Drug Interactions;Humans;Intestinal Absorption;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/pharmacokinetics;Male;Middle Aged;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacokinetics*
9330784;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Diet;Dietary Fats/administration & dosage*;Fasting;Food-Drug Interactions*;Histamine Antagonists/administration & dosage;Histamine Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Mass Spectrometry;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
9330779;Administration, Oral;Adult;Analysis of Variance;Antidepressive Agents/administration & dosage;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Diet;Fasting;Food-Drug Interactions*;Humans;Male;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*
9333047;Adolescent;Adult;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Anti-Ulcer Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/adverse effects;Ofloxacin/pharmacokinetics*;Reference Values;Spectrophotometry, Ultraviolet;Sucralfate/pharmacology*
9322548;Absorption;Adolescent;Adult;Aged;Aging/metabolism*;Anemia, Pernicious/metabolism;Food-Drug Interactions;Humans;Malabsorption Syndromes/etiology;Malabsorption Syndromes/metabolism;Middle Aged;Stomach/metabolism*;Vitamin B 12/blood*;Vitamin B 12/metabolism;Vitamin B 12/pharmacokinetics;Vitamin B 12 Deficiency/blood*;Vitamin B 12 Deficiency/etiology;Vitamin B 12 Deficiency/metabolism
9332549;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Antiviral Agents/pharmacokinetics;Antiviral Agents/therapeutic use;Biological Availability;Food-Drug Interactions*;Ganciclovir/pharmacokinetics;Ganciclovir/therapeutic use;Gastric Acid/metabolism;Humans;Itraconazole/pharmacokinetics*;Itraconazole/therapeutic use;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
9312310;Administration, Oral;Adult;Analysis of Variance;Androgen Antagonists/administration & dosage;Androgen Antagonists/blood;Androgen Antagonists/pharmacokinetics*;Anilides/administration & dosage;Anilides/blood;Anilides/pharmacokinetics*;Animals;Area Under Curve;Dietary Fats/administration & dosage;Eating;Fasting/blood;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Nitriles;Rats;Stereoisomerism;Tosyl Compounds
9279885;Animals;Anti-Arrhythmia Agents/pharmacokinetics*;Bile/metabolism;Colon/metabolism;Disopyramide/pharmacokinetics*;Fasting;Food-Drug Interactions*;Gastrointestinal Transit/drug effects;Hydrogen-Ion Concentration;Ileum/metabolism;Intestinal Absorption/drug effects;Jejunum/metabolism;Male;Permeability;Piperidines/pharmacokinetics*;Rats;Sodium Chloride/pharmacology
9269874;Acetates/administration & dosage;Acetates/blood*;Amines*;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood*;Area Under Curve;Cyclohexanecarboxylic Acids*;Diet;Dogs;Female;Food-Drug Interactions;Intestinal Absorption;Jejunum;Male;Rats;Rats, Sprague-Dawley;gamma-Aminobutyric Acid*
9267685;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology*;Analysis of Variance;Antacids/pharmacology*;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/blood;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage;Imidazoles/blood;Imidazoles/pharmacokinetics*;Indoles/administration & dosage;Indoles/blood;Indoles/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male;Solutions;Tablets
9267682;Absorption;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Aromatase Inhibitors*;Biological Availability;Cross-Over Studies;Eating;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Fasting/blood;Food-Drug Interactions*;Humans;Male;Nitriles/administration & dosage;Nitriles/blood;Nitriles/pharmacokinetics*;Reproducibility of Results;Tablets, Enteric-Coated;Triazoles/administration & dosage;Triazoles/blood;Triazoles/pharmacokinetics*
9263375;Area Under Curve;Chemistry, Pharmaceutical;Clinical Trials as Topic;Cyclosporine/chemistry;Cyclosporine/pharmacokinetics*;Food-Drug Interactions;Guidelines as Topic;Humans;Immunosuppressive Agents/chemistry;Immunosuppressive Agents/pharmacokinetics*;Therapeutic Equivalency*;Time Factors;Transplantation
9262944;Animals;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Digestive System/drug effects*;Digestive System/microbiology;Digestive System Physiological Phenomena;Fat Substitutes/chemistry;Fat Substitutes/metabolism*;Fat Substitutes/toxicity*;Fatty Acids/chemistry;Fatty Acids/metabolism*;Fatty Acids/toxicity*;Food-Drug Interactions;Guidelines as Topic;Humans;Intestinal Absorption;Pharmaceutical Preparations/metabolism;Sucrose/analogs & derivatives*;Sucrose/chemistry;Sucrose/metabolism;Sucrose/toxicity
9260035;Adrenergic Uptake Inhibitors/chemistry;Adrenergic Uptake Inhibitors/pharmacokinetics*;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Antirheumatic Agents/chemistry;Antirheumatic Agents/pharmacokinetics*;Area Under Curve;Computer Simulation;Disopyramide/chemistry;Disopyramide/pharmacokinetics;Doxepin/chemistry;Doxepin/pharmacokinetics;Drug Interactions;Flurbiprofen/chemistry;Flurbiprofen/pharmacokinetics;Food-Drug Interactions;Guidelines as Topic;Hydroxychloroquine/chemistry;Hydroxychloroquine/pharmacokinetics;Ibuprofen/chemistry;Ibuprofen/pharmacokinetics;Nadolol/chemistry;Nadolol/pharmacokinetics;Nortriptyline/chemistry;Nortriptyline/pharmacokinetics;Propafenone/chemistry;Propafenone/pharmacokinetics;Stereoisomerism;Therapeutic Equivalency;Verapamil/chemistry;Verapamil/pharmacokinetics
9260033;Administration, Cutaneous;Aging/metabolism;Area Under Curve;Cohort Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology;Male;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacokinetics*;Monoamine Oxidase Inhibitors/pharmacology*;Selegiline/administration & dosage;Selegiline/pharmacokinetics*;Selegiline/pharmacology*;Sex Factors;Structure-Activity Relationship;Tissue Distribution
9241001;Beverages*;Child;Food-Drug Interactions*;Fruit*;Humans;Psychotropic Drugs/pharmacology*
9290996;Adult;Aged;Anti-Ulcer Agents/adverse effects*;Enteral Nutrition/adverse effects*;Equipment Failure;Esophageal Stenosis/diagnosis;Esophageal Stenosis/etiology*;Esophageal Stenosis/therapy;Fatal Outcome;Female;Food-Drug Interactions;Humans;Intubation, Gastrointestinal/adverse effects*;Male;Middle Aged;Sucralfate/adverse effects*;Vomiting/etiology*
9220063;Anaphylaxis/diagnosis;Animals;Antitubercular Agents/adverse effects*;Diagnosis, Differential;Food-Drug Interactions*;Foodborne Diseases/diagnosis*;Foodborne Diseases/etiology;Humans;Isoniazid/adverse effects*;Tuna*
9210983;Adult;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Coffee*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Milk*;Tea*;Tetracycline/administration & dosage;Tetracycline/pharmacokinetics*
9211455;Biological Availability;Diet;Enteral Nutrition/adverse effects;Enteral Nutrition/nursing*;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intubation, Gastrointestinal;Sorbitol/adverse effects
9205821;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Blood Cell Count/drug effects;Blood Chemical Analysis;Blood Pressure/drug effects;Body Temperature/drug effects;Chromatography, Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Endopeptidases/metabolism;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Heart Rate/drug effects;Humans;Japan;Male;Mass Spectrometry;Pilot Projects;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine
9845494;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Biological Availability;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/blood;HIV Infections/etiology;HIV Infections/prevention & control*;Health Personnel*;Humans;Occupational Exposure/adverse effects*;Patient Compliance
9164129;Food-Drug Interactions;Humans;Nutritional Requirements*;Nutritional Support*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology
9160173;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use*;Arteriosclerosis/drug therapy;Arteriosclerosis/etiology;Brain/metabolism;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/therapeutic use*;Fatty Acids, Monounsaturated/pharmacokinetics;Fatty Acids, Monounsaturated/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/complications;Hypercholesterolemia/drug therapy;Indoles/pharmacokinetics;Indoles/therapeutic use;Liver/metabolism;Lovastatin/analogs & derivatives;Lovastatin/pharmacokinetics;Lovastatin/therapeutic use;Pravastatin/pharmacokinetics;Pravastatin/therapeutic use;Simvastatin
9155792;Adult;Cheese/adverse effects*;Emergencies;Female;Food-Drug Interactions*;Humans;Hypertension/drug therapy;Hypertension/etiology*;Hypertension/nursing;Monoamine Oxidase Inhibitors/adverse effects*
9140560;Allopurinol/administration & dosage;Allopurinol/blood;Allopurinol/pharmacokinetics*;Animals;Chromatography, High Pressure Liquid/methods;Chromatography, High Pressure Liquid/veterinary;Creatinine/urine;Cross-Over Studies;Diet/veterinary*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacology*;Dogs/blood;Dogs/metabolism*;Dose-Response Relationship, Drug;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions;Injections, Intravenous;Minerals/analysis;Oxypurinol/administration & dosage;Oxypurinol/blood;Oxypurinol/pharmacokinetics*;Time Factors
9129871;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology;Calcium Channel Blockers/therapeutic use*;Delayed-Action Preparations;Drug Interactions;Food-Drug Interactions;Humans;Myocardial Ischemia/drug therapy*;Myocardial Ischemia/metabolism;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology;Nisoldipine/therapeutic use*;Randomized Controlled Trials as Topic
9274239;Adolescent;Adult;Age Factors;Aged;Calcium Compounds/therapeutic use*;Calcium, Dietary/administration & dosage*;Calcium, Dietary/adverse effects;Child;Child, Preschool;Female;Food, Fortified*;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Nutritional Requirements*;Pregnancy;Sex Factors
9169308;Adrenergic Uptake Inhibitors/pharmacokinetics*;Age Factors;Animals;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Brain/metabolism;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver/drug effects;Liver/enzymology;Liver Diseases/metabolism;Morpholines/pharmacokinetics*;Morpholines/urine;Stereoisomerism
9129557;Adult;Anti-Allergic Agents/pharmacokinetics*;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus/adverse effects*;Electrocardiography/drug effects;Food-Drug Interactions*;Humans;Male;Oxidation-Reduction;Reference Values;Terfenadine/pharmacokinetics*
9129556;Anti-Allergic Agents/adverse effects;Anti-Asthmatic Agents/adverse effects;Citrus*;Food-Drug Interactions*;Humans;Pharmacology;Societies;Terfenadine/adverse effects;Torsades de Pointes/chemically induced;United States;United States Food and Drug Administration
9113437;Absorption;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/urine;Child;Child, Preschool;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Naproxen/administration & dosage;Naproxen/blood;Naproxen/pharmacokinetics*;Naproxen/urine;Tissue Distribution
9112140;Clinical Trials, Phase I as Topic/methods*;Clinical Trials, Phase I as Topic/standards;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Hemodynamics/drug effects;Hemodynamics/physiology*;Homeostasis;Humans;Pharmacokinetics*;Pharmacology, Clinical*/methods;Pharmacology, Clinical*/standards;Reproducibility of Results;Risk Assessment;Therapeutic Equivalency;Volunteers
9075501;Anticoagulants/antagonists & inhibitors*;Food, Fortified;Food-Drug Interactions*;Humans;Male;Middle Aged;Panax*;Plant Extracts/pharmacology;Plants, Medicinal*;Warfarin/antagonists & inhibitors*
9144013;Aged;Aged, 80 and over;Animals;Female;Food-Drug Interactions*;Histamine/poisoning*;Humans;Isoniazid/administration & dosage;Isoniazid/adverse effects*;Tuberculosis, Lymph Node/drug therapy*;Tuna*
9105546;Administration, Oral;Animals;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Autoradiography;Biotransformation;Dioxolanes/administration & dosage;Dioxolanes/blood;Dioxolanes/pharmacokinetics*;Dogs;Female;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Injections, Intravenous;Intestinal Absorption;Macaca fascicularis;Male;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Quinolones/administration & dosage;Quinolones/blood;Quinolones/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Sex Characteristics;Tissue Distribution
9082033;16,16-Dimethylprostaglandin E2/administration & dosage;16,16-Dimethylprostaglandin E2/pharmacology*;Absorption;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Chromium/pharmacokinetics*;Chromium/urine;Chromium Radioisotopes;Enteral Nutrition;Epoprostenol/administration & dosage;Epoprostenol/pharmacology*;Food-Drug Interactions;Indomethacin/administration & dosage;Indomethacin/pharmacology*;Injections, Intraperitoneal;Male;Misoprostol/administration & dosage;Misoprostol/pharmacology*;Random Allocation;Rats;Rats, Sprague-Dawley;Tissue Distribution
9050793;Bile/metabolism;Biological Availability;Clinical Trials as Topic;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions/physiology*;Gastrointestinal Transit/drug effects;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Lymphatic System/metabolism;Permeability;Pharmaceutical Preparations/metabolism*;Postprandial Period;Stomach/drug effects*;Stomach/metabolism
9095977;Drug Therapy/methods*;Enteral Nutrition;Food-Drug Interactions;Humans;Intestinal Absorption
9043563;Adult;Drug Administration Schedule;Drug Labeling*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Nurses;Nutritional Status/drug effects;Patient Education as Topic;Pharmacists;Pharmacy Service, Hospital;Pilot Projects;Surveys and Questionnaires
10423596;Adult;Area Under Curve;Biological Availability;Butyrophenones/administration & dosage;Butyrophenones/adverse effects;Butyrophenones/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Food-Drug Interactions;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Tablets
9552426;Calorimetry, Differential Scanning;Cellulose/chemistry;Chemistry, Pharmaceutical;Chlorpheniramine/administration & dosage;Delayed-Action Preparations*;Dietary Fats;Elasticity;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/administration & dosage;Microscopy, Electron, Scanning;Peanut Oil;Plant Oils;Solubility;Spectrophotometry, Ultraviolet
9162174;Asthma/chemically induced;Asthma/immunology;Asthma/pathology;Benzoates/adverse effects*;Child;Child, Preschool;Drug Compounding;Drug Eruptions/etiology;Drug Eruptions/immunology;Drug Eruptions/pathology;Drug Hypersensitivity/epidemiology;Drug Hypersensitivity/etiology*;Drug Hypersensitivity/immunology;Drug Hypersensitivity/pathology;Eczema/chemically induced;Eczema/immunology;Eczema/pathology;Female;Food Hypersensitivity/epidemiology;Food Hypersensitivity/etiology*;Food Hypersensitivity/immunology;Food Hypersensitivity/pathology;Food Preservatives/adverse effects*;Food-Drug Interactions;Humans;Hypersensitivity, Immediate/genetics;Infant;Male;Radioallergosorbent Test;Skin Tests;Urticaria/chemically induced;Urticaria/immunology;Urticaria/pathology
9147710;Adult;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/blood;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Food-Drug Interactions/physiology*;Half-Life;Humans;Spectrophotometry, Ultraviolet;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
9062858;Analysis of Variance;Chlorhexidine/adverse effects;Chlorhexidine/chemistry;Chlorhexidine/pharmacology*;Coffee/adverse effects*;Food-Drug Interactions*;Humans;Saliva;Spectrophotometry, Ultraviolet;Tea/adverse effects*;Tooth Discoloration/chemically induced*
9062853;Anti-Infective Agents, Local/chemistry;Anti-Infective Agents, Local/pharmacology*;Bacteria, Anaerobic/drug effects*;Food-Drug Interactions*;Gels;Microbial Sensitivity Tests;Tea*/adverse effects;Tea*/chemistry;Tin Fluorides/adverse effects;Tin Fluorides/chemistry;Tin Fluorides/pharmacology*;Tin Polyphosphates/chemistry;Tin Polyphosphates/pharmacology;Tooth Discoloration/chemically induced*;Toothpastes
9022564;Acute Kidney Injury/chemically induced;Aminoglycosides;Amphotericin B/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Animals;Anti-Bacterial Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Antihypertensive Agents/pharmacology;Antihypertensive Agents/therapeutic use;Cisplatin/adverse effects;Contrast Media/adverse effects;Diet, Sodium-Restricted/adverse effects*;Food-Drug Interactions*;Humans;Hypertension/therapy*;Immunosuppressive Agents/adverse effects;Renal Circulation/drug effects
9480647;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects;Bacteriophages/drug effects;Dietary Fiber/pharmacology;Drug Antagonism;Food-Drug Interactions;Pectins/pharmacology*;Penicillinase/metabolism*;Penicillins/pharmacology*;Plant Proteins/pharmacology;Soybean Proteins/pharmacology
9433652;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Diet;Drug Interactions;Famotidine/pharmacology*;Fasting;Fluoroquinolones*;Food-Drug Interactions*;Gastric Acid*;Histamine H2 Antagonists/pharmacology*;Humans;Male;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Quinolones/administration & dosage;Quinolones/blood;Quinolones/pharmacokinetics*
9342171;Animals;Beverages;Binding Sites;Cimetidine/metabolism;Citrus;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Ethinyl Estradiol/metabolism;Food-Drug Interactions;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*;Terfenadine/metabolism
9248388;Food-Drug Interactions*;Humans;Risk Factors
9112062;Adult;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Delayed-Action Preparations;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Hypertension/drug therapy;Hypertension/physiopathology;Male;Middle Aged;Models, Biological;Nisoldipine/administration & dosage;Nisoldipine/pharmacokinetics*;Nisoldipine/pharmacology*
9068936;1-Naphthylamine/administration & dosage;1-Naphthylamine/analogs & derivatives*;1-Naphthylamine/pharmacokinetics;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Middle Aged;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline
9049582;Administration, Oral;Adult;Cholesterol/blood*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Single-Blind Method;Sterol O-Acyltransferase/antagonists & inhibitors*;Sterol O-Acyltransferase/blood*
8996854;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/chemistry;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
8988067;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Acetaminophen/urine;Administration, Oral;Adult;Anticarcinogenic Agents/metabolism;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Isothiocyanates/metabolism;Lung Neoplasms/metabolism;Lung Neoplasms/prevention & control;Male;Middle Aged;Oxidation-Reduction;Reference Values;Vegetables*
8971430;Adult;Area Under Curve;Biological Availability;Bumetanide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Diuretics/pharmacokinetics*;Food-Drug Interactions*;Furosemide/pharmacokinetics*;Humans;Intestinal Absorption;Male
9074912;Aged;Antiparkinson Agents/therapeutic use*;Blood Pressure/drug effects;Brain Chemistry/drug effects*;Bromocriptine/therapeutic use*;Double-Blind Method;Female;Food-Drug Interactions;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Levodopa/therapeutic use*;Lisuride/therapeutic use*;Male;Middle Aged;Parkinson Disease/drug therapy*;Parkinson Disease/physiopathology;Tilt-Table Test
8947993;Adult;Analgesics/administration & dosage*;Analgesics/pharmacokinetics*;Animals;Benzophenones/administration & dosage*;Benzophenones/pharmacokinetics*;Biological Availability;Bromobenzenes/administration & dosage*;Bromobenzenes/pharmacokinetics*;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Mice;Models, Biological;Pain/drug therapy*;Randomized Controlled Trials as Topic;Retrospective Studies
8947977;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects*;Caffeine/pharmacokinetics*;Caffeine/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male
8947972;Anticoagulants/blood;Anticoagulants/therapeutic use*;Drug Antagonism;Drug Resistance;Food-Drug Interactions;Humans;Thrombosis/drug therapy;Treatment Refusal;Vitamin K/pharmacology;Warfarin/blood;Warfarin/therapeutic use*
8906150;Dietetics/standards*;Food Service, Hospital/standards*;Food-Drug Interactions;Guidelines as Topic;Humans;Joint Commission on Accreditation of Healthcare Organizations*;Nutrition Assessment;Patient Education as Topic/standards;United States
8906141;Animals;Food-Drug Interactions;Humans;Immune System/physiology*;Nutrition Disorders/immunology*;Nutritional Physiological Phenomena*
8932097;Computer-Assisted Instruction/methods*;Drug Therapy/methods*;Food-Drug Interactions*;Humans;Patient Care Team;Patient Education as Topic/methods*
8930779;Adult;Analysis of Variance;Biological Availability;Chromatography;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Ephedrine/administration & dosage;Ephedrine/adverse effects;Ephedrine/blood;Ephedrine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/administration & dosage;Loratadine/adverse effects;Loratadine/blood;Loratadine/pharmacokinetics*;Male;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/adverse effects;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
8930778;Adult;Biological Availability;Clemastine/administration & dosage;Clemastine/blood;Clemastine/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Combinations;Drug Therapy, Combination;Food-Drug Interactions;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Phenylpropanolamine/administration & dosage;Phenylpropanolamine/blood;Phenylpropanolamine/pharmacokinetics*;Radioimmunoassay;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
8930774;Adolescent;Adult;Analysis of Variance;Anticonvulsants/administration & dosage;Anticonvulsants/analysis;Anticonvulsants/pharmacokinetics*;Biological Availability;Chromatography, Gas;Double-Blind Method;Food-Drug Interactions*;Fructose/administration & dosage;Fructose/analogs & derivatives*;Fructose/analysis;Fructose/pharmacokinetics;Humans;Linear Models;Male;Metabolic Clearance Rate
8859044;Adult;Beverages*;Citrus*;Cyclosporine/administration & dosage*;Food-Drug Interactions;Humans;Male;Middle Aged;Psoriasis/drug therapy*
8889900;Adult;Area Under Curve;Drug Interactions;Female;Food*;Food Analysis;Food-Drug Interactions;Humans;Isotretinoin/pharmacokinetics;Keratolytic Agents/pharmacokinetics*;Metabolic Clearance Rate;Retinoids/blood;Retinoids/pharmacokinetics*;Tretinoin/pharmacokinetics;Vitamin A/administration & dosage*;Vitamin A/analysis
8888098;Deamino Arginine Vasopressin/adverse effects*;Food-Drug Interactions;Humans;Renal Agents/adverse effects*;Water Intoxication/etiology*
9070019;Anticonvulsants/administration & dosage*;Anticonvulsants/pharmacokinetics;Enteral Nutrition*;Food-Drug Interactions;Humans;Phenytoin/administration & dosage*;Phenytoin/pharmacokinetics;Research Design;Time Factors
8881693;Dermatitis, Phototoxic/pathology*;Female;Food-Drug Interactions;Humans;Middle Aged;PUVA Therapy/adverse effects*;Vegetables/adverse effects*
8866042;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Vegetarian;Flurbiprofen/administration & dosage;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Humans;Ibuprofen/administration & dosage;Ibuprofen/pharmacokinetics*;Male
8866038;Administration, Oral;Adult;Area Under Curve;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Excipients;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Middle Aged;Nicardipine/administration & dosage;Nicardipine/pharmacokinetics*;Tablets;Therapeutic Equivalency
11363607;Anti-Infective Agents/administration & dosage*;Antiviral Agents/administration & dosage*;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage*;Humans
8980916;Biological Availability;Diet;Food*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology*;Micronutrients;Nutrition Disorders;Pharmaceutical Preparations/metabolism*
8927634;Animals;Drug Interactions*;Food-Drug Interactions*;Humans;Pharmacokinetics*
8844449;Absorption;Adult;Analysis of Variance;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions;Humans;Lactones/pharmacology*;Male;Middle Aged;Phenytoin/blood;Phenytoin/pharmacokinetics*
8842054;Administration, Oral;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Eating;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged;Nadolol/pharmacokinetics*;Therapeutic Equivalency
8812227;Acetonitriles/pharmacokinetics*;Animals;Cyanides/blood*;Dietary Proteins/administration & dosage*;Food-Drug Interactions*;Inactivation, Metabolic;Male;Rats;Rats, Sprague-Dawley
8665000;Adrenergic alpha-Antagonists/therapeutic use*;Beverages*;Blood Pressure/drug effects*;Calcium Channel Blockers/therapeutic use*;Citrus*;Food-Drug Interactions;Humans;Hypertension, Renovascular/drug therapy*;Male;Middle Aged;Nifedipine/therapeutic use*;Prazosin/analogs & derivatives*;Prazosin/therapeutic use
8818844;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Azithromycin/administration & dosage;Azithromycin/pharmacokinetics*;Biological Availability;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Powders;Suspensions;Tablets
8799515;Administration, Oral;Aged;Aluminum Hydroxide/pharmacology*;Antacids/pharmacology*;Area Under Curve;Arthritis, Rheumatoid/blood;Arthritis, Rheumatoid/drug therapy;Arthritis, Rheumatoid/metabolism*;Cross-Over Studies;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male;Middle Aged;Mycophenolic Acid/administration & dosage;Mycophenolic Acid/analogs & derivatives*;Mycophenolic Acid/blood;Mycophenolic Acid/pharmacokinetics
8735684;Adolescent;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Middle Aged;Morphine/blood;Morphine/pharmacokinetics*;Narcotics/blood;Narcotics/pharmacokinetics*;Tablets
8726601;Adult;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Antifungal Agents/urine;Cross-Over Studies;Dextrins/administration & dosage*;Dosage Forms;Drug Delivery Systems;Female;Food-Drug Interactions*;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Itraconazole/urine;Male;Middle Aged
8711315;Anticoagulants/therapeutic use*;Food-Drug Interactions*;Humans;Nutritional Sciences/education*;Patient Discharge*;Vitamin K/pharmacology*;Warfarin/therapeutic use*
8616441;Acne Vulgaris/drug therapy*;Adult;Anti-Bacterial Agents/therapeutic use*;Biological Availability;Food-Drug Interactions*;Humans;Minocycline/therapeutic use*
8901078;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Male;Middle Aged;Nausea/chemically induced;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*
8728348;Adolescent;Adult;Aged;Beverages*;Biological Availability;Citrus*;Cohort Studies;Electroencephalography/drug effects;Female;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Phenotype;Prospective Studies;Terfenadine/blood;Terfenadine/pharmacokinetics*
8713690;Animals;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
8851570;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Atovaquone;Biological Availability;Food-Drug Interactions;HIV Seropositivity/metabolism*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Suspensions
8786524;Animals;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena*;Pharmaceutical Preparations*
8693949;Alcoholic Beverages;Beverages;Diet*;Food-Drug Interactions*;Humans;Hypertension/chemically induced*;Mental Disorders/drug therapy;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/metabolism
8617704;Acute Disease;Animals;Beer;Cheese/adverse effects;Depressive Disorder/drug therapy;Diet/adverse effects*;Fishes;Food-Drug Interactions*;Fruit;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Meat;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Poultry;Tyramine/adverse effects;Vegetables
8700059;Algorithms*;Decision Trees*;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Nursing Assessment;Phenytoin/adverse effects*
8920203;Biological Availability;Drug Interactions;Food-Drug Interactions*;Intestinal Absorption/drug effects*
8858282;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Postprandial Period;Stereoisomerism;Thioctic Acid/blood;Thioctic Acid/pharmacokinetics*
8858279;Adult;Beverages*;Citrus*;Cross-Over Studies;Double-Blind Method;Erythromycin/pharmacology;Female;Food-Drug Interactions;Humans;Hypnotics and Sedatives/pharmacology*;Male;Midazolam/blood;Midazolam/pharmacology*;Psychomotor Performance/drug effects*;Triazolam/pharmacology*
8857073;Adult;Analysis of Variance;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Design;Drug Hypersensitivity/drug therapy;Drug Packaging;Food-Drug Interactions;Histamine/pharmacology;Humans;Male;Middle Aged
8857072;Adrenergic Agents/pharmacology*;Adult;Analysis of Variance;Benzamides/adverse effects;Benzamides/therapeutic use*;Blood Pressure/drug effects;Double-Blind Method;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Injections, Intravenous;Male;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Selegiline/adverse effects;Selegiline/therapeutic use*;Tyramine/pharmacology*
8803526;Administration, Oral;Adult;Analysis of Variance;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Propafenone/analogs & derivatives*;Propafenone/blood;Propafenone/pharmacokinetics
8803525;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;Adult;Bridged Bicyclo Compounds/pharmacokinetics*;Bridged Bicyclo Compounds/pharmacology;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/pharmacology;Food-Drug Interactions*;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/pharmacology;Prostaglandin Antagonists/pharmacokinetics*;Prostaglandin Endoperoxides, Synthetic/antagonists & inhibitors;Thromboxane A2/analogs & derivatives;Thromboxane A2/antagonists & inhibitors;Vasoconstrictor Agents/antagonists & inhibitors
8737764;Anticoagulants/pharmacokinetics*;Antioxidants/analysis;Beverages*;Chromatography, High Pressure Liquid;Citrus*;Coumarins/pharmacokinetics*;Coumarins/urine;Flavanones*;Flavonoids/analysis;Fluorescence;Food-Drug Interactions*;Humans;Male;Umbelliferones/urine
8737763;Adult;Area Under Curve;Biological Availability;Cholinergic Antagonists/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Female;Food*;Food-Drug Interactions*;Half-Life;Humans;Male;Mandelic Acids/pharmacokinetics*
8729584;Adult;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use;Drug Interactions;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/therapeutic use;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Sex Factors;Time Factors
8707145;Caffeine/adverse effects*;Food-Drug Interactions*;Humans;Nicotine/adverse effects*;Nursing Assessment
8685023;Child Nutritional Physiological Phenomena*;Child, Preschool;Diet*;Digestion;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Infant;Infant Food*;Infant, Newborn;Intestinal Absorption;Male;Pharmacokinetics
8603792;Animals;Anisoles/pharmacology;Antimutagenic Agents/pharmacology*;Antioxidants/pharmacology;Bone Marrow/drug effects;Caffeic Acids/pharmacology;Carotenoids/pharmacology;Chlorogenic Acid/pharmacology;Coffee*/metabolism;Coumaric Acids/pharmacology;Curcumin/pharmacology;DNA Damage*/drug effects;Diet*;Ellagic Acid/pharmacology;Eugenol/pharmacology;Flavoring Agents/pharmacology;Food-Drug Interactions*;Male;Mice;Micronucleus Tests;Mutagens/toxicity;Vitamin E/pharmacology;beta Carotene
8603789;Animals;Coffee*/metabolism;Cyclophosphamide/toxicity;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drosophila melanogaster;Female;Food-Drug Interactions;Male;Mitomycin/toxicity;Mitosis*/drug effects;Mutagens/toxicity*;Mutation*/drug effects;Recombination, Genetic*/drug effects;Urethane/toxicity
8592993;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Biotransformation;Blood Proteins/metabolism;Creatinine/blood;Creatinine/urine;Feces/chemistry;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Probenecid/pharmacology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Renal Agents/pharmacology;Saliva/metabolism
8564609;Angiotensin-Converting Enzyme Inhibitors/chemistry*;Beverages*;Drug Stability;Drug Storage;Food-Drug Interactions;Fruit/chemistry*;Polyethylene Terephthalates;Ramipril/chemistry*;Solutions;Time Factors;Water/chemistry*
10151952;CD-ROM;Clinical Pharmacy Information Systems/standards*;Computer Graphics;Costs and Cost Analysis;Drug Interactions*;Evaluation Studies as Topic;Food-Drug Interactions;Humans;Microcomputers*;Software/economics;Software/standards*;United States;User-Computer Interface
8587159;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/pharmacology;Biological Availability;Dogs/metabolism*;Dogs/microbiology;Eating/physiology*;Erythromycin/administration & dosage;Erythromycin/blood;Erythromycin/pharmacokinetics;Erythromycin/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions;Gram-Positive Bacteria/drug effects;Intestinal Absorption;Male;Microbial Sensitivity Tests/veterinary;Roxithromycin/administration & dosage;Roxithromycin/blood;Roxithromycin/pharmacokinetics*;Roxithromycin/pharmacology
8587148;Albendazole/administration & dosage;Albendazole/analysis*;Animals;Anthelmintics/administration & dosage;Anthelmintics/analysis*;Diet;Drug Residues/analysis;Drug Residues/standards*;Eating;Food-Drug Interactions;Guidelines as Topic;Humans;International Cooperation;Ivermectin/administration & dosage;Ivermectin/analysis*;Meat Products/analysis;Meat Products/standards*;Therapeutic Equivalency;World Health Organization
8584285;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics;Drug Interactions;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics;Intestinal Absorption;Nutritional Status*;Pharmacokinetics
8568017;Administration, Oral;Adult;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Enzyme Inhibitors/pharmacokinetics*;Fasting/blood;Female;Food-Drug Interactions*;Heptanoic Acids/blood;Heptanoic Acids/pharmacokinetics*;Humans;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Male;Middle Aged;Pyrroles/blood;Pyrroles/pharmacokinetics*
8549555;Dietary Fiber/analysis;Dietary Fiber/metabolism*;Food Handling/methods*;Food-Drug Interactions*;Humans;Nutritive Value
8549508;Dietary Fiber/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Kidney/metabolism;Liver/metabolism;Metabolic Clearance Rate;Tissue Distribution
7573208;Adolescent;Adult;Aged;Aged, 80 and over;Child;Child, Preschool;Drug Hypersensitivity/etiology;Drug Therapy*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Patient Education as Topic;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism;Risk
7572551;Asthma/blood;Asthma/drug therapy;Bronchodilator Agents/administration & dosage*;Bronchodilator Agents/pharmacokinetics;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Fasting;Food-Drug Interactions;Humans;Theophylline/administration & dosage*;Theophylline/pharmacokinetics
8577211;Adult;Aged;Analysis of Variance;Biological Availability;Diabetes Mellitus/drug therapy;Diabetes Mellitus/metabolism*;Diet;Eating*;Fasting;Female;Food-Drug Interactions*;Humans;Hypoglycemic Agents/metabolism;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Metformin/therapeutic use;Middle Aged;Therapeutic Equivalency
7496046;Alanine/pharmacokinetics;Alkaline Phosphatase/metabolism;Biological Transport/drug effects;Calcium/pharmacokinetics;Choline/pharmacokinetics;Female;Food-Drug Interactions;Humans;Liposomes/metabolism;Microvilli/metabolism;Nutritive Value;Pharmacology/methods*;Placenta/metabolism*;Placenta/ultrastructure*;Pregnancy;Reproducibility of Results;Tritium
7630329;Beverages*;Caffeine/pharmacokinetics;Citrus*;Cyclosporine/pharmacokinetics;Estrogens/pharmacokinetics;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans;Midazolam/pharmacokinetics;Nifedipine/pharmacokinetics;Terfenadine/pharmacokinetics
8562295;Adult;Analysis of Variance;Beverages;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Cross-Over Studies;Delayed-Action Preparations;European Continental Ancestry Group;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/metabolism;Felodipine/pharmacokinetics*;Food-Drug Interactions;Humans;Linear Models;Male;Reproducibility of Results
7648762;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Female;Food-Drug Interactions;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Reference Values;Sleep Stages/drug effects;Triazolam/administration & dosage;Triazolam/blood;Triazolam/pharmacokinetics*;Triazolam/pharmacology
7493544;Adrenergic beta-Antagonists/pharmacokinetics*;Amino Acids/pharmacology*;Animals;Biological Availability;Biotransformation;Dietary Proteins/pharmacology;Dose-Response Relationship, Drug;Food-Drug Interactions*;In Vitro Techniques;Liver/drug effects;Liver/metabolism*;Male;Propranolol/pharmacokinetics*;Rats;Rats, Sprague-Dawley
7473485;Administration, Oral;Adolescent;Antirheumatic Agents/administration & dosage;Antirheumatic Agents/blood;Antirheumatic Agents/pharmacokinetics*;Arthritis, Juvenile/drug therapy*;Biological Availability;Child;Child, Preschool;Fasting*;Female;Food*;Food-Drug Interactions;Humans;Male;Methotrexate/administration & dosage;Methotrexate/blood;Methotrexate/pharmacokinetics*
8751044;Adult;Beverages;Citrus*;Estradiol/metabolism*;Estriol/antagonists & inhibitors;Estriol/metabolism;Estrogen Antagonists/pharmacology*;Estrone/antagonists & inhibitors;Estrone/metabolism;Flavanones*;Flavonoids/pharmacology*;Food-Drug Interactions;Humans;In Vitro Techniques;Kaempferols*;Male;Microsomes, Liver/metabolism*;Middle Aged;Quercetin/analogs & derivatives*;Quercetin/pharmacology*
8751037;Animals;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Bronchodilator Agents/urine;Capsicum*;Food-Drug Interactions;Male;Plants, Medicinal*;Rabbits;Theophylline/blood;Theophylline/pharmacokinetics*;Theophylline/urine
8580149;Administration, Oral;Animals;Biological Availability;Biotransformation;Blood Proteins/metabolism;Chromatography, High Pressure Liquid;Doping in Sports;Fasting/metabolism;Female;Fenoprofen/pharmacokinetics*;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Horses/metabolism*;Hydrogen-Ion Concentration;Hydrolysis;Indicators and Reagents;Protein Binding;Temperature;Time Factors
8520091;Anticonvulsants/pharmacokinetics;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Clinical Trials as Topic;Epilepsy/drug therapy;Folic Acid/pharmacology*;Folic Acid Deficiency/drug therapy;Food, Fortified;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics;Phenytoin/pharmacology*;Phenytoin/therapeutic use
7628179;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Midazolam/metabolism;Midazolam/pharmacokinetics*;Midazolam/pharmacology*
7592095;Animals;Cattle;Cattle Diseases/physiopathology*;Cholesterol/blood;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Drug Implants;Estrus/physiology;Female;Food-Drug Interactions;Growth Hormone/blood;Insulin/blood;Luteal Phase/drug effects;Luteal Phase/physiology*;Nutrition Disorders/physiopathology;Nutrition Disorders/veterinary*;Ovulation/physiology*;Ovulation Induction/veterinary;Postpartum Period/physiology;Pregnenediones/administration & dosage;Pregnenediones/pharmacology;Progesterone Congeners/administration & dosage;Progesterone Congeners/pharmacology;Random Allocation
7581255;Animals;Biological Availability;Chemical Phenomena;Chemistry, Physical;Cholinergic Antagonists/pharmacology;Delayed-Action Preparations;Dogs;Drug Interactions;Food-Drug Interactions;Hardness Tests;Histamine H1 Antagonists/administration & dosage*;Histamine H1 Antagonists/pharmacokinetics*;In Vitro Techniques;Male;Niacinamide/administration & dosage;Niacinamide/analogs & derivatives*;Niacinamide/pharmacokinetics;Solubility;Tablets;Waxes
7560252;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Drug Tolerance;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Isoxazoles/administration & dosage;Isoxazoles/adverse effects;Isoxazoles/pharmacokinetics*;Male;Metabolic Clearance Rate;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Time Factors
7651978;Biological Availability;Food-Drug Interactions*;Pectins/chemistry;Pectins/pharmacology*;Permeability;Propranolol/pharmacokinetics*;Structure-Activity Relationship;Viscosity
7582380;Absorption;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Beverages*;Biotransformation;Chemical Fractionation;Chromatography, High Pressure Liquid;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP1A2;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Flavanones*;Flavonoids/pharmacokinetics;Flavonoids/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases/metabolism;Reference Values;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
7550125;Clarithromycin/chemistry;Clarithromycin/pharmacokinetics;Food-Drug Interactions;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Models, Biological;Pharmacokinetics*;Solubility
7722194;Administration, Oral;Alcoholic Beverages/adverse effects;Allium;Anticoagulants/administration & dosage;Anticoagulants/pharmacology*;Beverages;Caffeine/pharmacology;Coumarins/administration & dosage;Coumarins/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Peptide Hydrolases/administration & dosage;Peptide Hydrolases/pharmacology;Silicones/administration & dosage;Silicones/pharmacology;Vitamin K/administration & dosage;Vitamin K/pharmacology;Vitamins/administration & dosage;Vitamins/pharmacology
7722187;Adult;Aged;Bumetanide/adverse effects;Bumetanide/therapeutic use*;Cross-Sectional Studies;Diet Records;Female;Food-Drug Interactions;Furosemide/adverse effects;Furosemide/therapeutic use*;Heart Failure/complications;Heart Failure/drug therapy*;Heart Failure/physiopathology;Humans;Male;Middle Aged;Prevalence;Risk Factors;Thiamine/administration & dosage;Thiamine Deficiency/chemically induced;Thiamine Deficiency/epidemiology*;Thiamine Deficiency/etiology;Ventricular Function, Left
7669261;Absorption;Anti-Infective Agents/pharmacokinetics*;Chelating Agents/pharmacology;Drug Interactions;Fluoroquinolones;Food-Drug Interactions;Humans
7661453;Allopurinol/pharmacology*;Ammonia/urine*;Animals;Diet, Protein-Restricted/veterinary;Dietary Proteins/pharmacology*;Dogs/urine*;Female;Food-Drug Interactions;Uric Acid/blood;Uric Acid/urine*;Urinary Calculi/therapy;Urinary Calculi/veterinary;Xanthines/blood;Xanthines/urine*
7659846;Amikacin/metabolism;Ampicillin/metabolism;Animals;Anti-Bacterial Agents/metabolism*;Cecum/metabolism*;Food-Drug Interactions*;Gastrointestinal Contents;Horses/metabolism*;Hydrogen-Ion Concentration;In Vitro Techniques;Oxytetracycline/metabolism;Penicillin G/metabolism;Time Factors
7659841;Animals;Biological Availability;Digoxin/blood;Digoxin/pharmacokinetics*;Dogs/metabolism*;Dose-Response Relationship, Drug;Eating;Female;Food-Drug Interactions;Male;Tablets
7657851;Adult;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics;Cross-Over Studies;Diet, Atherogenic;Food*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Prodrugs/pharmacokinetics*;Time Factors
7621642;Adult;Extremities/blood supply*;Fasting/metabolism;Female;Food-Drug Interactions*;Forearm/blood supply;Humans;Leg/blood supply;Male;Plethysmography*;Regional Blood Flow/physiology
7585849;Adult;Anti-Ulcer Agents/pharmacology*;Chronic Disease;Dietary Fats/pharmacology;Feces/chemistry;Food-Drug Interactions;Gastric Acid/metabolism*;Humans;Hydrogen-Ion Concentration;Intestine, Small/drug effects;Intestine, Small/metabolism*;Lipid Metabolism;Middle Aged;Omeprazole/pharmacology*;Pancreatitis/blood;Pancreatitis/complications;Pancreatitis/metabolism*;Proton Pump Inhibitors
7634121;Biological Availability;Carbohydrates/pharmacology*;Ciprofloxacin/pharmacokinetics*;Dietary Sucrose*;Food, Formulated*;Food-Drug Interactions*;Humans;Intestinal Absorption;Ofloxacin/pharmacokinetics*
8681219;Adolescent;Adult;Age Factors;Child;Child, Preschool;Drug Therapy/classification;Drug Therapy/methods;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Infant;Infant, Newborn
7790687;Education, Medical;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Internship and Residency*;Patient Education as Topic;Physician's Role;Physicians, Family/education*
7790684;Education, Medical*;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena
7709893;Absorption;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage;Pharmacokinetics
7776769;Depression/drug therapy;Drug Interactions;Food-Drug Interactions;Humans;Mental Disorders/drug therapy;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*
7884114;Aged;Calcium, Dietary/pharmacokinetics*;Cross-Over Studies;Female;Food, Fortified*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Middle Aged;Postmenopause;Psyllium/pharmacology*
7860949;Adult;Cross-Over Studies;Drug Interactions;Female;Folic Acid/administration & dosage;Folic Acid/blood;Folic Acid/pharmacology*;Food-Drug Interactions;Humans;Phenytoin/blood;Phenytoin/pharmacokinetics*
7860942;Aged;Aged, 80 and over;Algorithms;Biological Availability;Data Collection/methods;Eating;Female;Follow-Up Studies;Food Services/standards*;Food-Drug Interactions*;Humans;Hyperkalemia/epidemiology;Hyperkalemia/etiology;Hypokalemia/epidemiology;Hypokalemia/etiology;Incidence;Intermediate Care Facilities*;Male;Medical Records;New York;Nutritional Status;Retrospective Studies;Skilled Nursing Facilities*;Time Factors
7697949;Adult;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Kidney Transplantation*;Male;Prednisolone/pharmacokinetics;Prednisone/pharmacokinetics*
7627861;Acetaminophen/blood;Adult;Blood Glucose/metabolism;Duodenum/physiology;Eating/physiology*;Food-Drug Interactions;Gastric Emptying/physiology*;Gastrins/blood;Gastrointestinal Motility/physiology*;Humans;Male;Manometry;Myoelectric Complex, Migrating/physiology*;Pyloric Antrum/physiology
7608314;Adolescent;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Diet, Atherogenic;Drug Administration Schedule;Ephedrine/administration & dosage*;Ephedrine/blood;Ephedrine/pharmacokinetics;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Therapeutic Equivalency
7769577;Food-Drug Interactions*;Humans;Inservice Training;Patient Education as Topic*;Psychiatric Nursing/education;Psychotropic Drugs/administration & dosage;Psychotropic Drugs/adverse effects*
7751427;Adult;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Drugs, Generic/administration & dosage;Drugs, Generic/pharmacokinetics*;Fasting/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Tablets;Therapeutic Equivalency;Verapamil/administration & dosage;Verapamil/analogs & derivatives;Verapamil/pharmacokinetics*
7751425;Administration, Oral;Adult;Biological Availability;Delayed-Action Preparations;Food-Drug Interactions*;Gastric Emptying;Humans;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/pharmacokinetics;Male;Monitoring, Physiologic
7742206;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Food-Drug Interactions*;Humans
7742162;Adult;Animals;Cross-Over Studies;Enoxacin/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/physiology;Male;Milk/physiology*
7738788;Administration, Oral;Aminoquinolines/administration & dosage;Aminoquinolines/pharmacokinetics*;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Biological Availability;Dogs;Food-Drug Interactions*;Half-Life;Sesame Oil/pharmacology*;Sterol O-Acyltransferase/antagonists & inhibitors*
7723291;Administration, Oral;Ampicillin/administration & dosage;Ampicillin/blood;Ampicillin/pharmacokinetics*;Animal Feed;Animals;Biological Availability;Dogs;Eating*;Fasting;Female;Food-Drug Interactions*;Male;Time Factors
8845456;Absorption;Anti-Bacterial Agents/pharmacokinetics;Anticoagulants/pharmacokinetics;Antidepressive Agents/pharmacokinetics;Antiparkinson Agents/pharmacokinetics;Antiviral Agents/pharmacokinetics;Biological Availability;Delayed-Action Preparations/pharmacokinetics;Diphosphonates/pharmacokinetics;Food-Drug Interactions*;Humans
8845455;Antidepressive Agents/administration & dosage;Antidepressive Agents/pharmacology;Antidepressive Agents/therapeutic use*;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/pharmacology;Antidepressive Agents, Tricyclic/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacology;Serotonin Uptake Inhibitors/therapeutic use
8620672;Absorption;Adult;Analysis of Variance;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Eating/physiology*;Fasting/physiology;Food-Drug Interactions*;Humans;Hydroxyurea/administration & dosage;Hydroxyurea/analogs & derivatives*;Hydroxyurea/blood;Hydroxyurea/pharmacokinetics;Lipoxygenase Inhibitors/administration & dosage;Lipoxygenase Inhibitors/blood;Lipoxygenase Inhibitors/pharmacokinetics*;Male;Reproducibility of Results
8549357;Animals;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Female;Fleroxacin/blood;Fleroxacin/pharmacokinetics*;Food-Drug Interactions;Humans;Male;Milk*
8549353;Adult;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Cross-Over Studies;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Oxazines/blood;Oxazines/pharmacokinetics*;Saliva/metabolism
7777652;Adolescent;Adrenocorticotropic Hormone/blood*;Adult;Corticotropin-Releasing Hormone/blood*;Delta Sleep-Inducing Peptide/administration & dosage;Delta Sleep-Inducing Peptide/pharmacology*;Electroencephalography/drug effects;Food-Drug Interactions;Humans;Hydrocortisone/blood*;Infusions, Intravenous;Male
7547087;Adult;Aluminum Hydroxide/pharmacology*;Analysis of Variance;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Cross-Over Studies;Drug Combinations;Drug Interactions;Fasting;Food-Drug Interactions;Humans;Indoles/blood;Indoles/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male
19489169;Adult;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use;Drug Interactions;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/therapeutic use;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Sex Factors;Time Factors
7857345;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Immunologic Factors/blood;Immunologic Factors/pharmacokinetics*;Male;Pyrrolidonecarboxylic Acid/adverse effects;Pyrrolidonecarboxylic Acid/analogs & derivatives*;Pyrrolidonecarboxylic Acid/blood;Pyrrolidonecarboxylic Acid/pharmacokinetics;Spectrophotometry, Ultraviolet;Therapeutic Equivalency;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazolidines
7813990;Animals;Beverages*;Citrus*;Food-Drug Interactions*;Liver/drug effects;Liver/metabolism;Male;Oxotremorine/metabolism;Pentobarbital/metabolism*;Pentobarbital/pharmacology;Rats;Rats, Sprague-Dawley;Theophylline/blood;Theophylline/pharmacokinetics*;Tremorine/metabolism*
7727796;Alkalies/metabolism*;Animals;Arginine/analogs & derivatives;Arginine/pharmacology;Bicarbonates/metabolism;Capsaicin/pharmacology;Dogs;Duodenum/drug effects;Duodenum/metabolism*;Food-Drug Interactions;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Meat;Nitric Oxide/antagonists & inhibitors;Nitric Oxide/physiology*;Nitroarginine;Nitroglycerin/pharmacology;Prostaglandin Antagonists/pharmacology;Prostaglandins/pharmacology;Stomach/drug effects;Stomach/metabolism*
7944078;Animals;Clinical Trials as Topic;Drug Interactions*;Food-Drug Interactions*;Humans;Warfarin/pharmacology*
7821234;Administration, Inhalation;Animals;Behavior, Animal;Conditioning, Operant;Food-Drug Interactions*;Male;Mice;Milk*;Trichloroethanes/administration & dosage;Trichloroethanes/pharmacokinetics*
7814718;Animals;Cattle/metabolism*;Cobalt/administration & dosage;Cobalt/pharmacology*;Dietary Fiber*;Digestion/drug effects*;Food-Drug Interactions;In Vitro Techniques;Linear Models;Male
7698084;Aflatoxin B1/metabolism*;Animals;Aryl Hydrocarbon Hydroxylases*;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2A6;Cytochrome P-450 CYP2E1;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Ethanol/metabolism*;Food-Drug Interactions;Humans;Mice;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Mixed Function Oxygenases/metabolism*;Oxidoreductases/metabolism*;Oxidoreductases, N-Demethylating/metabolism*;Plants, Toxic*;Rats;Tobacco/metabolism*;Urethane/metabolism
7858704;Altretamine/blood*;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Humans;Indicators and Reagents;Intestinal Absorption;Ovarian Neoplasms/metabolism
7836549;Aged;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Middle Aged;Tacrine/adverse effects;Tacrine/blood;Tacrine/pharmacokinetics*
7836548;Adolescent;Adult;Biological Availability;Cholestyramine Resin/pharmacology;Chromatography, High Pressure Liquid;Diet, Fat-Restricted;Drug Interactions;Enterohepatic Circulation/drug effects;Enterohepatic Circulation/physiology*;Fasting/metabolism*;Food-Drug Interactions*;Gilbert Disease/metabolism*;Glucuronates/metabolism;Humans;Infusions, Intravenous;Lorazepam/administration & dosage;Lorazepam/pharmacokinetics*;Male;Neomycin/pharmacology
7972311;Adult;Beverages*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/pharmacokinetics*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Spectrophotometry, Ultraviolet
7899804;Adolescent;Adult;Animals;Antimalarials/pharmacokinetics*;Antimalarials/pharmacology;Antimalarials/toxicity*;Artemisinins*;Bridged Bicyclo Compounds/pharmacokinetics*;Bridged Bicyclo Compounds/pharmacology;Bridged Bicyclo Compounds/toxicity*;Bridged Bicyclo Compounds, Heterocyclic*;Food-Drug Interactions;Humans;Male;Middle Aged;Plasmodium falciparum/drug effects;Styrenes/pharmacokinetics*;Styrenes/pharmacology;Styrenes/toxicity*
7899788;Adolescent;Adult;Albendazole/adverse effects;Albendazole/pharmacokinetics*;Albendazole/therapeutic use*;Animals;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Ivermectin/adverse effects;Ivermectin/therapeutic use*;Male;Microfilariae/drug effects;Middle Aged;Onchocerca/drug effects;Onchocerca/embryology;Onchocerca/growth & development;Onchocerciasis/drug therapy*;Onchocerciasis/parasitology
7859239;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Fasting;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/pharmacokinetics*;Therapeutic Equivalency
7937514;Animals;Calorimetry*;Chemistry, Pharmaceutical/instrumentation*;Drug Stability;Excipients;Food-Drug Interactions;Humans
7988627;Adult;Drug Interactions;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Ofloxacin/pharmacokinetics*;Sucralfate/pharmacology*
7984681;Adult;Blood Pressure/drug effects;Diet;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Mexico;Nifedipine/pharmacokinetics*;Nifedipine/pharmacology;Zea mays*
7875640;Adult;Analysis of Variance;Anti-Arrhythmia Agents/pharmacokinetics*;Body Weight/physiology*;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Propylamines/pharmacokinetics*;Pyridines/pharmacokinetics*;Sex Factors
7830228;Aged;Barbados;Female;Food-Drug Interactions*;Geriatric Assessment*;Humans;Male;Medical Audit*;Middle Aged;Prevalence;Risk Factors;Sampling Studies;Sensitivity and Specificity
